{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 93,
   "id": "77071c0a",
   "metadata": {},
   "outputs": [],
   "source": [
    "import networkx as nx\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "import numpy as np\n",
    "import re\n",
    "from tqdm import tqdm\n",
    "# import spacy\n",
    "# import textacy\n",
    "import networkx as nx\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "import pickle as pkl\n",
    "# import stellargraph as sg\n",
    "import tensorflow as tf\n",
    "# from stellargraph.data import BiasedRandomWalk\n",
    "from gensim.models import Word2Vec\n",
    "from sklearn.naive_bayes import GaussianNB\n",
    "from sklearn.tree import DecisionTreeClassifier\n",
    "from sklearn.metrics import accuracy_score, confusion_matrix, ConfusionMatrixDisplay, f1_score\n",
    "from sklearn.model_selection import train_test_split\n",
    "from sklearn.manifold import TSNE\n",
    "from sklearn.decomposition import PCA\n",
    "# from stellargraph import datasets\n",
    "from IPython.display import display, HTML\n",
    "from sklearn.cluster import KMeans\n",
    "from scipy import stats\n",
    "from sklearn.preprocessing import LabelEncoder\n",
    "from sklearn.svm import LinearSVC\n",
    "from scipy import stats\n",
    "from sklearn.metrics import roc_curve, auc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "id": "a7aed9f2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>0</th>\n",
       "      <th>a</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Thyroid_Cancer</td>\n",
       "      <td>Thyroid surgery in  children in a single insti...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Thyroid_Cancer</td>\n",
       "      <td>\" The adopted strategy was the same as that us...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Thyroid_Cancer</td>\n",
       "      <td>coronary arterybypass grafting thrombosis ï¬b...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Thyroid_Cancer</td>\n",
       "      <td>Solitary plasmacytoma SP of the skull is an u...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Thyroid_Cancer</td>\n",
       "      <td>This study aimed to investigate serum matrix ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                0                                                  a\n",
       "0  Thyroid_Cancer  Thyroid surgery in  children in a single insti...\n",
       "1  Thyroid_Cancer  \" The adopted strategy was the same as that us...\n",
       "2  Thyroid_Cancer  coronary arterybypass grafting thrombosis ï¬b...\n",
       "3  Thyroid_Cancer   Solitary plasmacytoma SP of the skull is an u...\n",
       "4  Thyroid_Cancer   This study aimed to investigate serum matrix ..."
      ]
     },
     "execution_count": 101,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df0 = pd.read_csv(\"Data/cancer_dataset.csv\", encoding='latin1', index_col=0)\n",
    "df = df0[\"a\"]\n",
    "df0.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "id": "78ccde96",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "({'Colon_Cancer', 'Lung_Cancer', 'Thyroid_Cancer'}, 7570)"
      ]
     },
     "execution_count": 102,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "set(df0['0']), len(df0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "7c152888",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(2580, 2180, 2810)"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(df0[df0['0'] == 'Colon_Cancer']), len(df0[df0['0'] == 'Lung_Cancer']), len(df0[df0['0'] == 'Thyroid_Cancer'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "cd413201",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{0, 1, 2}"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "label_encoder = LabelEncoder()\n",
    "labels = label_encoder.fit_transform(df0['0'])\n",
    "set(labels)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "5e458c5f",
   "metadata": {},
   "outputs": [],
   "source": [
    "#"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "909890e4",
   "metadata": {},
   "outputs": [],
   "source": [
    "#nlp = spacy.load(\"en_core_web_lg\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "5f3c4ee4",
   "metadata": {},
   "outputs": [],
   "source": [
    "#"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "077c77a1",
   "metadata": {},
   "outputs": [],
   "source": [
    "def draw_graph(G):\n",
    "    plt.figure(figsize=(15,10))\n",
    "\n",
    "    pos = nx.spring_layout(G, k=1)\n",
    "    node_color = \"skyblue\"\n",
    "    edge_color = \"black\"\n",
    "\n",
    "    nx.draw_networkx(G, pos=pos, with_labels=True, node_color=node_color, \n",
    "            edge_color=edge_color, \n",
    "            node_size=2000, connectionstyle='arc3,rad=0.1')\n",
    "\n",
    "    nx.draw_networkx_edge_labels(G, pos=pos, label_pos=0.5, \n",
    "                             edge_labels=nx.get_edge_attributes(G,'relation'),\n",
    "                             font_size=12, font_color='black', alpha=0.6)\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "5f326237",
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(\"Data/graphs.pkl\", \"rb\") as f:\n",
    "    Gs = pkl.load(f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "id": "1d5efa00",
   "metadata": {},
   "outputs": [],
   "source": [
    "G_combined = Gs[0].copy()\n",
    "for G in Gs[1:]:\n",
    "    G_combined.update(G)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "58a43de8",
   "metadata": {},
   "outputs": [],
   "source": [
    "GG = nx.disjoint_union_all(Gs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "00556b43",
   "metadata": {},
   "outputs": [],
   "source": [
    "from pyvis.network import Network\n",
    "\n",
    "net = Network(notebook = True, cdn_resources = \"remote\",\n",
    "                bgcolor = \"#eeeeee\",\n",
    "                #font_color = \"#00FF00\",\n",
    "                height = \"1400px\",\n",
    "                directed=True,\n",
    "                width = \"100%\",\n",
    "                select_menu = True,\n",
    "                filter_menu = True,\n",
    ")\n",
    "\n",
    "net.from_nx(Gs[0])\n",
    "# net.from_nx(GG)\n",
    "\n",
    "for node in net.nodes:\n",
    "    node['shape'] = \"circle\"\n",
    "    node['color'] = \"#00FF00\"\n",
    "\n",
    "\n",
    "html_content = net.generate_html()\n",
    "\n",
    "with open(\"KG_with_menu.html\", \"w\", encoding=\"utf-8\") as file:\n",
    "    file.write(html_content)\n",
    "\n",
    "# net.show_buttons()\n",
    "# net.show(\"KG_with_menu.html\");"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "20aeb632",
   "metadata": {},
   "outputs": [],
   "source": [
    "import matplotlib.font_manager as fm\n",
    "\n",
    "# Print a list of available font families\n",
    "# for font in fm.findSystemFonts(fontpaths=None, fontext='ttf'):\n",
    "#     print(fm.FontProperties(fname=font).get_name())\n",
    "# plt.rcParams['font.family'] = 'DejaVuSans'\n",
    "plt.rcParams['font.family'] = 'sans-serif'\n",
    "plt.rcParams['font.sans-serif'] = ['Arial']\n",
    "\n",
    "# draw_graph(Gs[1])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "216f2c38",
   "metadata": {},
   "outputs": [],
   "source": [
    "degree_dict = dict(G_combined.degree)\n",
    "sorted_nodes_by_degree = sorted(degree_dict.items(), key=lambda x: x[1], reverse=True)\n",
    "highest_degree_node = sorted_nodes_by_degree[0][0]\n",
    "second_highest_degree_node = sorted_nodes_by_degree[5][0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "0d02201c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'role'}"
      ]
     },
     "execution_count": 66,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# neighbors1 = set(G_combined.neighbors('lung_cancer'))\n",
    "neighbors1 = []\n",
    "for node in list(G_combined.neighbors('lung_cancer')):\n",
    "    neighbors1.extend(list(G_combined.neighbors(node)))\n",
    "neighbors1 = set(neighbors1)\n",
    "        \n",
    "# neighbors2 = set(G_combined.neighbors('thyroid_cancer'))\n",
    "neighbors2 = []\n",
    "for node in list(G_combined.neighbors('colon_cancer')):\n",
    "    neighbors2.extend(list(G_combined.neighbors(node)))\n",
    "neighbors2 = set(neighbors2)\n",
    "\n",
    "neighbors1 & neighbors2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a846111a",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "id": "42c63ca2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "5"
      ]
     },
     "execution_count": 74,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "degree_dict['colon_cancer']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "id": "f619b77a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('we', 2680),\n",
       " ('that', 1757),\n",
       " ('which', 1628),\n",
       " ('We', 909),\n",
       " ('it', 826),\n",
       " ('patients', 797),\n",
       " ('expression', 737),\n",
       " ('study', 664),\n",
       " ('role', 648),\n",
       " ('they', 588),\n",
       " ('who', 581),\n",
       " ('studies', 579),\n",
       " ('cells', 506),\n",
       " ('data', 501),\n",
       " ('results', 501),\n",
       " ('analysis', 333),\n",
       " ('effect', 333),\n",
       " ('effects', 329),\n",
       " ('number', 290),\n",
       " ('authors', 265),\n",
       " ('this', 246),\n",
       " ('genes', 238),\n",
       " ('activity', 228),\n",
       " ('patient', 222),\n",
       " ('risk', 204),\n",
       " ('levels', 197),\n",
       " ('This', 185),\n",
       " ('It', 173),\n",
       " ('use', 169),\n",
       " ('treatment', 155),\n",
       " ('association', 154),\n",
       " ('activation', 151),\n",
       " ('findings', 150),\n",
       " ('mice', 147),\n",
       " ('level', 141),\n",
       " ('difference', 137),\n",
       " ('information', 136),\n",
       " ('i', 135),\n",
       " ('increase', 134),\n",
       " ('apoptosis', 134),\n",
       " ('differences', 132),\n",
       " ('response', 130),\n",
       " ('factors', 127),\n",
       " ('overexpression', 126),\n",
       " ('model', 126),\n",
       " ('potential', 125),\n",
       " ('correlation', 125),\n",
       " ('impact', 122),\n",
       " ('work', 120),\n",
       " ('evidence', 118),\n",
       " ('method', 118),\n",
       " ('cases', 117),\n",
       " ('research', 117),\n",
       " ('participants', 117),\n",
       " ('survival', 115),\n",
       " ('one', 114),\n",
       " ('inhibition', 112),\n",
       " ('manuscript', 111),\n",
       " ('total', 108),\n",
       " ('changes', 108),\n",
       " ('prognosis', 108),\n",
       " ('value', 108),\n",
       " ('tumors', 108),\n",
       " ('I', 107),\n",
       " ('ability', 105),\n",
       " ('proliferation', 104),\n",
       " ('samples', 103),\n",
       " ('approach', 102),\n",
       " ('us', 101),\n",
       " ('roles', 101),\n",
       " ('disease', 99),\n",
       " ('analyses', 98),\n",
       " ('development', 98),\n",
       " ('relationship', 97),\n",
       " ('presence', 95),\n",
       " ('decrease', 95),\n",
       " ('functions', 94),\n",
       " ('expression_levels', 94),\n",
       " ('experiments', 93),\n",
       " ('function', 92),\n",
       " ('he', 89),\n",
       " ('mutations', 88),\n",
       " ('pathways', 84),\n",
       " ('proteins', 83),\n",
       " ('values', 82),\n",
       " ('review', 80),\n",
       " ('features', 80),\n",
       " ('she', 80),\n",
       " ('proportion', 80),\n",
       " ('group', 79),\n",
       " ('mechanisms', 79),\n",
       " ('knockdown', 79),\n",
       " ('incidence', 78),\n",
       " ('cancer', 77),\n",
       " ('diagnosis', 77),\n",
       " ('consent', 77),\n",
       " ('progression', 77),\n",
       " ('test', 77),\n",
       " ('Patients', 76),\n",
       " ('process', 76),\n",
       " ('reduction', 75),\n",
       " ('mechanism', 75),\n",
       " ('methods', 75),\n",
       " ('interaction', 75),\n",
       " ('growth', 74),\n",
       " ('tumor_growth', 74),\n",
       " ('case', 73),\n",
       " ('gene', 73),\n",
       " ('pathway', 73),\n",
       " ('performance', 73),\n",
       " ('characteristics', 72),\n",
       " ('groups', 71),\n",
       " ('They', 70),\n",
       " ('those', 70),\n",
       " ('significance', 70),\n",
       " ('concentrations', 70),\n",
       " ('trial', 69),\n",
       " ('sensitivity', 69),\n",
       " ('rate', 69),\n",
       " ('protein', 69),\n",
       " ('%', 69),\n",
       " ('events', 68),\n",
       " ('cancer_cells', 66),\n",
       " ('outcomes', 65),\n",
       " ('combination', 65),\n",
       " ('tumor', 64),\n",
       " ('attention', 64),\n",
       " ('downregulation', 63),\n",
       " ('therapy', 61),\n",
       " ('link', 61),\n",
       " ('assay', 61),\n",
       " ('upregulation', 61),\n",
       " ('result', 59),\n",
       " ('system', 59),\n",
       " ('importance', 58),\n",
       " ('some', 58),\n",
       " ('people', 58),\n",
       " ('transcription', 58),\n",
       " ('criteria', 57),\n",
       " ('all', 57),\n",
       " ('symptoms', 57),\n",
       " ('these', 57),\n",
       " ('associations', 57),\n",
       " ('sites', 57),\n",
       " ('type', 57),\n",
       " ('drugs', 57),\n",
       " ('antibodies', 56),\n",
       " ('percentage', 56),\n",
       " ('change', 56),\n",
       " ('you', 55),\n",
       " ('researchers', 55),\n",
       " ('variables', 55),\n",
       " ('expression_level', 55),\n",
       " ('images', 55),\n",
       " ('alterations', 55),\n",
       " ('cell_proliferation', 55),\n",
       " ('responses', 54),\n",
       " ('women', 54),\n",
       " ('distribution', 53),\n",
       " ('efficacy', 53),\n",
       " ('majority', 53),\n",
       " ('resistance', 53),\n",
       " ('cancers', 53),\n",
       " ('fig', 53),\n",
       " ('trials', 52),\n",
       " ('reports', 52),\n",
       " ('exposure', 52),\n",
       " ('need', 51),\n",
       " ('binding', 51),\n",
       " ('targets', 50),\n",
       " ('metastasis', 50),\n",
       " ('surgery', 49),\n",
       " ('subjects', 49),\n",
       " ('them', 49),\n",
       " ('\\x93', 49),\n",
       " ('time', 49),\n",
       " ('eï¬ect', 49),\n",
       " ('properties', 48),\n",
       " ('loss', 48),\n",
       " ('score', 48),\n",
       " ('These', 48),\n",
       " ('administration', 48),\n",
       " ('application', 48),\n",
       " ('part', 48),\n",
       " ('outcome', 47),\n",
       " ('most', 47),\n",
       " ('assays', 47),\n",
       " ('gene_expression', 47),\n",
       " ('blotting', 47),\n",
       " ('addition', 46),\n",
       " ('production', 46),\n",
       " ('interactions', 46),\n",
       " ('models', 46),\n",
       " ('network', 46),\n",
       " ('quality', 45),\n",
       " ('types', 45),\n",
       " ('paper', 45),\n",
       " ('degree', 45),\n",
       " ('using', 45),\n",
       " ('dose', 44),\n",
       " ('lesions', 44),\n",
       " ('inflammation', 44),\n",
       " ('abundance', 43),\n",
       " ('stress', 43),\n",
       " ('cell_lines', 43),\n",
       " ('migration', 43),\n",
       " ('access', 43),\n",
       " ('variation', 43),\n",
       " ('limitations', 42),\n",
       " ('understanding', 42),\n",
       " ('amount', 42),\n",
       " ('site', 42),\n",
       " ('phosphorylation', 42),\n",
       " ('capacity', 41),\n",
       " ('numbers', 41),\n",
       " ('ethics_committee', 41),\n",
       " ('prevalence', 40),\n",
       " ('differentiation', 40),\n",
       " ('scores', 40),\n",
       " ('effectiveness', 39),\n",
       " ('complex', 39),\n",
       " ('investigation', 39),\n",
       " ('structure', 39),\n",
       " ('evaluation', 39),\n",
       " ('formation', 39),\n",
       " ('enrichment', 39),\n",
       " ('accumulation', 39),\n",
       " ('sample', 39),\n",
       " ('range', 38),\n",
       " ('the', 38),\n",
       " ('assessment', 37),\n",
       " ('variety', 37),\n",
       " ('regulation', 37),\n",
       " ('tissue', 37),\n",
       " ('regression', 37),\n",
       " ('hypothesis', 37),\n",
       " ('protein_levels', 37),\n",
       " ('concentration', 36),\n",
       " ('treatments', 36),\n",
       " ('diseases', 36),\n",
       " ('each', 36),\n",
       " ('ratio', 36),\n",
       " ('accuracy', 36),\n",
       " ('heterogeneity', 36),\n",
       " ('influence', 36),\n",
       " ('support', 36),\n",
       " ('tissues', 36),\n",
       " ('int_page', 36),\n",
       " ('comparisons', 35),\n",
       " ('staining', 35),\n",
       " ('chemotherapy', 35),\n",
       " ('approaches', 35),\n",
       " ('trend', 35),\n",
       " ('amounts', 35),\n",
       " ('biomarkers', 35),\n",
       " ('none', 35),\n",
       " ('et', 35),\n",
       " ('EMT', 35),\n",
       " ('activities', 35),\n",
       " ('status', 34),\n",
       " ('infection', 34),\n",
       " ('sections', 34),\n",
       " ('miRNAs', 34),\n",
       " ('comparison', 34),\n",
       " ('observation', 34),\n",
       " ('eï¬ects', 34),\n",
       " ('involvement', 33),\n",
       " ('cytotoxicity', 33),\n",
       " ('molecules', 33),\n",
       " ('figure', 33),\n",
       " ('resection', 32),\n",
       " ('parameters', 32),\n",
       " ('what', 32),\n",
       " ('area', 32),\n",
       " ('pattern', 32),\n",
       " ('algorithms', 32),\n",
       " ('factor', 32),\n",
       " ('OS', 32),\n",
       " ('transfection', 32),\n",
       " ('processes', 32),\n",
       " ('mutation', 32),\n",
       " ('a0et', 32),\n",
       " ('complications', 31),\n",
       " ('care', 31),\n",
       " ('procedure', 31),\n",
       " ('She', 31),\n",
       " ('et_al', 31),\n",
       " ('detection', 31),\n",
       " ('flow_cytometry', 31),\n",
       " ('neutrophils', 31),\n",
       " ('imaging', 31),\n",
       " ('p', 31),\n",
       " ('RNA', 31),\n",
       " ('table', 31),\n",
       " ('costs', 31),\n",
       " ('virus', 30),\n",
       " ('panel', 30),\n",
       " ('approval', 30),\n",
       " ('population', 30),\n",
       " ('place', 30),\n",
       " ('conditions', 30),\n",
       " ('carcinoma', 30),\n",
       " ('axis', 30),\n",
       " ('nature', 29),\n",
       " ('markers', 29),\n",
       " ('cohort', 29),\n",
       " ('finding', 29),\n",
       " ('source', 29),\n",
       " ('report', 29),\n",
       " ('rates', 29),\n",
       " ('cytokines', 29),\n",
       " ('investigators', 29),\n",
       " ('others', 29),\n",
       " ('more', 29),\n",
       " ('datasets', 29),\n",
       " ('macrophages', 29),\n",
       " ('phenotype', 29),\n",
       " ('blot_analysis', 29),\n",
       " ('cell_apoptosis', 29),\n",
       " ('viability', 29),\n",
       " ('al', 29),\n",
       " ('cell_viability', 29),\n",
       " ('t_cells', 29),\n",
       " ('mirnas', 29),\n",
       " ('miR-182', 29),\n",
       " ('antibody', 28),\n",
       " ('to_be', 28),\n",
       " ('insights', 28),\n",
       " ('WHO', 28),\n",
       " ('variants', 28),\n",
       " ('half', 28),\n",
       " ('lack', 28),\n",
       " ('measures', 28),\n",
       " ('Table', 28),\n",
       " ('Fig', 28),\n",
       " ('reaction', 28),\n",
       " ('version', 28),\n",
       " ('algorithm', 28),\n",
       " ('individuals', 28),\n",
       " ('sample_size', 28),\n",
       " ('components', 28),\n",
       " ('metastases', 27),\n",
       " ('size', 27),\n",
       " ('ablation', 27),\n",
       " ('transition', 27),\n",
       " ('series', 27),\n",
       " ('questions', 27),\n",
       " ('set', 27),\n",
       " ('tumor_cells', 27),\n",
       " ('sequences', 27),\n",
       " ('damage', 27),\n",
       " ('signals', 27),\n",
       " ('stability', 27),\n",
       " ('immunity', 27),\n",
       " ('observations', 27),\n",
       " ('methodology', 26),\n",
       " ('age', 26),\n",
       " ('secretion', 26),\n",
       " ('probability', 26),\n",
       " ('T_cells', 26),\n",
       " ('h', 26),\n",
       " ('two', 26),\n",
       " ('examination', 26),\n",
       " ('depletion', 26),\n",
       " ('participant', 26),\n",
       " ('Figure', 26),\n",
       " ('fraction', 26),\n",
       " ('history', 26),\n",
       " ('protocol', 26),\n",
       " ('Cell_Int_Page', 26),\n",
       " ('inhibitor', 26),\n",
       " ('inhibitors', 26),\n",
       " ('cell_death', 26),\n",
       " ('cancer_page', 26),\n",
       " ('cause', 25),\n",
       " ('technique', 25),\n",
       " ('implications', 25),\n",
       " ('form', 25),\n",
       " ('control', 25),\n",
       " ('correlations', 25),\n",
       " ('solution', 25),\n",
       " ('frequency', 25),\n",
       " ('diversity', 25),\n",
       " ('blot', 25),\n",
       " ('phase', 25),\n",
       " ('protein_expression', 25),\n",
       " ('cell_growth', 25),\n",
       " ('list', 25),\n",
       " ('opportunity', 25),\n",
       " ('a0', 25),\n",
       " ('toxicity', 25),\n",
       " ('utility', 24),\n",
       " ('improvement', 24),\n",
       " ('sequence', 24),\n",
       " ('patterns', 24),\n",
       " ('tool', 24),\n",
       " ('lncRNAs', 24),\n",
       " ('interest', 24),\n",
       " ('domain', 24),\n",
       " ('therapies', 24),\n",
       " ('line', 24),\n",
       " ('cell', 24),\n",
       " ('possibility', 24),\n",
       " ('both', 24),\n",
       " ('sequencing', 24),\n",
       " ('degs', 24),\n",
       " ('sarscov2', 24),\n",
       " ('knowledge', 23),\n",
       " ('years', 23),\n",
       " ('fact', 23),\n",
       " ('risk_factors', 23),\n",
       " ('clinicians', 23),\n",
       " ('animals', 23),\n",
       " ('availability', 23),\n",
       " ('occurrence', 23),\n",
       " ('author', 23),\n",
       " ('All', 23),\n",
       " ('target', 23),\n",
       " ('increases', 23),\n",
       " ('strategies', 23),\n",
       " ('release', 23),\n",
       " ('variant', 23),\n",
       " ('region', 23),\n",
       " ('tests', 23),\n",
       " ('compounds', 23),\n",
       " ('team', 23),\n",
       " ('enrichment_analysis', 23),\n",
       " ('anova', 23),\n",
       " ('erianin', 23),\n",
       " ('procedures', 22),\n",
       " ('many', 22),\n",
       " ('advances', 22),\n",
       " ('lines', 22),\n",
       " ('images_party_material', 22),\n",
       " ('agents', 22),\n",
       " ('species', 22),\n",
       " ('pain', 22),\n",
       " ('state', 22),\n",
       " ('identification', 22),\n",
       " ('dataset', 22),\n",
       " ('migration_invasion', 22),\n",
       " ('ml', 22),\n",
       " ('He', 22),\n",
       " ('signaling', 22),\n",
       " ('means', 22),\n",
       " ('laboratories', 22),\n",
       " ('stage', 22),\n",
       " ('sensitivity_specificity', 21),\n",
       " ('lesion', 21),\n",
       " ('blood', 21),\n",
       " ('techniques', 21),\n",
       " ('susceptibility', 21),\n",
       " ('mixture', 21),\n",
       " ('SARSCoV2', 21),\n",
       " ('power', 21),\n",
       " ('relationships', 21),\n",
       " ('suppression', 21),\n",
       " ('basis', 21),\n",
       " ('cancer_patients', 21),\n",
       " ('enzymes', 21),\n",
       " ('spectrum', 21),\n",
       " ('burden', 21),\n",
       " ('step', 21),\n",
       " ('c', 21),\n",
       " ('subtypes', 21),\n",
       " ('cthrc1', 21),\n",
       " ('management', 20),\n",
       " ('metaanalysis', 20),\n",
       " ('mass', 20),\n",
       " ('project', 20),\n",
       " ('benefit', 20),\n",
       " ('angiogenesis', 20),\n",
       " ('physicians', 20),\n",
       " ('phenomenon', 20),\n",
       " ('measurements', 20),\n",
       " ('condition', 20),\n",
       " ('variations', 20),\n",
       " ('bacteria', 20),\n",
       " ('strategy', 20),\n",
       " ('records', 20),\n",
       " ('[', 20),\n",
       " ('s', 20),\n",
       " ('DEGs', 20),\n",
       " ('investigator', 20),\n",
       " ('lung_cancer', 20),\n",
       " ('expressions', 20),\n",
       " ('ANOVA', 20),\n",
       " ('PCR', 20),\n",
       " ('protein_level', 20),\n",
       " ('insight', 20),\n",
       " ('networks', 20),\n",
       " ('advantage', 20),\n",
       " ('surgeons', 20),\n",
       " ('fyy', 20),\n",
       " ('propolis', 20),\n",
       " ('luteoloside', 20),\n",
       " ('structures', 19),\n",
       " ('doses', 19),\n",
       " ('generation', 19),\n",
       " ('products', 19),\n",
       " ('benefits', 19),\n",
       " ('elements', 19),\n",
       " ('dysfunction', 19),\n",
       " ('theexpression', 19),\n",
       " ('framework', 19),\n",
       " ('clusters', 19),\n",
       " ('centrifugation', 19),\n",
       " ('consequences', 19),\n",
       " ('guidelines', 19),\n",
       " ('efforts', 19),\n",
       " ('Ethics_Committee', 19),\n",
       " ('weight', 19),\n",
       " ('qRTPCR', 19),\n",
       " ('tumorigenesis', 19),\n",
       " ('signs', 19),\n",
       " ('proliferation_migration_invasion', 19),\n",
       " ('concept', 19),\n",
       " ('cell_migration', 19),\n",
       " ('validation', 19),\n",
       " ('course', 19),\n",
       " ('membranes', 19),\n",
       " ('capability', 19),\n",
       " ('selection', 19),\n",
       " ('vector', 19),\n",
       " ('microenvironment', 19),\n",
       " ('cell_responses', 19),\n",
       " ('a', 19),\n",
       " ('plates', 19),\n",
       " ('autophagy', 19),\n",
       " ('cell_carcinoma', 19),\n",
       " ('microbiota', 19),\n",
       " ('chemosensitivity', 19),\n",
       " ('contribution', 19),\n",
       " ('to_be_phagocytosing_cells_evtam_using_ _a_ _z1_ _axio_observer_ _microscope_ _equipped_ _with_ _a_ _ld_ _plan_centrifugation_hct116_dld1_cells_ultracentrifugation_mm_tris\\x93hcl_using_ _graphpad_prism_   _graphpad_ _software_ _statistical_ _significance_t_test_effect_1a_1b_tam',\n",
       "  19),\n",
       " ('recommendations', 18),\n",
       " ('nodules', 18),\n",
       " ('steps', 18),\n",
       " ('component', 18),\n",
       " ('protocols', 18),\n",
       " ('DNA', 18),\n",
       " ('viruses', 18),\n",
       " ('affinity', 18),\n",
       " ('intervention', 18),\n",
       " ('light', 18),\n",
       " ('health', 18),\n",
       " ('survey', 18),\n",
       " ('promise', 18),\n",
       " ('Data', 18),\n",
       " ('survival_rate', 18),\n",
       " ('±', 18),\n",
       " ('requirement', 18),\n",
       " ('silencing', 18),\n",
       " ('translocation', 18),\n",
       " ('primers', 18),\n",
       " ('t_test', 18),\n",
       " ('modules', 18),\n",
       " ('action', 18),\n",
       " ('metabolism', 18),\n",
       " ('gut_microbiota', 18),\n",
       " ('Overexpression', 18),\n",
       " ('behavior', 18),\n",
       " ('trs', 18),\n",
       " ('design', 17),\n",
       " ('regions', 17),\n",
       " ('improvements', 17),\n",
       " ('marker', 17),\n",
       " ('pandemic', 17),\n",
       " ('absence', 17),\n",
       " ('SNPs', 17),\n",
       " ('months', 17),\n",
       " ('hospital', 17),\n",
       " ('study_protocol', 17),\n",
       " ('mortality', 17),\n",
       " ('nodes', 17),\n",
       " ('synthesis', 17),\n",
       " ('obesity', 17),\n",
       " ('manifestations', 17),\n",
       " ('software', 17),\n",
       " ('recurrence', 17),\n",
       " ('infiltration', 17),\n",
       " ('intensity', 17),\n",
       " ('tumours', 17),\n",
       " ('recruitment', 17),\n",
       " ('experiment', 17),\n",
       " ('Results', 17),\n",
       " ('focus', 17),\n",
       " ('introduction', 17),\n",
       " ('p_values', 17),\n",
       " ('exercise', 17),\n",
       " ('diï¬erentiation', 17),\n",
       " ('metformin', 17),\n",
       " ('lncrnas', 17),\n",
       " ('mir4255p', 17),\n",
       " ('circrnas', 17),\n",
       " ('dner', 17),\n",
       " ('probiotics_plant', 17),\n",
       " ('notion', 16),\n",
       " ('areas', 16),\n",
       " ('grants', 16),\n",
       " ('control_group', 16),\n",
       " ('injection', 16),\n",
       " ('option', 16),\n",
       " ('death', 16),\n",
       " ('stimulation', 16),\n",
       " ('rise', 16),\n",
       " ('are', 16),\n",
       " ('environment', 16),\n",
       " ('mg', 16),\n",
       " ('receptors', 16),\n",
       " ('members', 16),\n",
       " ('ttest', 16),\n",
       " ('woman', 16),\n",
       " ('P', 16),\n",
       " ('drug', 16),\n",
       " ('radiotherapy', 16),\n",
       " ('performed', 16),\n",
       " ('parts', 16),\n",
       " ('examinations', 16),\n",
       " ('men', 16),\n",
       " ('section', 16),\n",
       " ('TTNAS1', 16),\n",
       " ('transformation', 16),\n",
       " ('data_analysis', 16),\n",
       " ('cancer_progression', 16),\n",
       " ('A', 16),\n",
       " ('committee', 16),\n",
       " ('inclusion', 16),\n",
       " ('enhancement', 16),\n",
       " ('induction', 16),\n",
       " ('other', 16),\n",
       " ('catenin', 16),\n",
       " ('shift', 16),\n",
       " ('clones', 16),\n",
       " ('probes', 16),\n",
       " ('recovery', 16),\n",
       " ('sectionThis', 16),\n",
       " ('cells_cells', 16),\n",
       " ('MTX', 16),\n",
       " ('OMS', 16),\n",
       " ('rna', 16),\n",
       " ('bmj', 16),\n",
       " ('pathology', 15),\n",
       " ('layer', 15),\n",
       " ('distance', 15),\n",
       " ('investigations', 15),\n",
       " ('similarity', 15),\n",
       " ('membrane', 15),\n",
       " ('comorbidities', 15),\n",
       " ('intake', 15),\n",
       " ('extent', 15),\n",
       " ('aspects', 15),\n",
       " ('infections', 15),\n",
       " ('degradation', 15),\n",
       " ('balance', 15),\n",
       " ('idea', 15),\n",
       " ('mean', 15),\n",
       " ('categories', 15),\n",
       " ('interests', 15),\n",
       " ('period', 15),\n",
       " ('tissue_samples', 15),\n",
       " ('BMC_Cancer_Page', 15),\n",
       " ('efficiency', 15),\n",
       " ('pathologists', 15),\n",
       " ('density', 15),\n",
       " ('uptake', 15),\n",
       " ('duration', 15),\n",
       " ('composition', 15),\n",
       " ('oneway', 15),\n",
       " ('deaths', 15),\n",
       " ('breast_cancer', 15),\n",
       " ('index', 15),\n",
       " ('l', 15),\n",
       " ('cell_line', 15),\n",
       " ('cell_cycle', 15),\n",
       " ('expression_profiles', 15),\n",
       " ('connection', 15),\n",
       " ('tumor_growth_metastasis', 15),\n",
       " ('peptides', 15),\n",
       " ('maturation', 15),\n",
       " ('vaccine', 15),\n",
       " ('lymph_nodes', 15),\n",
       " ('HHT', 15),\n",
       " ('cost', 15),\n",
       " ('indication', 15),\n",
       " ('fda', 15),\n",
       " ('os', 15),\n",
       " ('qrtpcr', 15),\n",
       " ('4cypsmac', 15),\n",
       " ('igg4', 15),\n",
       " ('defb4a', 15),\n",
       " ('3', 15),\n",
       " ('Sp1', 15),\n",
       " ('serum_levels', 14),\n",
       " ('presentation', 14),\n",
       " ('subset', 14),\n",
       " ('signatures', 14),\n",
       " ('tools', 14),\n",
       " ('advantages', 14),\n",
       " ('latter', 14),\n",
       " ('Authors', 14),\n",
       " ('journal', 14),\n",
       " (']', 14),\n",
       " ('classification', 14),\n",
       " ('metabolites', 14),\n",
       " ('problems', 14),\n",
       " ('domains', 14),\n",
       " ('severity', 14),\n",
       " ('interventions', 14),\n",
       " ('Participants', 14),\n",
       " ('medium', 14),\n",
       " ('content', 14),\n",
       " ('included', 14),\n",
       " ('specimens', 14),\n",
       " ('day', 14),\n",
       " ('signal', 14),\n",
       " ('database', 14),\n",
       " ('variability', 14),\n",
       " ('modulation', 14),\n",
       " ('tumor_progression', 14),\n",
       " ('file', 14),\n",
       " ('contributions', 14),\n",
       " ('questionnaire', 14),\n",
       " ('error', 14),\n",
       " ('survival_rates', 14),\n",
       " ('proliferation_migration', 14),\n",
       " ('family', 14),\n",
       " ('relevance', 14),\n",
       " ('Cells', 14),\n",
       " ('Some', 14),\n",
       " ('stages', 14),\n",
       " ('progress', 14),\n",
       " ('description', 14),\n",
       " ('peptide', 14),\n",
       " ('choice', 14),\n",
       " ('image', 14),\n",
       " ('crosstalk', 14),\n",
       " ('chemoresistance', 14),\n",
       " ('pairs', 14),\n",
       " ('likelihood', 14),\n",
       " ('prediction', 14),\n",
       " ('DCs', 14),\n",
       " ('act', 14),\n",
       " ('p005', 14),\n",
       " ('cm', 14),\n",
       " ('PAX6', 14),\n",
       " ('works', 13),\n",
       " ('n', 13),\n",
       " ('grant', 13),\n",
       " ('cycles', 13),\n",
       " ('d', 13),\n",
       " ('inclusion_criteria', 13),\n",
       " ('literature', 13),\n",
       " ('pressure', 13),\n",
       " ('a0_al', 13),\n",
       " ('injury', 13),\n",
       " ('days', 13),\n",
       " ('guidance', 13),\n",
       " ('PFS', 13),\n",
       " ('AE', 13),\n",
       " ('entry', 13),\n",
       " ('energy', 13),\n",
       " ('complexes', 13),\n",
       " ('measure', 13),\n",
       " ('way', 13),\n",
       " ('Treatment', 13),\n",
       " ('sense', 13),\n",
       " ('curves', 13),\n",
       " ('predictors', 13),\n",
       " ('tobe', 13),\n",
       " ('probe', 13),\n",
       " ('conflicts', 13),\n",
       " ('proliferation_invasion', 13),\n",
       " ('pvalues', 13),\n",
       " ('measurement', 13),\n",
       " ('mortality_rate', 13),\n",
       " ('bias', 13),\n",
       " ('alteration', 13),\n",
       " ('member', 13),\n",
       " ('question', 13),\n",
       " ('experience', 13),\n",
       " ('representation', 13),\n",
       " ('less', 13),\n",
       " ('countries', 13),\n",
       " ('C', 13),\n",
       " ('invasion', 13),\n",
       " ('field', 13),\n",
       " ('CENPM', 13),\n",
       " ('existence', 13),\n",
       " ('genotype', 13),\n",
       " ('discussion', 13),\n",
       " ('transcription_factors', 13),\n",
       " ('stem_cells', 13),\n",
       " ('transcripts', 13),\n",
       " ('quantification', 13),\n",
       " ('incubation', 13),\n",
       " ('skin', 13),\n",
       " ('statistics', 13),\n",
       " ('amplification', 13),\n",
       " ('details', 13),\n",
       " ('pathogenesis', 13),\n",
       " ('weeks', 13),\n",
       " ('m', 13),\n",
       " ('exons', 13),\n",
       " ('curcumin', 13),\n",
       " ('hcc', 13),\n",
       " ('legend', 13),\n",
       " ('mrna_expression', 13),\n",
       " ('wtap', 13),\n",
       " ('disease_fmd_hepatitis_b_c_etc_booster_vaccination_antigens_transgene_proteins_prospects_tools_challenges_plant_cells_outbreak_requirements_criteria_kinds_vaccines_eg_potato_rice_pea_protein_content_to_ _express_ _very_high_level_of_foreign_proteins_ _edible_vaccine_from_the_plant_source_ _possibility_nature_choice_to_avoid_overprotection_of_the_encapsulated_antigen_inhibiting_the_release_of_the_therapeutic_or_premature_ _release_ _if_ _protection_ _is_ _inadequate_ _action_apcs_structure_risk_have_ _certain_ _challenges_ _that_ _have_ _to_ _be_ _overcome_ _for_ _efficient_ _and_ _pure_ _beneficial_edible_vaccination_dose_system_itse',\n",
       "  13),\n",
       " ('search', 12),\n",
       " ('screening', 12),\n",
       " ('three', 12),\n",
       " ('users', 12),\n",
       " ('MMP9', 12),\n",
       " ('failure', 12),\n",
       " ('success', 12),\n",
       " ('subtype', 12),\n",
       " ('data_sets', 12),\n",
       " ('P_values', 12),\n",
       " ('examples', 12),\n",
       " ('similarities', 12),\n",
       " ('Studies', 12),\n",
       " ('challenges', 12),\n",
       " ('volume', 12),\n",
       " ('overlap', 12),\n",
       " ('overview', 12),\n",
       " ('location', 12),\n",
       " ('populations', 12),\n",
       " ('length', 12),\n",
       " ('ROC_curve', 12),\n",
       " ('sum', 12),\n",
       " ('specificity', 12),\n",
       " ('reference', 12),\n",
       " ('problem', 12),\n",
       " ('response_rate', 12),\n",
       " ('tumor_response', 12),\n",
       " ('adenocarcinoma', 12),\n",
       " ('is', 12),\n",
       " ('lncRNA', 12),\n",
       " ('radiologists', 12),\n",
       " ('biopsy', 12),\n",
       " ('±_SD', 12),\n",
       " ('material', 12),\n",
       " ('appearance', 12),\n",
       " ('circ_0020123', 12),\n",
       " ('survival_time', 12),\n",
       " ('fusion', 12),\n",
       " ('diet', 12),\n",
       " ('feedback', 12),\n",
       " ('replication', 12),\n",
       " ('plot', 12),\n",
       " ('average', 12),\n",
       " ('inhibitory_effect', 12),\n",
       " ('dots', 12),\n",
       " ('immunotherapy', 12),\n",
       " ('complexity', 12),\n",
       " ('lincROR', 12),\n",
       " ('deletion', 12),\n",
       " ('inactivation', 12),\n",
       " ('1b', 12),\n",
       " ('circsmarca5', 12),\n",
       " ('colitis', 12),\n",
       " ('evs', 12),\n",
       " ('medium_gibco_waltham_ma_to_eachtube_then_ _to_tube_  _µl_of_epithelial_cell_adhesion_molecule_epcam_antibody_ebioscience_to_tube_ _empty_label_after_ _min_of_incubation_at_\\x97_¦_c_dropwise_using_tem345dimethylthiazol2yl25diphenyltetrazolium_bromideassaycrc_cells_or_colorectal_cscs_in_the_logarithmic_growthphase_pab180013_bioswamp',\n",
       "  12),\n",
       " ('esmo', 12),\n",
       " ('ICC', 12),\n",
       " ('supply', 11),\n",
       " ('Comparison', 11),\n",
       " ('landscape', 11),\n",
       " ('miRNA', 11),\n",
       " ('challenge', 11),\n",
       " ('side_effects', 11),\n",
       " ('impairment', 11),\n",
       " ('event', 11),\n",
       " ('monitoring', 11),\n",
       " ('receptor', 11),\n",
       " ('module', 11),\n",
       " ('person', 11),\n",
       " ('sleep', 11),\n",
       " ('technology', 11),\n",
       " ('capabilities', 11),\n",
       " ('Most', 11),\n",
       " ('exploration', 11),\n",
       " ('weights', 11),\n",
       " ('reactions', 11),\n",
       " ('CI', 11),\n",
       " ('feature', 11),\n",
       " ('draft', 11),\n",
       " ('risks', 11),\n",
       " ('behaviors', 11),\n",
       " ('fluorescence', 11),\n",
       " ('MRI', 11),\n",
       " ('animal_experiments', 11),\n",
       " ('regimen', 11),\n",
       " ('saline', 11),\n",
       " ('review_board', 11),\n",
       " ('origin', 11),\n",
       " ('formula', 11),\n",
       " ('IL6', 11),\n",
       " ('nurses', 11),\n",
       " ('effort', 11),\n",
       " ('None', 11),\n",
       " ('adherence', 11),\n",
       " ('healing_assay', 11),\n",
       " ('A549_cells', 11),\n",
       " ('antitumor_activity', 11),\n",
       " ('repression', 11),\n",
       " ('class', 11),\n",
       " ('FDA', 11),\n",
       " ('kinds', 11),\n",
       " ('tendency', 11),\n",
       " ('decline', 11),\n",
       " ('kinases', 11),\n",
       " ('localization', 11),\n",
       " ('min', 11),\n",
       " ('absorbance', 11),\n",
       " ('qPCR', 11),\n",
       " ('researcher', 11),\n",
       " ('individual', 11),\n",
       " ('establishment', 11),\n",
       " ('M_oleifera', 11),\n",
       " ('NLR', 11),\n",
       " ('blots', 11),\n",
       " ('options', 11),\n",
       " ('mouse', 11),\n",
       " ('ferroptosis', 11),\n",
       " ('supernatant', 11),\n",
       " ('threshold', 11),\n",
       " ('resolution', 11),\n",
       " ('0c', 11),\n",
       " ('GPs', 11),\n",
       " ('consensus', 11),\n",
       " ('AURKA', 11),\n",
       " ('providers', 11),\n",
       " ('One', 11),\n",
       " ('example', 11),\n",
       " ('SIRT1', 11),\n",
       " ('isoforms', 11),\n",
       " ('traits', 11),\n",
       " ('survival_curves', 11),\n",
       " ('ros', 11),\n",
       " ('manuscriptfundingthis_study', 11),\n",
       " ('lbx2as1', 11),\n",
       " ('mir578', 11),\n",
       " ('ppi_network', 11),\n",
       " ('ko_mice', 11),\n",
       " ('covid19', 11),\n",
       " ('aspirin', 11),\n",
       " ('nps', 11),\n",
       " ('cd14_hla_dr_viable_cd45_cells', 11),\n",
       " ('pax9', 11),\n",
       " ('12', 11),\n",
       " ('fusion_protein', 11),\n",
       " ('scFvMTBHsp70', 11),\n",
       " ('ibuprofen', 11),\n",
       " ('Hsp70', 11),\n",
       " ('sulindac_metabolites', 11),\n",
       " ('eribulin', 11),\n",
       " ('niclosamide', 11),\n",
       " ('node_metastasis', 10),\n",
       " ('papers', 10),\n",
       " ('grade', 10),\n",
       " ('male', 10),\n",
       " ('controls', 10),\n",
       " ('efï¬\\x81cacy', 10),\n",
       " ('risk_factor', 10),\n",
       " ('standard', 10),\n",
       " ('situation', 10),\n",
       " ('remission', 10),\n",
       " ('glucose_metabolism', 10),\n",
       " ('cohort_study', 10),\n",
       " ('ELISA', 10),\n",
       " ('protection', 10),\n",
       " ('sorafenib', 10),\n",
       " ('edges', 10),\n",
       " ('definition', 10),\n",
       " ('inpatients', 10),\n",
       " ('ACE2_expression', 10),\n",
       " ('expression_pattern', 10),\n",
       " ('spread', 10),\n",
       " ('signiï¬\\x81cance', 10),\n",
       " ('explanation', 10),\n",
       " ('AUC', 10),\n",
       " ('map', 10),\n",
       " ('deviation', 10),\n",
       " ('points', 10),\n",
       " ('ans', 10),\n",
       " ('feasibility', 10),\n",
       " ('BMI', 10),\n",
       " ('questionnaires', 10),\n",
       " ('proliferation_apoptosis', 10),\n",
       " ('importantrole', 10),\n",
       " ('safety', 10),\n",
       " ('cancer_growth', 10),\n",
       " ('mRNA', 10),\n",
       " ('materials', 10),\n",
       " ('serum', 10),\n",
       " ('times', 10),\n",
       " ('antigens', 10),\n",
       " ('elevation', 10),\n",
       " ...]"
      ]
     },
     "execution_count": 103,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sorted_nodes_by_degree"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "8942a4ac",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 111,
   "id": "25ba7c35",
   "metadata": {},
   "outputs": [],
   "source": [
    "inconsistencies_with_degree = pd.Series(dict(sorted_nodes_by_degree))[inconsistent_words]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 187,
   "id": "d1c7e813",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "84.08071996399268"
      ]
     },
     "execution_count": 187,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sum(inconsistencies_with_degree)/len(inconsistent_words)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "792f84ae",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 141,
   "id": "07a18129",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|█████████████████████████████████████████████████████████████████████| 657644/657644 [00:00<00:00, 1716745.71it/s]\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "0.0013852783072654214"
      ]
     },
     "execution_count": 141,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "degree_centrality = nx.degree_centrality(G_combined)\n",
    "j = 0\n",
    "for inconsistent_word in tqdm(inconsistent_words):\n",
    "    j += degree_centrality[inconsistent_word]\n",
    "j/len(inconsistent_words)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 190,
   "id": "617a41fd",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|████████████████████████████████████████████████████████████████████████████| 60200/60200 [10:43<00:00, 93.51it/s]\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "2.0561424796390462e-05"
      ]
     },
     "execution_count": 190,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "j = 0\n",
    "k = 0\n",
    "for word, value in tqdm(degree_centrality.items()):\n",
    "    if word not in inconsistent_words:\n",
    "        j += value\n",
    "        k += 1\n",
    "        \n",
    "j/k"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "f6358d9e",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "8d7653e3",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 142,
   "id": "332fe1a5",
   "metadata": {},
   "outputs": [],
   "source": [
    "eigenvector_centrality = nx.eigenvector_centrality(G_combined)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 167,
   "id": "cceee4fb",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|██████████████████████████████████████████████████████████████████████| 657644/657644 [00:00<00:00, 821661.29it/s]\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "0.017054374067364823"
      ]
     },
     "execution_count": 167,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "j = 0\n",
    "temp_inconsistent = []\n",
    "for inconsistent_word in tqdm(inconsistent_words):\n",
    "    j += eigenvector_centrality[inconsistent_word]\n",
    "    temp_inconsistent.append((inconsistent_word, eigenvector_centrality[inconsistent_word]))\n",
    "j/len(inconsistent_words)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 170,
   "id": "413115ea",
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|███████████████████████████████████████████████████████████████████████████| 60200/60200 [04:39<00:00, 215.59it/s]"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'presentedMAIN': 9.148819220060914e-58, 'MEASURES_Indications': 9.148819220060914e-58, 'thyroid_surgery': 0.0011075402231842013, 'thyroidectomy_procedures': 0.0011075402231842013, 'Sixtysix_patients': 0.0005253840276496832, 'thyroid_surgery_Specific_data': 0.0004734482721133418, 'Specific_data': 0.0004734482721133418, 'thyroidectomy_Surgeries': 8.263922883666513e-55, 'adult_surgeon_surgeon': 1.1686951820486561e-54, 'nerve_monitoring': 8.263922883666513e-55, 'series_procedures': 9.370878031379284e-06, 'endocrine_surgeons': 0.0005744186125156013, 'surgeons_endocrine_surgeons': 0.000426827576725533, 'Transient_hypocalcemia': 9.370878031379284e-06, 'preoperative_cords_assessment': 0.001845170519318405, 'completion_thyroidectomy': 0.0011075402231842013, 'using_the_t_test_for_continuous_data_and_the_chisquare_or_Fisher_exact_tests_for_proportionsRESULTSBetween_   _and_     ': 0.0015677370595522013, 'Eightyone_patients': 7.355661289455479e-06, 'thyroid_cancer_goiter_Table_Indications': 0.0004509738748200637, 'FNA': 0.005268850017504501, 'thyroidectomy_Hypocalcemia': 9.311519742549789e-09, 'thyroidectomy_hemithyroidectomy_completion_thyroidectomy_Neck_dissection': 0.00046041693843165406, 'node_metastasis_patients': 0.0002517139390143281, 'lung_None': 9.148819220060914e-58, 'wound_infection_tracheal_injury': 9.148819220060914e-58, 'iodine_RAI': 0.0005612913089309412, 'RAI': 0.001845170519318405, 'Children': 0.0007862569594425692, 'hypocalcemia': 6.558450856396835e-05, 'to_reach_statistical_significance': 0.004017334243903157, 'previously26_Multiple_studies': 0.004315547045054443, 'highvolume_endocrine_surgeons': 9.148819220060914e-58, 'outcomes_lengths': 9.148819220060914e-58, 'predictors_involvement_subtype_tumor_stage': 0.0018006682651940404, 'validity_quality': 0.00020581955335681126, 'THYROID_MED_JULYAUGUST': 0.0010298344840079976, 'Hameed_R_Zacharin': 0.00014571907968447722, 'Brain_P_Butler_G_et_al_Thyroid_Surgery_Eur_J_Pediatr_Surg': 9.148819220060914e-58, 'LX_Cai_Y_Schwenk_et_al_Pediatric_Endocrine_Surgery': 9.148819220060914e-58, 'factor_analysis': 0.0001655807179399721, 'size_interpretation_model_Onco': 9.148819220060914e-58, 'Ther_\\x93_Papillary_thyroid_carcinoma_Barisella_M_Ferrari': 9.148819220060914e-58, 'ChinaThese_authors': 9.148819220060914e-58, 'AffiliatedHospital': 9.148819220060914e-58, 'probability_tothe_outcomes': 0.0013081885260205425, 'tothe_outcomes': 0.0010325216439875707, 'cementedprosthesis_syndrome': 9.148819220060914e-58, 'to_occur_morefrequently_in_CTA_than_UTA8_Cementedprosthesis_syndrome_theoretically_poses_asignificantlifealthough': 9.148819220060914e-58, 'Cementedprosthesis_syndrome': 9.148819220060914e-58, 'asignificantlifealthough': 9.148819220060914e-58, 'methodsStudy_approval': 8.263922883666513e-55, 'Consecutiveelderly_individuals': 1.1686951820486561e-54, 'YatsenUniversityforinformed_consent': 8.263922883666513e-55, 'manufacturer': 1.1686951820486561e-54, 'offollowup': 8.263922883666513e-55, 'Corporation_Kalamazoo_MI': 8.263922883666513e-55, 'n¼_CTA': 1.1686951820486561e-54, 'stems_cups': 8.263922883666513e-55, 'FNFs_dyskinesia_surgery_cancer': 9.148819220060914e-58, 'comorbidities_thyroiddisorder': 9.148819220060914e-58, 'comorbidities_mechanism': 9.148819220060914e-58, 'using_the_chisquaretest_or_the_Mann\\x93Whitney_test_A_Kaplan\\x93Meier_survival_curve_was_used_to_assess_theprobability_of_revision_Hazard_ratios_werecalculated_using_a_Cox_proportional_hazards_model': 9.148819220060914e-58, 'Kaplan\\x93Meier_survival_curve': 9.148819220060914e-58, 'to_assess_theprobability_of_revision_Hazard_ratios_werecalculated_using_a_Cox_proportional_hazards_model': 9.148819220060914e-58, 'patientsarthroplasties': 0.00017754737915906231, 'arthroplasty_CTA': 0.00041801091420623775, 'p¼_patients_whounderwent_CTA': 9.148819220060914e-58, 'higherfunctionalscores': 9.148819220060914e-58, 'betweengroup_differenceswere': 0.0011075402231842013, 'fracture_dislocation': 0.0002825778555366326, 'revision_prosthesis': 7.417164383651313e-53, 'kgm2BMDSide_leftrightFNFs': 9.148819220060914e-58, 'diseaseMechanism_HHS_neck_fracturesTable': 9.148819220060914e-58, 'arthroplasty_Harris_hip_score': 6.819082656457022e-06, 'hip_arthroplasty': 6.819082656457022e-06, 'n¼_pvalueData': 3.429965887741882e-05, 'Kaplan\\x93Meier_curves': 0.0021017441500042573, 'hiparthroplastysurgeryProbableDiscussionThis_review': 6.819082656457022e-06, 'prosthesis_effect_duration_mechanisms': 9.148819220060914e-58, 'bonemicrostructure': 9.148819220060914e-58, 'results_looseningand_periprosthetic': 0.00238803522972525, 'patientsaccording': 0.00238803522972525, 'survivalcurve': 2.274211562945482e-53, 'using_theKaplan\\x93Meier_method_and_competitiverisks': 1.4055400435083287e-53, 'thesurvival': 0.0001558796594873967, 'lostrevisionHence': 0.00018750364596568773, 'CTA': 0.007713134335009549, 'to_be_acceptable_as_the_followup_timeincreasesDeclaration_of_conflicting': 1.8751550342077923e-05, 'complications_singleblinded': 0.00035730068962257737, 'A_Pet_al_Cementless_results': 9.148819220060914e-58, 'reference_implants_treatment_component_totalhip_arthroplasty': 9.148819220060914e-58, 'alceramiconResults': 9.148819220060914e-58, 'yearsof': 9.148819220060914e-58, 'al_outcome': 9.148819220060914e-58, 'proï¬\\x81ciency_thresholdresults': 9.148819220060914e-58, 'alContemporary': 9.148819220060914e-58, 'Orthop_\\x93_SS_Baker_PN_Mason_J_et_al_Thedesign': 9.148819220060914e-58, 'alConversion': 9.148819220060914e-58, 'hip_screw': 9.148819220060914e-58, 'femur': 0.0019127833147525456, 'reviewof': 9.148819220060914e-58, 'trials_\\x93_0c': 9.148819220060914e-58, 'fatigue_events_hypertension': 0.00015319874332371669, 'treatment_tolerability_quality': 0.00015319874332371669, 'exposure_tolerability': 0.004315547045054443, 'consumption_smoking_obesity_diabetes': 0.0006962110463623345, 'clinicians_patients': 0.0006313632619292757, 'sorafenib': 0.00197643730053593, 'survival_PFS': 0.00012094074060835584, 'event_AE': 0.001845170519318405, 'event_AE_challenges': 0.00022770977125509355, 'treating_patients_with_advanced_HCC': 0.0001605551227252273, 'treatment_tolerability': 0.004315547045054443, 'to_have_had_prior_treatment_with_sorafenib': 0.00018750364596568773, 'ChildPugh_liver_function': 9.148819220060914e-58, 'to_have_had_prior_treatment_with_sorafenib_regimens': 9.148819220060914e-58, 'a0_Cabozantinib': 0.00017731000520225518, 'to_manage': 3.012831237073818e-05, 'Eightyfour_percent': 0.00011083140704636044, 'to_dose_interruption': 0.004315547045054443, 'dose_interruption': 0.004315547045054443, 'Sixtytwo_percent': 4.878200787065819e-05, 'Thirtythree_percent': 4.878200787065819e-05, 'to_dose_interruption_ _and_dose_reduction_ ': 0.004315547045054443, 'dose_interruption_rate': 0.001845170519318405, 'PPE_fatigue': 9.148819220060914e-58, 'appetite_diarrhea_nausea': 9.148819220060914e-58, 'Fig_Incidence_rates': 0.001845170519318405, 'cabozantinib': 0.000379170394600513, 'event_palmarplantar_erythrodysesthesiawho': 3.2261538207425514e-05, 'to_impact_the_types_or_rates_of_grade_ ': 0.0007129960827382031, 'ChildPugh_C': 0.001845170519318405, 'headaches_seizures_altered': 0.0038806204677737646, 'HCCrelated_comorbidities': 9.148819220060914e-58, 'disease_NASH_diabetes': 9.148819220060914e-58, 'excluded': 0.000514692913697106, 'immunosuppression_TKIs': 9.148819220060914e-58, 'to_treat_posttransplant_HCC_recurrence': 9.148819220060914e-58, 'collaboration': 8.263922883666513e-55, 'efficacy_tolerability': 0.0038806204677737646, 'Awareness': 0.00018869384058700235, 'to_have_a_minimal_effect_on_cabozantinib_exposure': 4.7223204598687044e-05, 'European_Summary': 9.148819220060914e-58, 'dose_adjustments': 9.148819220060914e-58, 'levels_efficacy_risk': 9.148819220060914e-58, 'enzyme_cytochrome': 9.148819220060914e-58, '¢_Patients': 9.148819220060914e-58, 'cabozantinib_esod_dloHgrade': 9.148819220060914e-58, 'osteonecrosis': 6.420103923978744e-06, 'a0_mg': 0.00039360733056005966, 'CYP3A4_inducers': 9.148819220060914e-58, 'to_be_coadministered': 9.148819220060914e-58, 'Cabozantinib': 0.0001249115260204846, 'a0_mg_a0_mg': 2.038018885672177e-06, 'antiarrhythmics_QTprolonging_agents': 0.0011075402231842013, 'QT_interval': 0.0023895703205376083, 'a0ms': 3.9000533540774874e-05, 'QTcF_QT': 9.148819220060914e-58, 'using_Fridericia\\x99s_method': 9.148819220060914e-58, 'exposure_levels': 0.0007956673215405282, 'hypomagnesemia': 0.00011233760546888353, 'Pretreatment_AssessmentsGiven': 0.004315547045054443, 'care_team': 9.148819220060914e-58, 'oncology_pharmacist': 9.148819220060914e-58, 'duplications': 8.263922883666513e-55, 'to_minimize_the_risk_of_drugdrug_interactions_  ': 1.1686951820486561e-54, 'concomitant_PPIs_antagonists_H2_blockers_Switching_deprescribing': 8.263922883666513e-55, 'to_grade_\\x89¤': 0.00010862599653768998, 'a0_Palmar\\x93Plantar_PPE': 9.148819220060914e-58, 'pain_redness': 9.148819220060914e-58, 'diffuse_pattern': 0.0038806204677737646, 'Prophylaxis_management': 9.148819220060914e-58, 'to_minimize_the_impact_of_PPE_on_QoL_and_adherence': 9.148819220060914e-58, 'Prophylactic_measures': 9.148819220060914e-58, 'care_practices': 9.148819220060914e-58, 'Recommendations': 0.0007956673215405282, 'Treatment_strategies': 9.148819220060914e-58, 'moisturization_prevention': 9.148819220060914e-58, '0cTable_event_management': 0.00018750364596568773, 'force_rubbing_dish_washing': 0.004315547045054443, 'Advise': 6.440032671203723e-06, 'GastrointestinalDiarrheaProphylaxisInstruct_patients': 0.00011470062400604284, 'L_oz_a0Advise_patients': 9.28788186522461e-05, 'stool_diary': 1.515277479635216e-06, 'GI_events': 0.004315547045054443, 'careAdminister_loperamide': 9.148819220060914e-58, 'diphenoxylate_tincture_modifications': 9.148819220060914e-58, 'hydration_correction': 9.148819220060914e-58, 'lactosecontaining_food_and_drink': 9.148819220060914e-58, 'BRAT_applesauce_toast_diet': 9.148819220060914e-58, 'to_alleviate_mild_diarrhea': 9.148819220060914e-58, 'scheduled': 0.0011075402231842013, 'neurotransmitters': 0.004315547045054443, 'caries_ulcers': 1.979324738051553e-06, 'fooddrink': 3.5025312451811044e-05, 'Lactobacillus_lozenges': 9.148819220060914e-58, 'to_reduce_inflammation': 9.148819220060914e-58, 'event_management': 9.148819220060914e-58, 'laboratory_evaluation_instrument_test': 9.148819220060914e-58, 'BP_log': 0.0013882295497307361, 'Check_for_potential_drugdrug_interactions_of_existing_antihypertensive_agents_with_cabozantinib_Supplementary_Table_a0Consider_effects_of_concomitant_medications_on_BP_eg_antiinflammatory_drugs': 9.148819220060914e-58, 'BP_opiates': 9.148819220060914e-58, '[_]_Check_for_potential_drugdrug_interactions_of_existing_antihypertensive_agents_with_cabozantinib_Supplementary_Table_a0Consider_effects_of_concomitant_medications_on_BP_eg_antiinflammatory_drugs_can_increase_BP_opiates': 3.068955104805565e-05, 'enzyme_inhibitors_receptor_blockers': 1.1686951820486561e-54, 'to_treat_hypertension': 8.263922883666513e-55, 'CYP3A4_substrates': 8.263922883666513e-55, 'a0Amlodipine_felodipine_lercanidipine_nisoldipine_nifedipine': 9.148819220060914e-58, 'to_be_CYP3A4_inhibitors': 9.148819220060914e-58, 'visits\\x94phone_calls': 1.454071093465488e-05, 'to_report_early_signs_of_PPE_to_their_healthcare_provider': 0.00018750364596568773, 'reporting_management': 0.001845170519318405, 'inChina': 0.0038806204677737646, 'theiractivity': 0.00014571907968447722, 'surgeons_maxillofacialsurgeons_ophthalmologists_dentists': 0.007713134335009549, 'dysphonia': 9.148819220060914e-58, 'intubation_scarring': 9.148819220060914e-58, 'obstructionalso': 9.148819220060914e-58, 'to_be_urgently_treated': 9.148819220060914e-58, 'atrofolds_disappearance': 0.0006313632619292757, 'fold_disfunctionVFD': 0.0011075402231842013, 'possibility_ofrecovery': 0.0006313632619292757, 'indicationthat': 0.007713134335009549, 'need_possibility_oftreatments_delay': 0.004315547045054443, 'health_emergencythe_management_phase': 0.007713134335009549, 'limits_andweaknesses': 4.8731369232800345e-05, 'resumption': 0.0010325216439875707, 'preferring_less_invasive_techniques': 0.0007862569594425692, 'evenin_healthcare_services': 0.0007956673215405282, 'teleconference': 0.004315547045054443, 'conï¬\\x82ict_ofinterestPublisher\\x99s_note': 0.0013882295497307361, 'BreeA_Rinaldo_RP': 9.148819220060914e-58, 'A_Carvalho_CR_Bradford_V_Paleri_PiazzaPD_JP_Rodrigo_O_GuntinasLichius_WM': 9.148819220060914e-58, 'LLC_part': 0.0014616190772430405, 'Medrxiv_Google_Scholar_PubMEDMEDLINE': 0.00010049604554307965, 'outcome_timing_setting': 1.1686951820486561e-54, 'to_perform_the_review_Of_the_ _identified_studies_ ': 8.263922883666513e-55, 'salivary_endothelial_cells': 6.919720243997144e-05, 'to_be_the_functional_receptor_of_some_coronavirus_species_as_initially_discovered_in_ _during_the_severe_acute_respiratory_syndrome_coronavirus_SARSCoV_epidemic': 3.152676267993047e-06, 'spread_development': 3.962922384738482e-05, 'authorsjeromelechienumonsacbe_Lechien_author_information': 6.471759908259953e-07, 'transmembrane_protease': 0.00010596020021879068, 'to_shed_light_on_the_pathophysiology_of_disease_in_the_head_and_neck': 0.00033788292231117737, 'review_process': 8.263922883666513e-55, 'ACE2_TMPRSS2_expressions': 0.00010049604554307965, 'CriteriaThe_papers': 9.148819220060914e-58, 'to_include_either_human_or_animal_subjects_The_authors_extracted_substantial_information_about_the_sample_characteristics_including_species_involved_and_ACE2_and_TMPRSS2_identification': 9.148819220060914e-58, 'intervention_studies': 0.007713134335009549, 'Scholar_Medrxiv_Scopus_Cochrane_search': 0.0007959416758056306, 'publications_\\x98coronavirus\\x99_\\x98salivary\\x99': 0.0007959416758056306, '\\x98TMPRSS2²_\\x98SARS\\x99': 0.0007959416758056306, 'ACE2_expression_Table_Studies': 0.0018006682651940404, 'Nasal_Nasopharyngeal_Epithelium_endotheliumACE2': 8.21290040927368e-11, 'ACE2_TMPRSS2_Olfactory_EpitheliumHuman': 9.148819220060914e-58, 'ACE2_gene': 9.148819220060914e-58, 'characteristics_comorbidities_medication_use': 0.00010867396690586445, 'expression_ACE2': 9.148819220060914e-58, 'thyroid_cells': 9.148819220060914e-58, 'Angiotensin_Immunohistochemistry_RTPCR': 9.148819220060914e-58, 'polymerase_chain_reaction_syndrome': 9.148819220060914e-58, 'ACE2_expression_study': 0.0018006682651940404, 'ACE2_TMPRSS2_Table': 0.004315547045054443, 'ACE2_TMPRSS2_Tissue_Expression': 1.1357482212867279e-05, 'Vaarala_et': 9.148819220060914e-58, 'TMPRSS2_expression': 9.148819220060914e-58, 'Sungnak': 9.148819220060914e-58, 'ACE2_Lee_et': 9.148819220060914e-58, 'whatever': 0.00012264967119603705, 'Hikmet': 0.00010867396690586445, 'studies_RNAseq': 0.0016810521528134112, 'to_entry_into_the_cells_which_is_allowed_through_ACE2_and_TMPRSS2_receptors': 3.142797333726909e-05, 'TMPRSS2_receptors': 9.148819220060914e-58, 'light_picture': 9.148819220060914e-58, 'virus_concentration': 0.0011075402231842013, 'olfactory_dysfunction': 0.0004294386118539378, 'SARSCOV2': 0.0011125787591309202, 'olfactory_cleft_epithelium': 7.723613244264731e-05, 'infection_process': 0.0006750162805663558, 'to_be_the_case_for_a_majority_of_patients': 0.0006313632619292757, 'literature_findings_parotitis': 0.0014616190772430405, 'monkeys': 0.00016343501035482602, 'characteristics_comorbidities_medication': 0.00010867396690586445, 'polymorphism_TMPRSS2_expression': 0.0006264573400700461, 'to_be_considered_in_future_studies_Otherwise_according_to_the_Bgee_database_https_bgee_expression_of_ACE2_and': 0.004315547045054443, 'to_be_confirmed_in_humans': 0.0008822241915335798, 'Sorokin_et': 0.0009886750493927547, 'complementarity': 0.0013882295497307361, 'to_enlarge_and_diversify_patient_cohorts_and_to_combine_transcriptomic_and_proteomic_strategies_as_well_as_colocalize_different_markers_of_SARSCoV2_such_as_ACE2_and_TMPRSS2_to_provide_an_accurate_representation_of_ACE2_expression_through_all_head_and_neck_areas_of_the_whole_populationSecond': 0.00210348072096923, 'factors_use': 0.0002307607641150719, 'pattern_entry': 9.148819220060914e-58, 'to_better_understand_the_cell_entry_mechanisms_of_SARSCoV2Author_contributions_ _JR_TR_SS_JM_design_acquisition_of_data_data_analysis_ _interpretation_drafting_final_approval_and_accountability_ _0cHead_and_Neck_Pathology_for_the_work_final_approval_of_the_version_to_be_published_agreement_to_be_accountable_for_all_aspects_of_the_work_in_ensuring_that_questions_related_to_the_accuracy_or_integrity_of_any_part_of_the_work_are_appropriately_investigated_and_resolved_CCH_CMCE_MRB_IG_design_data_analysis_ _interpretation_revising_the_manuscript_for_important_intellectual_content_final_approval_of_the_version_to_be_published_final_approval_and_accountability_for_the_work_final_approval_of_the_version_to_be_published_agreement_to_be_accountable_for_all_aspects_of_the_work_in_ensuring_that_questions_related_to_the_accuracy_or_integrity_of_any_part_of_the_work_are_appropriately_investigated_and_resolved_LS_SH_GC_GD_JH_LV_GR_design_acquisition_of_data_data_analysis_ _interpretation_drafting_some_parts_of_the_manuscript_final_approval_of_the_version_to_be_published_final_approval_and_accountability_for_the_work_final_approval_of_the_version_to_be_published_agreement_to_be_accountable_for_all_aspects_of_the_work_in_ensuring_that_questions_related_to_the_accuracy_or_integrity_of_any_part_of_the_work_are_appropriately_investigated_and_resolvedCompliance_with_Ethical_Standards_Conflict_of_interest_ _The_authors_declare_that_they_have_no_conflict_of_interestReferences_   _Crackower_MA': 9.148819220060914e-58, 'analysis_interpretation': 0.0002353888884382476, 'GR_design_acquisition': 0.0002353888884382476, 'Lechien_JR_De_Siati': 9.148819220060914e-58, 'study_Thompson_M_Tiwari': 9.148819220060914e-58, 'mechanisms_need': 0.0016810521528134112, 'ACE2_protein_expression': 9.148819220060914e-58, 'ACE_inhibitors_receptor_blockers': 9.148819220060914e-58, 'CNVR': 0.007931022133590704, 'PennCNV_QuantiSNP': 0.004445204961498913, 'gain_ _loss_and_ _gainloss_events': 0.007713134335009549, 'caprine_breeds': 0.0019127833147525456, 'CNV': 0.007854223330154756, 'deletions_duplications': 0.00012840823518985223, 'Evol_Page_susceptibility': 4.652039493512524e-06, 'pleiotropy': 0.0009466755491730313, 'genes_mapping': 9.148819220060914e-58, 'housekeeping_functions': 9.148819220060914e-58, 'CNV_mapping': 0.00024810373354211296, 'genomewide_genotyping': 7.31082106841838e-05, 'population_history': 0.0013882295497307361, 'results_samples': 0.004315547045054443, 'Genomic_DNA': 9.148819220060914e-58, 'saltingout_procedure': 9.148819220060914e-58, 'Tween': 4.222254431697653e-06, 'EDTA': 0.00025897772538688237, '\\x97g_Pelleted_cells': 4.222254431697653e-06, 'centrifuging': 9.148819220060914e-58, 'a0mmolL_Tris_a0mmolL_EDTA': 9.148819220060914e-58, 'software_packages': 0.007713134335009549, 'CNV_Evol_Page': 0.007743912198506766, ']_Bayes_hiddenMarkov_model': 9.148819220060914e-58, 'to_improve_the_accuracy_of_segmental_ _aneuploidy_ _identification_ _and_ _mapping_ ': 9.148819220060914e-58, 'CNV_software': 9.148819220060914e-58, 'to_improve_the_accuracy_of_segmental_ _aneuploidy_ _identification_ _and_ _mapping_ _algorithm_beta_version': 9.148819220060914e-58, 'algorithm_beta_version': 8.75289702099033e-05, 'to_ _generate_ _a_ _set_ _of_ _initial_ _CNVR_ _by_ _using_ _the_ _heuristic_ _algorithm_ _threshold_of_ _minimum_ _overlap_   ': 0.00012840823518985223, 'CNV_calls': 0.007842792251454019, 'callers': 0.004315547045054443, 'NCBI_https_wwwncbinlmnihgov': 0.004315547045054443, 'GO_enrichment_pathway_analyses': 0.007713134335009549, 'qPCR_experiments': 0.00771518910792271, 'CNVR_506_chr6_CNVR_160_chr2_CNVR_1229_chr21_Primers': 0.00012613970685026185, 'BST1': 9.148819220060914e-58, 'Table_a0_S1': 9.148819220060914e-58, 'melanocortin_receptor_MC1R_GCG_genes': 0.007713134335009549, 'PCR_reactions': 9.148819220060914e-58, 'Applied_Biosystems_a0pmol': 9.148819220060914e-58, 'BeadChip_data': 5.98275832447814e-06, 'calling': 0.00012840823518985223, 'QuantiSNP_CNVR': 2.0977983107287385e-06, 'a0Mb': 0.0002481436736472543, 'Fig_a0_see': 8.263922883666513e-55, 'CNVR\\x9d': 1.1686951820486561e-54, 'a0_Six': 8.263922883666513e-55, 'proteincoding_ _genes_ ': 0.007713134335009549, 'Evol_Page': 9.148819220060914e-58, 'number_gain': 9.148819220060914e-58, 'olfactory_receptors_genes': 1.6305647145567253e-06, 'file_a0_Table': 9.995919888039129e-05, 'receptor_activity_0cGuan_a0et_Evol_Page_CNVR': 3.701062656309244e-07, 'threshold_qvalue': 6.918627002654179e-05, 'Several': 1.1686951820486561e-54, 'roles_cell_receptor': 8.263922883666513e-55, 'nucleotide_receptor': 0.00038852985528957303, 'DNA_bindingGO0045028_G\\x91protein': 6.335025160465715e-06, 'CNVR_CNVR_506_chr6': 0.007713134335009549, 'deletion_duplication': 0.0010298344840079976, 'axes': 9.148819220060914e-58, 'sample_ID_quantification_error': 9.148819220060914e-58, 'average_Evol_Page': 0.007713134335009549, 'breeds': 0.0013882295497307361, 'parameter': 0.00043463382250315263, 'proteincoding_genes': 0.0006333821608604568, 'Pathway_analyses': 0.0002788738900395108, 'enrichment_enrichment': 9.603340748678197e-05, '\\x9cGprotein': 9.148819220060914e-58, 'nucleotide_receptor_activity\\x9d': 9.148819220060914e-58, 'odor_responsiveness': 0.004315547045054443, 'perceptions': 0.00012470894175528098, 'increases_reductions': 0.0038806204677737646, 'olfactory_receptor_genes': 9.148819220060914e-58, 'gene_superfamily': 9.148819220060914e-58, '[_]_Interestingly_copy_number_changes_in_the_olfactory_receptor_genes_of_wild_and_domestic_mammals': 0.00035613247455696745, 'enrichment_result': 0.007713134335009549, 'ABC_transporters': 8.263922883666513e-55, 'mission': 1.1686951820486561e-54, 'ABC_genes': 8.263922883666513e-55, 'enrichment_comparison': 0.007713134335009549, 'metalloproteinase': 0.0003322263502299899, 'Taking_ _the_ _above_ _evidence_ _into_ _account_the_implication_of_structural_chromosomal_variations_in_the_ _genetic_ _determinism_ _of_ _traits_ _of_ _economic_ _interest_with_a_complex_inheritance': 0.0001259499022484664, 'inferring_CNVR_genotypes_with_high': 0.004315547045054443, 'CNV_surveys': 0.0008522036149147152, 'nucleotide_receptor_activity': 0.001388599655996367, 'cm_decrease': 8.263922883666513e-55, 'cm_events_signs_decrease': 0.001913293146368052, 'VAS': 0.005362496865508147, 'events_signs': 8.756957618756808e-05, 'pain_relief': 8.939903090837168e-05, 'Nalbuphine': 1.4583367481568567e-06, 'dissatisfaction': 9.148819220060914e-58, 'discharge_hospital_admission': 9.148819220060914e-58, 'discharge_hospitaladmission': 9.312279735551695e-06, 'to_achieve_early_recovery_after_surgery': 0.0002919243480472275, 'hospitalization_mobility': 0.000514692913697106, 'considerationsfor_patients': 9.148819220060914e-58, 'to_prolong_postoperativeanalgesia_such_as_tramadol': 9.148819220060914e-58, '[_]_Nalbuphine_[_]_exerts_its_analgesic_and_hypnotic_effects_through_its_Îº_opioid_receptorwhich': 9.148819220060914e-58, 'adverseevents_studies': 9.148819220060914e-58, 'Committee_ofXiangya_Hospital': 0.0019127833147525456, 'Thestudy': 1.1686951820486561e-54, 'score_  _cm': 8.263922883666513e-55, 'kgm2and': 9.148819220060914e-58, 'consentPatients': 9.148819220060914e-58, 'inthe_product': 9.148819220060914e-58, 'score_  _cm_pressure_headinjury': 9.148819220060914e-58, 'pressure_headinjury': 8.263922883666513e-55, 'monoamine_oxidaseinhibitor_antidepressants': 0.0011075402231842013, 'mgL_Group_Cwas': 8.263922883666513e-55, 'tramadol_hydrochloride': 1.1686951820486561e-54, 'Anesthesiawas': 0.00010091043324597703, 'to_evaluate_the_efficacy_of_the_medications_and_wasrecorded_before_administration_T1_and': 0.002192218464447407, 'pressure_MAP': 3.578740395375256e-05, 'rescue_name_dose': 0.0007956673215405282, 'analgesics': 9.148819220060914e-58, 'to_control_the_pain': 9.148819220060914e-58, 'pain_intensity': 3.579694085374223e-05, 'Î¼BAEach_group': 0.0002968905730015634, 'subjects_to_describe_all_demographic_data_The_ttest_was_applied_to_analyze_thechanges_in_VAS_scores_between_the_two_treatmentgroups_at_each_timepoint_and_at_different_timepointsrelative_to_the_baseline_toanalyze_using_the_chisquared_Ï\\x872_testP_  _codedpatients': 0.001845170519318405, 'to_describe_all_demographic_data_The_ttest_was_applied_to_analyze_thechanges_in_VAS_scores_between_the_two_treatmentgroups_at_each_timepoint_and_at_different_timepointsrelative_to_the_baseline': 4.8449738335945846e-06, 'to_analyze_thechanges_in_VAS_scores_between_the_two_treatmentgroups_at_each_timepoint_and_at_different_timepointsrelative_to_the_baseline': 0.00011026011152073265, 'Wilcoxon_test': 3.523365424243955e-05, 'using_the_chisquared_Ï\\x872_testP_  ': 5.841614546987672e-07, 'codedpatients': 0.00046683359119049114, 'theeligibility_criteria': 0.0013882295497307361, '±_MAP_mmHgaGroup_E': 8.263922883666513e-55, 'OutcomesPrimary_outcomeA_comparison': 9.148819220060914e-58, 'nodifference': 9.148819220060914e-58, 'surgery_Group_E': 9.148819220060914e-58, 'longerduration': 9.148819220060914e-58, 'Canesthesia_need': 9.148819220060914e-58, 'avoid_complications_related_to_surgery_and_anesthesiasuch_as_pain_nausea_and_vomiting_Numerous_studies': 9.148819220060914e-58, 'experience_pain': 1.1686951820486561e-54, 'patients\\x99_rehabilitation': 8.263922883666513e-55, 'hospitalizationit': 8.263922883666513e-55, 'opioidreceptors': 3.216357772176876e-05, 'analgesic_adversereactions_asnalbuphine_dezocine': 9.148819220060914e-58, 'ceiling_effectImplementation': 9.148819220060914e-58, 'NSAIDscan': 0.0003640060763646834, 'opioid': 0.00054686425127897, 'nalbuphine': 0.0019132930105159865, 'surgery_results': 3.1235511726865175e-05, 'antagonism': 8.198185194464105e-05, 'neonate': 0.0003640060763646834, 'stress_responses_fluctuations': 9.109139931402274e-06, 'eventsand_change': 8.756957618756808e-05, 'collectionand_analysis': 3.333920198953135e-05, 'LCJ': 3.333920198953135e-05, 'most_CZG': 3.333920198953135e-05, 'FukudaK': 9.148819220060914e-58, 'discharge_acceptability_pain_treatment': 9.148819220060914e-58, 'surgeryERAS': 9.148819220060914e-58, 'Time': 9.148819220060914e-58, 'httpsdoi104097kjae2017704398Acalovschi_Gavrus_R_Tramadol': 9.148819220060914e-58, 'Anesth_Analg_MP_Djordjevic_DR_Pavlovic_MSDoes': 9.148819220060914e-58, 'D_B_Addition': 9.148819220060914e-58, 'Anaesthesiol_Clin_Pharmacol': 9.148819220060914e-58, 'N_Intrathecal': 2.2480340991203723e-51, 'to_beundermanaged_Anesth_Analg_\\x93_table_of_contents_Aubrun_F_Ecoffey_C_Benhamou_D_Jouffroy_L_Diemunsch_P_Skaare': 8.937521195812353e-05, 'D_levels': 1.1686951820486561e-54, 'risks_pregnancy_birth_outcomes': 8.263922883666513e-55, 'risks_pregnancy_birth_outcomes_explorationMethods': 0.0016480626375926124, 'explorationMethods': 8.263922883666513e-55, 'Outcomes_Cox_regression_analysis': 9.148819220060914e-58, 'to_explore_these_associationsResults': 9.148819220060914e-58, 'definitive': 0.0003645333095764079, 'Severalproblems': 9.148819220060914e-58, 'to_be_solved_by_further_studies_the_heterogeneity_of_associations_from_diverse_areas_and_populations_with_different_vitamin_D_status_serve_as_evidencethewhen_makingguidelinesregionsforspecific': 9.148819220060914e-58, 'BMC_Pregnancy_Childbirth_Page': 0.00014504133342722406, 'problem_inference': 2.367229043103349e-06, 'complications_birth_outcomes': 9.148819220060914e-58, 'age_increases': 9.148819220060914e-58, 'andmore_studies': 9.148819220060914e-58, 'to_better_illustrate_the_problemWe': 9.148819220060914e-58, 'pregnancy_serum': 0.0011075402231842013, 'twin': 3.987512783397426e-05, 'pregnancies_seriousdiseases': 3.987512783397426e-05, 'twin_pregnancies_seriousdiseases_aclinical_laboratory': 0.00013767629634858926, 'aclinical_laboratory': 3.987512783397426e-05, 'tolerance_test': 2.923500917078736e-07, 'deviation_SD_median': 1.7902809750475368e-05, 'GDM': 2.923500917078736e-07, 'Stratifiedanalyses': 1.3137913424028145e-05, 'nmolL_subjects': 9.148819220060914e-58, 'percentage_incidence_incidence': 9.148819220060914e-58, 'CI_decrease_CI_decrease': 0.0003802249829989744, 'for25OHD2_25OHD3': 0.0016480626375926124, 'CI_decrease_CI_decrease_for25OHD2_25OHD3': 0.0003645333095764079, 'distressand_macrosomia': 0.0008522036149147152, '\\x89¥_nmolL': 8.263922883666513e-55, 'decrease_decrease': 1.1686951820486561e-54, 'Seasonspring_ _summer_±_ _±_ _±_autumn_ _winter_±_ _±_ _±_P_  _25OHD_nmolL25OHD2_nmolL25OHD3_nmolLDiscussionIn_this_retrospective_cohort_study_including_ _Chinese_motherinfant_pairs_protective_associations_werefound_for_higher_serum_25OHD_concentrations_withGDM_cesarean_section_postpartum_hemorrhage_preterm_birth_and_low_birth_weight_but_not_for_the_otheroutcomes_The_results_for_25OHD2_tended_to_be_morepronounced_than_those_for_25OHD3Interestinglyhigher_serum_vitamin_D': 0.0004033468197677982, 'to_be_morepronounced_than_those_for_25OHD3Interestinglyhigher_serum_vitamin_D': 0.0016480626375926124, 'D_status': 0.0007862569594425692, 'vitamin_D': 9.148819220060914e-58, 'birthweight': 9.148819220060914e-58, 'update_study': 0.0016480626375926124, '25OHDconcentrations': 9.148819220060914e-58, 'to_increase_the_ _riskof_preterm_delivery_in_a_prospective_study_of_pregnant_Chinese_women': 9.148819220060914e-58, 'D_deficiency': 8.799503466160653e-05, 'to_be_associated_with_a_2fold_increased_risk_of_cesarean_section_ina_cohort_of_ _lowincome_pregnant_women': 1.4360699361432554e-06, 'status_\\x89¥_nmolL_doseof_IUd_supplement': 9.148819220060914e-58, 'Subclass_analysis': 9.148819220060914e-58, 'explain_the_ethnic_heterogeneity': 0.0006768252640912667, 'forcausal_inference_preventionBecause_25OHD3': 0.00025126313729024964, 'to_represent_25OHDin_many_studies_and': 0.00210348072096923, 'on25OHD2': 0.0018006682651940404, 'to_be_more_pronounced_in_25OHD2_than_in25OHD3_and_mightindicate_the_prominence_of25OHD2_over_25OHD3_for_the_prevention_of_relateddiseases_This_theory_merits_further_confirmation_Nevertheless_our_results_and_others_provide_further_evidencefor_the_importance_of_a_better_early_vitamin_D_status_forthe_prevention_of_GDM_cesarean_section_preterm_birthand_low_birth_weight_in_a_population_with_a_high_prevalence_of_vitamin_D_deficiency': 0.0003645333095764079, 'ages_women': 0.00021180960367334957, 'to_improve_the_gestational_vitamin_D_status_ofChinese_populationVitamin_D_deficiency_was_found_to_decrease_vasculardiameter_within_the_labyrinth_region_and_dysregulateplacental_development_during_early_pregnancy_in_an_animal_experiment': 0.00018738920974274527, 'to_decrease_vasculardiameter_within_the_labyrinth_region_and_dysregulateplacental_development_during_early_pregnancy_in_an_animal_experiment': 1.3938540432009226e-05, 'D_supplementation': 5.557887566346264e-05, 'to_explain_the_beneficialinfluences_of_vitamin_D_for_maternal_and_infanthealth_and_emphasize_the_importance_of_improving_vitamin_D_status_during_early_pregnancyOurstudy': 0.0004405647755333974, 'comprehensiveunderstanding': 0.0038816544549862162, 'thelack': 0.0019127833147525456, 'survey_sowe': 0.0008581749454218445, 'to_be_underestimated_instead_of': 0.0003645333095764079, 'to_control_several_potential_covariatesConclusionsThis_retrospective_cohort_study': 0.007713134335009549, 'birth_Standard_deviationAcknowledgementsWe': 1.1686951820486561e-54, 'associations_preterm_birth_birthweight': 8.263922883666513e-55, 'to_thank': 8.263922883666513e-55, 'Liu_Haojing_Wangdong_Huang_Shaobing_ZPL': 0.0035092159424802275, 'DXL_DZF': 0.001129870936471824, 'GDC_TTP': 9.148819220060914e-58, '2019A1515110163_GDC_theFoundation': 9.148819220060914e-58, 'XLG_ZPL_XLG_ZPL': 3.1558237422569986e-05, 'andZPL': 3.4213118569611756e-05, 'Basic_ResearchFoundation': 0.0003167145330801072, 'funding_sponsors': 9.148819220060914e-58, 'role_study_manuscript': 9.148819220060914e-58, 'BMC_Pregnancy_Childbirth_Page_datasets': 0.00015405187241821327, 'details1Foshan_Institute': 0.0013882295497307361, 'TK_Makitie_OM': 9.148819220060914e-58, 'diabetes_size_Vallibhakara_SA_Tantrakul_V_Vallibhakara_O_Rattanasiri_S': 9.148819220060914e-58, 'Thakkinstian_D_supplementation_forprevention': 0.0005453157274894982, 'Zhang_Y_Gong_Y_Xue_H_Xiong_J_Cheng_G_Vitamin_D_gestationaldiabetes': 8.896473974437824e-06, '\\x93_MX_Pan_GT_Guo_JF_Li': 8.896473974437824e-06, 'Luo_BA': 9.148819220060914e-58, 'Maternal_Vitamin_D_DeficiencyIncrease_Risk': 9.148819220060914e-58, 'A_Espada_M_Sunyer_J_et_alAssociations_birth_outcomes': 0.00015266313713209798, 'Thomas_status_effects': 0.00020329019466379467, 'hormone_hypothesis': 9.148819220060914e-58, 'Biochem_MolBiol': 9.148819220060914e-58, 'lowerrisk': 0.001997833656450503, 'yetMethods_Data': 0.0005345134679592639, 'proliferationapoptosis_migration': 9.148819220060914e-58, 'TUNEL_Transwell_woundhealing_assays': 9.148819220060914e-58, 'reporter_RNA': 9.148819220060914e-58, 'LINC00992_interactedwith': 9.148819220060914e-58, 'to_detect_the_interplays_amongLINC00992_miR3935': 4.549016255259865e-06, 'levels_to_detect_the_interplays_amongLINC00992_miR3935_LINC00992_interactedwith_to_elevate_GOLM1_expression_in_prostate_cancer_cells_use_link': 0.0010431809981970577, 'to_elevate_GOLM1_expression_in_prostate_cancer_cells': 0.00019097738328234247, 'tumor_amongmen': 0.0002069818544961052, 'patientsduring_deprivation_treatment': 9.148819220060914e-58, 'castrationresistance': 9.148819220060914e-58, 'RNAs_lncRNAsare': 0.0004294386118539378, 'LncRNAs': 9.148819220060914e-58, 'to_be_related_to_tumor_neoplasia_and': 9.148819220060914e-58, 'tumor_aspects': 0.000302093565533489, 'A1BGAS1': 9.148819220060914e-58, 'cell_proliferation_invasionin_hepatocellular_carcinoma': 9.148819220060914e-58, 'to_be_elevated_in_tumors_and_substantiated_as_a_master_regulator_for_chemoresistance': 0.004315547045054443, 'LINC00992': 0.0040874486506725025, 'to_work_asmolecular_scaffolds_or_alternative_splicing_assistants': 2.797763910584555e-05, 'exampleTNFÎ±induced_lncRNA_LOC105374902': 7.906954776487077e-05, 'LncRNA_TTNAS1': 8.263922883666513e-55, 'whetherLINC00992': 0.0012486352241149578, 'functions_research_scopeMethodsTissue_tissue_samples': 6.866838687639994e-05, 'scopeMethodsTissue_tissue_samples': 2.037037645676908e-05, 'consentsbefore_study': 5.973401273075715e-05, 'NCmimics_NCinhibitor': 5.326770801494381e-05, 'STR_profilingand': 0.00031278352800590204, '0cChen_BMC_Cancer_Page': 0.00018114260846750725, 'devised': 7.846956370266175e-05, 'blotanalysis_lysis_buffer': 0.00018114260846750725, 'LINC00992WT': 9.148819220060914e-58, 'GOLM1MUT': 9.148819220060914e-58, 'reportersand': 9.148819220060914e-58, 'cellsapplying_lipofectamine2000_Invitrogen': 9.148819220060914e-58, 'mimics_inhibitor_cotransfected_assessed': 4.429086638504429e-07, 'cellsapplying_lipofectamine2000_Invitrogen_ratio': 2.7189975659556832e-06, 'luciferase_activity_GloMax_Multimode_Microplate_Reader_Promega': 0.0003285968246522835, 'RIP_lysisbuffer': 4.429086638504429e-07, 'China_FISH': 9.148819220060914e-58, 'permeabilization_DU145': 9.148819220060914e-58, 'PC3_cellswere': 0.0002411562353885948, 'permeabilization_DU145_solution': 0.0002065529613752868, 'absorbance_values': 8.263922883666513e-55, 'inparaffin': 0.00029675846166351524, 'proliferation_apoptosis_qRTPCR_RWPE1_cells_qRTPCR': 0.00013756805643468518, 'RWPE1_cells': 0.00013756805643468518, 'c_expression': 0.00019947110862862885, 'to_examine_the_expression_of_apoptosisrelated_proteins': 0.0002517988922651906, 'migration_PC3_cellswas': 2.9279898096832442e-06, 'healing_scale_bar': 0.00017943886791910068, 'proliferation_Fig_1d_Fig_1e': 0.00011931918217645773, 'expression_levels_D1': 9.148819220060914e-58, 'Figure_S1C': 9.148819220060914e-58, 'LINC00992knockdown': 9.148819220060914e-58, 'apoptosis_PC3cells': 9.148819220060914e-58, 'pSrc_pFAK': 9.148819220060914e-58, 'Figure_S1E': 9.148819220060914e-58, 'outgainoffunction_assays': 0.007713134335009549, 'Figure_S2A_cellproliferation': 0.00021109575081830262, 'expectedthe_expression': 0.00045660454367155184, 'suppress_apoptosisin_prostate': 9.148819220060914e-58, 'LINC00992Given_correlation': 9.148819220060914e-58, 'mainlyin_Fig_2a': 9.148819220060914e-58, 'assay_RNAisolation': 9.148819220060914e-58, 'LINC00992_located_mainlyin_cytoplasm_Fig_2a_Likewise_FISH_assay_and_RNAisolation_of_nuclear_and_cytoplasmic_fractions': 0.000254619872099857, 'depletion_Fig_2e_overexpression': 0.0016810521528134112, 'byBiomiR3935WT_Fig': 6.675147913951406e-05, 'RIP_assay': 0.004262805876921271, 'LINC00992_miR3935were_enriched': 9.148819220060914e-58, 'associationof_LINC00992': 9.148819220060914e-58, 'miR3935_upregulation': 0.0007008712380191807, 'prostate_cancerLINC00992': 0.0016810521528134112, 'andeight_mRNAs': 0.0016810521528134112, 'normalcells_we': 9.148819220060914e-58, 'target_genes_expression': 9.148819220060914e-58, 'membraneprotein_GOLM1': 9.148819220060914e-58, 'Fig_3aFurther': 9.148819220060914e-58, 'GOLM1_expression': 0.00771518910792271, 'GOLM1': 4.649709951488235e-52, 'Thenwe': 0.0008522036149147152, 'wereboth': 9.148819220060914e-58, 'inhibition_miR3935upregulation': 9.148819220060914e-58, 'fromRIP_assay': 0.0004694385672555256, 'afterinhibiting_miR3935_expression': 0.0008522036149147152, 'LINC00992_upregulatedGOLM1_expression': 9.148819220060914e-58, 'proliferationand_migration': 9.148819220060914e-58, 'cellproliferation_apoptosis_migration': 6.675147913951406e-05, 'rescue_experiments': 0.007740371469685373, 'MiR3935': 6.376152517023749e-05, 'LINC00992_LncLocator': 1.0399416567926554e-06, 'RNA_isolation': 0.0003260903091169294, 'DIANAlncBase_e_expression': 0.0002792326030019249, 'miR3935': 4.554741228061612e-06, 'g_RNA': 0.000362499724437477, 'levels_miR3935': 5.912100612214494e-06, 'i_RIP_assay': 0.0004694385672555256, 'sitebetween_LINC00992_miR3935': 9.148819220060914e-58, 'vialuciferase_reporter_assay_PC3_cells_to_be_satisfactory': 9.148819220060914e-58, 'vialuciferase_reporter_assay_PC3_cells': 0.0007008712380191807, 'to_be_satisfactory': 0.0004202357087063657, 'subsequentGOLM1_elevation': 9.148819220060914e-58, 'inhibitory_trend': 9.148819220060914e-58, 'viability_Results': 9.148819220060914e-58, 'trends_that': 9.148819220060914e-58, 'restraining_effect': 9.148819220060914e-58, 'GOLM1_upregulationFigure_S3_G': 9.148819220060914e-58, 'cellapoptosis_rate': 9.148819220060914e-58, 'depletion_andthen': 9.148819220060914e-58, 'increasedapoptosis_rate': 2.5164048986301264e-52, 'overexpressing_GOLM1': 0.001128162151175775, 'b_GOLM1': 0.00019338140904154145, 'mRNAand_protein_levels': 1.1686951820486561e-54, 'qRTPCR_blot_d_Thebinding_sites': 8.263922883666513e-55, 'qRTPCR_blot_d_Thebinding_sites_GOLM1WT_reporter_NCmimics_qRTPCR_blot_analyses': 7.4420885530179e-08, 'Luciferase_reporter_assay': 9.148819220060914e-58, 'GOLM1WT_reporter': 9.148819220060914e-58, 'NCmimics': 8.263922883666513e-55, 'qRTPCR_blot_analyses': 0.00012613970685026185, 'mRNA_proteinlevels': 9.148819220060914e-58, 'fulllength_gels': 9.148819220060914e-58, 'Transwellmigration_wound_assays': 9.148819220060914e-58, 'retarding_influence': 9.148819220060914e-58, 'S3H_Moreover_Transwellmigration_and_wound_healing_assays_illuminated_thatthe_retarding_influence_of_silenced_LINC00992_on_cellmigration': 9.148819220060914e-58, 'GOLM1_overexpression': 9.148819220060914e-58, 'effect_MMP2_pSrc_andpFAK': 9.148819220060914e-58, 'overexpression_Figure': 9.148819220060914e-58, 'thanthose_tumor_weight': 0.0001259499022484664, 'thanthose': 0.0001259499022484664, 'afterGOLM1_overexpression': 3.892781801115544e-06, 'prostate_cell_proliferation_migration': 0.0001376047264645618, 'DU145_cells': 2.2419990831966955e-06, 'impactof': 6.675147913951406e-05, 'Taken': 0.000234776026210296, 'lncRNA_SNHG7': 9.148819220060914e-58, 'cancer_carcinogenesis': 9.148819220060914e-58, 'LncRNA_SChLAP1': 9.148819220060914e-58, 'prostatecancer_cell_proliferation_metastasis': 9.148819220060914e-58, 'LncRNA_PCAT1': 9.148819220060914e-58, 'to_prostatecancer_tumorigenesis_through_modulating_FSCN1_andsponging': 9.148819220060914e-58, 'to_be_highly_expressed_in_prostate_cancer_tissuesand_cells_but': 6.675147913951406e-05, 'tumorpromotingfunction': 6.675147913951406e-05, 'distribution_data_FISH_RNA_isolation': 0.007713134335009549, 'microenvironment_TME': 0.0015851358577966632, 'role_effect_to_quantify_the_immune_score': 4.226264638068343e-07, 'Additionally_Cox_analyses': 9.148819220060914e-58, 'to_construct_two_prognosticsignatures_for_overall_survival_OS_and_diseasefree_survival': 9.148819220060914e-58, 'DFS_datasets': 9.148819220060914e-58, 'to_validate': 9.148819220060914e-58, 'patients_GEO_datasets': 0.002023641526393833, 'GEO_datasets': 0.001845170519318405, 'Prognostic_models': 3.302871068716546e-05, 'OS_DFS': 0.0018456622073465703, 'Tumor_microenvironment': 3.012831237073818e-05, 'Osteosarcoma_Prognosis_Immune': 9.148819220060914e-58, 'NomogramBackgroundOsteosarcoma': 9.148819220060914e-58, 'GSE39055': 9.148819220060914e-58, 'Gene_Expression_Omnibus': 9.148819220060914e-58, 'obtained_obtained': 3.301018398116077e-07, 'analysisAfter_scores': 0.001845170519318405, 'KaplanMeier_survivalanalysis': 3.301018398116077e-07, 'studyDEGexpressed': 9.148819220060914e-58, 'gene_analysisDifferentiallyanalysis': 9.148819220060914e-58, 'to_perform_the_differential_analysisand_genes_with_log_FC_  _and_adjusted_pvalue': 8.263922883666513e-55, 'Ontology_GOincludingbiological': 0.0006992128660964839, 'toestimate_proportions': 1.382937646822722e-05, 'to_cluster_in_an_unbiased_and_unsupervisedmanner_based_on_the_overlapping_DEGs': 1.382937646822722e-05, 'to_determine_theoptimal_number_of_clusters': 8.263922883666513e-55, 'GSE21257_dataset': 0.0009466755491730313, 'GSE21257_dataset_onthe_coefficient': 0.0009466755491730313, 'onthe_coefficient': 0.00013836210901492678, 'to_show_the_discrimination_of_signatures_and_the_KaplanMeier_survivalcurve_with_the_logrank_test_was_generated_to_show_thedifferences_of_OS_and_DFS_between_high_and_lowriskgroups': 7.0423427883996e-05, 'develop_a_nomogram_based_on_the_TMErelated_genessignature_and_clinicopathologic_data_to_predict_the_prognosis_of_osteosarcoma_patients_Firstlythe_univariateCOX_analysis_was_performed_to_filter_prognostic_variableswhich_will_be_further_included_in_the_multivariate_COXanalysis_Secondly_based_on_independent_prognostic_variables_two_nomograms_were_established_for_predicting_theOS_and_DFS_respectively_The_Cindex_was_used_to_assessthe_discriminatory_performance_of_the_nomogram_whichrange_from_ _to_ _[': 0.007713134335009549, 'univariateCOX_analysis': 8.263922883666513e-55, 'agreement_Cindex': 8.263922883666513e-55, 'to_evaluate_the_effectiveness_of_nomogramsResultsImmune_significantly_associated_with_the_prognosis_ofosteosarcoma_patients_osteosarcoma_patients_were_included_in_the_presentstudy_including_ _males_and_ _females': 8.263922883666513e-55, 'OSand_DFS_Fig_1a': 4.231733910899555e-05, 'investigated': 6.225902483254868e-05, '2a_b_Supplementary_Table': 0.0038806204677737646, 'KEGG_analysis': 0.0016480626375926124, 'that_DEGsare': 0.0038806204677737646, 'killer_cell': 2.2480340991203723e-51, '\\x9cNF\\x88\\x92kappa_Bsignaling': 2.2480340991203723e-51, 'comparisonof_types_DEG': 9.148819220060914e-58, 'geneHence_risk_score': 9.148819220060914e-58, 'heat_map': 0.002173360557476222, 'survival_status_characteristiccurves': 2.5673305271225477e-06, 'calibrationDiscussionThe_relationship': 0.0038806204677737646, 'to_quantify_the_immunescore_based_on_gene_expression_profiles_in_ _osteosarcomapatients_from_TARGET_database': 0.00238803522972525, 'heterogeneity_TME_studyindicated': 0.007713134335009549, 'basedon_genes_signatures': 0.0004953178798221558, 'DFS_nomogram': 9.148819220060914e-58, 'managementof_osteosarcoma_patients': 9.148819220060914e-58, 'to_be_responsible_forthe_prognosis_of_pancreatic_ductal_adenocarcinomaCYP2S1': 0.0038806204677737646, 'ICAM3': 0.0007039285763105162, '[_]_showed_that_the_ICAM3can_enhance_the_migratory_and_invasive_potential_ofhuman_nonsmall_celllung_cancer_cells_by_inducingMMP2_and_MMP9_via_Akt_pathwayAlthough_the_role_of_TME_and_TMErelated_genes_inosteosarcoma_patients_have_been_initially_studied_by_bioinformatic_and_statistical_analyses_in_our_research_somelimitations': 0.0009466755491730313, 'ICAM3can': 9.148819220060914e-58, 'migratory_invasive_potential_ofhuman_celllung_cancer_cells_role': 9.148819220060914e-58, 'externalvalidation': 0.0009466755491730313, 'inthe_training_cohort_DEGs': 9.148819220060914e-58, 'asOS_DEGs': 9.148819220060914e-58, 'July_conclusion_TME': 0.0015842910551982499, 'microenvironment_DEG': 0.0002277800506641863, 'survival_survival_Receiver_characteristiccurve_ESTIMATE_Estimation': 3.717476748010337e-06, 'Hl_X_Y_Jy_L': 0.0014749995440586266, 'survival_survival_Receiver_characteristiccurve_ESTIMATE_Estimation_data_manuscript': 0.0008200171109747039, 'study_C_H_R_Sand_C_L': 9.148819220060914e-58, 'search_R_S_L_Y_B_C': 9.148819220060914e-58, 'themanuscript_Sq_T_L_Y': 1.9982525325514424e-51, 'manuscriptFundingWe': 0.0007959416758056306, 'interestsAuthor_details1Department_University_China_3Department': 0.0013882295497307361, 'JM_Du_YC_Jain': 0.0005450251520539939, 'WTreviÃ±o_Levine_DA': 9.148819220060914e-58, 'tumour_purity_cell_admixture': 9.148819220060914e-58, 'PXu_analysis': 9.148819220060914e-58, 'Res_Int_Zhao_K_Yang_H_Kang_H_Wu': 9.148819220060914e-58, 'More_to_report_highlevel_evidence_of_the_diagnostic_accuracy_of_MRI_for_the_detection_ofliver_metastases_resulting_in_significant_value_for_clinical_decision_making_guideline_development_and_improved_stratification_fortreatment_strategies_and_future_trials': 0.0006411065628305975, 'DIAPANC_trial': 0.0005972948874079344, 'to_report_highlevel_evidence_of_the_diagnostic_accuracy_of_MRI_for_the_detection_ofliver_metastases_resulting_in_significant_value_for_clinical_decision_making_guideline_development_and_improved_stratification_fortreatment_strategies_and_future_trials': 9.743300901321744e-06, 'DIAPANC': 9.148819220060914e-58, 'imaging_characteristics': 9.148819220060914e-58, 'Rivi¨re': 0.0008666133362454501, 'use_survival_rate_rate_cure': 1.414086189487674e-05, 'rate_cure': 1.414086189487674e-05, 'regulation_use_BMC_Cancer_Page': 3.5057934680564676e-05, 'regulation_BMC_Cancer_Page': 0.0007956673215405282, '[_]_CECT_is_highly_accurate_in_assessing_the_relationship_ofthe_tumor_to_critical_arterial_and_venous_structures_sincetheir_involvement': 9.148819220060914e-58, 'resection_HoweverCECT': 9.148819220060914e-58, 'to_futile': 0.0006313632619292757, 'imaging_DWI': 9.148819220060914e-58, 'to_be_valuable_in_both_detection_and_characterizationof_focal_liver_lesions_with_a_high_sensitivity_\\x93_evenfor_subcentimeter_lesions_\\x93_[': 9.148819220060914e-58, 'to_detect_and_characterize_liver_lesionsbased_on_decreased_diffusion_of_water_molecules': 0.00012264967119603705, 'blood_effect': 3.4358152916695635e-05, 'Itis_adds_American_Society': 9.148819220060914e-58, 'choice_physician': 9.148819220060914e-58, 'to_use_MRI_as_a_problemsolving_tool_in_addition_to_CECT_eg_when_the_primarytumor_can_not_be_visualized_or_in_case_of_undefined_liver_lesions_[_\\x93': 0.00016123382553553652, 'study_Gadolinium_Gd': 9.148819220060914e-58, 'MRI_sensitivity': 9.148819220060914e-58, 'Gdenhanced_MRIespecially_DWI': 8.060994491191838e-06, 'prediction_effect': 5.973401273075715e-05, 'planto': 9.148819220060914e-58, 'age_performance_status': 9.148819220060914e-58, 'mass_indexweight_loss': 5.973401273075715e-05, 'tumor_markers': 1.57083852739054e-05, 'Amsterdam_procedures': 3.0633029563551144e-06, 'to_fill_in_validated_quality_of_life_questionnaires': 4.997544093021624e-08, 'CTMRI_scans': 9.148819220060914e-58, 'study_period_to_fill_in_validated_quality_of_life_questionnaires': 9.148819220060914e-58, 'smm2and': 2.1697831945333385e-07, 'using_chest_CT_MRI_and_CECTwill_radiologist_radiologistblinded': 1.3285906050971848e-05, 'phase_chest': 9.148819220060914e-58, 'using_chest_CT_MRI_and_CECTwill': 9.148819220060914e-58, 'radiologistblinded': 3.622598338048949e-05, 'to_minimize_the_risk_of_recall_biasThe': 2.7061642950048522e-05, 'liver_lesions': 4.4166412220158497e-07, 'side_effects_reaction': 0.0015599594565223272, 'contrast_agent': 5.057938109215477e-05, 'Patientsdiagnosed': 2.5466482854151278e-05, 'pvalueless_confirmation_place': 0.008692860734793183, 'SPSS_variables': 0.00014208846031518805, 'pvalueless': 0.0003069306742853986, 'analysis_cross_tabulation': 0.00014208846031518805, 'MRI_CECT_Performance': 9.148819220060914e-58, 'using_McNemar\\x99s_test_We_willreport': 9.148819220060914e-58, 'andoverall_survival': 9.148819220060914e-58, 'using_KaplanMeierplots_Survival_curves': 9.148819220060914e-58, 'Kappak_value': 0.0014616190772430405, '\\x93_pooragreementWe': 0.0014616190772430405, 'to_start_with_inclusionInselspital_Universit¤tsspital_Bern_Bern_SwitzerlandUCHealth': 0.0001285257790231156, 'performing_contrastenhanced_diffusionweightedMRI': 0.007713134335009549, 'Additionally_we_will_evaluatewhether_performing_contrastenhanced_diffusionweightedMRI': 0.00022655961142434313, 'ina_T_MRI': 0.0006191469481200436, 'T_MRI': 3.124724487280804e-06, 'study_weplan': 9.148819220060914e-58, 'MRIs_potentialdownside': 9.148819220060914e-58, 'Availability': 7.417164383651313e-53, 'to_be_an_issue_asMRI_is_available_in_every_expert_center_for_pancreaticdiseases': 1.284690556057437e-52, 'problems_time_interval': 7.417164383651313e-53, 'intervallesions': 7.417164383651313e-53, 'to_compare_liver_specific_contrast_MRI_and_CECT_in_liver_metastasis_of_pancreatic_cancer_with_a_target_sample_size_of_ _patients': 0.0019127833147525456, 'to_simultaneously_gather_information_on_early_localrecurrence_or_metastases_after_resection_disease_progression_and_therapy_response_evaluation_on_MRI_and_CECTIn_conclusion_the_DIAPANC_trial_is_expected_to_report_highlevel_evidence_of_the_diagnostic_accuracy_ofMRI_for_the_detection_of_liver_metastases': 3.410286168774167e-05, 'to_report_highlevel_evidence_of_the_diagnostic_accuracy_ofMRI_for_the_detection_of_liver_metastases': 9.743300901321744e-06, 'Capture_CarcinoembryonicAntigen_CECT': 9.148819220060914e-58, 'Enhanced_Tomography_CA19\\x93': 9.148819220060914e-58, 'cancer_module': 9.148819220060914e-58, 'patients_Act_WMO': 9.148819220060914e-58, 'DR': 0.00022771936739542464, 'Society_KWF': 9.148819220060914e-58, 'Project_reference_number': 9.148819220060914e-58, 'notinfluence_collection_interpretation': 0.00028569540831235814, 'participatinginstitutions': 0.00021509105295728132, 'board_region_ArnhemNijmegen_Nijmegen_TheNetherlands': 9.148819220060914e-58, 'Furthermoresecondary_approval': 9.148819220060914e-58, 'substudies': 2.233298236880626e-05, 'willbe': 3.647412862002658e-07, 'consentto_participate': 0.00018750364596568773, 'HA_interval': 0.00046703013980541936, 'Davidson_BR_Diagnosticaccuracy': 9.148819220060914e-58, 'forassessing_the_resectability_with_curative_intent_in_pancreatic_andperiampullary_cancer_Cochrane_Database': 9.148819220060914e-58, 'Michor_modeling': 4.462825280616495e-07, 'Heo_JS_Choi_DW_Analysis': 9.148819220060914e-58, 'Motosugi_U': 9.148819220060914e-58, 'Thismetaanalysis': 9.148819220060914e-58, 'to_systematically_assess_the_relationship_between_hypothyroidism_and_breast_cancer_riskand_to_assess_whether_thyroid_hormone_replacement_therapy_can_increase_breast_cancer_riskMethods_The_relevant_s_about_hypothyroidism_and': 9.148819220060914e-58, 'hormone_replacement_therapy': 9.148819220060914e-58, 'cancer_riskMethods_relevant': 9.148819220060914e-58, 'ofbreast_cancerodd_ratios': 0.001845170519318405, 'replacement_therapy_risk': 0.0006810685397702696, 'Hypothyroidism': 0.0007862569594425692, 'regulation_effects': 9.148819220060914e-58, 'enlightenment': 9.148819220060914e-58, 'Kapdi_et_alfirst': 1.2833264574456584e-05, 'thathypothyroidism': 0.0007864664894503318, 'relationship_risk': 9.033660132973853e-06, 'disease_cancer_risk': 0.0018006682651940404, 'Thereforewhether_hypothyroidism': 0.0007862569594425692, 'prospectivestudies_population_studies': 0.007713134335009549, 'systematicretrieval': 0.00021944374809642538, 'includedor\\x9chypothyroidism\\x9d_\\x9cHT\\x9d_\\x9cthyroid_diseases\\x9d_cancer\\x9d_\\x9cBC\\x9d_\\x9cbreast_neoplasms\\x9d_\\x9cmammarmy_cancer\\x9d_or\\x9cincidence\\x9d_we': 9.148819220060914e-58, 'potentialliterature_criteria': 9.148819220060914e-58, 'studies_hypothyroidism_thediagnosis': 0.00021921962201374475, 'Scale_NOS': 9.148819220060914e-58, 'to_assessthe_quality_of_the_study_from_three_aspects_cohort_selection_cohort_comparability_and_outcome_evaluation': 9.148819220060914e-58, 'P_I2_\\x89¥': 0.0003689975995246945, 'chiefcharacteristics': 0.00013756805643468518, 'explorethefurtherrelationshipSubgroup_analysis': 2.4039310083099884e-06, 'typepopulation_distribution_followup_time': 0.00014752106586886585, 'patients_withhypothyroidism': 0.0007862569594425692, 'withhypothyroidism': 0.0007862569594425692, 'riskA_total': 0.0006625816769337724, 'fixedeffect': 9.148819220060914e-58, 'usedI_p_result': 9.148819220060914e-58, 'hormone_replacementtherapy': 0.0011075402231842013, 'biasFigure_4a': 0.0016480626375926124, 'funnel_plot_therapy_Metaanalysis_estimates': 9.148819220060914e-58, 'Kalache_Hoffman': 9.148819220060914e-58, 'hypothyroidismcould': 0.0007862569594425692, 'Beatson': 9.148819220060914e-58, 'thyroid_extracts': 9.148819220060914e-58, 'women_women': 0.0019127833147525456, 'thyroxine_levels': 0.0007862569594425692, 'thathypothyroidism_mice': 0.0011768544063466776, 'thyroidhormone_replacement_therapy': 0.0011075402231842013, 'risk_analysis_ethnicities_ability': 0.0030144925697952957, 'to_demonstrate_the_relationship_between_hypothyroidism_andbreast_cancer_risk_In_the_metaanalysis_five_studies_provided_North_American_population_data_and_two_reported_Asian_population_data': 0.0001565902901966816, 'population_data_population_data': 0.0018006682651940404, 'ethnicities': 0.0006264573400700461, 'T3': 0.001336799898183856, 'effect_proliferation': 2.181138498366791e-05, 'relationship_breast_cancer': 2.181138498366791e-05, 'T1_gene': 0.000404948725608525, 'MartinezIglesias_Afterthathypothyroidism': 0.00047983738574547787, 'Tosovic': 5.302300083937517e-05, 'T3_levels': 0.00046683359119049114, 'metaanalysis_resultsalso': 3.1235511726865175e-05, 'we_conclusion': 9.148819220060914e-58, 'to_be_taken_with_caution_as_this_study_has_several_limitations_First_the_studies_that_have_been_included_do_not_adjust_for_importantrisk_factors_for_breast_cancer_Second_in_subgroup_analysis_for_example': 9.148819220060914e-58, 'that_there_is_a_large_heterogeneity_between_studiesFourth_followup_time_at_different_endpoints_can_not_beuniform_Finally_publication_bias_can_not_be_avoidedentirelyConclusionHypothyroidism': 9.148819220060914e-58, 'risk_population_significant': 9.148819220060914e-58, 'manuscriptFundingNo_sources': 9.148819220060914e-58, 'to_conduct_this_study_or_prepare_this_letterAvailability_of_data': 9.148819220060914e-58, 'MP_Thyroid_disease_breast_cancerfindings': 9.148819220060914e-58, 'Fraumeni_Breast_cancer': 9.148819220060914e-58, 'influence_Int_JEpidemiol_\\x93': 9.148819220060914e-58, 'PPThyroid_disorders_breast_cancer_relationship': 9.148819220060914e-58, 'conditions_risk_Br_J_Cancer_\\x93': 0.00013756805643468518, 'thyroid_disorders': 0.0007862569594425692, 'Epidemiol': 9.148819220060914e-58, 'Prevent': 9.148819220060914e-58, 'B_Booth': 0.0003334530047039951, 'Del_Sordo_M_DeCesare': 0.00016553660791656055, 'MA_RW_Hypothyroidism': 0.00039947355805761766, 'Hypothyroidismenhances_tumor_invasiveness_metastasis_development_CR_Brentani_MM_Triiodothyronine': 0.0010068765747081726, 'httpsdoi101002mc10046Tosovic': 0.0008522036149147152, 'role_age_odds_ratio': 0.00238803522972525, 'Pearson_coefficient': 8.263922883666513e-55, 'to_rise_further_in_the_future': 0.004315547045054443, 'Inhibiting_TROP2_expression': 1.2992676322681829e-05, 'Amongtheinvolved': 0.0015842910551982499, 'intumorigenesis_shed_is': 9.148819220060914e-58, 'to_determine_the_mechanical_properties_of_tumor_tissues_in_a_variety_of_cancers_such_asthose_of_the_breast': 9.148819220060914e-58, 'Advancements': 8.263922883666513e-55, 'TROP2': 0.00018196418253393857, 'males_females_sections': 0.0004576368763948737, 'chemotherapy_immunotherapy_Pathologicalanalysis': 0.00028896621761707614, 'Cancer_lymph_nodetissues': 0.0005371082976310824, 'stainingOSCC_tissues': 4.802074000626765e-06, 'Olympus_BX53': 0.00029454004553875596, 'China_paraffin': 4.802074000626765e-06, 'sites_site': 3.901700916169037e-05, 'Hertz_contact_modelto': 0.002388671506211953, 'Forcespectrum_data': 1.104747393560732e-05, 'KaplanMeier_curves': 0.0006771861099267665, 'Pearson_Chisquaretest': 9.148819220060914e-58, 'to_analyze_clinical_features_and_TROP2_expression_based_on_the_calculated_odds': 9.148819220060914e-58, 'intervalCI_Survival': 1.104747393560732e-05, 'differentiation_morphology': 0.00013756805643468518, 'tumor_differentiation': 0.0016815001133323047, 'anincrease_Fig': 0.007713134335009549, 'TROP2_expressionwas': 0.0006323546019229276, 'morphology_differentiation': 9.148819220060914e-58, 'irregularmorphology_tissueanization_Figure': 9.148819220060914e-58, 'roughness_ofOSCC_tissues': 1.0315794690529797e-05, 'contact_points_theaverage_variation_range': 7.057820664165564e-05, 'BioAFM': 8.263922883666513e-55, 'Forcedistance_curves': 1.1510968529637387e-06, 'usedto_calculate_modulus_Figure': 8.263922883666513e-55, 'Surface_roughness_results': 9.148819220060914e-58, '±_SEM': 9.148819220060914e-58, 'to_be_a_parameter_of_cell_hardness_for_various_cells_and_tissuePa_P_  ': 0.00013756805643468518, 'associationbetween_stiffness_Fig_r': 7.05405714108373e-05, 'TROP2expression': 1.1504832171912508e-06, '\\x93]In': 9.148819220060914e-58, 'to_be_a_highlysensitive_and_specific_marker_of_tongue_squamous_cellcarcinoma_and_tissue_stiffness_The_relative_thickness_ofsamples': 9.148819220060914e-58, 'highTROP2_expression': 0.0006321861226151657, 'downregulationloss': 0.0006246792128329638, 'shownthat_TROP2': 8.263922883666513e-55, 'JAK2STAT3_signaling': 2.9685186092418687e-06, 'Note_changes': 0.0006812500420437589, 'statisticalsignificance_P': 1.1114958351429976e-05, 'to_be_elucidated_HE_staining_isthe_gold_standard_for_tumor_diagnosis_With_the_development_of_biomechanics_in_the_past_two_decades': 0.0004405647755333974, 'to_be_investigated_based_on_biomedical_and_physical_parametersIn': 0.0002712952666904031, 'levelsof': 7.169194268374071e-05, 'roughness_stiffness': 1.170272380166535e-06, 'Thus_using_a_largerpatient_cohort_and_multiple_techniques_in_molecular_andcell_biology': 9.148819220060914e-58, 'validate_our_findings_and_developTROP2_as_a_specific_and_efficient_prognostic_biomarker_forOSCCConclusionThese_findings_could_promote_new_methods_for_the_earlyOSCC_diagnosis_depend_on_the_stage_of_cancer_and_developing_screening_methods_with_high_sensitivity_andspecificity_More_detailed_studies': 9.148819220060914e-58, 'forOSCCConclusionThese_findings': 0.0005371174057381335, 'carcinoma_cell_surfaceantigen_force': 9.148819220060914e-58, 'thank_the_individual_who_participated_in_this_studyAuthors\\x99_contributionsBZ_SG_and_RPL': 9.148819220060914e-58, 'Fundamental_Research_Funds': 0.0003167145330801072, 'CART_cell': 9.148819220060914e-58, 'cancer_Am_JCancer_Unexpectedgrowthpromoting_effect': 9.148819220060914e-58, 'repair_crosscomplementation_group': 9.148819220060914e-58, 'cancer_cellsPharmacology': 9.148819220060914e-58, 'Nishimura_T_Mitsunaga_M_Sawada_R_Saruta_M_Kobayashi_H_Matsumoto_N_Photoimmunotherapy': 1.573750550592874e-06, 'Trop2_inhibitionsuppresses': 9.646638677217505e-05, 'X_TROP2_increasesgrowth_metastasis_Int_J_Mol_Med\\x93Trerotola_M_Li_J_Alberti_S_Languino': 9.148819220060914e-58, 'cancer_celladhesion_Masau_JF_Wei_X_effects_T_Goldstein': 9.148819220060914e-58, 'JM_Huang_J_Witte': 9.148819220060914e-58, 'selfrenewalvia_betacatenin': 9.148819220060914e-58, 'I_Lazcano_JJ_Samaniego_R_Calvo_E_remodeling': 9.148819220060914e-58, 'tumor_invasion_Cell_\\x93Edge': 9.148819220060914e-58, 'Eur_Thyroid_J_Zhao_P_Zhang_Z_TNFÎ±': 8.263922883666513e-55, 'RNA_SNHG1': 9.148819220060914e-58, 'cellproliferation_pathway': 9.148819220060914e-58, '\\x93_SC_Xin_T_Fan_HT_Overexpression': 9.148819220060914e-58, 'proliferation_andEpCAM_Trop2_Pathol_\\x93metastasis': 9.148819220060914e-58, 'prognosisClin_Yuan_B_Zou_M_Zhao_Zhang_K_Sun_Y_Peng_X_Upregulation': 9.148819220060914e-58, 'PTENPI3KAKTNFÎºB_pathway': 9.148819220060914e-58, 'XP_TROP2': 1.0894041310713923e-06, 'Deng_Zhang_G_Hu_X_Cui_H_TROP2': 8.263922883666513e-55, 'alRASSF1A': 0.0011125787591309202, 'therapycomprising': 0.0006315314916528435, 'consolidation_therapy_TRADEhypo_trial': 1.0313068720503174e-05, 'patientsoften': 0.00015813566720597306, 'CONgroup_hypofractionated': 9.148819220060914e-58, 'willassess_safety': 9.148819220060914e-58, 'radiation_schedule': 8.192622784358272e-05, 'intend': 0.0006324067207528349, 'toxicity_trial': 8.192622784358272e-05, 'research_program': 9.148819220060914e-58, 'to_gain_insights_into_the_tumorhost_biology_and_to_identify_suitable_biomarkers_to_predict': 9.148819220060914e-58, 'NSCLC_Immune_checkpoint_inhibition_NSCLCrepresenting_\\x93': 0.00015266313713209798, 'effects_anticancer_mechanisms': 0.00210348072096923, 'thepatients\\x99_antitumor_immunity': 2.4187090552832177e-05, 'patients_PACIFICtrial': 9.148819220060914e-58, 'antibody_durvalumab': 9.148819220060914e-58, 'radiotherapyalone': 0.001845170519318405, 'Moreoverif': 9.148819220060914e-58, 'localdatathatsuggestradiotherapy': 9.148819220060914e-58, 'TRADEhypo_trialis': 2.090183731727088e-05, 'durvalumab': 0.0011114440886537057, 'safety_stopandgophase': 2.090183731727088e-05, 'phase_patients': 2.090183731727088e-05, 'treatmentinduced_changes_TRADEhypo_trial_TRT_incombination': 0.00013588610209050726, 'inthe_clinic': 0.0013882295497307361, 'written_informedconsentEach_participant': 5.693284547016032e-05, 'functionPatients': 9.148819220060914e-58, 'agents_thoracic_radiotherapy': 9.148819220060914e-58, '0cBozmehr_BMC_Cancer_Page': 8.263922883666513e-55, 'HYPOgroup': 1.1686951820486561e-54, 'HYPOgroup_\\x9cStop\\x9d': 0.00038821680642614145, '\\x89¤_event': 0.00042075216298420966, 'immunosuppressivemedication': 0.00042075216298420966, 'Onegroup': 9.148819220060914e-58, 'durvalumab_immunotherapy': 9.148819220060914e-58, 'GTV\\x9dshould': 8.263922883666513e-55, 'GyIn': 1.1686951820486561e-54, 'planning_Motionmanagement': 9.148819220060914e-58, '4DCT_midbreathing_errors': 9.148819220060914e-58, 'HYPOarm_fractions': 8.263922883666513e-55, 'Allparticipating_institution': 9.148819220060914e-58, 'to_perform_regular_if_no_daily_positioning_control_using_either_portalimaging_or_onboardCT_devicesStudy': 9.148819220060914e-58, 'criteriacid129_Fullyinformed': 0.0004100538998299479, 'authorization_thisdecision': 5.693284547016032e-05, 'yearscid129': 1.8202465927305273e-08, 'life_expectancy': 1.1155910134408826e-06, 'pregnancy_test': 0.001845170519318405, 'disorders_skin_condition': 0.0007862569594425692, 'therapy_Patients': 0.004315547045054443, 'gastrointestinal_conditions': 0.0007862569594425692, 'nonmelanoma_skin_cancer_lentigo_maligna': 0.004315547045054443, 'exceptions': 9.148819220060914e-58, 'steroids_steroid_injections': 9.148819220060914e-58, 'court_order': 0.0011075402231842013, 'intention': 0.0001875536080905259, 'nature_significance_implications': 0.0013882295497307361, 'Fig_Toxicitywill': 9.148819220060914e-58, 'intention_screening': 9.148819220060914e-58, 'scheme_Patients': 9.148819220060914e-58, 'thoracic_radiotherapy': 9.148819220060914e-58, 'Gy_Gy': 5.32352954094066e-06, 'randomization_strategy': 0.0003264382226163854, 'progression_tumor_imaging': 5.32352954094066e-06, 'start_end': 9.148819220060914e-58, 'telephone_callsiBiomarker_sample': 9.148819220060914e-58, 'visitX_events': 5.32352954094066e-06, 'theHYPOarm': 9.148819220060914e-58, 'patients_enterthis_treatment_group': 9.148819220060914e-58, 'safety_criteria': 3.012831237073818e-05, 're': 0.0018456622073465703, 'study_management': 0.001845170519318405, 'only_If_safety_criteria_in_the_HYPOcohort_are_met_the_HYPOarm_willbe_re_ed_to_continue_toxicity_assessment_and_patients_will_solely_be_allocated_to_this_arm_Fig_ _Inorder_to_avoid_any_bias_patients_will_be_allocated_centrally_by_the_study_management_during_this_phase_If_thenontoxicity_criteria_in_the_safety_cohorts_are_met_thestudy_will_proceed_to_theandremaining_patients': 5.32352954094066e-06, 'survival_Patients': 9.148819220060914e-58, 'followup_FU': 9.148819220060914e-58, 'to_return_to_the_site_for_evaluationswill': 0.0011075402231842013, 'biomaterials': 0.00035730068962257737, 'justificationSafety_runin': 8.263922883666513e-55, 'to_distinguish_between_a_toxicity_scenario_pTox_  _and_anontoxicity_scenario': 0.0006625588963947697, 'ofn': 0.0003647528107482472, 'efficacy_analysis': 9.148819220060914e-58, 'ORR_andexpansion_phase_III_NSCLC': 9.148819220060914e-58, 'radiotherapy_patienthas': 0.001845170519318405, 'Ï_CON': 9.148819220060914e-58, 'ORR_CON': 9.148819220060914e-58, 'Ï_HYPO_Ï_CONamount': 9.148819220060914e-58, 'twostage_design': 9.148819220060914e-58, 'taking_intoaccount_the_twostage_nature_of_the_design': 5.284363978080408e-05, 'carcinoma_NSCLCDiscussionIn_years': 0.0006324067207528349, 'incancer_therapy': 0.0003377049630876618, 'NEC_tumors': 0.00018750364596568773, 'to_investigate_whether_there_is_a_distinct_difference_in_overall_survival_OS_between_gastricneoplasms_containing_NEC_components_and_gastric_adenocarcinomaMethods': 0.00238803522972525, 'NEC_tumors_neoplasms': 0.00018750364596568773, 'BMC_Cancer_Page_neoplasms': 5.000208731566849e-08, 'AmericanJoint_Committee': 9.148819220060914e-58, 'NEN': 9.148819220060914e-58, 'GNEC': 9.148819220060914e-58, 'progressionfree_survival_PFS': 9.148819220060914e-58, 'evidence_thattumors': 5.303442291821601e-05, 'to_further_verify_the_matching_resultsFollowupWe_patients_to_reexamine_patients': 0.0005830350453695843, 'MannWhitney_Utest': 9.5169063182755e-06, 'to_further_verify_the_matching_resultsFollowupWe': 1.5542010605467715e-07, 'markers_test_gastroscope_tomography_CT_scans': 9.148819220060914e-58, 'to_reexamine_patients': 9.148819220060914e-58, 'Neuroendocrine_components': 5.45687689079892e-07, 'Patients_surgery_group': 9.148819220060914e-58, 'stagingsystem': 9.148819220060914e-58, 'staging_system': 0.001845170519318405, 'pr_sity_scores': 0.001845170519318405, 'test_U_test': 9.514369836730777e-06, 'analysis_resultsBetween': 1.5537867429339714e-07, 'KaplanMeier_method_logrank_test_hazards_models': 9.148819220060914e-58, 'to_identify_predictors_of_survival_outcome_P_  _was_regarded_as_thethreshold_of_significanceResultsPatient_selection_and_PSM': 9.148819220060914e-58, 'inclusioncriteria': 0.0003833771411240826, 'NEC_GHMiNEN_GHMiNEN_GHMiNEN': 0.001845170519318405, 'GHMiNEN_group': 0.007713134335009549, 'analysis_resultsBetween_inclusioncriteria_therapy_neuroendocrine_components': 1.5546158205031853e-07, 'group_Table_Table': 0.0006264573400700461, 'Table_Patients': 9.047980193612276e-05, 'group_Table_Table_OS_group_Table': 1.4763420355139445e-06, 'group_Table': 0.0006264573400700461, 'NEC_NEC_GHMiNEN_groups_NEC_components': 9.148819220060914e-58, 'OS_information_significantdifference': 9.148819220060914e-58, 'notprogressionfree_survivalPFS': 8.263922883666513e-55, 'tumors_tumors': 0.000762899462924001, 'study_regression_analysis': 9.148819220060914e-58, 'thattumor_categoryneoplasm_BMC_Cancer_Page': 9.148819220060914e-58, 'Table_Comparison_PSM': 0.00018001983766047135, 'overdiagnosisof': 0.0006313632619292757, 'prognosis_study': 0.0021841712255363664, 'to_be_higher_in_the_pure_NECgroup_than_that_in_the_  _GHMiNEN_group_Therole_of_CD56_in_the_diagnosis_of_NEC': 8.263922883666513e-55, 'abnormalities_similarlosses_LOH_mutations': 0.00035695096505492413, 'considering_mixed_tumorscontaining_NEC_components_as_a_whole_rather_than_defining_them_based_on_the_ _definition_for_both_tumorcomponents_which_has_not_been_raised_by_other_studiesPreviously_many_studies': 0.00238803522972525, 'group_S2_Comparison': 0.0001291437681840634, 'tumor_Magnetic_resonance_OS_emission_tomography': 0.00012421895344124877, 'WorldHealth': 4.98030979413283e-05, 'illustrationsZB': 0.00022771936739542464, 'JJ': 0.0019273936602113683, 'Thefunders': 0.0015842910551982499, 'written': 0.00012421895344124877, 'Cochrane_Library_SinoMed': 9.148819220060914e-58, 'registries': 9.148819220060914e-58, 'analysisResults': 0.00016553660791656055, 'Twentynine_s': 0.0006674076661460604, 'supportingthe_notion': 1.3909946949554081e-05, 'tumorigenesis_refer_interleukin': 0.000852430718203068, 'kindsof_adipokines': 9.148819220060914e-58, 'to_be_associated_withthyroid_carcinoma_Rehem_RA_ ': 9.148819220060914e-58, 'envidence': 2.2480340991203723e-51, 'centers_httpwwwclinicaltrialsgov': 0.00025094954260364283, 'Hand_searchingwas': 2.9402948113849672e-05, 'Dataincluded_participant_characteristics_size_type': 1.1686951820486561e-54, 'studies_to_be_of_high_quality_Disagreements': 8.263922883666513e-55, 'to_be_of_high_quality_Disagreements': 8.263922883666513e-55, 'Greece_IranItaly_Denmark_Serbia': 0.0019127833147525456, 'take_thyroid': 0.0005715966671738797, 'interval_CI_I2': 9.148819220060914e-58, 'to_assess_heterogeneity_between_studies_and_I2_values_of_   _and_ _representing_no_lowmoderate_and_high_heterogeneity_respectively_Visual_inspection_of_the_funnel_plot_was_done_to_assess': 9.148819220060914e-58, 'Manager_Cochrane_Kingdom_httpwwwcochraneQuality_assessment_risk': 0.0005263009120446208, 'amaximum_Flow_chart': 0.0019127833147525456, 'ATCand_adenoma_andnormal_Characteristic': 9.148819220060914e-58, 'studiesFirst_authorYearCountryPathologicaltype': 9.148819220060914e-58, 'needle_aspiration_cytologynodular_goiterPTCQuality': 6.715229150406809e-50, 'quality_assessment': 1.1686951820486561e-54, 'bythe_NOS_resultis': 8.263922883666513e-55, 'thyroid_carcinoma_needle_aspiration_cytologynodular_goiterPTCQuality_expression': 0.00033945059596749853, 'rest_studies': 5.5357043904189334e-06, 'to_merge_the_SMDvalues_of_serum_TNFÎ±_level': 0.0006943564809761616, 'heterogeneity_test': 0.0003689975995246945, 'heterogeneity_test_heterogeneity_effect_size': 0.0003689975995246945, 'thyroid_carcinomaAmong_studies': 0.0006674076661460604, 'Chi2_I2_randomeffectmodel': 9.148819220060914e-58, 'to_pooled_the_SMD_values_and_thepooled_effect_size_in_favor_of_control_subjects': 9.148819220060914e-58, 'Twostudies': 0.0003285968246522835, 'ofserum_pooled': 9.148819220060914e-58, 'to_merge_the_values_and_analysis': 9.148819220060914e-58, 'ofIL6_immunoreactivity': 1.029454787886047e-05, 'result_amongUS_adults': 0.006442305619365413, 'Adipokines': 0.0002892179326628974, 'IL8_we': 8.263922883666513e-55, 'to_combine_statisticsTherefore_in_this_metaanalysis': 1.1686951820486561e-54, 'analyzedTNFÎ±': 8.263922883666513e-55, 'Meanwhile_TNFÎ±': 0.0015842910551982499, 'amount_ofTNFÎ±': 0.001128162151175775, 'Moreover_TNFÎ±': 9.724844068332e-07, '\\x88\\x92PI2Not_0cZhao_BMC_Cancer_Page': 3.903865469504451e-06, 'decreasedlevel_difference': 8.263922883666513e-55, 'serum_TNFÎ±': 9.148819220060914e-58, 'to_be_a_significant_prognosticator_for_overall_survival_in_PTC_patients': 9.148819220060914e-58, 'DTCcases': 0.004315547045054443, 'metaanalysis_TNFÎ±': 0.0008581749454218445, 'research_IL6': 1.104747393560732e-05, 'hormone': 0.0014616190772430405, 'Kim_WG': 0.001128162151175775, 'expression_Leptin': 0.0016810521528134112, 'significance_carcinoma': 4.588646295138582e-06, 'ofcancer_cells': 2.2480340991203723e-51, 'closely_correlated_with_the_developmentof_PTC_Adiponectin': 8.263922883666513e-55, 'to_be_associated_with_a_betterprognosis': 0.0010325216439875707, 'results_ideas': 0.0034957715861153836, 'blot_colony_formation': 4.553527713819781e-06, 'to_study_the_role_of_LINC02418_in_LAD': 0.0009015003440277985, 'LINC02418': 0.008006812242784975, 'miR46773pexpression': 0.00013089836268742648, 'miR46773p_overexpression': 4.13949409743745e-05, 'KNL1_expression': 8.263922883666513e-55, 'miR46773p': 1.1686951820486561e-54, 'LINC02418Furthermore': 0.00013089836268742648, 'intoproteins': 0.004315547045054443, 'EZH2_expression': 0.000762889468397268, 'instance': 0.0003402493734878284, 'expression_progression': 6.877089425857604e-05, 'Galectin3': 1.284690556057437e-52, 'TLR4NFÎºBsignaling_pathway': 7.417164383651313e-53, 'MIR31HG_overexpression': 0.0004738574283430153, 'to_probe_into_the_biological_role': 0.007713134335009549, 'Thetop_lncRNAs': 0.000302093565533489, 'bioinformatics_analysis_mechanismbased_experiments': 9.148819220060914e-58, 'to_determine_the_miRNAs_that_could_bind': 9.148819220060914e-58, 'to_investigate_whether_lncRNA_LINC02418could_affect_LAD_development_via_regulating_itsdownstream_genesMethodsCell_culture_and_transfectionHuman_LAD_cell_lines_A549_SPCA1_H1299_and_PC_and_normal_lung_epithelial_cells_BEAS2B': 0.0019127833147525456, 'lncRNA_LINC02418could': 9.148819220060914e-58, 'LAD_development': 9.148819220060914e-58, 'Invitrogen': 3.490117452605609e-05, 'use_consents_utilizing_NanoDrop_ _ThermoWaltham_MA_USA': 0.0002877794366103506, 'Ethic_Committee': 4.693751473925079e-06, 'total_RNA': 4.693751473925079e-06, 'utilizing_NanoDrop_ _ThermoWaltham_MA_USA': 5.696537093857032e-07, 'RTqPCRTotal_RNA': 9.148819220060914e-58, 'utilizing_TRIzol_InvitrogenThermo_Fisher_Scientific_Inc': 9.148819220060914e-58, 'ReverseTranscriptase_Thermo_Fisher_USA_RTqPCR': 9.148819220060914e-58, 'using_One_Step_SYBR': 9.148819220060914e-58, 'operated': 9.148819220060914e-58, '2Î\\x94Î\\x94Ct': 9.148819220060914e-58, 'assayCell_proliferation': 7.521610348345944e-51, 'utilizing_the_CCK8_kitBoster_based_on_the_manufacturer\\x99srequirementsBriefly_cells_ _Ã\\x97_ ': 3.663928614052708e-51, 'formation_assayCells': 3.952063296437027e-51, 'utilizing_the_CCK8_kitBoster_based_on_the_manufacturer\\x99srequirementsBriefly_cells_ _Ã\\x97_ _using_methanol_invasion_estimation': 8.113114351926761e-51, 'laterthe_colonies': 5.18158255397614e-51, 'using_methanol': 2.524055076631849e-51, 'invasion_estimation': 3.663928614052708e-51, 'CAUSA_incubated': 0.0019335232359137433, 'tofasten_cells_use': 0.0015174865429343817, 'tofasten': 3.155350678800993e-05, 'nick': 1.4055400435083287e-53, 'grown': 0.0007956673215405282, 'reporter_assay_systemPromega': 7.74241605630692e-09, 'Madison_WIRNA_immunoprecipitation_RIP': 9.148819220060914e-58, 'utilizing_the_EZMagna_RIP_kitMillipore_Billerica_MA': 9.148819220060914e-58, 'IgG_Millipore': 9.148819220060914e-58, 'magnetic': 9.148819220060914e-58, 'RNA_complexes': 1.3706689935419844e-48, 'Proteinase_K': 4.4705161968877317e-07, 'to_detect_the_probableinteraction_among_miR46773p_LINC02418_and_to_be_miR46773p_biotinprobe_by_GenePharma_Company_Shanghai_ChinaMiR46773p_biotin_probe': 2.7383959414654634e-05, 'to_detect_the_probableinteraction_among_miR46773p_LINC02418_and': 7.297311703316055e-09, 'KNL1MiR46773p': 9.148819220060914e-58, 'to_be_miR46773p_biotinprobe_by_GenePharma_Company_Shanghai_ChinaMiR46773p_biotin_probe': 9.148819220060914e-58, 'nobiotinprobe': 4.4693252330379317e-07, 'lncRNAs_lncRNAs': 0.007713134335009549, 'function_Heatmap': 9.148819220060914e-58, 'RTqPCR_c': 9.148819220060914e-58, 'RTqPCR_d': 0.000373367259807947, 'to_examine_the_level_of_migrationrelated_proteins_after_knocking_down_LINC02418_P_  _0cWang_ _BMC_Pulmonary_Medicine_           _Page_ _of_Fig_1c_P_  ': 0.00019097738328234247, 'absencemation': 0.000404948725608525, 'cellapoptosis': 9.148819220060914e-58, 'depletionFigure': 9.148819220060914e-58, 'thatLINC02418': 2.967189715706181e-07, 'depletioncould': 0.00022450055823258405, 'withLINC02418': 0.004315547045054443, 'RTqPCR_analysis': 0.0007080023910910008, '2bfound': 8.263922883666513e-55, 'level_ofmiR46773p': 0.007713134335009549, 'comparedwith_NC': 9.148819220060914e-58, 'group_2d_P': 9.148819220060914e-58, 'role_targets': 1.9982525325514424e-51, 'bioinformatics_analysis': 3.996505065102884e-51, 'b_Relativeexpression': 6.039766052724699e-06, 'RTqPCR_d_to_detect_cell_proliferation_in_miR46773p_mimicstransfected': 0.0003702139467055087, 'to_detect_cell_proliferation_in_miR46773p_mimicstransfected': 9.866650683337054e-08, 'to_access_the_level_ofmigrationrelated_proteins_in_A549_and_SPCA1_cells_when_overexpressing_miR46773p_P_  _0cWang_ _BMC_Pulmonary_Medicine_           _Page_ _of': 0.00017939106177220415, 'MRP9': 9.148819220060914e-58, 'part_inLADKNL1': 9.148819220060914e-58, 'onlyKNL1_expression': 9.148819220060914e-58, 'miR46773pmimics': 9.148819220060914e-58, 'KNL1': 9.148819220060914e-58, 'to_carry_out_the_following_assays_As_illustratedin': 9.148819220060914e-58, 'miRmap': 9.148819220060914e-58, 'to_research_the_potential_target_genes_for_miR46773p_b': 9.148819220060914e-58, 'left_Luciferase_reporter_assay': 0.00039436183359109516, 'starBaseupper_Luciferase_reporter_assay': 0.00039436183359109516, 'enrichmentof_LINC02418_KNL1': 0.00039436183359109516, 'nobiotin_probe': 9.148819220060914e-58, 'starBaseupper_Luciferase_reporter_assay_assay_enrichmentof_LINC02418_KNL1': 9.148819220060914e-58, 'ofpmirGLOLINC02418Mut': 5.8757551610179185e-05, 'KNL1_wherethe_binding': 0.00013588610209050726, 'to_determine_whetherLINC02418': 0.007713134335009549, 'KNL1_upregulation': 9.148819220060914e-58, 'hinderingimpact': 9.148819220060914e-58, 'byLINC02418': 9.148819220060914e-58, 'KNL1_overexpresP_ns': 9.148819220060914e-58, 'ofSubsequentlyKNL1_offsetthe_obstructivefunction': 0.00011931918217645773, 'behaviorsin_LAD': 0.00013089836268742648, 'upregulation_absence': 0.007713134335009549, 'illustrationmiR4500': 9.148819220060914e-58, 'anticancerfunction': 9.148819220060914e-58, 'MiR205': 9.148819220060914e-58, 'E2F1_expression': 9.148819220060914e-58, 'MiR6293p': 9.148819220060914e-58, 'SFTPCexpression': 9.148819220060914e-58, 'MiR608_andmiR4513': 0.0006578099350934741, 'study_showedthe': 0.0016810521528134112, 'suppressedcell_proliferation_migration': 0.0005218289698578611, 'function_miR193b3psilencing': 0.0004738574283430153, 'tobe_transcripts': 0.0003535708123475912, 'lncRNA_mRNAcan': 0.0006246792128329638, ']_To_be_specific_lncRNA_and_mRNAcan_competitively_bind_with_the_shared_miRNA_tomodulate_cancer_progression_For_instancelncRNAHOXDAS1_promotes_liver_cancer_metastasis_throughsponging_miR130a3p_and_targeting_SOX4_[_]_LncRNA_TUG1_facilitates_the_development_of_papillary[]LncRNAUCA1_exertsfunction_inesophageal_cancer_through_acting_as_the_ceRNA_ofthyroid_cancer_via_miR145ZEB1_axisits_oncogenic_0cWang_ _BMC_Pulmonary_Medicine_           _Page_ _of_Fig_ _LINC02418': 7.91843250950269e-05, 'targeting_SOX4_LncRNA_TUG1': 0.0006246792128329638, 'Cell_migration': 9.148819220060914e-58, 'transwell_P_ns_meansno': 9.148819220060914e-58, 'KNL1overexpressionUpregulation': 0.0001186502426005426, 'Ethics_Committee_signedthe_consents': 0.00013089836268742648, 'Expression_pattern': 9.148819220060914e-58, 'RTqPCR_P_P': 9.148819220060914e-58, 'cells_Transwell_assay': 1.104908323071169e-07, 'cellinvasion': 6.7687091991596565e-06, 'blot_testedexpression_cell_apoptosisin': 9.148819220060914e-58, 'groups_EMTrelated_proteins_gel_images_4bS2C_region_ANOVA_Analysis': 9.148819220060914e-58, 'gene_DMEM': 9.148819220060914e-58, 'groups_cellinvasion_EMTrelated_proteins_gel_images_4bS2C_region_ANOVA_Analysis': 9.148819220060914e-58, 'MALAT1_Metastasis': 9.148819220060914e-58, 'miRNAs_microRNAs_significanceNEAT1': 9.148819220060914e-58, 'MAP_LC3B_Microtubule': 9.148819220060914e-58, 'protein_chain_betaMIR31HG': 9.148819220060914e-58, 'PVT1_Pvt1_oncogene_RIP_RNA': 3.529128599037858e-05, 'gene_SRYbox_transcription_factor': 9.148819220060914e-58, 'TUNEL': 9.148819220060914e-58, 'Terminaldeoxynucleoitidyl_transferase': 9.148819220060914e-58, 'nick_end': 9.148819220060914e-58, 'ReferencesChou_J_Wang_B_Zheng_T_Li_Zheng_L_Hu_J_Zhang_Y_Xing_Y_Xi_T_MALAT1': 0.00014265292060500713, 'review_RNA_LINC00312': 9.148819220060914e-58, 'lungadenocarcinoma_migration_mimicry': 9.148819220060914e-58, 'Novel_RNA_lncRNALL22NC03N64E91': 8.263922883666513e-55, 'throughepithelialMesenchymaltransition': 0.00019915147656230243, 'allcause_mortality': 0.004315547045054443, 'NLST_trial': 1.1686951820486561e-54, 'LDCT_screening': 8.263922883666513e-55, 'Xray_screening': 0.0015281830404996106, 'thesame_outcome': 2.4946635808691535e-05, 'PLCOTrial_it': 0.00012626865361833805, 'risk_smokers': 0.0002919243480472275, 'PLCOtrial': 5.462046093137549e-07, 'cancer_deaths_irregularitiesReich': 3.3467631614105835e-05, 'PLCO_trial': 1.1686951820486561e-54, 'irregularities': 8.263922883666513e-55, 'less_shortcoming': 8.263922883666513e-55, 'importantoutcome_Allcause_Mortality': 0.0007959416758056306, 'careAs': 9.148819220060914e-58, 'WC_Allcause': 9.148819220060914e-58, 'complication_rates': 8.263922883666513e-55, 'CXR_screening_trials': 0.0007080023910910008, 'Black': 0.004315547045054443, 'LDCT_screeninghad': 0.0010298344840079976, 'Randomised': 4.0201465185332776e-05, 'Benjamin': 0.00014543055860482567, 'screeningFundingThe_research': 9.148819220060914e-58, 'Incorporated_ona_recommendation': 9.148819220060914e-58, 'flaw_inclaims': 0.004315547045054443, 'ReferencesHuang_KL_Effects': 9.148819220060914e-58, 'review_metaanalysis_trial': 9.148819220060914e-58, 'inhibitors_ICIs': 0.000597348627632446, 'thyrotoxicosis': 0.00783720183830918, 'TSAbtest_results': 0.00012198022841850962, 'thyroid_functionConclusions': 0.0006324067207528349, 'nivolumabtherapy': 9.148819220060914e-58, 'thyroid_uptake_conversion': 9.148819220060914e-58, 'anssuch_insufficiency_type_diabetes': 0.0038806204677737646, 'endocrine': 9.148819220060914e-58, 'CTLA4_inhibitors': 9.148819220060914e-58, 'regulation_use_thyroiditis_syndrome': 3.5057934680564676e-05, 'thyroiditis_syndrome': 3.5057934680564676e-05, 'tumour_thrombus_patient': 9.150169635962028e-05, 'line_chemotherapy': 0.00012198022841850962, 'administration_thyrotoxicosis': 0.00020207254642467623, 'He_family_members': 9.148819220060914e-58, 'history_Thyroidthyroid_diseases': 9.148819220060914e-58, 'Fig_scintigraphywhich': 9.148819220060914e-58, 'bilateraland': 9.148819220060914e-58, 'DPB10501We': 0.0006324067207528349, 'KI': 0.007713134335009549, 'thedosage': 0.007713134335009549, 'to_be_ineffectivebased_on_the_CT_and_OGD': 9.806968693132074e-06, 'to_be_ineffectivebased_on_the_CT_and_OGD_resonance': 0.0006324067207528349, 'irinotecan_therapy': 0.0006324067207528349, '0cYamada_BMC_Disorders_Page_patient': 0.00045085371770963703, 'gamma_knife': 0.00012198022841850962, 'conclusionsWe': 0.00045085371770963703, 'scintigcarcinomaraphy': 7.098236077976898e-05, 'Thyroid': 9.148819220060914e-58, 'goitre': 9.148819220060914e-58, 'Brancatella': 0.00045085371770963703, 'anenlargement': 8.263922883666513e-55, 'titreHowever_ultrasonography': 9.148819220060914e-58, 'enlargement_thyroid_vascularisation_pattern': 9.148819220060914e-58, 'to_presume_that_Graves\\x99_diseasewas_induced_by_nivolumab_although_there_is_a_possibilityof_coincidence': 0.0005915726387590047, 'Graves\\x99': 9.806968693132074e-06, 'to_be_associatedwith_Japanese_Graves\\x99_disease': 0.0038806204677737646, 'bycase_ofGraves\\x99_disease': 0.00012813228880322785, 'scintigraphy_ultrasonography': 9.148819220060914e-58, 'to_accurately_diagnose_and_treat_ICIinduced_thyrotoxicosisA_relationship_between_thyroid_antibodies_and_PD1inhibitorinduced_thyroid_dysfunction': 9.148819220060914e-58, 'bynivolumab_Osorio': 0.001845170519318405, 'imaging_with99mTcpertechnetate': 9.148819220060914e-58, 'blood_flow_uptakevia': 9.148819220060914e-58, 'hyperfunctioning_in_pertechnetate_imaging': 7.289006093636522e-05, 'Graves\\x99_diseasewith': 0.00045085371770963703, 'uptakein_scintigraphy': 0.00045085371770963703, 'antibody_TPOAb': 0.0006324067207528349, 'SF': 0.0006325752554057456, 'details1Department_0cYamada_BMC_Disorders_Page': 0.0013882295497307361, 'August_ReferencesGonzalezRodriguez_E_RodriguezAbreu_D_Spanish_Group': 9.148819220060914e-58, 'andmanagement': 9.148819220060914e-58, 'A_alNivolumab': 9.148819220060914e-58, 'thyroid_dysfunction_presentation_C_Vitti_disease_case': 9.148819220060914e-58, 'Treatment_ofipilimumab': 9.148819220060914e-58, 'graves\\x99_disease': 9.148819220060914e-58, 'to_investigate_the_association_between_selfreportedsnoring_and_body_composition_in_peripost_menopausal_Chinese_women_as_well_as': 0.0019127833147525456, 'body_composition': 2.274211562945482e-53, 'using_bioelectrical_impedance_analysis_BIA_Besides_blood_samplewere': 1.4055400435083287e-53, '\\x89¥_nights': 9.148819220060914e-58, 'to_be_an_independent_riskfactor_for_higher_fat_mass_total_upper_limbs_trunk_with_the_highest_risk_of_ _times_for_fat_mass_of_trunk_afteradjusting_for_metabolic_confoundersp_  ': 9.148819220060914e-58, 'snoring': 9.148819220060914e-58, 'to_be_correlatedwith_obesity': 9.148819220060914e-58, 'diabetes_mellitus_OSA': 9.148819220060914e-58, 'to_be_more_prevalent_in_men_than_Correspondence_yctengsjtueducn_taomfsjtueducn_\\xa0_Yang_Zhou_and_Fei_Liu': 9.148819220060914e-58, 'quality_life': 0.0038806204677737646, 'confoundthe_association': 7.141308139176537e-05, 'to_explore_the_association_with_snoring_and_body_composition_in_menopausalwomenMethodsStudy_participantsThis_crosssectional_study': 0.007713134335009549, 'Menopause_Clinic': 0.0011075402231842013, 'HanChinese_woman': 8.263922883666513e-55, 'rhinitis': 9.148819220060914e-58, 'internalsuch': 9.148819220060914e-58, 'level_income': 3.921395895544557e-05, 'Variables': 6.400168473855899e-07, 'smoke_alcoholconsumption': 9.148819220060914e-58, 'Guiding': 9.148819220060914e-58, '\\x89¥_yearsgroup_absence': 0.0005371082976310824, 'diabetes_mellitus': 1.1686951820486561e-54, '\\x89¥_mmolL': 8.263922883666513e-55, 'treatmentfor_diabetes': 8.263922883666513e-55, 'frequency_assessmentParticipants': 0.00021457154721453482, 'dividingweight': 0.00017025116477781125, 'blood_pressure_blood': 0.00238803522972525, 'Blood_samples': 6.075138805368378e-52, 'glucose_FBG_rate': 3.287841426025112e-52, 'glucose_FBG': 3.287841426025112e-52, 'compositionWe': 2.274211562945482e-53, 'limbs_trunk': 1.4055400435083287e-53, 'kg_\\x89¥_kg_mass': 0.00238803522972525, 'Armonk_NY_USA_Data': 0.0005263009120446208, 'distributionswhereas_medians_inter_range': 0.0013882295497307361, 'distributions': 0.014790379321251233, 'Ï\\x872_testcategorical_variables': 0.0003069306742853986, 'referencegroup_Relationship': 0.0002698537781800097, 'Covariates': 0.00012961804051640142, 'snorerstended': 1.1686951820486561e-54, 'triglyceridelowerHDLC': 8.263922883666513e-55, 'income_p': 8.263922883666513e-55, 'differenceamong_status_respect': 0.007713134335009549, 'limbs': 9.148819220060914e-58, 'roles_P_mass_P_mass': 5.8791748802789936e-05, 'postmenopause': 0.0005573368904834178, 'associationUpper_airway_resistance_collapsibility': 0.0004405647755333974, 'KgHeight': 9.148819220060914e-58, 'mmolLSBP': 9.148819220060914e-58, 'Fig_Odds': 1.029454787886047e-05, 'sleep_regulation_breathing_tothe': 0.0038806204677737646, 'menopause_status': 0.0018006682651940404, 'snoreobesity_association': 0.0038806204677737646, 'lipoprotein_FBG': 9.148819220060914e-58, 'glucose_BMI_Body_mass_Fat_mass': 9.148819220060914e-58, 'to_acknowledge_all_women_who_consented_to_takepart_of_this_study_We_are_also_thankful_for_the_support_and_cooperation_fromstaff_members_of_obstetrics_and_gynecology_in_Shanghai_Jiao_TongUniversity': 0.0007959416758056306, 'to_takepart_of_this_study': 0.0011075402231842013, 'Sixth': 0.0036021217593910104, 'YT': 0.0019127833147525456, 'LG_SJ': 9.148819220060914e-58, 'questionnairesurvey': 9.148819220060914e-58, 'finalmanuscriptFundingThis_study': 8.176613467474116e-05, 'andor_study': 0.00023557425055950736, 'July_GenderSpecific_Association': 9.148819220060914e-58, 'Snoring_Hemoglobin_A1c_Levels': 9.148819220060914e-58, 'RY_association': 9.148819220060914e-58, 'PMID_Phillips': 9.148819220060914e-58, 'Rep_httpsdoi101038s41598017014897': 9.148819220060914e-58, 'PMID_PubMed_status_sleepdisorderedbreathing': 9.148819220060914e-58, 'PMCID_PMCPMC2633408': 1.6805631307987923e-47, 'Zhou_Y_Zheng_Y_Li_C_Association': 1.6805631307987923e-47, 'functionalrequirement': 0.00782878996536959, 'Spint5_Ces5a_testisspecific_genes': 0.007713134335009549, 'knockout_mice_results': 0.0001279932340156963, 'plethora_Sperm_maturation': 0.0003167145330801072, '0cRobertson_BMC_Biology_Page': 0.0004111663773473564, 'to_reach_nearly_ten_billion_by_theyear_ ': 0.0010298344840079976, 'identifying_ _human_genes_as_testisspecific': 5.0560809961532645e-08, 'Numerous_reproductivetractspecific_targets_mouse_modelexists': 9.148819220060914e-58, 'to_stratify_the_resultsinto_subgroups_based_on_protein_druggability_and_on_theavailability_of_a_mouse_model': 9.148819220060914e-58, 'to_be_of_vast_importanceresults': 8.263922883666513e-55, 'gene_knockouts_Spint3': 0.007713134335009549, 'One_hundred_sixtytwo': 0.0010298344840079976, 'Figure_1a_b': 0.0006030236714318566, 'Mouse_data': 0.00024831101020746386, 'Additionalinterestsamplesin_Additionalfile_BMC_Biology_Page': 2.527533085858669e-07, 'RNAseqdata': 0.007713134335009549, 'file_file_Table_file_Table_S4': 9.148819220060914e-58, 'change_identity': 9.148819220060914e-58, 'tissue_file_Table_S6': 1.392107439368786e-05, 'filters_value': 2.2728498245748842e-07, 'colors_size_N_values': 0.0010298344840079976, 'filters': 0.004315547045054443, 'number_human_combinednewly_datasets': 0.0010301089944991153, 'FDR_filter': 0.004315547045054443, 'file_file_S7_Thirtysix': 1.6814744700550177e-05, 'BMC_Biology_Page': 8.263922883666513e-55, 'human_combinednewly_datasets': 2.745104911175676e-07, 'Additionalfile_FigS4A': 8.263922883666513e-55, 'The_majority_of_thecandidate_genes_do_not_have_a_reported_mouse_modelAdditional_file_ _Fig_S4B_Additional_file_ _Table_S9summarizes_model_availability': 0.00018962392250449942, 'listof': 0.0010096565812634467, 'throughhuman': 0.00018962392250449942, 'bioinformatics_analysis_inhumans_Fig': 1.5460876911313743e-05, 'ortholog_Fig': 0.0009466755491730313, 'geneortholog': 1.5460876911313743e-05, 'PRAMEF2SSX2': 9.148819220060914e-58, 'greater_symbols': 9.148819220060914e-58, 'gene_symbols': 0.0008822241915335798, 'obtainedfrom_MGI_IMPC_testisspecificThree_hundred_eightysix_genes': 0.001129870936471824, 'SPPL2C\\x94that': 0.0018006682651940404, 'proteins_PCR_heatmap': 9.148819220060914e-58, 'TPM_value_expressionprofile': 9.148819220060914e-58, '\\x89¥_TPM': 0.0014616190772430405, 'IQCM': 1.9650118403951925e-06, 'datasetsAdditionalfile_Seventysix_genes': 0.00012043310221323763, 'Thirtyfour_geneswere': 9.148819220060914e-58, 'PRSS48_SATL1_GPR156TAS2R13_TAS2R30_TAS2R46': 9.148819220060914e-58, 'VN1R2': 7.064525965822062e-05, 'Humans': 1.545263727514792e-05, 'proteincoding_equivalent': 0.0009469278262817738, 'encode_transcription': 2.74685240497079e-05, 'OBP2B': 1.883444682651394e-12, 'ISM2_MAGEC2': 1.545263727514792e-05, 'MAGEC2': 0.0009469278262817738, 'mouse_data': 9.148819220060914e-58, 'Ism2': 9.148819220060914e-58, 'orthologs_Krtap47': 2.05272894510854e-05, 'Gm11555none': 3.3524848223258533e-07, 'ratios_IRRs': 0.0019127833147525456, 'cohorts_cohort': 0.0018018967041603627, 'regression_CI_\\x93_for_CI': 0.00238803522972525, 'Hyperthyroidism': 9.148819220060914e-58, 'goiter': 9.148819220060914e-58, 'effects_studies': 0.000291411853346343, 'using_a_specific_subgroup_of_womenMoreover_no_study_to_date': 9.148819220060914e-58, 'ofdifferent_subtypes': 9.148819220060914e-58, 'differences_ofdifferent_subtypes': 0.00210348072096923, 'Mammographic_density': 9.148819220060914e-58, 'tothe_percentage': 9.148819220060914e-58, 'when_investigating_the_associationbetween_hyperthyroidism_and_breast': 0.001128162151175775, 'pleiotropicpathways': 0.0008581749454218445, 'nucleotide_polymorphismsSNPs_cancer_risk': 0.0019127833147525456, 'susceptibility_mammographicdensity': 0.000347488144371561, 'Projectfor': 0.00021180960367334957, 'E05_Types_of_hyperthyroidism_weredefined_by_the_ICD_codes_E050_goiter_E053\\x93E059_types': 1.1481395008562046e-05, 'whichever': 3.8077349155409544e-07, 'code_cohort': 9.148819220060914e-58, 'throughan_invitation': 9.148819220060914e-58, 'to_join_the_study_with_a_participationrate_of_ _Aside_from_mammographic_imaging_andblood_sample_collection_participants': 0.00021180960367334957, 'KARMA_cohort': 0.00042075216298420966, 'KARMAcohort': 0.0015234007210098185, 'PRSwas': 9.148819220060914e-58, 'using_the_following': 9.148819220060914e-58, 'totalnumber': 0.00012613970685026185, 'method_tomeasure_density': 0.00771518910792271, 'Regional_Review_Board': 0.0019127833147525456, 'Sweden_Dnr_analysisFor_cohorts_rate_ratio': 0.0008584036440639407, 'Poisson_regression_density': 1.4005991677684801e-05, 'Theanalysis': 0.00012961804051640142, 'Poisson_regression_association_having_had_a_benign_breast_diseasenumber_of_births_age_at_first_birth_breastfeeding_durationBMI_analysis_density': 1.3141414868934549e-05, 'Theserisk_factors': 2.147105663446278e-07, 'having_had_a_benign_breast_diseasenumber_of_births_age_at_first_birth_breastfeeding_durationBMI': 3.5014449064039076e-09, 'family_history_models': 0.001129870936471824, 'Linear_regressionmodels': 9.148819220060914e-58, 'to_test_the_effect_of_hyperthyroidism_on_mammographic_density_square_roottransformed_as_a_continuous_variableTo_test_the_association_between_hyperthyroidism_andhaving_a_genetic_predisposition_to_breast_cancer_we_usedlogistic_regression_models_to_calculate_the_ORs_of_hyperthyroidism_among_KARMA_women_who_had_beengenotyped_by_quartiles_of_PRS_for_breast_cancer_overallfor_ERpositive_cancers_and': 9.148819220060914e-58, 'cohort_cases': 9.148819220060914e-58, 'to_test_the_effect_of_hyperthyroidism_on_mammographic_density_square_roottransformed_as_a_continuous_variableTo_test_the_association_between_hyperthyroidism_andhaving_a_genetic_predisposition_to_breast_cancer_we_usedlogistic_regression_models_to_calculate_the_ORs_of_hyperthyroidism_among_KARMA_women_who_had_beengenotyped_by_quartiles_of_PRS_for_breast_cancer_overallfor_ERpositive_cancers_and_components': 9.148819220060914e-58, 'Patientswith_hyperthyroidism': 9.148819220060914e-58, 'IRR_CI': 9.148819220060914e-58, 'KARMA_women': 0.0008977501830715706, 'association_betweenbreast_cancer_goiter': 8.76810296065524e-06, '\\x93which': 9.148819220060914e-58, 'file_Table_S3': 9.148819220060914e-58, 'registers_IRRs': 9.148819220060914e-58, 'comparinghyperthyroidism_patients': 9.148819220060914e-58, 'exactage': 9.148819220060914e-58, 'Model_ _adjusted_for_calendar_period': 9.148819220060914e-58, 'mass_indexAnalyses': 0.0013882295497307361, 'goiter_Hyperthyroidism': 9.148819220060914e-58, 'risk_predictors': 9.148819220060914e-58, 'patientsbetween_hyperthyroidism_breast_cancer': 0.0007862569594425692, 'nonthyroidalillnesssyndrome': 0.0038816547305533795, 'K_pathways': 0.00059863872410753, 'I131_iodine_treatment': 0.0007862569594425692, 'hyperthyroidism_patients': 0.00030586813508869646, 'association_betweenhyperthyroidism_breast_cancer': 0.00015012659540506961, 'study_hyperthyroidism': 9.148819220060914e-58, 'risk_factors_Graves\\x99disease_goiter': 9.148819220060914e-58, 'Thisdisparity': 0.00031504101255819624, 'hyperthyroidism_BMI': 8.263922883666513e-55, 'withthyroid_nodules': 4.3223763381732904e-05, 'suggesting_the_role_of_deiodinaseactivity_in_the_association_between_thyroid': 0.0005253840276496832, 'underlyingmechanisms': 0.0006685521372541687, 'severallimitations': 0.00238803522972525, 'misclassification': 0.0038806204677737646, 'to_minimize_any_potential_misclassificationby_using_main_diagnoses_only_Due_to_increased_medicalsurveillance_of_patients_with_hyperthyroidismthesewomen_may_be_diagnosed_earlier_with_breast_cancer_thanwomen_without_hyperthyroidism_While_this_possiblebias_might_slightly_shift_the_temporal_risk_pattern_amongwomen_with_hyperthyroidism': 0.007713134335009549, 'possiblebias': 9.148819220060914e-58, 'pattern_amongwomen': 9.148819220060914e-58, 'againstthis_surveillance_bias': 0.0003142854144885643, 'detailedinformation': 9.148819220060914e-58, 'point_estimates': 9.148819220060914e-58, 'byfactorsbetween': 0.0008822241915335798, 'paper_association': 0.0007641347695089468, 'Projectfor_Risk_Prediction_ratio_PRS_Polygenic': 0.0019185608626820132, 'scoreSNPs': 3.1321580722278994e-05, 'T4_ThyroxineAcknowledgementsWe': 0.0005573368904834178, 'studyAuthors\\x99_contributionsHY': 0.0003365073515628987, 'responsibility_integrity': 5.4906762875123896e-06, 'accuracy_KC_NH_andHY': 9.148819220060914e-58, 'scoreSNPs_study_Swedish_Research_Council_Swedish_Cancer_Society_CAN190266_no': 9.148819220060914e-58, 'HY_NH': 0.00022771936739542464, 'HY': 0.001129870936471824, 'KC_HY': 0.00014652584739847748, 'applicableFundingThis_work': 9.148819220060914e-58, 'Swedish_Research_Council': 9.148819220060914e-58, 'Swedish_Cancer_Society': 3.1321580722278994e-05, 'CAN190266': 3.1321580722278994e-05, 'to_also_acknowledge_MÃ¤rit_and_Hans_Rausing\\x99s_Initiative_against_Breast_Cancer_Haomin_Yang': 0.00238803522972525, 'Fund_forhighlevel_talents': 0.00238803522972525, 'using_the_followinglinks_httpsbestalladatasocialstyrelsensedataforforskning_and_httpswwwscbsevaratjansterbestallamikrodataEthics_approval_and_consent_to_participateThe_study': 0.0007641347695089468, 'KARMA_participantsconsented': 9.148819220060914e-58, 'using_the_followinglinks_httpsbestalladatasocialstyrelsensedataforforskning_and_httpswwwscbsevaratjansterbestallamikrodataEthics_approval_and_consent_to_participateThe_study_Review_Board_manuscript': 9.148819220060914e-58, 'Estrogenlike_effects': 0.0010068765747081726, 'to_estimate_the_func\\x91tions_of_TTN\\x91AS1_in_OSCC_cells_RIP_and_luciferase_reporter_assays_were_utilized_to_detect_the_interaction_between_TTN\\x91AS1_and_miR\\x91\\x913p_as_well_as_between_miR\\x91\\x913p_and': 0.0016810521528134112, 'func\\x91tions_luciferase_reporter_assays': 9.148819220060914e-58, 'to_detect_the_interaction_between_TTN\\x91AS1_and_miR\\x91\\x913p_as_well_as_between_miR\\x91\\x913p_and': 9.148819220060914e-58, 'miR\\x91\\x913p_sponge': 9.148819220060914e-58, 'inhibitory_functions': 9.148819220060914e-58, 'overexpressing_NFAT5': 3.939333272693138e-06, 'to_involve_ _in_ _different_ _cell_ _progression_ _such_ _as_ _cell_ _proliferation_ _and_ _cell_ _apoptosis_ ': 0.000302093565533489, 'PVT1': 8.263922883666513e-55, 'carcinoma_cell_migration_invasion': 1.1686951820486561e-54, 'GAPLINC': 0.00027078059233556784, 'TTNAS1': 0.00853994896379691, 'mechanisms_functions': 0.007713134335009549, 'Hospital_Patients': 9.148819220060914e-58, 'TTNAS1_mechanisms_functions': 9.148819220060914e-58, 'Japan': 1.1686951820486561e-54, 'nologies_Island_NY_USA': 8.263922883666513e-55, 'amplification_\\x88\\x92Î\\x94Î\\x94Ct_method': 2.0170598013233685e-07, 'to_quantify_PCR_products_U6_snRNA_or_GAPDH_was_used_as_the_internal_control_for_lncRNA_mRNA_or_miRNA': 1.2354001104571252e-05, 'NC_mimicsinhibitor': 0.0007956673215405282, 'SCC9_cells': 0.002396120321324867, 'Kit_Beyotime_Shanghai_China': 1.2508257973977775e-06, 'to_ _detect_ _cell_ _viability_under_ _manufacturer\\x99s_ _protocols_ _Cells_   _cellswell_were_planted_in_96well_plates_After_   _and_a0h': 7.668198957165733e-05, 'Cell_Int_Page_SCC9_cells': 8.263922883666513e-55, 'employing_ _the_ _flow_ _cytometer_ _BD_ _Biosciences_ _Franklin_ _Lakes_ _NJ_ _in_ _the_ _presence_ _of_Annexin_ _VPI_ ': 1.1686951820486561e-54, 'kit_Cell_samples': 8.263922883666513e-55, 'employing_ _PBS_ _and_ _fixed_ _using_   _PFS_ _for_TUNEL_ _assay_ ': 0.0006032739562245517, 'SCC9': 1.532252980982392e-05, 'RNA_immunoprecipitation': 0.0009908263261843922, 'overnight_Complex': 1.616194458608858e-05, 'to_ _construct': 0.0003373197309518599, 'triplicateWestern_blotCells': 8.263922883666513e-55, 'to_assess_the_concentration_of_protein_Separation_of_equal_amount_of_proteins_was_conducted_via_ _SDSPAGE_BioRad_Laboratories_ _Hercules_ _CA_ _followed_ _by_ _the_ _transformation_ _to_ _PVDF_ _membranes_ ': 1.1686951820486561e-54, 'kit_Pierce_Biotechnology_Rockford_IL': 8.263922883666513e-55, 'Hercules_CA': 0.00023629147773967076, 'using_ _a_ _ECL_ _detection_kit': 0.0004473525626575851, 'test_0cFu': 2.485116341903048e-05, 'p_ResultsKnockdown': 9.148819220060914e-58, 'a0proliferation_a0migration': 9.148819220060914e-58, 'TTNAS1_expression': 0.00776108169307199, 'number_EdU': 0.001128162151175775, 'TTNAS1_depletion_Fig_a01c': 0.0004738574283430153, 'flow_cytometry_experiments': 0.00210348072096923, 'assay_distribution': 0.007713134335009549, 'to_ _be_ _located_ _in_ _the_ _cytoplasm_ _of_ _SCC4_ ': 0.00013959276999845252, 'to_ _regulate_ _mRNAs_ _through_ _sponging_ _miRNAs_at_ _posttranscriptional_ _level_ ': 6.877089425857604e-05, 'website': 0.007713134335009549, 'site_miRNA_miR4113p': 0.0038806204677737646, 'miR4113p_reporter_assay': 0.0013882295497307361, 'miR4113p': 0.008018930683735357, 'reporter_assay': 0.0035653883386215007, 'miR4113p_overexpression': 0.0006054349545841993, 'miR4113p_order': 0.00013959276999845252, 'OSCC_cell_growth': 0.00013959276999845252, 'overexpressing_ _miR4113p_ ': 0.000399580041015592, 'proliferation_SCC9_cells': 6.522449773414495e-06, 'apoptosis_SCC9_cells': 0.00013109373273007577, 'databases_candidate_target_genes': 9.148819220060914e-58, 'a0_4a': 9.148819220060914e-58, 'to_ _detect_ _the_ _influence_ _of_ _miR4113p_ _overexpression_ _and_ ': 8.263922883666513e-55, 'NFAT5': 0.009399193288440168, 'to_ _evaluate_ _the_ _relationship_ _of_ _TTNAS1_ _NFAT5_ _and_ _miR4113p_ ': 4.549016255259865e-06, 'interference_efficiency': 2.749052194772785e-05, 'cells_proliferation_ability': 4.4867800672637674e-07, 'colony_formation_EdU_experiments': 4.4867800672637674e-07, 'cells_proliferation_ability_colony_formation_EdU_experiments_to_estimate_cell_migration': 7.8054086220574e-08, 'g_healing_assays': 9.148819220060914e-58, 'to_estimate_cell_migration': 9.148819220060914e-58, 'to_predict_the_possible_miRNAs_that_could_bind_with_TTN\\x91AS1_d_MiR\\x91\\x913p_expression_was_detected_through_qRT\\x91PCR_in_OSCC_cells': 0.0001088596871057638, 'FISH_StarBsae_website': 1.7757736044771485e-06, 'to_evaluate_the_relationship_between_miR\\x91\\x913p_and_TTN\\x91AS1_g': 0.00039436183359109516, 'Luciferase_reporter_assays': 9.148819220060914e-58, 'to_verify_the_correlation_of_miR\\x91\\x913p_and_TTN\\x91AS1_P_  _P_ ': 9.148819220060914e-58, 'NFAT5_expression': 7.73441244412031e-06, 'TTNAS1_depletion': 0.00047411010896072274, 'miR4113p_inhibition': 1.2635714323875756e-07, 'knockdown_efficiency_Fig': 0.007713134335009549, 'file_NFAT5_expression': 9.148819220060914e-58, 'expression_knockdown_efficiency_Fig': 9.148819220060914e-58, 'b_Cell_proliferation': 4.13949409743745e-05, 'miR\\x91\\x913p': 0.0011587884740779588, 'qRT\\x91PCR_analysis': 0.0016832959807680282, 'to_screen_out_the_mRNAs_which_could_be_inhibited_by_NFAT5_depletion_and_miR\\x91\\x913p_overexpression': 2.7475874469815004e-05, 'i_Cell_proliferation': 2.7475874469815004e-05, 'silencing_NFAT5': 1.0651133472190604e-07, 'cell_apoptosis_capability': 9.148819220060914e-58, 'NFAT5_depletion': 9.148819220060914e-58, 'assays_a0et': 2.1050490145489324e-05, 'migration_capability_a04_m_0cFu': 1.7380264309518192e-09, 'OSCC_progression': 0.00022981859498001972, 'NFAT5_levels': 7.732352270694441e-06, 'NFAT5_overexpression_miR4113p_inhibition': 0.00210348072096923, 'knockdown_upregulation_NFAT5': 6.415730648988953e-07, 'TTNAS1_depletion_Fig': 0.0038806204677737646, 'OSCC_cell_growth_migration': 0.00013959276999845252, 'to_ _play_ _a_ _crucial_ _role_ _in_ _promoting_ _the_ _development_ _of_OSCC': 9.52819159130264e-06, 'PLAC2': 0.00027078059233556784, 'CEBPAAS1': 9.148819220060914e-58, 'to_ _correlate_ _with_ _the_bad_ _prognosis_ ': 9.148819220060914e-58, 'P4713': 9.148819220060914e-58, 'to_contribute_to_the_malignant_phenotypes_of_ _OSCC_ _through_ _activating_ _the_ _JAKSTAT3_ _pathway': 9.148819220060914e-58, 'study_TTNAS1': 9.148819220060914e-58, 'to_ _be_ _highly_expressed_ _in_ _OSCC_ _cells_ ': 9.148819220060914e-58, 'Overall_TTNAS1': 0.001128162151175775, 'PAGBC': 9.148819220060914e-58, 'gallbladder_tumorigenesis': 9.148819220060914e-58, 'bioinformatics_tools': 0.000234035537295674, 'to_be_associated_ _with_ _several_ _cancers_ ': 0.0026514494750263864, 'to_conduce_to_the_glycolytic_phenotype_rewiring_and_ _pancreatic_ _cancer_ _progression_ _through_ _transcription_of_PGK1': 0.00015362721729975134, 'celldriven_angiogenesis': 0.00015362721729975134, 'OSCC_progression_to_examine_the_overexpression_efficiency_of_NFAT5_in_SCC\\x91_and_SCC\\x91_cells_b_c_Cell_proliferation_capability_in_SCC\\x91_and_SCC\\x91_cells_colony_formation_EdU_assay': 2.7561271142173034e-05, 'to_examine_the_overexpression_efficiency_of_NFAT5_in_SCC\\x91_and_SCC\\x91_cells_b_c_Cell_proliferation_capability_in_SCC\\x91_and_SCC\\x91_cells': 2.7475874469815004e-05, 'colony_formation_EdU_assay': 9.022582498156722e-05, 'f_healing_assays': 4.498331077162804e-07, 'TTN\\x91AS1_expression': 9.148819220060914e-58, 'analysis_CCK\\x91_assay': 9.148819220060914e-58, 'collection_DMEM': 9.148819220060914e-58, 'Polyvinylidene_fluoride': 9.148819220060914e-58, 'Horseradish_peroxidase': 8.261252151162673e-07, 'deviation_ANOVA_Analysis': 9.148819220060914e-58, 'people_draft_manuscript': 9.148819220060914e-58, 'Cell_Int_Page_patients': 0.0004100538998299479, 'Accepted_ _June_References_  _Krishna_Rao_SV_Mejia_G_Roberts\\x91Thomson_K_Logan_R_Epidemiology_of_oral_cancer_in_Asia_in_the_past_decade\\x93an': 9.148819220060914e-58, 'Cancer_Prev_Cancer_statistics': 9.148819220060914e-58, 'RNA_circRNA': 9.148819220060914e-58, 'to_be_involved_in_the_progression_of_NSCLC': 9.148819220060914e-58, 'to_detect_the_expression_of_circ_0020123_miR5905p_and_Thrombospondin_ _THBS2_in_NSCLC_tissues_and_cells_Cell_proliferation_and_migration_were_examined_by_Cell_Counting_Kit8_CCK8_assay_and_Transwell_assay_respectively': 0.0019127833147525456, 'Counting_Kit8': 0.0016810521528134112, 'Flow_cytometry_assay': 0.0010071448933776737, 'to_detect_the_apoptosis_of_NSCLC_cells_The_protein_levels_of_Ki67_matrix_metalloprotein9_MMP9_Cleavedcaspase9_Cleavedcasp9_and_THBS2_were_detected_by_Western_blot_The_targets_of_circ_0020123_and_miR5905p_were_predicted_by_starBase_ _and_TargetScan_and_then_confirmed_by_dualluciferase_reporter_assay_and_RNA_immunoprecipitation_RIP_assay_The_animal_experiment_showed_the_effect_of_circ_0020123_on_tumor_growth_in_vivoResults_ _The_expression_of_circ_0020123_was_upregulated_in_NSCLC_tissues_and_cells_Functionally_circ_0020123_downregulation_inhibited_the_proliferation_and_migration_and_promoted_the_apoptosis_of_NSCLC_cells_Interestingly_circ_0020123_directly_targeted_miR5905p_and_inhibition_of_miR5905p_reversed_the_knockdown_effects_of_circ_0020123_on_NSCLC_cells': 1.6435761703528167e-05, 'blot_targets': 0.00023308907442208475, 'starBase': 0.00023308907442208475, 'dualluciferase_reporter_assay_RIP_assay': 0.00023308907442208475, 'miR5905p': 0.0012369458115431733, 'axisConclusion_RNA_circ_0020123': 4.320435905431836e-06, 'THBS2': 0.00026489780621965754, 'Circ_0020123': 0.00019394654026033434, 'China_Circ_0020123': 2.018017300680915e-05, 'to_obtain_permission_directly_from_the_copyright_holder_To_view_a_copy_of_this_licence_visit': 0.00016902585554135613, 'Commons_Dedication_waiver': 0.00030203405200795866, 'ligand_CCL22': 4.13949409743745e-05, 'to_be_further_studiedAs_ ': 0.00015889971901811653, 'miR23b27b241_miR1133a': 0.00027915818211639477, 'further_investigationThrombospondin_   _THBS2_ ': 0.00046345855666667525, 'to_be_highly_expressed_in_different_cancers_ _including_ _cervical_ _cancer_ ': 0.0004254422540019666, 'poorly_definedIn_ _this_ _study_ ': 0.0005346559204959019, 'a0specimensNSCLC_tissues_lung_tissues': 8.720855896303402e-06, 'gain_lossoffunction_experiments_biology_techniquesMaterials': 0.0010068765747081726, 'People\\x99s_Hospital': 3.0198125116445793e-05, 'sicirc_00201232_RNA_shRNA': 1.4520711190229424e-08, 'circ_0020123_shcirc_0020123': 2.3708239109067426e-10, 'Lipofectamine_Thermo_Fisher_Waltham_MA_USA_0cWang_a0et': 8.263922883666513e-55, 'kit': 0.0003631075583458118, 'Invitrogen_qRTPCR': 9.148819220060914e-58, 'using_ _the_ABI_ _SYBR_ ': 9.148819220060914e-58, 'CellCounting_Kit8': 1.6453552271063444e-06, 'CellCounting_Kit8_C': 1.831366877878739e-05, 'OD_values': 9.148819220060914e-58, 'medium_C': 9.148819220060914e-58, 'Sciences_Corning_NY_USA': 1.142700471961327e-06, 'to_detect_cell_migration': 7.005067847323869e-05, 'DMEM_Thermo_Fisher_Scientific': 1.142700471961327e-06, 'to_resuspend_cells_and_the_Annexin_Vfluorescein': 1.817750855552481e-05, 'Thermo_ScientificWestern_blot': 0.00012267293572245904, 'proteins_cells': 9.148819220060914e-58, 'RIPA_lysis_buffer': 9.148819220060914e-58, 'sulphate_polyacrylamide_electrophoresis_SDSPAGE': 0.000494595879613311, 'MMP9_antibody_membranes': 2.6909254076977078e-05, 'using_Kodak_film_developer_Fujifilm_JapanDual\\x91luciferase_reporter_assaysThe_ _wild_ _type_ _circ_0020123_ _sequences_ _circ_0020123WT_ _mutant_ _circ_0020123_ _sequences_ _circ_0020123MUT_wild_type_THBS2_²UTR_sequences_THBS2WT_mutant_ _THBS2_ _²UTR_ _sequences_ _THBS2MUT_ _were_cloned_into_pGL3': 0.0016485018034048215, 'THBS2_²UTR': 1.1686951820486561e-54, 'THBS2WT_mutant': 8.263922883666513e-55, 'plasmid_miR5905p_miRNC': 1.831366877878739e-05, 'System_Promega': 9.148819220060914e-58, 'to_ _detect_ _the_luciferase_activityRNA_immunoprecipitation_RIPFirstly_ ': 9.148819220060914e-58, 'Vitalriver_Beijing_China': 0.0002851023350336312, 'Cell_Int_Page_mice': 2.1737500818559108e-05, 'to_suspend_A549_cells_ _Ã\\x97_  _transfected_ _with_ _shcirc_0020123_ _or_ _shNC': 8.263922883666513e-55, 'Experimentation_Ethics_Committee': 0.0007265761376826108, 'THBS2_animal_experiment': 1.1850035146916195e-05, 'GraphPad_Prism': 1.1850035146916195e-05, 'oneway_analysis': 0.0003141502552305981, 'QRTPCR': 2.754624833166683e-06, 'P_Downregulation_H1299_cells': 0.0016810521528134112, 'P_Downregulation_a0proliferation_migration_apoptosis_effects_sicirc_00201231_H1299_cells': 5.849733118588048e-53, 'to_detect_the_ _proliferation_ _and_ ': 0.0016487038051870126, 'proliferation_H1299_cells': 5.118769933167775e-07, 'protein_Ki67_cell_protein': 0.00025890337079117256, 'Fig_a0_3a': 0.0003373197309518599, 'miR5905pinhibitor': 0.0010068765747081726, 'to_ _detect_ _the_transfection_ _efficiency_ _Fig_a0_4a_ ': 4.496830188085306e-08, 'apoptosis_transfection_efficiency': 9.022582498156722e-05, 'to_detect_the_proliferation_of_A549_and_H1299_cells_transfected_with_sicirc_00201231_or_sicirc_00201232': 0.00036240313892865647, 'Transwell_Flow_cytolysis_assay': 0.00017939106177220415, 'protein_levels_protein_Cleavedcasp9': 9.148819220060914e-58, 'Fig_miR5905pinhibitors': 9.148819220060914e-58, 'Fig_a0_4e': 0.0038806204677737646, 'effects_H1299_cells': 0.00017245730531167117, 'effects_MiR\\x91\\x915p': 0.0005403072527347841, 'to_ _contain_ _the_ _binding_sites_of_miR5905p_through_the_online_software_TargetScan_Fig': 8.263922883666513e-55, 'cotransfection_THBS2WT': 7.74241605630692e-09, 'miR5905p_site': 3.161299546101561e-06, 'reporter_assay_c_QRTPCR': 0.0007008712380191807, 'to_detect_the_expression_of_miR5905p_in_A549_and_H1299_cells': 0.0007008712380191807, 'to_confirm_the_relationship_between_circ_0020123_and_miR5905p_P_ _THBS2_overexpression_reversed_the_a0effects_of_a0circ_0020123_knockdown_on_a0the_a0proliferation_migration_and_a0apoptosis_of_a0NSCLC_cellsBased_ _on_ _the_ _work_ _ahead_ _of_ _us_ _the_ _pcDNA31THBS2_was_ _constructed_ ': 0.0016810521528134112, 'THBS2_expression': 3.1140668924524826e-06, 'Fig_a0_6e': 0.00022709638132718343, 'THBS2_overexpression': 0.0014616190772430405, 'effects_Fig_a0': 0.0004686411271822266, 'A549_cells_shNC': 0.0005345134679592639, 'circ_0020123_knockdown': 0.0001503845112545349, 'tomosynthesis_DTS': 3.4358152916695635e-05, 'to_detect_the_expression_of_miR5905p_in_A549_and_H1299_cells_transfected_with': 4.496830188085306e-08, 'to_measure_the_migration_of_A549_and_H1299_cells_transfected_with': 0.000404948725608525, 'Flow_cytolysis_assay': 9.148819220060914e-58, 'to_detect_the_apoptosis_of_A549_and_H1299_cells_transfected_with': 9.148819220060914e-58, 'blot_P': 0.00023308907442208475, 'blot_P_attention': 0.0002543534709449633, 'sponges': 0.0018006682651940404, 'ctransferrin_receptor': 8.263922883666513e-55, 'TFRC': 1.1686951820486561e-54, 'MiR5905p': 9.148819220060914e-58, 'muscle_cells': 9.148819220060914e-58, 'effects_clue': 0.0006625816769337724, 'study_circ_0020123': 2.018017300680915e-05, 'Dualluciferase_reporter_assay': 5.915252679824553e-06, 'to_measure_the_luciferase_activity_of_THBS2WT_or_THBS2MUT_reporter_plasmid_in_A549_and_H1299_cells_transfected_with_miRNC_or_miR5905p_c_QRTPCR': 9.663702170085357e-08, 'to_detect_the_mRNA_expression_of_THBS2_in_NSCLC_cells': 9.663702170085357e-08, 'f_blot': 0.0016810521528134112, 'to_measure_the_protein_level_of_THBS2_in_A549_and_H1299_cells_transfected_with_sicirc_00201231_or_sicirc_00201232_P_ _Our_ _study_ ': 0.00014649172945341936, 'metalloproteinase_MMP_genes': 0.004315547045054443, 'conclusion_research': 0.0011366059794247468, 'proliferation_migration_apoptosis_tumor_growth': 1.854050540022203e-05, 'assay_e': 0.00017939106177220415, 'cytolysis_assay': 0.0005521751935137136, 'P_apoptosis': 0.00023308907442208475, 'Nonsmall_lung_cancer': 0.0007959416758056306, 'EZH2_homolog_Signal_transducers_activators': 9.148819220060914e-58, 'to_design_the_study_LZ_were_responsible_for_experiments_analyzed': 9.148819220060914e-58, 'data_YW': 0.00024801800887098703, 'HospitalConsent': 1.847076099487801e-10, 'manuscript_0cWang_tumor_growth': 1.1310055943464116e-08, 'manuscript_0cWang': 3.013729701271102e-12, 'tomosynthesis': 0.0010298344840079976, 'blot_e_tomosynthesis': 2.2483516665683055e-06, 'Zhong_T_Wang_L_Zhang_MyoDinduced_RNA_CDR1as': 0.0004055798914257878, 'VIII_alpha_chain': 9.148819220060914e-58, 'to_be_downregulated_in_BRIP1\\x91knockdown_breast_cancer_cells_its_clinical_role_in_breast_cancer': 9.148819220060914e-58, 'to_evaluate_the_protein_expression_of_COL8A1_in_breast_cancer': 3.302904024872297e-05, 'interaction_pathwaysConclusions': 0.00017939106177220415, 'to_be_the_most_common_cancer_and_the_ _second_ _most_ _common_ _cause_ _of_ _cancerassociated_ _The_Authors_ ': 0.0006313632619292757, 'to_be_the_most_common_cancer_and_the_ _second_ _most_ _common_ _cause_ _of_ _cancerassociated_ _The_Authors_ _link': 0.0006313632619292757, '0cPeng_a0et': 4.652039493512524e-06, 'cancer_TNBC_patients': 0.0006321861226151657, 'females_\\x93_\\x93': 8.263922883666513e-55, 'patients_anthracyclines_taxanes': 7.05217663403483e-05, 'vascular_endothelial_growth_factor': 7.05217663403483e-05, 'to_ _optimize_ _the_ _clinical_management_of_breast_cancerMolecular_events_occurring_in_breast_cancer_help_us_better_understand_the_onset_and_progression_of_breast_cancer_ ': 0.0003996210712050996, 'circSEPT9': 9.148819220060914e-58, 'tumor_formation_TNBC_progression': 9.148819220060914e-58, '\\x88\\x86Np63': 9.148819220060914e-58, 'to_ _participate_ _in_ _breast_ _cancer_ _metastasis_ _and_dissemination_ ': 9.148819220060914e-58, 'to_ _elucidate_the_ _breast_ _cancer_ _mechanisms_ _and_ ': 0.0005479687540571566, 'unknownConsidering_ _this_ _knowledge_ _gap_ _our_ _study_ _aimed_ _to_explore_ _the_ _role_ _of_ _COL8A1_ _in_ _breast_ _cancer_ _We_ _were_focused_on_investigating_the_expression_of_COL8A1_messenger_ _RNA_ _mRNA_ _in_ _various_ _molecular_ _subtypes_ _of_breast_ _cancer_ _by_ _analyzing_ _gene_ _microarray_ _and_ _RNA_sequencing_ _data_ _sets_ _The_ _COL8A1_ _protein_ _expression_level_ _was_ _validated_ _by_ _immunohistochemistry_ _staining_We_also_aimed_to_determine_prognostic_value_of_COL8A1_in_breast_cancer_to_pave_the_way_for_future_clinical_applications_ ': 0.0015842910551982499, 'to_explore_ _the_ _role_ _of_ _COL8A1_ _in_ _breast_ _cancer_ _We_ _were_focused_on_investigating_the_expression_of_COL8A1_messenger_ _RNA_ _mRNA_ _in_ _various_ _molecular_ _subtypes_ _of_breast_ _cancer_ _by_ _analyzing_ _gene_ _microarray_ _and_ _RNA_sequencing_ _data_ _sets_ _The_ _COL8A1_ _protein_ _expression_level_ _was_ _validated_ _by_ _immunohistochemistry_ _staining_We_also_aimed_to_determine_prognostic_value_of_COL8A1_in_breast_cancer_to_pave_the_way_for_future_clinical_applications_ ': 0.0019127833147525456, 'to_determine_prognostic_value_of_COL8A1_in_breast_cancer_to_pave_the_way_for_future_clinical_applications_ ': 0.00238803522972525, 'mechanisms_0cPeng': 0.007713134335009549, 'data_sets_difference_to_ _evaluate_ _the_ _stability_ _of_ _the_ _SMD_ _results_ _Subgroup_analysis_was_performed_to_compare_the_COL8A1_expression_ _levels_ _between_ _molecular_ _subtypes_ _luminal_A_ _luminal_ _B_ _human_ _epidermal_ _growth_ _factor_ _receptor': 0.0005482193106334627, 'to_compare_the_expression_of_COL8A1_mRNA_between_breast_cancer_patients_and_control_samples_using_STATA_v120_Heterogeneity_between_the_ _included_ _studies_ _was_ _assessed_ ': 1.1693440026123651e-05, 'heterogeneity_Sensitivity_analysis': 8.934303247204245e-06, 'bias_test': 9.148819220060914e-58, 'to_ _evaluate_ _the_ _stability_ _of_ _the_ _SMD_ _results_ _Subgroup_analysis_was_performed_to_compare_the_COL8A1_expression_ _levels_ _between_ _molecular_ _subtypes_ _luminal_A_ _luminal_ _B_ _human_ _epidermal_ _growth_ _factor_ _receptor': 9.148819220060914e-58, 'to_ _assess_ _the_ _clinical_significance_ _of_ _COL8A1_ _in_ _breast_ _cancer_ ': 0.00048362067048935835, 'to_compute_the_area_under_the_curve_AUC_using_IBM_SPSS_Statistics_v190_AUC_ _values_ _of_ _less_ _than_   _between_   _and_   _and_greater_than_ _represented_weak_moderate_and_strong_discriminatory_ _capability_ _of_ _COL8A1_ _respectively_between_breast_cancer_patients_and_control_samples_The_true_ _positives_ _false_ _positives_ _true_ _negatives_ _and_ ': 1.9764223988593213e-07, 'SPSS_Statistics_AUC_values_positives_negatives': 7.202915523487203e-05, 'negatives_rates': 3.2244277998847637e-09, 'cutoff_values': 3.2244277998847637e-09, 'cancerTo': 8.889791260872402e-05, 'to_identify_statistically_significant_differences_ _in_ _COL8A1_ _expression_ _between_ _two_ _or_ _more_groups_ _A_ _Pvalue_ _of_   _was_ _considered_ _statistically_significant_Kaplan\\x93Meier_curves_were_used_to_compare_high_and_low_COL8A1_expression_groups_in_terms_of_survival_The_logrank_test_was_used_to_determine_whether_the_prognostic_difference_was_statistically_significantInvestigation_of_a0COL8A1_protein_expression_in_a0breast_cancer_by_a0immunohistochemistry_stainingA_total_of_ _nonspecific_invasive_breast_carcinoma_and_  _normal_ _breast_ _tissue_ _specimens_ _were_ _obtained_ _from_the_ _First_ _Affiliated_ _Hospital_ _of_ _Guangxi_ _Medical_ _University_ _PRCHINA_ _All_ _patients_ _had_ _previously_ _signed_informed_consent_forms_and_our_research_was_approved_by_the_Ethics_Committee_of_the_First_Affiliated_Hospital_of_ _Guangxi_ _Medical_ _University_ _The_ _breast_ _cancer_ _and_normal_ _breast_ _tissue_ _specimens_ _were_ _fixed_ _with_ _formalin_ _The_ _two_ _steps_ _immunohistochemistry_ _method_ _was_used_ _to_ _determine_ _the_ _protein_ _expression_ _of_ _COL8A1_The_ _primary_ _antibody_ ': 5.123300770874827e-06, 'to_determine_whether_the_prognostic_difference_was_statistically_significantInvestigation_of_a0COL8A1_protein_expression_in_a0breast_cancer_by_a0immunohistochemistry_stainingA_total_of_ _nonspecific_invasive_breast_carcinoma_and_  _normal_ _breast_ _tissue_ _specimens_ _were_ _obtained_ _from_the_ _First_ _Affiliated_ _Hospital_ _of_ _Guangxi_ _Medical_ _University_ _PRCHINA_ _consent_forms_Ethics_Committee_to_ _determine_ _the_ _protein_ _expression_ _of_ _COL8A1_The_ _primary_ _antibody_ ': 0.0006266242915349712, 'to_compare_high_and_low_COL8A1_expression_groups_in_terms_of_survival': 3.429965887741882e-05, 'to_determine_whether_the_prognostic_difference_was_statistically_significantInvestigation_of_a0COL8A1_protein_expression_in_a0breast_cancer_by_a0immunohistochemistry_stainingA_total_of_ _nonspecific_invasive_breast_carcinoma_and_  _normal_ _breast_ _tissue_ _specimens_ _were_ _obtained_ _from_the_ _First_ _Affiliated_ _Hospital_ _of_ _Guangxi_ _Medical_ _University_ _PRCHINA_ ': 1.2424007252334804e-05, 'breast_cancer_tissue_specimens': 1.0222701944398597e-05, 'steps_immunohistochemistry_method': 9.148819220060914e-58, 'to_ _determine_ _the_ _protein_ _expression_ _of_ _COL8A1_The_ _primary_ _antibody_ ': 9.148819220060914e-58, 'httpcbiop': 5.477739185425278e-05, 'to_ _be_ _a_ _powerful_ _tool_ _and_ ': 8.93677947439673e-07, 'Invasive_Carcinoma': 0.00238803522972525, 'TCGA_We': 0.00012613970685026185, 'DEGs_COL8A1': 0.00771518910792271, 'mutation_types': 9.148819220060914e-58, 'Catalogue': 9.148819220060914e-58, 'to_ _perform_ _function_enrichment_ _to_ _shed_ _light_ _on_ _the_ _potential_ _mechanisms_of_COL8A1_underlying_breast_cancer': 0.0004405647755333974, 'clusterProfiler_package': 9.148819220060914e-58, 'to_conduct_Gene_Ontology_GO_Kyoto_ _Encyclopedia_ _of_ _Genes_ _and_ _Genomes_ _KEGG_Disease_Ontology_DO_and': 9.148819220060914e-58, 'Reactome_pathway': 9.148819220060914e-58, 'to_conduct_Gene_Ontology_GO_Kyoto_ _Encyclopedia_ _of_ _Genes_ _and_ _Genomes_ _KEGG_Disease_Ontology_DO_and_using_ _Cytoscape_ _v361_ ': 9.148819220060914e-58, 'using_ _STRING_ _https_strin_gdb_ _to_ _investigate_ _protein_ _interactions_ _Hub_ _genes_ _and_ ': 2.0033120402046222e-05, 'using_ _Cytoscape_ _v361_ ': 0.0003574577063110077, 'I2_P': 9.148819220060914e-58, 'SMD_value': 9.148819220060914e-58, 'file_a0_Figure': 3.903865469504451e-06, 'platforms': 0.0016815001133323047, 'to_ _be_ _promising_ _Among_ _the_ _thirteen_ _platforms_ _showing_high_COL8A1_expression_twelve_platforms': 0.0006264573400700461, 'capability_file_S8_area': 2.7446560661786228e-05, 'DOR': 0.000704362469235278, 'Table_a0S1': 0.0016810521528134112, 'groups_a0Expression_levels_significance': 9.148819220060914e-58, 'to_ _perform_in_immunohistochemistry_ ': 9.148819220060914e-58, 'cil_bupeRhcezCESG': 9.148819220060914e-58, 'abarA': 9.148819220060914e-58, 'elbaT': 0.00045660454367155184, 'file_Protein_expression': 0.00045660454367155184, 'coloration_intensity': 0.00032032472333784836, 'cancerA_total': 9.148819220060914e-58, 'to_determine_ _the_ _DEGs_ _The_ _approach_ _has_ _been_ _aforementioned_ ': 9.148819220060914e-58, 'Figure_S12': 1.104453032589865e-05, 'DEGs_CEGs': 0.0006770056389244467, 'survival_condition': 0.0004576368763948737, 'BRCA_tissues': 0.0016810521528134112, 'a06a_proteoglycans': 2.9708537579923713e-05, 'Reactome_pathway_analysis': 9.148819220060914e-58, 'surface_interactions_degradation_Fig_a0': 9.148819220060914e-58, 'proteoglycans_ECMreceptor_interaction_pathways': 9.148819220060914e-58, 'to_construct_PPI_networks': 9.148819220060914e-58, 'enrichment_results_DEGs': 0.0005073330404429016, 'file_a0_Table_highlight': 0.0014616190772430405, 'difference_Immunohistochemistry_staining': 0.00045660454367155184, 'nowWe': 0.0005865071468874085, 'TCGA_cohort_analysis': 9.148819220060914e-58, 'upregulation_levels': 9.148819220060914e-58, 'COL8A1': 9.148819220060914e-58, '0cPeng': 9.148819220060914e-58, 'Reactcome_DEGs': 9.148819220060914e-58, 'genes_0cPeng_a0et': 9.148819220060914e-58, 'Ontology_DEGs': 9.148819220060914e-58, 'genes_Kyoto_Encyclopedia': 9.148819220060914e-58, 'Uncovering_the_potential_mechanism_of_MM_initiation_and_progression': 4.091158797154258e-06, 'to_measure_the_migration_and_invasion_abilities_of_MM_cells_Cell_apoptosis_was_also_assessed_by_flow_cytometry_The_interaction_between_miR3383p_and_circ_0007841_or_BRD4_was_confirmed_by_dualluciferase_reporter_assay_and_RNApull_down_assayResults_ ': 1.071259745404924e-05, 'assayResults': 0.000528146067012347, 'nPCs_Circ_0007841': 0.0005523223514578579, 'cell_cycle_metastasis': 9.009585432209905e-06, 'circ_0007841': 0.002786466823803801, 'miR3383p': 0.0025441261262191275, 'cell_cycle_metastasis_apoptosis_progression_role': 4.152011207621174e-05, 'axis_Exosomes': 7.906954776487077e-05, 'chemotherapy_radiotherapy_therapy': 0.0002436592976234707, 'to_ _be_uncoveredMiRNAs_ ': 0.0006992128660964839, 'to_elevate_the_levels_of_oncogenic_proteins_and_accelerate_the_progression_of_cancers': 0.00210348072096923, 'H19': 0.0006246792128329638, 'to_ _be_ _abnormally_upregulated_in_MM_Lossoffunction_experiments': 0.0008413780742671413, 'investigatedIn_study_circ_0007841': 1.372207937294188e-05, 'proliferation_cycle_progression_migration_invasion': 0.0001186502426005426, 'Carlsbad_CA_USA': 1.372939340673219e-05, 'unitsmL_penicillin_culture_plates': 1.3302564969063052e-12, 'to_ _synthesize_ _complementary_ _DNA_ _cDNA_ _with_ReverTra_ _Ace_ _qPCR_ _RT_ _Kit_ _for_ _circ_0007841_ _BRD4_and_U6_Takara_Dalian_China_and_AllinOne\\x84¢_miRNA_glyceraldehyde3phosphate_ ': 8.15862526914375e-11, 'C_cells': 1.3302564969063052e-12, 'CAT_ACA': 9.148819220060914e-58, 'TAG': 9.148819220060914e-58, '²CCG_AGA_AG3²_U6': 9.148819220060914e-58, 'TCA_CGA': 9.148819220060914e-58, 'GAPDH_Forward': 9.148819220060914e-58, 'CCC_CCT_CCA_C3²_²TCC_ACC_TTG_CTG': 9.148819220060914e-58, 'control_overexpression_plasmid': 9.148819220060914e-58, 'Vector_overexpression_control': 9.148819220060914e-58, 'miR3383p_a0et': 4.152011207621174e-05, 'kit\\x91': 9.022582498156722e-05, 'absorbance_nm': 9.148819220060914e-58, 'BioTek_Winooski_VT_USAColony_formation': 9.148819220060914e-58, 'MM_cells': 0.0002569889547415629, 'using_cold_ _phosphate_ _buffer_ _saline_ _PBS_ ': 4.1943582727329065e-06, 'using_ _cold_ethanol_solution_overnight_Prior_to_propidium_iodide_PI_Solarbio': 4.1943582727329065e-06, 'RNase': 9.148819220060914e-58, 'to_ _remove_ _RNA_ _in_ _the_ _samples_The_percentage_of_MM_cells_in_different_phases_of_cell_cycle': 9.148819220060914e-58, 'FACSCalibur_Becton\\x93Dickinson': 4.1943582727329065e-06, 'software_Becton\\x93DickinsonTranswell': 9.148819220060914e-58, 'FACSCalibur_Becton\\x93Dickinson_using': 9.148819220060914e-58, 'chambers': 3.698186563818794e-06, 'microscope_circinteractome_targetscan_software': 0.00022661998665173344, 'circinteractome_targetscan_software': 4.152011207621174e-05, 'to_bind_to_miR3383p_along_with_the_mutanttype_sequence_with_miR3383p_in_circ_0007841_that_was_synthesized_ _through_ _using_ _Sitedirected_ _gene_ _mutagenesis_kit': 0.004315547045054443, 'Promega_Madison_WI_USA': 1.284690556057437e-52, 'circ_0007841_WT_BRD4_²UTR_miR3383p': 7.417164383651313e-53, 'a0_ng': 9.148819220060914e-58, 'WT_circ_0007841_MUT': 9.148819220060914e-58, 'kit_Promega': 9.148819220060914e-58, 'Plate_V_Hidex_Finland': 9.148819220060914e-58, 'to_ _bind_ _to_ _miR3383p_ _and_ _the_mutant_type_fragment_of_BRD4_²UTR': 0.004315547045054443, 'circ_0007841_MUT_Cotransfection_WT_BRD4_²UTR_miR3383p_to_test_the_interaction_between_circ_0007841_and': 7.417164383651313e-53, 'MUT_Cotransfection': 7.417164383651313e-53, 'to_test_the_interaction_between_circ_0007841_and': 0.00036240313892865647, 'wildtype_sites': 8.263922883666513e-55, 'to_ _obtain_ _Biocirc_0007841_ ': 1.1686951820486561e-54, 'to_bind_to_miR3383p': 0.004315547045054443, 'WT_Biocirc_0007841_MUT': 8.263922883666513e-55, 'blot_assayProteins': 0.000254619872099857, 'using_ _whole_ _cell_ _lysis_ _buffer_Roche_Basel_Switzerland_for_a0min_on_the_ice_Protein_samples': 0.000254619872099857, 'using_Pierce_BCA_Protein_Assay_kit_Thermo_Fisher_Scientific_Rockford_IL_USA': 0.000254619872099857, 'a0_µg': 0.0002851023350336312, 'Gray_analysis': 9.148819220060914e-58, 'to_ _quantify_ _the_ _expression_ _of_ _proteins_ _using_ _ImageJ_software_ _Primary_ _antibodies_including_ _antiBRD4_ab128874_antiphosphorylatedphosphatidylinositol_3kinase_ _antipPI3_K_ _ab70912_ _antiPI3_K_ _ab32089_antipAKT_ _serinethreonine_ _kinase_ _pAKT_ ': 9.148819220060914e-58, 'ab79559_antiÎ²actin': 3.409511056001331e-05, 'using_GraphPad_Prism_ ': 0.0020891895934638987, 'kit_Qiagen_Frankfurt_Germany': 9.148819220060914e-58, 'to_ _extract_ _exosomes_ _from_ _the_ _culture_ _medium_ _of_MM_cells_according_to_previous_studies': 9.148819220060914e-58, 'SD_Data': 3.409511056001331e-05, 'P_value_Linear_correlation': 9.148819220060914e-58, 'using_Spearman\\x99s_correlation_coefficientResultsCirc_0007841_elevates_the_a0malignant_behaviors_of_a0MM_cellsCirc_0007841_ ': 9.148819220060914e-58, 'correlation_coefficientResultsCirc_0007841': 7.906954776487077e-05, 'to_ _uncover_its_ _biological_ _functions_ _in_ _MM_ _cells_ _As_ _mentioned_ _in_Fig_a0_1c_ _and_ ': 2.7369366735337775e-05, 'Fig_Cell_proliferation': 1.1240375456594108e-05, 'circ_0007841_silencing': 1.0709742399770788e-05, 'circ_0007841_interference': 0.00014265292060500713, 'proliferation_cycle_progression_metastasis': 4.547530653407165e-05, 'a0_2a_miR3383p': 0.0003373197309518599, 'type_luciferase_plasmid': 9.148819220060914e-58, 'MUT': 9.148819220060914e-58, 'WT': 9.148819220060914e-58, 'target_relationship': 9.148819220060914e-58, 'circ_0007841_accumulation': 0.0005807607654450252, 'metastasis_ability': 1.1835596512959282e-06, 'flow_cytometry_P_P_P_P': 0.0005521751935137136, 'Circ_0007841': 0.0015847132313328567, 'miR3383p_inhibitor': 1.2581082352989103e-06, 'formation_ability': 7.705372273544618e-05, '3d_Additionally_cell_cycle': 0.00029599327620783605, 'to_verify_whether_miR3383p_could_bind_to_circ_0007841_in_MM_cells_d_e': 0.0003624997759503573, 'using_Spearman\\x99s_coefficient': 0.0006810685397702696, 'cells_P_P': 0.00029599327620783605, 'miR3383p_transfection': 0.001128162151175775, 'expression_correlation_miR3383p': 9.148819220060914e-58, 'using_ _Spearman\\x99s_ _correlation_ _coefficient_ _As_ _shown_ _in_ _Fig_a0': 9.148819220060914e-58, 'miR3383p_overexpression': 0.0023484598189594716, 'antitumor_role': 4.152011207621174e-05, 'expression_a0et': 2.4789958696029023e-05, '0cWang': 5.336030317054215e-06, 'a\\x93i_MM_cells': 0.00019338140904154145, 'proliferation_capacity': 0.00013093762556588576, 'flow_cytometry_P_addition': 4.27440232235726e-06, 'miR3383p_accumulation': 7.906954776487077e-05, 'behaviors_targetscan_software': 0.0006957127734518573, 'BRD4': 0.00010157771356675147, 'targetscan_software': 0.0003373197309518599, 'level_nPCs_cells': 2.3890299757996325e-06, 'using_Spearman\\x99s_coefficient_h': 0.0023436338297471836, 'to_detect_the_cell_cycle_of_MM_cells': 0.00036240313892865647, 'flow_cytometry_activation': 4.27440232235726e-06, 'inmiR3383p_group': 0.0006674076661460604, 'potential_roles': 0.007713134335009549, 'cycle_metastasis_apoptosis': 3.911601189262703e-05, 'MSCsderived_exosomes': 0.0003995800126312821, 'proliferation_cycle_motility_apoptosis': 6.520711283860127e-06, 'PI3KAKT_signal_pathway': 9.022582498156722e-05, 'sicirc_00078411_inmiR3383p_analysis': 9.148819220060914e-58, 'to_assess_the_abundance_of_these_proteins': 9.148819220060914e-58, 'expression_miR3383p_BRD4': 7.909062034625172e-05, 'blot_assay_P_transfection': 1.2901295443822227e-06, 'siNC_group': 0.0005530648993875772, 'cycle_metastasis': 5.449700985954514e-05, 'Mock_siNC_group_effects': 0.0001186502426005426, 'circCBFB': 0.0010345379902568968, 'to_ _be_ _overexpressed_ _in_BMderived_plasma_cells_of_MM_patients_and_MM_cells': 2.586668612581389e-05, 'apoptosis_findings': 4.547530653407165e-05, 'levels_1Î±_HIF1A': 1.2308418657316602e-07, 'polymerase_chain_reaction_qRTPCR': 7.539974218076676e-06, 'capacities': 0.00046188246859074644, 'lactate_product_triphosphate_ATP_levels': 2.3489925302722083e-09, 'dualluciferase_reporter_RNA_pulldown_assays': 1.4402058289597688e-07, 'HIF1A': 8.815903130830486e-06, 'silencing_or_miR578_overexpression': 0.0006578099350934741, 'circZFR': 0.002256733163290866, 'No1': 3.891289414475725e-05, 'noncoding_functions_processes': 0.004315547045054443, 'Work': 0.0005219680427898343, 'Dysregulation': 0.0005219680427898343, 'circRNA': 0.007501961338470725, 'circTADA2As': 9.148819220060914e-58, 'BC_progression_metastasis': 9.148819220060914e-58, 'miR578': 0.00017370636322094608, 'to_ _examine_ _the_ _biological_ _effect_of_ _circZFR_ _in_ _the_ _malignant_ _progression_ _of_ _BC_ _in_a0_vitro_and_ ': 0.007713134335009549, 'BC_patients': 0.007713134335009549, 'all_participantsTable_Correlation_features': 0.0004100538998299479, 'cell_lines_ATCC_®_ATCC_®_ATCC_Manassas_VA_USA': 6.678780673203977e-05, 'immortalized': 9.148819220060914e-58, 'Eagle\\x99s': 9.148819220060914e-58, 'expression_levels_miRNAs': 0.00019338140904154145, 'cDNA_synthesis': 9.148819220060914e-58, 'using_ _total_ _RNA_ _a0_ng_0cChen': 9.148819220060914e-58, 'using_ _the_ _TaqMan_ _Gene_ _Expression_Assays_with_the_indicated_primers': 1.4398220992262202e-07, 'using_the_TaqMan_MicroRNA_Assays_with_TaqManspecific_primer_probes_as_recommended_by_the_manufacturers_ _Applied_ _Biosystems_ _Rotkreuz_ _Switzerland_qRTPCR': 0.00027915818211639477, 'BioRad_Munich_Germany': 9.148819220060914e-58, 'PCR_conditions': 9.148819220060914e-58, 'Lentivirus_transduction_a0transient_knockdown': 1.8167819587673103e-05, 'control_Vectortransduced_cells': 3.2405773720969206e-07, 'Invitrogen_events': 4.851383983254107e-09, 'flow_cytometry_flow_cytometer_transwell_assay': 0.0011131719599854148, 'Kit_LLactate_Assay_Kit_ATP_Assay_Kit': 0.0002851023350336312, 'reporter_pulldown_assaysAnalysis': 9.148819220060914e-58, 'using_ _the_ _online_ _web_ _CircInteractome_ _https_circi_ntera_ctome_nianihgovindex_html_ _and_ ': 9.148819220060914e-58, 'CircInteractome_https': 9.148819220060914e-58, 'ctome_nianihgovindex_html': 9.148819220060914e-58, 'v7_software': 0.0003996210712050996, 'MutanBest_Kit': 9.148819220060914e-58, 'circZFRMUT_HIF1A3²UTRMUT': 9.148819220060914e-58, 'a0ng_a0nM': 1.3306110954394186e-12, 'lines_line_extracts': 1.817750855552481e-05, 'posttransfection_ratio': 1.817750855552481e-05, 'Cheniluminescence_GE_Healthcare': 0.00014650019025813331, 'Pairwise_comparisons': 9.148819220060914e-58, 'using_ _a_ _twotailed_ _Student\\x99s_ _t_ _test_ _Mann\\x93Whitney_ _U_ _test_ _or_ _analysis_ _of_ _variance_ _ANOVA_ _with_SPSS_version_ _software_SPSS_Chicago_IL_USA': 9.148819220060914e-58, 'link_Fig_a0_1c_a0et': 0.007713134335009549, 'link_Fig_a0_1c_viability_colony_formation_apoptosis_tumor_growth_circZFR_expression_a0et_level_group': 0.0006578099350934741, 'circZFR_expression': 9.443596096955869e-05, 'a0Silencing': 9.148819220060914e-58, 'viability_colony_formation_apoptosis': 9.148819220060914e-58, 'three_shRNAs': 1.5419454740124482e-06, 'qRTPCR_MCF10A_MCF7': 9.022582498156722e-05, 'MDAMB453_cell': 4.630340321606421e-08, 'level_group': 7.554977967181715e-10, 'shcircZFR1': 0.0005403072527347841, 'model_assays': 0.007713134335009549, 'BT549_cell_line': 0.007713134335009549, 'iSilencing': 9.148819220060914e-58, 'BC_migration_invasion_a0glycolysisWe_a0_3e': 9.148819220060914e-58, 'to_ _identify_ _whether_ _miR578_ _was_ _a_ _molecular_mediator_of_circZFR_in_BC_progression': 0.007713134335009549, 'circZFR_fragment': 0.00238803522972525, 'miR578binding_sites': 0.00238803522972525, 'miR578_expression': 0.00841400557302873, 'effect_a04f': 0.00014626258547791333, 'BiomiR578': 8.263922883666513e-55, 'effect_expression_a0et': 0.007713134335009549, 'Cell_Int_Page_shcircZFRtransduced_BT549_cell_lines': 9.148819220060914e-58, 'repression_a05d_a0_5e_promotion_invasion_glycolysis_a0apoptosis_BC_progression_miR578_antimigration': 9.148819220060914e-58, 'circZFR_antiviability_Fig_a0_6a': 0.0006674076661460604, '²UTR_fragment': 0.007713134335009549, 'mutation_HIF1A²UTRMUT': 6.920360188933788e-05, 'miR578_overexpression': 0.0008522036149147152, 'miR578_0cChen': 1.4398220992262202e-07, 'antimiR578_introduction': 0.00238803522972525, 'upregulation_Fig_a0': 0.0014616190772430405, 'miR578_a0et': 0.00045660454367155184, 'BC_progression_tissues': 9.022582498156722e-05, 'MCF7_BT549_cell_lines': 2.8352638450909267e-06, 'antimigration_Fig_links': 1.0689756691710107e-05, 'miR578_level': 1.2877549548919228e-06, 'shNCinfected_shcircZFRtransduced': 9.148819220060914e-58, 'assay_formation_assay': 9.148819220060914e-58, 'BC_progression': 0.0009762413545074942, '0cChen': 0.001715858388123994, 'target_sequence': 0.0021320560726135977, 'activity_BT549_cell_lines_miR578': 0.0008522036149147152, 'miRNC': 0.0008522036149147152, 'miR497': 0.0002675814244889632, 'HIF1A_protein_level': 2.054252479406355e-05, 'BT549_cell_lines_BT549_cell_lines': 9.148819220060914e-58, 'HIF1A_protein_level_BC_progression_paper': 9.148819220060914e-58, 'plasmid_P_circZFR': 1.4398220992262202e-07, 'CENPM': 0.002664930270187808, 'protein_PrognosisBackgroundHepatocellular_carcinoma': 4.349387631149362e-05, 'Byeno_et_]': 0.0002493007233839761, 'cells_analysis_toolMaterials_collectionInformation': 0.0003320992211073337, 'workflow_type_HTSeqCounts_format_BCR_XML': 5.415073659296883e-06, 'grade_Tphase_Nphase_survival_status_number': 9.148819220060914e-58, 'version_Bioconductor_software': 9.148819220060914e-58, 'Enrichment_Analysis_GSEA': 0.00018962392250449942, 'NES_Pvalues': 9.148819220060914e-58, 'to_classify_the_pathways_of_enrichment_in_each_phenotypeImmune': 9.148819220060914e-58, 'using_ _pathology_Methods_ ': 1.4967386114618882e-05, 'portal': 2.6163010002235093e-11, 'transcription_datasets': 4.2643226246676644e-13, 'transcription_datasets_cancer_studies': 4.264322624667665e-13, 'Funrich_tools': 0.00238803522972525, 'regression_Wilcoxon_sum_test_means_of_converting_P_values_to_FDR': 0.0006625816769337724, 'to_assess_the_ _effect_ _of_ _CENPM_ _expression_ _on_ _survival_ _and_ _other_clinical_factors_such_as_age_gender_stage_distant_metastasis': 8.263922883666513e-55, 'Yang_Cell_Int_Page_TCGA_database': 0.001845170519318405, 'followup_study_cohort': 9.148819220060914e-58, 'female_Table': 9.148819220060914e-58, 'N0_metastases': 0.00016558074145987873, 'T4': 2.704712735667497e-06, 'N0': 4.413354331819822e-08, 'N1': 0.0002517139390143281, 'HR_\\x93_P_Tclassification': 4.349387631149362e-05, 'Yang_Cell_Int_Page_association_scatter_plot': 0.0006768252640912667, 'multivariate_hazard_model': 0.0001261733407126887, 'CENPM_expression': 0.007717244975784016, 'Lymph_nodes': 0.0001261733407126887, 'a0years_\\x93_a0_years': 0.0003142854144885643, 'signaling_ _events_ _and_ _signal_transduction_events_mediated_by_hepatocyte_growth_factor_receptor_cMet_Fig_a06b\\x93eDiscussionIn_ _this_ _work_ ': 1.0814344646722718e-05, 'Huang_a0_al': 9.148819220060914e-58, 'cDNA_sequence': 9.148819220060914e-58, 'phenotype_CENPM': 9.148819220060914e-58, 'replication_RNA_degradation': 9.148819220060914e-58, 'CENPM_genes': 1.545263727514792e-05, 'mRNA_expression_significance': 0.0019127833147525456, 'LHX6': 9.148819220060914e-58, 'proliferation_invasion_P53_pathways': 9.148819220060914e-58, 'P53stabilizing_ _and_ _activating_ _RNA_ ': 0.000528146067012347, 'Yang_Cell_Int_Page': 0.0020194478966673295, 'correlation_Correlation': 3.295749780042528e-05, 'b_CENPM_expression': 3.295749780042528e-05, 'IIStage': 9.148819220060914e-58, 'cellsCD_cellCD4_T': 9.148819220060914e-58, '\\x93_\\x93_\\x93': 0.0018006682651940404, 'B_cells': 5.8791748802789936e-05, 'CD8_CD68': 0.0019127833147525456, 'colony_formation_migration': 2.8355744358672712e-06, 'removing_RAD21_in_a_background_lacking_Pds5': 0.0003247463263852347, 'events_pathways': 0.0005345134679592639, 'cMet_inhibitors': 0.00026772410356378304, 'PDL1_expression_tumor_immunity': 0.00023085081287514326, 'expression_Fig_network_neighbor_genesTable_type_a0frequency': 4.349387631149362e-05, 'components_Molecular_functions_research_study_manuscript': 4.3505466319766646e-05, 'components_Molecular_functions': 4.349387631149362e-05, 'WZH': 7.101545353592556e-07, 'YDL_WZH': 0.0014616190772430405, 'analysis_ontology_Consent': 1.3140465622238652e-07, 'element_Brickner_AG': 0.00040505663764074076, 'PANE1': 6.610648712912211e-06, 'PANE1_gene': 4.165425664237844e-06, 'anticancer_effects_signatures': 9.148819220060914e-58, 'hepatocarcinogenesis_A216\\x93': 9.148819220060914e-58, 'Qin_G_Tu_X_Li_H_et_al_lncRNA_PSTAR': 2.7451419515548387e-05, 'Int_Janco_JMT_Lamichhane_Karyampudi_L_Knutson_KL': 0.0011125787591309202, 'cohesin_dynamics': 9.148819220060914e-58, 'replication_fork_developments_\\x93_PV_al': 9.148819220060914e-58, 'c\\x91Met_activation': 9.148819220060914e-58, 'replication_fork_developments_\\x93_PV_al_PDL1_expression_tumor_immunity': 9.148819220060914e-58, 'B_Li_J_et_al_MACC1': 3.7671411755847702e-06, 'thyroidfunction': 8.263922883666513e-55, 'serum_ketones': 1.1686951820486561e-54, 'Dietary_intake_end': 0.0019127833147525456, 'KD_group': 0.0006055963491557644, 'quality_serum_lactate': 9.881382891962986e-06, 'ALP': 1.6139457156510028e-07, 'KD': 8.647121244992167e-05, 'patients_IRCT': 1.4109990550590335e-06, 'RecentlyKDs': 0.0006611997588271541, 'to_negativelyimpact_quality_of_life': 0.0013843836489182576, 'foundthat': 0.0018006682651940404, 'trialprovementin_sleep_emotionalfunction': 0.00032032472333784836, 'QoL': 0.0018020792642490994, 'MethodsThe_study_protocol': 9.148819220060914e-58, 'InstituteNNFTRI_Beheshti_University': 9.148819220060914e-58, 'oncology_clinic': 9.148819220060914e-58, 'hospital_Research_CenterTehran_Iran': 9.148819220060914e-58, 'comorbidities_symptoms_Karnofsky': 0.0005573368904834178, 'assigned': 9.148819220060914e-58, 'consent_hospital_Research_CenterTehran_Iran_comorbidities_symptoms_Karnofsky': 9.148819220060914e-58, 'Randomizationwas': 9.148819220060914e-58, 'statistician': 9.148819220060914e-58, 'project_coordinator': 0.000985397901725041, 'KD_control_diet': 9.148819220060914e-58, 'to_be_eucaloric_using_the_MifflinSt_Jeorformula_The_KD_consisted_of_ _of_calories_fromCHO_ _from_protein_ _from_mediumchain_triglyceride_MCT_oil_and_ _from_fat_A_dietitianprovided_specific_nutritional_counseling_to_each_participantfacetoface_meetings': 9.148819220060914e-58, 'forcompliance_effects': 1.6073908659133088e-05, 'participants_them_to_be_eucaloric_using_the_MifflinSt_Jeorformula_The_KD_consisted_of_ _of_calories_fromCHO_ _from_protein_ _from_mediumchain_triglyceride_MCT_oil_and_ _from_fat_A_dietitianprovided_specific_nutritional_counseling_to_each_participantfacetoface_meetings_forcompliance_effects_to_eachsubject_in_the_KD_group_For_better_tolerance_initialdosage_of_MCT': 0.0018456622073465703, 'limited': 9.148819220060914e-58, 'to_usemediumchain_triglyceride_MCT_oil_MCT_oil_anodorless_and': 9.148819220060914e-58, 'thecarbohydrate_limit': 0.0013882295497307361, 'Subjectswere': 9.148819220060914e-58, 'to_increase_their_fat_intake_and_toselect_from_a_variety_of_sourcesincluding_olive_oilbutter_and_cream_cheese_Patients': 9.148819220060914e-58, 'weeks_ml': 9.148819220060914e-58, 'to_eachsubject_in_the_KD_group_For_better_tolerance_initialdosage_of_MCT': 9.148819220060914e-58, 'Dosage': 3.012831237073818e-05, 'blood_betahydroxybutyrate_levels': 0.00012403645304252364, 'weeks_intake_end': 2.023815655958986e-06, 'validity_reliability': 3.707241871248117e-06, '24h_recall_total_andtwo_workdays': 3.2304917358750975e-05, '24HR': 5.9111257406571796e-05, 'usingcommon_household_containers': 9.148819220060914e-58, 'cups_measuring_cups_spoons': 9.148819220060914e-58, 'sample_sizewas': 1.8456309852282372e-05, 'to_compare_the_continuous_variables_within_the_two_groups_The_ANCOVA_test_wasused_to_eliminate_the_effect_of_confounding_to_estimate_associations_between_total_carbohydrate_intake_and_serumbetahydroxybutyrateData_were_analyzed_using_the_SPSS_version_ _software_Chicago_IL_USA_and_Stata_version_ _P_ _was_considered_as_statistically_significantResultsDetailed_patient_demographics_and_a_flow_diagram_werereported_previously': 0.0011308929070296527, 'finalnumber': 1.8456309852282372e-05, 'to_compare_the_continuous_variables_within_the_two_groups_The_ANCOVA_test_wasused_to_eliminate_the_effect_of_confounding': 4.194027591029344e-07, 'ANCOVA_test': 9.148819220060914e-58, 'to_eliminate_the_effect_of_confounding': 9.148819220060914e-58, 'to_estimate_associations_between_total_carbohydrate_intake_and_serumbetahydroxybutyrateData_were_analyzed_using_the_SPSS_version_ _software_Chicago_IL_USA_and_Stata_version_ _P_ _was_considered_as_statistically_significantResultsDetailed_patient_demographics_and_a_flow_diagram_werereported_previously': 8.263922883666513e-55, 'using_the_SPSS_version_ _software_Chicago_IL_USA_and_Stata_version_ _P_ _was_considered_as_statistically_significantResultsDetailed_patient_demographics_and_a_flow_diagram_werereported_previously': 0.0003645333095764079, 'total_cancer': 4.035101431513677e-05, 'toage_type_metastasis_marriage_educationstatus_P': 0.0024722864988815413, 'studyand': 0.001845170519318405, 'patients_disease_liver_andbone': 0.0006275337261994233, 'KD_groupwas': 9.148819220060914e-58, 'separatelyintakeat': 9.148819220060914e-58, 'energy_carbohydrate_protein_intake': 0.001129870936471824, 'ketones_mmolL': 0.001129870936471824, 'significantdifferences_observedStudent_ttest': 6.8454948206405245e-09, 'to_compare_the_continuous_variables_between_the_twogroups_Paired_sample_ttest_decreased_significantly_compared_tobaselineResults_of_a_systematic_review_and_metaanalysis_haveshown_that_KDs_suppress_appetite': 1.1180174066608716e-10, 'to_compare_the_continuous_variableswithin': 4.195145608436005e-07, 'KDs': 1.3031230494589648e-05, 'ghrelin_releasewhich': 0.00210348072096923, 'perceptionof_hunger': 0.0038806204677737646, 'that_resultsin_weight_loss': 0.007713134335009549, '\\x93Mann\\x93Whitney_U_test': 2.981159664814468e-08, 'to_compare_the_continuous_variables': 1.825742174185101e-06, 'asmedian_quartile_0cKhodabakhshi_Journal_Page': 8.252592359321672e-05, 'AfterpvalueStudent_ttest': 0.0006685214347069402, 'to_compare_the_continuous_variables_between_the_twogroups_Paired_sample_ttest': 1.090731766329555e-05, 'to_compare_the_continuous_variableswithin_the_groupsMD_Mean_differenceCI_Confidence_intervalaAncova_Adjusted_for_baseline_value': 1.090731766329555e-05, 'aKD': 9.148819220060914e-58, 'function_scores': 9.148819220060914e-58, 'control_group_appetite': 3.57610591824189e-50, 'treatmentthe_inconsistency': 0.0002768434257340561, 'study_constipation': 9.148819220060914e-58, 'participants_inthe_KD_arm': 9.148819220060914e-58, 'group_ofpatients': 0.00238803522972525, 'Journal_Page': 8.263922883666513e-55, 'mmoll_Cohen': 0.0006674076661460604, 'oflactate_KDs': 0.0007008712380191807, 'KD_diet': 9.148819220060914e-58, 'additionalbenefit': 9.148819220060914e-58, 'KD_diet_combined_to_chemotherapy_inpatients_with_breast_cancer_does_not_bring_additionalbenefit_about_QoL_and_physical_activity_at_ _weeksWhile_blood_biomarkers': 9.148819220060914e-58, 'significantlybetween': 9.148819220060914e-58, 'groups_ketosis': 0.001845170519318405, 'trial_arms': 9.148819220060914e-58, 'to_thank_all_the_patients_at_our_clinic_who_took_part_in_thisstudyAuthors\\x99_contributionsKhodabakhshi': 9.148819220060914e-58, 'Methodology': 9.148819220060914e-58, 'theexperiments_design': 9.148819220060914e-58, 'Iran': 9.148819220060914e-58, 'Tehran_Iran7Department': 9.148819220060914e-58, 'WT_Mantis_JG': 9.148819220060914e-58, 'diet_brain_cancer_trial': 9.148819220060914e-58, 'Nutrition\\x93_Epub': 9.148819220060914e-58, 'diet_brain_cancer_effects': 9.148819220060914e-58, 'A_Singh_K_Advancedstage': 9.148819220060914e-58, 'factor_forfemales': 9.148819220060914e-58, 'inwomen': 2.949935420897806e-05, 'U_Effects_experience': 0.00016553660791656055, 'U_Effects': 0.00016553660791656055, 'TÃ³th_C_Clemens_Z': 0.00039947355805761766, 'CM_Ayre_J_Franklin_J_Markovic_T_diets': 9.148819220060914e-58, 'appetite_review_metaanalysis_Obes_Rev': 9.148819220060914e-58, 'ME_Mirzaei_HR_Kazemian_E_Kalantari_K_Kalamian_M_Effects_protocol': 0.00035730068962257737, 'blood_samples_weeks': 0.00021192252614064737, 'hPG_data': 3.4577636638693546e-06, 'hPG_Theanalysis': 3.4577636638693546e-06, 'intervals_CIs': 9.148819220060914e-58, 'to_determine_the_associations_of_each_PFAS_compound_with_high_FPG_and_hPG_from_a_logistic_regression_modelResults_After_adjustment_for_potential_confounders_most_PFASs_were_positively_associated_with_high_ _hPG_concentrationsThe_OR_for_high_ _hPG_concentrations': 9.148819220060914e-58, 'tertiles': 1.5219582679146314e-05, 'PFTrDA': 0.0007080023910910008, 'PFAS_exposure': 0.0007081910728315311, 'suchassociation': 0.0007080023910910008, 'miaomaohua163com_Yanfeng_Ren_Longmei_Jin': 0.0007080023910910008, 'PFASs': 0.0001249115260204846, 'to_bioaccumulate_in_anisms': 2.038018885672177e-06, 'Human_studies': 0.0010068765747081726, 'to_metabolically_vulnerable': 0.0003645333095764079, 'status_maytherefore': 0.0007862569594425692, 'Valvi': 9.148819220060914e-58, 'noassociations': 9.148819220060914e-58, 'to_evaluate_the_associations_between_PFAS_exposure_and_fasting_plasma_glucose_FPG_and_1h_plasma_glucose_concentrations_ ': 0.007756674467721497, 'nohistory': 0.0013882295497307361, 'to_give_birth_in_the_study_hospital': 0.0013882295497307361, 'pregnantwomen': 0.0011078353336573638, 'LODwas': 0.002758982575187945, 'point_calibration_curve': 8.263922883666513e-55, 'pattern_information_results': 1.1686951820486561e-54, 'precursor_rangedfrom_\\x93': 8.263922883666513e-55, 'care_system': 0.00021180960367334957, 'to_provide_bloodafter_overnight_fasting_for_FPG_testing_at_their_earliestconveniences_generally_within_ _week': 0.00021180960367334957, 'that_pregnant_womenunderwent_a_ _h_50_g_OGTT_at_ _GW_in_order_toscreen_for_gestational_diabetes_if_they_were_consideredto': 0.0007862569594425692, 'performed_performed_shown': 1.1686951820486561e-54, 'interviewers_to_collect_information_on_the_covariates_Thewomen_were_asked_about_age_per_capita_household_income_education_level_passive_smoking_height_prepregnancy_weight_parity_history_of_abortion_and_stillbirth_pregnancy_complications_etc_Prepregnancy_BMIkgm2_was_calculated_as_body_weight_divided_by_bodyheight_squaredStatistical_analysisAmong_singleton_live_births_women_providedblood_samples': 8.263922883666513e-55, 'interviewers_to_collect_information_on_the_covariates_Thewomen_were_asked_about_age_per_capita_household_income_education_level_passive_smoking_height_prepregnancy_weight_parity_history_of_abortion_and_stillbirth_pregnancy_complications_etc_Prepregnancy_BMIkgm2_was_calculated_as_body_weight_divided_by_bodyheight_squaredStatistical_analysisAmong': 8.263922883666513e-55, 'singleton_live_births_women_providedblood_samples': 0.00021180960367334957, 'women_to_describethe_distributions_of_FPG_and_ _hPG': 7.156935939469457e-06, 'firstdescribed_compared_included_excluded_used': 1.8090871199370374e-05, 'characteristicsofthe': 1.1685255477946988e-07, 'SD': 9.148819220060914e-58, 'to_describethe_distributions_of_FPG_and_ _hPG': 9.148819220060914e-58, 'usedlogarithm': 0.00016524481030497039, 'Page_those': 0.0005865071468874085, '\\x89¥90th_concentrations': 8.263922883666513e-55, 'to_analyze_the_associationbetweenglucoseconcentrationscontinuousplasmaPFASsandPotential_confounders_were_identified_a_prior_according_to_the_previous_literature_Age_of_pregnant_womeneducation_economic_income_prepregnancy_BMI_passive_smoking_parity_history_of_abortion_and_stillbirthand_pregnancy_complicationsincluding_bleeding_thyroid_disease_and_pregnancyinduced_hypertension': 1.1686951820486561e-54, 'regressions': 8.263922883666513e-55, 'to_evaluate_the_appropriation_of_covariates_We_did_not_adjust_for_alcoholconsumptionn_  _in_the_final_models_because_of_thelow_prevalence': 2.312554407449812e-06, 'GWsfor_hPG': 0.001129870936471824, 'age_education_income_CNY': 0.00018001983766047135, 'complicationYesNo_History_collegeleveleducation_above_stillbirth': 2.5350912325605822e-05, 'LOD_PFTrDA': 9.148819220060914e-58, 'LOD_limit': 9.148819220060914e-58, 'PFOS': 9.148819220060914e-58, 'PFNA_ngmL_ngmL': 9.148819220060914e-58, 'lowestconcentrationsTable': 0.0003803263163412973, 'SD_FPG_hPG_concentrationswere_mmolL': 6.203522695791095e-06, 'not_in_those_with_FPGThe_concentration_of_FPG_was_lower_in_nulliparous_pregnant_women_but_not_in_those_with_ _hPGTable_ ': 1.284690556057437e-52, 'women_complicationand_history': 7.417164383651313e-53, 'education_levels': 7.417164383651313e-53, 'women_complicationand_history_education_levels': 7.417164383651313e-53, 'linearregressions': 2.6909254076977078e-05, 'to_analyze_the_association_betweenPFASs_and_plasma_glucose': 0.0016485018034048215, 'AORPFDoA_Linear_trends': 0.001129870936471824, 'respectivelyWe': 0.001129870936471824, 'pattern_hPG': 1.8444548091260086e-05, 'results_pattern': 0.0011301720283114149, 'andhigh_hPG': 0.0002881098923889073, 'disregard_time': 4.6979876832003056e-06, 'disregard_time_sample_size_to_be_associated_with_high_hPG_but_not_FPG': 0.0008628729331050448, 'PFAS_exposures': 0.0003342986407258492, 'to_be_associated_with_high_hPG_but_not_FPG': 4.6979876832003056e-06, 'Wang_al\\x99s_study': 0.0003645333095764079, 'It\\x99s': 0.0006264573400700461, 'absence_withprevious_GDM': 0.000704362469235278, 'aswell': 0.0018006682651940404, 'interval_FPG': 9.148819220060914e-58, 'plasma_glucose_hPG_hplasma_glucose': 9.148819220060914e-58, 'BAkt_activation': 0.0015842910551982499, 'PFAS_compounds': 0.0016815001133323047, 'Aktsignaling_pathway': 2.7446560661786228e-05, 'BothPFOA_PFOS': 9.148819220060914e-58, 'to_affect_glucose_metabolism_by_AKT_signaling_pathway': 9.148819220060914e-58, 'transcription_receptor': 9.148819220060914e-58, 'to_play_essentialroles_in_the_regulation_of_gene_expression_glucose_homeostasisfatty_acid_metabolism_and_inflammation': 9.148819220060914e-58, 'PPAR': 9.148819220060914e-58, 'glucosehomeostasis': 9.148819220060914e-58, 'insulin_secretion_PFOA': 0.0006940543140455221, 'interferewith': 1.3223987983910682e-06, 'singlepoint_measurement': 1.155393675369606e-05, 'ofGDM_cases': 9.148819220060914e-58, 'andIn_additionthus': 9.148819220060914e-58, 'observedassociation_Fifth_data': 0.00010452430922628992, 'weekHowever': 0.0003645333095764079, 'PFNA_PFDAPFUdA_PFDoA': 8.263922883666513e-55, 'andIn_additionthus_paper': 1.1686951820486561e-54, 'Furtherstudies': 8.263922883666513e-55, 'Perfluorotridecanoic_Odds': 9.148819220060914e-58, 'CIs_Confidence_intervals': 9.148819220060914e-58, 'receptorsAcknowledgementsThe_authors': 9.148819220060914e-58, 'fieldworkers': 9.148819220060914e-58, 'contributionsWY_HL_MM': 0.00021180960367334957, 'WY_MM_YR_FY_ZZand_JD': 0.0020730823308430907, 'grantnumber': 9.148819220060914e-58, 'numbersCX2017\\x93_Shandong_Development_Project': 9.148819220060914e-58, 'survey_authors': 4.231586438760668e-05, 'financialinterestsAuthor_details1Department': 0.0013882295497307361, 'Wang_Z_Wen_SLiang_H_Determinants': 0.0003608303843934633, 'MT_Butenhoff': 1.6435761703528167e-05, 'RNA_molecules_CircRNAs_areabundant': 0.0015847132313328567, 'stability_tissue_specificity': 2.586668612581389e-05, 'circRNAsserve': 8.676441305519892e-05, 'stability_tissue_specificity_role': 0.0002543534709449633, 'to_be_improved': 0.0005371082976310824, 'newera': 0.00013677751800091927, 'Wang_Lihua_Jiang_Li_Ma': 9.148819220060914e-58, 'work1Cancer_Medical_Center': 9.148819220060914e-58, 'Identifying_the_key_molecules_in_these_processes': 0.0005218289698578611, 'Theremaining_RNA': 9.148819220060914e-58, 'to_be_transcriptional_junk': 9.148819220060914e-58, 'noncodingRNAs_ncRNAs': 0.00028570359774207095, 'molecular_cellularncRNAs': 9.439241118758207e-06, 'to_promote_tumor_growth_and_metastasis_by_targeting_PTEN_in_lung_cancer_and_other_cancers_such_asmelanoma_and_B_cell_lymphoma': 6.514612946547909e-06, 'miR21_levels': 0.0006578099350934741, 'oncogeniclncRNA': 1.0105145629254031e-05, 'tumor_suppressors': 0.0006194770480396349, 'lncRNA_MEG3': 0.0016810521528134112, 'lncRNANKILA': 6.059685598915859e-06, 'tumor_evasion': 0.00210348072096923, 'to_play_an_important_rolein_cancer_studies_of_new_ncRNAs': 3.94242356788491e-05, 'to_improve_our_understanding_of_cancerIn': 0.00021326425905836418, 'RNAs_circRNAs': 0.0017099653034688036, 'circRNAs': 0.014448418712648398, 'Fig_Biogenesis': 7.141308139176537e-05, 'bFunctions': 6.33966136568193e-05, 'blood_cells': 0.0002697574286398722, 'circRNAs_ciRNAs': 0.0038806204677737646, 'intron_sequences': 0.0038806204677737646, 'biologicalfunctions': 0.0002360637219339373, 'functions_significance': 0.008237972046194055, 'TNM': 9.148819220060914e-58, 'CancercircFECR1_UpPromotes_tumor_metastasisMetastases': 9.148819220060914e-58, 'proliferation_migration_invasionmetastasis_autophagy_inhibitapoptosisAdvanced_TNM_stage': 9.148819220060914e-58, 'metastasis_Advanced_copy_numbers_circHIPK3_Migration_invasion': 9.148819220060914e-58, 'CircRNAs': 0.0005073330404429016, 'ofcancer': 1.1686951820486561e-54, 'significance_metastasis_TNM_stage': 8.263922883666513e-55, 'metastasis_TNM_stage': 8.263922883666513e-55, 'circRNArelatedindicators_expression': 9.148819220060914e-58, 'survival_diseasefreesurvival': 9.148819220060914e-58, 'inlonger_overall_survivaltheimportant_role_of_circRNAs_in_tumors': 0.0016810521528134112, 'cyclespecific_drugs': 9.148819220060914e-58, 'topoisomerase_inhibitors': 9.148819220060914e-58, 'anticancer_activity_topoisomerase': 1.845438324513534e-05, 'anticancer_activity': 0.004315547045054443, 'circ__': 0.0018609389812514051, 'inducescancer': 0.0002712952666904031, 'Sphereformation_assays': 9.148819220060914e-58, 'SW480_HCT116': 9.148819220060914e-58, 'circ_001680_overexpression': 1.1686951820486561e-54, 'stem_cellspheres': 8.263922883666513e-55, 'growth_ability': 8.263922883666513e-55, 'Itfunctionsmainly': 9.148819220060914e-58, 'circMTHFD2': 9.148819220060914e-58, 'Thebenefit': 1.1686951820486561e-54, 'circMTHFD2_couldbind_promote_MDR1_fluoropyrimidine': 8.263922883666513e-55, 'development_ofresistance_mechanisms': 8.263922883666513e-55, 'Xiong': 8.263922883666513e-55, 'hybridization_Fortyseven_chromosomes': 1.1686951820486561e-54, 'ThesecircRNAs': 8.263922883666513e-55, 'Cancer_Page': 0.0020474324897274128, 'to_be_capable_ofregulating_the_Wnt_signaling_pathway_which_is_deeplyinvolved_in_5FU_resistance': 3.3413790218329486e-05, 'expression__': 2.008760264671278e-05, 'CCNB1_ofmiR335': 8.263922883666513e-55, 'circ_0035483': 9.148819220060914e-58, 'gemcitabine_resistance': 9.148819220060914e-58, 'cellGemcitabine_resistance': 0.0002706453490515252, 'theline_comgemcitabineresistant_PANC1GR': 9.148819220060914e-58, 'circRNA_profiles': 9.148819220060914e-58, 'lineA_total': 9.148819220060914e-58, 'highthroughputtranscriptome': 9.148819220060914e-58, 'silencing_these_twocircRNAs': 9.148819220060914e-58, 'gemcitabine_sensitivity': 9.148819220060914e-58, 'twocircRNAs': 0.0005523223906988096, 'tubulin_apoptosis': 9.01198727618476e-06, 'drugs_Taxol': 1.4723641559151178e-07, 'tubulin': 2.401204213487234e-09, 'ncRNA': 0.0015842910551982499, 'thatcircPVT1_circRNA': 2.075065141973157e-06, 'Expression_profilesof': 0.0002360637219339373, 'silencingcirc_0063809': 0.0004358935679566294, 'CircAMOTL1': 9.148819220060914e-58, 'to_contribute_to_Taxol_resistance_by_activating_the_AKT_pathway': 9.148819220060914e-58, 'Xu': 9.148819220060914e-58, 'circRNA_profile': 9.148819220060914e-58, 'tovisualize_miRNAs': 9.148819220060914e-58, 'to_drive_Taxol_resistance': 9.148819220060914e-58, 'miR141': 9.148819220060914e-58, 'to_induce_Taxol_resistance_in_ovarian_cancer': 9.148819220060914e-58, 'miR34c5p': 2.7451419515548387e-05, 'Circ_0002483': 5.821467136575889e-05, 'reporter_assay_docetaxel_sensitivity': 9.500842858053308e-07, 'circ_0002483_overexpression': 9.148819220060914e-58, 'Taxol_sensitivity': 9.148819220060914e-58, 'circ_0002483miR1825p_interaction': 7.890105016352806e-05, 'Taxol_resistance': 0.0004686411271822266, 'docetaxel_sensitivity': 0.0011125787591309202, 'betweencirc_0003998_expression_expression_wasfound': 9.148819220060914e-58, 'bindingbetween_circ_0003998': 9.148819220060914e-58, 'miR326_miR_inhibitors': 9.148819220060914e-58, 'to_significantly_reverse_theincreased_sensitivity_to_docetaxel_caused_by_circ___siRNA': 9.148819220060914e-58, 'circCRIM1': 9.148819220060914e-58, 'tomiR422a': 9.148819220060914e-58, 'CircRNAs_alsobeen': 9.148819220060914e-58, 'to_play_a_role_in_doxorubicin_resistanceThe_differential_expression_profile_of_circRNAs_in_adoxorubicinresistant': 9.148819220060914e-58, 'line_THP1ADM': 0.001129870936471824, 'knockdown_ofcircPAN3': 9.148819220060914e-58, 'doxorubicin_resistance': 9.148819220060914e-58, 'alsoconfirmed': 1.7161337932577627e-07, 'to_be_a_downstream_target_of_both_miR1535pand': 2.7994244258655796e-09, 'circPAN3miR1535pmiR1835pXIAPaxis': 0.0003327007272384309, 'betweenanddoxorubicinsensitive_MCF7_cells': 7.417164383651313e-53, 'Kyoto_Encyclopedia': 7.417164383651313e-53, 'MAPK_pathways': 0.000576827339123862, 'circ___overexpression': 9.148819220060914e-58, 'thesensitivity': 9.148819220060914e-58, 'MDAMB231ADM': 4.0370902673476874e-05, 'to_be_involved_in_PI3KAkt_signaling_pathway_activation_and_chemoresistance_in_BC': 0.0038806204677737646, 'to_bea_target_of_circ_0006528_while_Raf1': 0.0016480626375926124, 'Liang_to_be_atumor_suppressor_in_BC': 3.3413790218329486e-05, 'resistance_cell_proliferation': 0.0004990942860418787, 'Luciferase_reporter_assay_results': 9.148819220060914e-58, 'thecircKDM4CmiR548pPBLD_axis_contributionof': 9.148819220060914e-58, 'Oxaliplatin_uptake': 9.148819220060914e-58, 'to_be_mediated_by_the_anic_cation_transporters_OCT1_and': 9.148819220060914e-58, 'Oxaliplatin_resistance': 1.8444548091260086e-05, 'to_compare_circRNAexpression_profiles_between_HCT116R_and_parentalHCT116_cells': 0.0011301720283114149, 'presenceof': 0.0003833771411240826, 'to_be_significantly_upregulated_in_CRCtissues_Several_microRNAs_such_as_miR5015p': 0.0003833771411240826, 'Hon': 0.0011125787591309202, 'circRNA_microarray_analysisto_identify_ _significantly_upregulated_and_ _downregulated_circRNAs_Consistent_with_a_previous_reportcirc_32883_and_circ_0338': 0.0003833771411240826, 'resistance_cells': 1.1686951820486561e-54, 'byknockdown': 8.263922883666513e-55, 'circRNA_circ__': 8.263922883666513e-55, 'This_circRNA': 9.148819220060914e-58, 'oxaliplatin_resistance': 9.148819220060914e-58, 'circ_0005963': 3.0481966747539836e-07, 'signaling_axis_hasgreat_therapeutic_potential_for_oxaliplatinresistant_CRCCisplatin': 9.148819220060914e-58, 'Michele_Peyrone': 9.148819220060914e-58, 'Michele_Peyrone_resistance': 1.958529442894203e-05, 'sensitivetumors': 0.0004360764270917066, 'circRNAs_downregulation': 0.00011433162374159948, 'circEIF3asmay': 0.001128162151175775, 'cisplatin_treatment': 0.0015847132313328567, 'to_effectively_upregulate_theexpression_of_circ_0076305_in_A549_and_H1650_cellsFurther_gain_and_lossoffunction_experiments_indicatedthat_circ_0076305_can_regulate_cisplatin_resistance_inlung_cancer_cells_Bioinformatic_and_mechanistic_experiments_such_as_circRNA_immunoprecipitation': 2.586668612581389e-05, 'circ_0076305': 0.0003327007272384309, 'to_validate_thebinding_of_circ_0076305_to_miR2965p_as_well_as_tomiR2965p_and': 5.65279085993988e-06, 'STAT3_Reports': 1.7818661480031832e-08, 'theexpression_levels': 0.0005034057898537578, 'cisplatin_resistance': 3.0374550471469477e-05, 'protein_CDR1_Knockdown': 9.148819220060914e-58, 'to_increase_cisplatin_resistance_in_A549_cells_and_the_resultsof_a_host_cell_reactivation_HCR_assay_and_Western_blotanalysis': 9.148819220060914e-58, 'silencing_circ_0001946': 9.148819220060914e-58, 'repair_NER_signalingpathway': 9.148819220060914e-58, 'expressionpatterns_blot': 0.00238803522972525, 'to_validate_the_dysregulation_of_circRNA_circSMARCA5': 0.00238803522972525, 'circLARP4___circ_100269': 8.263922883666513e-55, 'carcinoma_ciRS7': 8.263922883666513e-55, 'CIRCscore_expression': 0.007713134335009549, 'averageCIRCscores': 0.007713134335009549, 'establishedtwo_circRNAs_circHIPK3_circSMARCA5': 0.0005406986214565272, 'validation_results': 0.00238803522972525, 'Fig_1b_Figure': 0.0005406986214565272, '1dthe_ntcircSMARCA5': 9.148819220060914e-58, 'Northern_blotassaycircSMARCA5': 9.148819220060914e-58, 'b_Expression': 9.148819220060914e-58, 'RTqPCR_assay': 9.148819220060914e-58, 'RTqPCR': 0.0003398023478338369, 'fulllength_transcript': 0.0003421850007431465, 'Schematic_illustration': 9.148819220060914e-58, 'to_amplify_the_linear_or_backsplicing_products_upper_Total_RNA_from_MCF7_cellswith_or_without_RNase_R_treatment_was_subjected_to_RTPCR_lower_and_further_validated_by_Sanger_sequencing_Right_e_Northern_blot_using_ajunctionspecific_probe_or_an_exon_ _probe_showing_the_endogenous_existence_of_circSMARCA5_and_SMARCA5_mRNA_from_MCF7_cells_with_orwithout_RNaseR_treatment_R_or_R_The_ _bp_marker': 9.148819220060914e-58, 'RNase_R_treatment': 3.8635655151179244e-05, 'to_RTPCR_lower': 6.308390763207589e-07, 'RTPCR_GAPDH_hU6_serve_as_internal_references_of_the_cytoplasm_and_nucleus_respectively\\x9c\\x9d': 9.420389176017492e-06, 'SMARCA5_expression_levels': 1.5383757627475925e-07, 'Northernblotting_exon_probe_RNA_FISH_microscopy': 0.00015587902928206217, 'Northernblotting_exon_probe': 9.417879738638035e-06, 'RNA_FISH_microscopy': 0.00014646114954342413, 'SMARCA5_probe': 9.148819220060914e-58, 'DIG': 9.148819220060914e-58, 'circSMARCA5is_thatsequencecircSMARCA5': 0.0016810521528134112, 'exonsrespectivelyKnockdown': 9.078178055968954e-05, 'circSMARCA5': 0.0026647938496777634, 'incancer_cellscirSMARCA5': 0.0003631075583458118, 'phenomenon_sequencing': 3.7028892291290873e-06, 'ectopiccircSMARCA5_expression': 4.695015963958416e-06, 'MCF7_cells': 0.0028102639041045433, 'effect_insertedexons_Fig_4b': 0.0006867924726205918, 'sequence_GAPDH': 1.120552318155344e-05, 'orpLCDHcircSMARCA5_blot': 0.0011125787591309202, 'shcircSMARCA5_pLCDHciRcontrol': 0.0011125787591309202, 'samples_d_RCC_samplese_cell_lines': 9.148819220060914e-58, 'effect_insertedexons': 9.148819220060914e-58, 'EGFP': 9.148819220060914e-58, 'Fig_4b': 9.148819220060914e-58, 'EGFP_level': 9.148819220060914e-58, 'circSMARCA5_role': 9.148819220060914e-58, 'circSMARCA5overexpression': 9.148819220060914e-58, 'protein_levels_ofSMARCA5_SMARCA5Î\\x94SMARCA5_protein_levels': 9.148819220060914e-58, 'S6which': 9.148819220060914e-58, 'spectrometry_Fig': 9.148819220060914e-58, 'circSMARCA5_role_protein_levels_ofSMARCA5_SMARCA5Î\\x94SMARCA5_protein_levels_spectrometry_Fig': 0.007713134335009549, 'transcription_cells': 3.3413790218329486e-05, 'PCR_analysis_PCRproducts': 4.0768428838068477e-07, 'Sanger_sequencing_e_CircSMARCA5': 0.0003631075583458118, 'overexpression_d_Northern_blotting': 0.004315547045054443, 'hypothesisthat_circSMARCA5': 0.0016810521528134112, 'DRIP_qPCR': 0.007713134335009549, 'specificsequence': 0.00238803522972525, 'shownin_Fig_5e_bp_fragment': 0.0015842910551982499, 'DNA_fragments': 0.007713134335009549, 'generation_exon_sequenceplays': 3.3413790218329486e-05, 'flow_cytometry_c_circSMARCA5_overexpression': 8.263922883666513e-55, 'withDMSO': 0.0011125787591309202, 'MG132_blot_analysis': 7.436802289600315e-08, 'transcription_generation_exon_sequenceplays_fluorescence_reporters_flow_cytometry_c_circSMARCA5_overexpression_withDMSO': 4.550228508450411e-06, 'Î\\x94SMARCA5_protein': 0.00023408789193635874, 'ANT': 9.148819220060914e-58, 'circSMARCA5_binding': 9.148819220060914e-58, 'ANTmut': 0.001128162151175775, 'transfection_ofANT': 0.0005807607654450252, 'Fig_6fh_FigureS8': 0.0038806204677737646, '6i_Theseresults': 2.387847892225623e-06, 'Rloopswith': 4.3487415036223426e-05, 'functionTo': 9.148819220060914e-58, 'roles_effect': 9.148819220060914e-58, 'thatboth_circSMARCA5': 0.0016480626375926124, 'SMARCA5': 0.0010071448933776737, 'role_main': 1.6435761703528167e-05, 'Figure_S10B': 9.148819220060914e-58, 'proteinproduct': 9.148819220060914e-58, 'circSMARCA5_canthe_ofshowedlowerthan_thatsignificantlyformation': 0.0005345134679592639, 'thatcircSMARCA5_overexpression': 0.00013379269098258708, 'cells_expressingcircSMARCA5repaircapacity': 0.0011128752409327472, 'theDNA_damage': 1.8162977041424498e-05, 'Fig_damage': 0.0008522036149147152, 'higherin_MCF7_cells': 0.0008522036149147152, 'cellcycle_genes': 0.0008522036149147152, 'repair_function': 0.0001420904621788341, 'capacitywhile_ANTmut': 0.001128162151175775, 'hybridization_strength': 7.105089728241787e-07, 'DRIPqPCR_analysis_nucleus': 9.148819220060914e-58, 'DAPI_d_Dotblot': 9.148819220060914e-58, 'hybrids': 9.148819220060914e-58, 'antibody_e_Mapping': 9.148819220060914e-58, 'defects_overexpression': 0.0004686411271822266, 'cellstheevaluatecircSMARCA5_overexpression': 0.0001261733407126887, 'overexpression_clones': 0.007713134335009549, 'expressedcircRNAs': 0.007713134335009549, 'toDNA_damage_sites': 0.00238803522972525, 'exertfunctions': 2.091643040470876e-06, 'Rloop': 3.3413790218329486e-05, 'Thesequence_KEY_ensemble_structure': 9.148819220060914e-58, 'b_acid_analog': 9.148819220060914e-58, 'SMARCA5_protein_levels': 0.0004686411271822266, 'repair_capacity': 3.3413790218329486e-05, 'MCF7': 8.263922883666513e-55, 'control_vector': 1.1686951820486561e-54, 'to_measure_cellviability_b_Relative_colony_formation_units_of_MCF7_cells_stably_expressing_control_vector_or': 6.411675944001909e-07, 'circSMARCA5_overexpression': 8.263922883666513e-55, 'damage_MCF7_cells': 0.00016412077546252188, 'c_immunofluorescence_assay': 8.263922883666513e-55, 'DNA_repaircapacity': 1.8420392474163883e-05, 'age_sex_domains': 0.0014616190772430405, 'condition_Men': 9.148819220060914e-58, 'physical': 9.148819220060914e-58, 'individuals_years': 6.645910024184951e-05, 'olderindividuals': 0.0001338995849508461, 'population_sample': 9.148819220060914e-58, 'HRQoL_andlower_morbidity': 9.148819220060914e-58, 'theinterpretation': 0.0014616190772430405, 'II_Medical_University': 0.0013954552233724673, 'basedon_data': 0.007713134335009549, 'EORTC_Quality': 9.148819220060914e-58, 'panel_study_QLQC30': 9.148819220060914e-58, 'normativedata': 0.004315547045054443, 'age_data': 0.007713134335009549, 'panel_members': 0.0038806204677737646, 'to_participate_in_panelbased_studies': 0.0011075402231842013, 'fatigue_dyspnea_sleep_disturbances': 5.6866572417744966e-05, 'theresponses': 0.00238803522972525, 'regression_model_QLQC30_scores_twoway_interactionage_presence': 0.007713134335009549, 'regression_model_QLQC30_scores_twoway_interactionage_presence_Intercept_Age2_Interaction': 0.0006957357389991548, 'Intercept_Age2_Interaction': 0.0006943564809761616, 'ofHealth_Conditions_0cLehmann_Health_Quality_Outcomes_participants': 9.148819220060914e-58, 'thanone_health_condition': 9.148819220060914e-58, 'survey_datafrom_individuals': 0.007713134335009549, 'weighted': 1.284690556057437e-52, 'onehealth_condition': 7.417164383651313e-53, 'health_conditions': 7.417164383651313e-53, 'majority_weighted': 9.148819220060914e-58, 'postcompulsoryeducation': 9.148819220060914e-58, 'degree_bachelors': 7.417164383651313e-53, 'Floor_effects': 8.263922883666513e-55, 'Regression_model': 1.1686951820486561e-54, 'scoresTable': 8.263922883666513e-55, 'regression_model_model': 9.148819220060914e-58, 'EORTC_QLQC30': 9.148819220060914e-58, '\\x88\\x92_Presence': 9.148819220060914e-58, 'Intercept_Age_Age2': 9.148819220060914e-58, 'age_normativedata_QLQC30': 0.007713134335009549, 'Olderparticipants_\\x89¥_years': 1.1686951820486561e-54, 'higherfunctioning': 8.263922883666513e-55, 'symptom_burdeneg_pain_dyspnea_functioning': 8.263922883666513e-55, 'cancerspecific_questionnaire': 0.007713134335009549, 'Statistic_Austria': 0.00046703013980541936, 'prevalence_rates': 0.0014616190772430405, 'levelUniversity_degree': 9.148819220060914e-58, 'disorderObesityDrugalcohol_use': 9.148819220060914e-58, 'not_to_answer\\x9d_was_treated_as_missing': 5.346077787132973e-06, 'data_\\x93_\\x93_Outcomes_Page': 1.1198996297536272e-07, 'M_Mean': 9.148819220060914e-58, 'deviation_QoL_quality_Austrian_Health_Ministry': 9.148819220060914e-58, 'data_Comparisons_ratings': 9.148819220060914e-58, 'providing_insight_into_international_differences': 9.148819220060914e-58, 'nationaltwo': 9.148819220060914e-58, 'Health_Quality': 9.148819220060914e-58, 'interpretation_comparisonfor_sex_groups': 0.0014616190772430405, 'scores_presence_ofhealth_conditions': 0.00023338930766890486, 'to_generate_more_precise_predictions_than_those_made_throughcomparing_different_age_and_sex_groups_using_normative_dataCompared_with_other_score_interpretation_approachesnormative_data_in_particular_when_relying_on_regressionmodels': 0.00016524481030497039, 'approachthresholds': 9.148819220060914e-58, 'to_condense_theinformation_into_severity_categories_clinically_important_vs_not_clinically_important': 9.148819220060914e-58, 'tocompare': 0.0014616190772430405, 'to_determine_whether_cancer_survivors_return_to_population_levelsor': 0.0013882295497307361, 'countryspecific_normativedata': 0.00010611798230916072, 'theNetherlands_men': 5.655871721934623e-06, 'to_report_higher_functioningand_lower_symptom_burden_on_most_scales_than_womendid': 0.0003468775953019577, 'factors_sample': 0.0006264573400700461, 'emotionalfunctioning_to_be_independent_of_age': 0.0018006682651940404, 'higherdisparity': 0.0038806204677737646, 'health_conditions_diseases': 1.1198996297536272e-07, 'functioning_symptom_burden': 0.0003034732833474384, 'adult_population': 9.888566786529425e-05, 'interpretation_Outcomes_Page_cancer_survivors': 0.0019127833147525456, 'paper_AbbreviationsEORTC': 0.0007641347695089468, 'PhD': 0.00238803522972525, 'manuscriptAuthors\\x99_contributionsJL': 0.0016902390277357944, 'manuscript_to_draft_the_manuscript_LMW_data_manuscript_manuscript': 2.758815165796122e-05, 'to_draft_the_manuscript_LMW': 2.758815165796122e-05, 'BH': 0.00022784076628390402, 'dataassisted_manuscript': 3.7184676209466113e-06, 'dataassisted': 3.7184676209466113e-06, 'anisation': 0.0005479687540571566, 'informedconsent_participant': 7.31082106841838e-05, 'Segal_Lavallee_DC': 9.148819220060914e-58, 'patientvoice': 9.148819220060914e-58, 'Guide_wwwisoqolwpcontentuploads201909ISOQOLCompanionGuideFINALpdf': 9.148819220060914e-58, 'B_Bullinger_M_Cull': 9.148819220060914e-58, 'CD_review': 0.0004734482721133418, 'eceuropaeueurostatdatabrowserviewsdg_03_20defaultmaplangen': 9.148819220060914e-58, 'Mar': 9.148819220060914e-58, 'Tomaszewska_IMAaronson_NK_Holzner_B_Patients_understandingof_preferences': 9.148819220060914e-58, 'QLQC30': 9.148819220060914e-58, 'QLQC30_results_asummarizing': 9.148819220060914e-58, 'revision_Johnson_Kemmler_G_Tomaszewski_KA': 9.148819220060914e-58, 'tension_homolog_gene_presentation': 0.0003809665283472652, 'appearance_ofneoplasms': 0.00210348072096923, 'representation_case': 9.148819220060914e-58, 'woman_impairment': 9.148819220060914e-58, 'to_alert_to_the_clinical_signs_of_this_entity_and_the_clinical_supervision_and_followup_ofthese_patients': 0.0003277033018603857, 'syndrome_CS': 9.148819220060914e-58, 'Lloydand_Dennis': 9.148819220060914e-58, 'deformations': 0.0011075402231842013, 'PI3KAktmTOR_pathway': 0.004315547045054443, 'Proteuslike_syndrome': 9.148819220060914e-58, 'overgrowth_manifestations': 9.148819220060914e-58, 'to_be_clearly_associated_withPTEN_mutations_the_incidence_of_LDD_in_patients_withCS': 0.00210348072096923, 'support_the_association_of_arteriovenous_malformations_in_clinically_diagnosed_BRRS_patients': 0.0010298344840079976, 'Itis_importantto': 9.148819220060914e-58, 'thatin_addition': 9.148819220060914e-58, 'athorough_evaluation': 0.0008822241915335798, 'BRRS': 0.0007864664894503318, 'macrocephaly_hamartomas': 1.2833264574456584e-05, 'ASD_features': 9.148819220060914e-58, 'anomalieslarge_birth_weight_jointhyperextensibility': 9.148819220060914e-58, 'palate_scoliosis': 0.00038842632962585887, 'microcytic_hypochromicanemia_fineneedle_biopsy': 8.770946583746331e-05, 'microcytic_hypochromicanemia': 8.770946583746331e-05, 'cm_hypoechogenicnodule_areas_largest': 0.0038806204677737646, 'fineneedle_biopsy': 8.770946583746331e-05, 'meetingit': 9.148819220060914e-58, 'to_intervene_thepatient_with_total_thyroidectomyIn_September_ ': 9.148819220060914e-58, 'wasadministration': 0.00027587787348664266, 'breast_lump': 8.770946583746331e-05, 'breast_ultrasound': 0.00011306296477830058, 'polylobular_nodule': 1.845095611906761e-06, 'FNB': 0.00011303284306354076, 'to_undergo_palliativeright_total_mastectomy': 0.0005915726387590047, 'choseto': 9.148819220060914e-58, 'doxorubicin_onlyIn': 9.148819220060914e-58, 'BRCA2_gene_alteration': 0.0009466755491730313, 'Highgrade_sarcoma_0cMiguelote_World_Journal': 1.1686951820486561e-54, 'stepbrothers_stepsister_norelationship': 8.263922883666513e-55, 'stepbrothers_stepsister': 8.263922883666513e-55, 'norelationship': 8.770946583746331e-05, 'mother_uncles': 9.148819220060914e-58, 'notwant': 9.148819220060914e-58, 'to_knowIn_ ': 0.0013882295497307361, 'diagnosis_timecould': 9.148819220060914e-58, 'pathDiscussion_conclusionCS': 9.148819220060914e-58, 'lesionsThese': 9.148819220060914e-58, 'years_neoplasms': 9.148819220060914e-58, 'macrocephalyand_\\x89¥': 9.148819220060914e-58, 'ordermatologic_features': 9.148819220060914e-58, 'National_Comprehensive_Cancer_Network_LDD_gastrointestinalhamartomas_major_minor': 0.00042075216298420966, 'National_Comprehensive_Cancer_Network': 0.00042075216298420966, 'Pilarsky_criteria': 0.00210348072096923, 'LDD_gastrointestinalhamartomas_major_minor': 0.0006026042973632392, 'criterion_criteria_breast_cancer_lesions_criteriafollicular_variant': 0.00042075216298420966, 'criterion_criteria': 0.00042075216298420966, 'breast_cancer_lesions_criteriafollicular_variant': 0.0006324067207528349, 'CS_findings': 0.00042075216298420966, 'disability_QI': 0.00011839797567100296, 'Autism_spectrum': 9.148819220060914e-58, 'lipomatosisVascular_anomalies_disease': 9.148819220060914e-58, 'papillomas_particularlyon_tongue_gingiva_multiple\\x89¥_Papillary_thyroid': 0.00011839797567100296, 'Counseling': 2.592383228850439e-05, 'biopsy_\\x93': 0.00033788292231117737, 'women_men_NCCN': 0.0001479704890393708, 'colon_cancer_Colonoscopyshould': 0.0001479704890393708, 'trio': 9.148819220060914e-58, 'PTEN_gene': 9.148819220060914e-58, 'LE': 9.148819220060914e-58, 'thepatient_data': 9.148819220060914e-58, 'World_Journal': 0.001031515926365138, 'imaging_histological': 9.148819220060914e-58, 'thebioethics_department': 9.148819220060914e-58, 'The_respective_authorizationsof_the_hospital_ethics_committee_are_in_the_supplementConsent_for_publicationInformed_consent': 0.00015000303011146425, 'details1Faculty': 0.0013882295497307361, 'to_contribute_to': 0.0008204866367473326, 'tumor_growth_growth_factors_hypoxia_impact': 0.0010068765747081726, 'is_tumorsuppressor': 1.0132034972112839e-52, 'methodsAspartate': 5.849733118588051e-53, 'hydroxylase_ASPH': 9.148819220060914e-58, 'toelucidate_the_mechanisms_underlying_malignant_transformation_of_cells_methodsAspartate': 9.148819220060914e-58, 'calcium_binding_domain': 8.263922883666513e-55, 'P2_promoter': 9.148819220060914e-58, 'factor_MEF2': 9.148819220060914e-58, 'ASPH_gene': 8.263922883666513e-55, 'ASPH_transcript_differ': 9.148819220060914e-58, 'ASPH_protein': 9.148819220060914e-58, 'Humbug': 0.0015842910551982499, 'overexpressionhas': 0.0015842910551982499, 'factor_IGF1insulin_receptor_substrate_IRS1': 9.148819220060914e-58, 'PI3KAkt_pathways': 9.148819220060914e-58, 'ref': 0.00013588610209050726, 'Summary_nnTumor_tissuesDetectionmethodIHCAntibody': 0.00018994987973827007, 'ASPH_expression': 0.003960878758174663, 'Journal_expression': 0.0008522036149147152, 'levels_proliferation_epithelialmesenchymal_migration_invasion_angiogenesis_tumrowth_metastasis': 0.0003631075583458118, 'expression_Stability': 0.00024134924474519354, 'ASPH': 0.0005589894045298016, 'Finallyinactivation': 2.2716382614535907e-07, 'number_variation': 0.004724840039465589, 'ASPHprotein_expression': 0.00024134924474519354, 'stability_andthus': 2.2480340991203723e-51, 'expressionwas': 0.00017282301855397239, 'effects_phosphorylation': 0.001129870936471824, 'ThereforeASPH_phosphorylation': 8.263922883666513e-55, '[_]_ThereforeASPH_phosphorylation_probably_regulates_the_functionof_this_protein_by_various_mechanismsASPH_expression': 8.263922883666513e-55, 'HIF1Î±that': 9.148819220060914e-58, 'HIF_FIH': 9.148819220060914e-58, 'Brewitz': 1.1686951820486561e-54, 'hydroxylation_activity': 8.263922883666513e-55, 'ASPH_role': 8.263922883666513e-55, 'motif_cell_adhesionmolecule_EPCAM': 9.148819220060914e-58, 'matrix_metallopeptidase': 9.148819220060914e-58, 'MMP29_cyclin_D1': 9.148819220060914e-58, 'factor_VEGF_proliferatingcell_antigen_results_fragment_release': 9.148819220060914e-58, 'thereceptor_interaction': 0.0038806204677737646, 'interactionof_ASPH_domainADAM': 2.013456028480201e-05, 'cleavage_Notch_receptors_subsequentNICD': 3.289121035459026e-07, 'Consequentlythis_activation': 9.148819220060914e-58, 'growthand_metastasis': 9.148819220060914e-58, 'SRC_activation': 9.148819220060914e-58, 'matrixdegradation_tumor_invasiveness': 9.148819220060914e-58, 'Iwagami_et': 0.000528146067012347, 'GSK3_inactivation': 0.004315547045054443, 'Huang': 0.0004694385672555256, 'inactivates': 1.8162977041424498e-05, 'Antibodies': 9.148819220060914e-58, 'effectsInteraction': 9.148819220060914e-58, 'macrophages_protumorigenic_M2polarization': 9.148819220060914e-58, 'stimulators': 9.148819220060914e-58, 'Notch_pathway': 0.0015842910551982499, 'activation_ofNotch': 2.0356996611489255e-06, 'T_cellsit': 2.0356996611489255e-06, 'mutagenesis_inin_vivo_models': 0.0005248377111845071, 'ASPH_involvement': 0.0005248377111845071, 'Cellularalterations': 9.148819220060914e-58, 'EMTinhibition': 9.148819220060914e-58, 'ASPHinduced_extracellularmatrix_angiogenesis_transendothelial_migration_Notch_SRC_signaling': 8.263922883666513e-55, 'bySMIs_immunotherapySmall_molecule': 8.263922883666513e-55, 'immunotherapy_approaches': 0.00028936954403567647, 'immunotherapy_approaches_activity_activity': 0.0002896010150721585, 'reticulum_Differentcancers': 4.722563713201853e-06, 'Tetronimides': 9.148819220060914e-58, 'Dahn': 9.148819220060914e-58, 'ASPH_FatMass_Obesity_protein': 0.004315547045054443, 'to_be_potentcytotoxic_agents_with_subnanomolar_sarcoendoplasmicreticulum_calcium_ATPase_SERCA': 0.00024476027129020185, 'irondependent_dioxygenase_inhibitors_assayed': 9.148819220060914e-58, 'PHD2_FIH_lysinespecific_demethylase_4EKDM4E': 9.148819220060914e-58, 'both_andhumoralimmunityASPH': 0.004315547045054443, 'ASPH_activity_anddoes': 3.4358152916695635e-05, 'cells_pathways': 0.0021046020445995746, 'inhibitory_molecules': 3.4358152916695635e-05, '0cTuncer_Journal': 8.263922883666513e-55, 'to_be_statistically_significant_in_the_evaluation_of_ovarian_cancer_etiology_BRCA1_mutationstatus_and_ovarian_cancer_risk_in_accordance_with_the_obtained_dataThere': 1.1686951820486561e-54, 'miRNA_expressionprofiles': 8.263922883666513e-55, 'cancer_OC': 0.00021180960367334957, 'advances_outcomes': 3.4494196115867285e-05, 'genes_roles': 4.80231642887269e-05, 'BRCA1and_BRCA2': 0.0005218289698578611, 'to_locate_in_thechromosomal_breaks_This_DNA_breaks': 0.0009469278935472336, 'Thusstudies': 9.148819220060914e-58, 'target_molecules_biologicalindicators': 9.148819220060914e-58, 'to_have_BRCA1_gene_mutation': 0.0004231487615035667, 'approval_consents': 9.148819220060914e-58, 'Ethics_Committee_to_separate': 9.148819220060914e-58, 'Germany_density_gradient': 1.0320608402674031e-05, 'QIAzol_solution': 3.77736773751182e-07, 'mixturing_using_the_vortex_For_complete_nucleoproteinfractionation_°_C_roomtemperature_for_ _min': 2.313268825293284e-05, 'storedin_Cell_fractionation': 3.77736773751182e-07, 'Thesupernatant': 3.77736773751182e-07, 'microliters_RWT_buffer': 3.77736773751182e-07, 'sThe_procedure': 7.069543898189281e-05, 'RPE': 9.148819220060914e-58, 'bycentrifuging_min': 9.148819220060914e-58, 'purity_concentrations_miRNA_purity': 3.77736773751182e-07, 'Legend_pedigree_using': 0.0006031843797531792, 'dendrogram_mutation_carrierof_measurements': 9.839619407107218e-06, 'using_a_Bioanalyser_device_ _BioanalyserAgilent_Technologies_Santa_Clara_CA_USA_AgilentRNA_ _Nano_Kit_Agilent_Technologies_Santa_ClaraCA_USA_for_confirming_whether_the_miRNAs_were_appropriate_and_in_adequate_level_for_microarray': 5.979566988914394e-06, 'sample_concentrations_results': 9.148819220060914e-58, 'samples_number_values': 9.148819220060914e-58, 'Agilent_Scanner_Agilent_Microarray_Scanner': 0.00032618452265076087, 'Agilent_Technologies': 0.00032618452265076087, 'change_rates_twosample_T_test': 0.0011301720283114149, 'values_miRNAs': 1.8444548091260086e-05, 'using_the_HochbergmethodBioinformatic_analysisTarget_proteins': 5.4392439908607585e-05, 'errors_detection': 8.880870210494134e-07, 'miRNA_data': 0.00027915818211639477, 'Group_mutation': 0.00027915818211639477, 'comparison_groups': 0.00027915818211639477, 'ResultsWe': 9.148819220060914e-58, 'comparisonof_miRNAs': 9.148819220060914e-58, 'miR7663p_expressions': 7.417164383651313e-53, 'to_have_downregulated_After_the_bioinformatic_analysis_a_total_of_upregulated_and_downregulated_statistically_significantmiRNAs': 1.284690556057437e-52, 'target_molecules': 7.417164383651313e-53, 'miRNAs_level': 7.417164383651313e-53, 'total_target_molecules': 2.2480340991203723e-51, 'miRNA_levels': 2.2480340991203723e-51, 'miR7975_miR7977were': 2.2480340991203723e-51, 'IGF2BP1_PTEN_ATM_NOTCH2': 9.148819220060914e-58, 'BMP4_EIF2C1_NEUROG1': 9.148819220060914e-58, 'this_miRNAsSequence': 1.6855732572917737e-05, 'SYNCRIP_FBXO28DCTN5': 9.148819220060914e-58, 'CREBBP_DVL2': 9.148819220060914e-58, 'E2F3_RCAN3': 9.148819220060914e-58, 'APPL1': 9.148819220060914e-58, 'CCNB1GUGAGUAGUGGCGCGCGGCGGCDownregulatedTUBB2AMAPK1NRBF2': 9.148819220060914e-58, 'CHRDL1CCND2': 9.148819220060914e-58, 'miR8063_miR': 4.554741228061612e-06, 'to_have_downregulated_After_bioinformatic_analysis_a_total_of_ _upregulated_and_downregulated_statistically_significant_miRNAs': 0.0002793070238874551, 'targetmolecules': 4.554741228061612e-06, 'miR6127_miR': 9.148819220060914e-58, 'to_be_upregulated_The_expression_ofthe_ _miRNAs_consisting_of_let7i5p': 9.148819220060914e-58, '3p': 1.1686951820486561e-54, 'miR451a': 8.263922883666513e-55, 'to_have_downregulated_Atotal_of_ _upregulated_and_downregulated_statisticallysignificant_miRNAs': 8.263922883666513e-55, '0cTuncer_Journal_miRNAs_foldchanges': 7.676580874968233e-10, 'arole_thecandidate_miRNAs': 0.0009496819621362637, 'ofmonozygotic_siblings': 0.004315547045054443, 'discussion_comparison': 1.5491835105094046e-05, 'miR3135b_miR4430_miR7663p': 1.6814744700550177e-05, 'to_promote_the_cellular_invasion_and_metastasis_in_bladder_cancer_in_that_studyResearchers': 0.0003421850007431465, 'cycle_G1S_transfer': 5.756459558678552e-06, 'to_parallel_with_other_studies': 0.0006049075008066659, 'miR125a5p': 9.148819220060914e-58, 'to_inhibit_the_cervical_cancer': 9.148819220060914e-58, 'table_file': 0.0010325216439875707, 'to_determine_breast_cancer_cells_proliferation_Flow_Cytom\\x91etry_annexin_V_and_PI_staining_was_used_to_investigate_breast_cancer_cells_apoptosis': 0.0003535708123475912, 'Cytom\\x91etry_annexin_V_PI_staining': 2.2751795747730337e-07, 'results_Polymerase_Chain_Reaction': 0.0006940543140455221, 'Polymer\\x91ase_Chain_Reaction_blot_analysis': 1.844946435746173e-05, 'Bax_expression': 3.58775368949104e-05, 'cells_invasion_migration': 5.442618179122329e-06, 'to_investigate_the_antitumour_effects_of_levobupivacaine_on_breast_cancer_cellsMain_textMaterials_and': 0.0019127833147525456, 'cultureWe': 9.148819220060914e-58, 'MCF7_MDAMB231_breast_cancer_cells': 9.148819220060914e-58, 'China': 1.2561548575370726e-05, 'MCF7_MDAMB231_cells': 0.0024413029377401935, 'TransGen_Biotech_China': 0.0011125787591309202, 'subsequentlyAntibodies_a0reagentsEPR17671_Antibody_Abcam': 0.0011125787591309202, 'China_PRAP': 0.0002620234510256799, 'viability_to_treat_MCF7_and_MDAMB_ _cells_plated_in_96well_plates_ ': 4.272124150811566e-06, 'Proteintech_China_GAPDH': 9.148819220060914e-58, 'ChinaCell_viability_assay_a0IC50We': 9.148819220060914e-58, 'to_treat_MCF7_and_MDAMB_ _cells_plated_in_96well_plates_ ': 4.272124150811566e-06, 'PI_staining_assay': 1.1686951820486561e-54, 'to_ _investigate_ _the_ _apoptosis_ _of_ _MCF7_ _and_ _MDAMB_ _cells_following_levobupivacaine_treatment_After_treating_the_cells_for_a0h_ _trypsin': 8.263922883666513e-55, 'to_harvest_ _the_ _treated_ _cells_ _and_ _centrifugation_ _at_   _rcf_ _for_a0min': 8.263922883666513e-55, '²CAT_CGT_GGG_TGT': 9.148819220060914e-58, 'log_phase': 9.148819220060914e-58, 'to_ _measure_ _significance_ _p_  _Dunnett\\x99s': 1.8580551962618324e-05, 'to_test_the_difference_between_groupsResultsLevobupivacaine_decreases_breast_cancer_cell': 1.771400127825104e-05, 'MDAMB231_cells': 0.001128162151175775, 'e_blot_analysis': 9.148819220060914e-58, 'D1_expressions': 9.148819220060914e-58, 'file_gLevobupivacaine': 0.0015820096775217111, 'qPCR_data': 2.0041070343477455e-06, 'd_blot_analysis': 8.263922883666513e-55, 'file_fLevobupivacaine': 0.0005521751935137136, 'similar_apoptosis': 0.0005253840276496832, 'Levobupivacaine': 9.148819220060914e-58, 'proliferation_MCF\\x91': 9.148819220060914e-58, 'proliferation_MCF\\x91_IC50_results_Colony_formation_cells': 4.107493857418709e-06, 'IC50_results_Colony_formation_cells': 2.8861035212879448e-06, 'qPCR_expression_assessment': 0.0006049075008066659, 'gene_expression_cells': 0.0002517988922651906, 'P_a0et': 5.880741633587329e-05, 'MDA\\x91MB_cells': 9.595650200686874e-07, 'blotting_K_p\\x91Akt_p\\x91mTOR': 0.0011125787591309202, 'MCF_MDAMB231_cells': 0.007713134335009549, 'member_Bad': 9.742022379031115e-05, 'care_0cKwakye': 0.0038806204677737646, 'University_Ho_Ghana': 9.148819220060914e-58, 'protein_levels_expression': 9.148819220060914e-58, 'Supplementary': 7.417164383651313e-53, 'Figure_S2_Effect': 1.284690556057437e-52, 'Figure_S1_Levobupivacaine': 7.417164383651313e-53, 'file_gelsblots': 7.417164383651313e-53, 'Propidium_iodide_chain_reactionAcknowledgementsWe': 9.148819220060914e-58, 'First_Affiliated_Hospital_Department': 9.148819220060914e-58, 'Key_Laboratory': 0.002388671506211953, 'SK': 5.4762797638129146e-05, 'Key_Laboratory_Availability': 5.104979109783427e-07, 'Dalian_China_Department': 0.0013882295497307361, 'Cancer_statistics': 0.0005521751935137136, 'tumour_cells_Oncol_Res': 7.417164383651313e-53, 'Yuan_YF_Zeng_WA_lidocaine': 0.0005523292336258518, 'Minshall_RD': 0.0007865629393654117, 'Q\\x91P_Scorpion': 0.0007120351744212653, 'Kageyama_K_Yoshihiro_K_Munetaka_H_Lidocaine': 1.843021855196599e-05, 'WJ_Theodorou_Tamburo_Bella_M_Slade': 9.148819220060914e-58, 'sodium_channel_expression_potentiation': 9.148819220060914e-58, 'Lee_HT_Siegel_CD_Local_anaesthetics': 9.148819220060914e-58, 'cell_apoptosis_\\x93_Unami_analyses': 9.148819220060914e-58, 'MC_Local_anaesthetics': 0.0006993992070543573, 'apoptosis_Anesth_Analg_description': 1.1409928915704967e-05, 'Ogata_M_Sata_T_Chaudry_IH_Lidocaine': 0.0005521751935137136, 'Gradek_F_Chevalier_S_Roger_S_voltage\\x91gated': 1.1847131549316027e-05, 'Roger_S_Le_Guennec': 9.148819220060914e-58, 'sodium_channels_cancer': 9.148819220060914e-58, 'Pharmacol_Vandier_C_Besson_P_Le_Guennec_JY': 9.148819220060914e-58, 'sodium_channels': 9.148819220060914e-58, '\\x93_V_Collin_C_Guennec_JY_Besson_P_Roger_S_Ranolazine': 9.148819220060914e-58, 'cell_invasive\\x91ness_AA_Thomas_JR_Brackenbury_WJ': 9.148819220060914e-58, 'tumour_growth_metastasis_Mol_Yuan_T_Li_Z_Li_X_Yu_G_Wang_N_Yang_X_Lidocaine': 8.263922883666513e-55, 'Ortega_MA': 0.0003802249829989744, 'Srivastava_RK_Resveratrol': 9.148819220060914e-58, 'Growth_Arrest_Apoptosis': 9.148819220060914e-58, '1i32\\x93i3838_Li_K_Yang_J_Han_X_Lidocaine': 0.00030956355452942195, 'DUSP6': 0.00028529140040204666, 'transition_EMT_connection': 4.6548144197537464e-06, 'NCadherin': 4.6548144197537464e-06, 'DUSP6_involvement': 0.0014616190772430405, 'transition_EMTIntroductionDUSP6': 9.148819220060914e-58, 'role_breast_cancer_leukemia': 9.148819220060914e-58, 'U87MG_U251': 3.568810297240047e-05, 'adult_NHA_Fetal_Stem_Cells': 0.0003128669140382118, 'NaCl_a0mM': 7.392245403241764e-06, '®_FluoroBlok\\x84¢_Plate_Permeable_Support_cells': 0.0003114618595426564, 'glioblastoma_subtype': 0.0038806204677737646, 'T98_G': 4.695015963958416e-06, 'model_enrichment_gene': 9.148819220060914e-58, 'introns_a0_bp': 9.148819220060914e-58, 'assay_blotting': 0.007713134335009549, 'GBM_Panel_Panel_b': 6.900321140164759e-09, 'protein_levels_Fig_a0': 4.2273917371127125e-07, 'ERK_signals_De_novo_protein_synthesis': 9.148819220060914e-58, 'timecourse_cycloheximide_CHX_experiment': 9.148819220060914e-58, 'acutely_inhibiting_protein_synthesis': 9.148819220060914e-58, 'DUSP6_expression': 9.148819220060914e-58, 'stimuli_addition_deprivation_EGF_cisplatin': 4.462825280616495e-07, 'cisplatin_CDDP_cisplatin_treatment': 0.00036300091156384084, 'DiscussionThis_study': 9.148819220060914e-58, 'to_ _explore_ _DUSP6_ _involvement_in_glioblastoma_ ': 9.148819220060914e-58, 'overexpression_results': 0.00238803522972525, 'boxes_exons_location': 2.71486337655924e-06, 'variant_NM_0019464': 0.00023451537717603815, 'cancer_cell_lines': 0.007841328814772971, 'mesenchymal_MDAMB231': 0.0008522036149147152, 'protein_expression_values': 0.007713134335009549, 'immunoblot_characterization': 0.00238803522972525, 'Blot_analysis': 4.5142201509663625e-08, 'expression_U251MG_cell_lines': 8.263922883666513e-55, 'Blot': 1.1686951820486561e-54, 'decay': 8.263922883666513e-55, 'bar_graphs': 0.002716332952627978, 'expression_CDDP_µgmL': 4.433486265603101e-05, 'ECadherin': 3.7679996572330324e-06, 'Fibronectin_Cadherins_cells': 0.0007129960827382031, 'Vimentin': 0.000489923995670151, 'number_GBM_U251MG': 0.000332193218693602, 'contributionsSM': 1.4548125748021919e-08, 'BM': 3.4213118569611756e-05, 'SM_CZ_EDZ': 0.0003327007272384309, 'CZ_EDZ': 0.0003327007272384309, 'Dualspecificity_phosphatase': 9.148819220060914e-58, 'tumorpromoting_properties': 9.148819220060914e-58, 'Song_JL_al_Silencing': 0.0004358935679566294, 'RH_Heidel_F_Fischer_T_et_al_Expression_FLT3_ITD': 0.0008522036149147152, 'feedback_control': 0.00020506735733496112, 'PreB_cell_transformation_al_roles_201611e0148065': 3.345815313545259e-06, 'Li_MJ_Geng_F_Dusp6': 0.0002074138537015295, 'Fouse_G_VEGF': 9.148819220060914e-58, 'cell_invasion_transition': 9.148819220060914e-58, 'Ras_inhibition': 0.0006191469481200436, 'Oligodendrocyte_progenitor_cells': 8.263922883666513e-55, 'Mosaic_analysis': 1.1686951820486561e-54, 'MADM': 9.148819220060914e-58, 'tumor_celloforigin': 9.148819220060914e-58, 'Raisanen_Burns_DK_Johnson_Adult_lineage': 8.263922883666513e-55, 'CNS_progenitors': 9.148819220060914e-58, 'glioblastoma_subtypes': 9.148819220060914e-58, 'Malignant_astrocytomas': 2.3505988376243424e-06, 'kinase_phosphatase': 0.00014411995627503513, 'ZEB1_pathway': 9.148819220060914e-58, 'initiation_invasion_chemoresistance_Ecadherin_expression_ONE': 9.148819220060914e-58, 'Camand_F_Osmani_expression_level': 9.148819220060914e-58, 'polarity_impacts': 9.148819220060914e-58, 'A_B_Nelson_SF_U87MG': 0.0002589664773973477, '±_years': 0.0011075402231842013, 'PAX8': 0.0015847132313328567, 'to_ _be_expressed_among_endometrioid_carcinomas_transitional_The_Authors_ ': 2.586668612581389e-05, '0cAli': 0.0010374475928852155, 'paraffin_blocks': 0.00238803522972525, 'using_ _Rotary_ _microtome_ _Leica_Germany_from_each_histopathological_block': 8.263922883666513e-55, 'saline_TBS_treatment_Abcam_United_Kingdom': 0.0003771656327870355, 'Tris': 9.148819220060914e-58, 'saline_TBS': 9.148819220060914e-58, 'Abcam_United_Kingdom': 0.0001269402576603856, 'interpretation_number_expression': 6.1501394480981895e-06, 'Photomicrographs': 9.148819220060914e-58, 'using_Olympus_SP350_camera_Olympus_Imaging_America_Inc_USAStatistical_analysisThe_ _statistical_ _analysis_ _of_ _the_ _results_ ': 9.148819220060914e-58, 'ChiSquared_test': 9.148819220060914e-58, 'to_ _compare_ _the_ _frequencies_ _of_ _categorical_variables_ ': 9.148819220060914e-58, 'a0study_study': 0.001845170519318405, 'cancer_grades_expression': 9.148819220060914e-58, 'Metastatic_adenocarcinoma_0cAli': 9.148819220060914e-58, 'lack_SCC_adenocarcinoma': 0.0015842910551982499, 'ConclusionAlthough_PAX8': 0.0016810521528134112, 'data_analysis_EES_IRS_LAH_AMM': 4.832456564391882e-07, 'NSM_MSM_AAY_AA': 0.001129870936471824, 'manuscriptFundingNot_ApplicableAvailability': 0.0007959416758056306, 'Alfarrabi_College_Sinnar_University_Sennar': 5.973401273075715e-05, 'University_Khartoum_Sudan': 9.148819220060914e-58, 'Walther_C_Pax': 9.148819220060914e-58, 'S_Kapa_LB_Akhtar_M_Benigno_BB_McDonald': 0.0005218289698578611, 'Wright_JD_Greenebaum_EJDc': 0.00013576801370357422, 'C_Anjana_K_Coffey_D_Krishnan_B_Truong': 9.148819220060914e-58, 'PAX_expression': 9.148819220060914e-58, 'Schmidt_Squamous_differentiation': 0.0006578099350934741, 'to_possess_remarkable_biological_and_pharmacological_activities_including_anticancer_activity': 0.0005915726387590047, 'to_proceed_via_apoptosis': 0.0010068765747081726, 'cells_death': 0.0010068765747081726, 'tumor_weight_volume': 0.002104041233387171, 'mukonal': 0.0033456806362741807, 'Correspondence_wangcqy2020163comDepartment': 0.00210348072096923, 'place_biologicalprevention_chemoprevention_link': 0.0011015821709770897, 'biologicalprevention_chemoprevention': 0.0002436592976234707, 'antioxidant_antimicrobial_anticancer_activity_Samanta_et': 1.0877958558598054e-05, 'potential_PI3KAKT': 0.0005915726387590047, 'Li_investigation': 9.148819220060914e-58, 'to_unveil_the_antibreast_cancer_potential_of_mukonal_along_with_its_effects_of_autophagy_and_apoptosis_inductionMaterials_and_a0methodsReagents_chemicals_and_a0cell_culturesMukonal_with_ _of_purity_by_HPLC_and_other_chemicals': 9.148819220060914e-58, 'cell_cultures': 0.000404948725608525, 'to_monitor_ _and_ _quantify_ _apoptosis_ _in_ _mukonal_ ': 0.0007982967068852859, 'blotting_Mukonal': 2.824277147902771e-06, 'MDAMB231_SKBR3': 4.610868010550852e-08, 'treatment_procedure': 9.109139931402274e-06, 'using_MTT_assay_after_treatment_with_variant_Mukonal': 9.623930537852086e-05, 'to_ _monitor_ _the_ _impact_ _of_mukonal_treatment_over_colony_generation_propensity_of_MDAMB231_and_SKBR3_cells_On_treatment_of_MDAMB231_ _and_ _SKBR3_ _cells_ _with_ _mukonal_ _remarkable_suppression_of_their_colonies': 4.7947358062440836e-05, 'growth_Chemical_structure': 2.8220863862401385e-06, 'blotting_analysis': 0.0002928998007019293, 'Mukonal': 0.0006958122369580691, 'a0µM': 0.0006049075008066659, 'Which': 0.0005373063242131615, 'exhibits_effects': 9.148819220060914e-58, 'to_ _determine_ _in_a0_vivo_anticancer_ _effects_ _of_ _mukonal_ ': 9.148819220060914e-58, 'to_understand_and_recognize_this_disease_at_molecular_levels_Due_to_timely_diagnoses_of_ _the_ _disease_ _North_ _America_ _has_ _registered_ _over_  _5year_ _survival_ _rate_ _among_ _the_ _breast_ _cancer_ _patients_DeSantis_et_a0al_ _High_frequency_of_occurrence_late_diagnosis_and_disastrous_side_effects_of_present_day': 0.00035028915142444096, 'chemopreventives': 9.148819220060914e-58, 'emergency': 9.148819220060914e-58, 'to_induce_anticancer_effects_against_different_human_cancer_cell_lines': 0.0005915726387590047, 'typeI_PCD': 9.148819220060914e-58, 'death_Khursheed': 9.148819220060914e-58, 'et_a0_al_Apoptosis': 3.4348996837103175e-05, 'role_Bonofiglio': 0.002104041233387171, 'expression_levels_caspase3_Bax_expression_levels': 0.0016480626375926124, 'caspase3_Bax': 0.0016480626375926124, 'cells_SKBR3_cells': 2.8220863862401385e-06, 'Autophagosomes': 1.1686951820486561e-54, 'arrows_b_TEM_analysis': 8.263922883666513e-55, 'arrows_blotting_results': 8.263922883666513e-55, 'treated_groups_enhanced_activity_of_Beclin1_LC3BI_and_LC3BII_was_observed_with_increasing_concentrations_of_mukonalalso_ ': 0.00025761770367047364, 'et_a0_al_Mukonal': 2.6909254076977078e-05, 'to_induce_autophagic_cell_death_in_both_MDAMB231_and_SKBR3_cell_lines': 0.0016485018034048215, 'to_decline_comparative_to_increased_doses_of_mukonalIn_ ': 3.4348996837103175e-05, 'cancer_effects_cell_lines': 5.459644739761012e-05, 'cancer_effects': 1.1686951820486561e-54, 'to_mediate_through_induction_of_autophagy_and_apoptosis': 8.263922883666513e-55, 'to_mediate_through_induction_of_autophagy_and_apoptosis_to_fully_establish_it_as_a_lead_molecule_in_the_development_of_breast_cancer_chemotherapy_0cWang': 0.0018006682651940404, 'to_fully_establish_it_as_a_lead_molecule_in_the_development_of_breast_cancer_chemotherapy_0cWang': 8.263922883666513e-55, 'Serrano_Sandri_M_Autophagy': 2.274211562945482e-53, 'stemness': 1.4055400435083287e-53, 'Y_Hao_Y_Guan_Zhu_Z_Guo_F_Bai_J_Mukonal': 9.148819220060914e-58, 'stemness_apoptosis_autophagy': 9.148819220060914e-58, 'Targeting_autophagy': 9.148819220060914e-58, 'cycle_arrest_inhibition': 9.148819220060914e-58, 'A_Zheng_H_Autophagy': 1.5404011213821278e-07, 'Jingzhou_Hubei_China': 9.148819220060914e-58, 'protocolAuthors\\x99_contributionsWW': 9.148819220060914e-58, 'An_Jingzhou_Hubei_China_to_conduct_the_presented_protocolAuthors\\x99_contributionsWW_and_ZJ_designed_the_protocol_of_the_study_WW_ZZ_XZ_LC_and_SB': 0.0017783336103231477, 'ZJ': 0.0007488205239457954, 'ethics_committee_An_County': 3.334808855788314e-05, 'phosphatase_PDP1': 9.148819220060914e-58, 'role_study': 9.148819220060914e-58, 'ATP_production_PDP1_overexpression': 0.0006812500420437589, 'approachesResults_PDP1': 1.1114958351429976e-05, 'PDP1': 0.003905230437772987, 'colony_formation_invasion': 0.0006106187995597882, 'ATP_production': 0.0006810685397702696, 'PDP1_overexpression': 0.0024331541308402374, 'lianyu_chenhotmailcom_Ye_Li_Jia_Shen': 9.148819220060914e-58, 'to_ _be_ _the_ _second_ _leading_cause_of_cancerrelated_death_in_the_USA': 9.148819220060914e-58, 'PDC': 9.148819220060914e-58, 'decarboxylation': 9.148819220060914e-58, 'intolerance': 1.4229787878656414e-05, 'endurance_training': 0.0016810521528134112, 'to_ _signal_ _insulin_ _resistance_ _that_could_ _be_ _reversed_ _by_ _plasma_ _insulin_ _supplementation': 0.0004005448148874858, 'plasma_insulin_supplementation': 0.004315547045054443, 'cell_proliferation_tumor_growth': 8.835605370583042e-05, 'to_ _identify_ _the_ _expression_and_functional_role_of_PDP1_in_human_PDAC': 0.007713134335009549, 'cell_counting_formation_assays_chamber_assays': 0.004560986992597504, 'correlation_survival': 9.148819220060914e-58, 'to_evaluate_its_prognostic_value': 9.148819220060914e-58, 'assaysCell_proliferation': 2.990188717885811e-07, 'invasion_invasiveness': 9.148819220060914e-58, 'chamber_assays': 9.148819220060914e-58, 'SDSPAGE_Protein_C': 0.0005692603984725007, 'SDSPAGE_Protein': 3.0307251931401135e-06, 'oneway_ANOVA_p': 1.2728697782148145e-07, 'ectopic_expression': 2.274211562945482e-53, 'cancer_growth_progression': 1.4055400435083287e-53, 'phosphorylation_Tyr94': 0.0011824237771802639, 'survival_data': 0.007713134335009549, 'Panc1_Panc2_KP3_Capan1': 0.0015842910551982499, 'its_expression': 0.007713134335009549, 'KP3': 0.0015842910551982499, 'to_ _examine_ _whether_ _PDP1_ _expression_ _could_ _alter_ _cell_growth_in_PDAC': 8.909695929625467e-07, 'PDP1_expression': 0.0009518734944365814, 'PDP1_knockdown': 0.0010068765747081726, 'Cell_Page': 6.491057115554545e-07, 'to_be_overexpressed_in_PDAC_tissues_compared_with_normal_pancreatic_tissues_in_a_GSE15471_and_b_GSE28735_c_Immunohistochemical_staining_of_PDP1_survival_e_disease\\x91free': 1.0590622131193445e-08, 'to_be_overexpressed_in_PDAC_tissues_compared_with_normal_pancreatic_tissues_in_a_GSE15471_and_b_GSE28735_c_Immunohistochemical_staining_of_PDP1': 1.0590622131193445e-08, 'survival_e_disease\\x91free': 1.0590622131193445e-08, 'survival_f': 0.0016810521528134112, 'PDAC_cell_proliferation': 0.0017448067010942296, 'c_Overexpression': 2.474514720031763e-06, 'PDAC_cell_colony': 6.375454828081836e-05, 'number_d_Overexpression': 1.040620255693655e-06, 'PDAC_cell_migration': 6.3771538207461e-05, 'overexpression_Fig': 0.0004815525391610832, 'the_ _PDP1overexpressing_ _PDAC_ _cells_ ': 0.00013588610209050726, 'immunoblotting': 0.0005406986214565272, 'ATP_content': 0.0016877484207723672, 'ATP_supplementation': 0.001128162151175775, 'PDP1\\x91driven_cell_proliferation': 0.004315547045054443, 'PDAC_growth': 0.007776888883290368, 'PDAC_cell_proliferation_migration': 3.971340791542998e-05, 'ATP_levels': 0.0004990942860418787, 'proliferation_rate_Fig': 0.0006940543140455221, 'mTOR_activation': 4.649709951488232e-52, 'inhibition_mediates': 2.516404898630125e-52, 'to_activate_AMPKÎ±_as_a_stress_response_pathway_to_limit_growthrelated_signaling_[': 0.0011125787591309202, 'to_ _restrict_ _cancer_ _cell_ _proliferation_and_aggressiveness_in_previous_studies': 4.207274934948232e-06, 'AMPKÎ±_activity': 9.148819220060914e-58, 'PDP1_Overexpression': 9.148819220060914e-58, 'AMPKÎ±_6a_Inhibition': 9.148819220060914e-58, 'mTOR_activity': 9.148819220060914e-58, 'AMPATP_ratio': 9.148819220060914e-58, 'AMPK_activity': 9.148819220060914e-58, 'AMP_a0et': 0.00238803522972525, 'phosphorylation_b_Transfection': 0.0004990942860418787, 'switch_method': 0.0006940543140455221, 'PDP1induced_PDAC_cell_proliferation_migration_ _and_ _invasion_ ': 0.00011931918217645773, 'to_be_critical_in_some_other_cellular_processes_such_as_recovery_from_injury_and_cell_differentiation': 1.5524668160803743e-05, 'PDC_system_processesWe': 0.00012667025119561404, 'phosphorylation_process': 0.0038806204677737646, 'ligation': 7.05029712940268e-05, 'TCA_cycle': 0.004345236525349896, 'reducing_equivalents_in_the_form_of_NADH_FADH2_etc_which_were_used_for_ATP_ _production_ _by_ _oxidative_ _phosphorylation_ _in_ _PDP1_knockdown_ _cells_ _As_ _we_ _assumed_ _that_ _suppression_ _of_ATP_ _production_ _in_ _PDP1_ _knockdown_ _cells_ _is_ _responsible_for_inhibition_of_tumor_growth_we_used_acetate_as_an_alternative_source_of_ATP_production_in_these_cells_and_our_ _observations_ _proved_ _that_ _ATP_ _restoration_ _in_ _PDP1_knockdown_cells_recovered_tumor_cell_proliferation_and_growth_supporting_our_claims_We_also_observed_that_the_addition_of_acetate_had_a_minimal_effect_on_tumor_growth_in_mock_tumor_cells_Mock_cells_can_consume_glucose_to_ _0cLi': 7.095887926818771e-05, 'ATP_restoration': 9.148819220060914e-58, 'tumor_cell_proliferation_growth': 9.148819220060914e-58, 'Mock_cells': 7.165326686822077e-05, 'proliferation_c_colony_formation_d_migration': 0.0005269923949341242, 'PDAC_cells_Fig_regulation': 0.000254619872099857, 'equivalents': 0.0038816544549862162, 'acetylCoA_synthetases_reason': 0.0038806204677737646, 'ratelimiting_steps': 1.0590622131193445e-08, 'cell_proliferation_growth': 0.00029599327620783605, 'to_primarily_downregulate_mTOR_activity_in_cancers': 0.0006940543140455221, 'mTOR_signalingAMPK': 6.920360188933788e-05, 'mTOR_activity_Repression': 0.0038806204677737646, 'JZ': 0.00013481355048464152, 'YL_JS': 0.0003327007272384309, 'data_CC': 5.776236801647642e-05, 'National_Science_Foundation_Foundation_Availability': 0.0003167145330801072, 'National_Science_Foundation_Foundation_Availability_andor': 4.438818170818159e-05, 'China_Department': 0.0013882295497307361, 'summary_we': 0.000199629432709579, 'effects_Overexpression': 0.0002069818544961052, 'PDAC_cells': 9.148819220060914e-58, 'cell_proliferation_PDP1_knockdown': 9.148819220060914e-58, 'References_Collaborators': 0.000199629432709579, 'seed_leaves': 3.45387337299085e-07, 'M_oleifera': 0.00703585554715468, 'Moringa_genus': 9.148819220060914e-58, 'M_drouhardii': 9.148819220060914e-58, 'resources_seeds_pods': 9.148819220060914e-58, 'to_treat_several_pathologies': 9.148819220060914e-58, 'ValdezSolana_et_M_oleifera': 6.023716090269162e-07, 'times_vitamin_C_vitamin_A_potassium_iron': 0.007713134335009549, 'leavesa\\x93\\x93\\x93\\x93Energy': 9.148819220060914e-58, 'gCarbohydrate': 9.148819220060914e-58, 'Witt': 0.004315547045054443, 'to_be_a_good_regulator_of_insulin_Thus_according_Sileshi_et_a0al_ _patients_suffering_from_lack_of_insulin': 0.0001148823169947285, 'when_treating_thyroids_M_oleifera_compounds_of_the_leaf': 1.362742322327277e-05, 'chemical_compounds_Maizuwo_et': 0.0005915726387590047, 'extract_Nutrabasics\\x94MoringaRegulates_cholesterol_levels': 1.1686951820486561e-54, 'conditionDelays': 8.263922883666513e-55, 'conditionDelays_conditionStrengthens': 0.000498273905934873, 'tonifies_body_value_source': 0.00038842632962585887, 'conditionStrengthens': 8.263922883666513e-55, 'to_restore_your_imbalances_in_your_dietThe': 0.0007956673215405282, 'Moringa_leaf': 1.0852499745858376e-05, 'Flavonoids_Polyphenols': 8.263922883666513e-55, 'Moyo': 9.148819220060914e-58, '0cTable_Compilation': 9.148819220060914e-58, 'lotionTwinkle_toes': 8.263922883666513e-55, 'Moringa_body': 2.253096700536861e-05, 'mistPurifying_action_protects': 2.253096700536861e-05, 'cleansingpurification': 2.253096700536861e-05, 'leaf_infusionoilM': 9.148819220060914e-58, 'ingredient_peptide': 9.148819220060914e-58, 'seedsM': 9.148819220060914e-58, 'extractM_pterygosperma_seed_oleifera_seeds_oleifera': 9.148819220060914e-58, 'Eliminates': 0.0010076819599700148, 'skinRejuvenate': 1.6444525612313975e-05, 'skinRepairs_strengthens': 1.6444525612313975e-05, 'fallEnhanced_power': 1.6444525612313975e-05, 'Seed': 0.00023408789193635874, 'Adding_fresh_or_dried_leaves_to_the_feed_of_milk_cows': 1.1686951820486561e-54, 'milk_production_leaf': 8.263922883666513e-55, 'lactating_mothers_produce_more_milk_and_help_to_treat_malnutrition_in_young_children_Phytosterols_from_M_oleifera': 8.263922883666513e-55, 'to_treat_malnutrition_in_young_children_Phytosterols_from_M_oleifera': 3.702049874367614e-07, 'doseage_AsieduGyekye_extract': 1.042342356642722e-06, 'et_Table_a0': 1.2227367139234318e-06, 'potential_Bharali': 4.196122883882698e-05, 'component_presence_C': 0.00016085087796596776, 'properties_insulin_secretion_plasma_cholesterol_HDL_Nambiar': 0.001128162151175775, 'properties_insulin_secretion': 0.0018006682651940404, 'HDL_Nambiar': 0.001128162151175775, 'esaercnI': 9.148819220060914e-58, 'laidnarp_tsop': 9.148819220060914e-58, 'laminA_a0_a0': 9.148819220060914e-58, 'laminA_a0_a0_p_ledomnamuHc_ilA_latceroloc_tsniaga_ytivitca_recnacitnAdna_la_la_a0te_pniap_tnioj_la_ilAledom_a0_a0_p_la_a0_a0_a0te_lednoroTnoitardyh_niks': 9.148819220060914e-58, 'pAN': 9.148819220060914e-58, 'dna_paos_fognihsaw_tnereffiddnah_ni_seitreporp': 9.148819220060914e-58, 'gnul_etuca': 9.148819220060914e-58, 'a0te': 9.148819220060914e-58, 'Leone': 1.645423058733246e-05, 'Leaves_extracts': 9.148819220060914e-58, 'anticancer_properties_compounds_et': 9.148819220060914e-58, 'apoptosis_M_enrichment': 2.2480340991203723e-51, 'Ali_et': 0.00210348072096923, 'to_be_phenolics_eg_kaempferol_and_quercetin_and_antioxidants_such_as_vitamins_A_C_and': 0.00024476027129020185, 'M_extract_cream': 1.1686951820486561e-54, 'patch_test': 8.263922883666513e-55, 'tested_proved': 9.148819220060914e-58, 'to_clean_hands_when_four_grams_of_wet_more_efficient_or_dried_powder_are_applied_on_hands_and_rubbed_Torondel_et': 9.148819220060914e-58, 'to_be_nonirritant_and_well_accepted_by_the_volunteers_also_reducing_skin_erythema_Ali_et_a0al_2013a_b_c_ _Table_a0_M_oleifera_leaf_powder': 8.263922883666513e-55, 'Torondel_et': 7.417164383651313e-53, 'scarceA_leave_extract': 0.00040523548652301664, 'dnuof_tonelbacilppanon': 0.00037036254408407267, 'yllacitsitats_size_resistance': 9.148819220060914e-58, 'tea_studies': 9.148819220060914e-58, 'Moringa_tea': 3.411519604855072e-05, 'vegetable_oil': 0.0010068765747081726, 'to_cook_as_a_source_to_prepare_biodiesel_as_a_lubricant_and_in_the_cosmetic_industry_Rashid_et': 3.051226470404316e-09, 'moisturizing_antioxidant_protective_properties_oil_extracts_patients': 0.0005915726387590047, 'moisturizing_antioxidant_protective_properties': 0.0005915726387590047, 'allowing_the_extraction_of_fragrances_and_active_compounds_from_difficult_sources_as_flower_petals_Milled_M_oleifera_seed_shells_can_be_used_as_a_natural_exfoliating_agentMoringa_oleifera_seeds': 6.544411272929142e-07, 'Oleifera_seeds': 8.263922883666513e-55, 'Hamza': 5.715171440071452e-06, 'Hamza_Treatment': 0.0002821774092107797, 'promising_antiarthritic_property': 1.8377358875524265e-06, 'Seed_powder': 9.148819220060914e-58, 'capacity_Sharma_et': 9.148819220060914e-58, 'to_present_the_conditional_distribution_of_WC_andNC_values_according_to_BMI_stratiï¬\\x81ed_by_age_and_sex_from_the_Brazilian_Longitudinal_Study_of_Adult_Health_ELSABrasilbaseline_data_We_analyzed_ _ELSABrasil_participants_with_complete_data_We_used_spline_quantile_regression_modelsstratiï¬\\x81ed_by_sex_and_age_to_estimate_the_NC_and_WC_quantiles_according_to_BMI_To_test_a_putative_association_between_ageand_median_NC_or_WC_values_we_built_sexspeciï¬\\x81c_median_regression_models_using_both_BMI_and_age_as_explanatoryvariables_We_present_estimated_25th_50th_75th_and_90th_percentiles_for_NC_and_WC_values_according_to_BMI_age_and_sexPredicted_interquartile_intervals_for_NC_values_varied_from_ _to_ _cm_and_for_WC_values_from_ _to_ _cm_Median_NCwas_not_associated_with_age_in_men_P011_nor_in_women': 0.00238803522972525, 'ELSABrasil_participants': 0.00238803522972525, 'sexspeciï¬\\x81c_regression_models': 0.007713134335009549, 'body_fatdistribution': 0.0007641347695089468, 'regionalfat_distribution': 0.0015842910551982499, 'adipose_tissue': 0.0006333431476805851, 'WC': 1.1686951820486561e-54, 'hypertensives': 8.263922883666513e-55, 'distribution_patterns': 0.0003645333095764079, 'positivecorrelations': 0.0003645333095764079, 'habits_number': 0.0003645333095764079, '\\x93Hingorjo': 9.148819220060914e-58, 'universitystudents': 9.148819220060914e-58, 'approximately': 2.037468695226519e-07, 'thatthe': 8.263922883666513e-55, 'yearsThis': 0.0005248377111845071, 'servants': 0.004315547045054443, 'baselinedata_\\x93_Approvals': 0.007713134335009549, 'thesubjects': 0.0004100538998299479, 'BMI_NC_data': 0.004315547045054443, 'menand_women': 0.000506763478011233, 'Res_1015901414431X20209815meters_kgm2_WC': 3.193799046590178e-05, 'Smoking_status': 3.193799046590178e-05, 'alcohol_drinking': 3.193799046590178e-05, 'method_HDLcholesterol_lowdensity_cholesterol_LDLcholesterol_triglycerides': 7.165326686822077e-05, 'to_estimatethe_25th_50th_75th_and_90th_percentiles_for_NC_and_WCvalues_in_the_BMI_range_between_ _and_ _kgm2': 0.00035483153171244545, 'regression_models_details': 0.007713134335009549, 'college_education': 2.4473668059666446e-05, 'havingsmoked': 3.919221211082396e-05, 'sexspeciï¬\\x81c_regression_models_usingboth_BMI_age': 0.0026911511848678547, 'withage': 8.263922883666513e-55, 'cm_mean±SDWaist_circumference_cm': 9.148819220060914e-58, 'mean±SDHDLcholesterol': 9.148819220060914e-58, 'Res_1015901414431X20209815_Neck_circumference': 9.148819220060914e-58, 'quantiles': 9.148819220060914e-58, 'NC_values_kgm2DiscussionWe': 0.0003260903091169294, 'thatWC': 0.007721647952463805, 'NC_values': 0.0005221448462608798, 'to_explaindifferent_fat_tissue_distribution_within_individuals_with_thesame_BMI_such_as_dysfunctional_adipose_tissue_sedentary_lifestyle_or_both_ _As_mentioned_above_local_bodyfat_mass_and_its_clinical_markers_as_NC_and_WC_areassociated_with_multiple_phenotypes_of_higher_cardiovascular_risk': 0.0004405647755333974, 'association_andNC_WC': 9.148819220060914e-58, 'higherBMIs_Evidence': 9.148819220060914e-58, 'Res_1015901414431X20209815_waist_circumference_circumference': 9.148819220060914e-58, 'quantiles_BMIAge\\x93_data': 9.148819220060914e-58, 'Stern': 5.480530082427866e-05, 'BMI_value': 9.148819220060914e-58, 'WCvalues': 9.148819220060914e-58, 'adults_notin_individuals': 0.0021696214683340413, '\\x93_n8313': 9.148819220060914e-58, 'data_increase': 9.148819220060914e-58, 'Elobeid': 9.148819220060914e-58, 'timeframe': 9.148819220060914e-58, 'data_WC_values': 0.00238803522972525, 'inclusion_period_WC_values_BMI_values': 0.0038806204677737646, 'WC_values': 0.00238803522972525, 'First_Stern': 0.0002578525437194323, 'quantileregression': 0.007713134335009549, 'to_compare_similar_agestrata': 0.007713134335009549, 'strengths_ourstudy': 9.148819220060914e-58, 'oftwo_anthropometricmeasurements_distribution': 9.148819220060914e-58, 'Ministry_ofHealth_CNPq': 0.0019212969322068008, 'sex_values': 0.007713134335009549, 'to_thank_the_participants_of_the_ELSABrasil_who_made_this_studypossibleReferences_Canoy_D_Boekholdt_SM_Wareham_N_Luben_R_Welch': 0.0007959416758056306, 'D_Thakkinstian': 0.0019127833147525456, 'Schmidt_MI_Griep_RH_VM_Luft_VC_Goulart': 9.148819220060914e-58, 'S_Strategies_ofquality_assurance_control': 9.148819220060914e-58, 'HL_Stevenson_CE_Mannan': 7.085795002274248e-07, 'circumference_values': 9.148819220060914e-58, 'beyondincreases': 9.148819220060914e-58, 'Albert_Einstein_we': 0.000644200608702639, 'total_history': 0.0002697637996803167, 'to_deal_with_this_pandemicKeywords': 0.0038806204677737646, 'tempo_mdio': 9.148819220060914e-58, 'come§aram': 9.148819220060914e-58, 'Pneumopatiasepidemiologia_SARSCoV2': 9.148819220060914e-58, 'por_coronav\\xadrus': 9.148819220060914e-58, 'SARSCoV22_Huang_al': 0.0005612913089309412, 'Chinese_Center': 0.0014616190772430405, 'OBJECTIVETo_ _describe_ _epidemiological_ _and_ _clinical_ _features_ _of_patients_ _with_ _confirmed_ _infection_ _by_ _SARSCoV2_diagnosed_ _and_ _treated_ _at_ _Hospital_ _Israelita_ _Albert_Einstein_ _which_ _admitted_ _the_ _first_ _patients_ _with_ _this_condition_in_Brazil_\\x9d\\x9a': 0.0018006682651940404, 'OBJECTIVETo': 0.0005373063242131615, 'laboratorial_information': 0.0014616190772430405, 'records_laboratorial_information_Teich_VD_Almeida_AC_Laselva_CR_MG_Berwanger_Cendoroglo_Neto_Meinstein': 0.0014616190772430405, 'Teich_VD_Almeida_AC_Laselva_CR_MG_Berwanger_Cendoroglo_Neto_Meinstein': 0.0014616190772430405, 'treatment_measures': 4.919501744246771e-07, 'analysis_to_ _be_ _descriptive_ ': 3.0144376254154353e-05, 'LOS': 0.001129870936471824, 'to_ _be_ _descriptive_ ': 0.00015955002081907, 'laboratory_facilities': 0.001845170519318405, '±_patients_care_myalgia_arthralgia': 0.001845170519318405, 'continueCharacteristicAntidiabeticPain': 0.0007956673215405282, 'distribution_ESI': 3.0136345382509326e-05, 'Radiologic_findings': 9.148819220060914e-58, 'Abnormalities': 9.148819220060914e-58, 'mmolL_Results_admission_lymphocytopenia': 0.0008522036149147152, 'indicatedCT_computer_tomography': 9.148819220060914e-58, 'rangeleukopenia': 9.148819220060914e-58, 'care_therapy': 0.0002307607641150719, 'care_mean': 0.001845170519318405, 'to_determine_severity_of_illness': 0.00210348072096923, 'that_ _diagnostic_ _algorithms_ _using_ _fever_ _for_testing': 0.0010298344840079976, 'care_accounting': 6.540662732794284e-05, 'ICU7The_majority': 1.0667734098177236e-06, 'replacement_therapy': 0.0003833771411240826, 'to_deal_with_this_pandemic_\\x9d\\x9a': 0.0038806204677737646, 'CONTRIBUTION': 0.0007959416758056306, 'exactness_completeness': 0.0007959416758056306, 'AUTHORS\\x99_INFORMATIONTeich_VD': 9.148819220060914e-58, 'CW_YW_Outbreak': 9.148819220060914e-58, 'Baseline_characteristics_outcomes': 9.148819220060914e-58, 'WHO_guidance': 9.148819220060914e-58, 'DF_Ministrio_da_Saºde_citado': 9.148819220060914e-58, 'em_httpswwwsaudegovbrimagespdf2020marco2929COVIDpdf_Young': 9.148819220060914e-58, 'biomarker_Tumor_mutation': 0.0005828796252635297, 'ORR_factors_use_link': 0.0002768434257340561, 'Biomarker_Research_Page_variety': 0.000498273905934873, 'monitoringefficacy_disease_development': 1.4055400435083294e-53, 'to_read_and_include_all_therelevant_s': 0.007713134335009549, 'beinvolvedAdvances': 9.148819220060914e-58, 'Tumor_genome_neoantigen_biomarkersTumor_mutation': 9.148819220060914e-58, 'Network_NCCN_guidelines': 9.148819220060914e-58, 'TMBas_test_HPVpositive_HNSCC': 9.148819220060914e-58, 'respondersand': 9.045569613289207e-05, 'studies_American_Society': 0.0005865071468874085, 'theUS_Administration_FDA': 3.547576260046241e-07, 'CDx_panel': 2.5226418651023156e-05, 'NGSpanels': 1.715676556058368e-07, 'to_estimate_TMB': 0.004315547045054443, 'durableclinical': 0.0004033468197677982, 'NGS_panel': 9.148819220060914e-58, 'isstill': 9.148819220060914e-58, 'bTMB': 9.148819220060914e-58, 'to_differentiate_patients_with_OS_benefits_researchers_consider_the_need_toexplore_other_more_precise_factors_eg_allele_frequencyAF_A_study_that_developed_a_new_bTMB_algorithm_intwo_independent_cohorts_POPLAR_and_OAK_showedthat_modified_bTMB_low_AF_bTMB_LAFbTMB_mutation_counts_with_an_AF_  _was_significantly_associated_with_favorable_HR_  _95CI_\\x93_p_ _PFS_HR_  _95CI_\\x93_p_  _andORR': 9.148819220060914e-58, 'mutation_counts': 0.0019127833147525456, 'TMBNSCLCs': 0.00012873717907987224, 'aberrance_CNVs': 2.842146881592359e-06, 'to_produce_threetimes_more_candidate_neoantigens_per_mutation_thannonsynonymousnsSNVs': 8.263922883666513e-55, 'pathwaysGenetic_variation_pathway': 0.0004024603399562249, 'TMB_OS': 0.001845170519318405, 'HRR_MMR_HRR_BER': 0.0005915726387590047, 'Comutpatients': 9.148819220060914e-58, 'ORR_longer_PFS_OS': 9.148819220060914e-58, 'inactivating_mutations_in_a_mammalian_analog_of_the_chromatin_remodeling': 0.0009466755491730313, 'Pbrm1deficient_murine_melanomas': 0.0038806204677737646, 'confirmedin': 0.00023318672782142425, 'editing_adenosine_deaminase': 4.0351838843229717e-07, 'IFNÎ³_signalingpathway': 6.583030809327546e-09, 'IFNÎ³_signalingpathway_editing': 6.583030809327546e-09, 'demethylation': 0.0007008712380191807, 'to_be_associated_withreduced_response_rates_to_ICIs_and_low_TMB': 0.000598820003809177, 'firstline_ICIstreatment': 1.715676556058368e-07, 'types_ARID1A': 3.1260447342280273e-06, 'NOTCH_mutation': 5.107302598749379e-05, 'NOTCH_pathway': 8.337795325564524e-07, 'retroviruses_ERVs_Pancancer': 0.0006810685397702696, 'to_identify_thepossibly_effective_ones_For_example': 0.001130172108569446, 'withanalysispemigatinib_therapy_FDA_approval': 3.0136343241812733e-05, 'neoantigen_predictionshave': 0.0004694385672555256, 'DAI': 9.148819220060914e-58, 'TMB_neoantigenload': 9.148819220060914e-58, 'detection_forneoantigen': 8.263922883666513e-55, 'Neopepseealgorithm': 1.1686951820486561e-54, 'aspeptides_genomes_study': 8.263922883666513e-55, 'benefit_population': 0.00042644740830607715, 'PDL1': 0.0019216107861501099, 'Immuneinflamed': 0.0005269923949341242, 'abundance_T_cells': 6.576796517606881e-06, 'theabsence_response': 0.0003247463263852347, 'superiority_valueof_immunoscore': 3.747801148684578e-05, 'Analysisof': 9.148819220060914e-58, 'RNA_genes': 9.148819220060914e-58, 'Ascierto': 9.148819220060914e-58, 'morethan_genes': 9.148819220060914e-58, 'IFNÎ³_scores': 0.0024992904616399536, 'sequencingscRNAseq_data_analysis': 0.0019127833147525456, 'furtherfound': 9.148819220060914e-58, 'response_survival': 9.148819220060914e-58, 'fact_study': 0.00013677751800091927, 'glycan_ofthe_drug_FcÎ³_receptor_FcÎ³R': 0.000704362469235278, 'toPD1_inhibitor_resistance': 0.0038806204677737646, 'inmelanoma_cohorts': 0.0006750162805663558, 'to_be_complex_with_some_studies_finding_apositive_correlation_between_TIL_clonality_and_the_response_to_ICIs_before_[': 1.1050419114748406e-05, 'whetherbaseline_TILs': 9.148819220060914e-58, 'receptor_TCR_repertoire_density_theimmune_repertoire_TCR_clones_T_cells': 9.148819220060914e-58, 'usage_population': 1.0384562968726982e-06, '10times_increasein': 1.0384562968726982e-06, 'IRindex': 8.263922883666513e-55, 'activation_expression': 1.1686951820486561e-54, 'Biomarker_Research_Page': 9.148819220060914e-58, 'value_cohorts': 9.148819220060914e-58, 'viewpoints': 0.0004347496547523664, 'to_be_further_validated_in_a_large_patient_populationiiiLiquid_biopsy_biomarkersPeripheral_blood_cell_biomarkersPeripheral': 7.091762252655221e-06, 'OS_PFS': 0.004316696915208163, 'FoxP3Treg_concentratreatmenttions_counts': 4.163091622378127e-06, 'ORR_PFS': 0.00025094954260364283, 'relativeabsolute_eosinophil_counts_lymphocyte_counts': 7.069126239207944e-05, 'CTLA4': 0.00042098041381652033, 'TERTpmut': 0.0005707090386207647, 'TERTp_variants': 0.00856417769670554, 'TERTp': 1.1686951820486561e-54, 'c1124_C_T_C_T': 8.263922883666513e-55, 'TERTpdup': 0.000677749688271323, 'Etwentysix_transcription': 1.1052826975796829e-05, 'T_hotspot': 0.0038806204677737646, 'Correspondence_cristinamecucciunipgit_robertalastarzaunipgit_Mecucci_Roberta_La_Starza': 0.00210348072096923, 'TERTp146_base': 8.263922883666513e-55, 'bp': 1.1686951820486561e-54, 'CNS_tumors': 0.004315547045054443, 'TERTp_mutations_amplification_gain': 0.0004202357087063657, 'cIMPACT_Update': 9.148819220060914e-58, 'to_ _use_ _one_ _of_ _these_ _molecular_ _criteria_to_ _classify_ _this_ _subgroup_ _of_ _astrocytomas_ _as_ _\\x9cdiffuse_astrocytic_ _glioma_ _IDHwildtype_ _with_ _molecular_ _features_ _of_ _glioblastoma_ _WHO_ _grade_ _IV\\x9d_ _and_ _to_ _revise_the_classification_of_DAAA_IDHwt': 9.148819220060914e-58, 'different': 0.0002589664773973477, 'TERT_transcription': 0.001388599458763146, 'Committee_University': 0.0019127833147525456, 'pleomorphism': 0.0011125787591309202, 'Hotspot_TERTpmut': 1.3419031271107524e-05, 'alignments_analyses': 9.148819220060914e-58, 'Clustal_Ensembl_Omega_httpwwwensem': 9.148819220060914e-58, 'affinity_number': 9.148819220060914e-58, 'to_define_the_statistically_ _significant_ _changes_ _induced_ _by_ _TERTpmut_ ': 9.148819220060914e-58, 'CORE': 0.0010068765747081726, 'TERTp_TERTp146': 0.007713134335009549, 'JASPAR': 2.274211562945482e-53, 'to_analyze_two_TERTpdup_ _which_ _have_ _been_ _previously_ _reported_ _in_ _a_ _case_ _of_MDS_c1110_1101dup': 1.4055400435083287e-53, 'Venn_diagram_probability_a0et': 0.007713134335009549, 'study_luciferase_assayTo_study': 0.001128162151175775, 'TERTp124_UPN216': 8.263922883666513e-55, 'TERTpmut_constructs': 9.148819220060914e-58, 'Invitrogen_Milan_Italy': 9.148819220060914e-58, 'control_Luciferase_assay': 9.148819220060914e-58, 'using_ _the_ _GBM_U87MG_ _cell_ _line_ _maintained_ _in_ _Dulbecco\\x99s_ _Modified_Eagle_Medium_Thermo_Fisher_Scientific_Monza_Italy_with_   _fetal_ _bovine_ _serum_ _and_   _streptomycinpenicillin_at_a0_°_C5_ _CO2_U87MG_cells_were_seeded_in_ _a_ _6multiwell_ _plate_  _\\x97_  _cellsml_ _cotrasfected_with_ _a0_µg_ _of_ _modified_ _pGL410[luc2_]_ _plasmids_ _and_with_   _of_ _pGL474[hRlucTK': 9.148819220060914e-58, '24h_incubation_cells': 8.263922883666513e-55, 'using_DualGlo_Luciferase_assay_kit_ _Promega_ ': 1.1686951820486561e-54, 'fluorescence_emission': 8.263922883666513e-55, 'cancersangeracukcosmic': 7.216962324342707e-05, 'site_absence': 1.1772528918956057e-06, 'UPN131In_silico_analysis': 9.148819220060914e-58, 'site_absence_origin': 9.148819220060914e-58, 'TERTp124_TERTp146': 9.148819220060914e-58, 'to_increase_the_binding_affinity_for_ _and_ _sites_and_to_enhance_the_probability_of_binding_for_ _and_ _TFs': 9.148819220060914e-58, 'ETS_group': 0.0003373197309518599, 'file_a0_Table_Venn_diagram': 8.263922883666513e-55, 'TERTp_mutations': 0.0007080023910910008, 'files_Tables_S7_S8': 1.4055400435083287e-53, 'files_Tables_S9_S10': 2.274211562945482e-53, 'increase_TERTp124': 0.0003736388273348608, 'gainoffunction_mutations': 0.000530061173243405, 'start_point': 4.547506802907892e-06, 'TERT_remodeler_ATRX_genes_regulator': 0.000598820003809177, 'a0_bp': 0.004315547045054443, 'these_new_TERTdup_affect_the_transcriptional_regulation_of_the_gene_through_the_creation_of_new_binding_sites_for_TFs_that_mainly_belong_to_the_ETS_family_Fig_a02c_Additional_file_a0_Table': 2.2673179907113364e-05, 'TERTdup': 9.148819220060914e-58, 'regulation_file_a0_Table': 9.148819220060914e-58, 'to_ _assess_ _the_ _possible_ _interrelationship_ _between_ _the_ _four_ _diverse_ _TERTp_ _mutations_ _using': 0.007713134335009549, 'to_ _share_ _an_ _increase_ _binding_ _capacity_ _for_  _ETS_members': 0.0001399919041947769, 'Table_a0S8': 9.148819220060914e-58, 'TERTp146': 9.148819220060914e-58, 'GABPA_oncogene': 0.0038806204677737646, 'to_act_as_a_putative_oncogene_in_GBM_ _favoring_ _cell_ _infiltration_ _in_a0_vitroin_ _vivo_ _models': 0.004315547045054443, 'TERTp146_variants': 0.0010068765747081726, 'latters': 0.0003402493734878284, 'Fig_Venn_diagrams': 9.148819220060914e-58, 'S11IDHwildtype': 9.148819220060914e-58, 'IV\\x9d': 4.98030979413283e-05, 'TERTp_variants_UPN131_UPN171': 0.007713134335009549, 'to_be_ _0cPierini_a0et': 0.00014169599163553216, 'files_definition': 0.00010326217625457773, 'to_ _enrich_ _the_ _spectrum_ _of_recurrent_ _somatic_ _TERTpdup_ _variants_ _reporting_ _for_the_first_time_two_new_gainoffunction_mutations_ie_TERTp10079': 1.6847930232954353e-06, 'codeletion': 9.148819220060914e-58, 'gliomas': 9.148819220060914e-58, 'Table_a0S2Samples': 3.862536298193456e-05, 'Table_a0S3_Primer': 9.148819220060914e-58, 'used_to_create_constructs_for_luciferase_assay_Additional_file_a0_Table': 9.148819220060914e-58, 'JASPAR_analysis': 1.6305647145567253e-06, 'a0S7_Transcription_Factors': 9.148819220060914e-58, 'to_be_involved_in_TERTp_variants': 9.148819220060914e-58, 'a0S8_Transcription_Factors': 9.148819220060914e-58, 'to_be_involved_in_different_TERTp_variants_Additional_file_a0_Table_a0S9_JASPAR_analysis_for_the_two_published_TERTp_duplications': 9.148819220060914e-58, 'ref_Transcription_factors': 9.148819220060914e-58, 'to_be_involved_in_the_ _TERTpdup': 9.148819220060914e-58, 'ref_a0S11_Transcription_factors': 9.148819220060914e-58, 'to_be_involved_in_all_TERTp_duplications_Additional_file_a0_Table_a0S12': 9.148819220060914e-58, 'oligodendroglioma_DA': 9.148819220060914e-58, 'astrocytoma_AA_a0et': 9.148819220060914e-58, 'glioblastoma_IDHwildtype_DA_IDHwt': 9.148819220060914e-58, '0cPierini': 9.148819220060914e-58, 'committee_CEAS_code_number': 0.00028081729389583404, 'paper_TP': 0.001129870936471824, 'CN': 0.001129870936471824, 'FP_VN_PG': 0.001129870936471824, 'PG_SA_MEL': 9.148819220060914e-58, 'diagnosis_tissue_sections': 9.148819220060914e-58, 'FundingThe_project': 9.148819220060914e-58, 'Comitato': 9.148819220060914e-58, 'files]Ethics_approval_consent': 4.578052027174547e-06, 'factor_GABP': 0.00042097647704806597, 'TERT_promoter_criteria': 6.869136554428337e-06, 'TERT_promoter': 6.869136554428337e-06, 'Glioma_groups': 6.7152291504068095e-50, 'casefor_presentation': 0.007713134335009549, 'mastectomyof': 3.4006139395373004e-05, 'chemotherapy_endocrinetherapy': 3.4006139395373004e-05, 'endocrine_therapy': 6.989110961770699e-05, 'DIEP_flap': 2.253096700536861e-05, 'nipple': 3.7479930562956964e-06, 'DIEP_flap_malignantfindings': 6.12652606104177e-08, 'nipple_carcinoma': 9.985453216555777e-10, 'MRI_tomography': 9.148819220060914e-58, 'malignantfindings': 9.148819220060914e-58, 'Pathologicalfindings': 0.0002812637223256724, 'mastectomy': 0.004988160690957966, 'trauma': 9.148819220060914e-58, 'micrometastases': 9.148819220060914e-58, 'cyclesof': 8.770946583746331e-05, 'Vshaped_resection': 6.124893511846658e-08, 'nipple_erosion': 7.600205644894206e-05, 'nipple_lesion': 8.263922883666513e-55, 'erosion': 0.00022962142610989672, 'Scrape_cytology': 7.91843250950269e-05, 'theright_nipple_carcinoma': 7.91843250950269e-05, 'treatmentThough': 0.007964848274023877, 'closedwith': 0.0002812637223256724, '4a_Pathologicalexamination': 0.0002812637223256724, 'reconstruction_ABR': 9.148819220060914e-58, 'nippleareola_NAC_reconstruction': 9.148819220060914e-58, 'erosion_marginal': 0.00036300091156384084, 'strongpositive': 0.00027573473885584285, 'Tilldate_report': 1.6296587701099264e-05, 'disease_carcinoma': 0.00045085371770963703, 'novo_carcinoma': 9.148819220060914e-58, 'lesion_similarto_to_develop_from_the_epithelia_of_terminal_duct_lobular_units_TDLUs_includingcases_of_in_situ_and_invasive_carcinomas_TDLUs_usuallyexistin_distal_mammary_glands_through_a_series_ofbranches': 9.148819220060914e-58, 'donor_nipple': 9.148819220060914e-58, 'lesion_similarto': 9.148819220060914e-58, 'to_develop_from_the_epithelia_of_terminal_duct_lobular_units_TDLUs_includingcases_of_in_situ_and_invasive_carcinomas_TDLUs_usuallyexistin_distal_mammary_glands_through_a_series_ofbranches': 6.124893511846658e-08, 'TDLUs': 0.0003566367105840476, 'epithelialproliferation': 5.821654628633252e-06, 'mastectomies_onlytwo_patients': 3.0608233335642203e-06, 'infiltration_growth': 0.0001788354435343705, 'sheetlike_acinar_growth_patterns': 0.0001923205957753865, 'hereHER2_positivity': 9.148819220060914e-58, 'nipple_mass': 9.148819220060914e-58, 'Inour_case_patient': 9.148819220060914e-58, 'pagetoidspread': 9.148819220060914e-58, 'contrast_scrape_cytology': 0.0002812637223256724, 'thenipple_surface': 0.0011125787591309202, 'review_failedto': 8.79715916165841e-05, 'NAC_surgery': 0.00021921962201374475, 'tumors_stroma': 0.00016343501035482602, 'signalingcascades': 0.004315547045054443, 'Hypoxia': 8.263922883666513e-55, 'oncogenicchanges': 0.00043975773664194475, 'nipplewas': 6.124893511846658e-08, 'donor_tissue_timing': 0.0004360097354757312, 'stressors': 7.112492206702588e-06, 'to_monitor': 0.007713134335009549, 'imagingNAC_YokohamaJapan_5Department': 0.0002277800506641863, 'Terminalduct_unitAcknowledgementsWe': 9.148819220060914e-58, 'to_thank_Editage_wwweditagecom_for_English_languageeditingConsent_to_participateThis_study': 9.148819220060914e-58, 'cancer_surgery_whicharose': 3.717476748010337e-06, 'KN': 9.148819220060914e-58, 'TSperformed': 9.148819220060914e-58, 'surgery_operations': 0.00022771936739542464, 'HSSI_MM_SA_AY_KS_YI': 1.2990978528579814e-05, 'manuscript_cancer_surgery_whicharose': 0.0007961537877135015, 'MA_Brock_JE_Harrison_BT_Wieczorek': 0.0004968127217041802, 'Cucin_RL_Gaston_JP_Case': 9.148819220060914e-58, 'implantation_plea': 9.148819220060914e-58, 'theimplications_101038s41392020002598INTRODUCTIONIn_Johnson': 0.007713134335009549, 'melanoma_antigen': 7.069126239207944e-05, 'aliasnames': 7.069126239207944e-05, 'forms_CD146': 1.1686951820486561e-54, 'formation_ligands_kinases_proteins8_Abnormalexpression': 8.263922883666513e-55, 'sCD146': 9.148819220060914e-58, 'cell_cellCAM': 9.148819220060914e-58, 'providesignals_for': 0.00025761770367047364, 'ligands_kinases_proteins8_Abnormalexpression': 8.263922883666513e-55, 'sCD146_itsligands_functions': 0.007713134335009549, 'CD146may_act': 0.007713134335009549, 'CD146_protein': 9.148819220060914e-58, 'CD146lhas_domains_cytoplasmic_tail21': 9.148819220060914e-58, 'tail1718': 0.0003531322339906675, 'CD146_isoforms': 9.148819220060914e-58, 'exon_splicing_strategies': 9.148819220060914e-58, 'recognition_sites_China_2College': 0.00010908077636851838, 'Zhaoqing_Wang': 0.00010908077636851838, 'CD146glycosylation': 9.148819220060914e-58, 'b16Nacetylglucosaminyltransferase3': 9.148819220060914e-58, 'melanomas_Suchglycosylations': 9.148819220060914e-58, 'stability_upregulateCD146_protein_levels': 9.148819220060914e-58, 'CD146': 0.0003979211411415263, 'inmajority': 6.494534518410917e-06, 'CD146_expression': 9.148819220060914e-58, 'tissues_strength': 9.148819220060914e-58, 'wideexpression_patterns': 0.0038806204677737646, 'thatCD146': 0.0002892179326628974, 'CD146mediated_adhesion': 0.0003377049630876618, 'CD146\\x99s_ligand': 9.148819220060914e-58, 'using_chickensmooth_muscle_cells': 9.148819220060914e-58, 'forIn': 3.683951335427423e-07, 'receptor_VEGFR2': 6.494534518410917e-06, 'PDGFBPDGFRÎ²': 0.0005218289698578611, 'mesenchymaltransition_EMT_attachment': 0.002040280956207747, 'laminin': 0.0005341454593270934, 'tissues_blood_vesselsnerves': 8.709257420760027e-06, 'blood_vesselsnerves': 8.709257420760027e-06, 'ECM': 6.253546940592786e-06, 'theirsurrounding_ECM': 1.1686951820486561e-54, 'speciï¬\\x81c_manner_byalmost': 8.263922883666513e-55, 'laminin_chain': 9.148819220060914e-58, 'speciï¬\\x81c_manner': 9.148819220060914e-58, 'byalmost': 8.263922883666513e-55, 'Laminin': 7.292596415800973e-05, 'endothelium687375This_laminin_isoform': 7.290653383518817e-05, 'asa_speciï¬\\x81c_ligand': 1.1894913851508839e-06, 'entertissues': 9.148819220060914e-58, 'puriï¬\\x81ed_Laminin': 9.148819220060914e-58, 'puriï¬\\x81ed_CD146Fc': 8.263922883666513e-55, 'toLaminin': 1.1686951820486561e-54, 'thatthis': 8.263922883666513e-55, 'CD146_puriï¬\\x81ed_Laminin': 0.0007959416758056306, 'haveanticancer_activity': 0.0018006682651940404, 'lamininsof': 9.148819220060914e-58, 'blood_lymphaticvessels_stroma84\\x93To': 9.148819220060914e-58, 'laminin_chains': 0.0013882295497307361, 'Î±4laminins': 0.004315547045054443, 'cancers_blocking': 0.00022128502836857812, 'metastasisGalectin1_CD146': 3.6068173645753186e-06, 'CAM': 9.148819220060914e-58, 'lactoseGalectins': 9.148819220060914e-58, 'Sequence_analysis': 0.0001360596895686607, 'residues': 5.511247513941373e-06, 'withgalectins_binding': 9.005360128245084e-08, 'Galectin1_0cCD146': 3.7711607362685093e-06, 'therapy9192_mechanisms': 9.148819220060914e-58, 'interfering_with_drug_efï¬\\x81cacydelivery_or_reducingthe_antitumor_effect_of_immune_cells_For_instance_Galectin1confers_drug_resistance_via_inducing_the_expression_of_multidrugresistance_protein_ _which_in_turn_helps_tumor_cells_to_pump_outcytotoxic_drugs_facilitating_cancer_cells_to_combat': 9.148819220060914e-58, 'tumor_clearance94Galectin3': 1.1686951820486561e-54, 'IFNÎ³': 8.263922883666513e-55, 'antiPD1': 8.263922883666513e-55, 'CD146_galectins': 9.148819220060914e-58, 'IFNÎ³_antiPD1': 9.148819220060914e-58, 'prefers': 0.0001537775005421378, 'thatGalectin1Galectin1': 9.148819220060914e-58, 'to_bind_with_the_branched_Nglycans_of_cellsurface_glycoproteins_and_mediates_a_glycosylationdependentangiogenesis91100\\x93increasedsecretion_of_Galectin1_in_the_ECM': 9.148819220060914e-58, 'Galectin1': 9.148819220060914e-58, 'toCD146_survival107': 9.148819220060914e-58, 'thattheinteraction': 0.00028569540831235814, 'Yazawa_thusfurther': 0.0006992128660964839, 'features108': 0.00210348072096923, 'expressionidentity_function': 0.0007959416758056306, 'expressionidentity_function_perspective': 0.0007959416758056306, 'development_oftherapies': 9.148819220060914e-58, 'to_prevent_tumor_progression': 9.148819220060914e-58, 'tumors_receivecontinuedglycosylationdependentGalectin1receptorsuch': 0.00022122606240763297, 'cell\\x93cell_communications': 0.00210348072096923, 'to_havehigher_concentrations_of_circulating_Galectin3_than_those_withonly_localized_tumors121_Increased_circulating_Galectin3': 0.00018750364596568773, 'et_alreceptorto': 9.148819220060914e-58, 'to_havehigher_concentrations_of_circulating_Galectin3_than_those_withonly_localized_tumors121_Increased_circulating_Galectin3_molecules': 9.148819220060914e-58, 'to_Nlinkedglycans_on_CD146': 7.417164383651313e-53, 'CD146_dimerization_andsubsequent_activation_suppression': 7.417164383651313e-53, 'thatGalectin3': 0.0007959416758056306, 'understandingof': 0.00015319874332371669, 'endothelial_galectins': 9.148819220060914e-58, 'thatGalectin3_understandingof': 9.148819220060914e-58, 'Thesegrowth_factors': 0.0015403772258027757, 'ofglycoconjugates': 9.148819220060914e-58, 'processes_inangiogenesis_levels': 9.148819220060914e-58, 'proteinsIn_humans': 0.0005215586792733971, 'EFhand_calciumbindingmotifs': 0.0038806204677737646, 'homodimers_asheterodimers_trimers_tetramers_proteins_family_members': 1.198238415621029e-05, 'extracellularfunctions134135_Upregulation': 0.0005215586792733971, 'cellsurfacereceptors': 9.148819220060914e-58, 'S100': 9.148819220060914e-58, 'signaling_is_lacking_and_howS100_protein_secretion_is_dynamically_regulated_in_biologicalprocesses': 9.148819220060914e-58, 'to_require_the_release_ofThe_secreted_S100A8A9_proteins_are_theS100A8A9_heterodimer\\x82ammatorybest': 9.148819220060914e-58, 'itself156157': 4.320389861152695e-05, 'upregulatedS100A8A9': 0.0016810521528134112, 'prognosis168S100A8A9_proteins': 0.0010068765747081726, 'Hiratsuka': 9.148819220060914e-58, 'thatlung_S100A8A9': 9.148819220060914e-58, 'primarytumor': 0.0006114020353250768, 'TGFÎ²_VEGFA': 1.1686951820486561e-54, 'lungs26178': 8.263922883666513e-55, 'expression_secretion': 8.263922883666513e-55, 'S100A8A9': 0.0015912094964870874, 'metastasis_lung_S100A8A9': 0.0004254422540019666, 'authorsconclude_S100A8A9': 9.148819220060914e-58, 'role_step': 9.148819220060914e-58, 'S100A8A9CD146': 2.6639512501173265e-05, 'liver_bone_sites': 0.00019822037502218665, '\\x9cseed_soil\\x9d_theory179': 0.00023078931020485309, 'actsas_cytokine': 0.0006674076661460604, 'EMTinducer_ZEB1': 0.0003247463263852347, 'signalingprocesses_thatCD146': 2.59727244230626e-05, 'stemprogenitor_NSP': 0.0015842910551982499, 'In_ _the_directbinding_between_brain_endothelial_CD146_and_NSP_matriptase_wasidentiï¬\\x81ed_to_be_involved_in_the_direct_endotheliaNSP_contact189Such_binding': 9.148819220060914e-58, 'downstream_cascades_inCD146endothelia': 9.148819220060914e-58, 'ramucirumab_cabozantinib_checkpoint_inhibitors': 8.787900985651322e-05, 'ICIsOver_combination_therapies': 0.00011291471971619839, 'promise_to_develop_additional_novel_therapeutic_agents_which_could_potentiallyaugment_the_presently_available_options_and_understand_the_underlying_mechanisms_responsible_for_drug_resistance_with_the_goalof_improving_the_survival_of_patients_with_HCCSignal_Transduction_and_Targeted_Therapy_     _101038s4139202000264xINTRODUCTIONPrimary_liver_cancer_remains_a_major_problem_for_all_health_caresystems_worldwide_and_is_associated_with_a_significant_clinicaleconomic_and_psychological_burden_Hepatocellular_carcinomaHCC_accounts_for_ _of_cases_of_nonmetastatic_tumors_of_theliver1': 1.8425047906932888e-06, 'to_develop_additional_novel_therapeutic_agents_which_could_potentiallyaugment_the_presently_available_options_and_understand_the_underlying_mechanisms_responsible_for_drug_resistance_with_the_goalof_improving_the_survival_of_patients_with_HCCSignal_Transduction_and_Targeted_Therapy_     _101038s4139202000264xINTRODUCTIONPrimary_liver_cancer_remains_a_major_problem_for_all_health_caresystems_worldwide_and_is_associated_with_a_significant_clinicaleconomic_and_psychological_burden_Hepatocellular_carcinomaHCC_accounts_for_ _of_cases_of_nonmetastatic_tumors_of_theliver1': 8.513575047858228e-06, 'thesepatients_systemic_therapy': 0.0005479687540571566, 'roleand_potential': 0.0005479687540571566, 'to_facilitate_substantial_progress': 0.0038806204677737646, 'FIRSTLINE_AGENTS': 9.148819220060914e-58, 'approvalof_sorafenib': 9.148819220060914e-58, 'dovotinib14': 0.0038806204677737646, 'inhibitors_ICIs_tosorafenib': 0.0038806204677737646, 'end_points': 6.918627002654179e-05, 'antitumoreffects': 3.2261538207425514e-05, 'HCCs': 9.148819220060914e-58, 'surgery24\\x93_therapies': 9.148819220060914e-58, 'zhoujianzshospitalshcnThese_authors': 9.148819220060914e-58, 'Ao_Huang_XinRong_YangReceived': 9.148819220060914e-58, 'alFirstlineSorafenibSharpAsiaPacificCediranibNCT00427973SunitinibNCT0069937BrivanibBRISKFLLinifanibNCT01009593NintedanibNCT01004003DovitinibNCT01232296ATEZOBEVGO30140IMbrave150LenvatinibREFLECTPEMLENKEYNOTE524NivolumabCheckMate459DonofenibChina_SecondlineBrivanibBRISKPSEverolimusEVOLVE1AxitinibNCT01210495RamucirumabREACHRegorafenibRESORCENivolumabCheckMate040PEMKEYNOTE224TivantinibMETIVHCCS1SCUBEPEMKEYNOTE240CabozantinibCELESTIALRamucirumabREACH2NIVIPICheckMate040CAMChinaApatinibChinaFig_Overview_IPI': 9.148819220060914e-58, 'theinvestigation_EGFEGFR_pathwayinhibitors_HGFcMet': 9.148819220060914e-58, 'gemcitabine_oxaliplatin_GEMOX3637_gemcitabinealone38': 1.487722587505902e-06, 'III_trialsSince_sorafenib_TACE': 9.11964579718389e-05, 'survivalbeneï¬\\x81t': 0.00029599327620783605, 'that_the_addition_of_sorafenib_did_not_confer_any_survivalbeneï¬\\x81t_in_patients_with_unresectable_HCCs_who_had_alreadyresponded_to_TACE41_Contrasting_with_these_ï¬\\x81ndings_retrospective_studies_from_China': 9.148819220060914e-58, 'therapywith_sorafenib_OS': 9.148819220060914e-58, 'PFS_sorafenibcompared': 0.00035730068962257737, 'redeï¬\\x81ned_PFS': 0.00035730068962257737, 'He_et_al65': 9.148819220060914e-58, 'thatsorafenib_HAIC': 9.148819220060914e-58, 'studies6667': 0.0038806204677737646, 'HAIC': 0.00035730068962257737, 'modiï¬\\x81cation_ratesshort_treatment_durations_enrollment': 0.0010327967928462102, 'itfailed': 1.6855732572917737e-05, 'tosorafenib': 0.0011075402231842013, 'Far_East': 9.148819220060914e-58, 'patientswith_HCCs': 9.148819220060914e-58, 'positiveSorafenib': 9.148819220060914e-58, 'tumor_recurrence': 9.148819220060914e-58, 'treatment_followinghepatectomy': 9.045569613289207e-05, 'hepatectomy': 0.0011075402231842013, 'andrecurrencefree_survival': 3.2261538207425514e-05, 'stratiï¬\\x81cation': 3.887758198881266e-05, 'to_evaluate_the_role_of_sorafenib_inpatients_with_MVI_following_radical_resection': 4.9041707996457254e-08, 'decade': 0.002104041233387171, 'intensity_RDI': 0.00017731000520225518, 'to_achieve_agood_therapeutic_effect': 1.3323160608155145e-05, 'todiscontinue': 0.0011075402231842013, 'sorafenibsensitive': 9.148819220060914e-58, 'activity_attempts': 9.148819220060914e-58, 'Yoo_et_al99': 0.0006313632619292757, 'to_be_effective_in_patients_with_HCCrecurrence_following_liver_transplantation_with_a_median_OS_ofregardless_ofSignal_Transduction_and_Targeted_Therapy_    _Targeted_therapy_for_hepatocellular_carcinomaHuang': 3.5520460160053994e-05, 'demonstration': 0.0006313632619292757, 'hypertension_PHT_acuteadministration': 9.148819220060914e-58, 'haemodynamics': 9.148819220060914e-58, 'trial_cabozantinib': 9.148819220060914e-58, 'primaryendpoint': 9.148819220060914e-58, 'costeffectivenessof': 8.192622784358272e-05, 'sequentialtreatment': 6.184359078312274e-06, 'treatment_option': 0.00210348072096923, 'IgG1_monoclonalantibody': 9.148819220060914e-58, 'VEGF2_receptor': 9.148819220060914e-58, 'AFPenriched_HCCs': 9.148819220060914e-58, 'significantactivation': 9.148819220060914e-58, 'mechanism_ofaction': 0.0038806204677737646, 'cohort_studyadvanced_HCC_refractory': 9.148819220060914e-58, 'safety_efï¬\\x81cacy': 9.148819220060914e-58, 'signiï¬\\x81cance_ofimproved_PFS_OS': 0.00038868156652095183, 'underway': 0.0022164771778134156, 'multicenter_phase': 0.00035730068962257737, 'treatment_HCC': 0.0004788000636220941, 'to_achieve_its_endpoints_ESMO_ _butnivolumab': 7.813145375312333e-06, 'whose': 1.1686951820486561e-54, 'HBVHCV': 8.263922883666513e-55, 'hepatitis_CamrelizumabSHR1210': 8.263922883666513e-55, 'to_have_antitumor_activity_in_previouslytreated_Chinese_patients_with_advanced_HCC_in_a_multicenteropenlabeltrialNCT02989922130_providing_evidence_for_the_effectiveness_ofPD1_therapy_for_HBV_related_HCC_in_Chinese_patients': 0.0005915726387590047, 'resultsICIs': 9.148819220060914e-58, 'resultsand': 9.148819220060914e-58, 'thatHCClenvatinib_regorafenib': 0.0016810521528134112, 'cancer_immunity': 0.0016810521528134112, 'results_atezolizumab_bevacizumab': 0.00024152081240079936, 'effectwhich': 0.00047983738574547787, 'atezolizumab_bevacizumab': 1.715676556058368e-07, 'breakthrough_therapy': 1.4055400435083287e-53, 'promisingresults': 2.274211562945482e-53, 'Galunisertib_effects_number_hepatitis_pneumonitis_myocarditisendocrine_glands_arthritis_arthralgiamyositis': 0.0016489412033307868, 'thatatezolizumab': 0.0038806204677737646, 'Galunisertib': 0.0016480626375926124, 'events_IRAEs': 2.6916426852543886e-05, 'besignificant140_Activation': 2.6916426852543886e-05, 'effects_number': 0.0016480626375926124, 'hepatitis_pneumonitis_myocarditisendocrine_glands_arthritis_arthralgiamyositis': 0.0016480626375926124, 'antitumorPromising_agents_treatment': 0.00018159201441078236, 'attention_investigation': 0.00038054170435993304, 'occured149150': 0.0002517139390143281, 'Combination_therapy': 9.148819220060914e-58, 'TACE': 9.148819220060914e-58, 'heterogeneousnature': 9.148819220060914e-58, 'ï¬\\x81rm_conclusions_recommendations': 9.148819220060914e-58, 'ISecond_Regorafenib_responseaTrials': 9.148819220060914e-58, 'patientsTable_Trials': 9.148819220060914e-58, 'anlotinib_evidence': 9.148819220060914e-58, 'promise_supports': 9.148819220060914e-58, 'number_increase': 1.1686951820486561e-54, 'milciclibribociclibNCT02524119': 8.263922883666513e-55, 'antibody_emibetuzumab': 0.0002675814244889632, 'excellentsafetyproï¬\\x81le169': 8.263922883666513e-55, 'PLK1signaling_inhibitorit': 9.148819220060914e-58, 'milciclibribociclibNCT02524119_antitumor_activity_excellentsafetyproï¬\\x81le169': 9.148819220060914e-58, 'classiï¬\\x81cation_alYearClassiï¬\\x81cationG1\\x93G6S1\\x93S3Msig_\\x93iC1\\x93iC3': 9.148819220060914e-58, 'cell_proï¬\\x81lingImmunomicroenvironmentTranscriptome': 9.148819220060914e-58, 'which_notto_date': 0.00042075216298420966, 'itsdevelopment': 0.00042075216298420966, 'NCT02560779Biomarkerdriven': 0.0005479687540571566, 'none_haveso': 9.148819220060914e-58, 'to_be_able_to_predict_the_effect_of_or_responseto_treatment_with': 9.148819220060914e-58, 'molecularclassiï¬\\x81cation': 9.441080414990252e-05, 'precisionmedicine': 0.00035730068962257737, 'trials_designs': 0.0001725776170596485, 'germline_HRAS_mutations': 0.004315547045054443, 'Th2typecytokines_IL33_expression': 0.007713134335009549, 'Dfb': 1.1686951820486561e-54, 'skinbarrier_function': 8.263922883666513e-55, 'Th2typecytokines': 0.007713134335009549, 'IL33_expression': 6.456411694380894e-05, 'MEK_inhibitor': 0.002025112885075553, 'theepidermis': 9.148819220060914e-58, 'IL33_expression_lymphoid': 9.148819220060914e-58, 'role_patients6': 6.943850355962435e-05, 'to_resultinCorrespondence_Yoko_Aoki_aokiymedtohokuacjp1Department_of_Medical_Genetics_Tohoku_University_Graduate_School_ofMedicine_Sendai_Japan2Department_of_Pediatrics_Tohoku_University_Graduate_School_of_MedicineSendai_JapanFull_list_of_author_information': 0.0006940543140455221, 'RASMAPK_pathway89': 0.0038806204677737646, 'Costello_syndrome': 1.039521917371706e-06, 'germline_mutations_link': 6.373588657041808e-05, 'Cell_Death_Disease_Page_patients': 0.0005828796252635297, 'mutationthat': 0.0005423312279404596, 'withCostello_syndrome': 0.0003208044612686651, 'thepathogenesis_remainsunclearWe': 3.0063095734595998e-05, 'facialdysmorphia_cardiomyocyte_hypertrophy_fatty_acid': 0.0038806204677737646, 'diet_fedHrasG12Smice': 0.0003809665283472652, 'to_generate_experimentally_induced_dermatitisin_HrasG12S_mice': 1.644014482587299e-05, 'journal_scarring_eczema': 0.0007129960827382031, 'IgEelevations': 9.148819220060914e-58, 'Dfb_ointmentWe': 9.148819220060914e-58, 'dermatitisinHrasG12S_mice': 4.165601196153333e-05, 'hyperkeratosis_hyperplasia': 0.001129870936471824, 'skin_lesions_features': 1.1891983300442064e-05, 'Dfb_mice': 9.148819220060914e-58, 'dermatitis': 9.148819220060914e-58, 'oneway_P_mice': 0.0010298344840079976, 'P_Hras_Dfb': 9.148819220060914e-58, 'P_mice': 9.148819220060914e-58, 'cytokinesTo': 9.148819220060914e-58, 'lesions_factors': 9.148819220060914e-58, 'acanthosis_b_c_Immunohistochemistryof_CD4_Scale_bars': 0.001129870936471824, 'SD_Signiï¬\\x81cance': 0.0005418901125768185, 'oneway_ANOVA_method_P_twotailedStudent\\x99s_t': 8.840183599872585e-06, 'skinIl4mRNA_levels': 6.936254875044987e-05, 'cytokinesIl33': 1.1322754297846852e-06, 'to_appear': 1.3921075382642995e-05, 'inthe_skin': 4.695015963958416e-06, 'Il1': 8.263922883666513e-55, '5aAtopic_dermatitis': 9.148819220060914e-58, 'acanthosis_loss_\\x81ltration': 9.148819220060914e-58, 'response_mice_journal': 0.007713134335009549, 'acanthosis_loss_\\x81ltration_response_mice_journal': 0.0006768252640912667, 'ADlike_dermatitismay': 0.0006750162805663558, 'ofPD0325901': 1.3921075382642995e-05, '7a_b_PD0325901treatment': 0.0008522036149147152, 'Il33': 2.253096700536861e-05, 'ERK_inhibition': 1.3921075382642995e-05, 'mice_not_Hras_mice': 1.1891983300442064e-05, 'Expression_cytokines': 0.0016810521528134112, 't_skin_lesions': 4.614611075682467e-05, 'oneway_ANOVA_P_P_P_P': 8.840183599872585e-06, 'TSLP': 7.537058455307642e-07, 'skin_lesions_IL33_production': 0.00200848332852201, 'hyperproliferation': 0.0005411681930881713, 'IgE_serum_levels': 8.263922883666513e-55, 'claudin1expression': 1.1686951820486561e-54, 'IL33_receptor_ST2are': 8.263922883666513e-55, 'respectively3536': 9.148819220060914e-58, 'skineczema_pruritus': 9.148819220060914e-58, 'skin_claudin1_expression': 9.148819220060914e-58, 'IL33_expressionhyperproliferation': 9.148819220060914e-58, 'BRAFRAF1_deï¬\\x81cient': 9.148819220060914e-58, 'dermatitis_syndrome_patients': 9.148819220060914e-58, 'serumIgE_levels_Th2': 0.0038806204677737646, 'acitretin': 9.148819220060914e-58, 'to_treat_palmoplantar_keratosis_in_patients_with_Costello_and_CFC': 9.148819220060914e-58, 'MEKtumorigenesis46inhibitorsimpaired_enamel_formation_hyperkeratosis_hyperplasia': 0.0002543534709449633, 'studyPD0325901_treatment': 1.1686951820486561e-54, 'to_reverse_these_lesions_byreducing_hyperproliferation_of_pERKpositive_epidermalcells_and_the_production_of_\\x82ammatory_cells_and_cytokines_including_IL1_IL4_and_IL33_Treatment_withU0126_an_MEK_inhibitor_in_human_keratinocytes': 8.263922883666513e-55, 'hasalso': 1.1686951820486561e-54, 'to_restore_the_reduced_expression_levels_ofclaudin1': 8.263922883666513e-55, 'activationthrough_excess': 8.263922883666513e-55, 'inDfbstimulated': 8.830761096542854e-06, 'increasedIL33_expression': 0.0005413124153687537, 'oneway_ANOVA_theTukey\\x88\\x92Kramer_method_P_P_P_skin_rush_toxicity': 8.840183599872585e-06, 'ADlike_skinlesions': 0.0007131860921213638, 'IL33_antibody': 1.1636549905330657e-05, 'PCRusing_KOD_FX_Neo_TOYOBO_Osaka_Japan': 0.0006768252640912667, 'days_culture': 4.533771745563349e-07, 'skin_ears': 1.2354001104571252e-05, 'Japanan_ointment': 2.0170598013233685e-07, 'weekaccording': 0.001388599458763146, 'thicknessThe_dermatitis_scores': 2.2673179907113364e-05, 'severity_All': 3.3053717804830274e-05, 'b_Gross': 9.148819220060914e-58, 'dermatitis_score_thickness': 9.148819220060914e-58, 'HrasG12S_PD0325901': 8.840183599872585e-06, 'keratinocytes_show': 9.148819220060914e-58, 'expression_throughhyperproliferation': 9.148819220060914e-58, 'Excess_IL33': 1.1686951820486561e-54, 'basophil': 8.263922883666513e-55, 'ST2_receptors_production': 8.263922883666513e-55, 'ERK_signaling_dendritic_cellsnumber': 0.00018655327714248962, 'ERK_signaling_dendritic_cellsnumber_using_xylene_andrehydrated_with_ethanol_Frozen_specimens': 6.376800645775491e-05, 'sample_Mast_cells': 1.0403345688987395e-06, 'using_xylene_andrehydrated_with_ethanol_Frozen_specimens': 0.0002943830798898022, 'dryer_Antigens': 9.148819220060914e-58, 'using_aHistoï¬\\x81ne_simple_stain_kit': 9.148819220060914e-58, 'TrisHCl_pH_SDS': 0.0001559963661892288, 'proteinconcentration': 0.00015607953668344814, 'CA_Western_blotanalyses': 0.0001559963661892288, 'bandintensities': 9.148819220060914e-58, 'NIH_ImageJ': 9.148819220060914e-58, 'IgE': 9.148819220060914e-58, 'using_LBIS_Mouse_IgEELISA_Kit_FUJIFILM_Wako_Shiba': 9.148819220060914e-58, 'CDKN2BAS1': 0.010705393278262195, 'expression_Dasgupta_Priyanka_KulkarniEdited': 0.00054686425127897, 'characteristics_CDKN2BAS1_attenuation_overexpression': 9.238641995294468e-08, 'Dasgupta_Priyanka_KulkarniEdited': 0.007713134335009549, 'regulation_use_factors9': 3.5057934680564676e-05, 'factors9': 3.5057934680564676e-05, 'CyclinD': 0.00010905940088698344, 'RNA_ceRNAwhich': 0.00031430932618137393, 'suggesting_that_lncRNAs_and_mRNAscommunicate_with_each_other_by_competing_for_commonmiRNA_response_elements24\\x93In_this_context_we_describe_the_novel_role_of_lncRNACDKN2BAS1_and_miR1413p_miR141_in_the_regulation_of_CyclinD_to_govern_the_metastatic_progression': 8.263922883666513e-55, 'DNA_shorttandem_repeat_analysis': 8.263922883666513e-55, 'Mimic_nmolL_antimiR_miRNA_inhibitor_nmolLThermo': 9.148819220060914e-58, 'RNAi_Max_Thermo_FisherScientiï¬\\x81c': 9.148819220060914e-58, 'miRNA_inhibitor_control_siRNAcontrol': 9.148819220060914e-58, 'boardcertiï¬\\x81edpathologist_to_check_theexpression_levelsRNAmiRNA_extraction_and_quantitative_realtime_PCRqRTPCRTotal_RNA_was_extracted_from_microdissected_FFPEtissues_and_cell_lines_using_miRNeasy_FFPE_and_miRNeasymini_kits_Qiagen_respectively_in_accordance_to_manufacturer\\x99s_instructions_Mature_miRNA_and_mRNAs_wereassayed_by_qRTPCR_using_QuantStudio_ _FlexReal': 9.148819220060914e-58, 'ccRCC_slides': 8.263922883666513e-55, 'cohorts_forRCC': 9.148819220060914e-58, 'to_check_theexpression_levelsRNAmiRNA_extraction_and_quantitative_realtime_PCRqRTPCRTotal_RNA_was_extracted_from_microdissected_FFPEtissues_and_cell_lines_using_miRNeasy_FFPE_and_miRNeasymini_kits_Qiagen_respectively_in_accordance_to_manufacturer\\x99s_instructions_Mature_miRNA_and_mRNAs_wereassayed_by_qRTPCR_using_QuantStudio_ _FlexReal': 9.148819220060914e-58, 'System_Applied_Biosystem': 8.263922883666513e-55, 'SYBR_MixTaqMan_master_mixprobes_primers': 1.1686951820486561e-54, 'RNU48': 8.263922883666513e-55, 'cycle_Primer_sequencesare': 0.0016810521528134112, 'percent_primers_sequences': 1.8332127815714843e-05, 'h29_RNA': 1.8332127815714843e-05, 'andapoptosis_assaysCell_viability': 3.970463819644188e-52, 'to_grow_until_visible_colonies_were_formed': 7.55224768720263e-52, 'coatedwith': 1.8332127815714843e-05, 'DevicesFACS_analysis': 1.8332127815714843e-05, 'vector_Luciferase': 1.8332127815714843e-05, 'controlmiR': 1.8332127815714843e-05, 'Luciferase_activities': 1.8332127815714843e-05, 'bynormalizing_Fireï¬\\x82y_luciferase_to_Renilla': 0.0007008712380191807, 'imprint_RIP_kitwas': 9.148819220060914e-58, 'following_the_manufacturer\\x99s_protocol_SigmaAldrich_St_Louis_MO_USA_IgG_control_and_Ago2antibodies': 9.148819220060914e-58, 'kit_Thermo_Fisher': 0.0002788738900395108, 'Proteins': 5.728575019306865e-10, 'Gels_Invitrogen': 9.378293331313689e-12, 'membraneResulting_blots': 5.725524371629579e-10, 'Gels_Invitrogen_using_anOdyssey_Infrared_Imaging_System_Scan': 3.516868710831108e-08, 'using_anOdyssey_Infrared_Imaging_System_Scan': 9.378293331313689e-12, 'mounted': 0.0003022970628059641, 'effects_groups': 4.929658390468002e-06, 'model_cancer_xenograftsWe': 0.0010068765747081726, 'Statisticalanalyses': 0.00022053583466579164, 'using_the_Student\\x99s_ttest_Alltests_were_performed_either_one_tailed_or_two_tailed_andresults_were_considered_statistically_significant_at_P': 0.0006768252640912667, 'CDKN2BAS1_expression': 3.012831237073818e-05, 'ROC_analysis': 0.00040934888618673193, 'luciferase_reporter_ACHN_cells': 0.007713134335009549, 'thatmiR141': 9.148819220060914e-58, '1h': 9.148819220060914e-58, 'withCDKN2BAS1_siRNAs': 0.0006054349545841993, 'Figs_g_S3Expression_importance': 8.263922883666513e-55, 'RCC_cell_lines_Caki1': 0.0001813881936933869, 'cell_lines_decrease_Fig_3jindicating_regulation': 0.007713134335009549, 'Luciferase_assays': 9.148819220060914e-58, 'EV': 9.148819220060914e-58, 'overexpression_phenocopies': 9.148819220060914e-58, 'to_determine_if_CDKN2BAS1_causes_itsantitumorigenic_effects_through_miR141': 9.148819220060914e-58, 'Fig_4a_overexpression': 9.148819220060914e-58, 'expression_Fig_4b': 9.148819220060914e-58, 'Caki1': 2.474514720031763e-06, 'decrease_growth': 9.148819220060914e-58, 'delivery_ofmiR141': 9.148819220060914e-58, 'theinduction_increase_adecrease': 0.0015842910551982499, 'significantdecrease': 0.008076978651254266, 'EMT_markers': 0.00238803522972525, 'We_observedthat_CDKN2BAS1': 9.148819220060914e-58, 'miR141_bindingsites': 9.148819220060914e-58, 'we_ACHN_cells': 0.0002788738900395108, 'Page_expression': 0.00238803522972525, 'SEMthat_overexpression_inhibition': 3.8014933307324206e-06, '6f\\x93hS8A_B': 0.00023315119875083978, 'miR_Fig_S7': 0.001128162151175775, 'knockdown_effect_tumorigenicity': 0.0011131718807915394, 'Signiï¬\\x81cant_decrease': 1.8167818297264612e-05, 'controlse_Pictures': 1.8167818297264612e-05, 'Graph': 7.1611214236785185e-06, 'tumor_volume_mouse': 1.1685247084415465e-07, 'miR1413pMimic': 0.0003833771411240826, 'SEMAttenuation': 0.0001350248425456392, 'noticeableincrease': 7.417164383651313e-53, 'to_be_upregulated_in_tumortissues_and_function_as_an_oncogenic_lncRNA_in_pancreatic_ovarian_and_laryngeal_squamous_cell_carcinoma36\\x93': 1.284690556057437e-52, 'located': 7.417164383651313e-53, 'Human_miR141': 7.417164383651313e-53, 'to_be_anovel_target_of_miR141': 0.00210348072096923, 'Apoptosis_cells': 9.148819220060914e-58, 'totalapoptosis_Immunoblots': 9.148819220060914e-58, 'methylation_status_thepresence': 0.007713134335009549, 'RCC': 0.00014763345632963333, 'coreceptorthat': 0.000576827339123862, 'to_investigate_upstream_lncRNAs_that_control_theexpression_of_miR320aneuropilin1_axis_and_dissect_some_of_the_underlying_mechanisms': 0.0019132930105159865, 'titinantisense': 0.007713134335009549, 'RNA_immunoprecipitation_analyses': 3.1235511726865175e-05, 'RNA_interference_pathway': 0.00013959276999845252, 'TTAAS1': 1.284690556057437e-52, 'transition_tumor_angiogenesis': 7.417164383651313e-53, 'factor_TGFTGF_receptor': 7.417164383651313e-53, 'CCA': 0.00013373624578579387, 'to_significantly_improve_theprogressionfree_survival_of_patients_with_link': 0.0007215288397397289, 'to_significantly_improve_theprogressionfree_survival_of_patients_with': 0.0006578099350934741, 'human_CCA': 0.0008522036149147152, 'thevascular_pathways': 0.0038806204677737646, 'miRNAs_functions': 0.008304706973768554, 'regulates_expressed': 9.148819220060914e-58, 'proliferation_cells': 9.148819220060914e-58, 'regulating_gene_expression': 0.000302093565533489, 'to_regulate_key_factorsinvolved_in_cancer_cells18': 0.000142506981501866, 'S2A_BRBE_cells': 0.0008522036149147152, 'httpbioinfolifehusteducnand_candidates': 0.0011125787591309202, 'TTNAS1_hasbeen': 9.148819220060914e-58, 'to_promote_the_progression_of_several_cancertypes_including_esophageal_squamous_cell_carcinomaESCC21_lung_adenocarcinoma22_and': 9.148819220060914e-58, 'inall_CCA_cell_lines': 0.0016810521528134112, 'CCA_tumor': 0.0008522036149147152, 'bileductIn_CCA': 0.0007422205882319402, 'CCA_cases': 0.007713134335009549, 'qRTPCRn_number': 7.573369607860032e-05, 'staging_Table_differentiation_positivelymph_vein_invasion': 9.148819220060914e-58, 'higherexpression': 9.148819220060914e-58, 'expression_butdepletion': 0.00028038455419288966, 'miR320a': 0.0018104040039984535, 'lackingthe_site': 9.148819220060914e-58, 'miR320a_biotinlabeledwildtype_miR320a_miR320a': 9.148819220060914e-58, 'biotinlabeledwildtype_miR320a': 0.00013959276999845252, 'tolncRNATTNAS1': 2.9549923956629317e-05, 'tomiR320a': 0.00013959276999845252, 'antiAgo2_Ab': 0.0016020654700351987, 'datasuggest_expression': 9.148819220060914e-58, 'TTNAS1_overexpression_upregulatedby_TTNAS1_knockdown': 9.148819220060914e-58, 'miR320a_mimics_S6A_B': 0.0010068765747081726, 'mm\\x89¥_mmTNM': 9.148819220060914e-58, 'differencebAccording': 9.148819220060914e-58, 'invasionNoYes00042a00182a001823a001543a002709a003307aaindicates': 9.148819220060914e-58, 'Ï\\x872_testCCA': 9.148819220060914e-58, 'NRP1_neuropilin10009076a00194a004106aTTNAS1': 0.000404948725608525, 'cellviability_Supplementary_Fig': 0.007713134335009549, 'depletion_ofNRP1': 0.00012630877451023521, 'miR320amimics': 0.001128162151175775, 'TTNAS1_knockdown': 0.0011284627910272927, 'asignificant_upregulation': 1.8415484017042953e-05, 'viability_probe': 0.0004686411271822266, 'c_wasmeasured': 0.0002788738900395108, 'respective_controls320a_mimics': 0.001128162151175775, 'ofNRP1_cyclin_E_CDK2_downregulation': 0.001128162151175775, 'Fig_S8DTTNAS1': 0.00017939106177220415, '3a\\x93d_CCA': 9.148819220060914e-58, 'effectacquire': 9.148819220060914e-58, 'zymography_assays': 0.0016489412033307868, 'RBE_cells': 2.6916426852543886e-05, 'Migratedcells': 2.6916426852543886e-05, 'b_Numbers': 9.148819220060914e-58, 'Scratch_areas': 9.148819220060914e-58, 'e_f_Cells': 7.117471070861166e-08, 'to_actin': 4.355820386486975e-06, 'g_Cells': 7.117471070861166e-08, 'antagomiR320a': 9.148819220060914e-58, 'Fig_3f': 9.148819220060914e-58, 'mm3Tumors': 0.0005828796252635297, '±_mm3_cotreatment': 0.00047983738574547787, 'effects_effect': 6.380478194315262e-05, 'CotreatmentFig_0cZhu_Cell_Death_Disease_Page': 0.0003152090535259894, 'inoculation': 5.1429744047330575e-06, 'growth_curve': 0.000704452199586233, 'growth_angiogenesis_inoculation_treatments': 0.0016925446436582032, 'shRNATTNAS1treatment': 5.091845768938364e-06, 'growth_bypromoting': 0.0004686411271822266, 'Fig_S11TTNAS1': 0.000576827339123862, 'NRP1': 0.0006942392743112329, 'HGFcMet_pathway': 1.1327846616133142e-05, 'Fig_TTNAS1': 0.000576827339123862, 'b_Cell_lysates': 8.263922883666513e-55, 'oppositeeffects_cointeracts': 1.1686951820486561e-54, 'pAkt_downregulationof_p27_incubation': 8.263922883666513e-55, 'cMet_pathway': 0.0006768252640912667, 'TGF_protein_LY2157299': 0.001128162151175775, 'LY2157299expression': 0.001128162151175775, 'TGFRI_expression': 0.00024134924474519354, 'regulatoryeffects': 0.00013959276999845252, 'themiR133bactinbinding_protein_fascin_homolog_ _axis_inESCC_cells21': 0.00013959276999845252, 'incancer_progression111438': 0.004315547045054443, 'CDK2cyclinE_complex': 0.0038806204677737646, 'cMet_inhibitor': 0.0006940543140455221, 'NRP1inducedactivation': 4.009894884126125e-05, 'expressionof_Snail': 0.004315547045054443, 'TGFinduced_repression_ofEcadherin_stimulation': 0.0038806204677737646, 'LY2157299': 6.548708278574968e-07, 'Asdemonstrated_previously14_not_investigated_in_thisstudy_the_above_signaling_pathways': 0.00010740789809797397, 'ceRNA_tissues_association': 0.0015842910551982499, 'CCA_TTNAS1': 0.0007008712380191807, 'miR320a_inCCA': 0.0016810521528134112, 'cycleprogression_EMT_angiogenesis': 7.417164383651313e-53, 'HGFcMet': 0.0038806204677737646, 'target_biomarkers': 0.0019127833147525456, 'regulation_activation\\x9c\\x8a¥\\x9d': 1.1686951820486561e-54, 'inhibition_regulation': 8.263922883666513e-55, '\\x9cp\\x9d_indicatesphosphorylation': 8.263922883666513e-55, 'regionmiR320a': 1.4055400435083287e-53, 'luciferaseactivities': 2.274211562945482e-53, 'endogenousTTNAS1_miR320a': 2.614541530218833e-05, 'them_pairs': 2.614541530218833e-05, 'informed': 0.0019132930105159865, 'to_be_negative_for_mycoplasma_infection_by_using_aPCRbased_Universal_Mycoplasma_Detection_kit_AmericanType_Culture_Collection_Manassas_VA_USA_Relevantinformation_regarding_antibodies_Abs_reagents_and_kitsare': 3.1235511726865175e-05, 'HCCC9810_RBE_QBC939CC262_FRH0201': 0.0004101631845799797, 'reagentsHuman_CCA': 6.6895860393239445e-06, 'SYXK20020009_theInstitute_Animal_Ethics_BALBc_mice_H2b': 0.00020438662347026346, 'mice_tumors': 9.148819220060914e-58, 'to_be_negative_for_mycoplasma_infection_by_using_aPCRbased_Universal_Mycoplasma_Detection_kit_AmericanType_Culture_Collection_Manassas_VA_USA_Relevantinformation_regarding_antibodies_Abs_reagents_and_kitsare_SYXK20020009_theInstitute_Animal_Ethics_BALBc_mice_H2b': 9.148819220060914e-58, 'TTNAS1_knockdown_study': 6.43504146181673e-05, 'micefrom_days_microarrays_Establishment': 0.0005422187709947302, 'threegroups': 9.109139931402274e-06, 'injectionsof_control_shRNATTNAS1_shRNATTNAS1_antagomiR320a': 0.0038806204677737646, 'TTNAS1_overexpression_study': 0.0003022165162482692, 'TTNAS1_orTTNAS1_miR320a': 9.148819220060914e-58, 'micefrom_microarrays_Establishment': 9.148819220060914e-58, 'vectors_Plasmid': 0.0001610882056271696, 'HerecIARS': 9.148819220060914e-58, 'to_be_the_most_highly_expressed_circRNA_after_sorafenib_SF_treatment_in_HCCcells': 9.148819220060914e-58, 'Small': 0.00019915147656230243, 'Small_interfering_RNA_against_cIARS_sicIARS': 0.0006191469481200436, 'proteinRBP_ALKBH5': 0.00019915147656230243, 'sicIARS': 0.004000336316610861, 'ALKBH5_downregulationOverall': 0.00054686425127897, 'ferroptosis': 0.015043906820768178, 'latestage_HCC': 9.148819220060914e-58, 'challenging_The_standard_ï¬\\x81rstline_systemic_drug_against_advanced_HCC_issorafenib_SF_BAY_ _Nexavar_which_is_currentlyCorrespondence': 9.148819220060914e-58, 'Liu_Qi_WangEdited': 0.0007959416758056306, 'limitedeffects': 0.00010140499121387615, 'years_ferroptosis': 9.148819220060914e-58, 'to_be_anessential_mechanism_in_SF_treatment7': 9.148819220060914e-58, 'autophagic_ï¬\\x82ux': 1.0320608402674031e-05, 'ubiquitinlikeconjugation_systems': 1.1686951820486561e-54, 'bybaï¬\\x81lomycin_A1_chloroquine_lack': 8.263922883666513e-55, 'more_Autophagy_inhibition': 0.0005423312279404596, 'ATG5_ATG7': 9.148819220060914e-58, 'ferritinophagyinactivation': 9.148819220060914e-58, 'iron_release13\\x93CircRNAs': 9.148819220060914e-58, 'bybaï¬\\x81lomycin_A1_chloroquine_lack_ferritinophagyinactivation_research_to_be_a_promoter_offerroptosis_in_HCC_cells_after_SF_treatment_which_waspartially_attributed_to_the_activation_of_autophagy_andferritinophagy': 9.148819220060914e-58, 'to_be_a_promoter_offerroptosis_in_HCC_cells_after_SF_treatment_which_waspartially_attributed_to_the_activation_of_autophagy_andferritinophagy': 8.263922883666513e-55, 'significantchanges': 0.00044905408673205416, 'theother': 9.148819220060914e-58, '\\x89¥_pvalue': 9.148819220060914e-58, 'volcano_plots': 0.00023451537717603815, 'linear': 0.0038806204677737646, 'inhibitionwas': 6.533328717772989e-05, 'HCCcells': 9.148819220060914e-58, 'effects_nosignificant': 9.148819220060914e-58, 'SFor_Erastin': 9.148819220060914e-58, 'cellsHowever_apoptosisinhibitor': 9.148819220060914e-58, 'necroptosis_inhibitor': 9.148819220060914e-58, 'nosignificant': 9.148819220060914e-58, 'autophagosomesicIARS': 9.148819220060914e-58, 'amount_ofredautolysosome_autophagosome_puncta_percell': 9.148819220060914e-58, 'TEM': 3.0638546304527204e-05, '\\x88\\x92log10_pvalue': 1.5575770082129888e-07, 'change_\\x89¥': 6.171298691014034e-05, 'b_cluster_analysis': 0.00012247929350465457, 'columnsrepresent_row': 1.4760668105859679e-08, 'Agarose_gel_electrophoresis': 2.4954590467311193e-05, 'junction_site': 9.148819220060914e-58, 'to_assess_the_resistance_of_RNAs_to_RNase_R_h_RNA_decay_assayevaluating_the_stability_of_cIARS_and_IARS_by_qPCR_after_ActD_ ': 9.148819220060914e-58, 'RNA_decay': 0.0001438653184561452, 'deviation_SD_number': 0.0016480626375926124, 'Furthermoretheprotein_levels_andcargo_receptor': 9.148819220060914e-58, 'WBassay_sicIARS': 9.148819220060914e-58, 'circRNA\\x93RBP_interaction': 0.0005218289698578611, 'ofautophagyALKBH5': 9.148819220060914e-58, 'to_be_an_autoprole_inin_cancer2526_Howeverhagy_inhibitoritsOfï¬\\x81cial_journal_of_the_Cell_Death_Differentiation_AssociationSFtreated': 9.148819220060914e-58, 'inin': 3.0638546304527204e-05, 'WB_assay': 2.517565330329382e-05, 'showedthat_siRNA': 0.00023629147773967076, 'andWB': 0.0007095919825356841, 'Fig_5b_c_siALKBH5': 0.0007095919825356841, 'siALKBH5': 0.0011287635911564062, 'dissociation_step': 1.8420392474163883e-05, 'phenotyperescueexperiments_First_siALKBH5': 0.007713134335009549, 'Fig_increase': 9.148819220060914e-58, 'attention_portion': 9.148819220060914e-58, 'Discovery_Page': 9.148819220060914e-58, 'to_be_a_significant_regulator_of_SFinduced_ferroptosis_a_The_expression_levels_of_cIARS_after_transfection_of_sicIARS_or': 9.148819220060914e-58, 'evaluation_NC': 0.0011125787591309202, 'AUF1_These': 9.148819220060914e-58, 'thepotential': 9.148819220060914e-58, 'to_be_aninteractor_of_RBP_ALKBH5_which_had_previously_beenreported_to_be_a_N6methyladenosine_m6A_eraser_Itsrole_in_autophagy_regulation': 0.00024580291837657486, 'autophagy_ferritinophagy_expression_levels_wasvisualized': 0.00024580291837657486, 'number_level': 0.000254619872099857, 'puncta': 9.148819220060914e-58, 'autolysosomes_puncta': 9.148819220060914e-58, 'doublemembranedvacuoles': 1.2514976858356395e-06, 'assessment_NC': 1.1529429245224884e-05, 'cancer25ALKBH5_upregulation': 9.148819220060914e-58, 'UBE2C_autophagyinhibitor': 9.148819220060914e-58, 'ALKBH5': 0.000531503056238604, 'autophagy_throughactivating': 8.669292443608725e-06, 'to_be_apivotal_regulator_of_autophagy_ferroptosis_and_ferritinophagy': 8.669292443608725e-06, 'transfection_experiments': 2.2429939073210704e-07, 'RNA_oligonucleotides_ALKBH5and_controls_NC_NC\\x99Sequences': 2.2429939073210704e-07, 'study_axis': 2.9402948113849672e-05, 'to_be_a_key_mechanism_regulating_ferroptosisduring_SF_treatment': 0.001801148090838322, 'cDNA': 9.148819220060914e-58, 'to_detect_the_qPCRampliï¬\\x81cation_of_cDNA_and_genomic_DNA_after_applyingwith_the_divergent_and_convergent_primers_of_cIARSTherelative_fold_changes_in_expression_were_calculated_withthe_formula_\\x88\\x92Î\\x94Î\\x94Ct': 9.148819220060914e-58, '²\\x93²': 0.00015442122856028365, 'expression_NC': 9.148819220060914e-58, 'HCC_cellsd_e_assessment': 9.148819220060914e-58, 'effect_p62_accumulation': 1.8420392474163883e-05, 'insicIARS_HCC_cells': 0.00012655084031411176, 'insicIARS': 0.0006674076661460604, 'ALKBH5_knockdown': 0.00010819705594308642, 'to_detect_the_stability_of_RNA_ _Î¼gmlActD_reagent_was_used_to_treat_HepG2_and_Huh7_cellsAfter_    _or_ _h_of_administration': 0.0008569990185419674, 'Î¼gmlActD_reagent': 9.148819220060914e-58, 'to_treat_HepG2': 9.148819220060914e-58, 'antiLC3B_Cell': 9.148819220060914e-58, 'ab133689_antiFMRP': 9.148819220060914e-58, 'chemiluminescence_detection_Burlington_MA_USA': 6.338402539226231e-06, 'BioRad_Hercules': 1.0358088145899844e-07, 'IP': 1.0358088145899844e-07, 'IP_assayconsists_volume': 4.0535209879586194e-05, 'supernatant_to_evaluate_RNA\\x93protein_interaction_using_biotinlabeled_junctionspeciï¬\\x81c_probe_and_itsnegative_control_designed_and_synthesized_by_ViageneBiotech_Jiangsu_China_Detailed_procedure': 6.61222627102e-07, 'protein_AG_sepharose': 1.0803362494222728e-08, 'to_evaluate_RNA\\x93protein_interaction_using_biotinlabeled_junctionspeciï¬\\x81c_probe_and_itsnegative_control_designed_and_synthesized_by_ViageneBiotech_Jiangsu_China_Detailed_procedure': 6.610465034051699e-07, 'LightShift_EMSA_Scientiï¬\\x81c': 3.0737634512052054e-06, 'to_evaluate_theinteraction_between_cIARS': 0.00018856112077619613, 'adenovirus_h_incubation_cells': 9.148819220060914e-58, 'using_a_ï¬\\x82uorescence_microscope': 9.148819220060914e-58, 'Student_ttests': 0.00043463382250315263, 'AcknowledgementsThis_work': 3.642154034038064e-05, 'reticulum_stress_\\x93_Jung_H_ULKAtg13FIP200_complexes': 3.0638546304527204e-05, 'process_\\x93_Hou_W_Autophagy': 0.00024580291837657486, 'circRNA_102171': 9.148819220060914e-58, 'thyroid_cancer_progression': 9.148819220060914e-58, 'learningbased_segmentation_methods': 0.0001605551227252273, 'sample_preparation_methods': 0.00021509105295728132, 'biology_group': 0.00015513807198772443, 'Kromp_Eva_Bozsaky': 9.148819220060914e-58, 'Berneder_Wolfgang': 9.148819220060914e-58, 'feasibility_power': 0.0001923205957753865, 'segmentation_algorithms': 9.148819220060914e-58, 'tissues_cell_aggregations': 9.148819220060914e-58, 'to_separate_each_nucleus_in_cases_of_tightly_clustered_nuclei17_Remaining_aggregations_of_nuclei': 0.0013882295497307361, 'to_train_machine': 0.004315547045054443, 'datasets_IHC_images': 0.00021509105295728132, 'generation_publication': 9.148819220060914e-58, 'comprehensive': 9.148819220060914e-58, 'Shimada': 0.0007933422922558964, 'singlenuclei_annotations': 0.00771518910792271, 'to_ _validate_the_quality_of_the_annotated_dataset_by_comparing_the_ground_truth_annotations_to_the_singlenuclei_expert_annotations_and_ _to_set_a_baseline_for_machine_learningbased_image_segmentation': 0.00012613970685026185, 'realworld_dataset': 0.00021509105295728132, 'to_train_and_evaluate_machine_learningbased': 0.00021509105295728132, 'segmentation_architectures': 0.000704362469235278, 'Histobond_glass': 9.148819220060914e-58, 'Data_101038s4159702000608wwwwnaturecomscientificdatawwwnaturecomscientificdata_0cMarienfeld': 9.148819220060914e-58, 'airdried': 1.7086439854124747e-05, 'Vectashield': 9.148819220060914e-58, 'DAPI_coverslips': 9.148819220060914e-58, 'Mononuclear_cells': 9.148819220060914e-58, 'gradient_centrifugation_cytospinned': 9.148819220060914e-58, 'illumination_time': 0.00021412848656986267, 'using_ _an_AxioplanII_microscope_from_Zeiss_equipped_with_a_Maerzhaeuser_slide_scanning_stage_and_a_Metasystems_Coolcube_ _camera_using_the_Metafer_software_system_V386_from_Metasystems_ _an_AxioplanII_microscope_from_Zeiss_equipped_with_a_Zeiss_AxioCam_Mrm_ _using_the_Metasystems_ISIS_Software_for_microscopy_image_acquisition_ _an_LSM_ _microscope_from_Zeiss_equipped_with_an_Argonlaser_ _nm_a_photomultiplier_tube_PMT_detector_\\x93_nm_and_a_motorized_Piezo_Zstage_using_the_Zeiss_Zen_software_package_and_ _a_SP8X_from_Leica': 1.1176735774867664e-06, 'II_Zeiss_LSM_aperture_Representative_field': 0.0001990750549774987, 'students_expert_biologists_to_be_refined_to_serve_as_ground_truth_annotation_visualization_tools': 0.00010373107074805525, 'students_expert_biologists': 3.2443219529853725e-06, 'learningbased_framework': 9.148819220060914e-58, 'supporting_the_process_of_annotation_by_learning_characteristics_of_annotation_in_multiple_steps24': 9.148819220060914e-58, 'MLF_annotations': 1.6929286894375803e-06, 'to_be_refined_to_serve_as_ground_truth_annotation': 3.2443219529853725e-06, 'Illustrator_AI_CS6_AI': 7.229788447789438e-05, 'expert': 9.927994518112209e-05, 'expert_pathologist': 9.148819220060914e-58, 'to_revise_all_image_annotations_and_annotations': 9.148819220060914e-58, 'images_to_revise_all_image_annotations_and_annotations': 1.3140465622238654e-07, 'signaltonoise_ratio_images_preparations_tissue_sections_ISIS_software_signaltonoise': 5.815401258176349e-07, 'to_be_used_to_train_and_evaluate_machine_learningbased_image_segmentation_methods_we_created_a_dataset_split_into_training_set_and_test': 0.00021509105295728132, 'signaltonoise_ratio': 5.816951587296943e-07, 'images_preparations_tissue_sections_ISIS_software_signaltonoise': 5.815401258176349e-07, 'to_annotate_the_raw_image_learning_from_user_interaction_within_three_consecutive_steps_S1_foreground_extraction_S2_connected_component_classification_red_ _nonusable_objects_blue_ _nuclei_aggregations_green_ _single_nuclei_and_S3_splitting_of_aggregated_objects_into_single_nuclei_resulting_in_an_annotation_mask_c_Zoomin_of_the_SVGfile_showing_the_nuclear_image_overlaid_with_polygons_representing_each_annotated_nucleus_Polygons': 6.341351419432926e-05, 'nuclei_S3_splitting': 0.0001788354435343705, 'expert_biologists_to_fit_effective_nuclear_borders_Challenging_decisions_on_how_to_annotate_nuclei_mainly_occurring_due_to': 6.341351419432926e-05, 'to_annotate_the_raw_image_learning_from_user_interaction_within_three_consecutive_steps_S1_foreground_extraction_S2_connected_component_classification_red_ _nonusable_objects_blue_ _nuclei_aggregations_green_ _single_nuclei_and_S3_splitting_of_aggregated_objects_into_single_nuclei_resulting_in_an_annotation_mask_c_Zoomin_of_the_SVGfile_showing_the_nuclear_image_overlaid_with_polygons_representing_each_annotated_nucleus_Polygons_expert_biologists_to_fit_effective_nuclear_borders_Challenging_decisions_on_how_to_annotate_nuclei_mainly_occurring_due_to': 1.0962487138407105e-05, 'biology_expert': 0.0002152631328657947, 'set_classes': 3.5091208005596733e-06, 'biologist_Nuclei': 3.5091208005596733e-06, 'The_singlenuclei_annotations_described_as_singlecell_annotations_within_the_dataset': 3.5091208005596733e-06, 'to_be_annotated_as_exact_as_resolution_and_blurring_allows_forIf_parts_of_a_nucleus_are_out_of_focus': 1.0962487138407105e-05, 'annotation_masks': 0.00238803522972525, 'resulting_in_the_meanbackground_signal_Dilation': 9.93196240259489e-05, 'to_exclude_pixels_neighboring_nuclei_from_the_calculation_as_they_do_not_represent_the_background_signal_but': 9.93196240259489e-05, 'background_signal': 0.0013882295497307361, 'Y_ValidationTo': 0.00021518210433707708, 'coefficient_Y': 0.00238803522972525, 'Dice_coefficient': 0.007713134335009549, 'blurriness_overlapping': 0.00042644740830607715, 'ground_truth': 9.148819220060914e-58, 'to_benchmark_the_accuracy_of_machine_learningbased_image_segmentation_architectures_in_comparison_to_the_baseline_set_by_human_annotatorsScientific': 9.148819220060914e-58, 'HaCaT_Cell_line': 0.000184520788473123, 'll_e_c': 0.0004499048194399722, 'Cell_line': 9.148819220060914e-58, 'toucharrowe_mnoBZeissLeicawnTissue': 9.148819220060914e-58, 'sectionSISIModality_rFig_Heterogeneity': 9.148819220060914e-58, 'Tissue_tissue_expGNBIGNBII': 9.148819220060914e-58, 'Dice_coefficient_imaged_values': 9.105137979575733e-08, 'identification_quantification_Res_\\x93': 9.148819220060914e-58, 'proteome_topology_function': 9.148819220060914e-58, 'AIPF_analysis_cytology_Am_J_Pathol': 9.148819220060914e-58, 'tumor_growth_\\x93_learning_framework': 9.148819220060914e-58, 'grant_project': 5.944217241461164e-07, 'VISIOMICS_grants': 9.148819220060914e-58, 'BMK_BMDW_Province': 9.148819220060914e-58, 'W_Doerr': 3.895921044249875e-07, 'BMK_BMDW_Province_data_manuscript_interestsAdditional_informationCorrespondence': 2.3869684037014614e-05, 'study_T_Weiss_S_TaschnerMandl_M_Ambros': 0.0006030236714318566, 'material_F_Kromp_Bozsaky_Ambros_T_Weiss_S_TaschnerMandl': 9.927994518112209e-05, 'TaschnerMandl_PF_Ambros_IM_Ambros_D_Lazic_L_Fischer': 0.0014620086693474654, 'F_Kromp_L_Fischer': 0.001129870936471824, 'F_Kromp_E_Bozsaky': 0.00022771936739542464, 'affiliationsOpen_Access': 0.00040934415372960003, 'shock_waves': 3.974244312322314e-06, 'Control_bones': 9.148819220060914e-58, 'growth_arrests_growth_impairment': 9.148819220060914e-58, 'treatment_rSWT': 8.263922883666513e-55, 'growth_impairment': 1.1686951820486561e-54, 'exposed': 8.263922883666513e-55, 'bone_growth': 0.0006458509721851324, 'cell_size': 1.0541661008426995e-05, 'bones_transcription_factor': 4.119784612443779e-05, 'bones_cell_size_effect_strategy_transcription_factor': 4.119784612443779e-05, 'morphology_Bones': 9.148819220060914e-58, 'bone_growth_growth_plate': 9.148819220060914e-58, 'rSWT': 0.0013059333672639575, 'highenergy_wave_treatment': 9.148819220060914e-58, 'uptake_Children\\x99s': 9.148819220060914e-58, 'Sweden_authors': 9.148819220060914e-58, 'Lars_Svendahl_sowmyarameshkiseScientific_RepoRtS': 9.148819220060914e-58, 'Rescuing_metatarsal_bones': 0.00016032962580117682, 'increase_vismodegib_rSWT': 0.00012892528205456674, 'bones': 0.007886092063037352, 'Magnification': 0.0003640060763646834, 'to_investigate_the_potential_for_rSWT_to_prevent_growth_retardation_caused_by_two_different_Hhantagonists_vismodegib_and_the_Gli1_antagonist': 0.00238803522972525, 'growth_failure': 2.1311636644781442e-05, 'session_both_n_followed_graph': 0.00016032962580117682, 'Height_measurements_cell_size': 9.148819220060914e-58, 'using_the_ImageJ_software_p_  _p_ _on_day_  _±_ _vs_ _±_ _respectively': 9.148819220060914e-58, 'growth_velocity': 2.1317315528474394e-05, 'to_be_higher_in_rSWT_ _vismodegib_compared_to_vismodegib_alone_Fig_a01bGrowth_plate_morphology_ _Histological_evaluation': 3.4801352768318135e-07, 'plate_morphology': 2.1323108130757226e-05, 'to_be_more_normal_in_bones_receiving_rSWT': 3.481080994614126e-07, 'height_±_a0_µm_µm': 0.007713134335009549, 'Fig_a01_height': 9.148819220060914e-58, 'to_be_increased_in_bones_exposed_to_rSWT_ _vismodegib': 9.148819220060914e-58, 'Compared': 4.152256230357653e-07, 'to_be_disturbed_with_disanized_chondrocyte_columns_on_day_ ': 3.548807227068656e-07, 'to_be_lower_in_GANT61_treated_bones': 0.0010298344840079976, 'Immunoexpression': 9.148819220060914e-58, 'to_be_reduced_in_GANT61_treated_bones_p_ _ns_vs_control_whereas_bones_treated_with_rSWT_ ': 9.148819220060914e-58, 'Hhantagonist': 1.715676556058368e-07, 'to_impair_bone_ _growth19': 0.00018655327714248962, 'shockwave_treatment': 9.148819220060914e-58, 'to_reduce_inflammation_and_apoptosis_while_stimulating_the_regeneration_of_various_ _tissues2021': 9.148819220060914e-58, 'vismodegib': 9.148819220060914e-58, 'Gli1': 9.148819220060914e-58, 'to_cause_permanent_defects_in_bone_and_growth_plate_ _structure9_Similar_to_the_previous_in_a0vivo_observations_in_young_ _mice9_our_histomorphometric_growth_plate_data_suggest_that_partial_loss_of_Hhactivity_may_result_in_the_breakdown_of_chondrocyte_columnar_anization_and_reduced_size_of_hypertrophic_chondrocytes': 0.00054686425127897, 'plate_ultrastructure': 9.148819220060914e-58, 'growth_deficit': 9.148819220060914e-58, 'Hhinhibitors': 0.0017158769514586277, 'Ihh': 0.00031430932618137393, 'growthOur_study': 4.119784612443779e-05, 'testing_diagram': 0.0038806204677737646, '101038s41598020699040Vol1234567890wwwnaturecomscientificreports_0cFigure': 3.410286168774167e-05, 'ex_findings': 9.148819220060914e-58, 'to_be_validated_in_an_in_a0vivo_animal_model_like_the_rabbit_where_growth_plate_fusion_normally_occurs_just_like_in_humansMethodsThe_experiments': 9.148819220060914e-58, 'overviewExposure': 7.97765208886232e-06, 'metatarsal_bones': 0.0001610882056271696, 'Alcian': 0.0001610882056271696, 'antibody_antibody_Denmark_dilution_sections': 7.668895225227707e-06, 'To_quantify_immunostaining_using_means_±_SD_for_the_bone_length_measurements_and_histomorphometric_assessments': 0.00047041073593408585, 'To_quantify_immunostaining': 0.00012892528205456674, 'software_Bethesda_MD_USA': 7.668895225227707e-06, 'using_means_±_SD_for_the_bone_length_measurements_and_histomorphometric_assessments': 0.001129870936471824, 'twoway_ANOVA': 7.417164383651313e-53, 'to_visualize_the_change_in_bone_length_Kruskal\\x93Wallis': 1.284690556057437e-52, 'Margin_plots': 7.417164383651313e-53, 'Man\\x93Whitney_U_test': 7.417164383651313e-53, 'study_Transient_inhibition': 7.657065756374441e-06, 'wave_treatment': 9.148819220060914e-58, 'bone_growth_chondrogenesis': 9.148819220060914e-58, 'wave_therapy_rESWT': 8.263922883666513e-55, 'A_shock_waves': 9.148819220060914e-58, 'effect_interaction': 9.148819220060914e-58, 'Canaparo_energy_shock': 9.148819220060914e-58, 'HESW': 9.148819220060914e-58, 'et_al_Nitric_oxide': 0.00016085087796596776, 'hedgehog_inhibitor_GANT61': 9.148819220060914e-58, 'prostate_cancer_cells_e50523': 9.148819220060914e-58, 'Dose_translation': 9.148819220060914e-58, 'FASEB_J_\\x93': 9.148819220060914e-58, 'estrogen': 1.1686951820486561e-54, 'bone_growth_effect': 8.263922883666513e-55, 'apoptosis_J_Endocrinol': 8.263922883666513e-55, 'AM_Hogendoorn_C_Upregulation': 0.00039947355805761766, 'data_SR': 3.1558237422569986e-05, 'which_gene_activities': 0.00014120710818717644, 'to_find_a_method_that_efficiently_avoids_false_positives_while_keeping_a_high_sensitivity_We_here_present_a_new_network\\x91based_method_ANUBIX_based_on_sampling_random_gene_sets_against_intact_pathway': 0.00210348072096923, 'ANUBIX': 0.0003111747797054818, 'methodsImprovements': 0.004315547045054443, 'lists': 0.00391600345182332, 'sets_pathways': 3.124383789880943e-05, 'genes_eg': 8.278244596725021e-06, 'repeating_this_process_with_a_background_list_of_genes': 0.0005074682467178767, 'Gene_Set_AnalysisGSA4_Analysis_GSEA5': 0.00029628649182082434, 'FCS_ORA': 0.00044941264492739084, 'overlap_associations_interactions6_issue': 0.0009466755491730313, 'ORA_FCSWe': 9.148819220060914e-58, 'network_enrichment_tools': 9.148819220060914e-58, 'NEArender14_BinoX7_GeneSetDPGeneSetMC15_EnrichNet': 2.0815386017514286e-05, 'enrichment_tools': 0.0005073330404429016, 'to_obtain_null_model_parameters_which_makes_them_computationally_very_slow': 0.0013882295497307361, 'network_randomization': 0.0038806204677737646, 'randomization_NEAT': 0.001355924793124927, 'GeneSetDP': 0.004403648103163825, 'programming': 7.190264394765284e-05, 'MonteCarlo_sampling': 0.0010325216439875707, 'to_allow_large_scale_pathway_enrichment_analysisThe_null_model_assumption_of_NEAT_NEArender_and_BinoX_is_that_compared_gene_sets_are_expected_to_behave_like_random_gene_sets_For_real_pathways_that_are_very_nonrandom_eg_highly_intraconnected_this_can_lead_to_underestimating_the_expected_level_of_crosstalk_and_produce_a_high_false_positive_rate_FPR_To_avoid_this_it_is_important_that_the_method_can_cope_with_the_nonrandomness_of_pathways_To_this_end_we_have_developed_a_novel_networkbased_pathway_enrichment_analysis_algorithm_called_ANUBIX_Adaptive_NUll_distriButIon_of_Xtalk_which_is_based_on_scoring_random_gene_sets_against_real_pathways_to_build_its_null_model_We_show_that_ANUBIX_clearly_outperforms_recent_network_crosstalk_methods_like_BinoX_NEArender_and_NEAT_in_terms_of_avoiding_False_Positives_FP_showing_that_it_can_model_expected_network_crosstalk_to_pathways_more_preciselyMaterial_and_methodsOur_networkbased_pathway_enrichment_analysis_tool_ANUBIX_depends_on_a_global_functional_association_network_We_used_the_network_Funcoup_version_ _with_a_link_confidence_cutoff_of_ _containing_ _genes_and_ ': 0.00029628649182082434, 'to_behave_like_random_gene_sets_For_real_pathways_that_are_very_nonrandom': 0.00022815212252705314, 'crosstalk_methods': 5.072888932064798e-06, 'network_crosstalk': 0.00210348072096923, 'network_Funcoup_version': 0.00238803522972525, 'matrix_A': 0.00029628649182082434, 'thataij_1if_gi': 9.148819220060914e-58, 'to_allow_large_scale_pathway_enrichment_analysisThe_null_model_assumption_of_NEAT_NEArender_and_BinoX_is_that_compared_gene_sets_are_expected_to_behave_like_random_gene_sets_For_real_pathways_that_are_very_nonrandom_eg_highly_intraconnected_this_can_lead_to_underestimating_the_expected_level_of_crosstalk_and_produce_a_high_false_positive_rate_FPR_To_avoid_this_it_is_important_that_the_method_can_cope_with_the_nonrandomness_of_pathways_To_this_end_we_have_developed_a_novel_networkbased_pathway_enrichment_analysis_algorithm_called_ANUBIX_Adaptive_NUll_distriButIon_of_Xtalk_which_is_based_on_scoring_random_gene_sets_against_real_pathways_to_build_its_null_model_We_show_that_ANUBIX_clearly_outperforms_recent_network_crosstalk_methods_like_BinoX_NEArender_and_NEAT_in_terms_of_avoiding_False_Positives_FP_showing_that_it_can_model_expected_network_crosstalk_to_pathways_more_preciselyMaterial_and_methodsOur_networkbased_pathway_enrichment_analysis_tool_ANUBIX_depends_on_a_global_functional_association_network_We_used_the_network_Funcoup_version_ _with_a_link_confidence_cutoff_of_ _containing_ _genes_and_ _matrix_A': 9.148819220060914e-58, '\\x8a\\x86_Q_genes': 0.008122478488739149, 'Q_pathway_P': 0.0003322263502299899, 'QP': 0.00238803522972525, 'to_be_independent': 2.214958588306065e-05, 'µ': 0.0006313632619292757, 'distribution_BetaÎ±': 0.0003647528107482472, 'likelihood_estimation': 0.007713134335009549, 'a0_Workflow': 0.0005073330404429016, 'types_NEAT_computes': 0.00035028915142444096, 'hypothesis_test_changes': 0.0002915557546050062, 'v70123_pathways_REACTOME_v6224_pathways': 0.007713134335009549, 'hierarchy': 0.007713134335009549, 'representative': 0.008045360685239538, 'KEGG_pathways_REACTOME_pathways': 0.007713134335009549, 'To_analyze_stability_we_generated_the_null_distribution_ _times_for_the_crosstalk_between_the_same_gene_set_to_the_same_pathways_for_increasing_numbers_of_random_samples_For_each_sample_size': 0.00043463382250315263, 'a_CV_lower_than_ _to_limit_the_dispersion_of_the_mean_of_the_null_distribution': 0.00238803522972525, 'significance_a_CV_lower_than_ _to_limit_the_dispersion_of_the_mean_of_the_null_distribution_etdpScientific_RepoRtS': 0.0010325216439875707, 'limit_theorem': 0.007713134335009549, 'distribution_statistics': 0.007713134335009549, 'programs_group_binox_NEAT_cranrproje_ctwebpacka_githu_bcomstati_stica': 9.148819220060914e-58, 'etdpScientific_RepoRtS': 9.148819220060914e-58, 'a0_Overdispersion': 0.00024169193363446966, 'dispersion_values': 0.007713134335009549, 'distribution_fit': 9.148819220060914e-58, 'to_generate_a_null_distribution_of_crosstalk_to_the_A_\\x9cBetaalanine_metabolism\\x9d_B_\\x9cProstate_cancer\\x9d_and_C_\\x9cAlzheimer\\x99s': 9.148819220060914e-58, 'Betabinomial': 1.4235037169605493e-05, 'binomial_wwwrproje_ctResultsTo': 0.0005073330404429016, 'to_model_crosstalk_between_random_query_gene_sets_versus': 0.00024169193363446966, 'Green_distribution': 0.0005424757619081179, 'FPR_wwwrproje_ctpathway_pathway_\\x9cAlzheimer\\x99s_pathway': 8.849133782924347e-06, 'triangle_circle': 9.148819220060914e-58, 'FPR_wwwrproje_ctpathway': 9.148819220060914e-58, 'Fig_a03C': 9.148819220060914e-58, '\\x9cAlzheimer\\x99s_pathway': 9.148819220060914e-58, 'fit_betabinomial': 0.008039224644126477, 'betabinomial': 0.00022770977125509355, 'to_be_affected_by_the_size_of_the_gene_set': 0.000576827339123862, 'enrichment_method': 0.007713134335009549, 'pvalues_Pvalues': 0.000127439997597395, 'enrichment_method_taking_on_only_four_possible_values_for_\\x9cProstate_cancer\\x9d_due_to_few_overlapping_genes_ANUBIX_fraction_results_significance': 0.007794873673985646, 'NEArender_GEA': 0.00012747396897477752, 'to_be_lower': 0.007713134335009549, 'taking_on_only_four_possible_values_for_\\x9cProstate_cancer\\x9d_due_to_few_overlapping_genes_ANUBIX': 2.07655534153302e-06, 'to_run_at_a_large_scale_NEAT_NEArender_and_BinoX': 0.00210348072096923, 'FPR_values': 0.001515669547328131, 'NEArender_pathways': 5.284363978080408e-05, 'GEA': 0.0005190223242390124, 'FDR_positives_FPR_distributions_to_be_very_different_for_different_pathways_For_the_ _tests_performed_per_pathway_FPR': 0.0010325216439875707, 'FPR_distributions': 8.463934488641445e-06, 'FPR': 0.0005769810645354518, 'to_be_very_different_for_different_pathways_For_the_ _tests_performed_per_pathway': 9.412681118686772e-06, 'case_FPR_values': 0.0002004337912132277, 'query_gene': 1.1223264120411068e-05, 'user': 0.0003322263502299899, 'FDR_threshold': 0.00024831101020746386, 'enrichment_depletion': 0.00024831101020746386, 'less_correlation_fatty_liver': 0.0005852912736125035, '\\x9cAlzheimer\\x99s_\\x9cParkinson\\x99s': 0.000576827339123862, '\\x9cOxidative': 9.148819220060914e-58, 'fatty_liver': 9.148819220060914e-58, 'topologies': 0.0001260170553222508, 'FPsWe': 0.00036637714731608417, 'using_the_igraph_package_in_R': 0.0006810685397702696, 'benchmark': 0.007713134335009549, 'method\\x99s_ability': 0.007713134335009549, 'giving_an_amount_of_gene_overlap_between_the_two_parts_emulated_based_on_the_average_overlap_between_MSigDB_gene_sets_and_KEGG_and_REACTOME_pathways_We_compared_the_methods_by_their_Receiver_Operating_Characteristic_ROC': 1.530426991928727e-07, 'Figure_a06A': 1.771400127825104e-05, 'only_considering_enrichment_ANUBIX': 9.148819220060914e-58, 'TPR': 9.148819220060914e-58, 'FP_BinoX': 9.148819220060914e-58, 'TPR_TPR': 9.148819220060914e-58, 'ROC_curve_NEArender_NEAT': 2.0031394091466016e-05, 'a0_Analysis_pathways_FPR': 0.0010298344840079976, 'number_times': 0.007713134335009549, 'showing_that_ _random_samples_are_enough_Moreover_because_of_sampling_the_pvalue_is_not_an_exact_pvalue_but_a_point_estimate_of_it_we_also_provide_with_the_ _confidence_interval_of_each_of_the_pvalues_Supplementary_Data_Compute_time_ ': 5.284363978080408e-05, 'Compute_time': 0.009101363884740284, 'To_benchmark_its_speed': 0.0038806204677737646, 'compute_time': 0.00238803522972525, 'ANUBIX_BinoX': 8.263922883666513e-55, 'precomputation_step': 1.1686951820486561e-54, 'a0s': 8.263922883666513e-55, 'a0min_0cFigure': 0.00210348072096923, 'a0_Receiver_ROC_curve': 9.148819220060914e-58, 'KEGG_REACTOME_pathway': 9.148819220060914e-58, 'R_version_wwwrproje_ctwe': 9.148819220060914e-58, 'iterations_drawback': 9.148819220060914e-58, 'computation_time_scale_analyses': 9.148819220060914e-58, 'time_gene_sets': 9.148819220060914e-58, 'a0min': 0.00040928894108187346, 'pathway_analysis_study': 0.00238803522972525, 'number_GEA': 9.148819220060914e-58, 'to_have_a_high_occurrence_of_pathway_enrichments': 9.148819220060914e-58, 'parallelization': 5.072888932064798e-06, 'run': 0.00771518910792271, 'a0min_version_wwwrproje': 0.00210348072096923, 'obesity_ethnicity': 0.0004324474998927936, 'Krueger2_Jan_L': 2.7446560661786228e-05, 'attention_expression': 0.0016815001133323047, 'R_Holt3Obesity': 0.00020913182120630444, 'African_Americans': 0.0016810521528134112, 'Obesity': 4.851779253373102e-05, 'acanthosis_nigricans': 4.851779253373102e-05, 'collagen_formation_delayedtype_hypersensitivity': 0.0001261733407126887, 'attention_growth14': 0.002972520604928986, 'to_independently_affect_dermal_cell_proliferation_and_hair_ ': 0.0038806204677737646, 'skin_immunity11': 3.4358152916695635e-05, 'skin_microbiome': 9.148819220060914e-58, 'Hospital_York_USA_2Laboratory': 9.148819220060914e-58, 'USA_6Department': 9.148819220060914e-58, 'Jeanne_M_Walker_Sandra': 9.148819220060914e-58, 'to_compare_gene_expression_in_skin_of_healthy_obese_and_nonobese_subjects_and_to_evaluate_the_potential_importance_of_parallel_changes_in_the_microbiome_and_metabolites_found_on_the_adjacent_skin_surface_and_in_the_adipose_tissue_immediately_below_the_skinMaterials_and_methodsSubjects_ _Participants_were_recruited_from_the_surrounding_community_through_advertisements_and': 0.0019127833147525456, '±_a0years': 0.0003022165162482692, 'ethnicity': 0.00030238349821304724, 'NSAID_use': 9.148819220060914e-58, '±_a0years_ethnicity': 9.148819220060914e-58, 'criteria_inclusion_criteria_swab_collections_biopsy_consent': 0.008629918477970512, 'swab_collections': 0.0002968114767005874, 'to_undergo_punch_biopsy_one_was_withdrawn_due_to_an_intercurrent_illness_two_with_a_BMI_outside_the_required_range_one': 0.0002968114767005874, 'punch_biopsy': 0.0011075402231842013, 'Postmenopausal_women': 9.148819220060914e-58, 'to_exclude_effects_of_the_menstrual_cycle_upon_study_end_points_and_to_exclude_gender_effectsBased_on_preliminary_data_from_a_previous_study_comparing_skin_from_seven_obese_and_six_nonobese_postmenopausal_women': 9.148819220060914e-58, 'history_examination': 0.0002738773298738178, 'blood_testing': 0.0002738773298738178, 'consent_document': 0.0005573368904834178, 'to_shower_biopsy_area_areas': 1.22563579505337e-06, 'calculatorBlood_collection_analysis': 8.263922883666513e-55, 'to_shower': 1.2253092364551366e-06, 'biopsy_area_areas': 1.2253092364551366e-06, 'Libraries': 9.148819220060914e-58, 'using_a_Thermo_Fisher_Qubit_Fluorometer_and_an_Advanced_Analytical_Fragment_Analyzer_Libraries': 9.148819220060914e-58, 'Athena_compute': 9.148819220060914e-58, 'compute_system': 9.148819220060914e-58, 'kmers_taxa_abundances': 0.001386370626689457, 'March_KrakenUniq': 2.2630377144612075e-05, 'kmers': 3.694487965233619e-07, 'KrakenUniq': 0.0010298344840079976, 'package_ALDEx2': 9.148819220060914e-58, 'stabilization_read_counts': 9.148819220060914e-58, 'testingDimensionality_reduction': 4.755544211804391e-07, 'methanol_water': 2.9123279671896297e-05, 'nonhuman': 0.007713134335009549, 'alignments': 9.148819220060914e-58, 'using_Resistome_Analyzer_commit_15a52dd_and_normalized_by_total_reads_per_sample_and_gene_length_to_give_RPKMs_MegaRes_includes_an_ontology_grouping_resistance_genes_into_gene_classes_AMR_mechanisms_and_gene_groupsSkin_metabolome_ ': 9.148819220060914e-58, 'Resistome_Analyzer': 1.3104487659414685e-08, '15a52dd': 2.1404152331574389e-10, 'MegaRes': 9.148819220060914e-58, 'grouping_resistance_genes_AMR_mechanisms_metabolome': 9.148819220060914e-58, 'Swab_heads': 4.755544211804391e-07, 'analysis_samples': 1.844946435746173e-05, 'C_QToF_Corp_Manchester_UK': 0.001130473280667068, 'sample_chamber': 0.00010078719550483667, 'elution_A': 9.148819220060914e-58, 'gradient_A': 9.148819220060914e-58, 'MS_component': 9.148819220060914e-58, 'QToF_Corp_Manchester_UK': 9.148819220060914e-58, 'Raw_spectra': 1.844946435746173e-05, 'biopsy_site': 1.4055400435083287e-53, 'to_return_for_suture_removalGene\\x91array_and_quantitative_real\\x91time_PCR_analysis_ _RNA_was_extracted_followed_by_hybridization_to_Affymetrix_Human_U133_Plus_ _gene_arrays_Santa_Clara_CA_or_quantitative_RTPCR': 2.274211562945482e-53, 'Subjects': 2.274211562945482e-53, 'batch_effect': 0.00018697206834376073, 'protocol_consent': 3.901700916169037e-05, 'a0_Differences_JWA0921ResultsThis_study': 9.148819220060914e-58, 'weight_waist_circumference_weight_waist_circumference': 9.148819220060914e-58, 'weight_waist_circumference': 0.0002968114767005874, 'Comparing_gene_expression_in_obese_versus_nonobese_skin': 0.002183000717651916, 'gene_expression_separation_expression': 0.0008664491865957661, 'peptide_part': 0.0038806204677737646, 'Fig_a0_gene_expression': 9.148819220060914e-58, 'acid_receptor_29foldScientific_RepoRtS': 9.148819220060914e-58, 'to_function_in': 0.0038806204677737646, 'skin_dependent_Kinase': 0.00014626258547791333, 'interferon_gamma_IL12_activity_serpins_mediators': 0.004315547045054443, 'S5': 0.00018962392250449942, 'osteopontin': 0.004315547045054443, '85fold': 0.0016825541366727488, 'metalloproteinase_ILTRN': 0.0038806204677737646, 'separation_list': 0.0016810521528134112, 'genes_FCGR1Î²_CCL3_CZXCL8_interleukin_CLEC7A': 0.0006313632619292757, 'upregulation_differences': 0.0014973092546498807, 'expression_analysis_subgroups': 2.4439933258712573e-05, 'QTPCR': 0.0006412203048989927, 'former': 0.0016926846749969757, 'a0S4': 0.0006264573400700461, 'S6_Microbiota_analysis': 0.0010298344840079976, 'PCA_plot': 6.950106494571144e-05, 'Figure_a0_Differences': 0.0006264573400700461, 'differences_side': 0.0006264573400700461, 'Wilcox_test': 0.0006768252640912667, 'OPLSDA_models': 8.89410348511755e-06, 'Hirt_et': 0.0005451704010514204, 'frequency_severity': 0.0038806204677737646, 'blot_immunofluorescence_staining': 0.0004254422540019666, 'to_evaluate_the_effects_of_drugs_on_GBM_cells': 0.0016480626375926124, 'co\\x91treatment': 0.008186991763352563, 'combination_strategy': 9.148819220060914e-58, 'to_better_understand_the_underlying_mechanism_of_GBM_pathways_in_vivo_and': 9.148819220060914e-58, 'survival_benefits': 0.0038890401121630816, 'cyclic_TMZ2': 1.8090871199370374e-05, 'MGMT_activity': 0.00022918772206369312, 'NFÎºB_inhibitors': 0.0005828796252635297, 'NFÎºB_inhibitor_CBL0137': 0.00016531463508263585, 'to_bind_DNA_leading_the_functional_inactivation_of_the_Facilitates_Chromatin_Transcription_FACT_complex_a_chromatin_remodeling_complex_regulating_transcription_replication_and_DNA_ _repair2021_In_a0vitro_evaluation_of_the_CBL0137_on_FACT_p53_and_NFÎºB': 2.6936218520750945e-06, 'GBM_cells': 0.010110825939499172, 'inhibitor_BAY': 0.002233227346327125, 'combining_multiple_gene_targets': 0.0006864658295143006, 'Bay_TMZ': 0.0007526287367594249, 'to_analyze_functionally_the_combined_effect_of_Bay_ _and_TMZ_in_different_GBM_cells_For_this_purpose': 0.007713134335009549, 'PEGDAbased_microwell_platform31\\x93': 0.007713134335009549, 'cells_U87_LN229': 0.00238803522972525, 'cotreatment_TMZ': 0.0016175784840318222, 'levels_p65_p50': 0.0007641347695089468, 'Tumor_biopsy_samples': 0.0007641347695089468, 'to_continue_our_experiments_with_only_using_our_patientderived_GBM_cells_We_treated_patientderived_GBM_cells_with_Bay_ _and_TMZ_or_alone_and_analyzed_specific_cellular_proteins_along_with_their_posttranslational_modifications_via_reversephase_protein_arrays_RPPA_to_elucidate_the_mechanism_of_action_of_the_ _proteins3839': 0.007713134335009549, 'exploration_\\x91': 0.001128162151175775, 'TMZ': 0.0003259879181368796, 'LN229_U87_cells': 0.00238803522972525, 'spheroids': 0.011499572565104511, 'a0µM_a0µM': 0.010101169564734799, 'LN229_U87': 0.0016480626375926124, 'a0cotreatment': 0.0018073609273236465, 'to_control_groups': 0.00042715439627748463, 'compound_access_differences': 0.0020929823391723163, 'spheroids\\x99_sizes': 0.008428375200044073, 'decrease_101038s41598020703925Vol1234567890wwwnaturecomscientificreports_images': 0.00013777625675559253, 'decrease_101038s41598020703925Vol1234567890wwwnaturecomscientificreports_images_treatment_edge_±_SD': 0.00020954005670185475, 'Dotted_black_lines': 7.681768567174926e-05, 'Prism_v5_Data': 5.3129355551869074e-05, 'Bay': 1.1686951820486561e-54, 'NFÎºB_activation': 8.263922883666513e-55, 'experiments_co\\x91treatment': 2.628715582734087e-05, 'NFÎºB_subunits': 0.00018383646965595502, 'RPPA_platform': 0.007713134335009549, 'drug_treatments': 0.000576827339123862, 'NF\\x93kB_activity_GBM_cell': 9.148819220060914e-58, 'subunit_activity': 9.148819220060914e-58, 'Bcl2_family_proteins': 0.0005521751935137136, 'cotreatment': 0.0022338224647901624, 'RPPA_data': 1.1686951820486561e-54, 'increase_0cFigure': 8.263922883666513e-55, 'group_Red_green': 3.423927091594385e-07, 'Fold': 5.3129355551869074e-05, 'Wilcoxon_c_Analysis': 0.0006940543140455221, 'Representative_immunoblot_validation': 0.000576827339123862, 'loading_control': 0.00013588610209050726, 'fold_changes_p_Fig': 8.263922883666513e-55, 'blot_results': 0.0005807607654450252, 'RPPA_blot_results': 3.6456146093996145e-05, 'chromatin_aggregation': 0.007713134335009549, 'furtherCo\\x91treatment': 0.007713134335009549, 'actin_dynamics_migration_process': 0.0038806204677737646, 'Depolymerization_cleavage': 9.148819220060914e-58, 'to_be_involved_in_cell_ _apoptosis54\\x93': 9.148819220060914e-58, 'a0_Apoptosis': 9.148819220060914e-58, 'Fluorescent_images': 9.148819220060914e-58, 'networks_panel': 0.0011125787591309202, 'day_Fig_panel': 9.148819220060914e-58, 'to_be_polymerized_to_filaments_as_it_can_be_seen_by_its_interaction_with_phalloidin_at_both_days_ _and_ ': 9.148819220060914e-58, 'Factin_anization_shape': 0.0011125787591309202, 'a05c_cotreatment': 0.0006674076661460604, 'migration_patterns': 0.007713134335009549, 'to_develop': 2.648776284353415e-05, 'a0_Changes': 7.48700983901382e-05, 'Representative_immunoblots': 9.148819220060914e-58, 'levels_FAK': 9.148819220060914e-58, 'using_ImageJ_right_panel_Data_were_normalized_to_Bactin_Data': 0.0008522036149147152, '3D_spheroids': 0.00023338930766890486, 'size_drug_effects': 0.00023338930766890486, 'Additionally_using_3D_in_a0vitro_tumor_models': 9.148819220060914e-58, 'LN229_U87_GBM_cells': 9.148819220060914e-58, 'PEGDA_hydrogelbased_microwell': 0.00238803522972525, 'monolayer_cultures': 0.0006683740194778514, 'Akt_promote': 0.004315547045054443, 'agents_TMZ': 9.148819220060914e-58, 'NFÎºB': 9.148819220060914e-58, 'drug_concentrations': 0.007713134335009549, 'decrease_blot_data': 0.0005807607654450252, 'to_inhibit_its_ _phosphorylation46_However_in_the_cotreated_group': 8.263922883666513e-55, 'Glioblastoma_tumors': 0.0008522036149147152, 'GBM_samples': 9.148819220060914e-58, 'to_be_highly_resistant_to_ _apoptosis77': 9.148819220060914e-58, 'RPPA_results': 5.615494744583322e-05, 'interaction_0cFigure': 0.0014616190772430405, 'cytoskeleton_anization_JNK_PI3KAKT': 0.0038806204677737646, 'surface_death_receptors_procaspase8': 0.004315547045054443, 'coupled8081The_literature': 0.000762889468397268, 'human_diseases': 0.000598820003809177, 'Repairing_these_mutations': 0.00024810373354211296, 'to_repair_pathogenic_allele\\x91specific_single\\x91nucleotide_mutations_using_a_single_round_of_genome_editing_Using_high\\x91fidelity_site\\x91specific_nuclease': 0.007713134335009549, 'to_repair_pathogenic_single\\x91nucleotide_variants_SNVs_in_disease\\x91specific': 0.007713134335009549, 'to_repair_pathogenic_single\\x91nucleotide_variants_SNVs_in_disease\\x91specific_variation': 0.0005715966671738797, 'One\\x91SHOT': 9.148819220060914e-58, 'to_repair_other_types_of_mutations_with_potential_beyond_human': 9.148819220060914e-58, 'RET_c2753TC': 0.0038806204677737646, 'end_joining': 0.00025126313729024964, 'palindromic': 0.00038842632962585887, 'wildtype_SpCas9': 9.327263445268705e-06, 'repair_rate': 0.000571748998785482, 'mismatch_tolerance': 0.00027652137160087475, 'tricks': 0.0038806204677737646, 'comparison_MhAX': 4.0341085044264433e-07, 'genome_editing': 6.581276746014844e-09, 'method_MhAX_editing': 0.00026701832080125866, 'bacterium_ND2006': 9.369098874629247e-07, 'cleavage_activity': 5.737506270271671e-05, 'Cas12a_endonucleases': 0.0005373063242131615, 'Cas9': 0.004316696915208163, 'editing_range': 0.004315547045054443, 'First_Cas12a': 8.263922883666513e-55, 'PAM_upstream': 1.1686951820486561e-54, 'PAM_downstream': 7.05029712940268e-05, 'PAMinteracting_variants': 8.263922883666513e-55, 'Cas12a_target': 0.004315547045054443, 'cut': 0.00014894798567909924, 'guide_CRISPR_RNA_crRNA': 9.148819220060914e-58, 'target_recognition': 9.148819220060914e-58, 'Cas12a': 3.4815510793311746e-05, 'cells37': 1.1686951820486561e-54, 'insertions_twonucleotide_substitutions': 8.263922883666513e-55, 'exonskipping': 8.263922883666513e-55, 'to_carry_out_allelespecific_singlenucleotide_repair_of_iPSCs_carrying_the_pathogenic_SNVs_found_in_MEN2B_and_DEB_patients_in_a_single_round_of_genome_editing_To_accomplish_this': 5.681271780288694e-07, 'PAM_variant': 0.007713134335009549, 'HDR_singlestranded': 0.007713134335009549, 'OneSHOT': 1.7244412239089496e-05, 'AsCas12a': 9.148819220060914e-58, 'doublestrand_break': 9.148819220060914e-58, 'ssODN': 0.007713134335009549, 'to_accomplish_allelespecific_singlenucleotide_substitution_of_the_wildtype_alleleWe': 0.0005741125271172155, 'FB414_cells': 4.50144640367801e-06, 'gene_markers': 7.35700295278499e-08, 'using_the_template_by_the_endogenous_HDR_machinery': 1.721776452472901e-06, 'markerpossible_target_sites': 9.1074836528553e-05, 'TYCV': 0.0038806204677737646, 'PAM_sites_TYCV_crRNAs_crRNA_RET2': 0.00238803522972525, 'Y_V_ACG_TTCC': 8.263922883666513e-55, 'upstream': 1.1686951820486561e-54, 'TTCA': 8.263922883666513e-55, 'crRNA_RET2_crRNA_RET2_a0_Fig_a02aTo': 9.148819220060914e-58, 'cleavage_activity_targetrecognition_specificity': 9.148819220060914e-58, 'guide_sequences': 0.0038806204677737646, 'target_sequences': 0.004315547045054443, 'T7E1_assay': 0.007713134335009549, 'Fig_P': 0.0007008712380191807, 'a0X2a_Puromycin_treatment': 9.369098874629247e-07, 'to_replace_the_wildtype_nucleotide_RET_c2753_T_at_the_Met918_site_in_the_wildtype_allele_in_FB414': 0.007713134335009549, 'line_template_ssODN_RET_M918T_I913silentC_marker': 0.0038806204677737646, 'SNMDPCR': 0.007713134335009549, 'to_replace_a_single_nucleotide_in_an_allelespecific_manner_while_minimising_offtarget_effects_As_in_the_preliminary_experiment_direct_sequencing_analysis_around_the_target_sites': 0.0005715966671738797, 'GE1Scientific_RepoRtS_substitution': 0.00025126313729024964, 'sequence_template': 9.849136608862707e-05, 'sites_crRNA_RET2_a0': 0.00013822472623458614, 'Arrowheads': 5.02497942858923e-09, 'analysis_crRNA_RET1': 8.263922883666513e-55, 'RET_Met918_SNMDPCR_analysis': 1.1686951820486561e-54, 'gel_image': 8.263922883666513e-55, 'PCR_amplicon': 8.263922883666513e-55, 'cleavage_activity_recognition_specificity_crRNA_RET2_Fig_a02a': 0.007713134335009549, 'MEN2B_target_sequence': 1.5287975297524316e-08, 'AsCas12a_RR': 9.371595774122743e-07, 'crRNA_RET1_a0_m': 0.007713134335009549, 'marker_C_substitution': 0.00015722628711537504, 'offtarget_effects': 0.007713134335009549, 'sequencing_analysis': 9.148819220060914e-58, 'duplication_events': 9.148819220060914e-58, 'nucleotide_repair': 0.00025126313729024964, 'to_repair_the_pathogenic_SNV_in_RET_without_including_the_singlenucleotide_marker_which_would_achieve_true_scarless_repair_We_therefore_performed_OneSHOT_repair_in_the_FB414_cells_using_AsCas12a_RR_crRNA_RET1_a0_m_and_the_ssODN_repair_template_with_only_a_wildtype_nucleotide_at_Met918': 0.0005715966671738797, 'scarless_repair': 0.0038806204677737646, 'iPSCs': 0.00238803522972525, 'GE5_indels': 9.148819220060914e-58, 'SNV': 9.148819220060914e-58, 'GE5Scientific_RepoRtS': 0.00015722628711537504, 'GIleIleMetThrThrScientific_RepoRtS': 9.148819220060914e-58, 'CellGE1GE2GE3GE4GE5FB414FB414FB414FB414B1173Genotype_\\x86\\x92_MEN2B': 9.148819220060914e-58, 'gene_DNA_samples': 0.00015442122856028365, 'mutation_Positive_screening': 0.00010883068312907455, 'Underline': 9.148819220060914e-58, 'PAM': 9.148819220060914e-58, 'Lower_letters': 5.7903580772134124e-06, 'Lower_letters_indicate_mismatched_bases_in_the_offtarget_candidates_as_compared_with_the_original_target_sequence_b_Number_of_indel_clones_relative_to_the_number_of_analysed_clonesDiscussionMany_hereditary_human_diseases': 0.000598820003809177, 'singlebase_alterations': 0.0007035667068513752, 'to_carry_out_the_repairs_in_a_single_stepUsing_the_OneSHOT_approach_developed_in_this_study_we_successfully_repaired_a_RET_gene_SNV_in_MEN2B_iPSCs_with_the_addition_of_a_singlenucleotide_selective_marker_in_a_single_step': 0.007713134335009549, 'gene_SNV': 0.007713134335009549, 'to_carry_out_scarless_repair_in_MEN2B': 0.00012264967119603705, 'termination_codon': 0.004315547045054443, 'obstacles': 0.0005372605519915083, 'AsCas12a_nuclease': 0.007713134335009549, 'highfidelity_targetrecognition3536': 0.0038806204677737646, 'recutting': 6.341351870118068e-05, 'candidate_clones': 0.0038806204677737646, 'scarless_editing': 0.00771518910792271, 'SNVs': 0.00012613970685026185, 'to_repair_the_SNVs_in_RET_and_COL7A1_within_a_3week_period_with_sufficient_efficiency_for_handpicking': 0.0005715966671738797, 'CORRECT_method': 1.7244412239089496e-05, 'Conversely_MhAX': 9.148819220060914e-58, 'nucleotide_mutation': 9.148819220060914e-58, 'to_have_several_advantages_over_currently_available_methods_see_Supplementary_Table': 0.0005715966671738797, 'HDRspecific_cleavage_activity': 4.008826725939137e-05, 'Ile920': 9.148819220060914e-58, 'using_the_alternative_marker': 9.148819220060914e-58, 'substitutions': 0.00023278977260229162, 'primers_study': 0.00044941264492739084, 'steps5253': 0.0038806204677737646, '1day_recovery_culture_suspension': 4.3215413725238556e-05, 'to_improve_this_rate_by_combining_OneSHOT_with_other_procedures_based_on_alternative_principles_such_as_introducing_a_blocking_base_into_the_repair_ _template2627_andor_using_HDRNHEJ_modification_ ': 0.00238803522972525, 'modification_compounds': 6.203999499665668e-08, 'HDR': 3.7983051208308128e-06, 'HDRpromoting_effects': 0.00024476027129020185, 'to_finetune_the_protocol_and_to_confirm_differentiation_potential_and_functionality_of_the_proteins_in_the_corrected_cell_populationsTo': 0.0003167145330801072, 'AmpliSeq_analysis': 0.007713134335009549, 'repair_fidelity': 0.0005715966671738797, 'ccRcc': 1.6768061092937373e-05, 'Cytoscape_software_DAVID_web_GEPIA_web_set': 0.0010272928914316138, 'circRNAs_DECs': 1.6763594169477137e-05, 'tool_miRWalk': 0.0038806204677737646, 'Cytoscape_software_DAVID_web': 0.00013079212294529716, 'GEPIA_web_set': 2.7376207462107006e-07, 'hsa_circ_0035442': 0.0038806204677737646, 'CXCL5_MTNR1B': 8.263922883666513e-55, 'to_have_a_significant_effect_on_the_overall_survival_time_of_patients_with_ccRCC': 1.1686951820486561e-54, 'CXCL5_GRM4_APLN': 8.263922883666513e-55, 'analysis_study': 7.825401382771421e-05, 'symptoms_biomarkers': 2.761427992200034e-05, 'ccRCC': 0.0005215586792733971, 'RNA_exonuclease': 0.00210348072096923, 'RNA_exonuclease_gene_expression_stability': 0.0005915726387590047, 'pharmacogenomics_analysis': 9.148819220060914e-58, 'to_predict_bioactive_compounds_and_potential_drugs_for_the_treatment_of_ccRCC_which_may_provide_a_new_method_in_the_latent_therapeutic_capacity_of_circRNAs_in_ccRCCMethodsData_obtained_and_DECs_acquired_ _Gene_Expression_Synthesis_GEO_ _wwwncbinlmnihgovgeo_is_a_public_functional_genomic_database_that_allows_users_to_query_locate_review_and_download_research_and_gene_expression_ _profiles11_Microarray_datasets_that_provide_circRNA_expression_profile_data_in_clear_cell_renal_cell_carcinoma_ccRCC_were_acquired_from_the_GEO_database_All_raw_expression_data_were_normalized_and_log2transformed_Then_Limma_a_Bioconductor_package_in_R_was_applied_for_differential_analysis_of_microarray_data_to_determine_DECs_in_microarray_dataset_with_the_criteria_of_log2_fold_change_ _and_P_value_ _prediction_of_MRes_ _Cancerspecific_circRNA_database': 9.148819220060914e-58, 'gbwhueducnCSCD': 0.0005263009120446208, 'response_elements_DIANAmiRPath': 9.148819220060914e-58, 'miRNA\\x99s_functions': 9.148819220060914e-58, 'miRWalk_Microt4_mirbridge': 0.0005915726387590047, 'DEGs_genes_database': 7.668388873262754e-05, 'to_perform_Gene_Ontology_GO_analysis_and_Kyoto_Encyclopedia_of_Genes_and_Genomes_KEGG_pathway_enrichment_analysis_about_the_overlapped_genes_with_a_setting_P_  _and_counts_ _Establishment_of_PPI_network_and_identification_of_hubgenes_ _The_Search_Tool_for_the_Retrieval_of_Interacting_Genes_database': 0.0005917302700768776, 'mappings_Detection_MCODE': 0.00210348072096923, 'interaction_data': 9.148819220060914e-58, 'datasets_annotations': 9.148819220060914e-58, 'mappings': 0.00210348072096923, 'Detection_MCODE': 0.0003208044612686651, 'PPI_networks': 9.66171941997871e-06, 'network_network': 9.148819220060914e-58, 'to_explore_the_influence_on_OS_by_differentially_expressed_hubgenes_between_ccRCC_tissues_and_normal_onesconstruction_of': 9.148819220060914e-58, 'DECs': 7.48700983901382e-05, 'Acquire_selected': 0.0006768252640912667, 'to_treat_the_ccRCC_Negatively_related_drugs': 2.234197400028377e-06, 'P_connectivity_score': 3.654274736736117e-08, 'knowledge_Fig_a02a': 0.00016385845265801986, 'network_database': 9.148819220060914e-58, 'to_predict_drugs_that_might_act_on_hubgenesResultsAcquiring_ _DECs_in_clear_cell_renal_cell_carcinoma': 9.148819220060914e-58, 'carcinoma_tissues_nontumor_tissues': 0.0038806204677737646, 'credible': 0.0038806204677737646, 'characteristics_evidence': 0.004315547045054443, 'which_all': 0.00024940455416981735, 'CircInteractome': 9.148819220060914e-58, 'to_collect_and_explore_potential_target_miRNAs_for_them_A_total_of_ _circRNA\\x93miRNA_interactions_including_hsa_circ_0029340miR1205miR657_hsa_circ_0025135miR587miR637_and_hsa_circ_0039238Scientific_RepoRtS_             ': 9.148819220060914e-58, 'DIANAmiRPath': 9.148819220060914e-58, 'to_probe_the_signaling_pathways_in_that_the_ _miRNAs_may_be_involved_As_shown_in_Fig_a0_these_RNAs_are_involved_in_some_pathways_in_the_development_of_tumorigenesisobtaining_the_overlapped_genes_ ': 9.148819220060914e-58, 'miRNAs\\x99_function': 8.263922883666513e-55, 'tissue_samples_controls': 1.1686951820486561e-54, 'RNAseq_data': 8.263922883666513e-55, 'pathways_target_genes': 0.0009466755491730313, 'PTGER3': 9.148819220060914e-58, 'CXCL5_GRM4_NPY5R_CXCR4_ACKR3': 9.148819220060914e-58, 'axis_hsa_circ_0025135hasmiR637GRM4_axis_hsa_circ_0025135hasmiR637MTNR1B_axis_hsa_circ_0039238hasmiR548pMCHR1_axis_hsa_circ_0039238hasmiR548pCXCR4': 0.0003541698196599458, 'hubgenes_it\\x99s': 5.7759155612946345e-06, 'to_have_significant_effects_on_Scientific_RepoRtS_             ': 0.0010946666812697067, 'pathway_analysis_represents_PTGER3_prolong_act_have': 0.0016810521528134112, 'color_intensity': 0.0002800361681909777, 'dot_size': 9.148819220060914e-58, 'count': 9.148819220060914e-58, 'ADCY2': 0.0004686411271822266, 'APLN': 0.0006321861226151657, 'ADCY2_survival_effects': 0.0009466755491730313, 'candidate_compounds': 9.148819220060914e-58, 'CMap_showing_in_Table_a0': 9.148819220060914e-58, 'molecule_compound_drug': 0.00040934415372960003, 'credibility25Pharmacogenomics_analysis': 2.759578436984271e-06, 'link_credibility25Pharmacogenomics_analysis': 4.8228513050373845e-06, 'processes_RepoRtS': 0.0030515515460231186, 'a0_Bevacizumab': 9.148819220060914e-58, 'Neoplasms_efficiency': 9.148819220060914e-58, 'circRNAs_miRNAs': 0.0005219680427898343, 'a0_changes': 0.0006264573400700461, 'circRNAmiRNA': 0.0008581749454218445, 'hsa_circ_0029340': 8.513575047858228e-06, 'hsa_circ_0084927': 4.469324915591992e-07, 'yet36': 2.7383957469528435e-05, 'effusion_circRNAs': 4.469324915591992e-07, 'to_have_a_function_as_sponge_to_absorb_corresponding_miRNA_by_interacting_with_miRNA_binding_sites_and_thus_playing_a_role_in_regulating_genes_expression_indirectly_Among_the_ _DECs_above_ _circRNAs_hsa_circ_0029340_hsa_circ_0025135': 8.507470976386674e-05, 'a0_network': 0.0006264573400700461, 'miR657_miR587': 9.148819220060914e-58, 'to_act_as_tumorpromoting_molecules_in_some_cancer_ ': 9.148819220060914e-58, 'cells_abilities': 0.0026514494750263864, 'RepoRtS_0cGenesSNPDrugSignificantP_value': 0.0003322263502299899, 'PlainCXCR4rs2228014BevacizumabYesYesIn_patients': 9.148819220060914e-58, 'progressionfree_survival_CC_P': 9.148819220060914e-58, 'CG_GGAllele_C': 2.2355146325637425e-06, 'Apolipoprotein_B_Secretion_Lipid_Synthesis': 0.00013688691036411346, 'allele_TGenotypes_AA_AG': 2.2355146325637425e-06, 'cancer45\\x93_MiR548p': 2.2355146325637425e-06, 'hepatoma_cell_growth_tumorigenesis': 0.004315547045054443, 'miR1278': 0.0015842910551982499, 'KEGG_analysis_pathway_pathways': 9.66171941997871e-06, 'to_have_an_interaction_in_some_cancers_which_may_indicate_that_these_circRNAs_explored_in_this_study_may_exert_the_same_or_related_regulatory_functions_by_acting_on_the_circRNAmiRNAmRNA_axis': 0.0005917302700768776, 'RAS_pathway': 0.0026458119489096896, 'Rap1': 0.00018383646965595502, 'role_ADCY2': 0.0009466755491730313, 'circRNAs_indirectly': 0.0038806204677737646, 'MTNR1B': 0.0010138704761754804, 'systematic': 0.00016385845265801986, 'GRM4': 0.0010068765747081726, 'CXCL5_GRM4': 0.0010068765747081726, 'aggressive': 0.0038806204677737646, 'macrocyclic_lactone_ring': 0.004315547045054443, 'Josamycin': 0.0006246792128329638, 'anticancer': 0.00774138547562212, 'antibiotics_roxithromycin_clarithromycin': 0.0011284627910272927, 'ring_macrolide': 1.8415484017042953e-05, 'josamycin': 0.001128162151175775, 'pairs_signature': 0.0006578099350934741, 'Huang2To_screen_genes': 0.00045647862893717503, 'gene_data': 1.1332775643647009e-05, 'gene_pairs_influence_machine_learning_Using_the_Uclcan_to_analyze_the_immune_genes_expression_in_cervical_cancer_and_to_further_explore_the_association_with_the_expression_level_and_the_clinical_stage_and_prognosis_of_cervical_cancer': 0.0006945415217269727, 'Using_the_Uclcan_to_analyze_the_immune_genes_expression_in_cervical_cancer_and_to_further_explore_the_association_with_the_expression_level_and_the_clinical_stage_and_prognosis_of_cervical_cancer': 7.444813181255613e-06, 'IRGPs': 0.0015842910551982499, 'infiltration_metastasis': 3.0692047075242674e-05, 'set_gse4400116': 0.0009466755491730313, 'compilation_GEO_wwwncbinlmnihgovgeo_database': 0.0009466755491730313, 'cells_chemokines_receptors_cytokines_receptors': 4.165425664237844e-06, 'R_we': 0.00017214475949562278, 'expression_amount': 2.8051737105987167e-06, 'IRGP': 0.001615799062055586, 'expression_data_expression_amount': 0.0014629739253462538, 'to_screen_the_prognosis_IRGP_FDR_  _Cox_risk_regression_analysis_and_glment_in_R_ _were_used_to_perform_tenfold_cross_validation_to_analyze_the_candidate_IRGP_and_obtain_the_IRGP_index_We_constructed_the_best_ _gene_pairs_as_immune_gene_pair_model_We_use_ROC_to_calculate_the_optimal_cutoff_value_of_IRGP_index_and_use_it_as_the_basis_to_distinguish_high_and_low_risk_groupsIRGPs_model_validation_ ': 7.2071164024907285e-06, 'Cox_regression_analysis_glment': 9.148819220060914e-58, 'to_perform_tenfold_cross_validation_to_analyze_the_candidate_IRGP_and_obtain_the_IRGP_index_We_constructed_the_best_ _gene_pairs_as_immune_gene_pair_model_We_use_ROC_to_calculate_the_optimal_cutoff_value_of_IRGP_index_and_use_it_as_the_basis_to_distinguish_high_and_low_risk_groupsIRGPs_model_validation_ ': 9.148819220060914e-58, 'IRGP_IRGP_to_screen_the_prognosis_IRGP_FDR_  _Cox_risk_regression_analysis_and_glment_in_R_ _were_used_to_perform_tenfold_cross_validation_to_analyze_the_candidate_IRGP_and_obtain_the_IRGP_index_We_constructed_the_best_ _gene_pairs_as_immune_gene_pair_model_We_use_ROC_to_calculate_the_optimal_cutoff_value_of_IRGP_index_and_use_it_as_the_basis_to_distinguish_high_and_low_risk_groupsIRGPs_model_validation_ ': 0.001129870936471824, 'CIBERSORT17_to_evaluate_and_predict_the_enrichment_of_immune_cells_in_the_samples_CIBERSORT_is_a_tool_for_deconvolution_of_the_expression_matrix_of_immune_cell_subtypes_based_on_the_principle_of_linear_support_vector_regression_RNA_SEQ_data_can_be_used_to_estimate_the_infiltration_of_immune_cells_CIBERSORT_can_analyze_the_relative_abundance_of_ _immune_infiltrating_cells_in_each_sample_including_NK_cells_T_cells_B_cells_and_macrophagesFunctional_ _enrichment_ _analysis_ _of_ _GSEA_ _go_ _and_ _KEGG_ _Gene_ _set_ _enrichment_ _analysisGSEA_enrichment_analysis_was_carried_out_for_each_gene_related_to_immune_prognosis_using_the_fgsea_package_in_R_ _Cluster_ _profiler19_was_used_to_enrich_Gene_ontologyGOfunction_and_KEGG_pathway_Significant_enrichment_criteria': 0.007713134335009549, 'regression_RNA_SEQ_data': 1.1686951820486561e-54, 'to_estimate_the_infiltration_of_immune_cells_CIBERSORT_can_analyze_the_relative_abundance_of_ _immune_infiltrating_cells_in_each_sample_including_NK_cells_T_cells_B_cells_and_macrophagesFunctional_ _enrichment_ _analysis_ _of_ _GSEA_ _go_ _and_ _KEGG_ _Gene_ _set_ _enrichment_ _analysisGSEA_enrichment_analysis_was_carried_out_for_each_gene_related_to_immune_prognosis_using_the_fgsea_package_in_R_ _Cluster_ _profiler19': 8.263922883666513e-55, 'KEGG_Gene': 0.0002788738900395108, 'to_enrich_Gene_ontologyGOfunction_and_KEGG_pathway_Significant_enrichment_criteria': 8.263922883666513e-55, 'Ualcan': 9.148819220060914e-58, 'to_ _analyze_ _the_ _expression_ _of_immune_genes_in_cervical_cancerStatistical_ _analysis_ _Measured_ _data_ _were_ _expressed_ _as_ _mean_±_standard_ _deviation_ ': 9.148819220060914e-58, 'test_Meier_method': 0.0001559963661892288, 'curve_ROC_curve_ROC_analysis': 2.7032711681648335e-06, 'studies_TCGA_101038s41598020705005Vol0123456789wwwnaturecomscientificreports_0cFigure': 6.0025617222710656e-06, 'expression_data_genes': 0.00238803522972525, 'ROC_curve_a0_prognosis': 0.0002698537781800097, 'prognosis_gene': 0.00010401223498676455, 'CIBERSORT': 0.00238803522972525, 'training_patients': 0.0006943564809761616, 'groups_C_Training': 9.148819220060914e-58, 'set_multivariate': 9.148819220060914e-58, 'function_enrichment': 0.004036097867317862, 'kappa_B': 2.3941537278156315e-05, 'killer': 1.1686951820486561e-54, 'proteins_cytokines_Th1_Th2_cell_differentiation': 8.263922883666513e-55, 'Fig_a06HExpression': 0.0016480626375926124, 'HPV_infection': 9.148819220060914e-58, 'to_be_the_main_cause_of_cervical_ _cancer2122': 9.148819220060914e-58, 'patients_PDL1_inhibitors': 0.00022918772206369312, 'PD1': 0.0011075402231842013, 'C_Validation': 9.148819220060914e-58, 'Cox_regression_analysis_\\x89¥_\\x89¥_datahigher_risk': 9.148819220060914e-58, 'to_standardize_and_scale_the_data_This_method_has_been_used_in_many_studies_including_cancer_molecular_classification_with_high_ _reliability3233In_this_study_we_screened_ _pairs_of_IRGP_to_construct_the_immune_prognosis_model_related_to_the_overall_survival_rate_of_cervical_cancer_patients': 0.0038806204677737646, 'effect_infiltration_analysis': 0.0019361983037878927, 'mast_cells_macrophages': 0.00022918772206369312, 'infiltration_status': 9.148819220060914e-58, 'D_Expression': 9.148819220060914e-58, 'CD4_T_cells_cd8_t_cells': 0.0016810521528134112, 'binding_binding_binding': 0.0009466755491730313, 'Histogram_graph_pathway_analysis': 9.148819220060914e-58, 'Point_graph': 9.148819220060914e-58, 'cancer_IL10': 1.284690556057437e-52, 'Torres_et': 7.417164383651313e-53, 'effectTGF\\x94Î²': 7.417164383651313e-53, 'T_cell_proliferation': 7.417164383651313e-53, 'response41_Research': 9.148819220060914e-58, 'effectTGF\\x94Î²_T_cell_proliferation_Torres_et': 9.148819220060914e-58, 'Growth': 0.00021559585552483182, 'proliferation_invasion_remodeling': 0.00047983738574547787, 'protein_cytokine_cell_differentiation': 8.263922883666513e-55, 'cancer_HPV': 0.0005521751935137136, 'duox1': 0.0015842910551982499, 'DUOX1': 0.0008412492848308453, 'proliferation_resistance': 1.372478220887687e-05, 'data_samples': 0.007713134335009549, 'a0_Expression_M_Expression': 9.148819220060914e-58, 'pair_model': 9.148819220060914e-58, 'IRGP_genes': 0.0006943564809761616, 'field_radiation_therapy_study_Phys_\\x93': 0.0002812637223256724, 'a0work_a0a': 9.148819220060914e-58, 'a0feature_a0selection': 9.148819220060914e-58, 'a0combined': 9.148819220060914e-58, 'a0subjects_a0subjects': 9.148819220060914e-58, 'a0from_a0subjects_a0': 9.148819220060914e-58, 'a0model_a0periods_a0precision': 9.148819220060914e-58, 'a0model': 9.148819220060914e-58, 'a0all_a0active': 9.148819220060914e-58, 'to_be_a_combination_of_genetic_environmental_and_psychological_factors_that_disrupt_the_microbial_ecosystem_of_the_ _colon34_Genomewide_association_studies_risk_loci': 5.4724502518353575e-05, 'to_be_a_combination_of_genetic_environmental_and_psychological_factors_that_disrupt_the_microbial_ecosystem_of_the_ _colon34_Genomewide_association_studies': 0.00210348072096923, 'ecosystem': 0.004315547045054443, 'Boland': 5.090489166208544e-06, 'IBD_machine_learning': 9.148819220060914e-58, 'to_classify_IBD_paediatric_patients_using_endoscopic_and_histological_ _data15_to_distinguish_UC_colonic_samples_from_control_and_Crohn\\x99s_disease_colonic_ _samples16_and_to_discriminate_between_healthy_subjects_UC_patients_and': 9.148819220060914e-58, 'Genome_U133_ArrayAffymetrix_ArrayAffymetrix_Gene_ST_Array': 9.148819220060914e-58, 'UsageModel': 9.148819220060914e-58, 'machine': 0.007713134335009549, 'Omnibus_database': 0.00238803522972525, 'numbers_GSE11521819': 0.00238803522972525, 'three_dataset_validation_dataset_criteria': 0.0001957784396452663, 'validation_dataset': 0.00238803522972525, 'mucosa_abnormalities_GSE1152': 0.0002182471618650516, 'GEO2R25': 9.148819220060914e-58, 'to_retrieve_the_mapping_between_probe_IDs_and_gene_symbols_Probe_IDs_without': 9.148819220060914e-58, 'removed': 9.148819220060914e-58, 'mucosa_abnormalities_GSE1152_to_retrieve_the_mapping_between_probe_IDs_and_gene_symbols_Probe_IDs_without': 9.148819220060914e-58, 'GSE1152_GSE11223_GSE22619': 0.007713134335009549, 'weightTo': 9.148819220060914e-58, 'training_datasets': 9.148819220060914e-58, 'UC_samples_controls_genes': 0.0011617666021303125, 'features_genes': 0.007713134335009549, 'DRPT': 0.010436175505281345, 'perturbation_theory': 0.00017057723572539983, 'repetitions': 0.007719350026983925, 'precision_AP': 0.00238803522972525, 'candidate_SVM_model': 0.007713134335009549, 'SVM_implementation': 0.007713134335009549, 'Weka_\\x93': 0.00238803522972525, 'training_dataset_animalsResultsFeature_a0selection': 0.007713134335009549, 'BioDiscML': 0.00210348072096923, 'validation_datasets': 0.00238803522972525, 'classifier_configuration': 0.007713134335009549, 'wekaclassifierstreesRandomTree_\\x93_K_V_S_\\x9d': 0.00016553660791656055, '5fold_crossvalidation': 0.007713134335009549, 'QQ_plot': 0.0025884690209384774, '\\x88\\x92_value': 7.48700983901382e-05, 'Horizontal_line': 0.0013882295497307361, 'AP': 0.008041460566471202, 'AUPRC34': 0.00013145983038309643, 'candidate_models': 0.00048587472835324937, 'AUPRC_AUPRC': 0.007713134335009549, 'API_Version': 0.00238803522972525, 'the_utility': 0.00238803522972525, 'GO_term_pathway': 0.00021944374809642538, 'to_have_an_antiinflammatory_effect_on_a_murine_colitis_ ': 8.263922883666513e-55, 'to_be_critical_in_the_production_of_hydrogen_peroxide_within_the_colon_and_to_be_upregulated_in_active_ _UC47Scientific_RepoRtS_             ': 1.3872920953912478e-06, 'MajorBlood_protein_levels': 9.148819220060914e-58, 'spectrum_disorders': 9.148819220060914e-58, 'reticulocyte_percentage': 0.00029540981397560654, 'mineral_degeneration_protein_levels': 9.148819220060914e-58, 'ALT_levels_virus_susceptibility': 9.148819220060914e-58, 'S_erythrocyte': 9.148819220060914e-58, 'thyroglobulin_synthesis_decline_rate': 9.148819220060914e-58, 'protein_levels_function': 4.430023696406686e-06, 'distinguishing_UC_patients_from_Crohn\\x99s_CD_patients': 8.126432409595075e-05, 'to_assess_the_accuracy_of_our_32gene_model_in_gene_expression_profiles_of_blood_samples_A_recent_ _study48': 0.0005479687540571566, 'to_diagnose_UC_instead_of_a_colonoscopy_or_sigmoidoscopyIn_a_previous_study_where_machine_learning_was_employed_to_perform_a_risk_assessment_for_CD_and_UC_using_GWAS_ _data49_a_twostep_feature_selection_strategy_was_used_on_a_dataset_containing_ _Crohn\\x99s_disease_cases_ _UC_cases_and_ _controls_with_ _SNPs': 0.00032618452265076087, 'links_features': 0.00238803522972525, 'to_find_associations_with_UC_To_put_the_performance_of_our_32gene_model_into_perspective': 0.0009466755491730313, 'a0al17': 9.148819220060914e-58, 'feature_selection_SMO_classifier_type': 9.148819220060914e-58, 'to_evaluate_the_ _genes_as_potential_biomarkers_on_a_external_set_of_subjectsReceived_ _March_ ': 0.0005479687540571566, 'Ulcerative_colitis': 0.000199629432709579, 'gens8_Genomewide_association_study': 0.0006940543140455221, 'A_et_al_Metaanalysis': 9.148819220060914e-58, 'risk_loci_v201401028_al_performances_biomarker_analysis': 9.148819220060914e-58, 'Lepage_et_al_Twin_study': 9.148819220060914e-58, 'loss_LennardJones_J_E_Classification': 9.148819220060914e-58, 'methylome_map': 9.148819220060914e-58, 'rse': 9.148819220060914e-58, 'Mach_Learn_Res_\\x93_Yates_Ensembl_data_Schulte_LDL_cholesterol': 0.00010611798230916072, 'Rafael_Blesa45_Alberto_Lle45_Francisco': 9.148819220060914e-58, 'Juan': 9.148819220060914e-58, 'comorbidities_conditions': 0.0007080023910910008, 'expanding_the_knowledge_about_their_clinical_characteristics_and_related_laboratory_parameters': 0.0007080023910910008, 'comorbidities_conditions_expanding_the_knowledge_about_their_clinical_characteristics_and_related_laboratory_parameters': 0.00026774693124157075, 'DS_individuals': 0.0002469065850070426, 'age\\x91_differences': 0.00238803522972525, 'years_CKDEPI_DS_ESR_FT4': 7.65502412836493e-06, 'Spain_2Institute': 9.148819220060914e-58, 'Research_Council_Spain_3Translational_Research_IRBLleida': 9.148819220060914e-58, 'Spain_8Center': 9.148819220060914e-58, '0cHDLc_LDLc': 9.148819220060914e-58, 'populations6_DS': 0.000514692913697106, 'population_laboratory_results': 0.0007080023910910008, 'basis_i': 0.001129870936471824, 'Down_Medical_Center': 0.0002919243480472275, 'Analyzed': 2.5164048986301268e-52, 'venipuncture_pathologyDermatological': 4.649709951488235e-52, 'using_Wilcoxon_ranksum_test_bilirubin_triglycerides_proteins_vitamin': 0.0008745153713472323, 'range_Differences': 9.148819220060914e-58, 'using_Wilcoxon_ranksum_test': 9.148819220060914e-58, 'bilirubin_triglycerides_proteins_vitamin': 0.0003069306742853986, 'count_blood_cell': 1.4912070028742668e-05, 'hemoglobin': 2.436162613582785e-07, 'to_summarize_the_characteristics_of_the_study_population_Data': 0.00015955002081907, 'Data_normality': 9.148819220060914e-58, 'using_the_Kolmogorov\\x93Smirnov_test': 9.148819220060914e-58, 'to_compare_continuous_variables_across_the_study_groups': 0.0003022165162482692, 'rho_coefficient': 9.148819220060914e-58, 'to_assess_the_correlation_between_continuous_variables_The_statistical_software_package_R_ _wwwrproje_ct_was_used_for_statistical_analyses_A_Pvalue_  _was_considered_statistically_significantEthical_aspects_ ': 9.148819220060914e-58, 'Sant_Pau_Ethics_Committee_cohort_characteristics': 0.0019127833147525456, 'participants_representatives': 0.0004100538998299479, 'total_subjects_males_females': 0.00238803522972525, 'Sant_Pau_Ethics_Committee_consent_cohort_characteristics': 0.0005373063242131615, 'AF_MCV_ESR_MCH_RDW': 0.0006810685397702696, 'age_differences_fact': 0.007713134335009549, 'women_women24': 0.000347488144371561, 'described48925': 0.000347488144371561, 'Platelet': 4.655526554039629e-05, 'fLWBC_109LFemales_OOR_\\x93_\\x93': 0.0018019081382898503, 'categoricalpvalue': 0.00015266313713209798, 'trisomy': 9.148819220060914e-58, 'cell_biology': 9.148819220060914e-58, 'derangements': 2.9415354164400537e-05, 'function_number': 0.0038806204677737646, 'existence_mUILNa_mmolLK': 0.00019772319418830678, 'mmolLGlucose': 9.148819220060914e-58, 'µmolLeGFR_parametersHemoglobin': 9.148819220060914e-58, 'fLWBC': 7.59844970826807e-07, 'Table_Differences_group_Differences': 0.0007641347695089468, 'cholesterol_TG_concentrations': 0.007713134335009549, 'to_answer_questions_regarding_lipid_metabolism_lowdensity_lipoprotein_cholesterol_LDLc_and_highdensity_lipoprotein_cholesterol_HDLc': 0.0019127833147525456, 'unfavorable41\\x93': 0.0018006682651940404, 'incidence_incidence': 0.0006768252640912667, 'incidence_forms': 0.004315547045054443, 'hemoglobin_HbA1c_concentrations': 9.148819220060914e-58, 'making_it_difficult_to_draw_conclusions_regarding_dyslipidemia_and_diabetes_mellitus_in_our_cohort': 9.148819220060914e-58, 'comorbidities_use': 0.0013882295497307361, 'making_it_difficult_to_draw_conclusions_regarding_dyslipidemia_and_diabetes_mellitus_in_our_cohort_number': 0.0013652598249100716, 'analysis_fact': 0.00238803522972525, 'life_span': 5.814494100451633e-05, 'DIO3_expression': 0.001956166102174684, 'relapse23_Genomic_tests_improve_the_clinical_prediction_of_patient_outcomes_and_determine_the_necessity_of_adjuvant_chemotherapy_with_endocrine_ _therapy34_However_it_is_a_highly_heterogeneous_disease_that_is_diverse_in_its_behavior_and_responsiveness_to_the_different_modalities_of_ _treatment56_Breast_cancer_is_characterized_based_on_receptor_and_gene_expression_profiles_that_together_with_the_classic_clinicopathological_variables_guide_the_treatment_and_estimate_the_risk_of_ _recurrence34_Gene_expression_profiling_studies_have_established_at_least_four_molecularly_distinct_types_of_breast_cancer_that_can_be_expanded_to_the_\\x9cintrinsic\\x9d_subtypes_luminal_A_LumA_luminal_B_LumB_HER2enriched_basallike_and_normallike7\\x93Numerous_studies_have_established_thyroid_hormones_THs_as_critical_regulators_of_multiple_cellular_processes_in_normal_and_tumor_ _cells10_They_contribute_to_cellular_proliferation_and_differentiation_during_development_and_adulthood_and_are_finetuned_for_tissuespecific_ _control1011_Clinical_studies_associate_TH_levels_with_breast_1Thyroid_Unit_Endocrine_Division_Hospital_de_Cl\\xadnicas_de_Porto_Alegre_Rua_Ramiro_Barcelos_ _Porto_Alegre_RS_CEP_   _Brasil_ _2Institute_ _of_ _Informatics_Universidade_ _Federal_ _Do_ _Rio_Grande_ _Do_ _Sul_ _Porto_Alegre_Brazil_3Bioinformatics_Core_Hospital_de_Cl\\xadnicas_de_Porto_Alegre_Porto_Alegre_Brazil_4Department_of_Pathology_Hospital_de_Cl\\xadnicas_de_Porto_Alegre_Porto_Alegre_Brazil_ _5Faculdade_de_Medicina_Universidade_Federal_Do_Rio_Grande': 0.001845170519318405, 'LumA_luminal_B_basallike_studies': 1.0037703150157868e-05, 'tissuespecific_control1011_Clinical_studies': 9.148819220060914e-58, 'TH_levels': 9.148819220060914e-58, 'B_breast_carcinoma_intensity_level': 9.148819220060914e-58, 'to_calculate_the_Hscore_combined_with_the_percentage_of_positive_cells_see_\\x9cMethods\\x9dcancer_risk_and_ _mortality1213': 9.148819220060914e-58, 'effect_T4': 0.0004738574283430153, 'unclear1920Modulation': 0.0004576368763948737, 'Briefly_type_deiodinase': 1.1686951820486561e-54, 'activation_inactivation': 8.263922883666513e-55, 'triiodothyronine': 8.263922883666513e-55, 'Type_deiodinase': 0.00210348072096923, 'DIO2': 9.148819220060914e-58, 'locally_converting_the_prohormone_ _T4_into_the_active_ _T3_Meanwhile_type_ _deiodinase_DIO3': 9.148819220060914e-58, 'hyperexpression': 2.6916426852543886e-05, 'T3_concentrations': 0.00210348072096923, 'DIO3_immunohistochemistry_staining': 9.148819220060914e-58, 'promoter_hypermethylationResultsDIO3': 9.148819220060914e-58, 'receptor_statusHER2_statusCPNSpositivenegativeTNM': 9.148819220060914e-58, 'negativePatients': 9.148819220060914e-58, 'metastasisPNSBEerocSHerocSHerocSHerocSHnegativepositiveabsencepresenceIIIIIIIVGLog': 9.148819220060914e-58, 'p0012liavvrusfoytilibaborPDIO3': 9.148819220060914e-58, 'status_C_HER2_metastasis_staging_Kaplan\\x93Meier_plot': 0.0010300353536037577, 'association_mean_Hscore': 0.00238803522972525, 'growth_factor_Patients': 0.0006321861226151657, 'value_Fig_a03A': 0.0005915726387590047, 'to_be_reduced_in_primary_solid_tumors_N_  ': 3.192306292396919e-05, 'Fig_a03F_DIO3_expression': 0.0005865071468874085, 'methylation_analysis': 0.007826983625777101, 'to_decreased_DIO3_ _expression_ _in_ _breast_ _cancer_ ': 0.004315547045054443, 'methylation_levels': 3.0981158789700008e-06, 'to_be_extremely_G_ _C_rich_ _of_the_sequence': 0.00019005116353045318, 'kbp': 3.0981158789700008e-06, 'tumor_subtypes': 0.0055616726205871755, 'A_subtypes': 9.148819220060914e-58, 'expression_P_value_DIO3_expression': 9.148819220060914e-58, 'a0_Kaplan\\x93Meier_estimates_Patients': 0.00025094954260364283, 'DIO2_DIO3': 0.00025094954260364283, 'to_be_upregulated_in_MCF7_cells_and_downregulated_in_MDAMB231_cells': 5.8214989465141035e-06, 'cells_mRNA': 9.512079050307224e-08, 'invasiveness_dedifferentiation': 0.0007065571154795519, 'to_maintain_DIO3_expression_during_adulthood': 0.00030237797101608573, 'existence_explanation_T3': 9.148819220060914e-58, 'cycle_progression_proliferation_mechanism': 9.148819220060914e-58, 'ERalpha': 4.413354331819822e-08, 'Contributing_to_this_Scientific_RepoRtS_             ': 0.0016480626375926124, 'promoter_elements': 4.28614392401054e-05, 'estrogen_progesterone_receptors': 9.148819220060914e-58, 'DIO3_activity': 9.148819220060914e-58, 'Fig_a05C': 0.00044941264492739084, 'DIO3_expression_DIO3_gene': 9.148819220060914e-58, 'to_be_hypermethylated_in_Bcell_Tcell_and_myeloid_malignancies_and': 9.148819220060914e-58, 'cancer5152Our_study': 0.00044941264492739084, 'consequence': 0.0005115696522712492, 'DIO3_expression_gene_hypermethylation_N_reports': 0.0016161918113630467, 'gene_hypermethylation': 0.0016480626375926124, 'fibroadenomas': 0.0002543534709449633, 'Ethics_Committee_studies': 0.0019127833147525456, 'Pro_software_Surrey_BC_Canada': 1.1686951820486561e-54, 'to_capture_the_images_DIO3_staining_was_evaluated_by_an_experienced_pathologist_blinded_to_the_molecular_profile_and_TNM_staging': 8.263922883666513e-55, 'DIO3_staining': 7.116285144947346e-07, 'to_capture_the_images_DIO3_staining_was_evaluated_by_an_experienced_pathologist_blinded_to_the_molecular_profile_and_TNM_staging_percentage_intensity_level_using_the_following_formula_[_\\x97_ _cells_    _\\x97_ _cells_    _\\x97_ _cells_ _]_to_define': 0.0016602676715648304, 'Hscore': 9.148819220060914e-58, 'percentage_intensity_level': 9.148819220060914e-58, 'using_the_following_formula_[_\\x97_ _cells_    _\\x97_ _cells_    _\\x97_ _cells_ _]': 8.263922883666513e-55, 'Hochberg63_Clinicopathological_information_for_TCGABRCA_samples_was_downloaded_through_TCGAbiolinks_and_the_Broad_GDAC_Firehose_ _gdacbread_insti_tute_merged_level_ _clinical_data_For_tumors_of_the_TCGABRCA_cohort_data_retrieved_from_PAM50_classification': 9.148819220060914e-58, 'to_define': 9.148819220060914e-58, 'Kaplan\\x93Meier_method': 8.42128346242614e-06, 'TCGAbiolinks_RBioconductor_package30_RepoRtS': 0.007713134335009549, 'Shogo_Kuriyama1_Hiroki': 9.148819220060914e-58, 'toyoshima3_takahiro': 9.148819220060914e-58, 'X\\x91ray': 0.004332515817159164, '\\x9chybrid\\x9d_compton_camera': 0.007721530385997435, 'detector': 0.0005147343668135562, 'Am_ _keV_and_ _Cs_ _keV_in_the_same_field_of_view_achieving_an_angular_resolution_of_\\x97_¦_FWHM_for_both_sources_in_addition_imaging_of_ _At_was_conducted_for_the_application_in_future_nuclear_medicine_particularly_radionuclide_therapy_the_initial_demonstrative_images_of_the_ _At_phantom': 0.00238803522972525, 'roles_they': 1.090830747319825e-05, 'energy_range': 0.0006685521372541687, 'PET': 9.148819220060914e-58, 'positron_emitters': 9.148819220060914e-58, '511keV_gamma_rays': 0.004315547045054443, 'Compton_camera12': 9.148819220060914e-58, 'to_cause_a_breakthrough_in_nuclear_ _medicine34': 9.148819220060914e-58, 'Attempts': 9.148819220060914e-58, 'to_develop_Compton_cameras_aiming_the_image_of_prompt_gamma_rays_emitted_from_the_patient\\x99s_body_during_proton_ _therapy5\\x93': 9.148819220060914e-58, 'to_realize_tracer_visualization_using_the_Compton_camera': 0.000151402946533101, 'Compton_camera': 0.00037313147848826346, 'a0_Comparison_a0al': 9.148819220060914e-58, 'gamma_imaging': 9.148819220060914e-58, 'to_be_researched_in_the_future': 0.000285771535607769, 'keV': 0.0038806204677737646, 'application_SPECT_tracer': 4.665878355305047e-06, 'using_a_Compton_camera_consisting_of_SiCdTe_semiconductors_which_is_however_limited_both_in_terms_of_detection_efficiency_and_angular_ ': 1.4302588181528897e-06, 'radionuclide': 0.0038806204677737646, 'RNT': 0.0006611997588271541, 'SPECT_use': 3.459195799446709e-05, 'Î±p_emitter': 5.648096362206708e-07, 'radionuclides': 9.148819220060914e-58, 'Xrays_gamma_rays': 9.148819220060914e-58, 'Xrays': 3.458274301555502e-05, 'highenergy_gamma_rays_Table_a0_imaging_system': 0.00023791614304068028, '\\x9chybrid\\x9d_Compton_camera': 9.148819220060914e-58, 'using_the_front_detector_as_a_scatterer_for_highenergy_photons_a0_keV_and_an_active_pinhole_for_lowenergy_photons': 9.148819220060914e-58, 'hole': 8.396050987886213e-06, 'prototype': 0.00238803522972525, 'imagingResultsperformance_evaluation': 0.00238803522972525, 'imaging_performance': 1.0977942309711817e-05, 'simulation_configuration': 1.030402844775557e-05, '101038s41598020710195Vol1234567890wwwnaturecomscientificreports_0cFigure': 1.682646216562177e-07, 'scintillator': 9.148819220060914e-58, 'MPPC_arrays_metal_case': 9.148819220060914e-58, 'point_source': 1.4055400435083287e-53, 'equation_101038s41598020710195Vol1234567890wwwnaturecomscientificreports_0cFigure': 2.274211562945482e-53, 'reconstruction_flow': 0.007713134335009549, 'details_detection_efficiency': 7.97765208886232e-06, 'configuration_MLEM': 9.927994518112209e-05, 'resolution_measure': 0.007713134335009549, 'to_measure_the_angular_resolution_of_Compton_cameras_For_measuring_the_angular_resolution_of_pinhole_imaging': 0.004315547045054443, 'resolution_FWHM_distance': 2.1050490145489324e-05, 'Compton_mode': 0.00027811538871549263, 'energy_spectrum': 9.148819220060914e-58, 'LaBr3_scintillator': 9.148819220060914e-58, 'using_a0keV': 9.927994518112209e-05, 'mm_weight_a0': 3.2844744110215605e-06, 'overdose': 6.757701162272892e-06, 'Compton_image': 0.0003309404805354376, 'a0_Compton_MLEM': 9.148819220060914e-58, 'image_¦_a0': 9.148819220060914e-58, 'pinhole_MLEM': 0.00017917985644983153, 'possibly_owing_to_the_lack_of_event_statistics_as_shown_in_Fig_a0': 0.0001788354435343705, 'Examples_configuration': 9.148819220060914e-58, 'view_Compton_event': 9.148819220060914e-58, 'source_position': 9.148819220060914e-58, 'pinhole_reconstruction': 9.148819220060914e-58, 'Moreover_Xray_gammaray_energy': 9.148819220060914e-58, 'nuclides_energies': 9.148819220060914e-58, 'gammaray': 9.148819220060914e-58, 'Ac': 9.148819220060914e-58, 'tracers': 0.0002737940764806342, 'performance_hole_size': 0.0002737940764806342, 'Compton_cameras': 0.0004214107470383819, 'pinhole_imaging': 6.869833174687398e-06, 'a0keV': 0.004315547045054443, '2D_energy_spectrum': 0.00010549291232432236, 'Ã\\x97_array': 1.371808579681404e-07, 'Ã\\x97_mm2_pinhole': 8.398288057338509e-06, 'time_range': 9.148819220060914e-58, 'to_be_±_a0_a0Î¼s_and': 9.148819220060914e-58, 'imaging_similar_to_that_of_a_pinhole_camera': 0.00014750438006977417, 'to_have_passed_through_the_hole_in_the_front_detector': 0.0007956673215405282, 'anticoincidence_events': 0.004315547045054443, 'energy_cut': 9.148819220060914e-58, 'to_restrict_the_energy_range_of_photons_deposited_in_each_detector': 9.148819220060914e-58, 'Cs_sources': 0.004315547045054443, '0cRadionuclide241Am137Cs211At211AtTarget_keV_ModePinholeComptonPinholeComptonEnergy': 9.148819220060914e-58, 'keV_Efront_Efront_Efront_Erear_Table_numbers': 9.148819220060914e-58, 'red': 0.00047308630336515304, 'Figure_a0_left_red': 0.00014027187310178076, 'approximation_method153536': 1.5503291205945584e-10, 'to_improve_the_image_quality_This_method_uses_statistical_iterations_to_locate_sources_with_greater_accuracy_and_better_signaltonoise_ratio_alternate_to_the_simple_back_projection_method_The_number_of_iterations_is_ _for_each_mode_except_for_the_\\x9cL\\x9dshaped_Compton_image_which_is_ _In_the_pinhole_mode': 9.488516943657745e-09, 'Compton_telescope': 9.148819220060914e-58, 'COMPTEL': 9.148819220060914e-58, 'Instrum_P06009': 0.00028570359774207095, 'analysis_imaging_technology': 0.00027626151939488195, 'A_et_al_Development': 9.148819220060914e-58, 'Instrum_Methods_Phys_Res_Sect': 9.148819220060914e-58, 'likelihood_reconstruction': 9.148819220060914e-58, 'camera_images': 9.148819220060914e-58, 'a0_\\x93_C199877387_AcknowledgementsThis_research': 9.148819220060914e-58, 'Number_JP15H05720': 9.148819220060914e-58, 'At': 1.3004838797472323e-05, 'manuscriptcompeting_interests': 0.0007970033104328572, '16H06278Author_contributionsJK': 1.3004838797472323e-05, 'YL_KM_TK_TW_ES_JH': 0.0003327007272384309, 'Access': 0.00040934415372960003, 'a0Wang1_a0Shili_a0Wang3': 9.148819220060914e-58, 'a0Wang4_Xiaoming': 9.148819220060914e-58, 'a0_a0SARS\\x91CoV\\x91_a0has': 7.48700983901382e-05, 'a0cell_a0receptor_a0indirect_a0products': 9.148819220060914e-58, 'a0Thus': 9.148819220060914e-58, 'branch': 1.9851622383047223e-05, 'a0based': 3.241342047734272e-07, 'betacoronaviruses': 0.00014084186830440697, 'realtime_transcriptase_chainreaction_RTPCR_gene_sequencing': 9.1938554709618e-06, 'troponin_I_procalcitonin5711_Ruan_et_a0al12': 0.0006266242915349712, 'laboratory_findings_patients': 1.0222701944398597e-05, 'to_be_applied_in_a_clinicaldecision_support_system_to_improve': 0.0001497505750522014, 'to_establish_a_prediction_model_of_outcome_of_SARSCoV2_pneumonia_based_on_laboratory_data1Department_ _of_ _Radiology_ _Tongji_ _Hospital_ _of_ _Tongji_ _Medical_ _College_ _of_ _Huazhong_ _University_ _of_ _Science_ _and_Technology_Wuhan_China_2Julei_Technology_Wuhan_China_3Computational_Biology_Carnegie_Mellon_University_Pittsburgh_ _USA_ _4Department_ _of_ _Medical_ _Ultrasound_ _Tongji_ _Hospital_ _of_ _Tongji_ _Medical_ _College_ _of_ _Huazhong_University_of_Science_and_Technology_Wuhan_China_email_751884926qqcom_lilyboston2002qqcomScientific_RepoRtS_             _101038s41598020711147Vol0123456789wwwnaturecomscientificreports_0cMethodsAll': 0.00238803522972525, 'to_establish_a_prediction_model_of_outcome_of_SARSCoV2_pneumonia_based_on_laboratory_data1Department_ _of_ _Radiology_ _Tongji_ _Hospital_ _of_ _Tongji_ _Medical_ _College_ _of_ _Huazhong_ _University_ _of_ _Science_ _and_Technology_Wuhan_China_2Julei_Technology_Wuhan_China_3Computational_Biology_Carnegie_Mellon_University_Pittsburgh_ _USA_ _4Department_ _of_ _Medical_ _Ultrasound_ _Tongji_ _Hospital_ _of_ _Tongji_ _Medical_ _College_ _of_ _Huazhong_University_of_Science_and_Technology_Wuhan_China_email_751884926qqcom_lilyboston2002qqcomScientific_RepoRtS_             _101038s41598020711147Vol0123456789wwwnaturecomscientificreports_0cMethodsAll_Ethics_Commission': 0.0009471713055680814, 'Ethics_Commission': 0.0004100538998299479, 'test_serum_tests': 9.148819220060914e-58, '\\x93_a0days': 9.148819220060914e-58, 'RTPCR_tests_\\x93_a0days_therapy': 0.001845170519318405, 'to_deteriorate': 0.001845170519318405, 'a0collection_cases': 9.148819220060914e-58, 'record_system': 9.148819220060914e-58, 'age_gender': 0.00012613970685026185, 'Mar_We': 0.00013180864470590292, 'protein_albumin': 7.417164383651313e-53, 'Laboratory_findings': 1.2028534541210146e-07, 'machine_a0analysis_a0modeling_a0_First': 0.0017694925857541178, 'data_nonsurvivor_discharge': 2.8877485976218375e-05, 'features1617_Features': 2.8877485976218375e-05, 'to_compute_the_relevance_and_redundancy_of_the_ _features1617_Third': 3.2144911158066846e-05, '\\x9ccorrplot\\x9d_package': 1.1686951820486561e-54, 'to_calculate_Spearman\\x99s_correlation_coefficient_the_\\x9cmRMRe\\x9d_package_was_used_to_implement_the_mRMR_algorithm': 8.263922883666513e-55, '\\x9cmRMRe\\x9d_package': 9.148819220060914e-58, 'to_implement_the_mRMR_algorithm': 9.148819220060914e-58, '\\x9cglmnet\\x9d': 9.148819220060914e-58, 'to_perform_the_LASSO_logistic_regression_model_and_the_\\x9cpROC\\x9d_package': 9.148819220060914e-58, 'to_construct_the_ROC_ _curve1617ResultsNine_laboratory_features': 8.263922883666513e-55, 'matrix_heatmap': 7.97765208886232e-06, 'selection_process': 7.97765208886232e-06, 'PRC': 0.0019202526904341954, 'Hosmer\\x93Lemeshow_test': 9.148819220060914e-58, 'calibration_P': 9.148819220060914e-58, 'to_compute_the_relevance_and_redundancy_of_the_featuresNonsurvivors': 0.0018773154304764722, 'a0_Contribution_histogram': 9.148819220060914e-58, 'contribution_a0injury_a0markers': 9.148819220060914e-58, 'dysfunction_SARSCoV2': 0.0003359417404809486, 'bilirubin_level': 8.263922883666513e-55, 'to_occur_during_the_course_of_the_ _disease2324': 1.1686951820486561e-54, 'Acute_kidney_injury': 8.263922883666513e-55, 'Blood_urea_level': 9.148819220060914e-58, 'to_increase_in_some_cases': 9.148819220060914e-58, 'Nonsurvivors': 9.148819220060914e-58, 'blood_urea': 9.148819220060914e-58, 'Myocardial_injury': 7.562265611368425e-06, 'to_increase_in_some_cases_blood_urea': 0.0004635820703636805, 'prediction_accuracy': 0.004315547045054443, 'RepoRtS_101038s41598020711147Vol1234567890wwwnaturecomscientificreports': 4.774322076570771e-05, 'PTA': 0.0002801107957677198, 'coagulation_function': 4.57056091239336e-06, 'bilirubin_Î¼molLIndirect_bilirubin': 9.148819220060914e-58, 'filtration_rate_I_isoenzyme_dehydrogenase_dehydrogenase_ULCreatine_kinase': 9.148819220060914e-58, 'sFibrinogen': 8.263922883666513e-55, 'Features': 5.057094591538643e-05, 'degree_systems': 0.003096862579043484, 'hemolysis_Myoglobin': 0.0002800361681909777, 'laboratory_features': 9.148819220060914e-58, 'to_construct_a_new_signature_with_the_model': 9.148819220060914e-58, 'simpletouse_model': 0.00238803522972525, 'learning_method': 0.00238803522972525, 'to_exclude_noncontinuous_clinical_factor_with_the_current_machine_learning_method_By_using_other_methods': 0.00238803522972525, 'variables_category_variables': 0.004315547045054443, 'submodel': 0.007713134335009549, 'lab_signature': 0.00044941264492739084, 'to_validate_our_prediction_model_Second_our_model_may_not_be_directly_used_in_other_centers': 8.263922883666513e-55, 'to_reveal_the_bias_Fourth_statistical_approach_conducted_in_this_study_is_not_perfect_As_LASSO_was_used_for_ _variables_ _or_more_patients_were_needed_More_patients_should_be_collected_in_future_studyIn_conclusion_it_is_feasible_to_establish_a_accurate_prediction_model_of_outcome_of_SARSCoV2_pneumonia_based_on_laboratory_findings_Injury_of_liver_kidney_and_myocardium_coagulation_disorder_and_excess_immune_response_all': 1.177566817662189e-06, 'al_Chest_CT_findings': 9.148819220060914e-58, 'COVID19_relationship': 9.148819220060914e-58, 'Clinical_predictors_I_et_al_Nextgeneration': 0.00017392869868643751, 'radiogenomics': 2.9508646133502996e-06, 'Makhdoum_MERSCoV_infection': 0.0005536611936400708, 'Wang_J_et_al_Machine': 0.0014616190772430405, 'to_improve_the_diagnostic_performance_of_PIRADS_v2_in_clinically_relevant_prostate_cancer_Eur_Radiol_ _\\x93_   _Sauerbrei_W_Royston_P_ _Binder_H_Selection_of_important_variables_and_determination_of_functional_form_for_continuous_predictors_in_multivariable_model_building': 0.001129870936471824, '\\x93_AcknowledgementsWe': 1.2990978528579814e-05, 'TW_WL_SW': 0.0014616190772430405, 'manuscript_TW_XL': 9.148819220060914e-58, 'manuscriptCompeting': 9.148819220060914e-58, 'interestsAdditional': 0.0007959416758056306, 'Proteasomes': 0.0015847132313328567, 'role_ELISA': 2.586668612581389e-05, 'value_Serum_20Sproteasome': 1.7925185011550313e-08, 'BMC_Rheumatology_Page': 2.2673179907113364e-05, 'role_nonlysosomal_pathways': 0.001388599458763146, 'peptide_bonds': 1.844946435746173e-05, 'interferongamma_IFNÎ': 1.844946435746173e-05, 'proteasome_levels': 2.274211562945482e-53, 'to_beassociated_with_disease_severity_and_activity': 1.4055400435083287e-53, 'Similarlyelevated_proteasome_levels': 9.148819220060914e-58, 'inautoimmune_diseases': 9.148819220060914e-58, 'controlsWe': 0.0005612913089309412, 'excludedOf': 0.0006030236714318566, 'MPOAAV_patients': 9.148819220060914e-58, 'serumsamples': 9.148819220060914e-58, 'rabbit': 0.00027401999083637483, 'plateswere': 0.00027401999083637483, 'Bonferronicorrection': 0.00012613970685026185, 'variance_ANOVA': 0.00771518910792271, 'fortwogroup_comparisons': 1.5542010605467715e-07, 'BonferroniDunn_test_Correlations': 9.148819220060914e-58, 'correlation_test_0cMaruyama': 9.148819220060914e-58, 'ROC_curvesand_area': 0.002388671506211953, 'leveland_variables_Pvalues': 3.901700916169037e-05, '20Sproteasome_levelsAs': 9.148819220060914e-58, 'platelet_countsTable': 9.148819220060914e-58, 'albumin_gdLSerum_creatinine': 9.148819220060914e-58, 'vasculitisActivevasculitis': 9.148819220060914e-58, 'bars_values_p_serum': 0.0002025883833728602, 'involvement_±': 0.0005034057898537578, 'theWBC': 9.148819220060914e-58, 'level_mgdL_serum_20Sproteasome_level': 9.148819220060914e-58, 'Multivariate_analysis\\x93\\x88\\x92\\x88\\x92\\x88\\x92\\x93\\x88\\x92Pvalue\\x93\\x93': 1.4055400435083287e-53, 'kinase_levels': 2.274211562945482e-53, 'serum_20Sproteasome': 9.148819220060914e-58, 'elevationswere': 9.148819220060914e-58, 'serum_proteasome': 0.004315547045054443, 'proteasomes': 9.148819220060914e-58, 'immunosubunits': 9.148819220060914e-58, 'thatserum_proteasome': 9.148819220060914e-58, 'fraction_structure': 9.148819220060914e-58, 'remissionand': 0.0006324067207528349, 'Thusthe_proteasome': 0.00044941264492739084, 'study_includingvasculitis_patients': 0.0016480626375926124, 'atone_facility': 0.0019127833147525456, 'diseases_patients': 3.0136343241812733e-05, 'withoverexpression': 8.014401137946441e-05, 'Althoug': 9.148819220060914e-58, 'serum20Sproteasome': 9.148819220060914e-58, '[_]_Althoug_elevated_serum20Sproteasome_in_active_AAV': 0.0006750162805663558, 'paper_relationships': 0.0007641347695089468, 'Microscopic_polyangiitis': 0.0001342199430812954, 'KH': 0.0001342199430812954, 'logicalinterpretation_presentation': 0.0019127833147525456, 'KO_RT': 0.0001342199430812954, 'collection_MT_HS': 0.0002892179326628974, 'KH_MK': 0.0001342199430812954, 'funds': 9.148819220060914e-58, 'only_to_purchase_ELISAkitsAvailability_of_data': 9.148819220060914e-58, '0cMaruyama_BMC_Rheumatology_Page': 1.2704213225195535e-05, 'subtype_pattern_BurletSchiltz_approach': 1.2704213225195535e-05, 'gel_electrophoresisand': 9.148819220060914e-58, 'tag_labeling': 9.148819220060914e-58, 'growth_inducesapoptosis': 7.711159860189784e-06, 'drug_resistance_Aries_use': 7.711159860189784e-06, 'ubiquitin_system': 9.148819220060914e-58, 'J_BiolChem': 9.148819220060914e-58, 'Ornithine_decarboxylase': 0.000494595879613311, 'Pasquini_JM_Soto_EF': 9.148819220060914e-58, 'pathway_apoptosis_HD_Huber_RStructure': 9.148819220060914e-58, 'system_effect': 9.148819220060914e-58, 'J_Stock_D_Bochtler_M_Bartunik': 9.148819220060914e-58, 'PMInterferon_gamma_stimulation': 9.148819220060914e-58, 'site_preference': 9.148819220060914e-58, 'Heider_UKaiser_Fleissner_C': 0.00016553660791656055, 'Inconsistency_RANKL': 9.148819220060914e-58, 'us_treatment': 9.148819220060914e-58, 'RANK': 0.0031700813205763115, 'realtime_PCR_RANKL': 8.450300047468488e-05, 'RANKL_serum_levels': 1.7925185011550313e-08, 'rs8086340_G_allele': 1.7925185011550313e-08, 'homozygotes_p_p': 0.0019364435256617272, 'RA_susceptibility': 0.00022140346913729984, 'Biologic_agents': 1.284690556057437e-52, 'disease_symptoms': 7.417164383651313e-53, 'bone_damage': 7.417164383651313e-53, 'disability_Geiler_et': 7.417164383651313e-53, 'Page_et': 0.0018006682651940404, 'disease_susceptibility': 0.0005687442105011875, 'proliferation_differentiation': 1.4055400435083287e-53, 'RANKL': 3.4697467111625425e-05, 'role_Nemeth': 5.661951480714229e-07, 'activity_factors': 0.0009401799561455532, 'Kitaura_we': 0.0005073330404429016, 'Yang_et': 0.0015842910551982499, 'age_history_examination': 0.00017754737915906231, 'WrocÅ\\x82aw_Committee_Identification_Code_KB6252016': 0.0019127833147525456, 'parameters_levels_using_the_DAS28_score_based_on_four_components_number_of_swollen_and_tender_joints_levels_of_CRP_and_ESR_patients\\x99_global_assessment_of_general_health_expressed_on_the_visual_analogue_scale': 0.0008856548280111121, 'parameters_levels': 3.906750040250447e-06, 'OutcomeDisease_activity': 9.148819220060914e-58, 'using_the_DAS28_score_based_on_four_components_number_of_swollen_and_tender_joints_levels_of_CRP_and_ESR_patients\\x99_global_assessment_of_general_health_expressed_on_the_visual_analogue_scale': 9.148819220060914e-58, 'EULAR_criteria': 0.0006750162805663558, 'Iwaszko_et': 0.00037373840998787495, 'dbSNP_Information': 6.094462329839731e-06, 'RANKL_gene': 0.001129870936471824, 'G_A': 0.001129870936471824, 'RANKL_rs7325635_rs7988338_alleles': 0.001129870936471824, 'AnalysisSerum_concentration': 9.148819220060914e-58, 'DY626_Minneapolis_MN_USA': 9.148819220060914e-58, 'applying_the_Mann\\x93Whitney_U_test_for_quantitative_data_and_the_Fisher\\x99s_exact_test_for_parametric_values_The_frequencies_of_respective_genotype_groups_among_RA_patients_in_relation_to_the_antiTNF_outcome': 1.3148569362178621e-06, 'microplate_reader_applying_the_Mann\\x93Whitney_U_test_for_quantitative_data_and_the_Fisher\\x99s_exact_test_for_parametric_values_The_frequencies_of_respective_genotype_groups_among_RA_patients_in_relation_to_the_antiTNF_outcome_to_compare_genotype_variation_distribution_within_patients_and_controls_p_values_less_than_ _were_considered_statistically_significant': 0.0007490540607649716, 'to_compare_genotype_variation_distribution_within_patients_and_controls_p_values_less_than_ _were_considered_statistically_significant': 0.00048362067048935835, 'A_genotypes': 5.218470251477567e-07, 'to_be_associated_with_any_of_the_polymorphisms_studied_For_details': 0.0002982561651127239, 'DAS28': 4.863878117404565e-06, 'administration_RANK': 9.148819220060914e-58, 'GG_rs7325635_GG': 9.148819220060914e-58, 'p_b_p_c_p_0cArchivum': 3.259762205837823e-05, 'CC_carriers': 1.0892073836463245e-05, 'Therapystudied_polymorphisms': 9.148819220060914e-58, 'to_affect_the_outcome_of_biological_treatmentRelationship_between_a0Patients\\x99_Genotypes_and_a0Bone_Parameters_or_a0Thyroid_DysfunctionResponse': 9.148819220060914e-58, 'numbers_VAS': 0.00018001983766047135, 'GG_homozygotes': 7.05029712940268e-05, 'dysfunction_ulUml': 0.001845170519318405, 'RANKL_rs9525641': 9.148819220060914e-58, 'to_be_associated_with_younger_age_at_onset_of_RA_disease_Tan_et': 9.148819220060914e-58, 'rs2277438_G_allele': 9.148819220060914e-58, 'to_be_associated_with_radiographic_progression_of_joint_damage_Furuya_et': 9.148819220060914e-58, 'to_evaluate_the_role_of_the_RANK': 0.0020093264180027688, 'RA_risk': 6.602871851488568e-05, 'Wang_a0al': 3.280353107517915e-05, 'to_be_related_with_RA_risk': 3.143788628802585e-05, 'heterozygotes_allele_carriers': 0.007713134335009549, 'frequency_heterozygotes_allele_carriers_correlation_RF': 0.008571309280431393, 'correlation_RF': 0.007713134335009549, 'rs8086340': 0.0015842910551982499, 'RANKL_concentration': 0.007713134335009549, 'to_be_associated_with_an_increased_risk_for_RA_development_Patients_carrying_the_G_allele_presented_with_an_average_of_a0pgml_RANKL_in_serum_vs_a0pgml_for_patients_lacking_this_genetic_variantAs_for_RANKL_SNPs_investigated_in_our_study': 2.501802547966757e-06, 'RuyssenWitrand_et': 9.148819220060914e-58, 'RANKL_rs7325635_et': 9.148819220060914e-58, 'allele_carriers': 0.0003640060763646834, 'effects_glucocorticosteroids': 0.00039947355805761766, 'protein_concentration_observation': 0.0004472423269940801, 'decrease_role': 0.00028569540831235814, 'rs7325635_polymorphisms': 0.0015842910551982499, 'Regional_Centre_Conflict': 0.0007959416758056306, 'competing_interestOpen': 0.0013882295497307361, 'regulation_use_0c_Page': 3.5057934680564676e-05, 'regulation_0c_Page': 0.0007956673215405282, 'to_obtain_permission_directly_from_the_copyright_holder_To_view_a_copy_of_this_licence_visit_httpcreat_iveco_mmons_orglicen': 0.00016902585554135613, 'RANKL_levels': 0.00018159201441078236, 'Deng_HW_Association_analyses': 0.0010068765747081726, 'osteoclastogenesis': 0.0007000951832348714, 'nalghanimalfaisaleduNone': 9.148819220060914e-58, 'Center_Riyadh': 9.148819220060914e-58, 'manifestations_skin_changes_myxedema': 0.0005915726387590047, 'to_optimize_the_surgical_outcomeThis': 0.00014571907968447722, 'to_achieve_a_euthyroid_state_in_the_patient_with_the_addition_of_saturated_solution_of_potassium_iodide_SSKI_and_thus_rendering_him_eligible_for_urgent_surgeryWe': 6.292247267039724e-05, 'Hypothyroidism_Fulltext_PDF': 9.148819220060914e-58, 'PMC': 9.148819220060914e-58, 'gland': 0.003882689269047051, 'diffuse_swelling': 0.0038806204677737646, 'to_achieve_a_euthyroid_state_before_proceeding_for_a_total_thyroidectomy_The_patient_was_managed_by_a_multidisciplinary_team_with_the_goal_of_clearing_him_for_surgery_During_the_patient\\x99s_3week_hospital_stay': 0.000662175054298706, 'to_ _mUL_and_ _pmolL_to_ _pmolL': 0.0008522036149147152, 'drops_three_times': 0.000641830283066621, 'patient\\x99s_thyroid_gland': 1.0345384202351055e-06, 'to_be_enlarged_and_vascular_with_each_lobe_measuring_approximately_ _to_ _cm': 6.343041923869033e-05, 'BackgroundGraves\\x99_disease': 0.00210348072096923, 'TSH_receptors': 3.9055812674816186e-05, 'skin_changes': 0.00018750364596568773, 'to_distinguish_Graves\\x99_disease_from_thyroiditis_and_other_causes_of_hyperthyroidism_In': 1.3889875284177662e-05, 'iodine_approaches': 2.6923603453029665e-05, 'tremor': 0.0006324067207528349, 'diffuse_hyperplasia_consistent_with_Graves\\x99_disease': 6.44811047627927e-05, 'to_be_stable_with_no_signs_and_symptoms_of_thyrotoxicosis_or_hypocalcemia': 0.00012198022841850962, 'to_be_in_good_health_with_no_active_complaints_He_had_lost_weight_and': 0.00012198022841850962, 'diffuse_hyperplasia_consistent_with_Graves\\x99_disease_state': 5.081082898833491e-06, 'American_Association_ATA_to_achieve_a_euthyroid_state_and_thus_lower_risk_of_intraoperative_complications': 0.00014571907968447722, 'Use_Graves\\x99_disease': 0.001845170519318405, 'euthyroidism': 0.0029527107425026066, 'prednisolone_andor_lithium': 0.0022964692130119273, 'SSKI': 9.148819220060914e-58, 'to_not_only_decrease_vascularity_of_the_thyroid_gland_but_also_as_adjunctive_therapy_to_achieve_preoperative_euthyroidismshould_be_prepared_for_surgery_using_adjunctive_therapy': 9.148819220060914e-58, 'ATA_management_guidelines': 0.00020207254642467623, 'hormone_levels': 0.00210348072096923, 'Cholestyramine': 9.148819220060914e-58, 'to_treat_Graves\\x99_disease_in_ _in_Korea': 9.148819220060914e-58, 'to_achieve_a_preoperative_euthyroid_state_with_conventional_antithyroid_medications_Within_ _to_ _weeks_of_administration_of_cholestyramine_as_adjunctive_therapy': 0.004207130093443387, 'cholestyramine': 9.148819220060914e-58, 'to_safely_and_rapidly_achieve_preoperative_euthyroidism_[_\\x93]References_   _Pokhrel_B_Bhusal_K_Graves_disease_In_StatPearls_Treasure_Island': 9.148819220060914e-58, 'JR_concepts_it': 9.148819220060914e-58, 'Avram_AM_Efficacy': 9.148819220060914e-58, 'Diabetes_E_Preoperative_management': 0.00016553660791656055, 'rutgers_eduIntroduction_BA_biotransformation': 7.054057141083732e-05, 'BA_profile': 0.004316697528271634, 'impacts_signaling_Altered_signaling': 8.263922883666513e-55, 'diet_LFD_LFD': 1.1686951820486561e-54, 'BA_profile_BA_FXR': 1.1504832171912505e-06, 'BA_FXR': 1.1504832171912505e-06, 'microbiota_composition_expression_markers': 8.263922883666513e-55, 'Gut_anoids': 9.148819220060914e-58, 'to_investigate_effects_of_individual_BAs_on_ileal_FXR_activityResults_ ': 9.148819220060914e-58, 'GP': 0.0015359149413450995, 'abundance_serum_levels': 2.6378751425903072e-05, 'BA_changes_expression_type': 0.0014898595597876013, 'enzyme_Cyp7a1_GP': 9.148819220060914e-58, 'BA_changes': 9.148819220060914e-58, 'synthesis_GP_treatment': 0.0038806204677737646, 'Smpd3_Sptlc2_Cers4': 2.4317885088169288e-05, 'GPs': 0.0011026786614021006, 'BA_FXR_acids_BAs_signal': 1.799286885416737e-05, 'foods': 2.3435040893710554e-52, 'to_ _improved_ _glycemic_ _control_ _in_Significance_of_this': 1.3005466519908921e-52, 'BA_synthesis_glucose': 0.004315547045054443, 'GP_supplementation': 7.943057145082372e-05, '\\x96º_GP_supplementation': 0.0016810521528134112, 'BA_FXR_muciniphila1_microbe': 0.0019141057135509364, 'acids_BAs': 0.00018383646965595502, 'salt_hydrolases_deconjugate_taurine_glycine': 8.228461987003387e-05, 'BAs_receptor': 0.0038806204677737646, 'BA_Bacteroidetes_Firmicutes_profiles': 1.3432121961226132e-06, 'WT_mice': 1.3227511800000665e-06, 'improvements8_Studies': 9.148819220060914e-58, 'tissue_knockout_mice': 9.148819220060914e-58, 'FXR_activity': 1.284690556057437e-52, 'to_mediate_HFD': 7.417164383651313e-53, 'dysfunctions9_inhibition': 7.417164383651313e-53, 'acid_Gly_MCA': 9.148819220060914e-58, 'to_gut_microbial_remodeling_and_improved_glucose_and_lipid': 9.148819220060914e-58, 'community_changes': 1.799286885416737e-05, 'to_ _observed_ _improvement_ _in_ _glucose_homeostasis1_   ': 1.799286885416737e-05, 'described4_Mice': 1.1686951820486561e-54, 'addition_community_changes_to_ _observed_ _improvement_ _in_ _glucose_homeostasis1_   _evidence_diet_LFD': 8.263922883666513e-55, 'GP_SPI': 4.0841564078008265e-05, 'ingredient': 4.0830679739939466e-05, 'diet_LFD': 8.263922883666513e-55, 'GP_HFD': 6.662838344186608e-07, 'GP_HFD_GP_Online_table': 6.662838344186608e-07, 'C_Mice': 2.098628334967566e-06, 'to_ _receive_ _LFD_n7_or_LFD_GP_n7_for_ _days': 0.00012882641009896506, 'Metabolic_phenotyping': 9.148819220060914e-58, 'food_body_body_composition': 9.148819220060914e-58, 'CO2_inhalation': 0.0005411681930881713, 'inhalationTissue_gene_expression': 0.0005411681930881713, 'described4_Data': 9.97460563475645e-10, 'using_ _2Î\\x94CT_ _method_ _using_ _hydroxymethylbilane_synthase_HMBS_as_housekeeping_geneqPCR_ _of_ _A_ _muciniphila_ _in_ _fecal_ _and_ ': 6.122033755853181e-08, 'cecal_samples': 3.744115145455896e-06, 'to_prepare_V4_amplicons_of_the_16S_rRNA_gene_for_sequencing_ _on_ _a_ _MiSeq_ _system_ _resulting_ _in_ _Ã\\x97': 0.00022962629461863523, 'BA_analysis': 9.148819220060914e-58, 'puncture_BAs': 9.148819220060914e-58, 'methods16_Crypts': 2.098628334967566e-06, 'BMJ_Diab_Res_Care_growth_factor': 1.1686951820486561e-54, 'to_polymerize_°_C_for_\\x93_materials_CGM': 8.263922883666513e-55, 'to_polymerize_°_C_for_\\x93': 8.263922883666513e-55, 'materials_CGM': 2.179150599615875e-05, 'using_Prism_ _GraphPad_Software_La_Jolla_California_USA_Significant_differences_ _two_ _groups_ _were_ _assessed_ _with_ _a_ _two_tailed_unpaired_ _Student\\x99s_ _t_ _test_ _with_ _Welch_ _correction_ _for_unequal_ _variance_ _when_ _needed_ _or_ _by_ _one_way_ _or_ _two_way_analysis_of_variance_ _groups_followed_by_Sidak\\x99s_or_Tukey\\x99s': 0.00019915147656230243, 'using_QIIME_   _details_ _in_ _online_ _supplementary_ _materials_ADONIS_ _and_ _permutation_ _analysis_ _were_ _conducted_using_ _R_ _Studio_ _V342_ _R_ _Studio_ _Software_ _Boston_Massachusetts_USA_and_Python_RESULTSGPs': 0.001129870936471824, 'permutation_analysis': 9.148819220060914e-58, 'using_ _R_ _Studio_ _V342_ _R_ _Studio_ _Software_ _Boston_Massachusetts_USA_and_Python_RESULTSGPs': 9.148819220060914e-58, '1B\\x93DGPs': 2.506980332742072e-05, 'figure_1A4_Area': 5.085784081145587e-06, 'decrease_gain_body_composition_liver_weights_figure': 0.0003118580945304769, 'fed_LFD_GP': 0.0005858465495261709, 'GP_group': 9.148819220060914e-58, '±_mg': 9.148819220060914e-58, 'gain_body_composition_liver_weights_figure': 0.0003022165162482692, 'Î±diversity': 0.0005411681930881713, 'figure_Principal_coordinate_analysis': 4.094345638764069e-07, 'community_structure_figure': 1.799286885416737e-05, 'figure_Metabolism1E_treated_germ_mice_consistent_GP': 7.417164383651313e-53, '2B': 1.284690556057437e-52, 'abundance_ceca_samples': 0.0005411681930881713, 'Ceca': 7.417164383651313e-53, 'fecal_Bacteroidetes': 7.417164383651313e-53, 'levels_figure_3DE': 1.2963617808878293e-06, 'bloom': 1.799286885416737e-05, 'integrity5_GP': 0.000229153030081846, 'gut_barrier': 3.738958820155425e-06, '2E_GPs': 0.0006681652127777817, 'to_ _alter_ _BA_ _diversity_ _abundance_and_ _signaling_ _Targeted_ _liquid_ _chromatography_mass_spectrometry_LC_MS_analysis': 0.004315547045054443, 'tolerance_tests': 0.00012658315091127492, 'LFD_squares': 0.0005411681930881713, 'bars_Difference': 9.148819220060914e-58, 'using_two_way': 9.148819220060914e-58, 'TÏ\\x89MCA': 0.000852430718203068, 'acid_TDCA_difference': 2.159322644144211e-08, '3EF_Blautia_Clostridium': 9.148819220060914e-58, 'BMJ_Res_Care': 9.148819220060914e-58, 'Supplementation': 9.148819220060914e-58, 'composition_diversity_Î±diversity_metrics': 9.148819220060914e-58, 'Difference': 0.00013360670637670873, 'qPCR_using_primers_specific_for_A_muciniphila_AM1AM2_and_universal_V4_primers_515F806R_E_Total_16S_bacterial_and_archaeal_gene_countsng_of_gDNA_extracted_from_fecal_or_cecal_samples_Group_mean±SD': 0.000254619872099857, 'C\\x93E': 9.148819220060914e-58, 'using_two_way_ANOVA_followed_by_Sidak\\x99s_posthoc_test_intergroup_comparison_or_Tukey\\x99s_posthoc_test_intragroup_comparison_Different_letters_a_b_and_c': 9.148819220060914e-58, 'Sidak\\x99s_intergroup_comparison_intragroup_comparison_b_c': 2.485116341903048e-05, 'to_ _possess_ _7Î±dehydroxylating_activity_required_for_conversion_of_PBAs_to_SBAs21\\x93': 0.0038806204677737646, '3EFGPassociated_BA_changes': 0.00054686425127897, 'Fxr_gene_expression': 1.2963617808878293e-06, 'SBAs_to_determine_the_mean_concentration_of_individual_PBAs_and_SBAs': 1.799286885416737e-05, 'SBAs': 1.799286885416737e-05, 'to_determine_the_mean_concentration_of_individual_PBAs_and_SBAs': 3.508765578912573e-05, 'n7_samples': 8.263922883666513e-55, 'bars_bars_BA_concentration': 1.1686951820486561e-54, 'GP_diet_groups': 8.263922883666513e-55, 'tauroÎ±MCA_TMCA': 0.0006810685397702696, 'LFD_squares_LFD_GP': 1.8216599326642615e-05, '4B_Fgf15_Shp': 9.148819220060914e-58, 'BA_synthesis': 9.148819220060914e-58, 'Shp_expression': 7.417164383651313e-53, 'encoding_anic': 9.148819220060914e-58, 'Ost30_Obp2a': 9.148819220060914e-58, 'expression_Cyp7a1_activity': 0.0014616190772430405, 'Cyp7a1_activity': 0.0014616190772430405, 'figure_FXR_activity': 0.0016810521528134112, 'proglucagon_protein_Gcg': 9.148819220060914e-58, 'prohormone_convertase': 9.148819220060914e-58, 'PC13': 9.148819220060914e-58, 'Pcsk134': 9.148819220060914e-58, 'mice_expression_changes': 2.5056352627512004e-05, '4A_GPs': 0.0016810521528134112, 'to_ _investigate_ _how_ _individual_ _BAs_ _altered_ _by_GP_supplementation': 0.00238803522972525, 'figure_5B': 0.00238803522972525, 'system_anoids': 9.148819220060914e-58, 'FXR_agonist_CDCA': 9.148819220060914e-58, 'CDCA': 0.002114062868283401, 'DCA': 3.450074201149185e-05, 'FXR_agonists': 9.148819220060914e-58, '5B': 9.148819220060914e-58, 'activity_anoids': 8.263922883666513e-55, 'activation_expression_dbdb': 1.3909946949554081e-05, 'PBA': 9.148819220060914e-58, 'dbdb': 9.148819220060914e-58, 'Ileal_anoids': 0.0010074133550934795, 'circles_combination': 1.644014248996932e-05, 'SBA': 1.644014248996932e-05, 'horizont': 9.960390269833145e-05, 'development_reporting_assessment': 0.004315547045054443, 'to_develop_an_AGREE_II_extension_document_for_application_in_surgical_guidelinesMethods_and_analysis_ _We_have_performed_a_structured_literature_review_and_assessment_of_guidelines_in_surgery_using_the_AGREE_II_instrument_In_exploratory_analyses_we_have_identified_factors_associated_with_guideline_quality_We_have_performed_reliability_and_factor_analyses_to_inform_the_development_of_an_extension_document_We_will_summarise_this_information_and_present_it_to_a_Delphi_panel_of_stakeholders': 0.00238803522972525, 'literature_review_assessment': 0.00238803522972525, 'reliability_factor_analyses': 0.00238803522972525, 'Delphi_rounds': 0.00238803522972525, 'guidelines_Authors_employers': 0.004315547045054443, 'disciplines': 3.4213118569611756e-05, 'research_evidence': 3.4213118569611756e-05, 'Reporting': 1.1686951820486561e-54, 'Enhancing_Network5_Appraisal_framework': 8.263922883666513e-55, 'Enhancing_Network5_Appraisal': 8.263922883666513e-55, 'AGREEII': 0.00023530010952105463, 'agencies': 0.0005915726387590047, 'members_guideline_developers': 7.520315349683549e-05, 'document': 0.0001477206635772738, 'evidence_synthesis_experts': 0.004315547045054443, 'AGREE_research_team': 0.00030586813508869646, 'AGREE': 3.4213118569611756e-05, 'to_ _support_ _dissemination_ _activities_ _by_making_ _this_ _new_ _tool_ _available_ _in_ _the_ _AGREE_ _website_https_agreetrust_This_ _protocol_ _complies_ _with_ _the_ _Guidance_ _for_ _Developers_of_Health_Research_Reporting_Guidelines21Patient_and_public': 0.0013882295497307361, 'literature_review_analysesWe': 0.0005453157274894982, 'reporting': 0.00238803522972525, 'BMJ_202010e037107_use': 8.896473974437824e-06, 'guideline_quality': 8.896473974437824e-06, 'appraisal_data': 0.00238803522972525, 'II_document': 0.00238803522972525, 'stakeholders': 1.1686951820486561e-54, 'to_ _provide_ _their_ _input_ _through_ _a_ _Delphi_ _process_which_will_inform_the_preparation_of_an_AGREE_II_extension_for_surgical_guidelinesParticipantsThe_ _executive_ _group_ ': 8.263922883666513e-55, 'ML_C_IDF_MB_GS_NKF_evidence_synthesis_experts': 8.263922883666513e-55, 'Commission_representativeGIN': 0.0005915726387590047, 'review_group': 0.00021944374809642538, 'evidence_synopsis_group': 1.143549771281586e-06, 'evidence_BMJ_202010e037107': 1.865355739415413e-08, 'day_meeting': 0.0004576368763948737, 'stakeholder_groups': 0.00238803522972525, 'methodology_design_stakeholder_groups': 0.00238803522972525, 'document_Responses': 9.148819220060914e-58, 'evidence_BMJ_202010e037107_methods_group': 9.148819220060914e-58, 'methods_group': 7.000667402416116e-05, 'strongmoderate_disagreement': 2.9667956906285047e-05, 'scoring_items_those': 0.00238803522972525, 'panel\\x99s_contribution': 9.148819220060914e-58, 'group_authorship_elaboration_document': 9.148819220060914e-58, 'supporting_toolsQualitative_research_synthesisWe_ ': 9.148819220060914e-58, 'evidence_synthesis': 9.148819220060914e-58, 'to_be_more_relevant_to_an_AGREE_II_extension_for_surgical_guidelinesWe': 0.0002454333162130257, 'editorials_letters': 0.00238803522972525, 'breadth_discussions': 0.004315547045054443, 'to_ _identify_ _characteristics_ _that_ _specifically_ _apply_ _to_surgical_guidelinesThe_ _realist_ _review_ ': 3.8077349155409544e-07, 'to_reflect_the_ _specific_ _aspects_ _of_ _surgical_ _guidelines_ ': 0.0001612768127681551, 'AGREE_II': 2.6293111116536627e-06, 'to_identify_the_specific_features_relevant_to_development_and_reporting_of_surgical_guidelines_research_team_users_Facebook_Twitter_email_newsletters_responses': 0.0001218164636085057, 'to_identify_the_specific_features_relevant_to_development_and_reporting_of_surgical_guidelines': 0.00012178400936577942, 'Themes': 1.3046560060864696e-05, 'Adjudication_triangulation': 1.9877871448382007e-06, 'to_understand_findingsFurthermore_ ': 0.0038806204677737646, 'users_Facebook_Twitter_email_newsletters': 0.007713134335009549, 'Delphi_process': 1.3100003784340454e-05, 'meeting_instrument_validity_BMJ_202010e037107': 0.0002456473215514306, 'plausibility_inclusion': 0.004315547045054443, 'extension_document': 0.0004577588409424046, 'meeting': 0.0005575508958218227, 'search_process': 0.0038806204677737646, 'validity_BMJ_202010e037107': 6.292247267039724e-05, 'EE_document': 0.0012533041979354018, 'guideline_developers_to_ _summarise_ _development_and_reporting_parameters_guideline_users_to_appraise_quality_ _peer_ _reviewers_ _and_ _journal_ _editors_ _to_ _assess_adequacy_of_reporting_parameters27Feedback_and_criticismWe_ ': 0.00012582550826258795, 'feedback_need': 0.0006877849293123533, 'executive_group': 1.12214240409022e-05, 'practice_healthcare_delivery': 0.0006246792128329638, 'to_substitute_established_detailed_guidance_on_guideline_development_principles_processes_and_procedures_such_as_the_GRADE_approach15_ ': 0.0005915726387590047, 'need_reporting': 0.0005915726387590047, 'practitioners_policymakers_stakeholders_to_inform_decisions_regarding_the_use_of_an_existing_guidelineIn_ _addition_ _AGREE_ _II_ _has_ _been_ _shown_ _to_ _be_ _a_ _valuable_ _tool_ _for_ _assessment_ _of_ _guideline_ _quality_ _in_ _several_clinical_ _disciplines_ _and_ _evidence_ _fields22_ _\\x93_ _Such_summaries_ _alert_ _the_ _scientific_ _community_ _to_ _the_ _need_for_improving_specific_aspects_of_clinical_practice_guidelines_corresponding_to_the_instrument_domains_or_the_overall_ _quality_ _of_ _guidelines_ _Our_ _previous_ _research_ _has_highlighted_the_need_for_improvement_of_the_quality_of_surgical_guidelines22': 0.00210348072096923, 'to_ _be_ _a_ _valuable_ _tool_ _for_ _assessment_ _of_ _guideline_ _quality_ _in_ _several_clinical_ _disciplines_ _and_ _evidence_ _fields22_ _\\x93_ _Such_summaries_ _alert_ _the_ _scientific_ _community_ _to_ _the_ _need_for_improving_specific_aspects_of_clinical_practice_guidelines_corresponding_to_the_instrument_domains_or_the_overall_ _quality_ _of_ _guidelines_ _Our_ _previous_ _research_ _has_highlighted_the_need_for_improvement_of_the_quality_of_surgical_guidelines22': 4.298723261858784e-08, 'II_extension': 9.148819220060914e-58, 'to_meet_this_need_ ': 9.148819220060914e-58, 'to_ _elaborate_on_AGREE_II': 0.007713134335009549, 'development_reporting_appraisalStrengths': 0.00210348072096923, 'Delphi_panel': 1.1686951820486561e-54, 'stakeholders_members': 8.263922883666513e-55, 'face_meeting': 8.263922883666513e-55, 'participation_exchange': 0.00238803522972525, 'participation_engagement': 0.007713134335009549, 'Authority_approval': 9.148819220060914e-58, 'participation_engagement_conflict_andor': 9.148819220060914e-58, 'paper_BMJ_202010e037107': 0.0004100538998299479, 'interest_conflictWe': 0.0011075402231842013, 'Reporting_Guidelines21We': 7.466462206905239e-06, 'anisations': 0.00238803522972525, 'dissemination': 0.00238803522972525, 'surgical_development_anisations_policymakers': 0.007713134335009549, 'editors': 9.148819220060914e-58, 'to_provide_an_extension_instrument_checklist_that_authors_of_clinical_practice_guidelines_should_submit_along_with_the_original_manuscriptThe_GAP_III_study': 9.148819220060914e-58, 'to_address_the_need_for_improvement_ _of_ _the_ _methodology_ _reporting_ _and_ _appraisal_ _of_surgical_ _guidelines_ _An_ _extension_ _document_ _specifically_designed_ _for_ _clinical_ _practice_ _guidelines_ _in_ _surgery_ ': 0.0004100538998299479, 'Mavridis': 9.148819220060914e-58, 'Sofia_Tsokani_STsokani': 9.148819220060914e-58, 'to_thank_Mrs_Meropi_Gioumidou_for_the_tireless_contribution_and_the_excellent_administrative_support_to_the_projectContributors_ _GAA_conception_and_design_interpretation_of_data_drafting_the_work_final_approval_for_the_work_to_be_published_agreement_to_be_accountable_for_all_aspects_of_the_work_in_ensuring_that_questions_related_to_the_accuracy_or_integrity_of_any_part_of_the_work_are_appropriately_investigated_and_resolved_DM_conception_and_design_analysis_of_data_interpretation_of_data_drafting_the_work_final_approval_for_the_work_to_be_published_agreement_to_be_accountable_for_all_aspects_of_the_work_in_ensuring_that_questions_related_to_the_accuracy_or_integrity_of_any_part_of_the_work_are_appropriately_investigated_and_resolved_ST_analysis_of_data_interpretation_of_data_revising_the_work_critically_for_important_intellectual_data_final_approval_for_the_work_to_be_published_agreement_to_be_accountable_for_all_aspects_of_the_work_in_ensuring_that_questions_related_to_the_accuracy_or_integrity_of_any_part_of_the_work_are_appropriately_investigated_and_resolved_ML_C_acquisition_of_data_analysis_of_data_interpretation_of_data_revising_the_work_critically_for_important_intellectual_data_final_approval_for_the_work_to_be_published_agreement_to_be_accountable_for_all_aspects_of_the_work_in_ensuring_that_questions_related_to_the_accuracy_or_integrity_of_any_part_of_the_work_are_appropriately_investigated_and_resolved_IDF_conception_and_design_interpretation_of_data_drafting_the_work_final_approval_for_the_work_to_be_published_agreement_to_be_accountable_for_all_aspects_of_the_work_in_ensuring_that_questions_related_to_the_accuracy_or_integrity_of_any_part_of_the_work_are_appropriately_investigated_and_resolved_MB_conception_and_design_interpretation_of_data_revising_the_work_critically_for_important_intellectual_data_final_approval_for_the_work_to_be_published_agreement_to_be_accountable_for_all_aspects_of_the_work_in_ensuring_that_questions_related_to_the_accuracy_or_integrity_of_any_part_of_the_work_are_appropriately_investigated_and_resolved_SRM_interpretation_of_data_revising_the_work_critically_for_important_intellectual_data_final_approval_for_the_work_to_be_published_agreement_to_be_accountable_for_all_aspects_of_the_work_in_ensuring_that_questions_related_to_the_accuracy_or_integrity_of_any_part_of_the_work_are_appropriately_investigated_and_resolved_GS_interpretation_of_data_revising_the_work_critically_for_important_intellectual_data_final_approval_for_the_work_to_be_published_agreement_to_be_accountable_for_all_aspects_of_the_work_in_ensuring_that_questions_related_to_the_accuracy_or_integrity_of_any_part_of_the_work_are_appropriately_investigated_and_resolved_NF_interpretation_of_data_revising_the_work_critically_for_important_intellectual_data_final_approval_for_the_work_to_be_published_agreement_to_be_accountable_for_all_aspects_of_the_work_in_ensuring_that_questions_related_to_the_accuracy_or_integrity_of_any_part_of_the_work_are_appropriately_investigated_and_resolvedSA_conception_and_design_acquisition_of_data_analysis_of_data_interpretation_of_data_drafting_the_work_final_approval_for_the_work_to_be_published_agreement_to_be_accountable_for_all_aspects_of_the_work_in_ensuring': 0.0007959416758056306, 'DM_conception_design_analysis': 0.0002353888884382476, 'ST_analysis': 0.0002353888884382476, 'C_acquisition': 0.0002353888884382476, 'IDF_conception_design_interpretation': 0.0002353888884382476, 'MB_conception_design_interpretation': 0.0002353888884382476, 'SRM_interpretation': 0.0002353888884382476, 'GS_interpretation': 0.0002353888884382476, 'NF_interpretation': 0.0002353888884382476, 'Bhaskaran1To': 9.148819220060914e-58, 'Strongman_a0H_Williams_a0R': 9.148819220060914e-58, 'helen_strongman_lshtm_ac': 9.148819220060914e-58, 'To_describe_the_benefits_and_limitations_of_using_individual_and_combinations_of_linked_English_electronic_health_data_to_identify_incident_cancersDesign_and_setting_ _Our_descriptive_study_uses_linked_English_Clinical_Practice_Research_Datalink_primary_care_cancer_registration_hospitalisation_and_death_registration_dataParticipants_and_measures_ _We_implemented_case_definitions_to_identify_first_site_specific_cancers_at_the_ _most_common_sites_based_on_the_first_ever_cancer_diagnosis_recorded_in_each_individual_or_commonly_used_combination_of_data_sources_between_ _and_ ': 9.148819220060914e-58, 'ukObjectives_calculated': 0.00043463382250315263, 'study_uses': 9.148819220060914e-58, 'dataParticipants_measures': 9.148819220060914e-58, 'dataINTRODUCTIONThe_Research_Datalink_CPRD': 0.000163902114178729, 'de': 2.6763316345454167e-06, 'a0H': 0.0003034732833474384, '0c_data_HES_APC_Office': 9.148819220060914e-58, 'to_analyse_factors_contributing_to_the_risk_of_cancer_and_the_ _consequences_ _of_ _cancer_ _and_ _its_ _treatment_ _Use_ _of_linked_ _data_ ': 9.148819220060914e-58, 'epidemiology_studies': 9.148819220060914e-58, 'using_ _NCRAS_ _and_ _HES_ _APC_ _data_ _provided_ _by_ _National_Health_Service_NHS_Digital_and_Public_Health_England_PHE_without_linkage_to_CPRD_primary_care': 9.148819220060914e-58, 'values_PPVs': 0.0006313632619292757, 'cancers_papers_evidence_cohort': 0.00011433162374159948, 'to_describe_and_compare_the_benefits_and_limitations_ _of_ _using_ _different_ _combinations_ _of_ _linked_ _CPRD_primary_care_data_HES_APC_ONS_mortality_and_NCRAS_cancer_ _registration_ _data_ _for_ _conducting_ _cancer_ _epidemiology_ _studies_ _Our_ _analyses_ ': 0.00238803522972525, 'cancers_papers_evidence_assessment_to_describe_and_compare_the_benefits_and_limitations_ _of_ _using_ _different_ _combinations_ _of_ _linked_ _CPRD_primary_care_data_HES_APC_ONS_mortality_and_NCRAS_cancer_ _registration_ _data_ _for_ _conducting_ _cancer_ _epidemiology_ _studies_ _Our_ _analyses_ _definitions_cohort': 0.00238803522972525, 'concordance_study': 0.0005191866840966338, 'December': 3.57610591824189e-50, 'GOLD_database': 0.0002394531921586528, 'Vision_General_practice_staff': 0.0011075402231842013, 'Diagnoses': 9.148819220060914e-58, 'duringfollowing_ _a_ _consultation_ _or_ _from_ _written_ _information_that_ _is_ _returned_ _to_ _the_ _practice_ _from_ _secondary_ _care_CPRD_GOLD_data_are_linked_to_HES_APC_ONS_mortality_and_ _NCRAS_ _through_ _a_ _trusted_ _third_ _party_ _for_ _English_practices_ _that_ _have_ _agreed_ _to_ _participate_ _in_ _the_ _linkage_programme2_HES_APC_data_are_collected_by_NHS_Digital_to_ _co_ordinate_ _clinical_ _care_ _in_ _England_ _and_ _calculate_hospital_payments12_Admissions_for_and_related_to_cancer_diagnoses_are_recorded_using_International_Classification_of_Diseases_version_ _ICD10_codes_National_cancer_registration_ _data_ _are_ _collected_ _by_ _NCRAS_ _which_ _is_ _part_of_ _PHE_ _in_ _accordance_ _with_ _the_ _Cancer_ _Outcomes_ _and_Services_Data_set13_which_has_been_the_national_standard_for_ _reporting_ _of_ _cancer_ _in_ _England_ ': 9.148819220060914e-58, 'to_ _participate_ ': 0.004315547045054443, 'HES_APC_data': 1.1686951820486561e-54, 'NHS_Digital': 8.263922883666513e-55, 'payments12_Admissions': 8.263922883666513e-55, 'NCRAS': 8.490824145272302e-06, 'January_Data': 9.148819220060914e-58, 'ICD10_codes': 9.148819220060914e-58, 'male_patients': 0.00012606650784256865, 'December_Start': 2.340732116405961e-05, 'CPRD': 2.340732116405961e-05, 'practice_ONS_mortality_date': 0.0006324067207528349, 'algorithm_NCRAS_National_ONS_Office': 0.0001261733407126887, 'case_definitions_HES_APC_cancers_cancer_site_individual_data_source': 0.007717244975784016, 'HES_APC': 0.0001261733407126887, 'definitionWe': 0.0001500430247497033, 'NCRAS_data': 0.004319035854269895, 'BMJ_202010e037719_0c_access': 2.274211562945482e-53, 'categories_quality_patients_appendix_figures': 1.4055400435083287e-53, 'PPVs': 0.00029984867202228013, 'Case_definitions': 2.7996636528135717e-06, 'CPRD_GOLD': 0.004315547045054443, 'n2228_in_n995_Table': 9.148819220060914e-58, 'number_percentile_lag_record': 9.148819220060914e-58, 'mortality_et': 2.516404898630126e-52, 'respectivelyFigure': 0.00023673972000612265, 'using_ _NCRAS_ _only_ _Recording_ _of_grade_ ': 0.0003991561001946192, 'Cancer_sites': 1.4055400435083287e-53, \"version_ _ICD10_Four_most_common_cancer_sites_CNS_central_nervous_system_NHL_Non_Hodgkin_'s_lymphoma\": 2.274211562945482e-53, 'BMJ_202010e037719_Cancer_sites': 2.274211562945482e-53, 'using_the_first_ever_record_in_each_combination_of_sources': 0.004315547045054443, 'nwohs_nommoc_tsom': 9.148819220060914e-58, 'sesaesDi_fonoitacfissaCliscitsitatS': 9.148819220060914e-58, \"s'inkgdo_HnoNC\": 9.148819220060914e-58, 'revLiStrongman': 9.148819220060914e-58, 'version_ _ICD10_Four_most_common_cancer_sites_CNS_central_nervous_system': 1.4055400435083287e-53, 'Completeness_Cancer_sites': 9.148819220060914e-58, 'version_ _ICD10_Four_most_common_cancer_sites': 9.148819220060914e-58, 'COSD_Cancer_Outcomes_Services_Data': 0.0003482466952890437, 'lymphomaStrongman': 9.600782509555746e-05, 'using_the_gold_standard_algorithm_this_rose_to_ _of_the_four_most_common_cancers_Use_of_cancer_registration_data_alone_or': 0.00017176117217827986, 'data_cut': 7.054118167844663e-05, 'diagnosis_Use': 0.0004988292642554344, 'incident_cancersWe': 0.00021549859572312776, 'ConcernExpression': 0.0016815001133323047, 'theinvasion_migration': 2.7446560661786228e-05, 'epithelial\\x93mesenchymaltransition': 4.133299807705136e-06, 'Wentao_Yu12': 3.901700916169037e-05, 'RNAseq_transcriptomics': 9.148819220060914e-58, 'to_determine_gene_expression_in_blood_samples_from_radiationexposed_workers_followed_by_bioinformatics_analysis_Normal_bronchialepithelial_cells_16HBE_were_irradiated_for_different_durations_and_subjected_to_immunofluorescence_Western_blotting_scratch_healing_and_adhesion_assays_to_detect_the_progressionof_EMT_and_its_underlying_molecular_mechanismsResults': 9.148819220060914e-58, 'inthe_expression': 0.0003608303843934633, 'gradualincrease': 0.0016810521528134112, 'International_WorkersStudy_INWORKS': 9.148819220060914e-58, 'radiation_hazards_risk': 9.148819220060914e-58, 'Abbott_A': 0.0007862569594425692, 'Keil': 9.148819220060914e-58, 'cohort_mortalitystudies': 9.148819220060914e-58, 'Kamiya': 1.9298067748241525e-07, 'study_workers': 3.1462140568408892e-09, 'ERR_values': 3.1462140568408892e-09, 'cancer_mortality': 1.180551678356941e-05, 'byloss': 0.0007641347695089468, 'to_analyze_the_mRNA_expression_profiles_of_workers_with_or_withoutradiation_exposure_Normal_bronchial_epithelial_cells_underwent_EMT_following_multiple_rounds_radiation_and_thedifferentially_expressed_mRNAs_were_validated_using_a_cellular_model_These_findings_provide_an_experimental_basisfor_radiationinduced_carcinogenesisSubjects_and': 0.0019127833147525456, 'radiationinduced_carcinogenesisSubjects': 0.0008822241915335798, 'workerswith': 0.0038806204677737646, 'Ecad_ab40772': 5.705417164324465e-06, 'RNA_library': 9.148819220060914e-58, 'using_the_ _bp_pairedendmethod_in_an_Illumina_Hiseq_ ': 9.148819220060914e-58, 'to_generate_thetranscript_abundance_of_LncRNA_and_mRNA_known_as_FPKM_Fragments_per_kilobase_of_exon_per_million_fragments': 1.3104487659414685e-08, 'Cuffdiff_program': 2.1404152331574389e-10, 'Primers_project_httpwwwgeneontology': 1.1686951820486561e-54, 'set_min': 8.263922883666513e-55, 'to_be_statistically_significant_By_mapping_multiple_types_of_omics_data_such_as_genomics_transcriptomics_proteomics_and_metabolomicsinto_KEGG_pathway': 8.263922883666513e-55, 'set_to_be_statistically_significant_By_mapping_multiple_types_of_omics_data_such_as_genomics_transcriptomics_proteomics_and_metabolomicsinto_KEGG_pathway_min': 0.0005345134679592639, 'concentration_purity': 9.148819220060914e-58, 'using_a_NanoDrop_®_ND1000RNA': 9.148819220060914e-58, 'melting_curve': 6.0762327941524466e-05, 'using_the\\x88\\x92ä\\x89\\xadä\\x89\\xadCT_method_The_primers_used_are_shown_in': 0.002799336329108656, 'Meilunbio_China': 0.00010140499121387615, 'rectangle': 6.075138805368378e-52, 'foldchange_\\x89¥': 3.287841426025112e-52, 'foldchange_\\x89¥_fluorescence_microscopy_Images_using_the_BCA_methodSolarbio_China_and_the_lysates': 0.0005056931361422782, 'fluorescence_microscopy_Images': 3.287841426025112e-52, 'Protein_concentration': 8.251437779991868e-06, 'using_the_BCA_methodSolarbio_China_and_the_lysates': 1.3476939056011358e-07, 'to_downregulated_mRNAs_P\\x89Table_ _Baseline_characteristics_of_participantsAgeSmokeAlcoholTeaRiceVegetableOilSugarChiliSaltedFruitSaltMeatControl': 1.828014687832449e-05, 'reader_Synergy': 9.148819220060914e-58, 'to_determine_the_OD_at_ _nm_The_formula_used_for_calculating_cellviability_was_cell_viability_  _OD_of_test_cells_\\x88\\x92_OD_of_cellfree_medium_ _OD_of_control_cell': 9.148819220060914e-58, 'using_SPSS_ ': 0.0014616190772430405, 'pathways_pathways': 9.417879738638035e-06, 'ie': 9.148819220060914e-58, '\\x89¥_Pvalue': 9.148819220060914e-58, 'membrane_laminin_complex': 3.679367396913154e-08, 'effector_process_defense_response_CCs': 3.680348276610292e-08, 'involved_included': 9.148819220060914e-58, 'protein_bindingidentification': 9.148819220060914e-58, 'BPs': 5.992424023837361e-10, 'to_participate_in_changes_in_cell_morphology_or_cell_migration_Insummary': 0.0003420233287464351, 'FN1': 0.0018509147952789364, 'confidentialityissues': 0.0009560007527540245, 'difficulties': 0.004988160690957966, 'corroboration': 5.767273741641787e-05, 'GO_KEGG': 9.148819220060914e-58, 'to_identify_the_potential_functions_of_these_differential_mRNAs': 9.148819220060914e-58, 'correlation_to_identify_the_potential_functions_of_these_differential_mRNAs': 0.00238803522972525, 'smokers_nonsmokers': 0.0004405647755333974, 'to_be_overexpressed_in_lung_cancer_prostate_cancer_andthyroid_cancer': 0.0038806204677737646, '16HBE': 1.0907317663295551e-05, 'silicon_dioxide': 1.7811096457932583e-07, 'Ecad_and_VIM_serves_as_a_marker_for_EMT_in_nonsmall_cell_lung_cancer_MoreoverFN1': 0.0015842910551982499, 'Development_Project': 6.786073079812448e-05, 'to_published_version_of_the_manuscriptAbbreviations16HBE_human_normal_bronchial_epithelial_cells_EMT_epithelial\\x93mesenchymal_transition_FN1_fibronectin_ _rRNA': 0.0007959416758056306, 'lung_cell_line_miRNA21_cooperation': 5.326770801494381e-05, 'H_NLRP3_inï¬\\x82ammasome_inhibition': 8.263922883666513e-55, 'X_Lyn': 9.148819220060914e-58, 'transition_Xu_L_Xiang_X_Ji_X_Wang_W_Luo_M_Luo_S_Effects_mechanism_Exp_Res_\\x93': 9.148819220060914e-58, 'light_treatment_strategies': 0.0038806204677737646, 'miRNAs_cell_target_pathway': 0.0015842910551982499, 'Wnt_signaling': 0.006427672210408067, 'receptors_LRP56': 9.148819220060914e-58, 'fate_growth_tissue': 9.148819220060914e-58, 'Wnt_ligand': 0.0011194965680474886, 'Terms_uses': 3.401352137389888e-05, 'plasma_membrane_receptor_complex': 0.0006942420386366003, 'Axin': 1.1497336468776362e-05, 'activation_Axin': 6.298805075748078e-05, 'Wnt_signal': 1.037471015656171e-05, 'APC_glycogen_synthase_kinase': 7.858082617607471e-10, 'destruction_complex': 4.818485838795331e-08, 'phosphorylation_degradation8Other_mechanisms': 0.0038806204677737646, 'E3_ubiquitin_ligase_transducin': 0.0005915726387590047, 'YAPTAZrecruited_TrCP': 0.00024134924474519354, 'Cullin_3KLHL12': 0.00018065691001969275, 'DVL': 2.94922781330236e-06, 'ZNRF3RNF43': 0.00010596020021879068, 'LRP_receptor': 0.0004254422540019666, 'recognition_synthase_kinase': 0.0005191866840966338, 'histone': 1.1686951820486561e-54, 'coactivators': 8.263922883666513e-55, 'TCFLEF': 0.0004324474998927936, 'factor_LEF_enhancer_factor_polyposis_coli': 4.817201965402133e-08, 'leucinerich': 9.148819220060914e-58, 'containing_Gproteincoupled_receptors_ _ASPM_abnormal_spindlelike_microcephaly_associated': 9.148819220060914e-58, 'alleucinerich_ligand_family': 8.263922883666513e-55, 'to_ _participate_ _in_ _the_ _generation_ _of_ _canonical_Wnt_signaling_ASPM_interacts_with_Wnt_regulator_DVL': 1.1686951820486561e-54, 'signal_axis': 8.263922883666513e-55, 'GTPases_Rho': 0.0038806204677737646, 'phospholipase_C_PLC': 4.817201965402133e-08, 'Ca2_release': 0.00016032962580117682, 'PKC_CaN_CaMKII': 0.00016032962580117682, 'DovepressIP3_IP3': 1.1686951820486561e-54, 'Ca2_release_DAG': 8.263922883666513e-55, 'II_CaMKII': 8.263922883666513e-55, 'Deptor_DEP_domain': 9.148819220060914e-58, 'mTOR_inhibitor': 9.148819220060914e-58, 'Furthermore_Deptor_The_DEP_domain_containing_ _mTOR_ _interacting_ _an_ _mTOR_ _inhibitor_ ': 7.05217663403483e-05, 'Silencing_Deptor': 9.148819220060914e-58, 'differentiation_inhibition': 9.148819220060914e-58, 'Wntcatenin_inhibitors': 6.795633186884302e-05, 'Vset_transmembrane_domain': 0.00012613970685026185, '2A': 0.00771518910792271, 'MAGI1_Free_catenin': 2.820213485255625e-05, 'expression20_SATB1': 0.0016810521528134112, 'interconversion': 0.0009466755491730313, 'phenotypeWntcatenin_signaling': 0.00039947355805761766, 'Supplementing_ _RSPO1_ _or_knocking_ _down_ _Znrf3Rnf43_ ': 9.148819220060914e-58, 'Wntcatenin_signal_gradient': 9.148819220060914e-58, 'addition_liver_regeneration': 9.148819220060914e-58, 'type_protein': 9.148819220060914e-58, 'CTNNB1_mutations23': 1.1199857462963908e-05, 'GPC3': 0.001099003039654047, 'GPC3_FZD': 0.00021921962201374475, 'GSK3_phosphorylation': 9.148819220060914e-58, 'Wnt_signaling_promoting': 9.148819220060914e-58, 'silencing_canonical_Wnt_signaling': 0.0004358935679566294, 'Dickkopf1_DKK1': 0.00014496056951849028, 'DKK1': 9.148819220060914e-58, 'bone_metastasis': 9.148819220060914e-58, 'HCC_CTNNB1': 0.0003631075583458118, 'CSCs': 1.8100518952634073e-05, 'characteristics_differentiation_ability': 2.952678199728054e-07, 'Lgr5_cells': 9.148819220060914e-58, 'tumorinitiating_ ': 9.148819220060914e-58, 'Mature_leukemia_cells': 0.0002712952666904031, 'mutations_inflammation_changes': 2.952678199728054e-07, 'induction_hepatocytes': 1.1686951820486561e-54, 'tumor_nodules': 8.263922883666513e-55, 'cell_markers52': 8.263922883666513e-55, '170B_WIF1_signaling': 0.0015842910551982499, 'Reilein': 0.0015842910551982499, 'report54': 0.0003689975995246945, 'box_gene': 9.148819220060914e-58, 'Twist_family': 9.148819220060914e-58, 'Twist1': 2.013992634969584e-05, 'complex_CSC_phenotype': 3.289997898029029e-07, 'CSC_phenotype': 3.289997898029029e-07, 'proliferation_cancer': 0.00027587787348664266, 'stem_phenotype': 0.0011125787591309202, 'LCC_cells': 0.0001398556650862435, 'reaction_MSPCR': 0.00012613970685026185, 'to_conï¬\\x81rm_the_methylation_level_and_expression_level_ofthe_interleukin_receptorassociated_kinase_IRAK3_gene_in_glioma_cells_ _glioma_samplesand_the_corresponding_normal_samples_In_vitro_the_proliferation_apoptosis_rate_migrationand_invasion_abilities_of_glioma_cells_were_detected_by_Cell_Counting_Kit8_assay_Transwellassay_enzymelinked_immunosorbent_assay_and_ï¬\\x82ow_cytometry_respectively': 0.0002517988922651906, 'enzymelinked_immunosorbent_assay_ï¬\\x82ow_cytometry': 2.967189715706181e-07, 'thexenograft_assay': 1.4055400435083287e-53, 'to_conï¬\\x81rm_the_effect_of_the_IRAK3_on_glioma_in_vivoResults': 2.274211562945482e-53, 'methylation_level_expression_levelof': 0.0003327007272384309, 'overexpression_demethylation': 0.0006246792128329638, 'IRAK3': 0.0017533084809684771, 'attention_methods': 0.0004405647755333974, 'longtermsurvivors': 0.0005536611936400708, 'role_modiï¬\\x81cationinvolved_geneexpression': 0.0004001752419276083, 'ofnormal_cells': 8.263922883666513e-55, 'balance_betweenmethylation_demethylation': 1.1686951820486561e-54, 'biologicalactivities6_Hypermethylation': 8.263922883666513e-55, 'speciï¬\\x81cpromoters': 0.0003631075583458118, 'strategy_forpatients': 0.0038806204677737646, 'diagnosis_prognosis': 0.00019396529043020443, 'speciï¬\\x81c_methylation': 0.0005865071468874085, 'development_ofcomprehensiveaanalysisgliomas': 0.0038806204677737646, 'Written': 0.0004100538998299479, 'People\\x99sHospital': 0.0006030236714318566, 'GOS3_cells': 2.63595245090252e-05, 'kinase_pcDNA31IRAK3': 2.63595245090252e-05, 'SigmaAldrich_USA_U251_cells': 2.63595245090252e-05, 'cell_conï¬\\x82uence': 2.63595245090252e-05, 'IL6_level': 7.417164383651313e-53, 'to_extract_proteinsfrom_glioma_cells_and_tissues_respectively': 1.284690556057437e-52, 'Fisher_Scientiï¬\\x81c': 7.417164383651313e-53, 'totalprotein': 7.417164383651313e-53, 'ï¬\\x82uoride': 9.148819220060914e-58, 'ThermoFisher': 9.148819220060914e-58, 'AGTTTGGGATAGTGGTTAATATTTT': 0.00022771936739542464, 'normalization_procedures': 0.0006813930207159834, 'AssayU251_cells': 9.148819220060914e-58, 'toadhere': 9.148819220060914e-58, 'to_test_the_cell_viability_at_respective_time_points_To_summarize_ _mL_of_the_triazoliumsubstrate': 8.263922883666513e-55, 'polyethylene_terephthalatemembrane': 0.0038806204677737646, 'Viability_Staining_Solution': 0.0007129960827382031, 'cytometer_Data': 9.148819220060914e-58, 'Kaluza_softwarethe_mice_mice_weeks': 9.148819220060914e-58, 'Allina': 5.553445178064334e-05, 'animal_house_Hospital_toguarantee': 9.065972235386102e-07, 'food_water': 9.065972235386102e-07, 'ï¬\\x82ank': 0.0012849032601894472, 'U251_cells': 2.096673876340557e-05, '5azadC_andPD325901': 2.096673876340557e-05, 'software_Differences': 0.00048362067048935835, 'sampledata': 9.148819220060914e-58, 'to_revealthe_global_DNA_methylation_patterns_of_glioma_Firstdensity_plots_of_Î²_values_generated_from_each_samplewere_used_identifying_a_poor_performance_of_methylatedsignals_for_raw_data_Figure': 9.148819220060914e-58, 'TypeII_probe_assays': 0.0003260903091169294, 'datawere_MDSplot_dendrogram': 0.0006770056389244467, 'Figure_1C_DFurther_heatmap': 1.104453032589865e-05, 'Figure_1EDistribution': 9.148819220060914e-58, 'CpG_SitesBased': 9.148819220060914e-58, 'region_UTRs_body_transcription': 1.554197642486984e-05, 'sites_CpGisland_sea': 0.0009528015094790272, 'Hypermethylated': 9.148819220060914e-58, 'to_present_the_top_ _hypermethylationgenes_in_glioma_compared_with_normal_tissues_so_as_to_ï¬\\x81gureout_the_most_characteristic_gene_with_methylation_change_intumors_indicating_that_the_IRAK3_was_hypermethylated_theCancer_Management_and_Research_submit_your_manuscript_ _wwwdovepresscomDovePress': 9.148819220060914e-58, 'theCancer_Management_Research': 0.00022771936739542464, 'MAPK_pathway': 0.0016489413204500746, 'Figure_4C': 2.6916428764493715e-05, 'genes_genes': 0.00022660464963088025, 'glioma': 0.0019973735765056355, 'whether_any_correction_existed_with_thedevelopment_of_glioma': 9.148819220060914e-58, 'to_be_veriï¬\\x81edMAPK_Signaling_Pathway_Expression_Leveland_State_in_GliomaFor_the_identiï¬\\x81cation_of_gliomarelated_signaling': 9.148819220060914e-58, 'methylation_thetop': 1.0897881470433689e-05, 'manuscript_wwwdovepresscomDovePressCancer_alFigure_Effect': 5.8791748802789936e-05, 'lines_U251_SF539_andGOS3': 9.148819220060914e-58, 'hypermethylation_expressioncompared': 9.148819220060914e-58, 'Demethylation': 9.148819220060914e-58, 'Development': 9.148819220060914e-58, 'to_understand_whether_the_correctionof_abnormal_IRAK3_methylation_and_expression_affected_thedevelopment_of_glioma_After_using_pcDNA31IRAK3_tooverexpress_or_5azadC_to_demethylate_the_IRAK3_the_proteinexpression_level_of_the_IRAK3_in_glioma_U251_cells_increasedin_the_tumor_group_compared_with_the_normal_group_Figure7A\\x93C_IL6_an_inï¬\\x82ammatory_factor_secreted_by_the_MAPKsignaling_pathway': 2.8609344202128524e-05, 'IRAK3_methylation_expression': 5.62926585617289e-10, 'to_represent': 0.0006677634841063962, 'ofMAPK_pathway_activation': 1.089497687952226e-05, 'migration_invasivenesscapability': 1.089497687952226e-05, 'PD325901_pcDNA31IRAK3_groups': 4.27440232235726e-06, 'P_P': 1.1686951820486561e-54, 'manuscript_wwwdovepresscomDovePressCancer': 8.263922883666513e-55, 'associationbetween_IRAK3_development': 0.0038806204677737646, 'theOverexpression_Demethylation': 9.148819220060914e-58, 'ofGlioma_CellsThe_MAPK': 9.148819220060914e-58, '5azadC': 9.148819220060914e-58, 'to_conï¬\\x81rm_the_inï¬\\x82uence_of_the_IRAK3and_MAPK_signaling_pathways_on_glioma': 9.148819220060914e-58, 'MAPK_theOverexpression_Demethylation': 9.148819220060914e-58, 'Glioma': 9.148819220060914e-58, 'suppression_aloneor': 2.3941537278156315e-05, 'differences_P_Cancer_Management_Research': 0.00022771936739542464, 'P_IRAK3': 0.001128162151175775, 'detectedthey': 5.011203529266787e-07, 'to_be_significantly_decreased_in_thePD325901_pcDNA31IRAK3_ _PD325901_or_5azadC_PD325901_group_Figure_10D\\x93FDiscussionAccording_to_the_World_Health_anization_the_overallsurvival_of_patients_with_cancer': 3.070620087427118e-05, 'inï¬\\x82uenceon': 0.0007956673215405282, 'inï¬\\x82ammation': 0.00210348072096923, 'to_becontrary_to_the_previous': 0.0038806204677737646, 'activation2425_Likewisethese': 5.7123592486022485e-05, 'events_stimuli': 1.1327846616133142e-05, 'MAPKsignaling_pathway': 0.0006942392743112329, 'theMAPK_pathway': 1.6202760994678573e-05, 'MIBG_scintigraphy': 0.00034563374604989724, 'tumors_Genetic_testing': 9.148819220060914e-58, 'masses_accumulation': 9.148819220060914e-58, 'normalization_secretion': 0.0004202357087063657, 'VHL_disease': 9.148819220060914e-58, 'to_bethe_most_frequent_genetic_disorder_causing': 9.148819220060914e-58, 'Whileinchildrenpheochromocytomas': 5.526896120685606e-51, 'wasreportedAs_symptoms': 0.0006324067207528349, 'monthShe': 9.148819220060914e-58, 'asthenia_weight_loss': 9.148819220060914e-58, 'body_weight_mass_index': 8.770946583746331e-05, 'Electrocardiogram': 0.0005536916195397168, 'glwithout_ketosisFundoscopy': 8.252592359321672e-05, '\\x97_mm': 1.4055400435083287e-53, 'measuring_ _\\x97_ _mm': 8.764714436124261e-05, 'MetaiodobenzylguanidineMIBG_scintigraphy': 0.000327079770302999, 'molecularinvestigation_DNA_analysis': 9.148819220060914e-58, 'protooncogene_mutation': 9.148819220060914e-58, 'mutationc191_G_C': 0.00210348072096923, 'adrenalectomy': 3.4006139395373004e-05, 'adrenalectomy_normalization': 0.0004202357087063657, 'RCC_2B_families': 0.00046683359119049114, 'VHL': 9.148819220060914e-58, '2C_kinds': 9.148819220060914e-58, 'to_be_more_likelycarrying_a_missense_mutation_in_the_VHL_gene': 0.00015663202972484368, ']_Genotypephenotype_correlations': 2.552392444247408e-06, 'Pheochromocytoma': 9.148819220060914e-58, 'to_be_seen_at_ayounger_age': 9.148819220060914e-58, 'hypertensionassociated': 0.0011075402231842013, 'cholesterol': 0.0038806204677737646, 'Inour_case_term_followup': 0.0007643384077950606, 'outMeasurement': 1.247090053228339e-05, 'VHL_tumors': 9.148819220060914e-58, 'totaltissue_contents': 9.148819220060914e-58, 'norepinephrine': 0.004315547045054443, 'VHLassociated_pheochromocytomas': 9.148819220060914e-58, 'tumor_capsule': 9.148819220060914e-58, 'pheochromocytomas': 2.1387029401438546e-05, 'Hypercalcemia': 9.148819220060914e-58, 'thePTH_receptor': 9.148819220060914e-58, 'intactPTH': 9.148819220060914e-58, 'generationchemiluminescence_immunoassay': 9.148819220060914e-58, 'recognizePTHrpird': 0.0038806204677737646, 'PTH_substance': 5.718649076399572e-07, 'conï¬\\x82icts_guideline\\x9d_e_Journal_pp': 0.0013882295497307361, 'Conception_MarseilleFrance': 0.0007959416758056306, 'S_G_T_Rich_E_Grubbs': 9.148819220060914e-58, 'etiology_diagnosis_treatment_paraganglioma\\x9d_e_Journal': 9.148819220060914e-58, '\\x9cAcromegalysecondary_byan': 9.148819220060914e-58, 'EndocrinePathology_vol': 9.148819220060914e-58, 'tumor_spinal_hemangioblastoma_hyperparathyroidism\\x9d': 0.0002812637223256724, 'R_D_Luijt': 6.206879147866061e-05, 'ESW_increase_cell_proliferation_diï¬erentiation': 0.0011309661121321178, 'bronchial': 0.00238803522972525, 'proliferation_markers': 0.00019338140904154145, 'h_Protein_levels': 0.00019338140904154145, 'ese_data': 9.148819220060914e-58, 'increase_airï¬\\x82ow_limitation': 9.148819220060914e-58, 'ofsmall_airways_ii_destruction': 0.0004499048194399722, 'Chronic': 0.0015842910551982499, 'httpwwwgoldcopdcom_RegenerativeforCOPD': 8.263922883666513e-55, 'cell_MSC_tissueengineering_therapies': 1.1686951820486561e-54, 'tissue_MSC_treatments': 8.263922883666513e-55, 'keratinocyte_growth_factor': 9.148819220060914e-58, 'alveolarization': 9.148819220060914e-58, 'regeneration_enhancedlung_vascularization': 0.00020207254642467623, 'andVEGF_administration': 0.00047983738574547787, 'agonist_administration': 9.148819220060914e-58, 'nodiï¬erences': 9.148819220060914e-58, 'tissue_regeneration': 0.000404948725608525, 'therapy_ESWT': 0.00014084186830440697, 'ESW': 9.992835703198152e-05, 'patients_control': 9.148819220060914e-58, 'CD117_cKit_orSCFR': 9.148819220060914e-58, 'Itcan': 9.148819220060914e-58, 'cells_melanocytes': 9.148819220060914e-58, 'cellnuclear_antigen': 0.00013576801370357422, 'to_analyze_the_proliferative_eï¬ectof_shock_waves_when_applied_as_an_external_challenge_toprimary_bronchial_ï¬\\x81broblasts_of_COPD_patients_and_controlsmokers_and_to_immortalized_bronchial_epithelial_cells16HBE_To_this_end': 0.00238803522972525, 'markers_expression': 0.007713134335009549, 'andprocessing': 9.148819220060914e-58, 'ethics_Clinici_Scientiï¬\\x81ciMaugeri_CTS_p102_Luigi_Hospital': 9.148819220060914e-58, 'SV40_cellline': 0.00238803522972525, 'thediï¬erentiated_morphology_function': 0.0038806204677737646, 'controls_Cell_growth': 0.00048362067048935835, 'RNAspin_Isolation_kit': 0.00019920455220160467, 'using_aUVvisible_spectrophotometer_Î»260280_nm_EppendorfBioPhotometer': 1.4055400435083287e-53, 'system_Onestep_realtime_PCR': 3.249284936003049e-06, 'using_the_Rotor_Gene_Qsoftware_RotorGene_Q_Series_Software_ ': 0.00012613970685026185, 'eCatexpression_levels': 9.148819220060914e-58, 'toGAPDH_levels': 9.148819220060914e-58, 'Cruz_CA_USA': 2.2742115629454836e-53, 'nonspeciï¬\\x81cmouse_rabbit_immunoglobulins_Graphics_program': 2.2742115629454836e-53, 'nonspeciï¬\\x81cmouse_rabbit_immunoglobulins': 1.4055400435083294e-53, 'Group_data': 1.4055400435083294e-53, 'mediandeviationrangeconsidered_Data_analysis': 9.148819220060914e-58, 'Graphics_program': 9.148819220060914e-58, 'CA_USA': 0.00015510796575148185, 'ESW_Eï¬ects_characteristics': 2.527548135775763e-06, 'Results_control': 9.148819220060914e-58, 'vitalAge_years': 9.148819220060914e-58, 'bronchialï¬\\x81broblasts_expiratory_volume': 0.0011075402231842013, 'List': 1.1686951820486561e-54, 'cell_proliferation_extraction_kits': 8.263922883666513e-55, 'dilution_detection_limits': 8.263922883666513e-55, 'buï¬erInvitrogenAbnovaNo': 9.148819220060914e-58, 'proliferation_index': 9.148819220060914e-58, 'ï¿½': 0.005023549436145444, 'ESW_Eï¬ects': 9.194124291429792e-05, 'inprimaryof_COPD': 0.0006683433237423609, 'cellproliferation_ï¬\\x81broblasts': 6.485968377876936e-08, 'ï¬\\x81broblasts': 0.001817788713652672, 'Ct0005101520CS_CNCS': 9.148819220060914e-58, 'CtT0T24T48T72012316HBE_CN16HBE': 9.148819220060914e-58, 'ofCOPD_patients': 5.546558238404185e-07, 'decrease_purposes': 3.3958814874665265e-05, 'h_T0': 0.0005807607654450252, 'Ttest': 6.48954223849123e-06, 'II_cells': 0.0003979000999523727, 'alsoin_adulthood': 9.148819220060914e-58, 'potential[\\x93': 9.148819220060914e-58, 'the_proliferative_action_of_ESW_at_low_dosage_inbronchial_epithelial_cells_and_in_primary_bronchial_ï¬\\x81broblasts_of_control_smokers_CS_and_patients_with_COPD_Ourdata_show_that_all_the_cell_types_studied': 9.148819220060914e-58, 'proliferation_index_test': 9.148819220060914e-58, 'kinase_protein_mRNAwere': 2.966939893193355e-05, 'cKit_protein': 2.966939893193355e-05, 'ESW_stimulation': 3.0831158614263884e-05, 'cellresponse': 2.74685240497079e-05, 'CD90_protein_level': 0.0003608303843934633, 'TTF1_expression': 9.148819220060914e-58, 'antigen_h': 9.148819220060914e-58, 'thisdecrease': 0.0007080023910910008, 'ESW_challenge': 0.0015842910551982499, 'procollagen1production': 0.0015842910551982499, 'programs_nature': 0.004315547045054443, 'expression_cytokines_chemokines_messengers': 0.000576827339123862, 'understanding_location': 0.007713134335009549, 'World_Healthanisation': 0.0005915726387590047, 'cancerhas': 9.148819220060914e-58, 'to_be_the_third_leading_cause_of_cancerrelated_death_in_the_European_Union_by_[': 9.148819220060914e-58, 'cause_factors': 0.0002321359877387567, 'subgroupof_patients': 0.00029711816816522314, 'basement_membrane_neoplasms_IPMNs_cysticneoplasms_MCNs': 1.1760252042511068e-50, 'neoplasms_IPMNs_cysticneoplasms_MCNs': 1.1760252042511068e-50, 'IPMNsdevelop_MCNs': 9.148819220060914e-58, 'ductal': 9.148819220060914e-58, 'Desmoplasia': 1.1686951820486561e-54, 'cells_PSCs': 8.263922883666513e-55, 'fibroblasts_CAFs': 8.263922883666513e-55, 'PSCs_CAFs': 8.263922883666513e-55, 'myCAFs': 0.0008522036149147152, 'iCAFs': 0.0013088081585862672, 'IL6_andinstead': 0.0008522036149147152, 'Tcells': 9.148819220060914e-58, 'cells_MDSCs_killer_NK_cells_nerve_cells': 9.148819220060914e-58, 'Interactions': 0.0006992128660964839, 'ECM_stiffness': 9.148819220060914e-58, 'myCAF_phenotype': 9.148819220060914e-58, 'tumour_behaviour_Figure': 0.00035695096505492413, 'PDAC_tumour_growth_progression': 0.004315547045054443, 'understanding_PDAC_PanIN_lesions': 9.148819220060914e-58, 'andormetastatic': 9.148819220060914e-58, 'to_drive_development_of_precursor_PanIN_lesions_andwhen_combined_with_an_appropriate_tumour_suppressor_mutation': 1.7291635429183054e-05, 'to_drive_development_of_precursor_PanIN_lesions_andwhen_combined_with_an_appropriate_tumour_suppressor_mutation_activating_mutations_indownstream_effector_molecules_such_as_BRAF_or': 0.0003809665283472652, 'metastaticPDAC_Patient_tumours': 9.148819220060914e-58, 'activating_mutations_indownstream_effector_molecules_such_as_BRAF_or': 9.148819220060914e-58, 'mutations_KDM6A_DNAdamage_repair_ATM_processes': 0.00015319874332371669, 'exocrinesubtype': 0.0001299257119781746, 'valuable': 6.018495916924562e-06, '\\x93]Surgery': 0.0003503299682769458, 'Radiotherapy': 9.174112200359154e-06, 'to_modestly_reduce_overall_survival': 8.263922883666513e-55, 'to_improve_median_survival_by_just_over_ _month_compared_with_fluorouracil': 0.00210348072096923, 'theTME': 6.680299491429861e-05, 'IL6_family': 9.148819220060914e-58, 'CT1_cytokine_CLC_neuropoietin': 9.148819220060914e-58, 'IL6_IL11': 9.148819220060914e-58, 'complex_glycoprotein_gp130': 9.148819220060914e-58, 'Converselytranssignalling': 9.148819220060914e-58, 'IL6R_molecules': 9.148819220060914e-58, 'Phosphotyrosine_pY': 9.148819220060914e-58, 'docking_sites_Authors_Schematic_representation': 9.148819220060914e-58, 'SOCS3_PIAS3_PTPs': 0.000426827576725533, 'STAT_dimers_dimers': 9.148819220060914e-58, 'Figure_2B': 9.148819220060914e-58, 'to_be_activated_by_a_Src_homology_domain_2containing_phosphatase_SHP2mediated_mechanism': 2.6923601540570044e-05, 'SHP2': 4.3939995717428855e-07, 'SOCS3': 0.0005471557777693269, 'SH2_domain': 8.931742657117757e-06, 'E3_ubiquitin_ligasecomplex': 8.931742657117757e-06, 'PIAS3': 0.0007010580158717714, 'pSTAT3': 1.1438778072363615e-05, 'TCGA': 0.0014616190772430405, 'cells_PCCs_PSCs': 5.584650993676719e-05, 'H_CTF1_CT1': 9.148819220060914e-58, 'fromOncoLnc': 9.148819220060914e-58, 'CLC_J_IL27': 0.00016553660791656055, 'Science': 5.584650993676719e-05, 'IL6_production': 0.0007000951832348714, 'PCCderived_IL1Î±has': 9.148819220060914e-58, 'to_induce_autocrine_LIF_secretion_and_thereby_promote_the_iCAF_phenotype_including_activation_ofthe_JAKSTAT_signalling_pathway_and_IL6_production': 9.148819220060914e-58, 'immunohistochemistry_expression_analysis': 6.56456448942153e-07, 'lowgrade_PanINs': 0.0005411681930881713, 'PanIN3': 0.0005034057898537578, 'to_induce_IL6_production': 0.0005373063242131615, 'Il6_mice': 2.6947187936785378e-05, 'to_contribute_to_this_reduced_tumour_progression_as_demonstrated_by_appropriate_immunohistochemical_analyses_with_upregulation_of_proapoptotic_anddownregulation_of_antiapoptotic_BCL2_family_members': 0.0005521751935137136, 'IL6_stimulation': 0.0016810521528134112, 'tumour_growth_progression': 0.002601754626904103, 'PDAC_cell_lines': 0.0007000951832348714, 'modulationof_system': 0.004315547045054443, 'GCSF': 0.000704362469235278, 'J_Oliver2_Jorrit_De_Waele1_Delphine': 9.148819220060914e-58, 'Jinthe_Van': 9.148819220060914e-58, 'this_tumors': 0.0006026042973632392, 'to_explore_the_potentialof_combining_both_priming_and_activation_of_the_immune_systemTo': 0.00238803522972525, 'CD40_agonist': 0.00939418648782296, 'combination_regimen': 9.148819220060914e-58, 'this_Results_tumors': 9.148819220060914e-58, 'survival_ofmice': 0.0006054349545841993, 'ain': 0.00238803522972525, 'past': 9.148819220060914e-58, 'rendering_PDAC_a_disease_whichrepresents_the_very_deï¬\\x81nition_of_an_urgent_unmetneed_for_novel_therapeutic_approaches_to_ï¬\\x81nallyimprove_the_outcome_of_patientsAbout_ _of_patients_are_not_eligible_for_curativesurgical_resection_because_of_locally_advanced_ormetastatic_disease_at_the_time_of_diagnosis_Hencepatients_are_treated_with_either_FOLFIRINOX_emcitabinenabpaclitaxel': 9.148819220060914e-58, 'treatment_highlightsthe_need_use': 0.00035028915142444096, 'potentresults': 0.0005191866840966338, 'furtherinvestigation': 0.0014616190772430405, 'killer_NK_cells': 9.148819220060914e-58, 'tumor_cells_stellatecells': 9.148819220060914e-58, 'CD40_agonists': 0.0011287635911564062, 'theexpression_activation': 1.8420392474163883e-05, 'antitumor_T_cells': 1.8420392474163883e-05, 'CD40_agonistantibody_IL15': 9.148819220060914e-58, 'effectsin_terms': 9.148819220060914e-58, 'dose_reduction_antitumoreffect': 9.148819220060914e-58, 'cells_amounts': 9.148819220060914e-58, 'rationale_toinitiate_clinicalinvestigating_agonist_therapyresults': 0.0014616190772430405, 'thecombination': 1.4805495055674868e-05, 'tumor_models': 0.0009077161491390516, 'furthertumorvolume_increase': 5.540504689756876e-06, 'weobserved_Supplementaryï¬\\x81gure_1B_was': 9.148819220060914e-58, 'antitumor_activities': 9.148819220060914e-58, 'CD40_agonisttreatment': 0.00019207340813507976, 'genes_NK_cellcytotoxicity': 9.148819220060914e-58, 'showing_that_gene_sets_involved_inNK_cellmediated_cytotoxicity_Figure_2d_and_eand_Supplementary_ï¬\\x81gure_2A_the_IL122_pathwayFigure': 9.148819220060914e-58, 'inNK_Figure_2d_eand_Supplementary': 0.00022272389152648344, 'i_Supplementary': 1.1686951820486561e-54, 'thegroups_2j_k_Supplementary': 8.263922883666513e-55, 'thegroups_2j_k_Supplementary_depletion_antibodies': 0.0005373063242131615, 'antitumor_responseswe': 1.2377503083827084e-05, 'depletion_antibodies': 8.263922883666513e-55, 'Vol_C57BL6j_mice': 0.0011128752409327472, 'mm2_mice': 8.263922883666513e-55, 'cells_control_CD40_agonist_IL15_CD40': 1.1686951820486561e-54, 'control_CD40_agonist_IL15_CD40': 1.8162977041424498e-05, 'Treatment_scheme': 8.263922883666513e-55, 'Tumor_growth_kinetics': 0.0005411681930881713, 'experiments_Survival': 9.148819220060914e-58, 'tumor_size_reaching_ _mm2Logrank_test_f_g_Waterfall_plots_showing_the_ _change_in_tumor_area_relative_to_baseline_after_ _days_Panc02_n_  _or_ _days_KPCn_  _Pooled_data_of_ _Panc02_or_ ': 9.148819220060914e-58, 'P_Ë\\x82_P': 0.0014616190772430405, 'control_group_combination_group': 2.2742115629454836e-53, 'Volcano_plot': 1.4055400435083294e-53, 'Waterfall_plots': 1.8580551962618324e-05, 'l_Data': 8.263922883666513e-55, 'g_h_Howeverdepletion': 9.148819220060914e-58, 'Panc02_tumor_model': 9.148819220060914e-58, 'theseT_cells_wereexperiments': 9.148819220060914e-58, 'modelSupplementary': 9.148819220060914e-58, 'jstatisticallyCombination_therapy': 1.4055400435083287e-53, 'monitorTo': 4.090580356865688e-07, 'strikingdifferences': 0.00238803522972525, 'lymphocytesbut': 0.0006264573400700461, 'number_offollowingcombination_therapy': 0.007713134335009549, 'analysis_ofrelevant': 0.0016480626375926124, 'upregulation_The': 0.0005272733558584883, 'activation_signature_asIFNÎ³_CD69': 8.602224517769383e-06, 'activation_signature_asIFNÎ³_CD69_antitumor_effect_presence_significantincrease_Figure': 8.602224517769383e-06, 'to_play_critical_roles_inantigen_processing_and_presentation_and_are_keyplayers_in_the_activation_of_both_NK_and_T_cellsWe': 0.0007080023910910008, 'significantincrease_Figure': 0.007713134335009549, 'amount_wasIL15': 9.148819220060914e-58, 'HereDCs': 9.148819220060914e-58, 'DCsbehaved_we': 0.0005269923949341242, 'TDLN': 9.148819220060914e-58, '3fold_increase': 9.148819220060914e-58, 'Tumors': 7.417164383651313e-53, 'initiation_Singlecell_suspensions': 7.417164383651313e-53, 'e1165Page_migrated_Furthermoregene_signatures': 0.0016810521528134112, 'CXCL10_notCXCL11': 9.148819220060914e-58, 'theirinvolvementin_the_trafï¬\\x81cking_of_antitumorimmune_cells_to_the_tumor_site_Figure_5eincreaseTheInduction_of_immune_memorythe_goals_ofimmunotherapy_isOne_oftheinduction_of_strong_immunological_memory_toprevent_future_relapse_We_observed_in_our_studyan_increased_number_of_effector_and_centralT_cells_in_KPC_tumors_when_treatedmemory_CD8with': 9.148819220060914e-58, 'tumororand_bcontrolFigure': 3.28784142602511e-52, 'b_DCs_CD103DCs': 0.0003327007272384309, 'PDAC_models': 1.8580551962618324e-05, 'CD40agonist_therapy': 9.148819220060914e-58, 'immunepriming': 9.148819220060914e-58, 'CD44hi_memorycells_T_cells': 0.007713134335009549, 'to_be_transpresentedby_the_IL15RÎ±_on_DCsto_beeffective2023': 6.934407046106269e-05, 'CD44hi_memorycells_T_cells_wereFigure_Rechallenge_experiments': 0.007713134335009549, 'combiningboth_agents': 0.0010071448933776737, 'immuneactivation': 1.6435761703528167e-05, 'immuneactivation_effects_response': 0.007713134335009549, 'CD40agonist': 0.0006750162805663558, 'combinedenhanced': 1.6008736828638907e-07, 'survivalrates': 9.802754226811548e-06, 'wereFigure_Rechallenge_experiments': 0.007713134335009549, 'b_Tumor_kinetics_test': 0.0007129960827382031, 'd_Tumor_kinetics_survival': 0.0011125787591309202, 'inthese': 0.0001609151854222451, 'mouse_models_donot': 5.557887566346264e-05, 'NK_cells': 0.0004360097354757312, 'promising_resultsalbeit_with_less_surviving_mice': 0.0007959416758056306, 'underscoring_the_enormous_potentialof': 0.0002584379969449155, 'combination_approach24': 8.954573548380085e-05, 'boththat': 7.112492206702588e-06, 'analysis_ofDCs': 0.00036576662780187614, 'areduction': 0.007713134335009549, 'elucidates': 9.148819220060914e-58, 'therapy_models': 9.148819220060914e-58, 'behindour': 1.1200822721618559e-05, 'Tcellthey': 0.0004360097354757312, 'effectorcytokines': 7.112492206702588e-06, 'CD40_IL15': 0.00011931918217645773, 'modalitiesTcell_numbers': 0.0007080023910910008, 'to_beresponsible_for_chemoattraction_of': 5.427312839716404e-10, 'Theactivation_marker_CD69': 9.148819220060914e-58, 'fact_Vol': 9.148819220060914e-58, 'to_be_anearly_activation_marker_which_disappears_after_days37_Among_the_CD8subsets_wememory_T_cellsfound_higher_presence_of_CD8which_is_linked_to_immune_memoryIL15_hasbeen_described_to_be_important_for_the_inductionin_our_models35_Furthermorecorrelated_with_increased_survivalfollowingandCXCL10TcellCCL5andCX3R1aª_ _The_Authors_Clinical_ _Translational_Immunology_published_by_John_Wiley_ _Sons_Australia_Ltd_on_behalf_ofAustralian_and_New_Zealand_Society_for_Immunology_Inc_ ': 0.0005828796252635297, 'immunotherapy_sincethey': 9.148819220060914e-58, 'to_mediate_successful_andefï¬\\x81cient_antitumor': 9.148819220060914e-58, 'cellsdid': 9.148819220060914e-58, 'effect_combination': 9.148819220060914e-58, 'toT': 0.00210348072096923, 'toin_tumorformation': 0.0010325216439875707, 'administeredwe': 4.120723086887277e-05, 'Tregreduction': 9.148819220060914e-58, 'to_be_elucidated_althoughone_study': 9.148819220060914e-58, 'withimproved_overall_survival_in_cancer_patients46_andresponse_to_therapy4748CD8TreginteractionincreasedbetweenratioFinally_reduction_of_Tregs_in_PDAC': 0.0010325216439875707, 'DCsimmuneto': 9.148819220060914e-58, 'antitumorT_cells49': 9.148819220060914e-58, 'Ourresponse': 9.148819220060914e-58, 'CD8data': 9.148819220060914e-58, 'to_bethe_only_APCs_to_transport_intact_antigens_totumordraining_lymph_nodes_and_prime_tumorT_cells53': 0.0013882295497307361, 'dataspeciï¬\\x81c': 3.7711607362685093e-06, 'using_a_probabilistic_approach_andapplying_processing_factors_for_food': 0.0003608303843934633, 'MOEapproach': 9.148819220060914e-58, 'MOEs': 9.148819220060914e-58, 'health_concern_MOEs': 8.009886660854752e-06, 'Panel': 4.182727520945865e-06, 'to_thank_the_following_for_the_support_provided_to_thisscientiï¬\\x81c_output_Kelly_Niermans': 6.8355556584823e-08, 'to_acknowledge_all_European_competentinstitutions_Member_State_bodies_and_other_anisations_that_provided_consumption_and_occurrencedata_for_this_scientiï¬\\x81c_outputSuggested': 6.8355556584823e-08, 'aubergine_S_melongena': 0.0010101344558187907, 'GAs_asolamargine_asolasonine_toxicity_studies': 1.6484547600194986e-05, 'GAs_asolanine_achaconine': 8.263922883666513e-55, 'species_Hamsters': 9.148819220060914e-58, 'absorption_slowerexcretion_rates': 9.148819220060914e-58, 'serum_halflives': 9.148819220060914e-58, 'suggesting_a_possible_accumulation': 9.148819220060914e-58, 'to_be_slow_Accordingly_levels_of_solanidine_wereregularly_detected_in_the_blood_of_human_volunteers_in_several_studies_suggesting_hydrolysis_of_GAs_Nofurther_information': 8.263922883666513e-55, 'liver_weight': 0.0001830818689618328, 'Holtzman_rats': 4.3520991553734995e-08, 'weight_cauda_epididymal': 2.6646837455957046e-06, 'potato_TGAskg_bw': 0.0002208255543092432, 'forhumans_Results': 0.0006264573400700461, 'thePanel': 9.148819220060914e-58, 'margin_MOE_approach': 9.148819220060914e-58, 'MOE': 8.263922883666513e-55, 'GAs_aglycones': 0.000762889468397268, 'intake_GAs_aglycones': 0.0014616190772430405, 'to_combine_the_occurrence': 6.8355556584823e-08, 'using_a_probabilistic_approach_includingonly_days_in_which_there_was_consumption_of_maincrop_potatoes': 0.0003608303843934633, 'uncertaintiescid129_Occurrence_data_0cGlycoalkaloids_Summary_studies_GAs': 2.9223018006482062e-52, 'baking': 1.300546651990892e-52, 'the_GA_contentby_\\x93_boiling_in_water_and_blanching_of_peeled_potatoes_by_\\x93_and_frying_in_oil_of_peeledpotatoes_by_\\x93_Microwave_and_oven_baking_of_unpeeled_potatoes': 0.0006054349545841993, 'exposure_estimatesthe': 8.009886660854752e-06, 'aubergine_GAs_risk': 8.009886660854752e-06, 'Immunotoxicity': 9.148819220060914e-58, 'Studies_Neurotoxicity_studies': 9.148819220060914e-58, 'Considerations_animals_assessment_Occurrence_data': 9.148819220060914e-58, 'occurrence_data_Processing': 9.148819220060914e-58, 'exposure_assessment': 9.148819220060914e-58, 'exposure_assessments': 9.148819220060914e-58, 'Margin_MOE_approach_Occurrence_exposure_Food': 9.148819220060914e-58, 'Risk_characterisation_risk_characterisation_Recommendations_Documentation': 9.148819220060914e-58, 'glycoalkaloids_aglycones_Solanaceae': 8.263922883666513e-55, 'to_be_naturaltoxins': 0.0013882295497307361, 'European_Commission': 9.148819220060914e-58, 'theEuropean_Safety_Authority': 9.148819220060914e-58, 'Opinion': 6.392004260460355e-06, 'evaluation_composition_feed_samples_products_estimation_productse_assessment': 1.0435557616758986e-07, 'term_GAs_TGA': 1.0435557616758986e-07, 'termTGA': 0.0007641347695089468, 'Desfosses': 0.004315547045054443, 'glycoside_sidechain': 8.263922883666513e-55, 'solanidineaglycone_Kuhn_L\\x82¬ow': 0.004315547045054443, 'solasodine_tomatidenoltomatidine_backbone_GAs': 8.263922883666513e-55, 'Friedman_in': 7.141308139176537e-05, 'aubergine_fruit': 9.148819220060914e-58, 'preï¬\\x81xe': 9.148819220060914e-58, 'Purpose_ductal_adenocarcinomas': 0.0006303661364679235, 'to_determine_if_the_addition_of_a_monoclonal_antibody_to_connective_tissue_growth_factor_pamrevlumab_to_neoadjuvant_chemotherapy_would_be_safe_and_lead_to_improved_resectability_in_this_surgically_adverse_patient_populationMethods_ ': 0.0019127833147525456, 'evaluatedResults': 8.263922883666513e-55, 'Network_criteria': 1.1686951820486561e-54, 'Sixteen': 8.263922883666513e-55, 'OS_curability': 0.0019127833147525456, 'bias_lack_resection_rates': 4.933964380273162e-06, 'PDAC': 0.0002801167269529004, 'CTGF': 9.148819220060914e-58, 'to_play_a_central_role_in_the_biology_ _of_ _pancreatic_ _cancer_ _affecting_ _both_ _its_ _cellular_biology_ _and_ _its_ _extracellular_ _matrix_ _composition_ ': 9.148819220060914e-58, 'to_ _determine_resectability_of_pancreatic_tumours_Executing_a_pharmacological_intervention_on_the_pancreatic_cancer_stromal_environment_ ': 0.004315547045054443, 'CTGF_studies': 0.004315547045054443, 'study_n75_pamrevlumab': 9.148819220060914e-58, 'outcomes16We': 9.148819220060914e-58, 'antiapoptotic': 0.0038806204677737646, 'to_explore_the_safety_and_efficacy_of_pamrevlumab_in_combination_ _with_ _gemcitabinenab_paclitaxel_ _in_ _LAPC_ _with_special_emphasis_on_surgical_eligibility': 0.00035730068962257737, 'gemcitabine_mgm2_infusion': 0.0007465209059563179, 'figure_Patients': 9.148819220060914e-58, 'pamrevlumab_mgkg_infusion': 9.148819220060914e-58, 'AE_toxicity': 0.0004100538998299479, 'flow_surgery_outcomes': 7.468017544528108e-05, 'vein_thrombosis': 3.503165414227344e-05, 'SMA_encasement': 0.0004968127217041802, 'reduction_definition': 1.4055400435083287e-53, 'development_Picozzi_a0V': 0.00010452430922628992, 'ESMO_101136esmo_2019000668absolute_contraindication_eg_recovery_decision': 9.148819220060914e-58, 'surgeonendpointsSafety_endpoints': 9.148819220060914e-58, 'resection_survival_PFS_survival_rate_treatment_difference': 0.0005536611936400708, 'PP_population_intention': 0.0018999333169565343, 'using_the_Cochran_Mantel_Haentzel_test_controlling_for_baseline_factors': 8.263922883666513e-55, 'years_FemaleAge_group': 1.4055400435083287e-53, 'Patient_disposition': 3.836261193971619e-05, 'Twenty_patients_treatment_cycles_treatment_patients_decision_Forty_one': 6.263491956097576e-07, 'Twenty_patients': 6.26182329956255e-07, 'patients_decision': 0.001845170519318405, 'patientssafetySAEs': 9.148819220060914e-58, 'Forty_one': 9.148819220060914e-58, 'toxicity_category': 1.0222724327911554e-08, '\\x89¥_\\x93_decline': 2.8661339949023323e-07, 'NCCN_criteria': 0.0006176923471786672, '\\x98exceptional\\x99_responses': 0.001845170519318405, 'PET_SUVmax': 0.00018776857467682725, 'RECIST_response': 1.1686951820486561e-54, '\\x93_response_Arm': 8.263922883666513e-55, '\\x98exceptional\\x99_PET_response': 8.263922883666513e-55, 'Ca_response': 9.148819220060914e-58, 'evaluationOverall': 9.148819220060914e-58, 'completed': 9.148819220060914e-58, '\\x93_response_\\x98exceptional\\x99_PET_response_Arm': 9.148819220060914e-58, 'sepsis_gallbladder_perforation': 3.012831237073818e-05, 'declined_declined': 4.2222550313367e-06, 'Eight': 0.0006324067207528349, 'progressionPredictors': 0.0006324067207528349, 'one_both': 3.8882627567949516e-08, 'CA_\\x93': 9.148819220060914e-58, 'SUVmax_decrease': 9.148819220060914e-58, 'Grade_IIIB': 0.0006324067207528349, 'significantsurvivalAs': 2.6432538359546687e-05, 'to_ _be_ _alive_ _with_ _a_ _median_ _length_of_ _follow_up_ _at_ _approximately_   _months_ _PFS_ ': 4.3149760962908505e-07, 'CI_NR_CI': 9.148819220060914e-58, 'dIsCussIonThe_treatment': 1.1358194502641073e-08, 'volume_centres': 1.1358194502641073e-08, 'institution_study': 9.148819220060914e-58, 'R0_resection_rate': 9.148819220060914e-58, 'challenges_therapy': 0.0018006682651940404, 'FOLFIRINOX': 0.0011075402231842013, 'response_criteria_\\x93_RECIST': 0.0007196694966512437, 'that_ _pamrevlumab_ _a_ _human_ _monoclonal_ _antibody_with_anti_CTGF_mechanism_of_action': 1.1358194502641073e-08, 'coeliac_andor_SMA_factors': 0.001845170519318405, 'examination_CA_\\x93_PET_response': 0.0001700035525728, 'prognostic_insightWith_regard': 0.00031995314978350303, 'impact_prognostic_insightWith_regard': 0.00011023309857947745, 'attribute_complexity': 0.0001700035525728, 'ESMO': 9.148819220060914e-58, 'had_ _longer_ _PFS_ _and_ _OS_ _highlighting_ _the_ _importance_ _of_ _surgical_ _resection_ _of_ _the_tumour_Therefore_more_investigation_into_newer_agents_targeting_ _LAPC_ _and_ ': 9.148819220060914e-58, 'longer_PFS_OS': 1.0753396196933055e-06, 'study_FGR': 0.004315547045054443, 'potential_manuscript_FibroGen_Inc_Francisco_CAdisclaimer': 0.0019127833147525456, 'FibroGen_Inc_Francisco_CAdisclaimer': 0.0019127833147525456, 'right_andor_stock_options': 3.333920198953135e-05, 'Lenvatinib': 0.0007014625765222825, 'efficacy_safety_impact_therapies6': 0.0018006682651940404, 'chemotherapiesWhat_study': 3.124383789880943e-05, 'promising_ _antitumour_ _activity_with_ _acceptable_ _toxicity_ _for_ _heavily_ _pretreated_ _patients_with_metastatic_colorectal_cancer_refractory_to_standard_chemotherapies': 1.14453778354339e-05, 'prospective': 0.0018006682651940404, 'efficacy_safety_promising_ _antitumour_ _activity_with_ _acceptable_ _toxicity_ _for_ _heavily_ _pretreated_ _patients_with_metastatic_colorectal_cancer_refractory_to_standard_chemotherapies_impact_survival_therapies6': 0.0018006682651940404, '0c_accesslenvatinib': 0.0005282868232816249, 'tumour_growth10_phase_trials': 8.61672416363823e-06, 'Japan13': 2.6909254076977078e-05, 'interaction_tumour_growth10_phase_trials': 0.0016485018034048215, 'to_standard_therapiesPaTIenTs_and_meTHodsstudy_design': 0.0005253840276496832, 'consentProceduresPatients': 0.001845170519318405, 'grade_event': 0.0006324067207528349, 'using_the_National_Cancer_Institute_ _Common_ _Terminology_ _Criteria_ _for_ _Adverse_Events_version_Blood_ _sampling_ _for_ _biomarker_ _analyses_ _Angiopoietin2_Quantikine_ELISA_Kit_RD_Systems_Minneapolis_DCR': 0.004326358681329581, 'using_the_National_Cancer_Institute_ _Common_ _Terminology_ _Criteria_ _for_ _Adverse_Events_version_Blood_ _sampling_ _for_ _biomarker_ _analyses_ ': 0.00038821680642614145, 'Angiopoietin2_Quantikine_ELISA_Kit_RD_Systems_Minneapolis_DCR': 0.00038821680642614145, 'PFS_time': 0.0011075402231842013, 'disease_progression_OS_time': 5.693284547016032e-05, 'DCR_analysis': 5.693284547016032e-05, 'CharacteristicsOverall_N': 9.148819220060914e-58, 'range_type_status': 9.148819220060914e-58, 'access_number': 9.148819220060914e-58, 'patients_instability_Microsatellite_stableendpoint_ORR': 9.148819220060914e-58, 'using_Brookmeyer_ _and_ _Crowley_ _method_ _The_   _CIs_ _of_ _month_and_ _year_survival_probabilities_were_calculated_based_ _on_ _the_ _Greenwood\\x99s_ _formula_ _HRs_ _and_   _CIs_were_estimated_by_Cox_regression_We_did_subgroup_analyses_divided_by_prespecified_baseline_patient_and_disease_characteristic_variables_including_RAS_status_for_DCR_PFS_and_OS': 0.0005715966671738797, 'January_patients': 0.001129870936471824, 'medication_Table': 9.148819220060914e-58, 'baseline_characteristics': 9.148819220060914e-58, 'IQR_\\x93efficacyThe': 3.0136343241812733e-05, 'colon_Left': 9.148819220060914e-58, 'colorectum_status_site': 9.148819220060914e-58, 'assessmentn30_Events': 4.39325597256349e-05, 'study_treatment_alanine_aminotransferase_anorexia_patients': 0.0026918850581477876, 'OS_CI': 1.4115723111363262e-09, 'Kaplan_Meier': 9.148819220060914e-58, 'anorexia': 9.148819220060914e-58, 'CI_CI_Plasma_angiopoietin2_levels': 0.0007129960827382031, 'ESMO_patients': 2.3082544880686775e-11, 'median_PFS_CI': 2.944132033924775e-05, 'oralSerum_increasedSerum_creatinine': 0.00038821680642614145, 'improvements_months_OS_months': 8.263922883666513e-55, 'post_study_treatment': 3.365560733702061e-05, 'Regorafenib_nivolumab': 2.0140307143447083e-05, 'antitumour_activity_size': 0.00210348072096923, 'Prior_treatment': 0.001128162151175775, 'to_ _have_ _a_ _better_ _prognosis_ _compared_ _with_right_sided_tumoursIn_conclusion_lenvatinib_provided_promising_activity_with_prolonged_survival_relative_to_the_anticipated_median_PFS_in_ _heavily_ _pretreated_ _patients_ _with_ _metastatic_ _colorectal_cancer': 0.0038806204677737646, 'conclusion_lenvatinib': 0.0007008712380191807, 'NAI': 9.148819220060914e-58, 'patients_families_study_data_progress': 9.148819220060914e-58, 'study_manuscript': 0.0007961538442557918, 'SI_KK_TH_NB_YY': 0.0014616190772430405, 'AK_GO_MK_KN': 3.4494196115867285e-05, 'SI': 3.644097761008915e-05, 'honoraria_requiredethics_approval_guidelines': 0.0019127833147525456, 'Center_Review_Board': 1.2704213225195535e-05, 'Regorafenib_monotherapy': 2.099800722020954e-06, 'E7080': 0.00014169599163553216, 'Kinase_inhibitor_E7080': 0.0002517139390143281, 'escalation_study': 0.00016553660791656055, 'escalation_study_biomarker_analysis_Res_\\x93_phase_study': 0.00016553660791656055, 'Regorafenib_care_care': 2.099800722020954e-06, '0c_access_combination_treatment': 0.00023318672782142425, 'mRNAs_microRNAs': 8.263922883666513e-55, 'to_be_fully_elucidated': 7.827486913144158e-05, 'Cytoscape_MCODE': 9.148819220060914e-58, 'to_construct_a_proteinprotein_interaction_PPI_network_and_to_screen_hub_genes_The_interactions_between_miRNAs_and_mRNAs_were_predicted_using_miRWalk_ _and_a_miRNAmRNA_regulatory_network_was_constructed_The_prognostic_value_of_the_identified_hub_genes_was_then_evaluated_via_KaplanMeier_survival_analyses_using_datasets_from_The_Cancer_Genome_Atlas_A_total_of_ _DEGs_and_ _DEMs_were_identified_from_the_ _GEO_datasets_The_enriched_pathways_and_functions_of_the_DEGs_and_target_genes_of_the_DEMs_included_osteoclast_differentiation_cell_adhesion_response_to_a_drug_plasma_membrane_extracellular_exosome_and_protein_binding_A_subnetwork_composed_of_ _genes_was_extracted_from_the_PPI_network_and_the_genes_in_this_subnetwork_were_mainly_involved_in_the_cell_cycle_cell_division_and_DNA_replication_A_miRNAgene_regulatory_network_was_constructed_with_ _miRNAgene_pairs_based_on_ _DEMs_and_ _DEGs_KaplanMeier_survival_analysis_Correspondence_to_Professor_Lei_Pan_Department_of_Pulmonary_and_Critical_Care_Medicine_Beijing_Shijitan_Hospital_Capital_Medical_University_ _Tieyi_Road_Haidian_Beijing_ _PR_ChinaEmail_panleibjsjthcnKey_words': 9.148819220060914e-58, 'using_miRWalk_ ': 0.0006917804157571707, 'guidance_ligand_miR\\x91130b_miR\\x91_miR\\x91': 0.0016810521528134112, 'avenues': 0.0038806204677737646, 'to_be_involved_in_these_processes_ ': 0.000576827339123862, 'to_improve_the_low_survival_rate': 0.0009405371471580499, 'to_suppress_or_promote_oncogenesis_via_specific_effects_on_relevant_target_mRNAs_ ': 0.0001631814013721936, 'profiling_efforts': 0.0019127833147525456, 'tumors_controls': 0.0018218857764605342, 'GSE32863_dataset': 0.00021934176594480163, 'GSE29250_dataset': 2.9717843440302217e-05, 'tool_httpwwwncbinlmnihgovgeogeo2r': 9.148819220060914e-58, 'to_individually_identify_DEMs_and_DEGs_in_each_dataset_To_control_for_type_I_error_as_a_result_of_multiple_comparisons_within_each_dataset': 9.148819220060914e-58, 'Genomes': 1.1686951820486561e-54, 'focusing_specifically_on_humans_and_using_all_genes_as_an_enrichment_background_to_improve_the_reliability_of_the_analysis_the_expression_of_hub_genes_was_validated_in_TCGA_datasets_using_Gene_Expression_Profiling_Interactive_Analysis_GEPIA_v10_httpgepiacancerpkucn': 8.263922883666513e-55, 'focusing_specifically_on_humans_and_using_all_genes_as_an_enrichment_background_to_generate_the_network_Cytoscape_v340_cytoscapeorg_was_used_to_visualize_the_regulatory_interactions_between_these_genes_and_CentiScaPe_v22_Center_for_Biomedical_Computing_University_of_Verona_Italy_ _to_analyze_network_distributions_based_on_topological_properties_The_Molecular_Complex_Detection_application_MCODE_v16_was_used_to_identify_and_extract_subnetworks_from_the_global_PPI_network_based_on_the_kcore_algorithm_ _The_genes_with_a_degree_\\x89¥_in_this_regulatory_network_were_identified_as_hub_genes_as_described_previously_Prediction_of_the_mRNA\\x91miRNA_interactions_An_online_tool_called_miRWalk_ _httpmirwalkummuniheidelbergde_which_integrates_predictive_outputs_of_TargetScan_ _and_miRDB_ _was_used_to_predict_DEG_and_DEM_interactions_A_score_\\x89¥_was_considered_as_the_critical_criterion_for_the_miRWalk_predictive_analysis_Only_the_target_mRNAs_predicted_by_all_ _tools_miRWalk_TargetScan_and_miRDB_were_used_for_further_analysis_By_overlaying_identified_DEGs_and_these_predicted_mRNA_targets_a_miRNAmRNA_regulatory_network_was_constructed_and_then_visualized_using_CytoscapeAnalysis_of_datasets_from_the_cancer_genome_atlas_TCGA_TCGA_is_an_online_database_that_may_be_used_to_research_and_explore_publicly_available_datasets_cancergenomenihgov_accessed_March_  _including_RNA_sequencing_RNAseq_data_from_TCGA_samples_of_ _different_types_of_cancer_In_the_present_study_the_tumor_types_were_limited_to_LUAD_and_LUSC_RNAseq_data_and_clinical_data_from_ _LUAD_and_ _LUSC_samples_from_TCGA_datasets_were_used_Based_on_the_approach_previously_outlined_by_Li_and_Dewey_ _a_PERL_program_was_used_to_multiply_the_\\x98scaled_estimate\\x99_by_ _yielding_transcripts_per_million_TPM_values_for_all_gene_expression_as_TPM_values_were_thought_to_be_a_more_reliable_means_of_comparing_gene_expression_than_fragments_per_kilobase_of_TPMmapped_reads_or_reads_per_kilobase_of_TPMmapped_reads_values_ _to_improve_the_reliability_of_the_analysis_the_expression_of_hub_genes_was_validated_in_TCGA_datasets_using_Gene_Expression_Profiling_Interactive_Analysis_GEPIA_v10_httpgepiacancerpkucn': 0.000279419906750467, 'similarity_score': 0.004315547045054443, 'The_online_Search_Tool_for_the_Retrieval_of_Interacting_Genes_and_proteins_STRING_database_v110_stringdborg_was_used_for_PPI_network_construction_PPI_pairs_with_a_combined_score_\\x89¥': 9.148819220060914e-58, 'to_generate_the_network_Cytoscape_v340_cytoscapeorg_was_used_to_visualize_the_regulatory_interactions_between_these_genes_and_CentiScaPe_v22_Center_for_Biomedical_Computing_University_of_Verona_Italy_ ': 9.148819220060914e-58, 'v340_cytoscapeorg': 9.148819220060914e-58, 'to_visualize_the_regulatory_interactions_between_these_genes_and_CentiScaPe_v22_Center_for_Biomedical_Computing_University_of_Verona_Italy_ ': 9.148819220060914e-58, 'to_analyze_network_distributions_based_on_topological_properties_The_Molecular_Complex_Detection_application_MCODE_v16_was_used_to_identify_and_extract_subnetworks_from_the_global_PPI_network_based_on_the_kcore_algorithm_ _The_genes_with_a_degree_\\x89¥_in_this_regulatory_network_were_identified_as_hub_genes_as_described_previously_Prediction_of_the_mRNA\\x91miRNA_interactions_An_online_tool_called_miRWalk_ _httpmirwalkummuniheidelbergde_which_integrates_predictive_outputs_of_TargetScan_ _and_miRDB_ _was_used_to_predict_DEG_and_DEM_interactions_A_score_\\x89¥_was_considered_as_the_critical_criterion_for_the_miRWalk_predictive_analysis_Only_the_target_mRNAs_predicted_by_all_ _tools_miRWalk_TargetScan_and_miRDB_were_used_for_further_analysis_By_overlaying_identified_DEGs_and_these_predicted_mRNA_targets_a_miRNAmRNA_regulatory_network_was_constructed_and_then_visualized_using_CytoscapeAnalysis_of_datasets_from_the_cancer_genome_atlas_TCGA_TCGA_is_an_online_database_that_may_be_used_to_research_and_explore_publicly_available_datasets_cancergenomenihgov_accessed_March_  _including_RNA_sequencing_RNAseq_data_from_TCGA_samples_of_ _different_types_of_cancer_In_the_present_study_the_tumor_types_were_limited_to_LUAD_and_LUSC_RNAseq_data_and_clinical_data_from_ _LUAD_and_ _LUSC_samples_from_TCGA_datasets_were_used_Based_on_the_approach_previously_outlined_by_Li_and_Dewey_ _a_PERL_program_was_used_to_multiply_the_\\x98scaled_estimate\\x99_by_ _yielding_transcripts_per_million_TPM_values_for_all_gene_expression_as_TPM_values_were_thought_to_be_a_more_reliable_means_of_comparing_gene_expression_than_fragments_per_kilobase_of_TPMmapped_reads_or_reads_per_kilobase_of_TPMmapped_reads_values_ ': 8.263922883666513e-55, 'Detection_application': 1.545263727514792e-05, 'to_identify_and_extract_subnetworks_from_the_global_PPI_network_based_on_the_kcore_algorithm_ ': 0.0009469278262817738, 'to_predict_DEG_and_DEM_interactions_A_score_\\x89¥_was_considered_as_the_critical_criterion_for_the_miRWalk_predictive_analysis_Only_the_target_mRNAs_predicted_by_all_ _tools_miRWalk_TargetScan_and_miRDB_were_used_for_further_analysis_By_overlaying_identified_DEGs_and_these_predicted_mRNA_targets_a_miRNAmRNA_regulatory_network_was_constructed_and_then_visualized_using_CytoscapeAnalysis_of_datasets_from_the_cancer_genome_atlas_TCGA_TCGA_is_an_online_database_that_may_be_used_to_research_and_explore_publicly_available_datasets_cancergenomenihgov_accessed_March_  _including_RNA_sequencing_RNAseq_data_from_TCGA_samples_of_ _different_types_of_cancer_In_the_present_study_the_tumor_types_were_limited_to_LUAD_and_LUSC_RNAseq_data_and_clinical_data_from_ _LUAD_and_ _LUSC_samples_from_TCGA_datasets_were_used_Based_on_the_approach_previously_outlined_by_Li_and_Dewey_ _a_PERL_program_was_used_to_multiply_the_\\x98scaled_estimate\\x99_by_ _yielding_transcripts_per_million_TPM_values_for_all_gene_expression_as_TPM_values_were_thought_to_be_a_more_reliable_means_of_comparing_gene_expression_than_fragments_per_kilobase_of_TPMmapped_reads_or_reads_per_kilobase_of_TPMmapped_reads_values_ ': 0.00018049906186689923, 'score_\\x89¥': 0.0003996210712050996, 'to_research_and_explore_publicly_available_datasets_cancergenomenihgov_accessed_March_  _including_RNA_sequencing_RNAseq_data_from_TCGA_samples_of_ _different_types_of_cancer': 0.004315547045054443, 'PERL_program': 9.148819220060914e-58, 'to_multiply_the_\\x98scaled_estimate\\x99_by_ _yielding_transcripts_per_million_TPM_values_for_all_gene_expression_as_TPM_values_were_thought_to_be_a_more_reliable_means_of_comparing_gene_expression_than_fragments_per_kilobase_of_TPMmapped_reads_or_reads_per_kilobase_of_TPMmapped_reads_values_ ': 9.148819220060914e-58, 'TPM_values': 9.148819220060914e-58, 'to_be_a_more_reliable_means_of_comparing_gene_expression_than_fragments_per_kilobase_of_TPMmapped_reads_or_reads_per_kilobase_of_TPMmapped_reads_values_ ': 9.148819220060914e-58, 'Volcano_plots_clustering_A1_Volcano_plots_graph': 1.1686951820486561e-54, 'expression_UP_upregulation_DW_downregulation': 8.263922883666513e-55, 'downregulation_blue': 0.0005865071468874085, 'Red': 8.816255089437275e-06, 'upregulation_green': 0.0005404512468836777, 'difference_heat_maps': 8.263922883666513e-55, 'dataset_B2': 0.00045660454367155184, 'datastratified': 9.148819220060914e-58, 'generating_hazard_ratio_HR_and_ _CI_values_as_well_as_logrank_Pvalues_for_each_comparison_ResultsIdentification_of_DEGs_and_DEMs': 9.148819220060914e-58, 'Fig_1A_B_A_list_1C_enrichment_analysis': 0.0008457865950910515, 'Fig_1A_B_A': 0.00024303626370416874, '1C_enrichment_analysis': 0.00024303626370416874, 'GSE32863': 0.00031570829781304126, 'to_generate_the_network': 0.00017865891892946315, 'to_generate_the_network_nodes': 0.00013079212294529716, 'genes_total': 0.0002800361681909777, 'DEMs': 9.148819220060914e-58, 'microRNAs_Kyoto_Encyclopedia_matrix_ligase_UBE2C_cycle_protein': 9.148819220060914e-58, 'to_construct_an_overlapping_regulatory_network': 0.00015319874332371669, 'to_downregulate_ _DEGs': 0.0003833771411240826, 'to_be_associated_with_increased_expression_of_ _DEGs_TCGAbased_survival_analysis': 0.0016810521528134112, 'miR\\x91': 9.045569613289207e-05, 'Fig_7B_MELK': 0.00013588610209050726, 'Figure_PPI_network_subnetwork_B': 2.2254505308302245e-05, 'multistep_progression': 0.000598820003809177, 'MCM_CDC': 7.417164383651313e-53, 'AKRUA_CRBIKEN': 9.148819220060914e-58, 'XPT': 9.148819220060914e-58, 'CDC_CRBI_FPNECCEBU_BKRUA': 7.417164383651313e-53, 'AKRUA_ditamorhc': 9.148819220060914e-58, 'noitanitiuqibu_nietorp_tnednepedxelpmoc_gnitomorpesahpana_noitacilper': 9.148819220060914e-58, 'ANDni_devlovnielcyc': 9.148819220060914e-58, 'citotimAFIKAFIK_BKRUA': 9.148819220060914e-58, 'CRBI_FPNEC': 9.148819220060914e-58, 'CRPCRBI_FPNEC': 9.148819220060914e-58, 'CRBI_NEF_APOT': 9.148819220060914e-58, 'ACDC': 9.148819220060914e-58, 'CDCMPSA': 9.148819220060914e-58, 'BKRUA_BKRUA': 9.148819220060914e-58, 'PASUNCDC': 9.148819220060914e-58, 'XPT_KENBKRUA': 9.148819220060914e-58, 'AKRUA_XPT_CRP_BNCCAKRUA': 1.1686951820486561e-54, 'sisylana_OG_C_deunitnoC_II': 8.263922883666513e-55, 'AFIK': 8.263922883666513e-55, 'XPT_PASUN': 9.148819220060914e-58, 'PASUN_CRPAPOT_MCM_KLEM_BKRUA': 9.148819220060914e-58, 'ytivitca_esanik': 9.148819220060914e-58, 'gnidnib_OGOGOGOGOGOGOGOG_gnidnib': 9.148819220060914e-58, 'nietorp_noisivid_sisenikotyc_CEBU_rotaluger_nietorp_CRP': 9.148819220060914e-58, 'esaremosiopot': 9.148819220060914e-58, 'esaelcunodne_cfi_arorua_ssecorp': 9.148819220060914e-58, 'noitcnuf_ralucelom_pafl': 9.148819220060914e-58, 'hits': 0.0009466755491730313, 'to_be_a_key_factor_linked_to_tumor_development_and_progression_ ': 0.00013086187032336694, 'subnetwork_module': 2.1319398710895087e-06, 'binding\\x99_binding\\x99_cycle_dysregulation': 2.1319398710895087e-06, 'network_mRNAs_Red': 0.00013360670637670873, 'triangles': 0.00027915818211639477, 'AURKA_CCNB2_MELK': 0.0006578099350934741, 'to_be_upregulated_in_lung_cancer_ _and': 0.0016810521528134112, 'Similar_observations_have_previously_been_made_in_ovarian_cancer_ _breast_cancer_ _and_gastric_cancer_ _UBE2C_is_involved_in_the_progression_of_the_cell_cycle_and_transcription_and_upregulation_of_UBE2C': 9.148819220060914e-58, 'growth_colony_formation_autophagy': 9.148819220060914e-58, 'UBE2C': 0.0006191469481200436, 'expression_impairment': 8.263922883666513e-55, 'to_be_upregulated_at_mRNA_and_protein_levels_in_NSCLC': 8.263922883666513e-55, 'inhibition_proliferation_TOP2A': 9.148819220060914e-58, 'to_be_upregulated_in_numerous_types_of_tumor_including_breast_nasopharyngeal_and_renal_cell_carcinomas': 9.148819220060914e-58, 'TOP2A': 0.0005218289698578611, 'survival_months_Violin_plots': 0.00032874997356751706, 'NSCLC_prognosis': 9.148819220060914e-58, 'to_be_associated_with_elevated_expression_of_these_ _genes_ ': 9.148819220060914e-58, 'CCNB2': 9.177220763137124e-05, 'to_be_closely_associated_with_tumor_differentiation_grade_and_histological_type_and_upregulation_of_CCNB2_at_the_protein_level_stage': 1.4981327510011856e-06, 'to_be_closely_associated_with_tumor_differentiation_grade_and_histological_type_and_upregulation_of_CCNB2_at_the_protein_level': 1.4981327510011856e-06, 'to_be_highly_expressed_in_several_human_cancer_types_prostate_breast_brain_colorectal_and_gastric_cancer_and_glioblastoma_multiforme_stem_cells_ ': 0.004315547045054443, 'THERAPEUTIC_MEDICINE': 1.0852499745858376e-05, 'to_interact_with_DEGs_yielding_ _hub_miRNAs_and': 0.004315547045054443, 'to_be_elevated_in_LUAD_and_associated_with_poor_prognosis_ _consistent_with_the_results_of_the_present_study_High_levels_of_miR127': 3.788772386814274e-05, 'tumor_resistance': 3.788772386814274e-05, 'to_be_elevated_in_LUAD_and_associated_with_poor_prognosis_ _consistent_with_the_results_of_the_present_study_High_levels_of_miR127_transition_tumor_resistance': 0.00046332997787010933, 'investigation_miR134': 9.148819220060914e-58, 'to_be_differentially_regulated_in_lung_cancer_and_other_types_of_cancer_including_gastric_cancer_breast_cancer_and_oral_cancer_with_certain_studies_reporting_increased_expression_in_lung_cancer_ ': 9.148819220060914e-58, 'investigationmiR1181': 9.148819220060914e-58, 'to_be_downregulated_in_nasopharyngeal_carcinoma_ovaria': 9.148819220060914e-58, 'effector_proteins': 0.004315547045054443, 'RUFY_FYVE_3phosphatecytoskeletonINTRODUCTIONThe_anization': 6.34741488884513e-05, 'Intracellular_transport': 0.00012738415201057722, 'dynamics_proteins': 0.00028569540831235814, 'literature_Cterminal_FYVEdomain': 0.007713134335009549, 'Dunkelberg_GutierrezHartmann_Mari_KukimotoNiino_Kitagishi_Matsuda': 0.00024940455416981735, 'FYVE_Coiledcoil': 4.064627884309675e-05, 'Theseendocytic_vesicles': 6.496590036160093e-05, 'inSE': 0.00038821680642614145, 'Naslavsky_Caplan_BOn': 0.0015842910551982499, 'endosomes_EE': 5.670448673356345e-06, 'membrane_anization': 2.586668612581389e-05, 'vesicles_Gruenberg_NextLE': 1.4616578941788462e-06, 'Pillay_endosomes': 0.0015842910551982499, 'endocyticpathway': 0.0006992128660964839, 'Hinze_Boucrot_Endocytosis_events_endosomes': 9.148819220060914e-58, 'microtubules_Fletcher_Mullins_Pegoraro_endocytosis_autophagy': 9.148819220060914e-58, 'cytoplasmicmaterials_role': 0.0011125787591309202, 'Mizushima_Komatsu_Autophagy': 0.0015842910551982499, 'cytosolic_components': 8.263922883666513e-55, 'Volume_FYVE_domain': 9.148819220060914e-58, 'Schematic_representation_pathways': 9.148819220060914e-58, 'Created_with_BIoRendercomFrontiers_in_Cell_and_Developmental_Biology_ ': 0.00010883068312907455, 'GTPases_Boucrot_link': 3.505995154185285e-05, 'Boucrot_link': 0.0003377049630876618, 'B_FYVE': 9.148819220060914e-58, 'motives_zinc': 9.148819220060914e-58, 'Gray_numbers': 8.505798743716227e-08, 'acids_position_alignment_Blacknumbers': 2.340732116405961e-05, 'Seaviewer': 0.0001813869441080195, 'Accession_numbers': 9.148819220060914e-58, 'NP_0035573_mouse': 9.148819220060914e-58, 'NP_0787892_mouse_FYCO1NP_0011037232Yoshida': 0.0015842910551982499, 'Figure_FYVE_domains': 9.148819220060914e-58, 'zinc_Hurley_Kutateladze_Overduin_Inaddition_types': 9.148819220060914e-58, 'beenFrontiers': 8.7507226527143e-06, 'proteins_FYVEdomains': 1.1686951820486561e-54, 'PtdIns3P': 8.263922883666513e-55, 'Function': 8.263922883666513e-55, 'FYVE_proteinsdisplay_copy': 9.148819220060914e-58, 'proteinprotein_proteinDNARNA_interactions_Dunkelberg_GutierrezHartmann': 9.148819220060914e-58, '\\x9cclassical\\x9d_FYVE_domain': 8.263922883666513e-55, 'amino_acid_\\x9c\\x9d': 8.263922883666513e-55, 'it_Stenmark_Misra_Hurley_Stenmark_Aasland_Kutateladze_Overduin': 0.00010908077636851838, 'FYVE_protein_subcellularlocalization_function': 0.00010908077636851838, 'associated_to_EE_orphagosomes_Stenmark_  _Gaullier_ _Stenmark_and_Aasland_ _Figure': 0.000494595879613311, 'Class_IIIPtdIns': 0.0005269923949341242, 'FYVE_proteins': 1.852331742816923e-07, 'ribonucleoprotein_ps': 9.148819220060914e-58, 'ribosomes': 9.148819220060914e-58, 'Importantlymany_FYVE_proteins': 0.00033788504629392297, 'residues_interactions': 5.509779559665398e-06, 'selection_membranesHe_Pankiv': 3.0228862794968625e-09, 'bivalentmechanism': 9.148819220060914e-58, 'FYVE_domains': 9.148819220060914e-58, 'functions_homeostasis_Kamentseva': 5.36083153560277e-06, 'For_example_EEA1_protein_early_endosome_antigen_ _isknown_to_be_crucial_for_endosome_dynamics_and_any_mutation_inits_conserved_residues_or_the_oligomerization_site': 9.148819220060914e-58, 'aï¬\\x83nity_copies': 9.148819220060914e-58, 'RUFY_family': 0.0009466755491730313, 'CG31064_Figure': 0.0038806204677737646, 'RUFY_protein': 8.263922883666513e-55, 'Caenorhabditis': 1.1686951820486561e-54, 'protein_T10G35': 8.263922883666513e-55, 'T10G35': 9.148819220060914e-58, 'PtdIns3P_bindingactivity': 9.148819220060914e-58, 'Rubicon\\x99sintegration_toFYCO1': 0.0002321359877387567, 'not_to_bind_toPI3P_Burman_and_Ktistakis_ ': 0.0038806204677737646, 'Rabip4\\x99that': 9.148819220060914e-58, 'RUN_domain': 9.148819220060914e-58, 'RUFY1': 8.263922883666513e-55, 'trafï¬\\x81ckingRegulation': 1.1686951820486561e-54, 'proliferation_migration_Golgi': 8.263922883666513e-55, 'Rab33_andautophagosome_formation': 8.263922883666513e-55, 'gastriccancer_progression_proliferation_metastasisAutophagosome_formation_lysosome_clusteringMAP1LC3ABAutophagosome_formation_transport': 0.0009484785129277045, 'Olsvik_Wang_Krau\\x9f_Haucke_Raib_Rab4A_adaptor': 9.148819220060914e-58, 'inendosomes': 9.148819220060914e-58, 'Moreover_silencing_the_Rabip4\\x99isoform_ofRUFY1': 0.0015842910551982499, 'retention_Cormont_RUFY1': 9.148819220060914e-58, 'SH3binding_motif': 9.148819220060914e-58, 'ETKand': 1.4055400435083287e-53, 'tractYang_RUFY2': 9.148819220060914e-58, 'Nterminalleucinezipper_domains_Cterminal_FYVEï¬\\x81nger_domainAlthough': 9.148819220060914e-58, 'RUFY2': 9.148819220060914e-58, 'to_associate_speciï¬\\x81cally_with_the_Golgicomplexassociated_Rab33A_Fukuda_  _Table_ _GivenFrontiers_in_Cell_and_Developmental_Biology_ ': 9.148819220060914e-58, 'Volume_Proteins_interaction_RUFY2': 0.000528146067012347, 'Ceppi_rufy2_gene': 0.0004358935679566294, 'FYVE_domain': 0.00210348072096923, 'FYVE_domain_expression_Yoshida': 0.00210348072096923, 'RUFY3': 2.8288512913811807e-50, 'withRab5': 1.3163611668917179e-50, 'LikeRUFY2_RUFY3': 9.148819220060914e-58, 'to_bind_Rab33_through_its_coiledcoildomain_ _CC1_Fukuda_  _In_293_T_and_3Y1': 9.148819220060914e-58, 'not_to_interact_with_severalsmall': 1.3163611668917179e-50, 'Nussinov_Rap2': 1.1686951820486561e-54, 'maturationand_plasticity': 8.263922883666513e-55, 'growth_ofaxons': 8.263922883666513e-55, 'inlipid_rafts': 1.3163611668917179e-50, 'Rac_guanine_nucleotide_4B_RUFY3seems': 2.013456028480201e-05, 'AD_Zelaya': 3.289121035459026e-07, 'Zelaya_RUFY3': 7.055938651351604e-05, 'Hertz_Analysis': 0.0005345134679592639, 'Pineal': 9.148819220060914e-58, 'locomotor_activity': 9.148819220060914e-58, 'Additionallypineal_allopregnanolone': 9.148819220060914e-58, 'neuronalapoptosis': 9.148819220060914e-58, 'rhythms_ofindividuals': 9.148819220060914e-58, 'exposure_theseï¬\\x81ndings': 9.148819220060914e-58, 'allopregnanolone': 8.263922883666513e-55, 'steroidhormones': 1.1686951820486561e-54, 'Theproduction': 8.263922883666513e-55, 'neurosteroid_production': 9.148819220060914e-58, 'to_be_a_universal_feature_of_the_brain_in_vertebratesIt': 9.148819220060914e-58, 'death_functions': 0.007715190751220473, 'pinealgland': 2.056416210924281e-06, 'neurosteroids': 0.00012624066228184995, 'toNeuroendocrine_Sciencea_section': 4.799840618059953e-06, 'secretion_hormone_producedby': 7.417164383651313e-53, 'pineal_gland': 2.056416210924281e-06, 'injuvenile_birds': 2.056416210924281e-06, 'P450scc': 9.148819220060914e-58, 'chainreaction_RTPCR': 9.148819220060914e-58, 'chromatography3HHPLC': 0.00238803522972525, 'spectrometry_GCMS_assessment': 0.0038806204677737646, 'enzymes_cytochrome': 0.0003087151347901599, '014isomerase': 9.148819220060914e-58, 'thedehydrogenase_01Hsd3aisomerase_3HSD': 9.148819220060914e-58, 'exvivo_observations': 8.263922883666513e-55, 'GCMS_analysis': 1.1686951820486561e-54, 'pineal_glands': 8.263922883666513e-55, 'machinery': 1.1686951820486561e-54, 'HPLCanalysis': 9.148819220060914e-58, 'to_resolve_the_isomers_of_these_hormonesalloepipregnanolonesuch_as_7Î±hydroxypregnenoloneand_5Î±dihydrotestosterone': 9.148819220060914e-58, 'sets_ofisomers': 8.263922883666513e-55, 'chick_pineal_gland': 9.148819220060914e-58, 'To_search_for_genes_involved_in_thisa_diï¬erential': 9.148819220060914e-58, 'GeneChip_analysis': 1.1686951820486561e-54, 'Thisthethefullset': 8.263922883666513e-55, 'to_light_at_early_night_but': 6.341351869997941e-05, 'ï¬\\x81eld_apparatus': 8.263922883666513e-55, 'locomotoractivities': 9.148819220060914e-58, 'intracerebroventricularinjection': 9.148819220060914e-58, 'pineal': 8.263922883666513e-55, '7Î±hydroxypregnenolone_allopregnanolonemay': 0.0005218289698578611, 'pinealectomy': 0.0003359993918253942, 'pineal_allopregnanolone': 8.263922883666513e-55, 'to_be_an_essentialfactor_for_the_normal_development_of_cerebellar_Purkinje': 1.1686951820486561e-54, 'cellsIt': 8.263922883666513e-55, 'allopregnanolone_functions': 0.00028038455419288966, 'antagonistof_allopregnanolone': 0.0006940543140455221, 'expression_mechanism': 0.0001186502426005426, 'PACAP': 0.0006940543140455221, 'theapoptosis': 0.004315547045054443, 'panel_development_Thelightatnight_condition': 7.417164383651313e-53, 'allopregnanolone_synthesis': 9.148819220060914e-58, 'to_decreased_expressionof_PACAP_in_Purkinje_cells_Consequently_the_active_caspase3_level_increases_inducing_the_apoptosis_of_Purkinje_cells_in_the_cerebellumFrontiers_in_Endocrinology_ ': 9.148819220060914e-58, 'Pinealectomy': 9.148819220060914e-58, 'levels_factor': 9.148819220060914e-58, 'tothe_levels': 0.0001046564120671734, 'light_conditions': 0.004315547045054443, 'numberof_Purkinje_cells': 9.148819220060914e-58, 'lightatnightcondition_Figure': 9.148819220060914e-58, 'cerebellardevelopment': 0.004315547045054443, '101016S0742841399000651_Compagnone_NA_Mellon_SH_Neurosteroids_biosynthesis_and_functionthese_novel_neuromodulators_Front_Neuroendocrinol_ _\\x93of_ _101006frne19990188CONCLUSIONSthedatarecentreview_summarizedThison_pinealneurosteroids_Studies_have_indicated_that_the_pineal_glandproduces_neurosteroids_from_cholesterol_in_birds_Pineal_7Î±hydroxypregnenolone_regulates_locomotion_in_response_to_lightstimuli_in_birds_Pineal_allopregnanolone': 9.148819220060914e-58, 'Purkinje_cells': 9.148819220060914e-58, 'pineal_glandproduces_neurosteroids': 9.148819220060914e-58, 'locomotion': 9.148819220060914e-58, 'development_animals': 7.052177135109611e-05, 'modernlife_conditions': 0.0003608303843934633, 'T_Tashiro_KI_Sato_M_Nozaki': 7.417164383651313e-53, 'Volume_0cHaraguchi_TsutsuiPineal_Neurosteroids': 9.148819220060914e-58, 'melatonin_action': 9.148819220060914e-58, 'Hasunuma_I': 9.148819220060914e-58, 'synthesis_keyneurosteroid': 9.148819220060914e-58, 'et_al_Revisiting_the_roles_of_progesterone_and_allopregnanolone_in_thenervous_system_resurgence_of_the_progesterone_receptors_Prog_Neurobiol_\\x93_ _101016jpneurobio201309004_Belelli_D_Lambert_JJ_Neurosteroids_endogenous_regulators_of_the_GABAAreceptor_Nat_Rev_Neurosci_ _\\x93_ _101038nrn1703_Bernal_J_Thyroid_hormone_receptors_in_brain_development_and_function_NatClin_Pract_Endocrinol_Metabol_ _\\x93_ _101038ncpendmet0424_FalluelMorel_cyclaseactivating_polypeptide': 9.148819220060914e-58, 'eï¬ects_ofceramides_101073pnas04096_\\x93_S_alMode_MM': 9.148819220060914e-58, 'hydroxylase_distribution_activation': 9.148819220060914e-58, 'conditions_DulcisDSpitzerNCIlluminationcontrolsdopamineof\\x93_101038nature07569neuronsregulatingbehaviourdiï¬erentiationNature': 9.148819220060914e-58, 'Ohno_N_Fenner_et_al_Lightstimuli': 9.148819220060914e-58, 'migration_mousebiologicalclocklight': 9.148819220060914e-58, 'IGF1RPDK1': 9.600782509555746e-05, 'tumrowth_10115800085472CAN103837_Smarr_BL_Grant_AD_Perez_L_Zucker': 9.600782509555746e-05, 'Deoxyshikonin': 9.148819220060914e-58, 'Viability_andGlycolysis': 9.148819220060914e-58, 'Kaifeng_ChinaDeoxyshikonin': 9.148819220060914e-58, 'to_exhibit_an_antitumor_effect_in_colorectal_cancer_Howeverno_studies': 9.148819220060914e-58, 'effects_caspase37': 8.263922883666513e-55, 'cell_viability_rate_caspase37activity_protein_level_glucose_consumptionlactateproduction_expression': 0.001129870936471824, 'caspase37': 1.284690556057437e-52, 'assay_analysis_production': 7.417164383651313e-53, 'rate_caspase37activity_protein_level': 0.001129870936471824, 'Additionallydeoxyshikonin': 9.148819220060914e-58, 'glucose_consumptionlactateproduction_expression': 9.148819220060914e-58, 'ï¬\\x81rst_myeloid_leukemiaSpecialty': 0.0007959416758056306, 'Malignanciesa_section': 4.799840618059953e-06, 'August_CitationWu_H_Zhao_H_Chen_L_Deoxyshikonin': 4.799840618059953e-06, 'alDeoxyshikonin': 2.85474318464766e-05, 'AML_Cellsand_penicillinstreptomycin_SigmaAldrich_Louis_MO_USA': 4.660817441489815e-07, 'Chinawas': 1.2981537758449367e-07, 'Guangzhou_China_Transfection': 3.2580078188528607e-06, 'to_evaluate_the_viability_of_AML_cells_THP1_and_HL60cells': 2.0522463476478913e-07, 'Cytometry_Analysis_Nanjing_China': 9.148819220060914e-58, 'to_analyze_the_apoptosis_of_THP1_and_HL60': 9.148819220060914e-58, 'propertiesstudieshave': 0.00014169599163553216, 'shikonin_derivatives': 9.148819220060914e-58, 'researchinterest': 9.148819220060914e-58, 'deoxyshikonin': 0.001842098271626438, 'eï¬ects_underlyingmechanisms': 0.007713134335009549, 'apoptosisFrontiers': 0.0002618838152087058, 'AML_treatments_gelelectrophoresis_Millipore_Bedford_MA_USA_Afterblocking_Ser2448_Abcam_p70_ribosomal_kinasep70S6_K_Cell': 4.660817441489815e-07, 'HL60_cells': 1.4908189227619518e-49, 'medium_ofTHP1': 6.515117587621718e-50, 'AssayPKM2_activity': 9.148819220060914e-58, 'dehydrogenasecoupled_assay': 9.148819220060914e-58, 'phosphatebuï¬ered': 0.0011125787591309202, 'antibodiesagainst_C_Cyt_C_Cell': 9.148819220060914e-58, 'AktAbcam_glycogensynthase_GSK3Î²': 9.148819220060914e-58, 'GSK3Î²pGSK3Î²_Ser9_Abcam_mTOR_Abcam': 1.0545332049147075e-47, 'TechnologyIncPKM2_Abcam_Î²actin_Abcam': 9.148819220060914e-58, 'antibodies_Hercules_CA_USAQuantitative_RealTime_PCRRNAiso_TaKaRa': 9.148819220060914e-58, 'control_Theprotein_bands': 9.148819220060914e-58, 'VersaDoc': 9.148819220060914e-58, 'Dalian_China': 9.148819220060914e-58, 'to_extracttotal_RNA_from_treated_THP1_and_HL60_cells_and_theconcentration_of_extracted_RNA': 9.148819220060914e-58, 'TaKaRawas': 9.148819220060914e-58, 'to_detect_PKM2_mRNA_expressionon_the_StepOnePlus_qPCR_system_Thermo_Fisher': 9.148819220060914e-58, 'software_ttest_oneway_ANOVA': 9.148819220060914e-58, 'Dunnett\\x99s': 9.148819220060914e-58, 'inAML_CellsTo': 0.0004394889864169925, 'glucose_consumption_lactateproduction': 0.007713134335009549, 'thatdeoxyshikonin_exposure': 9.148819220060914e-58, 'glucoseconsumptionFigures_4AB_lactate_production_Figures_wwwfrontiersinAugust': 9.148819220060914e-58, 'CellsFIGURE_Deoxyshikonin': 0.0014208985251366242, 'assay_P': 0.00012630877451023521, 'ExpressionLevel': 6.386128628424973e-05, 'shikonin': 6.387830616205716e-05, 'whetherdeoxyshikonin': 1.1484455079704606e-05, 'deoxyshikonintreatment': 0.00023308907442208475, 'Inactivated': 8.897011252080791e-05, '\\x82uence_ofdeoxyshikonin': 0.00238803522972525, 'Asdemonstrated': 0.00024134924474519354, 'inmediating_the_antitumor_eï¬ects_of_deoxyshikonin_on_AML_cellsTHP1_and': 0.0005423312279404596, 'alternationon_Akt_mTOR_protein_levels_Figure_7B_aftercotreatment': 8.053128222333766e-50, '740YP_treatment': 3.5193460814460183e-50, 'alternationon_Akt_mTOR_protein_levels_Figure_7B': 6.515117587621718e-50, 'treatmentinduced_viability_reduction': 0.00036240313892865647, 'Figure_7F': 9.148819220060914e-58, 'aftercotreatment': 9.148819220060914e-58, 'AB_analysis': 6.515117587621718e-50, 'withincreasing_doses': 0.0011125787591309202, '740YP': 0.0005807607654450252, 'viabilityreduction': 9.148819220060914e-58, 'aftertransfection': 9.148819220060914e-58, 'THP1_HL60_cells_deoxyshikonin': 0.0016810521528134112, 'activity_eï¬ects': 0.0016810521528134112, 'prognosis_potentialto': 0.0005521751935137136, 'Sieb_et_Zucc': 9.148819220060914e-58, 'to_possess_a_wide_range_of_pharmacologicalactivities_including_antitumor_activity_by_suppression_of_cellproliferation': 9.148819220060914e-58, 'theviability_metastasis': 1.041842225599976e-06, 'expression_level_activity': 3.9617865395743656e-05, 'toincreasing_doses': 6.515117587621718e-50, 'qRTPCR_PKM2_activity': 0.0008522036149147152, 'Acetylshikonin_shikoninderivative': 9.148819220060914e-58, 'anchorageindependentgrowth': 9.148819220060914e-58, 'thatexposure': 0.007713134335009549, 'antitumor_activityin_AML_cells': 3.0042323825661444e-05, 'disruption_study': 0.000762889468397268, 'aerobicglycolysis': 0.0004360097354757312, 'tumor_development_oncogenesis': 7.112492206702588e-06, 'deoxyshikonin_inhibitedglycolysis': 0.000291411853346343, 'CellsFIGURE_Activation': 0.0010068765747081726, 'Theprotein_levels': 0.00033371976121604924, 'analysis_THP1_HL60cells': 5.442171272099169e-06, 'analysis_THP1_HL60cells_assessment_GH_protein_level': 5.442171272099169e-06, 'GH_protein_level': 5.442171272099169e-06, 'assay_blot_analysisrespectively_P': 7.417164383651313e-53, 'cancercell_proliferation_growth': 0.0038806204677737646, '\\x82uence_signaling': 0.007713134335009549, 'shownthat_deoxyshikonin': 6.803342852513206e-05, 'activation_signaling': 1.1096607766427506e-06, 'THP1and_HL60_cells': 0.0010068765747081726, 'realtimepolymerase_chain_reaction': 0.0006674076661460604, 'blot_PKM2_activity': 0.00014649172945341936, 'protein_levelsof': 0.0002517988922651906, 'Transfected_THP1_HL60_cells': 0.0003334530047039951, 'viability_glycolysis': 2.8532222102081478e-05, 'Future_studiesshould': 0.0015842910551982499, 'thatdeoxyshikonin': 9.148819220060914e-58, 'AML_cells': 9.148819220060914e-58, 'Shikonin_suppressesskin_carcinogenesis_ofshikonin': 9.148819220060914e-58, 'malfunction_proliferation_Shikonin_derivatives': 9.148819220060914e-58, 'Zhu_Ye_et_al_Deoxyshikoninisolated': 0.0005253840276496832, 'cellsDATA_AVAILABILITY_MaterialAUTHOR_CONTRIBUTIONSHW': 0.0011307746936671792, 'experiments_theexperiments': 1.845438324513534e-05, 'experiments_theexperiments_analysis_versionSUPPLEMENTARY_MATERIALThe_Supplementary': 1.845438324513534e-05, 'toanalyzing_the_data_and_drafting_the_manuscript': 1.3111967246295469e-06, 'versionSUPPLEMENTARY_MATERIALThe_Supplementary': 1.845438324513534e-05, 'Nemazanyy': 9.148819220060914e-58, 'tumorigenicityin_carcinoma': 9.148819220060914e-58, 'signaling_107150thno28992_Jiang_L_Li_L_Jia_S_et_al_Shikonin': 6.387830616205716e-05, 'tumor_growthin_mice_inhibition_PKM2stat3cyclinD1_signal_pathway_Chromosomal_localization': 1.041842225599976e-06, 'progress_status_leukemia_Hematol_Wang_X_Feng_medicines': 9.148819220060914e-58, 'cell_death_mechanisms_101016jcell201102013_Herst_PM_Howma': 9.148819220060914e-58, 'to_provide_essential_signals_fromregulating_mammary_gland_homeostasis_during_pregnancy_to_modulating_tumorigenesisThe': 0.0003839329340641303, 'toWomen\\x99s_Cancera_section': 4.799840618059953e-06, 'CitationMing_J_Cronin_Penninger_JM': 8.012111858245268e-05, 'Stephen_Paget': 1.3083258246803596e-06, 'bone_environment': 9.148819220060914e-58, 'as\\x9csoil\\x9d': 9.148819220060914e-58, 'cancer_targets': 9.148819220060914e-58, 'circle_ofmetastasis': 9.148819220060914e-58, 'receptor_LGR4': 9.148819220060914e-58, 'to_play_critical_bottleneck_functions_not_only_inregulating_bone_metabolism_but_also_in_immunity_and_tumorigenesis': 9.148819220060914e-58, 'Volume_asa_novel_agentRANKLRANKOPG_BONEHOMEOSTASISBone': 1.284690556057437e-52, 'strength_structure': 7.417164383651313e-53, 'data_pointing': 0.00238803522972525, 'ans_storesminerals': 7.417164383651313e-53, 'thebalance': 7.417164383651313e-53, 'bone_osteoclastsderived': 0.0038806204677737646, 'boneresorption': 0.004315547045054443, 'Figure_RANKLis': 9.148819220060914e-58, 'expression_role': 9.148819220060914e-58, 'which_mice': 8.263922883666513e-55, 'RANKLis_boneFIGURE_Role': 9.148819220060914e-58, 'osteoblasts_osteocytes': 9.148819220060914e-58, 'termed': 0.0010068765747081726, 'osteoimmunology_T_cells': 5.661951480714229e-07, 'onpreosteoclasts': 0.0038806204677737646, 'butadult_mice': 9.148819220060914e-58, 'numbers_bone_mass': 9.148819220060914e-58, 'TGF_OPG': 1.1686951820486561e-54, 'IL4_factor': 8.263922883666513e-55, 'toRANKL': 8.263922883666513e-55, 'to_ensure_healthybone_During_pathological_conditions_such_as_menopauserelatedosteoporosis': 0.0008522036149147152, 'OPGand': 5.661951480714229e-07, 'reversesignaling': 0.0019143764860450091, 'strategyto': 9.148819220060914e-58, 'bone_production': 9.148819220060914e-58, 'RANKwas': 0.0006321861226151657, 'RANKL_RANK': 0.0005811711094217892, 'The_interaction_betweenactivated_T_cellderived_RANKL_and_RANK_expressed_on_DCsincreases_the_antigenpresenting_capabilities_of_the_latter_thusaugmenting_the_number_and_cell_cycle_of_antigenspeciï¬\\x81c_Tcells_as_well_as_enhancing_the_immune_response_of_memory_Tcells_Interestingly_phenotyping_of_rankl_and_rankdeï¬\\x81cient_micerevealed_a_complete_absence_of_peripheral_lymph_nodes_but_intactspleen_and_Peyer\\x99s_plaque_structures_\\x93_Subsequent_studieshave_found_that_during_embryogenesis_RANKL_is_expressedby_hematopoietic_lymphoid_tissue_inducing_LTi_cells_andmesenchymallymphoid_tissue_anizer_LTo_cells_\\x93RANKL': 9.148819220060914e-58, 'to_stimulate_lymphotoxin_LTexpression_and_regulate_LTi_cell_accumulation': 9.148819220060914e-58, 'LTi_cells': 9.148819220060914e-58, 'anizer_LTo_cells': 9.148819220060914e-58, 'FurthermoreRANKL': 0.000404948725608525, 'LTo': 5.661951480714229e-07, 'cell_mTECmaturation': 2.7446560661786228e-05, 'inthe_intestine': 9.148819220060914e-58, 'RANKLRANK_interactions': 9.148819220060914e-58, 'IL22_patients': 4.649709951488235e-52, 'RANK_mutations_mice_lackingRANKL_RANK': 2.516404898630126e-52, 'B_RANKL': 9.148819220060914e-58, 'osteoclastnumbers_bone_loss': 9.148819220060914e-58, 'immunesystems': 3.5025312451811044e-05, 'mesenchymalcells': 5.661951480714229e-07, 'isstill_controversial_Ovariectomy': 9.148819220060914e-58, 'to_enhance_Tcelldependent_TNFalpha_production_in_a_bone_loss_mousemodel_because_of_the_enhanced_macrophage_colonystimulatingfactor_MCSF_and_RANKL': 9.148819220060914e-58, 'withosteoporosis': 3.2530263079460895e-06, 'RANKL_production': 0.004315547045054443, 'RANKL_T_cellsleads_induction': 0.0018006682651940404, 'Thelack': 8.263922883666513e-55, 'bone_loss': 1.1686951820486561e-54, 'suggestingthat_RANKL': 8.263922883666513e-55, 'growth_diï¬erentiation': 0.002104041233387171, 'Bcell_maturation': 5.661951480714229e-07, 'estrogen_\\x93furthermore_progesterone_levels': 0.0011075402231842013, 'Whereas_estrogen_triggers_the_expansion_ofthe_mammary_epithelium_in_puberty_progesterone_drives_theproliferation_of_mammary_epithelial_cells_in_the_estrous_cycleand_in_pregnancy': 3.4348996837103175e-05, 'Figure_Mechanistically_progesterone': 1.1686951820486561e-54, 'progesteronereceptor_cells': 8.263922883666513e-55, 'progesteronereceptor_cells_RANKL_expression_secretion': 5.173998541377103e-05, 'RANKL_expression_secretion': 8.263922883666513e-55, 'RANKL_expression': 0.0038806204677737646, 'wildtype_BRCA1_gene': 0.00021180960367334957, 'instability_DNA_damage_mutations_TP53_Progesterone_progestins': 0.0016810521528134112, 'stress_ampliï¬\\x81edproliferation_cues': 0.0006246792128329638, 'increase_RANKLlevels': 1.1686951820486561e-54, 'progestinMPA_DMBAinduced_mammary_tumorformation_progression_tumor_model': 8.263922883666513e-55, 'progestinMPA_DMBAinduced_mammary_tumorformation': 8.329345491138083e-05, 'progression_tumor_model': 8.263922883666513e-55, 'cancer_samples_SNP_data_analysis': 0.0008522036149147152, 'occurrence_ofmalignanttumors': 5.977268299869825e-05, 'development_Brca1Tp53_cancer_model_tumorigenesis_work_studies': 9.950326125649615e-05, 'women_beneï¬\\x81t': 0.0004394889864169925, 'study_DBEYOND': 0.0038806204677737646, 'inhibition_therapycan': 9.011986636252904e-06, 'signiï¬\\x81cant_change': 0.001845170519318405, 'epithelialmesenchymal_transitionEMT': 0.0005423312279404596, 'bioenergeticsand': 5.977268299869825e-05, 'modeling_inthe_mouse': 9.148819220060914e-58, 'ï¬\\x81ndings_tumors': 9.148819220060914e-58, 'recentlyshown': 0.00238803522972525, 'survival_advantages': 0.007713134335009549, 'gender_diï¬erences': 9.148819220060914e-58, 'lung_cancerRANKRANKL': 9.148819220060914e-58, 'axis_playsa_role': 0.00023078931020485309, 'anticancerimmune_responses': 1.0705183467201885e-05, 'Tumor_cells': 9.148819220060914e-58, 'secrete_cytokines': 9.148819220060914e-58, 'formation_thetumor_microenvironment_RANK_RANKLproduced_production_ofchemokines_proliferation_milieu': 0.0006944243331863645, 'therecruitment_activation_cytoplasmictail_TRAF6': 0.0038806204677737646, 'thetumor_microenvironment': 0.0006940543140455221, 'cancer_RANKL': 1.1330865854382043e-05, 'andmetastasis_RANKL_expression': 1.1330865854382043e-05, 'RANKLproduced': 0.0006940543140455221, 'RANKLRANKpathway': 9.148819220060914e-58, 'production_ofchemokines': 9.148819220060914e-58, 'uncovereda_association': 9.148819220060914e-58, 'earlydissemination': 9.148819220060914e-58, 'bonemetastases_p_patients': 0.0011075402231842013, 'tumordevelopment': 0.0015842910551982499, 'Denosumab': 2.4466205124723257e-05, 'rapideï¬ectiveness': 3.994790159965949e-07, 'Volume_aï¬ect_quality': 9.148819220060914e-58, 'cancer_CRPCbone_metastases': 9.148819220060914e-58, 'signiï¬\\x81cantimprovement': 0.0007129960827382031, 'SRE_delay': 8.263922883666513e-55, 'progressionfree': 1.1686951820486561e-54, 'survival_advantage_MM_patientsn': 9.148819220060914e-58, 'eï¬ectivity': 9.148819220060914e-58, 'occurrence_useof': 8.263922883666513e-55, 'researchIn_phase': 8.263922883666513e-55, 'Denosumabcan': 9.148819220060914e-58, 'DFS_rate': 9.148819220060914e-58, 'ABCSG18_study': 9.148819220060914e-58, 'comparedto_to_be_further_evaluated_with_largercohorts_of_patients_and_multiplecenter_analysis': 9.148819220060914e-58, 'thethat': 5.661951480714229e-07, 'not_only_markedly_reduces_the_risk_of_breaking_bones_butalso': 9.148819220060914e-58, 'reoccurrence': 9.148819220060914e-58, 'CANCERIMMUNOTHERAPYThe_ï¬\\x81eld': 0.00013360670637670873, 'onthose': 0.0011301720283114149, 'to_identify_independent_variables': 0.0005263009120446208, 'survival_DFS_survival_OS_Nomograms': 1.8444548091260086e-05, 'HBsAg': 5.7123592486022485e-05, 'Nomogramswere': 9.148819220060914e-58, 'TheCindex_values': 9.148819220060914e-58, 'Yang_Zhang_DT_Zheng_SYang_L_Wei_WD_Prognostic_Value_Patients_WithCuratively': 9.148819220060914e-58, 'Breast_CancerAnalyses': 9.148819220060914e-58, 'eï¬orts': 0.0004362816517264714, 'hepatitisB_surface_antigen': 0.00040378297050580684, 'HBV_infectionis': 0.004315547045054443, 'HBV_infection': 3.755098390938202e-05, 'issuesince_HBV': 9.148819220060914e-58, 'to_be_found_in_breast_cancertissue_ ': 9.148819220060914e-58, 'years_oldand': 0.0003503299682769458, 'registryofthis_center': 0.0021191674131950436, 'eighthinternational_classiï¬\\x81cation_system': 0.001845170519318405, 'recordsand_survival_data': 3.4594781879845565e-05, 'Breast_cancers': 0.0007641347695089468, 'to_have_curatively_resectedbreast_cancer_without_previous_therapy_other_than_neoadjuvanttherapy': 0.001845170519318405, 'deï¬\\x81niteinformation': 0.001845170519318405, 'et_alHepatitis_B_Virus_Breast_Cancerforindependent_OS': 9.148819220060914e-58, 'methodand_diï¬erences': 9.148819220060914e-58, 'OS_Covariates': 5.007801939203765e-06, 'laterality_\\x9crms\\x9d_package': 0.000307012499293813, 'laterality': 8.182500841442369e-08, 'DFSand_OS': 9.148819220060914e-58, '\\x9crms\\x9d_package': 9.148819220060914e-58, 'discriminationofthe_nomogram_models': 9.148819220060914e-58, 'Harrell\\x99sconcordance_index': 9.148819220060914e-58, 'to_assess_thepredictive_value_of_the_model_ ': 0.0005865071468874085, 'AvailabilityThe_authenticity_data': 0.0021845306697080673, 'theminimum_Pvalue': 0.0038806204677737646, 'AvailabilityThe_authenticity': 0.0005263009120446208, 'surgeryn': 9.148819220060914e-58, 'R0_resection': 9.148819220060914e-58, 'December_instances': 9.148819220060914e-58, 'Thenumber': 9.148819220060914e-58, 'higherfrequency': 0.001845170519318405, 'frequency_metastasis': 0.0013882295497307361, 'totalof_death_events': 0.0014616190772430405, 'group_CI_P': 9.148819220060914e-58, '3B': 9.148819220060914e-58, 'DFS_OS_Figures_Supplementary_Figures': 0.0009880562243877893, 'DFS_OS_Figures': 0.0008581749454218445, 'P_OS_P': 1.6122385684430742e-05, 'Supplementary_Figures': 0.0008581749454218445, 'et_B_Virus_patient_Figures': 0.0006321861226151657, 'optimalagreement': 2.0031394091466016e-05, 'thepatients_modelfor_DFS': 0.00771518910792271, 'Survival_analyses': 0.00012613970685026185, 'association_N_stage_subtype_area': 0.007713134335009549, 'to_build_nomograms_to_better_predict_prognosis_foryoung_patients_with_breast_cancer_The_results_of_our_studydemonstrated_that_the_prevalence_of_HBsAg_in_young_patientswith_breast_cancer_in_southern_China_was_ _which_wasin_accordance_with_the_\\x93_reported_in_the_populationof': 0.00238803522972525, 'accordance': 0.0038806204677737646, 'diï¬erentpattern': 0.001845170519318405, 'survival_mechanisms': 0.0005253840276496832, 'et_B_Virus_CancerFIGURE_Univariate_multivariate': 8.263922883666513e-55, 'to_be_elucidated_butthis_may_largelyrelate_to_the_presence_of_hepatitis_B_Xinteracting_proteinHBXIP_which_has_been_welldocumented_to_function_asan_oncoprotein_in_breast_cancer_ ': 1.1686951820486561e-54, 'to_function_asan_oncoprotein_in_breast_cancer_ ': 0.0038806204677737646, 'HBXIP': 8.263922883666513e-55, 'chemotherapy_HBV_reactivation': 0.0011078353336573638, 'failure_interruption': 1.8090871199370374e-05, 'Nomograms_predicting_  _and_10year_A_diseasefree_survival_and_B_overall_survival_for_very_young_patients_with_breast_cancer_CD_Thescatter_plots_of_percentage_of_patient_number_and_groups_of_C_total_prognostic_score_for_DFS_and_D_total_prognostic_score_for_OSbetween_the_HBsAg_and_patient_survival_include_the_immunesuppression_Chronic_HBV_infection_is_characterized_by_thefailure_to_elicit_an_eï¬ective_adaptive_immune_response_andthe_immune_modulation_of_key_innate_immune_response_Chronic_HBV_infection': 0.0005345134679592639, 'thefailure': 6.130928797033634e-07, 'to_protect_the_host_against_the_developmentof_nonviral_cancerstogether': 0.0038806204677737646, 'wecharacteristicscombined_HBsAgstatus_nomogram_models': 0.00015319874332371669, 'goodcalibration_discrimination': 0.00013824306710043735, 'nomogrammodels': 0.001845170519318405, 'therapy_Xtile_program': 4.9041707996457254e-08, 'monotonicity': 9.148819220060914e-58, 'universality': 9.148819220060914e-58, 'tothe_participants': 0.00012421895344124877, 'QCW_DTZ_SZ': 9.148819220060914e-58, 'data_Siegel_RL_Torre': 9.148819220060914e-58, 'QQZ_LYand_WDW': 0.0014616190772430405, '101111j14455994200902060x_Hu_CJ_Yong_X_Lu_MH_Cheng_BJ_et_al_HBV': 0.0007862569594425692, 'Control_\\x93_work': 3.641183465103046e-05, 'Bvirus_infection': 0.00010549291232432236, 'Q_B_virus': 2.0787832650315122e-07, 'Novel_evidence': 9.148819220060914e-58, '101016jcld200911009_SS_Cheung_PK_Lin_CK_Lo_KW_Patients': 9.148819220060914e-58, 'acid_levels': 0.004315547045054443, 'oncoproteinHBXIP': 5.655871721934623e-06, 'termsFrontiers': 0.0038806204677737646, 'histone_nonhistone_proteins': 0.0038806204677737646, 'manymyogenic_factors_factors': 9.148819220060914e-58, 'HDACs_HDACs': 9.148819220060914e-58, 'Durnin_It': 9.148819220060914e-58, 'secrete_factors': 9.148819220060914e-58, 'WangwangrutysuseducnPeijie_Chenchenpeijiesuseducn': 9.148819220060914e-58, 'contributedequally_Histone_Deacetylases': 9.148819220060914e-58, 'metabolite_acidglucose': 9.470784588431378e-05, 'control_whichin': 0.00011193202240712925, 'deacetylation_Haberland_Table': 1.8262417252422824e-06, 'modulategene_expression_protein_activity_it': 3.56595574835178e-05, 'Shahbazian_Howeverthephysiological_functions': 9.148819220060914e-58, 'to_be_well_examined_inskeletal_muscles_A_series_of_researches_shed_light_on_the_potentialof_drugs_targeting_HDACs_to_improve_muscle_ï¬\\x81tness_and': 9.148819220060914e-58, 'cardiacmuscle_disease': 0.0015842910551982499, 'clariï¬\\x81cation': 0.0038806204677737646, 'factor_MEF2MyoD': 0.00028747108910989435, 'Gregoire_HDAC3': 0.0005426203729373464, 'byHDAC_kinases_pathway': 8.851492232585183e-06, 'byHDAC_kinases': 8.851492232585183e-06, 'biogenesis_factorperoxisome': 9.148819220060914e-58, 'alpha_PGC1Î±_Whiteand_Schenk': 9.148819220060914e-58, 'howthese_HDACs': 0.007713134335009549, 'I_HDAC123': 8.12949236337054e-06, 'to_be_associated_withthe': 0.0004984067005749793, 'HDAC1_protein': 9.148819220060914e-58, 'myocyte_diï¬erentiation_transfers': 9.148819220060914e-58, 'inhibitory_property': 0.00030586813508869646, 'HDAC3': 0.00025708503473851745, 'myocyte_diï¬erentiationcan': 0.004315547045054443, 'MyoDMEF2PCAF': 4.194843091839781e-06, 'autophagy_ï¬\\x82ux': 4.194843091839781e-06, 'evidenceon_role': 8.263922883666513e-55, 'muscles': 0.00036356643571322663, 'germline_deletion': 5.929976429792307e-06, 'phenotypeMontgomery': 2.374409160663995e-05, 'TKO': 0.0004024603399562249, 'Mediates_CR': 1.1686951820486561e-54, 'sensitivity_hasno_effect_effect': 8.263922883666513e-55, 'capacityTG_mice': 8.263922883666513e-55, 'exercise_tolerance_protectagainst_HFDinduced': 9.148819220060914e-58, 'mKO_mice': 9.148819220060914e-58, 'ï¬\\x81ndingsdemonstrate': 9.148819220060914e-58, 'sarcomerehomeostasis': 9.148819220060914e-58, 'enduranceexercise_capacity': 2.3653854007546668e-06, 'test_GTT_test_ITTHong_Lipid': 9.148819220060914e-58, 'to_be_used_as_energy_fuel_in_HDAC_mKOmice_which_inhibits_glucose_absorption': 9.148819220060914e-58, 'glucose_absorption': 0.0038806204677737646, 'expressionof_AMP_deaminase': 3.77893866748077e-05, 'IMPfacilitating_aspartic_acid': 4.931778408237746e-07, '13C6': 9.148819220060914e-58, 'rate_inmuscles_expression': 9.148819220060914e-58, 'myoblast': 0.0010068765747081726, 'Hong_Gong': 0.0010068765747081726, 'oxidationin_mitochondria': 0.0007080023910910008, 'knockout_HDAC3': 2.608320286551595e-05, 'severeliver_steatosis': 4.2605159072808467e-07, 'shuttle_eï¬ect': 0.0038806204677737646, 'researchdemonstrates': 0.00014711692116740796, 'shuttle': 0.000704362469235278, 'ESCs': 9.148819220060914e-58, 'I_proportion_ofRegulation': 0.000489923995670151, 'Altogether_ï¬\\x81nding': 0.0004635820703636805, 'targetgenes_McKinsey_2000a': 7.562265611368425e-06, 'mechanism_targetgenes_McKinsey_2000a': 0.0004988292642554344, 'structure_exercise_capacity': 0.00016553660791656055, 'nuclearcytoplasmtransportation': 3.014437839542172e-05, 'Class_I_HDACs': 9.148819220060914e-58, 'exercisecapacity': 9.148819220060914e-58, 'leavingHDAC5': 9.148819220060914e-58, 'eï¬ect_activity': 9.148819220060914e-58, 'Class_IIaHDACs': 0.0005218289698578611, 'conï¬\\x81rmed_play_revealed_suggested_participates': 0.000494595879613311, 'followingapplication_Lee': 0.0038806204677737646, 'SIR2_encodes': 0.00010078719550483667, 'NPT1': 0.0005218289698578611, 'exert_IV': 9.148819220060914e-58, 'Imai_Lin': 9.148819220060914e-58, 'Mediates_Stress_Adaptation': 0.000494595879613311, 'myocyteswhich': 1.1484455079704606e-05, 'maytarget_SIRT1PGC1Î±': 7.17511255270123e-05, 'capacity_oxygen_consumptionand': 2.3653854007546668e-06, 'RSV': 7.996415927928173e-50, 'thedeacetylation': 3.57610591824189e-50, 'production_oxygenconsumption': 0.0038806204677737646, 'syndrome_Lagouge_function': 3.57610591824189e-50, 'greatattention': 3.57610591824189e-50, 'researchers_Researchers': 9.148819220060914e-58, 'skeletalmusclespeciï¬\\x81c_SIRT1mKO_mice': 9.148819220060914e-58, 'HDAC6': 1.1686951820486561e-54, 'MFN1': 8.263922883666513e-55, 'mitofusion_function': 8.263922883666513e-55, 'Canto_Overexpressionof_Sirt1': 0.0018006682651940404, 'overexpressing_Sirt1_in_liver_by_AAV8': 2.9402948113849672e-05, 'skeletalmuscles_adaptation_CR_aging_regeneration_Ryall_Figure': 0.001801148090838322, 'limitedregulation_capacity': 4.845184303089303e-05, 'deacetylase': 7.545906234072327e-05, 'mice_death': 1.2309691416781353e-06, 'exercise_capacity_mice': 8.263922883666513e-55, 'mice_death_insulinresistance_glucose_homeostasis': 1.1686951820486561e-54, 'Cui_Furthermoreresearchers': 9.148819220060914e-58, 'SIRT6_Sirt6BACmice': 9.148819220060914e-58, 'Anderson_Vitroexperiments': 8.263922883666513e-55, 'inskeletal_muscles': 0.0003692335358126249, 'Figure_MitochondriaLocated_SIRT34SIRT34': 9.148819220060914e-58, 'Mitochondria_Function': 9.148819220060914e-58, 'III_HDACs': 0.0005356450894538682, 'adaptation': 6.0580173590711324e-05, 'adaptation_PGC1alpha_insulin_sensitivityby_function': 0.0002678964139738006, 'PGC1alpha': 4.845184303089303e-05, 'insulin_sensitivityby': 8.73699886877187e-06, 'metabolismDittenhaferReed': 0.0006054349545841993, 'dehydrogenase_PDH_subunit': 9.148819220060914e-58, 'downregulationof_hexokinase_II_HK_II': 9.148819220060914e-58, 'SIRT3': 4.368613471479814e-06, 'knockoutskm\\x88\\x92\\x88\\x92mice': 7.492544656214743e-05, 'SIRT4_knockoutcan': 4.323527951542396e-05, 'exercisein_mice': 7.064081447894542e-07, 'TARGETS': 0.0004990942860418787, 'MS275': 9.148819220060914e-58, 'biogenesis_consumption_Galmozzi': 9.148819220060914e-58, 'speciï¬\\x81callyinhibiting_Class_I_rather_than_Class_II_HDACs_improvedGTT_and_insulin_sensitivityincreased_oxidative_metabolismof_skeletal_muscles_and_adipose_tissue_and_reduced_bodyweight_Galmozzi_  _Similar_to_the_eï¬ect_of_MS275knockdown_HDAC3_in_C2C12': 9.148819220060914e-58, 'Pgc1Î±Glut4': 9.148819220060914e-58, 'andits_target_genes': 0.0015842910551982499, 'HDAC_inhibitor': 0.0003692335358126249, 'suggesting_thatthese_drugs_may_indirectly_activate_SIRT1_Pacholec_ ': 0.0007008712380191807, 'thatthese_drugs': 9.148819220060914e-58, 'SIRT1_Pacholec': 9.148819220060914e-58, 'ADPribosepolymerase1_PARP1': 0.0007010580158717714, 'NAD_content': 1.1438778072363615e-05, 'Bai_PARP1_inhibitorscan': 0.000494595879613311, 'activatorthat': 1.1686951820486561e-54, 'function_exercise_capacity': 8.263922883666513e-55, 'obesity_Lagouge': 8.263922883666513e-55, 'protein_content_overexpression_protein_content': 0.0003640060763646834, 'data_showedthat_RSV': 9.148819220060914e-58, 'blood_pressure_assessment_indexindicating_glucose_metabolismability': 9.148819220060914e-58, 'ofSIRT1': 9.148819220060914e-58, 'CR_eï¬ect': 9.148819220060914e-58, 'populationsample_HDAC1_wascloned': 3.57610591824189e-50, 'Taunton': 3.57610591824189e-50, 'sabout_HDACs': 9.148819220060914e-58, 'populationsample_HDAC1_wascloned_Taunton': 9.148819220060914e-58, 'C_insulin_sensitivity': 9.148819220060914e-58, 'HDAC_proteins': 9.148819220060914e-58, 'HDACs_geneChIP_High_eï¬ects_diï¬\\x83culty_activity_greatpotential': 0.003695934925693589, 'HDACs_geneChIP_High': 0.00020422465499362284, 'eï¬ects_diï¬\\x83culty_activity': 0.0013882295497307361, 'researchesshould': 9.148819220060914e-58, 'importance_likePARP1': 9.148819220060914e-58, 'researchesshould_attach_importance_to_HDACs_regulatory_factors_likePARP1_when_direct_targeting_on_HDACs_fails_to_show_its_eï¬ectsFurther_development_of_their_inhibitors_with_more_speciï¬\\x81cityand_trials_for_the_treatment_of_metabolic_diseases': 9.148819220060914e-58, 'greatpotential': 9.148819220060914e-58, 'to_show_its_eï¬ectsFurther_development_of_their_inhibitors_with_more_speciï¬\\x81cityand_trials_for_the_treatment_of_metabolic_diseases': 1.605072156158138e-05, 'eduBackground_cancer_TNBC': 3.901700916169037e-05, 'strategy_tumors': 0.002388671506211953, 'PD1_blockade_survivalResults': 0.007713134335009549, 'inhibitory_axis': 8.263922883666513e-55, 'Sheybani': 0.0005034057898537578, 'FUS_regimes': 3.7711607362685093e-06, 'Pertaining_ _to_ _the_ _challenge_ _of_ _myeloid_ _cell_ _immunosuppression_ _in_ _TNBC_ _FUS': 9.148819220060914e-58, 'to_induce_the_expression_of_heat_shock_proteins24_ _and_proinflammatory_cytokines_including_interleukin_ _IL12_interferonÎ_IFNÎ_and_tumor_necrosis': 9.148819220060914e-58, 'layering': 2.28759606648211e-07, 'FUS_treatment': 0.004439290430148374, 'Tumor_outgrowth': 9.13080238559e-06, 'starting_ ': 8.263922883666513e-55, 'saline_Mouse_flanks': 3.942063782979162e-09, 'using_ _one_ _of_ _the_two_ _systems_ _System_ _and_ _treatment_ _details_ _are_ _provided_in_ _online_ _supplementary_ _materials_ _and_ _methods_ _Mice_that_ _did_ _not_ _receive_ _FUS_ _treatment_ _anesthesia_depilation': 6.440694627722734e-11, 'FUS_ablation': 0.0038806204677737646, 'using_ _one_ _of_ _the_two_ _systems_ _System_ _and_ _treatment_ _details_ _are_ _provided_in_ _online_ _supplementary_ _materials_ _and_ _methods_ _Mice_that_ _did_ _not_ _receive_ _FUS_ _treatment_ ': 6.440694627722734e-11, '\\x98sham\\x99_treatment_a0ND_blockade_checkpoint_inhibitor_therapy_rat_mouse_PD1_antibody_X_Cell\\x94were': 0.0005411681930881713, '\\x98sham\\x99_treatment_mgmouse_a0ND_blockade_checkpoint_inhibitor_therapy_rat_mouse_PD1_antibody_X_Cell\\x94were_every_tumors': 0.0009054155044859541, 'mgmouse': 0.0005411681930881713, 'Mylan': 1.4769002278782124e-05, 'Digital_images': 1.1686951820486561e-54, 'using_ _the_ _Vectra_   _Automated_ _Quantitative_ _Pathology_ _Imaging_ _System_ _Akoya_Biosciences_ _Whole_ _slide_ _screening_ _and_ _image_ _capture': 8.263922883666513e-55, 'using_ _Phenochart_  ': 8.263922883666513e-55, 'Akoya_BiosciencesFlow': 8.769663953107677e-05, 'Hybri_Max_Sigma_processed_ _and_ _stained_ _for_ _flow_cytometry_ _analysis_ _Additional_ _details_ _are_ _provided_ _in_online_supplementary_materials_and_methodsSamples_ablation_FUS_system_1B\\x93C': 0.0006890048151175952, 'Hybri_Max_Sigma': 1.4320719902360813e-06, 'pooled_nondraining': 1.1241518734685724e-05, 'tumor_DLNs': 0.00033962126629555366, 'processed_ _and_ _stained_ _for_ _flow_cytometry_ _analysis_ _Additional_ _details_ _are_ _provided_ _in_online_supplementary_materials_and_methodsSamples': 1.8362545556870106e-07, 'FUS_system_1B\\x93C': 0.007713134335009549, '1E': 0.00025634008500508406, '1H_DLNs_data': 0.00238803522972525, 'myeloid_cells_G_MDSCs': 0.00023788517169149556, '1J_ablation': 0.0010298344840079976, 'DC_activation': 7.643475415353497e-05, 'Design_overview': 7.643475415353497e-05, 'DC_activation_Design_overview_sonications_Schematic_illustration_study_layout': 7.643475415353497e-05, 'sonications_Schematic_illustration_study_layout': 7.643475415353497e-05, 'applied_applied_spaced_excised_superimposed': 9.148819220060914e-58, 'Representative_HE_staining_Absolute_number': 9.148819220060914e-58, 'sham_n6_FUS': 2.0191449121096517e-07, 'insets': 9.148819220060914e-58, 'transition_bars400_µm_µm': 9.148819220060914e-58, 'cells_G_MDSCs': 0.0011125787591309202, 'ultrasoundSheybani': 6.490035924524953e-05, 'tumor_implantation': 0.00011613074286455415, 'GEM_therapy_mgmouse': 0.007713134335009549, 'to_ _produce_ _significant_ _constraint_ _of_4T1_ _tumor_ _outgrowth_ ': 0.0003773263079576772, 'termination': 0.007713134335009549, 'GEM': 9.148819220060914e-58, 'tumors_figure_2B_tumor_projections': 9.148819220060914e-58, 'postimplantation': 0.0006054349545841993, 'FUSGEM': 4.44484308195754e-08, 'Theraclion_visualization_unit_MHz_tumor_outgrowth_figure': 7.643475415353497e-05, 'Combinatorial_therapy': 0.0010298344840079976, 'CD8_CD4': 0.0007080023910910008, '6A\\x93B': 0.0005807607654450252, 'p00021_FUS': 3.124786624800842e-05, 'Combination': 0.0008522036149147152, 'data_representative': 0.0014616190772430405, '0c_access_elevations': 0.0007080023910910008, 'antitumor_T_cell': 0.0003773263079576772, 'brefeldin_injection': 0.007713134335009549, 'FUS_monotherapy': 0.0002337533695104565, 'recipient_groups': 9.148819220060914e-58, 'increase_G': 9.148819220060914e-58, 'Rag1\\x88\\x92\\x88\\x92_model': 0.007713134335009549, 'andor_B_cells': 9.148819220060914e-58, 'role_mice': 9.148819220060914e-58, 'mice_relative': 3.630813137780908e-05, 'plasma_exchange': 1.1686951820486561e-54, 'Park5_Mathew_S_Block1': 8.263922883666513e-55, 'Yan1_Dronca6_L_Winters4To': 9.148819220060914e-58, 'Enninga': 9.148819220060914e-58, 'circulating_soluble_PD_L1_and_PD_L1_positive_extracellular_vesicles_Journal_for_ImmunoTherapy_of_Cancer': 8.263922883666513e-55, 'ligand_PD_L1': 0.0001238093543135896, 'prognosis_response_any_exchange_TPE': 2.0205053916706364e-06, 'prognosis_response': 2.0205053916706364e-06, 'exchange_TPE': 0.007713134335009549, 'sPD_L1_L1': 0.00039187267144829923, 'vesiclesConclusion': 6.3905498150449995e-06, 'L1': 1.1686951820486561e-54, 'homodimerization_domains': 8.263922883666513e-55, 'ELISA_sPD_L1': 8.263922883666513e-55, 'L1_inhibitors': 0.000796363312029855, 'CD8_T_cells': 1.2993312936040236e-05, 'vesicles_EVs': 0.0005828796252635297, 'L18_evPD_L1': 0.0002712952666904031, 'inhibitors_manipulation': 9.148819220060914e-58, 'to_ _reduce_ _release_ _of_ _these_ _forms_ _of_ _PD_L1_in_culture_or_animal_models': 9.148819220060914e-58, 'ions': 0.0038806204677737646, 'diffusion_TPE': 1.1016737136574871e-05, 'plasma_substances': 0.0006751961684051898, 'TPE_session': 0.00020307843122706578, 'plasma': 3.158566160786432e-05, 'diffusing_unbound': 5.15406995834872e-07, 'TPE': 0.0006056982000918612, 'A_model_L1_ADAM10ADAM17': 8.263922883666513e-55, 'L1_ectodomain_variant_sPD': 1.1686951820486561e-54, 'L1\\x94that': 0.000798759665660286, 'Meier_plot': 0.0006321861226151657, 'C_Patients': 8.263922883666513e-55, 'p0001RESULTSsPDL1_levels': 0.0006321861226151657, 'sPD_L1_levels': 0.007727125946773411, 'working': 0.0005865071468874085, 'table_Patients_L1_levels': 9.045569613289207e-05, 'p0001_hazards': 6.369083083474234e-07, 'sPD_L1': 3.905575731105812e-05, 'PD_L1': 0.0002858291977424513, 'consent_characteristics': 0.0038806204677737646, 'plasma_exchange_sample_collection': 0.001845170519318405, 'plasma_exchange_sample_collection_sPD_L1_levels': 0.001845170519318405, 'diagnosis_sPD_L1_levels': 0.001845170519318405, 'plasma_exchange_TPE': 7.417164383651313e-53, 'L1_levels': 1.284690556057437e-52, 'A_model': 7.417164383651313e-53, 'to_extract_non_cellular_substances_confined_to_the_plasma_B_A_diagram_of_the_present_study_in_which_ _patients_undergo_plasma_exchange_C_All_plasma_levels_of_sPD_L1_immediately_prior_to_pre_and_after_post_TPE_using_albumin_replacement_fluid': 5.15406995834872e-07, 'C_plasma_levels': 0.001845170519318405, 'rank_test_p00001_D': 7.417164383651313e-53, 'See_also': 9.148819220060914e-58, 'online_figures': 9.148819220060914e-58, '\\x93_mixture_impact': 0.002388672138033597, 'TPE_sessions': 0.00015270383055394153, 'TPE_courses': 0.00012636850614786046, 'Pre_TPE': 2.0585003226732874e-06, 'fig_TPE': 6.369083083474234e-07, 'p00001FFP': 4.159186333897339e-05, 'sPD_L1_fig': 0.007713134335009549, 'plasma_donors': 0.000126334829240796, 'evPD_L1': 9.875159293675455e-06, 'EV_levels_L1': 0.007713134335009549, 'p0008F122382_p0063Patients': 3.597657809630927e-06, 'plasma_concentration_figure': 0.0002207122731749244, 'ADAM10': 3.597657809630927e-06, 'pathogenesis11\\x93TPE': 3.597657809630927e-06, 'EVs': 2.492691778171436e-06, 'donor_FFP': 0.001845170519318405, 'L1_ADAM10ADAM17': 9.148819220060914e-58, 'sPD_L1_ectodomain_L1\\x94mediates_resistance': 9.148819220060914e-58, 'Plasma_exchange': 1.6143650512254446e-07, 'ligand_EV_levels': 9.877790206875056e-06, 'p0028_p00001': 9.875159293675455e-06, 'p094': 7.2071164024907285e-06, 'sPD_L1_evPD_L1': 9.875159293675455e-06, 'neuroendocrine_tumor': 0.0006324067207528349, 'TPE_sPD_L1': 0.0006324067207528349, 'Neither': 0.00022909197837626724, 'to_respond_Of_patients_that_benefit': 3.365560733702061e-05, 'investment': 0.00031504101255819624, 'dollars': 0.00026701832080125866, 'preimmunotherapy_TPE': 9.148819220060914e-58, 'immunotherapy_resistance': 9.148819220060914e-58, 'TPE_study_designIn': 2.505853482494148e-06, 'immunotherapy_treatments_Blood_TPE_study_designIn': 4.2596855152132785e-05, 'immunotherapy_treatments_Blood': 6.918627002654179e-05, 'study_adults': 5.693284547016032e-05, 'biotin_supplements': 0.00018750364596568773, 'Patients_ _taking_ _biotin_ _supplements_ ': 9.148819220060914e-58, 'using_ _centrifugation_based_ _cell_ _separators_ ': 9.148819220060914e-58, 'electrolyte_replacement': 0.00018750364596568773, 'push': 1.0484758855505112e-07, 'anticoagulant': 1.7925185011550313e-08, 'brief': 6.7595020175854576e-06, 'cross_reactivity': 1.103024712883499e-07, 'Systems_clone_clone_PL2_antibodies': 1.0360801091242583e-06, 'using_ _R_ _Statistical_Software_ _R_ _Foundation_ _Retrospective_ _progression_free_survival_was_analyzed_using_Kaplan_Meier_and_Cox_proportional_hazards_modeling_Optimal_cut_off_values_for_sPD_L1_levels_using_the_greyzoneSurv_package_test_Figures': 6.34079862780347e-05, 'team_members': 0.0001763219432583925, 'using_ _R_ _Statistical_Software_ _R_ _Foundation_ _Retrospective_ _progression_free_survival_was_analyzed_using_Kaplan_Meier_and_Cox_proportional_hazards_modeling_Optimal_cut_off_values_for_sPD_L1_levels': 1.6899687827906264e-08, 'Optimal': 0.00043463382250315263, 'using_the_greyzoneSurv_package': 1.6899687827906264e-08, 'to_compare_paired_pre_TPE_and_post_TPE_patient_sample_sPD_L1_and_EV_levels_as_indicated_Baseline_clinical_characteristics_for_the_study_were_compared_by_Kruskal_Wallis_test_for_continuous_variables_and_Pearson\\x99s_Ï\\x872_test_for_discrete_variables_as_indicated_Orme_a0JJ_et_a0al': 7.2071164024907285e-06, 'Wallis_test_Ï\\x872_test': 0.0005536611936400708, '0cOtherwise_groups': 9.148819220060914e-58, 'test_Figures': 9.148819220060914e-58, 'JakeOrmeMDPhDAcknowledgements_guidance': 9.148819220060914e-58, 'Nathan_Foster': 9.148819220060914e-58, 'illustrations': 9.148819220060914e-58, 'Mayo_Clinic_Media_Services': 9.148819220060914e-58, 'Summerfield_MD_MS': 0.0007959416758056306, 'JO': 1.9173531956767126e-05, 'EALE': 1.2448086383968435e-07, 'cohort_analysis': 7.620933768392123e-06, 'FL_M': 9.148819220060914e-58, 'cytometry_HD_EB': 9.148819220060914e-58, 'TPE_study_enrollment_sample': 0.0003327007272384309, 'MB_YY_HD_RD_JLW': 1.1686951820486561e-54, 'hypotheses_Role_CA23154101_Soluble_B7H1': 8.263922883666513e-55, 'support_oversightFunding': 8.263922883666513e-55, 'CA090628_YY_Foundation_HD_RDCompeting_interests_property': 0.00015144330283132633, 'conflicts_works_changes': 2.4680219296751273e-06, 'research_protocols': 9.148819220060914e-58, 'Review_Board_subjects': 9.148819220060914e-58, 'Plasma_levels': 9.148819220060914e-58, '\\x93_Fan_Y_Che_X_Qu_J_et': 9.148819220060914e-58, 'Exosomal_PD_L1': 0.0007008712380191807, 'Cancer_Immunol_Immunother': 4.6673626412722295e-06, 'Orme_Jazieh_KA_Xie_T_et': 7.616496213307106e-08, 'Proteolytic_processing_Cancer_Immunol_Immunother': 9.148819220060914e-58, 'AC_Zhang_W_et_Schuurman_HJ': 9.148819220060914e-58, 'tumor_immunity_Cell_\\x93': 7.417164383651313e-53, 'generation_Thromb_Haemost_SC_et': 8.263922883666513e-55, 'isolation_J_Extracell': 9.148819220060914e-58, 'Kowal_J_Arras_G_Colombo_M_et': 9.148819220060914e-58, '2016113E968\\x93_Winters': 9.148819220060914e-58, 'miRNA_146b_miRNA222_Res_\\x93': 9.148819220060914e-58, 'membrane_vesicles': 0.0006750162805663558, 'ar_rhythmogenicity': 0.004315547045054443, 'QT': 0.001128162151175775, 'monitoring_tools': 0.0004499048194399722, 'obstacles_issues': 0.004315547045054443, 'era_Elsevier_Inc': 0.00010616849003009921, 'Elsevier_Inc': 0.00010616849003009921, 'tumult': 3.961866732544363e-05, 'Arrhythmias': 3.1235511726865175e-05, 'arrests': 0.0019132930105159865, 'AF_odds': 0.00038832026168597134, 'diac_arrests': 6.336803339798388e-06, 'VF_patients': 9.148819220060914e-58, 'VAs_snapshot_survey': 9.148819220060914e-58, 'this_Trends': 1.4086189101362672e-05, 'Nonsustained': 1.6583321908634308e-05, 'schema': 9.148819220060914e-58, 'arrhythmias': 9.148819220060914e-58, 'text_AF_interval': 0.0010068765747081726, 'tachyarrhythmia': 0.0002069818544961052, 'block_RBBB_block_OR_p': 3.287639236201791e-05, 'rent_cardioversion': 9.148819220060914e-58, 'to_restore_sinus_rhythm': 9.148819220060914e-58, 'to_initially_proceed_with_a_rate_control_strategy_with_use_of_a_betablocker_when_there_is_no_contraindi_cation_eg_bronchospasm_acute_heart_failure_a_calcium_channel_blocker_in_the_absence_of_heart_failure_andor_digoxin': 0.0006026042973632392, 'coadministration': 1.1686951820486561e-54, 'to_achieve_rate_control_For_newonset_AF_within_the_last_ _hours_restoring_sinus_rhythm': 8.263922883666513e-55, 'amiodarone': 9.148819220060914e-58, 'to_be_relatively_safe_or_absence_of_under_lying_structural_heart_disease': 9.148819220060914e-58, 'be_low': 0.004315547045054443, 'to_achieve_rate_control_For_newonset_AF_within_the_last_ _hours_restoring_sinus_rhythm_study': 8.263922883666513e-55, 'AF_patients': 9.148819220060914e-58, 'prophy_anticoagulation_therapy': 9.148819220060914e-58, 'au_thors': 2.0199669870987695e-06, 'hypoxemia': 9.148819220060914e-58, 'ity': 9.148819220060914e-58, 'abnormalities_hypokalemia_hypomagnesemia_fever': 0.00015319874332371669, 'TdP_death_SCD': 0.00015319874332371669, 'ejection_range': 0.001845170519318405, 'QT_interval_prolongation_VAs': 0.004315547045054443, 'OOHCAs': 0.0019127833147525456, 'to_have_antiviral_effects': 0.00018159201441078236, 'Chloroquine': 0.0006054349545841993, 'HCQ': 2.274211562945482e-53, 'dispersion_results': 1.4055400435083287e-53, 'ini': 8.263922883666513e-55, 'VT': 1.1686951820486561e-54, 'Among_ _pa_tients_enrolled_with_COVID19_infection_  ': 2.1885082013697365e-05, 'instance_interval': 0.001341324188764922, 'CQ_authors': 9.148819220060914e-58, 'daily_ _ECG_ _monitoring_ _and_ _other_ _risk_ _mitigation_strategies_to_be_adopted_in_order_to_prevent_possible_arrhythmic_sideeffects_Macrolide_antibiotics': 9.148819220060914e-58, 'Azithromycin_AZM': 9.148819220060914e-58, 'interval_longation': 9.148819220060914e-58, 'Azithromycin': 8.263922883666513e-55, 'labels_ad_quinidine_procainamide_class_III_agents': 1.715676556058368e-07, 'Lopinavir': 9.148819220060914e-58, 'cytochrome_P450': 9.148819220060914e-58, 'drug_transporters': 0.00210348072096923, 'ritonavirlopinavir': 8.263922883666513e-55, 'plasma_concentrations': 1.1686951820486561e-54, 'Ritonavirlopinavir': 8.263922883666513e-55, 'dose_reductions_avoidance': 9.148819220060914e-58, 'to_ _cause_ _QT_ _and_ _PR_ _interval_ _prolongation_ _or_ _occasionally_second_or_thirddegree_AV_block_particularly_in_patients_with_un_derlying_structural_heart_disease_and_preexisting_conduction_sys_tem_abnormalities': 9.148819220060914e-58, 'lymphocyte_migration': 0.0038806204677737646, 'Fin_golimod': 9.148819220060914e-58, 'blockade_effect': 9.148819220060914e-58, 'potassium_channels': 0.0005915726387590047, 'therapies_Treatments': 8.263922883666513e-55, 'arrhythmia_risk_risk': 1.1686951820486561e-54, 'Drug_combinations': 8.263922883666513e-55, 'to_be_more_susceptible_to_druginduced_arrhythmias_compared_to_males_with_CV_disease_or_healthy_persons_of_either_gender_Please_cite_this_ _as_AS_Manolis_AA_Manolis_and_TA_Manolis_ _COVID19_infection_and_cardiac_arrhythmias_Trends_in_Cardiovascular_Medicine_101016jtcm202008002_0cJID_TCM_ _IN_PRESS': 7.417164383651313e-53, 'QTc': 0.00012669873152918566, 'AZM_ied_age': 4.373547284671339e-06, 'ms_p': 9.148819220060914e-58, 'ms_QTc_QTc': 9.148819220060914e-58, '\\x89¥_ms': 0.001845170519318405, 'CQ': 2.274211562945482e-53, 'AZM': 1.4055400435083287e-53, 'QTcinterval': 0.0019127833147525456, 'apy_p': 5.3523013564518495e-05, 'QTc_values_cohort_study': 0.001845170519318405, 'drugs_cohort': 0.001845170519318405, 'ms_increased': 9.148819220060914e-58, 'to_be_stopped_because_of_signiï¬\\x81cant_QTc_prolonga_tion_in_   _patients': 9.148819220060914e-58, 'HCQAZM': 3.4348996837103175e-05, 'to_be_interrupted_in_\\x89¥_ ': 0.002104041233387171, 'syndrome_LQTS': 2.067916744782798e-06, '[_]_  _Furthermore_ _silent_ _genetic_ _variants_ _or_\\x9cforme_ _fruste_\\x9d_of_ _congenital_ _LQTS_ _encountered_ _in_   _of_ _people': 7.916633471453218e-05, 'pSer1103Tyr': 9.148819220060914e-58, 'risk_factors_hypoxemia_cytokine_storm': 9.148819220060914e-58, 'correction_formula': 2.067916744782798e-06, 'AliveCor': 1.2099090324105423e-06, 'to_rise_in_the_coming_decades': 8.014401137946441e-05, 'discussedKEYWORDS_PRIMARY_CANCER_HEPATOCELLULAR': 9.148819220060914e-58, 'INTRAHEPATIC_CHOLANGIOCARCINOMA': 9.148819220060914e-58, 'accounting_for_ _of_total': 0.00018341571189742586, 'In_particularChina_experiences_the_highest_number_of_cases_of_PLC_with_a_high_incidencerate_ _cases100000_inhabitants5PLC': 9.148819220060914e-58, 'landscape_ICClike_features': 9.148819220060914e-58, 'ICCs': 9.148819220060914e-58, 'cirrhosis910_HCCs': 9.148819220060914e-58, 'PLC_subtypes': 1.1686951820486561e-54, 'alterations_molecularpatterns_HCCs_landscape_ICClike_features': 8.263922883666513e-55, 'alterations_molecularpatterns_HCCs': 8.263922883666513e-55, 'HCClikefeatures3637': 0.00037036254408407267, 'HCClikefeatures3637_Understanding_the_molecular_alterations_that_initiate_variousPLC_subtypes_is_of_great_importance_for_us_to_decipher_the_mechanisms_oftumorigenesis_Genetic_alterations_can_be_transformed_into_biomarkersthat': 1.1686951820486561e-54, 'treatmentdecisions': 8.263922883666513e-55, 'treatment_patientsHCCs': 8.263922883666513e-55, 'treatmentdecisions_treatment_patientsHCCs_subtype': 0.007713134335009549, 'alteration_treatment': 9.148819220060914e-58, 'therapy_drugs_therapies': 9.148819220060914e-58, 'HCC_HCC': 3.91057664130642e-05, 'riskfactors': 9.148819220060914e-58, 'B_virus_abuse_symptomssuch': 9.148819220060914e-58, 'hepatitis_metabolic': 0.00022943859288752802, 'risk_factors_poor': 0.0004670825529181705, 'cHCCICC': 7.620933768392123e-06, 'poor': 3.7400372930760105e-06, 'andpseudoglandular_pattern': 6.385888354813757e-07, 'duct_type': 9.148819220060914e-58, 'growth_patterns_formingMF_periductal': 9.148819220060914e-58, 'PI_subtype': 9.148819220060914e-58, 'dependingon': 9.148819220060914e-58, 'nodulesof': 0.0004024603399562249, 'mucinproducing_pseudoglands19': 0.0005828796252635297, 'stemprogenitor_cell_phenotypesconsisting': 1.2448086383968435e-07, 'Alterations_Widescale_studies': 0.0002768434257340561, 'formationof_cHCCICC3757': 3.903905056950078e-05, 'Vinci_surgery_surgery_surgery_transplantation': 0.0038806204677737646, 'rarity_lack': 4.496068198240745e-51, 'cancer_difï¬\\x81cult': 2.2480340991203723e-51, 'Surgicalresection': 2.2480340991203723e-51, 'cancer_difï¬\\x81cult_Surgicalresection_surgery_radiation': 2.2480340991203723e-51, 'surgery_radiation': 2.2480340991203723e-51, 'survival_rate_respectively_recurrence_rate': 0.00210348072096923, 'efï¬\\x81cacy_clinicaltrials_transarterialradioembolizationY90': 0.00020598579336589774, 'response_rates_toxicity': 0.00020598579336589774, 'onï¬\\x81rstline_chemotherapy': 0.0011075402231842013, 'advantage_months': 0.0019127833147525456, 'XELOX': 0.001128162151175775, 'study_NCT01926236_FOLFOX': 0.0007012448933034885, 'beneï¬\\x81t_ASC_others': 1.1441826859373991e-05, 'beneï¬\\x81t_ASC_activity_others': 1.1441826859373991e-05, 'multicenter_retrospectiveanalysis': 9.148819220060914e-58, 'Kobayashi': 9.148819220060914e-58, 'Median_PFS': 9.148819220060914e-58, 'gemcitabineplatinum_gemcitabine5FU_months': 9.148819220060914e-58, 'combination_ofgemcitabine_cisplatin': 0.000184520788473123, 'bottom_row': 9.148819220060914e-58, 'therapies_fortheir': 9.148819220060914e-58, 'beneï¬\\x81tedthough_others': 0.0004360764270917066, 'August_theFDA': 1.1686951820486561e-54, 'lenvatinib_HR_CI_hypertension_diarrhea': 8.263922883666513e-55, 'to_be_noninferior_to_sorafenib_in_the_phase_REFLECT_trial105Median_OS_in_the_lenvatinib_arm_and_sorafenib_arm': 1.3323160608155145e-05, 'appetite_withlenvatinib_palmarplantar_erythrodysesthesia_diarrhea': 8.263922883666513e-55, 'CSCOdonafenib': 9.045569613289207e-05, 'respectivelyThus': 9.045569613289207e-05, 'Regorafenib_Regorafenib_inhibitor': 0.0007008712380191807, 'VEGFR_\\x93_KIT_RAF_BRAF_PDGFR_FGFR_CSF1R': 0.0001440815567172776, 'torespond': 0.0011075402231842013, 'VEGFR2112': 0.005423087268238645, 'AsianPaciï¬\\x81cREFLECTRESORCECHECKMATE040CELESTIALKEYNOTE224REACH2Cohort': 1.1686951820486561e-54, 'efï¬\\x81cacy_AFP': 8.263922883666513e-55, 'AFP': 8.263922883666513e-55, 'safety_proï¬\\x81le_kinase_inhibitor': 7.05029712940268e-05, 'grade_worseadverse_events': 0.0007035667068513752, 'phase_inhibitor': 0.0002675814244889632, 'NCT02508467': 0.00016553660791656055, 'safety_OS_outcome_potential': 0.00016553660791656055, 'milciclib_cMET_inhibitors': 9.148819220060914e-58, 'adhesion_movement': 9.148819220060914e-58, 'growthfactor_EGFR_protein': 0.00037036254408407267, 'progress_target_therapy': 0.000347488144371561, 'FGFR1\\x93_FGF_signals': 0.0004738574283430153, 'FIGHT202_trial': 0.00037036254408407267, 'cholangiocarcinoma_fusions_rearrangements': 0.0019127833147525456, 'Pharmaceuticals_phase': 9.148819220060914e-58, 'Texas_Universityrecruitingphase_Eli_Lillyactive': 9.148819220060914e-58, 'tract_pathology_malignancy': 0.0011075402231842013, 'to_be_altered_to_consider_severity_of_disease_patient_comorbidity_and_prevalence_of_regional_COVID19_infections_amongst_other_factors_  ': 0.0005741125271172155, 'Synopsis': 0.0002524077091949532, 'to_discuss_some_of_the_areas_of_concern_related_to_ramping_up_clinical_volume_   ': 0.00210348072096923, 'United_States': 0.0010298344840079976, 'bat_pangolin_vector': 8.10622066090731e-06, 'to_be_marked_by_fever_ _of_patients_and_cough_ _of_patients_  _however': 0.0004969451253083701, 'litany': 8.10622066090731e-06, 'male_predominance': 0.0004969451253083701, 'a_litany_ _of_ _other_ _symptoms_ _have_ _also_ _been_ _described_ _including_ _gastrointestinal_ _upset_ _diarrhea_shortness_of_breath_headache_loss_of_smelltaste_among_others_Severe_disease_is_characterized_by_ _an_ _acute_ _respiratory_ _distress_ _syndrome_ _ARDS_ _with_ _a_   _mortality_ _for_ _patients_ _that_require_ _mechanical_ _ventilation_     _The_ _disease_ _has_ _a_ _slight_ _male_ _predominance_ _at_   _Severity_ _of_ _disease_ ': 9.148819220060914e-58, 'to_ _correlate_ _to_ _age_ _as_ _patients_ _who_ _are_ _aged_   _have_ _a_ _mortality_ ': 9.148819220060914e-58, 'diarrhea_shortness': 9.148819220060914e-58, 'syndrome_ARDS': 9.148819220060914e-58, 'those_cavity_nasopharynx': 9.148819220060914e-58, 'to_harbor_the_highest_viral_load_concentration_ _and': 9.148819220060914e-58, 'American_Academy': 0.0001628550928392614, 'otolaryngology_practices': 9.148819220060914e-58, 'to_ _ramp_ _up_ _activity_ _as_ _well_ _while_ _employing_ _telehealth_social_ _distancing_ _and_ _utilization_ _of_ _personal_ _protective_ _equipment_ _PPE_ ': 9.148819220060914e-58, 'to_ _move_ _forward_ _during_ _the_ _COVID19_ _era_ _considerations': 0.0001254113387783698, 'to_highlight_some_of_the_current_recommendations_for_patient_care_within_the_Laryngology_and_Head_and_Neck_Surgical_Oncology_scope_of_practice_  _Discussion_ _Laryngology_ _Journal_Preproof_0cAs_cases_continue_to_rise_increased_emphasis': 0.0005450251520539939, 'to_rise_increased_emphasis': 0.0005612913089309412, 'dysplasia_transoral_injection_laryngoplasty': 0.0006313632619292757, 'treatment_\\x9cIndications': 9.148819220060914e-58, 'hemoptysis_odynophagia_conditions\\x9d': 9.148819220060914e-58, 'reduction_hemoptysis_odynophagia_conditions\\x9d_should_ _take_ _place_ _in_ _negative_ _pressure_ _rooms_ _if_ _possible_   _with_avoidance_ _of_ _topical_ _lidocaine_ _spray_ _although_ _other_ _groups_ _recommend_ _administration_ _of_ _a_topical_anesthetic_to_theoretically_decrease_the_coughsneeze_reflex_unpublished_online_chats_ _A_ _substitute_ _to_ _standard_ _aerosolized_ _anesthesia_ _may_ _be_ _pledgets_ _soaked_ _in_   _lidocaine_ _and_Journal_Preproof_0c_ _oxymetazoline_ _using_ _videolaryngoscopy_ _whenever_ _possible_ _to_keep_ _the_ _practitioner_ _and_ _the_ _patient_ _farther_ _apart_ ': 3.459195799446709e-05, 'should_ _take_ _place_ _in_ _negative_ _pressure_ _rooms_ _if_ _possible_   _with_avoidance_ _of_ _topical_ _lidocaine_ _spray_ _although_ _other_ _groups_ _recommend_ _administration_ _of_ _a_topical_anesthetic_to_theoretically_decrease_the_coughsneeze_reflex_unpublished_online_chats_ _A_ _substitute_ _to_ _standard_ _aerosolized_ _anesthesia_ _may_ _be_ _pledgets_ _soaked_ _in_   _lidocaine_ _and_Journal_Preproof_0c_ _oxymetazoline_ ': 0.0007956673215405282, 'using_ _videolaryngoscopy_ _whenever_ _possible_ _to_keep_ _the_ _practitioner_ _and_ _the_ _patient_ _farther_ _apart_ ': 0.0004576368763948737, 'laryngoscopes': 5.648096362206708e-07, 'PPE_N95_mask_powered': 0.0018006682651940404, 'laryngoscopy': 3.187781776562203e-51, 'to_ _allow_ _visualization_ _of_ _the_ _larynx_   _Additionally_ _universal_ _masking_ _is_encouraged_in_all_clinical_spaces_in_accordance_with_many_state_policies_ _Patients_in_the_waiting_rooms_ _are_ _encouraged_ _to_ _physically_ _distance_ _or_ _wait_ _in_ _their_ _car_ _for_ _a_ _phone_ _call_ _prior_ _to_presenting_for_their_appointment_ _Crosby_also_suggests_offering_personal_protective_equipment_for_ _the_ _friends_ _and_ _family_ _accompanying_ _the_ _patient_ _during_ _laryngoscopy_   _and_ _other_ _sites_prevent_friends_and_family_from_accompanying_patients_inside_for_the_visit_Some_alternatives_to_flexible_laryngoscopy_have_been_raised_including_transcervical_laryngeal_ultrasound_which_has_a_reported_concordance_of_ _in_identifying_vocal_fold_motion_abnormalities_  _Another_ _key_ _consideration_ _for_ _the_ _laryngologist_ _in_ _the_ _COVID19_ _era_ ': 6.697518671218648e-51, 'Crosby': 9.148819220060914e-58, 'offering_personal_protective_equipment_for_ _the_ _friends_ _and_ ': 9.148819220060914e-58, 'friends_family': 0.0003373197309518599, 'Laryngoscope_turnover': 9.148819220060914e-58, 'disinfection': 9.148819220060914e-58, 'number_changeshour': 0.00040928894108187346, 'turnover_time': 2.3483810197144796e-06, 'to_ _purify_ _the_ _air_ _with_   _efficiency_ _which_ _may_ _be_ _either_   _minutes_ _or_   _minutes_depending_on_the_level_ _of_air_turnover_or_could_be_no_additional_time_if_any_additional_HEPA_filtration_ _system_ _and_ _negative_ _pressure_ _has_ _been_ _added_   _Limited_ _data_ _exists_ _to_ _support_ _this_approach_for_SARSCoV2_   _Laryngology_patients_are_quite_diverse_with_respect_to_their_level_of_acuity_Some_patients_require_more_ _urgent_ _intervention_ _while_ _others_ _may_ _have_ _their_ _care_ _deferred1221_ _Most_ _guidelines_advocate_ _for_ _a_ _tiered_ _approach_ _to_ _ramping_ _up_ _both_ _clinicbased_ _and_ _surgical_ _activity_   _The_American_Academy_of_Otolaryngology_published_guidelines_for_ramping_up_clinical_activity_on_May_  ': 0.00210348072096923, 'care_deferred1221': 0.00023791614304068028, 'AAO': 9.148819220060914e-58, 'limiting_patient_care_to_individuals_with_\\x9ctimesensitiveurgent_and_emergent_medical': 9.148819220060914e-58, 'Urgent_conditions': 1.1686951820486561e-54, '\\x9cimpending_airway_obstruction_due_to_infection_neoplasm_stenosis_foreign_body\\x9d_which_may_Journal_Preproof': 8.263922883666513e-55, '\\x9cmoderate_impending_obstruction_dysphonia_dysphagia': 8.263922883666513e-55, 'incompetence_toilet\\x9d': 9.148819220060914e-58, 'carcinoma_carcinoma_dysphagia\\x9d': 9.148819220060914e-58, 'Botox_injection\\x9d': 0.0038806204677737646, 'concerts': 6.375194495095285e-05, 'point_to_live_singing_as_being_a_potential_source_of_massive_spread_  ': 0.0039051893242254936, 'to_live_singing_as_being_a_potential_source_of_massive_spread_  ': 0.0018006682651940404, 'to_recover_from_hospitalizations_related_to_COVID19': 0.001845170519318405, 'Preoperative_Journal': 0.0007862569594425692, 'Lei_et_al': 0.0004878871533131428, 'preoperative': 0.0007959416758056306, 'test_48hrs': 0.00023791614304068028, 'to_have_the_highest_aerosol_generating_burden_  _It_is_recommended_that_intubation_be_performed_by_ _the_ _most_ _experienced_ _practitioner_ ': 0.0038806204677737646, 'intubation': 0.00034859463291702194, 'delaying_intubation_in_favor_of_noninvasive_means_of_ventilation': 0.00023791614304068028, 'cannula': 0.0006313632619292757, 'to_favor_open_tracheostomy_ _over_ _percutaneous_ _tracheostomy_   ': 0.0018006682651940404, 'to_ _increase_ _efficiency_ ': 0.0038806204677737646, 'safety_checklist': 8.712655419520022e-05, 'performing_tracheostomy_in_ _the_ _ICU_ _whenever_ _possible_ _decreasing_ _the_ _number_ _of_ _personnel_ _in_ _the_ _room_ _and_having_ _a_specific_ _tracheostomy_ _bundle_ _in_ _the_ _ICU_ _room_ _to_ _decrease_ _the_ _number_ _of_ _times_ _providers_ _and_nurses_need_to_break_scrub_to_leave_the_room_They_also_recommend_donning_inner_gloves_prior_to_gown_and_outer_gloves_after_donning_gown_to_maintain_clean_inner_gloves_for_the_removal_and_Journal_Preproof_0cdisposal_ _of_ _the_ _rest_ _of_ _the_ _PPE_ _Two_ _universally_ _agreed_ _upon_ _maneuvers_ _include_ _stopping_ventilation_prior_to_entrance_into_the_airway_and_holding_ventilation_until_after_the_tracheostomy_tube_cuff_has_been_inflated': 0.0006315314916528435, 'tracheostomy': 3.193799046590178e-05, 'to_break_scrub_to_leave_the_room_They_also_recommend_donning_inner_gloves_prior_to_gown_and_outer_gloves_after_donning_gown_to_maintain_clean_inner_gloves_for_the_removal_and_Journal_Preproof_0cdisposal_ _of_ _the_ _rest_ _of_ _the_ _PPE_ ': 3.193799046590178e-05, 'donning_inner_gloves_prior_to_gown_and_outer_gloves_after_donning_gown_to_maintain_clean_inner_gloves_for_the_removal_and_Journal_Preproof_0cdisposal_ _of_ _the_ _rest_ _of_ _the_ _PPE_ ': 0.00028569540831235814, 'tracheostomy_to_break_scrub_to_leave_the_room_They_also_recommend_donning_inner_gloves_prior_to_gown_and_outer_gloves_after_donning_gown_to_maintain_clean_inner_gloves_for_the_removal_and_Journal_Preproof_0cdisposal_ _of_ _the_ _rest_ _of_ _the_ _PPE_ _stopping_ventilation_prior_to_entrance_into_the_airway_and_holding_ventilation': 1.5112888183293684e-05, 'stopping_ventilation_prior_to_entrance_into_the_airway_and_holding_ventilation': 3.193799046590178e-05, 'Givi_colleagues': 1.0313068720503174e-05, 'tracheotomy': 9.148819220060914e-58, 'to_decrease_the_spread_of_aerosolized_particles': 9.148819220060914e-58, 'H2O_pressure': 4.881637558849666e-05, 'delaying_the_timing_of_tracheostomy_until_ _days_after_onset_of_symptoms_when_ _feasible_ _Finally_ _some_ _have_ _advocated_ _for_ _the_ _use_ _of_ _specific_ _air_ _containment_ _setups_including_plastic_draping_smoke_evacuator_tubing_or_specifically_designed_negative_pressure_box_  _The_field_of_laryngology_has_had_to_undergo_significant_change_in_the_setting_of_the_COVID_ _pandemic_As_the_numbers_of_COVID19_patients_have_continued_to_increase_during_the_month_of_June_ ': 0.0004576368763948737, 'pressure_box': 0.000347488144371561, 'to_undergo_significant_change_in_the_setting_of_the_COVID_ _pandemic_As_the_numbers_of_COVID19_patients_have_continued_to_increase_during_the_month_of_June_ ': 1.0689756691710107e-05, 'to_increase_during_the_month_of_June_ ': 0.0002584379969449155, 'to_ _be_ _carefully_ramped_up_to_protect_patients_and_providers': 3.207862124869787e-05, 'to_relax_restrictions_on_flexible_laryngoscopy_and_other_AGPs': 0.0007080023910910008, 'to_evolve_as_more_ _information_ ': 7.05029712940268e-05, 'delays': 0.0018895322652183342, 'that_ _delaying_ _cancer_ _surgery_ ': 8.263922883666513e-55, 'outcomes_morbidity': 1.1686951820486561e-54, 'Additionally_delays': 8.263922883666513e-55, 'Desai_colleagues': 0.0007862569594425692, 'Additionally_patients': 9.148819220060914e-58, 'to_ _have_ _a_ _higher_ _rate_ _of_severe_events': 9.148819220060914e-58, 'stage_Cancer_patients': 9.148819220060914e-58, 'have_a_higher_predisposition_to_death_  _Head_ _and_ _neck_ _cancer_ _patients_ _especially_ _are_ _considered_ _a_ _highrisk_ _population_ _for_complications_associated_with_COVID19_infection8_making_safe_coordination_of_care_difficult_but_ _imperative_   _Head_ _and_ _neck_ _cancer_ _patients_ _are_ _an_ _atrisk_ _group_ _for_ _a_ _number_ _of_ _reasons_Silverman_ _points_ _out_ _that_ _head_ _and_ _neck_ _cancer_ _patients_ _tend_ _to_ _present_ _with_ _advanced_ _age_history_ _of_ _tobacco_ _and_ _alcohol_ _abuse_ _and_ _cardiac_ _and_ _pulmonary_ _comorbidities_ _which_ _are_similarly_ _found_ _in_ _COVID19_     _Risk_ _of_ _respiratory_ _sequelae_ _in_ _patients_ _who_ _have_ _received_chemotherapy_ _andor_ _radiation_ _therapy_ _are_ _high_ _with_ _increased_ _rates_ _of_ _dysphagia_ _aspiration_and_ _pneumonia_   _Additionally_ _head_ _and_ _neck_ _cancer_ _patients_ _have_ _an_ _increased_ _risk_ _of_respiratory_infections_and_aspiration_pneumonitis_  _These_factors_may_expedite_deterioration_to_Journal_Preproof_0csevere_adverse_events_in_patients_with_COVID19_ ': 9.148819220060914e-58, 'head_cancer_patients': 0.0007864664894503318, 'are_ _high_ _with_ _increased_ _rates_ _of_ _dysphagia_ _aspiration_and_ _pneumonia_   ': 1.2833264574456584e-05, 'andor_radiation_therapy': 0.0011075402231842013, 'function_malnutrition_age': 0.001845170519318405, 'difference41_Correspondingly': 0.001845170519318405, 'difference41_Correspondingly_mortality_to_bear_some_of_the_gross_inequities_within_the_American_health_care_ _system_ _need_burden_cost_levels': 2.2480340991203723e-51, 'to_bear_some_of_the_gross_inequities_within_the_American_health_care_ _system_ ': 3.961866732544363e-05, 'burden_cost_levels': 0.001845170519318405, 'insurance_coverage': 0.0011075402231842013, 'laryngology_Providers': 8.263922883666513e-55, 'to_ _take_ _universal_ _precautions_ _regardless_ _of_ _the_ _patient\\x99s_COVID_ _status_   ': 1.1686951820486561e-54, 'fiberoptic_laryngoscopy': 8.263922883666513e-55, 'workarounds': 0.0002737940764806342, 'reconstruction_Telemedicine': 0.0015842910551982499, 'Telemedicine': 0.0015842910551982499, 'Dharmarajan_colleagues': 0.0005741125271172155, 'to_ _continue_ _the_ _virtual_ _multidisciplinary_ _format_ _once_ _in_ _person_ _meeting_ _restrictions_ ': 0.0013882295497307361, 'guidelines_list': 1.1686951820486561e-54, 'head_neck_cell_carcinomas_cancer_thyroid_cancer_skin_cancers': 8.263922883666513e-55, 'parathyroid_carcinomas': 9.148819220060914e-58, 'lowrisk_procedures': 9.148819220060914e-58, 'pathology_disease': 8.263922883666513e-55, 'Ranasinghe_colleagues': 0.0005741125271172155, 'considering_ _alternatives_ _to_ _longduration_ _microvascular_reconstructive_ _cases_   _It_ _is_ _recommended_ _that_ _the_ _focus_ _shift_ _to_ _simplifying_ _reconstruction_ _and_Journal_Preproof_0creducing_surgical_duration_when_it\\x99s_feasible_and_appropriate': 0.0005450251520539939, 'focus_shift': 5.1032212345557034e-05, 'take_precedent_  ': 0.0005741125271172155, 'Endocrine_surgery': 9.148819220060914e-58, 'Ashok_Shaha': 9.148819220060914e-58, 'to_weigh_the_pros_and_cons_of_elective_and_essential_surgery_in_the_midst_of_ _the_ _pandemic_ _some_ _authors_ _have_ _advocated_ _for_ _creating_ _rating_ _systems_ _to_ _allow_ _for_appropriate_ _surgical_ _triage_ _during_ _periods_ _of_ _limited_ _clinical_ _output_ _and_ _resource_ _reallocation_ _The_medically_necessary_timesensitive_MeNTS_procedures_scoring_system': 4.027827224178787e-05, 'scoring_system_MeNTS_score': 3.012831237073818e-05, 'disease_factors_Likert_scale': 0.0038806204677737646, 'is_approached': 0.00011457825193895318, 'Drug_resistance': 3.1235511726865175e-05, 'cells_A549PTX': 0.0019132930105159865, 'CHL1_overexpression': 8.791944097087223e-05, 'inhibitor_SC66': 3.879067934877452e-05, 'repair_Paclitaxel': 4.942501824099386e-05, 'molecule_CHL1': 0.0015851356325270348, 'CHL1': 0.00013642195481870065, 'to_be_involved_in_carcinogenesis_and_progression_in_a_variety_of_human_cancers_In_esophageal_squamous_cell_carcinoma_ESCC': 2.226903945653633e-06, 'to_investigate_its_potential_role_in_chemoresistanceMaterials_and_methodsData_ _processing_ ': 0.001801148090838322, 'GSE21656_microarray_dataset': 2.9402948113849672e-05, 'H460_cells_DDP\\x91resistant_cells_sample_cell': 0.0014616190772430405, 'repeats_samples_P005_set': 0.0014616190772430405, 'to_determine_the_differen\\x91tially_expressed_genes_in_H460_and': 0.00018049906186689923, 'NSCLC_cell_line': 9.148819220060914e-58, 'H460_cells_DDP\\x91resistant_cells_sample_cell_repeats_samples_P005_set': 9.148819220060914e-58, 'DNAs': 8.589327884000331e-06, 'mix_Thermo_Fisher_Scientific_Inc': 9.148819220060914e-58, 'to_perform_RT\\x91qPCR_using_a_LightCycler480_system': 9.148819220060914e-58, 'qPCR_min': 9.148819220060914e-58, 'cycles_extension': 9.148819220060914e-58, 'to_treat_A549_cells': 0.0003802249829989744, 'to_treat_A549DDP_cells': 0.0003802249829989744, 'to_treat_A549PTX_cells': 0.0003802249829989744, 'using_the_following_equation_Number_of_coloniesnumber_of_seeded_cells_x100Flow_ _cytometry_ ': 0.00046703013980541936, 'using_ _a_ _FITC_Annexin_V_Apoptosis_kit_BD_Pharmingen_BD_Biosciences': 1.880959619757839e-05, 'using_the_following_equation_Number_of_coloniesnumber_of_seeded_cells_x100Flow_ _cytometry_ _using_ _a_ _FITC_Annexin_V_Apoptosis_kit_BD_Pharmingen_BD_Biosciences_using_using_CytEXpert_ _software': 0.0015796088989363396, 'cytometer_Beckman_Coulter_Inc_Data': 9.148819220060914e-58, 'using_CytEXpert_ _software': 9.148819220060914e-58, '0cONCOLOGY': 1.1060871878653409e-07, 'using_the_Piercetm\\x84¢_BCA_Protein_Assay_kit_cat_no_ _Thermo_Fisher_Scientific_Inc_with_bovine_serum_album_as_a_standard_Equal_amount_of_protein_ ': 1.8051253103010116e-09, 'SDS\\x91PAGE_gel': 0.000494595879613311, 'resistance_gene': 0.0004947276920825566, 'Scientific_Inc': 8.070170041890405e-06, 'ProteinTech_Inc': 1.1686951820486561e-54, 'protein_MRP_cat': 8.263922883666513e-55, 'Inc_low\\x91density_lipoprotein': 9.148819220060914e-58, 'LRP_cat': 9.148819220060914e-58, 'cat_ab38449_Abcam_Akt_cat': 8.263922883666513e-55, 'antibodies_using_Image\\x91pro_plus_ _software_Media_Cybernetics_IncAnimal_experiments_The_animal_experiments_were_approved_by_the_Medical_Ethics_Committee_of_Xiangya_Changde_Hospital_approval_no_ _and_were_performed_in_compliance_with_all_regulatory_institutional_guidelines_for_animal_welfare_the_National_Institutes_of_Health_Publications_no_\\x91_ _A_total_of_ _male_BALBc\\x91nu_mice': 4.043307405468055e-05, 'reagent_Protein_expression': 9.148819220060914e-58, 'using_Image\\x91pro_plus_ _software_Media_Cybernetics_IncAnimal_experiments_The_animal_experiments_were_approved_by_the_Medical_Ethics_Committee_of_Xiangya_Changde_Hospital_approval_no_ _and_were_performed_in_compliance_with_all_regulatory_institutional_guidelines_for_animal_welfare_the_National_Institutes_of_Health_Publications_no_\\x91_ _A_total_of_ _male_BALBc\\x91nu_mice': 9.148819220060914e-58, 'humidity_timesh_mice': 0.0003364176984007392, 'iv_CHL1\\x91DDP': 0.0001046564120671734, 'injection_caliper': 0.0005411681930881713, 'SPSS_IBM_Corp': 9.148819220060914e-58, 'to_perform_the_analysis_P005_was_considered_to_indicate_a_statistically_significant_differenceResultsCHL1_is_downregulated_in_A549DDP_and_A549PTX\\x91resistant_cells': 9.148819220060914e-58, 'to_indicate_a_statistically_significant_differenceResultsCHL1_is_downregulated_in_A549DDP_and_A549PTX\\x91resistant_cells': 3.640523727840818e-06, 'CHL1\\x91knockdown': 0.002584158719710537, '2D_cytometry_results': 0.0005521751935137136, 'CHEMOSENSITIVITY_CHL1': 3.28079925958014e-07, 'A549PTX': 3.28079925958014e-07, 'IC50_values_A549_cells_IC50_values_A549_cells_C_blotting': 0.0016810521528134112, 'P005_levels_A549DDP_A549PTX': 9.148819220060914e-58, 'blotting_PCR': 9.148819220060914e-58, 'cytometry_results': 2.474514720031763e-06, 'overexpression_DDP_treatment': 0.0004816809115387495, 'Akt_activity': 2.2274973798337085e-06, 'A549PTX_cells': 2.02138236247974e-05, 'inhibiting_Akt_activity': 0.0010068765747081726, 'to_detect_apoptosis_in_A549_cells_transfected_with_CHL1_siRNA_in_the_presence_or_absence_of_ _µgml_DDP_or_ _ngml': 7.048424814961187e-05, 'overexpression_A549PTX_cells': 3.4125047886926076e-05, 'NSCLC_chemosensitivity': 2.226903945653633e-06, 'Senchenko': 0.003785541346719476, 'cell\\x91matrix_interactions_CHL1_has_an_important_effect_on_the_development_regeneration_and_plasticity_of_the_nervous_system_ _Previous_reports': 6.179555749888942e-05, 'to_promote_cell_proliferation_metastasis_and_migration_in_human_gliomas_ ': 2.226903945653633e-06, 'to_be_upregulated_in_DDP\\x91resistant_cells': 0.0009466755491730313, 'p\\x91Akt': 0.0005523223514578579, 'survival_cell_motility_angiogenesis': 9.009585432209905e-06, 'Akt_inhibitor': 3.6352845257737695e-08, 'ABC_members_mechanisms': 0.0019127833147525456, 'A549PTX_upregulation': 8.791944097087223e-05, 'CHEMOSENSITIVITY_development': 7.725671233982067e-05, 'efficacy_cancer_burden_Engelman_JA_Transformation_radiotherapy': 1.2616332844555826e-06, 'study_XC_BH_YH_PL': 0.0003327007272384309, 'ML_LZ': 0.0014616190772430405, 'XC_ML_LZ': 0.0023312000883646544, 'manuscriptEthics_approval_consent': 0.0007959416758056306, 'efficacy_andor_data_figure_cancer_burden_Engelman_JA_Transformation_radiotherapy': 0.0007959416758056306, 'interestsReferences': 0.0013882295497307361, 'Therapeutic_strategy': 9.148819220060914e-58, '\\x91_   _Cai_Y_Dong_ZY_and_Wang_JY_LncRNA_NNT\\x91AS1': 9.148819220060914e-58, 'YJ_Wang_WJ_Wu_F_Fei_Wang_L_Liang_EMT_phenotype': 0.00023078931020485309, 'Johnston_Translymphatic_chemotherapy': 0.00023078931020485309, 'Qin_Y_Loss': 9.148819220060914e-58, 'tumor_growth_metastasis_deletion_A_reactivity': 9.148819220060914e-58, 'N_Escors_D_hypermethylation': 0.00016553660791656055, 'rez\\x91Janices_Liu_L_Wang_J_Xi_Q_Gu_M': 0.0004961939616263455, 'tumor_growth_invasion_Biochem_Biophys_Commun_\\x91': 8.093362959138646e-06, 'lncRNA_RP11284F219': 2.586668612581389e-05, 'invasion_apoptosis': 7.303892804548776e-05, 'cytometry_blotting_existence_words': 0.0037857249400328717, 'miR6273p_Correspondence_Affiliated_Hospital_Shaanxi_PR_ChinaEmail_wangyuan8003126comAbbreviations': 0.0004990942860418787, 'noncoding_studies': 7.8564382168961e-05, 'lncRNAs_dysfunction': 0.00031308071508461124, 'adenocarcinoma_transcript': 8.263922883666513e-55, 'expression_PROMOTES': 0.0018006682651940404, 'PROLIFERATION_INVASIONis': 0.0004360764270917066, 'NCIH1299_A549': 0.00012094074060835584, 'using_TRIzol_®_reagent_Invitrogen_Thermo_Fisher_Scientific_Inc': 0.00019915147656230243, 'using_the_2Î\\x94Î\\x94Cq_method_Oligonucleotides_and_cell_transfection_The_small_interfering_RNA_siRNA_synthetic_negative_control': 0.0006415376296560972, 'miR\\x91\\x913p_inhibitor': 0.0010365319628419954, 'culture_medium_using_BD_FACS_Canto_II_flow_cytometry_FACS_Calibur_BD_Biosciences_Data_were_analyzed_using_FlowJo_software_version_ _Tree_Star_IncLuciferase_reporter_assay': 0.0011125787591309202, 'miR_small': 9.148819220060914e-58, 'controlSequence': 9.148819220060914e-58, 'using_BD_FACS_Canto_II_flow_cytometry_FACS_Calibur_BD_Biosciences_Data_were_analyzed_using_FlowJo_software_version_ _Tree_Star_IncLuciferase_reporter_assay': 0.0011125787591309202, 'vectors_µgml': 1.2174462718559795e-07, 'miR6273p': 0.00045672628829873744, 'SDS\\x91PAGE': 7.073313665269914e-05, 'ab70243_Abcam': 0.00013356700656843865, 'peroxidase': 8.263922883666513e-55, 'inhalation_flow_rate': 0.0005411681930881713, 'Animal_care_study': 6.762171675894366e-05, 'Target_prediction_target_miRNAs': 0.0001559963661892288, 'using_three_bioinformatics_algorithms_TargetScanV72_httpwwwtargetscanorgvert_72_and_miRDB_httpwwwmirdborgmininghtmlStatistics_analysis': 0.00016941179616561546, 'using_the_GraphPad_Prism_ _software_GraphPad_Software_Inc': 7.098498196691514e-05, 'to_indicate_a_statistically_significant_difference\\\\x0cLI_  _RP11\\x91284F219_PROMOTES_LUNG_CARCINOMA': 3.640523727840818e-06, 'using_RTqPCR_P0001_vs_adjacent_tissues_n13_B_Expression_of_RP11\\x91284F219_in_human_lung_carcinoma_cell_lines_NCIH460_NCIH1299_and_A549_using_RTqPCR_P005_P0001_vs_BEAS\\x912B_n3_LC_lung_carcinoma': 0.0016810521528134112, 'using_RTqPCR_P0001_vs_adjacent_tissues_n13_B_Expression_of_RP11\\x91284F219_in_human_lung_carcinoma_cell_lines_NCIH460_NCIH1299_and_A549': 0.0016810521528134112, 'line_BEAS2B': 9.148819220060914e-58, 'using_RTqPCR_P005_P0001_vs_BEAS\\x912B_n3_LC_lung_carcinoma': 9.148819220060914e-58, 'NCIH1299_A549_normal_cell_line': 0.0016810521528134112, 'RP11284F219': 0.001989239780806775, 'using_CCK\\x91_and_EdU_assays': 0.000404948725608525, 'knocking_down_RP11\\x91284F219': 0.000404948725608525, 'RP11\\x91284F219': 0.0016776913884455683, 'S1The_results': 2.738347816316027e-05, 'to_identify_the_downstream_miRNAs_of_RP11284F219': 0.0038806204677737646, '\\x91UTR': 0.00013207722628676396, 'a_direct_interaction_between_RP11284F219_and_miR6273p_in_which_RP11284F219_suppresses_the_expression_of_miR\\x91\\x913pRP11\\x91284F219_regulates_the_proliferation_and_invasiveness_of_lung_carcinoma_cells_via_miR\\x91\\x913p_To_rescue_the_antitumor_effects_of_siRP11284F219_in_lung_carcinoma': 1.6915525276853782e-05, 'carcinoma_cell_proliferation_invasion_using': 0.0010753992216668597, 'Magnification_x200_P005_P001_control_siRNA_small_miR\\x91NC': 0.000404948725608525, 'interacts': 1.1686951820486561e-54, 'cells_using_RTqPCR_P001_vs_si\\x91NC_n3_miR\\x91\\x913p_expression_in_C_LC_tissues_and_D_NCI\\x91H460_NCI\\x91H1299_and_A549_cells_compared_with_adjacent_healthy_tissues_and_normal_lung_epithelial_cells': 8.263922883666513e-55, 'using_the_DIANA_tools_and_a_luciferase_reporter_assay': 0.004315547045054443, 'using_RTqPCR_P001_vs_si\\x91NC_n3_miR\\x91\\x913p_expression_in_C_LC_tissues_and_D_NCI\\x91H460_NCI\\x91H1299_and_A549_cells_compared_with_adjacent_healthy_tissues_and_normal_lung_epithelial_cells': 8.263922883666513e-55, 'carcinoma_miR\\x91\\x913p_inhibitor': 0.0006054349545841993, 'participation_assay_results': 0.0014616190772430405, 'addition_transfection': 0.001128162151175775, 'CCAR1': 0.0039131780163394626, 'increased_the_expression_of_miR\\x91\\x913p_by_ _times_compared_with_cells_transfected_with_miRNC_Fig_S4After_validating': 0.00028713293471133676, 'CCAR1wt_vector': 4.683200463622141e-06, 'Fig_5C': 0.0016480626375926124, 'using_RT\\x91qPCR_analysis_n3_P005_vs_miR\\x91NC': 6.774125537122278e-06, 'Figure_RP11\\x91284F219': 2.9042198794535054e-05, 'Kit\\x91_assay': 1.1057925109307387e-07, 'EdU_assay': 1.1057925109307387e-07, 'PROLIFERATION_INVASIONFigure_miR\\x91\\x913p': 9.148819220060914e-58, 'CCAR1_analysis': 9.148819220060914e-58, 'n3_P005_CCAR1_expression': 1.8912533917052654e-05, 'using_RT\\x91qPCR_n13_P001_vs_adjacent_tissue_Expression_of_CCAR1_in_NCI\\x91H1299_and_NCI\\x91H460_cells_transfected_with_miR\\x91NC': 0.0003024585624525613, 'miR\\x91\\x913p_mimics': 4.931639171114672e-06, 'decreased': 9.148819220060914e-58, 'function_to_be_a_potential_non\\x91invasive_diagnostic_marker_in_gastric_and_breast_cancer_types_ ': 9.148819220060914e-58, 'to_be_a_potential_non\\x91invasive_diagnostic_marker_in_gastric_and_breast_cancer_types_ ': 2.797763910584555e-05, 'when_upregulated_by_calcitriol_miR627': 9.148819220060914e-58, 'demethylase_Jumonji_domain': 9.148819220060914e-58, 'group_box_protein_effect': 0.0016480626375926124, 'Figure_knockdown': 0.0004815525391610832, 'Using_the_publicly_available_RNA_interaction_prediction': 0.0004815525391610832, 'to_validate_RNA\\x91RNA_interactions_in_previous_studies_ _other_assays_such_as_RNA_pulldown_and_ _RNA_ _binding_ _protein_ _immunoprecipitation_ _that_would_provide_more_direct_evidence_for_the_RNARNA_and': 0.0005715966671738797, 'performedCCAR1': 0.00036240313892865647, 'cooperation_cancer_CCAR1': 9.148819220060914e-58, 'to_be_an_effector_of_Doxorubicin\\x91induced_apoptosis_ ': 9.148819220060914e-58, 'PAX9PAX9_functions': 8.513575047858228e-06, 'to_understand_the_complex_process_of_making_human_ribosomesthe_cellular_machines_critical_for_all_protein_synthesis': 9.642026660524338e-05, 'NationalInstitutes_R01GM115710R01GM122926_R35GM131687': 0.0003167145330801072, 'study_data_collection_analysisdecision_ribosome': 2.8044094937719146e-05, 'DBA_OMIM': 8.263922883666513e-55, 'DBA_patientsoften': 1.4055400435083287e-53, 'type_OMIM': 9.148819220060914e-58, 'mutationsin_POLR1A': 9.148819220060914e-58, 'prerRNA': 7.365719548204603e-09, 'RNA_polymerase_III_RNAPIII': 4.5125688876523415e-07, 'rRNAs': 7.365719548204603e-09, '47S': 9.148819220060914e-58, 'RNA_polymerase': 9.148819220060914e-58, '5S_rRNA': 9.148819220060914e-58, 'III_RNAPIII': 9.148819220060914e-58, 'II_RNAPII': 0.000494595879613311, 'torequiring_all_ _RNA_polymerases_synthesis_and_assembly_of_functional_ribosomes': 0.0010298344840079976, 'Box_PAX9': 2.59357728447526e-05, '101371journalpgen1008967_Box_PAX9': 0.00018140017250851866, 'PAX9': 0.009882348354128045, 'Ribosome_biogenesis_steps': 0.00016144891027906658, '47S_prerRNA': 0.00016553660791656055, 'Ribosomes': 8.342392533184651e-05, 'panel_Nuclei': 2.6339531790446088e-06, 'C_PAX9': 2.6339531790446088e-06, 'D_PAX9': 9.866721018304101e-05, 'SEM_N_Data': 9.148819220060914e-58, 'by2way_ANOVA': 9.148819220060914e-58, 'p_ï¿½_PTP': 9.148819220060914e-58, '47S_45S': 9.148819220060914e-58, 'nontargeting': 1.8585502876341614e-05, 'control_Quantitation': 3.0349201149631797e-07, 'passage_numbers': 0.0016480626375926124, 'Representative_polysome_profile': 9.148819220060914e-58, 'using_siRNAs_targeting_either_PAX9_red_or_a_nontargeting_siNT_blue_control': 9.148819220060914e-58, 'Pax9_mice': 8.263922883666513e-55, 'to_identify_the_signaling_pathways_regulated_by_PAX9_attempts_to_correct_the_developmental_defects': 0.0005479687540571566, 'PAX9_biogenesis': 8.263922883666513e-55, 'protein_synthesisWe': 2.6339531790446088e-06, 'mRNAsincluding_several_ribosomal_proteins': 8.263922883666513e-55, 'to_model_this_disease_in_Xenopus_tropicalis_X_tropicalis_embryos': 0.007713134335009549, 'processing_light': 8.263922883666513e-55, 'PAX9_connections': 0.0016810521528134112, 'ribosome_biogenesisResultsPAX9': 4.233022320834587e-07, 'subunit_ribosome': 0.00011931918217645773, 'siRNA_screen': 0.007713134335009549, 'PAX9_S1A_Fig': 0.0011125787591309202, 'PAX9_S1A': 5.407408612569724e-06, 'to_quantify_the_number_of_nucleoli_per_cellnucleus_which_shifted_from_\\x93_in_siGFP_control_cells_to_only_ _in_siPAX9_and_siUTP4treatedcells_We_had_previously_used_oligonucleotide_deconvolution_to_additionally_confirm_thatPAX9_depletion_leads_to_reductions_in_nucleolar_number': 0.00019664267814428865, 'Using_this_approach_individualdepletion_of_PAX9_using_ _of_the_ _siRNAs_from_the_original_PAX9_pool': 8.83695321642157e-08, 'transcription_factorWe': 9.148819220060914e-58, 'to_investigate_the_extent_to_which_PAX9_depletion_affects_human_ribosome_biogenesis_using_a_panel_of_ _assays_The_first_assay_probes_PAX9\\x99s_role_in_RNAPI_transcriptionusing_a_dualluciferase_reporter_system_previously_published_by_our_laboratory_and_others': 9.148819220060914e-58, 'PAX9_depletion': 0.0004665568159929012, 'targeting_PAX9': 0.001128162151175775, 'Mock_used': 0.0003631075583458118, 'Fig_1D': 0.0010298344840079976, 'processing_intermediates': 9.148819220060914e-58, 'transcript_andright_S2_Fig_Quantitation': 9.148819220060914e-58, 'SSU_biogenesis': 0.0007081910728315311, '18S_rRNAWe': 0.0038806204677737646, 'blottingfor': 9.148819220060914e-58, 'puromycin_shows': 9.148819220060914e-58, 'PAX9_depletion_results': 1.155393675369606e-05, 'ribosome_biogenesisRNAseq': 0.00016136288101054375, 'Pathway_Analysis': 2.2701729080912007e-06, 'RNAseq_transcriptomics_analysis': 0.0006681652127777817, 'mRNAsare': 0.0008522036149147152, 'siNT_PAX9depletion': 1.8714757582642377e-08, 'qRTPCR_using_primers_to_each_target_gene_relative_to_a_7SLcontrol': 0.0008522036149147152, 'siNT_Data': 9.148819220060914e-58, 'qRTPCR_using_primers_to_each_target_gene_relative_to_a_7SLcontrol_Oneway_ANOVA': 9.148819220060914e-58, 'SEM_Three': 9.148819220060914e-58, 'using_cells_of_different_passage_numbers_with_ _technical_replicates_each_wereperformed_Significance': 9.148819220060914e-58, 'SEM_N_Datawere': 9.148819220060914e-58, 'using_2way_ANOVA_in_GraphPad_Prism': 9.148819220060914e-58, 'p_ï¿½_Quantitation_relative': 0.0016480626375926124, 'siNT_nontargeting_siRNAs': 9.148819220060914e-58, 'signaling_differentialexpression_of_ _pathway_members': 9.148819220060914e-58, 'controls_G_Quantitation': 0.0011125787591309202, 'SEM_N_Significance': 0.00011026011152073265, 'enrichmentanalysis': 0.0002788738900395108, 'PAX_proteins': 0.00045577330845430737, 'DNA_sequence': 7.433506914544292e-06, 'knownroles': 0.00012040101594931771, 'S1_TableTo': 0.00046345855666667525, 'candidatesfrom_the_RNAseq_dataset_to_follow_up_on_in_greater_detail_The_mRNA_levels_for_the_ _candidates_were_all_downregulated_after_PAX9_depletion_and_all_code_for_nucleolar_proteins': 0.007713134335009549, 'theRNAseq_results': 0.00019338140904154145, '30Sincrease_characteristic': 0.00013588610209050726, 'synthesisRNAPII_ChIPseq_analysis': 0.0003631075583458118, 'to_map_how_RNAPII_distributes_on_genes_using_RNAPIIChIPseq_as_a_readout_of_transcription_Through_this_approach_we_aimed_to_untangle_the_effectsof_PAX9_depletion_on_RNAPII_transcription_from_its_effects_on_mRNA_stability_since_RNAPIIChIPseq_is_able_to_detect_genomewide_changes_in_RNAPII_occupancy_As_PAX_proteins_areable_to_both_activate_and_repress_target_protein_expression': 0.007713134335009549, 'to_untangle_the_effectsof_PAX9_depletion_on_RNAPII_transcription_from_its_effects_on_mRNA_stability_since_RNAPIIChIPseq_is_able_to_detect_genomewide_changes_in_RNAPII_occupancy_As_PAX_proteins_areable_to_both_activate_and_repress_target_protein_expression': 0.007713134335009549, 'RNAPII_occupancy': 7.522221639843822e-11, 'change_cutoff_MaxTags_S2_Table': 1.226444765360687e-12, 'CentriMo': 0.007713134335009549, 'PAX5_DNAbinding_motifs': 6.576796517606881e-06, 'thatthis_dataset': 3.679367396913154e-08, 'to_detect_changes_in_the_RNAPIImediated_transcription_of_a_number_of_mRNAs_encoding_nucleolar_proteins_after': 0.007713134335009549, 'collection_to_be_conducive_to_assess_the_suitability_of_these_samples_in_downstreammolecular_techniques': 0.0023576546201282966, 'to_be_conducive': 8.263922883666513e-55, 'Micropterus_dolomieu_liver': 9.148819220060914e-58, '®_PG': 9.148819220060914e-58, 'to_assess_the_suitability_of_these_samples_in_downstreammolecular_techniques': 0.0007095919825356841, 'to_optimize_the_methods_presented_here_for_different_tissue_types_fish_species_and_pathological_conditions_ _ACCESSCitation_Walsh_HL_Sperry_AJ_Blazer_VS_The_effects_of_tissue_fixation_on_sequencing_andtranscript_abundance_of_nucleic_acids_frommicrodissected_liver_samples_of_smallmouth_bassMicropterus_dolomieu_ _e0236104_101371journalpone0236104Editor_Rajakumar_Anbazhagan_National_Instituteof_Child_Health_and_Human_Development_NICHDNIH_UNITED': 0.0018006682651940404, 'modified': 9.148819220060914e-58, 'Availability_Statement': 9.148819220060914e-58, 'theUSGS_Contaminant_BiologyProgram_Program_MissionAreas': 0.0006313632619292757, 'ONE_interests': 6.715229150406811e-50, 'interests_existEffects': 9.148819220060914e-58, 'to_identify_adverse_effectsof_human_activities_on_aquatic_resources_[_\\x93_]_The_recognition_that_there_are_numerouschemical_contaminants_environmental_stressors_as_well_as_new_and_emerging_pathogensparasites_cooccurring_has_led_to_an_emphasis_on_biological_environmental_effectsbased_assessments_utilizing_resident_indicator_fish_species_or_caged_model_species_[_\\x93_]_Histopathologyhas_been_used_for_many_years_to_assess_the_health_of_wild_fishes_both_for_specific_studies_as_wellas_part_of_effectsbased_monitoring_programs_[_\\x93_]_More_recently_genomic_endpoints_arealso_being_incorporated_into_environmental_monitoring_and_risk_assessment_[_\\x93_]_Whenboth_histopathology_and_molecular_analyses_are_part_of_an_assessment_pieces_of_a_tissue_arecommonly_preserved_in_ _buffered_formalin_or_a_similar_preservative_and_adjacent_separatepieces_are_preserved_in_RNAlater1_ _ethanol_or_frozen_for_molecular_analyses': 9.148819220060914e-58, 'degrade': 2.8533183495764488e-05, 'tissues_tissues': 0.007778603169591112, 'extraction_methods': 1.930263139624845e-05, 'Laser': 9.148819220060914e-58, 'microdissection_LCM': 9.148819220060914e-58, 'nucleicacids': 9.148819220060914e-58, 'Thisallows': 9.148819220060914e-58, 'PAXgene1_Tissue_Systemwas': 9.148819220060914e-58, 'to_improve_tissue_quality_for_parallel_molecular_and_morphological_analyses': 9.148819220060914e-58, '0cEffects': 6.715229150406811e-50, 'US_Geological': 0.0007956673215405282, 'completion_tissues': 9.148819220060914e-58, 'tohardenTissues': 9.148819220060914e-58, 'andallows_RNA': 0.004315547045054443, 'Tissue_Kit': 9.148819220060914e-58, 'to_extract_DNA_from_LCMsamples': 9.148819220060914e-58, 'TechnologiesFor': 0.0003309404805354376, 'suitability': 9.148819220060914e-58, 'PCRPLOS': 9.148819220060914e-58, 'bp_ladder_Amplicons': 4.86668803754646e-08, 'sequencing_reactionswith_the_Applied_Biosystems_BigDye_Terminator_v31_Cycle_Sequencing_Kit_Product_ _Thermo_Fisher_Scientific_for_ _cycles_of_Ë\\x9aC_for_ _min_Ë\\x9aC_for_ _s_Ë\\x9aC_for_ _sand_Ë\\x9aC_for_ _min': 2.9769417529023125e-06, 'amplicons': 0.00018258741165038124, 'percentage_to_determine_sequence_similarityto_the_Micropterus_spp_EF1Î±_gene_HQ4248721_or_KT8277941NanoString_nCounter1_Technology_was_used_with_a_Custom_CodeSet_that_targeted_transcripts_expressed_in_the_liver_of_smallmouth_bass_as_described_in_Hahn': 8.198185194464105e-05, 'to_determine_sequence_similarityto_the_Micropterus_spp_EF1Î±_gene_HQ4248721_or_KT8277941NanoString_nCounter1_Technology_was_used_with_a_Custom_CodeSet_that_targeted_transcripts_expressed_in_the_liver_of_smallmouth_bass_as_described_in_Hahn': 8.263922883666513e-55, 'nCounter1platform': 0.00014763345632963333, 'onewayANOVA': 9.148819220060914e-58, 'comparison_posthoc_analysis': 9.148819220060914e-58, 'transcript_abundance_data': 0.001129870936471824, 'A_KruskalWallis_test': 9.148819220060914e-58, 'to_identify_differences_amongst_each_fixative_for_each_fixationtime_and_the_template_concentration_used_for_PCR_the_Q40_score_and_sequence_lengthobtained_with_Sanger_sequencing_Finally_Spearman\\x99s_rank_correlation_analyses_werePLOS_ONE_ ': 9.148819220060914e-58, 'rank_correlation': 9.148819220060914e-58, 'werePLOS_ONE': 9.148819220060914e-58, 'Liver_samples': 9.623930537852086e-05, 'concentrationsthan_samples': 9.623930537852086e-05, 'times_concentrations': 1.1176735774867664e-06, 'Pvalue_samples': 9.148819220060914e-58, 'quality_RIN_values': 9.148819220060914e-58, '0cEffects_EF1Î±_gene': 0.0005915726387590047, 'PG': 0.00024810373354211296, 'quality_sequences': 0.0006030236714318566, 'to_sequence_These_included_one_of_the_ETOH_samples_forward_and_reverse_sequences_three_NBF_ _day_samples_forward_sequences_oneNBF_seven_day_sample_forward_and_reverse_sequences_two_PG_seven_day_samples_forwardsequences_one_PG_ _day_sample_forward_sequence': 0.0006030236714318566, 'theFig': 0.00015741720099793, 'PG_samples': 9.148819220060914e-58, 'leastamount_hr': 9.148819220060914e-58, 'greatestnumber': 0.00210348072096923, 'PCR_primers': 9.148819220060914e-58, 'to_produce_an_amplicon_size_around_ _bp_manysequences': 9.148819220060914e-58, 'length_remainedsignificant_pvalue_template_concentration': 9.148819220060914e-58, 'length_percentage': 9.148819220060914e-58, 'Sanger_sequencing_NCBI_blastn': 4.2393694076093277e-05, 'KruskalWallis_test': 9.148819220060914e-58, 'to_identify_significant_differences_between_fixation_times_and_template_concentration_percentage_of_baseswith_a_Q40_score_or_greater_and_sequence_length_for_each_fixative_Table': 9.148819220060914e-58, 'nCounter1_results': 9.148819220060914e-58, 'occurrences_transcriptsat_days_protein_Protein_Dayspvalue_DayspvalueZ': 9.148819220060914e-58, 'sampleswith': 9.148819220060914e-58, 'transcripts_hr_amongsthousekeeping_transcripts': 9.148819220060914e-58, 'housekeeping_transcripts': 0.0016480626375926124, 'prescription_opioids': 0.0011075402231842013, 'study_Participants': 9.148819220060914e-58, 'sub_group': 9.148819220060914e-58, 'to_follow_up_with_their_primary_care_physician_Participants': 0.0007959416758056306, 'disease_andorhave_diabetes': 4.828435443707586e-05, 'care_management': 7.878617942784764e-07, 'management_intervention': 9.148819220060914e-58, 'identification_treatment': 9.148819220060914e-58, 'adults_Patients': 0.00024391624357961202, 'risks_death': 3.9771147627548414e-06, 'STOPBang_sleep_questionnaire': 0.00021513839407779188, 'to_have_a_greater_likelihood_of_developing_central_sleepapnea_which_worsens_the_severity_of_OSA_and_ataxic_breathing': 0.00018750364596568773, 'hyperalgesia': 0.0038806204677737646, 'sleep_disorders_shortage': 8.937521195812353e-05, 'ONE_0cIdentification_treatment': 6.715229150406811e-50, 'Brief_interventions': 0.00024784637831511895, 'empathy_tool': 0.001845170519318405, 'investigation_arm': 9.148819220060914e-58, 'opioid_use': 9.148819220060914e-58, 'theintervention': 3.0624865850302326e-06, 'study_group_prepost_intervention': 0.00039211751110906017, 'Healthcare_Consent': 9.148819220060914e-58, 'to_identify_a_historical_yet_contemporary_United_States_based_control_group_that_had_Obstructive_Sleep_Apnea_and_met_theinclusion_criteria_of_being_ï¿½_ _years_old_and_were_taking_a_daily_dose_of_opioids_The_controlthat_was_chosen': 9.148819220060914e-58, 'Sleep_Apnea': 0.004315547045054443, 'theinclusion_criteria': 0.004315547045054443, 'camefrom_a_study_that_lasted': 9.194124291429792e-05, 'SubjectsEach_participant': 9.148819220060914e-58, 'information_gathering_session': 9.148819220060914e-58, 'STOPBang': 0.0052107668578490396, 'Participant': 1.284690556057437e-52, 'decisions_treatment101371journalpone0237359g002PLOS': 7.417164383651313e-53, 'polysomnography': 0.0005576635647612046, 'workup': 0.0005573368904834178, 'end_stage': 7.417164383651313e-53, 'inperson_education': 7.417164383651313e-53, 'to_follow_up_with_their_primary_care_physician_All_primary_care_providers_were_made_aware_they_would_receive_electronic_data_onSTOPBang_questionnaires_and_participants_with_scores_ï¿½_ ': 0.0005573368904834178, 'score_greaterthan': 0.0011075402231842013, 'inperson_followup_appointments': 5.973401273075715e-05, 'to_use_the_FRAMESmethod': 0.004315547045054443, 'interaction_concerns': 5.186508369664841e-06, 'DAgostinoPearson_test': 9.148819220060914e-58, 'to_confirm_normality': 9.148819220060914e-58, 'variance_ttesting': 9.148819220060914e-58, 'to_compare_Age_BMI_and_Morphine_EquivalentDaily': 9.148819220060914e-58, 'Ztesting': 1.0905524118621054e-05, 'to_compare_the_control_group_daily_opioiduse_with_OSA_to_the_participants_in_the_intervention_group_with_OSA_on_CPAP_or_at_highrisk_for_OSA_STOPBang_ï¿½_ _with_regards_to_CPAP_use_Race_Gender_Diabetes_Cardiovascular_Disease_and_Hypertension_Two_proportion': 1.7809625655855588e-07, 'to_compare_the_participants_not_likely_to_have_OSA_STOPBang_ ': 1.7809625655855588e-07, 'OSA_STOPBang': 9.097766261529474e-06, 'to_compare': 0.00011043820777729121, 'use_prepost_intervention': 9.148819220060914e-58, 'ONE_0cIdentification_treatment_teamIRB': 9.148819220060914e-58, 'formsp': 0.0006264573400700461, 'p00001_Cardiovascular_Diseasep_Diabetes': 2.7292139634810088e-05, 'p_  _Race_Caucasian_p_  _Benzodiazepine_Use_p_ _Pregabalin_Use_p_  _and_Active_Chronic_Disease_States_Gastroesophageal_Reflux_p_ _Chronic_Kidney_Disease_ _Thyroid_Disease_p_  _and_Pulmonary_Diseasep_  ': 0.0006264573400700461, 'DailyOpioid_Use': 9.148819220060914e-58, 'mgdat_Conclusion_Pvalue_Average_Number': 9.148819220060914e-58, 'teambased_care': 9.148819220060914e-58, 'outcome_fact': 9.148819220060914e-58, 'apnea_participants': 0.00046703013980541936, 'CPAP': 0.0011075402231842013, 'management_approach': 0.004315547045054443, 'sleep_treatment': 0.0005573368904834178, 'CPAP_ï¿½': 0.0013882295497307361, 'to_be_nonadherent': 0.0013882295497307361, 'aherd_mentality': 0.0019127833147525456, 'mimicked_the_experimental_group_in_most_ways_daily_opioid_use_MEDD_race_age_andpercentages_of_diabetes_hypertension_and_cardiovascular_disease_it_varied_in_both_BMI_controlgroup': 9.194124291429792e-05, 'alower_BMI': 0.0038806204677737646, 'differentstudy': 9.148819220060914e-58, 'increase_another': 9.148819220060914e-58, 'Fig_Patients': 8.263922883666513e-55, 'followup_appointment': 1.1686951820486561e-54, 'notto': 8.263922883666513e-55, 'enblock': 0.00013187602593878607, 'education_to_be_compliant_to_CPAP': 0.000509146657658148, 'to_sufferfrom_OSA_and_ _of_patients': 0.00015266313713209798, 'to_be_compliant_to_CPAP': 5.973401273075715e-05, 'theadministration': 0.004315547045054443, 'Ionita_RN_Risk': 9.148819220060914e-58, 'ONE_0cIdentification_treatment_DMD_Primary_care_Journal_\\x93_101111j15264637200700343x': 9.148819220060914e-58, 'pain_analgesics': 9.148819220060914e-58, 'PMID_Crispiana_\\x9cOpioids': 9.148819220060914e-58, 'PMID_Liang_Y_Turner_B_Assesing_Risk': 9.148819220060914e-58, 'PMID_Heejin_Kim_Treatment_Outcomes_Compliance': 9.148819220060914e-58, 'HCMeserve_Exercise_influences_impactof': 0.0003608303843934633, 'role_effects': 2.8044094937719146e-05, 'pollutants_endocrine_disruptorsharmfully': 2.3834955310101007e-05, 'Thisbroad_influence': 0.000332193218693602, 'to_accelerate_wound_healing': 2.8044094937719146e-05, 'Interleukin6_IL6_granulocytemacrophage_colony': 8.263922883666513e-55, 'role_implications_to_accelerate_wound_healing_effects_effects_animals': 1.1686951820486561e-54, 'content_Results': 8.263922883666513e-55, 'PCB_exposure_exercise_patterns': 8.025576082628504e-05, 'IL1concentrations': 5.439271355978494e-06, 'Exercise': 0.0017164685572438566, 'PCB_exposure': 1.4230591665472239e-05, 'to_cause_carcinogenecity_genotoxicity_reproductive_toxicity_and_immunological_effects': 2.3234799840901345e-07, 'Exposure': 0.0011193623975945081, 'to_have_immunotoxic_effect_and_to_impair_the_functioning_of_severalimmune_responsive_cells': 1.8268868228345713e-05, 'PCB': 0.00047546325754142934, 'woundhealing': 7.989357307103668e-06, 'response_curve': 0.0007008712380191807, 'beneficialeffects': 0.0007008712380191807, 'intensity_exercisehas': 9.148819220060914e-58, 'to_provide_beneficial_effects_retarding_development_of_various_chronic_conditions_like_cardiovascular_disease_atherosclerosis_and_chronic_inflammation': 9.148819220060914e-58, 'to_have_delayed_wound_healing_Moderate_intensityexercise_in_these_animals_healing_rates': 0.00130749474453686, 'to_have_delayed_wound_healing_Moderate_intensityexercise_in_these_animals': 0.00017933259336108505, 'healing_rates': 0.001128162151175775, 'concentrations_cytokines': 0.0005915726387590047, 'cells_cytokines': 0.0002892179326628974, 'wound_healing_especially_in_aged_animals': 0.00038131906457456664, 'to_decrease_in_aged_mice': 0.0003802249829989744, 'Howeverthis_study': 0.0010068765747081726, 'species_PCB_administration': 9.148819220060914e-58, 'wound_healing_allograft_rejection': 9.148819220060914e-58, 'to_be_impaired_by_PCB_administration': 0.0005345134679592639, 'cytokine_data': 0.00041787318539719383, 'PCB_induced_modification_of_cytokine_concentrations_and_thus_negating_some_of_theimmunotoxic_effects_of_PCBMaterials_and_methodsAnimal_careFemale_C57BL6_mice_ _weeks_of_age': 0.00011386402488693955, 'amounts_insight_\\x93': 0.0018006682651940404, 'inanimals': 0.00021513839407779188, 'CO2_inhalationfollowed_decapitation': 0.00021513839407779188, 'PCBExercise': 0.0013882295497307361, 'Thecarts': 8.263922883666513e-55, 'exercise_animals': 9.148819220060914e-58, 'wereexposed': 9.148819220060914e-58, 'Woundswere': 5.55048631470028e-05, 'to_remove_the_hair_over_an_area_on_the_upper_back_alocation_inaccessible_to_the_animal_for_the_creation_of_wounds_to_harvest_the_wound_andthe_surrounding_tissueWound_cytokine': 0.00036420015359670075, 'TrimmerSterling_IL': 9.148819220060914e-58, 'to_remove_the_hair_over_an_area_on_the_upper_back_alocation_inaccessible_to_the_animal_for_the_creation_of_wounds': 9.148819220060914e-58, 'thencleaned': 5.939823762344884e-06, 'EOS_XTi_camera': 9.148819220060914e-58, 'to_photograph_the_wound_at_the_same_time_daily_until_the_wounds_were_reduced_to_ _of_original_sizeor_for_two_weeks_after_the_wounds_were_made_whichever_came_first_Image_J_software_version141o_NIH_was_used_to_analyze_the_wound_and_compare_it_to_the_reference_wound_thus_allowing_comparison_between_rates_of_wound_healingEuthanasiaThe_animals_were_euthanized_by_rapid_CO2_asphyxiation_followed_by_decapitation_with_a_guillotine_after_the_wound_size_reached_ _of_the_original_wound_or': 9.148819220060914e-58, 'to_analyze_the_wound_and_compare_it_to_the_reference_wound_thus_allowing_comparison_between_rates_of_wound_healingEuthanasiaThe_animals_were_euthanized_by_rapid_CO2_asphyxiation_followed_by_decapitation_with_a_guillotine_after_the_wound_size_reached_ _of_the_original_wound_or': 1.8167819587673103e-05, 'CO2_asphyxiation': 0.004596634145029243, 'post_woundingwhichever': 5.939823762344884e-06, 'punch_biopsy_instrument': 9.148819220060914e-58, 'to_harvest_the_wound_andthe_surrounding_tissueWound_cytokine': 9.148819220060914e-58, 'TNFÎ±_protein_concentrations': 9.148819220060914e-58, 'kit_BioRad_distribution_HealingPCB_doses_101371journalpone0237705': 9.148819220060914e-58, 'NJ_study': 1.0640120113403424e-06, 'homogenized_using_a_protocol_developed_by_Frank_and_Kampfer': 0.0006313632619292757, 'homogenized_in_an_extraction_solution_containing_sterile_1X_PBS_and_an_antiproteasebuffer_cOmplete_EDTAfree_Protease_Inhibitor_Cocktail_Roche_Diagnostics_GmbH_Mannheim_Germany': 3.657376547906612e-06, 'approx': 9.148819220060914e-58, 'to_load_a_single_wellof': 9.148819220060914e-58, '301R2_A_standardcurve': 0.0001559963661892288, 'Laboratories_Inc_Philadelphia_PA': 0.0001559963661892288, 'KCkeratinocyte_MCP1MCAF': 9.148819220060914e-58, 'chemotactic_activating_factor': 9.148819220060914e-58, 'protein_RANTES_analysis': 1.5711126779250663e-06, 'using_SPSS_software_IBM_ _version_ _Forthe_wound_size_data_general_linear_model_Repeated_Measures_ANOVA_along_with': 9.629061353610858e-05, 'hoctests_Bonferroni_Tukey': 1.5711126779250663e-06, 'Wounds': 3.1235511726865175e-05, 'changesor_trends': 8.263922883666513e-55, 'to_interact_indiverse_ways': 0.0003732887667714682, 'Comparison_treatment_groups': 2.3869684037014614e-05, 'to_study_the_day_effect_pattern101371journalpone0237705g001Fig_Effect': 0.0014620086693474654, 'to_study_the_day_effect': 3.895921044249875e-07, 'Day_days': 9.148819220060914e-58, 'pattern101371journalpone0237705g001Fig_Effect': 9.148819220060914e-58, 'wereadmininstered_PCB': 3.491587157297813e-06, 'differences_trends': 0.00021415873032525824, '\\x93_C_E_F': 1.4604557235991675e-05, 'differences_trends_difference': 1.5873702037666768e-05, 'concentrations_animal_concentrationsEffect_X_day': 0.00038048408575108483, 'concentrations_animal_concentrationsEffect': 2.5910275211042786e-07, 'Fig_UnivariateANOVA': 9.148819220060914e-58, 'following_significant_interactions_PCB_X_exercise_F351_  _p_ _PCB_X_day': 9.148819220060914e-58, 'X_day': 0.0005918317415111152, 'doses_D_E': 1.4604557235991675e-05, 'B_C_F': 3.491587157297813e-06, 'exercisedmice': 0.0003802249829989744, 'IL1_concentrations': 0.00034678516808638586, 'greaterconcentrations': 7.757009308694654e-06, 'Fig_5A_interactions_Tissue_PCB': 0.0003802249829989744, 'Fig_5D': 0.0003802249829989744, 'trend_Concentrations': 7.757009308694654e-06, 'animals_5DPLOS_ONE': 0.0003802249829989744, 'Effect_day_postwounding': 9.148819220060914e-58, 'to_be_no_difference_in_the_means_of_IL6_concentrations_across_PCB_dosesHowever': 9.148819220060914e-58, 'interactionsof': 0.0005915726387590047, '6B_Postwounding_Day': 9.148819220060914e-58, 'concentrations_¶t7_Fig_6B_Mice': 9.148819220060914e-58, 'mice_t7': 7.757009308694654e-06, 'animals_Day_mice': 0.0003802249829989744, 'p_Fig6C_Concentrations': 9.148819220060914e-58, 't8_Fig_6A': 9.148819220060914e-58, 't7_Fig_6B_6D': 4.157595671573054e-05, 'day_KCconcentrations': 0.00034678516808638586, 'PPAR_betadelta': 0.00047523466463657245, 'betadelta_overexpression': 1.4009724700659594e-05, 'inthe_review': 0.0006683847788508827, 'alpha_PPAR_gamma': 1.1686951820486561e-54, 'eï¬ect_\\x93': 8.263922883666513e-55, 'conï¬\\x82ictingstudies': 8.263922883666513e-55, 'Angiogenesis_Tumor': 0.0009471199423570387, 'role_tumor_development': 0.0005828796252635297, 'ability_life': 0.0015842910551982499, 'PPAR_alpha': 0.0004394889864169925, 'PPAR_alpha_agonist': 0.0018006682651940404, 'PPAR_alpha_activation': 7.417164383651313e-53, 'factor_VEGF': 6.678780673203977e-05, 'Howeverit': 9.148819220060914e-58, 'observation_neovascularization_Akt': 9.148819220060914e-58, 'alpha_activation': 9.148819220060914e-58, 'to_have_antineovascularization_eï¬ects_with_downregulation_of_VEGF_and_angiopoietin_expression_in_a_rat_alkali_burn_model': 9.148819220060914e-58, 'HUVEC_tubeformation': 0.0007830244265663299, 'PPARgamma_agonist': 0.0004394889864169925, 'PPAR_gammanull': 3.287841426025112e-52, 'whereascanonicalWntbetacatenin_signal_cascade': 9.148819220060914e-58, 'PPARgamma': 9.148819220060914e-58, 'implicating_a_negative_regulatory_role_of_PPARgamma_in_carcinogenesis_where_tumor_angiogenesis_mightbe_a_fundamental_stepstimulation_ofthetheIn_summary_PPAR_gamma_predominantly_displays_anantiangiogenic_eï¬ect_that_may_be_mediated_through_the_inhibition_of_VEGF_or_bFGFinduced_neovascularization_andreduction_of_the_expression_level_of_some_proangiogenicfactors_PPAR_BetaDelta_and_AngiogenesisUnlike_PPAR_alpha_and_PPAR_gamma_on_the_contrarymany_studies': 9.148819220060914e-58, 'eï¬ectsof_PPAR_betadelta_receptorVEGFR1': 9.148819220060914e-58, 'angiogenesis_mightbe_stepstimulation_PPAR_gamma': 0.0004394889864169925, 'prostacyclinPGI2': 0.00045660454367155184, 'musclespeciï¬\\x81c_betadelta_overexpression': 9.148819220060914e-58, 'toPPAR_betadeltaan_increase': 9.148819220060914e-58, 'PPARbetadelta_activation': 6.854784881700746e-08, 'muscleangiogenesis_animals': 1.1183617724082986e-09, 'withGW0742': 9.148819220060914e-58, 'growth_cardiac_angiogenesis': 9.148819220060914e-58, 'CNV_lesions': 8.263922883666513e-55, 'association_II_Ang_II': 7.751059242005992e-06, 'mitogen_Angiotensinconvertingenzyme_inhibitors': 8.263922883666513e-55, 'Inexperimental': 0.0003692335358126249, 'Ang_protein_synthesis': 0.0006940543140455221, 'to_inhibit_AngIImediated_atherosclerosis': 7.751059242005992e-06, 'relevance_PPARbetadelta_feature': 7.417164383651313e-53, 'demonstratedthat_PPAR_betadelta': 7.417164383651313e-53, 'formationwhereas_EPC': 0.0004394889864169925, '\\x93]such': 0.0015842910551982499, 'to_be_highly_correlated_to_pathologically_advancedtumor_stage_and_increased_cancer_risk_for_recurrence_and_distant_metastasis_in_patients_with_pancreatic_cancer': 0.0003421850007431465, 'indicating_the_crucial_association_of_PPAR_betadelta_withtumor_angiogenesis_progression_and_cancer_invasivenessPPAR_betadelta': 1.4009724700659594e-05, 'betadelta_activation_cells': 7.848076700959126e-05, 'UPR_UPR': 2.5544329903202734e-06, 'betadelta_activation': 9.148819220060914e-58, 'to_reduce_endoplasmic_reticulum_ER_stressassociated': 9.148819220060914e-58, 'PPAR_betadelta_mediatessenescence': 8.263922883666513e-55, 'PPARbetadelta': 8.263922883666513e-55, 'Crosstalk': 0.0016810521528134112, 'to_suppress_angiogenesis_in_vivo_and_in_vitro': 5.606618151720953e-07, 'LEPTIN': 0.00021565331044287443, 'to_mediate_angiogenesisin_vivo_and_in_vitro_through_induction_of_EC_proliferationand_expression_of_MMP2_and': 3.5187438011524213e-06, 'COX2': 0.0004358935679566294, 'respectivelylinks_cells': 9.148819220060914e-58, 'induce_and_sustain_tumor_angiogenesis_and_further_tofacilitate_tissue_invasion_and_tumor_metastatic_to_\\x81ltrate_eventually_promoting_tumor_angiogenesis': 9.148819220060914e-58, 'Chemotaxis': 9.148819220060914e-58, 'CXC_chemokines': 9.148819220060914e-58, 'whichfurther': 9.148819220060914e-58, 'VEGF_activation': 9.148819220060914e-58, 'ligand_CCL2_]': 6.253546940592786e-06, 'suppressorcellsCOX2': 9.148819220060914e-58, 'betainduced_angiogenesisin': 9.148819220060914e-58, 'anddisseminates_state': 0.004315547045054443, 'cells_activatesthem': 9.148819220060914e-58, 'ECs_cells': 9.148819220060914e-58, 'Gopinathan': 0.0002915557546050062, 'to_act_as_a_key_leaderin_\\x82ammatory_mediatordriven_tumor_angiogenesis_linkedto_TME_in_which_many_pro\\x82ammatory_mediators_chemokines_and_proangiogenic_factors_closely_communicate_with_0cPPAR_Researcheach_other_and_also_associate_with_tumor\\x81ltrating_myeloid_cells_such_as_neutrophils_TAMs_and_MDSCs': 7.751059242005992e-06, 'ETS1': 0.0016125895091140974, 'asMMP1_MMP3': 2.6321660851406754e-05, 'tumor_growthby': 5.088870929660028e-05, 'suggesting_that_PPAR_betadeltain_CAFs_is_also_an_important_player_in_tumor_developmentETS1': 0.0016810521528134112, 'WT1': 9.148819220060914e-58, 'to_regulate_tumor_angiogenesis_via_direct_transactivation_of_ETS1': 9.148819220060914e-58, 'HMGbox_SOX18': 9.148819220060914e-58, 'to_induce_angiogenesis_during_tissuerepair_and_wound_healing': 9.148819220060914e-58, 'NANOG': 1.3909946949554081e-05, 'PPAR_betadelta_factors': 9.148819220060914e-58, 'to_enhance_angiogenesisand_vasculogenesis_via_their_function_in_ECs': 9.148819220060914e-58, 'PDGFR_beta': 9.148819220060914e-58, 'PDGFBinduced_TAM_recruitment': 9.148819220060914e-58, 'cancer_growth_vascularizationin_cancers': 6.512877156704601e-06, 'TRF2': 0.0008522036149147152, 'PDGFB': 0.004315547045054443, 'to_accumulate_lipid_droplets_and_develop_morphologic_and_biochemical_characteristics_of_mature_adipocytesMesenchymal_stem_cells_MSCs': 0.0004025675977169704, 'lineagesAccumulating_evidence': 6.566833372158626e-06, 'to_diï¬erentiate_into_various_benign_cells_such_as_adipocytesï¬\\x81brocytes_variety': 0.0004358935679566294, 'mechanisms_signal_pathways_roles': 9.148819220060914e-58, 'Understanding_the_molecular_mechanism_of_adipogenesis_and_adipose_diï¬erentiation_of_cancercells': 9.148819220060914e-58, 'inducing_diï¬erentiation_into_benign_cells': 0.004315547045054443, 'characteristics_speciï¬\\x81c_cell_markers_proliferation_capacity': 2.1425356152800108e-05, 'cancer_cells_EMT_havebeen': 9.148819220060914e-58, 'to_be_induced_to_diï¬erentiate_into_adipocytes[\\x93': 9.148819220060914e-58, 'NCIH446_cells': 9.148819220060914e-58, 'to_differentiate_into_neurons_adipocytes_and_bone_cells_in_vitro': 9.148819220060914e-58, 'adipogenesis_diï¬erentiation_treatment': 9.148819220060914e-58, 'deletion_type': 9.148819220060914e-58, 'Thyroid_cancer_cells': 9.148819220060914e-58, 'to_diï¬erentiate_into_adipocytes': 9.148819220060914e-58, 'Adipogenesis': 9.148819220060914e-58, 'dexamethasone_indomethacininsulin_3isobutyl1methyl_xanthine_IBMX': 9.148819220060914e-58, 'to_have_an_important_role_in_adipocyte_diï¬erentiation_We_focus_on_understanding_the_complex_regulatory_mechanism_of_adipocytediï¬erentiation_that_can_contribute_to_the_clinical_treatmentof_human_diseases_including_those_caused_by_obesity_andadipocytes_dysfunction_especially_for_the_malignant_tumorwhich': 0.004315547045054443, 'Theinteraction': 2.6639512501173265e-05, 'The_ï¬\\x81rstphase_known_as_determination_involves_the_commitment_ofpluripotent_stem_cells_to_preadipocytes_The_preadipocytescannot': 0.0007035667068513752, 'mouse_C3H10T12': 1.87627095262873e-06, 'Regulatory_Pathways': 9.148819220060914e-58, 'years_factors': 9.148819220060914e-58, 'Wnt_family': 9.148819220060914e-58, 'catenindependent_independent_pathways': 9.148819220060914e-58, 'adipocyte_diï¬erentiation': 0.0039855700664819145, 'Wnt10b_expression': 9.148819220060914e-58, 'adipogenesis_Wnt10b': 9.148819220060914e-58, 'inputs_fromseveral_Wnt_signals': 9.829294553004592e-06, 'HH_signaling': 0.0004394889864169925, 'Thesecells': 9.148819220060914e-58, 'fat_accumulation_expression': 9.148819220060914e-58, 'HH_expression': 0.0004394889864169925, 'phase_ERK1_activity': 9.148819220060914e-58, 'toPPARÎ_phosphorylation': 9.148819220060914e-58, 'ERK1_activity': 8.263922883666513e-55, 'diï¬erentiation_reduction': 9.148819220060914e-58, 'MAPK_phosphatase1': 9.148819220060914e-58, 'KLFs': 9.148819220060914e-58, 'to_induceat_least_one_of_the_two_PPARÎ_promoters': 9.148819220060914e-58, 'factor_GATA': 7.318134159723203e-05, 'twoisomers': 0.0005659208618349831, 'PPARÎ1': 0.00030237797101608573, 'both_are_induced_during_adipogenesisPPARÎ1': 1.0798906856051064e-06, 'expressionfurtheractivate_PPARÎ_PPARÎ': 0.0038806204677737646, 'forms_diï¬erent_variousdimmers': 0.0003632043341281044, 'elementPPRE': 5.922710495980346e-06, 'toCEBPÎ±_expression': 0.0016810521528134112, 'CEBPÎ±expression': 8.059602068571773e-05, 'histone_deacetylase1_HDAC1': 0.0038806204677737646, 'CEBPÎ±': 0.0015847132313328567, 'CEBPÎ±_isnot': 0.0016810521528134112, 'Figure_Human': 9.148819220060914e-58, 'ability_cloning_ampliï¬\\x81cation': 9.148819220060914e-58, 'exogenousligands': 8.263922883666513e-55, 'inAdipocyte': 0.0004255556398718193, 'BMP_TGF': 9.148819220060914e-58, 'variedeï¬ects': 9.148819220060914e-58, 'includingadipocytes_TGF_inhibitor': 1.1675503541881247e-06, 'SMAD_inhibitionSMAD3': 1.472935272512395e-07, 'cells_eï¬ecton_adipogenesis_asTGF_insulin': 1.8268868228345713e-05, 'asTGF_insulin': 0.00210348072096923, 'BMP2': 0.0007059641234317006, 'to_be_associated_with_lipid_accumulation_aswell_as_increases_in_PPARÎ_and_FABP4': 0.0004686411271822266, 'CEBP_CEBPÎ_CEBP_CEBPÎ': 4.865616543085255e-07, 'KLF5_knockout': 0.0006054349545841993, 'thatKLF5': 0.0015842910551982499, 'CEBP_CEBPÎ': 4.865616543085255e-07, 'KLF4': 9.148819220060914e-58, 'CEBP_region': 9.148819220060914e-58, 'Adipocyte_diï¬erentiation': 0.0004992272920116505, 'KLF16_overexpression': 8.145441645486566e-06, 'KLF3_KLF7': 8.263922883666513e-55, 'STATprotein': 2.820213485255625e-05, 'STAT6': 2.820213485255625e-05, 'Early_adipocytediï¬erentiation': 9.148819220060914e-58, 'Cells_InternationalKLF5SREBP1cKLF15KLF2CHOPCEBPá¿«KROX20LigandCEBPð\\x9d\\x9b½CEBPð\\x9d\\x9b¿GATA23PPARá¿«CEBPð\\x9d\\x9b¼ProadipogenicAntiadipogenicGenes': 9.148819220060914e-58, 'adipogenesis_PPARÎ': 0.004315547045054443, 'factors_members': 2.586668612581389e-05, 'eï¬ects_interferon_Î': 0.0003692335358126249, 'theiradipocyte_diï¬erentiation': 8.263922883666513e-55, 'FABP4_promoter': 9.148819220060914e-58, 'to_speciï¬\\x81callyknock_out_STAT3_in_the_adipose_tissue_of_mice_and_theresults': 9.148819220060914e-58, 'STAT5A_STAT5B': 8.263922883666513e-55, 'Histone': 0.00014120710818717644, 'SIRT1_expressiondecreased': 9.992835703198152e-05, 'signal_protein_sFRP_promoters': 8.835605370583042e-05, 'SIRT1_knockdown': 7.973135968153667e-05, 'response_elementbindingprotein': 0.0005915726387590047, 'fromnuclei': 7.973135968153667e-05, 'SIRT1_SIRT2': 9.148819220060914e-58, 'FOXO1_nonphosphorylatednuclear_FOXO1': 9.148819220060914e-58, 'deacetylateand': 1.0502527165796223e-09, 'FOXO1could': 8.128491059873681e-05, 'demethylase_LSD1_expression': 8.263922883666513e-55, 'SET': 1.1330865854382043e-05, 'ectopic_expression_theuse': 0.0008522036149147152, 'triglyceride_accumulation_Inhibition': 1.1675503541881247e-06, 'miR210_miR30miR204211': 6.514612946547909e-06, 'miR519d_miR375': 0.0015842910551982499, 'miR130_miR448and_let7y': 9.992835703198152e-05, 'Lncu90926': 3.287841426025112e-52, 'HOXAAS3_expression': 1.167861516171542e-06, 'al_]': 1.423533251939928e-06, 'trimethylation_level_to_be_an_epigenetic_switch_regulating_MSCslineage_speciï¬\\x81city': 2.3221527737440525e-08, 'HOXAAS3': 9.148819220060914e-58, 'to_be_an_epigenetic_switch_regulating_MSCslineage_speciï¬\\x81city': 9.148819220060914e-58, 'Adipocyte_diï¬erentiationassociatedLncRNA': 0.0016810521528134112, 'LncRNA_NEAT1can': 9.992835703198152e-05, 'Biochemical_Response': 6.9406604780946884e-06, 'C3H10T12_adipocyte_differentiation': 1.1614886843686962e-05, 'increase_endoribonucleasetion': 0.0003638443162447166, 'CHOP_reticulum_stress_inducer_reticulum_stress': 9.148819220060914e-58, 'adipocyte_EIF2Î±_mutation_results': 9.148819220060914e-58, 'reticulum_stressinducers': 9.148819220060914e-58, 'complexI': 9.148819220060914e-58, 'formationFigure_Role': 0.0038806204677737646, 'diï¬erentiation_ability': 8.263922883666513e-55, 'cell_diï¬erentiation': 0.0005536611936400708, 'H2O2': 9.992835703198152e-05, 'NOSinduced_adipose_diï¬erentiation': 1.2844663249796055e-05, 'lipid_diï¬erentiation_Autophagy': 1.0897881470433689e-05, 'compoundingTGFð\\x9d\\x9b½1WNT1WNT10BTNF77233ADIPOQGLUT4SLC2A4_tetramerLEPFABP4lipid_dropletPLIN1PCK1PaPa_Pa4xPalmCCD36PaANGPTL4LPLFigure_ _Regulation_of_adipocyte_diï¬erentiation_A_regulatory_loop_exists_between_PPARÎ_and_CEBP_activation_Transcription_factor_CoeEBF_activates_CEBPÎ±_CEBPÎ±_activates_EBF1_and_EBF1_activates_PPARÎ_CEBP_and_CEBPÎ_´_act_directly_on_the_PPARÎ_gene_bybinding_its_promoter_and_activating_transcription_CEBPÎ±_CEBP_and_CEBPÎ_´': 9.148819220060914e-58, 'EBF1_gene_KLF5': 9.148819220060914e-58, 'CEBPÎ±_CEBPÎ±': 1.1686951820486561e-54, 'EBF1_EBF1': 8.263922883666513e-55, 'PPARÎ_CEBP_CEBPÎ': 8.263922883666513e-55, 'recruits_transcription_repressors': 0.00010339466758122505, 'expression_ofPPARÎ_transcription_factors': 8.263922883666513e-55, 'heterodimer': 1.1686951820486561e-54, 'health_data': 1.2127063895164571e-05, 'healthcare_systems': 1.1498008639303412e-05, 'hype_challenges': 0.0006611997588271541, 'disparities_inequities': 9.148819220060914e-58, 'to_present_a_diverse_set_of_challenges_   ': 9.148819220060914e-58, 'sets_machine_learning_implementation': 0.00014096957803779486, 'precision_oncology': 0.00036576662780187614, 'nci_medicine_initiativeoncology': 9.823752575177217e-05, 'implications_challenges_opportunities': 0.007713134335009549, 'proceedings_to_demonstrate_the_value_of_employing_digital_health_technologies_to_improve_cancer_prevention_and_care_ _for_example_apps_and_webbased_interventions_have_been_used_to_support_exercise_  _and_in_digital_outreach_efforts_focused_on_cancer_screening_  _in_a_webbased_exercise_intervention_to_mitigate_the_effects_of_chemotherapy_breast_cancer_patients_improvements': 1.0350905837599729e-06, 'to_bring_together_disparate_data_streams_generated_by_patients_from_technologies_such_as_ _smartphones_ _social_ _media_ _platforms_wearable_activity_trackers_and_internet_of_things_iot_devices_such_as_smart_home_sensors_ ': 0.00210348072096923, 'to_demonstrate_the_value_of_employing_digital_health_technologies_to_improve_cancer_prevention_and_care_ _for_example_apps_and_webbased_interventions_have_been_used_to_support_exercise_  _and_in_digital_outreach_efforts_focused_on_cancer_screening_  _in_a_webbased_exercise_intervention_to_mitigate_the_effects_of_chemotherapy_breast_cancer_patients': 0.0018006682651940404, 'to_support_exercise_  ': 0.0005865071468874085, 'google_search_facebook_advertisements': 8.263922883666513e-55, 'to_promote_cancer_screening_  ': 1.1686951820486561e-54, 'advertising_campaigns': 8.263922883666513e-55, 'communications': 0.0018006682651940404, 'activity_outcomes': 0.0007035667068513752, 'support_taylor': 9.148819220060914e-58, 'evidence_facebook_twitter_macmillanuk': 9.148819220060914e-58, 'posts': 9.148819220060914e-58, 'number_comments_support': 9.148819220060914e-58, 'using_pros_for_cancer_care_symptom_assessments': 9.148819220060914e-58, 'survival_quality': 9.148819220060914e-58, 'to_identify_key_domains_relevant_to_improving_outcomes_ _in_ _cancer_ _care_ _for_ _example_ _a_clinical_ _advisory_ _group_ _identified_ _priority_domains_ _and_ _measures_ _to_ _enhance_ _cancer_care_which_included_distress_and_symptoms_  _and': 0.00018738920974274527, 'priority_domains_measures': 0.0004576368763948737, 'distress_symptoms': 0.0038806204677737646, 'unmet': 1.1686951820486561e-54, 'girgis_  ': 8.263922883666513e-55, 'meddra_term': 0.0016480626375926124, 'feasibility_studies': 1.9804990679599668e-07, 'topics': 0.001845170519318405, 'lee_conversations': 1.1686951820486561e-54, 'to_ _optimize_ _interventions_ ': 8.263922883666513e-55, 'supportrecognizing_scarcity': 8.263922883666513e-55, 'datasets_researchers': 9.148819220060914e-58, 'science_efforts': 9.148819220060914e-58, 'collections': 0.00010801604270058882, 'sets_contain': 9.148819220060914e-58, 'competitions': 9.148819220060914e-58, 'information_mart': 1.7623816132889508e-06, 'benchmarks': 0.004315547045054443, 'risk_discrimination_methods': 9.148819220060914e-58, 'to_be_superior_to_dermatologists_in_ _diagnosing_ _and_ _detecting_ _skin_ _cancers': 9.148819220060914e-58, 'employing_deep_learning_approaches_to_classify_lung_pathology_ _images_ _yielded_ _more_ _accurate_results_when_compared_to_pathologists_  _additionally': 5.341824436340477e-07, 'progress_ml': 0.0005479687540571566, 'six_ml': 9.148819220060914e-58, 'to_assist_pathologists_in_detecting_gene_mutations_or_cancer_subtypes': 9.148819220060914e-58, 'cancer_genomics': 0.00031570829781304126, 'to_optimize_and_tailor_safe_and_effective_care_for_patients_based_on_their_individual_characteristics_precision_medicine': 0.0038806204677737646, 'discoveries': 0.009465059055267521, 'level_assays': 9.148819220060914e-58, 'settings_role_feasibility': 9.148819220060914e-58, 'research_highlights': 0.0010298344840079976, 'therapeutics_workflows': 1.0689756691710107e-05, 'savova': 9.148819220060914e-58, 'language_processing': 9.148819220060914e-58, 'reduce_time_ _spent_ _reviewing_ _clinical_ _documents_guan_  _used_nlp_techniques_to_extract_genomic_sequencing_information_from_clinical_progress_notes': 0.0038806204677737646, 'documents_guan': 0.00020422465499362284, 'to_extract_the_primary_site_of_tumor_origin_from_pathology_ _reports_    _given_ _that_ _cancer_stage_and_origin_are_rarely_captured_in_structured_format_within_ehrs': 0.00017392869868643751, 'to_extract_these_data': 0.00012040101594931771, 'seneviratne': 0.0004734482721133418, 'nlp': 0.004315547045054443, 'zhang': 5.713881500263957e-05, 'imia_yearbook_patient_engagement': 9.325067483958254e-07, 'patients_trials': 0.0001725776170596485, 'us_centers': 0.00033751281321690884, 'to_adopt_strategies_to_capitalize_on_biomarkers_and_genomic_information_to_enhance_precision_medicine_applications_for_instance': 5.503856920273344e-06, 'cancerspecific_resources': 0.0038806204677737646, 'bridges': 0.0005479687540571566, 'identify_modifiable_risk_factors_for_cancer_interoperability_standards_and_numerous_us_initiatives_such_as_the_21st_century_cures_act_and_the_promoting_interoperability_program_formerly_named_the_meaningful_use_program_are_transforming_ _the_ _way_ _individuals_ _access_medical_services_and_manage_their_health_thereby_accelerating_the_meaningful_application_of_digital_health_technologiesthe_evidence_base_for_digital_health_in_cancer_ _care_ ': 0.004315547045054443, 'century_cures': 9.891201964690107e-05, 'access_health': 1.614129649213458e-06, 'interoperability_program': 0.0003364176984007392, 'way_individuals': 7.05405764255948e-05, 'google': 0.0003922220153906259, 'to_adopt_strategies_to_capitalize_on_biomarkers_and_genomic_information_to_enhance_precision_medicine_applications_for_instance_knowledge_base_resource_capability_investigation_interpretation_performance_to_mitigate_some_of_the_challenges_facing_the_field_of_ml_several_anizations_frameworks': 6.397044290127281e-06, 'partnerships_eli_lilly_fitbit': 9.148819220060914e-58, 'partnerships': 9.148819220060914e-58, 'uk\\x99s': 0.0007956673215405282, 'health_apps_technologies': 2.1710329112496642e-05, 'challenging_for_patients_and_caregivers_to_determine_which_apps_are_trustworthy_effective_and': 0.00210348072096923, 'usefulimia_yearbook': 0.00019396529043020443, 'platforms_innovations': 8.160234840602243e-06, 'screening_mammograms_in_the_uk_due_to_algorithm_failure_  ': 0.00021180960367334957, 'curricula': 0.00023629147773967076, 'ml_research': 9.148819220060914e-58, 'learning_ _approaches_ _which_ _do_not_require_direct_data_sharing': 9.148819220060914e-58, 'interpretation_performance': 0.00020581955335681126, 'having_high_quality_training_data_and_development_procedures_ _testing_algorithm_performance_against_independent_test_data_and_ _evaluating_performance_continuously_  _even_with_benchmarking_appropriate_selection_of_realistic_and_biascontrolled_test_cases': 0.0038806204677737646, '\\x9cintrinsic_uncertainty\\x9d': 0.0003161853187357929, 'to_mitigate_some_of_the_challenges_facing_the_field_of_ml_several_anizations': 5.503856920273344e-06, 'nci_informatics_technology': 0.0013804914321168984, 'analysis_application': 0.004315547045054443, 'number_approaches': 2.252391286776244e-05, 'nlm_training': 0.00011288463700136564, 'management_implementation': 0.0004734482721133418, 'ae_jensen': 9.148819220060914e-58, 'i_system_ecuidatechemo': 9.148819220060914e-58, 'basch': 1.212383347469041e-05, 'bn_adashek_jj': 9.148819220060914e-58, 'chen_l_wang_x_peng_res_20182010e11515_taylor_j_pagliari_c_dynamics_h_silver_luong_kt_cancer_communication_examination': 9.148819220060914e-58, 'jco_clin_cancer': 9.148819220060914e-58, 'shoenbill_k_mitchell': 9.148819220060914e-58, 'institute\\x99s_outcomes_version': 9.148819220060914e-58, 'assoc_gresham': 9.148819220060914e-58, 'patients_results_treatment_duration': 0.00011367287672887825, 'materials_methods': 0.0002963772411368234, 'rate_orr_rate_dcr': 9.148819220060914e-58, 'results_treatment_duration': 9.148819220060914e-58, 'to_decline12_hepatocellular_carcinoma_ ': 1.13460300497246e-06, 'to_ _exceed_   _for_ _patients_ _with_advanced_liver_cancer': 0.0010327967928462102, 'surgery_recurrence_rates': 0.0011075402231842013, 'survival_pfs': 9.148819220060914e-58, 'to_be_ _months8_molecular_targeted_drugs_are_also_one_of_the_options_ _for_ _patients_ _with_ _advanced_ _liver_ _cancer_ _such_ _as_sorafenib_ _and_ _lenvatinib_ _however_ _according_ _to_ _reports_on_sorafenib_the_only_approved_molecular_targeted_therapy_for_advanced_hcc': 9.148819220060914e-58, 'tcm_therapies': 1.6855732572917737e-05, 'xiexin_decoction': 0.00045249509522850994, 'to_treat_digestive_diseases_such_as_bloating_and_abdominal_pain': 0.00210348072096923, 'response_cr11': 0.0006026042973632392, 'treatment_effect': 0.00771518910792271, 'to_have_ _at_ _least_ _one_ _measurable_ _lesion_ _defined_ _by_ _modified_response_ _evaluation_ _criteria_ _in_ _solid_ _tumors_ _for_ _hcc_mrecist_and_recist_version_ _inclusion_criteria': 0.001845170519318405, '2015bl003_patients': 0.0007129960827382031, 'components_doses': 9.148819220060914e-58, 'patients_ethics_committee_treatment': 9.148819220060914e-58, 'ml_patients': 9.148819220060914e-58, 'to_take_ _ml_each_time_ _times_dailytreatment_ ': 9.148819220060914e-58, 'to_do_sofollowing_an_initial_baseline_assessment_within_ _days_of_ _the_ _start_ _of_ _study_ _treatment_ ': 0.0006324067207528349, 'proportion_0cwang': 1.0228528432016754e-07, 'incidence_nature': 2.0432310822021455e-05, 'pr_disease': 0.0011075402231842013, 'using_ _the_ _kaplanmeier_method_ _all_ _statistical_ _analyses_ _were_ _performed_ _using_graphpad_ _prism_ _software_ _version_   _graphpad_ _software_inc_and_logrank_testresultsfrom_august_  _to_august_  ': 6.586694811007939e-05, 'using_graphpad_ _prism_ _software_ _version_   _graphpad_ _software_inc_and_logrank_testresultsfrom_august_  _to_august_  ': 0.0005263009120446208, 'to_report_in_this_midterm_analysis': 0.0016480626375926124, 'to_use_it_as_an_adjuvant_treatment_to_other_treatment_such_as_tace_moleculartargeted_therapy_and': 1.1743177520729953e-06, 'figure_thirtysix_patients': 0.0002768434257340561, 'subgroup_analysis_median_pfs': 0.007713134335009549, 'tace': 0.0011075402231842013, 'to_be_better_p_  _figure': 0.00012613970685026185, '5a_blood_tests': 8.263922883666513e-55, 'µgml_status_score': 1.1686951820486561e-54, 'anticancer_treatment': 0.0006324067207528349, 'target_lesion': 2.0432310822021455e-05, 'to_have_hcc_in_december_ ': 0.00012198022841850962, 'to_have_hcc_in_december_ _resection': 0.0007129960827382031, 'recurrence_lung_metastasis': 0.00210348072096923, 'figure_blood_tests': 8.263922883666513e-55, 'to_ _insist_ _on_ _treatment_ _after_ _the_ _disease_ _progressed': 0.00012198022841850962, 'nausea_noliver_cirrhosis': 0.0019020370917361502, 'noextrahepatic': 3.1235511726865175e-05, 'therapy_joint_committee': 0.0019132930105159865, 'hcc_patients': 9.148819220060914e-58, 'os_p': 9.148819220060914e-58, 'median_pfs': 0.0003242975375640313, 'median_os': 0.0004059702095650985, 'reaction_events': 0.0012768675847493482, 'china_food_drug_administration': 0.00210348072096923, 'cancer_therapies': 0.0011290645516913236, 'b_imaging_data': 1.842530354854743e-05, 'phase_trials': 3.4503386999365115e-05, 'to_improve_outcomes_over_sorafenibin_immunotherapy_immune_checkpoint_inhibitors_represented_by_pd1pdl1_monoclonal_antibodies': 5.635397965704171e-07, 'sorafenib_treatment_pabrizumab': 0.0011075402231842013, 'hbv_infection': 6.7860631771785984e-06, 'to_ _have_ _a_ _greater_ _benefit_ _for_patients_ _with_ _advanced_ _liver_ _cancer_ _who_ _have_ _progressed_with_interventional_therapyoverall': 0.0007129960827382031, 'table_reactionsgrade': 6.558450856396835e-05, 'iiigrade_literature': 0.004017334243903157, 'tcm_treatment': 0.0018456622073465703, 'scope': 3.012831237073818e-05, 'kinase_akt_phosphorylation': 3.506844957972254e-05, 'vegf': 5.722467201963997e-07, 'occurrence_development_tumors4446': 8.000183878777583e-05, 'coptis4047': 0.0005828796252635297, 'atractylodes_have': 0.0005423312279404596, 'astragalus54': 0.0010068765747081726, 'expression_growth': 3.531226980776358e-05, 'pinellia27_ginseng3839': 0.001128162151175775, 'liver_cancer_patients': 9.148819220060914e-58, 'to_obtain_longer_pfs_and_osin_ _china_ _most_ _patients_ _with_ _hcc_ ': 9.148819220060914e-58, 'cirrhosis_disease': 0.00010743652934456448, 'effects_licorice': 0.0002768434257340561, 'studylimitationsthe_report': 9.148819220060914e-58, 'singlearm_research_design': 9.148819220060914e-58, 'therapy_immunotherapy': 1.842530354854743e-05, 'endpoints_dcr': 0.004315547045054443, 'to_ _assess_ _the_comparative_efficacy_of_tcm_treatment_versus_other_antitumor_therapies_in_this_patient_populationappendixcomponents_and_their_doses_in_the_modified_xiexin_recipe_decoction_chinese_latin_and_english_nameschinese_namelatin_nameenglish_nameplace_of_origin_production_batch_dose_gbanxiahuangqinganjiangrenshenhuangliandazaogancaobaizhuchenpihuangqirhizoma_pinelliaeradix_scutellariaerhizoma_zingiberisradix_ginsengrhizoma_coptidisfructus_jujubaeradix_glycyrrhizaerhizoma_atractylodis_macrocephalaepericarpium_citri_reticulataeradix': 0.0018006682651940404, 'contributions_contributionslijuan_wang_jianlong_ke_shaoquan_xiong': 8.263922883666513e-55, 'the_study_lijuan_wang_jianlong_ke_cui_wang_yaling_li_qiuyue_luo_rui_cai_qian_ding_panpan_lv_and_tingting_song_ _collected_ _the_ _data_ _lijuan_ _wang_ _jianlong_ _ke_ _and_ ': 1.1686951820486561e-54, 'wang_yaling_li_qiuyue_luo_rui_cai_qian': 9.148819220060914e-58, 'panpan_song': 9.148819220060914e-58, 'cui_wang': 8.263922883666513e-55, 'lijuan_wang_jianlong_ke': 0.00022771936739542464, 'h_treatment_modalities_drug_targets_trevisani_f_farinati_f_cillo_u_treatment': 0.0005253840276496832, 'study_chemotherapy': 9.148819220060914e-58, 'cheng_al_kang_yk_chen_al_efficacy_safety': 9.148819220060914e-58, 'phase_iii': 2.132106024521249e-05, 'doubleblind_placebocontrolled_oncol_doi101016s1470204508702857': 3.481737112730939e-07, 'american_association_update_hepatology': 9.148819220060914e-58, 'llovet_jm_recist_mrecist_assessment': 9.148819220060914e-58, 'bromelain_bl': 0.0011125787591309202, 'eac_cell_line': 1.1686951820486561e-54, 'bl_pretreatment': 8.263922883666513e-55, 'receptor_pparÎ±': 1.6805631307987923e-47, 'peroxidation_depletion': 0.00016463522079533424, 'chemopreventive_compounds': 0.0038806204677737646, 'to_ _potentiate_ _radiation_ _therapyinduced_ _cytotoxic_1drug_radiation_research_department_national_centre_for_radiation_research_and_technology': 0.0005828796252635297, 'therapies_effects': 0.00011023309857947745, 'to_ _develop_ _numerous_ _antioxidant_ _drugs_ _of_ _both_natural_ _and_ _synthetic_ _origin_ ': 0.0005479687540571566, 'genistein_daidzein_glycitein': 1.1686951820486561e-54, 'to_enhance_the_efficacy_of_radiotherapymediated_suppression_of_the_growth_and_metastatic_ability_of_cancers1011_along_parallel_lines_resveratrol_and_piperine_which_possess_antitumor_ _activity_ ': 8.263922883666513e-55, 'to_ _augment_ _ionizing_radiation_irinduced_apoptosis_and_loss_of_mitochondrial_membrane_potential_in_murine_colon_carcinoma_and_melanoma_ _cells_ _via_ _enhancing_ _irinduced_ ': 8.263922883666513e-55, 'ros_generation12_pentoxifylline': 9.148819220060914e-58, 'methylxanthine': 9.148819220060914e-58, 'ros_ _generation12_moreover_pentoxifylline_ptx_a_methylxanthine_that_possesses_antioxidant_properties_is_known_for_improving_tumor_tissue_oxygenation_in_murine_hypoxic_tumors_and_inhibiting_post_ _radiation_ _induced_ _normal_ _tissue_ _injury_ _in_ _mice1314_consequently_ _searching_ _for_ _a_ _natural_ _product_ _possessing_anticancer_ _activity_ _that_ _increases_ _radiosensitivity_ _of_ _tumor_cells_and_radioresistance_of_normal_cells': 1.0921693716039305e-05, 'effect_reduction': 0.0006694191899910165, 'thiol_endopeptidases_components_anticancer_activity': 1.0921693716039305e-05, 'bl': 0.00016045210047866475, 'to_evaluate_ _the_ _radiosensitizing_ _and_ ': 0.0019127833147525456, 'to_evaluate_ _the_ _radiosensitizing_ _and_ _eac_cells': 0.0017307664485390146, 'eac_cells': 0.0006026042973632392, '\\x97_cellswell': 9.148819220060914e-58, 'rpmi_media': 9.148819220060914e-58, 'uml_penicillin_streptomycin': 3.629986931477202e-07, '1diphenyl2picrylhydrazyl': 1.645423058733246e-05, 'glutathione_sulfur': 7.1732556849280095e-06, 'dpph_loss': 0.004315547045054443, 'primer²ccatcgacgtcaactacga3²²caatggctacacaggacca3²²actccacctgcagagcaacca3²²gcgtggggacagccgcatctt3²²gtgcgtggtagcatgagtgt3²²cactgtcacctggaaccaga3²²tagatctcctgcagtagcggg3²²atcggcagaaggggcggaga3²pharmacy_university_egypt': 0.00016123382553553652, 'subculturing': 8.263922883666513e-55, 'to_ _multiply28_ _the_ _ehrlich_ _solid_ _tumor_est_ _was_ _obtained_ _by_ _the_ _intramuscular_ _inoculation_ _of_ _ml_ _of_  _\\x97_  _viable_ _eac_ _in_ _the_ _right_ _lower_ _limb_ _of_each_mouse29_mice_with_a_palpable_solid_tumor_diameter_ _mm3': 0.00210348072096923, 'tumor_est': 8.403168258468193e-08, 'were_ _randomly_ _divided_ _into_  _groups_ _mice_each_group_ _control_not_bearing_tumor': 8.403168258468193e-08, 'doses_est': 0.00015840564465597284, 'body_weight_change': 3.281982611313524e-06, 'inhibition_ratio': 0.00020136340182189108, 'inhibitory_ratio': 3.281982611313524e-06, 'using_assessment': 0.0006497925314270183, 'paraffin_sections': 1.0600955172409034e-05, 'genes_Î²actin_c_c': 1.6805631307987923e-47, 'reaction_rtpcr_total_rna': 1.6805631307987923e-47, 'genes_Î²actin_reaction_rtpcr_total_rna_c_c_using_ _the_ _comparative_ _\\x88\\x86\\x88\\x86ct_method_ _for_ _relative_ _mrna_ _quantification_ _of_ _target_ _genes_normalized_to_an_endogenous_reference_measurement_to_measure_the_generation_of_ros_by_ _the_ _intracellular_ _conversion_ _of_ _nitro_ _blue_ _tetrazolium_nbt_ _to_ _formazan_ _by_ _the_ _action_ _of_ _superoxide_ _anion_paraoxonase_activity_was_estimated_by_using_fluorometric_assay_enzchek_®_kit_invitrogen_uk_for_the_anophosphatase_activity_of_paraoxonase_based_on_the_hydrolysis_of_a_fluorogenic_anophosphate_analog34hematological_ _and_ ': 0.0002929990790165998, 'using_ _the_ _comparative_ _\\x88\\x86\\x88\\x86ct_method_ _for_ _relative_ _mrna_ _quantification_ _of_ _target_ _genes_normalized_to_an_endogenous_reference': 3.5483839328833007e-06, 'to_measure_the_generation_of_ros_by_ _the_ _intracellular_ _conversion_ _of_ _nitro_ _blue_ _tetrazolium_nbt_ _to_ _formazan_ _by_ _the_ _action_ _of_ _superoxide_ _anion_paraoxonase_activity_was_estimated_by_using_fluorometric_assay_enzchek_®_kit_invitrogen_uk_for_the_anophosphatase_activity_of_paraoxonase_based_on_the_hydrolysis_of_a_fluorogenic_anophosphate_analog34hematological_ _and_ ': 1.6805631307987923e-47, 'analyses_blood': 4.7776197042580385e-06, 'using_ _oneway_ _analysis_ _of_ _variance_ ': 0.001129870936471824, 'anova_groups': 4.497339031352969e-07, 'viability_percentage': 2.7555311044054116e-05, 'bonferroni\\x99s': 5.9902271010618945e-05, 'posttest_graphs': 9.148819220060914e-58, 'using_ _graph_ _pad_ _prism_isi_®_software_usa_version_ _software_data_were_presented_ _as_ _mean_±_standard_ _error_ _se_ _and_ _p_ _values_  _considered_significantresultsin_vitro_studieseffect_of_bromelain_and_gammairradiation_blirr_on_tumor_cell_growth_and_viability_ ': 9.148819220060914e-58, 'prism_software_usa_software_data': 9.623930537852086e-05, 'radiosensitizing_effect': 1.2188689337472235e-05, 'bonferroni\\x99s_using_ _graph_ _pad_ _prism_isi_®_software_usa_version_ _software_data_were_presented_ _as_ _mean_±_standard_ _error_ _se_ _and_ _p_ _values_  _considered_significantresultsin_vitro_studieseffect_of_bromelain_and_gammairradiation_blirr_on_tumor_cell_growth_and_viability_ _mean_analysis': 0.0005867062134110649, 'eac': 3.259762205837823e-05, 'mean_analysis': 0.0005865071468874085, 'bonferroni_posttests': 5.9902271010618945e-05, 'est_group': 8.263922883666513e-55, 'pleomorphism_hyperchromatism_activity': 0.0011125787591309202, 'cells_arrow_head_areas': 0.0004576368763948737, 'cells_arrow_cells_arrow_figure': 0.00210348072096923, 'estirradiated_group': 9.148819220060914e-58, 'muscle_fibers': 9.148819220060914e-58, '3d_\\x97': 1.81823575620778e-05, 'tumor_weight_inhibition_ratio': 0.0003327007272384309, 'ir_br': 9.148819220060914e-58, 'bromelain_irradiation': 9.148819220060914e-58, 'photo_micrograph': 1.842530354854743e-05, 'groups_est_sections': 0.0002800361681909777, 'bromelain_area_groups_m': 1.712750863054237e-05, '3h_\\x97_3i': 0.0002800361681909777, 'bl_irr': 9.148819220060914e-58, 'group_change_group_pparÎ±_expression': 9.148819220060914e-58, 'hepato_figure_effect_gammairradiation_blirr': 2.618112662188242e-06, 'wbcs_plts': 2.1536918496565862e-05, 'increases_decrease_increase_groups_pparÎ±_gene_expression': 0.001320019255305022, 'bl_treatment': 0.0006022976839415911, 'pparÎ±_gene_expression': 1.6805631307987923e-47, 'radiation_damage': 2.618112662188242e-06, 'control_pbs': 0.0005411681930881713, 'irr': 0.00016032962580117682, 'treatment_bl_irr': 0.0007080023910910008, 'est': 5.139476146855293e-07, 'mean_group': 0.0005865071468874085, 'bromelain_irradiationeach_value': 0.00018001983766047135, 'mtt': 0.0004686704161497273, 'to_estimate_the_effect_of_bromelain_bl_as_a_tumor_radiosensetizer_and_to_show_to_what_ _extent_ _it_ _can_ _protect_ _normal_ _tissue_ _from_ _radiation_hazardsradiosensitizers_ ': 0.0019127833147525456, 'therapy_bl_irr': 9.148819220060914e-58, 'to_be_more_effective_than_single_agent_therapy_in_reducing_tumor_volume_and_weight_indicating_that_bl_could_possess_a_radiosensitizing_effect': 9.148819220060914e-58, 'to_be_in_agreement_with_other_findings_of_ _the_ _role_ _of_ _bl_ _in_ _reducing_ _metastasis_ _and_ _local_ _tumor_growth2342_in_chemically_induced_mouse_skin_papillomas_topical_application_of_bl': 0.0010325216439875707, 'formation_tumor_volume': 0.0010325216439875707, 'digestion_diffusion': 0.0038806204677737646, 'use_figure_effect_c_pparÎ±': 0.0019127833147525456, 'inhibitory_action': 1.284690556057437e-52, 'decrease_side_effects': 7.417164383651313e-53, 'tissue44for_estimation': 7.417164383651313e-53, 'decrease_side_effects_tissue44for_estimation': 7.417164383651313e-53, 'scavenging': 2.618112662188242e-06, 'membrane_phospholipids_lipids': 0.0038806204677737646, 'to_catalyze_hydrolysis_of_lipid_hydroperoxides_and_lactones51_pon1': 0.00210348072096923, 'iv_epithelioid_mesothelioma': 0.001128162151175775, 'malignancy_nuclei': 9.148819220060914e-58, 'chromatin_pattern_staining': 9.148819220060914e-58, 'to_ _occur_ _in_ _patients_with_asbestos_exposure_leading_to_chronic_inflammation_of_the_pleura67_subsequently': 4.945541649587606e-06, 'cell_borders': 0.0010325216439875707, 'cell_borders_requirement': 0.0010325216439875707, 'survivalaverage_age_yearsabbreviation_ct': 8.937521195812353e-05, 'to_rule_out_adenocarcinomas_and_cancers_causing_peritoneal_carcinomatosis810_key_markers_for_mesothelioma': 0.0007073655433340525, 'cell_12100mm3_hematocrit_abdominal_ct': 9.550143716621319e-05, 'terminal_ileum': 9.148819220060914e-58, '\\x97_cm_both': 9.148819220060914e-58, 'see_figure_esophagogastroduodenoscopy_ _confirmed_ _concerns_ _for_extrinsic_ _compression_ _of_ _gastroesophageal_ _junction_ _and_fundus_ _of_ _stomach_ _suggesting_ _an_ _underlying_ _mass_ _no_endoluminal_ _gastric_ _masslesions_ _were_ _appreciated_ _see_figure_ _colonoscopy_was_attempted_but_scope_was_not_able_ _to_ _advance_ _past_ _the_ _sigmoid_ _colon_ _safely_ _due_ _to_colonic_stricturecomputed_tomography_chest_with_iv_contrast_identified_moderate_diffuse_emphysema_a_right_upper_lung_lobe_spiculated_mass_measuring_ _cm_and_indeterminate_small_left_upper_and_lower_lobe_nodules_see_figure_ _diffuse_retrocrural_and_gastroesophageal_lymphadenopathy_was_noted_in_addition_to_the_retroperitoneal_lymphadenopathygiven_the_concern_for_lymphoma_versus_alternative_neoplastic_ _disease_ _ctguided_ _biopsy_ _was_ _performed_ _on_ _the_retroperitoneal_abdominal_mass_and_an_intramuscular_paraspinal_mass_hematoxylin_and_eosin_staining_revealed_pleomorphic_malignancy_nuclei_containing_a_vesicular_chromatin_pattern_ _and_ _prominent_ _nucleoli_ _see_ _figure_   _cells_ _were_predominantly_ _polygonal_ _with_ _occasional_ _spindling_ ': 0.000762889468397268, 'figure_esophagogastroduodenoscopy': 4.26359750424666e-06, 'mass_gastric_masslesions': 9.148819220060914e-58, 'see_figure_ _colonoscopy_was_attempted_but': 9.148819220060914e-58, 'lobe_nodules': 3.327143301642844e-06, 'clinic_laboratories': 0.004315547045054443, 'to_ _have_ _a_ _moderate_ _pneumoperitoneum_ _with_bowel_ _perforation_ ': 0.00012198022841850962, 'compression': 0.0010325216439875707, 'gastric_masseslesions': 4.482661386438385e-05, 'originating_from_the_retroperitoneal_spacediscussionthe_diagnosis_of_mm': 0.0006579852393580266, 'originating_from_the_retroperitoneal_spacediscussionthe_diagnosis_of_mm_carries_a_poor_prognosis_and_requires_careful_ _review_ _by_ _pathology_ _our_ _case_ _details_ _the_ _workup_necessary_to_diagnosis_mm_in_a_patient_with_an_atypical_presentation_ _of_ _intermittent_ _abdominal_ _pain_ _found_ _to_ _have_figure_  _computed_tomography_chest_with_intravenous_contrast_identified_moderate_diffuse_emphysema_a_right_upper_lung_lobe_spiculated_mass_measuring_ _cm_green_arrows_and_indeterminate_small_left_upper_and_lower_lobe_nodules_as_this_did_not_involve_the_pleura_as_is_traditionally_seen_this_was_felt_to_be_a_metastasis_of_the_primary_retroperitoneal_mass_with_metastasis_to_lungs_and_ileumsignificant_metastatic_disease_prior_to_identification_of_a_primary_malignancyreview_of_the_case_reveals_the_importance_of_tissue_analysis_and_the_continued_public_health_concern_of_mesothelioma_ _0c_  _of_investigative_medicine_high_impact_case_reportsongoing_ _research_ _is_ _investigating_ _whether_ _these_ _genetic_changes_have_a_role_in_disease_development_in_cases_without_asbestos_ _exposure610_ _in_ _the_ _case_ _of_ _malignant_ _peritoneal_mesothelioma_there_is_a_higher_fraction_of_mm_without_an_identifiable_environmental_exposure_which_raises_the_question_whether_the_disease_process_and_role_of_genetics_vary_by_the_location_of_mm14_in_the_future_these_will_hopefully_lead_to_the_development_of_immunotherapies_that_are_able_to_target_these_pathways_and_improved_disease_prognosis6known_asbestos_exposure_was_not_a_factor_in_our_case_and_ _should_ _not_ _be_ _used_ _to_ _rule_ _out_ _mesothelioma10_ _over_ _of_mm_cases_are_attributable_to_asbestos_exposure_with_  _of_ _malignant_ _peritoneal_ _mesothelioma_ _attributed_ _to_asbestos1516_recent_studies_detail_that_despite_the_restriction_of_asbestos_products_in_the_united_states_for_over_ _years_the_role_of_asbestos_in_chronic_inflammation_and_dna_damage_ _will_ _continue_ _to_ _cause_ _malignancy615_ _in_ _the_ _united_states_alone_there_were_approximately_ _new_mm_cases_in_   _with_ _current_ _estimates_ _anticipating_ _a_ _peak_ _incidence_of_mm_worldwide_in_ _given_the_continued_use_of_asbestos_ _worldwide_ _and_ _time_ _to_ _disease_ _development6715_this_case': 0.0005248377111845071, 'review_case_details': 1.0735283238638374e-05, 'prognosis_review_case_details': 3.327143301642844e-06, 'pleura': 0.0010325216439875707, 'to_be_a_metastasis_of_the_primary_retroperitoneal_mass_with_metastasis_to_lungs_and_ileumsignificant_metastatic_disease': 0.0010325216439875707, 'to_ _cause_ _malignancy615_ _in_ _the_ _united_states_alone_there_were_approximately_ _new_mm_cases_in_   _with_ _current_ _estimates_ _anticipating_ _a_ _peak_ _incidence_of_mm_worldwide': 0.0015842910551982499, 'chromatin_pattern_survival_time_staining_presence': 0.0002210783864881559, 'chromatin_pattern': 2.6694243822196132e-05, 'differentiationmm': 5.753543596378351e-05, 'yf_zheng_song_h_yin': 8.263922883666513e-55, 'l_ct_differentiation_gastroenterol_hepatol_gill': 9.148819220060914e-58, 'results_al_guidelines': 9.148819220060914e-58, 'galateausalle_roggli_mesothelioma_nonasbestos': 9.516906318275503e-06, 'rl_torre_estimates_vde_recchia_l_cafferata_mesothelioma_multicenter_study': 0.0004499048194399722, 'throughput_methods': 0.0020367110587161705, 'number_capability_effects_byconsensus_matrix_agglomerations_approach': 2.0573240121796337e-06, 'byconsensus_matrix': 2.0567759297802077e-06, 'agglomerations_approach': 0.0007641347695089468, 'experiments_comparisons': 3.3581010048076986e-08, 'data_agglomerationtechniques': 0.0006683740194778514, 'to_be_the_first_time_that_amodel_based_on_fuzzy_logic_is_used_for_the_agglomeration_of_multiomic_data_theresults': 0.00210348072096923, 'fhclust': 8.771239636319873e-06, 'value_clinical': 1.4326586459746e-07, 'creativecommons_dedication_waiver': 0.000643915093468904, 'gene_expression_methylation_information_matrix': 0.0004914087449523927, 'learningjargon': 0.0002664871522256321, 'gene_expression_methylation_information': 0.00024940455416981735, 'multiomics_analysis': 9.148819220060914e-58, 'theeffects_kinds': 9.148819220060914e-58, 'omic': 0.0003393230566503665, 'mirna_expression_methylation_clustering_approach': 0.0014616190772430405, 'approach_data_normalization_e_clustering_visualization': 0.00013104677090598646, 'to_build_a_hierarchyof_clusters': 0.0038806204677737646, 'inits': 0.0003034732833474384, 'hc': 0.00031581568550424115, 'data_integration_methodologybased': 0.007713134335009549, 'fl': 9.148819220060914e-58, 'to_obtain_a_soft_clusteringinstead_of_an_hard_clustering_of_data_  _specifically_data_points': 9.148819220060914e-58, 'value_membership_function': 0.0005865071468874085, 'setsthrough': 0.0003069306742853986, '21suppl_page': 0.0077152030777233585, 'generalisation': 0.00015217293409589968, 'equivalencerelation': 0.007713134335009549, '\\x88\\x88': 0.00771518910792271, 'lettingd': 0.00012613970685026185, 'onetoone_correspondence': 0.007713134335009549, 'similaritymeasure': 9.355439500346905e-05, 'similarity_matrix_si': 5.996616951571968e-06, 'input_dendrograms': 0.0001262729425119799, 'sti_¦_sicid8': 1.5011192567516048e-06, 'to_obtain_a_perfectseparation_of_the_source_partitionsresults_and_discussionin': 0.0005741125271172155, 'e_a\\x88\\x97_a\\x88\\x97': 8.657387773748207e-08, 'a\\x88\\x97': 9.148819220060914e-58, 'a\\x88\\x97_step_else': 9.148819220060914e-58, 'mirna_expression': 0.00023557425055950736, 'dnaoridatasetamlbiccoadgbmkirclihcluscskcmovsarclnrfmirnaorilnmethyorilnmultiomicsorilnrfrfrfthe_number': 9.148819220060914e-58, 'ln_logarithm_andnormalisation_forest': 9.148819220060914e-58, 'carcinoma_cell_carcinomalusc': 9.148819220060914e-58, 'ovsarcoma_sarc': 9.148819220060914e-58, 'ovsarcoma_sarc_it': 0.0010298344840079976, 'subspace': 9.849136608862707e-05, 'subspace_threshold': 9.849136608862707e-05, 'to_be_the_state_of_the_art_inthis_area': 0.0003540754526695089, 'to_be_very_powerful_makes_the_algorithm_sensitive_to_small_changes_in_molecularmeasurements_or_in_its_parameter_settings¢_mcca_  _multi_canonical_correlation_analysis_mcca_which_extends_theapplication_of_canonical_correlation_analysis_cca_to_more_than_two_views_is_oneof_the_most_widely_used_dimension_reduction_method_for_finding_linear_relationsbetween_two_or_more_multidimensional_random_variables1row_data_are_available_at_httpacgtcstauacilmulti_omic_benchmarkdownloadhtml2httpsgithubcomshamirlabmultiomicscancerbenchmark_0cciaramella_  _bmc_bioinformatics_ _21suppl_page_ _of_evaluation_metricsin_order_to_assess_the_performance_of_each_method_we_adopt_three_evaluation_metricsthat_are_the_logrank_test_the_enrichment_of_clinical_labels_in_the_clusters_and_the_methods_runtime_  _the_logrank_test_assumes_that_if_clusters_of_patients_have_significantlydifferent_survival_they_are_different_in_a_biologically_meaningful_way_for_the_enrichmentof_clinical_labels_in_clusters_six_clinical_labels_are_considered_gender_age_at_diagnosispathologic_tumor_pathologic_metastases_pathologic_lymph_nodes_and_pathologic_stagethe_four_latter_parameters_are_discrete_pathological_parameters_measuring_the_progression_of_the_tumor_metastases_and_cancer_in_lymph_nodes_and_the_total_progressionpathologic_stage_enrichment_for_discrete_parameters_was_calculated_using_the_Ï\\x872_testfor_independence_and_for_numeric_parameters_using_kruskalwallis_test_not_all_clinicalparameters_were_available_for_all_cancer_types_so_a_total_of_ _clinical_parameters_wereavailable_for_testing_to_derive_a_pvalue_for_the_logrank_test_the_Ï\\x872_test_for_independence_the_kruskalwallis_test_and_the_statistic_for_these_three_tests_is_assumed_to_have_Ï\\x872distribution_ _preprocessingtcga_datasets_were_preprocessed_as_follows_patients_and_features_with_more_than_missing_values_were_removed_and_missing_values_were_imputed_using_knearest_neighborimputation_the_sequence_features_were_logtransformed_the_ _features_with_highestvariance_from_geneexpression_and_methylation_omics_were_selected_in_the_mirna_omicfeatures_with_zero_variance_were_filtered_all_features_were_then_normalized_to_have_zeromean_and_standard_deviation_ _for_methylation_we_selected_the_ _features_with_maximal_variance_in_each_dataset_and_also_adopted_the_standard_pipeline_proposed_in_ _whose_procedure_filters_out_the_probes_from_the_x_and_y_chromosomes_or_probes_that_areknown_to_have_common_snps_at_the_cpg_sitea': 0.0003540754526695089, 'theapplication': 0.0038806204677737646, 'using_the_Ï\\x872_testfor_independence_and_for_numeric_parameters_using_kruskalwallis_test_not_all_clinicalparameters': 0.00029817669559437587, 'total_kruskalwallis_test_statistic': 9.148819220060914e-58, 'to_have_Ï\\x872distribution_ _preprocessingtcga_datasets_were_preprocessed_as_follows_patients_and_features_with_more_than_missing_values_were_removed_and_missing_values_were_imputed_using_knearest_neighborimputation_the_sequence_features_were_logtransformed_the_ _features_with_highestvariance_from_geneexpression_and_methylation_omics_were_selected_in_the_mirna_omicfeatures_with_zero_variance_were_filtered_all_features_were_then_normalized_to_have_zeromean_and_standard_deviation_ _for_methylation_we_selected_the_ _features_with_maximal_variance_in_each_dataset_and_also_adopted_the_standard_pipeline_proposed_in_ _whose_procedure_filters_out_the_probes_from_the_x_and_y_chromosomes_or_probes_that_areknown_to_have_common_snps_at_the_cpg_sitea': 9.148819220060914e-58, 'to_have_zeromean_and_standard_deviation_ _for_methylation_we_selected_the_ _features_with_maximal_variance_in_each_dataset_and_also_adopted_the_standard_pipeline_proposed_in_ _whose_procedure_filters_out_the_probes_from_the_x_and_y_chromosomes_or_probes_that_areknown_to_have_common_snps_at_the_cpg_sitea': 0.0005373063242131615, 'forest': 0.004315547045054443, '\\x9celbowmethod\\x9d': 0.007713134335009549, 'i_information': 0.0008009545823607212, 'tothe_guidelines': 0.007713134335009549, 'selection_methods': 0.007713134335009549, 'process_pipeline': 0.007713134335009549, 'performance_algorithms': 0.00048587472835324937, 'pins_mcca': 9.148819220060914e-58, 'respectivelyin_table': 9.148819220060914e-58, '\\x88\\x92log10_testpvalue': 1.6841776171074526e-05, 'snf': 0.001877533669348865, 'method_solution': 0.0006321861226151657, 'value_number_enrichmentfhclustkmeansspectrallraclusterpinssnfmcca_21suppl_page': 7.997554819136466e-06, 'itsclustering': 0.0002788738900395108, 'authors_value_labels_number_enrichmentfhclustkmeansspectrallraclusterpinssnfmcca_21suppl_page': 0.0010298344840079976, 'value_significanceconcerning': 0.00016189805038001264, 'gotlower': 1.4460951649719655e-05, 'methods_performance': 0.0003313074447267851, 'results_enrichment': 0.004315547045054443, 'value_significance': 1.4326586459746e-07, 'method_suchas_snf': 9.148819220060914e-58, 'hyperparameter': 9.148819220060914e-58, 'mining_capabilities': 0.00027626151939488195, 'runtime': 0.0006026042973632392, 'work_concerns_logic_use': 2.3863323261202395e-05, 'feature_selection_step': 0.0014620085655300467, 'fhclustprovides_permitsfig': 0.00048587472835324937, 'omic_21suppl_page': 0.0005715966671738797, 'betweenclusterssupplementary_information': 0.00024801800887098703, 'forwriting_the_manuscript_read': 0.0007959416758056306, 'manuscriptfundingpublication_costs': 5.883089155027185e-05, 'interestsauthor_degli': 0.0013882295497307361, 'integrationmethodology_bmc_bioinformatics': 2.308969901044471e-05, 'role_relationship_multiple_biologicalprocesses': 2.595070359516317e-05, 'role_link_inactivity_obesity_metabolicsyndrome_twothirds_risk_factor_unclearfrequent_pathologicalin_relationship_multiple_biologicalprocesses_to_be_associated_with_increased_obesityrisk_  _in_young_obese_individuals': 0.003014562074979641, 'role_ofwntctnnb1': 0.000704362469235278, 'pathology_records': 0.007713134335009549, 'tma': 1.4055400435083287e-53, 'pathologists_intensity_staining': 2.274211562945482e-53, 'ihc_results': 2.274211562945482e-53, 'obesity_wntcatenin_pathway': 0.0007037542069379237, 'to_be_independent_in_africanamerican_patients_wntcatenin_signaling_pathway': 1.1481395008562046e-05, 'inactivity_obesity_metabolicsyndrome_twothirds': 2.595070359516317e-05, 'account': 0.0038806204677737646, 'crcs': 3.1235511726865175e-05, 'adenoma': 0.0019132930105159865, 'etiologicalcauses': 4.920423980238722e-05, 'unclearfrequent_pathologicalin': 1.090830747319825e-05, 'degradation_accumulation': 0.00018114260846750725, 'inthe_nucleus_catenin': 9.148819220060914e-58, 'cmyc_cyclin_d1and_genes': 9.148819220060914e-58, 'activated': 9.148819220060914e-58, 'differentiation_cascade': 9.148819220060914e-58, 'cebpa_pparg': 0.0038806204677737646, 'receptorÎ': 0.0038806204677737646, 'to_be_associated_with_increased_obesityrisk_  _in_young_obese_individuals': 0.0007000951832348714, 'obesity_risk': 0.0003632043341281044, 'andthereby': 5.922710495980346e-06, 'importantimplications': 0.0008822241915335798, 'predisposing_mutations_to_colorectal_cancer': 0.004315547045054443, 'patients\\x99data': 8.263922883666513e-55, 'age_sex_height_weight': 1.1686951820486561e-54, 'index_bmi': 8.263922883666513e-55, 'weremade': 0.00012198022841850962, 'block': 9.148819220060914e-58, 'importantimplications_tothe_ihc_procedure_target_retrievalinvolvedimmersion_heat': 9.148819220060914e-58, 'tmas': 9.148819220060914e-58, 'tothe_ihc_procedure_target_retrievalinvolvedimmersion': 9.148819220060914e-58, 'regression_analysis_p': 0.007713134335009549, 'crcthe_bmi': 6.171298691014034e-05, 'cellcell_adhesion': 7.417164383651313e-53, 'role_wnt_pathway': 7.417164383651313e-53, 'expansion_differentiation': 0.004315547045054443, 'disappearance_membrane_levelinas': 0.0013882295497307361, 'to_expand_as_a_pandemicworldwide_  ': 0.0038806204677737646, 'which_to_promote_crc': 4.3223763381732904e-05, 'increase_ingrowth_proliferation': 0.0008522036149147152, 'thatoverweight_patients': 0.007713134335009549, 'frz1_frizzled': 9.148819220060914e-58, 'stabilityinhibits_apoptosis_adipogenesisross': 9.148819220060914e-58, 'wnt_acts_upregulationof_wnt_signaling': 9.829294553004592e-06, 'wnt_signaling': 1.1686951820486561e-54, 'theydifferentiate': 8.263922883666513e-55, 'gsk3catenin_pathway': 0.004315547045054443, 'adenomas_crcswere_patients': 9.148819220060914e-58, 'adenoma_crc': 9.148819220060914e-58, 'experiments_bs': 0.0003327007272384309, 'hb': 9.148819220060914e-58, 'data_hb_mn_th_aa': 9.148819220060914e-58, 'zs': 8.263922883666513e-55, 'reagentsmaterialsanalysis_tools': 1.1686951820486561e-54, 'hb_bs_el': 0.001130473280667068, 'manuscriptbs_analysis': 1.844946435746173e-05, 'manuscriptbs': 1.844946435746173e-05, 'mn_manuscriptfundingthis_project': 5.883089155027185e-05, 'august_referencesresearch_iafco': 9.148819220060914e-58, 'incidence_mortality_prevalenceworlwide': 9.148819220060914e-58, 'activity_\\x93_wong_mc_lam_ty_tsoi_kk': 0.0018006682651940404, 'colorectal_screening_score_z_obesity': 0.0006942392743112329, 'tnfalpha': 1.1327846616133142e-05, 'l_activating_mutations_in_betacatenin_incolon_cancer_cells': 9.148819220060914e-58, 'interaction_role_wntbetacatenin_pathway': 9.148819220060914e-58, 'jl_weis_wi': 9.148819220060914e-58, 'biol_201351a007898_microarray_analysis': 9.148819220060914e-58, 'perspect': 9.148819220060914e-58, 'phosphobetacatenin': 9.148819220060914e-58, 'update_horm_metab_res_\\x93': 0.0001338995849508461, '\\x93_wang_y_adiponectin': 0.0005423312279404596, 'mutations_cancers': 0.00019843649485691832, 'cases_data': 0.007713134335009549, 'additionalmutations': 4.80231642887269e-05, 'genetics_page': 0.0006631117016177797, 'group_phenotype': 1.0817227640764496e-05, 'multiplestudies': 0.0006321861226151657, 'pole': 0.0001340067097831585, 'strand_synthesis': 0.0038806204677737646, 'duringdna_replication_pole': 9.148819220060914e-58, 'dnapolymerization_proofreading_exonuclease_activities': 9.148819220060914e-58, 'dna_synthesis': 0.0038816544549862162, 'mutationrates': 0.0003991561001946192, 'to_occur': 0.0006750162805663558, 'to_be_caused_by_neoantigens_that_are_generated_as_a_result_of_the_high_mutation_burden': 0.00210348072096923, 'telomere': 9.148819220060914e-58, 'aredeprotected': 9.148819220060914e-58, 'polz': 0.00014027187310178076, 'functions_andsynergy': 0.0018006682651940404, 'frequencyof_mutations': 0.00771518910792271, 'toother_polymerases': 0.00012613970685026185, 'polq_polzrev3l': 2.1856040384675155e-06, 'number_data_visualization_cancer_types': 0.007713134335009549, 'genes_pole': 0.007713134335009549, 'annotation_type': 0.00012613970685026185, 'selection_criteriawe': 1.0987149551122205e-05, 'that_pancandata': 0.007713134335009549, 'colorectal_adenocarcinoma_stomach_adenocarcinoma': 0.007713134335009549, 'author_jr': 9.927994518112209e-05, 'using_estimate_estimation_of_stromal_and_immune_cells_inmalignant_tumor_tissues_using_expression_data_ _estimate_score': 0.00033936015038966223, 'immunescores': 0.007713134335009549, '1st2nd_quartiles_whiskers_range_significance': 9.849136608862707e-05, 'table_cancer_types': 0.0005614408921726238, 'mutations_fig_1b': 9.159789807189547e-06, 'dna_polymerases': 0.007713134335009549, 'eqz_mutations': 0.00771518910792271, '1c_mutations': 0.00012613970685026185, 'mutation_frequencies_p': 0.00771518910792271, 'contrast_thepercentage': 0.00012613970685026185, 'tumor_mutationfrequencies': 0.000598820003809177, 'endometrialto': 0.0015842910551982499, 'cases_genetics_page_number': 0.007713134335009549, 'adenocarcinoma_stadcolon_rectum_adenocarcinoma': 0.0010298344840079976, 'luad_cell_carcinoma_adenocarcinomacesc_paad_cell_carcinoma': 9.148819220060914e-58, 'head_cell_carcinoma': 9.148819220060914e-58, 'case_numbers_number': 6.090898756032753e-06, 'mutations_mutation_status_number_genetics_page': 0.0003734730099819821, 'number_genetics_page': 0.0010298344840079976, 'ratio_transversions_tv': 6.090898756032753e-06, 'ucec_the_xaxis': 6.090898756032753e-06, 'fig_2b': 0.0003343877866148172, 'eqz_tumors': 2.2742115629454836e-53, 'mutational_nucleotide_transversions': 2.2742115629454836e-53, 'exonuclease': 0.0002469065850070426, 'difference_inmutation_rates_association': 1.4055400435083294e-53, 'eqcases_ez_cases': 9.148819220060914e-58, '2cstratified': 9.148819220060914e-58, 'mutationalhotspots': 0.004315547045054443, 'mutational': 1.4055400435083294e-53, 'nucleotide_transversions': 0.007713134335009549, 'domain_positive_tumors_in_additionanalysisin': 8.263922883666513e-55, 'bcelllymphoma_p_data': 1.1686951820486561e-54, 'preliminaryevidence': 8.263922883666513e-55, 'cancerconfers_prognosis': 8.263922883666513e-55, 'p_individual': 9.148819220060914e-58, 'pole_p_eqz_vrs_none_p_eq_ez_eqz_vrs_analysis_ofcases': 9.148819220060914e-58, 'red_bar': 0.0005612913089309412, 'msi_tmn_stage': 1.0817227640764496e-05, 'poleonly': 3.906156580050855e-05, '2a_comparing_the_poleonly_and_cancers': 0.0006768252640912667, 'derivedfrom_digital': 0.00042644740830607715, 'fiure': 0.00012198022841850962, 'estimate_immune': 0.007713134335009549, 'msitumors': 0.00033936015038966223, 'domainmutations_mss_tumors': 9.148819220060914e-58, 'lowerimmunescores': 9.148819220060914e-58, 'figurediscussionan_analysis': 9.148819220060914e-58, 'mutations_inspecific_polymerases': 9.148819220060914e-58, 'polzrev3l_ezand_eqz': 3.2378727458579475e-06, 'cancers_time': 0.001845170519318405, 'incontrast_patients': 0.000598820003809177, 'dfs': 0.0025638622958617, 'mutationfrequencies': 9.777652699983278e-08, 'mutation_groups_msi_estimate_scores_quartiles_scores_number': 1.0817227640764496e-05, 'topole_exonuclease_mutations': 0.004315547045054443, 'evolution_factors': 0.007713134335009549, 'concept_tumors': 0.0005828796252635297, 'bystander_events': 4.2040332007214226e-05, '2a_bmechanistically_polq_polz': 9.148819220060914e-58, 'to_function_in_different_repair_processes_polq_in_alternativemicrohomologymediated_nonhomologous_dna_repair_pathway_and_polz_in_translesion_dna_synthesishow': 9.148819220060914e-58, 'findings_clinicalimplications': 9.148819220060914e-58, 'prognosticimpact': 9.148819220060914e-58, 'to_confirm_the_concept_that_isrevealed_in_the_current_studycolorectal_core_stomach_stad_and_endometrial_ucec_cancers_byspecific_polymerase_mutated_groups_in_tcga_data_sets_supplementaryfigure_ _locations_of_mutations_in_pole_polq_and_rev3l_exomes_inindividual_colorectal_core_stomach_stad_and_uterine_cancers_ucecsupplementary_figure_ _relationships_between_mutation_spectrumand_mutation_counts_pole_polq_and_rev3l_exome_mutations_msi_andtumor_stage_of_individual_cases_supplementary_figure_ _mutationrates_per_mb_yaxis_of_core_stad_and_ucec_cases_with_msi_and_eq_ez_and_eqz_xaxis_mutations_supplementary_figure_ _relationshipbetween_pathology_inflammation_score_and_estimate_immune_scores_forcore_stad_and_ucec_supplementary_figure_ _estimate_immunescores_in_colorectal_core_endometrial_ucec_and_stomach_stadcancers_supplementary_table_ _number_of_cases_with_pole_polq_zrev3l_or_multiple_exome_mutations_in_the_pancan_cohortsupplementary_table_ _contingency_tables_showing_number_of_casesof_colorectal_endometrial_and_stomach_cancers_in_each_categoryabbreviationspole_polymerase_epsilon_polq_polymerase_theta_polzrev3l_rev3_likedna_directed_polymerase_zeta_polz_catalytic_subunit': 0.0002527761692376148, 'likedna': 9.148819220060914e-58, 'polz_subunit': 9.148819220060914e-58, 'content_salaries': 4.336837442112607e-05, 'salaries': 0.0011301720283114149, 'bsk': 1.8444548091260086e-05, 'mention': 3.937935634511928e-08, 'views_policies': 6.421730737670613e-10, 'paper_polemutations_mutations_institute_center': 0.0007641347695089468, '0chuang_genetics_page': 9.148819220060914e-58, 'july_n_cherniack_ad': 9.148819220060914e-58, 'axin2_variants': 0.00025459254806018685, 'therapy_thepatient': 0.0003503299682769458, 'to_have_a_personal_history': 8.770946583746331e-05, 'endoscopy_colonoscopy': 8.770946583746331e-05, 'knownassociation_wntbetacatenin_disordersupports': 9.148819220060914e-58, 'registry': 9.148819220060914e-58, 'risk_odds': 4.154282905155049e-06, 'patientshave': 0.0002608234675785565, 'teeth': 0.0006013795761903325, 'threeof': 4.75607098677357e-06, 'colon_cancers': 0.00029148951293082913, 'neoplasia_one': 9.148819220060914e-58, 'polyposis_adenomas': 9.148819220060914e-58, 'sister': 0.0023667947261930885, 'daughter': 9.148819220060914e-58, 'completedcolonoscopy': 9.148819220060914e-58, 'axin2_family': 9.148819220060914e-58, 'eyebrows_hair': 9.148819220060914e-58, 'eyebrows_hairwith': 8.263922883666513e-55, 'yearsof_age': 9.148819220060914e-58, 'colonoscopy_atage': 9.148819220060914e-58, 'attention_months': 8.770946583746331e-05, 'sinus': 9.148819220060914e-58, 'procedure_duralresection': 9.148819220060914e-58, 'neuroblastoma_neuroesthioblastomabiopsy': 9.148819220060914e-58, 'flap': 9.148819220060914e-58, 'pathology_report': 0.0005371082976310824, 'tumor_vidian_canal_skull_base': 0.0002765895020011375, 'patient\\x99s_recent': 0.001129870936471824, 't_parg2328cys_genes': 0.0003736388273348608, 'hraskit_max_men1': 9.148819220060914e-58, 'mlh1_msh2': 9.148819220060914e-58, 'nest': 0.00011260388781945176, 'incisors': 0.00016065997763415002, 'premolars': 2.6180746742600376e-06, 'video': 0.0006324067207528349, 'history_wisdom_teeth': 8.770946583746331e-05, 'cuspids': 9.148819220060914e-58, 'to_appear_more_similar_to_lateral_incisorson_physical_examination_eyebrows_hair_pattern_andnails': 9.148819220060914e-58, 'dysmorphicfeatures': 0.0006324067207528349, 'bridge_teeth_typicalnumber': 0.009827085960189955, 'mmhyperplastic_polyp': 0.00016061716485395416, 'axin2_testing_thepatient': 8.263922883666513e-55, 'aunthad': 0.00016061716485395416, 'typicalnumber': 1.2880321990609326e-06, 'photograph': 0.00016065997763415002, 'duringupper_endoscopy': 2.6180746742600372e-06, 'axin2_variants_bard1': 9.849136608862707e-05, 'variants_neuroblastoma_areboth_cases': 9.148819220060914e-58, 'seer_tumor_registrybetween_dysregulation': 9.148819220060914e-58, 'gene_panelsnot': 5.79567403594424e-06, 'exomesequencing_technologies': 0.0006026042973632392, 'involving17q241': 0.0014616190772430405, 'features_familyhistory': 0.00010452430922628992, 'hypodontiabased': 0.00015259049938488466, 'andcolonoscopy': 0.00015259049938488466, 'to_bedone_more_frequently_than_every_ _years_0f_yearly_history_and_physical_assessment': 0.00017783908289502142, 'referralto': 0.007713134335009549, 'specialist_imagingthe': 0.00015259049938488466, 'germline_axin2_variants': 0.0004576368763948737, 'monthsadrenalmissensecdnachangec684': 9.148819220060914e-58, 'mutations_genetics_page': 9.148819220060914e-58, 'wholeexome_sequencing': 9.148819220060914e-58, 'geneticmutations': 9.148819220060914e-58, 'doihttpsdoi1018632oncotarget18079_greenwood': 9.148819220060914e-58, 'weinberg_abstract_highrates': 9.148819220060914e-58, 'polyposis_coli': 9.148819220060914e-58, 'modifier_mutation': 9.148819220060914e-58, 'za_genomicanalysis': 0.0014620085655300467, 'deletions': 2.3863323261202395e-05, 'inolfactory_neuroblastoma_implications': 1.4055400435083287e-53, 'deletions_work_drjacquired_data': 2.274211562945482e-53, 'work_njs': 2.274211562945482e-53, 'work_drjacquired': 1.4055400435083287e-53, 'clinic_center': 0.00026701832080125866, 'ofgastroenterology_mayo_clinic': 9.148819220060914e-58, 'h_lahermo': 9.148819220060914e-58, 'i_mutationsin_axin2': 9.148819220060914e-58, 'tooth_agenesis': 9.148819220060914e-58, 'payment': 0.00400914624679688, 'tumors_treatment': 9.148819220060914e-58, 'resection_radiotherapy': 9.148819220060914e-58, 'outpatient_service_medication': 8.263922883666513e-55, 'variableswere': 1.1686951820486561e-54, 'wilcoxson_ranksum_test': 0.0004734482721133418, 'institute_inc_cary': 1.007692708565637e-06, 'payment_variableswere_wilcoxson_ranksum_test_payments_ky_usa_access': 6.172943166471345e-05, 'payments_ky_usa_access': 0.0001285257790231156, 'effort_it': 9.823752575177217e-05, 'payment_clivus': 0.00017082660595042082, 'insurer': 0.0002670894914027044, 'bp_value': 4.353744106680101e-06, 'to_reduce_the_cost_andincrease_the_quality_of_care': 1.1579472589378159e-05, 'reimbursement_model_forcare_improvement': 0.0001285257790231156, 'using_historical_financial_data_ ': 0.0007129960827382031, 'bpci_initiative': 0.00035483153171244545, 'neuroaxis': 0.00210348072096923, 'characteristics_management': 0.004315547045054443, 'bpci_model': 0.007713134335009549, 'monthsafteruptomethodsdata_sourcewe': 0.0014616190772430405, 'to_study_patient\\x99s_healthcare_utilization_longitudinally': 0.00210348072096923, 'tables': 1.6448908735281393e-05, 'summarizedat_were_use_refills': 1.284690556057437e-52, 'component_hadsacrococcygealgroup_chordoma_fig': 7.417164383651313e-53, 'index_admission': 9.148819220060914e-58, 'osteoporosis_hypertension_heartfailure_chf': 9.148819220060914e-58, 'days_months': 0.007713134335009549, 'presence_vein_thrombosis_infection_pneumonia_variables': 0.0002825778555366326, 'means_fullranges': 7.417164383651313e-53, 'component_means_fullranges_group_spine_group_hadsacrococcygealgroup_chordoma_fig': 0.00031823430335478886, 'test_outcomes': 9.148819220060914e-58, 'comparisons_use_payment': 9.148819220060914e-58, 'covariates_age_elixhauser_index_insuranceinaddition': 0.0038806204677737646, 'group_odds_ratios': 5.1897053226075e-06, 'wasperformed': 5.1897053226075e-06, 'spine_group': 7.417164383651313e-53, 'p_females': 1.284690556057437e-52, 'medicaid_medicareinsurance_medicaid_medicareinsurance_sacrococcygeal_group': 7.417164383651313e-53, 'medicaid_medicareinsurance': 7.417164383651313e-53, 'medicaid_medicareinsurance_sacrococcygeal_group': 7.417164383651313e-53, 'andmedicare_insurance': 2.68533315251271e-07, 'index_hospitalization_days': 9.148819220060914e-58, 'dischargeoutcomesindex_hospitalization': 9.148819220060914e-58, 'coccyxn_pvalue': 2.6050536248453345e-07, 'payments': 1.594823976376802e-05, 'rr_rate_group_groups_had': 1.1686951820486561e-54, 'spinal_groupgroups': 8.263922883666513e-55, 'hospital_readmission_medication_refill': 8.263922883666513e-55, 'spinal_groupgroups_hospital_readmission_medication_refill': 8.56718042887189e-05, 'days_multivariate': 0.0003142854144885643, 'medicaid_insurance': 8.263922883666513e-55, 'age_resection_andradiotherapy_treatment': 1.1686951820486561e-54, 'froup_ei': 8.263922883666513e-55, 'management_paradigm': 9.148819220060914e-58, 'resection_andradiotherapy_treatment': 9.148819220060914e-58, 'hospital_readmission': 0.0007862569594425692, 'prescription_refills_cost': 4.9225737744954527e-05, 'neurology_page_days_readmission_rate': 0.0007000951832348714, 'feasibility_bundles': 9.148819220060914e-58, 'situations': 9.148819220060914e-58, 'payments_payments': 4.62610275464176e-05, 'listof_bundles': 9.148819220060914e-58, 'tumors_ormalignancies': 9.148819220060914e-58, 'bpci': 0.0009774762989847197, 'cc_patients': 0.00021836352969597554, 'los': 3.5604405279328306e-06, 'drains_need': 0.0010325216439875707, 'effects_servicesrendered': 0.0010325216439875707, 'neurology_page': 0.0007000951832348714, 'days_readmission_rate': 0.0007002817596366058, 'lau': 1.1424227512080455e-05, 'utilization_effort': 0.001388599458763146, 'beenbecause': 0.0038806204677737646, 'type_medicaid': 2.2673179907113364e-05, 'patients\\x99_diagnoses': 0.0006943564809761616, 'modelon_patients': 0.0013882295497307361, 'to_decrease_thelength_of_stay_complications_rate_and_readmissions': 0.0038806204677737646, 'complications_ratewhich': 9.148819220060914e-58, \"therefore_itmight_be_important_for_the_bpci_to_stipulate_that_certainrare_and_complex_neurosurgical_conditions_should_bemanaged_at_centers_of_excellencelimitationsthe_limitations_of_our_study_and_the_marketscan_database_should_be_recognized_in_light_of_the_results_thedatabase_combined_data_for_both_chordoma_and_chondrosarcoma_because_both_conditions_were_coded_usingthe_same_icd910_codes_the_database_does_not_includedata_on_various_surgical_techniques_the_extent_of_resection_and_the_exact_anatomical_location_of_the_tumor_besidesthe_marketscan_database_has_information_oncomplications_readmission_and_outpatient_services_itdoesn't_include_information_regarding_details_such_ascauses_for_readmission_complications_radiotherapy_useand_type_of_radiotherapy_used\": 9.148819220060914e-58, 'extent_location': 0.00018956311875359112, \"itdoesn't\": 9.148819220060914e-58, 'information_ascauses': 9.148819220060914e-58, 'report_treatment_biases': 2.566848444534555e-05, 'cases_sarcoma': 0.0014616190772430405, 'system_reimbursement': 0.0016897886161942328, 'data_manuscript_data': 2.7580800009212732e-05, 'to_improve_outcomes_and_decrease_cost_chordoma_and_chondrosarcoma': 6.0762327941524466e-05, 'radiotherapy_ofoutpatient_services': 0.004315547045054443, 'patients\\x99_comorbidities_disease_complexity_risk_hospitalsshould': 9.148819220060914e-58, 'measures_infarction_classification': 9.148819220060914e-58, 'condition_categoryeras': 0.00017933259336108505, 'contributionsza': 0.0014616190772430405, 'to_access_the_raw_data': 2.9747504732969153e-05, 'geneva': 0.0011075402231842013, 'yf_overuse_payment': 9.148819220060914e-58, 'sci_\\x93': 9.148819220060914e-58, 'luthi_jc_saundersld_beck': 9.148819220060914e-58, 'wa_algorithms_penson_d_whiteside_ma_concepts_management_directions': 9.148819220060914e-58, 'bv': 8.263922883666513e-55, 'kindblom_lg_prognostic': 0.0004202357087063657, 'prevost': 9.148819220060914e-58, 'outcome_cost_variation_m_reband_andpostdischarge_outcomes': 9.148819220060914e-58, 'viola_dc_schoedl': 9.148819220060914e-58, '\\x93_gopalakrishnan_cv_shrivastava': 9.148819220060914e-58, 'study_designs': 7.598189069294107e-06, 'to_identify_the_unwarranted_share_of_practice': 1.2408975727002461e-07, 'variationand': 7.596165063911731e-06, 'considerably_raising_questions_abouttheir_appropriateness_studies_focused_on_measuring_practice_variation_rather_than_contributing_to_the_reduction_ofunwarranted_practice_variation': 0.0004656260911730009, 'embase_ebscocinahl_wileycochrane_library': 0.007713134335009549, 'questionsabout_differences': 7.752673078131058e-05, 'cannotbe': 9.148819220060914e-58, 'characteristics_preference': 9.148819220060914e-58, 'healthcare_professionals': 0.00024791243738548854, 'infant_health': 0.0002943830798898022, 'mother_child_healthmay': 0.000489923995670151, 'remainedstrong_practicevariation': 0.0018006682651940404, 'practice_variation': 0.0019281462280566753, 'when_identified_\\x93': 3.147172152063794e-05, 'researchprotocol': 0.0018006682651940404, 'followingterms': 0.0018006682651940404, 'term_\\x9ccaesarean_section\\x9d': 1.1686951820486561e-54, 'meshterm\\x9cpractice': 8.263922883666513e-55, 'bmc_pregnancy_childbirth_page': 0.0016557804685556309, 'meshterm\\x9cpractice_tworesearchers': 0.0003292446759758836, 'type_prospective_retrospective': 0.007713134335009549, 'version_x81_duplicates': 0.0018006682651940404, 'tworesearchers': 8.263922883666513e-55, 'titles_abstractsthe_researchers': 9.148819220060914e-58, 'inaustralia': 9.148819220060914e-58, 'whether_to_include_the_ _or_not_mv_and_pdb_in_case_of': 8.322709924400053e-05, 'text_screening': 9.148819220060914e-58, 'researcherswho': 9.148819220060914e-58, 'criteria_data': 9.148819220060914e-58, 'researcher_data': 9.148819220060914e-58, 'researcher_pdbdata_extractionto': 0.00024831101020746386, 'section_rates': 0.0009413905413816556, 'casemix_correction': 0.007713134335009549, 'robson_classification': 4.04810352605764e-05, 'rate_reporting_using': 6.613082962170237e-07, 'measured_measuring_patient_preference_requiresadditional_data_collection': 0.0006324067207528349, 'cohortsize': 0.0018006682651940404, 'asample': 0.00013772387192018587, 'feedbackto': 0.00013772387192018587, 'physiciangroup_we': 0.004315547045054443, 'outcome_reporting': 4.0416527735472175e-06, 'variablesin_addition_wescored': 0.007713134335009549, 'abstracts': 0.007713134335009549, 'subsaharanregions': 0.0002943830798898022, 'section_rate': 0.007965688364544891, 'reportedminimum_section_rates': 9.148819220060914e-58, 'outlier': 9.148819220060914e-58, 'reportingon_variation_sample': 0.002031429029309112, 'selection_frame': 0.0014616190772430405, 'characteristics_correction': 0.0003069306742853986, 'reduce_this_heterogeneity_and_to_increase_the_quality_of_casemix_correction_the_who_in_ _recommended_to_use_the_robson_classification_as_the_standardfor_casemix_correction_for_studies_on_caesarean_sectionrates_  _in_the_period_\\x93_ _out_of_ _studiesused_the_robson_classification_ _four_of_these_studies_ ': 3.365560733702061e-05, 'to_use_the_robson_classification_as_the_standardfor_casemix_correction_for_studies_on_caesarean_sectionrates_  _in_the_period_\\x93_ _out_of_ _studiesused_the_robson_classification_ _four_of_these_studies_ ': 0.0011075402231842013, 'patient_characteristics': 0.0010298344840079976, 'the_robson_classification_ _thepercentage_of_studies_that_corrected_for_casemix_did_notchange_over_time_figure_ ': 1.5355432501961963e-05, 'rate_odds_ratios': 0.0018006682651940404, 'patientpreference_questionnairesthat': 0.0018006682651940404, 'birth': 0.004315547045054443, 'to_measure_these_outcomes_arelisted_in_additional_file_ _many_different_variables_wereused_to_measure_neonatal_ _and_maternal_ _outcomes_neonatal_mortality_ _apgar_score_ _maternal_mortalityandhaemorrhage_ _are_outcomes_that_were_measured_mostoften_half_of_the_outcome_variables_were_used_in_justone_single_study_table_ _shows_the_numbers_of_studiesper_aggregation_level_that_took_neonatal_and_maternaloutcome_into_account_neonatal_and_maternal_outcomeswere_most_often_reported_if_variation_of_caesarean_nicu_admissionprior_to_the_survey_patient_preference_was_assessed_byposing_a_variety_of_questions_on_the_reason_of_the_caesarean_section_and_perceived_influence_on_decision_makingno_studies_reported_the_quality_of_decision_making_in_of_the_ _studies_ _a_sample_of_the_study_populationwas_used_to_measure_patient_preference_samples_variedbetween_ _and_ _women_and_three_studies_used_apredefined_sampling_frameusefulness_for_audit_and_feedbacktable_ _shows_the_study_characteristics_by_aggregation_levelthe_majority_of_the_studies_ _used_one_aggregationlevel_a_minority_used_two_ _and_only_three_studies_used_three_aggregation_levels_healthcare_providersindividual_physicians_group_of_physicians_hospitals_or_hospital_categories_were_compared_in_ _studies_ _andgeographic_areas_national_or_regional_in_ _studies_hospitals_ _and_grouped_hospitals_ _eg_private_vspublic_hospitals_were_most_often_used_as_aggregation_levelof_analysis_medical_practice_variation_of_caesarean_sectionfig_ _the_effect_of_casemix_correction_on_different_aggregation_levels_0cvink_  _bmc_pregnancy_and_childbirth_           _page_ _of_table_ _study_characteristics_by_aggregation_levelnumber_of_studiesaverage_cohort_sizemedian_cohort_sizeentire_population_measured_instead_of_samplereported_variation_in_caesarean_section_rate_average_ofstudiesreported_variation_in_caesarean_section_rate_median_ofstudiescasemix_correctionmedical_outcomeindividuallevelgroup': 0.004315547045054443, 'shows_the_numbers_of_studiesper_aggregation_level_that_took_neonatal_and_maternaloutcome_into_account_neonatal_and_maternal_outcomeswere_most_often_reported_if_variation_of_caesarean_nicu_admissionprior_to_the_survey_patient_preference_was_assessed_byposing_a_variety_of_questions_on_the_reason_of_the_caesarean_section_and_perceived_influence_on_decision_makingno_studies_reported_the_quality_of_decision_making_in_of_the_ _studies_ _a_sample_of_the_study_populationwas_used_to_measure_patient_preference_samples_variedbetween_ _and_ _women_and_three_studies_used_apredefined_sampling_frameusefulness_for_audit_and_feedbacktable_ _shows_the_study_characteristics_by_aggregation_levelthe_majority_of_the_studies_ _used_one_aggregationlevel_a_minority_used_two_ _and_only_three_studies_used_three_aggregation_levels_healthcare_providersindividual_physicians_group_of_physicians_hospitals_or_hospital_categories_were_compared_in_ _studies_ _andgeographic_areas_national_or_regional_in_ _studies_hospitals_ _and_grouped_hospitals_ _eg_private_vspublic_hospitals_were_most_often_used_as_aggregation_levelof_analysis_medical_practice_variation_of_caesarean_sectionfig_ _the_effect_of_casemix_correction_on_different_aggregation_levels_0cvink_  _bmc_pregnancy_and_childbirth_           _page_ _of_table_ _study_characteristics_by_aggregation_levelnumber_of_studiesaverage_cohort_sizemedian_cohort_sizeentire_population_measured_instead_of_samplereported_variation_in_caesarean_section_rate_average_ofstudiesreported_variation_in_caesarean_section_rate_median_ofstudiescasemix_correctionmedical_outcomeindividuallevelgroup': 3.365560733702061e-05, 'neonatal_maternaloutcome': 0.004315547045054443, 'byposing_a_variety_of_questions_on_the_reason_of_the_caesarean_section': 5.687294677383274e-05, 'sampling_frameusefulness': 0.0003034732833474384, 'hospitallevel\\x93hospitalcategory\\x93regionnational_sections': 0.0006674076661460604, 'level_to_explain_differences_in_caesarean_section_rates_thevariables_that_were_used_are_listed_in_additional_file_ _financial_consequences_of_unwarranted_variation_of_caesarean_section_rates': 0.0010298344840079976, 'to_explain_differences_in_caesarean_section_rates_thevariables_that_were_used_are_listed_in_additional_file_ _financial_consequences_of_unwarranted_variation_of_caesarean_section_rates': 0.0005536611936400708, 'to_reduce_unwarranted_variation_of_caesareansection_ratesstrengths_and_limitationsa_strength_of_our_review': 2.8168276501110494e-06, 'anindepth_overview': 9.148819220060914e-58, 'qualityassessment': 9.148819220060914e-58, 'to_distinguish_between_warranted_and_unwarranted_practicevariation_by_performing_casemix_correction_and_analysing': 0.0018006682651940404, 'section_ratesbetween_healthcare_providers': 0.0018006682651940404, 'odds_regression_analysis': 0.0003732887667714682, 'noimprovement_aspect': 0.007713134335009549, 'variation_canbe': 0.0006264573400700461, 'who_figo': 2.1648286725769866e-05, 'sectionrates': 0.00024831101020746386, 'at_least_use_the_robson_classificationand_to_standardise_variables_for_additional_casemix_correction': 0.007713134335009549, 'obstetricians': 0.00032618452265076087, 'ismore': 0.004315547045054443, 'casemix_differences': 9.148819220060914e-58, 'differences_this': 9.148819220060914e-58, 'requiresthat_to_decompose_regional_unwarranted_variation_into_lower_levels_of_aggregation_thisdecomposition': 0.0018006682651940404, 'clientbase': 0.0004294386118539378, 'thelower_number': 9.148819220060914e-58, 'validityand_reliability': 9.148819220060914e-58, 'stimulusfor_change': 0.0013882295497307361, 'professionalsmight': 9.148819220060914e-58, 'to_adapt_clinical_behavior_our_results_show_that_the_wide_variation_in_outcome_variablesdemands_consensus_and_standardization_studies_will_become_more_comparable_and_better_interpretable_when_astandard_set_of_outcomes_is_used_for_maternal_infectiousmorbidity_outcomes_after_caesarean_delivery_a_core_outcome_set_cos_is_developed_  _we_encourage_to_develop_a_cos_for_neonatal_outcomes_after_caesareansectionforty_years_of_research_on_caesarean_section_rates_havebeen_unable_to_reduce_unwarranted_practice_variationour_study': 9.148819220060914e-58, 'astandard_set': 9.148819220060914e-58, 'core_outcome': 9.148819220060914e-58, 'to_develop_a_cos_for_neonatal_outcomes_after_caesareansectionforty_years_of_research_on_caesarean_section_rates': 0.007713134335009549, 'searchstrategies': 6.298103209041554e-05, 'title_title': 9.148819220060914e-58, 'period_years': 9.148819220060914e-58, 'questionnaire_survey': 5.445560655733074e-05, 'cohort_size': 0.007713134335009549, 'to_calculate_the_most_recent_caesarean_section_rate_data_source_data_source_that_was_used_by_the_authors_to_calculate_thereported_caesarean_section_rate_it_is_reported_as_\\x9cother\\x9d': 0.004315547045054443, 'authors_to_calculate_thereported_caesarean_section_rate': 0.004315547045054443, 'correction_thestudy': 0.00013022768211194103, 'caesareansection_rate': 0.00013022768211194103, 'odds_ratios': 0.0002578525437194323, 'to_explain_reported_difference_in_caesarean_section_rates_between_healthcare_professionals_hospitals_groupsof_hospitals_or_geographic_areas_ynadditional_file_ _studies_per_country_additional_file_ ': 0.0005536611936400708, 'approachfor_resection': 0.0008131326422280233, 'tmehas': 9.148819220060914e-58, 'to_decreased_local_recurrence_rates_and_increasedcancerspecific_survival_rates_  ': 9.148819220060914e-58, 'to_have_the_sameoncological_and_functional_postoperative_outcome_ ': 0.00021921962201374475, 'difference_patient_populations': 0.0018006682651940404, 'negativeimpact': 8.649691595586185e-05, 'resection_study': 0.0011075402231842013, 'hadundergone': 1.2059392419268918e-05, 'followup_one_astumor_recurrence_surveys_variableswere_using_anova_or_regression': 0.0007392767855917426, 'surgery_foradenocarcinoma': 0.0011075402231842013, 'imaging_mri': 9.148819220060914e-58, 'mri_therapyconsisted': 9.148819220060914e-58, 'rectum': 0.0007956673215405282, 'otherpatients': 9.8867410745592e-07, 'radiochemotherapy_conditions': 5.191680018473243e-05, 'sepsis_gas_pus_feces': 1.2056180270553533e-05, 'ofasymptomatic_al_treatment': 1.2056180270553533e-05, 'pathology_outcomes': 1.2056180270553533e-05, 'contrast_enema': 0.00011433162374159948, 'ctscanning_results': 0.00021513839407779188, 'bloodtests': 9.148819220060914e-58, 'one_surveys': 9.148819220060914e-58, 'astumor_recurrence': 0.00023671983705856548, 'followup_data_quality': 1.2056180270553533e-05, 'severity_ofsymptoms': 0.0002825778555366326, 'stoma_placement_colostomy_ileostomy': 0.0011075402231842013, 'andwithout_al_wal': 8.263922883666513e-55, 'using_the_logrank_testall_statistical_analyses': 0.0038806204677737646, 'using_anova_or': 1.9703013732189786e-07, 'anova_tests_factors': 0.0002578525437194323, 'period_patients': 0.0005255240447748787, 'ansand': 9.148819220060914e-58, 'resectionandor_resection': 9.148819220060914e-58, 'resectionandor_resection_procedure_sal_aal_stomadetails': 0.00016514592078180446, 'p_patients': 0.00032618452265076087, 'anastomosis': 0.0020747306964931833, 'groups_variables': 2.691485445926056e-06, 'sal_aal_stomadetails': 4.1424744396117665e-07, 'screening_testsymptoms_aal_\\x93': 0.00011433162374159948, 'bmi_index_iqrinterquartile': 0.00016468766601768244, 'al_aal': 7.417164383651313e-53, 'stoma': 1.284690556057437e-52, 'ctscan': 0.0005377432961335719, 'stoma_reversal': 0.0018458055178208945, 'aal': 3.890286553500586e-05, 'outcome_leakage_aal_management': 3.801034089328411e-05, 'ctscan_stoma_reversal_ileostomy_followup_chemotherapy': 0.00232909012027474, 'symptomaticanastomosis_leakage_sal_acute_management': 0.0011075402231842013, 'colostomy_placement': 0.00572579098709217, 'stomathere': 0.001845170519318405, 'to_undergo_redo_surgery_for_evisceration_and_smallbowel_ileus_both_on_postoperative_day': 0.0038806204677737646, 'stoma_placement_colostomy': 5.9158009567006e-06, 'ileostomy': 3.801034089328411e-05, 'groups_resection_margins': 9.148819220060914e-58, 'colostomyplacement': 9.148819220060914e-58, 'recurrence_whereasone_patient': 9.148819220060914e-58, 'colostomy': 9.148819220060914e-58, 'ileostomy_followup': 0.00010740789809797397, 'p_respectivelyeight_percent': 3.801034089328411e-05, 'groups_p_details': 0.0006321861226151657, 'permanentredosurgery_patients': 9.148819220060914e-58, 'colostomy_placement_aftersoma_reversal': 9.148819220060914e-58, 'colostomy_placement_comorbidities_cardiac_insufficiency': 0.001845170519318405, 'colostomyplacement_analysis': 0.001845170519318405, 'p_data': 9.148819220060914e-58, 'center_study': 9.148819220060914e-58, 'intent_outcomes': 0.0011075402231842013, 'not_to_be_at_risk_for_an_increased_0cartus_  _bmc_cancer_           _page_ _of_ano_at_risksymptomatic_leakageasymptomatic_leakageno_leakagebno_at_risksymptomaticleakageasymptomaticleakageno_leakagewalsalaalwalsalaalp0527p0480fig_ ': 0.001845170519318405, 'to_be_similar_incontrast_equivalentlocal_distant_disease_recurrencerates_and_overall_survival_rates': 0.00011413593752663788, 'al_al': 2.057141871636397e-06, 'to_be_associated_with_animpaired_overall_survival_in_such_patients': 0.00012628521083484743, 'findingscould': 0.00019772319418830678, 'blood_testing_enema': 0.0038806204677737646, 'hain_we': 0.0006768252640912667, 'impact_sal_asymptomatic_al_aal_±_iqrmedian': 0.007713134335009549, 'differencebetween': 0.0038806204677737646, 'sal': 9.148819220060914e-58, 'percent_rate_finding': 9.148819220060914e-58, 'cystectomy': 0.0011078353336573638, 'hospital_staythey': 0.0009689454592459252, 'information_protocol_baseline_postintervention': 2.596508998541679e-05, 'interventiongroup': 0.00011503764056533725, 'exercise_programme': 0.00017779642312808948, 'aerobic': 2.897444739235557e-06, 'strengtheningexercises': 9.148819220060914e-58, 'weeks_aerobic': 9.148819220060914e-58, 'baseline_postintervention': 0.00014977554237073727, 'neoplasm_complications': 9.148819220060914e-58, 'process_evaluation': 9.148819220060914e-58, 'cystectomy_rarc': 1.8090871199370374e-05, 'physicaloutcomes_support': 0.0019127833147525456, 'phystec_sweden': 0.007713134335009549, 'evidence_studies': 9.148819220060914e-58, 'exercise_programmes': 9.148819220060914e-58, 'recommendations_it': 0.0004988292642554344, 'tworeviews': 9.148819220060914e-58, 'performance_recommendations_it': 9.148819220060914e-58, 'thesame_exercise_studies': 1.5437633414959574e-05, 'exercise_mobilisation_cystectomy': 0.0001829542651610016, 'model_programme_conductedat_hospital': 9.148819220060914e-58, 'effectson_function': 9.148819220060914e-58, 'exercise_adherence_intervention': 0.0001877208272571672, 'to_understand_thekinds_of_support_that_are_optimal_use_behaviour_change_0cporserud_  _bmc_cancer_           _page_ _of_screened_for_eligibility_in_medical_records_by_the_responsible_researcher_rr': 0.007713134335009549, 'studyprotocol_wellbeing_readmissions_tocomplications': 0.007713134335009549, 'cancerto': 0.0007643384077950606, 'physicalhypothesiswe_hypothesise_recommendations': 1.247090053228339e-05, 'standardised': 1.877466124912009e-06, 'intervention_inphc_support': 9.148819220060914e-58, 'exerciseprogramme_recommendations': 9.148819220060914e-58, 'afterhaving': 0.0004100538998299479, 'confirmation_email': 4.742954335461825e-08, 'physicalhypothesiswe_hypothesise_standardised_exerciseprogramme_recommendations_inthe_treatment_arm_recommendations_aerobicexercise_trainingby_research_activity_information_information': 2.900534634787894e-06, 'enrolment_log': 4.742954335461825e-08, 'inthe_treatment_arm': 0.0006324067207528349, 'anindividual': 0.00012184426248535181, 'function_capability_intervenes': 5.822320874193418e-06, 'behaviour_change': 0.0003570460998910372, 'behaviour_calore_taxonomy': 3.012831237073818e-05, 'information_weeks': 0.0018456622073465703, 'to_be_used_to_improve_the_specification_of_interventions_behavioural_techniques_proven_effective_tosupport_behaviour_change_are_goalsetting_graded_tasksselfmonitoring_feedback_and_reward': 8.263922883666513e-55, 'techniques_tosupport_behaviour_change': 9.148819220060914e-58, 'tasksselfmonitoring_feedback': 9.148819220060914e-58, 'interventionall_patients': 0.0007641347695089468, 'physiotherapists': 9.148819220060914e-58, 'afig_logic_model': 9.148819220060914e-58, 'aerobicexercise': 2.897444739235557e-06, 'file_theprogramme': 4.742954335461825e-08, 'followed_are': 4.742954335461825e-08, 'patientsare': 1.1686951820486561e-54, 'to_take_daily_walks_in_their_neighborhoodthe_number_of_recommended_steps_per_day': 8.263922883666513e-55, 'periodthe_physiotherapist': 0.0007008712380191807, 'physiotherapist': 9.148819220060914e-58, 'trainingby_research': 9.148819220060914e-58, 'to_walk_as_faras_possible_for_ _min': 0.001845170519318405, 'outcome_variablewill': 0.0002627390828414282, 'walks_sittostandexercises': 0.004315547045054443, 'to_determine_walking_speed_in_metersper': 0.00048362067048935835, 'm_walk_testchair': 0.00024810373354211296, 'chair': 0.001845170519318405, 'dynamometer': 0.001845170519318405, 'chairstand_test_patient': 1.6810264108211965e-05, 'to_rise_from_a_chairas_many_times_as_possible_for_ _s_the_outcome_variableis': 0.0010301089213447113, 'posture': 0.0007641347695089468, 'transition_activity_monitor': 8.263922883666513e-55, 'posture_using_the_2item_stanford_brief_activitysurvey_sbas_ _the_sbas_assesses_the_usualamount_and_intensity_of_physical_activity_during_thepast_year_that_a_person_performs_the_first_item': 1.1686951820486561e-54, 'does_not_provide_feedback_to_the_patientthe_monitor': 8.263922883666513e-55, 'using_the_2item_stanford_brief_activitysurvey_sbas_ _the_sbas_assesses_the_usualamount_and_intensity_of_physical_activity_during_thepast_year_that_a_person_performs_the_first_item': 0.0007641347695089468, 'sbas': 9.148819220060914e-58, 'usualamount_intensity': 9.148819220060914e-58, 'seconditem': 0.0002664871522256321, 'job_work': 0.0011075402231842013, 'using_the_hospital_anxiety_and_depression_scale_hads_  ': 0.000542390738251689, 'ethicsthe_project': 0.00034919108093261076, 'attentionthan': 0.0002182471618650516, 'itwill': 9.148819220060914e-58, 'to_motivate_the_physiotherapists_inphc_to_offer_such_treatmentsample_sizefunction_evaluatedthe_primary_outcome': 9.148819220060914e-58, 'readmissions': 0.007713134335009549, 'board_attentionthan_increase_analysis_sample_readmissions_study_significance_to_assess_the_effect_of_theinterventionimplementation_processbecause_the_intervention_design_is_intricate_we_will_inaddition_to_testing_effects_of_the_canmore_programmeon_patientlevel_outcome_measures_also_observe_andgather_information_on_factors_that_might_have_influencedthe_implementation_of_the_programme_  _the_evaluation_of_the_implementation_process_will_be_based_on_themedical_research_council_guide_for_process_meetings': 0.0018742935706510437, 'management_plan': 3.0595973736304487e-05, 'to_sign_off_all_reported_datasource_datain_this_study_physicaltests_movement_sensor_datapatientreported_outcome_measures_and_medical_recordswill_be_regarded_as_source_datacodingin_the_study_database_patients_will_be_identified_onlythrough_the_unique_randomisation_number_all_data_willbe_stored_with_coded_identification_and_no_access_to_thepatients\\x99_i_d_patient_identification': 5.693284547016032e-05, 'to_assess_the_effect_of_theinterventionimplementation_processbecause_the_intervention_design_is_intricate_we_will_inaddition_to_testing_effects_of_the_canmore_programmeon_patientlevel_outcome_measures_also_observe_andgather_information_on_factors_that_might_have_influencedthe_implementation_of_the_programme_  _the_evaluation_of_the_implementation_process_will_be_based_on_themedical_research_council_guide_for_process': 5.698140837742175e-06, 'inaddition': 0.0007641347695089468, 'meetings': 0.00025766632575304214, 'to_offer_recommendations_on_whichstrategies_to_use_when_implementing_the_canmoreprogramme_in_other_clinical_settings_and_on_a_largescalethe_initial_strategies_for_the_process_evaluation': 0.0002705087950104099, 'extentto': 9.889054295935379e-07, 'canmore_programme': 0.00012040101594931771, 'registerediethe_extentcontext': 0.0007000951832348714, 'to_conduct_an_interviewstudy_on_patients\\x99_experiences_of_the_intervention_inaddition_we_plan_to_collect_information_on_possiblebarriers_that_might_have_influenced_the_implementation_ofthe_programme_and_facilitators_that_mighthave_supported_it_at_the_various_clinical_sites': 0.007713134335009549, 'to_collect_information_on_possiblebarriers_that_might_have_influenced_the_implementation_ofthe_programme_and_facilitators_that_mighthave_supported_it_at_the_various_clinical_sites': 0.007713134335009549, 'implementation_programme_facilitators': 0.004315547045054443, 'mighthave': 9.148819220060914e-58, 'that_it': 9.148819220060914e-58, 'to_assess_how_the_intervention_was_delivered_aswell_as_experiences_of_the_different_stakeholders_patients_physiotherapists_and_other_health_care_staff_aswell_as_managersby_using_several_sources_for_data_collection_triangulation': 0.0003022165162482692, 'to_assess_how_the_intervention_was_delivered_aswell_as_experiences_of_the_different_stakeholders_patients_physiotherapists_and_other_health_care_staff_aswell_as_managersby_using_several_sources_for_data_collection_triangulation_length_events_information_group_receivea_light_intervention': 0.0023815910984605762, 'trustworthinessof': 0.0038806204677737646, 'to_guide_the_investigation_of_context_ie_potentialbarriers_and_facilitators_of_the_implementation_processconstructs_that_we_believe_specifically_impact_the_implementation_outcomes_in_the_present_study_and_guidelinesforand_observation_protocolsinterview': 0.00023530010952105463, 'specifically_impact_the_implementation_outcomes_in_the_present_study_and_guidelinesforand_observation_protocolsinterview': 0.007713134335009549, 'processevaluation': 0.0019127833147525456, 'beneficialto': 0.0005742866231974045, 'activity_hrqolreduce_fatigue': 9.366803170790729e-06, 'to_design_feasible_and_easy_to_implement_interventions_in_a_health_care_setting_our_intervention': 0.00210348072096923, 'intervention_period': 3.8870609694154056e-05, 'care_forpatients': 3.8880967771215806e-05, 'aerobic_and_musclestrengthening_exerto_ourcises_to_be_associated_with_increased_physical_activity_behaviour_ _setting_graded_taskseg_goalsupportat_discharge_from_the_hospital': 0.00029599327620783605, 'information_group_receivea_light_intervention': 6.34646531476322e-07, 'not_to_give_the_control_group_any_advice_onphysical_activity': 0.007713134335009549, 'movement_thesepatients': 0.00011386402488693955, 'patientperspectives_experiences': 3.8870609694154056e-05, 'theprocess': 0.0016480626375926124, 'qol_quality': 0.002104041233387171, 'idea_it': 3.4348996837103175e-05, 'physiotherapistinvolved': 0.00014977554237073727, 'secondwe': 9.148819220060914e-58, 'recruitment_period': 9.148819220060914e-58, 'to_have_continued_contact_withthe_clinics_and_a_new_educational_structure_for_trainingif_neededcystectomyin_summary': 0.007713134335009549, 'rct': 0.0007035667068513752, 'cystectomyrct': 9.148819220060914e-58, 'spirit_protocol_itemsrecommendations': 9.148819220060914e-58, 'walk': 0.00013481355048464152, 'ma_lh_mnb_mh': 0.00022771936739542464, 'proceeds_allauthors': 9.148819220060914e-58, 'manuscri': 9.148819220060914e-58, 'nlr_plr_lmr': 3.132554582128079e-07, 'to_identify_underlying_significance_in_surgical_pdac_bestfit_cutpoints_ratiocomponents_link_tostratify_patients_with_earlystage_pancreatic_cancer_andguide_future_treatment_plansconventionally_survival_outcomes_among_cancer_patients_outcomes_counts_percentages': 1.9158911843352603e-05, 'to_identify_underlying_significance_in_surgical_pdac': 5.108919907837911e-09, 'pdac_patients_estimates': 9.148819220060914e-58, 'analyses_ratio_analysis': 9.148819220060914e-58, 'resectionbetween': 0.0011075402231842013, 'bestfit_cutpoints': 5.108919907837911e-09, 'ratiocomponents': 5.108919907837911e-09, 'driversresults': 7.417164383651313e-53, 'nlr_plr': 1.284690556057437e-52, 'controversy': 0.0005234829536595234, 'tostratify_patients_with_earlystage_pancreatic_cancer_andguide_future_treatment_plansconventionally_survival_outcomes_among_cancer_patients': 5.108919907837911e-09, 'manysingleinstitution_studies': 0.0004737611937116502, 'to_have_promising_prognostic_value_fewstudies_have_examined_the_effect_of_these_inflammatoryratios_in_us_surgical_cohorts_[': 0.00013254910181495863, 'value_fewstudies': 0.001128162151175775, 'to_establish_optimal_nlr_plrand_lmr_cutpoints_for_determining_os_and_recurrencefree_survival_rfs_and_define': 0.007713134335009549, 'withpdac': 2.9402948113849672e-05, 'pdac_patients': 3.3749696566974736e-07, 'pancreatectomy': 2.0660128746278286e-05, 'counts_percentages': 0.0005263009120446208, 'were_were': 9.148819220060914e-58, 'using_maximallyselected_rank_statistics_based_on_the_logrank_method_ _the_resulting_cutpoint_for_each_ratio': 9.148819220060914e-58, 'based': 8.591617795464591e-06, 'using_maximallyselected_rank_statistics_based_on_the_logrank_method_ _the_resulting_cutpoint_for_each_ratio_inrelation_comorbidity_index': 0.0005264412061919845, 'inrelation': 1.4033153603315118e-07, 'comorbidity_index': 4.80231642887269e-05, 'cci': 7.503404333639232e-08, '\\x89¥_medicare': 7.503404333639232e-08, 'insurance_provider': 1.223650718343573e-09, 'cci_\\x89¥_medicare_nlr_plr_\\x89¥': 7.505404213370705e-08, 'nlr_plr_\\x89¥': 7.503404333639232e-08, 'p_analysestable': 9.148819220060914e-58, 'rfs_hr': 9.148819220060914e-58, 'plr_lmr': 0.0008581749454218445, 'stage_presence_nlr_node_positivity_perineuralinvasion': 0.0002208255543092432, 'to_identify_optimal_cutpoints_forpredicting_os_and_rfs_os_optimal_cutpoints_for_nlrplr_and_lmr': 0.00015371581455614675, 'lymphocyte_percentagealone': 5.583047209616082e-06, 'nlr_os_rfs_inpdac_patients': 6.298103209041554e-05, 'curativeintent': 0.0011075402231842013, 'highvolume_center_plr_lmr': 0.0006810685397702696, 'andperform': 0.0005263009120446208, 'metastasis_furthermorelinkshave': 7.417164383651313e-53, 'nora': 7.417164383651313e-53, 'nlr': 0.0007050220401446327, 'nlr_\\x89¥': 9.148819220060914e-58, 'potential_association_range': 9.148819220060914e-58, 'hr_p_giakoustidis': 9.148819220060914e-58, 'pretreatment_nlr': 9.148819220060914e-58, 'significance_metaanalyses': 0.0038806204677737646, 'association_range': 1.1502101790576655e-05, 'aclaviendindo_classification_ratio_plr_platelet_nlr': 8.00361361770791e-05, 'additionallywe': 0.0008581749454218445, 'reference_nodesamodel': 9.148819220060914e-58, 'claviendindo_complicationsabbreviations_comorbidity_nlr_neutrophil_contrast_patients_nodesabbreviations_comorbidity_nlr_neutrophil': 9.148819220060914e-58, 'cancer_page_decrease': 9.148819220060914e-58, 'nlr_pdacalthough_cutpoint': 9.148819220060914e-58, 'nlr_variations': 9.148819220060914e-58, 'withsome_groups': 9.148819220060914e-58, 'to_perform_a_continuous_analysis_to_identify_an_optimal_cutpoint_for_the_nlr_in_relation_to_survival_based_solely_onthe_data_from_our_cohort_optimal_cutpoints_of_ _foros_and_ ': 0.007713134335009549, 'count_percentage': 5.584534783033191e-06, 'study_supportsthe': 9.121588534293335e-08, 'findingis': 0.0005034057898537578, 'showedlow_lymphocyte': 9.148819220060914e-58, 'to_be_poor_prognostic_indicatorsin_pancreatic_and_colorectal_cancers': 9.148819220060914e-58, 'science_findings': 0.0038806204677737646, 'chawla': 0.0003342986407258492, 'pdacresection': 0.0011075402231842013, 'ratioa_model': 0.0003022165162482692, 'populations_differences': 0.00013784269647271227, 'monocyte_presence': 0.0038806204677737646, 'claviendindo_complicationsabbreviations_comorbidity_nlr_neutrophil_withsome_groups_implications_contrast_significance_cohort_patients_nodesabbreviations_comorbidity_nlr_neutrophil_groups_populations_differences_investigatedthis_parameter': 0.0018006682651940404, 'inangiogenesis_tumor_growth_prognosis': 9.148819220060914e-58, 'lmr': 9.148819220060914e-58, 'investigatedthis_parameter': 0.0018006682651940404, 'li': 0.0007927789382340439, 'oflmr_cutpoints_patients': 0.0024992904616399536, 'abeet': 0.0018006682651940404, 'comparedto_other': 9.148819220060914e-58, 'ratios_application_ofplr': 9.148819220060914e-58, 'giakoustidis': 1.1686951820486561e-54, 'pretreatmentplr': 8.263922883666513e-55, 'decreasedos_plrdid_patients': 8.263922883666513e-55, 'plr_tobe': 0.0007959416758056306, 'cutpoint_values_plr': 0.00013784269647271227, 'usedfor': 1.284690556057437e-52, 'inthe_literature_plr_cutpoint': 7.417164383651313e-53, 'inthe_literature_plr_cutpoint_to_be_little_doubt_about_the_importanceof_inflammation_and_immunity_in_cancer_biology_thenlr_and_other_immunologic_ratios_nlr_values_index_lmr_lymphocyte_survival_plr_platelet_moffitt_department': 7.417164383651313e-53, 'wasrobust': 0.0014616190772430405, 'draws': 2.2893014799768525e-09, 'ourgroup_rates': 0.001845170519318405, 'pretreatment_immunologicratios': 0.007713134335009549, 'whetherchemotherapy': 9.148819220060914e-58, 'valuesthere': 9.148819220060914e-58, 'to_be_little_doubt_about_the_importanceof_inflammation_and_immunity_in_cancer_biology_thenlr_and_other_immunologic_ratios': 7.417164383651313e-53, 'findingsof': 0.0005479687540571566, 'outcomes_amongpatients': 0.004315547045054443, 'survival_osin': 9.148819220060914e-58, 'nlr_values_index_lmr_lymphocyte_survival_plr_platelet': 9.148819220060914e-58, 'resection_assistance': 9.148819220060914e-58, 'moffitt_department': 9.148819220060914e-58, 'approval_approval_approval_approval_approval_approval_support_grant_moffitt_cancer_center': 0.0003167145330801072, 'contributionsdp_conception_design_acquisition': 9.148819220060914e-58, 'approval_manuscript_dr_acquisition': 9.148819220060914e-58, 'analysis_andinterpretation': 0.00021170400988292817, 'jp_analysis_andinterpretation': 0.00012094074060835584, 'support_grant': 0.0003167145330801072, 'moffitt_cancer_center': 0.0017783336103231477, 'reviewboard_mcc': 0.00016468766601768244, 'review_metaanalysisoncotarget_mg_seruga_b_role_review_metaanalysisj_natl_cancer_costa_neves': 9.148819220060914e-58, 'role_ratio_markers': 9.148819220060914e-58, 'zy_prognostic_role_of_systemic_immuneinflammation_index_in_solid_tumors_a_systematic_review_and_metaanalysisoncotarget_\\x93templeton_aj_mcnamara_mg_seruga_b_  _prognostic_role_of_neutrophiltolymphocyte_ratio_in_solid_tumors_a_systematic_review_and_metaanalysisj_natl_cancer_inst_20141066dju124_giakoustidis_a_neofytou_k_costa_neves_m_  _identifying_the_role_ofneutrophiltolymphocyte_ratio_and_plateletstolymphocyte_ratio_asprognostic_markers_in_patients_undergoing_resection_of_pancreatic_ductaladenocarcinoma_ann_hepatobiliary_pancreatic_surg_\\x93_glazer_es_rashid_om_pimiento_jm_hodul_pj_malafa_mp_increasedneutrophiltolymphocyte_ratio_after_neoadjuvant_therapy': 0.0006321861226151657, 'lymphocytemonocyte_ratios': 9.148819220060914e-58, 'cellpopulation_rearrangement': 9.148819220060914e-58, 'balkwill_f': 9.148819220060914e-58, '\\x93_giakoustidis_neutrophil': 9.148819220060914e-58, 'platelettolymphocyte_ratio': 0.0004734482721133418, 'subtypes_disease_hypermutationmicrosatellite_instability_msi_infiltration_cms2_wntand_myc_deregulation': 0.0021040413827844023, 'to_assess_the_tumor_response_per_cms_in_the_neoadjuvant_chemotherapy_settingthis': 0.007713134335009549, 'value_study': 9.148819220060914e-58, 'to_be_performed_in_\\x93_dutch_hospitals': 9.148819220060914e-58, 'inwhich': 0.000547220554320165, 'benefitfrom_chemotherapy': 0.0011075402231842013, 'crc_cms1': 3.435815291669564e-05, 'hypermutationmicrosatellite_instability_msi_infiltration_cms2': 5.606618151720953e-07, 'wntand_myc': 3.909534922212017e-05, 'colorectal_cancer': 0.0006266242915349712, 'howeverthis': 2.274211562945482e-53, 'dilemmas': 1.4055400435083287e-53, 'totreat_patients': 0.007713134335009549, 'predictivevalue': 0.007713134335009549, 'therapyefficacy': 0.0006683740194778514, 'to_include_patients_in_\\x93_dutch_hospitals_that_participatein_plcrcin_connection_ii_patients_with_a_mss_ct3\\x934nxm0_colon_tumor_will_be_treated_with_two_courses_ofneoadjuvant_and_two_courses_of_adjuvant_capecitabineand_oxaliplatin_capox_fig_ _and': 0.00771518910792271, 'cmsclassification': 0.00012613970685026185, 'multiregion_biopsies': 9.148819220060914e-58, 'pretreatment_toensure': 9.148819220060914e-58, 'ii_trial_baselinectscans': 4.270975864177719e-05, 'msi_status': 9.148819220060914e-58, 'to_exclude_patients_with_an_msi_tumor_ _patients': 9.148819220060914e-58, 'followingconsent': 0.0013882295497307361, 'blood_withdrawal': 7.174249640755005e-06, 'to_be_performed_ _weeks_after_cycle_ _day_xcarcinoma_in_situ_and_early_stage_disease_with_a_recurrence_risk_of_less_than_ _0f_colonic_obstruction_that_can_not_be_defunctioned_by_0f_pregnant_or_lactating_womena_stomamain_study_parameterendpointthe_primary_endpoint': 0.00043987493768573834, 'chemotherapy_pathologicalresponse': 9.148819220060914e-58, 'resection_specimen': 9.148819220060914e-58, 'cms_classification': 0.00018016564231000513, 'asffpe_samples': 2.939037092488453e-06, 'ryan_scheme': 0.0006751961684051898, 'using_chisquare_analysis_or_fisher\\x99s_exact_test_and_are_shown_asnumbers_relative_and_absolute_rates_continuous_datacytolym_and_caf_infiltration_scoresradiologicaltumor_response_pathological_response_by_percentage_ofki67_and': 1.1016737136574871e-05, 'using_nonparametric_ttest_or_mannwhitney_utest_where_appropriate_and_are_shown_as_mean_andstandard_deviation_or_median_and_interquartile_range\\x93_pvalues_are_twotailed_and_results_  ': 0.0011125787591309202, 'rfs': 0.00019043327784947934, 'significantthe_os': 3.1046262938735776e-06, 'areconsidered_calculated_depicted_compared': 9.148819220060914e-58, 'size_calculationwe_margin': 9.148819220060914e-58, 'significantthe_os_means_using_the_stratified_logrank_test_hazard_ratios_and_ _confidence_intervals': 3.1046262938735776e-06, 'using_the_stratified_logrank_test_hazard_ratios_and_ _confidence_intervals': 3.1046262938735776e-06, 'responseall_estimates': 9.148819220060914e-58, 'size_calculationwe': 9.148819220060914e-58, 'responses_wewill': 0.0003833771411240826, 'cms1_tumors': 0.0038806204677737646, 'handling_storage_data_managers': 0.0038806204677737646, 'monitor': 1.454071093465488e-05, 'safety_wellbeing_rights_quality': 8.263922883666513e-55, 'trialmonitor': 0.00013772387192018587, 'ae_sae': 4.722161482953914e-06, 'to_be_different_as_both_the_treatment_with_capox_and_the_surgery_are': 0.0002893721198814622, 'onpatients': 4.722161482953914e-06, 'chemotherapy_treatmentand': 0.0011075402231842013, 'to_be_postponed_for_more_than_ _0f_if_patients_can_not_complete_all_the_neoadjuvantweeks_after_the_start_of_cycle_ _of_capoxchemotherapy_courses': 0.00043975773664194475, 'neoadjuvantweeks': 0.001845170519318405, 'saes': 0.00016468766601768244, 'ofsurgery': 1.5501286888618154e-05, 'istherefore': 0.0002517139390143281, 'chemotherapymoreover_\\x93': 0.0004968127217041802, 'cms2': 1.7808914890539758e-06, 'survival_overallsurvival_advantage': 2.907917514874035e-08, 'survival_overallsurvival_advantage_benefit_from5fu': 0.0001090884800621322, 'benefit_from5fu': 2.907917514874035e-08, 'ina': 0.001129870936471824, 'cms4': 0.0006321861226151657, 'cms1\\x93': 0.0004734482721133418, 'regression_trg0': 0.004315547045054443, 'tnm_staging': 0.0005741125271172155, 't1\\x93': 8.263922883666513e-55, 'to_beovertreated_[': 1.1686951820486561e-54, 't_stage': 8.263922883666513e-55, 'to_refrain_from_adjuvant_chemotherapy_in_highrisk_stage_ii_msi_colon_cancer_patientsas': 0.0038806204677737646, 'group_group_ofpatients': 0.0006683740194778514, 'patientoutcomeabbreviationscaf_cancer': 9.148819220060914e-58, 'capox': 9.148819220060914e-58, 'mk2_authors': 0.00019728275443691047, 'finalapproval': 0.0007959416758056306, 'ii_trial': 2.12168450161151e-07, 'cancerresearch': 0.004315547045054443, 'contributions_ethics_committee_ampletime_opportunity': 5.69631957627366e-05, 'utrechtmec18712': 9.29846662360804e-07, 'guidelines_regulations_actsauthorships': 9.29846662360804e-07, 'ichgcp_regulationsin': 0.001845170519318405, 'explaining_theconnectionii_study_to_the_patient_providing_himher_with_informationsuch_as_the_expected_efficacy_and_possible_side_effects': 0.0010325216439875707, 'refusal': 0.0002970389774685686, 'ampletime_opportunity': 5.693284547016032e-05, 'to_takeplace_shortly_after_diagnosis_to_prevent_delay_in_treatmentpatients': 8.649691595586185e-05, 'anisation_department': 9.148819220060914e-58, '7department': 9.148819220060914e-58, 'netherlandsreceived': 9.148819220060914e-58, 'referencesnederlandse_kankerregistratie_nkr_iknl': 9.148819220060914e-58, 'radiotherapy_trial_lancet_af_theimpact_pilot_phase': 1.3943580049956421e-05, 'j_clinoncol_foxtrot': 9.148819220060914e-58, 'g_feasibility': 9.148819220060914e-58, 'pts': 9.148819220060914e-58, 'chemotherapy_nac': 9.148819220060914e-58, 'harbron': 9.148819220060914e-58, 'robustness_sensitivity': 9.148819220060914e-58, 'kl_gavin_pg': 9.148819220060914e-58, 'nl_outcome': 9.148819220060914e-58, 'park_jo_nanostringbasedmultigene_assay': 0.0004499048194399722, 'benefit_deficientmismatch_repair_transition_j_cancer\\x93_accuracy': 0.00018011764021066588, 'detection_cc': 0.0007335617696401911, 'value_act_risk_\\x98trial': 1.1967238105410825e-05, 'act_presence': 0.0011075402231842013, 'medocccreate_trial': 0.00042568857598206995, 'ctdna': 7.593211226814675e-06, '\\x98trial': 1.1967238105410825e-05, 'twics_design_patients': 9.148819220060914e-58, 'authorrja_fijneman_gr_vink_author1department': 9.148819220060914e-58, 'give_informed_consent_forcollection_of_clinical_data_tissue_and_blood_samples_and_consent_for_future_randomization_medocccreate_is_asubcohort_within_plcrc_consisting_of_ _stage_ii_cc_patients_without_indication_for_act_according_to_currentguidelines_who_are_randomized_ _into_an_experimental_and_a_control_armin_the_experimental_arm_postsurgery_blood_samples_and_tissue_are_analyzed_for_tissueinformed_detection_ofplasma_ctdna_using_the_pgdx_elio\\x84¢_platform_patients_with_detectable_ctdna_will_be_offered_act_consisting_of_cycles_of_capecitabine_plus_oxaliplatin_while_patients_without_detectable_ctdna_and_patients_in_the_control_groupwill_standard_followup_according_to_guidelinethe_primary_endpoint_is_the_proportion_of_patients_receiving_act_when_ctdna_is_detectable_after_resection_themain_secondary_outcome_is_2year_recurrence_rate_rr_but_also_includes_5year_rr_disease_free_survival_overallsurvival_time_to_recurrence_quality_of_life_and_costeffectiveness_data': 3.0624865850302326e-06, 'ofplasma_ctdna': 9.148819220060914e-58, 'elio\\x84¢_platform_patients': 9.148819220060914e-58, 'authorrja_fijneman_gr_vink': 7.571497046169008e-06, 'm_koopman': 9.148819220060914e-58, 'author1department': 9.148819220060914e-58, 'regulation_use_cancer_page': 3.5057934680564676e-05, 'biomarker_testing': 0.00014666373686096008, 'measurement_dilemmas': 9.148819220060914e-58, 'chemotherapy_twics': 9.148819220060914e-58, 'act_whichmeans': 0.0011075402231842013, 'procedures_patients': 0.0002584379969449155, 'mrd': 0.0011075402231842013, 'adjuvanttreatment': 0.0011075402231842013, 'shorthalflife': 9.148819220060914e-58, 'ranging_from_ _to_min_the_presence_of_ctdna_in_blood_samples': 9.148819220060914e-58, 'state_ofmrd': 0.00043975773664194475, 'dilemma_forrandomization': 0.0016480626375926124, 'ctdna_0cschraa_cancer_page': 0.004315547045054443, 'therapy_warrants_trial_\\x98trialdifferent': 0.0013882295497307361, 'twics_design': 0.0004645793751046339, 'whether_act_reduces_the_rr_in_these_ctdnapositive_patientsmethodsdesignaimthis_study': 9.148819220060914e-58, 'willingness': 9.148819220060914e-58, 'cancer_groupdccg': 2.2925595830345323e-05, 'proms': 2.2925595830345323e-05, 'inmedocc': 2.2925595830345323e-05, 'standard_0cschraa_cancer_page_blood_sampling': 0.0018006682651940404, 'criteria_consent': 0.0013882295497307361, 'consisting_indication_foract': 9.148819220060914e-58, 'hadanother_malignancy': 9.148819220060914e-58, 'act_forpatients': 0.00016123382553553652, 'service': 9.148819220060914e-58, 'therandomization_code': 9.148819220060914e-58, 'protocol_items': 0.001845170519318405, 'detectablectdna': 0.0004988292642554344, 'detectablectdna_preferablywithin_weeks': 0.0023439997835738393, 'whether_they_accept_or_refuse_thistreatment_patients_without_detectable_ctdna': 3.050145982307007e-05, 'preferablywithin_weeks': 0.0004988292642554344, 'arm_patients': 6.944348430476448e-06, 'followup_care': 1.1345248991310006e-07, 'medocccreate_trial_followup_care': 9.594934446705883e-05, 'physiciansfollowupblood_samples': 3.9740927981223185e-05, 'study_protocol_ctdna': 0.0016487113275249776, 'ffpetissue_block': 7.116285144947346e-07, 'surgerysamples': 9.148819220060914e-58, 'mail': 9.148819220060914e-58, 'analysistumor_tissue_dna': 5.442171272099169e-06, 'diagnostics_baltimore_mdusa_plasma_ctdna': 5.442171272099169e-06, 'nextgeneration_sequencing_nextgeneration_sequencing': 3.453496181223943e-05, 'to_confirm_the_recurrence_thedate_of_the_said_investigation_is_considered_the_date_ofrecurrencedata_about_followup_recurrences_and_survival_areroutinely_collected_within_plcrc_using_the_netherlandscancer_registry_ncr_managed_by_the_netherlandscomprehensive_cancer_anisation_iknl_to_provideinsight_in_the_characteristics_and_magnitude_of_cancer_inthe_netherlands_ _other_secondary_endpoints_include_2year_rr_in_aperprotocol_analysis_5year_rr_intentiontotreatand_perprotocol_analysis_time_to_recurrence_ttr_and_5year_disease_free_survival_dfs_rate_ _and7year_diseaserelated_os_rate_ _and_5year_rr_inpatients_with_undetectable_ctdna_after_surgery_quality_of_life_qol_and_costeffectiveness_of_the_ctdnaguided_strategytimetoevent_outcomesos_rate_is_expressed_as_proportion_of_patients_that_arealive_ _and_ _years_after_surgery_dfs_rate_is_expressed_asproportion_of_patients_that_did_not_experience_disease_recurrence_a_second_primary_cc_or_death_within_ _and_years_after_surgery_ttr_is_expressed_as_time_monthsbetween_surgery_and_detection_of_disease_recurrence_0cschraa_  _bmc_cancer_           _page_ _of_patients_will_be_censored_at_the_last_date_of_followup_if_adate_of_death_is_not_recorded_and_at_the_date_of_death_ifthe_cause_of_death_is_not_due_to_ccquality_of_lifeqol_is_measured_within_the_cohort_at_regular_intervalsin_patients_who_gave_consent_to_send_questionnaires_nationally_and_internationally_validated_questionnaires_areused_among_which_the_european_anisation_for_research_and_treatment_of_cancer_quality_of_life_questionnaire_core_ _and_the_colorectal_cancer_moduleeortcqlqc30_and_cr29_the_work_ability_indexwai_the_euro_quality_of_life5_dimensions_eq5dthe_multidimensional_fatigue_inventory20': 0.0012026472050392129, 'recurrence_thedate': 1.604120213469273e-05, 'analysis_time': 1.604120213469273e-05, 'surgery_quality': 7.622208514577694e-06, 'asproportion': 0.00046727913936815994, 'ccquality': 7.622208514577694e-06, 'consent_work_ability': 0.0011075402231842013, 'thatsimilar': 0.007713134335009549, 'toa_reduction': 3.5604405279328306e-06, 'to_be_included_in_botharms_assuming_a_prevalence_of_ctdna_after_surgery_of_and_adjustment_for_loss_to_followup_and_rejection_ofadjuvant_therapy_in_the_intervention_arm_of_ _a_totalsample_size_of_ _patients': 3.5187438011524213e-06, 'upfront': 8.263922883666513e-55, 'crossover': 0.00021684699207335205, 'to_complete_recruitment_of_patients_within\\x93_years_with': 0.007713134335009549, 'to_compare_patients_with_detectable_ctdna_who_received_act_inthe_intervention_arm_with_ _patients_with_detectablectdna_in_the_control_arm': 0.007713134335009549, 'act_inthe_intervention_arm': 0.0011075402231842013, 'physicians_means': 0.0004988292642554344, 'arecurrence': 0.004315547045054443, 'surgery_differences': 9.148819220060914e-58, 'survival_methodseg': 9.148819220060914e-58, 'survival_methodseg_means': 4.594118935489737e-06, 'factor_qol': 7.507437297780636e-08, 'treatment_differences': 0.00018327488191798982, 'sum_lifetime_horizon': 7.507437297780636e-08, 'analysis_survival_functions': 9.148819220060914e-58, 'to_extrapolate_dfs': 9.148819220060914e-58, 'study_coordinator': 2.0031394091466016e-05, 'i_crc_patients_stage_crc_patients': 9.148819220060914e-58, 'to_be_treated_according_to_thectdna_result_with_ _to_ _months_of_act_or_accordingto_standard_of_care': 9.148819220060914e-58, 'actrn12615000381583_thecobra_study': 9.148819220060914e-58, 'asimilar_rct_approach_nrggi': 9.148819220060914e-58, 'dynamiciii_actrn12617001566325': 1.0802223518261624e-05, 'iii_crc_patients_started_recently_dynamiciii_actrn12617001566325_in_the_near_future_thesestudies': 0.00031594210388407283, 'toimplementation': 5.1567102737448134e-06, 'twicsdesign': 9.148819220060914e-58, 'to_have_a_positive_impact_on_trialefficiency_also_by_enrolling_higher_proportions_of_eligible_patients_generalizability_to': 9.148819220060914e-58, 'dilemma': 9.148819220060914e-58, 'thetwics_design': 9.148819220060914e-58, 'highdropout_contamination': 0.007713134335009549, 'aclassical_rct_design': 9.148819220060914e-58, 'making_accrualand_interpretation_of_results_unfeasible_  _in_thistwics': 9.148819220060914e-58, 'blood_sampleswill': 9.148819220060914e-58, 'highdropout_contamination_potentiallimitations_challenges': 9.148819220060914e-58, 'potentiallimitations_challenges': 0.0019127833147525456, 'sample_size_patients': 9.148819220060914e-58, 'to_have_detectable_ctdnaafter_surgery_based_on_previous_data_ _relapses_areexpected_within_ _years_and_with_a_high_event_rate_smallnumbers_are': 9.148819220060914e-58, 'capecitabinewe': 9.148819220060914e-58, '6month_duration_firstadjuvant_trials': 9.148819220060914e-58, 'thistrial': 5.831081802143344e-06, 'clinicalrelevance_besidesit': 5.831081802143344e-06, 'months_cc': 0.00016123382553553652, 'additionalideafrance_esmocongress': 0.0006578099350934741, '6monthsact': 0.007713134335009549, 'to_be_proven_when_to_applywhat_technology_to_address_which_unmet_clinical_need_isa_key_question_that_remains_to_be_addressed_ _applying_ctdna_detection_as_a_biomarker_for_mrd_isa_challenging_task_biologically_only_a_very_low_amountof_ctdna_is_present_in_postsurgery_patients_with_mrdstochastically_by_looking_at_mutations_in_a_panel_ofgenes_chances': 1.0692604755008802e-05, 'utility_ofctdna_testing': 1.7470826455755143e-07, 'to_be_addressed_ _applying_ctdna_detection_as_a_biomarker_for_mrd_isa_challenging_task_biologically': 0.004315547045054443, 'whatmutations': 9.148819220060914e-58, 'ctdna_test_specificity': 9.148819220060914e-58, 'recent_observations_showed_that_ctdna_mutation_detection_can_beconfounded_by_mutations_that_are_present_in_clonalhematopoiesisincluding_mutations_in_genes_that_arecommonly_affected_in_cc_such_as_tp53_  _these_confounding_mutations': 8.263922883666513e-55, 'to_select_forpatients_who_truly_benefit_from_act_treatment_a_requirement_for_clinical_implementation_to_further_support_clinical_implementation_of_ctdna_analyses_in_thenetherlands_the_dutch_coin_initiative_aims_to_providea_validation_framework_for_clinicalimplementation_ofctdna_analyses_in_the_netherlands': 1.1686951820486561e-54, 'ctdna_mutation_detection': 0.000598820003809177, 'howeverthe_medocccreate_trial': 9.148819220060914e-58, 'to_resolvewhether': 9.148819220060914e-58, 'ctdna_test': 8.263922883666513e-55, 'to_answer_the_important_clinical_question': 0.0019127833147525456, 'prognosticas_value': 1.2404247193980366e-07, 'treatmentshould': 0.0006768252640912667, 'is_include_selected': 0.001845170519318405, 'to_have_anticancer_effects_in_preclinical_andclinical_studies': 0.004315547045054443, 'inhibiting_the_carcinogenesis_inhibiting_angiogenesisand_inhibiting_tumour_growth_this_study_aims_to_determine_the_clinical_effects_of_curcumin_in_different_types_ofcancers_using_systematic_review_approachmethods_a_systematic_review_methodology_is_adopted_for_undertaking_detailed_analysis_of_the_effects_of_curcuminin_cancer_therapy_the_results_presented_in_this_paper_is_an_outcome_of_extracting_the_findings_of_the_studiesselected_from_the_s_published_in_international_databases_including_sid_magiran_iranmedex_irandoc_googlescholar_sciencedirect_scopus_pubmed_and_web_of_science': 4.30514590741956e-05, 'to_determine_the_clinical_effects_of_curcumin_in_different_types_ofcancers_using_systematic_review_approachmethods_a_systematic_review_methodology_is_adopted_for_undertaking_detailed_analysis_of_the_effects_of_curcuminin_cancer_therapy': 0.0019127833147525456, 'review_research': 0.00031585793432508617, 'to_tumorformation_ ': 0.004315547045054443, 'threequarters': 0.001845170519318405, 'regulation_use_to_rise_to_million_by_ _furthermore_cancer': 0.0010651761975814635, 'to_rise_to_million_by_ _furthermore_cancer': 0.0010298344840079976, 'is_predicted_to_bethe_leading_cause_of_death_by_   _given_that_cancerstatistics_are_on_the_rise_and_their_treatments_are_costlyit_is_very_crucial_to_find_effective_and_economically_viablemethods_for_patients_in_low_and_middle_income_countries_therefore_this_study_is_motivated_by_using_effectiveand_relatively_cheap_treatments_for_cancer_therapy_asystematic_review_of_the_clinical_studies_on_curcumin_useand_its_effectiveness_in_inhabiting_and_treating_varioustypes_of_cancer': 1.7382849852180922e-05, 'review_documents': 9.148819220060914e-58, 'picture_ofcurcumin_effects': 9.148819220060914e-58, 'to_gather_information_and_derive_ _on_curcumin_effects_andeffectiveness_at_various_stages_of_cancer_therapyamong_the_medical_herbs_flavonoids': 0.000762889468397268, 'use_effectiveness': 1.1686951820486561e-54, 'research_efforts_cancers': 8.263922883666513e-55, 'mechanisms_ingredient': 8.263922883666513e-55, '\\x93]antioxidantincludingcurcumin': 2.9402948113849672e-05, 'to_have_preventive_and_therapeutic_effects_on_various_types_of_cancers': 0.001801148090838322, 'formationof_cancer': 5.8227726807094994e-05, 'formation_orspread': 0.00210348072096923, 'activity_kinase_protein': 0.00018383646965595502, 'angiogenesisin_tumors': 5.8227726807094994e-05, 'stat3phosphorylation': 0.0001440815567172776, 'cycle_progression_curcumin': 0.004315547045054443, 'reviewersmm': 5.7329206921586805e-05, 'reviewmetaanalysis_cohort': 1.1686951820486561e-54, 'descriptive': 8.263922883666513e-55, 'descriptive_basedon_criteria_items': 0.0005034057898537578, 'basedon_criteria': 8.263922883666513e-55, 'lastconsort_statement': 0.0002454333162130257, 'consort_statement': 9.148819220060914e-58, 'to_improve_the_scientific_quality_of_rct_reporting': 9.148819220060914e-58, 'result_ofstudies_quality_score': 2.5043603622738718e-05, 'to_have_low_quality': 0.001534068782415519, 'antioxidanteffects': 0.004315547045054443, 'nfkappab': 0.0015842910551982499, 'to_be_effective_on_liver_enzymescytochrome_p450': 5.8227726807094994e-05, 'thephase_enzymes': 0.00210348072096923, 'to_be_effective_on_liver_enzymescytochrome_p450_thephase_enzymes': 0.0004002818947444053, 'gene_products': 6.528133940545239e-06, 'inangiogenesis_process_hypoxia': 0.0016810521528134112, 'hypoxia_tumor_cells': 0.0016810521528134112, 'factor_hif1_hif1': 0.0016810521528134112, 'thathif1_activation': 0.0018006682651940404, 'nfkb_induced_angiogenesis_in_the_tumor_cells_furthermore_the_activation_ofgenes_such_as_insulinlike_growth_factor_ _igf2_transforming_growth_factor_a_tgfa_and_mapk_and_pi3ksignalling_pathway': 0.0015851356325270348, 'survival_proliferation_metastasis': 2.5873580930035818e-05, 'survival_proliferation_metastasis_role': 2.5873580930035818e-05, 'invasion_curcumin': 0.0016815001133323047, 'stress_activation': 0.0016810521528134112, 'expression_to_improve_the_overallhealth_of_patients_with_colorectal_cancercurcumin_peroxidation_increasedglutathione_content_prostatespecific_antigen_contentin_combination_dmalondialdehyde_deoxy_guanosine_contents_inthe_serum_salivano_difference_variation': 0.00210348072096923, 'transcription_withcurcumin': 0.0003309404805354376, 'skin_problemscurcumin': 0.0004472423269940801, 'activitycurcumin': 9.148819220060914e-58, 'e2_productionreduces': 9.148819220060914e-58, 'to_improve_the_overallhealth_of_patients_with_colorectal_cancercurcumin': 9.526346045234886e-06, 'peroxidation_increasedglutathione_content_prostatespecific_antigen_contentin_combination': 2.7446560661786228e-05, 'dmalondialdehyde_deoxy_guanosine_contents_inthe_serum_salivano_difference_variation': 0.0008522036149147152, ']_it_is_also_shown_thatcurcumin_will_reduce_the_expression_of_membrane_surface_moleculesadhesionmolecule1_vascular_cell_adhesion_molecule1_and_eselectin_which_play_a_role_in_cellular_adhesion_fig_ _intracellularincludingcurcumin_affects_a_number_of_adhesive_cellular_molecules_involved_in_tumor_growth_and_metastasis_processes_ _curcumin_caused_reduction_in_the_expression_ofadhesive_molecules_inside_the_cells_of_icam1_vcamvcam_or_vascular_cell_adhesion_molecule_and_mmpswhich_play_an_important_role_in_cellular_adhesion_andmetastasis_  _furthermore_curcumin_results_in_increase_ofthe_expression_of_various_antimetastatic_0cmansouri_  _bmc_cancer_           _page_ _of_fig_ _the_effect_of_curcumin_on_angiogenesis_and_metastasis_in_cancer_cells_  _by_coreldraw_graphics_suite_including_tissue_inhibitor_metalloproteinaseproteinstimp_the_nonmetastatic_gene_nm23_and_ecadherin_lack_of_ecadherin': 0.000312090869820137, 'thatcurcumin': 0.0016810521528134112, 'fig_intracellularincludingcurcumin': 0.0010298344840079976, 'processes_curcumin': 0.0006054349545841993, 'mmpswhich': 0.0015842910551982499, 'diseases_antioxidant': 0.0002821774092107797, 'mechanisms_curcumin': 0.0006942392743112329, 'lipids\\x99_peroxidation_glutathione_content_pathways_pharmacologicalsafety_efficiency_targets_product': 0.002153534494004319, 'resultsin': 0.0005521751935137136, 'specifications_details': 3.515032745249022e-05, 'symptoms_ofchemotherapy': 0.0010071448933776737, 'effects_polyps': 1.6435761703528167e-05, 'e2production_curcumin': 9.148819220060914e-58, 'polyps': 9.148819220060914e-58, 'lipids\\x99_peroxidation': 0.0005253840276496832, 'glutathione_content': 0.0018006682651940404, 'pharmacologicalsafety_efficiency_targets_product': 0.0018006682651940404, 'curcumin_importantin_bayetrobert': 0.0037579538340709504, 'to_continue_treatment': 0.001845170519318405, 'curcumintreatment': 0.0013882295497307361, 'fortumor_response': 0.001845170519318405, 'tumor_marker': 9.148819220060914e-58, 'butthe_cea_tumor_marker': 9.148819220060914e-58, 'reduced': 0.0002622637817294862, 'control_group_potential_sclerosis_disease_cancer': 0.002696571461425671, 'mg_ofcurcumin': 0.001845170519318405, 'throat_ulcers': 0.0011075402231842013, 'ofradiotherapy_mgcapsules': 9.148819220060914e-58, 'day_yu': 9.148819220060914e-58, 'hasshown': 0.0018006682651940404, 'sclerosis_disease_cancer': 1.3388368318019241e-05, 'effects_consumption': 0.0004358935679566294, 'minimaltoxicity': 0.00019941863725030497, 'regulatessignalling_pathways': 0.0016810521528134112, 'cell_growth_alsostimulates': 5.8227726807094994e-05, 'expectations_inhumans': 0.00016354550492052173, 'samples_inaddition_curcumin': 9.148819220060914e-58, 'autophagy_cycle_arrest': 9.148819220060914e-58, 'curcumin_receivingplacebo': 0.0011075402231842013, 'thecarcinogenesis_growth': 1.1327846616133142e-05, 'taking_curcumin': 0.0016810521528134112, 'patientsurvival': 0.00022348806153895951, 'reporting_items': 0.007719303035876401, 'faculty_members_ns_km': 0.00012620701047132057, 'is_received': 1.1686951820486561e-54, 'conflictingeffects': 8.263922883666513e-55, 'tissuespecific_dependencies': 9.148819220060914e-58, 'to_evaluate_the_prognostic_significance_of_ampk_dysregulation_on_patientoutcomesresults_a_total_of_ _and': 9.148819220060914e-58, 'hazards_regression_analyses': 0.007713134335009549, 'conflictingeffects_to_evaluate_the_prognostic_significance_of_ampk_dysregulation_on_patientoutcomesresults_a_total_of_ _and_tissuetype_dependencies': 1.0520665763405677e-06, 'tissuetype_dependencies': 8.263922883666513e-55, 'cox_regression_logrank_tests': 1.7186766290470542e-08, '24ampkgeneset': 0.00027587787348664266, 'access_tumorsuppressivestressorssuchasin_contrastof': 2.2480340991203723e-51, 'results_events_values': 4.496068198240745e-51, 'complexes_wherethe_human_genome': 0.0009466755491730313, 'ampkindependent_avenues': 0.00054686425127897, 'variation_analyses': 2.2480340991203723e-51, 'triggerampk': 9.148819220060914e-58, 'to_support_cancer_growthand_migration_through_crosstalk_with_other_prooncogenicpathways_for_instance_overexpression_of_oncogenes_mycand_src_or_the_loss_of_the_tumor_suppressor': 9.148819220060914e-58, 'theway': 0.0018006682651940404, 'ofampk': 0.0016815002327347822, 'to_rigorously_investigate_the_role_of_ampkin_diverse_cellular_context_using_multiomics_data_fromactual_tumors_where_we_examined_somatic_copy_numberalterations_transcriptional_and_clinical_profiles_of_tumorsfrom_ _cancer_types_our_analyses_of_clinical_samples_atscale': 2.745387658706267e-05, 'nonhuman_invivo': 4.480799213709324e-07, 'to_address_anunmet': 0.0019127833147525456, 'profiles_analyses': 0.007713134335009549, 'cellspecific_nature': 3.842636662530884e-06, 'kyoto_encyclopedia': 0.0002356998597804158, 'analysisof_variance_permanova': 2.2480340991203723e-51, 'expression_analyses': 2.2480340991203723e-51, 'effects_ampk_signalingpathway_factor_analysesgenes': 0.0003022165162482692, 'to_map_degs_to_the_chea_and_encodetranscription_factor_tf_databases_to_identify_tfs_thatwere_significantly_enriched_as_regulators_of_the_degsirs2pik3r1sirt1_tbc1d1calculating_the_24ampkgene_score_peroxisomeproliferatoractivated_receptors': 0.0005073644201409251, 'lai_bmc_cancer_page': 8.275473704013266e-06, 'enrichr_tool': 0.004315547045054443, 'mtorpi3kakt_scores': 9.148819220060914e-58, 'akt_mtor_gsk3_s6k_s6': 9.148819220060914e-58, '\\x93pten_figures': 9.148819220060914e-58, 'alterations_scna_file_number_example': 9.148819220060914e-58, 'alterations_scna_file': 0.007713134335009549, 'number_example': 8.329345491138083e-05, 'remarkablyhnf4a': 9.148819220060914e-58, 'to_be_the_most_amplified_gene_identified_as_being_recurrently_amplified_in_  _of_samplesin_all_ _cancers_fig_ _additionalfile_ _this_isfollowed_by_cftr_ _cancer_types_and_four_other_genesthat_were_amplified_in_ _cancer_types': 9.148819220060914e-58, 'features_underpinnings': 8.263922883666513e-55, 'impact_gain': 1.1686951820486561e-54, 'lossoffunctiongenes': 8.263922883666513e-55, '2a_thehighest_number': 9.148819220060914e-58, 'inglioma_gbmlgg_tumors_genes': 9.148819220060914e-58, '2a_esca': 9.148819220060914e-58, 'thehighest_number': 9.148819220060914e-58, 'minimalroles': 0.00037036254408407267, 'deletions_amplifications': 0.004315547045054443, 'types_fortysix_genes': 9.148819220060914e-58, 'inglioma_gbmlgg_tumors_genes_identification': 9.148819220060914e-58, 'venn_diagrams': 0.0002080473013030996, 'cancer_cohorts': 0.012028681380063992, 'carcinoma_blca_carcinoma': 4.4423405374281965e-05, 'adenocarcinoma_luad_cell_carcinoma': 9.148819220060914e-58, 'stes_carcinoma': 9.148819220060914e-58, 'cesc_chol_coad': 0.00040378297050580684, 'toexamine_impact': 0.007713134335009549, 'scores\\x99_foreach': 0.007713134335009549, 'irs2_pik3r1_pfkfb3_ppp2r2bprkaa2_pfkfb1': 0.0003313074447267851, '0cchang_lai_bmc_cancer_page': 0.0022213594055481957, 'ratio_values': 4.8318870888475234e-05, 'stratified': 3.27937688081132e-05, '24genescore': 9.148819220060914e-58, 'to_stratify_patients_into_high_andlowrisk_groups': 9.148819220060914e-58, 'tumorfrom_nontumor_samples': 0.00012643282536714355, 'significantseparation_lai_bmc_cancer_page': 1.771400127825104e-05, 'thecombined_model': 0.00031981941195114897, 'tocurves': 0.0006768252640912667, 'differentialexpression_analyses': 0.007713134335009549, 'inall': 0.00014120710818717644, 'tfs': 0.008112755406214648, 'ezh2_nfe2l2': 0.0003991561001946192, 'furtherexploration_analysesdemonstrated': 0.0038806204677737646, 'incommon_patterns': 4.840409146238793e-05, 'tfs_to_be_common_targets_of_ezh2_nfe2l2rest_smad4_and_suz12_respectively_in_all_four_cancers_to_gainfurther_insights_into_how_ampk_inactivation_influencestumor_progression_we_performed_cox_regression_analyses_to_determine_the_association_between_each_of_the_genes_and_survival_outcomes_the_highest_number_ofprognostic_genes_was_observed_in_glioma_ _genes_good_prognoses_and': 0.0020482293782589918, 'geneswere': 9.148819220060914e-58, 'to_be_common_targets_of_ezh2_nfe2l2rest_smad4_and_suz12_respectively_in_all_four_cancers': 9.148819220060914e-58, 'to_gainfurther_insights_into_how_ampk_inactivation_influencestumor_progression_we_performed_cox_regression_analyses_to_determine_the_association_between_each_of_the_genes_and_survival_outcomes_the_highest_number_ofprognostic_genes_was_observed_in_glioma_ _genes_good_prognoses_and': 7.417164383651313e-53, 'cox_regression_analyses': 0.007713134335009549, 'fig_andten': 3.342886648552284e-05, 'thebehavior': 0.0038806204677737646, 'ampk': 0.004629613392369511, 'to_explore_the_crosstalk_between_ampksignaling_and_tf_activity_in_glioma': 0.007713134335009549, '24ampkgene_scorefig_2b': 3.259854687994726e-05, 'delineation': 0.0006943564809761616, 'ampk_scoresfor': 0.007713134335009549, 'legend_0cchang_lai_bmc_cancer_page': 0.0019364501397407712, 'signaling_modules_a_venn_diagramillustrates_the_number_of_differentially_expressed_genes_degs_between_1st_and_4th_quartile_patients_as_stratified_using_the_24ampkgene': 1.0987149551122205e-05, 'b_dot_plots': 0.0010298344840079976, 'patients_lowlow_highhigh_score_tfexpression_score': 0.00771518910792271, 'tf_logrank_tests': 0.00012613970685026185, 'suz12patients': 6.908299630566665e-07, 'hr_p': 4.2328615921059535e-05, '6ccrosstalk': 9.148819220060914e-58, 'effects_receptors_ppar_target': 9.148819220060914e-58, 'studies_relevance_insights_limitations_genes': 0.008028992269334635, 'thoroughexamination': 0.007713134335009549, 'pathology_animal_models': 0.0013882295497307361, 'insights_limitations': 0.00031585793432508617, 'pancancer_population_data': 0.0016480626375926124, 'depiction': 0.0002664871522256321, 'b_forest_plots': 0.0005067035267353633, 'survivaloutcomes_hazard_ratios': 9.148819220060914e-58, 'extent_degs_to_act_as_a_metabolic_gatekeeper_tolimit_cancer_cell_division': 9.148819220060914e-58, 'confidence_intervals': 2.423250818919023e-05, 'wald_test_p_values': 9.148819220060914e-58, 'to_act_as_a_metabolic_gatekeeper_tolimit_cancer_cell_division': 9.148819220060914e-58, 'to_inhibit_pi3kaktmtor': 7.55973655964254e-05, 'to_inhibit_theproliferation_of_estrogen_receptor_Î±_erÎ±_negative_andpositive_breast_cancer_cell_lines_through_ampk_stimulation_  _however_when_tested_in_mice_models_metformin_contributes_to_enhanced_tumor_progression_andincreased_angiogenesis_providing_us_with_a_glimpse_ofpotential_proneoplastic_effects_of_ampk_activation_ _in_our_study': 0.00010711125068685399, 'to_enhanced_tumor_progression_andincreased_angiogenesis_providing_us_with_a_glimpse_ofpotential_proneoplastic_effects_of_ampk_activation_ _in_our_study': 0.00010711125068685399, 'to_inhibit_theproliferation_of_estrogen_receptor_Î±_erÎ±_negative_andpositive_breast_cancer_cell_lines_through_ampk_stimulation_  _however_when_tested_in_mice_models_metformin_contributes_to_enhanced_tumor_progression_andincreased_angiogenesis_providing_us_with_a_glimpse_ofpotential_proneoplastic_effects_of_ampk_activation_ _in_our_study_density_plots': 0.008322475568105201, 'median_ampkand_tf': 0.00013608363887198264, 'density_plots': 2.2171613687620164e-06, 'xaxes': 0.0001360473740416263, 'logrank_tests': 7.417164383651313e-53, 'scorethat': 0.000704362469235278, 'to_be_predictive_of_risk_of_developing_major_chronic_diseases_its_influence_oncancer_survival': 1.0725230201050377e-05, 'mortalitywe': 0.0010866462457958513, 'influence_influence_risk': 0.0008999557986747554, 'cancerspecific_deaths': 0.0038806204677737646, 'insulinemicdiets': 0.0011075402231842013, 'regulation_use_ishigh_potential': 3.5057934680564676e-05, 'ishigh_potential': 3.5057934680564676e-05, 'exists_notwith': 0.0016480626375926124, 'meats_desserts_potatoesis': 0.00034678516808638586, 'society_cancerprevention_guidelines': 9.148819220060914e-58, 'eating_index': 9.148819220060914e-58, 'to_clarify_ifdietary_patterns': 0.0005479687540571566, 'forexample_hyperinsulinemia_insulin_resistance': 0.0004405647755333974, 'positiveassociations_marker': 0.0018006682651940404, 'adietary_pattern': 9.148819220060914e-58, 'predictive': 9.148819220060914e-58, 'dietaryindex': 0.007713134335009549, 'to_be_predictive_of_nonfasting_cpeptide_concentrations': 0.0038806204677737646, 'initiatedin': 0.00012613970685026185, 'consent_nonmelanoma_skin_cancer': 0.00771518910792271, 'ethicalapproval': 9.148819220060914e-58, 'harvardth_chan_school_those_reviewboards': 9.148819220060914e-58, 'hospital_studyparticipants': 0.0004100538998299479, 'hpfs_diet_score': 9.148819220060914e-58, 'to_empirically_measure_the_insulinemic_potential_of_whole_diets_using_food_groups_hasbeen_described_in_detail_  _briefly_thirtynine_foodgroups_  _were_entered_into_stepwise_linear_regressionmodels_to_identify_a_dietary_pattern_most_predictive_ofplasma_cpeptide_levels': 9.148819220060914e-58, 'scores_foreach_participant': 0.007713134335009549, 'years_reports_study_physiciansthen': 9.148819220060914e-58, 'records_data': 9.148819220060914e-58, 'national_deathindex': 9.148819220060914e-58, 'to_identify_deaths_and_ascertain_anydiagnosis_of_colorectal_cancer_that_contributed_to_deathafter_ _years_of_followup_for_disease_diagnoses_\\x93_in_nhs_and_ _to_ _in_hpfs_we_identified_patients_with_pathologically_confirmed_colorectalcancer': 9.148819220060914e-58, 'nonmelanoma_skin_cancer': 0.0005573368904834178, 'diet_patientswho': 0.00012403645304252364, 'diet_assessment': 2.023815655958986e-06, 'hpfs_cause': 9.148819220060914e-58, 'assessmentboth_cohorts': 9.148819220060914e-58, 'activity_smoking_habits': 0.0007000951832348714, 'hormone_use': 0.0007956673215405282, 'analysiswe': 0.0007761129204498495, 'score_kaplanmeiermethod_to_calculate_hazard_ratios_sex_covariates_postdiagnosisfactors_activity_subgroup_analysesincategories_weight': 0.007719301939468782, 'edihscore': 0.00012620699251842968, 'bmi_hazards_regression': 8.263922883666513e-55, 'hrs': 0.00030311595514260516, 'entry_thecox_models': 0.00012620699251842968, 'stage_subsite': 9.148819220060914e-58, 'covariates_postdiagnosisfactors_activity': 9.148819220060914e-58, 'influence_survivalwe': 1.1686951820486561e-54, 'scores_atthe_median': 8.263922883666513e-55, 'to_create_a_change_variable_withlow_indicating_a_score_below_the_median_and_high_ascore_above_the_median_lowlow': 8.263922883666513e-55, 'diagnosis_highlowpatients': 4.081980120191072e-05, 'patternchanges': 0.007713134335009549, 'preand_postdiagnosis_weightwe': 9.148819220060914e-58, 'subgroup_analysesincategories': 9.148819220060914e-58, 'prediagnosis_score': 0.00012620699251842968, 'prediagnosisedih': 0.007713134335009549, 'thosewho': 3.225769395117772e-05, '\\x89¥years_tests_effect_modifiers': 9.148819220060914e-58, 'byentering_in_the_modelthe_cross_product_of_postdiagnosis_edih_score_and_the_stratification_variable_andevaluated_by_the_wald_test': 9.148819220060914e-58, 'disease_\\x88\\x92': 1.3633221579071079e-05, 'iiidisease_fortyone_percent': 0.00020329019466379467, 'edih_scores': 6.0751388053683735e-52, 'intakes_to_test_group_differences_quintile_ _vs_and_adjusted_for_postdiagnosis_total_energy_intake_and_postdiagnosis_body_mass_indexcomparing_colorectal_cancer_patients_classified_in_the_highestedih_quintile_to_those_in_the_lowest_quintile': 3.28784142602511e-52, 'to_test_group_differences_quintile_ _vs_and_adjusted_for_postdiagnosis_total_energy_intake_and_postdiagnosis_body_mass_indexcomparing_colorectal_cancer_patients_classified_in_the_highestedih_quintile_to_those_in_the_lowest_quintile': 3.28784142602511e-52, 'reference_category': 0.0005573368904834178, 'highhigh': 0.0005034057898537578, 'lowlow_highhigh_models': 9.148819220060914e-58, 'pattern_consumption': 9.148819220060914e-58, 'prediagnosis_edih': 0.00034678516808638586, 'body_weightthose': 0.0011075402231842013, 'dietarypattern': 0.0011075402231842013, 'insulin_index': 0.0007035667068513752, 'aparticularfood_item': 0.0005255240447748787, 'insulin_secretionindependent': 8.572729794799105e-06, 'insulin_exposureie': 0.0038806204677737646, 'fasting_nonfasting': 0.0010068765747081726, 'onestudy': 0.0007862569594425692, 'edih': 9.148819220060914e-58, 'insulin_increases_study': 9.148819220060914e-58, 'overtime_lead': 0.00210348072096923, 'cancerprognosis': 0.0038806204677737646, 'plantrichlowcarbohydrate_diet': 0.0011075402231842013, 'sourcesof_fat_protein': 0.0038806204677737646, 'insulinstimulates_growth_theinsulin_receptor': 8.263922883666513e-55, 'effectis': 1.1686951820486561e-54, 'isoformwhich': 8.263922883666513e-55, 'syndrome_obesity': 0.00040561912644835544, 'postdiagnosisperiod': 0.0011075402231842013, 'measurement_error': 0.0014616190772430405, 'confounding_byunmeasured_variables_given': 0.007713134335009549, 'diet_andsurvival_association_study_potential': 0.0038806204677737646, 'partlythrough_mechanisms': 0.0008581749454218445, 'phosphatidylinositol_kinaseprotein_kinase_software_®_acknowledgementswe': 9.148819220060914e-58, 'to_thank_the_participants_and_staff_of_the_nurses\\x99_health_studyand_health_professionals_followup_study_for_their_valuable_contributions': 9.148819220060914e-58, 'metabolism_alterations': 9.148819220060914e-58, 'to_contribute_to_cancer_progressionwe_hypothesized_that_lung_adenocarcinomas_with_high_recurrence_risk_contain_candidate_lipid_predictors_this_studyaimed_to_identify_candidate_lipid_predictors_for_the_recurrence_of_lung_adenocarcinoma_after_a_radical_surgerymethods_frozen_tissue_samples_of_primary_lung_adenocarcinoma_obtained_from_patients_who_underwent_a_radicalsurgery_were_retrospectively_reviewed': 9.148819220060914e-58, 'to_identify_candidate_lipid_predictors_for_the_recurrence_of_lung_adenocarcinoma': 0.0010325216439875707, 'radicalsurgery': 0.0011075402231842013, 'to_contribute_to_cancer_progressionwe_hypothesized_that_lung_adenocarcinomas_with_high_recurrence_risk_contain_candidate_lipid_predictors_this_studyaimed_to_identify_candidate_lipid_predictors_for_the_recurrence_of_lung_adenocarcinoma_after_a_radical_surgerymethods_frozen_tissue_samples_of_primary_lung_adenocarcinoma_obtained_from_patients_who_underwent_a_radicalsurgery_were_retrospectively_reviewed_lipids': 0.0005614408921726238, 'the_average_total_lipid_levels_of_the_nonrecurrent_andrecurrent_groups_were_compared_candidate_predictors': 9.159789807189547e-06, 'lipid_species': 0.000489923995670151, 'smd351': 0.007713134335009549, 'resection_experience': 0.0011075402231842013, 'to_reduce_therisk_of_death_due_to_lung_cancer_recurrence': 4.795130645358592e-06, 'surgerybenefit': 0.0011075402231842013, 'to_hinder_accurate_recurrence_prediction_and': 0.0025007634484289117, 'recurrence_risk': 9.148819220060914e-58, 'lipidomes': 9.148819220060914e-58, 'freezing': 5.417188368313177e-05, 'inductionchemotherapy_radiotherapy_those': 0.0011075402231842013, 'd2\\x93_stain': 9.148819220060914e-58, 'to_evaluate_lymphatic_vessel_invasion_and_elasticavan_gienson_stain_to_evaluate': 9.148819220060914e-58, 'invasion_allhistologicalsections': 9.148819220060914e-58, 'acetate_ultrapurewater': 9.148819220060914e-58, 'al_pc_120_120': 1.1686951820486561e-54, 'to_evaluate_lymphatic_vessel_invasion_and_elasticavan_gienson_stain_to_evaluate_acetate_ultrapurewater_lab_balance': 8.263922883666513e-55, 'lab_balance': 8.263922883666513e-55, 'mmol': 9.148819220060914e-58, '10minextraction': 9.148819220060914e-58, 'lv': 8.39810707329953e-05, 'lipid_c18_column': 6.302793016824041e-06, 'c18_column': 1.3701397397505932e-06, 'wateracetonitrilemethanol_mm_ammonium_formate_acidthe_components': 0.00035695096505492413, 'normalizedcollision_energies_performedwith_time_tolerance': 5.3523013564518495e-05, 'normalizedcollision_energies_to_identify_and_quantify_lipid_species_parameter_settings_for_identificationwere_followings_database_hcd_retention_time_min_search_type_product_qex_precursor_tolerance_ppm_and_productidentificationquality_filters_of_a_b_and_c_performed_at_mz_tolerance_of_±_with_retentiontime_range_from_\\x88\\x92_ _min_to_ _min_alignment_of_theidentified_lipid_species_among_ _cases_performedwith_time_tolerance': 0.002355772634929462, 'of\\x93_mz': 9.148819220060914e-58, 'xcalibur_v30_ppmlipid_identification_mitsui_knowledgeindustry': 9.148819220060914e-58, 'tokyo_japan': 9.148819220060914e-58, 'to_identify_and_quantify_lipid_species_parameter_settings_for_identificationwere_followings_database_hcd_retention_time_min_search_type_product_qex_precursor_tolerance_ppm_and_productidentificationquality_filters_of_a_b_and_c': 9.148819220060914e-58, 'performed_at_mz_tolerance_of_±_with_retentiontime_range_from_\\x88\\x92_ _min_to_ _min_alignment_of_theidentified_lipid_species_among_ _cases': 5.3523013564518495e-05, 'processingtrend_analysis': 3.844203468597609e-05, 'lipidlevel': 3.844203468597609e-05, 'species_pvalues': 9.148819220060914e-58, 'student_ttest': 9.148819220060914e-58, 'foldingchange': 3.844203468597609e-05, 'totallipid_amounts_describe': 1.3987822841354876e-05, 'byaccumulating_normalized_intensities_of_lipids_notablythe_average_total_lipid_level_of_the_recurrent_group': 0.000857488516311412, 'recurrenceor_survival_curve': 9.148819220060914e-58, 'using_thekaplan\\x93meier_method_the_optimal_cutoff_values_todiscriminate_the_two_groups_were_determined_using_thereceiver_operating_characteristic_roc_curve_analysisthe_area_under_the_roc_curves_aucs': 9.148819220060914e-58, 'using_thereceiver_operating_characteristic_roc_curve_analysisthe_area_under_the_roc_curves_aucs': 0.0003022165162482692, 'discrimination_abilities': 9.148819220060914e-58, 'to_validatethe_correlation_among_candidate_lipid_predictors_were_performedusing_r_the_r_foundation_for_statistical_computingvienna_austria_version_ _the_student_ttest_wasperformed_with': 9.148819220060914e-58, 'respectivelytrend_analysis': 1.3987822841354876e-05, 'pca_plot': 0.0038806204677737646, 'screen_lipids': 0.0038806204677737646, 'volcano': 8.29208001901855e-05, 'species_species': 0.007713134335009549, 'candidate_lipids': 0.0004576368763948737, 'toestablish': 0.0003022165162482692, 'foundwe': 8.263922883666513e-55, 'cutoff_values_auc': 1.1686951820486561e-54, 'lipidspecies': 8.263922883666513e-55, 'nh4': 9.148819220060914e-58, 'production_peaks': 9.148819220060914e-58, 'node_metastasis_blood_vesselinvasionwhich': 9.172331134492055e-05, 'stage_i': 0.0038806204677737646, 'candidate_predictors': 0.00016400412376167838, 'predictionto_those': 2.8708420687761313e-05, 'fc': 4.507129858783074e-05, 'arrowsabbreviations': 9.148819220060914e-58, 'phosphatidylcholine_pc_phosphatidylcholine': 9.148819220060914e-58, 'pvalues_presented': 0.00043463382250315263, 'pe_phosphoethanolamine_tg_triglycerideinvasion': 9.148819220060914e-58, 'wepropose_smd351': 9.148819220060914e-58, 'theaggressiveness': 0.0010298344840079976, 'sm': 9.148819220060914e-58, 'synthase_sms': 9.148819220060914e-58, 'head_group_results_candidate_predictors_factorspredictors': 9.148819220060914e-58, 'abilityabbreviations_cer_ceramide': 9.148819220060914e-58, 'sm_reconversion': 9.148819220060914e-58, 'sphingomyelinase_smase': 9.148819220060914e-58, 'to_playa_critical_role_in_cell_proliferation_and_survival_in_severalcancer_types_[_\\x93_]_with_regard_to': 0.0007008712380191807, 'metabolic_changes': 7.417164383651313e-53, 'synthase_sms_sphingomyelinase_smase_to_playa_critical_role_in_cell_proliferation_and_survival_in_severalcancer_types_[_\\x93_]_with_regard_to': 1.284690556057437e-52, 'speculated': 7.417164383651313e-53, 'sm_abundance': 0.004315547045054443, 'sm_andcer_levels': 7.417164383651313e-53, 'normallung_tissue_samples': 9.148819220060914e-58, 'increasedsmd351_cerd420': 9.148819220060914e-58, 'suggesting_that_energysupply_for_colon_cancer_with_higher_degree_of_malignancymay_depend_on_tg_hydrolysis_  _inconsistent_with_theprevious_study_  _the_total_tg_level_in_this_study': 0.0004968127217041802, 'tg_species': 0.004315547045054443, 'accurateretrospectiverecurrence_prediction_cancer_page_ofsmd351': 0.0005371174057381335, 'nearperfect_discriminationability': 8.263922883666513e-55, 'groupmay': 0.0002800361681909777, 'them_recurrence': 9.148819220060914e-58, 'adjuvantchemotherapy': 9.148819220060914e-58, 'group_inthis_study': 0.0005612913089309412, 'predictorsshould': 0.0005612913089309412, 'forthrough': 3.909534922212017e-05, 'lipidomic_approachthe_sample_cohortswe': 9.148819220060914e-58, 'type_forthrough': 9.148819220060914e-58, 'ablation_mwa': 7.417164383651313e-53, 'immunoreaction_levels': 7.643475415353497e-05, 'mwa': 0.0012365187107291078, 'ablation_data': 7.417164383651313e-53, 'spearman\\x99s_correlation': 7.417164383651313e-53, 'malignancy_cytokines': 0.00019685264459536156, 'mortality_rate_malignancies_aremediators': 5.025071142854711e-05, 'the_first_affiliated_hospital_of_soochow_universitysuzhou_china5division_of_neurosurgery_city_of_hope_beckman_research_institute_duartecalifornia_usafull_list_of_author_information_is_available_at_the_end_of_the_interventional_imaging_therapy': 0.00011631552306976502, 'mortality_rate_malignancies_investigators_group_to_treat_unresectable_hcc_and_recurrent_hcc_advantages_aremediators_tumor_development': 0.0009694250105118624, 'microwave_ablationmwa': 9.148819220060914e-58, 'to_treat_unresectable_hcc_and_recurrent_hcc': 9.148819220060914e-58, 'ici_treatment': 0.0022357023743599766, 'il8_il10_endothelial_growthfactor_vegf': 1.581947752668538e-05, 'disease_sd_partial': 8.263922883666513e-55, 'human_ethicscommittee': 0.00020438662347026346, 'tnfÎ±_vegf': 9.148819220060914e-58, 'then_incubated_with_a_biotinylated_detection_antibodyafter_the_beads_were_washed': 9.148819220060914e-58, 'fluorescent_intensities': 9.148819220060914e-58, 'il10_tnfÎ±_pgml': 9.148819220060914e-58, 'then_incubated_with_a_biotinylated_detection_antibodyafter_the_beads_were_washed_il10_tnfÎ±_pgml': 8.330612667003498e-09, 'vegf_pgml': 1.359245121302037e-10, 'using_a_onetailedpaired_ttest_characteristics': 0.0003802249829989744, 'using_a_onetailedpaired_ttest': 2.2198778283467915e-05, '0czhao_bmc_cancer_page': 0.00039446693694775875, 'w_±_ _±_±_±_average_energy_time_ _Ã\\x97_power_  _time_ _Ã\\x97_power\\x96¼\\x96¼_time_ _and_power_ ': 9.148819220060914e-58, 'time_power_ofdifferent_probes_il12_p40_il12_p70_afterthe_mwa_treatment_pgml': 9.148819220060914e-58, 'il8_il10': 8.832242571362864e-08, 'significantincrease_treatment_pgml_ci_\\x93': 0.0006674076661460604, 'ci\\x93_ci_\\x93': 0.0008524307787408606, 'level_levels_relationship_concept': 1.3913654449867556e-05, 'pgml_ci_\\x93': 0.0006674076661460604, 'afterthe_mwa_treatmentlevelselevated': 2.2716382614535907e-07, 'postmwa': 0.00022454027988380799, 'respectivelydiscussionas_technology': 8.263922883666513e-55, 'to_address_indications_for_mwa_in_these_patientsthermal_ablation': 8.263922883666513e-55, '\\x93_\\x93_\\x93_\\x93_\\x93_ci_\\x93effect': 0.00039436183359109516, 'antigens_cytokines_cellsin_increases': 0.004315547045054443, 'il8_cytokines': 3.501800966709466e-07, 'ifnÎ_tnfÎ±_antiinflammatory_cytokines': 2.144838707230353e-05, 'il8_macrophageand_cancer': 9.148819220060914e-58, 'cells_mdscs': 9.148819220060914e-58, 't_lymphocytesctls_il12': 9.148819220060914e-58, 'b_cells_macrophages_il12': 9.148819220060914e-58, 'il12_p40_p35': 0.00014196122844898728, 'cell_il12': 0.0004402126501869481, 'cytokineswere_researchers': 6.433333488885167e-06, 'ablation_cytokines': 0.00019941863725030497, 'heat_injurycould': 1.81823575620778e-05, 'il8_il10_tnfÎ±_d_postmwa_p': 0.0008522036149147152, 'correlation_reaction': 0.000898952546331454, '\\x9cenergy\\x9dindex': 0.007713134335009549, 'altered': 0.0001391293091783537, 'cellsil2': 0.0001391293091783537, 'il2': 0.0006750162805663558, 'lasting_mentionable_many_cytokines_detected': 0.0006750162805663558, 'thanliver_lung': 9.148819220060914e-58, 'to_followup_the_il6_at_ _months_afterhifu_ablation_as_our_data_demonstrated_mostly_cytokines_were_return_to_premwa_level_after_ _monthdetection': 9.148819220060914e-58, 'to_make_a_clarifieddata_and_answer_this_question': 2.2806948295214185e-05, 'effect_icis': 0.0018006682651940404, '[_]_icis_suchas_pd1pdl1_and_ctla4_antibodies_are_widely_applied_in_several_cancers_and_studies_have_indicated_thatici_treatment': 0.001128162151175775, 'effect_h': 0.001797209429769442, 'treatment_il6': 0.0015842910551982499, 'ofa_nanop_smallinterfering_rna_sirna': 1.1686951820486561e-54, 'to_target_the_il6mediated_locoregional_and_systemic_effects_of_thermal_ablation': 8.263922883666513e-55, 'knockout': 8.263922883666513e-55, 'induce': 9.148819220060914e-58, 'to_revealwhether_the_cytokines_altered_by_mwa_treatment_couldaffect_cancer_progression': 9.148819220060914e-58, 'visualization_writing\\x93original_draft_writing\\x93review_editingall_authors': 0.0003625963872087491, 'assay_data_conceptualizationand_writing\\x93review': 5.915252259826258e-06, 't_lymphocytes': 8.263922883666513e-55, 'mwa_ablation_collectsamples_yx': 1.1686951820486561e-54, 'patient_enrollment': 8.263922883666513e-55, 'data_conceptualizationand_writing\\x93review': 5.913676645907637e-06, 'declaration': 9.663701483373297e-08, 'foundation_ofchina': 0.0005415967957390505, 'workauthor': 9.148819220060914e-58, 'referencesfu_h_precision_diagnosis_treatment': 9.148819220060914e-58, 'pd1_blockade': 2.593130325493349e-07, 'lee_schange_\\x93': 9.148819220060914e-58, 'm_bale_r_breen_chen_mhchoi_baere_ablation_position_paper_solbiati_l': 9.148819220060914e-58, 'med_biol_soc': 9.148819220060914e-58, 'phys': 9.148819220060914e-58, 'expression_cells': 2.998760548839782e-05, 'tumorproducedinterleukin8': 8.263922883666513e-55, 'cells_secrete_il12_tnfalpha': 0.004315547045054443, 'fan_j_treatment': 9.148819220060914e-58, 'cell_deathoncotarget': 9.148819220060914e-58, 'der_voort_cg_ruerstj_adema_gj': 9.148819220060914e-58, 'antigen_source': 9.148819220060914e-58, 'nkcell_responsegastroenterology': 8.263922883666513e-55, 'economies': 0.00010798726456198564, '\"_ _national_economies_are_increasingly_facing_the_challenge_of_having_to_finance_the_prevention_andtreatment_of_human_diseases_and_of_having_to_compensate_for_the_resulting_loss_of_economic_production_physicalinactivity_is_demonstrably_closely_related_to_the_risk_of_developing_certain_disease_group_physical_inactivity_results_indirect_and_indirect_burdens_that_the_present_study_intends_to_quantify_in_hungary_for_the_period_between_ _and_methods_based_on_the_data_of_the_hungarian_public_finances_this_study_determines_the_direct_and_indirect_costsincurred_by_hungary_due_to_illnesses_and_through_the_par_method_it_quantifies_the_financial_burden_of_physicalinactivity_incurred_by_the_hungarian_treasuryresults_the_total_financial_burden_of_illnesses_in_hungary_showed_a_decreasing_tendency_from_ _to_ _eventhough_the_year_ _saw_an_increase_in_costs_compared_to_ _similarly_while_total_public_expenditure_on_illnessesassociated_with_physical_inactivity_increased_by_ _when_compared_to_ _the_total_amount_attributable_to_medicalconditions_stemming_from_physical_inactivity': 0.0005807607654450252, 'challenge_costsincurred': 0.0019127833147525456, 'that_to_quantify_in_hungary_for_the_period_between_ _and_methods_based_on_the_data_of_the_hungarian_public_finances': 0.0019127833147525456, 'costsincurred': 0.0019127833147525456, 'biggesteconomic_burden': 9.148819220060914e-58, 'diseases_hypertension_type_diabetess': 9.148819220060914e-58, 'decrease_diseases_hypertension_type_diabetess_impact': 0.0007080023910910008, 'increase_period': 0.0038806204677737646, 'types_diseases': 9.148819220060914e-58, 'hungaryfull_list_world_health': 9.148819220060914e-58, 'anizationwho': 0.00040561912644835544, 'acinactivity': 0.00040934415372960003, 'evidence_activity': 6.831096425835295e-05, 'lifestyles': 9.148819220060914e-58, 'mineral_composition': 9.148819220060914e-58, 'healtheffects': 1.1152937942653372e-06, 'sedentarylifestyle': 0.0007862569594425692, 'development_construction': 0.0007956673215405282, 'to_contribute_to_this_bodyof_research': 0.0019127833147525456, 'to_analyse_a_longer_timespectrummethodsto_analyze_the_economic_burden_of_physical_inactivity_weneed_to_start_with_the_burden_of_diseases_on_the_nationaleconomy_as_physical_inactivity_plays_a_vital_role_in_the_onset_of_several_diseases_and_leads_to_various_causes_of_deathat': 0.0019127833147525456, 'medications_sickpay_allowances_ancilliary': 0.0003519185601107666, 'inhungary': 9.148819220060914e-58, 'national_fund_nhif': 9.148819220060914e-58, 'loss_loss': 0.004315547045054443, 'thousand': 0.0010298344840079976, 'to_contribute_to_this_bodyof_research_to_analyse_a_longer_timespectrummethodsto_analyze_the_economic_burden_of_physical_inactivity_weneed_to_start_with_the_burden_of_diseases_on_the_nationaleconomy_as_physical_inactivity_plays_a_vital_role_in_the_onset_of_several_diseases_and_leads_to_various_causes_of_deathat_medications_sickpay_allowances_ancilliary_cost_thousand_people_assumptions_formulas_data': 0.0002654333902756132, 'unemployment': 0.0004111663773473564, 'formulas_data': 0.007713134335009549, 'becomefact': 0.004315547045054443, 'to_change_the_assumptions_about_the_labormarket_from_the_previouslyoutlined_conditions_as_by_hungarian_labor_market': 0.007713134335009549, 'to_increase_frictiontime': 0.007713134335009549, 'number_cost': 9.148819220060914e-58, 'lifestyle_activity_indicators': 9.148819220060914e-58, 'hungarianpopulation': 9.148819220060914e-58, 'fluctuations': 9.148819220060914e-58, 'risk_ratio': 0.008024143281886418, 'huf_sickness_benefit': 3.2577947408561978e-06, 'justover': 0.00019968263371052166, 'inactivity_fifthfor_costs': 0.0023037238670976933, 'burdens': 9.148819220060914e-58, 'huf': 9.148819220060914e-58, 'burden_onthe_state_budget': 3.760679157795937e-05, 'rolein_development': 0.00022937745517184345, 'fifthfor_costs': 0.000199629432709579, 'in_ _theexpenditures_in_the_state_budgetfor_the_ _diseasegroups_examined': 9.148819220060914e-58, 'base_total_increase': 9.148819220060914e-58, 'expenditures': 9.148819220060914e-58, 'base_total': 9.148819220060914e-58, 'diabetesand_osteoporosis': 0.0007080023910910008, 'ofexpenditure_diseases_colon_cancerare': 0.00014084186830440697, 'withosteoporosis_stagnation_decrease': 9.148819220060914e-58, 'disease_groups': 9.148819220060914e-58, 'page_practitioner_servicesdental_servicesoutpatient': 9.148819220060914e-58, 'centers_huf': 9.148819220060914e-58, 'pay': 0.0038806204677737646, 'cancer_howeverpercentagewise_nhif': 9.148819220060914e-58, 'cost_reduction': 9.148819220060914e-58, 'categories_sum_total': 9.148819220060914e-58, 'alsomakes': 9.148819220060914e-58, 'isso': 0.0006681652127777817, 'increasedat_level': 8.31666731057558e-05, 'theexpenditure': 0.0011284627910272927, 'decreaseof_table': 1.8415484017042953e-05, 'activityand_forms': 9.148819220060914e-58, 'protectiveeffect_effect': 9.148819220060914e-58, 'samplingpoints': 0.007713134335009549, 'costs_burdens': 8.735640777618301e-05, 'stateand_society': 1.4253247078174131e-06, 'sick': 0.0004111663773473564, 'withmattli': 0.0038806204677737646, 'depression_costs': 0.00015266313713209798, 'theintroduction_development': 0.00029907265845018327, 'haveresearch_data': 9.148819220060914e-58, 'bearing': 9.148819220060914e-58, 'thesemeasures': 9.148819220060914e-58, 'profit': 9.148819220060914e-58, 'activities_peoplewe': 9.148819220060914e-58, 'to_expand_the_scope_of_our_current_research_if_we_could_also_examine_how_the_patient_numbers_varied_each_year_by_disease_group_unfortunatelythe_data': 9.148819220060914e-58, 'activity_rate': 0.004315547045054443, 'anizationacknowledgementsthe_authors': 0.0011075402231842013, 'beitl_analistthe_authors': 9.148819220060914e-58, 'to_express_their_special_thanks_to_prof_attila_fabianformer_vice_state_secretary_for_his_cooperative_help_during_the_datacollectionabout': 9.148819220060914e-58, 'risk_ratios': 9.148819220060914e-58, 'par_indices_contributedto': 9.148819220060914e-58, 's_dp': 9.148819220060914e-58, 'calculations_inactivity': 9.148819220060914e-58, 'results_korosi_l_r_kriszbacher': 0.0004499048194399722, 'underlicense': 0.0038806204677737646, 'interestsauthor_details1university': 0.0013882295497307361, 'korosi_l_r_kriszbacher': 0.0004499048194399722, 'gn_owen_andhealth_implications_¡_cs_p_h_r_pa¡r_d_stocker': 8.263922883666513e-55, 'terhei_magyarorsz¡gon': 1.1686951820486561e-54, 'fizikai': 8.263922883666513e-55, 'k¶zgazdas¡gi': 9.148819220060914e-58, '\\x93_gabnai_z_m¼ller_burden_fizikai': 9.148819220060914e-58, 'cancer_deaths': 0.0019337023453711122, 'highmortality_provinces': 9.148819220060914e-58, 'to_look_for_specific_riskfactorskeywords_agespacetime_models_disease_mapping_inla_ovarian_cancer_mortality_smoothing_the_number_and_scientific_impact_of_publications_on_ovarian_cancer': 9.148819220060914e-58, 'models_disease': 9.148819220060914e-58, 'inla_cancer_mortality': 9.148819220060914e-58, 'tumorcorrespondence_lolaunavarraes1department': 8.263922883666513e-55, 'lithuania': 1.1686951820486561e-54, 'czech_republic_germany': 8.263922883666513e-55, 'toincrease_number_ofovulations_contraceptives_ligation_orhysterectomy_analyzedthe_ageadjusted_mortality_trends_deaths_peryear_to_drop_at_a_rateof_study': 0.004035351157225681, 'toincrease': 2.387783167851065e-05, 'number_ofovulations': 0.0007000951832348714, 'main': 9.148819220060914e-58, 'secondhand_contact': 9.148819220060914e-58, 'risk_exposure': 0.0018006682651940404, 'contraceptives_ligation_orhysterectomy': 2.387783167851065e-05, 'analyzedthe_ageadjusted_mortality_trends': 2.387783167851065e-05, 'peryear': 2.387783167851065e-05, 'to_drop_at_a_rateof': 2.387783167851065e-05, 'nit': 0.0004033468197677982, 'i_period_t_number': 9.148819220060914e-58, 'to_follow_a_poisson_distribution_with_mean_0ctrandafir_  _bmc_public_health_          _page_ _of_table_ _descriptive_statistics_of_observed_cases_and_crude_mortality_rates_per_ _women_disaggregated_by_age_groups': 9.148819220060914e-58, 'casescrude_ratesage_group_lograte': 0.0003260903091169294, 'to_be_gaussian_markov_random_fields_gmrf_  ': 5.7329206921586805e-05, 'firstorderrandom': 0.0003260903091169294, 'differentmodel_selection_criteria_model': 0.0004448724835359713, 'inthe_population': 0.0004515792443925681, 'summary_year': 4.346059685937982e-06, 'adini_Î³_fig': 0.0002665581784522052, 'rit': 0.004315547045054443, 'Î±\\x88\\x97': 9.148819220060914e-58, 'thatexpÎ±\\x88\\x97': 9.148819220060914e-58, 'source_map': 9.148819220060914e-58, 'authorsusing': 9.148819220060914e-58, 'library_tmap_licenses': 9.148819220060914e-58, 'to_use_or_publish_0ctrandafir_  _bmc_public_health_          _page_ _of_figure_ ': 9.148819220060914e-58, 'i_posteriorthis_provincespecificthe': 0.0002768434257340561, 'attention_toasturias': 0.00034678516808638586, 'inthe_centralnorthern_areas': 0.0003733882581898837, 'regions_rates': 6.088028264162595e-06, 'cancermortality_rates': 0.00046703013980541936, 'province': 1.284690556057437e-52, 'authors_touse_age_group': 7.417164383651313e-53, 'group_licenses': 9.148819220060914e-58, 'to_use_or_publish_ ': 9.148819220060914e-58, 'expÎ±\\x88\\x97o_source_maps': 0.0007959416758056306, 'one_pattern': 9.148819220060914e-58, 'to_have_decreased_duringthe_last_few_years_from_ _to_ _in_age_group': 9.148819220060914e-58, 'maps_we': 7.417164383651313e-53, 'significantrate': 7.417164383651313e-53, 'evolution_lines': 0.00046703013980541936, 'estimates_source_maps_licenses': 1.284690556057437e-52, 'to_use_or_publish_0ctrandafir_  _bmc_public_health_          _page_ _of_ _to_ _to_ _to_ _to_ _to_ _to_fig_ _mortality_rates\\x99_estimates_for_age_group_[_  ': 7.417164383651313e-53, 'to_use_or_publish_to_ _to_ _to_ _to_ _to_ _to_fig_ _mortality_rates\\x99_estimates_for_age_group_[_  ': 7.417164383651313e-53, 'to_use_or_publish_0ctrandafir_  _bmc_public_health_          _page_ _of_ _to_ _to_ _to_ _to_ _to_ _to_fig_ _mortality_rates\\x99_estimates_for_age_group_[_ _posterior_mean_estimates_of_mortality_rates_rit_for_age_group': 7.417164383651313e-53, 'source_maps_licenses': 9.148819220060914e-58, 'to_use_or_publishin_age_group_ ': 9.148819220060914e-58, 'asturias_lugo_salamanca_valladolid_huescateruel_gerona_balearic_islands': 9.148819220060914e-58, 'significantlyhigh_rates': 9.148819220060914e-58, 'variability_significantlyhigh_rates': 0.0003732887667714682, 'asturias': 9.148819220060914e-58, 'highestmortality_rate': 9.148819220060914e-58, 'madrid': 9.148819220060914e-58, 'tospain': 9.148819220060914e-58, 'province\\x99s': 0.00021180960367334957, 'to_informationvia': 0.0004472423269940801, 'sharpincrease': 0.0038806204677737646, 'althoughthis_decrease': 9.148819220060914e-58, 'to_be_significant_with_respectto_the_average_mortality_in_this_age_group': 9.148819220060914e-58, 'patterns_show': 8.263922883666513e-55, 'rates_situation': 1.1686951820486561e-54, 'variabilityobserved': 8.263922883666513e-55, 'taking_into_account_the_relationship_between_exposure_to_sunlight_provitamin_dand_ovarian_cancer': 0.0006264573400700461, 'forexample': 0.0021412026898250244, 'sunlight': 3.4955919161338953e-05, 'outthat': 0.007713134335009549, 'navarreand': 0.007713134335009549, 'childbearing_the_longest_  _additionally_hormonal_replacement_therapy': 0.00020049727878820533, 'part_mortality_rates': 0.0010325216439875707, 'provinces_years_age_groups_institute': 0.0006264573400700461, 'domains_groups_provinces': 0.0005263009120446208, 'provinces_years_age_groups': 0.0006264573400700461, 'highmortalityprovinces': 9.148819220060914e-58, 'to_look_more_closelyfor_specific_risk_factors_some_risk_factors_for_ovarian_cancer_like_getting_old_or_having_a_family_history_can_not_bechanged_however_women_may_slightly_decrease_their_riskby_avoiding_other_risk_factors_for_example_maintaining_0ctrandafir_  _bmc_public_health_          _page_ _of_a_healthy_weight_avoiding_tobacco_and_alcohol_consumption_or_not_receiving_hormone_replacement_therapy_aftermenopauseabbreviationsaei_spanish_research_agency_brca_breast_cancer_dic_deviance': 9.148819220060914e-58, 'riskby': 0.00021180960367334957, 'application_uk_united_kingdomacknowledgementswe': 1.5830621950620386e-09, 'pct_revision': 9.206423219926282e-07, 'materialdata': 5.9393305777184935e-06, 'views_institute_data_fromcancer_causes': 3.333920198953135e-05, 'data_fromcancer_causes': 3.333920198953135e-05, 'system_ariadna_httpariadnacneisciiiesevindexhtml': 9.148819220060914e-58, 'groneberg_mapping': 9.148819220060914e-58, 'cancer_j_clin_\\x93national_institute_recognition_management': 9.148819220060914e-58, 'jan_dos_santos_silva': 9.148819220060914e-58, 'mortality_iarc_cancer_base_lyoninternational_agency': 9.148819220060914e-58, 'coebergh_jcomber_hea_cancer_incidence_mortality_patterns_publication': 9.148819220060914e-58, 'multitude': 0.002293411154615955, 'multitude_to_detect_the_relevant_proteins_mirna_and_gene_expression_luciferase_reporterassays_were_used_to_illustrate_the_interaction_between_mir4255p_and_ptenresults': 0.008113309576937157, 'counting_kit8_blot_realtime_pcr': 0.0015842910551982499, 'to_detect_the_relevant_proteins_mirna_and_gene_expression_luciferase_reporterassays_were_used_to_illustrate_the_interaction_between_mir4255p_and_ptenresults': 0.00018993043364672486, 'luciferase_reporterassays': 9.148819220060914e-58, 'to_illustrate_the_interaction_between_mir4255p_and_ptenresults': 9.148819220060914e-58, 'mir4255p': 0.0010255344973683215, 'procancer_effects': 0.0016810521528134112, 'lca_tumorigenesis_cancer_pten': 1.6732570122096195e-05, 'requiredmicrornas_mirnas': 9.148819220060914e-58, 'differentiation_metabolism_tumorigenesis[\\x93': 9.148819220060914e-58, 'aberrantexpression': 1.1686951820486561e-54, 'upregulationof_contribution_tolca_development': 8.263922883666513e-55, 'shangchen_road_we': 9.148819220060914e-58, 'upregulationof': 9.148819220060914e-58, 'contribution_tolca_development': 8.263922883666513e-55, 'pten': 0.00771518910792271, 'no2015009all_participants': 9.148819220060914e-58, 'consent_anything': 9.148819220060914e-58, 'link_medicine_page': 0.00018423236767620154, 'medicine_page': 0.00043305519126401743, 'control_mirnanc': 9.148819220060914e-58, 'mediathe_china_lipofectamine_invitrogen_eugene_usa': 9.148819220060914e-58, 'growth_assayslca_viability': 9.148819220060914e-58, 'using_cell_counting_kit8from_shanghai_haling_biotechnology_co_ltd_shanghai_china': 9.148819220060914e-58, 'analysistotal_rna': 1.1686951820486561e-54, '®_reagent': 8.263922883666513e-55, 'to_estimate_its_quality_and_concentration_theexpression_of_mir4255p_was_done_by_reverse_transcription_using_the_mirx\\x84¢_mirna': 8.263922883666513e-55, 'pcr_rtqpcr': 0.00033788292231117737, 'to_evaluate_all_genes_expressions': 0.00033788292231117737, 'pcr_rtqpcr_to_evaluate_all_genes_expressions': 3.175735189870594e-06, 'att_tgc': 5.1905359709598846e-08, 'genepharma_thesewere': 3.28784142602511e-52, 'data_normalization': 0.0007008712380191807, 'renilla_luciferasewbcell': 7.392245403241764e-06, 'softwarestatistical_analysesdata_analysis': 0.0011291524075957185, 'using_a_oneway_pten_expressionfig_3bc_effect_fig3de': 4.2223054439435285e-05, 'using_a_oneway': 1.8426734781810828e-05, 'proliferation_apoptosisin_lca_cellsto': 1.955911621694577e-05, 'apoptosisin_lca_cellsto': 1.6732570122096195e-05, 'targetscan_pten': 3.1935228151996364e-07, 'pten_expressionfig_3bc': 1.6732570122096195e-05, 'fig3de': 0.0008522036149147152, 'tissue_r2_fig': 0.00012613970685026185, 'pten_overexpression_pten': 1.6732570122096195e-05, 'ptenlevels': 1.6732570122096195e-05, 'lca_proliferation': 1.6732570122096195e-05, 'effectsmir4255p': 9.148819220060914e-58, 'ptenpi3kakt_signalingit': 9.148819220060914e-58, 'effectsmir4255p_activates_ptenpi3kakt_signalingit': 9.148819220060914e-58, 'ptenpi3kakt': 9.148819220060914e-58, 'ptenpi3kakt_inhibitor_ly294002_mimic': 1.6732570122096195e-05, 'nsclc_cells': 9.148819220060914e-58, 'inhibitor_ly294002': 9.148819220060914e-58, 'ly294002_p': 9.148819220060914e-58, 'thisimplicates': 9.148819220060914e-58, 'forfig_mir4255p': 0.00011103066187167903, 'beas2b_cellsdata': 7.063749535528257e-06, 'lca': 1.6732570122096195e-05, 'mir4255p_expression': 0.00036240313892865647, 'lca_growth': 1.6732570122096195e-05, 'cck8_analysis': 1.6732570122096195e-05, 'andor_pten': 1.6732570122096195e-05, 'cells_data': 9.148819220060914e-58, 'sd_p_p_fig_effects': 9.148819220060914e-58, 'wb_analysis': 9.148819220060914e-58, 'figure_b': 9.148819220060914e-58, 'medicine_page_dysregulation': 4.2228866439237544e-07, 'to_be_overactive_in_a_multitude_of_human_cancers': 2.5873580930035818e-05, 'mir203_bindsto_zeb2': 9.148819220060914e-58, 'emt_yuan': 9.148819220060914e-58, 'thatmir30a': 9.148819220060914e-58, 'eya2_migration_invasion_andli': 9.148819220060914e-58, 'mir1304': 9.148819220060914e-58, 'lca_heme_oxygenase1': 9.148819220060914e-58, 'cell_survival_colony_formationability': 0.003560845952345158, 'cell_cycleprogression': 0.0005521751935137136, 'procancereffects': 9.148819220060914e-58, 'to_be_mediated_through_manipulationof': 9.148819220060914e-58, 'ptenpi3kakt_we': 9.148819220060914e-58, 'mir4255p_data': 9.148819220060914e-58, 'strategiesfor_diagnosis_treatment': 0.0008822241915335798, 'thefunctions_roles': 0.0003327007272384309, 'figure_s2': 9.148819220060914e-58, 'imagesof_blots_gels': 9.148819220060914e-58, 'zsy_syc_qf': 0.0014616190772430405, 'recruitment_assessment': 0.0003327007272384309, 'finalversionfundingthis_research': 9.148819220060914e-58, 'lq19h020010_program_ofdepartment': 9.148819220060914e-58, 'patientsgave': 0.0004100538998299479, 'microrna1973p': 4.342166032257358e-05, 'dq_downregulation': 9.148819220060914e-58, 'nrf2_expression': 9.148819220060914e-58, 'zp_liu_j_mir4943p': 0.00039947355805761766, 't_mir326': 1.284690556057437e-52, 'proliferation_andmigration': 7.417164383651313e-53, 'q_zhang_j_wang_x_li_b_mir134': 7.417164383651313e-53, 'nonsmall_lungcancer_growth': 7.417164383651313e-53, 'z_li_c_mir145_mir203': 9.148819220060914e-58, 'transition_invasion': 9.148819220060914e-58, 't_mir26a5p': 9.148819220060914e-58, 'invasion_apoptosis_resistance': 9.148819220060914e-58, 'zhou_b': 7.741407113465806e-05, 'throughptenpi3kakt': 9.148819220060914e-58, 'pharmacol_sci_\\x93_g_wang_c_song': 9.148819220060914e-58, 'song_jformaldehyde': 0.0005521751935137136, 'j_exosomes': 9.148819220060914e-58, 'metastasis_emt': 9.148819220060914e-58, 'p_mir590': 9.8683294751852e-07, 'l_interaction': 1.942602669582027e-06, 'a549_cell_line': 0.00014265292060500713, 'microrna1304': 9.148819220060914e-58, 'celllung_cell_growth': 9.148819220060914e-58, 'h_ptenmmac1tep1': 9.148819220060914e-58, 'tumorigenicity_andinduces_g1_cycle_arrest': 9.148819220060914e-58, 'natl_acad_sciu': 1.1686951820486561e-54, 'tumorigenicity_andinduces_g1_cycle_arrest_bellacosa': 8.263922883666513e-55, 'bellacosa': 8.263922883666513e-55, '\\x93_song_x_tian_wang_x_mir106a': 3.3592701529803897e-06, 'cellproliferation_apoptosis': 0.0002058744026790569, 'results_prognoses_sems_placement': 0.001845170519318405, 'surgery_es_group': 5.426551909250457e-05, 'placement_bts_group': 9.148819220060914e-58, 'results_prognoses': 9.148819220060914e-58, 'sems_placement': 0.0006007043099960055, 'quality_colorectalcancerkeywords_bowel_obstruction_surgicalintervention': 9.080081227347107e-05, 'colorectalcancerkeywords_bowel_obstruction': 0.0004734482721133418, 'cancer_crc': 1.4814161982827985e-06, 'resectionand_stoma_creation': 0.0038806204677737646, 'highriskemergency_surgeries': 0.00032618452265076087, 'anastomosis_rates': 9.800142950175336e-06, 'health_insurance_physicians': 9.148819220060914e-58, 'procedure_researchgroup_skills': 9.148819220060914e-58, 'study_we': 9.148819220060914e-58, 'prognosticfactors_survival_os_recurrencefreesurvival_rfs_rates': 9.148819220060914e-58, 'december_werereviewed': 9.148819220060914e-58, 'symptom_condition': 9.148819220060914e-58, 'oralintake_symptoms': 0.0005574854210405992, 'aftersems_placement': 9.09486045015627e-06, 'diagnosed_performed_recommended_obtained_defined': 1.5297177664711786e-05, 'afterthe_sems_placement_range_ml\\x93_\\x93_complication_rate_hospital_stay': 0.0009375380544045677, 'node_dissection_primaryanastomosis': 9.800142950175336e-06, 'colorectal_cancerwere': 9.148819220060914e-58, 'emergency_surgery': 9.148819220060914e-58, 'resultsand_prognoses': 0.007713134335009549, 'southkorea_placements': 8.263922883666513e-55, 'emergency_surgery_using_aguide_wire': 1.1686951820486561e-54, 'mentioned': 9.148819220060914e-58, 'using_aguide_wire': 9.148819220060914e-58, 'contrast_tube': 8.263922883666513e-55, 'endoscopist': 9.148819220060914e-58, 'contrast_agents': 9.148819220060914e-58, 'surgery_page': 0.0020420814574032002, 'wirewall': 9.148819220060914e-58, 'cmnitis_\\x93': 9.148819220060914e-58, 'clavien\\x93dindo': 3.333350526928045e-05, 'resultsa_total': 6.257032982443824e-06, 'semsplacement': 1.0219943343602803e-07, 'patient\\x99ssymptoms_intake': 9.148819220060914e-58, 'afterthe_sems_placement': 9.148819220060914e-58, 'es': 0.0005612913089309412, 'timemedian': 1.5297177664711786e-05, 'range_ml\\x93_\\x93': 2.498598202071861e-07, 'complication_rate_hospital_stay': 2.498598202071861e-07, 'iii': 9.148819220060914e-58, 'liver_metastasis': 9.148819220060914e-58, 'betweenthe': 9.148819220060914e-58, 'skillemergent_surgicalis': 9.148819220060914e-58, '\\x93survival_rate': 0.0006578099350934741, 'bts': 3.1046262938735776e-06, 'venous': 3.1046262938735776e-06, 'reducing_complication_rates': 0.0006578099350934741, 'suvivalall': 9.148819220060914e-58, 'hazard_ratio_hazard_ratio': 9.148819220060914e-58, 'v0\\x931v2\\x93lymphatic_invasion': 9.148819220060914e-58, '±_hr': 9.148819220060914e-58, 'thisisafirstretrospectivethese_findings': 1.284690556057437e-52, 'differentlengths_types_thickness_to_develop_a_treatment_strategy_forcrc_with_obstructionvascular_invasiveness_was_correlated_with_tumor_progression_after_a_sems_placement_and_os_and_rfs_rateswere_lower_in_bts_sems_placement': 7.417164383651313e-53, 'differentlengths_types_thickness': 7.417164383651313e-53, 'to_develop_a_treatment_strategy_forcrc_with_obstructionvascular_invasiveness_was_correlated_with_tumor_progression_after_a_sems_placement_and_os_and_rfs_rateswere_lower_in_bts_sems_placement': 7.417164383651313e-53, 'data_analysis_manuscript': 9.148819220060914e-58, 'grant_support_school': 9.148819220060914e-58, 'participants_guardians': 0.0004100538998299479, 'cancer_j_clin_\\x93': 9.148819220060914e-58, 'jd_jd_incidence_predictors_colorectalobstruction_treatment': 9.148819220060914e-58, 'color_dis_\\x93': 9.148819220060914e-58, 'benoit_faivre_j_bouvier': 9.148819220060914e-58, 'dis_rectum_\\x93': 9.148819220060914e-58, 'epub_m_abir_ra_longo': 9.148819220060914e-58, 'pmid_epub_dj_emergency_presentation': 1.0222701944398597e-05, 'review_metaanalysiscolor_dis_2012147e367\\x93': 9.148819220060914e-58, 'pmid_epub_engtilney_westonpetrides_gk_darziaw_comparison': 9.148819220060914e-58, 'pmid_epub_engsaito': 3.57610591824189e-50, 'i_aprospective_multicenter_study': 9.148819220060914e-58, 'uramatsu_bridge': 9.148819220060914e-58, 'yamada_stenting': 0.001129870936471824, 'surg_endosc': 6.0751388053683735e-52, 'analysis_stent': 3.28784142602511e-52, 'pmc6342866_epub_sheenchen_sm_obstruction_perforation': 3.57610591824189e-50, 'stents': 0.00043975773664194475, 'j_surg_\\x93': 9.148819220060914e-58, 'epub_engkim': 9.148819220060914e-58, 'pmid_epub': 4.649709951488232e-52, 'h_yamafuji_k_kaneda_h_katsura_h_kubochi_k_j_surg_\\x93': 9.148819220060914e-58, 'epub_engvan': 9.148819220060914e-58, 'stenting_trial_lancetoncol_\\x93': 9.148819220060914e-58, 'engvan_hooft_je': 9.148819220060914e-58, 'dijkgraaf_mg_je_outcome': 0.0005253840276496832, 'trial_br_j_surg_\\x93': 9.148819220060914e-58, 'epub_gorissen_tuynman_jb_jones_om_localrecurrence': 9.148819220060914e-58, 'surg\\x93': 1.1686951820486561e-54, 'pmid_epub_ormando_vm_palma_r_fugazza_stents': 8.263922883666513e-55, 'meddevices_\\x93': 8.263922883666513e-55, 'diseases_sciences': 9.148819220060914e-58, 'pmid_epub_engschwartz_e_ford_r_gwyther': 9.148819220060914e-58, 'altman': 0.0001262743140923793, 'sauerbrei_taube': 2.0569639768454843e-06, 'j_clin_oncol': 1.1686951820486561e-54, 'sauerbrei_taube_epub_eng_cortet_pmid_epub_r_value_t_erdman': 8.263922883666513e-55, 'jcancer_\\x93': 9.148819220060914e-58, 'pmid_epub_y_hamaguchi_t_japanesesociety': 9.148819220060914e-58, 'epub_eng_cortet': 8.263922883666513e-55, 'pmid_epub_r_value': 2.0569639768454843e-06, 't_erdman': 3.57610591824189e-50, 'maruthachalam_k': 9.148819220060914e-58, 'af_tumour_celldissemination': 9.148819220060914e-58, 'br_j_surg_\\x93': 9.148819220060914e-58, 'pmid_epub_eng_matsuda_cell_proliferation': 9.148819220060914e-58, 'metal_stent': 3.57610591824189e-50, 'utility_surg_\\x93': 2.516404898630125e-52, 'chung_cc_li_mk_endolaparoscopic_surgery': 9.148819220060914e-58, 'epub_eng_aprospective_evaluation': 9.148819220060914e-58, 'min_bs_oncologicoutcomes_oncol_\\x93': 8.263922883666513e-55, 'epub_engvan_guidelenines': 1.1686951820486561e-54, 'emerg_surg': 8.263922883666513e-55, 'arezzo_rev': 9.148819220060914e-58, 'pmid_epub_obstruction_minim': 9.148819220060914e-58, 'review_metaanalysiscrit': 9.148819220060914e-58, 'oncol_hematol_\\x93': 9.148819220060914e-58, 'ther_alliedtechnol_\\x93': 9.148819220060914e-58, 'halligan_scolorectal_stenting': 9.148819220060914e-58, 'motivations': 0.0003857229223199018, 'wellbeingmethods': 0.00014120710818717644, 'analysis_ipa': 0.0019127833147525456, 'motivations_analysis_ipa_link': 1.4387361263178909e-05, 'sampling_population': 9.148819220060914e-58, 'ofparticipants': 9.148819220060914e-58, 'to_be_the_primary_caregivers_of_older_palliative_care': 0.0011075402231842013, 'wellbeing_honoringfidelity_caregivers': 9.148819220060914e-58, 'to_commit_to_their_caregiving_roles_in_order_to_avoid_regret_ _alleviatingsuffering_caregivers_were_motivated_to_relieve_their_family': 9.148819220060914e-58, 'regret_caregivers': 9.148819220060914e-58, 'to_relieve_their_family': 9.148819220060914e-58, 'gratitude_caregivers': 4.192755958819432e-05, 'theme': 1.4407699485500454e-05, 'to_respond_accordingly_to_their_family_member\\x99s_prognosis': 2.3522863952994842e-07, 'to_respond_accordingly_to_their_family_member\\x99s_prognosis_to_influence_caregiver': 0.0008824594201731098, 'to_influence': 2.3522863952994842e-07, 'howcaregiving_motivations': 3.240081641694322e-05, 'caregiver': 0.001985364797631217, 'motivations_wellbeing': 0.0005479687540571566, 'pleasure_appreciation_gratitude': 0.00023148283708492395, 'somehave': 8.263922883666513e-55, 'journey': 1.1686951820486561e-54, 'peaks_ofdiagnosis': 0.0013882295497307361, 'duties': 7.159555343049058e-08, 'regimes': 1.1680121451797432e-09, 'family_caregivers': 0.00026207873551180934, 'regimes_amultitude_to_be_a_lack_of_or_adequate_coping_a_process_that_requires_the_individual_toconstantly_change_efforts_in_both_thoughts_and_behaviorsin_order_to_manage_internal_or_external_demands_thatare_considered_stressful_  _despite_this_indication_sight': 4.382284441876587e-06, 'dothey': 9.148819220060914e-58, 'resources_skills': 9.148819220060914e-58, 'amultitude': 1.1680121451797432e-09, 'toterms': 0.0013882295497307361, 'thread': 7.157647309304268e-08, 'to_be_a_lack_of_or_adequate_coping_a_process_that_requires_the_individual_toconstantly_change_efforts_in_both_thoughts_and_behaviorsin_order_to_manage_internal_or_external_demands_thatare_considered_stressful_  _despite_this_indication': 1.1677009250424893e-09, 'caregiverburnout_resilience': 0.004315547045054443, 'externalfactors': 0.0018006682651940404, 'sight': 0.0006026042973632392, 'tenet': 0.0013882295497307361, 'sustenance': 1.0400415941663145e-07, 'coping': 0.004316696915208163, 'folkman': 0.0005248377111845071, 'appraisals': 7.05029712940268e-05, 'gaining_insight_into_a_caregiver\\x99s_beliefs_values_and_goals_that_stimulate_them_incaregiving_defined_as_motivations_in_this_paper_wouldyield_valuable_information_that_could_be_used_to_enhancemeaningfocused_coping_such_interventions': 9.412681118686772e-06, 'to_enhancemeaningfocused_coping_such_interventions': 0.004315547045054443, 'emotionalfor_caregiverstresssymptom_management': 0.00023148283708492395, 'precedence': 2.5226418651023156e-05, 'to_further_understand_how_these_complexitiesmight_manifest_in_a_family': 0.0021071803924849783, 'family_caregivers_wellbeing': 9.148819220060914e-58, 'internalconflict': 9.148819220060914e-58, 'evolvingattitudes': 0.0010325216439875707, 'motivationsthis_paper': 9.148819220060914e-58, 'to_contribute_to_and_grow_the_currentbody_of_knowledge_for_asian_eol_family_caregivers_byanswering_the_following_research_questions_ ': 9.148819220060914e-58, 'interviewdata_family_dignity_intervention': 0.00025766632575304214, 'criteria_interview_procedure_study_protocol': 9.148819220060914e-58, 'ho_briefly': 9.148819220060914e-58, 'elements_oflogotherapy_life_review': 0.00210348072096923, 'fdi': 1.1686951820486561e-54, 'elements_oflogotherapy_life_review_interview_therapistuses': 8.263922883666513e-55, 'interview_therapistuses': 8.263922883666513e-55, 'languagespeaker': 0.00012741575168528436, 'familycaregivers': 0.00017754737915906231, 'ipato': 9.148819220060914e-58, 'internalizedmotivations': 9.148819220060914e-58, 'to_provide_insights_into_how_an_individual_makes_meaning_out_of_a_phenomenon_  _itis_important_to_note_that_as_the_current_study_drawsqualitative_data_from_the_larger_fdi_study_no_explicitinternalized_caregiver_motivationsquestionsaboutwere_asked_reflections_on_motivations_towards_caregiving_occurred_anically_throughout_the_interviewtranscripts_and_were_identified_by_the_researcher_usingipa_through_a_process_of_data_reduction_and_datareconstructionfirst_authors_ _and_ _screened_all_transcripts_andselected_those_that_had_adequate_inputfrom_familycaregivers_to_be_used_for_analysis_authors_ _and_ _thenconducted_linebyline_coding_to_develop_descriptivethemes_and_analytical_categories_conceptualizing_newinterpretation_of_the_data_this_was_followed_by_regularmeetings_among_all_authors_for_the_further_refinement_ofthemes_and_categories_to_encapsulate_the_meaning_andcontent_within_the_cluster_of_similar_codes_with_theemergent_themes_and_subthemes_created_via_a_summarychart_all_authors_reviewed_and_defined_the_emergentthemes_once_consensus_was_reached_operational_definitions_were_created_finally_relationships_between_categoriesthemes_and_subthemes_were_proposed_andmapped_with_supporting_quotes_from_transcripts_to_address_issues_of_trustworthiness_and_credibility_emergentthemes_were_constantly_compared_and_contrasted_withinand_across_groups_during_regular_meetings_the_finaltheme_categorization_and_definitions_were_agreed_uponby_the_entire_research_team_and_data_saturation_and_investigator_triangulation_were_achieved_ _table_ _demographics_of_family': 0.004315547045054443, 'that_caregiver': 4.353744106680101e-06, 'inputfrom_familycaregivers': 0.004315547045054443, 'regularmeetings': 0.0010325216439875707, 'emergentthemes': 0.0008002876352833232, 'withinand_uponby_table_demographics': 0.0002665251323171838, 'withinand': 0.000253466598330819, 'finaltheme_categorization_definitions': 9.148819220060914e-58, 'uponby': 9.148819220060914e-58, 'research_team_data_saturation_investigator_triangulation': 1.4055400435083287e-53, 'diagnosislung_cadph19dph34dph42dph53dph59dph68hca12hca68hca75hca81hca87hca109hca114hca116hca117mws004scs18ttsh61ttsh65spousespousesiblingspousechildspousespousechildchildchildspousespousespousespousespousesiblingspousechildchildchinesechinesechinesechinesechinesemalayeurasianchinesemalaychinesemalaychinesechinesechinesechinesechinesechinesemalaychineseprostate_calung_casigmoid_calung_cagynaecological_malignancylung_caprostate_cacolon_cabreast_caendometrial_cabrain_canasopharyngeal': 9.148819220060914e-58, 'calung_cagynaecological_prognosis': 9.148819220060914e-58, 'emotion_dedication': 4.275944569389733e-06, 'they_goto': 9.148819220060914e-58, 'care_andcomfortfamily_members\\x9ci': 9.148819220060914e-58, 'to_sacrifice_my_soul_to_make_that_happen': 0.0004499048194399722, 'member\\x99s': 0.0004499048194399722, 'beliefs_values_goals': 9.148819220060914e-58, 'to_affect_the_way_a_caregiver_makesmeaning_of_their_role_hence_leading_to_a_nurturance_ofcaregiver_wellbeing_termed_in_this_paper_as_blessings_ora_diminishment_in_caregiver_wellbeing_termed_in_thispaper_as_burdens_the_wellbeing_determinant_which_ischaracterized_by_the_caregiver\\x99s_sense_of_control_selfempowerment_and_kinship_derived_from_their_experiences_serves_as_an_indication_of_selfdetermination_andis_theorized_to_have_a_positive_influence_on_how_the_sixcaregiving_motivations_are_appraised_by_the_caregiverthese_themes_are_described_in_greater_detail_and_demfrom_study_participantsonstrated_by_direct_quotesbelowhonoring_fidelity_number_of_transcripts_theme': 9.148819220060914e-58, 'blessings_ora_diminishment': 9.148819220060914e-58, 'to_have_a_positive_influence_on_how_the_sixcaregiving_motivations_are_appraised_by_the_caregiverthese_themes': 9.148819220060914e-58, 'caregiver\\x99s_sense': 0.0038806204677737646, 'faithfulness_commitment': 4.275944569389733e-06, 'whatever_forhim': 0.0004499048194399722, 'whyfig': 6.508385695754648e-08, 'to_make_him_as_comfortable_as_he_canbe_every_medical_checkup_every_appointment_wewill_keep_to_it': 0.0004499048194399722, 'motivation_tosustain_attachment': 0.00017630719280704974, 'wellbeing_thesecaregivers': 0.000514692913697106, 'efforts_responses_me_family_member\\x99sprognosis_journey': 0.008167413640263974, 'circumstances_beliefs': 4.275944569389733e-06, 'efforts_responses': 0.0010325216439875707, 'shedidn\\x99t': 0.000134987044634517, 'herselfshe': 7.341748544824753e-06, 'mess': 0.0004500247192102474, 'religiousand_beliefs': 8.484066375858795e-05, 'to_settle_my_debt_in_thislifetime': 0.0004499048194399722, 'oftheir_family_members': 0.00028851977751805704, 'father_food': 7.05029712940268e-05, 'myhusband': 0.0002614327833666762, 'childothers': 0.0006681652127777817, 'legs': 0.0004499048194399722, 'knowledge_member\\x99s_prognosis': 4.275944569389733e-06, 'treasuredmemories': 1.198238415621029e-05, 'legacies\\x9call': 1.198238415621029e-05, 'moregood': 0.0006683740194778514, 'to_learn_about_mygrandmother_learn_about_my_mother': 0.007713134335009549, 'family_member\\x99sprognosis_journey': 0.0004499048194399722, 'becausei': 0.00013351743777491968, 'possibleshe': 9.148819220060914e-58, 'life\\x9d_dph14': 9.148819220060914e-58, 'to_have_familygatherings': 0.007713134335009549, 'childthey': 9.148819220060914e-58, 'pride': 9.148819220060914e-58, 'nothing': 0.004315547045054443, 'to_grow_because_of[my_husband_]': 0.0004499048194399722, 'to_face_the_insurmountablechallenges_that_come_your_way_i_learnt_how_toshoulder_my_responsibilities_on_my_own\\x9d_scs18spousediscussionthis_is_the_first_known_study_that_investigates_and_bringsattention_to_the_internalized_motivations_of_eol_familycaregivers_while_the_family_dignity_intervention_studyquestions_did_not_specifically_query_family_caregivers_ontheir_motives_these_motivationcentred_responses_occurred_spontaneously_and_abundantly_throughout_the_interviews_\\x93_an_indication_that_internalized_motivationsare_profoundly_espoused_within_eol_caregiving_attitudesand_behaviors_the_bobec_model_fig_ _illustrates_theduality_ofthese_caregiving_motivations_in_regard_tomeaningfocused_coping_  _and_intrapsychic_strains_ _as_well_as_identifies_an_important_influence_on_caregiver_wellbeingmotivations_with_cultural_influencessome_themes_revealed_cultural_undertones_that_reflectedthe_internalization_of_asian_values_into_family_caregivermotivations_in_their_motivation_for_alleviating_sufferingfamily_caregivers_displayed_the_desire_to_do_so_by_practical_means_such_as_administering_medication_to_theirfamily_member_and_experiencing_distress_when_suchmethods_were_not_feasible_this_is_in_line_with_the_asianculture_of_preferring_to_show_concern_for_their_familymembers_through_pragmatic_ways_  _in_their_motivation_for_preserving_gratitude_family_caregivers_demonstrated_the_significance_of_filial_piety_as_well_as_culturalbeliefs_about_karma_and_pastlife_  _within_theirattitudes_towards_caregiving_finally_in_their_motivationfor_reconciling_with_mortality_family_caregivers_indicated_the_importance_placed_on_close_intergenerationalconnections_as_well_as_longevity_for_their_elders_ _motivations_as_blessings_meaningfocused_copinghonoring_fidelityall_eol_caregiving_motivationsalleviating_suffering_enduring_attachment_preservinggratitude_navigating_change_and_reconciling_with_mortality_were_found_to_embody_the_tenets_of_meaningfocused_coping_fuelled_by_these_motivationsfamilycaregivers_displayed_the_propensity_for_benefitfindingand_benefitreminding_even_in_witnessing_their_familymember\\x99s_suffering_and_imminent_mortality_adaptivegoal_processes_in_adjusting_their_expectations_and_aspirations_in_accordance_with_their_family': 0.00016902585554135613, 'intervention_studyquestions': 9.148819220060914e-58, 'family_caregivers_motives': 9.148819220060914e-58, 'motivationsare_bobec_model_fig': 9.148819220060914e-58, 'caregiving_motivations': 9.148819220060914e-58, 'to_embody_the_tenets_of_meaningfocused_coping_fuelled_by_these_motivationsfamilycaregivers': 0.0005248377111845071, 'blessings': 9.148819220060914e-58, 'copinghonoring_fidelityall_eol': 9.148819220060914e-58, 'family_\\x98burdens\\x99': 6.287906988996188e-06, 'quality_motivations_stemmingfrom_selfdetermination': 0.0004734482721133418, 'bobec': 9.148819220060914e-58, 'wellbeingdeterminant': 9.148819220060914e-58, 'eolfamily_caregiver': 8.263922883666513e-55, 'mediums': 8.725505580541315e-06, 'to_give_caregivers_a_sense_of_control_as_well_as': 0.00022770977125509355, 'generativity': 8.725505580541315e-06, 'memories_expressappreciation': 0.004315547045054443, 'mediators_caregivers': 9.148819220060914e-58, 'competencesense': 9.148819220060914e-58, 'onlegacy_creationimplications_recommendationsfindings': 0.004315547045054443, 'thatcaregivers': 8.484066375858795e-05, 'to_have_positive_affect_on_their_motivations': 0.004315547045054443, 'caregiver_support_interventions': 0.0002768434257340561, 'identifyingtheir_risk_factors': 0.00014084186830440697, 'identifyingtheir_risk_factors_effectiveness_to_increase_by_ _to_more_than_ _million_newcases_leading_to_ _million_cancer_deaths_by_   _therisk_of_colon_cancer_increases_with_age': 0.0028035759042041013, 'to_increase_by_ _to_more_than_ _million_newcases_leading_to_ _million_cancer_deaths_by_   _therisk_of_colon_cancer_increases_with_age': 0.00046683359119049114, 'to_be_the_most_important_and_preventableones': 2.921425233804416e-10, 'health_behavior': 0.004316696915208163, 'which_to_develop_programs_the_most_effective_training_programs_are_based_on_the_theorydrivenapproaches_which_are_rooted_in_behaviorchanging_modelsalso_selecting_appropriate_model_or_theory': 0.0013882295497307361, 'susceptibility_perceivedseverity': 7.05029712940268e-05, 'threatalong': 0.0002698166319082279, 'behaviormaintenance': 0.0038806204677737646, 'materialssuch_employees_using_the_slides_that_were_used_totrain_the_intervention_group_an_informed_consent_wasobtained_from_the_participants_the_study_on_whichthese_data_analyses_are_based_theethical_board_committee_software_kolmogorov_smirnovtest_to_check_the_normality_of_the_data_to_assessthe_effectiveness_of_intervention_on_variables_of_knowledgeperceived_susceptibility': 0.0025944725840007605, 'grouprandom_sampling_method': 9.148819220060914e-58, 'to_select_samplesfrom_each_clusterinclusion_ _exclusion_criteriabeing_under_ _years_of_age_having_satisfaction_to_participate_in_the_study_and_not_having_serious_diseases_including_gastrointestinal_diseases': 9.148819220060914e-58, 'content_validity': 0.0003647528107482472, 'retest': 9.148819220060914e-58, 'to_ensure_the_reliability_of_the_awareness_variable_in_this_way_employees_completed_the_questionnaire_twice_and_theicc_  _was_obtained': 9.148819220060914e-58, 'theicc': 3.9203511979776795e-05, 'potentialconsequences': 0.00014349705247787946, 'truefalsedon\\x99t': 0.0002454333162130257, 'likert': 9.148819220060914e-58, 'to_stronglyagreestrongly_disagree_  ': 9.148819220060914e-58, 'behaviors_education_page': 0.00024784637831511895, 'analysisinterventionboth_intervention_control_groups': 3.9203511979776795e-05, 'materialssuch': 0.00014135366564385564, 'selfefficacycounseling_there': 0.00019685257567989044, 'pamphletstwo_pamphlets': 4.2333888336680965e-05, 'pamphlet_containedsections_risk_factors_secondpamphlet': 4.2333888336680965e-05, 'staffneeded': 0.00023148283708492395, 'to_somehow_incite_theindividuals_to_analyze_the_cost_of_optimal_behavioragainst_the_costs_of_risks_time_etc_involved_in_unhealthybehavior_the_educational_content_used_for_perceivedbenefits_intended_to_raise_awareness_on_the_usefulness_ofhealth_promoting_behaviors_to_reduce_the_risk_of_illnessor_to_understand_the_benefits_of_healthy_behaviors': 0.0001658558251864917, 'end_controlgroup': 4.234516868405677e-05, 'participantswere': 9.148819220060914e-58, 'to_enter_and_leave_the_study_at_any_timesuitable_conditions': 9.148819220060914e-58, 'using_the_slides_that_were_used_totrain_the_intervention_group_an_informed_consent_wasobtained_from_the_participants_the_study_on_whichthese_data_analyses_are_based': 6.91407029854282e-07, 'theethical_board_committee': 1.235964213276079e-05, 'software_kolmogorov_smirnovtest': 1.235964213276079e-05, 'to_check_the_normality_of_the_data_to_assessthe_effectiveness_of_intervention_on_variables_of_knowledgeperceived_susceptibility': 1.235964213276079e-05, 'selfefficacy_behavioralintention_behavior': 0.00019685257567989044, 'studyresultsthe_findings': 0.0006726058898794509, 'thekmo_history': 0.0016485018034048215, 'bartlett\\x99s_test_p_results': 2.6909254076977078e-05, 'bartlett_test': 1.1423324827902012e-05, 'to_confirm_adequacy_ofthe_samples_ _in_the_present_study_the_mean_score_of_behavioralconstruct_increased_after_the_intervention_in_the_intervention_group_and_there_was_significant_differencebetween_the_two_groups_after_the_intervention_in_thisregard_the_results_of_this_study_are_consistent_with_thefindings_of_abood_    _hart_    _roozitalabi_   _alidoosti_    _and_davoodi_   _studies_behavioral_intention': 0.0007005113887765658, 'engage': 0.00038375294655557893, 'time_andeffort': 0.00038375294655557893, 'strongerintention_motivation': 0.0013882295497307361, 'thetarget_adjustment': 0.0010325216439875707, 'achievement_andsustainability': 0.0010325216439875707, 'severity_constructs': 0.0006768252640912667, 'one\\x99sintention': 9.148819220060914e-58, 'perception_severity': 9.148819220060914e-58, 'campaigns_workshopsvideos': 9.148819220060914e-58, 'exhibitions': 9.148819220060914e-58, 'to_express_their_gratitude_and_appreciation_to_all_the_contributorswho': 0.0007959416758056306, 'mgh': 9.148819220060914e-58, 'education_page': 9.148819220060914e-58, 'firstdraft_sr_asm': 0.0005263009120446208, 'towriting_revising': 0.0007959416758056306, 'beheshti_university': 6.9615502053815656e-06, 'funding_agencies': 0.0015842910551982499, 'najimi': 9.148819220060914e-58, 'davodi_m_memarian_r_effect': 9.148819220060914e-58, 'gotay_cc': 0.0003917682579625804, 'u_effects_cengiz_b_use': 0.0001829542651610016, 'eur_j_oncol': 2.3648453213865442e-05, '201418s27_donadiki_©': 3.8616378769570536e-07, 'shamsi': 1.1686951820486561e-54, 'cancer_intervention_epidemiol_effect_ofeducation': 8.263922883666513e-55, 'dejam': 8.263922883666513e-55, 'publisher\\x99s_nature': 9.148819220060914e-58, 'cancer_intervention_epidemiol_effect_ofeducation_dejam': 9.148819220060914e-58, 'bray_f_globalpatterns_trends_survival_analysis': 0.0004499048194399722, 'wilkins_intervention_foruniversity_staff_application': 9.148819220060914e-58, 'griffin_l_tallon': 9.148819220060914e-58, 'popularization': 0.00036576662780187614, 'event_expressions': 0.0007641347695089468, 'piecewise_representation': 0.008897227986175937, 'input_sentences': 0.007713134335009549, 'stateoftheart_models': 0.00038842632962585887, 'thesystem': 3.773409229860406e-07, 'expressions_event_expressions': 0.00038842632962585887, 'eg_textwhich': 9.148819220060914e-58, 'information_events': 9.148819220060914e-58, 'informatics_decision_making': 7.070340244254255e-06, 'sentences': 0.00043370200556319834, 'to_map_the_correspondingmedical_events_in_the_clinical_records': 5.4762797638129146e-05, 'networks_wewant_somefig_example_textsmarked': 0.007713134335009549, 'mechanism_rnn': 0.0007956673215405282, 'stateoftheartperformance': 0.0007956673215405282, 'rules_support_vector_machine_fields_classification_approach': 5.0936115587985934e-05, 'rules_support_vector_machine_fields_classification_approach_place_network_approach_goodperformance': 5.0936115587985934e-05, 'features_guir': 9.148819220060914e-58, 'insemeval2017_task': 9.148819220060914e-58, 'expressions_extraction_tourille': 9.148819220060914e-58, 'network_approach': 9.148819220060914e-58, 'goodperformance': 5.0936115587985934e-05, 'task_tempeval_lin': 0.0003540754526695089, 'lu_liu': 9.148819220060914e-58, 'model_toextract': 9.148819220060914e-58, 'finkel': 9.148819220060914e-58, 'informationextraction_system': 9.148819220060914e-58, 'relation_features': 8.263922883666513e-55, 'rnnmodel': 0.012028681380063992, 'to_combine_bothhence': 0.00035028915142444096, 'memory_network': 0.004315547045054443, 'modelresults': 0.00025133009630877467, 'memory_networksattblstmfor_relation_classification': 4.101221178787619e-06, 'theattention_system': 0.007713134335009549, 'eg_coloncancerwe': 9.148819220060914e-58, 'pipeline_pipeline': 9.148819220060914e-58, 'relations_preprocessingincludestokenization_partofspeech': 0.0002395170137557082, 'corenlp_toolkit': 0.0038806204677737646, 'event_extractions': 3.9049157067446534e-06, 'offsets_annotations_expressions': 0.00047265164240973195, 'word2vec_mikolov': 9.238458440108085e-08, 'timing_behavior_state_vector': 9.148819220060914e-58, 'formulaht': 9.148819220060914e-58, 'rnn': 0.001969505351025414, 'wedo': 0.00210348072096923, 'entity': 0.00023816524877823356, 'to_predict_the_token\\x99sposition_tag_of_each_word_before_we_can_train_the_arnnmodel_to_predict_the_type_of_each_temporal_expressionwe_treat_each_temporal_expression_as_an_entity_and_eachentity': 0.007713134335009549, 'arnnmodel': 0.007713134335009549, 'valueof_word_embeddings': 0.007713134335009549, 'inthis_case': 1.4993111492271457e-05, 'attention_mechanism': 0.009393083572413214, 'to_be_learned_from_fig': 0.004315547045054443, 'theother_context_words': 0.004315547045054443, 'attime_t_st': 9.148819220060914e-58, 'combine_st_h3': 9.148819220060914e-58, 'to_match_themissing_temporal_expressions_extraction_the_eventexpressions_extraction_is_built_on_another': 3.882468415586054e-06, 'Ã¾_sth0': 0.0038806204677737646, 'methodof': 1.9846334094107197e-05, 'input_y²': 9.148819220060914e-58, 'erer_extraction': 9.148819220060914e-58, 'system_aprnnwhich': 0.007713134335009549, 'event_time_identifiedevent_expressions_expressions_indeedindicates': 2.2480340991203723e-51, 'thesevectors': 0.007713134335009549, 'theaverage_vector': 0.007713134335009549, 'entity_pairs': 0.007713134335009549, 'to_introduce_the_piecewise_representationtokens': 0.0010298344840079976, 'is\\x9cwe': 9.148819220060914e-58, 'ct_enterography': 9.148819220060914e-58, 'ct_partis': 0.0002589664773973477, 'entity_pair': 9.148819220060914e-58, 'thereare_reasons': 9.148819220060914e-58, 'to_extract_the_effectiveinformation_forextractingrepresentsinformation_to_the_greatest_extent_of_each_sequenceand': 7.070340244254255e-06, 'thefeature_vector': 3.28784142602511e-52, 'analysis_pos_information': 9.148819220060914e-58, 'end_ofentirethetendsto_fet': 9.148819220060914e-58, 'sequenceand': 9.148819220060914e-58, 'wordlevel_features\\x99': 9.148819220060914e-58, 'representations_andthen': 0.0005373063242131615, 'process_context': 0.0010068765747081726, 'relation_word': 1.1484455079704606e-05, 'to_screen_the_most_useful_information_we_use_the_bilinear_operator_to_computethe_attention_weight_Î±i_for_each_vector_h1_and_h2_toreflect': 0.00015353378993820157, 'expressions\\x9d_sectionwe': 9.327263445268705e-06, 'st_h3': 0.000571748998785482, 'feature_vector': 0.0005742655290288953, 'to_be_obtained_to_represent_the_entire_sentence_for_the_relation_classificationwe': 9.368381156604565e-06, 'vector_m': 1.2803292065661495e-06, 'statevector_m': 9.148819220060914e-58, 'output_layer_classes': 9.148819220060914e-58, 'thernn_network': 2.38824157668927e-05, 'thyme_project': 6.341351419432926e-05, 'thencombine': 0.0003260903091169294, 'informatics_decision_making_this': 0.0005741125271172155, 'expressions_extraction_results': 0.0005371174057381335, 'to_de_the_entityextractionsix_methods_of_temporal_expression_extraction_ _arulebased_method_ _a_system_based_on_crf_ _a_system_based_on_general_rnn_without_any_attention_mechanism_or_context': 0.0005371174057381335, 'method_words_asystem': 0.0003540754526695089, 'prepositionsaccording': 0.00012620699251842968, 'tokens': 0.007719301939468782, 'time_expressions': 0.00012620699251842968, 'time_dictionary': 0.007713134335009549, 'date_finallywe_extract_tokens_\\x9cpost\\x9d': 0.00210348072096923, 'it_existsome_expressions': 0.00012620699251842968, '\\x9cperi\\x9d_we': 9.148819220060914e-58, 'rule_tofind_expressions_partofspeech_rnn_system\\x99s_performances_information_iseffective': 9.148819220060914e-58, 'training_the_crf_and_svm_classifier': 0.007713134335009549, 'six_different_methodsthat_to_do': 0.007713134335009549, 'expressions_extraction_thepart': 0.0005406986214565272, 'methodrulebasedcrfrnnrnnattarnnpart_crfarnnblulab': 0.00012613970685026185, 'word_embeddings': 0.00771518910792271, 'blulab': 9.148819220060914e-58, 'andtype_typeguir_system': 9.148819220060914e-58, 'cleartk': 0.0005373063242131615, 'modelcannot': 0.0005536611936400708, 'arnn_system': 0.0016480626375926124, 'crf': 0.007713134335009549, 'guir_system': 9.148819220060914e-58, 'date_formats': 9.148819220060914e-58, 'attention_mechanismit': 9.148819220060914e-58, '0cli': 9.148819220060914e-58, 'informatics_decision_making_arnn_andcrfarnn_system': 0.0016480626375926124, 'system_contextwords': 0.0016490266427115817, 'results_results': 5.9060812893830076e-05, 'model_system_withoutany_attention_mechanism_piecewise_representationwe': 0.007713134335009549, 'thewhole_sentence': 0.007713134335009549, 'sentence_length': 0.00012613970685026185, 'sentence_rnn_system_butwith_piecewise_representation_rnnpie': 0.007713134335009549, 'extraction_results': 0.0006683740194778514, 'inpar1': 0.0016480626375926124, 'part_part_system_aprnn': 0.0005406986214565272, 'thepiecewise_representation_difference': 0.0006943564809761616, 'resultsof_part_part': 1.1050419114748406e-05, 'factors_factors': 1.1686951820486561e-54, 'to_make_better_use_of_contextual_informationwe': 8.263922883666513e-55, 'resultsare': 0.004315547045054443, 'litway_score': 8.263922883666513e-55, 'reviewedall_titles_s': 0.00012040101594931771, 'patientsurgeon_preferences': 0.004315547045054443, 'preferences_outcome_measures': 9.148819220060914e-58, 'studymethods': 9.148819220060914e-58, 'sdm': 0.0014439206201915186, 'surgeon_guidance': 5.532116142837267e-05, 'mostcommon_factors': 0.000762889468397268, 'decisionmaking_preferences_in_an_emergent_settings': 0.00019186598324507774, 'physicians_patients': 9.148819220060914e-58, 'to_integrate_care_plans_that_are_responsive_topatient_goals_and_values': 9.148819220060914e-58, 'autonomy': 0.004315547045054443, 'influenceguides_decisions': 8.56718042887189e-05, 'ethicists': 9.148819220060914e-58, 'arguedthat': 9.148819220060914e-58, 'that_even_subtle_attempts_by_a_physicianto_sway_a_patient_toward_a_particular_decision': 9.833681956083003e-06, 'respect': 0.0006027648913636512, 'physician_guidance': 0.001845170519318405, 'one_approaches': 0.0008822241915335798, 'autonomythere': 1.239023292080156e-05, 'somephysicians': 0.00020581955335681126, 'anencounter': 0.004315547045054443, 'options_fortreatment': 1.239023292080156e-05, '\\x9csince': 8.770946583746331e-05, 'whenconsidering_emergent_highly_complex_operations_that_areassociated_with_a_high_risk_of_mortality_or_morbidity_in_aninitial_effortto': 4.26359750424666e-06, 'towardsdm': 9.148819220060914e-58, 'to_conduct_a_scoping_review': 0.007713134335009549, 'inconjunction': 0.007713134335009549, 'making_preferences': 0.00012620699251842966, 'role\\x9d_\\x9cexpectations\\x9d\\x9cdesires\\x9d_reviews_letters_primary_authorlas': 0.007715190203162627, 'role\\x9d_\\x9cexpectations\\x9d\\x9cdesires\\x9d': 2.0558681530772516e-06, '\\x9csatisfaction': 9.148819220060914e-58, 'reviews_letters': 9.148819220060914e-58, 'primary_authorlas': 2.0558681530772516e-06, 'to_exclude_ _s_based_on_the_eligibility_criteria': 0.00012040101594931771, 'theremaining_s': 2.592383228850439e-05, 'informatics_decision_making_review_s': 2.592383228850439e-05, 'setting_disagreements': 2.592383228850439e-05, 'two_cjk': 5.7329206921586805e-05, 'decision_makingsurgeon': 8.322709924400053e-05, 'fivepointmeasure': 8.263922883666513e-55, 'to_make_the_decision_regarding_surgery_together_surgeon_guided_decisionmaking_sg_the_preference_is_for_the_surgeon_to_guidedecision_making_either_entirely_or_in_part_while_the_patient_takes_a_more_\\x9cpassive_role\\x9d_independent_decisionmaking_idm_the_preference_is_for_the_patient_to_take_amore_\\x9cactive_role\\x9d_in_decision_making_either_partly_orentirely_independent_from_the_surgeonthe_data_ion_form': 1.1686951820486561e-54, 'patient_surgeon': 8.263922883666513e-55, 'decisionmaking_sg': 5.191680018473243e-05, '\\x9cpassive_decisionmaking': 0.0006324067207528349, 'amore_role\\x9d': 0.0006324067207528349, 'ondecision': 0.007713134335009549, 'results_s': 9.148819220060914e-58, 'medline': 9.148819220060914e-58, 'cochrane_n_   _duplicateswere_removed_and_ _s_underwent_title_review_seventyfour_s_were_included_in_thefinal_analysis_because_they_specifically_addressed_existingempirical_evidence_about_patient_andor_surgeon_decision_making_preferences_toward_sdm_in_adult_surgerysetting_table_ ': 0.00015810430357204874, 'sixtyseven': 1.1686951820486561e-54, 'summary_outpatient_surgeries': 8.263922883666513e-55, 'outpatient_surgeries': 8.263922883666513e-55, 'most_s': 0.00043975773664194475, 'fifty_s': 7.996415927928173e-50, 'decision_making_breast_cancerpatientsurgentbeaver_health_professionalscaring_preferences': 3.57610591824189e-50, 'surgeonguided': 5.530642414878322e-05, 'sdm_surgeons': 5.530642414878322e-05, 'decision_making_breast_cancerpatientsurgentbeaver_health_professionalscaring_assistdevice_patients_preferences_thechoice_decision\\x9d': 3.57610591824189e-50, 'patients_weresurgeons_cardiologists': 9.148819220060914e-58, 'adecision': 9.148819220060914e-58, 'assistdevice_patients': 3.57610591824189e-50, 'andcandidatesburton_advocates_breast_cancersurgeonsurgenturgenturgenturgenturgent': 9.148819220060914e-58, 'role_acollaborative_role46_role': 9.148819220060914e-58, 'receivedon_average': 9.148819220060914e-58, 'being_\\x9cveryinvolved': 9.148819220060914e-58, 'thechoice': 3.57610591824189e-50, 'decision\\x9d': 3.57610591824189e-50, 'sdm\\x9d': 9.148819220060914e-58, 'to_make_the_decision_on_theirown\\x9d\\x9cdeferred_heavily_to_clinicians\\x9d_preferred_\\x9cpatientcentred\\x9d_\\x9cdoctorcentred\\x9d_ _sdm_of_surgeons_and_ _of_patientadvocates_preferred_sdm_breast_cancer_survivors': 9.148819220060914e-58, 'cohen_patients': 9.148819220060914e-58, 'approach_withdm_oftheinterventionstudy_populationmajor_findings': 9.148819220060914e-58, 'educationsdm': 4.1942840409957214e-07, 'informatics_decision': 2.5675325664185134e-05, 'options_type': 6.841218839585492e-09, 'prostate_cancersurvivors': 5.702217674421655e-05, 'surgeons_patients': 0.003492640692150317, 'to_fit_with_their_idea_of_aproper_doctorpatient_relationshipsg\\x93trust_in_surgeon_support_fromfamily_written_information_fromsurgeon_frail_and_olderpatients_ _care_teammembers': 2.3576371143104652e-05, 'approach\\x9d': 6.292247267039724e-05, 'surgical_medicalpatientselectiveurgent': 0.0015842910551982499, 'role_sdm': 0.0015851356325270348, 'role_content': 2.5873580930035818e-05, 'modelsurgeons': 0.00010740789809797397, 'educationsgsg\\x93\\x93\\x93female': 9.148819220060914e-58, 'clinician\\x9d': 9.148819220060914e-58, 'role_oftheinterventionstudy_populationmajor_findings': 0.0002321359877387567, 'to_decide_on_theirtreatment_options_together_with_theirphysician\\x9d_preferred_sdm_ _preferred_tomake_the_decision_\\x9cwith_physician_input\\x9d\\x9c_wanted_their_surgeons_to_make_arecommendation_and': 0.001845170519318405, 'arecommendation': 5.530642414878322e-05, 'treatmentplan\\x9d': 9.148819220060914e-58, 'role_inpatients': 9.148819220060914e-58, 'wasmore': 0.00023148283708492395, 'fear': 0.0015842910551982499, 'patientselective\\x9cmany_physicians': 0.0015842910551982499, 'butretains_control': 0.0011075402231842013, 'who_educates_the_patient_butretains_control_over_the_decisionmakingprocessothers': 0.001845170519318405, 'decisions_patients': 9.148819220060914e-58, 'trustin_decisions': 9.148819220060914e-58, 'thesurgeon': 0.0004277984666718556, 'alternatives': 3.746130009185427e-05, 'andcomplications_outlook_indicators': 6.114452219880002e-07, 'doctor_i': 9.148819220060914e-58, '\\x9c\\x9ci': 9.148819220060914e-58, 'approach_sdm': 0.001845170519318405, 'role\\x9cmost_patients': 2.0244725725685958e-07, 'option_sdm': 1.2393534190624313e-05, 'communication_styledoctor': 0.00040928894108187346, 'femalesung_patients': 0.0015842910551982499, 'midshaftclavicular_fractureelectiveurgent': 0.0015842910551982499, 'ageelective': 8.926329978263318e-05, 'patient_shouldmake_treatment_decision\\x9d': 2.5873580930035818e-05, 'idm_diagnosis_pt_patient_surg': 6.292247267039724e-05, 'operations_review': 0.0018006682651940404, 'patient_surgeon_preferences': 0.004315547045054443, 'patients_surgeonsmay': 9.031912359912895e-07, 'specifically_0cshinkunas_  _bmc_medical_informatics_and_decision_making_           _page_ _of_table_ _frequencies_for_characteristics_of_all': 9.148819220060914e-58, 'methodsqualitativequantitativemixed_methodsstudy_locationusnonusstudy_settinginpatientoutpatientbothtype': 9.148819220060914e-58, 'trained': 4.8901915620787934e-05, 'link_practice_mskimpact': 0.0010309076725766853, 'to_assess_the_performance_of_estimated_tmb_with_westmb_thekaplanmeier_survival_analysis_was_applied_to_evaluate_the_association_of_estimated_tmb_with_diseasefree_survivaldfs_overall_survival_os_and_response_to_antiprogrammed_death1_pd1_and_antiprogrammed': 0.00022572034470392795, 'to_evaluate_the_association_of_estimated_tmb_with_diseasefree_survivaldfs_overall_survival_os_and_response_to_antiprogrammed_death1_pd1_and_antiprogrammed': 0.0001763575529946107, 'jiachen_xu_qian_chu': 1.6823294372090067e-05, 'estimation_model_setof_tcga_cohort_validation_set': 9.148819220060914e-58, 'tmb_23gene_panelwas': 9.148819220060914e-58, 'clinicalapplication': 8.763430567149702e-06, 'mutation_profiling': 9.148819220060914e-58, 'mskimpact': 9.148819220060914e-58, 'megabase': 0.0038806204677737646, 'ngs_panels': 0.0002584379969449155, 'oncogenes_tumor_suppressenes': 3.453496181223943e-05, 'optimizedtmb_estimation_model': 0.007713134335009549, 'surgicaltreatment_immunotherapy_cohort_composingof_nsclc_patients': 0.0011075402231842013, 'ici_treatment_patients': 0.0011075402231842013, 'validation_cohorts': 0.000486004218143635, 'forvalidation': 7.927313038535103e-06, 'performance_forvalidation_wholeexome': 0.00017984158330317407, 'evaluation_criteria': 3.1616557782634456e-05, 'informed_consentwholeexome_sequencing_and_data': 0.001845170519318405, 'processingwe': 9.148819220060914e-58, 'wholeexome': 9.148819220060914e-58, 'percentage_ofpatients': 0.0001261733407126887, 'to_build_a_mutation_estimation_model_using_thefewest_genes_which_tightly_associated_with_westmbin_our_study': 0.007717244975784016, 'basedon_tcga_data_first': 0.0001261733407126887, 'tmbunder': 9.148819220060914e-58, 'coefficientr': 9.148819220060914e-58, 'modelwith_r': 0.0006683740194778514, 'expression_difference': 0.0011078353336573638, 'counts_lowtmb_groups_counts_gene_signatures_mutation_status': 0.007713134335009549, 'topathway_analysis_genes': 0.0009466755491730313, 'mannwhitney_u_test': 1.932492533953547e-05, 'to_assess_thedifferences_in_the_mutation_load_between_the_twogroups': 3.1563408275110717e-07, 'graphpad_graphpad_prismcorrelations': 0.0005263009120446208, 'mutation_data': 9.148819220060914e-58, 'fromtcga_database': 9.148819220060914e-58, 'cohort_mutation_matrix': 7.449895085848531e-05, 'd_maximumr': 0.004315547045054443, 'aplateau': 0.0003322263502299899, 'slowlyas_number': 0.0003313074447267851, 'rfig_b_correlation': 9.148819220060914e-58, 'pearson_correlationcoefficient_r_genes': 9.148819220060914e-58, 'tmb_model_file': 0.007713134335009549, 'goodperformances': 0.0006943564809761616, 'wes_nsclcpatients_correlation': 0.00048587472835324937, '23gene_tmb': 0.0006810685397702696, 'correlation_panels_withwestmb': 0.00019772319418830678, 'irreplaceability': 0.0038806204677737646, 'genescould': 0.0012575316720686688, 'association_discovery_rate_correlation_tmb_6d': 2.051515226223462e-05, 'tmbhigh': 9.148819220060914e-58, '23genepanel': 9.148819220060914e-58, 'gene_expressionsignatures': 0.007713134335009549, 'il6jakstat3': 9.148819220060914e-58, 'rejection_fig_response_prediction': 9.148819220060914e-58, 'performance_panel': 0.007713134335009549, 'association_difference_enrichment_performance_panel_pfscompared_performance_pathways_discovery_rate_correlation_tmb_totumors_6d': 0.00019687270525684534, 'tmblow_counts': 9.148819220060914e-58, 'pfscompared': 9.148819220060914e-58, 'logrank_p_fig': 0.00048587472835324937, 'wes': 0.007713134335009549, 'totumors': 2.051515226223462e-05, 'immunotherapy_cohort': 9.148819220060914e-58, 'to_be_ _empirical_p_value_of_r_ _fig': 9.148819220060914e-58, 'mutation_burden': 7.138990671242234e-05, 'counts_file_fig_s6': 0.001845170519318405, 'pole_pold1': 9.148819220060914e-58, 'to_correlate_with_elevated_tmblevels_[_\\x93_]_the_frequencies_ofthese_ _genes': 9.148819220060914e-58, 'muc16_mutations': 0.0006812500420437589, 'response_pfs_ourimmunotherapydiscussionin_study': 6.918627002654179e-05, 'estimation_model': 0.007713134335009549, 'estimation_wesbasedtmb': 1.1114958351429976e-05, 'correlation_estimation_wesbasedtmb': 0.000256262754619601, 'longestcds_length': 0.00210348072096923, 'study_ttn_mutation': 9.148819220060914e-58, 'to_be_associated_with_tmb_in_solid_tumors_including_nsclc_and_correlated_with_response_toicis_  _as_a_result': 9.148819220060914e-58, 'mutationalload': 4.154198837534421e-06, 'to_correlate_well_with_the_efficacy_oficis_or_survival_outcomes_after_resection_the_correlationof': 0.0009466755491730313, 'thesetwo_panels': 0.00048587472835324937, 'lyu': 1.8878337697196088e-05, 'fig_s10similar': 0.000256262754619601, 'rationality': 0.0016480626375926124, 'theshaping': 0.0038806204677737646, 'rationality_immunogenicity': 0.0008822241915335798, 'heterogeneity_platform_uniformitieshave': 4.343305942650097e-05, 'featuresmay': 0.004315547045054443, 'tobe_integratedsin_summary': 7.087674040736009e-07, 'noveltmb_estimation_model': 0.007713134335009549, 'to_estimate_the_westmb_and': 0.004315547045054443, 'survivalprognosis_ofici_therapy': 0.004315547045054443, 'httpsdoi101186s12916020016948competing_conflicts': 9.148819220060914e-58, 'table_s1_data_sets': 9.148819220060914e-58, 'study_cohorts': 9.148819220060914e-58, 's2_characteristics': 9.148819220060914e-58, 'training_setacknowledgementswe': 0.001845170519318405, 'wang_jing_zhao_shangli_cai': 0.007713134335009549, 'characterization_methods': 0.0016480626375926124, 'patientspecific_network': 0.007713134335009549, 'using_the_average_change_in_correlation_coefficients_and_node_degree_of_patientspecific_networks_of_thegroupresultsnetworks_with_multiomics_data': 0.0003540754526695089, 'individualspecific_networks_groupspecific_networks': 0.0016480626375926124, 'gene_networks': 0.002104041233387171, 'performance_thanthose': 3.4348996837103175e-05, 'genegene': 0.0006030236714318566, 'to_construct_cancer_samplespecific_gene_networks_based_onthe_difference_in_the_mrna_expression_levels': 0.0005371174057381335, 'cancer_sample_reference_samples': 0.0005715966671738797, 'to_construct_cancer_samplespecific_gene_networks_based_onthe_difference_in_the_mrna_expression_levels_method': 0.0001828044656075989, 'data_onlythis_paper': 0.0005715966671738797, 'propagation_strategies': 0.0005715966671738797, 'drugsynergy_zhang': 9.148819220060914e-58, 'propagation_algorithm': 9.148819220060914e-58, 'peng_identifiedbladder': 0.0009466755491730313, 'relations_networks': 5.61425797635606e-06, 'resultsof_groupspecific_gene_networks_institute_tcga_gdac_firehose': 0.0003440760754628197, 'networks_patient_networks_canbe': 1.1135653228465582e-07, 'resultsof': 6.821430392147528e-06, 'level_method': 5.611267135857622e-06, 'groupspecific_gene_networks': 9.172655554949356e-08, 'institute_tcga_gdac_firehose': 9.172655554949356e-08, 'multiomics_data_carcinoma': 0.007713134335009549, 'luscthe_multiomics_data_mirseq_data_mrnaseq_data': 6.0751388053683735e-52, 'rsem': 3.28784142602511e-52, 'rsem_genegene_relations': 4.649709951488232e-52, 'number_realmin_ofmatlab': 0.00012643282536714355, 'genegene_relations': 3.28784142602511e-52, 'template_reference_network': 0.007713134335009549, 'templatereference_network': 2.516404898630125e-52, 'pcc': 0.007713134335009549, 'reference_network': 0.007713134335009549, '\\x88\\x92_pccnwe': 0.0006768252640912667, 'ofpccn1\\x88\\x92pccn': 0.007713134335009549, '0clee': 0.007713134335009549, 'groupspecific_network': 0.00010361990157848738, 'multiomics_data_intergene_correlations': 0.0014616190772430405, 'intergene_correlations': 0.007713134335009549, 'thetop_pcc': 0.007713134335009549, 'weightednetworks': 0.007713134335009549, '\\x88\\x92_ppimethylwe': 9.148819220060914e-58, 'multiomics_data_regression_coefficients': 9.148819220060914e-58, 'i\\x99s_expression': 9.148819220060914e-58, 'levelmethylation_level_mirna_regulator_expression': 9.148819220060914e-58, 'symmetricso_wij_wji': 9.148819220060914e-58, 'w22_w33_w44': 9.148819220060914e-58, 'representsiÎ²mirnaij_submatrices': 0.0004499048194399722, 'tothe_neighbors': 0.00028570359774207095, 'jin_seed_genes': 0.0006761654654483486, 'nonseed_genes_page_superiority': 1.1030570827025004e-05, 'thegenes': 0.00013215649975202958, 'nonseed_genes_mirnas_groupspecific_genenetworks_page_hub_genes_validation_loocvto_score_st_subnetwork_b_subnetwork_edges_performance_default_label_superiority_performanceauc': 0.008084058017534411, 'ofeach_gene': 0.007713134335009549, 'patientspecific_genenetworks': 0.007713134335009549, 'groupspecific_genenetworks': 0.007713134335009549, 'subnetwork': 0.0003273559783566276, 'validation_loocvto': 0.00014530202967042563, 'score_st': 1.1030570827025004e-05, 'seed_gene': 0.00013215649975202958, 'negatives_genes': 0.0001321917277793115, 'subnetwork_b_subnetwork_edges': 2.1536266403559606e-06, 'infig_groupspecific_gene_network': 0.001845170519318405, 'cancer_relevance': 0.007713134335009549, 'seed_ratio': 9.148819220060914e-58, 'default_label': 9.148819220060914e-58, 'scoreof_genes': 0.00013215649975202958, 'auc_thecancer_relevance_score': 9.148819220060914e-58, 'performanceauc': 9.148819220060914e-58, 'cancer_relevancescore': 0.00048587472835324937, 'vector_model': 0.00771518910792271, 'svm_model': 0.00012613970685026185, '6a_01pcc': 0.00048587472835324937, 'string_database': 0.0011284627910272927, 'to_construct_a_  _network': 1.8415484017042953e-05, 'ppi_data': 9.148819220060914e-58, 'typespecific_characteristicsfigure': 9.148819220060914e-58, '6b': 0.001162699992444516, 'complexfunctions': 0.004315547045054443, 'lung_adenocarcinoma_genes': 0.000417872484439527, 'relation_page_subnetwork_page_coefficient_interactions_vector_machine': 6.819613160267411e-06, 'relation_attention_othergenes_page_subnetwork_mirnas_resultsof_page_coefficient_interactions_vector_machine_manuscript': 0.0021509574166184812, 'attention_othergenes': 8.889791260872402e-05, 'genepairs': 0.007713134335009549, 'to_note_that_all_the_gene_pairs_shown_in_table_include_at_least_one_gene_in_the_gene_pair_mamdc2hoxa7_and_that_they_are_correlationgained_edges_in_thegroupspecific_network_for_breast_cancer_figure_ _showsa_subnetwork_containing_mamdc2_and_hoxa7_in_thegroupspecific_network_of_breast_cancer': 0.00210348072096923, 'tshz2_hoxa7': 0.0006027648913636512, 'cldn11that': 9.833681956083003e-06, 'modification_epigenetics': 0.0001828044656075989, 'showedthat_genenetworks': 0.00210348072096923, 'to_validate_the_genes_and_genepairs_identified_in_the_cancer_patientspecific_and_groupspecific_networks': 1.4763738433670392e-05, 'paper_label': 0.0007641347695089468, 'httpsbmcmedgenomicsbiomedcentralcomssupplementsvolume13supplement6authors\\x99_contributionswl': 9.148819220060914e-58, 'initialmanuscript_dh': 9.148819220060914e-58, 'university_koreafundingthis_work': 9.148819220060914e-58, 'research_foundation': 9.148819220060914e-58, 'multiforme': 0.00039436183359109516, 'blotting_luciferase_reporter_assay': 2.7453876587062668e-05, 'to_study_the_function_of_lbx2as1_on_glioma_proliferation_and_apoptosis_bioinformatic_analysis': 4.480799213709324e-07, 'to_study_the_function_of_lbx2as1_on_glioma_proliferation_and_apoptosis_bioinformatic_analysis_rescue_assayresults': 0.0016815002327347822, 'rescue_assayresults': 0.00046345855666667525, 'lbx2as1': 0.0014040683006872822, 'mir4915p': 2.3166470092248292e-05, 'glioma_cell_proliferation_resistance': 0.0007326942129428969, 'types_overexpression': 0.0004738574283430153, 'notch_pathway': 2.290271926259945e-05, 'zeb1_zeb2': 2.290271926259945e-05, 'notch_pathway_zeb1_zeb2': 0.0006026042973632392, 'lncrna_expression': 9.148819220060914e-58, 'neuropathologists': 9.148819220060914e-58, 'to_ _explore_ _the_ _biological_ _role_ _and_ _molecular_mechanism_of_lbx2as1_in_gliomamaterials_and_a0methodspatients_and_a0samplestissue_samples_including_ _normal_brains_and_ ': 0.007713134335009549, 'classification_guidelines_consents': 0.0011075402231842013, 'who_hospital': 0.0006030236714318566, 'assaya_magna': 9.148819220060914e-58, 'rnabinding_ ': 9.148819220060914e-58, 'rip_used': 3.307756375391573e-05, 'reagent_rtpcr_to_ _study_ _the_ _association_ _between_ _lbx2as1_ _expression_and_ _prognosis_ _of_ _patients_ _with_ _glioma_ _the_ _association_between_ _lbx2as1_ _gepia_nanodrop_thermo_fisher': 5.398948066737458e-07, 'immunoprecipitation_kit_millipore_bedford_ma': 9.148819220060914e-58, 'to_ _perform_rip_ _in_ _a_ _brief_ _u87_mg_ _cell_ _lysate_ ': 9.148819220060914e-58, 'ma_total_rnas': 3.2580078188528607e-06, 'to_ _study_ _the_ _association_ _between_ _lbx2as1_ _expression_and_ _prognosis_ _of_ _patients_ _with_ _glioma_ _the_ _association_between_ _lbx2as1_ ': 5.398948066737458e-07, 'trim28': 1.6147223891543353e-05, 'gepia': 0.0009542728600022624, 'tarb_asesysueducn': 9.148819220060914e-58, 'to_ _predict_ _target_mirnas_of_lbx2as1_and_the_association_between_lbx2as1_and_mir4915p_expression_in_tcgalggquantitative_real\\x91time_polymerase_chain_reactiontotal_ _rna_ _was_ _extracted_ _from_ _cells_ _and_ _tissues_ _with': 9.148819220060914e-58, 'invitrogen_rna_concentration': 9.148819220060914e-58, 'nanodrop_thermo_fisher': 9.148819220060914e-58, 'mrna_lncrna': 2.7446560661786228e-05, '\\x88\\x92Î´Î´ct_method_primer_sequences': 0.0016815001133323047, 'aaa_ucc_aat_t3²': 9.148819220060914e-58, 'genepharma_suzhou_china': 9.148819220060914e-58, 'gac_caaa3²_mir4915p': 0.0002851023350336312, '²ccu_cau_guu_ccc': 9.148819220060914e-58, 'ribo_guangzhou_china': 9.148819220060914e-58, 'gag_cct_cat': 7.871324935398334e-06, 'gca_gtg_ggg_cgt_gga_²²cgc_acg_aat_cgt_gtca3²²gct_gca_cat_ata_cta_aaa_t3²²cgc_ttc_acg_loopforwardreversestem_loopforwardreverselipofectamine_invitrogen': 1.2860449482688648e-07, 'cat_ab6721_antibodies': 7.865035097564881e-06, 'gca_gtg_ggg_cgt_gga_²²cgc_acg_aat_cgt_gtca3²²gct_gca_cat_ata_cta_aaa_t3²²cgc_ttc_acg_loopforwardreversestem_loopforwardreverselipofectamine_invitrogen_sdspage_gel_to_develop_blotscell_proliferation_and_to_detect_cell_proliferative_ability_briefly_ _µl_cck8': 0.00048227928641676065, 'a0h': 0.0006402894513766783, 'cat_cat_antibodies': 1.0446664621386656e-05, 'fisher_scientific': 9.148819220060914e-58, 'to_ _extract_proteins_from_cells_proteins': 9.148819220060914e-58, 'sdspage_gel': 1.2860449482688648e-07, 'to_develop_blotscell_proliferation_and': 1.2860449482688648e-07, 'kit_beyotime_shanghai_china': 9.148819220060914e-58, 'to_detect_cell_proliferative_ability_briefly_ _µl_cck8': 9.148819220060914e-58, 'microplate_reader_biorad_hercules': 2.62206727267135e-05, 'assaylbx2as1': 9.148819220060914e-58, '²utr_forms': 9.148819220060914e-58, 'anova_analysis_association': 0.0016810521528134112, 'brains_glioma_tissues': 0.007713134335009549, 'lbx2as1_expression': 0.011672185603023811, 'brains_glioma_tissues_lbx2as1_expression': 0.00210348072096923, 'method_a0_2b': 0.007713134335009549, 'a0_p_expression': 0.0004294386118539378, 'fig_a0_2f': 0.0006810685397702696, 'mir4915p_overexpression': 7.74241605630692e-09, 'ago2_antibody': 9.148819220060914e-58, 'lbx2as1_mir4915p': 9.148819220060914e-58, 'increasing_ _concentrations_  _a0_nm_and_  _a0_nm_ _of_ _mir4915p_ ': 0.007713134335009549, 'u87_mg_cells_a0_nm': 1.3909946949554081e-05, 'fig_3a_overexpression': 0.000852430718203068, 'lbx2as1_silbx2as11_0cchen': 4.111114138107696e-06, 'detection_mg_a172_flow_chart': 8.450540934094419e-05, 'd_rtpcr_detection_e_comparison': 0.0008581749454218445, 'correlation_analysis_activity_lbx2as1_expression_trim28_protein_expression_phosphorylation': 0.001685501166289328, 'sirnas': 0.00021845302894039413, 'mg_cells': 1.1447318538147701e-05, 'a03c': 1.8691733831541865e-07, 'addition_knockdown': 9.148819220060914e-58, 'mir4915p_expression': 9.148819220060914e-58, 'trim28_protein_expression_phosphorylation': 0.0008581749454218445, 'lbx2as1_knockdown': 0.0001227056247204945, 'trim28_ps6k': 2.003038620894439e-06, 'mir4915p_inhibitor_expression': 0.0007013946301126828, 'mir4915p_inhibitor': 0.0005611862522840344, '²utr_mut': 0.0003313074447267851, 'glioma_cell_proliferation_survival': 2.6375082964884376e-07, 'trim28_expression_correlation_analysis': 8.450540934094419e-05, 'trim28_expression_correlation_analysis_expression_u251_mg_cell_proliferation': 0.0016810521528134112, 'silbx2as12': 9.148819220060914e-58, 'u251_mg_cell_proliferation': 9.148819220060914e-58, 'fig_a0_6b': 0.0038806204677737646, 'to_mediate_glioma_cell_proliferation_and_survivaldiscussionlbx2as1_ _is_ ': 2.290271926259945e-05, 'trim28_expression': 0.009478691897163903, 'figure_cell_proliferation_apoptosis': 2.949638214167946e-05, 'transfection_b_cells': 2.949638214167946e-05, 'diseasefree_survival_survival': 0.001845170519318405, 'typeslbx2as1': 3.7419440081762996e-07, 'procancer_functions': 2.2908821551195256e-05, 'to_cease_cell_proliferation': 0.007713134335009549, 'glioma_proliferation': 2.290271926259945e-05, 'notch_signaling': 2.290271926259945e-05, 'lxb2as1': 0.00046345855666667525, 'noncoding_rna': 0.00018060873800003873, 'lncrna_lbx2as1': 1.2217488114342604e-05, 'qc_rh_jg': 0.0003327893968491372, 'data_qc': 5.427453065668169e-06, 'rh': 1.2994441056095232e-05, 'experiments_data_qc': 2.12168450161151e-07, 'details_department': 0.0013882295497307361, 'bian_lg_significance_neurotherapeutics_\\x93': 9.148819220060914e-58, 'p_capper_d': 9.148819220060914e-58, 'neurobiol': 2.1648286725769866e-05, 'chen_b_j_wei_z_liu_l_upregulation': 9.148819220060914e-58, 'radiotherapy_resistance': 9.148819220060914e-58, 'al_analysis': 9.148819220060914e-58, 'lncrna_biomarkers': 9.148819220060914e-58, 'lncrna_linc00689': 9.148819220060914e-58, 'growth_metastasis_glycolysis': 9.148819220060914e-58, 'magea6': 6.861193889648784e-05, 'et_al_mir491': 9.148819220060914e-58, 'osteosarcoma_lung_metastasis_chemoresistance': 9.148819220060914e-58, 'lg_mir4915p': 3.28784142602511e-52, 'b_mir4915p': 9.148819220060914e-58, 'cell_proliferation_motility': 9.148819220060914e-58, 'cancer_invasion_metastasis': 3.2844744110215605e-06, 'xu_l_q_knockdown_rna_xist': 1.5031094704283641e-05, 'glioma_tumorigenesis': 8.599932426060134e-06, 'research_snapshot_assay': 8.94214926906283e-06, 'to_detect_snp_genotype_logistic_regression_analysis_was_applied_to_illustrate_the_underlying_associationresults_ ': 0.0005481147875300096, 'rs1045242': 0.0008222242350635759, 'rs11064': 0.0015842910551982499, 'difference_roles': 0.0038806204677737646, 'cancer_oc': 0.0002391424722625989, 'tnfaip8': 0.0002892179326628974, 'invasion_metastasis_resistance_polymorphisms': 9.148819220060914e-58, 'to_be_associated_with_risks_of_different_cancers': 9.148819220060914e-58, 'to_clarify_the_connection_ _between_ _tnfaip8_ _polymorphism_ _and_ _susceptibility_patients': 0.0006688552815892102, 'to_clarify_the_connection_ _between_ _tnfaip8_ _polymorphism_ _and_ ': 0.007713134335009549, 'a0blood': 0.001845170519318405, 'oc_cases': 0.0004100538998299479, 'endometrioid_cell_exclusion_criteria': 0.0038806204677737646, 'chemo_radio_immunotherapy_control': 0.0011075402231842013, 'a0_subjects': 0.0004100538998299479, 'number_ky201909': 1.2704213225195535e-05, 'using_ _a_ _blood_ _genomic_ _dna_ _extraction_ _kit_ _axygen_ _biotechnology_ _union_ _city_ _ca_ _usa': 1.2986134769934982e-05, 'rs11064_rs1045241_rs1045242': 0.0010405093879660118, 'primer_blast_dntp_a0Î¼l_a0Î¼l_a0u': 0.007730105938933497, 'snapshot_snp_assay': 9.148819220060914e-58, 'yessmoking_history': 9.148819220060914e-58, 'yesfigo': 8.252592359321672e-05, 'uml_umlrecurrence_twosided_chi': 9.148819220060914e-58, 'test_texta_complication_patients': 9.148819220060914e-58, 'federation': 9.148819220060914e-58, 'g3': 9.148819220060914e-58, 'biosystems_city_usa': 9.148819220060914e-58, 'to_ _analyzed_the_resulting_data_about_ _of_the_specimens_were_chosen_randomly_and_genotyped_twice_to_ensure_the_genotyping_accuracy_the_reproducibility_was_   _0cgao_a0et_a0al_cancer_cell_int_           _page_ _of_statistical_analysisall_ _statistical_ _analyses_ _were_ _performed_ _with_ _spss_  _spss_chicago_illinois_usa_genotype_and_allele_distributions_were_assessed_and_the_chisquare_test_was_used_to_ _evaluated_ _the_ _hardy\\x93weinberg_ _equilibrium_ _among_the_controls_continuous_variables_were_presented_using_mean_±_sd_ _and_ _statistically_ _analyzed_ _using_ _ttest_ _categorical_variables_were_statistically_analyzed_using_the_chisquare_test_or_fisher\\x99s_text_the_crude_odds_ratio_cor_adjusted_ _odds_ _ratio_ _aor_ _and_   _confidence_ _interval_ci_of_logistic_regression_analysis_was_calculated_in_four_genetic_models_allele_codominant_dominant_and_recessive_ _to_ _assess_ _the_ _association_ _between_ _tnfaip8_single_nucleotide_polymorphisms_snps_and_oc_susceptibility_with_adjustment_for_age_smoking_history_complication_and_family_history_all_tests_were_twotailed_and_p_  _was_considered_statistical_significanceresultsdemographic_characteristics_the_a0of_a0study_populationthe_ _connection_ _between_ _tnfaip8_ _snps_ _and_ _oc_risk_ _was_ _explored_ _in_ _heilongjiang_ _province_ _of_ _china_the_ _basic_ _information_ _of_ _all_ _individuals_ _was_ _summarized_in_table_a0_the_average_ages_of_cases_and_controls_were_  _±_  _and_  _±_ _a0_years_ _respectively_furthermore_ _no_ _significant_ _difference_ _was_ _observed_between_these_two_groups_p_  ': 9.148819220060914e-58, 'chicago_illinois_distributions': 8.182500841442369e-08, 'to_ _evaluated_ _the_ _hardy\\x93weinberg_ _equilibrium_ _among_the_controls_continuous_variables_were_presented_using_mean_±_sd_ _and_ _statistically_ _analyzed_ _using_ _ttest_ _categorical_variables_were_statistically_analyzed_using_the_chisquare_test_or_fisher\\x99s_text_the_crude_odds_ratio_cor_adjusted_ _odds_ _ratio_ _aor_ _and_   _confidence_ _interval_ci_of_logistic_regression_analysis_was_calculated_in_four_genetic_models_allele_codominant_dominant_and_recessive_ _to_ _assess_ _the_ _association_ _between_ _tnfaip8_single_nucleotide_polymorphisms_snps_and_oc_susceptibility_with_adjustment_for_age_smoking_history_complication_and_family_history_all_tests_were_twotailed_and_p_  _was_considered_statistical_significanceresultsdemographic_characteristics_the_a0of_a0study_populationthe_ _connection_ _between_ _tnfaip8_ _snps_ _and_ _oc_risk_ _was_ _explored_ _in_ _heilongjiang_ _province_ _of_ _china_the_ _basic_ _information_ _of_ _all_ _individuals_ _was_ _summarized_in_table_a0_the_average_ages_of_cases_and_controls_were_  _±_  _and_  _±_ _a0_years_ _respectively_furthermore_ _no_ _significant_ _difference_ _was_ _observed_between_these_two_groups': 5.007801939203765e-06, 'hardy\\x93weinberg_equilibrium': 1.848998764597156e-05, 'fisher\\x99s': 1.848998764597156e-05, 'effect_correlation_risk_a0': 0.007821180775462051, 'history_p_significance_p_relationship': 1.4765321127197675e-05, 'correlation_a0': 0.007713134335009549, 'odds_interval_data': 0.0002578525437194323, 'a0et_ct_tt_recessive_cc_ct_ttrs1045242_ag_ggcases': 9.148819220060914e-58, 'cip_\\x93_\\x93': 9.148819220060914e-58, 'rs1045242_ag_ggaa': 9.148819220060914e-58, 'risk_\\x93_p_years_file_a0_table': 9.148819220060914e-58, 'association_table': 0.007713134335009549, 'yes\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93figo_test_s': 0.0002851023350336312, 'yes\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93figo_test_s_risk': 0.00210348072096923, 'allele_gg_allele': 0.0015842910551982499, 'to_have_clinical_significance_in_no_other_reports_except_that_in_nhl_zhang': 0.0011284627910272927, 'data_tnfaip8_rs1045241_polymorphism': 1.8415484017042953e-05, 'g_allele_carriers': 0.0007862569594425692, 'gg_genotype': 9.148819220060914e-58, 'times_risks': 9.148819220060914e-58, 'rs1045242_polymorphism': 0.0020411027571827813, 'gg_allele': 0.000772778512461504, 'to_be_illuminatedmoreover_ _we_ _explored_ _the_ _connection_ _between_ _the_tnfaip8_genes_polymorphism_and_clinical_variables_of_oc_ _we_ _suggested_ _that_ _tnfaip8_ _genes_ _polymorphism_rs11064_ _rs1045241_ _and_ _rs1045242_ _were_ _significantly_connected_ _with_ _figo_ _stage_ _in_ _addition_ _tnfaip8_rs1045242_ _polymorphism_ _was_ _also_ _strongly_ _associated_with_ _residual_ _tumor_ _and_ _recurrence_ _indicating_ _its_ _role_of_progression_in_oc_for_rs11064_it_was_reported_that_it_positively_linked_to_deep_myometrial_invasion_and_lymph_node_ _metastasis_ _under_ _the_ _codominant_ _model_ _in_ _ecs_  _in_cervical_cancer_it_attempted_to_explore_the_relationship_between_tnfaip8_rs11064_polymorphism_and_drug_resistance_but': 0.00046345855666667525, 'to_explore_the_relationship_between_tnfaip8_rs11064_polymorphism_and_drug_resistance': 0.00210348072096923, 'to_ _verify_genotype\\x93phenotype_ _associations_ _and_ _functional_ _analysis_for_tnfaip8_snpthis_study': 0.00098670072444496, 'study_paper': 0.007713134335009549, 'hboc': 0.001845170519318405, 'doi101186s1293_file_a0_table': 0.001129870936471824, 'analysis_a0et': 2.2480340991203723e-51, 'analysis_a0et_study_llj_samples_data': 2.2480340991203723e-51, 'study_llj': 2.2480340991203723e-51, 'zrz': 9.148819220060914e-58, 'samples_data': 9.148819220060914e-58, 'data_tbl': 0.00022771936739542464, 'ssy': 0.00022771936739542464, 'fileethics_approval_consent': 0.00013767629634858926, 'xo_beeghlyfadiel_prediction_gynecol_oncol_kar_sp': 9.148819220060914e-58, 'gayther_cl_ramus_sj_schildkraut': 9.148819220060914e-58, 'jm_sellers': 9.148819220060914e-58, 'variation_susceptibility': 9.148819220060914e-58, 'cancer_epidemiol_biomarkers': 9.148819220060914e-58, 'pearce_cl': 9.148819220060914e-58, 'moorman_pike_mc_risch_h_sieh_w_stram': 9.148819220060914e-58, 'kl_whittemore': 9.148819220060914e-58, 'jm_kjaer_sk_cancer_epidemiol_biomarkers': 9.148819220060914e-58, 'horrevoets': 9.148819220060914e-58, 'van_zonneveld_aj_vries': 9.148819220060914e-58, 'endothelial_genes': 9.148819220060914e-58, 'li_l_guo_x_expression': 9.148819220060914e-58, 'proliferation_invasion_mol_rep_\\x93': 9.148819220060914e-58, 'xy_tumor_necrosis': 9.148819220060914e-58, 'protein_polymorphism_risk_c_chakravarty_d_ahmad': 9.148819220060914e-58, 'u_expression': 0.00046078277799857026, 'j_cancer': 6.0751388053683735e-52, '\\x93_liu_t': 3.28784142602511e-52, 'li_wang_e_tnfaip8': 3.788772386814274e-05, 's_y_overexpression': 3.788772386814274e-05, 'li_huang_j_wang_t_cai_l_tnfaip8': 9.148819220060914e-58, 'proliferation_cisplatin_chemoresistance_liu_t': 9.148819220060914e-58, 'wt_history': 2.1050490145489324e-05, 'kuchenbaecker_et_al_genomewide_association_study': 0.00020247752368411762, 'amankwah_ek_lin_hy': 9.148819220060914e-58, 'dennis_j_transition_gene_variants_genet_epidemiol': 9.148819220060914e-58, 'operator_regression': 0.007713134335009549, 'curve_cox_analysis': 9.148819220060914e-58, 'to_evaluate_the_prognostic_model_finally_a_coexpression_network_cibersort_and': 9.148819220060914e-58, 'estimate_algorithm': 1.1686951820486561e-54, 'to_explore_the_mechanism_related_to_the_modelresults_ ': 8.263922883666513e-55, 'to_evaluate_the_prognostic_model_finally_a_coexpression_network_cibersort_and_to_explore_the_mechanism_related_to_the_modelresults_ _risk': 0.0010777336221002441, 'to_stratify_the_risk_of_bladder_cancer_patients_which_is_beneficial_to_the_realization_of_individualized_treatmentkeywords_ _bladder_cancer_cox_regression_prognostic_model_overall_survivalcorrespondence_ _yyzhucmueducn_yumengcmueducn_\\xa0_jiaxing_lin_and_jieping_yang': 0.0006943564809761616, 'factors_markers': 3.4348996837103175e-05, 'applicabilitywith': 0.002104041233387171, 'verification_model': 0.0018006682651940404, 'guidance_gse32894_gse48075_n': 8.730160225303541e-06, 'extensibilityin': 8.730160225303541e-06, 'gene_expression_data': 2.776530134117973e-05, 'guidance_extensibilityin_hazard_regression_gse32894_gse48075_n_to_ _perform_ _univariate_ _cox_ _proportional_ _hazard_ _analysis_ _of_ _all_ _genes_ _in_ _tcgablca_ _gse13507_gse32548_ _and_ _gse32894_ _cohorts_ _the_ _hazard_ _ratio_hr_from_to_select_the_genes_that_were_positively_or_negatively_related_to_prognosis_a_gene_with_hr_  _was_considered_a_risk_gene_ _and_ _a_ _gene_ _with_ _hr_   _was_ _considered_ _a_ _protective_gene_statistical_significance_was_defined_as_p_  _the_ _genes_ _with_ _hr_   _and_ _p_   _were_ _selected_ _from_the_four_cohorts_and_then_risk_genes_were_obtained_by_overlapping_ _four_ _groups_ _of_ _genes_ _similarly_ _genes_ _with_hr_  _and_p_  _were_selected_for_the_four_cohorts_and_combined_to_obtain_the_set_of_protective_genes_a_venn_diagram_was_constructed_using_the_online_tool_bioinformatics_ _and_ _evolutionary_ _genomics_ _httpbioin_forma_ticspsbugent_bewebto_olsvenn_ _the_ _identified_ _risk_and_protective_genes_to_do_lasso_regression_to_ _further_ _screen_ _genes_ _and_ _function': 0.0017020765175196427, 'hazard_regression': 8.730160225303541e-06, 'shrinkage_operator_lasso_regression': 0.0006943564809761616, 'using_ _five_ _cohorts_ _this_robust_ _model_ ': 0.0006943564809761616, 'a0processingto': 0.001941409824696926, 'tcga_geo_databases': 0.007713134335009549, 'to_include_survival_status_and_survival_time_we_found_a_total_of_five_cohorts_the_raw_rna_sequencing_and_clinical_data_of_bladder_urothelial_carcinoma': 0.0002219331785316156, 'to_ _perform_ _univariate_ _cox_ _proportional_ _hazard_ _analysis_ _of_ _all_ _genes_ _in_ _tcgablca_ _gse13507_gse32548_ _and_ _gse32894_ _cohorts_ _the_ _hazard_ _ratio_hr_from': 0.0001261733407126887, '\\x9cedger\\x9d': 9.148819220060914e-58, 'to_ _standardize_ _the_ _raw_rna_expression_matrix_and_obtain_the_corresponding_log_valuesconstruction_of_a0prognostic_modelthe_ _cox_ _proportional_ _hazard_ _regression_ _model_ ': 9.148819220060914e-58, 'cox_regression_analysis': 0.0011032597634804428, 'to_select_the_genes_that_were_positively_or_negatively_related_to_prognosis_a_gene_with_hr_  _was_considered_a_risk_gene_ _and_ _a_ _gene_ _with_ _hr_   _was_ _considered_ _a_ _protective_gene_statistical_significance_was_defined_as_p_  _the_ _genes_ _with_ _hr_   _and_ _p_   _were_ _selected_ _from_the_four_cohorts_and_then_risk_genes_were_obtained_by_overlapping_ _four_ _groups_ _of_ _genes_ _similarly_ _genes_ _with_hr_  _and_p_  _were_selected_for_the_four_cohorts_and_combined_to_obtain_the_set_of_protective_genes_a_venn_diagram_was_constructed_using_the_online_tool_bioinformatics_ _and_ _evolutionary_ _genomics_ _httpbioin_forma_ticspsbugent_bewebto_olsvenn_ _the_ _identified_ _risk_and_protective_genes': 1.8004641048098213e-05, 'to_obtain_the_set_of_protective_genes': 0.0009786152689682502, '\\x9csurvival\\x9d': 9.148819220060914e-58, 'to_do_lasso_regression_to_ _further_ _screen_ _genes_ _and_ ': 9.148819220060914e-58, 'gene_coef': 2.776530134117973e-05, 'cv_function_took': 2.776530134117973e-05, 'k': 1.8100517666653846e-05, 'default_parameter': 2.9526779900574556e-07, 'deviance': 9.148819220060914e-58, 'to_ _estimate_ _the_ _accuracy_ _of_ _the_ _model': 9.148819220060914e-58, 'coef': 2.776530134117973e-05, 'genes_coef': 0.007713134335009549, '\\x9crescat\\x9d': 9.148819220060914e-58, 'to_find_the_best_cutoff_value_of_factors_the_cutoff_was_used_to_divide_the_sample_into_a_highrisk_group_and_a_ _lowrisk_ _group_ _to_ _construct_ _the_ _kaplan\\x93meier_ _curve_with_ _the_ _smallest_ _p_ _value_ _the_ _risk_ _score_ _distribution_gene_ _expression_ _and_ _patient_ _survival_ _status_ _data_ _were_plotted_using_the_r_package': 9.148819220060914e-58, 'to_divide_the_sample_into_a_highrisk_group_and_a_ _lowrisk_ _group_ _to_ _construct_ _the_ _kaplan\\x93meier_ _curve_with_ _the_ _smallest_ _p_ _value_ _the_ _risk_ _score_ _distribution_gene_ _expression_ _and_ ': 1.92342546114407e-05, 'roc_curves': 0.007824517706536607, 'using_ _the_ _r_ _package': 0.00023349890131819665, 'risk_scores_factors': 0.0001426607788817114, 'stage_grade_score_tcgablca_gse13507': 9.148819220060914e-58, 'stage_lymph_node_metastasisexploration_genomics\\x9d': 9.148819220060914e-58, 'methylation_data_score': 0.00018049906186689923, 'package_\\x9cwgcna\\x9d': 9.148819220060914e-58, 'wgcna_to_construct_the_coexpression_network_  ': 9.148819220060914e-58, 'advantage_genes': 0.0005715966671738797, 'pearson_correlation': 0.007713134335009549, 'correlation_pathway_enrichment': 0.0009466755491730313, 'methylation_data_advantage_genes_to_ _calculate_ _the_ _content_ _of_   _kinds_ _of_ _human_leukocyte_subsets_we_used_the_r_package_\\x9ccibersort\\x9d_to_calculate_the_number_of_immune_cells_in_each_sample_of_ _the_ _tcgablca_ _cohort_ _estimate_ _estimation_of_ _sttromal_ _and_ _immune_ _cells_ _in_ _malignant_ _tumours_using_expression_data_content_score': 0.0009466755491730313, '\\x9ckegg_pathway': 0.0002193731902628003, 'processes_reactome_gene': 0.000576827339123862, 'to_ _calculate_ _the_ _content_ _of_   _kinds_ _of_ _human_leukocyte_subsets_we_used_the_r_package_\\x9ccibersort\\x9d_to_calculate_the_number_of_immune_cells_in_each_sample_of_ _the_ _tcgablca_ _cohort_ _estimate_ _estimation_of_ _sttromal_ _and_ _immune_ _cells_ _in_ _malignant_ _tumours_using_expression_data': 0.0005191866840966338, 'rx64_r_packages': 6.075138805368377e-52, 'test_comparison_using_ _the_ _r_ _package_ _\\x9cbeeswarm\\x9d_ _r_package_raw_rna': 4.649709951488235e-52, 'bioconductor_httpwwwbioco_nduct_groups': 9.148819220060914e-58, 'test_comparison': 9.148819220060914e-58, 'test_significance': 2.5164048986301264e-52, 'p_difference': 2.0317128578806187e-05, 'using_ _the_ _r_ _package_ _\\x9cbeeswarm\\x9d_ ': 3.287841426025112e-52, 'raw_rna': 3.287841426025112e-52, 'data_information': 0.007713134335009549, 'year_±': 3.259762205837823e-05, 'grading_methods': 3.259762205837823e-05, 'tcgablca_gse13507': 0.0002069818544961052, 'criteria_hr_p': 0.004551121295613951, 'cohort_a02b': 0.007713134335009549, 'analysis_fig': 0.0009466755491730313, 'p6_ds_el_d_values': 9.148819220060914e-58, 'a0_s1': 9.148819220060914e-58, 'tnk1_fabp6_c16orf74': 9.148819220060914e-58, '144e\\x88\\x92': 9.148819220060914e-58, 'to_ _calculate_ _the_ _risk_scores_ _of_ _each_ _patient_ _in_ _the_ _training_ _set_ _tcgablca_ _and_ _three_ _test_ _sets_ _gse13507_ _gse32548_ _and_gse32894_ ': 0.0001813881936933869, 'expression_values_survival_status_risk_scores': 9.148819220060914e-58, 'univariate_cox': 9.148819220060914e-58, 'model_b_deviance': 0.0013882295497307361, 'correlation_blue': 0.0006810685397702696, 'cross': 0.0005073330404429016, 'prognosis_blue': 0.0016810521528134112, 'darker': 9.148819220060914e-58, 'smaller': 9.148819220060914e-58, 'risk_scores': 0.007713134335009549, 'group_p': 0.0007080023910910008, '163e\\x88\\x92_561e\\x88\\x92_\\x93136e\\x88\\x92italic_font': 0.00012792371862328244, 'kaplan\\x93meier_analysis_prognosis': 0.00013836210901492678, 'using_the_dynamic_pruning_tree_method_next_association_analysis': 0.0006810685397702696, 'genes_fig': 0.007713134335009549, 'cibersort_bar_chart_a06a_to_compare_the_ _difference_ _between_ _high_ _and_ _lowrisk_ _groups_ _the_results': 4.804368526884627e-06, 'cibersort': 4.804368526884627e-06, 'bar_chart_a06a': 4.804368526884627e-06, 'to_compare_the_ _difference_ _between_ _high_ _and_ _lowrisk_ _groups_ _the_results': 0.00048362067048935835, 'risk_score_infiltration_degree_a06c\\x93h': 0.00936119697260216, 'prognosis_s5_a0et': 0.00016548384165672298, 'model_model_to_ _construct_ _the_ _model_the_model_successfully_predicted_the_overall_survival_of_five_cohorts_about_ _bladder_cancer_patients': 0.0027473438143670714, 'model_model': 0.0018006682651940404, 'to_ _take_ _a_ _kind_ _of_ _gene_ _set_ _to_ _build_ _the_model_rather_than_the_whole_genome_into_the_screening_in_this_study': 0.00035483153171244545, 'to_ _construct_ _the_ _model_the_model_successfully_predicted_the_overall_survival_of_five_cohorts_about_ _bladder_cancer_patients': 0.0018006682651940404, 'to_jointly_develop_the_model_which_makes_the_model_have_higher_credibility_ _and_ _broader_ _applicability_ _in_ _our_ _study_ _all_genes_ _in_ _all_ _cohorts_ ': 0.0005479687540571566, 'credibility_applicability': 0.0006943564809761616, 'to_make_the_model_more_stable_and_ _reliable_ _the_ _patients_ _in_ _the_ _tcgablca_ _cohort_were_from_north_america_gse13507': 0.0009466755491730313, 'significance_gene_significance_module_membership': 9.148819220060914e-58, 'diagrams': 9.148819220060914e-58, 'risk_score_grade_p': 0.007713134335009549, 'gse32548_mutation_data': 0.007713134335009549, '[_]_these_s_indirectly_verify_the_prognostic_ability_of_the_risk_model_finally_the_11gene_model_ _was_ _successfully_ _verified_ _in_ _independent_ _cohort_gse48075_the_model_is_verified_by_four_internal_cohorts_and_one_external_cohort_which_shows_that_the_model_has_the_potential_to_be_used_in_the_cliniceleven_ _genes_ _are_ _potential_ _prognostic_ _markers_ _and_therapeutic_ _targets_ _for_ _bladder_ _cancer_ _these_   _genes_have_ _a_ _stable_ _prognostic_ _ability_in_ _tcgablca_gse13507_ _gse32548_ _and_ _gse32894_ _cohorts_ _and_kaplan\\x93meier_ _analysis_ _showed_ _that_ _serpine2_ _rtkn_prr11_mapk12_elovl4_dsel_and_comp_was_successfully_verified_in_gse48075_besides_the_methylation_level_of_tnk1_and_c16orf74': 0.0006578099350934741, 'gse32894_cohorts_kaplan\\x93meier_analysis': 0.000704362469235278, 'counting_kit8_cck8': 0.0004738574283430153, 'outcomes_overexpression': 0.001845170519318405, 'oe': 0.0015419762704638696, 'mir2143p_directly_targets_yap1_by_specifically_binding_on_the_²_utr_of_yap1_ _mir2143p': 0.0015842910551982499, 'cancer_lc': 3.27937688081132e-05, 'treatment_strategies': 0.0038917261112028597, 'news': 0.0038806204677737646, 'micrornas': 4.649709951488235e-52, 'to_ _regulate_ _tumorigenesis_ ': 2.5164048986301268e-52, 'cells_cscs': 0.0007709225949456636, 'mir205_oe': 0.000404948725608525, 'hippo_pathway_components': 9.148819220060914e-58, 'kinase_cascade_scaffold_proteins_yap1': 9.148819220060914e-58, 'mst12': 2.012919707845018e-05, 'yap1': 0.0024789032237903736, 'mir2143p': 0.0002893721198814622, 'gels_sdspage_gels_gel_electrophoresis': 9.148819220060914e-58, 'reagent_life_technologies': 9.148819220060914e-58, 'protein_strips': 9.148819220060914e-58, 'fisher_scientific_captured': 9.148819220060914e-58, 'oct4': 0.0003631075583458118, 'oct4_octamerbinding_ _transcription_ _factor4_ _and_ _nanog_genes_by_using_commercially_available_primer_and_probe_sequences': 9.148819220060914e-58, 'type_type_mut_pgl3yap1_promoter_renilla': 9.148819220060914e-58, 'luciferase_assay': 9.148819220060914e-58, 'using_ _the_ _dualbriefly': 9.148819220060914e-58, '0clu_a0et': 0.0005865071468874085, '0clu_a0et_a0_days_b27_0clu': 0.0017463930560174363, 'solarbio_china_image_j': 9.148819220060914e-58, 'photos': 9.148819220060914e-58, 'a0_days': 0.0006613772452775467, 'oncosphere_numbers': 2.849804077519546e-05, 'ny': 1.1686951820486561e-54, 'b27_0clu': 8.263922883666513e-55, 'using_ _a_ _confocal_ _laserscanning_ _microscope_leica_tcs_sp5_ii_germanytumor_xenograft_modellung_ _squamous_ _cells_ _transfected_ _with_ _mirnc_ _Ã\\x97_width_mm2_a0et_int_page': 0.0012022864054341924, 'using_ _a_ _confocal_ _laserscanning_ _microscope_leica_tcs_sp5_ii_germanytumor_xenograft_modellung_ _squamous_ _cells_ _transfected_ _with_ _mirnc_ ': 9.927994518112209e-05, 'matrigel_cells': 1.9611829808598858e-05, 'Ã\\x97_width_mm2': 4.0151239697261454e-07, 'shanghai': 0.0005411681930881713, 'fed_performed_suspended': 1.9611829808598858e-05, 'dilution_cst_danvers': 2.7477952615248198e-05, 'to_examine_the_effects_of_mir2143p_oe_on_lscc': 6.33966136568193e-05, 'e_qpcr': 1.9611829808598858e-05, 'to_ _assess_ _overall_survival_ _os_ _and_ ': 0.0016939383358917706, 'sem': 2.8317829285666288e-05, 'cox_model': 9.148819220060914e-58, 'to_identify_ _independent_ _prognostic_ _factors_ _the_ _statistical_significance_was_set_at_p_   _0clu': 9.148819220060914e-58, 'correlation_fig_a01a': 0.001129870936471824, 'mir2143p_rna_levels': 0.007713134335009549, 'reduction_1b': 0.007713134335009549, 'mir2143p_rna_levels_reduction_1b': 0.007713134335009549, 'fig_a01c': 0.001845170519318405, 'lscc_cell_proliferation_a0csc_properties': 4.535380216823717e-05, 'overexpression_oe': 0.000404948725608525, 'mir2143p_oe': 0.00023308907442208475, 'vimentin_protein_levels': 0.0004990942860418787, 'rna_expression': 2.5168970098670164e-05, 'proteins_level': 0.007738296600229679, 'proteins_level_csc_properties': 0.001113171959862159, 'a0s2mir\\x91\\x913p': 1.5603020032090705e-07, 'csc_properties': 9.551797443209296e-06, 'hcc95_mice_models_microscope_analysis': 1.8167819587673103e-05, 'yap1_levels': 0.0004938033924023567, 'yap1_phosphorylation': 4.722161482953914e-06, 'fig_a0_3i': 4.722161482953914e-06, 'lscc_tumor_progression': 2.5162265220130086e-05, 'mice_models': 0.007713134335009549, 'tumor_occurrence_tumor_size': 2.5162265220130086e-05, 'staining_ _assays': 0.0005807607654450252, 'hippo_pathway': 9.148819220060914e-58, 'protein_level_cells': 9.148819220060914e-58, 'mir214_overexpression': 4.0924155069270504e-05, 'lscc_tumor_initiation_progression_images_p_0clu_sites_mrna_levels_d_protein_levels': 6.681467511390383e-07, 'mir214': 0.000585457221567092, 'int_page_rescue_experiments': 6.607766781068479e-07, 'growth_csc_properties': 4.047264064482269e-05, 'mir214_mir2143p': 6.607766781068479e-07, 'mir214_oe': 0.0001427289722991413, 'yap1_mrna_protein_levels': 2.32899183911942e-06, 'knockdown_kd': 9.148819220060914e-58, '5c_d': 9.148819220060914e-58, 'type_fig_a0_5b': 0.007713134335009549, 'seed_sequences': 0.007713134335009549, 'cotransfection_hcc95_cells': 7.74241605630692e-09, 'mir2143p_directly_targets_yap1_by_specifically_binding_on_the_²_utr_of_yap1_in_lscc_cell_linesrescue_experiments': 0.004315547045054443, 'lscc_growth_csc_properties': 0.0002069818544961052, 'yap1_kd': 0.0015847132313328567, 'stemrelated_ _genes_ _levels_ _of_ _lung_ _cancer_cells_    ': 2.586668612581389e-05, 'proliferation_csc_phenotype': 0.0003535708123475912, 'rescue_experiment': 0.007713134335009549, 'yap1_plasmid_transduction': 9.148819220060914e-58, 'growths': 9.148819220060914e-58, 'reintroduction': 4.0201465185332776e-05, 'proliferation_abilities': 3.4823007157601506e-05, 'csc_phenotypes_we': 0.000762889468397268, 'to_promote_tumor_migration_in_melanoma': 0.00210348072096923, 'impact_mechanisms': 9.148819220060914e-58, 'to_be_extensively_exploredwe': 9.148819220060914e-58, 'attention_interest': 0.0038806204677737646, 'yap1_mrna_protein_expression': 2.32899183911942e-06, '²utr_sequence': 0.0038806204677737646, 'yap1_reexpression': 6.795633186884302e-05, 'lscc_proliferation_csc_capacities': 3.57610591824189e-50, 'lscc_cell_proliferation': 9.549253131653641e-06, 'lscc_cancer_yap1': 0.0011125787591309202, 'sav1_salvador': 9.148819220060914e-58, 'proteins_level_cells': 9.148819220060914e-58, 'rd_program': 6.9615502053815656e-06, 'grant_youth_talent_project': 0.00019636773680581997, '\\x93_calin_ga_microrna_signatures': 8.58883840750466e-06, 'b_et_al_mir613': 9.148819220060914e-58, 'cell_expansion_harvey_kf': 9.148819220060914e-58, 'ortholog_hippo': 0.0004738574283430153, '\\x93_udan_rs_et_al_hippo': 9.148819220060914e-58, 'proliferation_arrest_apoptosis': 9.148819220060914e-58, 'tead': 9.148819220060914e-58, 'gene_induction': 9.148819220060914e-58, 'the_lncrnamirnamrna_competing_using_molecular_complex_detection_mcode_networkanalyzer_mrnas_lncrnas': 0.00044118952165099517, 'mrnas_tissues': 0.007713134335009549, 'expression_analyses_genomes': 9.148819220060914e-58, 'the_lncrnamirnamrna_competing': 9.148819220060914e-58, 'rna_cerna_networks': 7.19764858251562e-06, 'interaction_ppi_network': 3.107116929757966e-05, 'string_hub_genes': 9.148819220060914e-58, 'using_molecular_complex_detection_mcode_networkanalyzer': 9.148819220060914e-58, 'mrnas_lncrnas': 0.007713134335009549, 'xu_xinyi_huang': 0.00040934415372960003, 'omnibus_geo': 9.148819220060914e-58, 'genes_gene_ontology': 9.148819220060914e-58, 'bioinformatics_analyses': 0.0002906438731946146, 'to_be_convenient_methods_for_identifying_ _potential_ _biomarkers_ _in_ _other_ _diseases_ _these_ _analytic_ _methods_ ': 4.74092431737015e-06, 'researchers_to_be_convenient_methods_for_identifying_ _potential_ _biomarkers_ _in_ _other_ _diseases_ _these_ _analytic_ _methods_ _microarray_datasets': 0.003042654251224369, 'linc01385': 9.148819220060914e-58, 'to_ _identify_ ': 9.148819220060914e-58, 'zhang_et': 0.0015883270599150508, 'chip_datasets': 0.0018006682651940404, 'mechanisms_processes': 9.148819220060914e-58, 'to_develop_a_precise_curative_treatment_for_npcin': 9.148819220060914e-58, 'rna_cerna': 9.148819220060914e-58, 'way_he': 9.148819220060914e-58, 'to_explore_the_molecular_pathogenesis_potential_biomarkers_and_prognostic_indicators_ _of_ _npc_ _by_ _analyzing_ _the_ _full_ _transcriptome_sequencing_data_from_fujian_cancer_hospital_along_with_six_microarray_datasets_acquired_from_the_gene_expression_ _omnibus_ _geo_ _to_ _identify_ _degs_ _between_ _npc_samples_ _and_ _normal_ _tissue_ _samples_ ': 0.007713134335009549, 'precision_treatment': 0.0008822241915335798, 'precision_treatment_stage_npc_stage': 0.0021481207697991314, 'npc_patients': 3.505995154185285e-05, 'stage_npc_stage': 0.001845170519318405, 'using_ _a_ _nano': 8.450540934094419e-05, 'rna_concentration': 4.327628165423396e-07, 'tissue_samples_using_ _a_ _nano_using_ _ethanol_ _precipitation_ _next_depleted_ _rna_ _by_ _using_ _the_  _nebnext_®_ ': 2.651852481984244e-05, 'rrnafree_residue': 4.328781346274998e-07, 'using_ _ethanol_ _precipitation_ _next_depleted_ _rna_ _by_ _using_ _the_  _nebnext_®_ ': 7.0668178256729875e-09, 'fragmentations': 9.148819220060914e-58, 'cations_strand_synthesis_reaction': 9.148819220060914e-58, 'firststrand_cdna': 0.0001559963661892288, 'nebnext_adapter': 9.228278485856382e-05, 'library_fragments_beckman_coulter_zheng_et_al_unknownnpcnpc': 0.007713134335009549, 'beverly_usa': 4.799811543738203e-07, 'using_ _phusion_highfidelity_ _dna_ _polymerase_ _general_ _pcr_ _primers_and_index_x_primer_finally_the_obtained_products_were_refined_ampure_xp_system_and_the_library_quality_was_evaluated_on_the_agilent_bioanalyzer_ _system_after_the_library_was_constructed_qubit20_was_used_for_preliminary_quantification': 2.940807337721665e-05, 'insert_size': 9.148819220060914e-58, 'to_ _be_ _as_ _expected_ _qpcr_ _was_ _used_ _to_ _confirm_the_ _valid_ _concentration_   _a0_nm_ _and_ _accurate_ _quantification_of_the_library_to_ensure_library_quality_when_the_library_was_deemed_eligible_varying_libraries_were_pooled_to_meet_the_demands_of_valid_concentration_and_enable_offline_ _data_ _volume_ _hiseq_ _sequencing_ _was_ _conducted_these_wholetranscriptome_sequencing_data_were_termed': 9.148819220060914e-58, 'to_ _confirm_the_ _valid_ _concentration_   _a0_nm_ _and_ _accurate_ _quantification_of_the_library_to_ensure_library_quality_when_the_library_was_deemed_eligible_varying_libraries_were_pooled_to_meet_the_demands_of_valid_concentration_and_enable_offline_ _data_ _volume_ _hiseq_ _sequencing_ _was_ _conducted_these_wholetranscriptome_sequencing_data_were_termed': 1.9172475277520724e-05, 'hiseq_sequencing': 9.148819220060914e-58, 'wholetranscriptome': 9.148819220060914e-58, 'highthroughput_ _sequencing_ _data_ _chips_ _and_ _microarrays': 0.0038806204677737646, 'library_fragments_beckman_coulter_using_r_software_version_ _via_ _annotation_ _documents_ _all_ _datasets_ _were_ _from_ _the_species_homo_sapiens_and_zheng_et_al_unknownnpcnpc': 0.00023557425055950736, 'using_r_software_version_ _via_ _annotation_ _documents_ _all_ _datasets_ _were_ _from_ _the_species_homo_sapiens_and': 0.00023557425055950736, 'profile_details': 9.148819220060914e-58, 'identify_ _degs_ _between_ _normal_ _tissue_ _samples_ _and_npc_samples': 9.148819220060914e-58, 'microarray_data': 0.007713134335009549, 'v10': 9.148819220060914e-58, '0cxu_a0et_int_page': 9.148819220060914e-58, 'mfs_components_ccs': 1.7640184386747729e-06, 'to_ _investigate_ _the_ _functional_ _and_ _pathway_enrichment_in_go_and_kegg_we_used_upsetr_to_identify_ _the_ _modules_ _involved_ _in_ _biological_ _functions_ _gene_set_ _enrichment_ _analysis_ _gsea_ _using_the_ _mircode_ _tool_ _httpwwwmirco_de_ _which_ _is_described_as_\\x9ca_map_of_putative_mirna_target_sites_in_the_long_ _noncoding_ _transcriptome\\x9d_    _three_ _convenient_online_databases_namely_mirdb_  _httpwwwmirdb_  _mirtarbas_    _httpmirta_rbase_mbcnctuedutw_ _and_ _targetscan_    _using_the_search_tool_for_the_retrieval_of_interacting_ _genes_    _string_ _httpstrin_gdb_ _version_ _online_database_using_ _string_ _and_ _a_ _comprehensive_ _score_ _over_   _to_visualize_the_proportion_of_degs_cytohubba_a_cytoscape_plugin_  _was_used_to_filter_out_the_top_ _hub_genes_with_the_strongest_connections_to_the_other_genes_in_the_merged_networkstatistical_analysismost_statistical_analyses_using_the_bioinformatics_ _tools_ _mentioned_ _above_ _and_ _the_ _version_ _of_r_software': 0.00010801409838545335, 'to_ _investigate_ _the_ _functional_ _and_ _pathway_enrichment_in_go_and_kegg_we_used_upsetr_to_identify_ _the_ _modules_ _involved_ _in_ _biological_ _functions_ _gene_set_ _enrichment_ _analysis_ _gsea_ ': 2.8799875124964845e-08, 'upsetr': 0.007713134335009549, 'networkthe_lncrnamirna_interactions': 9.148819220060914e-58, 'using_the_ _mircode_ _tool_ _httpwwwmirco_de_ _which_ _is_described_as_\\x9ca_map_of_putative_mirna_target_sites_in_the_long_ _noncoding_ _transcriptome\\x9d_    _three_ _convenient_online_databases_namely_mirdb_  _httpwwwmirdb_  _mirtarbas_    _httpmirta_rbase_mbcnctuedutw_ _and_ _targetscan_    ': 9.148819220060914e-58, 'httpwwwtarge_tscan': 9.148819220060914e-58, 'to_predict_the_target_mrnas_of_the_mirnas_data_with_five_or_more_binding_sites': 9.148819220060914e-58, 'cerna_networks': 0.0011166955941916577, 'using_upregulated_ ': 1.8216991513487365e-05, 'using_ _cytoscape_ _https_cytos_cape_ _version_ _a_popular_online_bioinformatics_database_ _protein\\x91protein': 0.00022770977125509355, 'using_the_search_tool_for_the_retrieval_of_interacting_ _genes_    _string_ _httpstrin_gdb_ _version_ _online_database': 5.072004462628588e-07, 'using_ _string_ _and_ _a_ _comprehensive_ _score_ _over_   ': 0.0004017220894362599, 'cytoscape_cytos_cape': 8.263922883666513e-55, 'to_visualize_biological_network_and_integrate_the_data_  ': 1.1686951820486561e-54, 'version_algorithm': 8.263922883666513e-55, 'to_visualize_the_proportion_of_degs_cytohubba_a_cytoscape_plugin_  _was_used_to_filter_out_the_top_ _hub_genes_with_the_strongest_connections_to_the_other_genes_in_the_merged_networkstatistical_analysismost_statistical_analyses': 2.8799875124964845e-08, 'cytoscape_plugin': 9.148819220060914e-58, 'to_filter_out_the_top_ _hub_genes_with_the_strongest_connections_to_the_other_genes_in_the_merged_networkstatistical_analysismost_statistical_analyses': 9.148819220060914e-58, 'using_the_bioinformatics_ _tools_ _mentioned_ _above_ _and_ _the_ _version_ _of_r_software': 2.8799875124964845e-08, 'version_expression_levels': 9.148819220060914e-58, 'using_ _a_twotailed_student\\x99s_ttest_for_the_identification_of_deg_benjamini_ _and_ _hochberg_ _false_ _discovery_ _rate_ _method': 9.148819220060914e-58, 'test_correction_variables': 1.2696312954413811e-48, 'a0preprocessingto': 1.762608660843892e-06, 'fig_expression_matrixes': 9.148819220060914e-58, 'using_the_ _limma_ _package_ _the_ _results_ _showed_ _that_  _mrnas_ _lncrnas_and_ _mirnas_were_dissimilarly_ _expressed_ _logfc_\\x89¥_  _adjusted_ _p_\\x89¤_  _fig_a0_ _between_ _the_ _npc_ _and_ _normal_ _tissues_ _of_ _these_  _mrnas_ _lncrnas_and_ _mirnas_were_significantly_upregulated_while_ _mrnas_ _lncrnas_and_   _mirnas_ _were_ _significantly_ _downregulated_ _in_total_   _degs_ _were_ _shared_ _among_ _the_ _three_ _mrna_datasets_fig': 9.148819220060914e-58, 'analysis_pca': 0.0002542979044388503, 'mrnas_lncrnas_mirnas': 6.172943166471345e-05, 'logfc_\\x89¥': 1.007692708565637e-06, 'insight_control_samples_control_samples': 0.0002542979044388503, 'npc_samples_dots': 8.042864302131433e-06, 'control_samples': 0.0002542979044388503, 'a0s1': 0.00023557425055950736, 'shared': 9.148819220060914e-58, 'targets_a0s1': 9.148819220060914e-58, 'target_mrnas_e\\x93g_volcano_plots': 0.007713134335009549, 'based_ _on_ _mircode_ ': 0.0009535107705353341, 'using_ _three_ _databases_ _mirdb_ _mirtarbas_and_targetscan_lncrnas_mirnas_and_mrnas_were_included_in_the_upregulated_and_downregulated_lncrnamirnamrna_ _cerna_ _networks_ ': 1.9846334094107197e-05, 'a0_3a_b': 0.0016480626375926124, 'bps': 9.148819220060914e-58, 'segregation_regulation_mfs': 9.148819220060914e-58, 'ccs': 9.148819220060914e-58, 'to_be_largely_enriched_in_the_chromosomal_region_condensed_chromosome_chromosome_centromeric_region_ _0cxu': 9.148819220060914e-58, 'rnas_lncrnas_micrornas_mirnas': 0.00017131433607981848, 'upsetr_plot': 0.00017131433607981848, 'progression_metastasis_network_analysis': 9.148819220060914e-58, 'to_explore_the_ppi_network_based_on_the_correlations_among_the_ _degs_ _in_ _npc_ _the_ _obtained_ _data_ ': 9.148819220060914e-58, 'using_ _cytoscape_ _software_ ': 0.0001327562468548339, 'networkanalyzer_plugin': 9.148819220060914e-58, 'to_further_analyze_the_ppi_network_according_to_the_scores_the_cytohubba_plugin_was_used_to_analyze_the_hub_genes_associated_ _with_ _npc_ _and_ _the_ _following_ _genes_ _with_ _the_top_ _grades_were_deemed_to_be': 9.148819220060914e-58, 'cytohubba_plugin': 9.148819220060914e-58, 'to_analyze_the_hub_genes_associated_ _with_ _npc_ _and_ _the_ _following_ _genes_ _with_ _the_top_ _grades_were_deemed_to_be': 9.148819220060914e-58, 'tpx2': 9.148819220060914e-58, 'ttk_mad2l1_ndc80': 9.148819220060914e-58, 'using_mcode_c_further_analysis_of_degs_using': 8.450540934094419e-05, 'spindle_fig': 0.0006681652127777817, 'spindle_fig_mirnas': 0.0001392888065741971, 'demrnas_demirnas_delncrnas': 0.00012670798267201027, 'lncrnamirnamrna_network': 0.00012670798267201027, 'analysis_enrichment_analysis_gsea': 0.00012670798267201027, 'lncrnamirnamrna_networks': 0.0005218289698578611, 'npc_mrnas': 4.787483283520024e-05, 'to_ _have_ _remarkable_ _differences_ _between_ _the_ _patients': 0.00018993043364672486, 'hsamir29a3p_hsamir103a3p': 0.007713134335009549, 'jun': 1.1686951820486561e-54, 'tumorigenesis_development_qing': 8.263922883666513e-55, 'inhibiting_ _cjun_ _expression': 0.00010645527251242273, 'cycle_arrest_apoptosis': 1.7367123416836983e-06, 'dna_repair_cells': 9.148819220060914e-58, 'rearrangements': 9.148819220060914e-58, 'cases_hybridization_cgh_technology': 0.0016480626375926124, 'cochrane_central_register': 2.398357667004784e-05, 'fistula_complication_resectionmargin_resection_edge': 0.0014698838124791516, 'complications_complication': 9.148819220060914e-58, 'fistula_complication': 9.148819220060914e-58, 'resectionmargin_resection_edge': 0.00033962126629555366, 'outcomessuch': 0.00210348072096923, 'nose_surgery': 9.148819220060914e-58, 'tohave_a_progress_of_minimally_invasive_surgeryrecently': 9.148819220060914e-58, 'metaanalysis_studies': 9.148819220060914e-58, 'orifice_extraction_nose': 9.148819220060914e-58, 'wemors': 0.00026302343882768755, 'reportingitems': 0.0002629533548932101, 'metaanalysis_reportingitems_retrievedlymph_nodes_recoveryhospitalization_duration': 0.000420864290126533, 'noselar_aiselar': 0.004315547045054443, 'language_restriction': 0.00045085371770963703, 'retrievedlymph_nodes': 4.2885682464238105e-06, 'recoveryhospitalization_duration': 0.0004734482721133418, 'thespecific_search_strategies': 0.0006264573400700461, 'bothreviewers': 0.0019127833147525456, 'thenewcastleottawa_scale': 0.0007862569594425692, 'cochrane_tool': 6.867306187339515e-06, 'variance_method_outcomes': 0.0001670671110721405, 'madedata_collection_analysisdata': 9.148819220060914e-58, 'tworeviewers_changjian_wang_chen_formeananalysis_outcome': 9.148819220060914e-58, 'ratio_hr_cis': 0.0019127833147525456, 'test_value': 0.0005371174057381335, 'nos': 5.526896120685608e-51, 'synthesis_studies': 0.0017364216209157179, 'onstata_softwareresultsliterature_selection_database_search': 2.8337660116868848e-05, 'excludedcharacteristics': 2.8337660116868848e-05, 'postoperativecomplication': 0.0018006682651940404, 'incisionrelated_complication': 9.148819220060914e-58, 'anastomoticfistula': 9.148819220060914e-58, 'noselar_of_studies': 0.0011075402231842013, 'aiselar_the': 0.0011075402231842013, 'fistula': 0.0018006682651940404, 'aiselar_classification_\\x89¥_iii_thesevere_complication_withnoselar_of': 1.1504832171912505e-06, 'i2_fig': 0.0003689975995246945, 'distalresection_margin': 9.148819220060914e-58, 'forest_plot': 9.148819220060914e-58, 'outcomesa_total': 9.148819220060914e-58, 'operation_time_blood_loss': 9.148819220060914e-58, 'operation_time_blood_loss_forest_plot': 0.0014616190772430405, 'complication_0che_world_lymph_nodes': 9.148819220060914e-58, 'resectionmargin': 9.148819220060914e-58, 'edgesix_studies': 9.148819220060914e-58, 'data_wmd': 9.148819220060914e-58, 'postoperative': 9.148819220060914e-58, 'hisada': 9.148819220060914e-58, 'remaining': 0.003153776721987723, 'pain_scores_wmd_group_operation_time_b_blood_loss': 5.148053033373733e-05, 'was_was_presented_proved_lead_lives_was_althoughthe': 0.0002228512251195019, 'costantino': 3.6324077544318073e-06, 'otheroutcomes': 0.0002337533695104565, 'reduction_ofcomplications': 9.148819220060914e-58, 'tothe_decrease': 9.148819220060914e-58, 'bacteria_contamination': 0.0002825778555366326, 'to_avoid_the_contamination_of_the_peritonealcavity_ _irrigationtransanallavagethe_postoperative_pathology_results_to_some_extentalso': 0.00029907265845018327, 'noselar': 9.148819220060914e-58, 'moreadvantages': 9.148819220060914e-58, 'thatnoselar': 0.0005034057898537578, 'twotechniques': 0.007713134335009549, 'methods_loss_evaluation': 0.00017783908289502142, 'thecomparability': 0.00210348072096923, 'heterogeneity_difference': 0.0007217443521323071, '0che_world': 0.0021251968022424524, 'existedheterogeneity': 0.000347488144371561, 'homogeneity_heterogeneity': 0.0003689975995246945, 'complications_complications': 0.00017933259336108505, 'hospital_stay': 8.937521195812353e-05, 'conditionssuch': 0.00021241348748990692, 'indicationsthe_noselar': 5.530642414878322e-05, 'enthusiasm': 0.0008822241915335798, 'paper_results': 0.0005741125271172155, 'acknowledgementswe': 1.284690556057437e-52, 'to_thank_the_timely_help_given_by_junfeng_hu_in_statistic_analysisand_mengdan_zhou_in_language_editingauthors\\x99_grant_no_ _and_the_hangzhou_health_science_andtechnology_project_grant_no_2017a26availability_of_data_and_materialsall': 7.417164383651313e-53, 'contributionsguangen_yang_zhong_shen': 8.263922883666513e-55, 'literature_search_writing': 0.00012198022841850962, 'to_revise_the_intellectual_content_the_authors_read_and_approved_the_final_version_of_the_manuscriptfundingthis_work': 7.417164383651313e-53, 'zhejiang_foundation_grantno_lq19h160013_medical_health_science_technologyproject': 7.417164383651313e-53, 'to_thank_the_timely_help_given_by_junfeng_hu_in_statistic_analysisand_mengdan_zhou_in_language_editingauthors\\x99_jun_to_revise_the_intellectual_content_the_authors_read_and_approved_the_final_version_of_the_manuscriptfundingthis_work_zhejiang_foundation_grantno_lq19h160013_medical_health_science_technologyproject_grant_no_ _and_the_hangzhou_health_science_andtechnology_project_grant_no_2017a26availability_of_data_and_materialsall': 0.0014616190772430405, 'zhejiang_hospitalhangzhou_zhejiang': 2.0755631062298746e-07, 'taguri_m': 0.0003503299682769458, 'me_mistrangelo_m': 3.28784142602511e-52, 'liberman_boutros': 9.148819220060914e-58, 'feldman_lsincidence': 9.148819220060914e-58, 'park_sy_jun_sh': 9.148819220060914e-58, 'hemicolectomy_quah_hm_fu': 9.148819220060914e-58, 'z_wang_xcomparison': 9.148819220060914e-58, 'res\\x93_c_comparison_specimen_extraction': 9.148819220060914e-58, 'efficacy_orifice_extraction_surgery_j_altman': 0.0001527038197066919, 'reporting_items_reviews_metaanalyses': 2.4920273741511323e-06, 'l_sterne_ja': 0.0007862569594425692, 'mean_variance_size_data': 0.0004499048194399722, 'adam_jp': 9.148819220060914e-58, 'b_laurent_c_excision': 9.148819220060914e-58, 'tzuliang': 9.148819220060914e-58, 'orifice_specimen_extraction': 9.148819220060914e-58, 'artery_rectalartery': 2.3820219106448325e-06, 'operation_time_tme_correspondence': 0.00014587222812961027, 'operation_time': 3.8882630329896323e-08, 'tme_correspondence': 3.8882630329896323e-08, 'resection_range': 1.284690556057437e-52, 'adequatecure_rate_resection_stricturetosudeck\\x99s_point': 7.417164383651313e-53, 'adequatecure_rate_resection': 7.417164383651313e-53, 'stricturetosudeck\\x99s_point': 7.417164383651313e-53, 'toinsufficient_vascularization': 0.0038806204677737646, 'procedure_technicalpoints': 0.0019127833147525456, 'standardtme_surgery': 8.572729794799105e-06, 'usa_clips': 9.148819220060914e-58, 'side_foot_side_monitor_space_belowthe_sra': 9.148819220060914e-58, 'beforethe_operation': 3.5192759331781424e-05, 'operating_surgeon_camera_assistant': 1.351306116526075e-05, 'foot_side_monitor': 6.98090867427405e-06, 'trocar': 0.0001299950678468054, 'ports': 0.0001299950678468054, 'devices_scissors': 0.007713134335009549, 'space_belowthe_sra': 0.007713134335009549, 'to_open_the_peritoneal_reflection': 0.007713134335009549, 'colon_mesocolon': 0.007713134335009549, 'bundle': 4.111114138107696e-06, '3b_to_be_preservedand_the_sigmoid_vessels_and_vessel_branch_from_the_superior_rectal_vessels_to_the_intestinal_wall_were_selectedand_severed_according_to_the_tumor_positiondissection_at_the_correct_presacral_space_and_cephaladdissection_to_the': 0.00010905940088698344, 'to_be_preservedand_the_sigmoid_vessels_and_vessel_branch_from_the_superior_rectal_vessels_to_the_intestinal_wall_were_selectedand_severed_according_to_the_tumor_positiondissection_at_the_correct_presacral_space_and_cephaladdissection_to_the': 0.0001972963137505561, 'i_m_a': 0.0005741125271172155, 'artery_dissection': 0.0004500247192102474, 'm_left': 3.3791045745736495e-06, 'nerves_ureterwere_circumference': 0.00020709220224450083, 'g_tsme_preserving': 7.341748544824753e-06, 'wecould': 9.148819220060914e-58, 'nerve_fibers_pelvicnerve': 9.148819220060914e-58, 'lymphnode_no253': 3.3791045745736495e-06, 'mesocolon': 0.0002294710317562525, 'arteriae_world': 0.0004499048194399722, 'sigmoideae_finallywe': 9.148819220060914e-58, 'arteriae': 9.148819220060914e-58, 'devicesand_hemolocks': 0.0001254113387783698, 'themesorectum': 0.007713134335009549, 'using_a_Ï\\x872_test': 1.4762964828946743e-05, 'cm_incision': 0.00020422465499362284, 'presacralanastomosis': 0.00020422465499362284, 'tme_group': 7.417164383651313e-53, 'using_a_Ï\\x872_test_using_a_mannwhitney_u_test_p_values_of_ ': 0.0003069306742853986, 'using_a_mannwhitney_u_test_p_values_of_ ': 0.0003069306742853986, 'cea_levels': 9.148819220060914e-58, 'cea_levels_disease_type': 0.001845170519318405, 'that_blood_loss': 0.00010115299535317135, '±_days': 9.148819220060914e-58, 'conversion_complication_rates': 9.148819220060914e-58, 'complications_discussionin_surgeon_heald': 0.00184763583488959, 'tme_accordingto_tumor_situation_survival_recurrence_ratelaw_patients': 3.01605244759076e-05, 'accordingto_tumor_situation': 3.01605244759076e-05, 'survival_recurrence_ratelaw': 3.01605244759076e-05, 'margin_zakir': 0.001129870936471824, 'tsme_surgery_recurrence_rate': 0.0011075402231842013, 'laparoscopic_surgerywas_duration': 0.0016558653515238884, 'laparoscopic_surgerywas': 0.0016480626375926124, '5fu': 0.0006790143470593036, 'tsme': 0.0011078353336573638, 'similarguidelines': 1.8090871199370374e-05, 'difference_difference': 0.00046703013980541936, 'morethan_years_hadexperience_contributionslz_yx': 5.530642414878322e-05, 'theassistant': 8.263922883666513e-55, 'mesentery': 1.1686951820486561e-54, 'mesorectumis': 0.0001530897675652326, 'morethan_years_hadexperience_complexity_risk_contributionslz_yx_study_cz_yx_hw_qz_zd_whcollected_analyzed_data_ma': 0.009366186179114803, 'mesocolonagain': 8.263922883666513e-55, '\\x93cm': 0.0001530897675652326, 'preoperativeexamination': 0.0007641347695089468, 'complexity_risk': 0.000514692913697106, 'defunctioning_stoma': 7.417164383651313e-53, 'xh': 4.293458859802889e-05, 'study_cz_yx_hw_qz_zd_whcollected_analyzed_data_ma': 7.008209394243488e-07, 'datalz': 7.008209394243488e-07, 'cz': 0.0001465649042837502, 'manuscript_lz_ma_yx': 2.3883173327265673e-06, 'jiangsu_science': 6.9615502053815656e-06, 'conflicts_hospital_hospital_people\\x99shospital': 0.0013882295497307361, 'nk_outcomes': 5.320123532834587e-06, 'pathologic_resection': 0.0003262714585484908, 'rln_count': 0.002303972848451517, 'rlncountresults': 0.004315547045054443, 'metastasis_univariate': 0.0006768252640912667, 'countof_\\x89¥': 9.148819220060914e-58, 'edition_tnmclassification': 9.148819220060914e-58, 'gc': 9.148819220060914e-58, 'pn_stage': 9.148819220060914e-58, 'okajima': 9.148819220060914e-58, 'rlncount': 9.148819220060914e-58, 'deng': 3.7608225306274136e-05, 'abovestudies': 0.00040934415372960003, 'ratio_loddslog_odds': 0.0005373063242131615, 'ratio_loddslog_odds_type_ofresection_operation_time_depth': 0.0001531580056395792, 'quality_oflife': 0.0038806204677737646, 'r0_gastrectomy': 0.001845170519318405, 'r0_gastrectomy_characteristics': 0.0005373063242131615, 'ethicscommittee': 0.0019127833147525456, 'type_ofresection_operation_time': 4.085742850589715e-08, 'loss_postoperativefeatures': 2.0597198291100726e-06, 'univariate_analyses': 0.00118434703779093, 'variable_univariate_andmultivariate_analyses': 1.931977764355581e-05, 'median_rln_count': 0.0006768252640912667, 'nfever_°': 1.1686951820486561e-54, 'failurekidney_failurebrain_v_ngrade': 8.263922883666513e-55, 'function_retrieved': 0.0007000951832348714, 'nodes_mods': 8.263922883666513e-55, 'stratification_bytype': 0.0007000951832348714, 't3\\x93lymph_node_metastasisptnm_stage': 9.148819220060914e-58, 'lymph_nodes_odds': 9.148819220060914e-58, 'westerncountries': 0.00032618452265076087, 'emergingevidence': 0.00022454027988380799, 'aboutits_effects': 3.761996194028925e-05, 'to_influence_the_rln_count_including_the_confidence_and_enthusiasm_of_doctors': 0.0007000951832348714, 'situation_lymph': 5.530642414878322e-05, 'belower': 1.1686951820486561e-54, 'lymph_nodepick_to_increase_the_number_of_lymphnodes_dissected_during_surgery_such_as_fluorescentindocyanine_green_icg_and_5aminolevulinic': 8.263922883666513e-55, 'li_elucidatedthat': 9.148819220060914e-58, 'lymph_nodepick': 9.148819220060914e-58, 'to_increase_the_number_of_lymphnodes_dissected_during_surgery_such_as_fluorescentindocyanine_green_icg_and_5aminolevulinic': 8.263922883666513e-55, 'nodes_node_ratiolodds': 3.287639236201791e-05, 'mw': 1.4610345458823014e-05, 'manuscriptfundingthere': 0.0007959416758056306, 'calculation_method': 0.00013771298236743876, 'medsunfeng163comethics_approval_consent': 2.2483516665683055e-06, 'medsunfeng163comethics_approval_consent_ethics_committee': 0.0001895688378391432, '\\x93li_bu_z_wu': 9.148819220060914e-58, 'world_oncol_markl_b_kerwel': 9.148819220060914e-58, 'j_value_fluorescent_indocyanine_green': 8.263922883666513e-55, 'lymph_nodemapping_review_metaanalysis_j_n_y_murayama_y_harada_k_beika': 1.1686951820486561e-54, 'm_y_detection': 8.263922883666513e-55, 'g_wang_j_jin_k_liu_y_wang_f_effect': 0.0007095919825356841, 'liang_h': 0.00014349705247787946, 'sasako': 0.0003573959133248925, 'vendrame_dg_kim_hh_roviello_f_kassab_wittekind_c_proposal_lymph_nodes': 5.829528158834104e-06, 'plays_remains_identify': 0.00014503787009912032, 'using_bca_mice_xenograft_modelsresults_relb_deficiency_impairstumor_growth_lung_metastasis': 2.363317578660039e-06, 'role_genes': 0.001128162151175775, 'relb': 0.0010151901002210001, 'cellproliferation_motility': 1.6559978078242297e-05, 'using_bca_mice_xenograft_modelsresults_relb': 0.001128162151175775, 'deficiency_impairstumor_growth': 2.363317578660039e-06, 'link_therapy': 0.00018423236767620154, 'signaling_           _page_ _of_guidance_of_clinical_implementation_of_the_individualizedtreatment': 1.414508150539322e-05, 'responses_inflammation': 0.00013501590758590158, 'to_promote_bcaprogression_toward_erindependent_phenotypes_especially_fortriplenegative_bcatnbc_after_hormone_treatment': 0.00013501590758590158, 'nfÎºb1_rela_p65_relb_crel': 7.024805546098807e-06, 'attention_tissuematerials_tissue_samples_hospital': 0.0006940543140455221, '[_]_nevertheless_the_molecular_basisfor_the_activation_of_the_noncanonical_nfÎºb_pathway_awell_as_its_role_in_cancer_progression_have_been_recentlyreceiving_increased_attention_ _tissuematerials_and_methodsbca_patient_tissue_samples_and_immunohistochemistryihcthe_first_affiliated_hospital_with_nanjing_medical_university_nanjing_china': 0.00027587787348664266, 'to_examine_the_correlation_between_the_level_of_relb_and_bcapathological_grade_or_stage_the_tissues': 0.0003833771411240826, 'slides_theslides_slides': 9.148819220060914e-58, 'rinsingwith': 9.148819220060914e-58, 'c_slides': 0.00012651144182902996, 'tumor_rinsingwith_toobserve_immunostaining_images_incancer_progression': 0.007737938190906188, 'kit_cell': 0.00012654516580676728, 'toobserve_immunostaining_images': 2.061381161469389e-06, 'totalcell_positivity': 0.00012651144182902996, '\\x9chscore\\x9d': 0.00012651144182902996, 'grnas': 9.148819220060914e-58, 'doublestrand_oligo_dna': 9.148819220060914e-58, 'singlecell_colonieswere': 1.1686951820486561e-54, 'doublestrand_oligo_dna_using_puromycin_and_neomycin': 8.263922883666513e-55, 'using_puromycin_and_neomycin': 8.263922883666513e-55, 'plates_cells': 1.9405581961688743e-07, 'to_analyze_apoptosis_and_cellcycle_for_apoptotic_cell_qualification_ ': 1.1884505969016552e-05, 'with1xpbscolonies': 1.9405581961688743e-07, 'annexin_vfitc_Î¼mpi_cells': 0.0010298344840079976, 'microscope_to_quantify_cell_migration_and_invasion_tocdna_libraries_adapters_system_pulled_down_by_an_igg_antibodyserved_as_a_negative_antibody_control_using_a_quantitative_pcr_with_the_genespecific_primerswestern_blottingcytosolic_and_nuclear_proteins_using_a_bca_assay_kit_key\\x93gen_biotech_china_tumorlengths_levels': 0.0032076627188750715, 'cycling_phases': 5.234923075801482e-05, 'transwell_assay_corning': 9.148819220060914e-58, 'to_quantify_cell_migration_and_invasion': 9.148819220060914e-58, 'chamber_inserts': 5.234923075801482e-05, 'tocdna_libraries_adapters': 7.197486791869363e-06, 'motif_usa': 9.148819220060914e-58, 'toquantify_relb_binding_to_the_nfÎºb_enhancer_elementlocated_at_the_²flanking_region_of_the_human_mmp1gene_briefly_chromatin_isolated_from_bca_cells': 9.148819220060914e-58, 'pulled_down_by_an_igg_antibodyserved_as_a_negative_antibody_control': 7.197486791869363e-06, 'enhancer_fragment': 9.148819220060914e-58, 'using_a_quantitative_pcr_with_the_genespecific_primerswestern_blottingcytosolic_and_nuclear_proteins': 9.148819220060914e-58, 'using_a_bca_assay_kit_key\\x93gen_biotech_china': 7.197486791869363e-06, 'immunoblots_intensities': 8.263922883666513e-55, 'using_a_standard_formulav_  _Ã\\x97_ab2_a_and_b': 1.1686951820486561e-54, 'validated': 8.263922883666513e-55, 'tumorlengths': 7.197486791869363e-06, 'bca_aggressivenesswe': 0.0003342986407258492, 'relb_levels': 9.148819220060914e-58, 'to_be_highly_associated_with': 9.148819220060914e-58, 'expression_ofrela_relb': 3.833863449824947e-05, 'ratesfig_1b': 0.0023490856410452255, 'tothe': 0.0013933718080028864, 'vstriplenegative_mdamb231_cells': 5.320692078023159e-06, 'ikkÎ±': 0.0003262641731116168, 'inmdamb231_cells': 0.00015847651945988082, 'phosphorylatedlevels': 5.320692078023159e-06, 'colony_number_fig': 0.0011294396313431265, 'nfÎºb_activity': 1.843353109608753e-05, 'to_confirm_the_relationship_between_nfÎºb': 9.142535307129281e-05, 'jrelb': 1.1686951820486561e-54, 'g1s_transition': 8.263922883666513e-55, 'apoptosisto': 8.263922883666513e-55, 'role_rate': 1.3246313407357781e-05, 'to_examine_thecorrelation_between_mrna_expression_profiles_of_rela_and_relb_and_bca_occurrence_and_over_survival_of_patients_c_bca_tumor_tissues_withdifferent_pathological_grades_and_normal_breast_tissues': 3.3947527305841205e-07, 'nfÎºb_activation_cell_lines': 1.4914186653001208e-06, 'cck8_assay_mean': 8.263922883666513e-55, 'experiments_p_p': 8.263922883666513e-55, 'cellrates': 0.00011931918217645773, 'overexpression_ofrelb': 9.148819220060914e-58, 'rate_cellrates': 9.148819220060914e-58, 'relb_depletion': 9.148819220060914e-58, 'incmyc_cyclin_e1_file_figure': 9.148819220060914e-58, 's2relb': 2.2480340991203723e-51, 'expression_construct': 0.0006625816769337724, 'signaling_additional_file_ _figure_s3bfurthermore_to_testify_whether_relb_contributes_toestrogendeprived_bca_progression': 1.6559978078242297e-05, 'i_vimentin_fig': 0.0004499048194399722, 'intnbc_cells': 0.0011395163984218883, 'cell_capacity': 0.0016810521528134112, 'fig_5d_and_f': 0.0011125787591309202, 'proteinmmp1to': 0.0009466755491730313, 'analysis_usingtotal_rna': 0.007713134335009549, 'fig_table': 0.0009466755491730313, 'mdamb231': 0.0011284627910272927, 'relbmay': 9.148819220060914e-58, 'gene_fig_6dto': 9.148819220060914e-58, 'mmp1_expressionwe': 9.148819220060914e-58, 'nfÎºb_element': 9.148819220060914e-58, 'activation_fragment': 9.148819220060914e-58, 'using_pcr_the_amount': 9.148819220060914e-58, 'dna_fragment': 0.00021247010294190858, 'mmp1can': 9.148819220060914e-58, 'emt_mmp1': 9.148819220060914e-58, 'cycling_process': 6.978293448298126e-05, 'cellwound_healing_abilities': 0.0005865488951805282, 'cell_communication_signaling_dna_fragment_pcr_iggserves_cells_mmp1_decrease_file_figures4a': 0.0003357497166515223, 'emtmetastasisrelating_d_protein_level': 0.00018994987973827007, 'core_promoter_region': 5.475587329948464e-06, 'enhancer_activity': 3.463692377778376e-06, 'pcr_iggserves': 9.5699487263409e-06, 'cells_mmp1': 9.5699487263409e-06, 'increases_silence': 9.148819220060914e-58, 'file_figures4a': 9.148819220060914e-58, 'resultedin': 0.000494595879613311, 'volume_mm3': 1.8415484017042953e-05, 'parent_cells': 9.148819220060914e-58, 'leg_area': 9.148819220060914e-58, 'speed_tumor_weight': 4.220716351571725e-06, 'groupfig_7e_tumor_tissues': 9.148819220060914e-58, 'byihc_analysis': 9.148819220060914e-58, 'stain_ki67': 9.148819220060914e-58, 'byihc_analysis_mrna_expression_profiles': 9.148819220060914e-58, 'tumor_images': 9.148819220060914e-58, 'mrna_expression_profiles': 9.148819220060914e-58, 'metallopeptidase_jun_jun_protooncogene_transcription_factor': 0.0004947276920825566, 'mdamb231_parent_cells': 8.070170041890405e-06, 'c_tumor_growth_rates_tumor_weights': 8.833114682035859e-06, 'mdamb231_parent_cells_mice_proteins': 0.0005414567145434454, 'lungmetastasis': 8.833114682035859e-06, 'he_staining': 0.00030237797101608573, 'described': 3.4348996837103175e-05, 'tissues_significance': 0.002104041233387171, 'mouserelb': 0.00022655961142434313, 'kinetics_localization': 0.0003009307466374016, 'thermodynamics_regulationall': 4.91029241877523e-06, 'enzymes_thermodynamics_regulationall_control': 4.91029241877523e-06, 'systemsinfluence_proteomes': 0.00041996783004742835, 'protein_abundances': 0.0019297287722195148, 'vitamin_intake_network_control_dehydrogenase_complex_fructose_correspondence': 0.0018006682651940404, 'vitamin_intake': 0.0018006682651940404, 'keymodulators': 9.148819220060914e-58, 'network_control': 9.148819220060914e-58, 'proteinexpression_responses': 0.0038806204677737646, 'dehydrogenase_complex_fructose_correspondence': 5.428231000569684e-06, 'nv83cornelledudivision': 9.148819220060914e-58, 'phosphofructokinase_status': 9.148819220060914e-58, '\"_the_kinetics_and_localization_of_the_reactions_of_metabolism_are_coordinated_by_the_enzymes_that_catalyze_themthese_enzymes_are_controlled_via_a_myriad_of_mechanisms_including_inhibitionactivation_by_metabolitescompartmentalization_thermodynamics_and_nutrient_sensingbased_transcriptional_or_posttranslational_regulationall_of_which_are_influenced_as_a_network_by_the_activities_of_metabolic_enzymes_and_have_downstream_potential_toexert_direct_or_indirect_control_over_protein_abundances_considering_many_of_these_enzymes_are_active_only_whenone_or_more_vitamin_cofactors_are_present_the_availability_of_vitamin_cofactors_likely_yields_a_systemsinfluence_overtissue_proteomes_furthermore_vitamins_may_influence_protein_abundances_as_nuclear_receptor_agonistsantioxidants_substrates_for_posttranslational_modifications_molecular_signal_transducers_and_regulators_ofelectrolyte_homeostasis_herein_studies_of_vitamin_intake_are_explored_for_their_contribution_to_unraveling_vitamininfluence_over_protein_expression_as_a_body_of_work_these_studies_establish_vitamin_intake_as_a_regulator_of_proteinabundance_with_the_most_powerful_demonstrations_reporting_regulation_of_proteins_directly_related_to_the_vitaminof_interest_however_as_a_whole_the_field_has_not_kept_pace_with_advances_in_proteomic_platforms_and_analyticalmethodologies_and_has_not_moved_to_validate_mechanisms_of_regulation_or_potential_for_clinical_applicationkeywords_proteomics_big_data_vitamin_metabolism_precision_nutrition_molecular_nutritionintroductionregulatory_mechanismscellular_metabolism_is_a_system_of_chemical_reactions_inwhich_cells_harness_the_energy_stored_in_the_chemicalbonds_of_substrate_molecules_to_perform_their_biologicalfunctions_maintain_homeostasis_or_to_synthesize_buildingblocks_for_structural_maintenance_or_cellular_division_thekinetics_of_these_reactions_are_dependent_on_the_activity_ofthe_proteins_which_catalyze_them_thus_proteins_are_keymodulators_of_metabolismmetabolic_activity_also_exerts_network_control_over_itselfby_a_diverse_array_of_mechanisms_which_finely_tune_proteinexpression_responses_via_nutrient_sensing_machineries_ _products_or_intermediates_of_a_metabolic_pathway_caninhibit_or_activate_metabolic_enzymes_eg_malate_inhibitsthe_succinate_dehydrogenase_complex_  _and_fructose_correspondence_nv83cornelledudivision_of_nutritional_sciences_cornell_university_ithaca_ny_usa26bisphosphate_activates_phosphofructokinase_  _theoxidative_status_of_a_cell': 1.1686951820486561e-54, 'directionality_ofredox_reactions_impact_abundances': 8.263922883666513e-55, 'keap1nrf2_network': 9.148819220060914e-58, 'directionality_ofredox_reactions_impact_abundances_network_nodes_splice_variants_isozymesof_impactthe_bridge': 9.148819220060914e-58, 'network_nodes_splice_variants_isozymesof_impactthe_bridge': 8.263922883666513e-55, 'molecularevents': 0.0038806204677737646, 'modification_responses': 0.004315547045054443, 'considering_that_many_metabolic_enzymes_do_notfunction_in_isolation_and_as_detailed_in_the_sections_thatfollow': 3.457878245416636e-05, 'vitamin_cofactors': 0.0021185115687692856, 'notfunction': 0.0002088291548399077, 'ascofactors_vitamins': 9.148819220060914e-58, 'direct_indirectmechanisms': 9.148819220060914e-58, 'expression_vitamin_d': 3.457878245416636e-05, 'receptors_regulation': 8.263922883666513e-55, 'b3_vitamin_b7': 0.0015861095313673109, 'figs_molecularfunctions_role': 8.551871537973802e-05, 'studies_impacts': 1.395928044663019e-06, 'currentwork': 9.148819220060914e-58, 'to_provide_  _informationto': 9.148819220060914e-58, 'figs_molecularfunctions': 2.5889474744098558e-05, 'hugogene_gene_symbolor': 0.000494595879613311, 'qqq': 9.148819220060914e-58, 'spectrometry_and2dge': 9.148819220060914e-58, 'structuresat_scan_speeds': 9.148819220060914e-58, 'influence_inthis_arena': 9.148819220060914e-58, 'proteomics': 1.1686951820486561e-54, 'exists_carotenoids_areprecursors': 8.263922883666513e-55, 'exists': 8.263922883666513e-55, 'esterforms': 9.148819220060914e-58, 'carotenoids_areprecursors': 9.148819220060914e-58, 'growth_differentiation': 0.0038806204677737646, 'deficiency_to_retinoicacid_by_retinol_dehydrogenases_rdh_and_dhrs_families_ _to_induce_abundance_alterations_inproteins_associated_with_craniofacial_development_and_0cjeong_and_vacanti_nutrition_ _metabolism_            _page_ _of_fig_ _schematic_of_vitamin_involvement_in_reactions_of_central_carbon_metabolism_mitochondiralmembrane_abbreviations': 1.3872920953912478e-06, 'to_retinoicacid_by_retinol_dehydrogenases_rdh_and_dhrs_families_ ': 1.3872920953912478e-06, 'to_induce_abundance_alterations_inproteins_associated_with_craniofacial_development_and_0cjeong_and_vacanti_nutrition_ _metabolism_            _page_ _of_fig_ _schematic_of_vitamin_involvement_in_reactions_of_central_carbon_metabolism': 1.3872920953912478e-06, 'lipid_bilayer': 9.148819220060914e-58, 'mitochondiralmembrane_abbreviations': 9.148819220060914e-58, 'process_pathway_enrichmentanalyses': 6.075138805368377e-52, 'mass_spectrometry_tissue_function': 4.649709951488235e-52, 'plasmawas': 0.0007959416758056306, 'mass_spectrometry': 3.287841426025112e-52, 'tissue_function': 3.287841426025112e-52, 'toprotein_abundance_responses': 2.5164048986301264e-52, 'transport_activity': 0.00010272223504059847, 'pathophysiologies': 0.00010274961208829277, 'to_directly_link_to_the_molecular_functions_ofvitamin_b1_ _in_a_2dgemsbased_study_of_type_ _diabetic_andhealthy_control_subjects_authors_report_treatment_withthiamine': 0.00010272223504059847, 'subjects_authors': 9.148819220060914e-58, 'treatment_withthiamine': 9.148819220060914e-58, 'kinase_rfk_by_fad': 0.002104041233387171, 'pdhb_pdhx': 3.4348996837103175e-05, 'reductase_dehydrogenasethesuccinateriboflavin_deficiency': 0.0005191866840966338, 'riboflavin': 0.0038806204677737646, 'nicotinamidenicotinic_acid_mononucleotidenmnat1': 0.0007108445214139587, 'vitamin_b3niacin_vitamin_b3': 0.000254619872099857, 'phosphoribosyltransferase_naprt_nicotinamide_phosphoribosyltransferase': 0.0038806204677737646, 'cycle_Î²oxidation': 1.284690556057437e-52, 'c_glutathione_thioredoxin_nad_nadk_nadk2': 7.417164383651313e-53, 'c_glutathione_thioredoxin_nad': 7.417164383651313e-53, 'nadk_nadk2': 7.417164383651313e-53, 'nadp_nadp': 8.198185194464105e-05, 'idh1_idh2': 6.33966136568193e-05, 'camp_protein_proteinexpression_niacin': 3.3657400121140674e-05, 'pyridoxalkinase_pdxk_alcohol': 0.0020621573437398454, 'carnitinesynthesis3hydroxy6ntrimethyllysine_aldolase': 9.148819220060914e-58, 'andsphingolipid_synthesis_sptlc1_sptlc2_pyridoxalphosphate': 9.148819220060914e-58, 'recognition_memory_impairment': 0.0019127833147525456, 'slc5a6_slc19a3': 0.00210348072096923, 'modificationbiotin': 9.148819220060914e-58, 'lysine_residues': 9.148819220060914e-58, 'expression_modification': 1.6757437534239016e-06, 'preventitsabsorption': 0.0018006682651940404, 'onsystemic_intake': 9.148819220060914e-58, 'ofwriting_this_review': 9.148819220060914e-58, 'amine': 0.0004576368763948737, 'folate_homeostasis': 8.263922883666513e-55, 'onwomen': 0.0019127833147525456, 'calmodulincalm1_calcium': 9.148819220060914e-58, 'to_be_elevated': 9.148819220060914e-58, 'whilecofilin_cfl1': 9.148819220060914e-58, 'to_be_depleted_under_folatedeficiency_  _other_studies': 9.148819220060914e-58, 'vitamin_b12': 0.0004576368763948737, 'cobalt_atom': 9.148819220060914e-58, 'nucleotide_fig': 9.148819220060914e-58, 'vitamin_b12_compounds': 2.3863323261202395e-05, 'methylcobalamin': 9.148819220060914e-58, 'ofhomocysteine': 9.148819220060914e-58, 'toonecarbon_donors_vitamin_b12_deficiency': 5.787265476032352e-06, 'topeak_homeostasis_mechanisms_0cjeong_vacanti_metabolism_page_ppara_regulator_offatty_acid_oxidation_function_to_impactplasma_protein_abundances_in_the_complement_7dehydrocholesterolis': 0.0003546872164673056, 'protein_products': 5.785723897062203e-06, 'topeak': 7.864279641368101e-05, 'gstp1_abundances': 5.785723897062203e-06, 'homeostasis_mechanisms_0cjeong_vacanti_metabolism_page': 0.00040561912644835544, 'ppara_regulator_offatty_acid_oxidation': 0.000254619872099857, 'vitamin_c': 0.0005402991918563261, 'dopamineepinephrine_norepinephrine_synthesis_vitamin_c': 5.785723897062203e-06, 'antioxidant_vitamin_c_deficiency': 5.785723897062203e-06, 'to_impactplasma_protein_abundances_in_the_complement': 9.452613766209384e-08, 'reports_upregulation_downregulation': 9.148819220060914e-58, 'to_be_inversely_related_to_vitamin_d': 9.148819220060914e-58, 'polypeptide_abundance_shifts': 9.148819220060914e-58, 'backbones': 9.148819220060914e-58, 'reductase_dhcr7_synthesizedde_novo': 9.148819220060914e-58, '7dehydrocholesterolis': 9.148819220060914e-58, 'influences_d_response_elementsregulating_transcription_identifiedextracellularimpactsnuclear_0cjeong_vacanti_metabolism_page': 2.7629245646464483e-05, '125oh2d3boundvitamin_receptor_vdr': 2.012919707845018e-05, 'd_response_elementsregulating_transcription': 2.7629245646464483e-05, 'therapidonsetreceptorindependent': 9.148819220060914e-58, 'identifiedextracellularimpactsnuclear_0cjeong_vacanti_metabolism_page': 9.148819220060914e-58, 'response_deficiency': 9.148819220060914e-58, 'rickets': 9.148819220060914e-58, 'inadults_d_deficiency': 9.148819220060914e-58, 'tocardiovascular_diseases': 9.148819220060914e-58, 'neurologicalimpairments_autoimmunediseases_proteins': 0.0001261733407126887, 'todifferentially_affect_abundances_of_proteins': 0.0015842910551982499, 'toblood_coagulation': 1.29210065447725e-06, 'quantifying_ _proteins_table_ _an_impressiveanalytical_depth_for_serum_  _in_a_2dgebased_studyvitamin_d_deficient_children': 0.0007959416758056306, 'fetub': 5.277990362301318e-06, 'tissueidentify_proteins': 0.0018006682651940404, 'prognosis_combination_analyses_staining_resultsresults': 0.00037610940752033374, 'staining_resultsresults': 0.0014616190772430405, 'byadenocarcinoma': 0.0007081910728315311, 'knownas_pap_test': 1.155393675369606e-05, 'kriegsmann': 9.148819220060914e-58, 'theuse_lining': 9.148819220060914e-58, 'rates_those': 7.084629343608724e-05, 'antigen_retrieval_wasperformed_peroxidase': 1.8965311589414154e-10, 'antibody_pathologist': 1.1632332051702669e-08, 'saline_pbs': 0.00027401999083637483, 'diaminobenzidine': 0.0005748172373734937, 'scoring_results': 7.118181676106286e-07, 'muc5acpositive_staining_Ã\\x97_0cli_  _diagnostic_pathology_           _page_ _of_and_cytoplasm_while_p40_and_p63': 0.0016815001133323047, 'effect_muc5ac': 2.7446560661786228e-05, 'effect_muc5ac_expression': 0.007713134335009549, 'muc5ac': 8.263922883666513e-55, 'aecnoreactivitymuc5ac': 1.1686951820486561e-54, 'ck7': 8.263922883666513e-55, 'expressionrate': 0.0006768252640912667, 'p_correlation': 0.0006625816769337724, 'ck56': 9.148819220060914e-58, 'sensitivityand_specificity_sensitivity_specificity': 9.148819220060914e-58, 'gene_family': 4.4423405374281965e-05, 'kaufmann': 4.4423405374281965e-05, 'p40': 0.0002459779138957347, 'combinationof_ck56': 0.0008651248620157782, 'ck7expression': 2.7446560661786228e-05, 'riethdorf_albarracin': 9.148819220060914e-58, 'immunohistochemistrymethods': 9.148819220060914e-58, 'salinedab': 0.00012198022841850962, '0cli_pathology_page': 9.37758605119494e-06, 'liand_xiaotong_jing': 9.148819220060914e-58, 'data_herpel_e_meister': 9.148819220060914e-58, 'jinan_liu': 0.0014620085655300467, '0cli_pathology_page_manuscript_data_data_chen_herpel_e_meister': 2.3863323261202395e-05, 'theimmunohistochemistry_jie_yu_tingguo_zhang': 9.148819220060914e-58, 'pathologicalsections': 9.148819220060914e-58, 'gulmann_c': 0.0007959416758056306, 'development_foundation_applicableethics_approval_consent': 1.0300722009980105e-06, 'foundation_ofchina_informedconsentcompeting': 6.311415971268187e-05, 'informedconsentcompeting': 0.001845170519318405, 'interestsauthor_weifangshandong_2department': 0.0013882295497307361, 'china5department': 9.148819220060914e-58, 'carcangiu_herrington_cs': 9.148819220060914e-58, 'herzog_lewin_sn_neugut': 9.148819220060914e-58, 'lu_ys_hershman': 9.148819220060914e-58, 'jt_baracat_ec': 9.148819220060914e-58, 'jp_hysterectomy_completion_surgery': 9.148819220060914e-58, 'locallyadvanced_adenocarcinoma_carcinomas_fan_m_dai_l_kang_liu_y_sun_h_liang_z_yan_w_chen_kexpression': 0.0001054814373890721, 'p_gidrol_xmantovani_ma_transcriptional_network': 9.148819220060914e-58, 'vosmik': 9.148819220060914e-58, 'c_pesci_a': 0.0011301720283114149, 'kiyokawa_t': 1.8444548091260086e-05, 'airways_mucus_annu': 1.284690556057437e-52, 'association_sk_ramifications': 7.417164383651313e-53, 'polymeric_mucins': 7.417164383651313e-53, 'physiol_\\x93': 7.417164383651313e-53, 'duran': 1.1686951820486561e-54, 'ja_tract_mucin_genes_mucinglycoproteins': 8.263922883666513e-55, 'ja_tract_mucin_genes_mucinglycoproteins_optimal_subtyping_humpathol_\\x93': 8.263922883666513e-55, 'montgomery_kd_aw_pai_panel': 9.148819220060914e-58, 'optimal_subtyping_humpathol_\\x93': 9.148819220060914e-58, 'gartner_f': 9.148819220060914e-58, 'fcdistribution': 9.148819220060914e-58, 'instage_cell_carcinoma': 0.0016810521528134112, 'ro_stockard': 0.0004499048194399722, 'expression_pathology_page_cp_differentialexpression_muc5ac': 0.007713134335009549, 'radiation_oncology_page': 0.00031712945954093306, 'increasein_risk': 5.171656492165785e-06, 'certainstudies': 9.148819220060914e-58, 'association_betweenthe_delay': 9.148819220060914e-58, 'analyses_patients': 3.082524572056833e-06, 'to_wait_longer': 0.001845170519318405, 'to_analyze_the_impactof_tti_and_growth_kinetics_of_individual_tumors_on_theoccurrence_of_localregional_failure': 0.007713134335009549, 'information_characteristics': 4.992758059685529e-06, 'result_information_characteristics': 0.0010298344840079976, 'ct_scans': 1.9378520863455993e-05, 'slice_thicknessof': 3.164897651659712e-07, 'metastaticneck_nodes': 8.09429027117468e-05, 'software_program': 9.1661424204338e-06, 'national_ethics_committee': 0.0007095919825356841, 'index_cancer_deaths': 9.148819220060914e-58, 'csh': 9.148819220060914e-58, 'causespecifichazard': 9.148819220060914e-58, 'to_be_events_of_interestin_the_analyses_where_locoregional_control_lrc_wasof_primary_interest_the_calculations_were_performed_in_0cÅ¾umer_  _radiation_oncology_           _page_ _of_regards_to_tumors_excluding_the_nonresponders_to_rtie_those_with_residual_local_or_regional_tumors_at_\\x93_weeks_after_rt_completion_for_the_latter_group_weconcluded_that_it_is_the_radioresistance_of_tumor_cellsthat_are_responsible_for_the_persistence_of_the_diseaseafter_therapy_and_not_that_patients_had_to_wait_for_rtthe_followup_time_was_calculated_from_the_last_day': 9.148819220060914e-58, 'to_wait_for_rtthe_followup_time_was_calculated_from_the_last_day': 0.001845170519318405, 'thetumor_volume': 0.00040928894108187346, 'tumor_volume_time': 9.148819220060914e-58, 'asÃ': 9.148819220060914e-58, 'year_posttreatment': 8.657387773748207e-08, 'ci_  _respectivelyin_the_fifth_year_posttreatment_ _out_of_ _patients': 1.8444548091260086e-05, 'radiation_oncology_page_tumorscharacteristicsgenderno_femalemaleage': 0.0011301720283114149, 'relationship_p_higherage': 9.148819220060914e-58, 'hazard_significant': 9.148819220060914e-58, 'tumorsci_confidence_interval_radiation_oncology_page_cihrpvaluetnm_iii_time': 0.001845170519318405, 'association_we': 9.148819220060914e-58, 'allowance': 9.148819220060914e-58, 'ie_cshwas': 9.148819220060914e-58, 'to_be_favorably_associated_with_a_lower_disease_stage_p_  _and_the_addition_of_cct_to_rtp_  _whereas_age_gender': 9.148819220060914e-58, 'interpretationof_covariates': 0.00014548202111895416, 'allowing_for_nonproportional_hazards': 2.37327693548952e-06, 'nochanges': 1.4985321964626232e-06, 'patients_ct_scans': 9.179667532903695e-05, '\\x9cduration': 8.263922883666513e-55, 'to_be_importantimpact_of_tumor_growth_kineticsdiagnostic_and': 1.1686951820486561e-54, 'effectdid': 8.263922883666513e-55, 'tstage': 1.4985321964626232e-06, 'increase_increase': 1.4985321964626232e-06, 'impact_cm3_increase_theresults_study': 0.0027803059850604966, 'yearperiod': 8.657387773748207e-08, 'impact_cm3_increase': 0.0006768252640912667, 'andthe_absence': 0.004315547045054443, 'sample_sizestumor_sitestage_mix_periods': 0.004315547045054443, 'radiation_oncology_page_effect': 0.0001821419182435067, 'eg_tumor_growth_kinetics': 0.0001821419182435067, 'to_be_relevant_inthis_respect_as_in_our_and_other_similar_studies': 0.0015842910551982499, 'whichdiffers': 0.00210348072096923, 'mix': 0.00021011086694334644, 'relationship_outcomes': 0.0018006682651940404, 'effect_oftti': 0.000712954256025908, 'disease_delay': 0.0011307218525758846, 'analysis_tumor': 5.2109122914128046e-05, 'end_resultsour_study': 9.148819220060914e-58, 'weaknesses': 9.148819220060914e-58, 'ofanalyses': 1.4763738433670392e-05, 'duringthe_followup': 0.001845170519318405, 'that_withsince': 0.0018006682651940404, 'perni': 0.0008581749454218445, 'control_os': 1.4993111492271457e-05, 'pretreatment_petct_scans': 0.0011075402231842013, 'limitationsin_ct_scan': 3.169048712224486e-06, 'highquality_pairs': 9.1661424204338e-06, 'radiation_oncology_page_outcomes': 0.00018049906186689923, 'promising_in_severalsmaller_and_statistically_underpowered_studies_in_orderto': 0.0038806204677737646, 'survival_interquartile_rangeci_confidence_interval_hpv_papillomavirusacknowledgementsthis_study': 1.1382759988517378e-07, 'research_agencyprogram': 6.9634048173220454e-06, 'b_pohar_perme': 3.306118552671458e-07, 'august_referencesbray_f_ferlay_j_soerjomataram': 2.0251393308748088e-05, 'ljubljana_si1000_ljubljana_slovenia': 3.306118552671458e-07, 'rl_torre_estimates_world_health_anization': 0.0004499048194399722, 'response_rate_care': 0.0003833771411240826, 'lcr_survival_os_progressionfreesurvival_pfs_events': 0.0003833771411240826, 'response_rate_lcr_survival_os_progressionfreesurvival_pfs_events_validation_care': 0.0003833771411240826, 'ert_group': 1.1686951820486561e-54, 'median_os_orr': 8.263922883666513e-55, 'to_chemoradiation': 3.8897633413564496e-05, 'metastasis_tumor_oxygenation': 3.8897633413564496e-05, 'angiogenesis_inhibitoris': 3.9460786507243995e-05, 'tumor_sensitivity': 6.444259080344139e-07, 'severalstudies': 1.284690556057437e-52, 'efficacy_tolerabletoxicity': 7.417164383651313e-53, 'howeverthe': 2.2742115629454836e-53, 'efficacy_tolerabletoxicity_publication_years_radiotherapy_dosagethe_method_to_assess_the_quality_of_theincluded_studiesstatistical_analysisstatistical_analyses_were_conducted_using_comprehensive_metaanalysis_version_ _software_biostat_rawproportion': 2.2742115629454836e-53, 'arm_studies': 0.00017074852371816256, 'written_fulltext_meeting': 1.4055400435083294e-53, 'inclusion_criteriadata_extraction_quality_assessmentdata': 0.004315547045054443, 'publication_years': 7.417164383651313e-53, 'radiotherapy_dosagethe_method': 7.417164383651313e-53, 'orr_pfs_oslcr_aes_newcastleottawa_scale': 9.148819220060914e-58, 'to_assess_the_quality_of_theincluded_studiesstatistical_analysisstatistical_analyses_were_conducted_using_comprehensive_metaanalysis_version_ _software_biostat': 9.148819220060914e-58, 'using_comprehensive_metaanalysis_version_ _software_biostat': 0.00024810373354211296, 'rawproportion': 0.007713134335009549, 'flowchart_using_thesearch_strategy_the_pooled_overall_orr_for_the_seven_studies': 0.00771518910792271, 'flowchart': 0.007713134335009549, 'using_thesearch_strategy': 0.0002394531921586528, 'toendostatin_administration': 0.0002394531921586528, '\\x93]involving_patients': 0.00012613970685026185, 'characteristicsthe_characteristics': 8.263922883666513e-55, 'dose_atweeks_via': 1.1686951820486561e-54, 'withsingle_rt_ert_patients': 8.263922883666513e-55, 'lansclc': 0.001845170519318405, 'lcr_data': 0.0007131860921213638, 'the_pooled_overall_orr_for_the_seven_studies': 1.1636549905330657e-05, 'inthe_ert_group_ci_\\x93': 8.263922883666513e-55, 'pfs_os': 9.148819220060914e-58, 'pfs_orr_aesecrt\\x93pfs_os_orrecrt\\x93wen': 9.148819220060914e-58, 'cyclesos': 9.150169635962028e-05, 'pfs_progressionfree_survival': 3.9027410700268706e-05, 'respectivelyfour_studies': 1.0753396196933055e-06, 'os_rate_fig_4b_onstratification_pooled': 6.588450029741738e-05, 'pfsvalues_patients': 3.012831237073818e-05, 'ecrt': 0.0018456622073465703, 'neutropenia_andleukopenia': 4.419783020737781e-06, 'median_pfs_table_ae_ofhypertension_durvalumab': 0.00027107563607256145, 'ert_endostatin': 0.0007377589009890748, 'ae_ofhypertension': 8.657387773748207e-08, 'endostatincombined_with_ccrt_or_rt': 0.00040655415156622577, 'ert': 9.148819220060914e-58, 'efficacy_benefitbut_patients': 9.148819220060914e-58, 'vegf_factor': 0.0013756136977289759, 'orr_for_all_patients_lcr_survival_administration_characteristics_sensitivity': 2.244164530400442e-05, 'orr_for_all_patients': 2.244164530400442e-05, 'lcr': 0.0003022165162482692, 'one_collagen_xviii': 9.148819220060914e-58, 'tumor_vasculature': 9.148819220060914e-58, 'to_interfere_with_theproangiogenic_action_of_growth_factors_such_as_basicfibroblast_growth_factor_and_vegf_preclinical_studieshave': 0.004315547045054443, 'thatcombination': 0.0014620085655300467, 'withoutchemotherapy': 2.3863323261202395e-05, 'stage_iiib_disease': 0.001129870936471824, 'inour': 0.001129870936471824, 'pfs_rates_endostatin': 5.171656492165785e-06, 'pacific_study': 9.148819220060914e-58, 'significantsurvival_advantage': 9.148819220060914e-58, 'ccrt': 0.0011078353336573638, 'role_patients': 1.8090871199370374e-05, 'bychemotherapy': 9.148819220060914e-58, 'to_receive_sequential_crt_or_evenrt': 9.148819220060914e-58, 'inmaximal_antitumor_outcomes': 0.002931320119149737, 'pfs_months': 4.7488995601161345e-05, 'chemotherapyof': 0.0011075402231842013, 'duration_intervals': 0.0004734482721133418, 'endostatin_treatment': 9.148819220060914e-58, 'tumor_vasculatureby': 9.148819220060914e-58, 'rt_delivery': 4.784749620510976e-05, 'endostatin': 9.148819220060914e-58, 'blood_perfusion': 9.148819220060914e-58, 'administration_inaddition': 0.00016710007717429584, 'outcomesof': 0.0038806204677737646, 'administration_routes': 0.004315547045054443, 'duration_intervals_administration': 9.148819220060914e-58, 'investigationin_analysis': 9.148819220060914e-58, 'aesin': 0.007713134335009549, 'aes_grade_radiation_pneumonitis': 0.00029599327620783605, 'severallimitations_firstlyfour_studies': 1.284690556057437e-52, 'control_group_oncology_page_events_\\x93': 7.417164383651313e-53, 'control_group_oncology_page': 7.417164383651313e-53, 'events_\\x93': 7.417164383651313e-53, 'vprtog': 9.148819220060914e-58, 'cams': 9.148819220060914e-58, 'pfs_progressionfree_survival_progressionfreesurvival_os_survival': 3.9027410700268706e-05, 'differences_treatment_methods': 9.148819220060914e-58, 'to_be_established': 9.148819220060914e-58, 'to_reach_definitivesincreasing_interest': 0.00025282913626928664, 'antiangiogenicagents': 0.0007035667068513752, 'impower150_study': 0.001128162151175775, 'vprt_pc_cet': 1.1686951820486561e-54, 'radiation_etoposide_paclitaxelplus_carboplatin_cetuximab_pp_pemetrexed_cisplatin_sp_vegfr_endothelial_growth_factor': 8.263922883666513e-55, 'endostatin_antipd1also': 0.001128162151175775, 'clinical_trialnct04094909': 9.148819220060914e-58, 'efficacy_safety_ofendostatin': 9.148819220060914e-58, 'administration_rt': 9.148819220060914e-58, 'approach_forsome_patients': 9.148819220060914e-58, 'to_validate_this_suggestion': 0.0018006682651940404, 'strategy_multiplechallenges': 0.001128162151175775, 'events_chemoradiotherapyecrt_endostatin_immune': 0.00210348072096923, 'lh': 9.148819220060914e-58, 'theproject': 9.148819220060914e-58, 'sz': 0.0014616190772430405, 'paper_jm': 8.263922883666513e-55, 'projectfundingthis_study': 0.0011075402231842013, 'materialsthe_authors': 9.148819220060914e-58, 'radiation_etoposide_paclitaxelplus_carboplatin_cetuximab_pp_pemetrexed_cisplatin_sp_vegfr_endothelial_growth_factor_theproject_paper_jm': 9.148819220060914e-58, 'rl_torre_estimates_\\x93_challenges_curran_p_metaanalysis_j_natl_cancer': 0.0004499048194399722, 'costeffectiveness_consequence_analysis_jama_oncol_hida_t_durvalumab': 0.0010068765747081726, 'karlsson_m_relationship': 0.0004499048194399722, 'predictions_oftumour_response': 2.2781514794467884e-07, 'production_drugtreatment': 0.00829217017245816, 'endoplasmicreticulum_ers_aggravation': 9.148819220060914e-58, 'pathways_levels': 9.148819220060914e-58, 'tumors_levels': 0.0007129960827382031, 'apoptosis_treatmentinduced_cell': 0.00013555238796894863, 'ers_protein': 9.148819220060914e-58, 'drugtreatment': 9.148819220060914e-58, 'immunosuppressivehypoxic_correspondence': 0.00020598579336589774, 'treatment_efficacy_andallows_cancer_cells': 0.004315547045054443, 'to_be_secreted_from_cells_  _proteins_that_fail_to_undergo_correct_foldingmaturation': 0.004315547045054443, 'to_undergo_correct_foldingmaturation': 0.004315547045054443, 'proteindegradation_erad': 0.0003208044612686651, 'processing_imbalance_hypoxia': 0.000704362469235278, 'upr_pathways': 7.520315349683549e-05, 'ers': 0.012947162597569449, 'tochaperone': 0.000494595879613311, 'to_correct_or_neutralize_ers_conversely_during_severe_andpersistent_ers': 0.004315547045054443, 'ers_levels': 0.009730556774261514, 'cell_deathwe': 0.0005191866840966338, 'orlistaters_activation': 0.00054686425127897, '[_cox2_]_target_sarcoplasmicendoplasmic_reticulum_calcium_atpase_[_serca_]_and_orlistaters_activation_by_fatty_acid_synthase_[_fasn_]_inhibition_[_\\x93_]_serca_inhibition_on_the_er_membrane': 0.0002116290799748951, 'fasn_inhibition': 0.00021157268701798546, 'overexpression_studies': 3.449423678279798e-06, 'bothcelecoxib_fasn_inhibitors': 0.0003208044612686651, 'elevatedbasal_ers': 0.0011125787591309202, 'expression_levelswe': 0.00015902946487566703, 'muc2_grp78': 0.007713134335009549, 'dntcf4ls174_t_cells': 0.0016480626375926124, 'shownwe': 0.0008581749454218445, 'producing_cellsand': 0.0006810685397702696, 'ourhypothesis': 0.0016480626375926124, 'toinduce_apoptosisers': 9.148819220060914e-58, 'drugtherapy': 9.148819220060914e-58, 'initiation_factor_chop': 1.3246313407357781e-05, '0cdilly_orphanet': 0.00021157268701798546, 'difference_brepresentative_pictures': 4.433486265603101e-05, 'dntcf4ls174_t_cells_bargraphs': 9.148819220060914e-58, 'representative_pictures': 9.148819220060914e-58, 'kd_cellscompared': 2.9077973048268384e-05, 'celecoxib': 9.148819220060914e-58, 'combination_ers_aggravation': 9.148819220060914e-58, 'celecoxib_ _Î¼mbination_of_orlistatcompared_to_low_mucin_producing_dntcf4ls174tcells_lacking_doxycycline_exposure_conversely_combination_therapyinduced_ers_aggravation': 9.148819220060914e-58, 'muc2_kd': 9.148819220060914e-58, 'lv_controlcells': 0.007713134335009549, 'orlistat': 0.00012620698354677196, 'muc2_secretion': 2.0558680071920793e-06, 'apoptosiswe': 0.0001391293091783537, 'combination_therapy_orlistat': 0.00012630877451023521, 'bim_noxa_caspase': 0.00015175328891448237, 'drug_therapy': 0.00771518910792271, 'effect_figs': 0.00012613970685026185, 'jc1_jc1_aggregates': 9.148819220060914e-58, 'jaggregates': 9.148819220060914e-58, 'induction_ofupr_proteins': 0.007713134335009549, 'cleavageof_caspase': 0.0003402493734878284, 'increase_markers_puma': 7.055938651351604e-05, 'ofpuma': 7.055938651351604e-05, 'orphanet': 0.0001524162296249257, 'drug_therapyin': 2.486955388348353e-06, 'assayhydroxylamine_ham_agent': 0.00036240313892865647, 'control_errorbars': 2.9077973048268384e-05, 'mucinoustumor_growth': 0.0005506199709643784, 'tumorinoculation_animals': 0.0001837298265031393, 'drug_aloneas': 0.00027573473885584285, 'jc1monomers': 9.148819220060914e-58, 'jc1aggregates': 9.148819220060914e-58, 'bargraph': 9.148819220060914e-58, 'intensity_difference': 9.148819220060914e-58, 'analysis_chop_drug_therapy_bar_graphdemonstrates': 9.148819220060914e-58, 'blot_assay_markers': 9.148819220060914e-58, 'mgkg_bw_orlistat_o': 0.0004815525391610832, 'pdk1_regulatesfasn_activity': 4.433486265603101e-05, 'mean_intensity_differenceasterisk': 0.0006768252640912667, 'celecoxib_hasbeen': 9.148819220060914e-58, 'to_inhibit_muc2_expression_and_decreasemucinous_tumor_growth_in_ex_vivo_and_in_vivo_modelsof_mucinous_colonappendix_cancers': 9.148819220060914e-58, 'fasnrequired': 0.00210348072096923, 'cox2_activitiesmodulate_cancer_signaling': 7.05217663403483e-05, 'cells_exposedto_doxycycline': 0.00015902946487566703, 'ers_aggravation': 9.148819220060914e-58, 'protectivemechanisms_upr': 9.148819220060914e-58, 'aggravators': 9.148819220060914e-58, 'efficacyagainst': 9.148819220060914e-58, 'expressionsecretionand_cancer_pathways': 0.0004405647755333974, 'inhibit': 0.00012613970685026185, 'incancer_models': 0.00771518910792271, 'approved': 0.00012617334968195346, 'formulations': 0.007717245523549822, 'lipases_therebydecreases_absorption': 0.00210348072096923, 'fasn_inhibitors': 9.148819220060914e-58, 'to_be_tested_asanticancer_drugs_in_clinical_trials_  _in_our_studycombination_treatment_celecoxib_ _orlistat_aggravateders': 9.148819220060914e-58, 'cultures_treatmentinduced_cell': 1.1686951820486561e-54, 'ersdependent': 8.263922883666513e-55, 'drug_treatment': 8.263922883666513e-55, 'studieswould': 9.148819220060914e-58, 'quantitate_the_magnitude_of_ers_aggravation_required_to_induce_this_transition_additional_studies_with_other_ers_aggravating_agentswould_confirm_findings_of_this_study_and_the_proposed_therapeuticthein_vivo_studies_celecoxib_and_orlistat_were_administered_ip_which_is_not_ideal_for_clinical_trials_whilecelecoxib': 9.148819220060914e-58, 'fetal': 8.263922883666513e-55, 'scientific_charlotte_nc_celecoxib_orlistat': 1.1686951820486561e-54, 'titer_solution_proliferation_assay': 8.263922883666513e-55, 'pierce_bca_protein_assay': 7.343705288176126e-06, 'frombd_biosciences': 0.00045014468290625236, 'san_jose': 7.343705288176126e-06, 'dntcf4': 9.148819220060914e-58, 'hans_cleversutrechtnetherlands': 9.148819220060914e-58, 'generationls174_t_cells': 1.1686951820486561e-54, 'h_lentiviral_ps_Î¼gml': 8.263922883666513e-55, 'h_lentiviral_ps_Î¼gml_dmem_proliferation_mts_assay': 0.0012157342384844945, 'g418': 1.9841532653318932e-05, 'covers': 1.9841532653318932e-05, 'room_temperaturethe_cells': 1.9841532653318932e-05, 'proliferation_mts_assay': 8.263922883666513e-55, 'h_cells': 1.205442421571829e-06, 'i_bd_biosciencessan_jose': 9.148819220060914e-58, 'washed_twice_with_cold_pbs_and': 9.148819220060914e-58, 'buffer_incubatedunstained_pi_cells': 4.1601871131532126e-08, 'flow_cytometry_run_on_\\x93_sds_gels_miniprotean_tgxgels_rad': 2.548564390681887e-06, 'run_on_\\x93_sds_gels_miniprotean_tgxgels': 2.5478852339772625e-06, 'rad': 6.791567046244633e-10, 'eph_receptors_ephrin_ligands': 0.0003540754526695089, 'a1_receptors_eph': 9.148819220060914e-58, 'importantclass': 9.148819220060914e-58, 'eph_receptors_ligands': 0.0006992128660964839, 'subcategoriesincluding_ephrin': 0.0013882295497307361, 'fig_manuscript': 0.00035613247455696745, 'link_tobind_epha': 0.00018423236767620154, 'tobind_epha': 0.00018423236767620154, 'expression_patternin_cancer': 9.148819220060914e-58, 'to_differ_from_that_of_epha2_with_attenuation_in_a_variety_of_aggressive_tumors_particularlythose_overexpressing_epha2_ _under_normal_conditions_epha2_interacts_with_ephrina1_on_the_neighboring_cell_and_induce_diverse_signalingnetworks_following_celltocell_contact_as_membraneproteins_ephrins_are_engaged_in_both_forward_termedephrinepha2_forward_and_reverse_called_epha2ephrinreverse_signaling_from_ephrin_ligands_to_epha2_and_viceversa': 9.148819220060914e-58, 'epha2_oligomerization_andtherefore': 9.148819220060914e-58, 'biologicalconsequences': 9.148819220060914e-58, 'inaddition_epha2': 1.843021855196599e-05, 'a1_signaling': 9.148819220060914e-58, 'morphology_celltocell_repulsion_adhesion': 9.148819220060914e-58, 'epha2': 0.004732609681423391, 'inducesepha2_phosphorylation': 7.728703914207112e-05, 'downstream_tyrosine_phosphorylation': 7.728703914207112e-05, 'epha2_degradation': 0.00017433779082564105, 'addition_tyrosinephosphorylation': 8.263922883666513e-55, 'fibrosarcoma_raf\\x93erk': 0.00023299036128717455, 'epha2_amplification_epha2_promoter': 9.148819220060914e-58, 'p53binding_sites_receptoris': 9.148819220060914e-58, 'ras': 9.148819220060914e-58, 'epha2as': 9.148819220060914e-58, 'epha2_gene_expression': 9.148819220060914e-58, 'multiplestimuli': 9.148819220060914e-58, '[_]_thusit_is_tempting_to_speculate_that_epha2_overexpression_inbreast_cancer_might_be_linked_to_the_loss_of_hormone_dependence_that_frequently_arises_in_advanced_stages_of_thediseasedecreased_ligandmediated_receptorinternalizationand_degradation_consequently_enhancing_protein_stability': 9.148819220060914e-58, 'increase_epha2_amounts_in_malignantcells_an_interesting_consequence_of_epha2_stimulationby_ligand_or_antibodyis_epha2_phosphorylationinternalization_and_degradation': 9.148819220060914e-58, 'degradation_tyrosine_phosphorylation': 1.1686951820486561e-54, 'increase_epha2_amounts_in_malignantcells_an_interesting_consequence_of_epha2_stimulationby_ligand_or_antibodyis_epha2_phosphorylationinternalization_and_degradation_lowmolecularweight_protein_phosphataselmwptp': 8.263922883666513e-55, 'lowmolecularweight_protein_phosphataselmwptp': 8.263922883666513e-55, 'lmwptp_expressionfunctions': 0.0007008712380191807, 'contact_commonlyfound': 0.00210348072096923, 'to_silence_epha2_in_human_cancer_cells_forexamplein_pancreatic_adenocarcinomaderived_cellssequencespecific_sirna_targeting_epha2_suppressesepha2_expression_retarding_tumor_growth_in_a_nudemouse_xenograft_model_  _in': 0.00010049604554307965, 'treatment_withepha2specific_sirna': 9.148819220060914e-58, 'malignancyin_glioma_nonsmall_cancer_nsclc_cancer_cells': 9.148819220060914e-58, 'epha2_tool_to_silence_epha2_in_human_cancer_cells_forexamplein_pancreatic_adenocarcinomaderived_cellssequencespecific_sirna_targeting_epha2_suppressesepha2_expression_retarding_tumor_growth_in_a_nudemouse_xenograft_model_  _in_malignancyin_glioma_nonsmall_cancer_nsclc_cancer_cells': 0.00029922026888170244, 'signal_dosing': 9.148819220060914e-58, 'safety_profile_promoteepha2_phosphorylation_degradation': 9.148819220060914e-58, 'featuresincludingephrin_a1': 9.148819220060914e-58, 'to_be_present_at_lowlevels_and_to_possess_tumor_suppressing_propertiesdependent_on_celltocell_contact_in_a_variety_of_tumors_[_ _]': 9.148819220060914e-58, 'suppression_anddegradationinhibit_tumor_growth_cell_rounding': 0.00028705643099414104, 'growth_proliferation_migration': 0.00028705643099414104, 'ephrin_a1': 2.274211562945482e-53, 'suppression_growth_proliferation_migration_cell_migration_manner_treatment_phosphorylation_phosphorylation_degradation_anddegradationinhibit_tumor_growth_cell_rounding': 1.4055400435083287e-53, 'cell_migration_manner_treatment': 0.00028705643099414104, 'growthfactors_treatment': 0.0038806204677737646, 'phosphorylation_degradation': 0.00028705643099414104, 'cancerinhibit_epha2_phosphorylationunipr129prostate': 9.148819220060914e-58, 'cell_rounding': 9.148819220060914e-58, 'a1\\x93pe38qqrglioblastoma': 9.148819220060914e-58, 'epha2_cell_survival': 9.148819220060914e-58, 'a1fc': 7.734887039617307e-05, 'cellularmotility_invasion': 1.2616931633442395e-06, 'to_play_a_critical_role_in_ephrin_a1fcassociated_epha2_catabolism_as_the_proteasome_suppressor_mg132_markedlyephrin_a1fcinhibitsrelated_epha2_degradation_likewise_ephrin': 8.263922883666513e-55, 'epha2_cellularmotility_invasion_0cxiao_tumor_immunity_enhancementtumorremarkablycouldalterthe': 1.2620294243002733e-06, 'epha2_phosphorylation': 0.0004799652686769752, 'epha2_protein_expression': 7.828065355870542e-06, '0cxiao': 1.2616931633442395e-06, 'epha2_overexpression': 9.148819220060914e-58, 'activation_epha2': 9.148819220060914e-58, 'anantigen': 0.00010908077636851838, 'thatepha2': 9.148819220060914e-58, 'monoclonalantibody_antibodies': 9.148819220060914e-58, 'ofephrin_a1': 9.148819220060914e-58, 'to_function_similarly_as_theligandstudies_have_shown_that_several_agonist_monoclonalantibodies_raised_against_epha2': 9.148819220060914e-58, 'a375_adcc_killscells_fasl_adcc': 2.061957479495135e-08, 'ea12': 1.1934897546769733e-06, 'morethan': 7.312769272333255e-05, 'capabilityof': 9.148819220060914e-58, 'coffman': 9.148819220060914e-58, 'tosignificantly_decrease_breast_and_lung_cancer_cell': 4.460051732478561e-05, 'tumor_immunity_enhancementtumorremarkablycouldalterthe': 3.3626095603378463e-10, 'foradcc_enhancement_mouseimmunization_humanized': 1.1686951820486561e-54, 'to_partially_inhibit_ephrin_a1associatedepha2_phosphorylation_in_agreement_treatment': 8.263922883666513e-55, 'withds8895a': 0.0004815525391610832, 'withds8895a_inhibits_tumor_growth_in_epha2positive_human_breast_and_gastric_cancer_xenografts_in_mice_ _another_epha2_effectorenhanced_agonist_monoclonalantibody_that_exhibits_adcc_activity_is_3f23_m_ _m': 9.148819220060914e-58, 'blood_monocytes': 9.148819220060914e-58, 'adcc_activity': 0.004315547045054443, '3f2wt_andb233': 0.0038806204677737646, '\\x93250fold': 8.263922883666513e-55, 'model_molecules': 0.0011934694226017832, 'treatment_growth_t1_density_andgrowth': 1.9469802997255887e-05, 'signaling_by_suppressing_the_interactions_of_endogenous_ephrins_with_epha_receptors_epha2fc': 0.00012487824641690569, 'soluble_receptors_repressepha_signaling_by_suppressing_the_interactions_of_endogenous_ephrins_with_epha_receptors_epha2fc': 1.1686951820486561e-54, 'protein_chimera': 8.263922883666513e-55, 'ephareceptor_activation': 8.263922883666513e-55, 'epha2_receptor_phosphorylation_activity': 5.693645257646466e-06, 'epha2fc': 1.631311290230189e-10, 'density_andgrowth': 1.9469802997255887e-05, 'thatlca': 2.274211562945482e-53, 'lcawas': 9.148819220060914e-58, 'to_competitively_and_reversibly_inhibit_epha2ephrin_a1_binding_ki_  _Î¼m_without_reducing_epha2\\x99skinase_activity_  _further_functional_assays': 9.148819220060914e-58, 'cytotoxicitythe_specificity': 1.4055400435083287e-53, 'acid_conjugates': 9.148819220060914e-58, 'thereby_bluntingmalignancy_unipr126n3ahydroxy5bcholan24oylltryptophan_a_novel_antagonist_derived_from_lcainhibits_epha2_phosphorylation_and_angiogenesis_in_cultured_cells_in_the_low_micromolar_range_  ': 9.148819220060914e-58, 'a1': 9.148819220060914e-58, 'to_inhibit_ephrin_a1fcassociated_ _0cxiao_    _of_hematology_ _oncology_           _page_ _of_prostate_cancer_cell_cytotoxicity_and_angiogenesis_in_vitroin_addition_both_unipr129_and_unipr126_reduce_polygon_formation_but': 9.148819220060914e-58, 'unipr129_unipr126': 9.148819220060914e-58, 'polygon_formation': 9.148819220060914e-58, 'unipr126': 2.0434599303552044e-05, 'cytotoxicityin_huvecs': 9.148819220060914e-58, 'dehydrogenase_ldh_release': 9.148819220060914e-58, 'administration_ofunipr1331': 9.148819220060914e-58, 'to_inhibit_gbm_growth_and_to_extend_the_time_to_progression_in_a_subcutaneous_xenograftmodel_through_inhibition_of_angiogenesis': 9.148819220060914e-58, 'analogues': 0.0038806204677737646, 'cholanic_acid': 7.603914600168149e-07, 'epha2_activation': 0.00210348072096923, 'viadirect_binding': 2.9437146440738177e-05, 'lca_analogues': 2.9437146440738177e-05, 'gw4064_stilbenecarboxylic_acid': 9.148819220060914e-58, 'complex_ic50': 9.148819220060914e-58, 'ic50_blocks_²²1e4e3oxopenta14diene15diylbisfuran52diylbis2hydroxybenzoic_acid': 0.00018748912976206141, 'ephrin_interaction': 3.0560653326846443e-06, 'kinaseinhibitor': 3.0560653326846443e-06, 'dasatinib': 1.843021855196599e-05, 'candidate_4a': 9.148819220060914e-58, 'tofeature': 9.148819220060914e-58, 'danger_alarmin': 6.343042825359576e-05, 'extracellularhmgb1': 8.263922883666513e-55, 'sprouting': 0.0005215586792733971, 'cellmigration': 0.0010618659320081813, 'exerts_different_biologicaleffects_under_different_stimuli_the_deregulation_ofhmgb1_is_associated_with_many_diseases_especiallyinflammatory_disorders_and_cancerhmgb1_in_inflammationhmgb1': 0.0015842910551982499, 'disulfidebonded_hmgb1': 0.0003364176984007392, 'promotes_axonal_sprouting_and_neurite_growth_hmgb1_can_be_transferred_to_extracellularcontext_by_two_ways_active_secretion_from_immunocompetent_cells_or_passive_release_from_apoptotic_or_necrotic_cells_participating_inimmune_responsesin_contrasttreatment_biomarker_for_iri_when_initially_secreted_byinnate_immune_cells_like_macrophages_hmgb1_is_proinflammatory_during_the_early_stages_of_sepsis_howeverthe_extracellular_hmgb1': 9.148819220060914e-58, 'tolerance_immunosuppression': 9.148819220060914e-58, 'caninduce_protective_autophagy_contribute_hmgb1': 9.148819220060914e-58, 'inflammasome_pathway': 9.148819220060914e-58, 'macrophage_death': 9.148819220060914e-58, 'hyperactivity_immunosuppression': 9.148819220060914e-58, 'acytokine': 9.148819220060914e-58, 'acidga': 9.148819220060914e-58, 'cytokine_release_inflammation': 0.00032874997356751706, 'thatlps': 0.00021668009229506161, 'canbe_released_to_extracellular_context_by_necrotic_cellsunder_hypoxia_in_growing_solid_tumor_extracellularhmgb1': 0.0023537734198894804, 'invasion_nucleusand_cytoplasmic_hmgb1': 0.0038806204677737646, '0cwang_zhang': 3.841238207806274e-05, 'assists_leads': 9.148819220060914e-58, 'thattargeting_chromosomal_architectural': 9.148819220060914e-58, 'may_provide_a_new_perspective_for_cancer_therapy_  _hmgb1located_in_the_cytosol_or_mitochondria': 9.148819220060914e-58, 'genes_hmgb1_functions': 9.148819220060914e-58, 'to_be_studied_whether_hmgb1interacts_with_other_tumor_suppressors_or': 0.00210348072096923, 'enhances_chemotherapy_efficacyby_transforming_tumor_cells_from_apoptosis_to_senescence_  _in_addition_hmgb1': 0.0002812359218822401, 'enhances_chemotherapy_efficacyby_transforming_tumor_cells_from_apoptosis_to_senescence_  _in_addition_hmgb1_can_mediate_immunogenic_cell_death_during_chemoradiotherapy_and_enhanceantitumor_immunity_in_response_to_chemotherapy_likeanthracycline_or_radiotherapy_hmgb1_can_be_rapidlyreleased_from_dead_cells_as_an_alarming_molecule_uponrelease_from_necrotic_cells_or_secreted_by_activated_macrophages_hmgb1': 1.1686951820486561e-54, 'cells_andmediate_interactions': 8.263922883666513e-55, 'cell_death_macrophages': 4.588909556213936e-06, 'cart_cells': 9.148819220060914e-58, 'hmgb1': 9.148819220060914e-58, 'potentialcombination_strategy': 8.263922883666513e-55, 'majorrole': 0.004315547045054443, 'roles_isinvolved': 0.0016480626375926124, 'developmentabbreviationshmgb1': 0.000181640406390718, 'group_box': 0.00781909453522834, 'factor_both': 2.964162307655337e-06, 'sw': 1.4610345458823014e-05, 'research_developmentprogram': 1.5295883694429703e-05, 'center_cancer_center_laboratory_biotherapy_zhengzhou': 0.0013882295497307361, 'chinareceived': 9.148819220060914e-58, 'august_referencesgoodwin_group': 9.148819220060914e-58, 'piperi_c_ishaikh_mf': 0.0015842910551982499, 'ininflammation': 9.148819220060914e-58, 'box_isdispensable_cells_infiltration_andersson_kj_hmgb1': 9.148819220060914e-58, 'al_glycyrrhetinic_acid': 9.148819220060914e-58, 'hepaticinflammation_injury': 9.148819220060914e-58, 'k_al_biomarkers': 0.0004734482721133418, 'viability_prolif\\x91eration': 0.007713134335009549, 'growth_serumresults': 0.004315547045054443, 'cannabidiol': 0.00174418175614197, 'deprivation': 0.0011125787591309202, 'eastman_serum': 9.148819220060914e-58, 'cells_link': 9.148819220060914e-58, 'viability_response': 0.007713134335009549, 'notes_page_a0methodsmaterialscbd': 9.148819220060914e-58, 'pharma_ag_switzerland_mccoy\\x99s': 9.148819220060914e-58, 'ab_invitrogen': 9.148819220060914e-58, 'l15_medium_l15_rpmi': 9.148819220060914e-58, 'sigmaaldrich_spain_paclitaxel': 7.534206901224172e-07, 'miguel_catalan_institute': 4.6150522381402075e-05, 'cbd': 0.0028272407430970656, 'del_llobregat_spain': 0.00015460373435595556, 'fcs_brdu_incorporation_using_using_ibm_spss_statistics_ _and_real_statistics_using': 0.00027936278310176986, 'fcs': 0.0011125787591309202, 'viability_a0proliferation_reduction': 0.0003733542770154514, 'ab': 0.007713134335009549, 'brdu': 0.007713134335009549, 'emits': 0.0001559963661892288, 'dna_dapi': 9.148819220060914e-58, 'cell_membranes': 9.148819220060914e-58, 'using_ibm_spss_statistics_ _and_real_statistics_using': 9.869508692533099e-07, 'excelwe': 9.148819220060914e-58, 'shapiro\\x93wilk_test': 9.148819220060914e-58, 'dunn_test': 0.007713134335009549, 'differencesresultsviability_a0proliferation': 0.0003022165162482692, '\\x89_a0_µm': 0.0007008712380191807, 'µm_cbd': 0.0013883672604380038, 'notes_page_ht\\x91_cells': 8.263922883666513e-55, 'incubation_p_viability_a0proliferation_viability_fig': 1.1686951820486561e-54, 'h_cell_viability': 0.00013356700656843865, 'mean_sd': 8.263922883666513e-55, 'bar_ht\\x91_cell_viability': 4.500247464149217e-06, 'ht\\x91_cells': 6.978293448298126e-05, 'p_viability_a0proliferation': 0.0011125787591309202, 'viability_fig': 0.00017229022923166394, 'viability_viability_differencesviability_a0proliferation_trend_a03c_dna_replication_fig_a03b': 0.0007080023910910008, 'to_find_whether_in_ _these_ _conditions_ _cbd_ _could_ _show_ _additive_ _or_ _synergistic_antiproliferative_effects_with_the_therapeutic_drug_paclitaxel_ _paclitaxel_ ': 0.007713134335009549, 'wst1': 0.0002618838152087058, 'paclitaxel': 6.33966136568193e-05, 'differencesviability_a0proliferation': 6.918627002654179e-05, 'cell_line_ags': 0.007841328814772971, 'a0_nm_paclitaxel': 0.007715942528612832, 'trend_a03c': 0.0007080023910910008, 'dna_replication': 2.265511779381847e-05, 'sw480': 7.577406784029517e-05, 'fig_a03b': 1.2370933772211745e-06, 'notes_page': 1.1686951820486561e-54, 'differences_sw480_ags': 8.263922883666513e-55, 'resultsin_summary': 0.001129870936471824, 'viability_study': 4.613822797385231e-05, 'cells_cbd': 0.00012630877451023521, 'concentrations_ht29_cells': 0.0002337533695104565, 'to_have_opposing_effects_on_cells': 0.0003802249829989744, 'cells_concentration': 8.263922883666513e-55, 'to_fig_  _ht\\x91_cells_were_incubated_for_ _days_with_ _fcs_and_different_concentrations_of_cbd_in_absence_or_presence_of_ _nm': 0.00210348072096923, 'sd': 0.0012942301868915818, 'mean_sd_sw480_assays': 9.148819220060914e-58, 'b_d': 9.148819220060914e-58, 'p_0csainz\\x91cort': 2.1123616777643316e-05, 'to_be_altered_during_drug_exposition_  _in_any_case_ ': 7.612082755476774e-05, 'serum_concentrations_serum_concentrations': 8.009977540950587e-05, 'which_ _increases_ _tumor_ _growth_ _and_ _may_ _modulate_ _the_therapeutic_effect_of_a_drug_in_tumors_that_are_highly_glycolytic_increasing_mitochondrial_activity_as_exerted_by_cbd': 0.0002821774092107797, 'growth_factors_nutrients_differences': 9.148819220060914e-58, 'viability_proliferation_differentiation': 9.148819220060914e-58, 'cbd_\\x93': 0.0012687603899168784, 'calf_serumacknowledgementswe': 0.00033305571318101307, 'to_thank_manuel_reina_for_his_expert_adviceauthors\\x99': 5.431795103367436e-06, 'contributionsschibano_pharma_ag': 8.876422456126361e-08, 'to_thank_manuel_reina_for_his_expert_adviceauthors\\x99_study_data_cm_experiments_work_august_references_\\x93_doi101016jtreca_n201905004_brand_singer_kolitzus_g_thiel': 5.433242320745603e-06, 'ee': 0.0022294978478326526, 'data_cm': 5.431795103367436e-06, 'barcelona_spain': 6.9615502053815656e-06, 'barcelona_spain_schibano_pharma_ag_gh_medicalavailability_andor': 0.0002681396639881138, 'schibano_pharma_ag_gh_medicalavailability': 6.9615502053815656e-06, 'august_references_\\x93_doi101016jtreca_n201905004_brand_singer_kolitzus_g_thiel': 5.431795103367436e-06, 'tumor_immunosur\\x91veillance_doi101016jcmet201608011eastman_t': 8.059768518230455e-08, 'drug_development': 9.148819220060914e-58, 'oncotarget_\\x93_https': 9.148819220060914e-58, 'j_cornnell': 9.148819220060914e-58, 'ibrahim\\x91hashim_st\\x91pierre_p_attenuation_link': 9.148819220060914e-58, 'rj_acidity': 0.00017271852372335994, 'waldman_d_gallily_r_mechoulam_r_toren': 0.0004499048194399722, 'dt_lee_s': 9.148819220060914e-58, 'kim_h_kim': 9.148819220060914e-58, 'oh_sc_lee_d\\x91h_apoptosis': 0.0006940543140455221, 'p_zeyland_r_nowak_perspectives_\\x93_https_massi_p_cinquina_monti_e_rubino_t_d_cannabidiol': 0.0004499048194399722, 'mitochondria': 0.003909079524435469, 'calcium_homeostasis': 0.0004499048194399722, 'cannabinoid_compound': 9.148819220060914e-58, 'g_glioma_cells': 9.148819220060914e-58, 'resection_feasibility_safety': 0.000347488144371561, 'italypaolo_delrio_delriopaologmailcom_ _colorectal_surgical_abdominal_oncology_department_istituto_nazionale_per_a0lo_studio_e_la_cura_dei_tumori_\\x9cfondazione_giovanni_pascale\\x9d_irccs_via_mariano_semmola_  ': 0.0004499048194399722, 'delriopaologmailcom_oncology_department': 8.263922883666513e-55, 'nazionale': 1.1686951820486561e-54, 'italy_surgery_department': 8.263922883666513e-55, 'safety_advantage': 0.0007956673215405282, 'feasibility_safety': 0.007713134335009549, 'ctt3n0_swab_test_versatility': 1.1075167429453585e-05, 'ctt3n0': 1.1075167429453585e-05, 'swab_test': 0.00012198022841850962, 'to_perform_a_synchronous_robotic_right_hemicolectomy_and_partial_gastrectomy_with_d2_lymphadenectomy_using_the_intuitive_da_vinci_ _xi_®_system_ ': 0.007713134335009549, 'vinci_xi_®': 1.9804990679599668e-07, 'sometimes_performing_surgical_procedures_in_two_different_abdominal_compartments': 9.148819220060914e-58, 'setup_positioning': 9.148819220060914e-58, 'to_find_a_single_positioning_of_the_trocars_suitable_for_both_the_submesocolic_and_the_supramesocolic_phases_with_only_two_dockings': 0.0005741125271172155, 'forceps': 3.6107002012997453e-05, 'instruments': 8.429954011098165e-07, 'scissors': 5.892037544880898e-07, 'using_the_veress_needle_and_mobilising_the_duodenum_and_the_posterior_side_of_the_stomach_using_the_gastrocolic_window_fig': 1.5531599005283642e-05, 'anastomosis_extraction': 2.5356707029510165e-07, 'pneumoperitoneum': 9.148819220060914e-58, 'using_the_veress_needle_and': 9.148819220060914e-58, 'port_placement': 2.5356707029510165e-07, 'trocars': 9.148819220060914e-58, 'trocar_0cupdates': 9.148819220060914e-58, 'antrum': 2.5356707029510165e-07, 'mobilising_the_duodenum_and_the_posterior_side_of_the_stomach_using_the_gastrocolic_window': 0.007713134335009549, 'mm_c_lymphadenectomy': 9.148819220060914e-58, '0c_updates': 9.148819220060914e-58, 'ligament_opening': 0.0005273737027551006, 'access_a0min_the_robotic_phase_ _a0min_the_open_phase_ _a0min_a0h_drinking_clear_fluids_on_postoperative_day_ _diet_diet_adenocarcinoma_dysplasiaintraepithelial_adenocarcinoma_recovery': 0.0007124445023952738, 'desufflation_dedocking_incision': 1.162341099327624e-05, 'anastomoses': 0.0043271704560477195, 'anastomosis_drain': 1.162341099327624e-05, 'dockings_time': 9.148819220060914e-58, 'a0min_the_robotic_phase_ _a0min_the_open_phase_ _a0min': 9.148819220060914e-58, 'drinking_clear_fluids_on_postoperative_day_ ': 0.0006324067207528349, 'diet_diet': 0.0006324067207528349, 'drain': 1.162341099327624e-05, 'histopathology_report': 5.49432397874446e-05, 'edition_lymph_nodes': 1.1626508102866915e-05, 'dysplasiaintraepithelial_adenocarcinoma': 1.8986535864158258e-07, 'recovery_vinci_xi_®': 0.0005741125271172155, 'incision': 0.004315547045054443, 'to_easily_reach_the_most_distant_points_of_the_surgical_dissection_indeed_the_operation_planning_time_and': 0.004315547045054443, 'safety_solution_disadvantages': 0.0038806204677737646, 'committee_approval': 0.0004100538998299479, 'to_obtain_permission_directly_from_the_copyright_holder_to_view_a_copy_of_this_licence_visit_httpcreat_iveco_mmons_licen': 0.00016902585554135613, 'delaney_cp': 9.148819220060914e-58, 'colectomies': 9.148819220060914e-58, 'spaziani': 0.00012613970685026185, '\\x93_httpjourn': 2.5226418651023156e-05, 'arch_surg_suh': 9.17886719819097e-05, 'carbone_f': 1.1686951820486561e-54, 'https_journ_impact': 8.263922883666513e-55, 'tekkis_p_kontovounisios_c': 8.263922883666513e-55, '\\x93_leview5420html_giuffrida_mc_marano_l_giraudo_g_barili_f_et_precision': 2.5226418651023156e-05, 'colectomy': 0.001129870936471824, 'note_springer_nature': 0.00018299232232298686, 'frequency_pattern': 7.723613244264731e-05, 'public_private': 7.31082106841838e-05, 'study_results': 9.148819220060914e-58, 'chisquare_testresults': 9.148819220060914e-58, 'participants_men_women': 7.31082106841838e-05, 'frequency_pattern_link': 0.0002924398759919755, 'exercises_orat': 0.0011075402231842013, 'regulation_use_allaspects': 3.925823753182075e-05, 'archives': 0.00025697230210688834, 'allaspects': 4.189845036686302e-06, 'transformedseveralthese_developmentshave': 6.410757410322498e-07, 'the_transition_from_hardcopyfilm_to_the_pacs_has_enabled_clinicians_to_readily_accessradiological_images_and_reports_at_any_time_or_placewhile_this_development': 7.417164383651313e-53, 'drawbackstoday_radiologists': 3.498062589628769e-06, 'effects_these': 9.148819220060914e-58, 'preventionand_management': 9.148819220060914e-58, 'amongindividuals': 0.0007862569594425692, 'studiesexamining': 0.0003646304627120289, 'using_the_questionpro_surveysoftware_seattle_wa_usa_in_our_study': 0.0002469065850070426, 'anonline_survey_format': 0.007713134335009549, 'anonymity_participants': 9.148819220060914e-58, 'to_assess_the_patternand_frequency_of_physical_exercises_and_their_effects_onworkrelated_musculoskeletal_symptoms_among_clinicalradiologists_including_residents_specialists_junior_staffand_consultants_staff_across_all_hospitals_academicpublic_and_private_in_the_major_cities_of_the_easternprovince_of_saudi_arabiarecruitment_of_participantswe_sent_a_personalized_message_with_a_link_to_the_onlinesurvey_to_each_of_radiology_residents_practicing_in_theeastern_province': 9.148819220060914e-58, 'usa_groupthe_link': 9.148819220060914e-58, 'associations_advent_link_days_thesurvey_forms': 9.148819220060914e-58, 'reminder_message': 0.00040934415372960003, 'latereach': 4.912481722715726e-07, 'duplicate': 7.31082106841838e-05, 'respondent_assurance_feature': 0.007713134335009549, 'contactinformation_investigators': 9.148819220060914e-58, 'departments': 9.148819220060914e-58, 'days_thesurvey_forms': 5.946880567293046e-06, 'group_sex_years_institutionof_practice_type': 0.0005536611936400708, 'inany': 2.2243029850918108e-07, 'musculoskeletalquestionnaire': 2.2515065738461363e-05, 'part_to_be_upper_activity_participants': 0.001380101324495264, '\\x9cno\\x9d': 0.0011075402231842013, 'using_ibm_spss_for_windows_version_ _ibm_corp_armonk_ny_usa': 0.0014616190772430405, 'questionnaire_forms': 0.00015955002081907, 'likerttype_scalefive_responses': 7.890401063967026e-06, 'to_examine_the_bivariate_relationship_between_the_exposure_and_outcome_variablesthe_level_of_statistical_significance_was_set_at_p_ _resultscharacteristics_of_the_participantsa_total_of_ _participants': 0.0004837495599503566, 'exercisesthere': 0.0005573368904834178, 'activity_participants': 0.0005573368904834178, 'participants_figure': 0.0002664871522256321, 'exercises': 0.001664877113667619, 'symptomsoverall_participants': 9.148819220060914e-58, 'having_symptoms_within_the_last_ _months_prior_to_the_study_thesefig_ _frequency_of_physical_exercises_among_genders_and_different_age_groups_0cgadeeb_  _archives_of_public_health_            _page_ _of_fig_ _the_pattern_of_physical_exercises_among_genders_and_different_age_groupstable_ _frequency_of_physical_exercise_according_to_the_participants\\x99_characteristicsvariableat': 9.148819220060914e-58, 'exercise_monthlynat': 0.0005573368904834178, 'min_day_days': 0.0004120011889880495, 'to_shoulderpain_more_specifically_ _of_participants_who_did_notdo_physical_exercises_regularly_suffered_from_disablingshoulder_pain': 0.00210348072096923, 'similarfindings': 0.0018006682651940404, 'durationrequired': 0.00021933251206688955, 'toprevent_the_negative_health_effects_of_prolonged_sitting_time': 0.0007956673215405282, 'ms_methodology_mk_writingreview_editing_dg': 5.883089155027185e-05, 'participantseither': 7.31082106841838e-05, 'saudi': 0.0013882295497307361, 'aj_larson_db': 9.148819220060914e-58, 'efficiency_radiol': 9.148819220060914e-58, 'cancer_societyguidelines_risk': 9.148819220060914e-58, 'clin_\\x93proper_ki_singh_health_outcomes_review': 9.148819220060914e-58, 'reis_rs_kohl_prevalence': 0.0008581749454218445, 'ts_theassociation': 9.148819220060914e-58, 'pf_gervais_d_zalis_multicenter_study': 9.148819220060914e-58, 'hsu_hc_sd_gender_differences': 9.148819220060914e-58, 'tack_c_exercise_therapy_disorders_workstation_use': 9.148819220060914e-58, 'eur_spine': 0.0003342986407258492, 'treatmentlandscape': 0.0038806204677737646, 'blockade_therapy': 9.823752575177217e-05, 'minority_ofpatients': 9.148819220060914e-58, 'to_experience_a_positive_response_to_pd1pdl1_blockade_therapy_and_the_primary_oracquired_resistance': 9.148819220060914e-58, 'therapy_resistance': 0.007713134335009549, 'to_address_the_limitation': 0.00018738920974274527, 'decade_cancer_immunotherapy': 9.148819220060914e-58, 'treatment_landscape_success': 9.148819220060914e-58, 'pd1pdl1': 0.0006940543140455221, 'hodgkin\\x99s': 3.7540980587151276e-05, 'to_experience_apositive_response_to_pd1pdl1_blockade_therapy[\\x93': 5.614351368108052e-06, 'overview_mechanisms': 0.007713134335009549, 'predictivefactors': 0.007713134335009549, 'whichwould': 0.0002712952666904031, 'blockadehas': 6.35171993277174e-05, 'antipd1therapy': 9.148819220060914e-58, 'outcomes_forpatients': 9.148819220060914e-58, 'response_i_trial': 0.0010298344840079976, 'response_factorshave': 9.148819220060914e-58, 'to_be_involved_in_the_efficacy_ofpd1pdl1_blockade_therapy_such_as_tumor_immunogenicity_t_celltumormicroenvironment': 9.148819220060914e-58, 'recognition_ability': 0.0002321359877387567, 'response_tumor_mutationburden': 0.0006750162805663558, 'response_rates_antigen_presentationand_activity_checkpoints_inhibitorypathways_to_upregulate_tim3_expression_which_inhibitedt_cells_activation_importance': 0.003458212861263415, 'mutation_burdenantipd1_therapy': 9.148819220060914e-58, 'rate_survival_outcome': 9.148819220060914e-58, 'yarchoan': 3.351090697688998e-05, 'therapy_mmr_deficiency': 9.148819220060914e-58, 'to_improve_their_survival_outcomes_nevertheless_in_pancreatic_cancer_patients_harboring_an_mmr_deficiency_they_appear_to_be': 9.148819220060914e-58, 'rate_whichcould': 9.148819220060914e-58, 'bythe_system': 9.148819220060914e-58, 'hla1_moleculewhose_mutation': 9.148819220060914e-58, 'antigen_presentationand': 9.148819220060914e-58, 'zaretsky': 9.148819220060914e-58, 'biopsy_samples': 9.148819220060914e-58, 'truncating_mutation': 0.0013882295497307361, 'b2_m_gene': 0.0013882295497307361, 'activity_checkpoints': 0.0018006682651940404, 'inhibitorypathways': 0.0018006682651940404, 'to_upregulate_tim3_expression_which_inhibitedt_cells_activation': 0.0004024603399562249, 'pdl1physiologicallyinteractions': 0.0005812897872908514, 'patternson_tumor_cells': 3.8897633413564496e-05, 'barrier_pdl1': 0.0038806204677737646, 't_cells_t_cells': 0.0038806204677737646, 'pdl1_gene': 6.152388811539577e-05, 'atezolizumab': 9.148819220060914e-58, 'response_rate_andof': 9.148819220060914e-58, 'vagueresponsenoncoding': 0.0008878386227483478, 'blockade_therapy_huber': 0.000256262754619601, 'thatthese_mirnas': 0.0004714212406436195, 'lncrnadependent_antigenicity_downregulationsuppression_breast_cancer_resistantto': 2.5873580930035818e-05, 'therapythey': 9.148819220060914e-58, 'linkalevels_components': 9.148819220060914e-58, 'linkalevels_components_toreduce_aggravate': 0.002193898052006178, 'linka_expressioncould': 9.148819220060914e-58, 'kinase_phosphorylation': 9.148819220060914e-58, 'receptor_pathways_linka': 1.0105145629254031e-05, 'theinfluence_response': 0.0018006682651940404, 'melanoma_mice': 0.0006750162805663558, 'toreduce_aggravate': 0.00020207254642467623, 'benefit_survival': 0.00013545084440826256, 'taxaor_gut_microbiome': 0.0015842910551982499, 'whether_a_specific_bacterial_taxaor_gut_microbiome_as_a_whole_plays_a_primary_role': 3.579631038830067e-05, 'events_costof_checkpoint_inhibitor_agents': 0.00031585793432508617, 'mutation_burdenpredictive_microbiomegut_microbiomegut_pdl1_testing': 3.7000762273735723e-07, 'response_thatpdl1_expression': 2.267922389263252e-05, 'cytokine_recruitment': 0.0038806204677737646, 'pdl1_expression_status': 0.0006750162805663558, 'thatpdl1_expression': 0.00210348072096923, 'associatedwith_therapy_response_recognitionantigen_recognition': 0.0015842910551982499, 'therapy_mandal': 8.263922883666513e-55, 'to_pd1_blockadetherapy_in_mmrdeficiency_tumors': 1.1686951820486561e-54, 'responsedegree': 8.263922883666513e-55, 'association_mutation_burden_response': 0.0018006682651940404, 'mariathasan': 0.0006031843797531792, 'highneoantigen_mutation_burden': 9.839619407107218e-06, 'multiplicity': 0.001845170519318405, 'moreovermatson': 9.148819220060914e-58, 'baseline_stool': 9.148819220060914e-58, 'to_validate_the_predictive_value_of_gut_microbiome_in_largercohorts_and_explore_their_efficiency_in_the_context_ofvarious_types_of_tumorsstrategies_problem': 0.0018006682651940404, 'to_validate_the_predictive_value_of_gut_microbiome_in_largercohorts_and_explore_their_efficiency_in_the_context_ofvarious_types_of_tumorsstrategies': 0.0018006682651940404, 'furtherapplication': 0.0038806204677737646, 'substantialeffort': 9.148819220060914e-58, 'multiplefactors_strategies': 9.148819220060914e-58, 'coadministration_tgfÎ²blockingagents': 3.4350859337071076e-08, 'immunityand_tumor_regression': 5.59178246236998e-10, 'tool_ans': 2.628715582734087e-05, 'efficiency_toxicity': 0.0001438653184561452, 'forexamplein_gastric_cancer_cells_blockadeconjugated_nanops': 9.148819220060914e-58, 'to_significantlyhigher_cellular_uptake_and_achieved_more_effective_inhibition_of_pdl1_expression_compared_with_the_controlgroups_  _moreover_in_patients_with_metastatic_triplenegative_breast_cancer_the_coadministration_of_nabpaclitaxelatezolizumabprolonged_progressionfree_survival_  ': 9.148819220060914e-58, '[_]_metformin_  _antivegf_agents_ _or_otherinhibitors_egcxcr4_  _has_been_demonstrated_as_a_clinicallyfeasible_strategy_with_improved_antitumor_efficacyand_reduced_toxicityimmune_checkpointinhibitor_agentspd1pdl1_blockade_usually_acts_on_the_whole_hostimmune_system_instead_ofsitespecifically_targetingtumorspecific_immune_cells_while_nanomedicine_technology_provides_a_powerful_tool_to_selectively_deliverimmune_checkpointto_tumors_orlymphoid_ans_using_drugloaded_nanops_usually_ _to_ _nm_in_diameter_  _recent_studies_suggest_that_the_pd1pdl1_antibody_could_be_conjugatedor_modified_on_the_surface_of_nanops_which_couldmaintain_their_stability_enhance_efficiency_and_minimizethe_toxicity_of_pd1pdl1_blockade_[_ _]_forexamplein_gastric_cancer_cells_the_pdl1_blockadeconjugated_nanops_contributed_to_significantlyhigher_cellular_uptake_and_achieved_more_effective_inhibition_of_pdl1_expression_compared_with_the_controlgroups_  _moreover_in_patients_with_metastatic_triplenegative_breast_cancer_the_coadministration_of_nabpaclitaxelatezolizumabprolonged_progressionfree_survival_  _owing_to_thesuccess_in_previous_research_  _clinical_trials_on_nanoimmunotherapysuch_asnct03589339_and_nct03684785_these_clinical_trialsshould_provide_substantial_evidence_for_the_combinationof_nanomedicine_and_pd1pdl1_blockade_in_the_nextfew_yearscurrently_underwayblockadepdl1plusarethe_manipulation_offurthermore_accumulating_evidence': 0.000844571058666313, 'progression_application': 1.377899880977228e-05, 'trialsshould': 9.148819220060914e-58, 'evidence_manipulation_offurthermore': 9.148819220060914e-58, 'theefficacy_response': 4.377951526189869e-06, 'toimprove': 0.0010071448933776737, 'controlaugment_cell_responses': 1.6435761703528167e-05, 'manipulation_andso_forthin': 0.0005411681930881713, 'to_exhibit_apositive_response_to_pd1pdl1_blockade_therapy_andthe_primaryacquired_resistance': 0.0005411681930881713, 'thedeterminants': 0.001845170519318405, 'xz': 9.148819220060914e-58, 'patel_applications_challengescancer_lett_\\x93andrews': 9.148819220060914e-58, 'research_developmentprojects': 6.9615502053815656e-06, 'appendectomy': 0.0006703486585587848, 'pain_ct_examination_aa_return': 2.1641039581413432e-05, 'aa_cases': 0.007713134335009549, 'laparoscopic_ia': 0.00012198022841850962, 'uc': 8.937521195812353e-05, 'duringsymptoms': 1.4993111492271457e-05, 'ct_examination_aa': 0.00014019350569404642, 'metastaticlesions': 3.5346595111705855e-07, 'interval_appendectomy': 0.0009953553257027916, 'operation_mostlyla': 0.00014575791264397625, 'aamay': 2.3783686056370902e-06, 'cases_man': 0.007713134335009549, 'cecum_blindend_structure_1a': 1.4993111492271457e-05, 'withfig_ct_findings': 0.00012198022841850962, 'appendix': 1.1686951820486561e-54, 'intraabdominalabscesses_arrow_heads': 8.263922883666513e-55, 'cecum_arrow': 0.0001342199430812954, 'findings_fig_1b': 0.0038806204677737646, 'laparoscopic': 0.00771518910792271, 'iliocecalstructures': 1.8167818297264612e-05, '2a_b': 0.0011131718807915394, 'rightlower_pain': 1.0725230201050377e-05, 'swollenon': 8.263922883666513e-55, 'symptomsendoscopy_examination': 0.0038806204677737646, 'pain_he': 3.867207086498569e-06, 'andhe': 4.942895482099519e-05, 'operation_thepathologicalfindings': 9.148819220060914e-58, 'cell_infiltration_characteristics': 9.148819220060914e-58, 'lymphoma_therapy': 0.0006683740194778514, '3bshe': 1.247090053228339e-05, 'ileocolectomy': 0.0007643384077950606, 'genotype_analyses': 0.0002812637223256724, 'fingings_ct': 9.148819220060914e-58, 'onevery_colonoscopic_findings': 9.148819220060914e-58, 'cells_infiltration_crypt_distortion': 0.00029922026888170244, 'arrow_heads_course': 1.4993111492271457e-05, 'interval_operation': 8.770946583746331e-05, 'chemotherapy_bevacizumab': 0.00011303284306354076, 'node_swelling': 5.766447963763384e-09, 'cases_reportssuggested': 0.007713134335009549, 'to_be_a_very_effective_therapeutic_choice_sofar_there_have_been_case_reports_with_a_single_case_regarding_the_efficacy_of_ia_the_current_manuscript': 0.0038806204677737646, 'massia': 0.00017949953710900678, 'admission\\x94one_lot': 0.00045085371770963703, 'complicationsand': 9.148819220060914e-58, 'recovery_shortlength': 9.148819220060914e-58, 'manuscriptinterval_operation': 0.007713134335009549, 'to_induce_hisfast_recovery_and_short_length_of_hospital': 0.0002825778555366326, 'to_be_one_of_the_greatest_benefits_of_iarecent_several_reports': 0.0016480626375926124, 'to_become_milder_after_appendectomy': 0.0004968127217041802, 'improvements_to_ameliorate_his_uc_conditionthere_have_been_considerable_studies_on_appendicealadenocarcinoma_in_a_recent_report_about_primary_appendiceal_carcinomas_with_an_average_age_of_ _years_old': 3.867207086498569e-06, 'to_ameliorate_his_uc_conditionthere_have_been_considerable_studies_on_appendicealadenocarcinoma_in_a_recent_report_about_primary_appendiceal_carcinomas_with_an_average_age_of_ _years_old': 3.867207086498569e-06, 'strategies_induction': 9.148819220060914e-58, 'to_be_approximately_\\x93months_  _needless_to_say_appendectomy_can_be_performed_easily_once_the_inflammation_abates_the_interval': 9.148819220060914e-58, 'pains': 0.00012198022841850962, 'moreoverinterval_appendectomy': 9.148819220060914e-58, 'recovery_length': 9.148819220060914e-58, 'declaredauthors\\x99_contributionsyk_hu': 9.148819220060914e-58, 'manuscript_yk': 9.148819220060914e-58, 'yn': 0.00043975773664194475, 'yn_performed_the_surgery_and_etand_sk_participated_in_the_surgery_yk_kn_ta_yn_mi_and_hu': 9.148819220060914e-58, 'inthe_study_design_coordination': 9.148819220060914e-58, 'etand_sk': 0.00043975773664194475, 'kt': 9.148819220060914e-58, 'staining_anddiagnosed_findings_hu': 9.148819220060914e-58, 'yk': 3.707241871248117e-06, 'manuscriptfundingthis_manuscript': 0.0007959416758056306, 'externallyavailability': 0.0007641347695089468, 'indication_survival_ileocolectomy_recovery_length_manuscript_yk_inthe_study_design_coordination_staining_anddiagnosed_findings_hu_anization_externallyavailability_center_koga': 0.0012149884872185838, 'center_koga': 0.0007641347695089468, 'purves_h_muhlbaier_lh_peterson_ed': 0.00012613970685026185, 'how_to_treatit_ann_r_coll_surg_engl_\\x93oliak_d_yamini_d_udani_vm_lewis_rj_arnell_t_vargas_h_  _initialnonoperative_management_for_periappendiceal_abscess': 0.007713134335009549, 'mass_conservativemanagement_interval_appendicectomy': 0.00012198022841850962, 'clavulanic_acid_\\x93_andersson': 9.148819220060914e-58, 'review_metaanalysis_ann_surg': 9.148819220060914e-58, 'appendectomy_findingthe_breaking_point': 9.148819220060914e-58, 'swarbrick_et_coggon_inflammatorybowel_disease_hygiene': 9.148819220060914e-58, 'wl_che_cl': 9.148819220060914e-58, 'wing_yl': 9.148819220060914e-58, 'inhibiting_pp2a_activity_in_tumor_cells': 0.0005741125271172155, 'cellsto': 0.00030586813508869646, 'failto': 0.0011125787591309202, 'inhibiting_pp2a': 0.00014173375196033287, 'correspondence_baolinqu301163com_xiao_lei_page': 2.312885694674057e-06, 'lehui_du': 9.148819220060914e-58, 'correspondence_baolinqu301163com_xiao_lei_activities_page': 9.148819220060914e-58, 'to_control_the_specificityand_localization_of_pp2a': 0.004315547045054443, 'gene_thatis': 0.0003364176984007392, 'pp2a': 0.0008848564495252557, 'cmyc': 1.4435734101850744e-05, 'apoptoticcell_death_sensitivity': 0.00047983738574547787, 'frequency_ofcells': 0.00054686425127897, 'cdk1_activity': 1.4435734101850744e-05, 'to_bea_primary_regulator_of_normal_cdk1_functionality_in_thecontext_of_mitosis_  _pp2a': 1.4435734101850744e-05, 'phosphorylation_activation': 3.3505302163288014e-05, 'dna_dna_damage': 9.148819220060914e-58, 'cycle_arrest_dna_damage_repair': 9.148819220060914e-58, 'activation_irradiationassociateddna_damage': 0.004315547045054443, 'required': 0.00021573561443331572, 'g2_phase': 0.0011125787591309202, 'to_govern_the_proliferation_of_quiescent_cells_following_mitosis': 1.3388048598132364e-05, 'thatcells': 0.00038868156652095183, 'levels_arelow': 2.2575116453731374e-07, 'ecdk2_activity': 1.382713534027288e-05, 'anisms_pp2a': 9.148819220060914e-58, 'to_promote_cellular_quiescence_  _in_studies_of_drosophila_eyes_andwings_researchers_have_determined_that_inhibiting_pp2aat_the_end_of_the_cell_cycle_can_induce_additional_cell_division_and_thereby_impair_such_quiescence_in_these_drosophila_the_pp2a_subunit_b56_family_member_wdb_servesas_an_important_regulator_of_pp2arelated_cellular_quiescence': 9.148819220060914e-58, 'inhibiting_pp2aat_the_end_of_the_cell_cycle': 8.069045131624385e-07, 'quiescence_regulator': 1.3179002785193696e-08, 'driver_oftumor_radioresistance_recurrence': 0.00018327488191798982, 'to_promote_bcl2_dephosphorization_and_to_thereby_promoteapoptotic_cell_death': 1.4435734101850744e-05, 'dephosphorylateand': 9.148819220060914e-58, 'camkii': 9.148819220060914e-58, 'baxnoxapuma': 0.00210348072096923, 'to_drive_apoptotic_death': 0.00210348072096923, 'atmsignaling_pathway': 1.503755389504267e-05, 'pp2a_bax_expression_cycle_studies_consequentinhibition': 2.4557083605445735e-07, 'cycle_studies': 2.4557083605445735e-07, 'consequentinhibition': 2.4557083605445735e-07, 'family_coactivator_catenin': 0.0007168600187878925, 'translocation_gene_expression_complexcomposed_catenin': 6.298805075748078e-05, 'complexcomposed': 6.298805075748078e-05, 'synthesis_kinase': 6.298805075748078e-05, 'to_downregulate_wntcateninsignaling_pathway_activity_via_inhibiting_pp2a_  _positive_pp2a_feedback_signaling': 7.890105016352806e-05, 'acid_anthraquinone_thesecompounds': 4.9231639267014605e-06, 'pp2a_activitylb100_pretreatment': 0.00015813566720597306, 'irradiation_lb100': 0.0009468834503148087, 'lb100': 9.148819220060914e-58, 'to_effectivelyradiosensitize_pancreatic_cancer_cells_without_adverselyaffecting': 9.148819220060914e-58, 'to_prevent_radiationinduced_rad51_foci_formation_and_homologous_recombination_repair_thereby_causing_sustaineddna_damage_in_cells_following_radiation_exposure_ ': 0.00054686425127897, 'to_be_oneof_the_key_mechanisms_underlying_tumor_recurrence_andtherapeutic_resistance': 0.0005269923949341242, 'impact_effect_participatein_the_review_design_baolin_qu_and_declare_that_they_have_no_competing': 4.402440989329684e-05, 'receptor_protein_complex': 9.148819220060914e-58, 'steroidshormone_receptors_transcription_factors': 9.148819220060914e-58, 'to_control_transcription_in_the_context_of_glial_differentiation_  _cytokineinduced_ciliary_neurotrophicfactor_stimulation_of_glioma_precursor_cells': 0.004315547045054443, 'causing_undue_harm_to_healthy_tissues_atpresent': 0.0001923205957753865, 'inhibitorsbe': 0.0002080473013030996, 'clinicalapplications': 0.0011125787591309202, 'mechanisms_toachieve_atr_atm': 3.124384011828309e-05, 'manuscript_yanjieliang': 9.148819220060914e-58, 'perspective_part': 9.148819220060914e-58, 'yanan_han_pei_zhang': 9.148819220060914e-58, 'participatein_the_review_design_baolin_qu_and_declare_that_they_have_no_competing': 9.148819220060914e-58, 'baolin_qu': 0.0005450251520539939, 'j_wang_y_ji_h_peng_r_jin_l_wu_w': 9.148819220060914e-58, 'inrefunctionalization_medchem_httpsdoi1021741871520619666191018172926': 9.148819220060914e-58, 'claude_l': 9.148819220060914e-58, 'rgrier': 9.148819220060914e-58, 'mrandall_rl': 9.148819220060914e-58, 'le_teuff': 9.148819220060914e-58, 'blanco_j_targeting_stem_cells': 8.844917647139273e-06, 'tumorsupon_release': 0.004315547045054443, 'xu_l_thehistone_fact': 2.9912601168113406e-05, 'phosphatase_2a': 0.00020752443353944144, 'drugs_page': 5.756459558678552e-06, 'silence_bymicrorna429': 7.56175124625702e-05, 'cells_specificity_drivingcellular_functions_deregulation': 1.2335985376422886e-06, 'thirumoorthy_k_jr_litzenberg_ktpatel_d_chakravarti': 0.0007045501797710301, 'tumor_suppressor_stks': 1.1494944926594961e-05, 'nagy_interleukin2_formation_biol_chem': 9.148819220060914e-58, 'mekerk_pathway_rafindependent_activation_inresponse_commun_\\x93_raabe_t_rapp_ur_ras': 9.148819220060914e-58, 'ksr_raf': 1.4435734101850744e-05, 'rm_han_m': 4.840409146238793e-05, 'langerem_christensen_dj': 9.148819220060914e-58, 'rc_cancer_metabolism': 9.148819220060914e-58, 'i_gomez': 9.148819220060914e-58, 'gonzalez_uroncor_statement_management': 9.148819220060914e-58, 'sh': 9.148819220060914e-58, '\\x93_gharbiayachi_substrate': 9.148819220060914e-58, 'ml_greatwall': 0.0004254422540019666, 'la_oakley_gg_li_c_peng_subunits': 0.0004001752419276083, 'teixeira': 9.148819220060914e-58, 'surg_edinb': 9.148819220060914e-58, 'biol\\x93_biau_j_chautard_e_p_dutreix': 9.148819220060914e-58, 'dna_repair': 9.148819220060914e-58, 'bai_ww_zhu_sc_53bp1': 9.148819220060914e-58, 'arrest_cancer_model_pharmacol_sci_\\x93': 9.148819220060914e-58, 'm_cycle_arrest': 8.291120431059059e-05, 'kikuchi_k': 9.148819220060914e-58, 'biochem_biophys': 9.148819220060914e-58, 'withverthandirad21': 3.385857077415711e-06, 'protein_phosphatases_wdb_andy_cucurbitacin_b': 0.0010068765747081726, '201914e0214469lv_ma_j_wang_z_li': 0.0006940543140455221, 'centromere_localization_function': 3.385857077415711e-06, 'frasson_m': 0.0004499048194399722, 'set_augments_2a_pp2ainhibitor': 0.0011125787591309202, 'cx_iqbal_k_liu_fpathological_tau': 1.1686951820486561e-54, 'sitespecifichyperphosphorylation_sds': 8.263922883666513e-55, 'aggregationof_tau': 8.263922883666513e-55, 'forrest_dl': 9.148819220060914e-58, 'cj_morin_gbjiang_response': 9.148819220060914e-58, 'cancer_stemcells': 0.00054686425127897, 'kitamura_y': 9.148819220060914e-58, 'irradiationinduced_mdm2phosphorylation_role': 9.148819220060914e-58, 'histol_histopathol_\\x93': 9.148819220060914e-58, 'storey': 9.148819220060914e-58, 'a_specific_pp2a_regulatory_subunitb56gamma_mediates_dna_damageinduced_dephosphorylation_of_p53_atthr55_embo_j_\\x93jin_z_wallace_l_harper_sq_yang_j_pp2ab56_a_substrate_of_caspase3regulates_p53dependent_and_p53independent_apoptosis_duringdevelopment_j_biol_chem_\\x93_park_ds_yoon_gh_lee_hs_choi_sc_capsaicin': 9.148819220060914e-58, 'pathway_farkhondeh_t_samarghandian_focus': 9.148819220060914e-58, 'alcohol_abstinence': 0.0011075402231842013, 'bioinformatics_approach': 0.007713134335009549, 'dmf': 0.008513336490015283, 'factor_oxygen_species_liver_injury_variety': 0.0003167145330801072, 'ald': 0.0003208044612686651, 'alcoholabstinence_corticosteroid': 0.0011075402231842013, 'changsha_hunan_chinathese_authors': 9.148819220060914e-58, 'shuang_zhaoedited': 9.148819220060914e-58, 'to_begenerally_safe_in_humans_and_available_for_clinical_use7_itis_possible_to_identify_safe_drugs_with_potentialforrepurposing_in_other_conditions_by_using_computationalstrategies_which_can_eliminate_the_need_for_a_phase_isafety_trial_and_expedite_phase_ii_efï¬\\x81cacy_trials_analysis_ofinteractions_between_genes_and': 2.825114061257124e-05, 'drugsallow': 0.00040934415372960003, 'computationalapproach': 0.007713134335009549, 'nucleus_nrf2': 8.263922883666513e-55, 'mafk': 9.148819220060914e-58, 'tothe_antioxidant_response_element': 9.148819220060914e-58, 'to_have_a_therapeutic_associationwith_ald_was_determined_to_have_a_strong_therapeuticpotential_for_repositioning_in_ald_we_evaluated_the_efï¬\\x81cacy_of_dmf_for_ald_in_liver_cells_and_in_vivo_using_anethanolinduced_mouse_model_concordant_with_our_computational_prediction_the_experimental_results_demonstratethat_dmf_is_able_to_significantly_ameliorate_ethanolinducedliver_injury_compared_to_untreated_groupsresultscomputational_repositioning_of_fdaapproved_drugs_foraldto_identify_efï¬\\x81cient_therapeutic_strategies_for_patientswith_liver_diseases_we_downloaded_drug_datasets_thatcontain_both_clinical_application_and_animal_test_fromgene_expression_omnibus_wwwncbinlmnihgovgeogse_accession_number_gse28619_and_ _then_weused_a_bioinformatics_approach_to_testthe_drugrepositioning_potential_of_fdaapproved_drugs_for_aldfrom_this_approach_we_computed_the_activity_score_ofcandidate_drugs_and_compared_geneexpression_proï¬\\x81les_inresponse_to_these_drugs_in_ald': 0.0038806204677737646, 'theknown_gene_targets': 0.007713134335009549, 'to_study_one_of_the_ï¬\\x81ve_topscored_candidate_genes_nrf2_among_nrf2compound_interactionsthe_main_use_of_dmf': 0.007713134335009549, 'aldgeneexpression_signature': 0.00013916293669907366, 'to_develop_asecond_generation_of_nrf2_inducers_as_prodrugs12therefore_wefumarateregulationmechanism_of_nrf2_in_liver_disorders_the_generation_oftoxic_metabolites_by_ethanol_such_as_lipidperoxidationproducts_contributes_to_the_pathogenesis_of_alcoholic_liverinjury_fumarates': 0.0006026042973632392, 'ros_accumulation': 0.0006026042973632392, 'ald_mousemodel_group_hepatic_modelnine_rats_rats_rats': 0.007713134335009549, 'weeks_dmf': 9.148819220060914e-58, 'steatosis': 9.148819220060914e-58, 'gclc_proteinlevels': 0.007713134335009549, 'immunohistochemistry_ihc_blotting': 0.007713134335009549, 'dmf_mmf': 0.0009944874364490595, 'dmf_andmmf': 0.00014653077725592008, 'al_cell_death_disease_page': 0.0012717916134747302, 'c_dmf': 9.148819220060914e-58, 'hepatic': 9.148819220060914e-58, 'd_e_dmf': 2.0683829310335103e-06, 'endogenous_nrf2_andgclc': 0.00012697409590610125, 'hepg2': 0.00771518910792271, 'dmf_mmftreatment': 0.00024134924474519354, 'sample_loading': 0.007713134335009549, 'theexpression_protein_levels': 0.0007129960827382031, 'bmoreover_nrf2_knockdown_decreasedgclc_ho1_protein': 9.148819220060914e-58, 'treatment_fig_2d_fig': 9.148819220060914e-58, 'fumarates': 0.009210082694724314, 'nrf2_pathway': 0.001263119034046615, 'nrf2_nuclearlocalization_dmf_mmf': 0.00015054027491569484, 'fig2e': 9.148819220060914e-58, 'pannel_mmf_fig': 9.148819220060914e-58, 'accumulation_we': 6.33966136568193e-05, 'inhepg2_cells_data': 0.000762889468397268, 'fumaratesactivate_nrf2_promote': 3.3890437814951465e-07, 'ros_level': 2.0763811628764808e-05, 'potency_offumarates': 7.562265611368425e-06, 'glutathioneand_gssg': 0.007713134335009549, 'dmf_mmfinduced_anticanceragent': 0.00017433779082564105, 'accumulation_fig': 2.3877571575501082e-06, 'cmxros': 4.942501824099386e-05, 'peroxidation_andferroptosis': 0.001128162151175775, 'tolipid_peroxidation': 0.000327079770302999, 'toexamine_ferroptosis': 0.00015054027491569484, 'dox_ethanoltreatment': 0.00012624702427403175, 'content_fig': 2.056520048739751e-06, '0czhang': 1.3246313407357781e-05, 'nrf2_pathway_increases_protein_level': 2.0758279991089172e-05, 'lo2_cells': 4.548349481769721e-05, 'nrf2_pathway_increases_protein_level_bywestern_blotting_e_dmf_or_mmf_promotes_nrf2_nuclear_accumulation_after_treated_with_ _Î¼m_dmf_left_panel_or_mmf_right_pannel_for_ _hhepg2_or_lo2_cells_blotting': 0.00023383186937971735, 'd_nrf2_knockdown': 9.148819220060914e-58, 'gclc_protein_levels': 9.148819220060914e-58, 'ho1_protein_levels': 9.148819220060914e-58, 'bywestern_blotting_e_dmf_or_mmf_promotes_nrf2_nuclear_accumulation_after_treated_with_ _Î¼m_dmf_left_panel_or_mmf_right_pannel_for_ _hhepg2_or_lo2_cells': 9.148819220060914e-58, 'relativenrf2_intensity': 7.091762252655221e-06, 'decrease_restoration_ofnadph': 0.0004347496547523664, 'peroxidation_results': 0.0038806204677737646, 'arestoration': 0.007713134335009549, 'livercells_inducer': 0.007713134335009549, 'suggestinga_peroxidation_andferroptosis': 2.392246717972457e-05, 'liver_injury_ferroptosis': 0.00013916293669907366, 'blotting_ihc': 0.007713134335009549, 'dmf_treatment': 9.148819220060914e-58, 'lipidperoxidationinduced_ferroptosis': 9.148819220060914e-58, 'to_activatethe_nrf2_antioxidant_pathway': 0.00210348072096923, 'liver_injury30_thatfumarates': 0.0001642889666773429, 'redoxpotential': 2.0758279991089172e-05, 'ros_level_redoxpotential': 3.531226980776358e-05, 'microscope_bar': 0.0011125787591309202, 'ros_damage': 0.00015054027491569484, 'byï¬\\x82uorescence_bar_disease_viruses_ordrugs': 0.0015842910551982499, 'byï¬\\x82uorescence_microscope_bar_ _Î¼mliver_disease_nafld_and_hcc2_elevated_cellularstresses_which_are_induced_by_alcohol_hepatic_viruses_ordrugs_play_a_vital_role_in_the_initiation_and_progression_ofmultiple_liver_pathologies31\\x93_certain_stressed_conditions': 0.000327079770302999, 'nrf2_signalingpathway': 0.00015054027491569484, 'liverinjury': 0.00015054027491569484, 'lipidhydroperoxides': 0.004315547045054443, 'alcoholaversion_drug': 9.148819220060914e-58, 'attention_approach': 9.148819220060914e-58, 'to_infer_drug_therapiesfor_ald_and_offer_experimental_evidence_that_the_nrf2inducer_dmf_is_capable_of_ameliorating_disease_pathophysiology_in_the_ald_mouse_model_dmf': 0.00019235243919971532, 'sigmaaldrich_mmf_sigmaaldrich': 8.663644092618485e-07, 'd8740_anderasitin_selleck': 0.00015013584691760327, 'liver_cells': 0.008030314084977333, 'minand': 7.573369607860032e-05, 'lipid_peroxidation_ferroptosis_obviouslyreverse_dox': 2.0758279991089172e-05, 'legend_lipid_peroxidation_ferroptosis_obviouslyreverse_dox_peroxidation_±_sd': 2.9035734838038372e-05, 'Î¼m': 0.00019104215256849955, 'ns': 6.172943166471345e-05, 'lipidperoxidation_ferroptosis': 0.00015054027491569484, 'fumarates_cells': 1.8444548091260086e-05, 'gels_membranes': 0.0011301720283114149, 'gels': 0.001129870936471824, '1ap_dilution_actbÎ²actin_proteintech_205361ap': 9.148819220060914e-58, 'interferenceknocking': 9.148819220060914e-58, 'bovineserum': 0.0038806204677737646, 'p_ns': 2.1123616777643316e-05, 'repeatsmeasurement': 0.0014616190772430405, 'erasitin_orliver_cells': 0.00013127857090320673, 'staininghepg2_cells': 0.00029599327620783605, 'ethanolinducedferroptosis_mice': 9.148819220060914e-58, 'liquid_gkg_maltodextrin_control_gavageand_sacriï¬\\x81ced_ferrostatin1_mgkg_min': 9.148819220060914e-58, 'liquid_gkg_maltodextrin_control_gavageand_sacriï¬\\x81ced_ferrostatin1_mgkg': 0.0005411681930881713, 'erastin_mgkg': 2.179150599615875e-05, 'dner': 0.011848467123284313, 'addition_dner': 2.7446560661786228e-05, 'cell_emt': 0.0016815001133323047, 'bc_cells_lipofectamine3000_invitrogen_usa_invitrogen_usa': 0.0001935859600922882, 'bc_cells_link_°_c_chemotherapy_radiotherapy_research_committee_ofrenmin_hospital_frompï¬\\x81zer_pharmaceutical_ltd_wuxi_china_lipofectamine3000_invitrogen_usa_invitrogen_usa': 0.0001935859600922882, 'emt': 0.0095239722193556, 'thatdner_functions': 0.0001935859600922882, 'one_bc_treatments': 8.263922883666513e-55, 'china2department': 3.571454876601469e-05, 'andtumour_progressiondner_transmembrane_protein': 0.0003208044612686651, 'regulation_use_proliferationmigration_invasion_effect_function_molecularmechanisms': 3.622598338048949e-05, 'effect_function_molecularmechanisms': 3.622598338048949e-05, 'value_roleof': 0.007713134335009549, 'chemotherapy_radiotherapy_research': 0.001845170519318405, 'committee_ofrenmin_hospital': 0.0001935859600922882, 'frompï¬\\x81zer_pharmaceutical_ltd_wuxi_china': 0.0001935859600922882, 'dojindo_japansolution': 2.803436973455439e-05, 'tumour_tissues': 0.0017179439491406777, 'described18the_results': 0.00032990662253897467, 'intensitythe_percentage': 5.5659790765967056e-06, 'attractant': 0.00031995314978350303, 'byprotein_sdspage': 0.0011132094121326075, 'to_detect_apoptosisa_fitc_annexin_v_apoptosis_detection_kit_i_ _bdpharmingen_usa_was_used_to_detect_cell_apoptosis_the_cellswere_seeded_in_sixwell_plates': 0.000494595879613311, 'i_bdpharmingen_usa': 9.148819220060914e-58, 'to_detect_cell_apoptosis_the_cellswere_seeded_in_sixwell_plates': 9.148819220060914e-58, 'dner_protein_expression': 0.00771518910792271, 'rfs_staining_cell_death_disease_page_cell': 0.00012613970685026185, 'sacriï¬\\x81ced': 5.649484193499694e-49, 'blotting_ihcfor_mammaryfatpad_tumour_assays_mice': 9.682361859077337e-49, 'blotting_ihcfor_mammaryfatpad_tumour_assays': 2.2503500924571362e-49, 'todetermine_presence': 0.00012198022841850962, 'tritonx': 0.0011125787591309202, 'microscopy_analysisstatisticalspss_software_spss_inc_chicago_il_graphpadanalyses': 9.148819220060914e-58, 'highn_p_valueage': 9.148819220060914e-58, 'ca_usa': 1.4055400435083287e-53, 'kaplan\\x93meier_analysis_test': 2.274211562945482e-53, 'invasionnegativepositiveki67': 9.148819220060914e-58, 'to_analyze_associationsbetween_dner_expression_levels_and_clinical_characteristics': 9.148819220060914e-58, 'to_compare_differencesin': 5.9918233568583966e-05, 'breast_tissue_expression_level': 0.0015842910551982499, 'tissues_dner_expression': 9.780176389835546e-07, 'dner_markers_resultsshowed': 0.007713134335009549, 'dner_expression': 0.0028092143039891862, 'fig_2d': 0.007713134335009549, 'ecadherin_dner_it': 9.148819220060914e-58, 'trend_2a': 9.148819220060914e-58, 'to_evaluate_cell_migration_capacitycompared_with_wound_closure_in_the_scramble_sirnagroup_dner_knockdown': 7.417164383651313e-53, 'transfection_to_determine_themigratory_ability_of_bc_cells_with_dner_knockdown_e_the_invasion_capacity_of_bc_cells_with_knockdown_of_dner_was_conï¬\\x81rmed_by_transwell_assaydown_quantitative_analysis_of_invasion_ratio': 1.4762964828946743e-05, 'knockdown_cells_cell_growth': 4.4686003626753065e-06, 'to_determine_themigratory_ability_of_bc_cells_with_dner_knockdown_e_the_invasion_capacity_of_bc_cells_with_knockdown_of_dner_was_conï¬\\x81rmed_by_transwell_assaydown_quantitative_analysis_of_invasion_ratio': 6.429301432373159e-05, 'that_dner_plays_a_crucial_role_inbc_growth_and_metastatic_potentialdner_induces_emt_in_bc_cellstumour_cell_emt': 0.00023078931020485309, 'inbc_growth_potentialdner': 0.00015553141995844084, 'proteinexpression': 0.007713134335009549, 'effect_fig': 8.263922883666513e-55, 'd_results': 9.148819220060914e-58, '3e_f_dner_knockdown': 9.148819220060914e-58, 'flagdner_transfection': 0.0001935859600922882, 'ofdner_knockdown': 5.102395340423043e-07, 'role_cell_death_disease_page': 0.0001935859600922882, 'ncadherin_vimentin_snail': 7.05029712940268e-05, 'analysis_protein_levels': 0.0003354942596134895, 'density_ratio': 0.0003354942596134895, 'e_f_dner': 0.0016810521528134112, 'andthose_notch1': 0.00010883068312907455, 'wntcateninsignalling_pathway': 0.0015842910551982499, 'wntcatenin_pathway': 0.0029088697419138144, 'dneroverexpression': 9.148819220060914e-58, 'effectnext': 9.148819220060914e-58, 'andthose_notch1_results': 0.00010883068312907455, 'dner_knockdown': 0.007718350708776022, 'thoseofï¬\\x81cial': 9.148819220060914e-58, 'signalling_pathway': 9.148819220060914e-58, 'qrtpcr_e': 4.114904199478952e-08, 'kaplan\\x93meier_survival_analysis': 6.701865945984654e-10, 'thatdner_knockdown': 8.263922883666513e-55, '4e': 0.0001935859600922882, 'to_show_the_correlation_between_the_highlevel_expression_of_both_dner_and_catenin_and_bcpatient_clinicopathologic_features_as_shown_in_table_these_data_suggest_a_strong_correlation_between_theexpression_of_dner_with_that_of_catenin_and_high_levelsof_dnercatenin_with_poor_prognosis_in_bcofï¬\\x81cial_  _of_the_cell_death_differentiation_associationthe_wntcatenin_signalling_pathway_is_involved_in_dnerinduced_emt_and_prometastatic_phenotypesto': 3.394976625095905e-05, 'to_show_the_correlation_between_the_highlevel_expression_of_both_dner_and_catenin_and_bcpatient_clinicopathologic_features_as_shown_in_table_these_data_suggest_a_strong_correlation_between_theexpression_of_dner_with_that_of_catenin_and_high_levelsof_dnercatenin_with_poor_prognosis_in_bcofï¬\\x81cial_  _of_the_cell_death_differentiation_associationthe_wntcatenin_signalling_pathway_is_involved_in_dnerinduced_emt_and_prometastatic_phenotypesto_effect_5a_b_effect_fig_ability': 0.00017366398796445735, 'pathwayfunctions_we': 9.148819220060914e-58, 'whetherchir': 9.148819220060914e-58, '5a_b': 3.394976625095905e-05, 'chir': 8.263922883666513e-55, 'thatxav939': 0.0006940543140455221, 'ofin_dneroverexpressing_cells': 0.000704362469235278, 'to_conï¬\\x81rm_the_upregulation_and_downregulation_by_western_blotting_fig': 0.00022956017717477826, 'cell_death_disease_page_b': 1.4055400435083287e-53, 'cck8': 0.0008089310350023148, 'dner_overexpression': 9.148819220060914e-58, 'translocation_effect_fig': 9.148819220060914e-58, '3c_inaddition_ihc_results': 9.148819220060914e-58, '6k_f_k': 9.148819220060914e-58, 'as_shown_in_fig_6l_theofï¬\\x81cial_  _of_the_cell_death_differentiation_association_       _0cwang_  _cell_death_and_disease_    _page_ _of_fig_ _dner': 0.000704362469235278, 'mdamb231cells': 0.007722569854247233, 'pagefig_dner': 8.791944097087223e-05, 'pcr_cell_viability': 9.148819220060914e-58, 'cck8_f_analysis': 9.148819220060914e-58, 'h_cell_growthwas': 2.207385514110736e-06, 'analysis_expression': 0.0003354942596134895, 'ncadherin_expres': 0.0016810521528134112, 'epcamhighpopulations': 8.263922883666513e-55, 'ros_activity': 1.1686951820486561e-54, 'to_be_a_concerted_interaction_of_interleukin6_il6_and': 0.00040934415372960003, 'p62_silencing': 9.148819220060914e-58, 'ros_activity_to_be_a_concerted_interaction_of_interleukin6_il6_and': 9.148819220060914e-58, 'nrf2_pathwayactivation': 0.0004360764270917066, 'regulation_use_factor_cells': 3.623563644479845e-05, 'included_permitted_exceeds_mediated_andprotects_indicated': 0.0004361926471901046, 'nrf2_genes': 0.0038806204677737646, 'efï¬\\x82ux5abnormalities': 5.915698549806129e-07, 'survivalof_cscs10': 7.114133495964661e-06, 'surface_markers': 9.148819220060914e-58, 'resistance_survivalof_cscs10': 9.148819220060914e-58, 'development_understanding': 0.0001642889666773429, 'to_chemotherapeuticresistanceofï¬\\x81cial_  _of_the_cell_death_differentiation_associationresultscancer': 0.004315547045054443, 'hnscc': 0.0015847132313328567, 'normalizedmrna_zscores': 0.007713134335009549, 'csc_markers_tumors': 0.007713134335009549, 'comparednrf2_expression_differences': 1.7266859970571246e-05, 'significantexpression_difference': 1.7266859970571246e-05, 'epcam_sox2_p': 9.148819220060914e-58, 'higherexpressions': 9.148819220060914e-58, 'hnscc_patienttumors': 0.0016810521528134112, 'acisplatinresistant_fadures_cells': 0.007713134335009549, 's1a_fadurescells': 0.0004360764270917066, 'faducells': 0.007713134335009549, 'epcamexpression': 0.007713134335009549, 'tissues_ratio': 0.00048025727118282413, 'group_ratio': 7.833676282533105e-06, 'values_pvalues': 9.148819220060914e-58, 'using_student\\x99s_t_testfig_s2': 9.148819220060914e-58, 'to_be_somewhat_resistantto_cisplatin_treatment_knockdown_ofepcam_with_siepcam': 0.0011125787591309202, 'map_analysis': 0.0004361926471901046, 'epcam_overexpressionit': 7.114133495964661e-06, 'theresistance': 0.00054686425127897, 'thatcisplatin_treatment': 9.148819220060914e-58, 'innrf2_pathway_activation': 9.148819220060914e-58, 'expression_epcampositive_cell_population': 1.284690556057437e-52, 'hnscc_cells_hnscc_cellproliferation_expression': 7.417164383651313e-53, 'hnscc_cells': 7.417164383651313e-53, 'hnscc_cellproliferation_expression': 7.417164383651313e-53, 'ec50_differences': 5.271144457310453e-05, 'twopopulations': 0.007713134335009549, 'facs': 2.7468520144342784e-05, 'cellofï¬\\x81cial_levels_ofepcam': 4.4831891738575227e-07, 'cellofï¬\\x81cial_expressions_tumor_cells_blotting_g_transcript_levels_values_levels_ofepcam_analysis_transcript_levels': 0.001681500471730797, '0cnoman_al_cell_death_disease_page': 0.007713134335009549, 'patient_tumorcells': 1.8162977041424498e-05, 'cellviability_determination': 0.0011128752409327472, 'tumor_cells_blotting_g_transcript_levels': 4.4831891738575227e-07, 'nrf2arepathwaytumorto_explore': 0.0010414255139823384, 'sortedepcamhigh_cells': 4.5349806270071345e-07, 'ï¬\\x82ow_cytometry_nrf2are_pathway': 7.4029318925637935e-09, '4a_cells': 1.2088814437851844e-10, 'resultscorroborated': 1.2088814437851844e-10, 'nrf2are_pathway': 0.0004990942860418787, 'analysis_transcript_levels': 4.4831891738575227e-07, 'to_detect_reporter_gene_activity_fromares_i_immunostaining_of_hnscc_cells_stained_with_epcam_green_nrf2_red_and_dapi_blue': 0.00036240313892865647, 'reporter_gene_activity': 7.114387814765427e-06, 'immunostaining': 0.0004361259649319665, 'csc_medium': 7.669171694757686e-05, 'd_sox2_protein_levels': 0.0011125787591309202, 'wasanalyzed_after_incubation_of_cisplatin_for_ _h_in_sinrf2_and_siscrambled_epcamhigh_cells': 0.0011125787591309202, 'sinrf2': 9.148819220060914e-58, 'cells_cell_viability': 9.148819220060914e-58, 'cells_transfection_offadu_scc15_cells': 8.263922883666513e-55, 'cellsand_cells_facs': 0.0011125787591309202, 'transfection_offadu_scc15_cells': 0.0003535708123475912, 'csc_enrichment_resistance': 0.0004202357087063657, 'expression_proteins': 0.00034123476095426726, 'intracellular_ros_levelresulting': 0.004315547045054443, 'indicator_ros_activity': 0.0006940543140455221, 'capacity_spheregrowth_invasion_capacity': 0.00054686425127897, 'cells_colony_forming_capacity': 0.00028747108910989435, 'growth_capacitycompared': 2.9547643663040736e-06, 'interleukin_il6_antioxidant_pathwaycontribute': 0.0015842910551982499, 'mrna_transcripts': 0.007713134335009549, 'tumors_comparedwith': 4.107493857418709e-06, 'normal_surgery_7a': 0.00025186600084341546, 'ofil6': 6.075138805368377e-52, 'detectableincrease_observed_in_the_cisplatintreated_cells': 4.649709951488235e-52, 'detectableincrease': 3.287841426025112e-52, 'observed_in_the_cisplatintreated_cells': 3.287841426025112e-52, '7baddition': 2.5164048986301264e-52, 'expression_ofnrf2': 0.004315547045054443, 'generation_whilecells': 0.0006674076661460604, 'receptor_antibody': 9.148819220060914e-58, 'westernblot': 9.148819220060914e-58, 'to_controls_resistance_toradiation_by_suppressing_oxidative_stress_via_nrf2_pathway28_cisplatintreated_cells_undergoing_il6_and_tocilizumab_ _ngml_treatment': 0.0038806204677737646, 'rosproduction': 0.0010532454562260317, 'p62_protein': 9.148819220060914e-58, 'blotting_p62protein': 9.148819220060914e-58, 'fig_7h_knockdown': 0.00047983738574547787, 'p62mediated': 9.148819220060914e-58, 'fig_theexpression': 9.148819220060914e-58, 'nrf2activity': 0.004315547045054443, 'p_d\\x93fnumbers': 9.148819220060914e-58, 'd_formation_e_invasion_capacity': 9.148819220060914e-58, 'link_betweenepcam_nrf2_pathway': 0.00013570449895215834, 'association_betweenthe_nrf2_pathway_cscs': 2.6383412545542474e-05, 'p62': 3.987527980748332e-05, 'bar_values': 0.0003327007272384309, 'experiments_p': 0.00043463382250315263, 'nrf2_knockdown': 9.148819220060914e-58, 'selfrenewalcapacity': 9.148819220060914e-58, 'inhibition_activation_association': 0.002457785326505863, 'inhibition_activation': 0.0007008712380191807, 'ros_levels': 4.011199112085732e-05, 'mechanisticinsights': 0.0006625816769337724, 'hasnever': 4.011199112085732e-05, 'emerged': 4.011199112085732e-05, 'award': 0.0005248377111845071, 'to_inducedamage_to_dna': 0.00014877118840123777, 'to_inform_clinical_practice': 0.0008007978903264432, 'literature_consensus': 0.0006683740194778514, 'repair_proteins': 0.00031585793432508617, 'toradioresistance': 0.00037036254408407267, 'withregions': 9.148819220060914e-58, 'ph_andimmune': 9.148819220060914e-58, 'joining': 9.148819220060914e-58, 'tosuffer_alterations': 9.148819220060914e-58, 'regulation_use_tavassoli_discovery_page': 3.622598338048949e-05, 'use_tavassoli_discovery_page': 3.622598338048949e-05, 'ddrtransducers': 0.0003483395094872172, 'ddr_alteration': 5.6806061381926055e-06, 'thisparticularly': 0.0005479687540571566, 'to_have_different_oxygen_pressureslevels_of_hypoxia': 0.00030237797101608573, 'data_results_rr_times_normoxia_physoxia': 0.007717244975784016, 'using_hypoxia_as_asingle_parametersignatureof\\x97\\x8f': 0.007713134335009549, 'becomeclear': 0.00210348072096923, 'protectingnormal_tissues': 9.148819220060914e-58, 'to_improved_locoregional_controland_quality_ofsincelife_for_patients78_howeverofï¬\\x81cial_  _of_the_cell_death_differentiation_associationtreatment_for_many_cancers_like_hnsccs_which_incidentally_are_also': 9.148819220060914e-58, 'patients1011': 1.1686951820486561e-54, 'oxygenconsumption12': 8.263922883666513e-55, 'blood_vesselfunctionality1314': 8.263922883666513e-55, 'allowedus': 0.0001636186356061753, 'rrthough_research_activity': 0.0001261733407126887, 'to_rr_particularly_by_modulation': 0.00016321626925891726, 'response_ddrpathways': 0.0001261733407126887, 'to_be_crucial_in_impactingthe_radiation_response27_as_these_changes': 0.0038806204677737646, 'aggressivity_microenvironmental_interactionsand': 9.148819220060914e-58, 'ph28\\x93_land': 9.148819220060914e-58, 'research_thelikelihood': 1.736836889713728e-05, 'metabolism_vegf': 9.148819220060914e-58, 'glossary': 9.148819220060914e-58, 'o2_levels': 8.976216310615154e-05, 'normoxia': 9.148819220060914e-58, 'frommckeown139_liu140_graham26fig': 9.148819220060914e-58, 'suffer': 9.148819220060914e-58, 'to_be_under_perfusion_limited_hypoxia_pl_hypoxia_where_lack_ofoxygen_is_a_function_of_distance_from_the_vessel_cells_experience_diffusion': 9.148819220060914e-58, 'occlusion_bv': 0.00015009837068188792, 'tobe_acute_chronic': 0.00210348072096923, 'reprogramming_behaviourofï¬\\x81cial_0cbegg': 0.00015175328891448237, 'forcellular': 0.004315547045054443, 'oftwo_subunits': 0.00028074246679799187, 'conï¬\\x82ictingresults': 0.00038842632962585887, 'hifs': 0.000666903855165711, 'modiï¬\\x81cations': 0.0002540064965694402, 'number_ofp300cbp': 1.6841776171074526e-05, 'forthis55ofï¬\\x81cial': 0.0016480626375926124, 'bestknown_hif_hif1_hif2': 1.778276456783751e-07, 'role_beenshown_genesmsh2_msh6': 1.0887885361259132e-05, 'demonstratingthat_each': 9.148819220060914e-58, 'speciï¬\\x81c_functions56': 9.148819220060914e-58, 'intermittenthypoxia': 8.263922883666513e-55, 'bothin_vitro': 1.1686951820486561e-54, 'signiï¬\\x81cant_effect': 3.945027156588972e-05, 'to_function_via_the_hif1Î±\\x93myc_pathway_in_which_hif1Î±_competes_with_the_transcriptionactivator_myc_for_sp1_binding_in_the_target_gene_promoter_to_downregulate_mismatch_repair': 8.263922883666513e-55, 'radio_chemotherapiesthemselves': 1.778276456783751e-07, 'dna_damageinducinginsults': 0.0006683740194778514, 'interactionwith_p53': 0.0005406986214565272, 'ddr': 8.126432409595075e-05, 'sensors': 0.004315547045054443, 'response_pathways': 0.00040939802155481745, 'effectorsfor_part': 6.677248792954807e-06, 'chromatids_torepair_dna_place_kinase_pikk': 0.00019975070905761997, 'errorprone': 9.148819220060914e-58, 'chromatids_torepair_dna': 9.148819220060914e-58, 'kinase_pikk': 0.00019975070905761997, 'form_ddr_pathways': 3.945027156588972e-05, 'oflow_oxygen': 2.68533315251271e-07, 'to_recruit_atm_independent_of_dna_damage68repression_of_the_mrn_machinery': 0.0003377049630876618, 'mrn': 9.148819220060914e-58, 'to_be_downregulated_both_at_themrna_and_protein_level_in_nsclcs_harbouring_egfrmutations': 9.148819220060914e-58, 'mrn_activation': 0.00011839797567100296, 'atsites_recruitmentand': 0.00011839797567100296, 'thatÎ³h2ax': 0.00011839797567100296, 'atm': 0.0003373197309518599, 'to_be_induced_by_hypoxia_following_replication_fork_stalling_this_phosphorylation': 6.650877703953926e-06, 'hypoxia_ku_complex_hasbeen_tavassoli_discovery_page': 6.650877703953926e-06, 'this_heavilyrelied': 9.148819220060914e-58, 'ï¬\\x81netuningku70_ku80': 9.148819220060914e-58, 'complexcid129_atmtransducer': 9.148819220060914e-58, 'byreplication': 9.148819220060914e-58, 'arrestcid129_downregulation': 9.148819220060914e-58, 'instabilitycid129_downregulation': 9.148819220060914e-58, 'expression_o2\\x93': 9.945806488615284e-05, 'o2': 0.006091138110594946, 'downregulation_upregulation': 0.0005403072527347841, 'oliveira82meng119crosby118meng119meng119lu117bindra120oliveira82meng119brca2effector': 0.0005403072527347841, 'hypoxia_o2': 0.00045660454367155184, 'to_be_activatedparticularly_in_acute_hypoxia_as_shown_in_the_study_bybencokova_et_al': 4.008826725939137e-05, 'atm_activation': 0.00034678516808638586, 'mrn_recruitment': 0.0038806204677737646, 'cid129_cid129': 0.0005403072527347841, 'o2_\\x93': 1.1686951820486561e-54, 'expression_o2_\\x93_expression_o2_\\x93': 8.263922883666513e-55, 'hypoxia_\\x93': 9.945806488615284e-05, 'expression_o2_\\x93': 8.263922883666513e-55, 'type_atm_canbe_study': 9.148819220060914e-58, 'mir18': 9.148819220060914e-58, 'l_potential_uses_activities_cycle_effects': 9.148819220060914e-58, 'apoptosis_eur_j_pharmacol_\\x93_cells_haematol_\\x93_h_use': 9.148819220060914e-58, 'ielg': 0.0005681429618985973, 'experiments_analyzed_experiments_experiments_manuscript_manuscript': 9.268650212118776e-06, 'synthesized': 2.3843375305771238e-05, 'using_the_following_method': 3.894218270784884e-07, 'a0_scheme': 1.3121389437173726e-09, 'method_type': 1.4157202854117288e-05, 'then_adding_a_ _a0ml_of_eluate_of_99mtc_\\x93_a0mbqml_to_the_mixtures_the_mixtures_were_incubated_for_ _a0min_at_a_temperature_of_\\x93_a0_°_c_the_preparation_is_ready_for_use_after_cooling_at_room_temperature_the_reducing_agent_ _sncl2\\x88\\x992h2o': 7.059568761374134e-06, 'dissolution': 9.844865688100917e-06, '99mtc\\x93nanocolloid_a0': 2.7316580780293494e-05, 'framebyframe_recording': 0.001673434322013953, 'viipertechnetate_content': 9.148819220060914e-58, 'using_acetone_as_the_mobile_phase_time_of_chromatography_ _a0min': 9.148819220060914e-58, 'scintigraphy': 2.7316580780293494e-05, 'institute_committee_protocol_number_manipulations': 6.977741684202455e-05, 'eluate': 9.148819220060914e-58, 'ii_concentration': 9.148819220060914e-58, 'csn_amount': 0.00040928894108187346, '99mtc_sn_ii': 6.343042374554208e-05, 'increase_b_c': 0.00029599327620783605, 'analyzer_the_obtained_dependence_of_the_change_in_the_density_of_the_distribution_of_the_number_of_ps_on_their_size_constructed_from_the_results_of_a_threedimensional_measurement_of_the_preparations_is_shown_in_fig_a0': 0.00037225843424422525, 'al2o3_dtpamod_99mtc_biodistribution_data': 7.48700983901382e-05, 'to_reach_a_rhp_greater_than_ _in_this_case': 4.2384483375679374e-05, '\\x94lymph_node_\\x94site_±_±_±_±': 0.0002584379969449155, 'table_biodistribution_data': 0.000327079770302999, 'stoffels': 0.00035730068962257737, 'eur_j_nucl': 9.148819220060914e-58, 'mol': 9.148819220060914e-58, 'm_studies_arenediazonium': 9.148819220060914e-58, 'preparation_structures_layer_chromatography_rfmefi57514x0034author_contributionsvs': 9.148819220060914e-58, 'publication_nv': 7.417164383651313e-53, 'preparation_structures_layer_chromatography_ministry_rfmefi57514x0034author_contributionsvs': 0.0007959416758056306, 'methods_results_discussion_sections_yz': 0.0004918489865500897, 'methods_results_sections': 8.022885101378207e-06, 'feedback_insights': 0.0007959416758056306, 'methods_results_sections_feedback_insights_manuscript_version': 0.0008039645609070089, 'to_obtain_permission_directly_from_the_copyright_holder_to_view_a_copy_of_this_licence_visit_httpcreat_iveco_mmons': 0.00016902585554135613, 'silver_iron_nanops_synthesis': 0.007713134335009549, 'percent_solution': 9.148819220060914e-58, 'silver_iron_nanops_synthesis_to_yield_pacagnp_and_pacfenp_the_synthesized_nanops_werecharacterized_by_uv_ftir_xrd_and_sem_analysis_and_evaluated_for_antimicrobial_potential_against_selectedmicrobes': 9.148819220060914e-58, 'to_yield_pacagnp_and_pacfenp_the_synthesized_nanops_werecharacterized_by_uv_ftir_xrd_and_sem_analysis_and_evaluated_for_antimicrobial_potential_against_selectedmicrobes': 0.007713134335009549, 'mtt_srb_trypan_assay_uv_spectroscopy': 5.62926585617289e-10, 'to_be_less_against_staphylococcus_aureus_pseudomonas_aeruginosa_andescherichia_coli': 7.237344874271509e-06, 'cytotoxicity_dm_ht29': 2.274211562945482e-53, '±_±_inhibition': 1.4055400435083287e-53, 'pac': 0.0005470100533968946, 'synthesis_method_proanthocynidin': 0.000126207882641634, 'newopportunity': 0.0007956673215405282, 'developednanops': 1.1075167429453585e-05, 'millionpeople': 0.00210348072096923, 'to_have_occurred_in_ _inthe_usa': 0.0005253840276496832, 'to_exhibit_antioxidant_and_free_radicalscavenging_properties_ _literature': 0.0038806204677737646, 'dosage_form': 9.148819220060914e-58, 'cellpenetration': 9.148819220060914e-58, 'solubility_nanops': 0.00010616849003009921, 'materialthat': 0.00021241348748990692, 'properties_andhence_agricultureinformationandheavy_industry': 0.0001658558251864917, 'to_be_a_powerful_inhibitor_ofaromatase_activity_it_is_an_enzyme_expressed_in_higherlevels_in_cancerous_than_in_usual_breast_tissues_ _pacs': 0.0038806204677737646, 'valuablehealth_effects': 0.0038806204677737646, 'to_defend_against_oxidative_stress_and': 0.00210348072096923, 'to_be_contributors_to_the_health_benefits_of_0cshejawal_    _of_genetic_engineering_and_biotechnology_            _page_ _of_fruits_and_vegetables': 7.05217663403483e-05, 'phytoconstituents': 0.0007008712380191807, 'staphylococcus_aureusatcc_pseudomonas_aeruginosaatcc_escherichia_coli_atcc_theculture': 2.305966047368653e-06, 'solution_chloride_solution': 2.305966047368653e-06, 'spectroscopy_thecollected_pacagnps': 0.0038806204677737646, 'pacfenps': 0.0038806204677737646, 'pacagnp_pacfenp': 9.148819220060914e-58, 'field_emission': 9.148819220060914e-58, 'alpha_echo_atr_spectrum': 0.0001796820992357605, 'ofpac': 9.148819220060914e-58, 'xrd_analysis': 9.148819220060914e-58, 'theplates': 2.63595245090252e-05, 'incubatedfor_h_cell_proliferation': 2.63595245090252e-05, 'thiazolyl': 8.263922883666513e-55, 'percent_cytotoxicity': 1.1686951820486561e-54, 'tris_buffer': 8.263922883666513e-55, 'clearcytoplasm': 1.1686951820486561e-54, 'to_find_out_the_number_ofviable_cells_present_in_a_cell_suspension_it_is_based_onthe_principle_thatlive_cells_possess_undamaged_cellmembranes_that_exclude_certain_dyes_such_as_trypanblue_eosin_or_propidium_whereas_dead_cells_do_not_exclude_in_this_test': 8.263922883666513e-55, 'cellmembranes': 3.492638984907098e-05, 'dyes': 0.004315547045054443, 'dye': 0.0011125787591309202, 'bluecytoplasmfifty_microliters': 0.00019838362704886956, 'colo_d': 8.263922883666513e-55, 'samples_trypan_blue': 1.7379843970490927e-06, 'mensor_microliters': 0.00010647533506371453, 'afterwhich_tubes': 9.148819220060914e-58, 'to_react_at_an_ambienttemperature_for_ _min_the_control_was_prepared_as_described_above_without_any_extract_and': 9.148819220060914e-58, 'nanopsmethanol': 9.148819220060914e-58, 'to_correct_the_baseline_after_ _minof_incubation': 9.148819220060914e-58, 'discoloration': 0.00014184840091396902, 'prism': 0.00030956355452942195, 'version_results': 5.1679227776130244e-05, 'analysis_meanstandard_error': 8.93412473617829e-06, 'sem_value': 1.4580211792455438e-07, 'sem_value_pac': 1.45840969959293e-07, 'sprthis_change': 2.3808098082110734e-09, 'max': 0.0006054349545841993, 'silver_nanop_pacagnp': 9.148819220060914e-58, 'wavelength': 9.148819220060914e-58, 'thepresence_aromatic_phenolic': 0.0038806204677737646, 'presence_aromatic': 0.0006055963061415867, 'cm\\x88\\x92which': 9.878750032984267e-06, 'proanthocynidin_nps': 9.148819220060914e-58, 'absorption_bands': 9.148819220060914e-58, 'absorptionbandsindicating': 1.627667689504627e-05, 'nps': 0.0009971834025546682, 'to_analyze_thestructure_of_pacagnp_and_pacfenp_nanops_thatare_developed_and_represented_in_fig_2b': 0.00210348072096923, 'infig_2c': 3.304914463482561e-06, 'aggregation': 5.403270103871369e-08, 'order_reflections': 5.403270103871369e-08, '°': 5.917513432574689e-06, 'peak_±_inhibition': 0.00036283167566678336, 'xrd_spectrum': 1.3448618710402041e-05, 'zone': 2.031537629324275e-05, 'infig_results': 0.00024831101020746386, 'silver_nanops': 1.1686951820486561e-54, '±_inhibition': 8.263922883666513e-55, 'srb': 9.148819220060914e-58, 'ofpac_pacagnp_pacfenp': 9.148819220060914e-58, 'inhibition_±_inhibition': 8.263922883666513e-55, 'silvernanopaticles_pacagnp': 9.148819220060914e-58, '±_nonviability': 9.148819220060914e-58, 'to_be_ _±_ ': 0.002804351958988411, 'to_be_ _±': 0.00210348072096923, 'proanthocynidin': 1.0132034972112839e-52, 'ironnanops': 5.849733118588051e-53, 'silver_iron_nanops': 9.148819220060914e-58, 'byuv_spectroscopy': 9.148819220060914e-58, 'change_information': 0.0038806204677737646, 'activityshifted_attributed_indicated_fenpsrb_assay': 0.0007035667068513752, 'to_be_   _Î¼m_and_  _Î¼m': 1.3448618710402041e-05, 'silver_andiron_nanops': 9.148819220060914e-58, 'ascompared': 9.148819220060914e-58, 'metal_nps': 0.0007035667068513752, 'inhibition_mtt_assay': 5.473908519290502e-05, 'stressesthat': 9.148819220060914e-58, 'dna_cytotoxicity_results': 9.148819220060914e-58, 'pacagnp': 9.148819220060914e-58, 'inhibition_mtt_assay_±': 9.148819220060914e-58, 'inhibitionofcolo320_dm_pacagnp': 8.935281594642543e-07, 'ht29assaysrbincasein_dpph_assay_pacfenp_pacagnp': 9.148819220060914e-58, '±_inhibition_respectivelythe_parameters_ofnanops': 9.148819220060914e-58, 'to_proanthocynidin_the_silver_and_iron_nanops_possess': 0.004315547045054443, 'to_be_provided_greater_attention_as_a_newer_research_area_also_several_review_papershave_been_published_about_the_synthesis_of_silver_nanops_using_natural_polymers_like_kcarrageenan_andsynthetic_polymers_like_poly_vinyl_pyrrolidone_and_polyethylene_glycol_to_improve_the_strength_and_stability': 0.0007035667068513752, 'polymer_nanops': 9.148819220060914e-58, 'research_area_percent_inhibition': 9.148819220060914e-58, 'pacagnps_pacfenps': 0.007713134335009549, 'indiareceived': 0.0013882295497307361, 'august_availability_materialsall': 0.003374402391995586, 'development_ofnanops': 5.6056697263058496e-05, 'antioxidantactivitycapacitiespacagnps_pacfenps': 0.007713134335009549, 'nps_pac': 0.0007037542069379237, 'spectroscopy_xrd_xraydiffraction_sem': 1.1481395008562046e-05, 'hydrazyl': 9.148819220060914e-58, 'bromide_srb': 9.148819220060914e-58, 'resection_eftr': 0.0002967516029581693, 'efficacy_safety_\\x82¬': 2.2939649791815707e-05, 'eftr': 0.0011085051628222744, 'cause_deaths_worldwide1_screening_programmes': 0.00015810430357204874, 'effectiveness_analyses': 6.424213231686695e-05, 'to_ _achieve_ _an_ _additional_ _r0_ _resection_ _by_ _surgical_treatment_ _compared_ _with_ _eftr_ _incremental_ _cost_effectiveness_ _ratio_ _an_ _additional_ _cost_ _of_ _\\x82¬_  ': 1.8101808506116696e-05, 'esd': 0.000514692913697106, 'july_authors_employers': 0.0007996010310488256, 'rights_permissions': 3.57610591824189e-50, 'treatmentmethodsstudy_populationto': 0.00026701832080125866, 'images_case': 0.0004100538998299479, 'form_crf': 9.148819220060914e-58, 'trial_endoscopists': 9.148819220060914e-58, 'treatment_alternatives': 1.1105643429095036e-05, 'ser': 0.000681090968984674, 'group_drg_web_grouper': 9.148819220060914e-58, 'to_ _determine_ _the_ _reimbursement_ _rate_for_ _each_ _patient_ _http_drg_uni_muenster_de_index_php_ ': 9.148819220060914e-58, 'operationen_prozedurenschl¼ssel_ops_code': 7.348717988782612e-06, 'yearto': 9.148819220060914e-58, 'cost_online': 9.148819220060914e-58, 'report_browser': 9.148819220060914e-58, 'www_system': 9.148819220060914e-58, 'following_ _the_ _rules_of_g_drg_ _version_the_main_and_secondary_diagnoses_are_shown_according_to_icd10_german_modification_gm_ _version_and_the_procedures_according_to_ops_ _version': 0.0014616190772430405, 'inek': 0.0014616190772430405, 'emresdcasemix_alternative': 9.148819220060914e-58, 'al_fujiya': 9.148819220060914e-58, 'eg_emr_cases_result': 4.0393870792664814e-05, 'open_accessicer': 0.0003519185601107666, 'esdcosts': 5.740282177885479e-06, 'costs_cost': 0.0003520123535702918, 'mean_costs': 0.0003519185601107666, 'mean_mean': 0.0003519185601107666, 'emr_casemix': 0.0003519185601107666, 'dissection_effectiveness_ratio': 0.0003519185601107666, 'ratioin_comparison': 0.0016480626375926124, 'discussionwith_progress_patient_care': 8.984045738017871e-06, 'to_be_evaluated_in_relation_to_their_costs13_to_our_knowledge': 0.0005507667148747168, 'survey_endoscopists': 0.0007129960827382031, 'expert_endoscopists': 0.00012613970685026185, 'administrator': 0.0003519185601107666, 'to_ _overcome_ _this_ _problem_ _the_ _mean_ _case_ _costs_for_ _eftr_ _per_ _case_ _in_ _our_ _home_ _institution_ _university_hospital_of_freiburg_germany_in_the_time_between_ _and_ _were_used_as_a_surrogate_in_ _an_economic_analysis_ _of_ _the_ _cost_ _of_ _eftr_ _in_ _germany_ ': 0.0014616190772430405, '\\x82¬': 9.148819220060914e-58, 'to_be_a_realistic_number14_in_ _our_ _analysis_ _we_ _chose_ _the_ _r0_ _rate_ _as_ _a_ _means_ _to_detemine_ _effectiveness_ _as_ _this_ _is_ _the_ _most_ _objective_parameter_ _to_ _assess_ _curative_ _resection_ _and_ _treatment_success': 9.148819220060914e-58, 'r0_rate': 0.00771518910792271, 'to_be_ _however': 0.00012613970685026185, '\\x98difficult': 0.0019127833147525456, 'to_ _be_ _higher_eftr_ _is_ _cost_effective_ ': 0.0004472423269940801, 'to_ _be_ _cost_effective_ ': 3.929025987757425e-05, 'follow_up_in_ _the_ _wall_ ': 1.8101808506116696e-05, 'icer': 0.0003519185601107666, 'compared_esd': 0.0003110089468768689, 'to_be_performed_due_to_the_lack_of_rcts_in_this_setting_the_strength_of_our_study': 0.0007862569594425692, 'tree_modelin_costs': 0.0003809665283472652, 'ludwigsburg_baden_w¼rttemberg_germany3department': 9.148819220060914e-58, 'nordrhein_germany4department_essen_nordrhein_westfalen_germany5department': 9.148819220060914e-58, 'w¼rttemberg_germanycontributors_kc': 0.00022784076628390402, 'study_resect_study_manuscript': 3.7184676209466113e-06, 'study_resect_study': 3.7184676209466113e-06, 'mg_rt': 0.0002893721198814622, 'manuscriptfunding_grant_lecture_fees_grants': 0.0013882295497307361, 'kc': 2.2480340991203723e-51, 'conflicts_et_gastro_factsheets_cancers_10__': 4.722161482953914e-06, 'resect_study': 1.50287929139109e-05, 'revieweddata_availability_statement': 4.722161482953914e-06, 'information_data': 8.263922883666513e-55, 'conflicts_revieweddata_availability_statement_changes_et_gastro_factsheets_cancers_10__': 1.1686951820486561e-54, 'trial_access': 8.263922883666513e-55, 'colorectum_fact_sheet_pdf': 9.148819220060914e-58, 'colonoscopic_polypectomy_term_prevention_engl_j_med_\\x93': 9.148819220060914e-58, 'agapov_m_dvoinikova_e_factors_\\x93_schmidt': 3.57610591824189e-50, 'survival_growth': 3.518095844487902e-05, 'mast_cellprecursors': 0.0021550047795934825, 'm2_macrophage': 0.000498273905934873, 'il4rs2070874': 0.0015842910551982499, 'snp': 0.003086797512855968, 'previousstudy': 3.5190333791601625e-05, 'gc_snp': 0.0003455629248948053, 'signal_transducer_activator': 0.0016159571862621879, 'studiedherpesvirus_mediator_hvem_role_to_be_expressed_in_lymphoid_cells_as_well_as_in_other_cells_a_previous_study_suggestedthat_the_hvemb_and_tlymphocyte_attenuatorlymphotoxincd160_network_in_immune_reaction_to_infection_andinflammation_could_play_a_bidirectional_regulatory_role_  _several_investigations_have_focused_on_the_role_of_hvemin_cancer_survival': 0.0019396768345484412, 'role_inantiapoptosis': 0.0038806204677737646, 'rs1800896_gallele_thers1800872': 0.0011075402231842013, 'promotor_variant': 0.0006674076661460604, 'ag_\\x88\\x92_variants': 9.148819220060914e-58, 'thesusceptibility': 9.148819220060914e-58, 'il10_snps': 0.0007862569594425692, 'controls_includedthe_association_of_the_il10_rs1800896_ag_and_rs1800872_ac_polymorphisms_with_ec_development': 9.148819220060914e-58, 'studiedherpesvirus_mediator_hvem': 9.148819220060914e-58, 'hvem': 0.0006248456899411843, 'to_be_expressed_in_lymphoid_cells_as_well_as_in_other_cells_a_previous_study_suggestedthat_the_hvemb_and_tlymphocyte_attenuatorlymphotoxincd160_network_in_immune_reaction_to_infection_andinflammation_could_play_a_bidirectional_regulatory_role_  _several_investigations_have_focused_on_the_role_of_hvemin_cancer_survival': 1.019386018508557e-05, 'attenuatorlymphotoxincd160_network': 0.0015842910551982499, 'escc_cases_data': 0.0019127833147525456, 'rs2070874_andrs2243263_il10_rs1800896_rs1800872': 1.1047474720114458e-05, 'escc_cases_data_genotypesof_thegenotypes_to_calculate_the_crude_and_adjusted_odds_ratios_ors_and_ _confidence_intervals_cis_sas_ _softwarepackage_sas_institute_inc_cary_nc_usa_ors_significance_to_determine_the_escc_stage_and': 0.0006771861580369777, 'genotypesof': 0.007713134335009549, 'rs1800872_loci': 9.148819220060914e-58, 'thegenotypes': 9.148819220060914e-58, 'chisquare_test_Ï\\x872': 0.007713134335009549, 'testto': 0.007713134335009549, 'to_calculate_the_crude_and_adjusted_odds_ratios_ors_and_ _confidence_intervals_cis_sas_ _softwarepackage_sas_institute_inc_cary_nc_usa': 0.0019127833147525456, 'relationship_polymorphisms': 9.148819220060914e-58, 'ors_significance': 9.148819220060914e-58, 'equilibriumhwe_test': 9.148819220060914e-58, 'to_assess_whether_the_distribution_of_hvemrs2234167_il4_rs2070874_and_rs2243263_and_il10_rs1800896_and_rs1800872_genotypes_could_represent_the_included_populationresultsbaseline_characteristicsin_total_ _escc_cases_and_ _controls_were_recruited_table_ _of_these_escc_cases_ ': 9.148819220060914e-58, 'distribution_il10_rs1800896_rs1800872_genotypes': 9.148819220060914e-58, 'characteristicsin_escc_cases_controls_table': 9.148819220060914e-58, 'version_criteria': 1.1050418330032144e-05, 'to_determine_the_escc_stage_and': 1.804710151421146e-07, 'cc_genotype': 0.0007862569594425692, 'il4_rs2070874_cc_genotype': 9.148819220060914e-58, 'escc_p0028_adjustment': 9.148819220060914e-58, 'controlsbioscience': 9.148819220060914e-58, 'node_statuspositivenegativetmn': 9.148819220060914e-58, 'escc_stage': 0.00014748175427506776, 'p0022': 9.148819220060914e-58, 'p0025_table': 9.148819220060914e-58, 'andrs1800896_loci': 0.0007862569594425692, 'loci_patients_patients': 9.148819220060914e-58, 'metastasis_\\x93_\\x93': 9.148819220060914e-58, 'rs2070874_or2_ci_pcctc_cccc': 9.148819220060914e-58, 'statusnevereveralcohol_consumptionnevereverbmi': 9.148819220060914e-58, 'snps_ininflammation_genes': 0.0007862569594425692, 'gene_snps': 0.007713134335009549, 'il4_rs2070874_tc': 9.148819220060914e-58, 'risk_iiisubgroup': 9.148819220060914e-58, 'subgroup_il4_rs2243263_gc': 9.148819220060914e-58, 'risk_association': 9.148819220060914e-58, 'il4_levels': 9.148819220060914e-58, 'development_il4': 9.148819220060914e-58, 'rs2070874_c_allele': 0.0007864664894503318, 'susceptibilityto_gc': 1.2833264574456584e-05, 'il4_rs2070874_polymorphism': 0.0003455629248948053, 'gccasecontrol1gggcccgggcadjusted': 0.0005263009120446208, 'il4_rs2070874_allele_c': 0.0014536646255886296, 'association_subgroup': 0.007713134335009549, 'association_rs2070874': 0.007713134335009549, 'il4_rs2243263_gc': 0.0011562795718906987, 'obesity_introns': 0.0006674076661460604, 'gc_polymorphism': 0.0014536646255886296, 'to_explore_the_potential_mechanismthe': 1.0279702791688033e-05, 'rs1800872_tg_snp': 0.0007862569594425692, 'cyclophosphamide_doxorubicin_vincristine_prednisone': 0.0006321861226151657, 'snps': 0.007713134335009549, 'il10_g_allele': 1.108137380925735e-06, 'training_project': 6.787881358556489e-05, 'theexperiments_sc_rc_cl': 0.0014616190772430405, 'wt_mk': 8.263922883666513e-55, 'mk': 9.148819220060914e-58, 'themanuscript_sc_rc_other': 9.148819220060914e-58, 'to_thank_dr_yan_liu_genesky_biotechnologies_incshanghai_china_for_technical_supportabbreviationsajcc_american_joint_committee_on_cancer_bc_breast_cancer_bmi_body_mass_index_ci_confidence_interval_ecesophageal_cancer': 0.007713134335009549, 'annu': 3.907663414439379e-05, 'immunol_rush_js_b_cells': 6.376579077339677e-07, 'division_burst': 6.376579077339677e-07, 'lymphocyte_interferon_killer_factoril12_synthesis': 8.263922883666513e-55, 'miteva_ld': 1.007692708565637e-06, '\\x93_cancer_growth_metastasis': 4.649709951488232e-52, 'm_blankenhaus_b_cutting_edge_the_btlahvem_regulatory_pathway': 2.516404898630125e-52, 'extractiontwo_investigators': 0.0018006682651940404, 'yjz': 0.001801148090838322, 'discrepancywas': 2.592383228850439e-05, 'engauge_digitizer_version_ _to_estimate_the_hrs_based_on_the_graphical_survival_plots_when_hrs_were_notdirectly_available_in_the_study_  ': 0.007713134335009549, 'omnibus_geo_database': 9.148819220060914e-58, 'genome_expression': 9.148819220060914e-58, 'nr': 9.148819220060914e-58, 'sc_survival_curvenrscscreportedscscreportedsc302foldmediannrmediannrmedianmedianmfsdfsosososrfsosrfsosnononoyesnonoyesnofrancechinachinachinachinachinachinachinanrnrnrtissuetissuetissueserumtissuetissuetissuetissuertpcrrtpcrrtpcrrtpcrrtpcrrtpcrrtpcrrtpcr\\x86\\x91\\x86\\x91\\x86\\x91\\x86\\x91\\x86\\x91\\x86\\x91\\x86\\x91\\x86\\x91statistical_cis': 9.148819220060914e-58, 'dss_rfs': 9.148819220060914e-58, 'to_evaluate_the_prognostic_effect_ofmalat1_in_breast_cancer': 9.148819220060914e-58, 'hr_ci': 0.0008581749454218445, 'test_pvalues': 9.148819220060914e-58, 'to_find_the_heterogeneityamong_studies': 9.148819220060914e-58, 'procedurea_total': 3.2544572600243254e-05, 'to_evaluate_the_prognostic_effect_ofmalat1_in_breast_cancer_association': 0.0019936681669710764, 'tnbc_subtypecells': 0.0008522036149147152, 'in_those_with_mixed_type_breast_cancer_hr_   _ci_ _p00001_next_we_performed_subgroup_analysis_according_to_the_sample_size_with_a_threshold_for_ _patientsthe_results': 0.0006627582576557305, 'reports_p019_randomeffects_model_correlation_ci_p057_model_tumor_size_ci_\\x93': 1.0811463188950833e-05, 'samplesize_n100_results': 0.0008581749454218445, 'hr_ci_p00001association': 0.00033201073213085506, 'malat1_expression': 0.00042334033500023927, 'significance_authors': 0.0003833771411240826, 'metastasis_node_metastasis_ci_\\x93_grade_status': 9.148819220060914e-58, 'modelsensitivity_analysis_publication_biaswe': 9.148819220060914e-58, '4a_rfs': 0.0019127833147525456, '4begger\\x99s_test_funnel_plot': 9.148819220060914e-58, 'to_test_publication_bias_as_shown_in_figure_5ab': 9.148819220060914e-58, 'funnel': 9.148819220060914e-58, 'shape_studies_egger\\x99stest_p0142': 9.148819220060914e-58, 'metaanalyses_metastasispositive_reports': 0.001129870936471824, 'figure_sensitivity_analysis': 0.0006049075008066659, 'malat1': 0.003969848863797362, 'further_investigationto_further_explore_the_possible_reason_why_malat1_is_responsible_for_poor_survival_in_patients_with_breast_cancerwe': 0.0005865071468874085, 'etiologies_behaviors_metaanalysis': 0.000676930361914846, 'having_elevated_malat1_expression_levels_ _the_authors': 0.0006049075008066659, '\\x98cerna\\x99_mechanism': 6.479516967864518e-05, 'metastasis_studies': 1.057928676736162e-06, 'andinvasion_malat1': 0.00021559585552483182, 'to_play_essential_roles_in_theinitiation_and_progression_of_cancers_  _low_levels_of_immuneinfiltrating_cells_in_the_tumor_microenvironmentmay': 3.8897633413564496e-05, 't_cells_ofmalat1': 0.002104041233387171, 'to_play_essential_roles_in_theinitiation_and_progression_of_cancers_  _low_levels_of_immuneinfiltrating_cells_in_the_tumor_microenvironmentmay_prognosis_it': 3.4348996837103175e-05, 'correlation_betweenmalat1_prognosis': 0.0038806204677737646, 'treatment_tamoxifen_resistance': 0.00016941179616561546, 'tamoxifen_resistance': 0.00016941179616561546, 'metastasissuppressing_error': 0.0005406986214565272, 'numberof': 9.148819220060914e-58, 'patients_enrollment_criteria': 9.148819220060914e-58, 'kwok': 9.148819220060914e-58, 'metastasissuppressing': 9.148819220060914e-58, 'to_identify_the_function_of_malat1_in_breast_cancer_and_verify_theassociation_between_clinical_parameters_and_malat1': 0.0018006682651940404, 'randomeffects_modelto': 0.00028570359774207095, 'multivariate_hr_estimate': 0.0018006682651940404, 'hr_valueextracted': 9.623930537852086e-05, 'thepreference': 0.007713134335009549, 'jadaliha_zuo': 0.0016480626375926124, 'bsr20200215101042bsr20200215fundingthis_work': 3.68289106346844e-05, 'grant_numbers': 0.0014962308015362895, 'project_research_yyw_yjz_kmh_literature_data': 5.883089155027185e-05, 'research_yyw_yjz_kmh': 2.442176276338123e-05, 'jlq': 0.00021944374809642538, 'manuscript_yh_mqz': 9.148819220060914e-58, 'manuscript_szz': 9.148819220060914e-58, 'nos_newcastle\\x93ottawa_scale_odds_survival_rtpcr_reverse_polymerase_chain_reaction': 2.9402948113849672e-05, 'v_surveillance_patients': 9.148819220060914e-58, '\\x93101016s0140673617333263_siegel_cancer_statistics': 9.148819220060914e-58, 'role_metaanalysis_onco': 8.263922883666513e-55, 'ther': 1.1686951820486561e-54, 'noncoding_rna_thymosin_beta4': 9.148819220060914e-58, 'metastasis_survival': 9.148819220060914e-58, 't_feedback_loop_mir200c3p': 9.148819220060914e-58, 'cell_migration_invasion_ductal_adenocarcinoma': 9.148819220060914e-58, 'j_downregulation': 0.0002074138537015295, 'ma_l_regulation': 9.148819220060914e-58, 'xue': 9.148819220060914e-58, 'rna_metastasis': 0.0006323546019229276, 'withestrogen_receptor': 1.0315794690529797e-05, 'exp_med_\\x93_rna_malat1': 9.644068520054712e-05, 'intriplenegative_breast_cancer': 9.644068520054712e-05, 'l_liu_y_lncrna_malat1': 7.417164383651313e-53, 'h_lu_k_delivery': 0.0004738574283430153, 'onco': 8.263922883666513e-55, 'rna_malat1': 4.136307302741756e-05, 'cell_growth_migrationplos_chemoresistance_prognosis_progression_andmetastasis': 6.753695575277803e-07, 'cell_growth_migrationplos': 6.751896307540392e-07, 'hy_malat1': 1.1022180359902081e-08, 'progression_andmetastasis': 6.751896307540392e-07, 'metastasis_nat_genet_\\x93101038s4158801802523_roche_v': 6.751896307540392e-07, 'blcap_mrna_expression': 0.0015842910551982499, 'genet_e1003368_thomson_dw_dinger_sponges_evidence_nat_rev_t_malat1': 9.148819220060914e-58, 'migration_invasion_biochem': 9.148819220060914e-58, '\\x93_wargo_j_ribas_adaptive': 0.00021559585552483182, '\\x93101016jcell201701017_kato_h': 9.148819220060914e-58, 'cd8': 9.148819220060914e-58, 'pathol': 0.0011125787591309202, 'treatment_condition': 1.5683981953593057e-06, 'technology_novelinsights_total_ethics_research_ethicscommittees': 0.00019684024792114004, 'studying_the_effect_of_genetic_factors_on_a_drug_  _recently_due_to_the_smooth_implementation_of_the_human_genome_project_and': 0.004315547045054443, 'criteria_exclusion_criteria': 3.2087667374762803e-06, 'ethics_research_ethicscommittees': 0.00014735379115642398, 'hgu133a': 9.148819220060914e-58, 'u133a_array_gse81558gpl15207': 9.148819220060914e-58, 'pca_authors': 3.151121807579653e-06, 'genes_degs': 0.0014621262776893034, 'tool_degs': 0.001129870936471824, 'to_draw': 0.00018049906186689923, 'maps_venn_diagrams': 0.001129870936471824, 'interaction_ppi_degs': 0.001129870936471824, 'database_tringdb': 0.0001327562468548339, 'cytoscape_version_kegg_analysis': 0.0038806204677737646, 'maryland_america': 0.0001327562468548339, 'david': 2.516404898630125e-52, 'to_make_analysisof_go_and_keggsignificant_module_and_hub_genesmolecular_complex_detection_tool_mcode_version_   ': 4.649709951488232e-52, 'cytohubba': 6.909571821437224e-05, 'to_authorize_the_hub_genes_when_the_degree_\\x89¥chiahao_chin\\x99s_  _research_introduce_a_novel_cytoscape_plugin_cytohubba_for_ranking_nodes_in_a_network_by_theirnetwork_features_cytohubba': 3.28784142602511e-52, 'cytoscape_plugin_cytohubba': 0.0002800361681909777, 'toolhttpwwwcoexpedia_expression_analysis': 0.0001853489194543981, 'correlation_regression_analysis': 1.5565015690659903e-05, 'version_ibm_york_america': 9.148819220060914e-58, 'to_conduct_all_thestatistical_analysis_a_pvalue_ _was_defined_as_statistical_significance_ _the_authors': 9.148819220060914e-58, 'release_secretion': 0.0005263009120446208, 'rnaiso_kit': 1.3199151784162022e-05, 'rtqpcrwas': 9.148819220060914e-58, 'using_a_light_cycler_®_ _system_with_specific_primers_for_the_ten_hub_genes_table_ ': 9.148819220060914e-58, 'rtqpcroverall_survival_analysis': 0.0003421850007431465, 'significantresultshigh_repeatability': 8.263922883666513e-55, 's1eone_volcano_plot': 0.0002542979044388503, 'degs_nodesindicate': 0.00017131433607981848, 'genes_ppi_volcano_plot': 0.0002542979044388503, 'degs_authors': 2.158504123365708e-05, 'thetumor_individuals_green': 9.148819220060914e-58, 'individuals_expression': 9.148819220060914e-58, 'chga': 9.148819220060914e-58, 'survival_timesthan_s5a': 9.148819220060914e-58, 'survey_results': 1.3063184650439524e-05, 'pathogenesisof_pcrc': 0.0008005492000574381, 'individualized': 1.3063184650439524e-05, 'survival_analysis_results': 0.007713134335009549, 'clca4': 1.284690556057437e-52, 'epithelial\\x93mesenchymaltransformation': 7.417164383651313e-53, 'bioinformatics_analysis_survivalanalysis': 7.417164383651313e-53, 'prognosis_insurvival': 0.001845170519318405, 'transition_communication': 7.417164383651313e-53, 'functions_ms4a12': 0.0038806204677737646, 'identify_critical_biomarkers_of_papillary_thyroidcarcinoma_as_a_form_of_molecular_marker_mrna_containing_the_most_abundant_genetic_information': 0.0002543534709449633, 'using_go_annotation_and_kegg_pathway_enrichment_analysis': 0.0015842910551982499, 'validation_survivalanalysis_enrichment_analysis': 9.148819220060914e-58, 'modules_genes_modules_using_go_annotation_and_kegg_pathway_enrichment_analysis_consent': 9.148819220060914e-58, 'manufacturer\\x99s_guidelines_tissuessample_numbers': 5.877927843407135e-06, '4c_number': 0.0006030236714318566, '\\x9cc\\x9d': 9.148819220060914e-58, 'cancersample': 9.148819220060914e-58, '\\x9cp\\x9d': 0.0006030236714318566, 'change1': 3.124786624800842e-05, 'using_the_r_package_ballgown_ _functional_enrichment_analysis_and_pathway_analysisto': 0.0005263009120446208, 'annotation_visualization_tool_david_httpdavidabccncifcrfgovhomejsp': 9.148819220060914e-58, 'to_perform_gene_ontology_go_enrichmentanalysis_and_kyoto_encyclopedia_of_genes_and_genomes_kegg_pathway_enrichment_analysis_p_values_less_than_were_considered_as_cutoff_criteriappi_network_construction_and_identiï¬\\x81cation_of_hub_genesppi_networks_were_constructed_successively_using_string_database_tringdb_  _the_interactions_ofdegs_with_a_combined_score_  ': 9.148819220060914e-58, 'to_thedefault_to_analyse_theirfunctional_roles_with_funrich_software_ _the_authors_this_is_an_open_access_ _published_by_portland_press_limited_on_behalf_of_the_biochemical_society_and_distributed_under_the_creative_commons_attributionlicense_ ': 0.0009466755491730313, 'to_analyse_theirfunctional_roles_with_funrich_software_ _the_authors_this_is_an_open_access_ _published_by_portland_press_limited_on_behalf_of_the_biochemical_society_and_distributed_under_the_creative_commons_attributionlicense_ ': 0.0009466755491730313, 'bsr20201555101042bsr20201555table_pcr_primersgene': 2.231909074854017e-06, 'sequencef5cid3ccacagacctacttccacacc3cid3r5cid3taccggagagggatcttgacc3cid3f5cid3cactcttccagccttccttcc3cid3r5cid3aggtctttgcggatgtccac3cid3f5cid3_gcgtagtaggagagacgaacg3cid3data_validation_analysisto': 0.00032587979945902947, 'analysis_databaseto': 0.0016810521528134112, 'kaplan\\x93meier_plots': 8.263922883666513e-55, 'utilizing_the_cbioportal_for_cancer_genomics_hub_genesrelated_to_clinicopathological_features': 0.00037036254408407267, 'using_the_online_database_ualcan_httpualcanpathuabedu_ ': 5.31447834401284e-06, 'accuracy_kaplan\\x93meier_plots_using_the_online_database_ualcan_httpualcanpathuabedu_ ': 0.0006812500420437589, 'analysis_total_rna': 1.1114958351429976e-05, 'qiagen_valencia_ca_usa_cdna': 1.0292080130476834e-08, 'to_actin_the_primers_to_extract_protein_from_four_pairs_of_tissue_from_ptc_patients': 6.304704953324052e-07, 'beijing_china_qrtpcr': 1.0289338306468391e-08, 'realtime_pcr_system': 9.148819220060914e-58, 'biosystems_life_technologies': 9.148819220060914e-58, 'to_actin_the_primers': 0.0016810521528134112, 'apoe_lpar5_actin': 1.0289338306468391e-08, 'to_extract_protein_from_four_pairs_of_tissue_from_ptc_patients': 1.6801017424590092e-10, 'the_sdspage_gel_was_used_for_electrophoresis_andpdvf_membrane': 1.0289338306468391e-08, 'dilution_bioss_actin_dilution': 0.00013356700656843865, 'usa_kaplan\\x93meier_method': 0.0015157116209702658, 'wasdetected_analyzed': 0.0009466755491730313, 'changesbetween_cancer_tissues': 0.0009466755491730313, 'genes_enrichment_analysis_anization_cellsubstrate_adhesion_and_urogenital_system_development_thecellular_component_category_results': 0.0002788738900395108, 'anization_cellsubstrate_adhesion_and_urogenital_system_development_thecellular_component_category_results': 0.0002542979044388503, 'enrichment_analysis_kegg_analysis': 0.0002543534709449633, 'resistance_renin_mellitus_cancer_nicotinate_nicotinamidemetabolism_apoptosismultiple_analysisppi_networks': 0.00018956311875359112, 'signal_cell_communicationgprotein': 9.148819220060914e-58, 'activity_ligand': 9.148819220060914e-58, 'figure_adora1': 0.0016810521528134112, 'adora1_chgb_tnc': 9.148819220060914e-58, 'associations_survival_analysis_figure': 9.148819220060914e-58, '7a': 0.0002469065850070426, '7a_showed_the_frequency_of_alterations_of_eachptc_related_key_gene_sstr3_fn1_and_adora1': 0.00025133009630877467, '7dshowed_reports': 4.101221178787619e-06, 'gnai_gpc3': 0.0007959416758056306, 'timp1are': 6.217408324407299e-08, 'apoe': 6.219065195576705e-08, 'p930e\\x88\\x92': 0.0001391293091783537, 'r0175p105e\\x88\\x92_neutrophils': 9.148819220060914e-58, 'p142e\\x88\\x92': 9.148819220060914e-58, 'lpar5_ador1': 0.0008822241915335798, 'roles_ofdcs': 1.0148542631797725e-09, 'genes_expression_mutation_analysis': 0.00037036254408407267, 'expressions_tothe_development_progression_genes_degs_network': 0.00023308907442208475, 'matched_adjacent_tissues_as_measured_bywestern_blot_ _p0001discussionptc_is_a_common_cancer_with_great_heterogeneity_in_morphological_features_and_prognosis_  _although_most_papillary_thyroid_carcinomas_exhibit_low_biological_activity_there_are_still_a_few_patients_with_higher_invasive_and_metastaticclinical_features_  _activation_of_oncogene_expression_and_loss_of_function_of_tumor_suppressor_genes': 9.148819220060914e-58, 'tothe_development_progression': 9.148819220060914e-58, 'gpc3_grm4_lpar5': 6.520711283860127e-06, 'mfge8': 0.0003995800126312821, 'gepia_databaseamong_expression_differences': 0.0002543534709449633, 'constituentto': 8.263922883666513e-55, 'gepia_databaseamong': 0.0002542979044388503, 'lin_et_al': 1.391736590441967e-05, 'adora1': 0.000404948725608525, 'ccl13': 0.0015842910551982499, 'overexpression_ofcdh2': 0.0008598938891937188, 'cdh2_actsas_oncogene_acts': 8.712655419520022e-05, 'eva1a': 0.00040505663764074076, 'reports_mfge8': 9.148819220060914e-58, 'to_be_a_potential_therapeutic_target_for_ovarian_cancer_owing_to_its_carcinogenic_effect_ _consistent_with_our_data': 9.148819220060914e-58, 'to_gpc3': 0.00210348072096923, 'expenses_project_grant_jyt2019015]author_contributionxu_lin': 1.9982525325514424e-51, 'authors_xu_lin': 9.148819220060914e-58, 'manuscriptjingfang_wu_gang_xue': 9.148819220060914e-58, 'gang': 0.001129870936471824, 'ptc_papillary_thyroid': 9.148819220060914e-58, 'kitahara_cm_sosa_ja_incidence': 9.148819220060914e-58, 'rna_expression_potentialpredictability': 0.001129870936471824, 'et_al_stringtie': 9.804941142458467e-06, 'g_jaffe_ae_et_al_ballgown': 9.470784588431378e-05, 'genetics_diagnosis': 9.148819220060914e-58, 'endocrinol_merighi_s_k_adenosine': 9.148819220060914e-58, 'effects_trends': 0.00210348072096923, '101016jtips201602006_lin_z_yin_p_reierstad': 9.148819220060914e-58, 'proliferativeeffects': 9.148819220060914e-58, 'sk_et_al_apolipoprotein_e': 0.00017271852372335994, 'gbm_cell_proliferation': 6.610648712912211e-06, 'type_malignancy': 9.148819220060914e-58, 'loss_difficulty': 9.148819220060914e-58, 'hence_identify_reliable_molecular_biomarkers_and_targets_for_escc_early_diagnosis_and_prognosis_indication': 0.00022909197837626724, 'thathave_proteincoding_capacity': 1.1016737136574871e-05, 'attention_studies': 0.0006751961684051898, 'to_be_tightly_associated_with_lncrnas_andtranscription_factors_tfs_and_accumulating_researches': 0.0016810521528134112, 'lncrna_tusc7': 9.148819220060914e-58, 'chemotherapy_resistance': 9.148819220060914e-58, 'reports_c': 0.0009466755491730313, 'escc_cell_proliferation': 0.0009469278262817738, 'lncrnas_mirnas_mrnas': 1.545263727514792e-05, 'expression_data_genome_atlas_database': 4.1091951992235226e-07, 'diagnosticvalues': 9.148819220060914e-58, 'roc_analyses': 9.148819220060914e-58, 'reports_represents_represents_interaction': 8.263922883666513e-55, 'cancer_tissue_platform_gpl21572': 1.1686951820486561e-54, 'ppi_network_gene': 7.714338180678462e-06, 'causa': 8.263922883666513e-55, 'mirna_v160_microarray': 9.148819220060914e-58, 'three_reports_reports_changes_cellularcomponent_c_changes_d_kegg_pathwaytermsthe_curves': 9.148819220060914e-58, 'web_tool': 2.2480340991203723e-51, 'three_reports_reports_assessed_using_a_km_plot_with_patients_divided_into_high_and_low_expression_groups_according_to_the_medianexpression_of_a_specific_query_gene_the_hazard_ratio_hr_with_ _confidence_intervals_and_log_rank_p_values_werecalculated_to_assess_the_relationship_of_gene_expression_with_survival_and_also_the_numberatrisk_is_displayed_below_ _the_authors_changes_cellularcomponent_c_changes_d_kegg_pathwaytermsthe_curves': 4.496068198240745e-51, 'log2fc_\\x89¥_theoverlapping_demirnas': 2.2480340991203723e-51, 'kegg_pathways': 2.1735208481905543e-06, 'degs_nodesrepresent': 0.00017131433607981848, 'p005ablncrnaprediction': 2.399267206696056e-05, 'to_predict_the_mirnarelated_mrnas_interactions_theinteraction_between_overlapping_demirnas_and_lncrnas_was_predicted_by_using_dianalncbase_v20_wwwmicrornagrlncbase_which_provides_a_compositive_integration_of_mirna\\x93lncrna_interactions_  _with_thescore\\x89¥_as_threshold_criterion_to_perform_the_prediction_in_the_prediction_module_no_other_than_mirnarelatedmrnas_included_in_all_of_mirpathdb_targetscan_and_mirwalk_databases_were_picked_out_for_the_further_functional_enrichment_analysis_and_constructed_the_ppi_network_after_the_predicted_lncrnas_were_intersected_withdelncrnas_in_gse89102_cytoscape_software_version_ _was_utilized_to_visualize_the_regulatory_network_oflncrna\\x93mirna\\x93mrna_ _the_authors_this_is_an_open_access_ _published_by_portland_press_limited_on_behalf_of_the_biochemical_society_and_distributed_under_the_creative_commons_attributionlicense_ ': 2.399267206696056e-05, 'mirnarelatedmrnas': 0.0001327562468548339, 'withdelncrnas': 9.148819220060914e-58, 'to_visualize_the_regulatory_network_oflncrna\\x93mirna\\x93mrna_ _the_authors': 9.148819220060914e-58, 'tool_stringdbthat': 0.0003377049630876618, 'to_explore_the_interaction_of_selected_mrnassubsequently_ppi_pairs_that_have_a_combined_score\\x89¥_the_value_was_used_as_a_threshold_criterion_for_statisticaldifference': 0.0003377049630876618, 'score\\x89¥': 0.004315547045054443, 'function_mf_component': 2.2480340991203723e-51, 'metascape_httpmetascape': 2.2480340991203723e-51, 'to_visualize_the_result_of_kegg_pathway_enrichment_analysis_by_using_a_bubblediagramcoexpression_analysis_of_selected_lncrnas_with_degsthe_gse89102': 0.00018049906186689923, 'matrix_expression': 1.3140465622238654e-07, 'to_construct_thecoexpression_network_with_cytoscapewe': 0.0009466755491730313, 'pathways_enrichment': 1.1686951820486561e-54, 'string': 8.263922883666513e-55, 'cytoscape': 8.263922883666513e-55, 'termsand_pathways': 0.00012613970685026185, 'to_construct_thecoexpression_network_with_cytoscapewe_genes_web_resource_database_analysis': 0.00771518910792271, 'interrelationwas': 0.0003342986407258492, 'web_resource': 0.00019727602822961572, 'database_analysis': 0.007713134335009549, 'expression_profiles_survival_information': 9.148819220060914e-58, 'to_evaluate_the_prognostic_value_of_these_meaningful_hub_genes_in_ec': 9.148819220060914e-58, 'assessed_using_a_km_plot_with_patients_divided_into_high_and_low_expression_groups_according_to_the_medianexpression_of_a_specific_query_gene_the_hazard_ratio_hr_with_ _confidence_intervals_and_log_rank_p_values_werecalculated_to_assess_the_relationship_of_gene_expression_with_survival_and_also_the_numberatrisk_is_displayed_below_ _the_authors': 6.586694811007939e-05, 'numberatrisk': 9.148819220060914e-58, 'to_assess_the_relationship_of_gene_expression_with_survival': 9.148819220060914e-58, 'mrnasthe_node': 9.148819220060914e-58, 'bsr20201727101042bsr20201727figure_result_primer_sequences_5cid3gggagcttgtccttttccga3cid3reverse': 9.148819220060914e-58, 'reports_represents': 8.263922883666513e-55, 'ex_taq\\x84¢_takara': 1.1686951820486561e-54, 'instructions_gapdh': 8.263922883666513e-55, 'using_the_ _\\x88\\x92ä\\x89\\xadä\\x89\\xadct': 0.0008522036149147152, 'shapes_red': 0.000195199478604598, 'abcam': 0.00028074246679799187, 'polyacrylamide_gel_electrophoresis_sdspage_membranes': 0.00036576662780187614, 'sodium_dodecyl': 1.6455919145849257e-06, 'polyacrylamide_gel_electrophoresis_sdspage': 2.6870445000920736e-08, 'using_imagej_software_national_institutes_of_healthbethesda_mdstatistical_analysiscorrelation_between_delncrnas_and_degs_using_pearson\\x99s_correlation_the_kaplan\\x93meier_survivalcurves_were_used_to_show_the_differences_of_hub_genes_in_patient\\x99_os_between_the_high_expression_group_and_lowexpression_group_and_the_statistical_significance_was_obtained_using_the_twosided_logrank_test_the_expression_ofhub_genes_in_gse89102_was_used_to_conduct_roc_analyses_the_difference_between_the_two_groups_was_estimatedusing': 7.296466640998506e-07, 'using_imagej_software_national_institutes_of_healthbethesda_mdstatistical_analysiscorrelation_between_delncrnas_and_degs': 7.296466640998506e-07, 'using_pearson\\x99s_correlation_the_kaplan\\x93meier_survivalcurves_were_used_to_show_the_differences_of_hub_genes_in_patient\\x99_os_between_the_high_expression_group_and_lowexpression_group_and_the_statistical_significance_was_obtained_using_the_twosided_logrank_test_the_expression_ofhub_genes_in_gse89102_was_used_to_conduct_roc_analyses_the_difference_between_the_two_groups_was_estimatedusing': 7.296466640998506e-07, 'kaplan\\x93meier_survivalcurves': 9.148819220060914e-58, 'to_show_the_differences_of_hub_genes_in_patient\\x99_os_between_the_high_expression_group_and_lowexpression_group_and_the_statistical_significance_was_obtained_using_the_twosided_logrank_test_the_expression_ofhub_genes_in_gse89102_was_used_to_conduct_roc_analyses_the_difference_between_the_two_groups_was_estimatedusing': 9.148819220060914e-58, 'ofhub_genes': 9.148819220060914e-58, 'to_conduct_roc_analyses': 9.148819220060914e-58, 'bsr20201727101042bsr20201727table': 0.0002543534709449633, 'change\\x89¥_gene_rank': 7.503404333639232e-08, 'rank_percentile': 0.0002584379969449155, 'gene_rank': 9.148819220060914e-58, 'percentileof_target_genes': 9.148819220060914e-58, 'normalization_scatterplot': 0.00024831101020746386, 'xpo4updownupdowndownfigure_tcga_portal_analysis': 3.1235511726865175e-05, 'suppinfoxls_table_suppinfoxls': 9.148819220060914e-58, 'escc': 9.148819220060914e-58, 'intersection_number': 0.000253466598330819, 'lncbase_v20_dataset': 4.787483283520024e-05, 'delncrnas': 0.000826329097596332, 'to_construct_a_specific_cerna_lncrna\\x93mirna\\x93mrna_network_using_cytoscape_figure_3a': 0.0006625816769337724, 'understanding_\\x98multiplelncrnasmultiple': 0.007713134335009549, 'domain_factor_runx1': 0.000195199478604598, 'terms_kegg_pathway': 0.0006992128660964839, 'reports_correlation_coefficients_coexpression_analysis': 1.135424724611318e-05, 'coexpressed': 2.172941870320097e-06, 'to_construct_the_ppi_network_of_the_lncrnacoexpressed_mrnas_a_total_of_ _except_cldn7_slpi_and_s100a14_of_ ': 0.00013337286069712748, 'online_database_cytoscape_software': 0.0001327562468548339, 'ndufaf3atp2c1': 9.148819220060914e-58, 'cldn7_slpi': 9.148819220060914e-58, 'that_sry_sex_determining_region_to_regulate_cdk1_vegfa_prdm10_runx1_cdk6_hsp90aa1_and_myc_ _hub_genes': 0.0003540754526695089, 'that_sry_sex_determining_region': 0.007713134335009549, 'ybox_sox2had': 9.148819220060914e-58, 'to_regulate_cdk1_vegfa_prdm10_runx1_cdk6_hsp90aa1_and_myc_ _hub_genes': 9.148819220060914e-58, 'vegfa_prdm10': 9.148819220060914e-58, 'growth_response': 9.148819220060914e-58, 'using_the_ualcan_and_oncomine_database_as_a_preliminary_step_we_measuredthe_expression_of_cdk1_vegfa_prdm10_runx1_cdk6_hsp90aa1_and_myc_in_ _different_kinds_of_cancerand_compared_with_normal_individuals_as_shown_in_figure_ _the_mrna_expression_of_cdk1_and_runx1_wassignificantly_raised_in_ec_samples_in_multiple_datasets_tcga_dataset_mining_was_performed_using_ualcan_toshown_that_abnormal_expression_of_the_hub_genes_including_cdk1_vegfa_prdm10_runx1_cdk6': 0.0016810521528134112, 'hsp90aa1and_myc': 9.148819220060914e-58, 'similarlythe_hub_genes': 9.148819220060914e-58, 'dataset_figure_sources': 0.0016810521528134112, 's_case': 9.148819220060914e-58, 'duplicate_studies_those': 9.148819220060914e-58, 'managementdata': 0.00010049604554307965, 'qu_kthe': 0.0014616190772430405, 'indexes': 0.00024810373354211296, 'to_contact_the_authors_to_request_the_missing_or_incomplete_data_if_those_relevant_data_are_notacquired_they_will_be_excluded_from_the_analysisquality_assessmentto': 0.007713134335009549, 'shortterm_and_longterm_clinical_efficacy_and_adverse_effectsaccording_to_response_evaluation_criteria_in_solid_tumors_ _recist_criteria_  ': 0.0004734482721133418, 'year_os_time_cochrane\\x99s': 0.0002563240305303972, 'orr_dcr_orr': 0.0005506199709643784, 'qol_qol': 9.148819220060914e-58, 'using_the_qualityoflife_improved_rate_qir': 9.148819220060914e-58, 'karnofsky': 9.148819220060914e-58, 'function_indicators': 9.148819220060914e-58, 'efficacy_year_os_time_using_the_qualityoflife_improved_rate_qir_function_indicators_cochrane\\x99s': 3.15642465854685e-05, 'using_the_funnel_plots': 0.0005269923949341242, 'trimandfill_method': 3.903865469504451e-06, 'estimates_results': 5.151722193212077e-07, 'n11': 0.00025282913626928664, 'granule': 0.0007424969077119944, 'qidong_pharmaceutical_co_ltd': 1.2114493811528609e-05, 'ofbias_red': 1.7297809411881257e-05, 'assessmentsorr_trials': 9.148819220060914e-58, 'orr_dcr': 9.148819220060914e-58, 'improved_\\x93_p002_dcr': 0.001845170519318405, 'to_analyze_rr_otherwise_arandomeffect_model_was_used_ _the_authors_this_is_an_open_access_ _published_by_portland_press_limited_on_behalf_of_the_biochemical_society_and_distributed_under_the_creative_commons_attributionlicense_ ': 0.0006943564809761616, 'to_pool_thismetaanalysis_otherwise': 0.0006943564809761616, 'effectsmodel': 9.148819220060914e-58, 'to_pool_this_metaanalysis_otherwise': 9.148819220060914e-58, 'to_analyze_rr_otherwise': 0.0006943564809761616, 'evaluationimmune_status': 7.0706272877937e-05, 'ci_\\x93_p00001_cd4cd8_ratio': 1.604120213469273e-05, 'reports_kps_b': 9.148819220060914e-58, 'rr_ci_\\x93p005': 9.148819220060914e-58, 'to_pool_thismetaanalysis_due_to_significant_heterogeneityassessment_of_adverse_eventsas_shown_in_figure_ _patients_treated_with_huaier_granule_and_conventional_methods': 0.0006943564809761616, '\\x93_\\x93_p006_nausea': 0.001129870936471824, 'andalopecia_rr_ci_\\x93_p020': 8.263922883666513e-55, 'rr_ci_\\x93p005_to_pool_this_metaanalysis_otherwise_the_fixedeffect_model_was_usedpublication_biasas_shown_in_figure_ _the_funnel_plots': 1.1686951820486561e-54, 'to_pool_this_metaanalysis_otherwise_the_fixedeffect_model_was_usedpublication_biasas_shown_in_figure_ _the_funnel_plots': 8.413484531389019e-09, 'egger\\x99s_regression_tests': 8.263922883666513e-55, 'trend_analysis': 1.604120213469273e-05, 'indicatorscd4_cd4cd8_ratio': 0.0018006682651940404, 'reports_cells_percentage_model_inverse_variancemethod': 0.0007959416758056306, 'qidong_ltd_thedosages': 0.0019024161085375757, 'funnel_plot_effects': 9.148819220060914e-58, 'to_be_systematically_evaluated_thus_indepth_knowledge_of_the_efficacy_and': 9.148819220060914e-58, 'clues_forresearchers': 0.00018869384058700235, 'granule_treatment': 0.0021144167978923737, 'orr_qol': 1.2114493811528609e-05, 'huaiergranule': 0.00011413593752663788, 'using_huaier_granule': 0.0010068765747081726, 'cell_subsets_cd4cd8_ratio_cells': 2.9932030120876944e-05, 'analysisdemonstrated': 0.001845170519318405, 'exhibiting_imbalance_of_t_lymphocytes_percentage_  _many_studies': 9.148819220060914e-58, 'immunefunction_activity': 9.148819220060914e-58, 'to_be_a_safe_auxiliary_antitumor_medicine_for_individuals_with_breast_cancerthere': 1.2114493811528609e-05, 'trials_table': 9.75282124191382e-07, 'nct02615457_nct02627248_trial': 5.974993042009456e-05, 'efficacy_outcomes': 0.00025282913626928664, 'granule_forstage_ii_breastcancer': 0.004315547045054443, 'medicaluniversity_chongqingchinabreast_cancer': 9.148819220060914e-58, 'highquality_evidence': 9.148819220060914e-58, 'paying_close_attention_to_upcoming_highquality_clinical_trials_in_our_later_studies_and_carry_out_further_analyseson_studies_conducted_huaier_granule_monotherapy_against_breast_cancer': 0.007713134335009549, 'analyseson_studies': 9.148819220060914e-58, 'granule_monotherapy': 9.148819220060914e-58, 'which_authors': 9.148819220060914e-58, 'to_deliver_positive_results_of_s_to_editors': 9.148819220060914e-58, 'anyconclusions': 9.148819220060914e-58, 'to_be_made_with_cautionconclusionin_summary_findings_of_this_metaanalysis': 9.148819220060914e-58, 'reports_ww': 0.0014620085655300467, 'xl': 0.0021851800433307462, 'yao_xl_wu': 2.3863323261202395e-05, 'ww_qu_k': 0.001129870936471824, 'xi_w_quk': 0.00022771936739542464, 'killer_cells': 0.00012620701047132057, 'dm_pi': 9.148819220060914e-58, 'cancer_incidence_mortality_bray_f_ferlay_j_soerjomataram_ej_overview_m': 9.148819220060914e-58, 'rl_torre_la_jemal': 0.0004499048194399722, 'breast_intervention_treatment_options_ros_mendoza_lh_breast_cancer_mr_deng_g_practice_guidelines': 9.148819220060914e-58, '\\x93_zhu_li_l_li_y_wang_j_medicine': 9.148819220060914e-58, 'h_extract': 0.0011125787591309202, 'zhen_effect': 9.148819220060914e-58, 'trial_gut_\\x93_zhang_y_wang_x_chen_t_efï¬\\x81cacy': 9.148819220060914e-58, '\\x93_101016jejca201603081_jackson_d_white_ir_riley_rd': 0.0007095919825356841, 'cacs': 0.0020375899270446665, 'to_summarize_the_available_evidence_on_association_of_cvd_risk_with_early_crn_detection_in_asymptomatic_populations_pubmed_web_of_science_and_embase_were_systematically_searched_for_eligible_studies_published_until_dec_  _studies_exploring_the_associations_of_recommended_cvd_risk_assessment_methods': 5.526896120685606e-51, 'association_odds_ratio': 0.0003833771411240826, 'frs10_frs': 9.148819220060914e-58, 'identify_subgroups_at_increased_risk_for_an_but_further_studies': 9.148819220060914e-58, 'frs10_frs_might_help_identify_subgroups_at_increased_risk_for_an_but_further_studies_are_needed_keywords_cardiovascular_disease_risk_assessment_colorectal_neoplasiaintroductionboth_ _colorectal_cancer_ _crc_ _and_ _cardiovascular_ _diseases_cvd_ _are_the_ _leading_causes_ _of_ _mortality_ _and_ _morbidity_ _worldwide12_ _previous_ _studies_ _have_ _shown_a_strong_coexistence_of_colorectal_neoplasia_crn_and_cvd_probably_due_to_the_shared_risk_factors_eg_smoking_obesity_and_metabolic_syndrome_and_pathophysiological_mechanisms_eg_chronic_inflammation_and_oxidative_stress3\\x93current_guidelines8\\x93_recommend_assessing_the_cvd_risk_in_healthy_people_using_risk_estimation_scores_such_as_framingham_risk_score_frs1112_procam13_and_the_pooled_cohort_equation14_which_are_based_on_individuals\\x99_medical_history_and_easily_available_ _laboratory_ _data_ _in_ _addition_ _assessment_ _of_ _subclinical_ _atherosclerosis_ _by_imaging_modalities': 1.1133903263398695e-05, 'commons_attribution': 0.0006824744630645701, 'worldwide12_studies': 7.200305628370537e-51, 'assessing_the_cvd_risk_in_healthy_people_using_risk_estimation_scores_such_as_framingham_risk_score_frs1112_procam13_and_the_pooled_cohort_equation14_which_are_based_on_individuals\\x99_medical_history_and_easily_available_ _laboratory_ _data_ _in_ _addition_ _assessment_ _of_ _subclinical_ _atherosclerosis_ _by_imaging_modalities': 3.4711755750831686e-51, 'press': 0.0009677804919467999, 'to_be_positively_related_to_the_increased_risk_of_adenoma_ad_and': 9.578432564920414e-06, 'to_be_positively_related_to_the_increased_risk_of_adenoma_ad_and_participants_discussionquality_assessment': 0.00020021422969648575, 'cvd_risk_assessment': 9.148819220060914e-58, 'trigger_crc_screening': 9.148819220060914e-58, 'disagreement_consensus': 3.2638818420870913e-06, 'xc': 2.513455262795535e-05, 'data_extraction': 4.1032340715043677e-07, 'year_study_period_number': 9.148819220060914e-58, 'ad_an_hazard_ratio': 9.148819220060914e-58, 'discussionquality_assessment': 5.3366458622320946e-08, 'to_calculate_pooled_estimates': 3.9208037262889986e-05, 'twosided_p_values': 0.0002208255543092432, 'to_be_characteristics_flowchart_risk': 0.00038347934055751865, 'study_characteristicstable': 0.0005536611936400708, 'flowchart_risk': 0.0004277984666718556, 'commons_license_disclaimer': 8.263922883666513e-55, 'bsd': 9.148819220060914e-58, 'cdetected_by_colonoscopies_in_all_included_studies_d100_cecum_intubation_rate_participants_with_failure_of_cecum_intubation_were_excluded': 9.148819220060914e-58, 'colonoscopies': 1.2989595986384956e-05, 'risk_applicability_concerns': 9.148819220060914e-58, 'cdetected_by_colonoscopies_in_all_included_studies_d100_cecum_intubation_rate_participants_with_failure_of_cecum_intubation_were_excluded_details_risk': 9.148819220060914e-58, 'table_details': 9.148819220060914e-58, 'yescacs_cacs': 9.148819220060914e-58, 'ci_studies': 0.00014637531747997777, 'cacs_levels': 9.148819220060914e-58, 'to_be_associated_with_the_increased_risk_of_ad_with_or_ranging_from_   _to_   _the_ _10year_ _chd_ _risk_ _estimated_ _by_frs_ _was_ _categorized_ _as_ _low_ _risk_   _intermediate_risk_ _\\x93_ _and_ _high_ _risk_ _\\x89¥_ _participants_with_ _high_ _risk_ _of_ _10year_ _chd_ _had_ _increased_ _risk_ _of_either_ad_or_an_in_the_study_by_basyigit_  _participants_at_high_chd_risk_had_about_4fold_or_  _ci_  _increased_risk_of_an28metaanalyses_of_available_ors_for_different_cvd_risk_assessment_methodsmetaanalyses_were_performed_in_the_studies_that_provided_ors_and_their_ _cis_for_the_same_cvd_risk_assessment_index_ _the_ _association_ _of_ _cap_ _with_ _the_ _risk_ _of_ _ad_ ': 9.148819220060914e-58, '10year_chd': 0.0007862569594425692, 'ors_cis': 0.004315547045054443, 'cacs0_participants': 0.0007862569594425692, 's1\\x93discussionthis_review': 9.148819220060914e-58, 'associations_total': 9.148819220060914e-58, 'study29': 9.148819220060914e-58, 'risk_associations_total': 9.148819220060914e-58, 'abi': 0.0007862569594425692, 'to_ _develop_ _via_a_process_of_insulin_resistance_inflammation_and_oxidative_clinical_epidemiology_                                                                                               ': 0.0021040413827844023, 'blood_pressure_treatment_generalizability_recall_bias_efforts_to_ _have_ _a_ _screening_ _for_ _crn_ _which_ _will_ _help_increase_ _compliance_ _and_ _uptake_ _of_ _crc_ _screening_ ': 0.0006674076661460604, 'number_metabolismrelated_pathways_pathways': 0.0013882295497307361, 'blood_pressure_treatment': 1.4483005687196646e-05, 'consumption_frs': 9.148819220060914e-58, 'generalizability_recall_bias': 9.148819220060914e-58, 'frs': 0.0010072862845068057, 'to_ _have_ _a_ _screening_ _for_ _crn_ _which_ _will_ _help_increase_ _compliance_ _and_ _uptake_ _of_ _crc_ _screening_ ': 0.0006674076661460604, 'increase_ _compliance_ _and_ _uptake_ _of_ _crc_ _screening_ ': 0.0038806204677737646, 'time_costs': 0.00210348072096923, 'chd_risk_cvd_risk': 1.643160004751786e-05, 'asians': 0.0007862569594425692, 'to_ _yield_results_with_wide_ci_probably_due_to_the_limited_number_of_participants_ _the_ _wider_ _the_ _ci_ _the_ _less_ _the_ _precision_ _in_summary': 1.643160004751786e-05, 'cvd_risk': 9.148819220060914e-58, 'crc_screening': 9.148819220060914e-58, 'to_ _improve_cvd_ _risk_ _assessment_ _and_ _serve_ _as_ _a_ _guide_ _for_ _initiating_ _preventive_therapies8\\x93_a_high_cacs': 0.0007956673215405282, 'is_ _generally_ _not_recommended_in_clinical_practice_but_use_of_these_imaging_techniques_ _has_been_ _shown_ _to_ _improve_cvd_ _risk_ _assessment_ _and_ _serve_ _as_ _a_ _guide_ _for_ _initiating_ _preventive_therapies8\\x93_a_high_cacs': 9.148819220060914e-58, 'modify_the_predicted_risk_ _obtained_ _from_ _frs_ _alone_ _especially_ _among_ _patients_in_ _the_ _intermediaterisk_ _developed_ _in_ _the_ _multiethnic_ _study_ _of_atherosclerosis_ _mesa_ _study_ _used_ _both_ _cacs_ _and_submit_your_manuscript_ ': 9.148819220060914e-58, 'chen_risk_factors': 0.00023692166185062638, 'explain_ _why_ _the_ _performance_ _of_ _risk_ _models_is_ _improved_ _by_ _adding_ _markers_ _with_ _anatomical_ _delineation_ _through_ _imaging_ _technology_ _accounting_ _for_ _the_higher_ _performance_ _of_ _the_ _combined_ _use_ _of_ _risk_ _scores_and_imaging_tools_on_cvd_risk_assessment_further_studies': 0.0010325216439875707, 'studies_data_risk': 0.0007862569594425692, 'to_ _help_ _identify_ _relevant_ _s_ _in_ _addition_ ': 8.604517831559114e-06, 'questionnaires_standard_deviationfundingthis_research': 3.68289106346844e-05, 'grant_disclosurethe_authors': 9.148819220060914e-58, 'conflicts_bray_f_ferlay_j_soerjomataram': 9.148819220060914e-58, 'siegel_m_al': 9.148819220060914e-58, 'burden_\\x93_doidoi101161circresaha117308903_chan_aoo_man_al_prevalence': 9.148819220060914e-58, 'siegel_ _rl_ _torre_ _la_ _jemal_ _a_global_cancer_statistics_ _globocan_estimates_of_incidence_and_mortality_ _worldwide_ _for_   _cancers_ _in_   _countries_ _ca_ _cancer_j_clin_\\x93_doidoi103322caac21492_joseph_ _p_ _leong_ _d_ _mckee_ _m_ _et_ _al_ _reducing_ _the_ _global_ _burden_ _of_cardiovascular_ _disease_part_  _the_epidemiology_and_risk_ _factors_circ_res_\\x93_doidoi101161circresaha117308903_chan_ _aoo_ _man_ _hj_ _kwok_ _fl_ _et_ _al_ _prevalence_ _of_ _colorectal_ _neoplasm_among_patients_with_newly_diagnosed_coronary_artery_disease_j_ _am_ _med_ _assoc_   _doidoi101001jama29812_clinical_epidemiology_                                                                                               ': 0.00022771936739542464, 'to_ _have_ _the_ _potential_ _to_ _metastasize_ _even_ _in_ _well_differentiated_ _tumors_ _and_ _are_ _resistant_ _to_ _therapies1\\x93_ _data_ _from_ _the_ _surveillance_epidemiology_and_end_results': 0.0013882295497307361, 'email_press_terms_commons_attribution': 0.0008062909115829067, 'email': 2.2742787312308305e-05, 'to_be_associated_with_lnm_and_poor': 0.004315547045054443, 'database_echoes_signal': 0.0009843506246251625, 'echoes_signal': 0.0004472423269940801, 'pathology_results': 0.007713134335009549, 'using_pearson\\x99s_Ï\\x872_test_in_univariable_analysis_ _and_ _logistic_ _regression_ _analyses_ _in_ _multivariable_analysis': 0.00022943859288752802, 'survival_os_progression_survival_pfs': 3.7400372930760105e-06, 'using_the_cox_proportional_hazards_model_statistical_significance': 0.001129870936471824, 'resected': 0.0007129960827382031, 'lnm': 0.0024484270987102214, 'to_have_liver_metastasis': 0.0006324067207528349, 'variablesage\\x89¥sexmalefemalebmi\\x89¥smoking_historydrinking_historyfamily_cancer_historyyesnoneoadjuvant_chemotherapyyesnoneoadjuvant_radiotherapyyesnodistance_from_the_anal_verge_cm\\x89¥tumor_locationrectumcolonappendixtreatmentemresdtransanal_excisionradical_resectionmultivisceral_resectionpalliative_resectionsystemic_treatmenttumor_diameter_cm\\x89¥t_stage_after_chemotherapyxn_                                 _variableslnmnegativepositivedistant_metastasisnegativepositivetumor_gradeg1g2g3cga_n101negativesyn_n109negativen_                _kaplan\\x93meier_survival_curveskaplan\\x93meier_survival': 0.0005536611936400708, 'i_ii_tumors': 1.1686951820486561e-54, 'variablesage\\x89¥sexmalefemalebmi\\x89¥smoking_historydrinking_historyfamily_cancer_historyyesnoneoadjuvant_chemotherapyyesnoneoadjuvant_radiotherapyyesnodistance_from_the_anal_verge_cm\\x89¥tumor_locationrectumcolonappendixtreatmentemresdtransanal_excisionradical_resectionmultivisceral_resectionpalliative_resectionsystemic_treatmenttumor_diameter_cm\\x89¥t_stage_after_chemotherapyxn_                                 _variableslnmnegativepositivedistant_metastasisnegativepositivetumor_gradeg1g2g3cga_n101negativesyn_n109negativen_                _kaplan\\x93meier_survival_curveskaplan\\x93meier_survival_to_ _be_ _as_ _high_ _as_   _and_   _but_ _dropped_ _to_   _and_ _for_stage_iii_and_iv_tumors_respectively22_according_to_epidemiological_data_from_the_seer_database_and_gkr_joint_cancer_registry': 8.263922883666513e-55, '\\x93discussionnets': 0.0006578099350934741, 'to_ _be_ _as_ _high_ _as_   _and_   _but_ _dropped_ _to_   _and_ _for_stage_iii_and_iv_tumors_respectively22_according_to_epidemiological_data_from_the_seer_database_and_gkr_joint_cancer_registry': 8.263922883666513e-55, 'Ï\\x872': 9.148819220060914e-58, 'valuen_hr_cip_staget0t1t2t3t4cganegativesynnegative_notes': 9.148819220060914e-58, 'valuep_diameter\\x89¥_locationrectumcolonappendix_tumor': 9.148819220060914e-58, 'to_ _be_ _risk_ _factors_ _for_ _lnm_ _by_ _numerous_studies1223_ _a_multicenter_clinical_study_in_china': 9.148819220060914e-58, 'values_os_rate': 2.9402948113849672e-05, 'to_be_a_strong_predictive_factor_ _for_ _lymph_ _node_ _metastasis_ ': 0.001801148090838322, 'tumor_grade': 0.00011077000528471037, '0cwu_analysis': 0.0003503299682769458, 'lnm_patients': 3.9961994326821176e-05, 'table_comparison_rate_notes': 0.00017163985562284115, 'examinations_ct': 0.0006683740194778514, 'et_al35': 6.586694811007939e-05, 'cga_levels': 0.0007409703675136236, 'os_rate': 0.001845170519318405, 'patients_therapies': 0.007713134335009549, 'treatment_method': 9.148819220060914e-58, 'submit_your_manuscript_ ': 9.148819220060914e-58, 'dovepress_050100150200020406080100months': 9.148819220060914e-58, 'positivemoderate_positivestrong_positivep0023050100150200020406080100months': 9.148819220060914e-58, '0cwu_dovepressthis_study': 0.00044941264492739084, 'survival_outcomes_factors': 0.007713134335009549, 'to_validate_our_main_sthe_clinical_and_pathological_characteristics_of_rectal_and_colon_ _neuroendocrine_ _tumors_ ': 0.0018006682651940404, 'glioma_initiates_from_glial_cells_and_contains_several_types_such_as_astrocytoma_and_oligodendroglioma1_ _over_ _a_ _quarter_ _of_ _brain_ _tumors_ _are_ _glioma_ _which_ _causes_a_large_number_of_cancerrelated_deaths_every_year_around_the_world1_ _the_current_clinically_ _therapeutic_ _strategies_ _are_ _surgery_ _combined_ _with_ _chemotherapy_ _and_radiotherapy2_ _however_ _the_ _prognosis_ _of_ _glioma_ _patients_ _remains_ _not_ _well_ _post_therapy3_ _hence_it_is_urgently_required_to_discover_new_molecular_mechanism_for_glioma_therapyboth_long_noncoding_rna_lncrna_and_microrna_mirna_belong_to_noncoding_rnas_which_have_no_proteincoding_ability_lncrna_is_characterized_with_more_than_ _nucleotides_while_mirna_is_about_ _nucleotides_in_length4_lncrna_and_mirna_are_involved_in_various_cellular_processes_including_cell_division_invasion_and_survival5_dysregulation_of_lncrna_or_mirna': 9.148819220060914e-58, 'tumor_initiation_progression67': 9.148819220060914e-58, 'post_therapy3': 0.0006578099350934741, 'to_discover_new_molecular_mechanism_for_glioma_therapyboth_long_noncoding_rna_lncrna_and_microrna_mirna': 0.00210348072096923, 'linc00152_upregulation': 0.00013886388020074755, 'lncrna_snhg6_overexpression': 9.148819220060914e-58, 'cancer_cell_proliferation': 9.148819220060914e-58, 'mir3405p_dysregulation': 0.00024590992947369467, 'press_terms': 0.0005009469007563088, 'definedlinc00173': 0.0006625816769337724, 'to_ _elevate_ _nutf2_ _expression_ _taken_together_ _our_ _findings_ _supported_ _that_ _linc00173_ _plays_essential_ _oncogenic_ _roles_ _in_ _glioma_ _through_ _activating_mir765nutf2_pathwaymaterials_and_methodsclinical_samplesthirtyseven_glioma_tissues_ _and_ _normal_ _tissues_were_ _collected_ _from_ _lishui_ _city_ _people\\x99s_ _radiotherapy_chemotherapy': 0.0016815001133323047, 'to_ _elevate_ _nutf2_ _expression_ _taken_together_ _our_ _findings_ _supported_ _that_ _linc00173_ _plays_essential_ _oncogenic_ _roles_ _in_ _glioma_ _through_ _activating_mir765nutf2_pathwaymaterials_and_methodsclinical_samplesthirtyseven_glioma_tissues_ _and_ _normal_ _tissues_were_ _collected_ _from_ _lishui_ _city_ _people\\x99s_ ': 0.0016810521528134112, 'linc00173': 0.000867778838962521, 'hospital_patients': 4.952971417653253e-05, 'n18pvalueexperiments': 2.7446560661786228e-05, 'inhibitors_using_qrtpcr': 5.877927843407135e-06, 'mir6293p': 0.00017245730531167117, 'using_qrtpcr': 5.877927843407135e-06, 'holdings_inc_tokyo_japan': 9.148819220060914e-58, 'to_ _generate_ _cdna_ _from_ _rna_ _template_qpcr': 9.148819220060914e-58, 'system_promega_madison_blot_assaycells': 9.148819220060914e-58, 'using_ _radioimmunoprecipitation_ _buffer_beyotime_ _shanghai_ _china_ _protein_ _concentration_ _was_determined_ _by_ _a_bca_ _protein_ _assay_kit_ _thermo_ _fisher_scientific_ma': 9.148819220060914e-58, 'buffer_china_protein_concentration': 9.148819220060914e-58, 'scientific_ma': 9.148819220060914e-58, 'antibodies_manuscript': 0.0007361855534323904, 'reagent_usathrough': 0.00022771936739542464, 'cancer_management_research_0cdovepress': 0.00022661998665173344, 'using_ _cck8_ _and_ ': 3.698186563818794e-06, 'using_ _cck8_ _and_ _detection': 0.007717602935372225, 'to_ _measure_migration_ _and_ _invasion_ _according_ _to_ _the_ _manufacturer\\x99s_instructions_ _in_ _brief_ _cells_ ': 8.263922883666513e-55, 'kaplan\\x93meier_method_rank_test_to_be': 0.001246477851408505, 'to_analyze_ _results_ _data_ _were_ _presented_ _as_ _means±standard_deviation_ _sd_ _significant_ _differences_ _were_ _analyzed_using_ _student\\x99s_ _ttest_ _or_ _oneway_ ': 5.877927843407135e-06, 'deviation_differences': 9.148819220060914e-58, 'using_ _student\\x99s_ _ttest_ _or_ _oneway_ ': 9.148819220060914e-58, 'kaplan\\x93meier_method': 7.048424814961187e-05, 'significantresultslinc00173_expression': 2.0339628351371368e-05, 'glioma_proliferation_migration_invasionto': 1.4156900215542214e-05, 'linc00173_knockdown': 0.00023616863904079525, 'edu': 0.0038806204677737646, 'linc00173_loss': 0.00014265292060500713, 'exerted_worked': 9.148819220060914e-58, 'to_serve_as_cerna_for': 9.148819220060914e-58, 'invasionlinc00173': 0.0005218289698578611, 'management_research': 0.0005444339004755319, 'glioma_proliferation_migration_invasion_analysis': 1.4156900215542214e-05, 'b\\x93e_proliferation_ability': 9.148819220060914e-58, 'using_cck8_edu': 9.148819220060914e-58, 'glioma_proliferation_migration_invasion_analysis_using_cck8_edu': 0.007740714078928659, 'figure_3a': 9.148819220060914e-58, 'reporter_assay_results': 9.148819220060914e-58, 'mir765_activity': 9.148819220060914e-58, 'interaction_pulldown': 9.148819220060914e-58, 'interaction_figure': 0.00011106025105097825, 'linc00173_overexpression': 0.0006675855277129212, '3e_luciferase_reporter_assay': 0.000528146067012347, 'figure_3f': 9.174348448241564e-06, 'mir765': 0.0005624450891059304, 'nutf2_level': 1.8120544773027172e-06, 'jlinc00173': 2.313872485543775e-07, '3i': 3.77413926148221e-09, 'glioma_progression': 1.4164447488744332e-05, 'nutf2_restoration': 7.537965559352772e-06, 'cancer_management_figure_linc00173': 1.9982525325514424e-51, 'to_glioma_progression_through_mir765nutf2': 3.2144911158066846e-05, 'lncrna_nck1as1': 1.2124458097915812e-05, 'to_inhibit_ _mir765_ _and_ _promote_ _nutf2_ _expression': 1.9795895752096003e-07, 'to_participate_in_glioma_development_for_example': 4.787483283520024e-05, 'lncrna_ccat2': 9.148819220060914e-58, 'to_inhibit_ _mir765_ _and_ _promote_ _nutf2_ _expression_growth_metastasis': 9.148819220060914e-58, 'lncrna_linc00467_upregulation': 9.148819220060914e-58, 'glioma_development': 9.148819220060914e-58, 'linc00173_downregulation': 8.263922883666513e-55, 'nonsmall_cell_cell_growth': 1.1686951820486561e-54, 'survival17_study': 8.263922883666513e-55, 'transwell_assay_p005lncrna': 1.4156900215542214e-05, 'cdkn2bas1_sponges': 9.148819220060914e-58, 'to_regulate_cellcycle_progression_in_laryngeal_squamous_cell': 9.148819220060914e-58, 'linc00173_sponges': 0.007713134335009549, 'mir765_expression': 1.0892073836463245e-05, 'to_ _suppress_ _tongue_ _squamous_ _cell_ _carcinoma_development20_ ': 9.174348448241564e-06, 'myeloma_osteosarcoma_progression2122': 0.0015934654036464915, 'klf6_axis': 0.0006246792128329638, 'to_promote_breast_cancer_progression26_through_bioinformatics': 0.00032874997356751706, 'nutf2': 9.174348448241564e-06, 'nutf2_expression': 9.148819220060914e-58, 'axis_function': 9.148819220060914e-58, 'nutf2_overexpression': 0.000234035537295674, 'analytical_testing_animal_program': 0.0003167145330801072, 'province_welfare_technology': 9.148819220060914e-58, 'research_project': 9.148819220060914e-58, '2017c37111_disclosureall_authors': 8.78179392754469e-05, 'v100': 9.148819220060914e-58, 'sponging_microrna13823p_ _and_ _activating_ _the_ _trim24wntbetacatenin_axis_ _j_ _exp_ _clin_ _cancer_ _res_   _101186s13046_tumorigenesis_through_ _chen_ _w_ _lei_ _c_ _liu_ _p_ _et_ _al_ _progress_ _and_ _prospects_ _of_ _recurrent_glioma_ _a_ _recent_ _scientometric_ _analysis_ _of_ _the_ _web_ _of_ _science_ _in_  _world_ ': 9.148819220060914e-58, '2020134e387\\x93e399_101016jwneu20': 0.00022771936739542464, 'asb16as1': 0.000234035537295674, 'linc00152': 9.836745328022287e-06, 'snhg6': 9.148819220060914e-58, 'growth_invasion': 9.148819220060914e-58, 'j_pik3c3': 1.1686951820486561e-54, '5p_med_sci_monit_z_cheng_viability': 8.263922883666513e-55, '5p_med_sci_monit_z_cheng': 8.263922883666513e-55, 'microrna126': 0.0002618838152087058, 'rna_ror': 2.7547970040346435e-05, 'al_linc00173': 9.148819220060914e-58, 'chemoresistance_progression': 9.148819220060914e-58, 'et_lncrna_linc00173': 0.0001497275464614471, 'sun_sl_shu_yg_tao': 0.00021559585552483182, 'linc00467': 2.3132559798549087e-07, 'mir1825p_accumulation': 0.000102575415207327, 'ttnas1': 2.4867840032305923e-05, 'linc00511': 9.148819220060914e-58, 'cell_migration_invasion_carcinoma_progression': 9.148819220060914e-58, 'chen_g_microrna765': 0.0015842910551982499, 'lv_gao_k_microrna765': 9.148819220060914e-58, 'mtus1': 9.148819220060914e-58, 'et_al_linc00994': 3.0013733933781622e-06, 'linc00312': 0.0001497275464614471, 'wwwdovepresscomcancermanagementandresearchjournalcancer_management_research': 0.00022771936739542464, 'function_protein': 0.007713134335009549, 'physical_interactionsof': 0.0004738574283430153, 'ability_results': 0.0015842910551982499, 'indesigning_novel_therapies_targeting_tnbcthis': 0.0038806204677737646, 'hormone_therapy_antiher2_therapy': 0.00016556279476844177, 'angiogenesis_events_activation': 0.0004005448148874858, 'angiogenesis_events': 0.0004005448148874858, 'resistanceat_stage_oncogenes_inthe_induction_unclearunveiling_the_roles_of_autophagy_throughout_differentstages_of_carcinogenesis_aids_in_developing': 6.710801136225571e-05, 'tobe_hallmark': 0.0015842910551982499, 'immunesurveillance_capabilities': 9.148819220060914e-58, 'initiation_promotion_acting': 9.148819220060914e-58, 'resistanceat_stage': 6.710801136225571e-05, 'oncogenes_tumor_suppressor_genes': 1.0313068720503174e-05, 'bcl2_inhibitors1920': 9.148819220060914e-58, 'inthe_induction': 9.148819220060914e-58, 'alsobeclin': 0.0004005448148874858, 'unclearunveiling_the_roles_of_autophagy_throughout_differentstages_of_carcinogenesis_aids_in_developing': 0.0015842910551982499, 'strategiessnares': 9.148819220060914e-58, 'to_regulate_the_initial_stepsof_autophagy_including_the_autophagosome_formation2324syntaxinbinding': 9.148819220060914e-58, 'protein_stxbp6': 9.148819220060914e-58, 'asa_regulator': 9.148819220060914e-58, '0clenka': 0.0006688016577034149, 'stxbp6': 1.1686951820486561e-54, 'tnbcprogressionmaterials_tissue': 8.263922883666513e-55, 'corporation_doha_qatar_patients': 0.0001142025392827344, 'hamad_committees_allpatients': 3.8979993308723807e-07, 'quantity_quality': 9.849136608862707e-05, 'mdamb231_mdamb468mcf7_zr751_cell_line': 0.0005253840276496832, 'milliporesigma': 2.628715582734087e-05, 'quantitativepcr_qpcr': 0.0004324474998927936, 'using_sybr_greenbased_gotaq_2steprtpcr_system_kit_promega_on_a_quantstudio_ _flexrealtime_pcr_system': 1.9172475277520724e-05, 'images_carl_zeiss': 5.7329206921586805e-05, 'carl_zeiss': 5.7329206921586805e-05, 'hrpactivity': 0.0004094262815172765, 'antibody_immobilon_crescendo_millipore_incubation': 0.00010601041703371442, 'immobilon_crescendo_millipore': 6.673987340943116e-06, 'grown_blocked': 1.7301857127532279e-06, 'tnbc': 0.0001264628547598116, 'rev': 1.7301857127532279e-06, 'agitated': 1.8220158181218793e-05, 'images_migration_assaycells': 1.8220158181218793e-05, 'pipet': 1.8220158181218793e-05, '2x_laemmlisample': 9.148819220060914e-58, 'scientific_boiled': 9.148819220060914e-58, '2x_laemmlisample_buffer_thermofisher_scientific_and_boiled_for_min_supernatant': 2.4945396697974886e-07, 'using_purespeed_tips_drieddown_in_the_speedvac_and_acidified_using_ _formicacid_to_run_in_the_qexactive': 1.5274014577666636e-05, 'speedvac_thepeptides': 2.4945396697974886e-07, 'peptideswere': 0.0003802249829989744, 'chromatography_lc': 9.148819220060914e-58, 'using_a_gradient_ranging_from_ _to_ _mobilephase_b_over_ _min_followed_by_a_10min_wash_andcolumn_reequilibration_cycle_data_dependent_mass_spectrometric_acquisition_employed_a_top_ _method_brieflythe_ _most_intense_ions_excluding_unassignedchargestates_and': 9.148819220060914e-58, 'ms_data': 0.00027479549607118417, 'discovery_rate_withswissmodel30_totwo_groups_ihcfor_metastasis_models_Ã\\x97_control_mock_isofluranethe_distribution_downregulation_cancer_patient_role': 0.009012877355323872, 'peptide_wasrequired': 0.00014730599916350568, 'withswissmodel30': 4.477312883593376e-06, 'proteins_coordinates': 0.00014730599916350568, 'poses': 0.00014730599916350568, 'thefigures': 9.148819220060914e-58, 'schrÃ¶dinger_primary_sequences': 9.148819220060914e-58, 'totwo_groups': 0.0005411681930881713, 'pharmalegacy_laboratories': 0.00017783908289502142, 'includedmice': 1.846583862460485e-10, 'pharmalegacy_laboratories_committee': 1.1310055140425744e-08, 'palpabletumors': 9.148819220060914e-58, 'to_evaluate_the_effectof_stxbp6overexpression_on_tumor_growth': 9.148819220060914e-58, 'ihcfor_metastasis_models_Ã\\x97_control_mock': 4.477312883593376e-06, 'stxbp6lenti_mdamb231cells': 9.148819220060914e-58, 'isofluranethe_distribution': 9.148819220060914e-58, 'fluorescence_index': 9.148819220060914e-58, 'ivis': 9.148819220060914e-58, 'expression_analysiswe': 9.148819220060914e-58, 'tcga_sequencingexpression_data_portalgdccancergov': 9.148819220060914e-58, 'count_data_files': 0.007713134335009549, 'tnbcsamples_37': 0.007713134335009549, 'tau_rank_corlenka_relation': 0.007713134335009549, 'tcga_sequencingexpression_data_portalgdccancergov_count_data_files_using_twowayanova_downregulation_1a': 1.8700952147504352e-05, 'course_difference': 0.0005073330404429016, 'using_twowayanova': 7.571497046169008e-06, 'downregulation_1a': 0.007713134335009549, '1b_we': 2.265328704190553e-05, 'expression_subtypemcf7_zr751_cells': 0.007713134335009549, 'analysis_mrna_levels': 9.148819220060914e-58, '\\x88\\x92Î´ct': 9.148819220060914e-58, 'ttest_p_b': 0.0003022165162482692, 'images_tissues_magnification': 9.148819220060914e-58, 'left_the_mean_values_of_the_ihc_quantification_in_arbitrary_units': 9.148819220060914e-58, 'standarddeviation': 0.0010298344840079976, 'sampleand_line_paz6': 0.0006264573400700461, 'stxbp6specific_island_methylation': 0.001129870936471824, 'highermethylation_percentage': 0.001129870936471824, 'overexpressing_stxbp6_lentistxpb6_tnbc_cells_by_infecting_mdamb231_and_0c_of_lenka_ ': 0.007713134335009549, 'loading': 0.0016815001133323047, 'band_intensity': 0.0016810521528134112, 'ttest_p_error_bars': 1.8090871199370374e-05, 'thesd': 2.7446560661786228e-05, 'expression_expression_ttest_p_error_bars_thesd_assaywhich': 3.909534922212017e-05, 'methylation_percentage_difference': 9.148819220060914e-58, 'd_determination': 9.148819220060914e-58, 'stxbp6_overexpression': 0.008221371705683841, 'assaywhich': 0.007713134335009549, 'colony_formation_figures5b': 0.0004990942860418787, 'cellgrowth_lentistxbp6_cells_cells': 8.263922883666513e-55, 'ina_xenograft_mouse_model': 0.0004990942860418787, 'to_fold': 0.0005828796252635297, 'interactingpartners': 0.007713134335009549, 'effect_proliferation_assays': 6.365864939041912e-09, 'twoway_panel_tnbc_cells': 3.900077063457207e-07, 'growth_difference': 2.38824157668927e-05, 'mtt_assay': 2.8486864292448765e-05, 'colony_formation_assays': 9.148819220060914e-58, 'panel_tnbc_cells': 9.148819220060914e-58, 'number_±': 6.365864939041912e-09, 'p_d': 9.148819220060914e-58, 'images_tumor_weight': 9.148819220060914e-58, 'deviation_replicates': 0.0003022165162482692, 'table_s1_msms_spectra_matchingto_stxbp6': 1.1277046026663835e-06, 'docking_docking_models_interactions_hydrogen_bonds_salt_bridges_scorpion_analysis': 6.911413757082649e-05, 'interactionof_snx27': 0.007713134335009549, 'docking_docking_models': 0.007713134335009549, '4b': 0.0005085847046313647, 'hydrogen_bonds_salt_bridges': 0.007713134335009549, 'scorpion_analysis': 1.8419356454247377e-08, 'interactionconsisted_contacts': 9.148819220060914e-58, 'r18': 9.148819220060914e-58, 'u_r_e_stxbp6': 1.1686951820486561e-54, 'msms_fragment_spectra': 8.263922883666513e-55, 'using_an_antimyc_antibody_bands_of_61k': 8.263922883666513e-55, 'ingreen_protein_interactions': 1.0912377232264814e-05, 'to_be_the_major_reason_for_crc_therapy_failure7': 0.0038806204677737646, 'activity_medicines': 0.00020598579336589774, 'dendrobium': 9.148819220060914e-58, 'to_exert_anticancer_activity_in_many_kinds_of_ _cancers89_ _erianin_ _2methoxy5[2345trimethoxy_phenylethyl]phenol_ _figure_ _1a_ _a_ _natural_ _compound_derived_ _from_ _dendrobium_ _candidum_ _shows_ _various_ _pharmacological_ _activities_ _and_ _therapeutic_ _potential_ _to_ _inhibit_multiple_cancers_in_vivo_and_in': 9.148819220060914e-58, 'activities_potential': 3.865500099287449e-05, 'erianin': 0.00472100001028795, 'cancer1213_erianin': 9.148819220060914e-58, 'invasion_metastasis_angiogenesis': 9.148819220060914e-58, 'sun_regulation_erianin': 9.148819220060914e-58, 'to_ _strongly_ _affect_ _the_serum_ _levels_ _of_ _cytokines_ _and_ _immune_ _response_ _in_ _liver_cancer16_ _more_ _importantly_ _in_ _addition_ _to_ _the_ _anticancer_effects_previous_a_study': 9.148819220060914e-58, 'anrelated': 7.703319630729864e-05, 'potential_mechanisms_cells': 0.007713134335009549, 'hdac2_cat_gapdh_cat': 8.263922883666513e-55, 'danvers_usa_antibody': 1.1686951820486561e-54, 't6199': 8.263922883666513e-55, 'using_sybr_green_master_mix_on_a_realtime_pcr_ _system_ _biorad_ _laboratories_ ': 0.0006030236714318566, '5Ê¹atccggtggtatggatgaga3Ê¹_gapdh_5Ê¹cacccactcctccacctttg3Ê¹': 3.28784142602511e-52, '5Ê¹atccggtggtatggatgaga3Ê¹_gapdh_5Ê¹cacccactcctccacctttg3Ê¹_to_calculate_the_relative_expression_levelswestern_blottingfor_ _western_ _blotting_   _Î¼g_ _cellular_ _protein_ _extracts_ _were_separated_ _in_ _sdspage_ _gel_ _and_ _were_ _then_ _transferred_ _to_nitrocellulose_ _membranes_ _emd_ _millipore_ _burlington_ma_ _usa_ _the_ _membrane_ _was_ _blocked_ _with_   _nonfat_milk_and_incubated_with_primary_antibodies_overnight_at_°_then_the_membranes_were_incubated_with_secondary_antibody_ _and_ _the_ _proteins_ _were_ _visualized_ _using_ _super_ _signal_west_ _pico_ _chemiluminescent_ _substrate_ _thermo_ _fisher_scientifictransit_transfectionplasmid_ _pegfpn1betacatenin_ _was_ _purchased_ _from_addgene_ _watertown_ _ma_ _usa_ _lipofectamine_  _thermo_ _fisher_ _scientific_  _carlsbad_ _ca_ _usa_ _was_used_for_transit_transfection_according_to_the_instructionscatenin_sirna_was_ _purchased_ _from_ _sigmaaldrich_co_ _lipofectamine_ _rnaimax_thermo_ _fisher_scientific_ _was_ _used_ _for_ _transfection_ _according_ _to_ _the_instructiondrug_design_development_and_therapy_                                                                       _submit_your_manuscript_ ': 0.0005715966671738797, 'to_calculate_the_relative_expression_levelswestern_blottingfor_ _western_ _blotting_   _Î¼g_ _cellular_ _protein_ _extracts_ _were_separated_ _in_ _sdspage_ _gel_ _and_ _were_ _then_ _transferred_ _to_nitrocellulose_ _membranes_ _emd_ _millipore_ _burlington_ma_ _usa_ _the_ _membrane_ _was_ _blocked_ _with_   _nonfat_milk_and_incubated_with_primary_antibodies_overnight_at_°_then_the_membranes_were_incubated_with_secondary_antibody_ _and_ _the_ _proteins_ _were_ _visualized_ _using_ _super_ _signal_west_ _pico_ _chemiluminescent_ _substrate_ _thermo_ _fisher_scientifictransit_transfectionplasmid_ _pegfpn1betacatenin_ _was_ _purchased_ _from_addgene_ _watertown_ _ma_ _usa_ _lipofectamine_  _thermo_ _fisher_ _scientific_  _carlsbad_ _ca_ _usa_ _was_used_for_transit_transfection_according_to_the_instructionscatenin_sirna_was_ _purchased_ _from_ _sigmaaldrich_co_ _lipofectamine_ _rnaimax_thermo_ _fisher_scientific_ _was_ _used_ _for_ _transfection_ _according_ _to_ _the_instructiondrug_design_development_and_therapy_                                                                       _submit_your_manuscript_ ': 0.0005715966671738797, 'using_ _super_ _signal_west_ _pico_ _chemiluminescent_ _substrate_ _thermo_ _fisher_scientifictransit_transfectionplasmid_ _pegfpn1betacatenin_ _was_ _purchased_ _from_addgene_ _watertown_ _ma_ _usa_ _lipofectamine_  _thermo_ _fisher_ _scientific_  _carlsbad_ ': 0.0005953981341549965, 'drugs_crc_cells': 1.8167819587673103e-05, 'corporation_madison_wi_usa': 9.148819220060914e-58, 'to_ _measure_caspase37_activity_briefly_apoone': 9.148819220060914e-58, 'caspase37_reagent': 0.0004298455060802725, 'to_detect_the_extent_of_apoptosis_ _induced_ _by_ _erianin_ _briefly_ _crc_ _cells_ _were_treated_with_erianin_for_ _h_and_were_then_collected_and_resuspended_in_ _Î¼l_annexin_vbinding_buffer_and_ _Î¼l_pi_ _for_   _minat_ _room_ _temperature_ _in_ _the_ _dark_ ': 7.011861479466218e-06, 'erianin_briefly_crc_cells': 9.148819220060914e-58, 'vbinding_buffer_pi': 9.148819220060914e-58, 'nitrogen_cells': 1.6219933526267364e-05, 'system_promega_using_a_microplate_luminometer_berthold_bad_wildbad': 7.74241605630692e-09, 'antibodies_samples': 2.0351572191744286e-06, \"using_ _the_ _simplechip_®_enzymatic_chromatin_ip_kit_cell_signaling_technologies_according_to_manufacturer_'s_instructions_using_the_antibodies_against_h3k27ac_immunoprecipitated_dna_was_analyzed_by_qrtpcr_using_the_following_primers_cd47_promoter_fragment_ _f\": 0.0001247202096416938, 'shanghai_slac_animal_co_china_mice': 4.745243281857178e-07, 'animal_care_committee_to_indicate_statistical_significanceresultserianin_inhibited_crc_cell_growthfigure_ ': 8.010265058044467e-05, 'to_indicate_statistical_significanceresultserianin_inhibited_crc_cell_growthfigure_ ': 7.703319630729864e-05, 'significanceresultserianin': 9.148819220060914e-58, 'crc_cell_growthfigure': 9.148819220060914e-58, 'chemical_structure': 3.865500099287449e-05, 'crc_cell_lines': 0.007713134335009549, 'c_erianin_treatment': 0.0002618838152087058, 'effects_1d_e': 7.703319630729864e-05, 'cycle_arrest_apoptosisto': 7.703319630729864e-05, 'erianin_cell_number': 0.00012738592534461142, '24h_incubation': 1.8167818297264612e-05, 'figure_2f': 7.703319630729864e-05, 'gerianin': 9.148819220060914e-58, 'translocationincreasing_evidence': 9.148819220060914e-58, 'topfop': 0.007713134335009549, '3f_gerianin': 9.148819220060914e-58, 'catenin_directlysince': 9.148819220060914e-58, 'shift_assay': 0.007713134335009549, 'erianin_treatment': 0.0015604987974113793, 'b_results': 0.001128162151175775, 'dovepress_treated_analyzed_treated_f_dapi_staining': 0.00022771936739542464, 'pi_staining_to_determine_cell_cycle_phase_distribution_c_sw480': 0.0012675836534498568, 'p_p_Ë\\x82_d_e': 7.417164383651313e-53, 'treated': 0.0003354942596134895, 'catenin_translocation': 7.703319630729864e-05, 'catenin_translocation_blotting_blotting': 0.0001550048943189367, 'topfop_Ë\\x82_p': 0.0007008712380191807, 'cmyc_design_development_therapy': 7.703319630729864e-05, 'inhibitory_effect_expression_cell_viability': 4.159771652421712e-07, 'overexpression_figure': 6.78601954455548e-09, 'crc_cell_growth': 7.703319630729864e-05, 'cd47_expression': 2.546753937836876e-05, 'protein_cd47': 9.148819220060914e-58, 'overexpression_figure_cd47_expression': 9.148819220060914e-58, 'to_know_whether_erianin_regulates_the_expression_of_cd47': 0.007713134335009549, 'protein_surface_level': 2.5460753358824207e-05, 'to_know_whether_erianin_regulates_the_expression_of_cd47_effects': 3.4348996837103175e-05, 'mouse_model': 9.148819220060914e-58, 's_c_injection': 9.148819220060914e-58, 'tumor_size_weight': 0.007713134335009549, 'using_ _western_blotting_as_shown_in_figure_7e_and_f_catenin_expression_ _in_ _cytoplasm_ ': 0.0005828796252635297, 'sun_figure_erianin': 0.002162604691974494, 'cck8_f_Ë\\x82protein_level': 1.0878083374253314e-05, 'viability_cck8_f_Ë\\x82protein_level': 0.0014616190772430405, 'dovepress_erianin': 0.0011284627910272927, 'cd47_expression_phagocytosis': 1.8415484017042953e-05, 'cd47_expression_phagocytosis_enrichment_enrichment_effect_analysis': 0.001113053283459106, 'genome_browser': 1.56801934831397e-06, 'phagocytosis_Ë\\x82_p': 0.00022771936739542464, 'c_erianin': 9.148819220060914e-58, 'tumor_volume_p_body_weight_groups': 9.148819220060914e-58, 'protein_level_group': 0.0003354942596134895, 'cd47': 0.0038806204677737646, 'to_control_cd47_transcription_therefore_mutations_in_components_ _of_ _the_ _wntcatenin_ _signaling_ _pathway_ _which_induced': 8.269877794507596e-06, 'caito_parvez_humans_species': 0.00046345855666667525, 'iasthat': 3.5344813551912834e-05, 'methylation_steps': 6.635681684419061e-07, 'protectionagency': 2.409524712436814e-06, 'center_protectionagency_views': 2.410166885510581e-06, 'endorsement_recommendation': 2.4954590467311193e-05, 'kb': 3.9037815012693685e-05, 'some_supplementalmaterial': 9.148819220060914e-58, 'tothe_complexity': 9.148819220060914e-58, 'assistanceaccessing_content': 0.00016902585554135613, 'intermediates': 3.902741347337616e-05, 'trivalent': 0.004315547045054443, 'masvand_dmasv': 9.148819220060914e-58, 'ias': 9.148819220060914e-58, 'intermediates_kb_elements': 0.0001269642925625728, 'inthe_brains': 9.148819220060914e-58, 'to_be_weaklycorrelated_li_   ': 9.148819220060914e-58, 'ias_exposure': 0.0016810521528134112, 'to_lack_ias_methylationactivity': 0.0038806204677737646, 'portions_species': 0.0018006682651940404, 'august_0cencountered': 0.000347488144371561, 'august_ _0cencountered_replicating_some_of_the_eï¬ects_of_ias_exposure_reportedin_humans': 2.516404898630126e-52, 'animalmodel': 4.649709951488235e-52, 'to_excise_the_61_kb_segment_of_mouse_dna_carrying_theas3mt_and_borc7_genes_it_region_correlation': 0.0010325216439875707, 'as3mt_study': 0.0013882295497307361, 'borcs7as3mt_locuswe': 9.148819220060914e-58, 'to_excise_the_61_kb_segment_of_mouse_dna_carrying_theas3mt_and_borc7_genes': 9.148819220060914e-58, 'it_region_correlation': 0.0010325216439875707, 'transcript_databases_university_ofcalifornia_genome_browser_ucsc': 9.148819220060914e-58, 'readthrough_borcs7as3mt_transcript': 9.148819220060914e-58, 'instituteoakland_ca_the_single_nucleotide_polymorphisms_snps_previously_associated_with_interindividual_diï¬erences_in_ias_metabolism_apata_   _or_schizophrenia_risk_li_  _which_were_included_in_the_this_borcs7as3mt_segment_aredescribed_in_table_s1_a_dna_segment_ _bp_extendingfrom_chr1946683032_to_ _were_deleted_from_the_mousegenome_and_replaced_with_a_59261bp_segment_of_human_dnaextending_from_chr10102845563_to_ _the_haplotypeof_the_as3mt_gene_carried_in_the_displacer_construct_is_1a_wood_  _the_resistance_marker_gene_used_for_selection_of_escells_in_which_the_displacer_construct_underwent_genomic_integration_consisted_of_a_phosphoglycerate_kinase_pgkneo_cassetteï¬\\x82anked_by_mutant_loxp_sites_the_marker_gene_can_be_excised_leaving_only_a_nonfunctional_lox_site_in_its_placeall_polymerase_chain_reactions_pcrs_carried_out_during_thedisplacer_assembly_used_taq_polymerase_bio_basic_with_an_initial_denaturation_temperature_of_°_c_for_ _s_followed_by_cycles_of_denaturation_for_ _s_at_°_c_annealing_for_ _s_at_a_°_c_and_extension_at_°_c_with_an_extension_time_of_ _min_per_bp_of_product_length_all_redet_recombination_reactionswere_carried_out_using_a_commercially_available_kit_gene': 8.263922883666513e-55, 'number_pcr_ampliï¬\\x81cation_ofsegments': 1.1686951820486561e-54, 'displacer': 9.148819220060914e-58, 'underwent_genomic_integration': 9.148819220060914e-58, 'homology_arms': 8.263922883666513e-55, 'ds_arm_primers': 9.148819220060914e-58, 'pcr_ampliï¬\\x81cation_ofsegments': 9.148819220060914e-58, 'as3mt': 6.366156693757803e-07, 'august_0cwas': 9.148819220060914e-58, 'to_insert_the_human_borcs7as3mt_segment_and_neomycin_resistance_cassette_by_redet_recombination_into_thebmq354l20_bac_carrying_the_short_arm_and_ampicillin_genesimultaneously_displacing_the_ampicillin_gene_this_reactionyielded_the_ï¬\\x81nal_borcs7as3mt_displacer_vector_which_wasdigested_with_noti_to_release_the_bac_backbone_before_transfection_into_es_cellsgeneration_of_mouse_es_cellsthe_parental_es_cell_line_phnx43_used_in_these_studies_was_generated_as_follows_male_and_female_129s6svevtac_mice_taconicbioscience': 9.148819220060914e-58, 'plugs_days_laterfemales': 8.263922883666513e-55, 'exposurefollowed_euthanasia': 1.1686951820486561e-54, '35d_embryos_blastocysts': 8.263922883666513e-55, 'cat_mm': 1.1686951820486561e-54, 'disruptionand_exposure_cryopreservation': 8.263922883666513e-55, 'd2660': 8.263922883666513e-55, 'disruptionand_exposure_cryopreservation_d2660': 0.0014160520424783584, 'mm_lglutamine_cat_hselection': 1.545263727514792e-05, 'see_details_below_once': 0.0009469278262817738, 'portion_culture_plates_cellswere': 3.0076095153444306e-50, 'colonies_r0198s_neb_cat_arms': 1.3826006677967127e-50, 'colonies_redet_recombination_ampliï¬\\x81cation_r0198s_neb_cat_arms': 3.7773350050509716e-50, 'homologousrecombination': 0.0001264628547598116, 'redet_recombination': 1.3826006677967127e-50, 'vector_backbone_spectinomycingene': 8.263922883666513e-55, 'bmq455l15_bac': 9.148819220060914e-58, 'table_s3_primers': 9.148819220060914e-58, 'ligation_reaction': 1.7364440634792414e-50, 'plasmidvector': 1.7364440634792414e-50, 'homology_arm_pcrs': 1.7364440634792414e-50, 'ampicillin_resistance_marker': 9.148819220060914e-58, 'inthe_displacer_vector': 9.148819220060914e-58, 'loxp_sites': 9.148819220060914e-58, 'table_s4': 9.148819220060914e-58, 'bio_rad': 4.0875184278752133e-05, 'pcr_product': 0.00028108709997479967, 'subjected': 0.002711609034677016, 'expression_number_pcr': 4.42568247699982e-05, 'biosystemshs00960526generation': 9.148819220060914e-58, 'to_generate_singlecell_suspensions_collection_of_recipient_blastocysts_blastocystinjection_and_transfer_to_pseudopregnant_dams_was_carried_out_bythe_unc_chapel_hill_animal_models_core_following_proceduresdescribed_by_longenecker_and_kulkarni_ _and_by_koller_  _to_maintain_the_mutation_on_the_129s6svevtac_background_the_chimeric_mice_were_bred_to_129s6svevtac_micetaconic_bioscience_the_resulting_f1_mice_were_identiï¬\\x81edby_taq_as_wildtype_wt_homozygotes_for_the_mouse_as3mtborcs7_locus_wtwt_or_heterozygous_wths_or_homozygoushshs_for_the_human_as3mtborcs7_locus_the_primers_usedwere_common_and_endo_for_the_endogenous_locus_and_common_anddisplaced_for_the_displaced_locus': 9.148819220060914e-58, 'suspensions_collection': 9.148819220060914e-58, 'models_core': 9.148819220060914e-58, 'as3mtborcs7': 1.2350710092036405e-05, 'pcr_assayswere': 1.1686951820486561e-54, 'humidity': 8.263922883666513e-55, 'mice_mice_f2_generations': 6.500936010559982e-06, 'humidity_purina_labdiet_5v5r_theuniversity_®_sigma': 0.00039873208315917074, 'purina_labdiet_5v5r': 1.0627837727786892e-07, 'males_females_measurement_gene': 6.499204601214539e-06, 'brainparts': 2.505853482494148e-06, 'parts_cord': 6.499204601214539e-06, 'othertissues': 6.499204601214539e-06, '®_sigma': 8.263922883666513e-55, 'interfacecontaining_cells': 6.499204601214539e-06, 'cortices': 3.1288445729064624e-06, 'e17_embryos': 5.107795126218422e-08, 'e17_embryos_gibco_catno_dnase_roche_cat': 5.10915629451765e-08, 'cthe_tissue': 8.337444638954413e-10, 'tryple': 9.148819220060914e-58, 'gibco_catno_dnase_roche_cat': 9.148819220060914e-58, 'using_a_ _mediachange_without_exposing_the_cells_to_air_the_cells': 5.10915629451765e-08, 'thecortices': 4.1670898062988435e-05, 'c6645': 8.337444638954413e-10, 'culture_brains': 0.00018645090769607825, 'quan_means_to_compare_rna_expression_inwhole_brain_cortex_hippocampus_pituitary_cerebellum_pons_medulla_spinal_cord_glial_cells_neurons_adrenals_ovaries_testesheart_kidney_liver_colon_jejunum_spleen_and_blood_ddpcr_wasused_to_assess_rna_expression_in_es_cells_whole_brain_liver_adrenals_spinal_cord_ovaries': 0.00019157047984417024, 'tube_cells': 4.1670898062988435e-05, 'cell_pellet': 4.1670898062988435e-05, 'microdissection_enrichment_analysis': 0.0011128752409327472, 'microdissection_enrichment': 1.2050685436544518e-05, 'protein_atlas': 9.148819220060914e-58, 'taqman_probes': 9.148819220060914e-58, 'mm01204952respectively_rna': 1.8162977041424498e-05, 'to_detect_and_quantify_as3mtas3mtd2d3_borcs7_as3mt_and_borcs7_mrna': 0.00030253919686273043, 'andborcs7_expression': 4.932953417851489e-06, 'speciï¬\\x81cmethod': 4.932953417851489e-06, 'quan': 3.039543298292255e-06, 'to_compare_rna_expression_inwhole_brain_cortex_hippocampus_pituitary_cerebellum_pons_medulla_spinal_cord_glial_cells_neurons_adrenals_ovaries_testesheart_kidney_liver_colon_jejunum_spleen_and_blood_ddpcr_wasused_to_assess_rna_expression_in_es_cells_whole_brain_liver_adrenals_spinal_cord_ovaries': 1.9172475277520724e-05, 'variant_borcs7as3mtfusion_transcript': 3.1263435616217294e-06, 'isoform_fullf_fullr': 3.4809887255688126e-06, 'ddpcr_supermix': 9.148819220060914e-58, 'gene_expressionassays': 9.148819220060914e-58, 'f2': 0.0009051742694528548, 'and_female_n_  _f2_oï¬spring_and_their_wtwtmale_n_  _and_female_n_  _littermates_the_mice_weregiven_a_single_dose_of_ias_sodium_arsenite_ _pure_sigmaaldrich_in_deionized_water_diw_by_gavage_ _lg_askg_ofbody_weight_immediately_after_dosing_each_mouse': 8.830761096542854e-06, 'cage_mousecage_urine_feces': 0.0005413124153687537, 'ias_content': 0.0014616190772430405, 'feces_samples': 8.830761096542854e-06, 'litter': 0.0005413124153687537, 'levels_inurine': 9.148819220060914e-58, '\\x9cresults\\x9d_section': 9.148819220060914e-58, 'wk': 1.9173603383811337e-05, 'pancreas_lung_adrenals': 2.2503500924571362e-49, 'biologicalmatrix': 0.0005715966671738797, 'digestates': 1.1686951820486561e-54, 'hydroxide_sigmaaldrich': 8.263922883666513e-55, 'hydroxide_sigmaaldrich_absorption': 8.263922883666513e-55, 'dmas': 0.0003802249829989744, 'comparison_posttest': 9.148819220060914e-58, 'to_assess_diï¬erences_in_gene_expression_and_in_the_concentrations_and_proportions_of_as_species_among_wtwt_and_hshs_mice_student\\x99s_ttest_was_applied_for_comparison_of_mouse_and_human_geneexpression_in_a_single_tissue_of_hswt_mice_and_for_comparisonof_as_species_concentrations_or_proportions_between_male_andfemale_mice_and_between_hshs_and_wtwt_mice_of_the_samesex_the_statistical_analyses_were_performed_using_prism_ _software_graphpad_software_diï¬erences_with_p_  _were_considered_statistically_significantresultsexpression_of_borcs7_and_as3mt_in_hswt_miceexpression_of_as3mt_and_borcs7_were_directly_compared_withthose_of_endogenous_mouse_genes_in_tissues_collected_from_f2male_hswt_mice_that_carried_one_copy_of_the_mouse_locus_andone_copy_of_the_human_locus_figure_2a_using_both_conventionalqpcr_and': 9.148819220060914e-58, 'significantresultsexpression': 9.148819220060914e-58, 'withthose': 9.148819220060914e-58, 'conventionalqpcr': 3.906156580050855e-05, 'mouse_genes': 0.0016810521528134112, 'treatment_efficacy_selection': 4.774322076570771e-05, 'treatment_efficacy_selection_effect_prognosis_survival_use': 0.0011431581630813499, 'to_have_poor_prognostic_characteristics': 0.002348576309172163, 'gpc_patients': 0.0004202357087063657, 'status_site': 1.0427159270199631e-06, 'tumour_characteristics_factors_treatment_characteristics': 4.774322076570771e-05, 'line_treatment': 0.0008143239094537082, 'profilewhat_study': 3.124383789880943e-05, 'to_be_factors_of_good_prognosis_in_late_line_mcrc_with_these_patients_experiencing_longer_time_on_ _treatment_ _and_ _greater_ _os_ _this_ _suggests_ _that_these_patients_could_be_candidates_to_receive_further_lines_of_therapy_post_trifluridinetipiracildecades1\\x93': 0.0004968127217041802, 'chemotherapy_regimens': 5.6417406889346156e-05, 'disease_toxicity': 1.9852351193437306e-05, 'status_ecog': 4.774322076570771e-05, 'line6_data': 9.148819220060914e-58, 'hr_p000110': 9.148819220060914e-58, 'that_ _only_   _of_ _patients_ _receiving_ _a_ _first_ _line_ _of_treatment_ _move_ _into_ _the_ _second_ _line_   _move_ _to_ _the_third_line_and_only_ _will_receive_a_fourth_line_of_treatment7_being_unable_to_receive_a_subsequent_line_of_treatment': 9.148819220060914e-58, 'to_have_a_negative_impact_on_the_patient\\x99s_survivalis_trifluridinetipiracil_ _ftdtpi_ _lonsurf': 9.148819220060914e-58, 'region_race_status10': 0.001128162151175775, 'to_explore_other_factors_that_could_extend_survival_in_the_recourse_population_for_the_purposes_of_our_exploratory_analysis': 0.007713134335009549, 'to_ _be_ _strong_ _prognostic_ _factors_ _in_ _patients_ _with_mcrc_ _with_ _good_ _ecog_ ': 0.0038806204677737646, 'treatment_outcomes': 0.00018869384058700235, 'treatment_selection': 0.00018869384058700235, 'placebo10_randomisation': 0.001845170519318405, 'aes_readministration': 0.0011075402231842013, '101136esmoopen2020000752_0cof_\\x93': 5.6417406889346156e-05, 'os_endpoints': 9.148819220060914e-58, 'pfs_objective_response_rate_clinical_benefit_rate_and_safety10patient_subgroupsin_ _examining_ _the_ _effects_ _of_ _prognostic_ _factors_ _on_ _treatment_outcomes_in_the_current_analysis_several_subgroups_of_ _recourse_ _patients_ _were_ _considered_ _patients_ _from_recourse_ _n800_ ': 9.148819220060914e-58, 'benefit_rate_safety10patient_subgroupsin': 0.0010068765747081726, '101136esmoopen2020000752_0cof_\\x93_to_be_defined_by_low_tumour_burden_ _metastatic_sites_by_recist_ _tumour_ _evaluation_ _at_ _randomisation_ _and_ _less_aggressiveindolent_disease_\\x89¥_months_from_diagnosis_of_ _first_ _metastasis_ _to_ _randomisation12_   _of_ _the_ _gpc_subgroup_n386_  _patients_received_trifluridinetipiracil_and_ _received_placebo': 0.002503647624492022, 'to_be_defined_by_low_tumour_burden_ _metastatic_sites_by_recist_ _tumour_ _evaluation_ _at_ _randomisation_ _and_ _less_aggressiveindolent_disease_\\x89¥_months_from_diagnosis_of_ _first_ _metastasis_ _to_ _randomisation12_   _of_ _the_ _gpc_subgroup_n386_  _patients_received_trifluridinetipiracil_and_ _received_placebo': 0.0006578099350934741, 'subgroup_n386_patients': 6.632773082185692e-05, 'trifluridinetipiracil': 0.002953792939837632, 'gpc_subgroup': 4.087448772630037e-05, 'patients_methodsdemographic': 9.148819220060914e-58, 'treatment_arm_subgroups_using_descriptive_statistics': 9.148819220060914e-58, 'frequency_distributions_ps_deterioration': 8.263922883666513e-55, 'using_kaplan_meier_ _curves_ ': 1.1686951820486561e-54, 'subgroup_survival': 8.263922883666513e-55, 'ecog_ps_status': 7.237344874271509e-06, 'ppc_patients': 9.148819220060914e-58, '\\x89¥_regimens': 9.148819220060914e-58, 'sites_months': 7.237344874271509e-06, 'ecog_ps_status_\\x89¥_regimens_sites_sites_months_patients_dose_delay_month_os_in_in': 0.0011492857679534186, 'dose_delay': 0.0004988292642554344, 'month_os_in_in': 0.001128162151175775, 'demographics_characteristics': 5.6417406889346156e-05, 'kras_status_type_months_\\x89¥_months_ppc': 1.0218164665304735e-05, 'liver_lung_lymph_prognostic_characteristics': 0.00023078931020485309, 'os_pfs_ecog_to_be_the_best_factor_of_prognosis_further_information_ _on_ _this_ _group_ _of_ _patients_ ': 5.6417406889346156e-05, 'os_pfs_ecog': 6.671700801421501e-07, 'to_be_the_best_factor_of_prognosis_further_information_ _on_ _this_ _group_ _of_ _patients_ ': 8.059602068571773e-05, 'b_survival_pfs_c_time': 5.6417406889346156e-05, 'ps_\\x89¥': 1.0427159270199631e-06, 'ppc_n414_subgroups': 9.148819220060914e-58, 'table_s4_figures': 9.148819220060914e-58, 'kras_status': 9.148819220060914e-58, 'to_affect_the_treatment_outcome_table': 9.148819220060914e-58, 'b_survival_pfs_c_time_to_affect_the_treatment_outcome_table': 0.0016480626375926124, 'anaemia_neutropenianeutrophil_count': 9.148819220060914e-58, 'count_decrease': 9.148819220060914e-58, 'trials10_\\x93': 0.0005034057898537578, 'placebo_trifluridinetipiracil': 9.148819220060914e-58, 'to_provide_a_significant_survival_benefit_to_patients_with_ _mcrc_ _refractory_ _to_ _standard_ _therapy_ _with_ _a_ _well_tolerated_ _safety_ _profile_ _in_ _three_ _large_scale_ ': 9.148819220060914e-58, 'placebopatients': 0.0011075402231842013, 'post': 9.148819220060914e-58, 'make_these_data_a_good_tool_to_estimate_the_expected_outcomes_when_treating_patients_with_refractory_mcrc_with_trifluridinetipiracil_the_smaller_size_of_some_of_the_subgroups_may_limit_the_s_that_can_be_drawn_thus_preventing_an_evaluation_of_other_parameters_that_might_impact_on_outcomes_such_as_lactate_dehydrogenase_levels_the_exact_definition_of_good_and_poor_prognostic_factors12_ ': 9.148819220060914e-58, 'internationales_like': 5.936279146722279e-05, 'fees_role_honoraria_boards_research_grant_honoraria_research_funding': 9.687375226463822e-07, 'leuven_flanders': 9.148819220060914e-58, 'to_thank_andrea_bothwell_who_wrote_the_first_draft_of_this_manuscript_on_behalf_of_springer_healthcare_communications_this_medical_writing_assistance_was_funded_by_institut_de_recherches_internationales_servier_suresnes_francecontributors_ _jt_and_srmv': 9.148819220060914e-58, 'writing_assistance': 9.148819220060914e-58, 'recherches_francecontributors_jt_srmv': 9.148819220060914e-58, 'in_writing_andor_revising_drafts_of_the_manuscript_all_authors_have_read_and_approved_the_final_draft_of_the_manuscript_and_accept_responsibility_for_the_finished_article_and_the_decision_to_submit_the_manuscript_for_publicationfunding_ _the_recourse_study_was_funded_by_taiho_oncology_and_taiho_pharmaceutical_co_this_analysis_was_funded_by_servier_in_partnership_with_taihocompeting_interests_ _jt': 9.148819220060914e-58, 'fees': 9.148819220060914e-58, 'draft_responsibility': 0.0007959416758056306, 'recourse_study': 9.148819220060914e-58, 'pharmaceutical_co': 9.148819220060914e-58, 'servier': 0.001129870936471824, 'diagnostics_ga': 0.0015842910551982499, 'squibb_afs': 0.0015842910551982499, 'speakers\\x99_bureau': 3.9142261473529694e-08, 'boards': 9.693762506199998e-07, 'dohme_merck': 9.148819220060914e-58, 'novartis_roche_servier_cb': 9.148819220060914e-58, 'celgene_rjm': 4.192755958819432e-05, 'ligand1_pd_l1': 0.0008756057187400466, 'signal_analysis': 0.0005371174057381335, 'wald_ci': 1.1686951820486561e-54, 'to_assess_the_precision_of_the_rorresults_ _out_of_the_   _adverse_events_aes_reported_to_faers_for_all_drugs_between_ _january_ _and_ _march_   _aes': 8.263922883666513e-55, 'care_outcomes': 0.0006750162805663558, 'to_exhibit_unique_toxicities_that_result_in_an_damage_known_ _as_ _immune_related_ _adverse_ _events': 0.001845170519318405, 'tuberculosis_tb_reactivation': 9.148819220060914e-58, 'lymphoma': 9.148819220060914e-58, 'pulmonary_tb': 0.0011075402231842013, 'to_be_highly_susceptible_to_tb_with_reduced_survival_compared_ _with_ _wild_type_ _mice12_ _however_    ': 0.0005411681930881713, 'infection_faers': 9.148819220060914e-58, 'ligand1_ror': 9.148819220060914e-58, 'l1_inhibitors_we': 9.148819220060914e-58, 'administration_events_pdl1_inhibitors': 9.148819220060914e-58, 'data_queries': 0.004315547045054443, 'ae': 0.00047370069601186063, 'error_reports_quality_complaints': 7.726527881512914e-06, 'identification_numbers_agent_treatment_indication_outcomes': 7.726527881512914e-06, 'date_country_names_date': 8.263922883666513e-55, 'excluded_\\x98nivolumab\\x99_l1_inhibitors_\\x98atezolizumab\\x99_is_were_elevated_were_cases': 0.0011801494413379247, 'outcome_region_l1_inhibitors_one_complications_frequency_to_occur_ _in_ _approximately_   _to_   _per_     _persons_with_an_increasing_incidence_in_developed_countries15_ _there_ _survival_events': 0.002479552452768229, 'tb_ami_events': 0.0002768434257340561, 'to_assess_the_precision_of_the_ror_when_lower_limit_of_ror_ _and_ci_did_not_cross_ _ror': 8.263922883666513e-55, 'limit_ci': 9.148819220060914e-58, 'ror': 9.148819220060914e-58, 'using_two_sided_Ï\\x872': 6.82745641754355e-05, 'using_sas_ _sas_institute_inc_cary_ _north_ _carolina_ _usa_ _and_ ': 0.0012647361320215537, 'region_inhibitor_\\x89¥': 0.0003277033018603857, 'cell_death1_pd_l1': 9.148819220060914e-58, 'ligand1_tb_tuberculosisror': 9.148819220060914e-58, 'asia_case': 9.148819220060914e-58, 'l1_inhibitors_one': 9.148819220060914e-58, 'tb': 0.00028265317121725723, 'l1_inhibitors': 5.409254372722525e-05, 'avelumab_no': 0.00038821680642614145, '20205e000866_101136esmoopen2020000866_0copen': 5.6417406889346156e-05, 'deaths14_amis': 4.049019967977053e-05, 'to_occur_ _in_ _approximately_   _to_   _per_     _persons_with_an_increasing_incidence_in_developed_countries15_ _there_ ': 6.60723380776127e-07, 'tb_reaction': 0.001845170519318405, 'to_ _have_ _latent_ _tb_ _treatment_ _with_ _isoniazid_ _is_recommended_as_it_substantially_reduces_the_risk_of_developing_tb_reactivation23_however': 0.0006324067207528349, 'that_ _pd1_ _inhibition_ _induced_ _tb_ _reactivation_ _is_ _actually_driven_ _by_ _tnf_alpha_ _and_ _use_ _of_ _tnf_alpha_ _inhibitor': 9.148819220060914e-58, 'complication24': 9.148819220060914e-58, 'tb_reactivation': 9.148819220060914e-58, 'tnf_alpha_use': 9.148819220060914e-58, 'none_qgt_test': 4.608188311345736e-06, 'developed_reported': 2.1512295790784834e-05, 'min_report': 0.00028426513726990005, 'n10': 0.00038821680642614145, 'death1_pd_l1': 0.00015647401273712215, 'programmed': 0.00038821680642614145, 'tb_ami': 0.0006324067207528349, 'anand_a0k_et': 0.00010740789809797397, 'faers': 0.001845170519318405, 'mr_et_nccn': 9.148819220060914e-58, 'lung_cancer_version_canc_netw_\\x93_events_wang_y_zhou': 9.148819220060914e-58, '\\x93_zaemes_j_kim_c_checkpoint_inhibitor_use_tuberculosis': 1.1686951820486561e-54, 'role_et_risk_consensus_statement': 8.263922883666513e-55, 'pd1_to_prevent_lethal_disease_plos_pathog_201612e1005667_  _solovic_i_sester_m_gomez_reino': 8.263922883666513e-55, 'disease_plos': 9.148819220060914e-58, 'solovic': 9.148819220060914e-58, 'j_trachtenberg': 9.148819220060914e-58, 'cardiotoxicity_review_et': 9.148819220060914e-58, '20205e000866_101136esmoopen2020000866_0c': 5.6417406889346156e-05, 'sgp130fc_protein': 0.003882689269047051, 'stock_ownership': 0.00012198022841850962, 'version_peer_review': 9.148819220060914e-58, 'f1000research': 9.148819220060914e-58, '1012688f1000research260581first': 9.148819220060914e-58, 'aug_rev1013': 9.148819220060914e-58, 'antibody_tocilizumab_nature': 0.0010325216439875707, 'intracellular_affinity': 6.219868465542395e-06, 'dimerisation_figure': 0.004315547045054443, 'gp130': 0.0054466588562058875, 'il61noteworthy_gp130': 0.0011125787591309202, 'cardiotrophin1_ct1': 0.0038806204677737646, 'membranebound': 9.148819220060914e-58, 'membranebound_metalloprotease': 9.148819220060914e-58, 'helices_a\\x93b': 7.723613244264731e-05, 'to_ _generate_ _a_soluble_ ': 0.00012040101594931771, 'the_murine\\x94sil6r': 0.0011358545701370894, 'translation_il6_signalling_even_on_cells_that_lack_the_ _membranebound_ _il6r23_ _this_ _process_ _use_complex_affinity_complex_gp130_cells_homolog_protein_kinase': 0.0005241489736169706, 'signalling_even_on_cells_that_lack_the_ _membranebound_ _il6r23_ _this_ _process_ ': 1.8533052020524414e-05, 'membranebound_il6r23': 0.004315547045054443, 'orange': 8.549232448840333e-06, 'dimerises': 0.0038806204677737646, 'affinity_complex': 1.8533052020524414e-05, 'cells_kinase': 1.8533052020524414e-05, 'yamaguchi': 9.148819220060914e-58, 'homolog_protein': 9.148819220060914e-58, 'janus_kinaseat_protein': 3.4348996837103175e-05, 'to_ _stimulate_ _gp130expressing_ _cells_ _in_ _vitro_and_ _in_ _vivo_ ': 0.002104041233387171, 'hyperil6': 0.0007035667068513752, 'protein_il6_ _transsignalling_ ': 0.00210348072096923, 'il6_ _transsignalling_ ': 0.00210348072096923, 'to_ _define_ _il6mediated_ _biologic_ _responses_ _which_ _were_ _dependent_ _on_classic_ _or_ _transsignalling_ _this_ _was_ _accomplished_ _by_ _comparing_ _the_ _treatment_ _of_ _animals_ _with_ _sgp130fc_ _or_ _with_ _neutralising_antibodies_ _against_ _il6_ _or_ ': 6.341351869997941e-05, 'classic_il6': 0.00014169599163553216, 'disorders_levels': 7.4429634017821505e-06, 'alarm_signal_body': 0.0015842910551982499, 'wildtype_mice': 1.0465633289864016e-05, 'adam17_ _on_ _macrophages_ ': 0.00025761770367047364, 'il6_sil6r': 0.00012468698175640766, 'to_ _be_ _an_ _efficient_ _treatment_ _for_ _patients_ _with_ _rheumatoid_ _arthritis_ _and_ _other_ _autoimmune_ _diseases2_ ': 9.950326125649615e-05, 'adam17_ _on_ _macrophages_ _il6_sil6r_to_ _be_ _an_ _efficient_ _treatment_ _for_ _patients_ _with_ _rheumatoid_ _arthritis_ _and_ _other_ _autoimmune_ _diseases2_ ': 0.00210348072096923, 'il6_transsignalling': 0.00014169599163553216, 'signalling_via_hyperil6': 9.148819220060914e-58, 'to_mimic_il6_transsignalling_b_the_sg130fc_protein_does_not_interfere_with_classical_il6_signalling': 9.148819220060914e-58, 'figure_activities': 0.00014169599163553216, '\\x9ccytokine_storms\\x9d': 0.001845170519318405, 'modalityinterleukin6': 0.00019685264459536156, 'activator_yap': 0.0004254422540019666, 'thank_colleagues': 9.148819220060914e-58, 'immunol_\\x93_ogata': 9.148819220060914e-58, 'al_identification': 9.148819220060914e-58, 'xu_han_treatment_cloning_text_c_harnish': 9.148819220060914e-58, 'shares_identity_regulates': 9.148819220060914e-58, 'cloning_expression': 9.148819220060914e-58, 'nguyen_qh': 9.148819220060914e-58, 'brain_repair': 9.148819220060914e-58, 'obesity_nat_med_\\x93_text_al_treatment': 0.0005411681930881713, 'jones_sa_jenkins': 0.0004017220894362599, 'h_heinrich_et_al_complex': 0.0016810521528134112, 'text_galun_e_zeira_e_al_liver_regeneration': 2.312885694674057e-06, 'hepatocellular_injury_text': 0.00014173375196033287, 'embo_j_\\x93': 9.148819220060914e-58, 'publisher_text_t_e_lazzaro': 9.148819220060914e-58, 'al_interleukin': 8.263922883666513e-55, 'publisher': 1.1686951820486561e-54, 'immunol_\\x93': 8.263922883666513e-55, 'response_text_sodenkamp': 0.0004499048194399722, 'waetzig_gh_scheller_targeting': 0.0004202357087063657, 'fracture_healing': 0.00054686425127897, 'al_egfr': 0.0015842910551982499, 'text_faculty_opinions': 0.0015842910551982499, '\\x93_text_gabay_vollenhoven_r_et_al_tocilizumab_monotherapy': 0.0003996210712050996, 'areversion_jacqueline_bromberg_department_york_ny_usa': 0.0011075402231842013, 'canzio_ji_lncrna': 0.0006992128660964839, 'dudunan05aliyuncomganfeng_xiexiegfaliyuncom_authorshipspecialty_sectionthis': 9.148819220060914e-58, 'medicinea_section_developmentalbiologyreceived': 9.148819220060914e-58, 'karner': 8.263922883666513e-55, 'functionshowever': 2.399267206696056e-05, 'medicinea_section_developmentalbiologyreceived_karner': 0.00016385845265801986, 'liang': 9.148819220060914e-58, 'associations_learning_methods': 9.148819220060914e-58, 'to_use_computational_methods_to_identifydiseaserelated_lncrnas_these_methods': 8.263922883666513e-55, 'prediction_ldap': 3.0448086737238422e-06, 'similarities_oflncrnas_diseases': 0.0013882295497307361, 'mirna\\x93lncrna': 0.0013882295497307361, 'associations_infer': 9.148819220060914e-58, 'neuralnetwork_cnn': 9.148819220060914e-58, 'kuang_wang_l_liu_thiskind': 0.0011846154990741902, 'lncrna\\x93protein_protein\\x93protein': 0.0006625816769337724, 'cnn': 0.007721361645195541, 'networks_information_network_novel_lncrnas': 0.00012627434104088138, 'matrix_completionlu': 9.148819220060914e-58, 'association_gmclda': 9.148819220060914e-58, 'diseasesimilarity_proï¬\\x81le_kernel_similarity': 0.0013882295497307361, 'dirichletallocation_llclplda': 9.148819220060914e-58, 'xie_localconstraint_features': 9.148819220060914e-58, 'linear_coding_llc_thenthey': 2.0569644150454282e-06, 'gene_expression_dbn': 7.13878731393036e-05, 'thisinformation_volume_method': 0.007713134335009549, 'belief_network_dbn': 2.0575124729314175e-06, 'proteincoding_geneslncrna': 2.88244993703458e-06, 'featureswe': 0.0016810521528134112, 'placenta_testisand_thyroidtherefore': 0.0038806204677737646, 'belief_networkthe_dbn': 9.148819220060914e-58, 'dependencies_betweenvariables_zhao_2019d': 9.148819220060914e-58, 'posteriorprobabilities': 0.0003069306742853986, 'dbn_canbe': 7.449895085848531e-05, 'rbm': 6.6802272777400075e-06, 'to_be_the_features_of_lncrnas_the_features': 0.007713134335009549, 'to_encode_these_genesf_ ': 0.007713134335009549, 'g1_g2_g1': 9.148819220060914e-58, 'gene_denotesthe_feature_g1_g1_weight_matrix_blfor': 9.148819220060914e-58, 'to_builda_dbn': 7.13878731393036e-05, 'modelthe_number': 8.263922883666513e-55, 'g13': 8.263922883666513e-55, 'e13': 9.148819220060914e-58, 'expression_volume_method_component_analysisfigure_component_expression_oftissues_k_tokas_d_c_plncrnadba_repository_database': 9.148819220060914e-58, 'structure_sigmoidwork_framefigure': 9.148819220060914e-58, 'work_frame': 9.148819220060914e-58, 'have_more_than_ _related_lncrnas_therefore_ _kindsof_cancers_were_selectedfigure_  _work_frame_of_deep_belief_network_dbn\\x93convolutional_neural_network_cnn_lncrna_long_noncoding_rnafrontiers_in_cell_and_developmental_biology_ ': 0.00012624068922316816, 'bao': 0.00016348254014949182, 'cancerthyroid_cancerprostate_cancerliver_cancerthetargetgenes_oflncrnas': 9.148819220060914e-58, 'fromlncrna2target_database': 9.148819220060914e-58, 'usedhuman_datalncrnas': 0.0002527761692376148, 'comparison_experimentsto': 8.263922883666513e-55, 'thistime': 0.007713134335009549, 'to_classify_the_features_after_pca_we_callthis_method_pca\\x93cnn': 0.00012624068922316816, 'pca\\x93cnn': 0.007713134335009549, 'neuralnetwork_dnn_volume_method': 0.007713134335009549, 'dbn\\x93dnnwe': 0.0005371174057381335, 'anddbn\\x93dnn': 2.0031394091466016e-05, 'dbn\\x93cnn': 0.007713134335009549, 'antisense_rna': 9.148819220060914e-58, 'expression_volume_method_component_analysisfigure_component_expression_oftissues_to_classify_the_features_after_pca_we_callthis_method_pca\\x93cnn_k_tokas_d_c_plncrnadba_repository_database': 9.148819220060914e-58, 'cdna_librariesmartensuzunova': 9.148819220060914e-58, 'h19_bladder_cancer': 9.148819220060914e-58, 'method\\x9cdbn\\x93cnn\\x9d': 0.007713134335009549, 'cnn_kindsof_features': 1.4055400435083287e-53, 'importantin_diï¬erentlncrnasreferencesavgeris': 2.274211562945482e-53, 'stravodimosk_loss': 9.148819220060914e-58, 'cancer_biomarker': 9.148819220060914e-58, 'inadditionregulation_function': 0.0006683740194778514, 'pca_canalso': 0.00022107773736140254, 'to_reduce_the_dimension_manuscript_yz_manuscript_cl_xy_data': 0.0017338381682959036, 'designed': 9.148819220060914e-58, 'manuscript_yz': 9.148819220060914e-58, 'researchand': 0.0005479687540571566, 'manuscript_cl_xy': 0.0016480626375926124, 'metsigdisa': 0.00015714055542688862, 'methods_health': 9.148819220060914e-58, '101109jbhi20192958389': 9.148819220060914e-58, 'oflncrna': 1.1686951820486561e-54, 'perspective_identiï¬\\x81cation_characterization': 8.263922883666513e-55, 'expression_biochem_biophys_res_commun': 8.263922883666513e-55, 'noncodingrna_loc554202': 0.000102575415207327, 'y_zang_t_cheng_l_mrtfb': 9.148819220060914e-58, 'expressionof_nomo1': 9.148819220060914e-58, 'y_zang_t_wang_y': 0.0014616190772430405, 'stem_cells_coding_rna_role': 7.048424814961187e-05, 'cancer_ipscs': 9.148819220060914e-58, 'stem_cells_coding_rna': 9.148819220060914e-58, 'reprogramming_identify_toimprove': 0.0015842910551982499, 'havebeen': 9.148819220060914e-58, 'to_play_critical_roles_in_transcription_posttranscriptional_processing_and_translation_such_as_epigeneticsposttranscriptional_regulation_chromatin_modiï¬\\x81cation_andregulation_of_the_cell_cycle_huarte_ _kondo_   _peng_ _2017b_additionally': 9.148819220060914e-58, 'to_provide_a_mechanism_forintercellular_communication_through_the_transfer_of_mirnaand_lncrna_to_recipient_cells': 0.0013882295497307361, 'alsobeen_havebeen': 1.1686951820486561e-54, 'to_regulate_the_expression_of_geneby_acting_as_mirna_sponges_in_a_mechanism_that_is_termedas_competitive_endogenous_rna_cerna_mechanism': 8.263922883666513e-55, 'to_harbor_conventional_mirna_bindingsites': 8.263922883666513e-55, 'hcc_han_additionallyour_study': 9.148819220060914e-58, 'to_regulate_the_expression_of_geneby_acting_as_mirna_sponges_in_a_mechanism_that_is_termedas_competitive_endogenous_rna_cerna_mechanism_to_harbor_conventional_mirna_bindingsites_rna_polymerase_ii': 9.148819220060914e-58, 'rna_polymerase_ii': 9.680158352934836e-08, 'thereby_indicating_thatlncrnas_were_associated_with_the_progression_of_cancers_yang_  _interestingly_increasing_evidence': 0.00038821680642614145, 'lu_studies': 8.263922883666513e-55, 'functionsof_lncrnas': 1.1686951820486561e-54, 'huang_wang_c_j_figure': 8.263922883666513e-55, 'lincror': 0.003672243310908926, 'to_be_predominantly_upregulated_intumors_peng_  _2017a': 5.993923884422439e-05, 'to_be_one_of_the_mainleading_factors_driving_the_development_the_main_ways_torevert_this_eï¬ect_would_be_to_aï¬ect_cell_growth_migrationand_invasionthus_leading_to_the_inhibition_of_epithelialmesenchymal_transition_emt_enhancement_of_the_sensitivityto_chemotherapy_etc_chen_  _2016a': 0.0016810521528134112, 'to_be_predominantly_upregulated_intumors_peng_  _2017a_to_be_one_of_the_mainleading_factors_driving_the_development_the_main_ways_torevert_this_eï¬ect_would_be_to_aï¬ect_cell_growth_migrationand_invasionthus_leading_to_the_inhibition_of_epithelialmesenchymal_transition_emt_enhancement_of_the_sensitivityto_chemotherapy_etc_chen_  _2016a': 3.4955919161338953e-05, 'the_octamerbinding_transcription_factor_a_novelfrontiers_in_cell_and_developmental_biology_ _wwwfrontiersinaugust_  _volume_    _0cchen_ _relevance_function_of_lincrorfigure_  _paradigms_for_the_function_of_long_ncrnas_recent_studies_have_identiï¬\\x81ed_a_variety_of_regulatory_paradigms_for_the_mechanism_by_which_long_ncrnasfunction_many_of_which_are_highlighted_here_transcription': 0.0016810521528134112, 'dicer': 3.560701850358638e-06, 'thatlincrormay': 9.148819220060914e-58, 'impact_tumorigenesis_metastasis': 9.148819220060914e-58, 'zhang_feng': 9.148819220060914e-58, 'to_beelevated_by': 9.148819220060914e-58, 'lincror_yang_p_lincror': 9.865699787981155e-07, 'ofpc_recentlyit': 7.417164383651313e-53, 'to_exert_a_signiï¬\\x81cantly_eï¬ect_onthe_stem_celllike_characteristics_and_to_serve_asa_cerna_therefore_promoting_the_migration_and_invasion_investigations': 1.284690556057437e-52, 'showed_that_lincror_couldbe_used_as_a_cerna_thus_exerting_its_impact_in_the_posttranscriptional_network_of_tumor_pathogenesis_for_examplein_triplenegative_bc_lincror': 9.148819220060914e-58, 'to_serve_asa_cerna_therefore_promoting_the_migration_and_invasion': 9.148819220060914e-58, 'thus_exerting_its_impact_in_the_posttranscriptional_network_of_tumor_pathogenesis_for_examplein_triplenegative_bc_lincror': 2.4905376453020585e-06, 'ofbc_cells': 7.417164383651313e-53, 'lincror_lincrormay': 7.417164383651313e-53, 'lincror_overexpression': 7.6529841323252e-06, 'emtprogram': 0.0016810521528134112, 'analysis_analysisfrom_hou': 9.148819220060914e-58, 'thatlincror_functions': 9.148819220060914e-58, 'behaviorfrontiers_relevance_function': 5.756459558678552e-06, 'chen_microarray_analysis': 0.007713134335009549, 'zhan': 0.00036240313892865647, 'showedthat_lincror': 9.148819220060914e-58, 'capability_andmetastasis': 9.148819220060914e-58, 'to_result_in_increased_levels_of_theepithelial_markers': 5.993923884422439e-05, 'decreased_levelsof_mesenchymal_markers_ncadherin_and_vimentin_indicatingthat_lincror': 0.0015842910551982499, 'to_be_negatively_correlated_to_that_of_mir145mir145': 0.0016810521528134112, 'g0g1': 0.002104041532261293, 'arrestand': 0.00015553141995844084, 'zeb2overexpression': 0.00015553141995844084, 'pc': 0.00029540981397560654, 'bray': 9.148819220060914e-58, 'to_account_for_\\x93_of_all_the_livercancer_cases_half_of_which_have_been_detected_in_china': 9.148819220060914e-58, 'threatto': 5.025071142854711e-05, 'torecrudescent': 0.0003430334595249958, 'thatlincror': 9.148819220060914e-58, 'promoting_role_in_regulating_migration_andinvasion_of_hcc_chen_   ': 9.148819220060914e-58, 'associatedwith_dna_repair_studies': 6.579443402530153e-05, 'thatfrontiers': 0.0006675855277129212, 'mir\\x88\\x92': 5.993923884422439e-05, 'hcc_tumorigenesis_autophagy': 0.004315547045054443, 'mir145': 8.818604784216684e-06, 'emt_tumormigration_invasion': 1.4403253561561982e-07, 'targeting_the_lincrormir\\x88\\x92145zeb2axis': 0.0004448724835359713, 'potentialstrategies_vivo_inï¬\\x82uence': 0.0018006682651940404, 'hu_kawaguchi': 0.0020571615603337447, 'crc_tissues': 0.00939418648782296, 'normaltissues_similarlylincror': 9.148819220060914e-58, '2020a': 9.148819220060914e-58, 'to_eï¬ectively_inhibit_the_proliferationof_crc_cells': 0.0016810521528134112, 'abilitiesof_crc_cells': 0.0004687660047793177, 'ability_assay_results': 7.6529841323252e-06, 'thatthelincror': 9.148819220060914e-58, 'viability_ofoverexpression_ofcrc_cells': 9.148819220060914e-58, 'apoptosisin_the_crc_cell_lines': 0.0004686411271822266, 'insights_2020a': 0.0038806204677737646, 'uncoveredthat_lincror': 9.148819220060914e-58, 'expression_level_bysponging_mir68333p': 9.148819220060914e-58, 'overexpression_oflincror': 0.000704362469235278, 'adenocarcinoma_lad_cells': 0.00032868440368843304, 'g0g1_phasearrest': 5.359403284355422e-06, 'to_reduce_the_expression_of_ecadherinand_Î²catenin_which_are_the_characteristic_biomarkers_ofepithelial_cells': 0.000704362469235278, 'eï¬ects_progress_meanwhileoverexpression': 9.148819220060914e-58, 'to_enhance_the_resistanceof_lad_to_docetaxel_dtx_pan_   ': 9.148819220060914e-58, 'resistanceof_lad_cells': 0.0005404512852703998, 'lincrorcould': 0.0003247463263852347, 'xie_tcm': 0.00014084186830440697, 'zheng_xie': 9.148819220060914e-58, 'tcm': 9.148819220060914e-58, 'activity_diï¬usa_willdbai_hua': 1.4896288093867526e-05, 'bufalin_component_su': 0.0004360764270917066, 'fromchan_su': 9.148819220060914e-58, 'tumor_neovascularization': 9.148819220060914e-58, 'radix_ren_shen': 9.148819220060914e-58, 'diï¬usa_willdbai_hua': 9.148819220060914e-58, 'she_cao_scutellaria_barbata': 0.00033788502228482303, 'radix_huang_qi_lee_wu_mechanisms': 5.5097791684865594e-06, 'proteinsproviding_a_foundation_for_tcm_application_zhang_  _fufang_yiliu_yin': 5.5097791684865594e-06, 'apoptosis_fyy': 5.742420693366831e-07, 'pharmacopoeia_fyy': 9.148819220060914e-58, 'was_stored_at_\\x88\\x92\\x97_¦_c_untiluse_and_was_further_diluted_to_the_required_concentrations_insubsequent_cell_experiments_human_crc_cell_lines': 9.148819220060914e-58, 'absorbance_value': 9.148819220060914e-58, 'thermo_fisherscientiï¬\\x81c_inc_united_stateshct116': 9.148819220060914e-58, 'fyy': 0.0037975774132550685, 'weretaken': 0.00011352695917658647, 'celldensity': 0.00011349671059720682, 'to_screen_for_common_targets_between_fyy_and_diseaserelated_targetsdrug_to_analyze_the_core_compoundsprotein_interaction_networks_of_the_common_fyy_and_analysis': 0.002111769935768925, 'bioavailabilityand_druglikeness': 3.4459065422966066e-05, 'crc_targets': 3.4459065422966066e-05, 'to_screen_for_common_targets_between_fyy_and_diseaserelated_targetsdrug': 0.0014616190772430405, 'themerge_function': 9.148819220060914e-58, 'to_analyze_the_core_compoundsprotein_interaction_networks_of_the_common_fyy_and': 9.148819220060914e-58, 'rejecting_the_target_proteinindependent_of_the_network_szklarczyk_  _gene_ontology': 0.001129870936471824, 'zhou_enrichedgo_terms_pathways': 0.001129870936471824, 'onto045_µm_laboratories_herculesca_united_states': 4.804368526884627e-06, 'milk_tween_pbst_ma_united_states': 0.00010080225454168545, 'finallythe': 9.148819220060914e-58, 'using_an_enhanced_chemiluminescence_reagentand': 9.148819220060914e-58, 'imagej_software': 9.148819220060914e-58, 'to_calculate_the_intensity_grayvalue_of_each_protein_band_and_gapdh': 9.148819220060914e-58, 'onto045_µm_laboratories_herculesca_united_states_ml10_g_bodyweight': 4.804368526884627e-06, 'thefyy_group': 9.148819220060914e-58, 'ml10_g_bodyweight': 9.148819220060914e-58, 'equivalentvolume': 9.148819220060914e-58, 'using_the_following_formula_tumor_volumemm3_  _\\x97_length_\\x97_width2': 9.148819220060914e-58, 'mice_excised': 9.148819220060914e-58, 'finallytumorfrontiers': 9.148819220060914e-58, 'cancer_progressiontissue_liver_tissue': 6.196654813613077e-05, 'cancer_progressiontissue_liver_tissue_byincubation_thrice_states_analysis_growth': 0.0006486465140831126, 'byincubation': 6.196654813613077e-05, 'thrice': 6.196654813613077e-05, '1a_formation_assay': 1.0581900103922479e-05, '1bcolony_formation_ability': 9.148819220060914e-58, 'mgml_p': 9.148819220060914e-58, 'mgml_p_fyy_for_cell_cycle': 0.00172120280568484, 'concentrationdependentmanner_fyy': 0.0016810521528134112, 'oncell_proliferationcell_apoptosis': 0.0010325216439875707, 'diï¬erence_expression_expression': 4.111114138107696e-06, 'likeness_\\x89¥': 0.001129870936471824, 'tothese_compounds_genes': 0.0003833771411240826, 'myc_andesr1_figure': 8.263922883666513e-55, 'prostatecancer_apoptosis': 1.1686951820486561e-54, 'function_pathwayenrichment_signaling': 9.148819220060914e-58, 'enrichmentresults': 9.148819220060914e-58, 'crc_throughmultiple': 0.00014120710818717644, 'pi3kakt_signaling_pathwayswe': 8.263922883666513e-55, 'mechanism_promotedapoptosis': 0.0016810521528134112, '5bc': 1.0122908289796082e-06, 'cancer_fufang_yiliu_yin': 6.199958052379783e-05, 'that_fyy': 0.0005521751935137136, 'mgrespectively_ki67': 1.0122908289796082e-06, 'yin_fyy': 0.0010492066709191824, 'cycle_progress': 6.196654813613077e-05, 'usinganovafrontiers_cancer_fufang_yiliu_yin_cell_apoptosis': 2.0051754478010525e-06, 'usinganovafrontiers': 5.284363978080408e-05, 'staining_analysis': 3.27238686018924e-08, 'b_flow_cytometry': 3.27238686018924e-08, 'groupthe_pvalues': 1.012290828979608e-06, 'analysis_enrichment_analysis_targetsof_compound\\x93disease\\x93target_networks_cancer_progressiontable_volume_table_continuedpubchem': 1.651619383352709e-08, 'analysis_enrichment_analysis': 6.196654813613077e-05, 'targetsof_compound\\x93disease\\x93target_networks_volume_table_continuedpubchem': 3.1939719795219034e-05, 'cancer_progressiontable': 6.196654813613077e-05, 'pakt_bcl2_bclxl': 0.0002337533695104565, 'theanticancer_eï¬ects': 0.0018006682651940404, 'crc_cell_apoptosisin': 0.0038806204677737646, 'xenograft_tumor_growth': 6.196654813613077e-05, 'total_database_table': 0.007713134335009549, 'quercetininhibits_crc_progression_inï¬\\x82ammationdarband_quercetin': 0.0005521751935137136, 'han_kaempferol': 9.148819220060914e-58, 'cell_apoptosischoi_formononetin_anticancer_eï¬ects': 9.148819220060914e-58, 'mutualenhancement_eï¬ect': 0.000323919559092138, 'using_singleor_mixed_compoundsfufang_yiliu_yin': 0.0010325216439875707, 'network_analysis': 0.0005524695878629878, 'cycle_arrest_activation': 9.011986636252904e-06, 'protein\\x93protein_network_kegg': 0.007713134335009549, 'cycle_arrest_apoptosis_activation': 9.011986636252904e-06, 'cmyc_analysis': 9.148819220060914e-58, 'apoptosis_pathways': 9.148819220060914e-58, 'medicine_formulas': 1.1686951820486561e-54, 'progression_tcmformula': 8.263922883666513e-55, 'jianpi_jiedu': 9.148819220060914e-58, 'crc_tumorigenesis': 9.148819220060914e-58, 'mtorhif1Î±vegf_pathway': 8.263922883666513e-55, 'formula_huang_qin_ge_gen_tang': 9.148819220060914e-58, 'anticancer_eï¬ect': 9.148819220060914e-58, 'fang_formula': 9.148819220060914e-58, 'multidrugresistance': 9.148819220060914e-58, 'formulas_fyy': 9.148819220060914e-58, 'astragaliradix_huang_qi_h_diï¬usa_willd_bai_hua': 9.148819220060914e-58, 'glabra': 8.770946583746331e-05, 'transcription_protein_levelof': 6.196654813613077e-05, 'akt_inhibition': 9.148819220060914e-58, 'afrontiers_volume': 9.148819220060914e-58, 'fyytreatment': 6.196654813613077e-05, 'group_values': 9.148819220060914e-58, 'expression_fyytreatment_c': 9.148819220060914e-58, 'xenograft_tumors': 6.198306432996431e-05, 'ttestdecrease': 5.284363978080408e-05, 'gu_calycosina_component': 9.148819220060914e-58, 'crcproliferation': 9.148819220060914e-58, 'signaling_pathways_zhao_   _quercetinkaempferol_and_rutin_in_h_diï¬usa_willd': 1.1686951820486561e-54, 'anticancereï¬ects': 8.263922883666513e-55, 'progressionfigure_representation_analysis_results': 8.263922883666513e-55, 'yang_fyy': 0.0004394889864169925, 'antimetastaticeï¬ect': 0.007713134335009549, 'liver_metastasis_model': 9.148819220060914e-58, 'to_investigate_thissecondfurther_studies': 9.148819220060914e-58, 'mutualenhancement_eï¬ects': 9.148819220060914e-58, 'resistancein_conclusion': 9.148819220060914e-58, 'fyy_inhibitedproliferation_promoted_therapy': 9.148819220060914e-58, 'animalethics_committee': 9.148819220060914e-58, 'qj': 4.496068198240745e-51, 'experimentssz_fyy': 2.2480340991203723e-51, 'fyy_formula': 2.2480340991203723e-51, 'pharmacology_analysis_program_ofshandong_provincefrontiers': 2.2480340991203723e-51, 'cs': 0.0014620088771761278, 'versiondata_availability': 0.0007959416758056306, 'china_grant_numbers': 0.0014616190772430405, 'progressiongrant_number': 2.2480340991203723e-51, 'foundationgrant_number_sciencefoundation': 0.0003692335358126249, 'l_wang_l_zhan_y_hedyotis_diï¬usawilld': 0.00013886388020074755, 'h_bray_f_cancerstatistics_oxygen_species_activation': 9.148819220060914e-58, 'apoptosis_food_chem_x_ganoderma_lucidum_inhibitsproliferation_b_sadighparvar': 9.148819220060914e-58, '107314apjcp201516177991gu': 3.28784142602511e-52, 'b_icariin': 9.148819220060914e-58, 'inhibitoryeï¬ects': 9.148819220060914e-58, 'stat3_pathways_m_song_y_zhang_quercetin': 9.8683294751852e-07, 'g_shikonin': 9.148819220060914e-58, 'proliferation_inducesapoptosis_study_integr_cancer': 9.148819220060914e-58, 'medicine_therapy': 4.926719745723713e-06, 'h_medicine_therapy': 9.148819220060914e-58, 'survival_inpatients': 9.148819220060914e-58, 'j_isorhamnetin': 0.00027078059233556784, 'huang_qin_ge_gen_tang': 9.148819220060914e-58, 'activitythrough_modulation': 9.148819220060914e-58, 'k_li_k': 9.148819220060914e-58, 't_wu': 9.148819220060914e-58, 'medicine_formula': 9.148819220060914e-58, 'tumorigenesismetastasis_angiogenesis': 9.148819220060914e-58, 'citationrahat_b_ali_t_sapehia_dmahajan_biomarkers_volume': 0.00010136339448812808, 'cytosine_ccfdnas': 2.8533183495764488e-05, 'sectionthis': 3.223461976075818e-50, 'toepigenomics_epigeneticsa_section': 1.494668473097834e-50, 'cellfree_genomicdnas_ccfdnas_and_cellfree_mtdna_kohler_  _thierry_   _and_cellfree_rnas_ccfrnas_includingproteincoding_messenger_rna_mrna_regulatory_noncodingrnas_like_micrornas_mirnaslong_noncoding_rnaslncrnas_circular_rnas_and_rnas_involved_in_translationlike_transfer_rnas_trnas_and_ribosomal_rnas_rrnaspos_  ': 1.2616688183393093e-05, 'cellfree_genomicdnas_ccfdnas_kohler_thierry_rnas_ccfrnas': 9.148819220060914e-58, 'rnas_rrnaspos': 9.148819220060914e-58, 'ccfnas_dnas_rnas': 9.148819220060914e-58, 'cellfree_genomicdnas_ccfdnas_and_cellfree_mtdna_kohler_  _thierry_   _and_cellfree_rnas_ccfrnas_includingproteincoding_messenger_rna_mrna_regulatory_noncodingrnas_like_micrornas_mirnaslong_noncoding_rnaslncrnas_circular_rnas_and_rnas_involved_in_translationlike_transfer_rnas_trnas_and_ribosomal_rnas_rrnaspos_  _tolymphoid_tissues': 9.148819220060914e-58, 'tolymphoid_tissues': 7.215039472607543e-05, 'snyder_associated_aï¬ectedtissues': 9.148819220060914e-58, 'amount_0crahat_ccfnas': 9.148819220060914e-58, 'treatment_methods_pattern_speciï¬\\x81c': 0.00020422465499362284, 'greatpotentialepigeneticmarks': 0.0003733542770154514, 'evenbefore_the_onset_of_actual_symptoms_and_hence_help_inbetter_management_ofthe_disease_precision_medicine_hasimproved_health_care_by_theidentiï¬\\x81cation_of_diï¬erentstagessubsets_of_diseases_precise_diagnosis_and_treatmentfurthermore_the_development_of_advanced_analytical_softwaretechniques_like_machine_learning_and_artiï¬\\x81cialintelligencecan_enhance_precision_medicine': 0.0007956673215405282, 'sequencing_to_identify_novel_ccfnabasedepigenetic_markersepigenetic_biomarkers_in_ccfnasreliable_markers': 0.00022770977125509355, 'amount_sequencing_to_identify_novel_ccfnabasedepigenetic_markersepigenetic_biomarkers_in_ccfnasreliable_markers_0crahat_ccfnas': 0.0010325216439875707, 'responseofbeltrangarcia_ccfdnas': 0.0007862569594425692, 'the_most_abundant_form_of_dna_methylationit_plays_an_important_role_in_the_regulation_of_gene_expressionand_is_widely_used_as_an_epigenetic_biomarker_for_ccfdnabasedassays_dna_methylation': 9.148819220060914e-58, 'mutationor_proteinbased_markers': 9.148819220060914e-58, 'deepsequencing_on_ccfdnas': 0.00022956017717477826, 'pattern_ofnucleosome_positioning': 0.00022956017717477826, 'use_nucleosome_positioning': 9.148819220060914e-58, 'biopsiesfor_deï¬\\x81nitive_diagnosis': 9.148819220060914e-58, 'nucleosomepositioning': 9.148819220060914e-58, 'to_infer_pathological_statesof_multiple_disease_types_a_comprehensive_public_databasecalled_cellfree_epigenome_atlas_cfea': 9.148819220060914e-58, 'methylation_markers_diï¬erentialexpression': 0.00025126313729024964, 'biomarkersrelativelyeasily': 9.148819220060914e-58, 'using_accessible_techniqueslike_methylight_methylspeciï¬\\x81c_pcr_methylationsensitivehighresolution_melting_and_pyrosequencing': 9.148819220060914e-58, 'rassf1a_stat5a': 6.075138805368377e-52, 'to_detect_andquantify_histone_modiï¬\\x81cations_on_ccfnas_in_serum_or_plasmaadli_and_bernstein_techniquesdiagnostic_approach_forepigenetic_modifications_in_ccfnathe_various_diagnostic_approaches_to_study_the_epigeneticmodiï¬\\x81cations_in_the_nucleic_acids_assay_mira_methylcap': 4.649709951488235e-52, 'enzymesthat': 5.148267144379345e-06, 'to_detect_andquantify_histone_modiï¬\\x81cations_on_ccfnas_in_serum_or_plasmaadli_and_bernstein_techniquesdiagnostic_approach_forepigenetic_modifications_in_ccfnathe_various_diagnostic_approaches_to_study_the_epigeneticmodiï¬\\x81cations_in_the_nucleic_acids': 3.287841426025112e-52, 'assay_mira_methylcap': 3.287841426025112e-52, 'onmethylcpgbinding_domains_mbd': 0.004315547045054443, 'mitchell_methods': 2.5164048986301264e-52, 'sequencing_and': 0.000347488144371561, 'levy': 0.000347488144371561, 'theseccfnas': 0.0007035667068513752, 'events_liver_nucleicacids_timeintervals_mgmt_rassf2a_ngfrand_sept9_plasma': 0.001187568705954946, 'thedetection': 0.00210348072096923, 'surprisinglyrna': 9.148819220060914e-58, 'ccfnas_diseases_changes': 9.148819220060914e-58, 'umu_changes': 0.0002208255543092432, 'diseasesfrontiers_volume': 0.004315547045054443, 'to_be_a_noninvasive_rapid_and_sensitive_markerfor_diagnosis_prognosis_and_therapy_response_monitoring_indiï¬erent_cancers_volik_   ': 0.00210348072096923, 'events_liver_nucleicacids': 3.1568831549947735e-05, 'timeintervals': 0.0013882295497307361, 'schmidt_mirnas': 1.9373358835021547e-05, 'notwell': 1.9373358835021547e-05, 'levels_bloodstream': 1.9373358835021547e-05, 'wang_methylation': 1.9373358835021547e-05, 'mgmt_rassf2a_ngfrand_sept9': 3.1568831549947735e-05, 'cst6': 0.0018006682651940404, 'biomarker_studies': 9.148819220060914e-58, 'hypermethylationof_cdkn2a': 9.148819220060914e-58, 'apgihas': 0.0008522036149147152, 'promoter_regionthe_genes': 0.00039947355805761766, 'set1a': 0.0001274660066607045, 'set1b_set1a': 1.0314965201501525e-06, 'vitalrole': 6.316602707724419e-05, 'set1a_vitalrole_to_be_a_signiï¬\\x81cant_prognostic_factor_for_osccpatients_based_on_cox_regression_analysis': 3.57610591824189e-50, 'to_be_a_signiï¬\\x81cant_prognostic_factor_for_osccpatients_based_on_cox_regression_analysis': 3.57610591824189e-50, 'serumsignature': 0.0019127833147525456, 'ccfmirnas': 0.00018049906186689923, 'mir155_mir': 0.0007645421546501083, 'information_innonmalignant_diï¬erentiated': 1.2474224390385085e-05, 'innonmalignant_diï¬erentiated': 1.2474224390385085e-05, 'clinicalapplication_wong': 0.0010325216439875707, 'henceit': 9.148819220060914e-58, 'biomarker_asprediction_foresight': 9.148819220060914e-58, 'target_antonia': 0.0010325216439875707, 'to_be_signiï¬\\x81cantlyupregulated_in_patients_of_prostate_cancer_pca': 1.3459183279590638e-05, 'investigation_mir9_3p': 2.1986974772814365e-07, 'using_ccfdna': 0.0004005448148874858, 'weaver_wakabayashi_studies': 9.148819220060914e-58, 'role_ccfnas': 9.148819220060914e-58, 'molecularproï¬\\x81ling': 0.004315547045054443, 'ednrb_eomes': 9.148819220060914e-58, 'pou4f2sept9_hltf': 9.148819220060914e-58, 'timp3': 0.00025516077299370923, 'vu_colorectal_carcinomatosis_palmisano_hauser_haldrup_management_diagnosis': 4.164248906682774e-06, 'blood_litton': 1.4885716696247642e-09, 'johnson_changes': 0.000598820003809177, 'diagnostics': 0.0018396776776553089, 'disease_signals_thuscan': 3.0028184974601816e-05, 'targetedtherapies': 0.0006054349545841993, 'pavedthe_way': 0.0005269923949341242, 'techniques_ccffetaldna': 0.00016032962580117682, 'adzick_ccffetaldna': 7.191965547582971e-08, 'vu_colorectal_carcinomatosis_palmisano_hauser_haldrup_blood_litton_management_diagnosis_acids_marker_detection_potential': 4.3996468163412685e-06, 'takai_testing': 0.0007956673215405282, 'h19igf2': 0.0011075402231842013, 'blood_poon': 5.98275832447814e-06, 'diï¬erential': 0.004315547045054443, 'maternalhypomethylated_ccfdna': 7.191965547582971e-08, 'methylatedsequences': 0.0007035667068513752, 'toestimate_positives': 0.00022770977125509355, 'to_calculate_the_allelic_ratio_to_diagnose_trisomy': 0.0007956673215405282, 'tong_trisomy': 1.0362787763763494e-08, 'identiï¬\\x81cation_markers': 6.348989383042303e-07, 'nextgeneration_sequencing_highthroughputtechniques': 3.8887944776576426e-05, 'array_withmethylated_dna_immunoprecipitation_medip': 9.148819220060914e-58, 'ina_genomewide_screen': 9.148819220060914e-58, '\\x82ammatory_site': 0.001387866934709057, 'account_are_recruitedto': 0.00022165572398622112, 'infections_neutrophils': 0.0006992128660964839, 'microbes_peptidesproteases_netosis': 0.004315547045054443, 'immunity_immunotherapya_section': 2.05846689113717e-50, 'precursorpopulation': 0.00027528817557813693, 'bone_marrow_spleen': 0.004315547045054443, 'to_accumulate_in_growing_tumors_ ': 2.7629245646464483e-05, 'exhibit_plasticity': 0.00027528817557813693, 'precursorpopulation_precursor_tumor_growth_exhibit_plasticity_oversimpliï¬\\x81cation_interestin_cell_population_hydrogen_peroxide': 4.485579771720759e-07, 'tumorassociatedneutrophils_tans': 0.0005345134679592639, 'oversimpliï¬\\x81cation': 4.485579771720759e-07, 'phenotypespresent': 9.148819220060914e-58, 'interestin_cell_population': 9.148819220060914e-58, 'we_brieï¬\\x82y': 9.148819220060914e-58, 'antitumorrelationshipsneutrophilreview': 9.148819220060914e-58, 'hydrogen_peroxide': 0.00027528817557813693, 'subsequentlyit': 7.503266534701476e-05, 'thus_neutrophilshave_the_capacity_to_mediate_rosdependent_direct_tumorcell_killingcausingthe_interplay_of_neutrophils_with_otherimmune_celltypes_can_also_indirectly_limittumor_progression_tumorassociated_neutrophils_suppress_the_protumorigenic_role_ofil17_secreting_ÎÎ_´_t_cells_by_inhibiting_their_proliferationlow_glutathione_levels_in_ÎÎ´17_t_cells_antitumoreï¬ects_nonmetastaticifnÎproducing_monocytes_to_be_involvedin': 0.0002765120695678718, 'interactionbetween': 9.148819220060914e-58, 'thus_neutrophilshave_the_capacity_to_mediate_rosdependent_direct_tumorcell_killingcausingthe_interplay_of_neutrophils_with_otherimmune_celltypes_can_also_indirectly_limittumor_progression_tumorassociated_neutrophils_suppress_the_protumorigenic_role_ofil17_secreting_ÎÎ_´_t_cells_by_inhibiting_their_proliferationlow_glutathione_levels_in_ÎÎ´17_t_cells': 9.148819220060914e-58, 'to_mediate_in_vitrotumor_cell_cytotoxicity_in_a_h2o2dependent_manner': 0.00010596020021879068, 'them_sensitiveto_neutrophilderived': 9.148819220060914e-58, 'oxidativestress_proliferation': 9.148819220060914e-58, 'antitumoreï¬ects_nonmetastaticifnÎproducing_monocytes': 1.2238939897348635e-06, 'cell_checkpoint': 9.148819220060914e-58, 'taken_together': 9.148819220060914e-58, 'thatneutrophils': 0.00014358123590668443, 'cell_suppression_differentiation_release': 0.00027528817557813693, 'proliferation_secretion': 0.0038806204677737646, 'killing': 0.0002753615472161239, 'colony_factor': 0.0038806204677737646, 'synthase_net_neutrophilextracellular_trap_caf': 0.000699585647362141, 'b4_inos': 1.1412969916417694e-05, 'constituents_structures': 8.619736022587219e-05, 'netshave': 9.148819220060914e-58, 'to_play_an_important_role_in_the_growth_of_aprimary_tumor_tumor_microenvironmental_changes_includingtumorassociated_coagulation_and_enhanced_thrombosishave': 9.148819220060914e-58, 'b4_inos_functions_gmcsf_suppression_tumor_growth': 1.671295841173954e-07, 'lps_stimulation': 9.148819220060914e-58, 'to_increase_c3arexpression_within_neutrophils': 9.148819220060914e-58, 'preferentiallyrespond': 9.148819220060914e-58, 'c3a': 9.148819220060914e-58, 'counts_thrombosis': 0.0004358935679566294, 'ros_production': 2.726757970710921e-09, 'gmcsf': 4.4541667024152473e-11, 'pdl1_neutrophils': 9.148819220060914e-58, 'to_suppress_t_cell_function_and_promote_tumor_growth_secretion_of_mmp9_matrix_metalloproteinase_ _from\\x81ltrating_neutrophils': 9.148819220060914e-58, 'suppression_tumor_growth': 1.1412969916417694e-05, 'tumor_progression_these': 0.00021668009229506161, 'tumorscan': 0.00016321626925891726, 'growthneutrophil_functions': 0.000704362469235278, 'aspectof_cancer_progression': 2.7260316428668585e-09, 'to_assist_cancer_cells_insuccessfully_navigating_several_of_these_distinct_steps_figure_supplementary_table_local_invasionintravasation\\x81ltrating_neutrophils_within_primary_tumors': 0.00031995314978350303, 'timp1': 1.1686951820486561e-54, 'anemt': 8.263922883666513e-55, 'cells_cancer_cells': 8.263922883666513e-55, 'ctcsto_surviveis': 9.148819220060914e-58, 'metastasis_formation': 9.148819220060914e-58, 'cell\\x94neutrophil_clusters': 0.00013916638672897274, 'to_greatlyincrease_metastatic': 2.270564301863107e-06, 'cell_accumulation': 2.9402948113849672e-05, 'to_greatlyincrease_metastatic_t_cells': 0.001801148090838322, 'interactions_adhesion': 9.148819220060914e-58, 'clearancein_circulation_cells': 9.148819220060914e-58, 'cancercell_proliferation': 0.0038806204677737646, 'cells_reducedendothelialtransendothelialmigration': 0.0004358935679566294, 'the_opposite_eï¬ect_cancer_cells_that_have_survived_in_circulation_must_exitthe_bloodstream_and_extravasate_into_tissue_parenchyma_neutrophils_have_been_shown_to_regulate_the_extravasationprocessthrough_several_mechanisms_neutrophilderivedfactors_can_diminish_the_integrity_of_the_endothelial_barrierpermitting_cancer_cellsil8il1_and_matrix_metalloproteasesmmp8_and_mmp9released_from_neutrophils_activated_endothelial_cells_reducedendothelialtransendothelialmigration_and_accelerated_the_rate_of_cancer_cell_extravasation_to_extravasate_more_easilyincreasedfunctionbarriersites\\x93netosis_and_net_constituents': 0.0009255610465795641, 'cancer_cellextravasation': 1.5101890313444526e-05, 'bloodstream_extravasate': 9.148819220060914e-58, 'to_regulate_the_extravasationprocessthrough_several_mechanisms_neutrophilderivedfactors_can_diminish_the_integrity_of_the_endothelial_barrierpermitting_cancer': 9.148819220060914e-58, 'neutrophilderivedfactors': 3.0261563917591726e-06, 'ctcs': 9.148819220060914e-58, 'netosisdecreases_cell_adhesion': 9.148819220060914e-58, 'cancer_cellextravasation_changes_netosis_metastasis': 1.5101890313444526e-05, 'that_neutrophils_play_animportant_role_in_enhancing_tumor_cell_survival_and_increasedextravasation_which_promote_cancer_metastasisrecruitmentearly_seedingsurvivalsystemic_and_tumorderived_factors': 9.148819220060914e-58, 'neutrophilin': 9.148819220060914e-58, 'cancer_factors': 0.0038806204677737646, 'secreted': 1.1686951820486561e-54, 'to_be_important_in_promoting_metastasisfrontiers_in_immunology_ _to_promote_metastasis_by_activating_cancerassociatedï¬\\x81broblasts_growth_in_the_metastatic_siteneutrophils': 8.263922883666513e-55, 'lung_burden': 9.148819220060914e-58, 'cell_seeding_metastases_induction': 9.148819220060914e-58, 'to_promote_the_growth_ofmetastases_after_seeding_minor_subclones_of_breast_cancer_cellsthat_secrete_il11_and_figf_cfosinduced_growth_factor': 8.263922883666513e-55, 'chemokine_secretion_neutrophils': 3.289121035459026e-07, 'mitogenicactivity': 0.0038806204677737646, 'growth_function': 0.004315547045054443, 'to_increase_the_expressionof_wnt_ligands_which_in_turn_upregulated': 0.0004358935679566294, 't_cells_testosterone_levels': 5.150423929550849e-05, 'checkpoint_inhibitors_thegrowth_resistance': 0.001673621127693342, 'neutrophilrecruitment': 0.0038806204677737646, 'burden_melanoma_models': 0.004315547045054443, 'andmetastasis_proangiogenic_functions': 2.7317148742676314e-05, 'mechanism_bywhich_neutrophils': 0.00021559585552483182, 'dormantresidual_disease_andtherapy_resistanceneutrophils_have_also_been_implicated_in_awakening_dormantcancer_cells_lpsinduced_tissue_\\x82ammation_led_to_metastaticoutgrowth_of_dormant_tumor_cells_in_a_neutrophildependentmanner_ _mmp9_produced_by_neutrophils': 2.526999568045659e-06, 'cancer_cells_growth_severalstudies': 0.0038806204677737646, 'neutrophilenrichedsubtype': 0.00046339357583438293, 'promoteresistance': 9.148819220060914e-58, 'il17_whichincreases_recruitment': 9.148819220060914e-58, 'growth_factora': 0.00027528817557813693, 'cancer_livermetastases': 9.148819220060914e-58, 'to_identify_patients_that_were_resistant_toantiangiogenic_therapy_metabolic_programming_inneutrophilsrecentinteresthasbeenconceptin_thethereofimmunometabolism_and_the_realization_that_altered_cellularmetabolism_in': 9.148819220060914e-58, 'cellularmetabolism': 0.004315547045054443, 'signiï¬\\x81cantimpact': 0.0011125787591309202, 'metastasis_neutrophilsare': 0.00015558411392074784, 'mitochondria_andinhibitors': 0.0003732887667714682, 'upregulationof_genes': 0.0038806204677737646, 'lungcarcinoma_exhibit': 9.148819220060914e-58, 'signiï¬\\x81cantimpact_notion_switch': 9.148819220060914e-58, 'to_mediate_many_neutrophil_functions_including_migration_and_t_cell_suppression_under_nutrient_limiting_conditions_such_as_low_glucoseneutrophils': 0.0002587375862772413, 'demands_nutrient_supply': 9.148819220060914e-58, 'cell\\x99s_ability': 9.148819220060914e-58, 'neutrophilsubpopulations': 7.723613244264731e-05, 'acid_oxidation': 0.00027528817557813693, 'cell_suppression': 0.00027528817557813693, 'to_support_theirprotumorigenic_functions': 0.004315547045054443, 'respectively_suchobservations': 0.000312090869820137, 'importance_futureperspectives': 0.0001360596895686607, 'tumor_growthand_metastatic_progressionclinical_importance_futureperspectives_on_treatmentin_keeping_with_their_protumorigenicmetastatic_functions_thepresence_of_neutrophils_across_ _shownto': 0.00027528817557813693, 'serum_il8_levels_neutrophil': 0.001845170519318405, 'that_insights': 9.148819220060914e-58, 'factorstumor_growth_andmetastasis': 9.148819220060914e-58, 'cowland_jb_granulopoiesis_granules': 9.148819220060914e-58, '\\x93_iwh_chong_sz_teng_kww': 9.148819220060914e-58, 'promotetumor_growth_metastasis': 9.148819220060914e-58, 'functions_concept': 9.148819220060914e-58, 'aï¬ord': 0.0005451704010514204, 'foundation_grant': 8.89410348511755e-06, 'versionfundingwork': 0.0007959416758056306, 'graduatestudentship_ys': 9.148819220060914e-58, 'review_foundation_grant': 9.148819220060914e-58, 'cw': 9.148819220060914e-58, 'breast\\x93_metastasis_cell_rep': 9.148819220060914e-58, 'c_lowdensity_neutrophils': 9.148819220060914e-58, 'metabolic': 9.148819220060914e-58, 'g_ling_l_phenotype_m': 2.966582108651456e-05, 'frommechanisms_kinship': 1.4764820064355897e-50, 'rv_granot': 6.913083538615695e-51, 'trpm2': 4.489700365145071e-06, 'rvcohendaniel_l_cues': 9.148819220060914e-58, 'tumor_cellsusceptibility_lowell_caerlebacher': 9.148819220060914e-58, '\\x93_lanca_t_ioannou': 6.656128740474994e-06, 'h_neutrophils': 9.148819220060914e-58, 'il17_gammadeltat_cells': 9.148819220060914e-58, 'eï¬ector_functions': 0.000535247340085233, 'maturationas': 4.273380630135268e-05, 'cell_maturation': 2.2685271101398567e-05, 'to_provide_a_framework_ofthe_current_knowledge_of_nk_cell_maturation_and': 0.007713134335009549, 'process_includingtranscription_factors_cytokines': 0.004315547045054443, 'byzhigang_tianuniversity': 0.004315547045054443, 'wangwangxuefuahmueducnspecialty_sectionthis': 4.496068198240745e-51, 'biologya_section': 2.2480340991203723e-51, 'august_citationbi_j_wang_molecularregulation': 3.9337095082972996e-06, 'adult_mice_cells': 9.148819220060914e-58, 'developmentbone_marrow': 9.148819220060914e-58, 'biologya_section_developmentbone_marrow_prob_cells_lymphoid_cellcilcpprenkps': 2.2480340991203723e-51, 'prob': 2.2480340991203723e-51, 'cells_lymphoid_cellcilcpprenkps': 2.2480340991203723e-51, 'acquisition_expressionmarks_cells': 9.148819220060914e-58, 'maturation_program': 9.148819220060914e-58, 'ly49': 0.0001387829349699916, 'periphery_cell_tnk_m2_stageand_figure_diï¬erentiate': 0.0001387829349699916, 'cell_tnk_m2_stageand_figure_diï¬erentiate': 0.0001387829349699916, 'theircytotoxic_capacity': 0.0011125787591309202, 'trajectories': 0.0011125787591309202, 'to_be_immature_andcan_diï¬erentiate_into_cd56dim_nk_cells_with_the_acquisition_ofcd16_ ': 0.0011125787591309202, 'cytokinescd56dim': 9.738652609604476e-05, 'terminalmaturation': 0.0016810521528134112, 'cd57on_surface': 0.0011125787591309202, 'singlecell_analysis': 0.000323919559092138, 'cd27_andcd11b': 9.148819220060914e-58, 'populations_tissues': 9.148819220060914e-58, 'maturation_process': 9.148819220060914e-58, 'egressof': 9.148819220060914e-58, 'cells_balancebetween_survival_proliferation_apoptosis': 0.00019730032585505341, 'gene_deletion': 2.662944294611317e-07, 'elicitedby': 0.0006945415217269727, 'thematuration': 1.1332775643647009e-05, 'diï¬erent_groups': 9.148819220060914e-58, 'thematuration_model': 9.148819220060914e-58, 'nk_diï¬erentiation_assays': 9.148819220060914e-58, 'op9_stromalcells': 9.148819220060914e-58, 'that_nk_cellmaturation_is_dependent_on_several_critical_signaling_pathwaysand': 0.0001164707776285202, 'factor_activity': 1.9002509855383614e-06, 'nk_lineage_commitment_andmaturation': 9.148819220060914e-58, 'to_be_involved_in': 9.148819220060914e-58, 'duringthe_process': 0.0016810521528134112, 'ifnÎ_production_expression_ofactivation_markers': 0.00210348072096923, 'whereasltÎ²r': 7.868473076283797e-05, 'il15_responsivenessin_progenitors_ablation': 1.2835289501698132e-06, 'il15_responsivenessin_progenitors_lymphocytes_ablation': 1.2838709420733754e-06, 'nk_activation_survival_homeostasisinduce_socs3cell_cycle_arrest_microarchitecture': 2.4131617812775543e-06, 'ltÎ²_receptor': 9.148819220060914e-58, 'membraneboundltÎ±1Î²2_heterotrimer': 9.148819220060914e-58, 'tbet_expressioninduced': 0.0004002818947444053, 'ink_mnk±': 1.284690556057437e-52, 'maturationinduce_expression_socs3promote': 7.417164383651313e-53, 'maturationinduce_expression': 7.417164383651313e-53, 'socs3promote': 7.417164383651313e-53, 's1pr5_ifng': 6.528133940545239e-06, 'nk_activation_survival_homeostasisinduce_socs3cell_cycle_arrest': 2.4131617812775543e-06, 'clp_nkp_ink_mnk_functions_features': 0.00012184426248535181, 'microarchitecture': 2.4131617812775543e-06, 'presence_these': 2.0969968264162178e-08, 'theinteraction': 8.009977540950587e-05, 'il15rÎ²_nk_development_il15': 2.41852018097332e-05, 'transpresentation': 0.0014822071864062408, 'ablationof_il15': 0.000291411853346343, 'onbone': 0.00015266313713209798, 'mice_mice_thatoverexpress_il15': 0.0007080023910910008, 'mnk_cell_survivaland': 9.148819220060914e-58, 'cell_expansion': 9.148819220060914e-58, 'nk_cellmaturation_homeostasis_ex_vivo': 0.0001700035525728, 'evidencefrom_patients': 0.0038806204677737646, 'cell_maturation_production_activity': 1.0309417252401542e-05, 'thosein_wildtype_mice': 7.0706272877937e-05, 'eï¬ects_onnk_cells': 8.263922883666513e-55, 'mechanisticallyil17a': 5.125803990169576e-06, 'suppresses': 0.0003143415539147518, 'il17_signaling': 1.284690556057437e-52, 'populations_mtor_activity_activity_minimaleï¬ect_mtoractivation': 7.417164383651313e-53, 'mtor_activity_activity': 7.417164383651313e-53, 'minimaleï¬ect': 0.0005411681930881713, 'mtoractivation': 7.417164383651313e-53, 'nk_cells': 9.148819220060914e-58, 'cytokinestimulatedmetabolism': 9.148819220060914e-58, 'production_thediï¬erences': 0.00045660454367155184, 'to_revealthe_temporal_regulation_of_nk_cell_maturation_by_tgfÎ²transcription_factors': 0.0018006682651940404, 'killer_cell_development': 9.148819220060914e-58, 'activity_figure': 9.148819220060914e-58, 'id2_tbet_eomes': 0.0004001752419276083, 'numbers_those': 1.0705183467201885e-05, 'ofe4bp4': 9.148819220060914e-58, 'cell_production': 9.148819220060914e-58, 'bone_marrow_cell_production': 0.00022770977125509355, 'nkpproduction_speciï¬\\x81cally_il15': 9.148819220060914e-58, 'e4bp4\\x88\\x92\\x88\\x92_bone_marrow_ectopic_expressionof': 9.148819220060914e-58, 'e4bp4': 2.7446560661786228e-05, 'nk_cell_production': 0.0016815001133323047, 'e4bp4_e4bp4': 0.0007008712380191807, 'to_be_critical_for_therecruitment_of_e4bp4_to_the_id2_locus_and_be_required_fornk_cell_maturation_but_not_nk_lineage_commitment_ _inaddition_notch1_has_been_identiï¬\\x81ed_as_an_e4bp4_target_genein_nk_cells_ ': 8.263922883666513e-55, 'abrogation_sumoylation_phosphorylation': 0.0007008712380191807, 'investigationfirth': 0.0004001752419276083, 'clps': 0.0007008712380191807, 'speciï¬\\x81c_ablation': 9.148819220060914e-58, 'eï¬ect_maintenanceand_homeostasis': 9.148819220060914e-58, 'ifnÎ_production': 7.05029712940268e-05, 'tcf1': 7.411398593905498e-05, 'to_bind_tothe_ly49a_promoter_and_be_required_for_the_acquisition_of_ly49aexpression_during_nk_cell_development_ _loss_of_tcf1': 1.2089969729206886e-06, 'prenkps_nkps_inkcells_mnk_cells': 1.2089969729206886e-06, 'ets1': 0.0015851357451468276, 'to_function_from_the_prenkpstage': 2.587358276835478e-05, 'ets1\\x88\\x92\\x88\\x92mnk_cells': 9.148819220060914e-58, 'eï¬ector_function': 9.148819220060914e-58, 'decreasedexpression': 9.148819220060914e-58, 'eï¬ector_function_ets1_expression': 9.148819220060914e-58, 'il': 9.148819220060914e-58, 'ets1_expression': 9.148819220060914e-58, 'ets1is': 9.148819220060914e-58, 'reduction_inhibition_periphery': 9.148819220060914e-58, 'nkcelldependent_tumor_surveillance': 0.0005411681930881713, 'nk_cell_maturation_function': 0.00014626258547791333, 'id2': 9.148819220060914e-58, 'to_play_an_essential_role_in_thegeneration_of_peripheral_lymphoid_ans_and_nk_cells_throughthe_use_of_id2\\x88\\x92\\x88\\x92_mice_ ': 9.148819220060914e-58, 'mysm1': 0.0015842910551982499, 't_cells_cells': 0.004339384069026662, 'role_binding': 0.0004001752419276083, 'tbetdeï¬\\x81cientnk_cells': 0.0008522036149147152, 'immaturity_tbet_isessential': 9.148819220060914e-58, 'roles_cells': 9.148819220060914e-58, 'tox_thymocyte': 1.284690556057437e-52, 'tomaintain_nk_cell_maturity': 7.417164383651313e-53, 'box_proteinbelongs': 7.417164383651313e-53, 'tox3and_tox4': 7.417164383651313e-53, 'id2_expression': 0.0001387829349699916, 'tox': 9.148819220060914e-58, 'nk_cells_aï¬ects_expression': 9.148819220060914e-58, 'oftox': 9.148819220060914e-58, 'investigationsbesides': 9.148819220060914e-58, 'tbet_overexpression': 9.148819220060914e-58, 'maturation_defects_results': 9.148819220060914e-58, 'nk_cell_maturationremains': 0.0011125787591309202, 'tox_andtox2': 9.148819220060914e-58, 'role_expression': 9.148819220060914e-58, 'nk_cell_numbers': 0.0005411681930881713, 'zeb2': 0.0002584379969449155, 'promotesnk_cell_maturation_absence': 6.343042825359576e-05, 'knockout_ko': 0.008383532384197919, 'ko_cells': 4.60578105484361e-07, 'mica': 7.513307530752525e-09, 'citrate_ï¬\\x82ux': 9.148819220060914e-58, 'mica_expression': 9.148819220060914e-58, 'changes_mica_expression_withstressinducers_nkg2dl_induction_atp_acetylcoa_oxaloacetate_oaa': 0.007713134335009549, 'nkg2d_receptor': 8.011123183126505e-06, 'cancer_cytotoxicity': 0.0004358935679566294, 'chronicnkg2dl_expression': 0.0004358935679566294, 'elimination_bydownmodulating_impairing': 0.0004358935679566294, 'nkg2dl_surface_expression': 0.004315547045054443, 'withstressinducers': 0.0001370441181840657, 'upregulatenkg2dls': 9.148819220060914e-58, 'nkg2dl_induction': 9.148819220060914e-58, 'inthe_cytosol_citrate': 9.148819220060914e-58, 'atp_acetylcoa_oxaloacetate_oaa': 9.148819220060914e-58, 'citrate': 0.0007192209053823597, 'acetylcoa': 1.1733819153235802e-05, 'class_we': 0.00025761770367047364, 'surface_expression': 0.0006396042038932523, 'mgat5': 0.0077235665609322515, 'andmitochondrial_export': 9.148819220060914e-58, 'micatranscription_regulation': 9.148819220060914e-58, 'antitumor_responses_diï¬erentiation': 0.0018006682651940404, 'modulateschromatin_accessibility': 9.148819220060914e-58, 'surveillancematerials_methodsanimalsfemale': 9.148819220060914e-58, 'inspectorate_ministry': 0.0018006682651940404, 'forlaboratory_science_associations': 9.148819220060914e-58, 'inhibitorsand_dna_constructspharmacologicalfrom_sigmaaldrich': 9.148819220060914e-58, 'd61345aminoimidazole4carboxamide2deoxydglucosetriï¬\\x82uoromethoxyphenylhydrazone': 9.148819220060914e-58, 'a9978_nacetylcysteine_nac': 9.148819220060914e-58, 'sodium_salt': 9.148819220060914e-58, 'arbor_mi_united_states': 9.148819220060914e-58, 'bristol_bms303141': 7.715394998113566e-08, 'myctag': 9.148819220060914e-58, 'dr_m': 9.148819220060914e-58, 'lymphocytes_pbls_pbmcs_weredepleted': 7.417164383651313e-53, 'states_g7513_mm_pyruvate_s8636_mm': 1.284690556057437e-52, 'previouslydescribed_pbls': 7.417164383651313e-53, 'dgalactose_g6404all': 7.417164383651313e-53, 'md_united_states_proliferationhuman_celllinehacat': 9.148819220060914e-58, 'mica_expressiondisease_jesperjurlander': 9.148819220060914e-58, 'mica_expressiondisease': 1.1733819153235802e-05, 'state_hospital': 9.148819220060914e-58, 'jesperjurlander': 9.148819220060914e-58, 'ko_cells_editingmgat5_ko_cells': 0.0004948318626078168, 'hek293cells': 1.4727567747505842e-07, 'zinc_loss_to_have': 9.01679160508971e-06, 'coliusing_heatshock_soc_medium': 1.4727567747505842e-07, 'k_treatmentconstructs': 8.263922883666513e-55, 'nucleobond_xtra_midi': 1.1686951820486561e-54, 'dna_waspuriï¬\\x81ed': 8.263922883666513e-55, 'pcmvvsvg_envelope_vector_µg': 9.148819220060914e-58, 'mgat5_µl': 9.148819220060914e-58, 'µg_pcmvvsvg_envelope_vector_ _µg_plx302vector_carrying_mgat5_and_ _µl_cacl2_to_a_ï¬\\x81nal_volume_of_µl_the_dna_mixture': 1.8167818297264612e-05, 'adjusted_to_a_ï¬\\x81nal_volume_of_ _µl_dna_mixture_wascomplexed_with_ _µl_2x': 0.0011131718807915394, 'hek293_t_cells': 1.8167818297264612e-05, 'p_preparations': 4.1670898062988435e-05, 'calciumphosphate_transfectionbrieï¬\\x82y_dnarna': 2.8410136746637048e-06, 'lonza_dna': 9.148819220060914e-58, 'using_the_nucleofector_programq001_for_gfpmyctagged_mica\\x88\\x97_and_mica\\x88\\x97constructs_cells': 9.148819220060914e-58, 'na2hpo4and': 5.7771282662203366e-09, 'sirnacontrol': 0.0011128752409327472, 'assaysfor_nkg2d_downmodulation_pbls': 1.8162977041424498e-05, 'nkg2d_downmodulation_assay': 9.148819220060914e-58, 'nkg2d_ligands': 9.148819220060914e-58, 'cocultivation_nkcd8_t_cells': 4.533771745563349e-07, 'franklin_lakes_nj': 9.148819220060914e-58, 'nkg2dreporter_cell': 9.148819220060914e-58, 'target_cells': 9.148819220060914e-58, 'dropwise_nkg2d_ligands': 9.148819220060914e-58, 'cellsthat': 1.816782087876967e-05, 'described_reported_measured_determined': 1.2321453111168058e-06, 'svortex': 7.547010781458245e-05, 'withtrypsinization': 0.0011125787591309202, 'resuspension': 0.0011125787591309202, 'ltd_cork_irelandand': 1.2321453111168058e-06, 'p_size_phases': 3.57610591824189e-50, 'to_measure_ocr_and_ecar_on_hek293cells_cells_were_seeded_at_the_density_ _\\x97_ _cellswell_\\x88¼_hbefore_the_experiment_one_hour_prior_to_assay_run_cells_wererinsed_and_switched_to_xf_media_agilent_technologies_with_mm_sodium_pyruvate_and_ _mm_glucose_or_galactose_andincubated_at_\\x97_¦_c_co2free_incubator_for_the_mitochondrialstress_tests_ocr_was_measured_under_basal_conditions_andduring_sequential_injection_of_ _µm_oligomycin_sigmaaldrich_ _µm_fccp_sigmaaldrich_c2920_and_ _µmrotenone_rot_sigmaaldrich_r8875_  _µm_antimycina_aa_sigmaaldrich': 7.996415927928173e-50, 'maintainedfor_min': 3.57610591824189e-50, 'columnoven': 3.57610591824189e-50, 'range_lchrmsï¬\\x81les': 3.57610591824189e-50, 'b06agilent_technologies': 3.57610591824189e-50, 'rotand_aa': 9.148819220060914e-58, 'respiration_display': 9.148819220060914e-58, 'subtracted': 0.00015175328891448237, 'rotand_aa_subtractedfor': 0.0004394889864169925, 'laboratories_tewksbury_states_medium_samples': 1.9182506632418292e-07, '\\x97_g': 1.1746335240292914e-05, 'ï¬\\x82ow_analytes': 1.9182506632418292e-07, 'corrected_calculated': 1.9182506632418292e-07, 'blottingproteins': 1.9182506632418292e-07, 'sonicated': 9.148819220060914e-58, 'sigmaaldrich_proteins': 9.148819220060914e-58, 'rdsystems_rd_systems': 9.148819220060914e-58, 'ulbp1rd_systems': 9.148819220060914e-58, 'green_fm_invitrogenm7514_bodipy_invitrogen': 9.148819220060914e-58, 'inpbs_fbs': 9.148819220060914e-58, 'pcr_analysistotal_rna': 9.148819220060914e-58, 'phase_separation': 9.148819220060914e-58, 'as_ _01mfifscsscreal_time_pcr_analysistotal_rna_was_extracted_by_phase_separation_in_trizolchlorophorm_and_puriï¬\\x81ed_on_directzol_spincolumns_zymoresearch_irvine': 0.00011349671059720682, 'mica_expressioncultures': 1.1733819153235802e-05, 'to_prepare_tagmented_chromatin_ _replicatesof': 1.1733819153235802e-05, 'wt_replicates': 9.148819220060914e-58, 'mica_expressioncultures_to_prepare_tagmented_chromatin_ _replicatesof': 9.148819220060914e-58, 'peakswere': 1.311147465485698e-08, 'quality_duplicate_mitochondrial': 2.1415567542837792e-10, 'chipseq_data': 2.1415567542837792e-10, 'analysisresults': 2.1415567542837792e-10, 'asstated_in_ï¬\\x81gure_legends_using_unpaired_ttest_in_1a_1c': 0.001129870936471824, '5c_7a_7ef': 9.148819220060914e-58, 'ttest_3d_sample_ttest': 9.148819220060914e-58, 'g_level': 3.93277794635785e-05, '\\x88\\x97p_\\x88\\x97\\x88\\x97p': 6.420466198721395e-07, 'nkg2d': 2.819719387086142e-05, '\\x88\\x97p_\\x88\\x97\\x88\\x97p_nkg2d_to_assess_the_role_of_mgat5_in_regulationof_nkg2dl_surface_expression_mgat5_ko_clones_weregenerated_in_hek293_cells_1a_1b_reporter_cells_nkg2d_reporter_cells': 1.1074272542574766e-05, 'to_assess_the_role_of_mgat5_in_regulationof_nkg2dl_surface_expression_mgat5_ko_clones_weregenerated_in_hek293_cells': 1.0432225922702625e-05, 'whetherthe_cancerassociated_glycosyltransferase_mgat5': 0.007713134335009549, '1a_modiï¬\\x81cation': 9.148819220060914e-58, 'nkg2d_activation': 9.148819220060914e-58, 'wt_cells': 1.7266859970571246e-05, 'reporter_cells': 6.420466198721395e-07, '1b_moreover_blocking_nkg2dls_withsoluble_nkg2dfc_receptor': 0.0006940543140455221, 'nkg2d_reporter_cells': 6.420466198721395e-07, 'signiï¬\\x81cant_increase': 0.007713134335009549, 'control_reporter': 7.723613244264731e-05, 'nkg2d_nkg2d': 0.007713134335009549, 'dataindicate_activation_expression': 2.754763394345853e-05, 'althoughmica\\x88\\x97': 2.2742115629454836e-53, 'dataindicate_activation_minor_unlikely_expression_nkg2d': 2.2742115629454836e-53, 'regulationof_mica': 0.007713134335009549, 'minor_unlikely': 1.4055400435083294e-53, 'changein': 9.148819220060914e-58, 'mica_figures': 9.148819220060914e-58, 'expressionfigure_knockout_increases': 1.1733819153235802e-05, 'isotypecontrol_staining_iso': 1.4055400435083294e-53, 'nkg2dactivation_nkg2dls': 1.8832489216197495e-05, 'relative_substrate_udpglcnac': 3.07688072548848e-07, 'substrate_udpglcnac': 0.007713134335009549, 'markers_targets': 0.0009466755491730313, 'lulem13705179888sinacnbinhui_renrobbishren163com_authors': 1.300137165123188e-05, 'geneticsa_section': 1.9040426261784626e-50, 'b_mnx1': 0.0005071782941827575, 'malignantprogression': 8.27196212448357e-06, '0czhu_mnx1': 0.00039994050343253773, 'homeobox_genes': 9.148819220060914e-58, 'to_be_implicated_in_various_human_cancers_acting_asoncogenes_or_tumor_suppressors': 9.148819220060914e-58, 'malignantprogression_protein_to_be_abnormally_expressed_in_several_cancertypes_including_prostate_cancer_hepatocellular_carcinoma_leukemia': 1.845438324513534e-05, 'mnx1': 0.0038705702463923356, 'diï¬erentiation_defects': 6.314920061308299e-05, 'malformation': 9.148819220060914e-58, 'to_be_abnormally_expressed_in_several_cancertypes_including_prostate_cancer_hepatocellular_carcinoma': 9.148819220060914e-58, 'methodsbioinformaticsthe_tcga_dataset': 8.263922883666513e-55, 'to_analyze_the_expressionof_mnx1_with_disease_free_survival': 1.1686951820486561e-54, 'analysis_httpgepiacancerpku_cnindexhtml': 8.263922883666513e-55, 'httpwww_cbioportal': 9.148819220060914e-58, 'to_obtain': 9.148819220060914e-58, 'site_p21cip_promoters_cell_lines': 0.007713134335009549, 'hacat_cells': 2.2975713440618216e-06, 'radiotherapy_fromshanghai_odctrputr03_odctrputr03006_formnx1_expression_to_generate_cdnaqrtpcr_to_extract_protein_of_cells_andtissues_and_protein_concentration': 0.0001408625019814988, 'cioms_thisstudy': 0.00013767629634858926, 'tissue_microarrays': 9.148819220060914e-58, 'fromshanghai_odctrputr03_odctrputr03006': 9.148819220060914e-58, 'formnx1_expression': 0.00017865891892946315, 'experiencedpathologists_tnm_stage': 0.00030237797101608573, 'invitrogen_carlsbad': 0.0005865071468874085, 'keygen': 2.298796006323272e-06, 'to_generate_cdnaqrtpcr': 3.755135770151793e-08, 'to_extract_protein_of_cells_andtissues_and_protein_concentration': 3.755135770151793e-08, 'ab79541_ _p21cip1cell_signaling_technology_  _pthr161cdk1_cellsignaling_technology_  _cdk1_cell_signalingfrontiers_in_0czhu_mnx1': 0.00039947355805761766, 'sirnasequences': 4.392034953391525e-08, 'pgpu6gfpneo_vigene_biosciencesshandong_china_h_aftertransfection': 2.685436242250786e-06, 'pgpu6gfpneo_vigene_biosciencesshandong_china': 7.153891694288704e-10, 'assaythe_proliferation_assays': 9.148819220060914e-58, 'h_aftertransfection': 9.148819220060914e-58, 'wasreplaced': 3.492638984907098e-05, 'cell_ratios': 3.0918290384868617e-06, 'wasreplaced_timesmigration_invasion_assayfor_to_evaluated_the_ability_of_migration_and_invasioncimplates_installation_and_baseline_measurement_progression_university_care_committee_mice': 0.00018965083911193754, 'were_stained': 9.148819220060914e-58, 'timesmigration_invasion_assayfor': 9.148819220060914e-58, 'wound_healing_assay_cells': 3.0918290384868617e-06, '24well_millicell_membrane_bdbiosciences': 0.0011125787591309202, 'to_evaluated_the_ability_of_migration_and_invasioncimplates_installation_and_baseline_measurement': 3.492638984907098e-05, 'immunoprecipitation_chipcells': 3.0918290384868617e-06, 'reactionwas': 3.0918290384868617e-06, 'solublechromatin': 3.0918290384868617e-06, 'to_immunoprecipitate_the_dnaprotein_complex': 6.0751388053683764e-52, 'igg_antibody': 3.287841426025112e-52, 'immunoprecipitation_products': 8.263922883666513e-55, 'chip_elution': 3.287841426025112e-52, 'areshown': 0.0002589664773973477, 'a_negative_control_relative_luciferase_activity_was_corrected_forfrontiers': 0.00039947355805761766, 'university_care_committee_mice': 3.492638984907098e-05, 'plasmids_thetransfection': 9.148819220060914e-58, 'transfection_accordingto': 9.148819220060914e-58, 'significantresultsoverexpression': 9.148819220060914e-58, 'prognosis_featuresanalysis': 9.148819220060914e-58, 'survival_nlow_p_figure': 1.7539085522784207e-06, 'ihc_images': 7.723613244264731e-05, '1kknockdown': 0.0005253840276496832, '2ab_tofurther': 0.0005345134679592639, 'favorablesuppression_eï¬\\x83ciency_2cd': 3.560701850358638e-06, 'proliferationability': 0.0004990942860418787, 'thatsilencing_mnx1': 0.0023524251068278903, 'induced_g2_m_cell_cycle_arrestand_upregulated_the_expression_of_p21cip1two_hundred_and_eight_genes_highly_correlated_with_mnx1were_used_for_go_kegg_and_reactome_pathway_analysisresults': 0.0016810521528134112, 'm_cell_cyclearrest': 0.0004990942860418787, 'expression_figure_4d_assay': 0.0004990942860418787, 'ectopicexpression': 0.0016810521528134112, 'helacells': 9.148819220060914e-58, '4ef': 9.148819220060914e-58, 'mnx1_staining_score': 1.5354499381884077e-06, 'expression_figure_4d_assay_progression_qrtpcr_blot': 9.405521282877909e-05, 'representative_ihc_staining_images': 1.5354499381884077e-06, 'p_frontiers': 0.00039947355805761766, 'sirna_si1_si2': 9.148819220060914e-58, 'blot_g\\x93i_edu_incorporation_assay_formation_assay': 9.148819220060914e-58, 'blot_g\\x93i': 0.00028705643099414104, 'edu_incorporation_assay_formation_assay': 5.686300664835389e-07, 'transfectionefï¬\\x81ciencies': 2.3877571575501082e-06, 'proliferation_functions': 9.148819220060914e-58, 'c_colony_formationassays': 9.148819220060914e-58, 'sd_values': 2.3508286345326627e-05, 'signiï¬\\x81cancemnx1': 0.0016810521528134112, 'knockdown_ectopicexpression': 0.0016810521528134112, 'mnx1_p21cip1': 9.148819220060914e-58, 'correlationn_p_figure': 9.148819220060914e-58, 'to_have_four_binding_sites': 6.314920061308299e-05, 'progression_p_p_5c': 6.526593592355919e-06, 'go_analysis': 0.0009477524976388204, 'analysis_b_knockdown': 0.00025126313729024964, 'cytometry_cf': 6.526593592355919e-06, 'progression_cytometry_cf_p_p_5b_5c_transcriptionalactivity': 2.2662740725472584e-07, 'bp_gcccattaat_showedhigher_combination_scores': 1.1357942794075184e-05, 'ccnb1': 0.0016810521528134112, 'changes_error_bars': 9.148819220060914e-58, '±_sdvalues': 9.148819220060914e-58, 'mnx1bound': 9.148819220060914e-58, '5effrontiers': 9.148819220060914e-58, 'p21cip1_transcription': 6.526593592355919e-06, 'progression_p21cip1_transcription': 0.0016810521528134112, 'sites_p21cip1_promoter': 9.148819220060914e-58, 'd_overexpression': 9.148819220060914e-58, 'p_p21cip11371_p_chromatinimmunoprecipitation_chip_assays': 9.148819220060914e-58, 'assay_ef': 9.148819220060914e-58, 'control_groupp_p_frontiers': 0.0003995800126312821, 'phenotypes_transfection': 6.520711283860127e-06, 'knockdown_error_bars': 3.838560796019728e-07, 'p21cip1': 9.148819220060914e-58, 'function_eï¬\\x83ciency_figure_6a': 9.148819220060914e-58, 'sirnas_table_s3': 0.007713134335009549, 'transwell_assay_matrigelassay': 0.00210348072096923, 'would_healing_assay': 9.148819220060914e-58, 'function_eï¬\\x83ciency_figure_6a_transwell_assay_matrigelassay': 9.148819220060914e-58, 'andinvasion_ability': 0.0001186502426005426, 'p21cip1_figure': 7.903964284759265e-07, '7fg_expression': 0.002162604691974494, 'ofp21cip1_ki67': 9.148819220060914e-58, '7h\\x93kfrontiers': 9.148819220060914e-58, 'factor_ofhomeobox_family': 0.00039947355805761766, 'mnx1exerted_showed': 0.0003996865239584377, 'to_promote_theinvasion_and_metastasis_of_gastric_cancer_through_repression': 6.522449310167642e-06, 'to_promote_theinvasion_and_metastasis_of_gastric_cancer_through_repression_neuron_development_processesof_fate_choice_endocrine_pancreas_progression_inhibitors': 0.0016480626375926124, 'andmnx1': 9.148819220060914e-58, 'member_protein_products': 9.148819220060914e-58, 'homeobox': 0.0038806204677737646, 'protagonist': 9.148819220060914e-58, 'neuron_development_processesof': 9.148819220060914e-58, 'fate_choice_endocrine_pancreas': 6.522449310167642e-06, 'greatapplication_prospect': 0.0009466755491730313, 'morphogenesis': 1.0314965201501525e-06, 'to_promote_sustainedproliferation_in_bladder_cancer_by_upregulating_ccne12_and_to_act_as_a_novel_oncogene_in_prostate_cancer_ _and_in_ourstudy_mnx1': 6.316602707724417e-05, 'replication_cycle_progression': 0.00017245730531167117, 'mnx1p21cip1pthr161cdk1_axis': 0.0012847184382551293, 'hpv': 0.0016810521528134112, 'geo_dataset': 0.007713134335009549, 'diï¬erences_ofmnx1_figure': 2.586668612581389e-05, 'thatliver_cancer': 0.0011075402231842013, 'nonalcoholic_liver_disease_cirrhosis': 0.0002069818544961052, 'topharmacology': 1.494668473097834e-50, 'cheng_sf_hsueh_c_andwang_magnololderivative': 1.1686951820486561e-54, 'hepatocellularcarcinoma_progression': 8.263922883666513e-55, 'hdac_expressionchemotherapy_radiation_therapy': 8.263922883666513e-55, 'surgicalresection_drugs_havelarge_side_eï¬ects': 0.0011075402231842013, 'to_improve_therapeutic_outcomes_ ': 0.0003773263079576772, 'hdacs': 0.000494595879613311, 'classes_class': 0.000704362469235278, 'expression_goodoutcomes': 0.0023793648440432556, 'overexpressioncan': 0.0016810521528134112, 'saha': 9.148819220060914e-58, 'administration_fda': 9.148819220060914e-58, 'treatment_eï¬\\x83cacy': 0.0007956673215405282, 'eï¬ects_amongthem_artemisinin_curcumin': 3.883303763748036e-05, 'goodoutcomes': 0.0002088291548399077, 'activities_activities': 2.8258801546866552e-05, 'mm1': 4.695587378060664e-07, 'biotech_co_ltdshanghai_china_mm1': 5.979566988914394e-06, 'hdac1_hdac2_hdac3': 0.0004499048194399722, 'suppresses_hdac_expressionusa_antibodies': 9.148819220060914e-58, 'chain_reactionanalysistotal_rna': 9.148819220060914e-58, 'usa_accordingto': 3.531226980776358e-05, 'manufacturer\\x99s_instructions': 9.148819220060914e-58, 'dna_wassynthesized_usa_tools': 9.148819220060914e-58, 'steponeplustm_system': 2.2480340991203723e-51, 'assaythe_proliferation_capacity': 2.4034808831478865e-05, 'cycle_analysiscells': 2.4034808831478865e-05, 'using_adeadendtm_fluorometric_terminal_deoxynucleotidyl_transferasedutp_nick_end_labeling_tunel_assay_kit_promega_madisonwi_usa': 1.9677964799357444e-08, 'mice_withtumors': 9.148819220060914e-58, 'to_grow_for_ _week_before_the_initiationof_drug_treatment_at_the_start_of_the_second_week': 9.148819220060914e-58, 'analysescomparisons': 9.148819220060914e-58, 'using_student\\x99sttests': 9.148819220060914e-58, 'using_student\\x99sttests_regression': 0.0016480626375926124, 'concentration_ic50values': 0.0002578525437194323, 'microsoft': 1.382937646822722e-05, 'to_indicate_a_statisticallysignificant_diï¬erenceresults2omethylmagnolol_mm1_has_superiorinhibitory_effects_on_hepatocellularcarcinoma_hcc_cell_growth_metastasisand_invasionto': 6.171298691014034e-05, 'diï¬erenceresults2omethylmagnolol_mm1': 0.0010068765747081726, 'magnolol_mm1_significantlyinhibited_cell_growth_dmso_magnolol': 0.00047983738574547787, '2omethylmagnolol': 5.092935923086953e-08, 'hdac_expressionfigure': 3.115727453869959e-06, 'magnolol_2omethylmagnolol_mm1': 0.000704362469235278, 'hdac_expressionfigure_ability': 3.532168200948518e-05, 'proliferation_status': 5.767653258941908e-07, 'i_effects': 9.148819220060914e-58, 'to_observe_the_apoptotic_cells_under_a_ï¬\\x82uorescence_microscopemagniï¬\\x81cation': 9.148819220060914e-58, 'punctate_staining': 9.148819220060914e-58, 'cells_white_arrowfrontiers': 9.148819220060914e-58, 'expressionfigure_mm1_magnolol': 8.263922883666513e-55, 'inhibit_assays_cells': 1.7266859970571246e-05, 'aftertreatment': 0.00012613970685026185, 'significantlystronger_inhibitory_eï¬ect': 7.660934295314403e-09, 'thatmagnolol_mm1': 0.0034826482041706262, 'withlow_toxicity': 5.684950877563591e-05, 'potential\\x82uences': 1.0892073836463245e-05, '0cchen_2omethylmagnolol': 5.0956517592064204e-08, 'hdac_expressionfigure_mm1': 8.302807087384292e-10, 'i_hdac_expression_andhepg2_cells': 0.0006052300015580405, 'blotting_quantitativeresults': 9.87402365848093e-06, 'bd_e': 9.87402365848093e-06, 'g1_phase_figures': 0.0011125787591309202, '1i': 0.0007131860921213638, 'magnolol_andmm1': 0.00027078059233556784, 'transwell_migration_assay': 0.007713134335009549, 'bothmagnolol_mm1': 0.0003692335358126249, 'analysis_mm1': 9.148819220060914e-58, 'inhibitory_eï¬ects': 9.148819220060914e-58, 'hcc_migration_invasionby': 7.660934295314403e-09, 'lowerexpression_ncadherin': 0.0016480626375926124, 'slugin_thecontrol_group': 9.148819220060914e-58, '2e\\x93h': 9.148819220060914e-58, 'hcc_migration_bysuppressing_emtfrontiers': 7.660934295314403e-09, 'thatmagnolol_2omethylmagnolol': 0.00019102831264157337, 'mm1_magnolol': 0.002162604691974494, 'acetylation_huh7_hepg2cells': 2.6909254076977078e-05, 'hdac_expressionfigure_expression_expression_levels_blot': 0.0016485018034048215, 'rna_levels': 0.0006049075008066659, 'p53_results': 0.0011125787591309202, 'deviation_expression': 2.3502024005420633e-05, 'magnolol': 9.148819220060914e-58, 'nonsmall_cancer_progression': 9.148819220060914e-58, 'hdacexpression_is_examine_indicated': 7.524123000786102e-09, 'antihcceffect': 4.6116097386084553e-07, 'theantihcc_eï¬ects': 2.8913150655392345e-05, 'treatedwith_magnolol': 0.0004499048194399722, 'overexpression_expression': 0.0016480626375926124, 'magnolol_mm1': 0.0032900209303618087, 'expressionof_hdac_proteins_inhibitoryeï¬ect': 5.36852643307485e-05, 'withmagnolol_mm1': 0.0002517988922651906, 'p53_acetylationhdacs': 8.263922883666513e-55, 'inducecarcinogenesis': 0.0004499048194399722, 'analyseswere': 9.148819220060914e-58, 'to_identify_the_eï¬ects_of_magnolol_and_mm1_onthe_expression_and_activation_of_p21': 9.148819220060914e-58, '4d\\x93e': 7.660934295314403e-09, 'suggestthat_use': 9.148819220060914e-58, 'eï¬ect_ofsorafenib': 9.148819220060914e-58, 'eï¬ectsmagnololmm1_sorafenib': 9.148819220060914e-58, 'individuallyand': 9.148819220060914e-58, 'using_an_xcelligence_realtime_cellanalyzer': 9.412201721605642e-09, 'cycle_status': 9.148819220060914e-58, 'd_effects': 9.148819220060914e-58, '5a\\x93c_these': 0.0004394889864169925, 'combineduse': 1.1686951820486561e-54, 'ofantiliver_cancer_treatmentsafety': 8.263922883666513e-55, 'use_ofmagnololmm1_abovecompounds': 7.832671284214429e-06, 'tothe_micemouse_tumor_tissues': 0.000755974981039013, 'inmiceto_conï¬\\x81rm': 1.2327999905950841e-05, 'sameinhibitory_eï¬ects_6d\\x93f': 5.36852643307485e-05, 'mouse_xenograftmodel': 9.148819220060914e-58, 'magnolol_ormm1': 9.148819220060914e-58, 'dmso_administration': 0.004315547045054443, 'growth_inmiceto_conï¬\\x81rm_staining': 1.2327999905950841e-05, 'cdk4cyclin_d1_ki67_ï¬\\x81ndingsconï¬\\x81rm': 0.0004499048194399722, 'p21_expression': 0.0004499048194399722, 'hcc_growth_figure_frontiers': 0.0004499048194399722, 'b_tumor_tissues': 9.148819220060914e-58, 'c_tumor_weights': 9.148819220060914e-58, '\\x97discussionin_cell_animal_models': 0.00012613970685026185, 'thatmagnolol': 0.00771518910792271, 'antihcc_eï¬ects': 0.007713134335009549, 'modesof_action': 0.007713134335009549, 'hcc_cell_tumor': 7.660934295314403e-09, 'cycle_progression_tumrowth': 0.007713134335009549, 'hdac_expression': 9.148819220060914e-58, 'expression_hdacs_andfrontiers': 9.148819220060914e-58, 'expressionfigure_representation': 8.302807087384292e-10, 'anticancer_mechanism': 0.0005769810645354518, 'to_investigate_the_eï¬ectsof_these_two_compounds_on_the_regulation_of_other': 9.412681118686772e-06, 'p21expression': 5.36852643307485e-05, 'cycle_magnolol_mm1': 9.148819220060914e-58, 'p53_proteinacetylation': 9.148819220060914e-58, 'sameconcentration': 0.0022064361804630945, 'eï¬\\x83ciency_of_mm1_compared_to_thoseof_magnolol_as_it_has_higher_eï¬\\x83cacy_at_the_same_concentrationthis_methoxylation': 3.4348996837103175e-05, 'clinicalfor_hdac_inhibitorstrials': 9.148819220060914e-58, 'excellent': 9.148819220060914e-58, 'hdac_inhibitor': 9.148819220060914e-58, 'bythe_fda': 9.148819220060914e-58, 'lymphoma_saha': 0.00011288463700136564, 'useof_hdac_inhibitors': 0.0003692335358126249, 'cancercell_apoptosis_use_gemcitabine': 8.263922883666513e-55, 'to_investigate_the_optimalcombination_and_dosage_of_magnololmm1_and_existing_clinicaldrugs_including_sorafenib_and_sahasorafenib': 0.0007035667068513752, 'thatthese_molecules': 0.0015842910551982499, 'to_determine_the_mechanisms_by_whichmagnololmm1_reduces_the_physiological_toxicity_of_sorafenibin_conclusion_although_hdac_inhibitors_have_been_usedextensively_for_the_treatment_of_various_cancers_their_sideeï¬ects_remain_a_bottleneck_to_their_clinical_application_in_thisstudy_we_synthesized_a_methoxylated_derivative_of_magnololmm1_and_veriï¬\\x81ed_its_superior_antihcc_activity_over_magnololadditionally_it_can_enhance_the_therapeutic_eï¬ect_of_sorafenibwhen_used_in_conjunction_and_does_not_present_physiologicaltoxicity': 0.00011023309857947745, 'physiologicaltoxicity': 0.00210348072096923, 'neoantigenspeciï¬\\x81c_tcells': 9.823752575177217e-05, 'tumor_regression': 9.735600441562086e-05, 'to_summarize_the_knownstrategies_for_isolating_neoantigenspeciï¬\\x81c_t_cellsedited_bycyrille_j_cohenbarilan_university_israelreviewed_bymanel_juanhospital_cl\\xadnic_de_barcelona_spainrodabe': 0.007713134335009549, 'n_amariauniversity_dingdingzhenyuscueducnspecialty_sectionthis': 1.2159058943018415e-50, 'august_citationli': 2.837958479291413e-06, 'immunity_immunotherapya_section_to_isolate_neoantigenspeciï¬\\x81csubpopulations_from_the_  _of_transferred_tils_in_earlystudies_to_be_responsible_for_the_antitumoreï¬ects_ _advanceshowever_the_timeconsuming_and_laborious_process': 0.00016574954824459371, 'redundancyresearchers': 9.148819220060914e-58, 'to_isolate_neoantigenspeciï¬\\x81csubpopulations_from_the_  _of_transferred_tils_in_earlystudies': 9.148819220060914e-58, 'constructedand': 2.704720265393342e-06, 'to_be_responsible_for_the_antitumoreï¬ects_ _advanceshowever_the_timeconsuming_and_laborious_process': 5.637984180393359e-51, 'requiredto': 2.704720265393342e-06, 'analysis_rosenberg\\x99s_group': 9.148819220060914e-58, 'predictedneopeptides_sequencing_antigen_hla_class_algorithms': 9.148819220060914e-58, 'that_tumor_regressions': 9.148819220060914e-58, 'method_neoantigenspeciï¬\\x81c': 9.148819220060914e-58, 'prickett_stevanovic': 2.704720265393342e-06, 'recognitionof_neoantigenspeciï¬\\x81c_t_cells_tils_volume_0cli_support': 5.148053033373733e-05, 'needfor_prediction': 0.00210348072096923, 'advent_ï¬\\x81eld': 9.148819220060914e-58, 'leap': 9.148819220060914e-58, 'tran': 9.148819220060914e-58, 'neoantigenspeciï¬\\x81c_t_celltherapy': 9.148819220060914e-58, 'lymphocyte_population_patient': 0.0006750162805663558, 'recognitionof_neoantigenspeciï¬\\x81c_t_cells_tils_study_receptors_volume_0cli_cellsunderwent_proportion_support_cells': 6.223892227312253e-05, 'proliferationpotential': 1.4055400435083294e-53, 'tcells_undetectable': 9.148819220060914e-58, 'to_transiently_activated': 9.148819220060914e-58, 'eï¬ector_tcells': 9.148819220060914e-58, 'cells_stimulatedby_tumor_antigens': 9.148819220060914e-58, 'partial': 0.0006324067207528349, 'pitfalls_potential_strategy': 0.0005741125271172155, 'cell_sortingfacs': 8.847275634607703e-06, 'neoantigensexpressed_by_autologous_tumor_cells': 0.004315547045054443, 'seliktaroï¬\\x81r': 0.00020438662347026346, 'tcrsequencing': 0.000498273905934873, 'cd137based_selection_protocol': 9.148819220060914e-58, 'antigen_coverage': 9.148819220060914e-58, 'interactionbetween_pd1_pdl1': 9.148819220060914e-58, 't_lymphocyte': 9.148819220060914e-58, 'site_tils': 1.0158747493576705e-06, 'cellsunderwent': 5.148053033373733e-05, 'cell_populationsamong_tils': 0.0004988292642554344, 'tumorresponsive_t_cells': 7.864279641368101e-05, 'study_gros': 9.148819220060914e-58, 'pd1expression': 9.148819220060914e-58, 'aninhibitory_receptor': 1.0158747493576705e-06, 'antitumor_function': 0.0001391293091783537, 'to_enrich_activatedcd4_cells_   ': 0.00210348072096923, 'limitingdilution': 0.0016866912862481358, 'cd134': 0.004315547045054443, 'cell_sequencing_approach': 0.00022655961142434313, 'traditionalfrontiers': 1.104453032589865e-05, 'neoantigenspeciï¬\\x81c': 0.00015722628711537504, 'repertoireof_tils': 9.148819220060914e-58, 'to_modify_t_cells_tcrt_howeverthe_lengthy_expansion_process_and_excessive_stimulation_wouldresult_in_tcr_repertoire_switching_ _to_avoid_this_problempasetto_   ': 9.148819220060914e-58, 'melanoma_tissues_til_subsets': 0.00017392869868643751, 'neoantigensthis_report': 0.0005741125271172155, 'to_have_been_made_by_agroup_led_by_lennerz_   _in_this_study': 2.966582108651456e-05, 'mononuclear_cells': 4.085742850589715e-08, 'methodto': 3.287841426025112e-52, 'act_tetramers': 9.148819220060914e-58, 'to_isolate_and': 9.148819220060914e-58, 'patients_mhcpeptidetetramers': 9.148819220060914e-58, 'to_monitor_neoantigenspeciï¬\\x81c_t_cells_  _cohen_   ': 9.148819220060914e-58, 'neoantigenspeciï¬\\x81c_t_cells': 0.0007956673215405282, 'adopted_enrolled': 9.148819220060914e-58, 'tmgrna': 9.148819220060914e-58, 'neoantigenspeciï¬\\x81c_lymphocytes': 9.148819220060914e-58, 'tmgrna_isolation': 9.148819220060914e-58, 'cd8pd1\\x93': 4.104398585916569e-06, 'solution_t_cells': 0.00013916638672897274, 'cells_tem_temrafrom_pbls': 2.270564301863107e-06, 'expression_to_enrichfor_neoantigenreactive_t_cells': 0.0011125787591309202, 'expression_to_enrichfor_neoantigenreactive_t_cells_identiï¬\\x81cation': 0.0016841754263047998, 'expandedfrom': 0.0002694080014674577, 'blood_lymphocytes': 7.864279641368101e-05, 'expansion_rep_tcrs': 3.7030363035135357e-07, 'to_modify_autologous_lymphocytes': 2.2697370358959754e-05, 'neoantigenspeciï¬\\x81c_t_cells_cells': 3.7030363035135357e-07, 'to_identify_na¯ve_antigenreactive_t_cells_from_small_volumes_of_blood_\\x93': 0.0038806204677737646, 'arapid': 1.1769474838827738e-07, 'suï¬\\x83cient_number_cells': 0.0038806204677737646, 'methodsof': 3.7030363035135357e-07, 'to_primecd4_and_cd8_\\x93': 0.0002436592976234707, 'thantils': 9.148819220060914e-58, 'to_primecd4_and_cd8': 9.148819220060914e-58, 'tcell_responses': 0.00015266313713209798, 'neoantigenspeciï¬\\x81c_cell_responses': 7.692853742618723e-06, 'tcells_responses': 7.692853742618723e-06, 'breadth_diversityof_response_t_cellsmay': 0.0013882295497307361, 'preparation_ofcancer_vaccines': 0.00040928894108187346, 'theemergence_ofimmunotherapy': 3.4348996837103175e-05, 'thatneoantigenspeciï¬\\x81c_t_cells': 9.148819220060914e-58, 'immunotherapytherefore': 9.148819220060914e-58, 'grail\\x9d': 4.104398585916569e-06, 'review_breakthroughs': 1.986617585410221e-05, 'manuscript_draft': 0.002104041233387171, 'versionql': 3.4348996837103175e-05, 'zyd': 9.148819220060914e-58, 'it_versionql': 9.148819220060914e-58, 'versionfundingthis_work': 1.1686951820486561e-54, 'researchcentersichuanuniversity': 8.263922883666513e-55, 'neoantigen_identiï¬\\x81cationstrategies': 0.0001349690031405697, 'jclin': 0.00015266313713209798, 'i_li_neoantigen_vaccine': 6.550803099862956e-05, 'rna_mutanome_vaccines': 9.148819220060914e-58, 'polyspeciï¬\\x81c_therapeuticimmunity': 9.148819220060914e-58, 'aa_cell_vaccine': 9.148819220060914e-58, 'breadth_anddiversity_\\x93_roberti': 9.148819220060914e-58, 'medimmunityovarianvaccineincancer_van_buuren_mm_philips_d': 9.148819220060914e-58, 'toebes': 9.148819220060914e-58, 'hellmann_md_snyder': 0.0006191469481200436, 'rosenberg_sa_yang_jc_sherry_rm': 9.148819220060914e-58, 'us_responses': 9.148819220060914e-58, 'inintenttotreat_analysis_eï¬\\x83cacyfrontiers_dingisolating': 9.148819220060914e-58, 'responses_draper': 9.148819220060914e-58, 'rosenberg_sa_robbins': 2.4954590467311193e-05, 'jc_mutatedppp1r3b': 0.0001391293091783537, 'bs_role': 9.148819220060914e-58, '\\x93_104049jimmunol16731313': 9.148819220060914e-58, 'survival_enhanceseï¬ector_function': 8.066895725818099e-07, 'ofcd137': 9.148819220060914e-58, 'cd8_cell_responses': 9.148819220060914e-58, 't_cells_t_crystaletalisolation': 0.0016810521528134112, 'isolation_andexpansion': 9.148819220060914e-58, '\\x93_101182blood200611056168_m_yamamoto_t': 9.148819220060914e-58, 'markel_gschachter_j_selection': 9.148819220060914e-58, 'immunol_\\x93_tcelltransfer_therapy': 9.148819220060914e-58, '101038nri1349': 9.148819220060914e-58, 'tran_e_robbins': 9.148819220060914e-58, 'rooijn_targeting': 9.148819220060914e-58, 'science_\\x93': 9.148819220060914e-58, 'em': 1.4031767613665197e-07, 'cancer_\\x93_tran_e_robbins': 8.591126880654115e-06, 'wangwangjianhuaman163comyansong_pudoctor_puyahoocom_sectionthis': 8.828739175764568e-51, 'august_citationliu': 2.837958479291413e-06, 'craig': 0.0004800932539064759, 'protooncogene_growth': 7.830152154725122e-06, 'nonreceptor_tyrosinekinase': 0.0015842910551982499, 'inhibition_imatinib': 0.000404948725608525, 'determinedthe_eï¬ect': 0.00024831101020746386, 'histopathology_biopsy_basedon': 0.0004405647755333974, 'kd_lentiviruses': 9.148819220060914e-58, 'using_pfugwgfprnai_vector_by_insertingshabl1_shppp3ca_and_shtgf1_sequence': 9.148819220060914e-58, 'pfugwgfp_vector': 0.0002589664773973477, 'to_infect_ascorresponding_controlsproliferation_and_colony_formation_assayproliferation_rate': 0.0001550048943189367, 'plated_added_used': 0.00017725850698908387, 'to_infect': 0.0001550048943189367, 'cellsovernight': 9.148819220060914e-58, 'ascorresponding_controlsproliferation_and_colony_formation_assayproliferation_rate': 9.148819220060914e-58, 'using_size_ï¬\\x82ow_cytometry_using_modfitlt_in_mac_v30_software_apoptosis': 0.0012753802400861454, 'wheneach_clone': 0.00037225843424422525, 'thedistribution': 9.148819220060914e-58, 'using_modfitlt_in_mac_v30_software_apoptosis': 9.148819220060914e-58, 'kit_qiagen_germantown_md_genomic': 9.148819220060914e-58, 'puriï¬\\x81cation': 9.148819220060914e-58, 'waltham_ma_anion_torrent_chip_sequencer': 1.490818922761952e-49, 'to_sequencecommon_gene_mutations_in_the_tumorsin_vivo_studybalbc_nude_mice_female_aged_ _weeks': 6.515117587621718e-50, 'fromshanghai_technology_ltd_shanghaichina': 6.515117587621718e-50, 'toany_experiments': 6.515117587621718e-50, 'micewere_sacriï¬\\x81ced_tumors': 9.148819220060914e-58, 'tumorfrontiers': 9.148819220060914e-58, 'pathway_analysisto': 0.00046345855666667525, 'kd_pcr_arraywas': 9.148819220060914e-58, 'genechem_co_ltd_shanghaichina_data': 9.148819220060914e-58, 'using_ingenuity_pathwayanalysis_ipa_software_to_elucidate_the_aï¬ected_molecules_andsignal_pathwaysimmunohistochemistryfor_crc_180point_tissue_microarray_hcolade180sur07which_contained_crc_tissuesfrom_ _patients_and_thecorresponding_adjacent_tissues_table': 2.2925595830345323e-05, '180point_tissue_microarray_hcolade180sur07which': 6.447036992588312e-05, 'tween_ph': 8.263922883666513e-55, 'mm_tissue_microarray_blocks_tumorsections': 3.5193460814460183e-50, 'to_sequencecommon_gene_mutations_in_the_tumorsin_vivo_studybalbc_nude_mice_female_aged_ _weeks_fromshanghai_technology_ltd_shanghaichina_toany_experiments_tothe_using_ingenuity_pathwayanalysis_ipa_software_to_elucidate_the_aï¬ected_molecules_andsignal_pathwaysimmunohistochemistryfor_crc_180point_tissue_microarray_hcolade180sur07which_contained_crc_tissuesfrom_ _patients_and_thecorresponding_adjacent_tissues_table_antigen_retrievalincitrate_tween_ph': 8.053128222333766e-50, 'crc_tissue': 1.376077922386354e-08, 'antigen_retrievalincitrate': 6.515117587621718e-50, 'wellestablishedprotocols': 0.0003423674422720453, 'population_l_y': 5.583967365217935e-06, 'blotting_assay': 0.0013882295497307361, 'ab85947abcam_cambridge_ma_antibcl2_antibody': 9.148819220060914e-58, 'san_diego': 9.148819220060914e-58, 'antibclxl': 9.148819220060914e-58, 'biotechnology_dallas_tx': 9.148819220060914e-58, 'antibody_ab175354_abcam': 5.583967365217935e-06, 'to_investigate_the_possiblerelationships_between_abl1_expression_and_clinic_pathologicalcharacteristics_mann\\x93whitney_utest_was_used_to_compare_thediï¬erence_in_abl1_protein_expression_between_paired_coloncancer_and_adjacent_normal_colon_tissues_survival_analysiswas_performed_using_the_kaplan\\x93meier_curve_and_the_logranktest_the_values_are_expressed_as_mean_±_sd_comparisonsbetween_two_groups_were_conducted_using_student\\x99s_ttest_allexperiments_were_carried_out_in_triplicate_results_with_p_ ': 0.0005264411687933505, '2test': 8.589327884000331e-06, 'to_compare_thediï¬erence_in_abl1_protein_expression_between_paired_coloncancer_and_adjacent_normal_colon_tissues_survival': 1.5558597683053515e-07, 'using_the_kaplan\\x93meier_curve_and_the_logranktest': 1.5558597683053515e-07, 'to_compare_thediï¬erence_in_abl1_protein_expression_between_paired_coloncancer_and_adjacent_normal_colon_tissues_survival_using_the_kaplan\\x93meier_curve_and_the_logranktest': 0.00043463382250315263, 'using_student\\x99s_ttest_allexperiments': 0.0003022165162482692, 'table_blot_realtime_pcr_results': 7.114387814765427e-06, 'colon_tissues': 1.1636549905330657e-05, 'role_proliferation': 0.00012184426248535181, 'c1222c_deletion': 0.00042869281721516495, '±_sd_p': 0.0016815001133323047, 'con_d_quantiï¬\\x81cation': 2.7446560661786228e-05, 'westernblot_results': 8.263922883666513e-55, 'assay_figure': 0.007713134335009549, '4dnext': 9.148819220060914e-58, 'wefrontiers': 9.148819220060914e-58, '0cliu_abl1': 0.00037225843424422525, 'lymphoma_bcl2were': 0.00037225843424422525, '5dtaken_results': 0.00011931918217645773, 'bodyweightincrease': 0.007713134335009549, 'figure_6e': 0.00011931918217645773, 'knockdown_crc_tumor_growth': 8.263922883666513e-55, 'tgf1': 1.1686951820486561e-54, 'ppp3cato': 8.263922883666513e-55, 'throughput_pcr_array': 0.000576827339123862, 'ipa': 9.148819220060914e-58, 'upregulatedgenes_genes': 9.148819220060914e-58, 'pi3kakt_pathways': 0.00011931918217645773, '7ato': 0.000528146067012347, 'blot_analysis_gene': 0.0002723716936239732, 'irs1': 4.44063591942313e-06, 'tgf1depletion_cell_line': 0.007713134335009549, 'establishing_a_ppp3ca_knockdown_cell_line_figures_8dewe_found_the_depletion_of_ppp3ca_signiï¬\\x81cantly_decreasedthe_expression_of_abl1_figure_8f_to_validate_the_regulatoryrole_of_ppp3ca_we_also_examined_the_abl1_expression_inppp3ca_overexpressed_cells_and_found_the_expression_of_abl1was_elevated_by_upregulated_ppp3ca_figure_s4_indicatingppp3ca_is_a_positive_regulator_of_abl1discussionas_a_ubiquitously_expressed_nonreceptor_tyrosine_kinase_abl1has_been_reported_to_be_associated_with_glioblastoma_and_breastcancer_  _in_this_study_we_examined_the_role_of_abl1_incrc_progression_the_results_indicated_that_abl1_might_play_animportant_role_in_crc_which_is_associated_with_the_mutation_andexpression_of_the_abl1_genewe_found_the_expression_of_abl1_was_remarkably_elevatedin_crc_tissues_and_cell_lines_figure_ _which_is_correspondedto_the_survival_rate_among_patients_with_crc_figure_s5indicating_abl1_is_a_potential_oncogene_in_crc_\\x93moreover_the_mutation_of_abl1_was_also_elevated_in_crcpatients_based_on_the_results_from_previous_studies_the_mutationrate_of_the_abl1_gene_is_relatively_higher_in_men_than_in_womenpatients_with_crc_worldwide_  _in_a_previous_study_theabl1_gene_was_found_to_be_mutated_in_ _of_patients_withcrc_at_sir_ganga_ram_hospital_delhi_india_ _in_the_presentstudy_the_mutation_rate_was_much_higher_  _in_crcpatients_accepted_in_our_hospital_the_diï¬erent_races_of_patientsfrom_diï¬erent_regions_of_the_world_reported_in_the_two_studiesfrontiers_in_oncology_ _wwwfrontiersinaugust_  _volume_    _0cliu_ _abl1_is_involved_in_carcinogenesis_of_colorectal_cancerfigure_  _tgf1_knockdown_deactivates_pi3kakt_pathway_in_hct116_cells_a_representative_images_of_hct116_cells_infected_with_gfpcontaining_lentivirusexpressing_shrna_against_tgf1_gfp_positive_lentivirus_with_scramble_shrna_was_used_as_control_images_were_captured_under_200x_magniï¬\\x81cation_bknockdown_of_tgf1_was_conï¬\\x81rm_by_western_blot_proteins_were_extracted_from_hct116_cells_at_ _h_postinfection_actin_was_used_as_loading_control_cwestern_blot_examined_irs1pi3kakt_pathway_in_hct116_cells_after_knockdown_of_tgf1_d_western_blot_examined_irs1pi3kakt_pathway_in_hct116_cellsinfected_with_gfpcontaining_lentivirus_expressing_shrna_against_ppp3ca_gfp_positive_lentivirus_with_scramble_shrna_was_used_as_control_e_representativeï¬\\x82uorescent_images_of_hct116_cells_at_ _h_postinfection_images_were_captured_under_200x_magniï¬\\x81cation_f_expression_of_abl1_after_ppp3ca_knockdown_wasdetermined_by_western_blot_proteins_were_extracted_from_hct116_cells_at_ _h_postinfection_actin_was_used_as_loading_controlcould_be_a_possible_reason': 0.000528146067012347, '8dewe': 0.00011931918217645773, 'expression_inppp3ca': 0.007713134335009549, 'abl1has': 9.148819220060914e-58, 'to_be_associated_with_glioblastoma_and_breastcancer_  _in_this_study': 9.148819220060914e-58, 'abl1': 0.0015966926486943069, 'crc_tissues_lines_figure': 0.0016810521528134112, 'mutation_rate': 9.148819220060914e-58, 'rate_isconsistent': 9.148819220060914e-58, 'imatinib': 2.606231296892903e-05, 'transition_cell_cycle': 7.05029712940268e-05, 's_phase': 0.0011125787591309202, 'abl1_interference': 1.1686951820486561e-54, 'p27_expression': 8.263922883666513e-55, 'expression_figure': 8.263922883666513e-55, 'abl1speciï¬\\x81c_inhibitor_studies': 9.148819220060914e-58, 'p27_expression_expression_figure': 9.148819220060914e-58, 'types_abl1': 0.00012267293572245904, 'inhibitor_danusertib_treatment_decreasedthe_expression': 8.263922883666513e-55, 'increasedbax_expression': 0.008565337949924265, 'afterabl1_interferenceit': 0.00012640203901035253, 'tgf_signaling': 0.0007340647040599299, 'outcome\\x93_studies': 0.00012640203901035253, 'abl1_inhibitor': 9.148819220060914e-58, 'tgf_level': 9.148819220060914e-58, 'abl1_mightinteract': 9.148819220060914e-58, 'tumor_development_crc_tumorigenesis': 9.148819220060914e-58, 'progressionexpression': 0.004315547045054443, 'novelevidence': 0.0010325216439875707, 'understandings': 9.148819220060914e-58, 'viablestrategy': 9.148819220060914e-58, 'these_resultsdemonstrated_novel_understandings_of_the_function_of_abl1during_the_progression_of_crc_thus_provides_a_clinically_viablestrategy_for_crc_therapydata_availability_statementthe_raw_data_supporting_the_conclusions_of_this_ _will_bemade_available_by_the_authors_without_undue_reservationethics_statementthe_studies_involving_human_participants': 0.00047983738574547787, 'people\\x99s_hospital_thepatientsparticipants': 0.0004100538998299479, 'scientiï¬\\x81c_contribution': 0.0007959416758056306, 'studyfundingstudy': 9.148819220060914e-58, 'programgrant_operating_expenses': 9.148819220060914e-58, 'theprevalence_prognostic_signiï¬\\x81cance': 0.0004499048194399722, 'surg_\\x93_proï¬\\x81ling': 0.0005450251520539939, 'sl_downregulationof_znf278': 0.00040505663764074076, 'cell_cycle_\\x93kinase': 6.610648712912211e-06, 'c_eya1': 9.148819220060914e-58, 'tumorangiogenesis': 9.148819220060914e-58, 'f_oberguggenbergeras': 9.148819220060914e-58, 'johnston_c_perren_feasibility_compliance_practice_oncol_\\x93': 9.148819220060914e-58, 'zhejiang_da_xue_xue_bao_yi_xue': 1.1686951820486561e-54, 'pathways_biomarkers': 8.263922883666513e-55, 'measure_ottaiano_della_vittoria_head_mechanismsoncolresponseand\\x93implicationonaletfrontiers': 8.263922883666513e-55, 'disease_message': 9.148819220060914e-58, 'j_recommendations': 9.148819220060914e-58, 'augustin_amorecelentano_di_napoli_cascella': 0.004315547045054443, 'mostpatients': 3.679509790570943e-05, 'relapseoften': 6.33966136568193e-05, 'factorsfor_risk_stratiï¬\\x81cation': 0.0015842910551982499, 'wgcnais': 8.009977540950587e-05, 'bm': 0.0004360764270917066, 'inhibitors_vla4_inhibitors_eselectininhibitors': 9.148819220060914e-58, 'trials_immunecells': 9.148819220060914e-58, 'to_explore_theprognostic_genes_in_the_microenvironment_of_aml_patients\\x93_most_studies_have_focused_on_diï¬erentially_expressedgenes_degs_however_the_interaction_and_relationship_betweengenes_are_open_to_investigate_moreover_the_coding_genes_wereextensively_explored_but': 0.00210348072096923, 'lncrnas_andmirnas': 0.004315547045054443, 'byabbreviations': 0.0011445270964369448, 'wgcna': 0.00042814069113365414, 'highlyrelated_genes': 6.982769139571284e-06, 'molecules_cerna_competing_endogenousrnas_deg': 0.0003322263502299899, 'subunit_keggkyoto_encyclopedia': 0.00018956311875359112, 'go_ppi_proteinprotein': 9.148819220060914e-58, 'tlr6_toll': 9.148819220060914e-58, 'cerna_network': 0.0010158165141556203, 'ofthe_aml_cohortin': 0.00019752526688517592, 'tcga_database': 0.00012620698354677198, 'to_calculate_theimmune_and_stromal_scores_of_these_aml_cases_using_theestimate_algorithm_diï¬erentially': 2.0558680071920793e-06, 'mrnas_andlncrnas': 9.148819220060914e-58, 'to_identify_the_modulesmost_relevant_to_the_aml_immune_microenvironment_thenthe': 9.148819220060914e-58, 'acquisitionall_data_sets': 9.148819220060914e-58, 'wgcnais_ofthe_aml_cohortin_to_calculate_theimmune_and_stromal_scores_of_these_aml_cases_using_theestimate_algorithm_diï¬erentially': 9.148819220060914e-58, 'estimate_algorithm2': 5.713881500263957e-05, 'to_calculate_the_immunescores_and_stromal_scores_of_ _aml_samples_diï¬erentiallyexpressed_genes_degs_such_as_lncrnas_mirnas': 9.325067483958254e-07, 'median_value': 5.55533272496008e-07, 'fdr_theexpression_level_to_evaluate_the_weightedcoexpression_relationship_between_all_datasettopics_in_theadjacency_matrix_in_this_study_wgcna_was_used_to_analyzemrnas_and_lncrnas_to_obtain_the_mrnas_or_lncrnas_mostrelevant_to_aml_immune_microenvironmentcerna_network_construction_andanalysisaccording_to_the_results_of_wgcna_mrnasand_lncrnas_mirnas_weretherelationship_theconstructed': 0.001710787037861785, 'characteristics_correlation_analysis': 9.148819220060914e-58, 'to_evaluate_the_weightedcoexpression_relationship_between_all_datasettopics_in_theadjacency_matrix_in_this_study_wgcna_was_used_to_analyzemrnas_and_lncrnas_to_obtain_the_mrnas_or_lncrnas_mostrelevant_to_aml_immune_microenvironmentcerna_network_construction_andanalysisaccording_to_the_results_of_wgcna': 9.148819220060914e-58, 'to_obtain_the_mrnas_or_lncrnas_mostrelevant_to_aml_immune_microenvironmentcerna_network_construction_andanalysisaccording_to_the_results_of_wgcna': 6.982769139571284e-06, 'mrnasand_lncrnas': 0.007713134335009549, 'turquoise_anddiï¬erentially': 0.00018993043364672486, 'stages_prediction': 1.6569325587581683e-05, 'miranda4_pita5': 0.007713134335009549, 'prediction_databases': 0.00018993043364672486, 'numberof_partnerssurvival_analysiskaplan\\x93meier': 2.7933459483481077e-05, 'weretherelationship': 4.558800865358961e-07, 'theconstructed': 0.0003421850007431465, 'theanalysis': 9.148819220060914e-58, 'using_the_r_package_of_survivalstatistical_analysisgraphpad_prismtm_ _san_diego': 9.148819220060914e-58, 'significant_theanalysis_was_conducted_using_the_r_package_of_survivalstatistical_analysisgraphpad_prismtm_ _san_diego': 9.148819220060914e-58, 'states_states_software': 9.148819220060914e-58, 'analyses_diï¬erences': 9.148819220060914e-58, 'kruskal\\x93wallis_test': 9.148819220060914e-58, 'tocalculate_the_immune_scores_and_stromal_scores_of_aml_patientsthe_median_immune_score': 8.263922883666513e-55, 'from\\x88\\x92': 0.00042644740830607715, 'caseswith_m3_subtype': 0.00033936015038966223, 'scoreswhereas_m0_subtypes': 1.7539085522784207e-06, 'b_lncrnas_e_mirnas': 9.148819220060914e-58, 'c_mrnas_d_lncrnas_f_mirnas': 9.148819220060914e-58, 'oflow': 0.0003540754526695089, 'score_groups': 0.0010745559563233602, 'research_analyses': 1.753147715306316e-05, '3ab': 0.0002542979044388503, 'cell_lineage_cell_adhesion': 9.325067483958254e-07, 'moleculescams_pathways': 9.148819220060914e-58, '4ab': 9.148819220060914e-58, 'identiï¬\\x81cation_ofkey': 9.327263445268705e-06, 'finally_ _modules_of_lncrnamrnacoexpression_networks_were_generated_and_the_heat_map_plot_oftopological_overlap_matrix_tom_was_shown_figure_5a_eachmodule_was_calculated_and_plotted_with_its_corresponding_clinicalcharacteristics_correlation_analysis': 0.000571748998785482, 'turquoisemodule': 0.0006625816769337724, 'mrnas_lncrnasfigure': 0.0038806204677737646, 'to_performthe_gene_enrichment_analysis': 0.00013337286069712748, 'signal_transduction_tolllike': 2.172941870320097e-06, 'turquoise_module': 9.148819220060914e-58, 'relationshipwith_immune_scores': 9.148819220060914e-58, 'lncrnas_mrnas_turquoise_module': 0.007713134335009549, 'cerna_networkby': 0.007713134335009549, 'interaction_ppinetwork_analysisto': 0.0006939897650724889, 'tlr8_toll': 9.148819220060914e-58, 'degrees_table': 9.148819220060914e-58, 'value_volume_0cwang': 0.0002219331785316156, 'to_analyze_genetic_modules_a_cluster_diagram_of_coexpression_network_modules_based_on_topological_overlap_in_mrna_andlncrna': 1.131498443875289e-05, 'relationship_rp11320g101_rp11421f163rp11439e1910_rp11792a83': 6.59715900820637e-05, 'gene_symbols_geneinteractions': 9.148819220060914e-58, 'to_study_the_pathway_enrichment_in_the_turquoise_module': 9.148819220060914e-58, 'correlation_networkanalysis': 3.842636662530884e-06, 'pou2f2': 9.148819220060914e-58, 'ralgps2': 9.148819220060914e-58, 'wereassociated': 7.417164383651313e-53, 'withoverall_survival': 1.284690556057437e-52, 'group_favorablevsintermediatenormal': 7.417164383651313e-53, 'lncrnas_mrnas_mirnas': 7.417164383651313e-53, 'progress_micrornas': 0.00018993043364672486, 'discussionin_years_studies_occurrence': 3.4494196115867285e-05, 'bm_microenvironmentwhich': 0.0015842910551982499, 'lncrnas_mirnas_mrnas_b': 1.6569325587581683e-05, 'mrnasand_triangle': 9.148819220060914e-58, 'downregulation_capability': 9.148819220060914e-58, 'lncrnas_red': 0.00045660454367155184, 'size_points': 0.00014763345632963333, 'mosttreatments_tumor_cells': 9.148819220060914e-58, 'tumor_microenvironmentindepth': 9.148819220060914e-58, 'to_furtherunderstand_the_mechanism_of_leukemia_development_and_mayï¬\\x81nd_new_targets_for_microenvironment_treatment_ _this_studyscreened_microenvironmentrelated_genes_based_on_the_tcgadatabase_and': 8.009977540950587e-05, 'microenvironmentrelatedlncrnamirnamrna_cerna_networks': 8.009977540950587e-05, 'scores_scores_ofaml_patients': 0.007713134335009549, 'aml_cells': 9.148819220060914e-58, 'bm_environment_cells': 9.148819220060914e-58, 'mrnas_mirnasstromaland_lncrnas': 5.7123592486022485e-05, 'studies_formation': 0.0006611997588271541, 'developmentof_immunotherapy_strategies': 0.0006611997588271541, 'disruption_offrontiers': 0.0003540754526695089, 'betweendiï¬erent_cerna_networks': 0.000332193218693602, 'basedon_rnaseq_data': 9.148819220060914e-58, 'to_furtherunderstand_the_mechanism_of_leukemia_development_and_mayï¬\\x81nd_new_targets_for_microenvironment_treatment_ _this_studyscreened_microenvironmentrelated_genes_based_on_the_tcgadatabase_and_microenvironmentrelatedlncrnamirnamrna_cerna_networks': 9.148819220060914e-58, 'mirnas_lncrnas_multiplexcox_regression_analyses': 0.0038806204677737646, 'to_establish_a_survivalmodel_with_ _target_mrnas_hoxa9': 1.8004641048098213e-05, 'area_undercurve': 9.148819220060914e-58, 'sensitivity_speciï¬\\x81city_ofprognostic_prediction': 9.148819220060914e-58, 'to_identify_the_modules_most_relevantto_the_amlimmune_microenvironment_then_using_wgcna_and_mirnaprediction_websites_a_lncrnamirnamrna_cerna_networkconsisting_of_ _lncrnas_ _mirnas_and_ _mrnaswas': 6.982769139571284e-06, 'role_lb_kiaa0513_kiaa0930lpcat1': 0.0003809665283472652, 'slc43a2_znf70': 3.245033701546182e-05, 'insights_pathogenesis_\\x93_ly_yx_dzmethodology_sw_cw_data_analysis_interpretationyjl_yfl_\\x93_review_editing_yfl': 0.0019865468381142686, 'to_be_related_to_mllpositive_aml_ _andother_lncrnas': 4.787483283520024e-05, 'to_be_related_to_mllpositive_aml_ _andother_lncrnas_to_be_associated_with_a_variety_of_cancers_\\x93': 0.0018485430980292406, 'to_be_associated_with_a_variety_of_cancers_\\x93': 4.787483283520024e-05, 'research_haslimitations_weshould': 0.0016480626375926124, 'target_data': 0.007713134335009549, 'insights_pathogenesis': 5.296534658304533e-07, '\\x93_ly_yx_dzmethodology_sw_cw_data_analysis_interpretationyjl_yfl': 5.296534658304533e-07, '\\x93_review_editing_yfl': 5.296534658304533e-07, 'sciencefoundation_grant_numbers_u1804191and_projectgrant_number_acknowledgmentswe': 8.263922883666513e-55, 'ferrara_f_schiï¬er': 9.148819220060914e-58, 'leukaemia': 9.148819220060914e-58, 'o_targetingthe_leukemia_microenvironment': 7.417164383651313e-53, 'kinase_inhibitors_chemotherapy': 1.284690556057437e-52, 'shafat': 7.417164383651313e-53, 'bone_marrowmicroenvironment\\x93home': 7.417164383651313e-53, 'rashidi': 9.148819220060914e-58, 'austin_r_smyth': 9.148819220060914e-58, 'mj_lane_sw': 0.00038842632962585887, 'mj_lane_sw_harnessing_the_immune_system_in_acutemyeloid_leukaemia_crit': 9.148819220060914e-58, 'oncol_hematol_musallam_rfridmandror': 9.148819220060914e-58, 'cebling': 9.148819220060914e-58, 'awry_cancer_discov': 9.148819220060914e-58, 'to_have_important_regulatory_roles_in_the_progression_of_several_types_of_cancer_including_cervical_cancer': 2.851205756672376e-05, 'roles_mechanisms': 1.276798849503755e-06, 'using_cck\\x91_flow_cytometry_transwell': 0.0010068765747081726, 'using_cck\\x91_flow_cytometry_transwell_assays': 0.00210348072096923, 'viability_migration_invasion': 0.0005002935495455584, 'c33a_cells': 4.633050837466721e-05, 'protein_yap1': 7.56342879385727e-07, 'to_be_directly_targeted_by_mir15a5p': 8.269877794507596e-06, 'to_be_negatively_regulated_by_mir15a5p_further_correlation_analysis': 0.00045660454367155184, 'to_have_important_regulatory_roles_in_the_progression_of_several_types_of_cancer_including_cervical_cancer_cm_ethics_committee': 0.0014612264467340806, 'strategy_equallykey_words': 0.00032874997356751706, 'cancer_cell_migration_invasion': 9.148819220060914e-58, 'protein_cancer': 9.148819220060914e-58, 'mir\\x9115a\\x915p': 1.3455598194317344e-05, 'mir499a': 9.148819220060914e-58, 'colony_formation_migration_invasion': 9.148819220060914e-58, 'mir15a': 7.417164383651313e-53, 'biosystems_thermo_fisher_scientific_inc_reaction': 2.383702397221873e-05, 'mir15a5p': 0.0026771594903333192, 'pcdnavector': 9.148819220060914e-58, 'ribobio_co_ltd': 9.148819220060914e-58, 'µg_pcdnavector_µg': 9.148819220060914e-58, 'siha_c\\x9133a_cells': 9.148819220060914e-58, 'ucc_gaa_cgu_guc': 4.368900587400653e-05, 'invitrogen_thermo_fisher_scientific_inc_sequences': 3.560701850358638e-06, 'ctc_atg_gag_aaa_ttt_a3_cgt_acg_t3_cells': 4.381830218427984e-08, 'blottingcell_viability': 2.6797980672980595e-06, 'inhibition_efficiency': 4.381830218427984e-08, 'v871_llcimmunofluorescence_assay': 0.0018980334020470872, 'siha_cells': 3.097700724288078e-05, 'using_a_10µl_pipette_tip_in_the_confluent_cell_monolayer': 5.059501006100227e-07, 'scratch': 8.254103704208562e-09, 'to_search_for_the_putative_targets_of_mir15a5p_pgl3yap1_widetype_or_pgl3yap1': 0.001113765635185862, 'healing_images': 1.817750855552481e-05, 'wound_healing_rate': 1.817750855552481e-05, 'targetscan_httptargetscanorg': 1.817750855552481e-05, 'type_promega_corporation': 1.817750855552481e-05, '2x105well': 9.148819220060914e-58, 'lipofectamine_invitrogen_thermo_fisher_scientific_inc': 9.148819220060914e-58, 'sdspage_cat': 0.0005779925057907071, 'protein_µglane': 5.660902509206472e-06, 'sdspage': 0.0003470856947775913, 'expression_mirnas_expression': 0.002280861502047909, 'technology_inc_membrane': 3.723102724974141e-05, 'using_imagej_v146_national_institutes_of_healthstatistical_analysis': 0.0014627384066326304, 'ecl_kit_levels': 2.3875234527140175e-05, 'ttest_oneway_posthoc_test_to_indicate_a_statistically_significant_differenceresultsmir\\x9115a\\x915p_is_downregulated_in_cc_to_examine_the_potential_involvement_of_mirnas_in_the_development_of_cc_microarray_analysis_was_performed_to_evaluate_the_mirna_expression_profiles_between_cc_tissues_and_adjacent_noncancerous_tissues_of_ ': 0.0006810685397702696, 'posthoc_test': 5.9902271010618945e-05, 'to_indicate_a_statistically_significant_differenceresultsmir\\x9115a\\x915p_is_downregulated_in_cc_to_examine_the_potential_involvement_of_mirnas_in_the_development_of_cc_microarray_analysis_was_performed_to_evaluate_the_mirna_expression_profiles_between_cc_tissues_and_adjacent_noncancerous_tissues_of_ ': 3.124786624800842e-05, 'expression_mirnas': 0.00018993043364672486, 'effect_overexpression': 0.0037535432479303614, 'to_examine_the_mir15a5p_level_in_four_cc_cell_lines': 0.00023078931020485309, 'siha_c33a_cells': 6.127457976923953e-05, 'cell_viability_cell_apoptosis': 0.0016815001133323047, 'c33a': 0.0010075235768976678, 'e_expression': 0.0004990942860418787, 'n3_green': 9.148819220060914e-58, 'downregulation_red': 9.148819220060914e-58, 'mir15a5p_expression': 2.0920249488247654e-05, 'c33a_caski_siha_cells_ect1e6e7_data': 6.127457976923953e-05, 'fig_2f': 0.0016480626375926124, 'invasion_migra\\x91tion_study': 8.263922883666513e-55, 'invasiveness_potential': 0.0004686411271822266, 'mir\\x9115a\\x915p_mimic': 0.0007085979900898482, 'mir15a5p_inhibitor': 0.002089100787749917, 'wound_healing_assay_results': 0.0006054349545841993, 'algorithms_yap1': 9.148819220060914e-58, \"to_have_a_putative_target_site_of_mir15a5p_in_its_'_utr_fig_4a_to_validate_the_possibility_that_yap1_is_a_direct_target_gene_of_mir15a5p_a_luciferase_reporter_assay_was_then_performed_the_data_revealed_that_mir\\x9115a\\x915p_mimic_significantly_inhibited_the_luciferase_activity_in_the_constructs_containing_the_wildtype_ _0cinternational_journal_of_molecular_medicine_     _figure_ _overexpression_of_mir15a5p_suppresses_cell_viability_and_promotes_cell_apoptosis_siha_and_c33a_cells_were_transfected_with_the_mir15a5p_mimic_or_inhibitor_for_ _h_and_then_cells_were_used_for_analysis_a_transfection_efficiency_was_assessed_by_reverse_transcription\\x91quantitative_pcr_cell_viability_was_measured_by_cck8_assay_at_indicated_times_for_b_siha_and_c_c33a_cells_d_the_expression_of_cleaved_caspase3_was_determined_by_immunofluorescence_assay_magnification_x200_e_the_caspase\\x91_activity_was_detected_by_a_commercial_caspase\\x91_activity_kit_f_cell_apoptosis_was_measured_by_flow_cytometry_data_are_expressed_at_the_mean_±_standard_deviation_n3_of_one_representative_experiment_p005_p001_vs_mimic_nc_p005_p001_vs_inhibitor_nc_mir_microrna_nc_negative_control_od_optical_density_pi_propidium_iodidebinding_site_of_yap13'utr_while_it_had_no_evident_effects_on_the_activity_of_yap13'utrmut\": 9.148819220060914e-58, 'apoptosis_siha': 1.156186225893678e-05, 'activity_apoptosis_siha': 0.0011133351020103058, 'cell_viability_cck8_assay': 0.0016810521528134112, 'magnification_x200_e': 8.263922883666513e-55, 'caspase\\x91_activity': 9.148819220060914e-58, 'kit_cell_apoptosis': 9.148819220060914e-58, 'transwell_assay_magnification': 0.00017939106177220415, 'transwell_assay_magnification_healing_assay': 9.930640191325513e-05, 'h_after_gaps_were_generated_wound_healing_was_quantified_by_the_distance_of_the_wounded_region_with_an_absence_of_cells_data': 1.6205971812012072e-06, 'microrna_controlyap1_inhibition': 0.00012630877451023521, '5a_yap1\\x91knockdown': 2.7446560661786228e-05, 'abilities_blotting': 5.482910402716698e-06, 'study_andor_mir15a5p': 0.00011190220085289574, '6a_yap1': 8.957647137260353e-08, 'nc_blotting_p001': 7.56342879385727e-07, 'nc': 7.56342879385727e-07, 'blotting_p001': 0.0006049075008066659, \"to_analyze_the_correlation_between_the_expression_of_yap1_and_the_expression_of_mir15a5p_expression_in_cervical_cancer_tissues_r_  _p001_data_are_expressed_at_the_mean_±_standard_deviation_n3_of_one_representative_experiment_yap1_yesassociated_protein_ _mir_microrna_'_utr_'_untranslated_region_wt_wildtype_mut_mutant\": 0.001129870936471824, 'study_mir15a5p': 9.148819220060914e-58, 'to_be_decreased_in_cc_tissues_and_cell_lines_and_associated_with_cc_metastasis': 9.148819220060914e-58, 'cc_viability_invasion_migration_cell_apoptosis': 0.0004686411271822266, 'mir641_upregulation': 9.148819220060914e-58, 'cc_cell_growth': 9.148819220060914e-58, 'mir2185p': 0.00039947355805761766, 'to_be_downregulated_in_cc_ _to_the_best_of_our_knowledge': 4.368900587400653e-05, 'blotting_transwell_cell_migration_wound_assay_data_changes': 0.0017233684068071412, 'invasion_migration_siha_c33a_cells': 1.8251619492009186e-05, 'cck\\x91_assay_c_flow_cytometry_cell_invasion_transwell_cell_migration': 0.0011128766859736692, 'cck\\x91_assay_c': 7.62540943771648e-06, 'flow_cytometry_cell_invasion': 0.00012267293572245904, 'transwell_cell_migration': 5.423730832918613e-06, 'wound_assay_data': 5.125803990169576e-06, 'mir137_upregulation': 9.148819220060914e-58, 'invasion_migration_transition': 9.148819220060914e-58, 'expression_change': 0.0019127833147525456, 'growth_inhibition_suppression': 0.0004687660047793177, 'guo': 7.6529841323252e-06, 'mir15a_overexpression': 2.2893978362264236e-06, 'to_play_an_important_role_in_different_types_of_carcinoma_ _for_example': 0.0010068765747081726, 'coactivator_oncogene': 4.368900587400653e-05, 'yap1_overexpression': 9.148819220060914e-58, 'invasion_migration_growth': 9.148819220060914e-58, 'to_target_mir\\x9115a\\x915p_to_suppress_cell_growth_and_metastasis_in_gastric_adenocarcinoma_ _and_colon_cancer_ _however_whether_yap1_is_a_target_of_mir15a5p_in_cc': 4.0451077270596384e-05, 'inhibition_to_target_mir\\x9115a\\x915p_to_suppress_cell_growth_and_metastasis_in_gastric_adenocarcinoma_ _and_colon_cancer_ _however_whether_yap1_is_a_target_of_mir15a5p_in_cc_inhibitory_effect': 0.0004686411271822266, 'to_act_as_an_oncogene_gene_in_cc_cells_and': 4.0451077270596384e-05, 'to_investigate_whether_mir15a5p_serves_its_role_via_other_downstream_targets': 0.0005479687540571566, 'studies_trial_data': 9.148819220060914e-58, 'to_validate_the_preliminary_in_vitro_results_obtained_therefore_the_function_of_mir15a5p_in_cc_needs_to_be_further_investigated_in_vivoin_ _conclusion_ _the_ _present_ _results_ _demonstrated_ _that_mir15a5p_suppresses_the_viability_migration_and_invasion_of_cc_cells_by_directly_targeting_yap1_based_on_these_findings_it_is_proposed_that_the_mir15a5pyap1_axis_may_serve_as_a_novel_biomarker_for_new_targets_in_cc_therapyacknowledgementsnot_applicablefundingfunding_was_received_from_the_scientific_research_project_of_shanghai_science_and_technology_commission_grant_nos_ _and_availability_of_data_and_materialsthe_datasets_used_andor_analysed_during_the_current_study': 9.148819220060914e-58, 'to_be_further_investigated_in_vivoin_ _conclusion_ _the_ _present_ _results_ _demonstrated_ _that_mir15a5p_suppresses_the_viability_migration_and_invasion_of_cc_cells_by_directly_targeting_yap1_based_on_these_findings_it_is_proposed_that_the_mir15a5pyap1_axis_may_serve_as_a_novel_biomarker_for_new_targets_in_cc_therapyacknowledgementsnot_applicablefundingfunding_was_received_from_the_scientific_research_project_of_shanghai_science_and_technology_commission_grant_nos_ _and_availability_of_data_and_materialsthe_datasets_used_andor_analysed_during_the_current_study': 0.0005345134679592639, 'tz_xy_sx': 0.0017947979623791836, 'paper_rc': 2.9290776326870562e-05, 'interests_references_trials_galazios': 0.0013882295497307361, 'zhang_z_mir1266': 0.000234035537295674, 'nanops_ceo2_nps': 0.0003347357351571664, 'nanotechnology': 0.00014084186830440697, 'infections_biomedicalintroductionnanotechnology': 0.00022165572398622112, 'exploited': 4.5178732407206925e-05, 'interest_array_interest_resources_commons_attribution_using_plant_extracts_microbial_and_other_biological_derivatives_plants_ _in_ _this_ _regard_ _plants': 0.002768179626981894, 'size_structures': 0.00210348072096923, 'nano_scale_entities': 0.0002712952666904031, 'figure_ceo2_nps': 4.5178732407206925e-05, 'reducing_ _solvents_ _posing_ _several_ _threats_ _to_ _the_ _biodiversity_and_ _ecosystem_ ': 0.0005371174057381335, 'using_plant_extracts_microbial_and_other_biological_derivatives_plants_ _in_ _this_ _regard_ ': 5.460946248868199e-06, 'ceo2_nps': 0.0009949546389750074, 'to_synthesize_ _ceo2_ _nps_ _with_ _spherical_ _morphologies_ _and_ _size_ _of_ _nm': 2.1050490145489324e-05, 'antimicrobial_wound': 1.627165191561768e-05, 'hibiscus_extract': 2.1050490145489324e-05, 'using_ _jatropha_ _curcus_ _leaf_extract_and_a_ _monodispersed_ _shape_ _of_ _\\x93_ _nm10_ _spherical_ _shaped_cerium_ _oxide_ _nanops_ ': 2.1050490145489324e-05, 'using_ _leaf_extract_ _of_ _oleo_ _europaea_ _with_ _a_ _size_ _of_   _nm_ ': 2.1050490145489324e-05, 'majorana_extracts': 9.148819220060914e-58, 'to_ _synthesize_ _ceo2_ _nps_ ': 9.148819220060914e-58, 'pseudo_photocatalytic_activity': 4.342148812468765e-05, 'to_be_responsible_for_the_reduction_and_stabilization_of_bulk_salts_into_respective_nanops_nps1619to_ _date_ ': 0.0038806204677737646, 'to_display_their_antimicrobial_actions_through_various_mechanisms9': 0.002104041233387171, 'kill_need': 3.4348996837103175e-05, 'to_ _be_ _conducted_to_fully_elucidate_the_complete_mechanism_of_action_here_in_ _this_ _review_ _we_ _aim_ _to_ _focus_ _on_ _the_ _following_ _topics_arrays_ _of_ _biological_ _resources_ ': 0.0018006682651940404, 'to_ _focus_ _on_ _the_ _following_ _topics_arrays_ _of_ _biological_ _resources_ ': 0.007713134335009549, 'discussed_synthesized': 0.00022784076628390402, 'using_ _various_ _physical_ _chemical_ _and_ _biological_ _methods9_ _manuscript': 3.7184676209466113e-06, 'solvents': 0.0005371174057381335, 'using_ _various_ _physical_ _chemical_ _and_ _biological_ _methods9_ ': 3.7184676209466113e-06, 'dovepress_international': 0.0001438653184561452, 'extract18_ceo2': 9.148819220060914e-58, 'using_ ': 9.148819220060914e-58, 'pedalium_murex_l': 8.263922883666513e-55, 'having_ _high_ _antibacterial_ _activity32_ _china_rose': 1.1686951820486561e-54, 'petal': 8.263922883666513e-55, 'ceo2_np\\x99s': 0.0001438653184561452, 'durability_everlasting': 0.0038806204677737646, 'niger_extract': 0.001585558258960799, 'water_dispensability': 2.5880479410895676e-05, 'fluorescent_properties': 2.5880479410895676e-05, 'fluorite_nps': 2.5880479410895676e-05, 'using_ _fusarium_ _solani_ _extract_ _which_showed_effective_growth_inhibition_and_biofilm_formation_of_ _pathogenic_ _bacterial_ _strains42_ _shadab_ _ali_ _khan': 1.623274105392598e-05, 'growth_inhibition_biofilm_formation': 0.0038806204677737646, 'ftir_xrd': 1.627165191561768e-05, 'antioxidant_potential': 1.627165191561768e-05, 'shortcomings_contamination_issues': 3.531910381053481e-05, 'walnutshellleafxrd_sem_tem': 9.148819220060914e-58, 'uvdrs_oh\\x93ceoc': 9.148819220060914e-58, 'hrtem_eds': 9.148819220060914e-58, 'ftirsphericalspherical\\x93ceo': 9.148819220060914e-58, 'ceo2_nanops': 1.627165191561768e-05, 'cn_cocaspergillus': 0.00022771936739542464, 'dovepress': 0.0010068765747081726, 'ftir_tgadta_analysis': 1.627165191561768e-05, 'cytotoxicity_effect': 0.00210348072096923, 'ceo2nps': 0.0010068765747081726, 'figure_representation': 0.0004005448148874858, 'outcomes2324_ceo2_nps': 0.00022165572398622112, 'microbes_ros': 1.623274105392598e-05, 'to_be_more_effcient_and_have_the_potential_to_range_ _of_ _pathogenic_ _bacterial_species1113151642_ ': 0.0038816544549862162, 'physiology1642': 6.33966136568193e-05, 'species1321374754': 0.0007008712380191807, 'structure_physiology': 0.0038806204677737646, 'nosocomial_other_activity': 0.001801148090838322, 'to_ _be_addressed_ ': 0.0038806204677737646, 'nosocomial_other': 0.0018006682651940404, 'therapies_ceo2_nps': 2.9402948113849672e-05, 'to_ _induce_ _apoptosis_ _andor_ _necrosis_ _in_ _cancer_cells46_ _ceo2_ _nps_ _synthesized_ _from_ _origanum_ _majorana_and_ _ceratonia_antioxidant_activity183157_ _results_ ': 1.627165191561768e-05, 'radicals': 0.0038806204677737646, 'mechanism_delivery_system': 9.148819220060914e-58, 'to_ _be_ _determined_moreover_ _cytotoxicity_ _and_ _genotoxicity_ _should_ _be_ _tested_in_ _vivo_ _models_ _to_ _evaluate_ _the_ _compatibility_ _in_ _both_in_vivo_and_in_vitro_modelssubmit_your_manuscript_ ': 9.148819220060914e-58, 'trends_understandings': 0.007713134335009549, 'surface_morphologies': 0.007713134335009549, 'trends_understandings_surface_morphologies_interest_death': 0.00016463522079533424, 'compartments': 0.00010080225454168545, 'anticancer_antioxidant_potential': 0.00210348072096923, 'to_ _be_ _addressed_despite_their_role_in_various_therapies': 0.0038806204677737646, 'to_be_optimized': 0.00046345855666667525, 'sls_static': 9.148819220060914e-58, 'xps_xray': 9.148819220060914e-58, 'diffractiondisclosurethe_authors': 9.148819220060914e-58, 'conflicts_jianrong_c_yuqing_et_al_nanotechnology_biosensors': 9.148819220060914e-58, 'jr_applications': 9.148819220060914e-58, 'mohanraj_klump_nanops_applications_prospects': 9.148819220060914e-58, 'carcinoma_crc': 0.0005253840276496832, 'aï¬ectwhich': 9.148819220060914e-58, 'pyruvate_mitochondrialmetabolism_fate': 9.148819220060914e-58, 'core_manifestationto': 5.319823916741082e-06, 'withimmunoregulation_morphology_mpc1_results': 0.0018006682651940404, 'withimmunoregulation_morphology': 0.0018006682651940404, 'mpc1_results': 0.0015842910551982499, 'adenocarcinoma_mpc1_deï¬\\x81ciency': 1.1686951820486561e-54, 'adenocarcinoma_progression': 8.263922883666513e-55, 'to_be_involved_instemness_and_metabolism_which_regulated_by_couptfii': 8.263922883666513e-55, 'couptfii': 0.004212846818003754, 'suggestedthat_mpc1_maybe_serves_as_a_suppressor_to_disrupt_tumormalignancy_however_whether_mpc1_is_involved_in_crcmetastasis_and_the_underlying_mechanisms_remain_to_beillustratedin_the_present_study_we_ï¬\\x81gured_out_the_relationshipbetween_the_mpc1_expression_and_crc_liver_metastasiswe_identiï¬\\x81ed_that_decreased_mpc1_was_closely_correlatedwith_patient\\x99s_metastasis_as_well_as_led_to_poor_prognosisfunctionally_mpc1_overexpression': 7.537965559352772e-06, 'mpc1': 0.0005842939653974886, 'crc_metastasisthrough': 9.531669346633657e-06, 'geo_datasets_gse21510': 0.0014616190772430405, 'gse89393_gse67675_gse4183and_tcga': 8.263922883666513e-55, 'to_analyze_the_mpc1_expression_pattern_in_crc': 1.1686951820486561e-54, 'data_data_feo_datasets': 8.263922883666513e-55, 'database_httpwwwoncolnc': 9.148819220060914e-58, 'to_detect_the_prognostic_value_of_mpc1_inthe_tcga_cohort_patients_and_clinical_specimens_in_our_study_a_total_of_patients_containing_paired_crc_tissues_and_adjacentnontumor_tissues_were_enrolled_from_the_department_of_gastrointestinal_surgery_renji_hospital_school_of_medicineshanghai_jiao_tong_university_among_them_ _cases_ofliver_metastases_were_collected_and_only_ _cases_wereavailable_with_complete_followup_data_for_survival': 9.148819220060914e-58, 'transfection_cells': 3.3321605959222744e-06, 'mpc1_expression_level': 0.00020444110131767436, 'immunoï¬\\x82uorescence_assays': 8.263922883666513e-55, 'bysdspage': 1.1686951820486561e-54, 'respectively_proteins': 8.263922883666513e-55, 'asfollows_mpc1': 0.0003465503081158997, '0c_enzyme_carrier_±_sd_spss_chicago_il': 0.0003465503081158997, 'matrixmitochondrion_matrixmitochondrionas': 4.470277225999304e-06, '0c_enzyme_carrier_to_analyze_theter_mix_roche_the_data_and_gapdh_was_used_as_a_loading_control_the_primersequences_are_listed_in_table_ _liver_metastasis_model_±_sd_spss_chicago_il_fold_change': 0.0019319557900300663, 'to_analyze_theter_mix_roche_the_data_and_gapdh_was_used_as_a_loading_control_the_primersequences_are_listed_in_table_ _liver_metastasis_model': 0.0003465503081158997, 'committee_iacucof_shanghai_jiao_tong_university': 0.00020438662347026346, 'mc38_cells': 9.148819220060914e-58, 'animal_care_committee_iacucof_shanghai_jiao_tong_university': 9.148819220060914e-58, 'graphpad_prism_software': 9.327263445268705e-06, 'to_manipulate_statistical_analyses': 0.000571748998785482, 'glycolysis_tca_cycleto': 0.0038806204677737646, 'dataset_resultsshowed': 0.007713134335009549, 'mpc1mpc2': 0.0038806204677737646, 'thatmpc1': 0.007713134335009549, 'crc_modelsfigure': 0.00022709638132718343, 'evitalertcga\\x81\\x8e\\x81\\x8e\\x81\\x8en_gse5206_gse9348normaltumorabhuman_samplecrcnormalaom': 0.00013391749528082216, 'fold_changes_xaxis_values_log10': 2.158504123365708e-05, 'e_ihc_staining': 9.148819220060914e-58, 'crc_mouse_models_andcontrol_scale_bar': 9.148819220060914e-58, 'representative_ihc_staining_cohortwhich': 0.00024036240069303988, 'test_\\x88\\x97\\x88\\x97p_tissues': 3.2844744110215605e-06, 'capabilityand': 0.0006578099350934741, 'to_ï¬\\x81gure_out': 0.007713134335009549, 'analysisbetween_incrc_table': 0.0038806204677737646, 'prognosiswas': 0.0015847132313328567, 'bothin_vitro_role': 2.586668612581389e-05, 'withoutmetastasis': 8.263922883666513e-55, 'mpc1_protein_expression': 0.007713134335009549, 'immunoblotsfigure_mpc1_knockdown': 0.00031278352800590204, 'mpc1_overexpression': 0.0014127716728138113, '3e_cells': 1.2370933772211745e-06, 'transplanting_luciferaseexpressingwhich': 9.148819220060914e-58, 'mc38_metastasis': 9.148819220060914e-58, 'mpc1knockdown': 9.148819220060914e-58, 'cells_metastasis': 9.148819220060914e-58, 'ability_3e_cells': 0.00031410834486656386, 'thatmpc1_knockdown': 9.148819220060914e-58, 'ofcrc': 9.148819220060914e-58, 'wntcatenin_pathwayby': 9.531669346633657e-06, 'abovewe': 9.148819220060914e-58, 'distribution_changes_4c': 9.148819220060914e-58, 'overexpression_weakenednuclear_catenin_localization_sw480': 3.7028892291290873e-06, 'ihc_figure': 0.00022715691095227456, 'mpc': 0.00010905940088698344, 'daysgse89393\\x81\\x8e\\x81\\x8enormal_crcmcrcbnoisserpxe_cpm': 9.148819220060914e-58, 'expressionmpc1_expressiongecrc': 9.148819220060914e-58, 'monthsmpc1': 0.0006640634820340671, 'mpc1_expressionwas': 9.148819220060914e-58, 'tumor_metastasis_prognosis': 9.148819220060914e-58, 'glucoseutilization': 0.0004005448148874858, 'invasion_migration_ability': 0.0007225277520848369, '\\x88\\x97\\x88\\x97p_\\x88\\x97\\x88\\x97\\x88\\x97p': 0.00011026011152073265, 'to_be_devised_to_illustrate_this_processfollowing_in_the_analysis_between_the_clinical_signiï¬\\x81cance_and_mpc1_expression_in_crc': 0.001810199934540674, 'outcome_especiallyin_patients': 0.0003733542770154514, 'species_ros_production': 0.00028441251889509887, 'maintenance_fate': 9.534209047811416e-06, 'to_conï¬\\x81rm_thissubsequently': 0.000762889468397268, 'the_underlying_mechanism_of_mpc1_inregulating_metastasis_was_explored_for_this_purpose_gseaanalysis': 1.5571618939516891e-07, 'to_interact_withusp9x_to_inhibit_the_degradation_of_catenin_through_thedeubiquitination_of_catenin_in_breast_cancer_  _a_constitutive_irs1_and_catenin_protein_interaction_activated_mycexpression_in_acute_lymphoblastic_leukemia_cells_  ': 6.298805075748078e-05, 'inhcc_catenin': 9.148819220060914e-58, 'to_interact_with_yap1_to_leadto_rapid_tumorigenesis_  ': 9.148819220060914e-58, 'cellcell_contacts_transition': 0.00012617334968195346, 'mpc1_mediatetumor_cell_motility': 0.007713134335009549, 'to_be_performed_to_clarify_the_detailed_underlying_mechanisms_conclusionsin_conclusion_we_ï¬\\x81rstly_demonstrated_that_decreased_mpc1was_closely_correlated_with_patient\\x99s_metastasis_as_well_as_ledto_poor_outcome_moreover_mpc1driven_nuclear_translocation_of_catenin_contributed_to_crc_cell_motility_thismeans_that_mpc1_has_the_potential_to_be_a_diagnostic_biomarker_and_therapeutic_target_for_metastasis_patientsabbreviationscrc_colorectal_carcinomampc_mitochondrial_pyruvate_carrieremt_epithelialmesenchymal_transitiongsea_gene_set_enrichment_analysisdata_availabilitythe_data_used_to_support_the_ï¬\\x81ndings_of_this_study_are_available_from_the_corresponding_author_upon_requestconflicts_of_interestall_authors': 0.0018006682651940404, 'chunjie_xu_obtained_anized_guangang_tian': 9.148819220060914e-58, 'themanuscript_guangang_tian_chunjie': 9.148819220060914e-58, 'kaixia_zhou': 0.0014616190772430405, 'data_zhigangzhang_jianren_gu': 9.148819220060914e-58, 'tools_xueli_zhang': 9.148819220060914e-58, 'workacknowledgmentsthis_work': 9.148819220060914e-58, 'sciencefoundation': 9.148819220060914e-58, 'to_analyze_the_statistical_diï¬erences_between_ibd_adenoma_and_crc_tissues': 3.68289106346844e-05, '\\x9cglutamine': 0.0006321861226151657, '\\x9cmitochondrialpyruvate_carrier': 9.148819220060914e-58, 'homeostasisthrough_regulation': 9.148819220060914e-58, 'j_xiong_ofmpc1': 9.148819220060914e-58, 'migration_invasion_stemcelllike_properties': 9.148819220060914e-58, 'al_\\x9cpgc1Î±': 0.00023078931020485309, '\\x9capplication': 0.0002712952666904031, 'developmentthrough_enhancing_angiogenesis_andmediating_resistance_to_imatinib\\x9d_scientiï¬\\x81c': 6.0025617222710656e-06, 'et_al_\\x9cnptx2': 0.00047983738574547787, 'to_be_a_previously_unrecognized_immune_evasion_mechanism_with_igg4_playing_an_essential_role_in_cancer_microenvironment_with_implications_in_cancer_diagnosis_and_immunotherapyintroductionwhile_ _new_ _immune_ _therapy_ _for_ _cancer_promise_structure': 0.009493919326339055, 'immunoglobulin_subtype_igg4': 0.0015842910551982499, 'igg4': 0.01023715389257993, 'b_lymphocytes_igg4_concentration': 0.00016729344731385043, 'igg4_concentrations': 0.00015516985755374517, 'to_associate_with_more_aggressive_cancer_growth_we_further_found_that_igg4_regardless_of_its_antigen_specificity_inhibited_the_classic_immune_reactions_of_antibody_dependent_cell_mediated_cytotoxicity_antibody_dependent_cellular_phagocytosis_and_complement_dependent_cytotoxicity_against_cancer_cells_in_vitro_and_these_effects_were_obtained_through_its_fc_fragment_reacting_to_the_fc_fragments_of_cancer_specific_igg1_that_has_been_bound_to_cancer_antigens': 0.00016729344731385043, 'reactions_cytotoxicity': 0.0010068765747081726, 'carcinogen': 9.148819220060914e-58, 'skin_papilloma': 9.148819220060914e-58, 'antibody_drug': 0.007713134335009549, 'to_be_a_previously_unrecognized_immune_evasion_mechanism_with_igg4_playing_an_essential_role_in_cancer_microenvironment_with_implications_in_cancer_diagnosis_and_immunotherapyintroductionwhile_ _new_ _immune_ _therapy_ _for_ _cancer': 0.00019396529043020443, 'subdued8_igg4': 0.0002915557546050062, 'which_chains': 9.148819220060914e-58, 'resulting_in_ _an_ _asymmetric_bispecific_ _antibody_ _with_ _reduced_ _ability_to_ _bind_ _to_ _antigen_ _and_ ': 9.148819220060914e-58, 'fae_fc_fc_reactivity': 0.0002915557546050062, 'et_al11': 9.148819220060914e-58, 'crystal_structure': 9.148819220060914e-58, 'competition_saline': 0.0022656210277573956, 'melanoma18_the_above_studies_were_performed_on_limited_ _number_ _of_ _cases_ _without_ _convincing_ _explanation_of_mechanism_or_significance_wu_ _19': 3.698565197959366e-05, 'igg4igg_ratio': 0.00023671983705856548, 'karagiannis': 0.0019127833147525456, 'investigation_stain_decolorize_stain_sds_technology22': 0.008061831776000162, 'volunteerswe': 9.148819220060914e-58, 'tissue_blood_samples': 9.148819220060914e-58, 'center_details': 0.00013179338208300345, 'pancreas_brain_antibodies': 0.007713134335009549, 'chromatography_fab': 0.00020444110131767436, 'prepared': 3.3321605959222744e-06, 'fc_fragments': 3.698565197959366e-05, 'igg_fc_fragment': 1.828014687832449e-05, 'polyacrylamide_gels': 0.00010082912498668636, 'reaction_density': 3.698565197959366e-05, 'statisticallymeasurement_concentrations_significance_1eh': 0.0011265283875315619, 'statisticallymeasurement': 0.0014616190772430405, 'rpmi_gibco_c22400500bt': 1.8377771958645018e-05, 'uml_penicillin_streptomycin_ml_cell_culture': 9.148819220060914e-58, 'preparationsdetails': 9.148819220060914e-58, 'to_inhibit_these_reactions_igg1_was_used_as_control_details_of_the_protocols_are_shown_in_online_supplementary_dataanimal_modelsbreast_cancer_and_colon_cancer_modelsbalbc_mice_were_obtained_from_vital_river_technical_beijing_china_mice_aged_between_ _and_ _weeks_and_weighed_ _±_g_ _were_ _used_ _in_ _all_ _experiments_ _all_ _mice_were_ _inoculated_ _with_ _4t1_ _mouse_ _breast_ _cancer_ _cells_ _or_ct26_mouse_colon_cancer_cells_subcutaneously_under_the_left_forearm_Ã\\x97_4t1_cells_per_mouse_to_build_cancer_models_ _the_ _mice_ _were_ _divided_ _into_ _different_ _groups_and_were_treated_with_igg1_or_igg4_derived_from_intravenous_ _igg_ _ivig_ _ivig_ _without_ _igg4_ _nivolumab_ _and_fc_of_nivolumab_respectively_details_of_the_protocols_are_shown_in_online_supplementary_datacarcinogeninduced_skin_tumor_modelwe_employed_a_well_established_carcinogen_induced_skin_tumor_model_to_study_the_effect_of_igg4_and_ivig_without_igg4_ _in_ _comparison_ _with_ _controls_ _phosphate_ _buffered_open_accesssaline_ _pbs_ _detailed_ _protocol_ _is_ _shown_ _in_ _online_supplementary_dataquantification_and_statistical_analysisdata_ _were_ _analyzed_ _in_ _graphpad_ _prism_ ': 0.00016729344731385043, 'patient_prognosiswe': 0.00039860275495761944, 'n70': 0.0003309404805354376, 'plasma_cell': 9.148819220060914e-58, 'igg_subtype': 9.148819220060914e-58, 'to_accumulate_more_in_tissues_with_extensive_cancer_cell_infiltration_than_in_other_areas': 8.263922883666513e-55, '1eh': 0.00013488041688643448, 'concentrations_n46_pairs_concentration': 0.007713134335009549, 'n18': 6.7860631771785984e-06, 'distribution_pattern_plasma_cell': 9.148819220060914e-58, 'subclass': 9.148819220060914e-58, 'igg1_igg4_to_ _react_ _to_ _igg1_ _igg2_ _igg3_ _and_ _igg4_ _at_ _the_molecular_weight_mw_of_about_ _kd': 0.0004990125168953021, 'notwe': 8.696066765303972e-08, 'igg1_igg4': 5.321241605857728e-06, 'igg1': 0.00033925710201121375, 'region_explanation': 4.165425664237844e-06, 'blot_igg4': 9.148819220060914e-58, 'to_react_to_other_iggs_igg1_igg2_igg3_and_igg4_via_an_fcfc_mechanism': 9.148819220060914e-58, 'experiments_to_react_to_other_iggs_igg1_igg2_igg3_and_igg4_via_an_fcfc_mechanism': 0.00016729344731385043, 'to_ _react_ _to_ _igg1_ _igg2_ _igg3_ _and_ _igg4_ _at_ _the_molecular_weight_mw_of_about_ _kd': 0.00016729344731385043, 'accessigg4': 0.007713134335009549, 'cancer_immunity_panel': 7.7258192183302e-05, 'figure_igg1': 1.3524125422286213e-06, 'tissue_section': 5.5543711353616176e-06, 'principle_igg4_igg1_3b\\x93e': 0.000256262754619601, 'igg4_2b': 0.0003261867581867448, 'followed': 0.000670917318037532, 'fcfc_reaction': 0.00013009077242344034, 'immunoglobulin_assays_igg4': 0.00795752645973963, 'technology_china_cl0239': 0.00013009077242344034, 'extracted_purchased': 0.00013009077242344034, 'fc_receptor_blocker': 0.00032627371885439785, 'figure_s8igg4': 8.198185194464105e-05, 'adcc': 0.00030956355452942195, 'to_ _take_ _place_ _at_ _the_ _site_ _of_ _the_ _cancer_specific_antibody_that_is_igg4_reacted_to_the_igg1_antibody_ _bound_ _to_ _cancer_ _cells_ _figure_ _2b_ _and_ _the_ _site_ _of_immune_ _effector_ _fc_ _receptors_ _the_ _latter_ _effect_ ': 0.00054686425127897, 'demonstrating_an_inhibitory_effect_of_igg4_in_adcc_n12_non_cancer_specific_igg1': 0.001128162151175775, 'adcp': 0.0004499048194399722, 'scale_bar30': 5.532311394706919e-06, 'cell_activity': 0.00015175328891448237, 'diamidino2': 9.148819220060914e-58, 'factor_receptor_hsa': 9.148819220060914e-58, 'adcp_experiment': 0.0008735351041388727, 'fitc': 6.978293448298126e-05, 'usa_c4215': 0.007713134335009549, 'igg4_igg1': 0.007713134335009549, 'cdc_effect': 0.00016729344731385043, 'cancer_cell_cell_growth': 0.001128162151175775, 'cancer_growth_experiment': 0.00016729344731385043, 'serine_residu': 0.0038806204677737646, 'macrophages_tam': 0.0011125787591309202, 'to_dissect_the_immunological_consequences_of_irradiation_in_macrophagesresults_ ': 9.849136608862707e-05, 'vesicles_ev': 5.8757551610179185e-05, 'term_radiotherapy': 9.148819220060914e-58, 'to_target_the_polarization_status_of_macrophages_to_enhance_future_immunotherapeutic_strategiesintroductionsince_ _the_ _introduction_ _of_ _immune_ _checkpoint_blockade_immunotherapy': 9.148819220060914e-58, 'plasticity_concept_damp': 0.0001753243138387261, 'tam': 0.010541402393443922, 'damp': 0.00017225462345503805, 'tissue_samples_phenotype_distribution_findings_to_dissect_the_immunological_consequences_of_irradiation_in_macrophagesresults_ _m1_phenotype_effects': 0.0016986226789398495, 'dose_irradiation': 1.1686951820486561e-54, 'repolarization_expression': 8.263922883666513e-55, 'm1_phenotype': 1.364444013841871e-05, 'tumor_ablation': 0.00011931918217645773, 'to_depend_on_the_model_irradiation_dose_tissue_as_well_as_on_the_investigated_time_point_after_irradiation_however_despite_the_controversial_reports': 0.001128162151175775, 'evidentmore_vesicles_ev': 0.0006611997588271541, 'course_irradiation': 0.0004988292642554344, 'tumor_specimen': 0.007713134335009549, 'briefly_tissue': 5.705135533991449e-07, 'cell_suspension_i_mgml': 9.314504973057242e-09, 'cell_suspension_i_mgml_gradient_centrifugation': 3.49433175979127e-05, 'gradient_centrifugation': 9.314504973057242e-09, 'table_discrimination': 5.702095897410298e-07, 'cd14_hla_dr_viable_cd45_cells': 0.001284137829433559, 'to_be_phagocytosing': 2.0956405340910197e-05, 'to_be_phagocytosing_cells_evtam_using_ _a_ _z1_ _axio_observer_ _microscope_ _equipped_ _with_ _a_ _ld_ _plan_centrifugation_hct116_dld1_cells_ultracentrifugation_mm_tris\\x93hcl_using_ _graphpad_prism_   _graphpad_ _software_ _statistical_ _significance_t_test_effect_1a_1b_tam': 0.0008827136539995065, 'cells_evtam': 2.0956405340910197e-05, 'collagen_cell_cylinders': 1.439786286066806e-05, 'using_ _a_ _z1_ _axio_observer_ _microscope_ _equipped_ _with_ _a_ _ld_ _plan': 2.0956405340910197e-05, 'using_tissuefaxstissuequest_image_analysis_software_tissuegnostics_gmbhpreparation_of_otaota_ ': 0.00020049727878820533, 'collagen_solutions': 1.439786286066806e-05, 'macrophage_differentiationpbmc': 9.148819220060914e-58, 'plaque_centrifugation_pbmc': 9.148819220060914e-58, 'macrophages_cells': 1.439786286066806e-05, 'centrifugation_hct116_dld1_cells': 2.0956405340910197e-05, '5a_medium': 1.439786286066806e-05, 'cells_supernatant': 1.439786286066806e-05, 'mm_tris\\x93hcl': 2.0956405340910197e-05, 'hettich_supernatant': 1.439786286066806e-05, 'evolution_rc_thermo_fisher': 2.2029273237439514e-06, 'using_ _a_ _nanoparticle_ _tracking_ _analyzer_zetaview_ _particlemetrix_ _results_ _were_ _analyzed_ _with_zetaview_software_ev': 2.5164048986301268e-52, 'mm_nacl_np40_sodium': 9.148819220060914e-58, 'sds': 9.148819220060914e-58, 'ev_suspensions': 1.439786286066806e-05, 'tween_detergent_membranes': 1.439786286066806e-05, 'g_igg': 9.148819220060914e-58, 'antibody_cell': 9.148819220060914e-58, 'cu_mesh': 1.439786286066806e-05, 'using_ _graphpad_prism_   _graphpad_ _software_ _statistical_ _significance': 2.0956405340910197e-05, 'strategy_cd45_cells': 9.148819220060914e-58, '1b_tam': 9.148819220060914e-58, 'samples_figure_1cd_phenotype': 2.754763394345853e-05, 'samples_figure_1cd': 2.8099825300458043e-06, 'lesions_tam': 0.0016810521528134112, 'productionlowdose_irradiation': 0.0003247463263852347, 'leucocytes': 0.007713134335009549, 'pd1_expression': 0.007713134335009549, 'antigen_presentation_cytokines': 0.0007008712380191807, 'cultures_figure': 1.153757197955562e-05, 'hla_dr_low': 0.007713134335009549, 'expression_il23_p19': 1.153757197955562e-05, 'il23': 9.148819220060914e-58, 'tendency_samples_figure': 9.148819220060914e-58, 'tam_polarization': 8.263922883666513e-55, 'tam_ _have_ _a_ _higher_probability_to_participate_in_antitumor_immune_responses_directly_ _by_ _phagocytosis_ _and_ _cytokine_ _secretion_ _as_ _well_as_indirectly': 0.004315547045054443, 'tam_polarization_function': 0.007713134335009549, 'use_cancer': 0.007713134335009549, 'specimen_cancer_patients_indication': 0.007713134335009549, 'cohort_figure_ex': 9.148819220060914e-58, 'polarization': 9.148819220060914e-58, 'example_macrophages': 1.6073293484330334e-07, 'example_cancer_lesions_cancer_macrophages': 1.5354541907056445e-05, 'cancer_lesions': 1.5354541907056445e-05, 'cancer_access_irradiation': 0.0001247534552418638, 'phagocytosis_marker': 2.0356996611489255e-06, 'cytometry_plots': 2.5102461132469756e-07, 'phagocytosis_marker_gy_c_percentage_cancer_data_macrophages': 1.5366821635776897e-05, 'then_gating_on_pe_cells_b_analysis_of_tam_phagocytosis_of_phrodo_e_coli': 2.5102461132469756e-07, 'gy_c_percentage': 2.0356996611489255e-06, 'histogram_non_irradiatedblue': 2.5102461132469756e-07, 'cancer_accessfigure_course_irradiation': 9.605279723541985e-05, 'representative_example': 1.5679331087186186e-06, 'irradiation_protocol': 9.148819220060914e-58, 'quantitative': 9.148819220060914e-58, 'nkt_cells': 9.148819220060914e-58, 'nk': 9.148819220060914e-58, 'quantitative_nk': 0.0011128753199612298, 'given': 1.8167818297264612e-05, 'n25_n45_images': 0.00027573473885584285, 'representative_example_peil10_fitc_tumor_sections_infiltration': 2.965608303096928e-07, 'peil10_fitc': 0.0001788354435343705, 'tumor_sections': 8.263922883666513e-55, 'cd56_cd3_cells': 0.0038806204677737646, 'cd68_cells': 2.2742115629454836e-53, 'resulting_ _in_ _a_ _significant_increase_in_the_m1m2_ratio_figure_3fg_similar_to_the_ex_vivo_cultures_we_observed_a_sixfold_decrease_of_il10_tam_in_tumors_from_irradiated_patients_as_compared_with_treatment_ _naive_ _tumors_ _figure_ _3hi_ _hallmarks': 2.2742115629454836e-53, '3eto': 0.0002069818544961052, 'tumor_specimens': 2.8099825300458043e-06, 'cells_irradiation': 1.4055400435083294e-53, 'resulting_ _in_ _a_ _significant_increase_in_the_m1m2_ratio_figure_3fg_similar_to_the_ex_vivo_cultures_we_observed_a_sixfold_decrease_of_il10_tam_in_tumors_from_irradiated_patients_as_compared_with_treatment_ _naive_ _tumors_ _figure_ _3hi_ ': 1.4055400435083294e-53, 'anotypic_cultures': 0.007713134335009549, 'hct116_caf_peripheral_blood': 9.148819220060914e-58, 'macrophages_figure_a_4e_expression': 9.148819220060914e-58, 'supplementary_b_non': 9.148819220060914e-58, 'gy_ota_macrophages': 9.148819220060914e-58, 'marker_profile': 0.0016810521528134112, 'to_have_biological_activityin_almost_all_living_anisms_including_plants_animals_and_microbes': 0.00210348072096923, 'itcan': 0.0011125787591309202, 'to_show_a_high_afï¬\\x81nity_towardsthis_hormone_melatonin_and_hence_act_on_receptors_and_bindingsites_  _studies_reported_by_tan_  ': 0.00030237797101608573, 'moleculethat': 9.148819220060914e-58, 'mitochondria_physicochemical_biologicalproperties': 9.148819220060914e-58, 'address_renjithsbcollegeacin_r_thomas101016jmolliq2020114082': 0.00210348072096923, 'bloodbrain_barrier': 1.7370921564672784e-05, 'sleepbehavior_disorder_patients': 3.894150558838119e-05, 'tumorï¬\\x81ghting_behavior': 0.00210348072096923, 'effectas_antioxidant_anti\\x82ammatory_melatonin': 0.00210348072096923, 'overreaction': 0.00210348072096923, 'using_the_gaussian09_ _software_package_with_the_dftb3lyp_functional_and': 0.00016166578465006543, 'geometry': 0.007713134335009549, 'analysis_performedthe_melatonin_molecule': 9.148819220060914e-58, 'reaction_sites': 9.148819220060914e-58, 'to_dock_the_molecule_with': 0.007713134335009549, '4c25o26c': 9.148819220060914e-58, 'bond_lengths': 9.148819220060914e-58, 'effect_transition_study_properties': 9.148819220060914e-58, 'electrontransfer_excitedstates': 9.148819220060914e-58, 'td\\x93dft_formalism_2dp_basis_sets_ofmethanol': 0.007713134335009549, 'energyis': 3.0490336817131566e-05, 'movement_ofelectrons_protons': 0.004315547045054443, 'Ï\\x89energy': 0.0004499048194399722, 'are_kcalmol': 9.148819220060914e-58, 'occupancy': 9.148819220060914e-58, 'rc18_h19_r_c23_r_o24_r_c30_r_h33_Ï\\x83_Ï\\x83_c30h32_Ï\\x83': 9.148819220060914e-58, 'having_the_energies_are_        _and_ _kcalmol_respectively_and_from_Ï\\x83': 9.148819220060914e-58, 'how_reactive_sites_canundergo_nucleophilic_or_electrophilic_addition_or_substitution_reactionsof_melatonin_shown_in_fig_ _within_ _bohr_  _and_a_color_changefrom_blue_to_red': 5.740282177885479e-06, 'sites_nucleophiles': 9.148819220060914e-58, 'themthe_alie': 9.148819220060914e-58, 'nucleophiles': 8.263922883666513e-55, 'bonds': 1.1686951820486561e-54, 'delocalised_electrons_and_unsaturated_bonds': 9.148819220060914e-58, 'thestability': 9.148819220060914e-58, 'der_waals': 1.1686951820486561e-54, 'forces': 8.263922883666513e-55, 'potentials_fig_interactions_rangesfrom': 8.263922883666513e-55, 'havocthroughout_world': 3.961866732544363e-05, 'called3cl_protease_6lu7': 0.00031995314978350303, 'peptidelike_inhibitor': 0.0003531322339906675, 'protease_protein': 0.0002915557546050062, 'narcissoside': 9.148819220060914e-58, '6lu7pdb_6m03_pdb': 9.148819220060914e-58, '6w63': 1.1686951820486561e-54, 'form_6lu7pdb_6m03_pdb': 8.263922883666513e-55, 'and6w63_solvent': 0.0004499048194399722, 'protein_residues': 0.00023148283708492395, 'residue_names': 0.00043463382250315263, 'solvent_accessibility_accessibility_values_fig_s2': 9.148819220060914e-58, 'residue_structure': 9.148819220060914e-58, 'pipi': 9.148819220060914e-58, 'pialkyl_pialkyl': 9.148819220060914e-58, 'kcalmol\\x88\\x92_kcalmol\\x88\\x92': 9.148819220060914e-58, 'kcalmol\\x88\\x92': 9.148819220060914e-58, 'kcalmol\\x88\\x92_kcalmol_kcalmol_kcalmol_kcalmol\\x88\\x92_kcalmol_kcalmol\\x88\\x92_kcalmol_kcalmol_kcalmol_kcalmol\\x88\\x92': 9.148819220060914e-58, 'amet165': 9.148819220060914e-58, 'nonbond_interactions': 8.263922883666513e-55, 'interactions_aleu141_acys145': 1.1686951820486561e-54, 'interactions_fig_s2_table': 8.263922883666513e-55, 'hydrogen_donor_oxygen_acceptors': 8.263922883666513e-55, 'amet165_aglu166_aleu167_ofprotein': 8.263922883666513e-55, 'tan_etal': 0.0005216976804313235, 'shownthat_melatonin_derivatives': 8.50907406077656e-06, 'follow': 0.0016480626375926124, 'pneumonia_conclusionswe': 0.00039211751110906017, 'intensity_data': 0.00029817669559437587, 'acidarginineaarg188agln189glutamineathr190threonineglutamineagln192\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x88\\x92\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93\\x93helixturnhelixcoilturnturncoilturnsheetsheetsheetsheetcoilcoilcoilhelixhelixcoilcoilturnturncoilturnsheetsheetsheetsheetcoilturnsheetcoilhelixcoilcoilcoilcoilhelixsheetsheetsheetcoilturncoilcoilcoilcoilcoilwavefunction_studies': 9.148819220060914e-58, 'information_datahelped': 9.148819220060914e-58, 'destructionhence_clinicians': 9.148819220060914e-58, '0cn_alzaqri': 9.148819220060914e-58, 'bond_otherhydrophobichydrophobichydrophobichydrophobichydrogen': 9.148819220060914e-58, 'bondconventional_hydrogen_bondcarbon_bondpidonor_hydrogen_bond': 9.148819220060914e-58, 'bumpunfavorable_bumpunfavorable': 9.148819220060914e-58, 'bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bumpunfavorable_bonds_validation_visualization': 9.148819220060914e-58, 'to_address_basic_needs_in_the_laundromat_where_people_must_ _scramble_ _for_available_ _machines_and_ _keep_ _a_ _close_ _eye_on_ _their_laundry_waiting': 0.004315547045054443, 'eye': 0.0004111663773473564, 'pressure_pain_people': 9.148819220060914e-58, 'years_section_voucher_hearing': 9.148819220060914e-58, 'efficiency_michael_effort': 2.1512295790784834e-05, 'intervention_work': 9.148819220060914e-58, 'to_identify_and_rectify_the_sources_of_protracted_times_to': 9.148819220060914e-58, 'satisfaction_outcomes': 9.148819220060914e-58, 'michael_effort': 9.148819220060914e-58, '101016jsocscimed2020113296': 0.0004937738841714825, 'august_socialsciencemedicine2642020113296availableonline19august2020027795362020publishedbyelsevierltd': 8.05354405050968e-06, 'disparities_researchers': 9.148819220060914e-58, 'behavior_action': 9.148819220060914e-58, 'than_does_the_more_frequently_used_word_delay_when_contemporary_health_disparities_researchers_examine_patient_behavior_and_action_as_it_relates_to_the_timing_of_treatment_they_often_focus_on_patients\\x99_delaying_diagnostic_tests_or_treatments_while_understanding_ _why_ _a_ _person_ _might_ _delay_ _a_ _diagnostic_ _procedure_ _or_treatment_regimen_can_identify_barriers_eg_long_wait_times_on_phones_or_for_followup_procedures_a_lack_of_transportation_or_money_that_discourage_individuals_from_taking_more_immediate_actions_diamant_   _thinking_in_terms_of_delays': 9.148819220060914e-58, 'responsibility_blame': 9.148819220060914e-58, 'scheduling_her_followup': 8.770946583746331e-05, 'to_schedule_her_appointment\\x9d_ _and_ _though_ _waiting_ _can_ _lead_ _to_ _assumptions_ _about_passivity_or_nonaction_social_scientists': 8.770946583746331e-05, 'august_socialsciencemedicine2642020113296availableonline19august2020027795362020publishedbyelsevierltd_experience_responsibility_blame_to_schedule_her_appointment\\x9d_ _and_ _though_ _waiting_ _can_ _lead_ _to_ _assumptions_ _about_passivity_or_nonaction_social_scientists_insights': 8.05354405050968e-06, 'us_others': 1.8095693790022095e-05, 'experience_action': 0.004315547045054443, 'scholarships': 0.007713134335009549, 'elucidation_other': 0.0038806204677737646, 'using_neoliberal_ideologies_that_privilege_among_other_things_individual_responsibility_mulligan_ _rylkobauer_and_farmer_ ': 0.00016696661840576824, 'hierarchies_they': 6.82745641754355e-05, 'scenes': 0.0011075402231842013, 'hay': 0.0016480626375926124, 'sj¨oling_   _we_expand_this_by_focusing_on_how_chronic_illness_feels_while_waiting_on_powerful_others_to_make_life_or_death_decisions_while_wait_time_is_lived_people_also_live_during_their_wait_times': 0.001845170519318405, 'peoples\\x99_perceptions': 0.00210348072096923, 'to_ _navigate_ _shorten_ _or_otherwise_survive_waiting_and_also_to_anticipate_and_craft_possible_futures_within_the_relationality_and_power_dynamics_of_bureaucratic_time_resisting_wait_times_by_seeking_information_and_other_resources': 0.0004111663773473564, 'wait_times': 0.0004111663773473564, 'action_feels': 0.007713134335009549, 'carr_teucher_casson': 1.8090871199370374e-05, 'itself_eg_feelings': 2.2679944690512395e-05, 'lives': 9.148819220060914e-58, 'sj¨oling_   ': 9.148819220060914e-58, 'healthcare_bureaucracy': 0.0004111663773473564, 'work_requirements': 5.436345664496885e-05, 'welfare_programs': 0.0003364176984007392, 'waits': 0.0021132837087652597, 'medicaid': 0.004315547045054443, 'insurance_plans': 0.00040561912644835544, 'insurers': 9.148819220060914e-58, 'prescription_drug_benefit': 9.148819220060914e-58, 'medicaid_program': 0.00016366224760477066, 'louis_illinois_missouri': 2.66729078741002e-06, 'health_program': 0.0004111663773473564, 'recruitment_interviews': 0.00012040101594931771, 'methods_results': 0.007713134335009549, 'to_recruit_ _interview_participants_stratified_evenly_based_on_prescription_insurance_coverage_age_and_gender': 0.007713134335009549, 'community_anizations': 0.0001302587861229614, 'consent_interviewees': 1.0817675896114124e-05, 'note_taker': 9.148819220060914e-58, 'field_notes': 9.148819220060914e-58, 'conversations': 0.00015810430357204874, 'codebook_development': 0.007713134335009549, 'repetition': 6.292247267039724e-05, 'to_include_in_our_analysis_all_aspects_of_waiting_described_by_participants_rather_than_focus_on_just_one_eg_waiting_for_health_insurance_coverage': 0.007713134335009549, 'waiting_that_is_interrelated_and_different_from_the_temporal_distinctions_made_by_many_healthcare_practitioners': 0.0004111663773473564, 'decisions_emotions': 0.0010325216439875707, 'aspirations': 0.0010325216439875707, 'study_activities': 9.148819220060914e-58, 'university\\x99s_board_results': 9.148819220060914e-58, 'health_coverage': 4.373547284671339e-06, 'breadth': 0.007713134335009549, 'living_their_lives_within_structures_of_power_that_make_them_wait_socialsciencemedicine26420201132963_0caa_lee_                                                                                                                                                                                                                                     _waiting_for_what_big_and_small_waits_because_we_cover_multiple_forms_of_waiting_we_wish_to_be_specific_about_what_participants_referred_to_when_they_talked_about_waiting': 0.0004111663773473564, 'to_be_specific_about_what_participants_referred_to_when_they_talked_about_waiting': 0.007713134335009549, 'waiting_ _in_ _waiting_ _rooms_ _for_ _transportation_on_the_phone_for_surgery_for_paychecks_and_welfare_checks_for_housing_and_for_approval_for_disability_and_insurance_benefits_the_things_participants_waited_for_varied_according_to_their_own_unique_health_and_social_circumstances': 0.00210348072096923, 'bureaucracies': 1.0132034972112835e-52, 'demands': 5.849733118588048e-53, 'waiting_eg_disability': 0.004315547045054443, 'waiting_ _eg_ ': 0.004315547045054443, 'wait_times_ride': 8.263922883666513e-55, 'transportation_paycheck': 0.0006026042973632392, 'what_\\x98big': 0.007713134335009549, 'hopedfor_endpoint_ones': 0.004315547045054443, 'individual\\x99s_health_situation': 0.004315547045054443, 'discussions': 0.001945566440214154, 'news_is\\x93': 0.0013882295497307361, 'osteoarthritis_disease_hepatitis_c_depression': 8.770946583746331e-05, 'to_afford_housing': 8.770946583746331e-05, 'working_through_her_arthritis_pain': 8.770946583746331e-05, 'kate': 0.007713134335009549, 'to_consult_with_a_doctor_about_surgeries_she_waited_on_a_disability_hearing_scheduled_months_away_ _though_she_ _had_ _been_ _diagnosed_ _with_hepatitis_ _c_ _her_ _doctor': 8.770946583746331e-05, 'repercussions': 0.0002768434257340561, 'to_get_the_medication_kate_found_herself_waiting_a_lot_on_a_lot_the_interdependence_of_her_waiting': 0.0004499048194399722, 'herself': 9.148819220060914e-58, 'lot_interdependence': 9.148819220060914e-58, 'wait': 0.000739056865675974, 'health_needs_bill_payments': 8.770946583746331e-05, 'housing': 8.770946583746331e-05, 'application_delays': 9.148819220060914e-58, 'to_postponed_medical_treatments_without_getting_her_health_and_injuries_under_control_she_could_not_work_and_get_out_of_transitional_housing_for_kate': 9.148819220060914e-58, 'debt': 0.0013882295497307361, 'lawyers': 9.148819220060914e-58, 'waits_\\x93': 9.148819220060914e-58, 'want_to_go_to_the_hospital_it_costs_ ': 0.00016902585554135613, 'much\\x9d_participants': 5.167996752221038e-06, 'illness_strain': 0.00016696661840576824, 'kidneys': 1.8116892083331244e-05, 'dialysis': 0.00012198022841850962, 'medicaid_coverage': 1.2058076296320673e-05, 'car_way': 0.00015266313713209798, 'to_be_picked_up_by_a_medicaidcovered_transportation_company': 0.00012198022841850962, 'to_wait_at_the_clinic_when_they_were_late': 0.00012198022841850962, 'to_pay_for_his_own_cab_or_push_back_his_dialysis_appointment_to_later_in_the_day_and_wait': 0.00012198022841850962, 'allen': 8.263922883666513e-55, 'promise_man': 0.00017630719280704974, 'waiting_period': 9.09486045015627e-06, 'tactics': 0.0005574854210405992, 'healthcare_ _holding_ _off_ _certain_ _appointments_ _until_ _that_ _time': 0.0013882295497307361, '\\x9cin': 0.00023791614304068028, 'to_wait_by_social_service_programs_appointment_schedules_hospital_and_clinic_waiting_rooms_insurance_company_call_centers': 0.0013882295497307361, 'waiting': 9.148819220060914e-58, '0caa_daytoday_lives': 9.148819220060914e-58, 'to_wait': 0.0013882295497307361, 'to_spend_a_lot_of_time_with_you': 0.001388599458763146, 'suspicions': 0.0005144405227900619, 'waiting_game': 0.0013882295497307361, '\\x9cthey': 2.2673179907113364e-05, 'theythey\\x99ve': 9.148819220060914e-58, 'to_make_a_living': 9.148819220060914e-58, 'on\\x9d': 0.0013882295497307361, 'patientprovider_dynamics': 0.0004111663773473564, 'bit': 4.545666881145652e-05, 'to_withhold_resources_by_imposing_waiting': 2.3834955310101007e-05, 'rachel': 0.00040928894108187346, 'taxes_her': 8.770946583746331e-05, 'taxes': 8.770946583746331e-05, 'welfare_system': 0.0001464675901650216, 'officer': 9.148819220060914e-58, 'michael_brown': 9.148819220060914e-58, 'application_processes': 0.0013882295497307361, 'to_give_it_to_you': 0.0013882295497307361, 'it\\x9d': 0.00016902585554135613, 'optimism': 0.0010298344840079976, 'saying_i_was_too_young_to_have_problems_i_had_you_know': 0.0015253533121186412, 'going_through_this': 0.0004499048194399722, 'length_types': 0.004315547045054443, 'to_say_racism_\\x93_but_just_unfair_treatment': 0.0004499048194399722, 'i\\x99m_voice_breaking_rachel\\x99s_doctors': 0.0001821419182435067, 'to_apply_for_disability': 8.770946583746331e-05, 'phases_phase': 0.0019127833147525456, 'toevaluate_adherences_deviations': 0.004315547045054443, 'to_determine_the_impactof_the_service_modiï¬\\x81cations_on_the_longterm_cancer_speciï¬\\x81c_outcomes_compared_to_the_national_standards_phase_ ': 0.004315547045054443, 'to_predict_costs_attributable_to_the_modiï¬\\x81cations_of_the_crc_services_and_additionalresources_required_to_treat_patients_whose_treatment_has_been_affected_by_the_pandemic_phase_ _aims_tocompare_the_impact_of_covid19_on_the_nhs_and_usa_model_of_healthcare_in_terms_of_service_provisionand_cost_and_to_propose_a_standardised_model_of_delivering_colorectal_cancer_services_for_future_outbreaksethics_and_dissemination_this_study_is_a_service_evaluation_and_does_not_require_hra_approval_or_ethicalapproval_in_the_uk_local_service_evaluation_registration_is_required_for_each_participating_centre_in_theusa_ethical_approval_was_granted_by_the_research_and_development_committee_the_results_of_thisstudy_will_be_disseminated_to_stakeholders_submitted_for_peer_review_publications_conference_presentations_and_circulated_via_social_mediaregistration_details_nil_ ': 0.00010800783433475696, 'tocompare_the_impact_of_covid19_on_the_nhs_and_usa_model_of_healthcare_in_terms_of_service_provisionand_cost_and_to_propose_a_standardised_model_of_delivering_colorectal_cancer_services_for_future_outbreaksethics_and_dissemination_this_study_is_a_service_evaluation_and_does_not_require_hra_approval_or_ethicalapproval_in_the_uk_local_service_evaluation_registration_is_required_for_each_participating_centre_in_theusa_ethical_approval_was_granted_by_the_research_and_development_committee_the_results_of_thisstudy_will_be_disseminated_to_stakeholders_submitted_for_peer_review_publications_conference_presentations_and_circulated_via_social_mediaregistration_details_nil_ ': 0.0003519185601107666, 'impact_phases_phase_to_predict_costs_attributable_to_the_modiï¬\\x81cations_of_the_crc_services_and_additionalresources_required_to_treat_patients_whose_treatment_has_been_affected_by_the_pandemic_phase_ _aims_tocompare_the_impact_of_covid19_on_the_nhs_and_usa_model_of_healthcare_in_terms_of_service_provisionand_cost_and_to_propose_a_standardised_model_of_delivering_colorectal_cancer_services_for_future_outbreaksethics_and_dissemination_this_study_is_a_service_evaluation_and_does_not_require_hra_approval_or_ethicalapproval_in_the_uk_local_service_evaluation_registration_is_required_for_each_participating_centre_in_theusa_ethical_approval_was_granted_by_the_research_and_development_committee_the_results_of_thisstudy_will_be_disseminated_to_stakeholders_submitted_for_peer_review_publications_conference_presentations_and_circulated_via_social_mediaregistration_details_nil_ _impact_number_toserviceprovision_standards_challenging101016jisjp20200700524683574': 0.00010800783433475696, 'toserviceprovision': 0.00010800783433475696, 'challenging101016jisjp20200700524683574': 0.00010800783433475696, 'courtney_international': 9.148819220060914e-58, 'uk': 9.148819220060914e-58, 'thecrisis': 9.148819220060914e-58, 'predicting_the_economic_impact_and_planningfor_this': 9.148819220060914e-58, 'hopedthat': 0.0004017220894362599, 'hopedthat_gaining_insights_from_both_perspectives': 0.0002559111248677476, 'colorectal_units': 9.148819220060914e-58, 'to_participate_all_study_and_recruitment_information': 9.148819220060914e-58, 'to_develop_the_tool': 1.7664947146720627e-07, 'beenmodiï¬\\x81ed': 0.00210348072096923, 'to_develop_the_tool_beenmodiï¬\\x81ed_questionsphase': 6.57787946655082e-05, 'questionsphase': 6.57787946655082e-05, 'responsibilityof': 9.148819220060914e-58, 'businessschools': 9.148819220060914e-58, 'leadphase': 0.0001497505750522014, 'covid19_0f': 0.0007129960827382031, '0ca_courtney_international_\\x93fig_phases': 0.0005741125271172155, 'collectionall_surveys_data_collection': 9.148819220060914e-58, 'gdpr_requirementsand': 9.148819220060914e-58, 'identiï¬\\x81able_data': 9.148819220060914e-58, 'approach_gdpr_requirementsand': 9.148819220060914e-58, 'checked': 0.001305640894603878, 'using_redcap_electronic_data_capture_tool_hostedat': 2.129568037946594e-05, 'audit_trails': 0.0014616190772430405, 'using_redcap_electronic_data_capture_tool_hostedat_toensure_data_accuracy_estimate_impact_diagnosis_staging_treatment_them': 0.0014833099199288574, 'data_validator': 9.148819220060914e-58, 'toensure_data_accuracy': 9.148819220060914e-58, 'where': 1.3461225584073894e-05, 'ofservice_provision': 2.198193090808916e-07, 'using_appropriatesummary_statistics': 0.00033936015038966223, 'using_unsupervised_learningkmeans_and_hierarchical_clustering_to_identify_clusters_of_homogeneous_response_to_the_pandemicphase_ _every_month_participating_centres': 0.00033936015038966223, 'baselineestimate': 2.4211290297431722e-05, 'timeseries_methods_data': 0.007713134335009549, 'methodologywill': 9.148819220060914e-58, 'to_predict_the_impact_of_the_pandemic_on_the_incidenceand_prevalence_of_different_colorectal_cancer_stages_in_the_following_ _months_under_different_scenarios_predictions': 9.148819220060914e-58, 'levelphase': 0.0003519185601107666, 'willallow_prediction_information': 0.0016831502933817382, 'to_gofurther_by_understanding_the_effects_of_diagnostic_and_treatmentdelay_by_prospective_data_collection_of_cancer_cases': 0.007713134335009549, 'diagnosis_staging_treatment': 2.129568037946594e-05, 'to_restore': 4.4365721048409436e-05, 'ethics_disseminationthis_study': 0.0010068765747081726, 'permission_tocommencement': 9.148819220060914e-58, 'hraapproval_approval': 9.148819220060914e-58, 'to_be_afterthe_routine_service_provision': 0.0038806204677737646, 'conferences_circumstances': 0.0014616190772430405, 'proposal': 0.0019127833147525456, 'project_piall_authors': 1.1686951820486561e-54, 'commented_on': 8.263922883666513e-55, 'study_designthe_protocol_manuscriptfundingthis_research': 8.263922883666513e-55, 'work_dashboard': 0.00015259049938488466, 'wwwbsgukcovid19adviceendoscopyactivityandcovid19bsgandjagguidance': 1.1686951820486561e-54, 'nhs_improvement_letter_gp_practices_carenetworks_providers_national_institute_cancernice_guideline_karandikar_bmoran_association_colorectal_dis_suppl_k_leong_j_karandikar_association': 8.263922883666513e-55, 'royal_college': 9.148819220060914e-58, 'surgeryguidance': 9.148819220060914e-58, 'ng151_wwwniceukguidanceng151accessed': 2.274211562945482e-53, 'march_national_institute_cancerrecognition': 1.4055400435083287e-53, 'bach': 8.263922883666513e-55, 'kjmonahan_mr': 9.148819220060914e-58, 'bonnington': 9.148819220060914e-58, 'r_wong_b_hibbert_j_marsh': 1.1686951820486561e-54, 'society_audit': 8.263922883666513e-55, '\\x93_courtney_international_report': 8.263922883666513e-55, 'v20_wwwnbocaukcontentuploads202001nboca2019v20pdf': 9.148819220060914e-58, 'society_\\x93_courtney_international_report_audit': 9.148819220060914e-58, 'jg_conde_researchelectronic_data': 0.00027626151939488195, 'support_jbiomed': 0.00015266313713209798, 'nboca_datagov': 9.148819220060914e-58, 'saving_lives': 9.148819220060914e-58, 'nothing_history_tsai_effect': 0.0004499048194399722, 't_price_time': 9.148819220060914e-58, 'to_survival_bmj_open_   _e031421_ _cancer_research_uk_bowel_cancersurvivalstatistics_ _wwwcancerresearchukhealthprofessionalcancerstatisticsstatisticsbycancertypebowelcancersurvival': 9.148819220060914e-58, 'thescreening': 0.0003377049630876618, 'cthrc1': 0.004570250198311505, 'cellmigration_cthrc1': 0.00024319213232429102, 'pathways_wound_healing': 3.967722470790786e-06, 'protein_cthrc1': 9.148819220060914e-58, 'inmultiple_pathophysiologies': 9.148819220060914e-58, 'cc_ccoohfigure_construct': 9.96725951112108e-05, 'acollagen_domain': 0.0004254422540019666, 'cysteine_residues': 0.0004254422540019666, 'exonsin_humans_exons': 0.00210348072096923, 'strand_species': 0.00210348072096923, 'weightcomplexes': 7.45913757369631e-05, 'to_tether_to_the_cell_membrane': 0.0007008712380191807, 'collagen_motif': 9.148819220060914e-58, 'presents': 9.148819220060914e-58, 'molecularweight': 9.148819220060914e-58, 'to_be_largerthan_that_of_cellular_cthrc1_ _kda_cthrc1': 9.148819220060914e-58, 'collagenlike_motif_increase_node_disease_prognosis': 8.49544989746772e-05, 'ofalsoand': 9.148819220060914e-58, 'collagenlike_motif': 9.148819220060914e-58, 'atthe_nterminus_inhibition': 7.45913757369631e-05, 'cthrc1might': 9.148819220060914e-58, 'biologicalthrough_proteolyticprocessingactivity': 9.148819220060914e-58, 'expression_to_be_replaced_with_a_galactosidase_expression_construct_which_demonstrated_the_expression_of_cthrc1_in_inner_ear_hair_cells_  _there': 7.45913757369631e-05, 'to_be_replaced_with_a_galactosidase_expression_construct_which_demonstrated_the_expression_of_cthrc1_in_inner_ear_hair_cells_  _there': 7.45913757369631e-05, 'iscthrc1_expression': 1.3867882487002001e-06, 'tgf_collagen_synthesis': 0.00033740963351282444, 'cthrc1_expression': 5.502154893106082e-06, 'node_disease_prognosis': 0.0016810521528134112, 'nonsmallcell_lung_carcinoma': 4.4423405374281965e-05, 'mrna_translation_process': 0.004315547045054443, 'gsk3catenin_signal': 0.00210348072096923, 'cellproliferation_invasion_migration': 0.00210348072096923, 'mir30ccan': 9.148819220060914e-58, 'baxcaspase9caspase3_downstreamsignal': 9.148819220060914e-58, 'signalingto': 7.461125779559984e-05, 'carcinoma_formation_mir9': 0.00017939106177220415, 'mir520d5pis': 0.0019161086228512664, 'proliferation_migration_invasion_cthrc1_asa_tumor_suppressor_gene_expression': 3.1274296317457834e-05, 'let7b': 7.45913757369631e-05, 'asa_tumor_suppressor_gene': 3.1274296317457834e-05, 'ofcthrc1_mir30': 3.1235511726865175e-05, 'signal_molecules': 0.0019132930105159865, 'overexpression_silencedownstream_cthrc1': 0.0007035667068513752, 'partof_cthrc1': 9.148819220060914e-58, 'waif1_receptor_researchsuggests': 9.148819220060914e-58, 'waifi_expression': 9.148819220060914e-58, 'suppressingmethylation': 9.148819220060914e-58, 'waif1': 0.0016810521528134112, 'enzyme_ratelimiting': 0.004315547045054443, 'expressionand_activity': 0.00018383646965595502, 'figure_properties\\x99': 0.0015842910551982499, 'isquite_complex': 1.0321324465787215e-05, 'pathway_pathway': 8.263922883666513e-55, 'pathway_pathway_gtpase_familysuch': 0.00018383646965595502, 'gtpase_familysuch': 0.00018383646965595502, 'pathway_rac1_fak': 0.0002990919339695472, 'mmp14_expression': 1.0883881378113255e-05, 'andthat': 0.0004738574283430153, 'change_mmp2mmp9_expression_hif1Î±_vegf': 1.4055400435083287e-53, 'bycthrc1': 2.274211562945482e-53, 'angiogenesis_cthrc1': 0.0038806204677737646, 'reepithelialization_ecm_superfamily_members': 9.148819220060914e-58, 'tgf_activin_bmps': 9.148819220060914e-58, 'signalingcthrc1': 1.0329580945349487e-05, 'to_have_a_relationship_withthe_tgf_family_since_its_discovery_as_their_expression_sitesoverlap_significantly_tgf1_and_bmp4_can_induce_thetranscription_and_expression_of_cthrc1_in_nih3t3_cells_ _cthrc1_can_activate_tgf_signaling_via_an_elevationin_smad2smad3_phosphorylation_activated_smad23_formsa_complex_with_smad4_and_accumulates_in_the_nucleus_causing_an_increase_in_collagen_type_i_deposition_during_vascularremodeling_[_loop_migration_invasioncharacteristics': 1.6849901529262125e-07, 'to_have_a_relationship_withthe_tgf_family_since_its_discovery_as_their_expression_sitesoverlap_significantly_tgf1_and_bmp4_can_induce_thetranscription_and_expression_of_cthrc1_in_nih3t3_cells_ _cthrc1_can_activate_tgf_signaling_via_an_elevationin_smad2smad3_phosphorylation_activated_smad23_formsa_complex_with_smad4_and_accumulates_in_the_nucleus_causing_an_increase_in_collagen_type_i_deposition_during_vascularremodeling_[': 1.6849901529262125e-07, 'expression_sitesoverlap': 8.263922883666513e-55, 'thetranscription_expression': 1.1686951820486561e-54, 'bmp4': 8.263922883666513e-55, 'cells_cthrc1': 9.148819220060914e-58, 'tgf_signaling_formsa_complex_deposition': 9.148819220060914e-58, 'collagen_deposition_tgf': 0.0038806204677737646, 'migration_invasioncharacteristics': 1.6849901529262125e-07, 'transition_emt_tumor_metastasis': 0.0006674076661460604, 'collagen_synthesis_metabolites': 7.45913757369631e-05, 'cthrc1_tgf_pathway': 9.148819220060914e-58, 'disputes_regulation': 9.148819220060914e-58, 'pathwaysto': 6.934054137440991e-05, 'metastasis_glycoproteins': 9.148819220060914e-58, 'wnt1_wnt1': 9.148819220060914e-58, 'tumors_wntproteins': 9.148819220060914e-58, 'noncanonicalamongwhich': 9.148819220060914e-58, 'lrp56_coreceptor_ck1Î±glycogen_synthase_kinase_polyposis_coli': 7.890105016352806e-05, 'enhancer_factorlef': 6.0751388053683764e-52, 'cytosolic_catenin': 9.148819220060914e-58, 'rasproteins': 9.148819220060914e-58, 'proteins_plasma_membrane': 3.287841426025112e-52, 'signalregulated_kinaseerk_cascade': 3.287841426025112e-52, 'expression_oftargetgenes': 2.012919707845018e-05, 'ccnd1_gene': 9.148819220060914e-58, 'cyclin_factor_receptor': 9.148819220060914e-58, 'lgr5_pathway': 0.0015973211543402718, 'translocation_ofcatenin': 1.1753494793657272e-05, 'role_factor_bfgf_expression_catenin_nucleartranslocation_inducestranscription_cell_adhesion_proliferation_cell_invasion_metastasis_wntpcp_pathway': 0.0007203187631517679, 'catenintcf_transcriptional_metastasis': 0.0006940543140455221, 'similarlycthrc1': 9.148819220060914e-58, 'snail1': 9.148819220060914e-58, 'to_bone_in_advanced_stages_cthrc1secreted_by_osteoclasts': 0.00210348072096923, 'factor_bfgf_expression': 2.607254101404241e-05, 'tumors_cthrc1': 9.148819220060914e-58, 'catenin_nucleartranslocation_inducestranscription': 9.148819220060914e-58, 'proliferation_cell_invasion_metastasis': 2.607254101404241e-05, 'catenincould': 6.463172286286948e-05, 'wntpcp_pathway': 2.607254101404241e-05, 'it_papillomavirushpv': 1.284690556057437e-52, 'to_activate_the_noncanonical_wntpcp_pathway': 7.417164383651313e-53, 'pcp': 7.45913757369631e-05, 'development_cthrc1': 0.00035695096505492413, 'tumor_malignancy': 7.417164383651313e-53, 'to_activate_the_noncanonical_wntpcp_pathway_tumor_malignancy_cellinvasion_andmetastasis': 4.840409146238793e-05, 'cellinvasion_andmetastasis': 7.417164383651313e-53, 'erk_jnkphosphorylation': 7.45913757369631e-05, 'paracrine_cthrc1': 0.0016810521528134112, 'pathwaysis_moretumorthe_cthrc1': 7.61239878666706e-05, 'series_cascades': 1.2419317476611128e-06, 'integrin_faksrc_signaling_pathway': 9.148819220060914e-58, 'aretransmembrane_receptors': 9.148819220060914e-58, 'cellecm_adhesion': 0.004315547045054443, 'ina_variety': 0.00210348072096923, 'andincreases_cell_survival': 7.45913757369631e-05, 'targeting_the_integrin_3fak_signaling_couldenhance_the_antitumor_activity_and_attenuate_cancermetastasiscancernsclc_and_escc_guo': 0.0015851357451168175, 'phosphorylationat_tyr397_role': 2.588047757257658e-05, 'phosphorylationat_tyr397': 2.5873582767864894e-05, 'srccan': 4.224012241806159e-07, 'fak': 0.0038816547305533795, 'src_paxillin': 6.341351419432926e-05, 'adaptor_molecule': 1.0342627796149705e-06, 'paxillin': 9.148819220060914e-58, 'rac1which': 9.148819220060914e-58, 'paxillin_phosphorylation': 9.148819220060914e-58, 'fakadhesion': 9.148819220060914e-58, 'interaction_results': 0.0006993992070543573, 'cell_adhesion_thedevelopment': 0.0038806204677737646, 'mekerk_pi3kakterk': 1.1409928915704967e-05, 'src': 9.148819220060914e-58, 'fak_sites': 9.148819220060914e-58, 'akt_cascades': 1.7783700196740192e-07, 'response_cthrc1': 9.148819220060914e-58, 'fosrelatedantigen1_fra1': 9.148819220060914e-58, 'family_transcription': 1.7783700196740192e-07, 'knockingdown_cthrc1': 0.0006335302641209558, 'gene_kim': 1.3306110954394186e-12, 'the_gene_kim_  _tested_the_luciferase_reporter_geneusing_the_erkresponsive_elk1_promoter_proposing_thatcthrc1_upregulates_mmp9_through_erk_activation_further_treatment_with_mek12_inhibitors': 6.0751388053683764e-52, 'tumorcell_invasion_erk_activation_aggressiveness': 3.287841426025112e-52, 'change_mmp2mmp9_expression': 0.0038806204677737646, 'carcinoma_hbv': 1.1686951820486561e-54, 'tumorcell_invasion_erk_activation_aggressiveness_invasiveness_metastasis_b_nfÎºb_creb_formation_migration_invasion_mmp9_angiogenesis_whatstudies': 8.263922883666513e-55, 'b_nfÎºb_creb': 8.263922883666513e-55, 'morecthrc1': 9.148819220060914e-58, 'formation_migration_invasion': 9.148819220060914e-58, 'mmp9_angiogenesis_whatstudies': 3.287841426025112e-52, 'alter_mmp9_expression_or_phosphorylate_mek_theinvasionpromoting_eï¬ect_of_cthrc1_on_eoc_cells_dependson_downstream_pi3kakt_and_erk12_signaling_dominatedby_egfr_  _besides_the_invasion_and_metastasis_of_endometrial_cancer_are_closely_related_to_the_upregulation_ofcthrc1mediated_cx3cr1_in_macrophages_this_processregulates_the_integrin_3pi3kakt_pathway_which_alsopromotes_the_recruitment_of_m2like_macrophages_  _cthrc1_activates_hifÎ±_pathway_and_contributes_totumor_angiogenesis_as_mentioned_above_cthrc1_in_hepatocellular_carcinoma': 9.148819220060914e-58, 'hif1Î±_expressionfurthermore': 9.148819220060914e-58, 'hifÎ±_pathway': 6.791732992330931e-05, 'totumor_angiogenesis': 6.791732992330931e-05, 'carcinoma_hif1Î±overexpression': 9.148819220060914e-58, 'upregulation_induceslymphangiogenesis_cell_invasion': 9.148819220060914e-58, 'inthe_nucleus': 9.148819220060914e-58, 'cxcr4': 9.148819220060914e-58, '´': 0.00047983738574547787, 'wntcatenin_pathwayin_cancer_cells': 5.4724502518353575e-05, 'wntcatenin_pathwayin_cancer_cells_phosphatase_alp_activity_pkcÎ_role_it_table_conclusiontumor_development_metastasis': 0.0021447153263177573, 'pkcÎ´phosphorylation': 9.148819220060914e-58, 'mek_inhibition_inhibition': 9.148819220060914e-58, 'enzymethat': 1.4055400435083287e-53, 'pkcÎ': 2.274211562945482e-53, 'phosphatase_alp_activity': 5.4724502518353575e-05, 'pkcÎ´signal': 0.0015842910551982499, 'brieï¬\\x82y_cthrc1': 3.50119831610517e-05, 'table_conclusiontumor_development_metastasis': 0.00023078931020485309, 'cell_adhesion_degradation': 3.50119831610517e-05, 'cthrc1_gene': 0.0004294386118539378, 'thoughcthrc1': 0.0004294386118539378, 'countriesgreen_tea': 9.148819220060914e-58, 'caï¬eine_and_polyphenolic_compoundsknown': 9.148819220060914e-58, 'egcgcould': 0.0007862569594425692, 'body_ofevidence': 1.1686951820486561e-54, 'to_demonstrate_a_variety_of_harmfuleï¬ects_from_excessive_consumption_of_green_tea_or_oraladministration_of_highdose_egcg_supplement_  _highdoses_of_egcg': 8.263922883666513e-55, 'cytotoxicity_eï¬ective_dosage': 8.263922883666513e-55, 'structureactivity_relationshipstudies': 0.0005248377111845071, 'number_location': 8.263922883666513e-55, 'remarkablepotential': 1.1686951820486561e-54, 'ion_theseabilities': 8.263922883666513e-55, '1b_catechol_structure': 0.0001492979911074831, 'oxygen_radicals_o2\\x8b_egcg_amountsperoxide': 2.738987127383607e-05, 'radicals_o2\\x8b_egcg': 2.4352808065248774e-06, 'amountsperoxide': 2.4352808065248774e-06, 'egcgmolecule': 1.1686951820486561e-54, 'h2o2_molecules_inphosphate_buï¬er_o2autooxidation': 8.263922883666513e-55, 'ros_theros': 8.263922883666513e-55, 'prooxidant_prophylactic_therapeutic_eï¬\\x83cacy': 8.608211748926757e-07, 'dna_strandbreakage': 0.00210348072096923, 'prooxidant': 1.7818661480031832e-08, 'role_antibacterial': 0.0016480626375926124, 'naturalproduct': 7.417164383651313e-53, 'prophylactic_therapeutic_eï¬\\x83cacy': 8.608211748926757e-07, 'to_accountfor_the_inhibitory_action_ofegcg_against_cancer_formation_and_growth': 0.0004405647755333974, 'to_be_potential_mechanisms_for_anticancer_action_the_anticancer_mechanismsvaried': 0.0003692335358126249, 'intracellularstresses': 0.0005423312279404596, 'activity_mightcontribute': 1.9603661493694067e-09, 'genomic_fragmentation_chen': 9.148819220060914e-58, 'fragmentation_assay': 9.148819220060914e-58, 'egcg': 0.0009380893766565956, 'cohboautooxidation·egcgoh\\x93o2h2o2ohboooquinonefigure': 2.6246699260249066e-06, 'chain_reaction_formation': 0.00016089374535730906, 'contribution_stress': 0.0011125787591309202, 'to_result_in_the_stimulationof_mitogenactivated_protein_kinase_mapk_  _themapk_signaling': 0.0006940543140455221, 'kinase_jnks_andp38': 0.0002304655499229112, 'response_egcg': 0.0002821774092107797, 'fenton_reactionto_form_hydroxyl_radicals': 1.53025207535977e-05, 'induced_dna_damagein_hl60_cells_as_8oxo78dihydro2²deoxyguanosine_oxodg_content_increased_which_was_a_characteristic_ofoxidative_dna_damage_  _nevertheless_no_significantincrease_in_8oxodg_was_observed_in_h2o2resistant_colonhp100_cells_suggesting_that_h2o2_was_involved_in_cellulardna_damage_egcg': 9.148819220060914e-58, 'proliferation_andinduce_apoptosis': 9.148819220060914e-58, 'dna_breakage': 9.148819220060914e-58, 'mobilization': 9.148819220060914e-58, 'agentleading_todna_breakage_in_the_nuclei': 0.0001264628547598116, 'malignancies_egcg': 9.148819220060914e-58, 'cancer_celldeath': 9.148819220060914e-58, 'cell_proliferation_apoptosis_apoptosis': 9.148819220060914e-58, 'medicine_longevitycell_line': 9.148819220060914e-58, 'kyse_   _one_possible_explanation_is_thath2o2_produced_from_egcg_autooxidation_in_the_cell_culturemedium': 7.05029712940268e-05, 'egfr': 0.004316696915208163, 'thategcg': 9.148819220060914e-58, 'stress_these': 9.148819220060914e-58, 'checkedand': 3.7189724366101935e-06, 'to_be_more_than_ _Î¼m': 0.00022777044722615736, 'byegcg': 0.00014353688113946252, 'uptake_egcg': 9.148819220060914e-58, 'ctr1expression': 9.148819220060914e-58, 'potency_iron': 2.341804767742033e-06, 'egcghas': 9.148819220060914e-58, 'to_generate_i_extracellular_ros_via_autooxidative_reaction_in_the_cell_culture_medium_ii_ros_in_cellular_mitochondria_and_iii_intracellular_ros_through_thefenton_reaction_upon_cell_entry_figure_ ': 9.148819220060914e-58, 'contribute': 4.57056091239336e-06, 'to_be_one_factor_aï¬ectingthe_ros_production_ability_of_egcg_future_research_willbe_required_to_determine_if_egcg_is_a_much_more_potentros_inducer_in_diï¬erentiated_than_in_undiï¬erentiated_cancercells': 0.0002801107957677198, 'adipocyte_death': 1.53025207535977e-05, 'cell_viability_to_raise_ros_level_anddescend_gsh_level_in_preadipocytes_and_adipocytes': 0.0007008712380191807, 'to_raise_ros_level_anddescend_gsh_level_in_preadipocytes_and_adipocytes': 0.0007008712380191807, 'kinase_ampk': 9.148819220060914e-58, 'kinase_hwang': 9.148819220060914e-58, 'catabolicpathway': 0.0006940543140455221, 'pathways_catabolicpathway_gluconeogenesis_expressionof_synthesis_proteins_lipid_catabolismproteins': 0.0006940543140455221, 'expressionof_synthesis_proteins': 0.0006940543140455221, 'lipid_catabolismproteins': 0.0006940543140455221, 'receptor_gamma_pparÎ³': 1.6805631307987923e-47, 'cpt1acad_pgc1ð\\x9d\\x9b¼ucps_atglfat_synthesislipid_catabolismantiobesityfigure_eï¬ects_peroxisome': 0.0012480679915542437, 'coactivator1Î±_pgc1Î±': 2.0368140554468443e-05, 'ampk_genes_protein_expression_signal_transduction': 0.0002821774092107797, 'coactivator1Î±_pgc1Î±_activity_inhibition': 0.00020329019466379467, 'damage_h2o2': 0.0003692335358126249, 'to_play_an_indispensable_role_in_the_bactericidal_actions_of_egcg': 2.341804767742033e-06, 'op50_strain_growth_action': 0.0003954048337911556, 'katgand_soda_expression': 6.444818689290265e-06, 'studiesegcg': 9.148819220060914e-58, 'to_have_broad_antibacterial_spectrumeï¬ects_on_both_grampositive_and_gramnegative_bacterianevertheless_egcg_might_function_through_diï¬erent_mechanisms_against_grampositive_and_gramnegative_bacteriaintracellular_ros_level_was_determined_by_ï¬\\x82ow_cytometrythe_results': 9.148819220060914e-58, 'ï¬\\x82ow_cytometrythe_results': 0.0004405647755333974, 'thebinding_abilityof_to_attack_the_lipid_bilayer_of_bacterialcell_membranes_leading_to_physical_disruption_of_the_membrane_  _as_for_the_cell_walls_results_from_atomic_forcemicroscopy_katgand_soda_expression_to_control_protein_homeostasis_in_the_cellenvelope_when_e_coli_was_exposed_to_egcg_apoptosis_diversity_drug': 0.0016794620467492141, 'destruction': 0.0038806204677737646, 'bioï¬\\x81lms_egcg': 9.148819220060914e-58, 'to_attack_the_lipid_bilayer_of_bacterialcell_membranes_leading_to_physical_disruption_of_the_membrane_  _as_for_the_cell_walls_results_from_atomic_forcemicroscopy': 9.148819220060914e-58, 'katgand_soxrs': 9.148819220060914e-58, 'soda': 9.148819220060914e-58, 'results_cpxsystem': 9.148819220060914e-58, 'to_control_protein_homeostasis_in_the_cellenvelope_when_e_coli_was_exposed_to_egcg_apoptosis': 9.148819220060914e-58, 'stress_regulator': 0.0006054349545841993, 'ofbactericidal_eï¬ect': 0.00210348072096923, 'fungicides': 0.00210348072096923, 'years_egcg': 9.148819220060914e-58, 'market_queriesthe_prooxidant_eï¬ect': 9.148819220060914e-58, 'queriesthe_prooxidant_eï¬ect': 0.00022279184197799345, 'governments': 9.148819220060914e-58, 'marketing': 9.148819220060914e-58, 'rat_hepatocytes': 0.002104041233387171, 'level_egcg': 3.4348996837103175e-05, 'swissalbino': 9.148819220060914e-58, 'andmalekunmingmice': 9.148819220060914e-58, 'il10_hepatic': 9.148819220060914e-58, 'nrf2target_gene_expression': 9.148819220060914e-58, 'rescue_response': 2.516404898630125e-52, 'andthe_nrf2_pathway': 4.496068198240745e-51, 'nrf2_target_genes': 2.2480340991203723e-51, 'mouse_survival': 0.0010298344840079976, 'mda_mt_increasedsingle_dosealt': 2.2480340991203723e-51, '108fold_mouse_survival': 2.2480340991203723e-51, 'egcg2²cysteine_egcg2³cysteine': 2.2480340991203723e-51, 'alt_activity': 3.4348996837103175e-05, 'nrf2_target_genes_mouse_survival_mda_mt_increasedsingle_dosealt_108fold_mouse_survival_egcg2²cysteine_egcg2³cysteine': 0.002104041233387171, 'egcg2²cysteinyl': 0.0005414567145434454, 'h_degcg_thiol': 8.833114682035859e-06, 'egcg2³cysteinyl': 8.833114682035859e-06, 'hepaticnecrosis_occurredamount': 9.148819220060914e-58, 'to_form_oquinonewhich': 9.148819220060914e-58, 'thiol': 9.148819220060914e-58, 'egcg2²cysteinyl_egcg2²²cysteinyl': 9.148819220060914e-58, 'ofand_egcg2²²egcg': 3.7189724366101935e-06, 'protein1keap1': 0.00022777044722615736, 'toresult': 0.00025761770367047364, 'states_nrf2': 1.8805649394408524e-08, 'doses_mgkg_ip': 0.0002502080510071652, 'antioxidantenzymes_sod_cat_glutathione_peroxidase': 4.082385207903573e-06, 'antioxidantenzymes_sod_cat_glutathione_peroxidase_damage': 0.0016810521528134112, 'to_display_anticancer_effects_on_a_variety_of_malignancies': 6.661063020059847e-07, 'rg3': 0.009410877330066942, 'whether_rg3_synergizes_the_effect_of_5fu_to_inhibit_the_growth_of_human_colon_cancer': 9.148819220060914e-58, 'to_display_anticancer_effects_on_a_variety_of_malignancies_to_ascertain_whether_rg3_is_able_to_enhance_the_anticolon_cancer_effect_of_5fu_the_results_revealed_that_combined_treatment_of_rg3_and_\\x91fu_significantly_enhanced_the_inhibition_of_the_proliferation_colony_formation_invasion_and_migration_of_human_colon_cancer_cells_sw620_and_lovo': 9.148819220060914e-58, 'to_ascertain_whether_rg3_is_able_to_enhance_the_anticolon_cancer_effect_of_5fu_the_results_revealed_that_combined_treatment_of_rg3_and_\\x91fu_significantly_enhanced_the_inhibition_of_the_proliferation_colony_formation_invasion_and_migration_of_human_colon_cancer_cells_sw620_and_lovo': 0.0019127833147525456, 'rg3_5fu': 0.0007129960827382031, 'vivo_rg3': 0.0028092143039891862, 'ginsenoside_rg3': 0.0006739906061774512, 'function_studies': 0.0014339292320376957, 'to_inhibit_the_migration_of_cancer_cells': 2.3401177044457218e-05, 'immunity_side_effects_drug_sensitivity_to_inhibit_the_migration_of_cancer_cells_effect_cell_apoptosis_cell_metastasis': 2.3401177044457218e-05, 'exhibits': 9.148819220060914e-58, 'to_activate_the_ampk_signaling_pathway_to_accelerate_apoptosis_in_colon_ _0chong_   _effects_of_ginsenoside_rg3_on_colon_cancercancer_cell_line_ht29_in_vitro_and_also_to_block_colon_cancer_progression_by_targeting_inhibition_of_cancer_stem_cells_and_tumor_angiogenesis_in_vivo_ _although_numerous_studies_have_shown_that_rg3_increases_the_efficacy_and_decreases_the_toxicity_of_chemotherapeutic_drugs_and_suppresses_the_chemotherapeutic_resistance_in_cancer_ _its_combination_with_chemotherapeutic_agent_\\x91fu_to_achieve_extra_benefits_in_anticolon_cancer_treatment_warrants_detailed_investigationin_the_present_study_the_effects_of_a_combined_treatment_of_rg3_and_5fu_on_the_biological_properties_of_sw620_and_lovo_cells_were_investigated_in_vivo_and_in_vitro_we_found_that_a_combined_treatment_of_rg3_and_5fu_not_only_enhanced_the_inhibition_of_colon_cancer_cell_proliferation_migration_and_invasion_but_also_promoted_apoptosis_of_colon_cancer_cells_and_arrested_the_cells_in_the_g0g1_phase_in_addition_it_was_also_found_that_rg3_could_synergize_the_capacity_of_5fu_to_inhibit_the_growth_of_human_colon_cancer_xenografts_in_nude_mouse_and_the_combined_treatment_of_rg3_and_5fu_enhanced_the_inhibition_of_the_pi3kakt_pathway_in_colon_cancer_cellsmaterials_and_methodscell_lines_and_agents_sw620_ccl\\x91_atcc_american_type_culture_collection_manassas_va_usa_and_lovo_ccl229_atcc_cell_lines_were_cultured_with_dmem_medium_ _cat_ _no_    _thermo_ _fisher_ _scientific_inc_ _supplemented_ _with_   _fetal_ _bovine_ _serum_ _fbs_cat_no_\\x91_thermo_fisher_scientific_inc_and_ _penicillinstreptomycin_cat_no_ _thermo_fisher_scientific_inc_the_cell_lines_used_in_the_present_study_were_cultured_at_Ë\\x9ac_with_ _co2rg3_cat_no_ _sigmaaldrich_merck_kgaa_and_5fu_cat_no_ _sigmaaldrich_merck_kgaa': 9.148819220060914e-58, 'treatment_warrants': 0.0019127833147525456, 'treatment_5fu': 0.002211618203923604, 'ccl\\x91_collection_manassas_va_usa_lovo_ccl229_cell_lines': 0.00015381177755799735, 'capacity_inhibition_ccl\\x91_collection_manassas_va_usa_lovo_ccl229_cell_lines': 1.1438778072363615e-05, 'to_activate_the_ampk_signaling_pathway_to_accelerate_apoptosis_in_colon_ _0chong_   _effects_of_ginsenoside_rg3_on_colon_cancercancer_cell_line_ht29_in_vitro_and_also_to_block_colon_cancer_progression_by_targeting_inhibition_of_cancer_stem_cells_and_tumor_angiogenesis_in_vivo_ _although_numerous_studies_have_shown_that_rg3_increases_the_efficacy_and_decreases_the_toxicity_of_chemotherapeutic_drugs_and_suppresses_the_chemotherapeutic_resistance_in_cancer_ _its_combination_with_chemotherapeutic_agent_\\x91fu_to_achieve_extra_benefits_in_anticolon_cancer_treatment_warrants_detailed_investigationin_the_present_study_the_effects_of_a_combined_treatment_of_rg3_and_5fu_on_the_biological_properties_of_sw620_and_lovo_cells_were_investigated_in_vivo_and_in_vitro_we_found_that_a_combined_treatment_of_rg3_and_5fu_not_only_enhanced_the_inhibition_of_colon_cancer_cell_proliferation_migration_and_invasion_but_also_promoted_apoptosis_of_colon_cancer_cells_and_arrested_the_cells_in_the_g0g1_phase_in_addition_it_was_also_found_that_rg3_could_synergize_the_capacity_of_5fu_to_inhibit_the_growth_of_human_colon_cancer_xenografts_in_nude_mouse_and_the_combined_treatment_of_rg3_and_5fu_enhanced_the_inhibition_of_the_pi3kakt_pathway_in_colon_cancer_cellsmaterials_and_methodscell_lines_and_agents_sw620_ccl\\x91_atcc_american_type_culture_collection_manassas_va_usa_and_lovo_ccl229_atcc_cell_lines_were_cultured_with_dmem_medium_ _cat_ _no_    _thermo_ _fisher_ _scientific_inc_ _supplemented_ _with_   _fetal_ _bovine_ _serum_ _fbs_cat_no_\\x91_thermo_fisher_scientific_inc_and_ _penicillinstreptomycin_cat_no_ _thermo_fisher_scientific_inc_the_cell_lines_used_in_the_present_study_were_cultured_at_Ë\\x9ac_with_ _co2rg3_cat_no_ _sigmaaldrich_merck_kgaa_and_5fu_cat_no_ _sigmaaldrich_merck_kgaa_rg3': 0.0006764722993640864, 'a_total_of_2x103_cellsml_were_seeded_in_6well_plates_with_ _ml_mediumwell_and_medium': 1.103353975485362e-05, 'cell_supernatant': 8.263922883666513e-55, 'using_a_plate_reader_elx808_bio\\x91tek_instrumentscell_colony_formation_assay': 1.1686951820486561e-54, 'added_density_od570': 8.263922883666513e-55, 'p0013c_beyotime_institute': 9.148819220060914e-58, 'to_extract_total_cellular_protein_and_the_bca_kit_cat': 9.148819220060914e-58, 'p0009_beyotime_institute': 9.148819220060914e-58, 'to_ _determine_ _the_ _protein_ _concentration_ _then_ _cell_lysates_of_sw20_and_lovo_cells_were_separated_by_ _sdspage_with_ _µg_total_protein_and_transferred_to_a_pvdf_membrane_the_following_primary_antibodies_were_selected_as_follows_anti\\x91n\\x91cadherin_antibody_ab18203_dilution_ _antiecadherin_antibody_ab1416_dilution_ ': 9.148819220060914e-58, 'dilution_anti\\x91pi3k\\x91p85': 9.148819220060914e-58, 'ab191606_dilution': 9.148819220060914e-58, 'to_detect_cell_viability_c_and_d_after_treatment_with_rg3_ _mmoll_or_5fu_ _µmoll_or_their_combination': 0.00012914745416855978, 'to_detect_the_cell_cycle_and_the_annexin_v_fitcpi_kit_invitrogen_thermo_fisher_scientific_inc_was_used_for_flow_cytometry_to_detect_apoptosisanimal_experiment_human_colon_cancer_cells_total': 0.0011132198246858464, 'analyzer_flow_cytometer_miltenyi_biotec': 1.8173440632523934e-05, 'to_detect_the_cell_cycle_and_the_annexin_v_fitcpi_kit_invitrogen_thermo_fisher_scientific_inc_was_used_for_flow_cytometry_to_detect_apoptosisanimal_experiment_human_colon_cancer_cells': 2.9665263946530955e-07, 'invitrogen_fisher_scientific_inc': 9.148819220060914e-58, 'to_detect_apoptosisanimal_experiment_human_colon_cancer_cells': 9.148819220060914e-58, \"rg3_to_determine_death_and_tumor_tissues_were_extracted_and_weighed_with_an_analytical_balance_bsa124s_ _beijing_ _sartorius_ _instruments_ _ltd_ _beijing_china_all_animal_experiments_were_approved_by_the_ethics_committee_of_quanzhou_first_hospital_affiliated_to_fujian_medical_universitystatistical_analysis_all_data_are_expressed_as_mean_±_standard_deviation_and_spss_ _ibm_corp_was_used_to_analyze_the_data_student_'s_ttest_was_used_to_compare\": 0.0005479258942504442, 'rg35fu_group': 0.00015381177755799735, \"to_determine_death_and_tumor_tissues_were_extracted_and_weighed_with_an_analytical_balance_bsa124s_ _beijing_ _sartorius_ _instruments_ _ltd_ _beijing_china_all_animal_experiments_were_approved_by_the_ethics_committee_of_quanzhou_first_hospital_affiliated_to_fujian_medical_universitystatistical_analysis_all_data_are_expressed_as_mean_±_standard_deviation_and_spss_ _ibm_corp_was_used_to_analyze_the_data_student_'s_ttest_was_used_to_compare\": 6.757701162272892e-06, \"ethics_committee_to_analyze_the_data_student_'s_ttest_was_used_to_compare\": 0.0014616190772430405, \"to_analyze_the_data_student_'s_ttest_was_used_to_compare\": 2.2806948295214185e-05, 'test_p005': 1.1686951820486561e-54, 'to_indicate_that_a_difference_was_statistically_significantresultscombined_treatment_of_rg3_and_\\x91fu_enhances_inhibition_of_cell_proliferation_after_treatment_with_different_doses_of_rg3_or_5fu_mtt_assay_was_used_to_measure_the_cell_viability_the_results_revealed_that_the_cell_viability_of_sw620_and_lovo_cells_was_significantly_and_gradually_decreased_with_an_increasing_dose_of_rg3_thus_we_chose_ _mmoll_rg3_for_subsequent_experiments_fig_1a_as_shown_in_fig_1b_the_proliferative_activity_of_the_colon_cancer_cells_in_the_combined_treatment_group_of_rg3_and_\\x91fu_was_significantly_lower_than_ _0chong_   _effects_of_ginsenoside_rg3_on_colon_cancerfigure_ _effect_of_the_combined_treatment_of_rg3_and_5fu_on_migration_and_invasion_of_colon_cancer_cells_in_vitro_treatment_of_colon_cancer_cells_with_combined_treatment_of_rg3_ _mmoll_and_5fu_ _µmoll_inhibited_the_migration_a_and_invasion_b_abilities_of_the_sw620_and_lovo_cells_scale_bar_ _µm_c_western_blot_analysis_was_used_to_detect_the_expression_of_emtrelated_protein_ncadherin_ecadherin_and_mmp9_the_solvent_group_was_used_as_a_baseline_for_the_migration_and_invasion_of_cells_three_independent_repetitions_for_each_experiment_were_performed_p005_p001_and_p0001_compared_with_the_rg35\\x91fu_group_\\x91fu_\\x91fluorouracil_rg3_ginsenoside_rg3_emt_epithelial\\x91mesenchymal_transition_mmp_matrix_metalloproteinase_that_of_the_5fu_treatment_alone_group_in_addition_the_cell_viability_of_sw620_and_lovo_cells_gradually_decreased_with_the_increasing_dose_of_5fu_however_after_treatment_with_the_combination_of_ _mmoll_rg3_and_ _µmoll_\\x91fu_for_ _h_the_cell_viability_of_sw620_cells_was_only_ _which_was_not_conducive_to_subsequent_protein_detection_experiments_thus_ _mmoll_rg3_and_ _µmoll_5fu_were_chosen_for_subsequent_experimentationcell_clone_formation_assays': 8.263922883666513e-55, 'to_measure_the_cell_viability': 0.0007129960827382031, 'p005_p001_p0001': 0.00012620777610110342, '5fu_µmoll': 9.148819220060914e-58, 'migration_abilities_scale_bar': 9.148819220060914e-58, 'to_detect_the_expression_of_emtrelated_protein_ncadherin_ecadherin_and_mmp9': 0.00025186600084341546, 'solvent_group': 4.107493857418709e-06, 'to_detect_in_vitro_proliferation_of_colon_cancer_cells_as_shown_in_fig_1c_and_d': 8.263922883666513e-55, '\\x91fu': 9.148819220060914e-58, 'inhi\\x91bition_ability': 9.148819220060914e-58, '0concology': 1.6853023365262927e-05, '5fu_alonewe': 0.00012738592534461142, 'to_analysis_the_cell_cycle_in_colon_cancer_cells': 6.978293448298126e-05, 'blot_analysis_protein': 0.00012620777610110342, 'proliferation_invasion_migration_ability': 0.0006940543140455221, 'proliferation_invasion_migration_ability_ginsenoside_rg3': 0.002250666934955852, 'to_detect_the_expression_of_emtrelated_proteins_cell_cyclerelated_proteins_and_key_proteins_in_the_pi3kakt_signaling_pathway_it_was_found_that_although_the_effects_of_the_rg3_and_5fu_combination_were_not_as_obvious_as_the_in_vitro_results_compared_with_rg3_of_5fu_alone_the_overall_trend_in_protein_expression_was_consistent_fig_6ce': 0.00029817669559437587, 'reports_blot_analysis': 9.148819220060914e-58, 'to_detect_the_expression_of_key_proteins_in_the_pi3kakt_signaling_pathway_after_treatment_with_rg3_ _mmoll_or_5fu_ _µmoll_or_the_combination_three_independent_repetitions_were_performed_for_each_experiment_p005_p001_and_p0001_compared_with_the_rg35\\x91fu_group_\\x91fu_\\x91fluorouracil_rg3_ginsenoside': 9.148819220060914e-58, '5fu_toxicity': 0.004315547045054443, 'to_inhibit_melanoma_cell_proliferation_by_decreasing_fut4ley_expression_ _rg3': 0.000404948725608525, 'caspase9': 0.0038806204677737646, 'caspase\\x91': 3.2653106155510205e-05, 'that_effects': 0.00019838362704886956, 'blot_analysis_to_evaluate_protein_expression_p005_p001_and_p0001': 0.0004254422540019666, 'mice_tumor_tissues': 9.148819220060914e-58, 'to_evaluate_protein_expression_p005_p001_and_p0001': 9.148819220060914e-58, 'r_point': 0.0001398556650862435, 'metastasis_invasion': 0.00015381177755799735, 'conduction': 0.002319854949290674, 'kinase_b_pathway': 0.0015842910551982499, 'signaling_molecules_it_acts_on_the_downstream_of_the_effects_of_a_variety_of_molecules': 1.5381453988271784e-06, 'medicine_medicine_monomers': 0.0015842910551982499, 'xm_yh_zl': 0.0014620085655300467, 'data_ethics_committee': 2.3863323261202395e-05, 'quanzhou_fujian_chinapatient_consent': 9.148819220060914e-58, 'yu_xq': 9.148819220060914e-58, 'interestsreferences_rl_ward_em': 0.0013882295497307361, 'siegel': 0.00037610940752033374, 'j_cancer_incidence_mortality_n': 9.148819220060914e-58, 's_kuwano_h_inhibition_\\x91fluorouracil_chemotherapy': 9.148819220060914e-58, 'gs_bindon_weight_procyanidins': 0.0007095919825356841, 'k_melatonin': 0.001128162151175775, 'l_liu_j_ginsenoside_rg3': 0.0004358935679566294, 'melastatin_channels': 0.0005521751935137136, 'oh_kw_han_sb_jt_combination': 0.0003455629248948053, 'cancer_\\x91': 8.58883840750466e-06, 'l_h_khanmohammadi_approach': 9.148819220060914e-58, 'chem_\\x91_cr_hughes_b': 9.148819220060914e-58, 'pathway_deactivation': 9.148819220060914e-58, 'melanoma_cell_proliferation': 9.148819220060914e-58, 'zeng_hq_lou_sf_dx_ginsenoside': 0.0005521751935137136, 'it_nh_usa3thayer_school': 0.0014620085655300467, 'data_to_be_verified_by_careful_studies_of_outcomes_related_to_the_measured_changes_in_levels_of_o2k_e_y_w_o_r_d_sclinical_measures_of_oxygen_oxygen_in_tissues_partial_pressure1department_of_radiology_dartmouth_medical_school_hanover_nh_usa2department_of_medicine_section_of_radiation_oncology_dartmouthhitchcock_medical_center': 2.3863323261202395e-05, 'to_enhance_precision_medicine': 0.00025094954260364283, 'heterogeneity_nature_information': 0.004315547045054443, 'heterogeneity_nature': 0.004315547045054443, 'characterizations': 0.004315547045054443, 'to_be_verified_by_careful_studies_of_outcomes_related_to_the_measured_changes_in_levels_of_o2k_e_y_w_o_r_d_sclinical_measures_of_oxygen_oxygen_in_tissues_partial_pressure1department_of_radiology_dartmouth_medical_school_hanover_nh_usa2department_of_medicine_section_of_radiation_oncology_dartmouthhitchcock_medical_center': 0.00040523548652301664, 'accuracy_effectiveness': 0.004315547045054443, 'to_advance_diagnosis_and_therapy': 0.0006948006944247312, 'healing_insufficient_attention': 0.00014977554237073727, 'a0_swartz': 9.148819220060914e-58, 'swartz_vaupel': 9.148819220060914e-58, 'complexity_dynamics': 0.0005741125271172155, 'to_ _describe_ _gases_such_as_o2_that_are_dissolved_in_liquids_or_solids_including_tissues_partial_pressure': 0.004315547045054443, 'et_a0_this': 0.0006625816769337724, 'to_depend_on_both_diffusion_and_solubility_in_the_bilayer_and_to_ _be_ _affected_ _by_ _changes_ _in_ _the_ _physical_ _state_ _and_ _by_ _the_lipid_composition_especially_the_content_of_cholesterol_and_unsaturated_fatty_acids_for_example': 1.9181537329749732e-07, 'et_a0_al_a0_difference': 0.00035613247455696745, 'to_know_whether_the_technique_is_reporting_[_o2_]_or_po2': 0.00210348072096923, 'to_produce_a_measure_based_on_a_sort_of_average_o2_within_that_volume_characterizing_that_\\x9caverage_measure\\x9d_is_made_difficult_both_by_the_imprecision_of_knowing_the_exact_volume_queried_but_also_because_the_detection_of_o2_in_that_volume_may_be_affected_by_factors_such_as_its_distance_from_the_detector_or_for_optical_techniques_different_rates_of_scattering_that_also_may_not_be_well_characterized': 1.0029608744522577e-05, 'measure\\x9d': 9.148819220060914e-58, 'imprecision': 9.148819220060914e-58, 'tissuenonobeseobesenana\\x93\\x93pasarica': 0.007713134335009549, 'po2_[_o2': 0.0014616190772430405, 'po2': 5.412138014362601e-05, 'data_diseases_median': 8.83412621090357e-07, 'spleen_values': 8.263922883666513e-55, 'vessel': 0.0003482466952890437, 'level_a0mmhg': 1.0987149551122205e-05, 'fraction_sarcoma': 0.0002208255543092432, 'to_be_an_outlier_on_the_range_glioma': 3.259854687994726e-05, 'to_be_more_varied_in_their_o2_levels': 0.0003482466952890437, 'values\\x9d_limb_diseasebraingray_matterwhite_mattermedian': 0.0014616190772430405, 'researchers_clinicians': 0.00044941264492739084, 'values\\x9d_a0_limb_diseasebraingray_matterwhite_mattermedian': 0.0014616190772430405, 'samecontinuesswartz_0c': 9.148819220060914e-58, 'der_heijde_tangelder_reichertthoen_linsenmeier': 9.148819220060914e-58, 'figure_a0': 0.00014977554237073727, 'clinical_number': 0.00038651496254465934, 'o2_measurements': 6.30087943241038e-06, 'indications_impact_evidence': 0.00356509979821227, 'oximetry_technique': 0.0014616190772430405, 'differences_o2': 0.0007095919825356841, 'amount_extent': 0.0005269923949341242, 'structuremorphology': 0.0005269923949341242, 'to_be_much_more_prone_to_leak_leakage_from_these_vessels': 0.0004815525391610832, 'to_be_much_more_prone_to_leak_leakage_from_these_vessels_factors_changes_response_presence_shortterm_changes': 0.0007092623104161768, 'line_abnormalities': 0.0002915557546050062, 'changes_response_presence': 0.0004815525391610832, 'shortterm_changes': 0.00022770977125509355, 'consumption_patterns': 0.0001725776170596485, 'o2_supplying_vasculature': 0.0001725776170596485, 'jain_a0_effects': 1.1686951820486561e-54, 'to_ _measure_actual_o2_in_tissues_potential': 8.263922883666513e-55, 'to_ _measure_actual_o2_in_tissues': 8.263922883666513e-55, 'hemoglobin_saturation_hemoglobin': 0.004315547045054443, 'schwarte_a0': 9.148819220060914e-58, 'link_techniques': 9.148819220060914e-58, 'laser_flow_measures': 0.004315547045054443, 'oximetry': 0.00014981546512120254, 'type_carbon_charcoal_phthalocyanine_particulates': 9.148819220060914e-58, 'materials_measurements': 9.148819220060914e-58, 'measurements_ps': 9.148819220060914e-58, 'measurements_to_have_modest_utility_in_itselfthe_other_method_of_clinical_epr_oximetry_is_based_on_the_use_of_microcrystalline_probes': 9.148819220060914e-58, 'india_ink': 0.00014977554237073727, 'to_have_modest_utility_in_itselfthe_other_method_of_clinical_epr_oximetry_is_based_on_the_use_of_microcrystalline_probes': 2.441409690283966e-06, 'eg_lipc_lincbuo': 8.83412621090357e-07, 'a0_hou_et_jarvis_et': 0.0038806204677737646, 'proteins_reducing': 0.0005865071468874085, 'mgg_antioxidant_capacity': 0.0005865071468874085, 'activity_z_eurypterum_seeds': 0.000163785780621542, 'othertaxa': 0.0007008712380191807, 'to_be_the_potential_source_of_natural_antioxidants': 0.004315547045054443, 'e0231612101371_pone0231612editor': 9.148819220060914e-58, 'sË\\x87iler_institute': 9.148819220060914e-58, 'manuscript_supportinginformation': 0.0014616190772430405, 'august_0cbiochemical_profile': 0.0007714274376494996, 'to_cure_various_ailments_and_to_reduce_risks_of_chronic_human_illness_such_as_inflammation': 0.00025126313729024964, 'stress_rise': 0.00040378297050580684, 'effects_disease_risk': 6.588278215775184e-06, 'harmaline_flavonoids_anthraquinones': 6.549094238085155e-07, 'tribulus_species': 0.0010298344840079976, 'phytochemicals': 9.148819220060914e-58, 'alkaloids_lignan': 9.148819220060914e-58, 'august_0cbiochemical_profile_potential': 0.00033123181039764935, 'zygophyllum_species': 9.148819220060914e-58, 'leading_to_the_identification_of_various_classes_of_compounds': 9.148819220060914e-58, 'to_have_antiinflammatory_and_antipyretic_activity_  ': 0.0038806204677737646, 'to_contain_flavonoids_steroids_and_saponins': 0.00210348072096923, 'to_contain_flavonoids_steroids_and_saponins_identified_following_themethod_as_used_in_the_flora_of_pakistan_  ': 0.0002707174838209944, 'permissions': 4.413779972716217e-06, 'area_species': 9.148819220060914e-58, 'identified_following_themethod_as_used_in_the_flora_of_pakistan_  ': 9.148819220060914e-58, 'bruguieri_fbh_f_olivieri_vouchers': 8.263922883666513e-55, 'shade': 1.1686951820486561e-54, 'faisalabad_pakistanchemicals_reagents_phosphate_chloride_sodium_carbonate': 8.263922883666513e-55, 'to_determine_sod_activity_by_homogenizing_the_fresh_aerial_partsand_fruits_of_selected_taxa_in_phosphate_buffer_ _mm_ph_ _edta_ _mm_and_dtt_mm_following_the_procedure_of_  ': 0.0017204587886996824, 'to_performfurther_phytochemical_activities': 4.051360603328636e-05, 'mm_cat': 9.148819220060914e-58, 'inphosphate_buffer_ _mm_ph_ _edta_ _mm': 9.148819220060914e-58, 'inphosphate': 9.148819220060914e-58, 'mm_ph_edta': 9.148819220060914e-58, 'measurement_assaybuffer': 0.0005719014116148634, 'buffer_mm_ph_edta_mm_ml_ph_h2so4_glycerol_volume': 9.329749357825185e-06, 'to_estimate_the_oxidation_rate_of_ascorbic_acid_ _hydrolytic_enzymesesterase_activity_the_Î±esterase_was_determined_by_using_the_method_as_suggested_by_ _Î±naphthyl_acetate_was_used_as_substrates_the_reaction_mixture_contained_ _mm_Î±naphthyl_acetate_ _mm_acetone_ _and_phosphate_buffer_ ': 9.329749357825185e-06, 'mm_acetone_phosphate_buffer': 9.422812056183623e-50, 'buffer_mm_ph_edta_mm_ml_to_estimate_the_oxidation_rate_of_ascorbic_acid_ _hydrolytic_enzymesesterase_activity_the_Î±esterase_was_determined_by_using_the_method_as_suggested_by_ _Î±naphthyl_acetate_was_used_as_substrates_the_reaction_mixture_contained_ _mm_Î±naphthyl_acetate_ _mm_acetone_ _and_phosphate_buffer_ _ph_plant_samples_method_h2so4_glycerol_volume_method_tomeasure_tpc': 0.0006212428503852985, 'plant_samples': 0.0005715966671738797, 'assayis': 0.0005269923949341242, 'chlorophylland_carotenoids': 0.0005715966671738797, 'contents_tpc': 7.055940156448075e-05, 'tomeasure_tpc': 0.00036240313892865647, 'fc_reagent_carbonate_mm': 7.069546589601866e-05, 'placethis_mixture': 1.1530100155613681e-06, 'regressionequation': 9.148819220060914e-58, 'placethis_mixture_reading': 9.148819220060914e-58, 'colorimetricmethod': 0.00036240313892865647, 'potassium_acetate1_m': 0.0006516110020194366, 'mixture_3ethylbenzothiazoline6_cation': 1.063092610904285e-05, 'mixture_reading_decrease_3ethylbenzothiazoline6_cation_reagentr1_mixture_acid_hydrogenperoxide_abts': 0.0005715966671738797, 'reagentr1_mixture_acid_hydrogenperoxide_abts': 9.422812056183623e-50, 'asa_ascorbic_acid': 0.001129870936471824, 'acid_method': 4.085742850589715e-08, 'mixturefor_minutes_c': 0.00010644696953013512, 'which_measures': 9.639534727038412e-05, 'mixturefor_minutes_c_byage_inhibition': 0.0001419430500276026, 'calibration_curve': 2.3169487467355962e-06, 'breakdown': 0.0038806204677737646, 'acid_reagent': 2.3169487467355962e-06, 'age_inhibition': 2.3175661720385148e-06, 'byage_inhibition': 3.782429377677945e-08, 'denaturation_methodthe_denaturation_assay': 9.148819220060914e-58, 'using_a_modified_method_as_described_by_ _briefly_the_reaction_mixture_ ': 9.148819220060914e-58, 'ml_ph': 2.3169487467355962e-06, 'diclofenac_sodium_drug': 7.006780462460508e-06, 'turbidity': 9.148819220060914e-58, 'spectrophotometer': 9.148819220060914e-58, 'diclofenac_sodium': 0.00010644696953013512, 'percentage_inhibition': 1.1446464400150988e-07, 'inhibition_¼½abs': 9.148819220060914e-58, 'abs_sampleï¿½abs_¼_results': 9.148819220060914e-58, 'significance_activities': 0.0019127833147525456, 'injury_values': 0.00016463522079533424, 'catalase': 1.1636549905330657e-05, 'diseases_fig_plantspecies': 0.0007131860921213638, 'fig_plantspecies': 0.0006768252640912667, 'to_have_a_good_antioxidant_capacity_  _similarly_calamintha_officinalis_also_has_potent_antioxidants_  _alphaamylase_and': 0.0002394531921586528, 'capacity_calamintha_officinalis': 9.148819220060914e-58, 'antioxidants_alphaamylase': 9.148819220060914e-58, 'esterase': 0.0015842910551982499, 'tac': 0.0003802249829989744, '±001Î¼mg_f_wt': 9.148819220060914e-58, 'f_indica': 9.148819220060914e-58, 'to_be_a_good_source_for_natural_antioxidants_  _previously': 8.915322310960016e-05, 'f_cretica': 9.148819220060914e-58, 'to_have_high_antioxidant_and_radical_scavenging_potential_due_to_the_high_tpc': 9.148819220060914e-58, 'fig_fruit_samples': 0.0005865071468874085, 'sample_±_f_wt': 0.00036300091156384084, 'Î¼gml_sample': 9.148819220060914e-58, 'tfc±167Î¼gml_sample': 9.148819220060914e-58, 'sample_flavonoids': 9.148819220060914e-58, 'to_be_effective_free_radical_scavengers_in_fruits_vegetables_and_medicinalplants_highest_ascorbic_acid_reported_in_p_harmala': 9.148819220060914e-58, 'medicine_use': 0.0010298344840079976, 'sugar': 0.004315547045054443, 'antioxidant_protein': 0.0003313074447267851, 'Î¼mg_f_wt': 9.148819220060914e-58, 'maximumamount': 9.148819220060914e-58, 'ml_sample_seeds': 9.148819220060914e-58, '±167Î¼gml_sample_analysis_potential': 9.148819220060914e-58, 'dryp_harmalat_simplexquercetin_equlientÎ¼gml': 9.148819220060914e-58, 'propinquum±1467bcd±4575az': 9.148819220060914e-58, 'bruguieri_fbn': 1.8649181921370194e-05, 's_wt': 9.148819220060914e-58, 'z_propinquum_±_Î¼mg': 9.148819220060914e-58, 'seed': 9.148819220060914e-58, 'pentandrus_varpterophorust_pentandrus±20884a±1325cf_bruguieri': 9.148819220060914e-58, 'propinquumz': 9.148819220060914e-58, 'var_fbnf_paulayanaf_olivierimgg': 9.148819220060914e-58, 'to_know_the_relative_quantificationof_bcl2_mrna_with_appropriate_reference_genes_for_the_choice_of_reference_genes\\x94i_reference_genes_were_selected_by_assessing_variation_of_ _genes_from_ _rnaseq_datasets_of_haematological_malignancies_followed_by_filtering_based_on_their_go_biological_processannotations_and_proximity_of_their_chromosomal_locations_to_known_disease_translocationsselected_genes': 0.00210348072096923, 'pone0236338': 3.7184676209466113e-06, 'number_btpr23078med2912532017by_department': 0.0006026042973632392, 'inferred_adopted_remains_is': 0.00017433779082564105, 'tothe_availability': 1.8827472971298497e-05, 'misinterpretation': 0.00210348072096923, 'to_relatively_quantify_bcl2_as_molecular_diagnostics': 6.918627002654179e-05, 'diagnosticsmaterials_methodsethics_statementthe_study': 2.2483516665683055e-06, 'are_deviation': 0.0016810521528134112, 'outliers': 0.00210348072096923, 'q3': 3.235746757240451e-05, 'q2': 0.0019828300612472908, 'candidates_genes': 9.148819220060914e-58, 'Ã¾_mad2': 9.148819220060914e-58, '¼all_parameters': 3.235746757240451e-05, 'log2': 0.0005865071468874085, 'cqr': 0.0005978287857640991, 'aless': 9.148819220060914e-58, 'bcl2Î²_table': 9.148819220060914e-58, 'table_s3_table_details': 1.2354001104571252e-05, 'sample_detailsrna': 2.0170598013233685e-07, 'himedia_india': 4.172615061388867e-05, 'pone0236338_diagnostics': 3.38010432932357e-06, 'qpcrfrom': 1.1686951820486561e-54, 'pone0236338_diagnostics_centrifugation_himedia_india_treatment': 8.263922883666513e-55, 'himedia_india_treatment': 8.263922883666513e-55, 'br_assay_kit': 0.0006683740194778514, 'iv_ssiv_thermo': 0.0006683740194778514, 'ii_machineoptimization': 0.00010115299535317135, 'wereused_nm_100nm100_nm': 0.00010115299535317135, 'amplification_factor': 9.148819220060914e-58, 'using_three_independent_algorithms\\x93genorm_  ': 9.148819220060914e-58, 'algorithms_delta_method_algorithm_genorm': 0.004315547045054443, 'rg_candidates': 0.00024831101020746386, 'furtherwe': 0.001129870936471824, 'to_select_novel_rgs_with_an_unbiased_approachselection_of_candidate_rgsstatistical_analysis_stepwise_filtration_of_the_number_of_genes_from_each_dataset': 3.8350600060857795e-07, 'also_in_graphical_abstract_fig_ _shows_gene_clusters_plotted_in_cv_normalized_mad_and_1pvalue_hyperspace_for_four_datasets_cluster_marked_in_green_in_eachfigure': 0.0022967778700727325, 's5_table': 3.749068383136418e-05, 'gene_clusters': 2.698714806866218e-06, 'hyperspace': 0.00016562736892862293, 's5_table_overlap_it': 3.749068383136418e-05, 'disease_association_cqr': 0.0009466755491730313, 'curve_analysis_efficiency_check': 1.8515255552101432e-06, 'to_show_single_amplification_peak_after_repeated_trials_with_new_experimental_conditions_and_even_new_primersequences_s3_table': 0.0013882295497307361, 'stability_analysis': 2.698714806866218e-06, 'rg_candidatessssstability_analysis': 9.148819220060914e-58, 'independentlyor': 9.148819220060914e-58, 'inputs_mean_ranks': 0.0013882295497307361, 'diagnostics_taqman_probes': 0.001129870936471824, 'to_differ_in_different_conditionsdue_to_its_involvement_in_apoptotic_cell_death_through_ubiquitin_ligase_  _membrane_trafficking_  _upregulation_in_aml_  _involvement_in_nonhodgkin\\x99s_bcell_lymphomas_ _and_inconsistency_in_several_other_cancers_  _on_the_other_hand': 0.00013035644597980832, 'normalizationwith_gapdh': 9.148819220060914e-58, 'quantification_rgs': 9.148819220060914e-58, 'rpkm_values': 0.007713134335009549, 'muchlesser_variations': 0.00012692105839004047, 'rgs\\x93ptcd2': 9.148819220060914e-58, 'sequence_similarity_identity': 9.148819220060914e-58, 'andother': 9.148819220060914e-58, 'rodent_models_s9_table': 9.148819220060914e-58, 'genes_ppp1r3b_fbxw9': 9.148819220060914e-58, 'test_diagnostics': 9.148819220060914e-58, 'abstracttiffacknowledgmentsauthors': 9.148819220060914e-58, 'prof_joy_chair_department': 9.148819220060914e-58, 'dwivedi_sreejeta': 9.148819220060914e-58, 'damodarsoftware_sujan_k_dharsupervision': 9.148819220060914e-58, 'dwivedi_sreejeta_kdhar_manjula': 9.148819220060914e-58, 'perini': 9.148819220060914e-58, 'dasreferences_bcl2': 2.6465113810697817e-08, 'ltd_gratiotdeans_j_merino_turka_la_bcl2_expression': 1.6216993483496114e-06, 'm_significances': 9.148819220060914e-58, 'review_uchida': 9.148819220060914e-58, 'isobe_y_asano_j_uemura_y_hoshikawa': 9.148819220060914e-58, 'bcl2_strategy_diagnostics': 9.148819220060914e-58, 's_correlation_manman_d_tzankov': 0.0006321861226151657, 'g_integration': 0.0006578099350934741, 'ml_lu_xc_li': 1.1686951820486561e-54, 'ccnd1bcl2_gene_network_target': 8.263922883666513e-55, 'biol_drug': 8.263922883666513e-55, 'sep_\\x93': 0.0007129960827382031, 'venetoclax_abt199_leukemia': 0.004315547045054443, 'bcell': 0.0006321861226151657, 'cells_effect_guideline_advantage_data_registry': 8.014401137946441e-05, 'guideline_advantage_data_registry': 8.014401137946441e-05, 'cancer_screenings_those': 0.0011075402231842013, 'havepermission': 0.0013686250359118159, 'pone0236836': 2.232863884588429e-05, 'coderelated': 4.6485889616323715e-05, 'pone0236836_declaredthat_changes_to_diagnose_cancers_early_and_reduce_cancer_deaths_ _for_example_in_the_past_ _years_factors_measures': 0.0028479580480036, 'to_investigate_the_associations_between_timeseriescvh_measures_and_cancer_screenings_in_an_ambulatory_population_patients_with_moreadverse_cvh_profiles': 6.786073079812448e-05, 'to_be_screened_for_cancers_and_cancer_screening': 6.786073079812448e-05, 'to_diagnose_cancers_early_and_reduce_cancer_deaths_ _for_example_in_the_past_ _years': 8.014401137946441e-05, 'colon_polyps': 9.594934446705883e-05, 'example_receiptof_mammography': 4.6485889616323715e-05, 'fromquestionnaires': 4.6485889616323715e-05, 'surveys_analysis_methods_regression_models': 9.148819220060914e-58, 'to_examine_the_associations_between_the_risk_factors_andcancer_screenings_electronic_health_records_ehr': 9.148819220060914e-58, 'healthcare_information_data': 9.148819220060914e-58, 'to_discover_new_patterns_and_relationships_from_the_rich_data_deeplearning_algorithms': 9.148819220060914e-58, 'features_patterns': 0.0013882295497307361, 'cancer_screenings': 0.0029610226581256688, 'acknowledgement_useagreement': 0.007713134335009549, 'data_registry': 1.1686951820486561e-54, 'tga_totrack': 8.263922883666513e-55, 'disease_management_care': 8.263922883666513e-55, 'tga_data': 0.008050454065961409, 'bcs_patients': 0.0011075402231842013, 'cocs': 0.0011075402231842013, 'comparison_group': 0.007713134335009549, 'multum_drug_database': 0.007713134335009549, 'cvh_measurements': 0.0011075402231842013, 'python_genism': 0.0009267366932279312, 'dimension_bag_model_onthe_training_data_model_input_layer_cvh_measures': 1.5121817571942223e-05, 'word2vec': 0.0005373063242131615, 'theminimum_number': 2.4697871487784996e-07, 'training_algorithm': 8.263922883666513e-55, 'time_information': 0.0006768252640912667, 'wassplit': 0.0014616190772430405, 'model_onthe_training_data': 0.007713134335009549, 'adam_optimizer': 9.148819220060914e-58, 'to_optimize_the_model_with_a_minibatch_size_of_sampleswe': 9.148819220060914e-58, 'distributions_we': 0.0006681652127777817, 'cvh_measures': 0.007713134335009549, 'cvhmeasures': 0.007713134335009549, 'visitthen': 0.001845170519318405, 'analysis_analyses': 2.6504393066921695e-05, 'populationwas': 0.00048362067048935835, 'screenedfig': 0.0011075402231842013, 'cancer_screening': 0.001108130680129769, 'cecsdemographicsage': 8.263922883666513e-55, 'cvh_factors': 4.835498853195695e-05, 'mmhgcurrent_smoking': 7.890131560856844e-07, 'risk_factors_receipt': 7.0706272877937e-05, 'avg_avg_avg_avg_avg_avg_ï¿½_the_percentages_may_not_add_up_to_ _due_to_rounding101371_pone0236836t002prevalence_of_poor_a1c_ _for_bcs_ _for_cecs_and_ _for_cocs_compared_topatients_who_did_not_receive_screening_ _for_bcs_ _for_cecs_and_ _for_cocsfig_ _shows_changes_in_cvh_submetrics_within_the_same_patient_screening_groups_fig_a\\x932c_show_the_changes_in_cvh_submetrics_for_the_patients_who_were_screened_while_fig2e_and_2f_show_the_changes_in_cvh_for_patients_who_were_not_screened_one_ _101371_pone0236836_august_    _one_0ccardiovascular_risk_factors_and_receipt_of_cancer_screenings_one_ _101371_pone0236836_august_    _one_0ccardiovascular_risk_factors_and_receipt_of_cancer_screeningsfig_ _the_area_under_the_curve_auc': 0.0004128754153107024, 'cocsfig': 0.0006681652127777817, 'fig_a\\x932c': 0.0006681652127777817, 'fig2e_2f': 0.0006681652127777817, 'pone0236836_risk_factors_receipt': 0.0011075402231842013, 'shown_is_is_showed_indicated_models': 9.148819220060914e-58, 'improvedselfmanagement': 9.148819220060914e-58, 'forall_comparison': 0.0019127833147525456, 'comparison_cvh_factors': 0.0038806204677737646, 'screenings_those': 0.0011075402231842013, 'cancer_screenings_associations': 0.0018006682651940404, 'screenings': 0.0003645333095764079, 'to_have_better_control_of_cvh_factors_especially_a1c_than_patients_whodid': 0.001845170519318405, 'cancerscreenings': 0.0011075402231842013, 'bcs_cocs_screenings': 0.001845170519318405, 'burden_cost': 4.834210573429441e-05, 'timeseries_cvh_measures_receipt': 2.8134193870395278e-05, 'prompt': 0.0002919243480472275, 'unhealthierpatients': 2.952677990057456e-07, 'favorablechanges_aixia_guosupervision_randi_e': 1.8100517666653846e-05, 'sh_breast_cancer': 9.148819220060914e-58, 'summary_pmid_edwards': 9.148819220060914e-58, 'booth_gl': 9.148819220060914e-58, 'screening_mammography_among_women_with_diabetesarch_intern_med_ ': 9.148819220060914e-58, 'robb_ka': 9.148819220060914e-58, 'factors_az_factors': 9.148819220060914e-58, 'wardle_j': 0.0007862569594425692, 'to_have_arisen_from': 0.00210348072096923, 'review_metaanalysis_diabetologia': 1.809569507565947e-05, 'culpepper_l_associations': 9.148819220060914e-58, 'health_subclinicalimpairments_study_ra_disease_cancer_101016jamepre201507039_yin_j_pone0236836': 9.148819220060914e-58, 'health_initiative': 9.148819220060914e-58, 'med_\\x93': 9.148819220060914e-58, 'database_appswhointhealthinfostatisticsmortalitywhodpms': 9.148819220060914e-58, 'anaconda_analysis': 9.148819220060914e-58, 'crosscountryanalysis': 0.0015851356325270348, 'statistics_systems_pone0237539_prospect_unpopulation_division_populationunwppdownloadstandardpopulation_role': 2.5873580930035818e-05, 'sdi': 0.0004988292642554344, 'statistics_systems_pone0237539': 2.5873580930035818e-05, 'august_one': 9.148819220060914e-58, 'prospect_unpopulation_division_populationunwppdownloadstandardpopulation': 9.148819220060914e-58, 'what_problem': 7.568076476087012e-05, 'utilityfor_use_proportion_impact_age_pattern': 0.000572546913686716, 'alarger_universe': 0.00023148283708492395, 'death_certificate': 9.148819220060914e-58, 'septicemia': 9.148819220060914e-58, 'to_prevent_these_deaths': 8.014401137946441e-05, 'resource_allocation': 9.148819220060914e-58, 'health_intelligence': 9.148819220060914e-58, 'to_target_improvements_in_cod_reporting_systems_in_this_study': 0.00031585793432508617, 'usability_patterns': 9.148819220060914e-58, 'toa': 9.148819220060914e-58, 'development_s1_file]to': 0.00024810373354211296, 'to_be_very_weak_or_nonexistent': 0.00023565968730597905, 'to_make_significant_progress_towardsimproving_the_evidence_base_for_policy_without_depending_on_further_socioeconomicdevelopmentdata_and_methodswe_carried_out_a_crosssectional_study_using_publicly_available_data_from': 0.00018738920974274527, 'who_mortalitydatabase': 9.148819220060914e-58, 'pone0237539': 9.148819220060914e-58, 'cod_data': 0.0038816544549862162, 'icd10': 0.0013882295497307361, 'policy_health_planning': 0.004315547045054443, 'utilityfor': 7.348717988782612e-06, 'to_have_agreater_fraction_of_garbage_codes': 0.00017045975082083655, 'age_distribution_pone0237539_fit': 0.007713134335009549, 'thepercentage': 9.148819220060914e-58, 'using_the_adairlopez_empirical_method_incorporated_into_anaconda_ ': 9.148819220060914e-58, 'cod': 0.004315547045054443, 'relationship_cdr': 0.0004988292642554344, 'facilities_physician_availability': 9.148819220060914e-58, 'policy_utility': 9.148819220060914e-58, 'causesand': 0.0013882295497307361, 'impact\\x9d': 9.148819220060914e-58, 'to_investigate_each_dataset_s1_file_to_identify_the_pattern_and_extentof_garbage_codes_in_the_data_their_frequency_among_the_leading_causes_the_completeness_ofthe_dataset_and_to_provide_an_overall_summary_index_of_the_quality_of_the_output_of_the_mortality_data_system_namely_the_vital_statistics_performance_index_for_quality_vspiq_ _resultsthe_proportion_of_garbage_codes_in_the_ _country_datasets_varied_substantially_by_countryranging_from_ _to_ _see_fig_ _while_the_relationship_between_sdi_and_amount_of_garbage_codes_in_the_data_is_broadly_apparent': 9.148819220060914e-58, 'sdi_low': 9.148819220060914e-58, 'pone0237539g001this_group': 9.148819220060914e-58, 'sociodemographic_development': 0.0004988292642554344, 'fig_kyrgyzstan': 0.00038842632962585887, 'ageadjb_completeness': 0.0007097810890664368, 'impact_deaths': 1.1579472589378159e-05, 'aï¿½bthis_equation': 0.00018341571189742586, 'agestandardisation': 0.0007095919825356841, 'development_categoryagestandardisation': 9.148819220060914e-58, 'age_pattern': 9.148819220060914e-58, 'injordan_tajikistan': 0.004315547045054443, 'combinedindicator': 0.0004988292642554344, 'sdicountries': 8.935281594642543e-07, 'impact_causes': 5.473908519290502e-05, 'japan_france': 9.148819220060914e-58, 'impact_garbage_codes': 9.148819220060914e-58, 'seventajikistan': 9.148819220060914e-58, 'nonefor_females': 9.148819220060914e-58, 'egypt': 0.0002483771818453479, 'iran_tunisia_tajikistan': 4.053261044966421e-06, 'sdi_countries': 0.0001705051860129118, 'to_report_atherosclerosis_hepaticfailure_intracerebral_hemorrhage_and_unattended_deaths_all_garbage_codes_as_leading_causesfig_ _achieved_scores_that_would_classify_them_as_havingmedium_performing_systems_with_lower_scores_mostly_arising_from_the_high_proportion_ofgarbage_codes_that_bias_their_cod_distributions_of_the_ _countries_only_jordan_tajikistanand_tunisia_were_classified_as_having_poorly_functioning_systemsdiscussionin_general': 2.778916404905594e-06, 'cod_distributions': 0.004315547045054443, 'france_japan_seemto': 9.148819220060914e-58, 'garbage_codes_causes': 9.148819220060914e-58, 'garbage_code': 6.33966136568193e-05, 'proliferation_migration_tumour_invasion': 0.004315547045054443, 'tnc_lossofffunction': 0.007713134335009549, 'sequence_homology': 0.007713134335009549, 'bothin_monolayer_culture_cells': 9.148819220060914e-58, 'forphenotypic_alterations': 9.148819220060914e-58, 'portals': 9.148819220060914e-58, 'to_assess_the_clinical_implication_oftnc_expression_on_breast_cancer_patient\\x99s_survival_showing_the_tnc_overexpression_associated_with_a_poor_survival_outcome_our_approach_applied_first_in_brain_tumors_and_then_inbreast_cancer_cell_lines_reveals_that_atnrna_significantly_diminishes_the_cell_proliferationmigration_and_additionally_reverses_the_mesenchymal_cells_phenotype_to_the_epithelial_onethus_tnc_could_be_considered_as_the_universal_target_in_different_types_of_tumors_wheretnc_overexpression_is_associated_with_poor_prognosisa1111111111a1111111111a1111111111a1111111111a1111111111open_accesscitation_wawrzyniak_d_grabowska_m_gÅ\\x82odowiczp_kuczyÅ\\x84ski': 9.148819220060914e-58, 'atnrna': 0.005861375669898526, 'cell_proliferationmigration': 9.569798249734919e-05, 'b_fedorukwyszomirska_downregulation': 9.148819220060914e-58, 'developmentby_growth_migration_copyright_wawrzyniak': 9.148819220060914e-58, 'manuscript_supportingintroductioninformation': 0.0014616190772430405, 'science_education_know_program_kk': 0.0003167145330801072, 'interactions_antigens': 2.8673840052333168e-05, 'ecm_proteins': 6.618984365889211e-05, 'migration_angiogenesis_contact_formation': 6.618984365889211e-05, 'to_be_associated_withinvasive_phenotype_  ': 0.00010740789809797397, 'migration_angiogenesis': 6.618984365889211e-05, 'contact_formation': 6.618984365889211e-05, 'epitope_us_expression_level': 0.007713134335009549, 'mock': 6.364718923148067e-05, 'who_showedthat_gbm_patients_antibody_targetvcedgftgpdcae': 0.0006578099350934741, 'atnrna_approach': 9.148819220060914e-58, 'impairing_the_basic_hallmarks_of_tumor_cells_with_the_performed_analysis_of_proliferation_migration_rate_multicaspases_induction_pathway_cell_cycle_analysis_spheroids': 9.148819220060914e-58, 'her2overexpressing_breast_cancer': 0.0006578099350934741, 'mdamb231_genome_clusters': 9.148819220060914e-58, 'factor_receptor_her2': 9.148819220060914e-58, 'adams': 9.148819220060914e-58, 'mdamb231cells_factor_receptor_her2': 9.148819220060914e-58, 'cell_linessuch_mdamb231_mdamb468': 9.148819220060914e-58, 'tenascinc_tnn_tnrtnxb': 9.148819220060914e-58, 'notas': 0.00031278352800590204, 'mrna_level': 0.0022219513602159823, 'brca_1a': 3.626281575122351e-05, 'tnr': 9.148819220060914e-58, 'fig_1b_1c': 9.148819220060914e-58, 'brca_1a_expression_downregulation': 0.002760641396723533, 'to_be_irrelevant': 0.000598820003809177, 'wedid': 9.148819220060914e-58, 'ppisurv_portal': 9.148819220060914e-58, 'greatimpact': 0.0003421850007431465, 'tnc': 5.455427634868729e-06, 'pone0237889_0cdownregulation': 0.0011382812302202414, 'cells_developmentvs_rna': 1.8571065005099152e-05, 'using_the_gepia_geneexpression_profiling_interactive_analysis_online_web_server_httpgepiacancerpkucn': 0.0014801043631374876, 'b_summary': 9.148819220060914e-58, 'na_not_available_nd_not_detectable_in_\\x9chealthy_breast\\x9d_column': 9.148819220060914e-58, 'tmas_tnc\\x93cab004592_tnn\\x93cab010907_tnr\\x93cab022343_images': 6.4432802524463065e-06, 'qrtpcr_analyses': 0.00039500168760568026, 'expression_level_response_genes': 0.0004358935679566294, 'using_the\\x93Î´Î´cp_method_statisticalevaluation_of_atnrna_versus_scrambled_sirnas_ccontrol_cells': 0.0003421850007431465, 'test_effect': 5.9902271010618945e-05, 'means_p': 0.0014616190772430405, 'decrease_protein_expression': 0.0003309404805354376, 'fig_3b_3c': 1.8571065005099152e-05, 'byqrtpcr': 9.569798249734919e-05, 'barstnc_knockdown': 0.0011145213618005021, 'potential_proliferation_mdamb_cell_line': 9.148819220060914e-58, 'cells_proliferation_cells': 9.148819220060914e-58, 'time_concentrationdependent_decrease': 0.007713134335009549, 'nm_nm': 0.00015175328891448237, 'thelowest_motility': 0.00015402658587275984, 'migration_potential': 0.0038806204677737646, '4dtnc': 0.0005521751935137136, 'themdamb231_cells': 9.148819220060914e-58, 'cell_analyzer_cells': 9.148819220060914e-58, 'cancer_cells_p': 1.8576013356989732e-05, 'impedance': 2.1803121407513838e-05, 'min_clarity': 3.5615230136164686e-07, 'clarity': 3.5615230136164686e-07, 'et50_value': 1.1686951820486561e-54, 'impendence_values_andcontrol_cells': 8.263922883666513e-55, 'normalized_shows_treated': 9.148819220060914e-58, 'using_oneway': 9.148819220060914e-58, 'plotted_as_normalized_half_maximaleffective_time_et50_of_cell_migration_against_atnrna_concentrations_d_adhesion_of_mdamb231_cell_line_was_observed_in_realtime_using_xcelligencesystem_graph': 9.148819220060914e-58, 'impendence_values': 9.148819220060914e-58, 'andcontrol_cells': 8.263922883666513e-55, 'test_symbols': 5.9902271010618945e-05, 'g0g1_phase': 3.033495071057994e-07, '5a_atnrna': 0.0001398556650862435, 'sirna_ccontrol': 0.00126660534500368, 'cancer_cells_activity': 1.8571065005099152e-05, '12fold': 0.0003403400547584985, 'impact_integrityto': 5.5506720826907454e-06, 'profile_image': 0.0003534945676816862, 'activity_cellpopulation': 5.765694037127165e-06, 'morphology_treatments': 0.0011284627910272927, 'spheroids_integrity': 0.0003802249829989744, '7a_atnrna_application': 9.148819220060914e-58, 'spheroid_volume_shape': 9.148819220060914e-58, 'fig_7ato': 0.00041787318539719383, 'atnrnaimpact_microscopy_imaging': 1.8415484017042953e-05, 'fluorescence_images': 4.500247464149217e-06, 'atnrna_concentrations': 9.148819220060914e-58, 'contour': 9.148819220060914e-58, 'markers_blot_analysis': 0.007713134335009549, 'survival_prognosis': 0.0016810521528134112, 'to_be_a_key_mechanism_in_cancer_progression_whereby_cancer_cells_acquire_more_aggressive_behavior': 0.004315547045054443, 'effects_monolayer_cultures': 0.0006238396313947969, 'cscr_concentrations_ofatnrna': 9.148819220060914e-58, 'using_leica_tcs_sp5_confocal_laser_scanningmicroscope_and_plan_apo_Ã\\x97_na_oilimmersion_objective_scale_bars_ _Î¼m101371_pone0237889g007suggest_that_tnc_can_induce_an_emt_like_phenotype_in_mcf7_breast_cancer_cells_via_theÎ±vÎ²6_and_Î±vÎ²1_integrins': 9.148819220060914e-58, 'demonstrateddownregulation': 0.0034496498942431435, 'towardsmesenchymal_phenotype': 5.631220219082674e-05, 'ecm_component': 9.148819220060914e-58, 'alsofig_effect_blot_analysis': 9.148819220060914e-58, 'increase_data_representsthe': 2.392246717972457e-05, 'cancer_cells_role': 1.8571065005099152e-05, 'antiadhesiverole': 8.914588896802953e-08, 'targeting_gbm_invasion': 1.0514941354266242e-08, 'downregulation_cell_lines': 0.000404948725608525, 'cdk2_inactivation_blocks_detachment': 8.914588896802953e-08, 'cell_carcinoma_scc': 9.148819220060914e-58, 'staining_diffuse_egfr_staining_in_additionwe_calculated_the_percentages_of_the_two_most_important_mutations_in_egfr_exon_ ': 9.148819220060914e-58, 'twentyone': 0.00027573473885584285, 'diffuse_egfr_staining_in_additionwe_calculated_the_percentages_of_the_two_most_important_mutations_in_egfr_exon_ ': 1.917957732852252e-05, 'promotermutations': 0.0018006682651940404, 'to_treat_most_carcinomas': 0.00020491329035321733, 'continuingto_increase': 9.148819220060914e-58, 'to_treat_most_carcinomas_expression_disease_status': 9.148819220060914e-58, 'expression_localization': 4.4238278954904666e-05, 'patientstreated_by_ophthalmologists_aa_mt_between_november_ _and_july_ ': 0.007713134335009549, 'features_age': 0.007713134335009549, 'histofine_nichirei_corporation_staining': 9.847489528056492e-06, 'tests_survival_usingspss_statistics_version_software': 0.0006035060964073859, 'egfr_technologies_danversma_usa_technologies': 0.007713134335009549, 'conjunctival_lesions': 9.844866387373342e-06, 'mrnawas': 0.0008144505702473652, 'using_descriptive_statisticscorrelations_between_immunohistochemical_demographic_and_clinicopathologic_factors': 1.3457639714946231e-05, 'tests_survival': 1.6083689444271213e-07, 'coxregression_modeling': 9.148819220060914e-58, 'to_evaluate_correlations_between_clinicopathologic_and_immunohistochemical_features_and_survival_outcomes': 9.148819220060914e-58, 'usingspss_statistics_version_software': 0.0005263009120446208, 'japan_values': 9.844866387373342e-06, 'scc': 0.001845170519318405, 'pone0238120_august': 0.0026734733500165934, 'expression_therapy_staining_diffuse_egfr_staining_fig_ _scores': 2.72011551222568e-49, 'diffuse_egfr_staining_fig_ ': 1.917957732852252e-05, 'tadv_table_conjunctival_lesions': 9.148819220060914e-58, 'staining_field': 9.148819220060914e-58, 'to_have_a_higher_score_p_  _and_ _respectivelytable_egfr_e746a750_del_and_egfr_l858r_expression': 0.0004576368763948737, 'exon_point_mutation': 0.0006625816769337724, 'correlations_correlation': 0.00010115299535317135, 'significantthe_cox_regression_model': 9.148819220060914e-58, 'to_examine_and_analyze_the_relationship_between_longterm_prognosis_including_orbital_exenteration_and_pfs_and_the_clinicopathological_statusegfr_staining_pattern_and_egfr_mutation_univariate_cox_regression_analyses': 9.148819220060914e-58, 'tumor_tissue_we': 9.148819220060914e-58, 'percentages_staining_focaln_±±egfr_diffusen': 9.148819220060914e-58, 'correlation_staining': 6.956539113115905e-06, 'to_bepresent_in_the_diffuse_egfr_staining_grouptable_ _summary_of_egfr_e746a750_del_and_egfr_l858r_point_mutationsmutationn_   _age_y_sex_mt_stage_egfr_staining_patterns_diffuseegfr_localization_score_membraneexon_ _egfr_e746a750_del_n_ _fexon_ _egfr_l858r_point_mutationn_  _t3_t2_tis_t3_tis_focalcytoplasmicm_male_f_female101371_pone0238120t004': 0.0004265610635693725, 'pone0238120g004intracellular_transfer': 9.148819220060914e-58, 'progressionand': 9.148819220060914e-58, 'loops': 9.148819220060914e-58, 'growth_factors_receptor_tyrosine_kinases': 9.148819220060914e-58, 'thisphenomenon': 0.0019127833147525456, 'point_mutation': 1.1686951820486561e-54, 'growth_factors_receptor_tyrosine_kinases_thisphenomenon_leucine': 8.263922883666513e-55, 'leucine': 8.263922883666513e-55, 'tyrosine_kinaseactivity': 0.00014626258547791333, 'oncogene_addiction_tkis': 0.0011066746715503305, 'atp_binding': 1.8059778937683202e-05, 'carboplatin_paclitaxel': 0.000598820003809177, '[_]_in_view_of_these_findings_in_lung_cancer_in_asians_our_findingsregarding_egfr_expression_and_mutations_will_provide_further_options_for_potential_treatmentof_ossn_for_pre_and_postsurgical_treatmentthe_association_of_scc_with_hpv': 5.376306750605744e-05, 'signaling_courseof_treatment': 0.00032858103560003425, 'pcrwhich': 0.007713134335009549, 'courseof_treatment': 0.00029922026888170244, 'pone0238120_cell_carcinomathis_study': 0.00044941264492739084, 'thatdiscovery': 0.000332193218693602, 'mizuki_kakehashi_norihiko': 9.148819220060914e-58, 'mizuki_mizuki_tagami': 9.148819220060914e-58, 'h_tert_promoter_mutations': 7.417164383651313e-53, 'ophthalmol': 1.284690556057437e-52, 'ning_pdl1pd1_expressioncomposition': 7.417164383651313e-53, 'targetedtherapy': 9.148819220060914e-58, 'trial_lancetoncol_\\x93': 9.148819220060914e-58, 'pathways_inhibition': 7.417164383651313e-53, 'pmid_ciardiello_f': 9.148819220060914e-58, 'approach_res_\\x93': 9.148819220060914e-58, 'expressions_risk_hpv_infection': 9.148819220060914e-58, 'agent_cancer': 9.148819220060914e-58, 'mechanism_rev_receptor_mutations': 9.148819220060914e-58, 'perspectives': 9.148819220060914e-58, 'delayedloops_nat': 9.148819220060914e-58, 'cell_biol_101038nrm3048_mitsudomi_t': 9.148819220060914e-58, 'mutation_inegfr_kinase': 6.680299491429861e-05, 'yang_pc_effectiveness': 9.148819220060914e-58, 'factor_receptor_mutations_pmid_maemondo': 9.148819220060914e-58, 'laparoscopic_twosegment_resection': 0.0011075402231842013, 'surgery_surgery': 1.159229535486031e-05, 'thatcontroversy': 9.148819220060914e-58, 'concerning_operative_procedures_for_multiple_segmental_resections_and_for_total_or_subtotal_colectomywe_report': 9.148819220060914e-58, 'blood_stool': 9.148819220060914e-58, 'tomography_ctand_barium_enema': 9.148819220060914e-58, 'to_create_a_single_minilaparotomy_for_specimen_retrieval_and_extracorporeal_reconstruction_after_lymph_node_dissection_and_mobilization_of_thecolonduring_the_operation_laparoscopic_exploration': 0.007713134335009549, 'sigmoid_colectomywere': 0.0001697152969056813, 'sidetoside_anastomosis': 9.148819220060914e-58, 'thepresence_half_tissue': 9.148819220060914e-58, 'tumor_locations': 9.148819220060914e-58, 'to_be_tailored_tothe_individual_based_on_tumor_location_invasion_status_andthe_patient\\x99s_health_condition_some_studies_have_suggestedtotal_or_subtotal_colectomy_to_remove_any_potential_existingsynchronous_tumors_or_polyps_that_have_not_been_detected_ ': 9.148819220060914e-58, 'suggestedtotal_colectomy': 0.0018006682651940404, 'surgerycombining_twosegment_resection_ofcourse': 0.007713134335009549, 'preserving_as_much_colonas_possible_considering_the_patient\\x99s_quality_oflife_aftersurgery': 0.007713134335009549, 'to_be_more_clearly_assessed_infuturewe_encountered_a_rare_case_of_advanced_quadruple_scrcsfor_which_we_achieved_a_curative_resection_that_required_twoanastomoses_through_a_laparoscopic_approach_we_suggest_thatlaparoscopic_surgery_that_requires_multiple_anastomoses_foradvanced_scrcs_can_be_a_safe_procedure_even_if_the_number_ofcolorectal_cancers_is_multiplefigure_ _abdominal_ct_scan_revealing_a_tumor_of_the_ascending_colon_aarrowhead_a_tumor_in_the_descending_colon_b_arrowhead_and_two_tumorsin_the_sigmoid_colon': 7.89769833840338e-05, 'infuturewe': 0.00045085371770963703, 'which_resection': 0.007713134335009549, 'twoanastomoses': 0.004315547045054443, 'scrcs': 3.287841426025112e-52, 'dis\\x93quadruple': 0.0003991561001946192, 'bowel_anastomoses': 0.0004734482721133418, 'cscsare': 4.496068198240745e-51, 'to_bea_promising_approach_for_curing_cancera_large_number_of_past_studies_to_identify_andcharacterize_the_cscs_as_normal_tissuespeciï¬\\x81c_stem_cellsare_considered_as_the_main_origin_of_cancer_  _to_be_inherited_at_least_partially': 2.2480340991203723e-51, 'to_bea_promising_approach_for_curing_cancera_large_number_of_past_studies': 2.2480340991203723e-51, 'to_identify_andcharacterize_the_cscs_as_normal_tissuespeciï¬\\x81c_stem_cellsare_considered_as_the_main_origin_of_cancer_  ': 2.2480340991203723e-51, 'to_be_inherited_at_least_partially': 2.2480340991203723e-51, 'cd133has': 9.148819220060914e-58, 'to_be_critical_in_the_maintenance_of\\x9cstemness\\x9d_of_stem_cells_in_various_tissues': 9.148819220060914e-58, 'bcl2and': 0.000576827339123862, 'bcl2and_mapkpi3k_signaling_pathways_[_\\x93_]_although_theexpressions_of_cd44_and_cd133_in_cancer_cells_likely_associate_with_the_resistances_to_radiotherapy_chemotherapy_andvarious': 7.574590165921176e-05, 'diï¬erent_0cstem_cells': 0.0014616190772430405, '0cstem_cells': 0.0015009079408970576, 'scientiï¬\\x81c_ma_usa_we': 9.148819220060914e-58, 'parent_hct8_cells': 9.148819220060914e-58, 'brieï¬\\x82y_hct8_cells': 1.817266084385707e-05, 'biotec_germany': 2.9663987986335773e-07, 'trypsinization_biotec_germany': 5.608112920626346e-07, 'twostep_isolation': 0.0006683740194778514, 'i_roche': 1.1686951820486561e-54, 'germany_asdescribed_ï¬\\x82ow_cytometry': 8.263922883666513e-55, 'brieï¬\\x82y_cells': 9.148819220060914e-58, 'germany_asdescribed_ï¬\\x82ow_cytometry_fitcconjugated_antimouse': 9.148819220060914e-58, 'fitcconjugated_antimouse': 8.263922883666513e-55, 'intracellularï¬\\x82uorescence_intensity': 0.00032716694518630064, 'nucleusaccumulation': 5.334608297015725e-06, 'roslevel_scientiï¬\\x81c': 2.0569641228472943e-06, 'Î¼m_antibodies_enhancedchemiluminescence_0cstem_cells': 0.00012627432307122023, 'factor_nrf2': 2.0569641228472943e-06, 'usa_blots': 9.148819220060914e-58, 'enhancedchemiluminescence': 9.148819220060914e-58, 'lifesciences_usa_semiquantitation': 9.148819220060914e-58, 'measuringthe_density': 9.148819220060914e-58, 'uk_cells': 4.519499327436966e-06, 'using_dharmafect_ _sirna_transfectionreagents_dharmacon': 0.0002769171994750819, 'ii_chicago_il_diï¬erences': 5.9902271010618945e-05, 'sensitivity_diï¬erence': 6.950106494571144e-05, 'to_purify_a_small_population_ofcd133_cells_from_these_cd44_cells_cd44_cells_almostnegatively_expressed_with_cd133_figure_1a': 0.007713134335009549, 'resultwe': 9.148819220060914e-58, 'hct_cells': 9.148819220060914e-58, 'amongsubpopulations': 1.7266859970571246e-05, '1d_cd44cd133cells': 9.148819220060914e-58, 'to_express_cd133_within_ _days_of_reculturing_ï¬\\x82uorescence_intensity_ _±_ _at_baseline_vs_ _±_at_ _days_p_  _figure': 9.148819220060914e-58, 'cells_we': 9.148819220060914e-58, 'sensitivity_addition': 9.148819220060914e-58, 'cellscd44133_hfl3h006hct8': 9.148819220060914e-58, 'hfl3h009hct8': 9.148819220060914e-58, 'cd44cd133\\x88\\x92doxv24': 9.148819220060914e-58, 'cd44cd133dox24_h00hct8_cd44cd133doxv24': 9.148819220060914e-58, 'figure_resistance_mtt_assay': 0.000327079770302999, 'levels_2b': 9.849136608862707e-05, 'cytometrythe_accumulation': 0.0003608303843934633, '2b_throughabcc1_figure': 0.00028936954403567647, 'not_change_by_the_treatment_with_bso_a_glutathione_synthesis_inhibitor_that_indirectly_regulates': 0.000327079770302999, 'to_have_comparable_levels': 0.007713134335009549, 'stress_responsekinase_p38mapk': 0.0005219680427898343, 'extracellularstresses': 8.513575047858228e-06, 'international\\x88\\x92': 9.148819220060914e-58, 'ytilibaiv': 9.148819220060914e-58, 'representative_histograms': 0.000327079770302999, '\\x88\\x92p': 0.0014620085655300467, 'p38mapk_data': 2.3863323261202395e-05, 'cells_internationaldxr': 9.148819220060914e-58, '\\x88\\x92verapamil_nrf2ð\\x9d\\x9b½tubulin': 9.148819220060914e-58, 'hours_p_\\x88\\x92\\x88\\x92control': 9.148819220060914e-58, 'levels_hr': 9.148819220060914e-58, 'thatdxr': 0.0002821774092107797, 'cd44133_cd44133': 9.148819220060914e-58, 'sirna_cd44133': 9.148819220060914e-58, 'sirna_abfigure': 9.148819220060914e-58, '0cstnuo0cstnuo0cexpression': 9.148819220060914e-58, 'presented_histograms': 0.00030956355452942195, 'ros_levelsfigure': 2.9747504732969153e-05, 'to_maintain_a_lower_level_of_phosphorylatedp38mapknrf2_a_transcription_factor_that_is_well_known_to_beactivated_by_oxidative_stress_such_as_ros_and_electrophilicsubstances': 3.8558070250495165e-05, 'figure_sirna_treatment': 0.0011125787591309202, 'to_silence_cd133expression_in_cd44cd133_cells_by_sirna': 0.007713134335009549, 'ofcd133_expression': 0.00030964606064186757, 'sirnap': 5.0489986500694426e-06, 'figure_silencing': 0.00028038455419288966, 'to_separate_thehct8_human_colon_cancer_cells_into_cd44_cd44_cd44cd133_and_cd44cd133_subpopulations': 0.007713134335009549, 'expressions_we': 9.148819220060914e-58, 'cancer_celllines': 9.148819220060914e-58, 'hela_cells_a549_cellsshowed_expression_hct8cells': 0.0016810521528134112, 'resistance_figure': 8.712655419520022e-05, 'cells_fraction': 9.148819220060914e-58, 'cd44_highexpressedcells': 9.148819220060914e-58, 'cd44cd133_cells': 0.0003421850007431465, '2a_cd44': 9.148819220060914e-58, 'to_beclosely_associated_with_drug_resistance_actuallythesecd44cd133_cells': 9.148819220060914e-58, 'lung_cancer_cells': 0.0004360764270917066, 'crossresistance': 0.0038806204677737646, 'dxr': 3.4358152916695635e-05, '5a_2b_3bsuggesting': 0.0015842910551982499, '6bbut': 0.0016810521528134112, 'unknownmechanisms': 9.148819220060914e-58, 'to_be_deï¬\\x81ned_on_the_dxr_resistance_of_cd44cd133_cellsbased_on_data_from_the_present_study_the_expression_ofcd133_rather_than_cd44_more_closely_associated_with_theresistance_of_cancer_cells_to_anticancer_drug_as_complexmechanisms_including_the_drug_excretion_and_redox_regulation': 9.148819220060914e-58, 'oxygen_speciessmall': 9.148819220060914e-58, 'availabilitythe_data': 9.148819220060914e-58, 'grantinaid': 2.3646382745868013e-05, 'ofjapan': 9.148819220060914e-58, 'numbers_16k15622': 9.148819220060914e-58, 'cell_premises': 9.148819220060914e-58, 'nature_medicine': 9.148819220060914e-58, '\\x9ccd44': 9.148819220060914e-58, 'oncancerassociated': 9.148819220060914e-58, 'f_burns_\\x9cacd44_survival_pathway': 3.879067934877452e-05, 'markernanogandankyrinregulated_multidrug_journal': 0.000528146067012347, 'hyaluronan_binding': 9.148819220060914e-58, 'multidrug_resistance_inmesothelioma_cells\\x9d_oncogene_vol_ ': 9.148819220060914e-58, 'h_deng_xia_factor_expression': 9.148819220060914e-58, 'prognosis_metaanalysis': 9.148819220060914e-58, 'sarvi': 9.148819220060914e-58, 'resistanceto_chemotherapy\\x9d_cancer_letters': 9.148819220060914e-58, 'hcc_stem_cells': 0.0016810521528134112, 'l_luo_c_y_guo_mitophagy': 9.148819220060914e-58, 'cancer_al_\\x9cinduction': 9.148819220060914e-58, 'to_calculate_a_tail_probability_for_a_heterogeneous_Bernoulli_process': 0.007713134335009549, 'to_change_the_formulas_for_uSi_and_CESS_as_follows': 0.007713134335009549, 'S.': 0.0003322263502299899, 'to_evaluate_the_proportion_of_false_positives_among_the_claimed_positives': 1.1463278847369882e-06, 'SJ': 9.148819220060914e-58, 'significantly_concordantly_enriched': 9.148819220060914e-58, 'number_R': 3.4358152916695635e-05, 'CES_level': 0.007713134335009549, 'version_8_]': 0.007713134335009549, 'p_values_0.01': 0.007713134335009549, 'proteasome_inhibitors': 1.1980657894090253e-06, 'proteasome': 9.148819220060914e-58, 'survival_factors': 9.148819220060914e-58, 'Subramanian_Tamayo': 0.00016526033473186454, 'proteasome_pathway': 0.0003322263502299899, 'analysis_approach': 0.0002788738900395108, 'z_-_scores': 8.042864302131433e-06, 'results_17': 0.00238803522972525, 'FDR_levels': 9.849136608862707e-05, '8_]': 1.0429520190868206e-05, 'Version': 0.00238803522972525, 'GSA_method': 9.148819220060914e-58, 'to_analyze_individual_data_sets_separately_for_700_gene_sets_(_see_above_for_details': 9.148819220060914e-58, 'listed': 0.00238803522972525, '%_%': 0.007713134335009549, 'enrichment_scores': 8.042864302131433e-06, 'CESs': 8.042864302131433e-06, 'data_sets_were_were': 9.148819220060914e-58, 'z_-': 9.148819220060914e-58, 'FDRs': 0.0005423312279404596, 'FDRs_0.1_FDRs_0.05': 0.000576827339123862, 'FDRs_0.25': 0.000576827339123862, 'setsThree_data': 9.148819220060914e-58, 'D_CES_Diff': 9.148819220060914e-58, 'As_shown_in_ _gene_sets_like_the_proteasome_and_BCR_signaling_pathways': 0.0005715966671738797, 'to_consider_more_robust_approaches': 0.007713134335009549, 'Thioredoxin_2': 1.4055400435083287e-53, 'Marker_LC3': 9.148819220060914e-58, 'Prognosis': 9.148819220060914e-58, 'B_release': 0.00048168087732480315, 'Nlrp3_inflammasome': 7.856705600874504e-06, 'Nat_Med19_ThorensB': 9.148819220060914e-58, 'TschoppJ': 9.148819220060914e-58, 'invasion_capabilities': 0.00011433162374159948, 'Nrf2_transcription': 9.148819220060914e-58, 'ROS_detoxification_tumorigenesis': 9.148819220060914e-58, 'LiYC_KongLD': 9.148819220060914e-58, 'inflammasome_activation_accumulation': 9.148819220060914e-58, 'PAI-2_expression': 8.263922883666513e-55, 'et_al_flavonoid': 0.0005521751935137136, 'Delphinidin': 1.81823575620778e-05, 'Autophagy_inhibition': 0.0005521751935137136, 'P16_reactivation': 4.4831882183043755e-07, 'antitumour_potency': 7.317875877424248e-09, 'Nilotinib': 0.0015590517682218864, 'cycle_arrests': 9.009585432209905e-06, 'Medicine_Drugs_Medicine_Oncology_Sulindac_Compounds': 5.101697218109943e-06, '-Lapachone': 7.417164383651313e-53, 'TW_YL': 0.0003327007272384309, 'cell_death_-lapachone': 0.0006940543140455221, 'drug_sulindac_metabolites': 6.700660819000809e-07, 'NQO1_levels': 0.0038806204677737646, 'increase_cytotoxicity': 8.263922883666513e-55, 'conclusion_sulindac_metabolites': 4.090580356865688e-07, '-Lapachone_a_natural_o_-_naphthoquinone_originally_obtained_from_lapacho_trees_in_South_America': 0.0007008712380191807, 'to_be_due_to_the_two_-_electron_reduction_of': 0.0007008712380191807, 'step_oxidation': 0.0038806204677737646, 'thiol_groups': 8.29208001901855e-05, 'membrane_depolarization_release': 8.29208001901855e-05, 'PET_studies': 9.148819220060914e-58, 'N_terminus_kidney_uptake': 9.148819220060914e-58, 'knot_probes': 9.148819220060914e-58, 'kidney_retention': 9.148819220060914e-58, 'capping_-_terminus': 9.148819220060914e-58, 'kidney_retention_PET_probes': 9.148819220060914e-58, 'size_peptides': 1.0182886102087001e-08, 'to_deliver_radiopharmaceuticals_or_chemotherapeutics': 9.96725951112108e-05, 'to_dramatically_affect_renal_uptake': 0.0006681652127777817, 'to_reduce_kidney_retention': 4.157595671573054e-05, 'PEGylation': 9.148819220060914e-58, 'to_improve_tumor_-_to_-_kidney_uptake_ratio': 9.148819220060914e-58, '10mer_peptide_sequence': 9.148819220060914e-58, 'RGD_moiety_integrin': 9.148819220060914e-58, 'imaging_results': 9.148819220060914e-58, 'v?6_expression': 9.148819220060914e-58, 'imaging_study': 0.007713134335009549, 'H2009.1_10mer': 8.263922883666513e-55, 'uptake_tumors_g': 1.2465514859286007e-05, 'N_probe': 9.148819220060914e-58, 'uptake_reduction': 9.148819220060914e-58, 'imaging_program_grant': 0.0003167145330801072, 'exquisite': 0.004315547045054443}\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\n"
     ]
    }
   ],
   "source": [
    "temp_consistent = {k: v for k, v in tqdm(eigenvector_centrality.items()) if k not in inconsistent_words}\n",
    "\n",
    "print(temp_consistent)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 173,
   "id": "56c93ee5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('ferroptosis', 0.015043906820768178),\n",
       " ('distributions', 0.014790379321251233),\n",
       " ('circRNAs', 0.014448418712648398),\n",
       " ('ers', 0.012947162597569449),\n",
       " ('cancer_cohorts', 0.012028681380063992),\n",
       " ('rnnmodel', 0.012028681380063992),\n",
       " ('dner', 0.011848467123284313),\n",
       " ('lbx2as1_expression', 0.011672185603023811),\n",
       " ('spheroids', 0.011499572565104511),\n",
       " ('CDKN2BAS1', 0.010705393278262195),\n",
       " ('tam', 0.010541402393443922),\n",
       " ('DRPT', 0.010436175505281345),\n",
       " ('igg4', 0.01023715389257993),\n",
       " ('GBM_cells', 0.010110825939499172),\n",
       " ('a0µM_a0µM', 0.010101169564734799),\n",
       " ('PAX9', 0.009882348354128045),\n",
       " ('bridge_teeth_typicalnumber', 0.009827085960189955),\n",
       " ('ers_levels', 0.009730556774261514),\n",
       " ('emt', 0.0095239722193556),\n",
       " ('to_be_a_previously_unrecognized_immune_evasion_mechanism_with_igg4_playing_an_essential_role_in_cancer_microenvironment_with_implications_in_cancer_diagnosis_and_immunotherapyintroductionwhile_ _new_ _immune_ _therapy_ _for_ _cancer_promise_structure',\n",
       "  0.009493919326339055),\n",
       " ('trim28_expression', 0.009478691897163903),\n",
       " ('discoveries', 0.009465059055267521),\n",
       " ('rg3', 0.009410877330066942),\n",
       " ('NFAT5', 0.009399193288440168),\n",
       " ('CD40_agonist', 0.00939418648782296),\n",
       " ('crc_tissues', 0.00939418648782296),\n",
       " ('attention_mechanism', 0.009393083572413214),\n",
       " ('morethan_years_hadexperience_complexity_risk_contributionslz_yx_study_cz_yx_hw_qz_zd_whcollected_analyzed_data_ma',\n",
       "  0.009366186179114803),\n",
       " ('risk_score_infiltration_degree_a06c\\x93h', 0.00936119697260216),\n",
       " ('fumarates', 0.009210082694724314),\n",
       " ('Compute_time', 0.009101363884740284),\n",
       " ('discovery_rate_withswissmodel30_totwo_groups_ihcfor_metastasis_models_Ã\\x97_control_mock_isofluranethe_distribution_downregulation_cancer_patient_role',\n",
       "  0.009012877355323872),\n",
       " ('piecewise_representation', 0.008897227986175937),\n",
       " ('pvalueless_confirmation_place', 0.008692860734793183),\n",
       " ('criteria_inclusion_criteria_swab_collections_biopsy_consent',\n",
       "  0.008629918477970512),\n",
       " ('frequency_heterozygotes_allele_carriers_correlation_RF',\n",
       "  0.008571309280431393),\n",
       " ('increasedbax_expression', 0.008565337949924265),\n",
       " ('TERTp_variants', 0.00856417769670554),\n",
       " ('TTNAS1', 0.00853994896379691),\n",
       " ('dmf', 0.008513336490015283),\n",
       " ('spheroids\\x99_sizes', 0.008428375200044073),\n",
       " ('miR578_expression', 0.00841400557302873),\n",
       " ('knockout_ko', 0.008383532384197919),\n",
       " ('to_inhibit_theproliferation_of_estrogen_receptor_Î±_erÎ±_negative_andpositive_breast_cancer_cell_lines_through_ampk_stimulation_  _however_when_tested_in_mice_models_metformin_contributes_to_enhanced_tumor_progression_andincreased_angiogenesis_providing_us_with_a_glimpse_ofpotential_proneoplastic_effects_of_ampk_activation_ _in_our_study_density_plots',\n",
       "  0.008322475568105201),\n",
       " ('miRNAs_functions', 0.008304706973768554),\n",
       " ('production_drugtreatment', 0.00829217017245816),\n",
       " ('functions_significance', 0.008237972046194055),\n",
       " ('stxbp6_overexpression', 0.008221371705683841),\n",
       " ('co\\x91treatment', 0.008186991763352563),\n",
       " ('efforts_responses_me_family_member\\x99sprognosis_journey',\n",
       "  0.008167413640263974),\n",
       " ('\\x8a\\x86_Q_genes', 0.008122478488739149),\n",
       " ('multitude_to_detect_the_relevant_proteins_mirna_and_gene_expression_luciferase_reporterassays_were_used_to_illustrate_the_interaction_between_mir4255p_and_ptenresults',\n",
       "  0.008113309576937157),\n",
       " ('tfs', 0.008112755406214648),\n",
       " ('nonseed_genes_mirnas_groupspecific_genenetworks_page_hub_genes_validation_loocvto_score_st_subnetwork_b_subnetwork_edges_performance_default_label_superiority_performanceauc',\n",
       "  0.008084058017534411),\n",
       " ('significantdecrease', 0.008076978651254266),\n",
       " ('investigation_stain_decolorize_stain_sds_technology22',\n",
       "  0.008061831776000162),\n",
       " ('tga_data', 0.008050454065961409),\n",
       " ('representative', 0.008045360685239538),\n",
       " ('AP', 0.008041460566471202),\n",
       " ('fit_betabinomial', 0.008039224644126477),\n",
       " ('liver_cells', 0.008030314084977333),\n",
       " ('studies_relevance_insights_limitations_genes', 0.008028992269334635),\n",
       " ('risk_ratio', 0.008024143281886418),\n",
       " ('miR4113p', 0.008018930683735357),\n",
       " ('LINC02418', 0.008006812242784975),\n",
       " ('section_rate', 0.007965688364544891),\n",
       " ('treatmentThough', 0.007964848274023877),\n",
       " ('immunoglobulin_assays_igg4', 0.00795752645973963),\n",
       " ('CNVR', 0.007931022133590704),\n",
       " ('bones', 0.007886092063037352),\n",
       " ('CNV', 0.007854223330154756),\n",
       " ('CNV_calls', 0.007842792251454019),\n",
       " ('cancer_cell_lines', 0.007841328814772971),\n",
       " ('cell_line_ags', 0.007841328814772971),\n",
       " ('thyrotoxicosis', 0.00783720183830918),\n",
       " ('functionalrequirement', 0.00782878996536959),\n",
       " ('methylation_analysis', 0.007826983625777101),\n",
       " ('roc_curves', 0.007824517706536607),\n",
       " ('effect_correlation_risk_a0', 0.007821180775462051),\n",
       " ('group_box', 0.00781909453522834),\n",
       " ('enrichment_method_taking_on_only_four_possible_values_for_\\x9cProstate_cancer\\x9d_due_to_few_overlapping_genes_ANUBIX_fraction_results_significance',\n",
       "  0.007794873673985646),\n",
       " ('tissues_tissues', 0.007778603169591112),\n",
       " ('PDAC_growth', 0.007776888883290368),\n",
       " ('TTNAS1_expression', 0.00776108169307199),\n",
       " ('to_evaluate_the_associations_between_PFAS_exposure_and_fasting_plasma_glucose_FPG_and_1h_plasma_glucose_concentrations_ ',\n",
       "  0.007756674467721497),\n",
       " ('CNV_Evol_Page', 0.007743912198506766),\n",
       " ('anticancer', 0.00774138547562212),\n",
       " ('glioma_proliferation_migration_invasion_analysis_using_cck8_edu',\n",
       "  0.007740714078928659),\n",
       " ('rescue_experiments', 0.007740371469685373),\n",
       " ('proteins_level', 0.007738296600229679),\n",
       " ('tumor_rinsingwith_toobserve_immunostaining_images_incancer_progression',\n",
       "  0.007737938190906188),\n",
       " ('primer_blast_dntp_a0Î¼l_a0Î¼l_a0u', 0.007730105938933497),\n",
       " ('sPD_L1_levels', 0.007727125946773411),\n",
       " ('mgat5', 0.0077235665609322515),\n",
       " ('mdamb231cells', 0.007722569854247233),\n",
       " ('thatWC', 0.007721647952463805),\n",
       " ('\\x9chybrid\\x9d_compton_camera', 0.007721530385997435),\n",
       " ('cnn', 0.007721361645195541),\n",
       " ('repetitions', 0.007719350026983925),\n",
       " ('reporting_items', 0.007719303035876401),\n",
       " ('score_kaplanmeiermethod_to_calculate_hazard_ratios_sex_covariates_postdiagnosisfactors_activity_subgroup_analysesincategories_weight',\n",
       "  0.007719301939468782),\n",
       " ('tokens', 0.007719301939468782),\n",
       " ('dner_knockdown', 0.007718350708776022),\n",
       " ('using_ _cck8_ _and_ _detection', 0.007717602935372225),\n",
       " ('formulations', 0.007717245523549822),\n",
       " ('CENPM_expression', 0.007717244975784016),\n",
       " ('case_definitions_HES_APC_cancers_cancer_site_individual_data_source',\n",
       "  0.007717244975784016),\n",
       " ('to_build_a_mutation_estimation_model_using_thefewest_genes_which_tightly_associated_with_westmbin_our_study',\n",
       "  0.007717244975784016),\n",
       " ('data_results_rr_times_normoxia_physoxia', 0.007717244975784016),\n",
       " ('a0_nm_paclitaxel', 0.007715942528612832),\n",
       " ('21suppl_page', 0.0077152030777233585),\n",
       " ('death_functions', 0.007715190751220473),\n",
       " ('role\\x9d_\\x9cexpectations\\x9d\\x9cdesires\\x9d_reviews_letters_primary_authorlas',\n",
       "  0.007715190203162627),\n",
       " ('qPCR_experiments', 0.00771518910792271),\n",
       " ('GOLM1_expression', 0.00771518910792271),\n",
       " ('method_tomeasure_density', 0.00771518910792271),\n",
       " ('DEGs_COL8A1', 0.00771518910792271),\n",
       " ('singlenuclei_annotations', 0.00771518910792271),\n",
       " ('run', 0.00771518910792271),\n",
       " ('scarless_editing', 0.00771518910792271),\n",
       " ('variance_ANOVA', 0.00771518910792271),\n",
       " ('2A', 0.00771518910792271),\n",
       " ('thepatients_modelfor_DFS', 0.00771518910792271),\n",
       " ('treatment_effect', 0.00771518910792271),\n",
       " ('\\x88\\x88', 0.00771518910792271),\n",
       " ('frequencyof_mutations', 0.00771518910792271),\n",
       " ('eqz_mutations', 0.00771518910792271),\n",
       " ('mutation_frequencies_p', 0.00771518910792271),\n",
       " ('to_include_patients_in_\\x93_dutch_hospitals_that_participatein_plcrcin_connection_ii_patients_with_a_mss_ct3\\x934nxm0_colon_tumor_will_be_treated_with_two_courses_ofneoadjuvant_and_two_courses_of_adjuvant_capecitabineand_oxaliplatin_capox_fig_ _and',\n",
       "  0.00771518910792271),\n",
       " ('patients_lowlow_highhigh_score_tfexpression_score', 0.00771518910792271),\n",
       " ('consent_nonmelanoma_skin_cancer', 0.00771518910792271),\n",
       " ('pten', 0.00771518910792271),\n",
       " ('word_embeddings', 0.00771518910792271),\n",
       " ('vector_model', 0.00771518910792271),\n",
       " ('flowchart_using_thesearch_strategy_the_pooled_overall_orr_for_the_seven_studies',\n",
       "  0.00771518910792271),\n",
       " ('drug_therapy', 0.00771518910792271),\n",
       " ('incancer_models', 0.00771518910792271),\n",
       " ('laparoscopic', 0.00771518910792271),\n",
       " ('hepg2', 0.00771518910792271),\n",
       " ('dner_protein_expression', 0.00771518910792271),\n",
       " ('r0_rate', 0.00771518910792271),\n",
       " ('to_construct_thecoexpression_network_with_cytoscapewe_genes_web_resource_database_analysis',\n",
       "  0.00771518910792271),\n",
       " ('thatmagnolol', 0.00771518910792271),\n",
       " ('CTA', 0.007713134335009549),\n",
       " ('surgeons_maxillofacialsurgeons_ophthalmologists_dentists',\n",
       "  0.007713134335009549),\n",
       " ('indicationthat', 0.007713134335009549),\n",
       " ('health_emergencythe_management_phase', 0.007713134335009549),\n",
       " ('intervention_studies', 0.007713134335009549),\n",
       " ('gain_ _loss_and_ _gainloss_events', 0.007713134335009549),\n",
       " ('software_packages', 0.007713134335009549),\n",
       " ('GO_enrichment_pathway_analyses', 0.007713134335009549),\n",
       " ('melanocortin_receptor_MC1R_GCG_genes', 0.007713134335009549),\n",
       " ('proteincoding_ _genes_ ', 0.007713134335009549),\n",
       " ('CNVR_CNVR_506_chr6', 0.007713134335009549),\n",
       " ('average_Evol_Page', 0.007713134335009549),\n",
       " ('enrichment_result', 0.007713134335009549),\n",
       " ('enrichment_comparison', 0.007713134335009549),\n",
       " ('to_control_several_potential_covariatesConclusionsThis_retrospective_cohort_study',\n",
       "  0.007713134335009549),\n",
       " ('outgainoffunction_assays', 0.007713134335009549),\n",
       " ('distribution_data_FISH_RNA_isolation', 0.007713134335009549),\n",
       " ('develop_a_nomogram_based_on_the_TMErelated_genessignature_and_clinicopathologic_data_to_predict_the_prognosis_of_osteosarcoma_patients_Firstlythe_univariateCOX_analysis_was_performed_to_filter_prognostic_variableswhich_will_be_further_included_in_the_multivariate_COXanalysis_Secondly_based_on_independent_prognostic_variables_two_nomograms_were_established_for_predicting_theOS_and_DFS_respectively_The_Cindex_was_used_to_assessthe_discriminatory_performance_of_the_nomogram_whichrange_from_ _to_ _[',\n",
       "  0.007713134335009549),\n",
       " ('heterogeneity_TME_studyindicated', 0.007713134335009549),\n",
       " ('performing_contrastenhanced_diffusionweightedMRI', 0.007713134335009549),\n",
       " ('prospectivestudies_population_studies', 0.007713134335009549),\n",
       " ('anincrease_Fig', 0.007713134335009549),\n",
       " ('GHMiNEN_group', 0.007713134335009549),\n",
       " ('to_probe_into_the_biological_role', 0.007713134335009549),\n",
       " ('lncRNAs_lncRNAs', 0.007713134335009549),\n",
       " ('level_ofmiR46773p', 0.007713134335009549),\n",
       " ('to_determine_whetherLINC02418', 0.007713134335009549),\n",
       " ('upregulation_absence', 0.007713134335009549),\n",
       " ('KI', 0.007713134335009549),\n",
       " ('thedosage', 0.007713134335009549),\n",
       " ('to_explore_the_association_with_snoring_and_body_composition_in_menopausalwomenMethodsStudy_participantsThis_crosssectional_study',\n",
       "  0.007713134335009549),\n",
       " ('differenceamong_status_respect', 0.007713134335009549),\n",
       " ('Spint5_Ces5a_testisspecific_genes', 0.007713134335009549),\n",
       " ('gene_knockouts_Spint3', 0.007713134335009549),\n",
       " ('RNAseqdata', 0.007713134335009549),\n",
       " ('to_minimize_any_potential_misclassificationby_using_main_diagnoses_only_Due_to_increased_medicalsurveillance_of_patients_with_hyperthyroidismthesewomen_may_be_diagnosed_earlier_with_breast_cancer_thanwomen_without_hyperthyroidism_While_this_possiblebias_might_slightly_shift_the_temporal_risk_pattern_amongwomen_with_hyperthyroidism',\n",
       "  0.007713134335009549),\n",
       " ('mechanisms_functions', 0.007713134335009549),\n",
       " ('assay_distribution', 0.007713134335009549),\n",
       " ('website', 0.007713134335009549),\n",
       " ('knockdown_efficiency_Fig', 0.007713134335009549),\n",
       " ('mechanisms_0cPeng', 0.007713134335009549),\n",
       " ('potential_roles', 0.007713134335009549),\n",
       " ('to_ _examine_ _the_ _biological_ _effect_of_ _circZFR_ _in_ _the_ _malignant_ _progression_ _of_ _BC_ _in_a0_vitro_and_ ',\n",
       "  0.007713134335009549),\n",
       " ('BC_patients', 0.007713134335009549),\n",
       " ('link_Fig_a0_1c_a0et', 0.007713134335009549),\n",
       " ('model_assays', 0.007713134335009549),\n",
       " ('BT549_cell_line', 0.007713134335009549),\n",
       " ('to_ _identify_ _whether_ _miR578_ _was_ _a_ _molecular_mediator_of_circZFR_in_BC_progression',\n",
       "  0.007713134335009549),\n",
       " ('effect_expression_a0et', 0.007713134335009549),\n",
       " ('²UTR_fragment', 0.007713134335009549),\n",
       " ('that_resultsin_weight_loss', 0.007713134335009549),\n",
       " ('CIRCscore_expression', 0.007713134335009549),\n",
       " ('averageCIRCscores', 0.007713134335009549),\n",
       " ('circSMARCA5_role_protein_levels_ofSMARCA5_SMARCA5Î\\x94SMARCA5_protein_levels_spectrometry_Fig',\n",
       "  0.007713134335009549),\n",
       " ('DRIP_qPCR', 0.007713134335009549),\n",
       " ('DNA_fragments', 0.007713134335009549),\n",
       " ('overexpression_clones', 0.007713134335009549),\n",
       " ('expressedcircRNAs', 0.007713134335009549),\n",
       " ('basedon_data', 0.007713134335009549),\n",
       " ('age_data', 0.007713134335009549),\n",
       " ('regression_model_QLQC30_scores_twoway_interactionage_presence',\n",
       "  0.007713134335009549),\n",
       " ('survey_datafrom_individuals', 0.007713134335009549),\n",
       " ('age_normativedata_QLQC30', 0.007713134335009549),\n",
       " ('cancerspecific_questionnaire', 0.007713134335009549),\n",
       " ('MCF_MDAMB231_cells', 0.007713134335009549),\n",
       " ('assay_blotting', 0.007713134335009549),\n",
       " ('protein_expression_values', 0.007713134335009549),\n",
       " ('to_ _identify_ _the_ _expression_and_functional_role_of_PDP1_in_human_PDAC',\n",
       "  0.007713134335009549),\n",
       " ('survival_data', 0.007713134335009549),\n",
       " ('its_expression', 0.007713134335009549),\n",
       " ('times_vitamin_C_vitamin_A_potassium_iron', 0.007713134335009549),\n",
       " ('sexspeciï¬\\x81c_regression_models', 0.007713134335009549),\n",
       " ('baselinedata_\\x93_Approvals', 0.007713134335009549),\n",
       " ('regression_models_details', 0.007713134335009549),\n",
       " ('quantileregression', 0.007713134335009549),\n",
       " ('to_compare_similar_agestrata', 0.007713134335009549),\n",
       " ('sex_values', 0.007713134335009549),\n",
       " ('to_read_and_include_all_therelevant_s', 0.007713134335009549),\n",
       " ('TERTp_TERTp146', 0.007713134335009549),\n",
       " ('Venn_diagram_probability_a0et', 0.007713134335009549),\n",
       " ('to_ _assess_ _the_ _possible_ _interrelationship_ _between_ _the_ _four_ _diverse_ _TERTp_ _mutations_ _using',\n",
       "  0.007713134335009549),\n",
       " ('TERTp_variants_UPN131_UPN171', 0.007713134335009549),\n",
       " ('casefor_presentation', 0.007713134335009549),\n",
       " ('to_monitor', 0.007713134335009549),\n",
       " ('theimplications_101038s41392020002598INTRODUCTIONIn_Johnson',\n",
       "  0.007713134335009549),\n",
       " ('sCD146_itsligands_functions', 0.007713134335009549),\n",
       " ('CD146may_act', 0.007713134335009549),\n",
       " ('Th2typecytokines_IL33_expression', 0.007713134335009549),\n",
       " ('Th2typecytokines', 0.007713134335009549),\n",
       " ('response_mice_journal', 0.007713134335009549),\n",
       " ('Dasgupta_Priyanka_KulkarniEdited', 0.007713134335009549),\n",
       " ('luciferase_reporter_ACHN_cells', 0.007713134335009549),\n",
       " ('cell_lines_decrease_Fig_3jindicating_regulation', 0.007713134335009549),\n",
       " ('methylation_status_thepresence', 0.007713134335009549),\n",
       " ('titinantisense', 0.007713134335009549),\n",
       " ('CCA_cases', 0.007713134335009549),\n",
       " ('cellviability_Supplementary_Fig', 0.007713134335009549),\n",
       " ('phenotyperescueexperiments_First_siALKBH5', 0.007713134335009549),\n",
       " ('Dice_coefficient', 0.007713134335009549),\n",
       " ('height_±_a0_µm_µm', 0.007713134335009549),\n",
       " ('likelihood_estimation', 0.007713134335009549),\n",
       " ('v70123_pathways_REACTOME_v6224_pathways', 0.007713134335009549),\n",
       " ('hierarchy', 0.007713134335009549),\n",
       " ('KEGG_pathways_REACTOME_pathways', 0.007713134335009549),\n",
       " ('limit_theorem', 0.007713134335009549),\n",
       " ('distribution_statistics', 0.007713134335009549),\n",
       " ('dispersion_values', 0.007713134335009549),\n",
       " ('enrichment_method', 0.007713134335009549),\n",
       " ('to_be_lower', 0.007713134335009549),\n",
       " ('benchmark', 0.007713134335009549),\n",
       " ('method\\x99s_ability', 0.007713134335009549),\n",
       " ('number_times', 0.007713134335009549),\n",
       " ('nonhuman', 0.007713134335009549),\n",
       " ('to_analyze_functionally_the_combined_effect_of_Bay_ _and_TMZ_in_different_GBM_cells_For_this_purpose',\n",
       "  0.007713134335009549),\n",
       " ('PEGDAbased_microwell_platform31\\x93', 0.007713134335009549),\n",
       " ('to_continue_our_experiments_with_only_using_our_patientderived_GBM_cells_We_treated_patientderived_GBM_cells_with_Bay_ _and_TMZ_or_alone_and_analyzed_specific_cellular_proteins_along_with_their_posttranslational_modifications_via_reversephase_protein_arrays_RPPA_to_elucidate_the_mechanism_of_action_of_the_ _proteins3839',\n",
       "  0.007713134335009549),\n",
       " ('RPPA_platform', 0.007713134335009549),\n",
       " ('chromatin_aggregation', 0.007713134335009549),\n",
       " ('furtherCo\\x91treatment', 0.007713134335009549),\n",
       " ('migration_patterns', 0.007713134335009549),\n",
       " ('drug_concentrations', 0.007713134335009549),\n",
       " ('to_repair_pathogenic_allele\\x91specific_single\\x91nucleotide_mutations_using_a_single_round_of_genome_editing_Using_high\\x91fidelity_site\\x91specific_nuclease',\n",
       "  0.007713134335009549),\n",
       " ('to_repair_pathogenic_single\\x91nucleotide_variants_SNVs_in_disease\\x91specific',\n",
       "  0.007713134335009549),\n",
       " ('PAM_variant', 0.007713134335009549),\n",
       " ('HDR_singlestranded', 0.007713134335009549),\n",
       " ('ssODN', 0.007713134335009549),\n",
       " ('T7E1_assay', 0.007713134335009549),\n",
       " ('to_replace_the_wildtype_nucleotide_RET_c2753_T_at_the_Met918_site_in_the_wildtype_allele_in_FB414',\n",
       "  0.007713134335009549),\n",
       " ('SNMDPCR', 0.007713134335009549),\n",
       " ('cleavage_activity_recognition_specificity_crRNA_RET2_Fig_a02a',\n",
       "  0.007713134335009549),\n",
       " ('crRNA_RET1_a0_m', 0.007713134335009549),\n",
       " ('offtarget_effects', 0.007713134335009549),\n",
       " ('to_carry_out_the_repairs_in_a_single_stepUsing_the_OneSHOT_approach_developed_in_this_study_we_successfully_repaired_a_RET_gene_SNV_in_MEN2B_iPSCs_with_the_addition_of_a_singlenucleotide_selective_marker_in_a_single_step',\n",
       "  0.007713134335009549),\n",
       " ('gene_SNV', 0.007713134335009549),\n",
       " ('AsCas12a_nuclease', 0.007713134335009549),\n",
       " ('AmpliSeq_analysis', 0.007713134335009549),\n",
       " ('CIBERSORT17_to_evaluate_and_predict_the_enrichment_of_immune_cells_in_the_samples_CIBERSORT_is_a_tool_for_deconvolution_of_the_expression_matrix_of_immune_cell_subtypes_based_on_the_principle_of_linear_support_vector_regression_RNA_SEQ_data_can_be_used_to_estimate_the_infiltration_of_immune_cells_CIBERSORT_can_analyze_the_relative_abundance_of_ _immune_infiltrating_cells_in_each_sample_including_NK_cells_T_cells_B_cells_and_macrophagesFunctional_ _enrichment_ _analysis_ _of_ _GSEA_ _go_ _and_ _KEGG_ _Gene_ _set_ _enrichment_ _analysisGSEA_enrichment_analysis_was_carried_out_for_each_gene_related_to_immune_prognosis_using_the_fgsea_package_in_R_ _Cluster_ _profiler19_was_used_to_enrich_Gene_ontologyGOfunction_and_KEGG_pathway_Significant_enrichment_criteria',\n",
       "  0.007713134335009549),\n",
       " ('data_samples', 0.007713134335009549),\n",
       " ('machine', 0.007713134335009549),\n",
       " ('GSE1152_GSE11223_GSE22619', 0.007713134335009549),\n",
       " ('features_genes', 0.007713134335009549),\n",
       " ('candidate_SVM_model', 0.007713134335009549),\n",
       " ('SVM_implementation', 0.007713134335009549),\n",
       " ('training_dataset_animalsResultsFeature_a0selection', 0.007713134335009549),\n",
       " ('classifier_configuration', 0.007713134335009549),\n",
       " ('5fold_crossvalidation', 0.007713134335009549),\n",
       " ('AUPRC_AUPRC', 0.007713134335009549),\n",
       " ('age_differences_fact', 0.007713134335009549),\n",
       " ('cholesterol_TG_concentrations', 0.007713134335009549),\n",
       " ('TCGAbiolinks_RBioconductor_package30_RepoRtS', 0.007713134335009549),\n",
       " ('reconstruction_flow', 0.007713134335009549),\n",
       " ('resolution_measure', 0.007713134335009549),\n",
       " ('submodel', 0.007713134335009549),\n",
       " ('heterozygotes_allele_carriers', 0.007713134335009549),\n",
       " ('correlation_RF', 0.007713134335009549),\n",
       " ('RANKL_concentration', 0.007713134335009549),\n",
       " ('users_Facebook_Twitter_email_newsletters', 0.007713134335009549),\n",
       " ('to_ _elaborate_on_AGREE_II', 0.007713134335009549),\n",
       " ('participation_engagement', 0.007713134335009549),\n",
       " ('surgical_development_anisations_policymakers', 0.007713134335009549),\n",
       " ('markers_expression', 0.007713134335009549),\n",
       " ('understanding_location', 0.007713134335009549),\n",
       " ('number_offollowingcombination_therapy', 0.007713134335009549),\n",
       " ('significantincrease_Figure', 0.007713134335009549),\n",
       " ('CD44hi_memorycells_T_cells', 0.007713134335009549),\n",
       " ('CD44hi_memorycells_T_cells_wereFigure_Rechallenge_experiments',\n",
       "  0.007713134335009549),\n",
       " ('immuneactivation_effects_response', 0.007713134335009549),\n",
       " ('wereFigure_Rechallenge_experiments', 0.007713134335009549),\n",
       " ('areduction', 0.007713134335009549),\n",
       " ('literature_Cterminal_FYVEdomain', 0.007713134335009549),\n",
       " ('eï¬ects_underlyingmechanisms', 0.007713134335009549),\n",
       " ('glucose_consumption_lactateproduction', 0.007713134335009549),\n",
       " ('thatexposure', 0.007713134335009549),\n",
       " ('\\x82uence_signaling', 0.007713134335009549),\n",
       " ('survival_advantages', 0.007713134335009549),\n",
       " ('association_N_stage_subtype_area', 0.007713134335009549),\n",
       " ('howthese_HDACs', 0.007713134335009549),\n",
       " ('PD1_blockade_survivalResults', 0.007713134335009549),\n",
       " ('FUS_system_1B\\x93C', 0.007713134335009549),\n",
       " ('GEM_therapy_mgmouse', 0.007713134335009549),\n",
       " ('termination', 0.007713134335009549),\n",
       " ('brefeldin_injection', 0.007713134335009549),\n",
       " ('Rag1\\x88\\x92\\x88\\x92_model', 0.007713134335009549),\n",
       " ('exchange_TPE', 0.007713134335009549),\n",
       " ('sPD_L1_fig', 0.007713134335009549),\n",
       " ('EV_levels_L1', 0.007713134335009549),\n",
       " ('treatmentdecisions_treatment_patientsHCCs_subtype', 0.007713134335009549),\n",
       " ('to_model_this_disease_in_Xenopus_tropicalis_X_tropicalis_embryos',\n",
       "  0.007713134335009549),\n",
       " ('siRNA_screen', 0.007713134335009549),\n",
       " ('candidatesfrom_the_RNAseq_dataset_to_follow_up_on_in_greater_detail_The_mRNA_levels_for_the_ _candidates_were_all_downregulated_after_PAX9_depletion_and_all_code_for_nucleolar_proteins',\n",
       "  0.007713134335009549),\n",
       " ('to_map_how_RNAPII_distributes_on_genes_using_RNAPIIChIPseq_as_a_readout_of_transcription_Through_this_approach_we_aimed_to_untangle_the_effectsof_PAX9_depletion_on_RNAPII_transcription_from_its_effects_on_mRNA_stability_since_RNAPIIChIPseq_is_able_to_detect_genomewide_changes_in_RNAPII_occupancy_As_PAX_proteins_areable_to_both_activate_and_repress_target_protein_expression',\n",
       "  0.007713134335009549),\n",
       " ('to_untangle_the_effectsof_PAX9_depletion_on_RNAPII_transcription_from_its_effects_on_mRNA_stability_since_RNAPIIChIPseq_is_able_to_detect_genomewide_changes_in_RNAPII_occupancy_As_PAX_proteins_areable_to_both_activate_and_repress_target_protein_expression',\n",
       "  0.007713134335009549),\n",
       " ('CentriMo', 0.007713134335009549),\n",
       " ('to_detect_changes_in_the_RNAPIImediated_transcription_of_a_number_of_mRNAs_encoding_nucleolar_proteins_after',\n",
       "  0.007713134335009549),\n",
       " ('implications_challenges_opportunities', 0.007713134335009549),\n",
       " ('subgroup_analysis_median_pfs', 0.007713134335009549),\n",
       " ('data_integration_methodologybased', 0.007713134335009549),\n",
       " ('equivalencerelation', 0.007713134335009549),\n",
       " ('onetoone_correspondence', 0.007713134335009549),\n",
       " ('\\x9celbowmethod\\x9d', 0.007713134335009549),\n",
       " ('tothe_guidelines', 0.007713134335009549),\n",
       " ('selection_methods', 0.007713134335009549),\n",
       " ('process_pipeline', 0.007713134335009549),\n",
       " ('pathology_records', 0.007713134335009549),\n",
       " ('regression_analysis_p', 0.007713134335009549),\n",
       " ('thatoverweight_patients', 0.007713134335009549),\n",
       " ('cases_data', 0.007713134335009549),\n",
       " ('number_data_visualization_cancer_types', 0.007713134335009549),\n",
       " ('genes_pole', 0.007713134335009549),\n",
       " ('that_pancandata', 0.007713134335009549),\n",
       " ('colorectal_adenocarcinoma_stomach_adenocarcinoma', 0.007713134335009549),\n",
       " ('immunescores', 0.007713134335009549),\n",
       " ('dna_polymerases', 0.007713134335009549),\n",
       " ('cases_genetics_page_number', 0.007713134335009549),\n",
       " ('nucleotide_transversions', 0.007713134335009549),\n",
       " ('estimate_immune', 0.007713134335009549),\n",
       " ('evolution_factors', 0.007713134335009549),\n",
       " ('referralto', 0.007713134335009549),\n",
       " ('bpci_model', 0.007713134335009549),\n",
       " ('days_months', 0.007713134335009549),\n",
       " ('embase_ebscocinahl_wileycochrane_library', 0.007713134335009549),\n",
       " ('type_prospective_retrospective', 0.007713134335009549),\n",
       " ('casemix_correction', 0.007713134335009549),\n",
       " ('variablesin_addition_wescored', 0.007713134335009549),\n",
       " ('abstracts', 0.007713134335009549),\n",
       " ('noimprovement_aspect', 0.007713134335009549),\n",
       " ('at_least_use_the_robson_classificationand_to_standardise_variables_for_additional_casemix_correction',\n",
       "  0.007713134335009549),\n",
       " ('to_develop_a_cos_for_neonatal_outcomes_after_caesareansectionforty_years_of_research_on_caesarean_section_rates',\n",
       "  0.007713134335009549),\n",
       " ('cohort_size', 0.007713134335009549),\n",
       " ('impact_sal_asymptomatic_al_aal_±_iqrmedian', 0.007713134335009549),\n",
       " ('phystec_sweden', 0.007713134335009549),\n",
       " ('to_understand_thekinds_of_support_that_are_optimal_use_behaviour_change_0cporserud_  _bmc_cancer_           _page_ _of_screened_for_eligibility_in_medical_records_by_the_responsible_researcher_rr',\n",
       "  0.007713134335009549),\n",
       " ('studyprotocol_wellbeing_readmissions_tocomplications',\n",
       "  0.007713134335009549),\n",
       " ('readmissions', 0.007713134335009549),\n",
       " ('to_conduct_an_interviewstudy_on_patients\\x99_experiences_of_the_intervention_inaddition_we_plan_to_collect_information_on_possiblebarriers_that_might_have_influenced_the_implementation_ofthe_programme_and_facilitators_that_mighthave_supported_it_at_the_various_clinical_sites',\n",
       "  0.007713134335009549),\n",
       " ('to_collect_information_on_possiblebarriers_that_might_have_influenced_the_implementation_ofthe_programme_and_facilitators_that_mighthave_supported_it_at_the_various_clinical_sites',\n",
       "  0.007713134335009549),\n",
       " ('specifically_impact_the_implementation_outcomes_in_the_present_study_and_guidelinesforand_observation_protocolsinterview',\n",
       "  0.007713134335009549),\n",
       " ('not_to_give_the_control_group_any_advice_onphysical_activity',\n",
       "  0.007713134335009549),\n",
       " ('to_have_continued_contact_withthe_clinics_and_a_new_educational_structure_for_trainingif_neededcystectomyin_summary',\n",
       "  0.007713134335009549),\n",
       " ('to_establish_optimal_nlr_plrand_lmr_cutpoints_for_determining_os_and_recurrencefree_survival_rfs_and_define',\n",
       "  0.007713134335009549),\n",
       " ('to_perform_a_continuous_analysis_to_identify_an_optimal_cutpoint_for_the_nlr_in_relation_to_survival_based_solely_onthe_data_from_our_cohort_optimal_cutpoints_of_ _foros_and_ ',\n",
       "  0.007713134335009549),\n",
       " ('pretreatment_immunologicratios', 0.007713134335009549),\n",
       " ('to_assess_the_tumor_response_per_cms_in_the_neoadjuvant_chemotherapy_settingthis',\n",
       "  0.007713134335009549),\n",
       " ('totreat_patients', 0.007713134335009549),\n",
       " ('predictivevalue', 0.007713134335009549),\n",
       " ('thatsimilar', 0.007713134335009549),\n",
       " ('to_complete_recruitment_of_patients_within\\x93_years_with',\n",
       "  0.007713134335009549),\n",
       " ('to_compare_patients_with_detectable_ctdna_who_received_act_inthe_intervention_arm_with_ _patients_with_detectablectdna_in_the_control_arm',\n",
       "  0.007713134335009549),\n",
       " ('highdropout_contamination', 0.007713134335009549),\n",
       " ('6monthsact', 0.007713134335009549),\n",
       " ('hazards_regression_analyses', 0.007713134335009549),\n",
       " ('profiles_analyses', 0.007713134335009549),\n",
       " ('alterations_scna_file', 0.007713134335009549),\n",
       " ('toexamine_impact', 0.007713134335009549),\n",
       " ('scores\\x99_foreach', 0.007713134335009549),\n",
       " ('differentialexpression_analyses', 0.007713134335009549),\n",
       " ('cox_regression_analyses', 0.007713134335009549),\n",
       " ('to_explore_the_crosstalk_between_ampksignaling_and_tf_activity_in_glioma',\n",
       "  0.007713134335009549),\n",
       " ('ampk_scoresfor', 0.007713134335009549),\n",
       " ('thoroughexamination', 0.007713134335009549),\n",
       " ('dietaryindex', 0.007713134335009549),\n",
       " ('scores_foreach_participant', 0.007713134335009549),\n",
       " ('patternchanges', 0.007713134335009549),\n",
       " ('prediagnosisedih', 0.007713134335009549),\n",
       " ('confounding_byunmeasured_variables_given', 0.007713134335009549),\n",
       " ('smd351', 0.007713134335009549),\n",
       " ('species_species', 0.007713134335009549),\n",
       " ('\\x9cenergy\\x9dindex', 0.007713134335009549),\n",
       " ('formulas_data', 0.007713134335009549),\n",
       " ('to_change_the_assumptions_about_the_labormarket_from_the_previouslyoutlined_conditions_as_by_hungarian_labor_market',\n",
       "  0.007713134335009549),\n",
       " ('to_increase_frictiontime', 0.007713134335009549),\n",
       " ('samplingpoints', 0.007713134335009549),\n",
       " ('outthat', 0.007713134335009549),\n",
       " ('navarreand', 0.007713134335009549),\n",
       " ('resultsand_prognoses', 0.007713134335009549),\n",
       " ('to_learn_about_mygrandmother_learn_about_my_mother', 0.007713134335009549),\n",
       " ('to_have_familygatherings', 0.007713134335009549),\n",
       " ('input_sentences', 0.007713134335009549),\n",
       " ('networks_wewant_somefig_example_textsmarked', 0.007713134335009549),\n",
       " ('theattention_system', 0.007713134335009549),\n",
       " ('to_predict_the_token\\x99sposition_tag_of_each_word_before_we_can_train_the_arnnmodel_to_predict_the_type_of_each_temporal_expressionwe_treat_each_temporal_expression_as_an_entity_and_eachentity',\n",
       "  0.007713134335009549),\n",
       " ('arnnmodel', 0.007713134335009549),\n",
       " ('valueof_word_embeddings', 0.007713134335009549),\n",
       " ('system_aprnnwhich', 0.007713134335009549),\n",
       " ('thesevectors', 0.007713134335009549),\n",
       " ('theaverage_vector', 0.007713134335009549),\n",
       " ('entity_pairs', 0.007713134335009549),\n",
       " ('time_dictionary', 0.007713134335009549),\n",
       " ('training_the_crf_and_svm_classifier', 0.007713134335009549),\n",
       " ('six_different_methodsthat_to_do', 0.007713134335009549),\n",
       " ('crf', 0.007713134335009549),\n",
       " ('model_system_withoutany_attention_mechanism_piecewise_representationwe',\n",
       "  0.007713134335009549),\n",
       " ('thewhole_sentence', 0.007713134335009549),\n",
       " ('sentence_rnn_system_butwith_piecewise_representation_rnnpie',\n",
       "  0.007713134335009549),\n",
       " ('to_conduct_a_scoping_review', 0.007713134335009549),\n",
       " ('inconjunction', 0.007713134335009549),\n",
       " ('ondecision', 0.007713134335009549),\n",
       " ('optimizedtmb_estimation_model', 0.007713134335009549),\n",
       " ('counts_lowtmb_groups_counts_gene_signatures_mutation_status',\n",
       "  0.007713134335009549),\n",
       " ('tmb_model_file', 0.007713134335009549),\n",
       " ('gene_expressionsignatures', 0.007713134335009549),\n",
       " ('performance_panel', 0.007713134335009549),\n",
       " ('wes', 0.007713134335009549),\n",
       " ('estimation_model', 0.007713134335009549),\n",
       " ('noveltmb_estimation_model', 0.007713134335009549),\n",
       " ('wang_jing_zhao_shangli_cai', 0.007713134335009549),\n",
       " ('patientspecific_network', 0.007713134335009549),\n",
       " ('multiomics_data_carcinoma', 0.007713134335009549),\n",
       " ('template_reference_network', 0.007713134335009549),\n",
       " ('pcc', 0.007713134335009549),\n",
       " ('reference_network', 0.007713134335009549),\n",
       " ('ofpccn1\\x88\\x92pccn', 0.007713134335009549),\n",
       " ('0clee', 0.007713134335009549),\n",
       " ('intergene_correlations', 0.007713134335009549),\n",
       " ('thetop_pcc', 0.007713134335009549),\n",
       " ('weightednetworks', 0.007713134335009549),\n",
       " ('ofeach_gene', 0.007713134335009549),\n",
       " ('patientspecific_genenetworks', 0.007713134335009549),\n",
       " ('groupspecific_genenetworks', 0.007713134335009549),\n",
       " ('cancer_relevance', 0.007713134335009549),\n",
       " ('genepairs', 0.007713134335009549),\n",
       " ('to_ _explore_ _the_ _biological_ _role_ _and_ _molecular_mechanism_of_lbx2as1_in_gliomamaterials_and_a0methodspatients_and_a0samplestissue_samples_including_ _normal_brains_and_ ',\n",
       "  0.007713134335009549),\n",
       " ('brains_glioma_tissues', 0.007713134335009549),\n",
       " ('method_a0_2b', 0.007713134335009549),\n",
       " ('increasing_ _concentrations_  _a0_nm_and_  _a0_nm_ _of_ _mir4915p_ ',\n",
       "  0.007713134335009549),\n",
       " ('to_cease_cell_proliferation', 0.007713134335009549),\n",
       " ('to_clarify_the_connection_ _between_ _tnfaip8_ _polymorphism_ _and_ ',\n",
       "  0.007713134335009549),\n",
       " ('correlation_a0', 0.007713134335009549),\n",
       " ('association_table', 0.007713134335009549),\n",
       " ('study_paper', 0.007713134335009549),\n",
       " ('operator_regression', 0.007713134335009549),\n",
       " ('tcga_geo_databases', 0.007713134335009549),\n",
       " ('genes_coef', 0.007713134335009549),\n",
       " ('pearson_correlation', 0.007713134335009549),\n",
       " ('data_information', 0.007713134335009549),\n",
       " ('cohort_a02b', 0.007713134335009549),\n",
       " ('risk_scores', 0.007713134335009549),\n",
       " ('genes_fig', 0.007713134335009549),\n",
       " ('risk_score_grade_p', 0.007713134335009549),\n",
       " ('gse32548_mutation_data', 0.007713134335009549),\n",
       " ('mir2143p_rna_levels', 0.007713134335009549),\n",
       " ('reduction_1b', 0.007713134335009549),\n",
       " ('mir2143p_rna_levels_reduction_1b', 0.007713134335009549),\n",
       " ('mice_models', 0.007713134335009549),\n",
       " ('type_fig_a0_5b', 0.007713134335009549),\n",
       " ('seed_sequences', 0.007713134335009549),\n",
       " ('rescue_experiment', 0.007713134335009549),\n",
       " ('mrnas_tissues', 0.007713134335009549),\n",
       " ('mrnas_lncrnas', 0.007713134335009549),\n",
       " ('to_explore_the_molecular_pathogenesis_potential_biomarkers_and_prognostic_indicators_ _of_ _npc_ _by_ _analyzing_ _the_ _full_ _transcriptome_sequencing_data_from_fujian_cancer_hospital_along_with_six_microarray_datasets_acquired_from_the_gene_expression_ _omnibus_ _geo_ _to_ _identify_ _degs_ _between_ _npc_samples_ _and_ _normal_ _tissue_ _samples_ ',\n",
       "  0.007713134335009549),\n",
       " ('library_fragments_beckman_coulter_zheng_et_al_unknownnpcnpc',\n",
       "  0.007713134335009549),\n",
       " ('microarray_data', 0.007713134335009549),\n",
       " ('upsetr', 0.007713134335009549),\n",
       " ('target_mrnas_e\\x93g_volcano_plots', 0.007713134335009549),\n",
       " ('hsamir29a3p_hsamir103a3p', 0.007713134335009549),\n",
       " ('twotechniques', 0.007713134335009549),\n",
       " ('devices_scissors', 0.007713134335009549),\n",
       " ('space_belowthe_sra', 0.007713134335009549),\n",
       " ('to_open_the_peritoneal_reflection', 0.007713134335009549),\n",
       " ('colon_mesocolon', 0.007713134335009549),\n",
       " ('themesorectum', 0.007713134335009549),\n",
       " ('analysis_usingtotal_rna', 0.007713134335009549),\n",
       " ('effect_muc5ac_expression', 0.007713134335009549),\n",
       " ('expression_pathology_page_cp_differentialexpression_muc5ac',\n",
       "  0.007713134335009549),\n",
       " ('to_analyze_the_impactof_tti_and_growth_kinetics_of_individual_tumors_on_theoccurrence_of_localregional_failure',\n",
       "  0.007713134335009549),\n",
       " ('rawproportion', 0.007713134335009549),\n",
       " ('flowchart', 0.007713134335009549),\n",
       " ('aesin', 0.007713134335009549),\n",
       " ('muc2_grp78', 0.007713134335009549),\n",
       " ('lv_controlcells', 0.007713134335009549),\n",
       " ('induction_ofupr_proteins', 0.007713134335009549),\n",
       " ('viability_prolif\\x91eration', 0.007713134335009549),\n",
       " ('viability_response', 0.007713134335009549),\n",
       " ('ab', 0.007713134335009549),\n",
       " ('brdu', 0.007713134335009549),\n",
       " ('dunn_test', 0.007713134335009549),\n",
       " ('to_find_whether_in_ _these_ _conditions_ _cbd_ _could_ _show_ _additive_ _or_ _synergistic_antiproliferative_effects_with_the_therapeutic_drug_paclitaxel_ _paclitaxel_ ',\n",
       "  0.007713134335009549),\n",
       " ('feasibility_safety', 0.007713134335009549),\n",
       " ('to_perform_a_synchronous_robotic_right_hemicolectomy_and_partial_gastrectomy_with_d2_lymphadenectomy_using_the_intuitive_da_vinci_ _xi_®_system_ ',\n",
       "  0.007713134335009549),\n",
       " ('mobilising_the_duodenum_and_the_posterior_side_of_the_stomach_using_the_gastrocolic_window',\n",
       "  0.007713134335009549),\n",
       " ('anonline_survey_format', 0.007713134335009549),\n",
       " ('respondent_assurance_feature', 0.007713134335009549),\n",
       " ('therapy_resistance', 0.007713134335009549),\n",
       " ('overview_mechanisms', 0.007713134335009549),\n",
       " ('predictivefactors', 0.007713134335009549),\n",
       " ('aa_cases', 0.007713134335009549),\n",
       " ('cases_man', 0.007713134335009549),\n",
       " ('cases_reportssuggested', 0.007713134335009549),\n",
       " ('manuscriptinterval_operation', 0.007713134335009549),\n",
       " ('how_to_treatit_ann_r_coll_surg_engl_\\x93oliak_d_yamini_d_udani_vm_lewis_rj_arnell_t_vargas_h_  _initialnonoperative_management_for_periappendiceal_abscess',\n",
       "  0.007713134335009549),\n",
       " ('bioinformatics_approach', 0.007713134335009549),\n",
       " ('computationalapproach', 0.007713134335009549),\n",
       " ('theknown_gene_targets', 0.007713134335009549),\n",
       " ('to_study_one_of_the_ï¬\\x81ve_topscored_candidate_genes_nrf2_among_nrf2compound_interactionsthe_main_use_of_dmf',\n",
       "  0.007713134335009549),\n",
       " ('ald_mousemodel_group_hepatic_modelnine_rats_rats_rats',\n",
       "  0.007713134335009549),\n",
       " ('gclc_proteinlevels', 0.007713134335009549),\n",
       " ('immunohistochemistry_ihc_blotting', 0.007713134335009549),\n",
       " ('sample_loading', 0.007713134335009549),\n",
       " ('glutathioneand_gssg', 0.007713134335009549),\n",
       " ('arestoration', 0.007713134335009549),\n",
       " ('livercells_inducer', 0.007713134335009549),\n",
       " ('blotting_ihc', 0.007713134335009549),\n",
       " ('value_roleof', 0.007713134335009549),\n",
       " ('dner_markers_resultsshowed', 0.007713134335009549),\n",
       " ('fig_2d', 0.007713134335009549),\n",
       " ('proteinexpression', 0.007713134335009549),\n",
       " ('normalizedmrna_zscores', 0.007713134335009549),\n",
       " ('csc_markers_tumors', 0.007713134335009549),\n",
       " ('acisplatinresistant_fadures_cells', 0.007713134335009549),\n",
       " ('faducells', 0.007713134335009549),\n",
       " ('epcamexpression', 0.007713134335009549),\n",
       " ('twopopulations', 0.007713134335009549),\n",
       " ('0cnoman_al_cell_death_disease_page', 0.007713134335009549),\n",
       " ('mrna_transcripts', 0.007713134335009549),\n",
       " ('using_hypoxia_as_asingle_parametersignatureof\\x97\\x8f',\n",
       "  0.007713134335009549),\n",
       " ('silver_iron_nanops_synthesis', 0.007713134335009549),\n",
       " ('to_yield_pacagnp_and_pacfenp_the_synthesized_nanops_werecharacterized_by_uv_ftir_xrd_and_sem_analysis_and_evaluated_for_antimicrobial_potential_against_selectedmicrobes',\n",
       "  0.007713134335009549),\n",
       " ('pacagnps_pacfenps', 0.007713134335009549),\n",
       " ('antioxidantactivitycapacitiespacagnps_pacfenps', 0.007713134335009549),\n",
       " ('genotypesof', 0.007713134335009549),\n",
       " ('chisquare_test_Ï\\x872', 0.007713134335009549),\n",
       " ('testto', 0.007713134335009549),\n",
       " ('gene_snps', 0.007713134335009549),\n",
       " ('association_subgroup', 0.007713134335009549),\n",
       " ('association_rs2070874', 0.007713134335009549),\n",
       " ('snps', 0.007713134335009549),\n",
       " ('to_thank_dr_yan_liu_genesky_biotechnologies_incshanghai_china_for_technical_supportabbreviationsajcc_american_joint_committee_on_cancer_bc_breast_cancer_bmi_body_mass_index_ci_confidence_interval_ecesophageal_cancer',\n",
       "  0.007713134335009549),\n",
       " ('engauge_digitizer_version_ _to_estimate_the_hrs_based_on_the_graphical_survival_plots_when_hrs_were_notdirectly_available_in_the_study_  ',\n",
       "  0.007713134335009549),\n",
       " ('thepreference', 0.007713134335009549),\n",
       " ('survival_analysis_results', 0.007713134335009549),\n",
       " ('database_analysis', 0.007713134335009549),\n",
       " ('understanding_\\x98multiplelncrnasmultiple', 0.007713134335009549),\n",
       " ('that_sry_sex_determining_region', 0.007713134335009549),\n",
       " ('to_contact_the_authors_to_request_the_missing_or_incomplete_data_if_those_relevant_data_are_notacquired_they_will_be_excluded_from_the_analysisquality_assessmentto',\n",
       "  0.007713134335009549),\n",
       " ('paying_close_attention_to_upcoming_highquality_clinical_trials_in_our_later_studies_and_carry_out_further_analyseson_studies_conducted_huaier_granule_monotherapy_against_breast_cancer',\n",
       "  0.007713134335009549),\n",
       " ('pathology_results', 0.007713134335009549),\n",
       " ('patients_therapies', 0.007713134335009549),\n",
       " ('survival_outcomes_factors', 0.007713134335009549),\n",
       " ('linc00173_sponges', 0.007713134335009549),\n",
       " ('function_protein', 0.007713134335009549),\n",
       " ('count_data_files', 0.007713134335009549),\n",
       " ('tnbcsamples_37', 0.007713134335009549),\n",
       " ('tau_rank_corlenka_relation', 0.007713134335009549),\n",
       " ('downregulation_1a', 0.007713134335009549),\n",
       " ('expression_subtypemcf7_zr751_cells', 0.007713134335009549),\n",
       " ('overexpressing_stxbp6_lentistxpb6_tnbc_cells_by_infecting_mdamb231_and_0c_of_lenka_ ',\n",
       "  0.007713134335009549),\n",
       " ('assaywhich', 0.007713134335009549),\n",
       " ('interactingpartners', 0.007713134335009549),\n",
       " ('interactionof_snx27', 0.007713134335009549),\n",
       " ('docking_docking_models', 0.007713134335009549),\n",
       " ('hydrogen_bonds_salt_bridges', 0.007713134335009549),\n",
       " ('potential_mechanisms_cells', 0.007713134335009549),\n",
       " ('crc_cell_lines', 0.007713134335009549),\n",
       " ('topfop', 0.007713134335009549),\n",
       " ('shift_assay', 0.007713134335009549),\n",
       " ('to_know_whether_erianin_regulates_the_expression_of_cd47',\n",
       "  0.007713134335009549),\n",
       " ('tumor_size_weight', 0.007713134335009549),\n",
       " ('to_explore_other_factors_that_could_extend_survival_in_the_recourse_population_for_the_purposes_of_our_exploratory_analysis',\n",
       "  0.007713134335009549),\n",
       " ('thisinformation_volume_method', 0.007713134335009549),\n",
       " ('to_be_the_features_of_lncrnas_the_features', 0.007713134335009549),\n",
       " ('to_encode_these_genesf_ ', 0.007713134335009549),\n",
       " ('thistime', 0.007713134335009549),\n",
       " ('pca\\x93cnn', 0.007713134335009549),\n",
       " ('neuralnetwork_dnn_volume_method', 0.007713134335009549),\n",
       " ('dbn\\x93cnn', 0.007713134335009549),\n",
       " ('method\\x9cdbn\\x93cnn\\x9d', 0.007713134335009549),\n",
       " ('chen_microarray_analysis', 0.007713134335009549),\n",
       " ('total_database_table', 0.007713134335009549),\n",
       " ('protein\\x93protein_network_kegg', 0.007713134335009549),\n",
       " ('antimetastaticeï¬ect', 0.007713134335009549),\n",
       " ('to_provide_a_framework_ofthe_current_knowledge_of_nk_cell_maturation_and',\n",
       "  0.007713134335009549),\n",
       " ('changes_mica_expression_withstressinducers_nkg2dl_induction_atp_acetylcoa_oxaloacetate_oaa',\n",
       "  0.007713134335009549),\n",
       " ('whetherthe_cancerassociated_glycosyltransferase_mgat5',\n",
       "  0.007713134335009549),\n",
       " ('signiï¬\\x81cant_increase', 0.007713134335009549),\n",
       " ('nkg2d_nkg2d', 0.007713134335009549),\n",
       " ('regulationof_mica', 0.007713134335009549),\n",
       " ('substrate_udpglcnac', 0.007713134335009549),\n",
       " ('site_p21cip_promoters_cell_lines', 0.007713134335009549),\n",
       " ('sirnas_table_s3', 0.007713134335009549),\n",
       " ('geo_dataset', 0.007713134335009549),\n",
       " ('transwell_migration_assay', 0.007713134335009549),\n",
       " ('antihcc_eï¬ects', 0.007713134335009549),\n",
       " ('modesof_action', 0.007713134335009549),\n",
       " ('cycle_progression_tumrowth', 0.007713134335009549),\n",
       " ('to_summarize_the_knownstrategies_for_isolating_neoantigenspeciï¬\\x81c_t_cellsedited_bycyrille_j_cohenbarilan_university_israelreviewed_bymanel_juanhospital_cl\\xadnic_de_barcelona_spainrodabe',\n",
       "  0.007713134335009549),\n",
       " ('assay_figure', 0.007713134335009549),\n",
       " ('bodyweightincrease', 0.007713134335009549),\n",
       " ('tgf1depletion_cell_line', 0.007713134335009549),\n",
       " ('expression_inppp3ca', 0.007713134335009549),\n",
       " ('mrnasand_lncrnas', 0.007713134335009549),\n",
       " ('miranda4_pita5', 0.007713134335009549),\n",
       " ('lncrnas_mrnas_turquoise_module', 0.007713134335009549),\n",
       " ('cerna_networkby', 0.007713134335009549),\n",
       " ('scores_scores_ofaml_patients', 0.007713134335009549),\n",
       " ('target_data', 0.007713134335009549),\n",
       " ('to_ _focus_ _on_ _the_ _following_ _topics_arrays_ _of_ _biological_ _resources_ ',\n",
       "  0.007713134335009549),\n",
       " ('trends_understandings', 0.007713134335009549),\n",
       " ('surface_morphologies', 0.007713134335009549),\n",
       " ('dataset_resultsshowed', 0.007713134335009549),\n",
       " ('thatmpc1', 0.007713134335009549),\n",
       " ('to_ï¬\\x81gure_out', 0.007713134335009549),\n",
       " ('mpc1_protein_expression', 0.007713134335009549),\n",
       " ('mpc1_mediatetumor_cell_motility', 0.007713134335009549),\n",
       " ('antibody_drug', 0.007713134335009549),\n",
       " ('pancreas_brain_antibodies', 0.007713134335009549),\n",
       " ('concentrations_n46_pairs_concentration', 0.007713134335009549),\n",
       " ('accessigg4', 0.007713134335009549),\n",
       " ('usa_c4215', 0.007713134335009549),\n",
       " ('igg4_igg1', 0.007713134335009549),\n",
       " ('tumor_specimen', 0.007713134335009549),\n",
       " ('leucocytes', 0.007713134335009549),\n",
       " ('pd1_expression', 0.007713134335009549),\n",
       " ('hla_dr_low', 0.007713134335009549),\n",
       " ('tam_polarization_function', 0.007713134335009549),\n",
       " ('use_cancer', 0.007713134335009549),\n",
       " ('specimen_cancer_patients_indication', 0.007713134335009549),\n",
       " ('anotypic_cultures', 0.007713134335009549),\n",
       " ('geometry', 0.007713134335009549),\n",
       " ('to_dock_the_molecule_with', 0.007713134335009549),\n",
       " ('td\\x93dft_formalism_2dp_basis_sets_ofmethanol', 0.007713134335009549),\n",
       " ('scholarships', 0.007713134335009549),\n",
       " ('action_feels', 0.007713134335009549),\n",
       " ('methods_results', 0.007713134335009549),\n",
       " ('to_recruit_ _interview_participants_stratified_evenly_based_on_prescription_insurance_coverage_age_and_gender',\n",
       "  0.007713134335009549),\n",
       " ('codebook_development', 0.007713134335009549),\n",
       " ('to_include_in_our_analysis_all_aspects_of_waiting_described_by_participants_rather_than_focus_on_just_one_eg_waiting_for_health_insurance_coverage',\n",
       "  0.007713134335009549),\n",
       " ('breadth', 0.007713134335009549),\n",
       " ('to_be_specific_about_what_participants_referred_to_when_they_talked_about_waiting',\n",
       "  0.007713134335009549),\n",
       " ('what_\\x98big', 0.007713134335009549),\n",
       " ('kate', 0.007713134335009549),\n",
       " ('timeseries_methods_data', 0.007713134335009549),\n",
       " ('to_gofurther_by_understanding_the_effects_of_diagnostic_and_treatmentdelay_by_prospective_data_collection_of_cancer_cases',\n",
       "  0.007713134335009549),\n",
       " ('tissuenonobeseobesenana\\x93\\x93pasarica', 0.007713134335009549),\n",
       " ('rpkm_values', 0.007713134335009549),\n",
       " ('acknowledgement_useagreement', 0.007713134335009549),\n",
       " ('comparison_group', 0.007713134335009549),\n",
       " ('multum_drug_database', 0.007713134335009549),\n",
       " ('model_onthe_training_data', 0.007713134335009549),\n",
       " ('cvh_measures', 0.007713134335009549),\n",
       " ('cvhmeasures', 0.007713134335009549),\n",
       " ('age_distribution_pone0237539_fit', 0.007713134335009549),\n",
       " ('tnc_lossofffunction', 0.007713134335009549),\n",
       " ('sequence_homology', 0.007713134335009549),\n",
       " ('epitope_us_expression_level', 0.007713134335009549),\n",
       " ('time_concentrationdependent_decrease', 0.007713134335009549),\n",
       " ('markers_blot_analysis', 0.007713134335009549),\n",
       " ('patientstreated_by_ophthalmologists_aa_mt_between_november_ _and_july_ ',\n",
       "  0.007713134335009549),\n",
       " ('features_age', 0.007713134335009549),\n",
       " ('egfr_technologies_danversma_usa_technologies', 0.007713134335009549),\n",
       " ('pcrwhich', 0.007713134335009549),\n",
       " ('to_create_a_single_minilaparotomy_for_specimen_retrieval_and_extracorporeal_reconstruction_after_lymph_node_dissection_and_mobilization_of_thecolonduring_the_operation_laparoscopic_exploration',\n",
       "  0.007713134335009549),\n",
       " ('surgerycombining_twosegment_resection_ofcourse', 0.007713134335009549),\n",
       " ('preserving_as_much_colonas_possible_considering_the_patient\\x99s_quality_oflife_aftersurgery',\n",
       "  0.007713134335009549),\n",
       " ('which_resection', 0.007713134335009549),\n",
       " ('to_purify_a_small_population_ofcd133_cells_from_these_cd44_cells_cd44_cells_almostnegatively_expressed_with_cd133_figure_1a',\n",
       "  0.007713134335009549),\n",
       " ('to_have_comparable_levels', 0.007713134335009549),\n",
       " ('to_silence_cd133expression_in_cd44cd133_cells_by_sirna',\n",
       "  0.007713134335009549),\n",
       " ('to_separate_thehct8_human_colon_cancer_cells_into_cd44_cd44_cd44cd133_and_cd44cd133_subpopulations',\n",
       "  0.007713134335009549),\n",
       " ('to_calculate_a_tail_probability_for_a_heterogeneous_Bernoulli_process',\n",
       "  0.007713134335009549),\n",
       " ('to_change_the_formulas_for_uSi_and_CESS_as_follows', 0.007713134335009549),\n",
       " ('CES_level', 0.007713134335009549),\n",
       " ('version_8_]', 0.007713134335009549),\n",
       " ('p_values_0.01', 0.007713134335009549),\n",
       " ('%_%', 0.007713134335009549),\n",
       " ('to_consider_more_robust_approaches', 0.007713134335009549),\n",
       " ('imaging_study', 0.007713134335009549),\n",
       " ('circRNA', 0.007501961338470725),\n",
       " ('M_oleifera', 0.00703585554715468),\n",
       " ('result_amongUS_adults', 0.006442305619365413),\n",
       " ('Wnt_signaling', 0.006427672210408067),\n",
       " ('o2', 0.006091138110594946),\n",
       " ('atnrna', 0.005861375669898526),\n",
       " ('colostomy_placement', 0.00572579098709217),\n",
       " ('tumor_subtypes', 0.0055616726205871755),\n",
       " ('gp130', 0.0054466588562058875),\n",
       " ('VEGFR2112', 0.005423087268238645),\n",
       " ('VAS', 0.005362496865508147),\n",
       " ('FNA', 0.005268850017504501),\n",
       " ('STOPBang', 0.0052107668578490396),\n",
       " ('ï¿½', 0.005023549436145444),\n",
       " ('mastectomy', 0.004988160690957966),\n",
       " ('difficulties', 0.004988160690957966),\n",
       " ('epha2', 0.004732609681423391),\n",
       " ('number_variation', 0.004724840039465589),\n",
       " ('erianin', 0.00472100001028795),\n",
       " ('ampk', 0.004629613392369511),\n",
       " ('CO2_asphyxiation', 0.004596634145029243),\n",
       " ('cthrc1', 0.004570250198311505),\n",
       " ('cell_counting_formation_assays_chamber_assays', 0.004560986992597504),\n",
       " ('criteria_hr_p', 0.004551121295613951),\n",
       " ('PennCNV_QuantiSNP', 0.004445204961498913),\n",
       " ('FUS_treatment', 0.004439290430148374),\n",
       " ('GeneSetDP', 0.004403648103163825),\n",
       " ('TCA_cycle', 0.004345236525349896),\n",
       " ('t_cells_cells', 0.004339384069026662),\n",
       " ('X\\x91ray', 0.004332515817159164),\n",
       " ('anastomoses', 0.0043271704560477195),\n",
       " ('using_the_National_Cancer_Institute_ _Common_ _Terminology_ _Criteria_ _for_ _Adverse_Events_version_Blood_ _sampling_ _for_ _biomarker_ _analyses_ _Angiopoietin2_Quantikine_ELISA_Kit_RD_Systems_Minneapolis_DCR',\n",
       "  0.004326358681329581),\n",
       " ('NCRAS_data', 0.004319035854269895),\n",
       " ('BA_profile', 0.004316697528271634),\n",
       " ('OS_PFS', 0.004316696915208163),\n",
       " ('Cas9', 0.004316696915208163),\n",
       " ('coping', 0.004316696915208163),\n",
       " ('health_behavior', 0.004316696915208163),\n",
       " ('egfr', 0.004316696915208163),\n",
       " ('previously26_Multiple_studies', 0.004315547045054443),\n",
       " ('exposure_tolerability', 0.004315547045054443),\n",
       " ('treatment_tolerability', 0.004315547045054443),\n",
       " ('to_dose_interruption', 0.004315547045054443),\n",
       " ('dose_interruption', 0.004315547045054443),\n",
       " ('to_dose_interruption_ _and_dose_reduction_ ', 0.004315547045054443),\n",
       " ('Pretreatment_AssessmentsGiven', 0.004315547045054443),\n",
       " ('force_rubbing_dish_washing', 0.004315547045054443),\n",
       " ('GI_events', 0.004315547045054443),\n",
       " ('neurotransmitters', 0.004315547045054443),\n",
       " ('need_possibility_oftreatments_delay', 0.004315547045054443),\n",
       " ('teleconference', 0.004315547045054443),\n",
       " ('ACE2_TMPRSS2_Table', 0.004315547045054443),\n",
       " ('to_be_considered_in_future_studies_Otherwise_according_to_the_Bgee_database_https_bgee_expression_of_ACE2_and',\n",
       "  0.004315547045054443),\n",
       " ('results_samples', 0.004315547045054443),\n",
       " ('callers', 0.004315547045054443),\n",
       " ('NCBI_https_wwwncbinlmnihgov', 0.004315547045054443),\n",
       " ('odor_responsiveness', 0.004315547045054443),\n",
       " ('inferring_CNVR_genotypes_with_high', 0.004315547045054443),\n",
       " ('to_be_elevated_in_tumors_and_substantiated_as_a_master_regulator_for_chemoresistance',\n",
       "  0.004315547045054443),\n",
       " ('to_rise_further_in_the_future', 0.004315547045054443),\n",
       " ('therapy_Patients', 0.004315547045054443),\n",
       " ('nonmelanoma_skin_cancer_lentigo_maligna', 0.004315547045054443),\n",
       " ('DTCcases', 0.004315547045054443),\n",
       " ('intoproteins', 0.004315547045054443),\n",
       " ('withLINC02418', 0.004315547045054443),\n",
       " ('allcause_mortality', 0.004315547045054443),\n",
       " ('Black', 0.004315547045054443),\n",
       " ('flaw_inclaims', 0.004315547045054443),\n",
       " ('filters', 0.004315547045054443),\n",
       " ('FDR_filter', 0.004315547045054443),\n",
       " ('metalloproteinase_MMP_genes', 0.004315547045054443),\n",
       " ('to_bind_to_miR3383p_along_with_the_mutanttype_sequence_with_miR3383p_in_circ_0007841_that_was_synthesized_ _through_ _using_ _Sitedirected_ _gene_ _mutagenesis_kit',\n",
       "  0.004315547045054443),\n",
       " ('to_ _bind_ _to_ _miR3383p_ _and_ _the_mutant_type_fragment_of_BRD4_²UTR',\n",
       "  0.004315547045054443),\n",
       " ('to_bind_to_miR3383p', 0.004315547045054443),\n",
       " ('noncoding_functions_processes', 0.004315547045054443),\n",
       " ('anticancer_activity', 0.004315547045054443),\n",
       " ('overexpression_d_Northern_blotting', 0.004315547045054443),\n",
       " ('normativedata', 0.004315547045054443),\n",
       " ('PI3KAktmTOR_pathway', 0.004315547045054443),\n",
       " ('GSK3_inactivation', 0.004315547045054443),\n",
       " ('ASPH_FatMass_Obesity_protein', 0.004315547045054443),\n",
       " ('both_andhumoralimmunityASPH', 0.004315547045054443),\n",
       " ('ofmonozygotic_siblings', 0.004315547045054443),\n",
       " ('plasma_insulin_supplementation', 0.004315547045054443),\n",
       " ('PDP1\\x91driven_cell_proliferation', 0.004315547045054443),\n",
       " ('Witt', 0.004315547045054443),\n",
       " ('servants', 0.004315547045054443),\n",
       " ('BMI_NC_data', 0.004315547045054443),\n",
       " ('to_estimate_TMB', 0.004315547045054443),\n",
       " ('CNS_tumors', 0.004315547045054443),\n",
       " ('a0_bp', 0.004315547045054443),\n",
       " ('to_act_as_a_putative_oncogene_in_GBM_ _favoring_ _cell_ _infiltration_ _in_a0_vitroin_ _vivo_ _models',\n",
       "  0.004315547045054443),\n",
       " ('signalingcascades', 0.004315547045054443),\n",
       " ('Î±4laminins', 0.004315547045054443),\n",
       " ('germline_HRAS_mutations', 0.004315547045054443),\n",
       " ('incancer_progression111438', 0.004315547045054443),\n",
       " ('expressionof_Snail', 0.004315547045054443),\n",
       " ('to_train_machine', 0.004315547045054443),\n",
       " ('methodsImprovements', 0.004315547045054443),\n",
       " ('interferon_gamma_IL12_activity_serpins_mediators', 0.004315547045054443),\n",
       " ('osteopontin', 0.004315547045054443),\n",
       " ('Akt_promote', 0.004315547045054443),\n",
       " ('surface_death_receptors_procaspase8', 0.004315547045054443),\n",
       " ('editing_range', 0.004315547045054443),\n",
       " ('Cas12a_target', 0.004315547045054443),\n",
       " ('target_sequences', 0.004315547045054443),\n",
       " ('termination_codon', 0.004315547045054443),\n",
       " ('characteristics_evidence', 0.004315547045054443),\n",
       " ('hepatoma_cell_growth_tumorigenesis', 0.004315547045054443),\n",
       " ('macrocyclic_lactone_ring', 0.004315547045054443),\n",
       " ('ecosystem', 0.004315547045054443),\n",
       " ('incidence_forms', 0.004315547045054443),\n",
       " ('to_decreased_DIO3_ _expression_ _in_ _breast_ _cancer_ ',\n",
       "  0.004315547045054443),\n",
       " ('511keV_gamma_rays', 0.004315547045054443),\n",
       " ('to_measure_the_angular_resolution_of_Compton_cameras_For_measuring_the_angular_resolution_of_pinhole_imaging',\n",
       "  0.004315547045054443),\n",
       " ('a0keV', 0.004315547045054443),\n",
       " ('anticoincidence_events', 0.004315547045054443),\n",
       " ('Cs_sources', 0.004315547045054443),\n",
       " ('prediction_accuracy', 0.004315547045054443),\n",
       " ('variables_category_variables', 0.004315547045054443),\n",
       " ('serum_proteasome', 0.004315547045054443),\n",
       " ('BA_synthesis_glucose', 0.004315547045054443),\n",
       " ('to_ _alter_ _BA_ _diversity_ _abundance_and_ _signaling_ _Targeted_ _liquid_ _chromatography_mass_spectrometry_LC_MS_analysis',\n",
       "  0.004315547045054443),\n",
       " ('development_reporting_assessment', 0.004315547045054443),\n",
       " ('guidelines_Authors_employers', 0.004315547045054443),\n",
       " ('evidence_synthesis_experts', 0.004315547045054443),\n",
       " ('breadth_discussions', 0.004315547045054443),\n",
       " ('plausibility_inclusion', 0.004315547045054443),\n",
       " ('to_ _participate_ ', 0.004315547045054443),\n",
       " ('CPRD_GOLD', 0.004315547045054443),\n",
       " ('using_the_first_ever_record_in_each_combination_of_sources',\n",
       "  0.004315547045054443),\n",
       " ('norepinephrine', 0.004315547045054443),\n",
       " ('programs_nature', 0.004315547045054443),\n",
       " ('PDAC_tumour_growth_progression', 0.004315547045054443),\n",
       " ('modulationof_system', 0.004315547045054443),\n",
       " ('Desfosses', 0.004315547045054443),\n",
       " ('solanidineaglycone_Kuhn_L\\x82¬ow', 0.004315547045054443),\n",
       " ('to_ _determine_resectability_of_pancreatic_tumours_Executing_a_pharmacological_intervention_on_the_pancreatic_cancer_stromal_environment_ ',\n",
       "  0.004315547045054443),\n",
       " ('CTGF_studies', 0.004315547045054443),\n",
       " ('study_FGR', 0.004315547045054443),\n",
       " ('similarity_score', 0.004315547045054443),\n",
       " ('to_research_and_explore_publicly_available_datasets_cancergenomenihgov_accessed_March_  _including_RNA_sequencing_RNAseq_data_from_TCGA_samples_of_ _different_types_of_cancer',\n",
       "  0.004315547045054443),\n",
       " ('to_be_highly_expressed_in_several_human_cancer_types_prostate_breast_brain_colorectal_and_gastric_cancer_and_glioblastoma_multiforme_stem_cells_ ',\n",
       "  0.004315547045054443),\n",
       " ('to_interact_with_DEGs_yielding_ _hub_miRNAs_and', 0.004315547045054443),\n",
       " ('effector_proteins', 0.004315547045054443),\n",
       " ('theapoptosis', 0.004315547045054443),\n",
       " ('light_conditions', 0.004315547045054443),\n",
       " ('cerebellardevelopment', 0.004315547045054443),\n",
       " ('boneresorption', 0.004315547045054443),\n",
       " ('RANKL_production', 0.004315547045054443),\n",
       " ('HBV_infectionis', 0.004315547045054443),\n",
       " ('acid_levels', 0.004315547045054443),\n",
       " ('myocyte_diï¬erentiationcan', 0.004315547045054443),\n",
       " ('ar_rhythmogenicity', 0.004315547045054443),\n",
       " ('obstacles_issues', 0.004315547045054443),\n",
       " ('be_low', 0.004315547045054443),\n",
       " ('QT_interval_prolongation_VAs', 0.004315547045054443),\n",
       " ('using_the_DIANA_tools_and_a_luciferase_reporter_assay',\n",
       "  0.004315547045054443),\n",
       " ('andallows_RNA', 0.004315547045054443),\n",
       " ('Sleep_Apnea', 0.004315547045054443),\n",
       " ('theinclusion_criteria', 0.004315547045054443),\n",
       " ('to_use_the_FRAMESmethod', 0.004315547045054443),\n",
       " ('management_approach', 0.004315547045054443),\n",
       " ('theadministration', 0.004315547045054443),\n",
       " ('anddisseminates_state', 0.004315547045054443),\n",
       " ('PDGFB', 0.004315547045054443),\n",
       " ('inducing_diï¬erentiation_into_benign_cells', 0.004315547045054443),\n",
       " ('to_have_an_important_role_in_adipocyte_diï¬erentiation_We_focus_on_understanding_the_complex_regulatory_mechanism_of_adipocytediï¬erentiation_that_can_contribute_to_the_clinical_treatmentof_human_diseases_including_those_caused_by_obesity_andadipocytes_dysfunction_especially_for_the_malignant_tumorwhich',\n",
       "  0.004315547045054443),\n",
       " ('adipogenesis_PPARÎ', 0.004315547045054443),\n",
       " ('benchmarks', 0.004315547045054443),\n",
       " ('nlp', 0.004315547045054443),\n",
       " ('identify_modifiable_risk_factors_for_cancer_interoperability_standards_and_numerous_us_initiatives_such_as_the_21st_century_cures_act_and_the_promoting_interoperability_program_formerly_named_the_meaningful_use_program_are_transforming_ _the_ _way_ _individuals_ _access_medical_services_and_manage_their_health_thereby_accelerating_the_meaningful_application_of_digital_health_technologiesthe_evidence_base_for_digital_health_in_cancer_ _care_ ',\n",
       "  0.004315547045054443),\n",
       " ('analysis_application', 0.004315547045054443),\n",
       " ('endpoints_dcr', 0.004315547045054443),\n",
       " ('dpph_loss', 0.004315547045054443),\n",
       " ('clinic_laboratories', 0.004315547045054443),\n",
       " ('forest', 0.004315547045054443),\n",
       " ('results_enrichment', 0.004315547045054443),\n",
       " ('predisposing_mutations_to_colorectal_cancer', 0.004315547045054443),\n",
       " ('expansion_differentiation', 0.004315547045054443),\n",
       " ('gsk3catenin_pathway', 0.004315547045054443),\n",
       " ('mutationalhotspots', 0.004315547045054443),\n",
       " ('topole_exonuclease_mutations', 0.004315547045054443),\n",
       " ('characteristics_management', 0.004315547045054443),\n",
       " ('radiotherapy_ofoutpatient_services', 0.004315547045054443),\n",
       " ('physiciangroup_we', 0.004315547045054443),\n",
       " ('birth', 0.004315547045054443),\n",
       " ('to_measure_these_outcomes_arelisted_in_additional_file_ _many_different_variables_wereused_to_measure_neonatal_ _and_maternal_ _outcomes_neonatal_mortality_ _apgar_score_ _maternal_mortalityandhaemorrhage_ _are_outcomes_that_were_measured_mostoften_half_of_the_outcome_variables_were_used_in_justone_single_study_table_ _shows_the_numbers_of_studiesper_aggregation_level_that_took_neonatal_and_maternaloutcome_into_account_neonatal_and_maternal_outcomeswere_most_often_reported_if_variation_of_caesarean_nicu_admissionprior_to_the_survey_patient_preference_was_assessed_byposing_a_variety_of_questions_on_the_reason_of_the_caesarean_section_and_perceived_influence_on_decision_makingno_studies_reported_the_quality_of_decision_making_in_of_the_ _studies_ _a_sample_of_the_study_populationwas_used_to_measure_patient_preference_samples_variedbetween_ _and_ _women_and_three_studies_used_apredefined_sampling_frameusefulness_for_audit_and_feedbacktable_ _shows_the_study_characteristics_by_aggregation_levelthe_majority_of_the_studies_ _used_one_aggregationlevel_a_minority_used_two_ _and_only_three_studies_used_three_aggregation_levels_healthcare_providersindividual_physicians_group_of_physicians_hospitals_or_hospital_categories_were_compared_in_ _studies_ _andgeographic_areas_national_or_regional_in_ _studies_hospitals_ _and_grouped_hospitals_ _eg_private_vspublic_hospitals_were_most_often_used_as_aggregation_levelof_analysis_medical_practice_variation_of_caesarean_sectionfig_ _the_effect_of_casemix_correction_on_different_aggregation_levels_0cvink_  _bmc_pregnancy_and_childbirth_           _page_ _of_table_ _study_characteristics_by_aggregation_levelnumber_of_studiesaverage_cohort_sizemedian_cohort_sizeentire_population_measured_instead_of_samplereported_variation_in_caesarean_section_rate_average_ofstudiesreported_variation_in_caesarean_section_rate_median_ofstudiescasemix_correctionmedical_outcomeindividuallevelgroup',\n",
       "  0.004315547045054443),\n",
       " ('neonatal_maternaloutcome', 0.004315547045054443),\n",
       " ('ismore', 0.004315547045054443),\n",
       " ('to_calculate_the_most_recent_caesarean_section_rate_data_source_data_source_that_was_used_by_the_authors_to_calculate_thereported_caesarean_section_rate_it_is_reported_as_\\x9cother\\x9d',\n",
       "  0.004315547045054443),\n",
       " ('authors_to_calculate_thereported_caesarean_section_rate',\n",
       "  0.004315547045054443),\n",
       " ('walks_sittostandexercises', 0.004315547045054443),\n",
       " ('implementation_programme_facilitators', 0.004315547045054443),\n",
       " ('outcomes_amongpatients', 0.004315547045054443),\n",
       " ('regression_trg0', 0.004315547045054443),\n",
       " ('cancerresearch', 0.004315547045054443),\n",
       " ('ctdna_0cschraa_cancer_page', 0.004315547045054443),\n",
       " ('arecurrence', 0.004315547045054443),\n",
       " ('to_be_addressed_ _applying_ctdna_detection_as_a_biomarker_for_mrd_isa_challenging_task_biologically',\n",
       "  0.004315547045054443),\n",
       " ('to_have_anticancer_effects_in_preclinical_andclinical_studies',\n",
       "  0.004315547045054443),\n",
       " ('to_tumorformation_ ', 0.004315547045054443),\n",
       " ('cycle_progression_curcumin', 0.004315547045054443),\n",
       " ('antioxidanteffects', 0.004315547045054443),\n",
       " ('enrichr_tool', 0.004315547045054443),\n",
       " ('deletions_amplifications', 0.004315547045054443),\n",
       " ('sm_abundance', 0.004315547045054443),\n",
       " ('tg_species', 0.004315547045054443),\n",
       " ('antigens_cytokines_cellsin_increases', 0.004315547045054443),\n",
       " ('cells_secrete_il12_tnfalpha', 0.004315547045054443),\n",
       " ('loss_loss', 0.004315547045054443),\n",
       " ('becomefact', 0.004315547045054443),\n",
       " ('activity_rate', 0.004315547045054443),\n",
       " ('rit', 0.004315547045054443),\n",
       " ('caregiverburnout_resilience', 0.004315547045054443),\n",
       " ('to_enhancemeaningfocused_coping_such_interventions', 0.004315547045054443),\n",
       " ('to_provide_insights_into_how_an_individual_makes_meaning_out_of_a_phenomenon_  _itis_important_to_note_that_as_the_current_study_drawsqualitative_data_from_the_larger_fdi_study_no_explicitinternalized_caregiver_motivationsquestionsaboutwere_asked_reflections_on_motivations_towards_caregiving_occurred_anically_throughout_the_interviewtranscripts_and_were_identified_by_the_researcher_usingipa_through_a_process_of_data_reduction_and_datareconstructionfirst_authors_ _and_ _screened_all_transcripts_andselected_those_that_had_adequate_inputfrom_familycaregivers_to_be_used_for_analysis_authors_ _and_ _thenconducted_linebyline_coding_to_develop_descriptivethemes_and_analytical_categories_conceptualizing_newinterpretation_of_the_data_this_was_followed_by_regularmeetings_among_all_authors_for_the_further_refinement_ofthemes_and_categories_to_encapsulate_the_meaning_andcontent_within_the_cluster_of_similar_codes_with_theemergent_themes_and_subthemes_created_via_a_summarychart_all_authors_reviewed_and_defined_the_emergentthemes_once_consensus_was_reached_operational_definitions_were_created_finally_relationships_between_categoriesthemes_and_subthemes_were_proposed_andmapped_with_supporting_quotes_from_transcripts_to_address_issues_of_trustworthiness_and_credibility_emergentthemes_were_constantly_compared_and_contrasted_withinand_across_groups_during_regular_meetings_the_finaltheme_categorization_and_definitions_were_agreed_uponby_the_entire_research_team_and_data_saturation_and_investigator_triangulation_were_achieved_ _table_ _demographics_of_family',\n",
       "  0.004315547045054443),\n",
       " ('inputfrom_familycaregivers', 0.004315547045054443),\n",
       " ('nothing', 0.004315547045054443),\n",
       " ('memories_expressappreciation', 0.004315547045054443),\n",
       " ('onlegacy_creationimplications_recommendationsfindings',\n",
       "  0.004315547045054443),\n",
       " ('to_have_positive_affect_on_their_motivations', 0.004315547045054443),\n",
       " ('memory_network', 0.004315547045054443),\n",
       " ('to_be_learned_from_fig', 0.004315547045054443),\n",
       " ('theother_context_words', 0.004315547045054443),\n",
       " ('resultsare', 0.004315547045054443),\n",
       " ('patientsurgeon_preferences', 0.004315547045054443),\n",
       " ('autonomy', 0.004315547045054443),\n",
       " ('anencounter', 0.004315547045054443),\n",
       " ('patient_surgeon_preferences', 0.004315547045054443),\n",
       " ('d_maximumr', 0.004315547045054443),\n",
       " ('featuresmay', 0.004315547045054443),\n",
       " ('to_estimate_the_westmb_and', 0.004315547045054443),\n",
       " ('survivalprognosis_ofici_therapy', 0.004315547045054443),\n",
       " ('complexfunctions', 0.004315547045054443),\n",
       " ('mir2143p_directly_targets_yap1_by_specifically_binding_on_the_²_utr_of_yap1_in_lscc_cell_linesrescue_experiments',\n",
       "  0.004315547045054443),\n",
       " ('noselar_aiselar', 0.004315547045054443),\n",
       " ('rlncountresults', 0.004315547045054443),\n",
       " ('modification_responses', 0.004315547045054443),\n",
       " ('andthe_absence', 0.004315547045054443),\n",
       " ('sample_sizestumor_sitestage_mix_periods', 0.004315547045054443),\n",
       " ('inclusion_criteriadata_extraction_quality_assessmentdata',\n",
       "  0.004315547045054443),\n",
       " ('to_interfere_with_theproangiogenic_action_of_growth_factors_such_as_basicfibroblast_growth_factor_and_vegf_preclinical_studieshave',\n",
       "  0.004315547045054443),\n",
       " ('administration_routes', 0.004315547045054443),\n",
       " ('treatment_efficacy_andallows_cancer_cells', 0.004315547045054443),\n",
       " ('to_be_secreted_from_cells_  _proteins_that_fail_to_undergo_correct_foldingmaturation',\n",
       "  0.004315547045054443),\n",
       " ('to_undergo_correct_foldingmaturation', 0.004315547045054443),\n",
       " ('to_correct_or_neutralize_ers_conversely_during_severe_andpersistent_ers',\n",
       "  0.004315547045054443),\n",
       " ('adcc_activity', 0.004315547045054443),\n",
       " ('majorrole', 0.004315547045054443),\n",
       " ('growth_serumresults', 0.004315547045054443),\n",
       " ('incision', 0.004315547045054443),\n",
       " ('to_easily_reach_the_most_distant_points_of_the_surgical_dissection_indeed_the_operation_planning_time_and',\n",
       "  0.004315547045054443),\n",
       " ('to_control_the_specificityand_localization_of_pp2a', 0.004315547045054443),\n",
       " ('activation_irradiationassociateddna_damage', 0.004315547045054443),\n",
       " ('to_control_transcription_in_the_context_of_glial_differentiation_  _cytokineinduced_ciliary_neurotrophicfactor_stimulation_of_glioma_precursor_cells',\n",
       "  0.004315547045054443),\n",
       " ('tumorsupon_release', 0.004315547045054443),\n",
       " ('lipidhydroperoxides', 0.004315547045054443),\n",
       " ('to_chemotherapeuticresistanceofï¬\\x81cial_  _of_the_cell_death_differentiation_associationresultscancer',\n",
       "  0.004315547045054443),\n",
       " ('intracellular_ros_levelresulting', 0.004315547045054443),\n",
       " ('expression_ofnrf2', 0.004315547045054443),\n",
       " ('nrf2activity', 0.004315547045054443),\n",
       " ('forcellular', 0.004315547045054443),\n",
       " ('sensors', 0.004315547045054443),\n",
       " ('dyes', 0.004315547045054443),\n",
       " ('to_proanthocynidin_the_silver_and_iron_nanops_possess',\n",
       "  0.004315547045054443),\n",
       " ('studying_the_effect_of_genetic_factors_on_a_drug_  _recently_due_to_the_smooth_implementation_of_the_human_genome_project_and',\n",
       "  0.004315547045054443),\n",
       " ('score\\x89¥', 0.004315547045054443),\n",
       " ('granule_forstage_ii_breastcancer', 0.004315547045054443),\n",
       " ('ors_cis', 0.004315547045054443),\n",
       " ('to_be_associated_with_lnm_and_poor', 0.004315547045054443),\n",
       " ('trivalent', 0.004315547045054443),\n",
       " ('data_queries', 0.004315547045054443),\n",
       " ('dimerisation_figure', 0.004315547045054443),\n",
       " ('membranebound_il6r23', 0.004315547045054443),\n",
       " ('hcc_tumorigenesis_autophagy', 0.004315547045054443),\n",
       " ('onmethylcpgbinding_domains_mbd', 0.004315547045054443),\n",
       " ('diseasesfrontiers_volume', 0.004315547045054443),\n",
       " ('molecularproï¬\\x81ling', 0.004315547045054443),\n",
       " ('diï¬erential', 0.004315547045054443),\n",
       " ('microbes_peptidesproteases_netosis', 0.004315547045054443),\n",
       " ('bone_marrow_spleen', 0.004315547045054443),\n",
       " ('growth_function', 0.004315547045054443),\n",
       " ('burden_melanoma_models', 0.004315547045054443),\n",
       " ('cellularmetabolism', 0.004315547045054443),\n",
       " ('to_support_theirprotumorigenic_functions', 0.004315547045054443),\n",
       " ('process_includingtranscription_factors_cytokines', 0.004315547045054443),\n",
       " ('byzhigang_tianuniversity', 0.004315547045054443),\n",
       " ('nkg2dl_surface_expression', 0.004315547045054443),\n",
       " ('dmso_administration', 0.004315547045054443),\n",
       " ('neoantigensexpressed_by_autologous_tumor_cells', 0.004315547045054443),\n",
       " ...]"
      ]
     },
     "execution_count": 173,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sorted(temp_consistent.items(), key=lambda x: x[1], reverse=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 180,
   "id": "4c205292",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.0006867520573417544"
      ]
     },
     "execution_count": 180,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sum(temp_consistent.values())/len(temp_consistent.values())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 168,
   "id": "44447075",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('we', 0.4732416428937844),\n",
       " ('that', 0.26454752349715543),\n",
       " ('which', 0.23788300121179723),\n",
       " ('We', 0.1464011597480411),\n",
       " ('it', 0.12889604445368286),\n",
       " ('study', 0.11721230219377587),\n",
       " ('patients', 0.11305919164611887),\n",
       " ('studies', 0.11033650565694238),\n",
       " ('expression', 0.10299679515790358),\n",
       " ('results', 0.10097976117828672),\n",
       " ('role', 0.09706814032731957),\n",
       " ('data', 0.08955054839308735),\n",
       " ('they', 0.08507985526193458),\n",
       " ('analysis', 0.06921717789344078),\n",
       " ('effect', 0.06910874864259489),\n",
       " ('cells', 0.06816011329000488),\n",
       " ('who', 0.06788386786863042),\n",
       " ('this', 0.06325459965544457),\n",
       " ('number', 0.06308485655135503),\n",
       " ('effects', 0.06167930125675183),\n",
       " ('genes', 0.05799012863100883),\n",
       " ('findings', 0.054040223839345605),\n",
       " ('association', 0.052562337822024345),\n",
       " ('levels', 0.05220111673134135),\n",
       " ('authors', 0.0487527760763784),\n",
       " ('use', 0.048734802684679536),\n",
       " ('risk', 0.048160706206199104),\n",
       " ('information', 0.0468015420585386),\n",
       " ('evidence', 0.04672383284573723),\n",
       " ('treatment', 0.04367020114789709),\n",
       " ('impact', 0.043456841295567906),\n",
       " ('increase', 0.04336078594657757),\n",
       " ('ability', 0.043139170541757685),\n",
       " ('potential', 0.04308862880718108),\n",
       " ('activity', 0.042927931575213414),\n",
       " ('factors', 0.0428743698109935),\n",
       " ('functions', 0.04282065672245246),\n",
       " ('model', 0.04252994653801559),\n",
       " ('activation', 0.04251144104536013),\n",
       " ('correlation', 0.041713040196532485),\n",
       " ('difference', 0.04144938316641721),\n",
       " ('response', 0.04134411887035247),\n",
       " ('us', 0.04093721270676203),\n",
       " ('changes', 0.04092286478120182),\n",
       " ('level', 0.04087654613771468),\n",
       " ('relationship', 0.04057505037132383),\n",
       " ('attention', 0.040490683950345815),\n",
       " ('prognosis', 0.04028821540272417),\n",
       " ('patient', 0.03873205031729694),\n",
       " ('survival', 0.038714659083286744),\n",
       " ('This', 0.038698476086758346),\n",
       " ('differences', 0.038365072553023905),\n",
       " ('development', 0.03825673321198141),\n",
       " ('sensitivity', 0.03791431517784623),\n",
       " ('reduction', 0.03707474456846156),\n",
       " ('expression_levels', 0.03704644396050136),\n",
       " ('samples', 0.03692777082550683),\n",
       " ('one', 0.036904983033400694),\n",
       " ('mutations', 0.03667023091667848),\n",
       " ('It', 0.03625513090947904),\n",
       " ('value', 0.03591557743214182),\n",
       " ('tumors', 0.03569710232638649),\n",
       " ('decrease', 0.03556944782611261),\n",
       " ('pathways', 0.03532520496436504),\n",
       " ('approach', 0.03515895031673552),\n",
       " ('method', 0.035004673550255515),\n",
       " ('cases', 0.034375774467569196),\n",
       " ('participants', 0.03413231678458129),\n",
       " ('characteristics', 0.033903313386262235),\n",
       " ('apoptosis', 0.03381286366319118),\n",
       " ('efficacy', 0.033717107662931914),\n",
       " ('research', 0.03355911535326235),\n",
       " ('inhibition', 0.03350820040478632),\n",
       " ('review', 0.03337881313811225),\n",
       " ('pathway', 0.03321060086813644),\n",
       " ('mice', 0.03314131561335783),\n",
       " ('result', 0.03311073209278726),\n",
       " ('downregulation', 0.0330871272538223),\n",
       " ('features', 0.032904042734709926),\n",
       " ('diagnosis', 0.03289164237321369),\n",
       " ('methods', 0.03288930742784244),\n",
       " ('function', 0.032729573749491286),\n",
       " ('interaction', 0.03233889958577951),\n",
       " ('presence', 0.032274754789428754),\n",
       " ('analyses', 0.03223458683870417),\n",
       " ('cancer', 0.03217319383859963),\n",
       " ('importance', 0.03213702882108714),\n",
       " ('roles', 0.031951825710637274),\n",
       " ('responses', 0.03193498387145484),\n",
       " ('combination', 0.03179381447560536),\n",
       " ('need', 0.03151889544709997),\n",
       " ('support', 0.031111687588991906),\n",
       " ('significance', 0.031067974246608544),\n",
       " ('those', 0.030826481683007338),\n",
       " ('knockdown', 0.03056866415254586),\n",
       " ('proportion', 0.030546652832106586),\n",
       " ('process', 0.03051022798399829),\n",
       " ('disease', 0.03042257426993379),\n",
       " ('proteins', 0.0302872082772988),\n",
       " ('change', 0.02999904999961894),\n",
       " ('performance', 0.029751381161016655),\n",
       " ('test', 0.02961292329996868),\n",
       " ('tumor_growth', 0.029486435641475458),\n",
       " ('growth', 0.029379311494602593),\n",
       " ('cell_proliferation', 0.029012481698309976),\n",
       " ('outcomes', 0.02899015857805224),\n",
       " ('binding', 0.028741947536732627),\n",
       " ('overexpression', 0.028717997332465613),\n",
       " ('rate', 0.02859851779838523),\n",
       " ('incidence', 0.028586166425088894),\n",
       " ('mechanism', 0.028380974582000004),\n",
       " ('group', 0.028021871978811064),\n",
       " ('upregulation', 0.027969754750578113),\n",
       " ('case', 0.027606109658298923),\n",
       " ('i', 0.027553023467472473),\n",
       " ('limitations', 0.027518545073929822),\n",
       " ('effectiveness', 0.027381979196272395),\n",
       " ('application', 0.027240539871585024),\n",
       " ('mechanisms', 0.026981138554533334),\n",
       " ('surgery', 0.026925470539774912),\n",
       " ('eï¬ect', 0.026907634364250366),\n",
       " ('resistance', 0.026699882550933567),\n",
       " ('cancer_cells', 0.026692982008504746),\n",
       " ('values', 0.026615284306975632),\n",
       " ('gene_expression', 0.026475295644686453),\n",
       " ('more', 0.026289228979010013),\n",
       " ('them', 0.026192920583291354),\n",
       " ('range', 0.026133590040264276),\n",
       " ('score', 0.026108702283879747),\n",
       " ('protein', 0.026048823695113885),\n",
       " ('criteria', 0.02577173769767197),\n",
       " ('outcome', 0.02573017899186138),\n",
       " ('availability', 0.02570983896114055),\n",
       " ('insight', 0.025583727681480053),\n",
       " ('people', 0.02517568732551565),\n",
       " ('consent', 0.025106539638351348),\n",
       " ('link', 0.025064490756346678),\n",
       " ('time', 0.025060158017937494),\n",
       " ('conditions', 0.024833371558133567),\n",
       " ('differentiation', 0.024829506502149986),\n",
       " ('utility', 0.024809165570643575),\n",
       " ('proliferation', 0.02480783880186607),\n",
       " ('prevalence', 0.024717726032723316),\n",
       " ('population', 0.02469395312826745),\n",
       " ('type', 0.02464521361549616),\n",
       " ('insights', 0.024594382156591238),\n",
       " ('loss', 0.024523278610702973),\n",
       " ('regulation', 0.024500756423309778),\n",
       " ('progression', 0.024470639029548994),\n",
       " ('targets', 0.024468486037740683),\n",
       " ('cancers', 0.024442743107327355),\n",
       " ('site', 0.024144941251556026),\n",
       " ('investigation', 0.02400856663451492),\n",
       " ('intervention', 0.023984631536738025),\n",
       " ('phase', 0.02379361719579626),\n",
       " ('events', 0.023780565421076153),\n",
       " ('system', 0.023776801801960894),\n",
       " ('individuals', 0.023495378283588844),\n",
       " ('total', 0.02347633924648475),\n",
       " ('inflammation', 0.023344170527088686),\n",
       " ('lesions', 0.023327435289658693),\n",
       " ('concentrations', 0.023281994557862753),\n",
       " ('therapy', 0.02310673923052723),\n",
       " ('biomarkers', 0.023029211582539587),\n",
       " ('variants', 0.022873576031984425),\n",
       " ('assays', 0.022858008948628113),\n",
       " ('rates', 0.022849828938951666),\n",
       " ('size', 0.022791304119579796),\n",
       " ('alterations', 0.02267578399112033),\n",
       " ('eï¬ects', 0.022602664732733885),\n",
       " ('heterogeneity', 0.02258860706599588),\n",
       " ('fraction', 0.022430192386634955),\n",
       " ('amounts', 0.02239035630608906),\n",
       " ('probability', 0.022330521909587224),\n",
       " ('associations', 0.022319159147075374),\n",
       " ('dose', 0.02228675298028319),\n",
       " ('markers', 0.022275033654351212),\n",
       " ('amount', 0.022234052326086055),\n",
       " ('transcription', 0.022228947229045434),\n",
       " ('assay', 0.02218864129263712),\n",
       " ('exposure', 0.02210554159797452),\n",
       " ('modules', 0.02188094167131897),\n",
       " ('trial', 0.021878373919452507),\n",
       " ('components', 0.02185214936745809),\n",
       " ('consequences', 0.021799301003665804),\n",
       " ('%', 0.021734926612977924),\n",
       " ('models', 0.02172581354131455),\n",
       " ('network', 0.021677712128719162),\n",
       " ('hypothesis', 0.0216451092347507),\n",
       " ('form', 0.021620757596104028),\n",
       " ('costs', 0.02154421945133867),\n",
       " ('resection', 0.021448835067105276),\n",
       " ('approaches', 0.021444290401635),\n",
       " ('types', 0.02132012681101484),\n",
       " ('some', 0.021275943966560528),\n",
       " ('severity', 0.021230955958747855),\n",
       " ('pattern', 0.02122779148019348),\n",
       " ('antibodies', 0.02121864216407412),\n",
       " ('susceptibility', 0.02115382814498729),\n",
       " ('symptoms', 0.02104241994825855),\n",
       " ('basis', 0.021001764729061206),\n",
       " ('microbiota', 0.020999362140199217),\n",
       " ('expression_level', 0.020951433253648292),\n",
       " ('GO_terms', 0.020934609350569212),\n",
       " ('percentage', 0.020890055295414985),\n",
       " ('involvement', 0.02083218049512195),\n",
       " ('lymph_nodes', 0.020789253053943104),\n",
       " ('scores', 0.020776263043133486),\n",
       " ('evaluation', 0.02068764784567311),\n",
       " ('interactions', 0.020673665807632215),\n",
       " ('sites', 0.0206504906656893),\n",
       " ('affinity', 0.020641143527108274),\n",
       " ('access', 0.020605587640570938),\n",
       " ('blotting', 0.02054068007348453),\n",
       " ('cohort', 0.020464405494843817),\n",
       " ('assessment', 0.020414376971121237),\n",
       " ('experiments', 0.020369775320994328),\n",
       " ('gene', 0.020343304602812036),\n",
       " ('implications', 0.02033647882434174),\n",
       " ('connection', 0.02032392979020525),\n",
       " ('fig', 0.020283834970329203),\n",
       " ('concentration', 0.02025908927222464),\n",
       " ('axis', 0.02012706901818043),\n",
       " ('ratio', 0.020114983349421765),\n",
       " ('report', 0.020064281160553258),\n",
       " ('accumulation', 0.020021947500346887),\n",
       " ('procedure', 0.019967524343233997),\n",
       " ('reaction', 0.01996658187660199),\n",
       " ('distribution', 0.019963957054491565),\n",
       " ('accuracy', 0.01994592377167161),\n",
       " ('phenotype', 0.019879375897021614),\n",
       " ('months', 0.019833803713531006),\n",
       " ('similarity', 0.019828026118571474),\n",
       " ('variety', 0.019639284232231023),\n",
       " ('expressions', 0.019616654762068208),\n",
       " ('cancer_patients', 0.019607327158268),\n",
       " ('series', 0.019585539854615648),\n",
       " ('laboratories', 0.01953725764946717),\n",
       " ('work', 0.01939086476918238),\n",
       " ('variations', 0.019357301384293077),\n",
       " ('understanding', 0.019351392302496915),\n",
       " ('steps', 0.01933275286602704),\n",
       " ('set', 0.019328163612054663),\n",
       " ('treatments', 0.019286945478013615),\n",
       " ('age', 0.01924145707640043),\n",
       " ('crosstalk', 0.019238935408739985),\n",
       " ('examination', 0.01923207283681757),\n",
       " ('cell_lines', 0.019147643285262167),\n",
       " ('possibility', 0.019105530395087417),\n",
       " ('bias', 0.019035120570769223),\n",
       " ('cytotoxicity', 0.018949955774576487),\n",
       " ('categories', 0.01894253098658763),\n",
       " ('observation', 0.01889954997896438),\n",
       " ('variables', 0.018790102329042088),\n",
       " ('SNPs', 0.018756125582670743),\n",
       " ('expression_profiles', 0.01874894626701244),\n",
       " ('state', 0.01872200433944219),\n",
       " ('sample', 0.01858831778832112),\n",
       " ('sex', 0.018552915052082147),\n",
       " ('tissues', 0.01850957151053451),\n",
       " ('protein_expression', 0.018509345285107753),\n",
       " ('groups', 0.01850177454471997),\n",
       " ('lncRNAs', 0.018495105346782722),\n",
       " ('diversity', 0.01847391725689674),\n",
       " ('algorithm', 0.018358165888257654),\n",
       " ('finding', 0.018329168941787138),\n",
       " ('measures', 0.018308183687483028),\n",
       " ('parameters', 0.01825482818473075),\n",
       " ('subjects', 0.018181984667898644),\n",
       " ('options', 0.018181489766276024),\n",
       " ('efficacy_safety', 0.018139837760849268),\n",
       " ('algorithms', 0.018136369465807763),\n",
       " ('addition', 0.01813460483973741),\n",
       " ('light', 0.018086988044996217),\n",
       " ('sections', 0.018018730105152182),\n",
       " ('care', 0.017879844817032687),\n",
       " ('structure', 0.017858210704278014),\n",
       " ('production', 0.017848771840846805),\n",
       " ('miR-182', 0.017774853000523113),\n",
       " ('part', 0.01771644292605117),\n",
       " ('inhibitor', 0.01771510426367909),\n",
       " ('place', 0.01766232621746605),\n",
       " ('secretion', 0.017653335993309913),\n",
       " ('capacity', 0.017609495503699467),\n",
       " ('transfection', 0.01757632291479536),\n",
       " ('They', 0.01750857971509144),\n",
       " ('feasibility', 0.01750417182193),\n",
       " ('influence', 0.017500206671061242),\n",
       " ('a0et', 0.017455011721368822),\n",
       " ('translocation', 0.017407243502902132),\n",
       " ('complications', 0.017295875273565693),\n",
       " ('stress', 0.017284234348591106),\n",
       " ('carcinoma', 0.017217569869712093),\n",
       " ('comparison', 0.017209406080516545),\n",
       " ('transcription_factors', 0.017182876964435316),\n",
       " ('injury', 0.017177865177085),\n",
       " ('theexpression', 0.017160667418925638),\n",
       " ('degree', 0.01715250206991743),\n",
       " ('miRNAs', 0.017090108668296935),\n",
       " ('enrichment', 0.017069229189436808),\n",
       " ('all', 0.016960297713114258),\n",
       " ('methodology', 0.0169118453917775),\n",
       " ('tumor', 0.016904169578936895),\n",
       " ('staining', 0.01687721015597863),\n",
       " ('neutrophils', 0.016850940560916402),\n",
       " ('antibody', 0.016773532227434527),\n",
       " ('sample_size', 0.016764884580710546),\n",
       " ('imaging', 0.016759838030727107),\n",
       " ('probes', 0.016666966136799334),\n",
       " ('layer', 0.016648603027243386),\n",
       " ('properties', 0.016617522462438753),\n",
       " ('cell_growth', 0.016574978643203512),\n",
       " ('selection', 0.01656610391153575),\n",
       " ('knowledge', 0.016559265922871956),\n",
       " ('EGFR', 0.01655701595793461),\n",
       " ('regression_analysis', 0.016515579802388682),\n",
       " ('individual', 0.016513578448587155),\n",
       " ('blood', 0.016489211351673447),\n",
       " ('design', 0.016421675972341523),\n",
       " ('focus', 0.01638877336491567),\n",
       " ('antitumor_activity', 0.016375915690573367),\n",
       " ('an', 0.01634421731805888),\n",
       " ('cost', 0.016341261963819135),\n",
       " ('EMT', 0.016329660165214324),\n",
       " ('patterns', 0.016311880088009153),\n",
       " ('elements', 0.01627627375033491),\n",
       " ('calculations', 0.016244279256343086),\n",
       " ('three', 0.01611864403796022),\n",
       " ('metaanalysis', 0.01609602635492759),\n",
       " ('distance', 0.01608020780558503),\n",
       " ('viability', 0.016030109601206054),\n",
       " ('words', 0.015998878549745667),\n",
       " ('forms', 0.015968680837902694),\n",
       " ('history', 0.01596685776894932),\n",
       " ('entry', 0.015931703830076565),\n",
       " ('fragment', 0.015913540478117088),\n",
       " ('sequence', 0.01585078496282256),\n",
       " ('mixture', 0.01584310140493056),\n",
       " ('metabolism', 0.01583690083331707),\n",
       " ('numbers', 0.015829559607910264),\n",
       " ('regression', 0.015784139185738004),\n",
       " ('formation', 0.015780531399603892),\n",
       " ('interventions', 0.015770228302883604),\n",
       " ('tumor_response', 0.015688069936576614),\n",
       " ('DCs', 0.01568762884196773),\n",
       " ('panel', 0.015686269867061668),\n",
       " ('problem', 0.01566335818653804),\n",
       " ('abundance', 0.01558730818521466),\n",
       " ('reports', 0.015572386253875702),\n",
       " ('degs', 0.01556543061186003),\n",
       " ('relationships', 0.015515322669758087),\n",
       " ('trials', 0.015489975240797),\n",
       " ('validation', 0.015472531149674389),\n",
       " ('indications', 0.015447299123003431),\n",
       " ('extent', 0.015447132953512308),\n",
       " ('metastases', 0.015416627284454119),\n",
       " ('blot_analysis', 0.015415940248506739),\n",
       " ('13', 0.015395308240779214),\n",
       " ('regimen', 0.01539495614450019),\n",
       " ('most', 0.015390999192883783),\n",
       " ('factor', 0.015370542859072557),\n",
       " ('version', 0.015355377514838401),\n",
       " ('damage', 0.01532060275513773),\n",
       " ('map', 0.015315901455787626),\n",
       " ('structures', 0.015264588236996435),\n",
       " ('sensitivity_specificity', 0.015258960592507021),\n",
       " ('variation', 0.01521089312762417),\n",
       " ('quality', 0.015197643312008178),\n",
       " ('length', 0.015187539814266498),\n",
       " ('paper', 0.015183065815438273),\n",
       " ('behavior', 0.015169585879865355),\n",
       " ('frequency', 0.01511525480117523),\n",
       " ('specificity', 0.015055599980640369),\n",
       " ('items', 0.01501981650510792),\n",
       " ('compounds', 0.01498048635815339),\n",
       " ('infection', 0.01495123742598594),\n",
       " ('strategies', 0.014924068857814447),\n",
       " ('pax9', 0.014890697185901653),\n",
       " ('recruitment', 0.01489039686783642),\n",
       " ('DEGs', 0.014875248845132588),\n",
       " ('phosphorylation', 0.014783508090191135),\n",
       " ('solution', 0.014768614098917783),\n",
       " ('records', 0.014656301165263291),\n",
       " ('curve', 0.01465495032164375),\n",
       " ('consistency', 0.014637530819959941),\n",
       " ('others', 0.014572851056016072),\n",
       " ('section', 0.014572272224130187),\n",
       " ('improvements', 0.014502898249931158),\n",
       " ('recurrence', 0.014497004493134489),\n",
       " ('completeness', 0.014486699637569473),\n",
       " ('transformation', 0.014460875937223736),\n",
       " ('therelationship', 0.014420557529342825),\n",
       " ('datasets', 0.014418733279702793),\n",
       " ('questions', 0.014406313784819689),\n",
       " ('framework', 0.014403711234736903),\n",
       " ('tumorigenesis', 0.01437909969224665),\n",
       " ('transcripts', 0.014352411643628733),\n",
       " ('proliferation_migration_invasion', 0.014333736067378824),\n",
       " ('peptides', 0.014326817823764569),\n",
       " ('trend', 0.014309498469775412),\n",
       " ('advantage', 0.014285390842477373),\n",
       " ('T_cells', 0.01428473712629331),\n",
       " ('protein_levels', 0.014267927287176532),\n",
       " ('screening', 0.014251191408824554),\n",
       " ('19', 0.014237145249554179),\n",
       " ('lack', 0.014221391420227004),\n",
       " ('amplification', 0.014180432050182918),\n",
       " ('what', 0.014169606314767862),\n",
       " ('majority', 0.014139703757503038),\n",
       " ('metastasis', 0.014137211670012337),\n",
       " ('contribution', 0.0141055491886114),\n",
       " ('viruses', 0.0140931535358297),\n",
       " ('tissue', 0.014052101669264967),\n",
       " ('DNA', 0.01404932397633894),\n",
       " ('position', 0.014043828294336178),\n",
       " ('risk_factors', 0.014037778518121234),\n",
       " ('E_expression', 0.014033021785842833),\n",
       " ('improvement', 0.014031714631698668),\n",
       " ('RepoRtS', 0.014025887959999114),\n",
       " ('logic_relationships', 0.013989242090953142),\n",
       " ('these', 0.013955291090913728),\n",
       " ('manuscript', 0.013950588707415121),\n",
       " ('paradigm', 0.013941464694816538),\n",
       " ('phenomenon', 0.013898319529416147),\n",
       " ('detection', 0.013878397014889748),\n",
       " ('dynamics', 0.01385847972205357),\n",
       " ('cell_migration', 0.013749939220874648),\n",
       " ('correlations', 0.013742991021300036),\n",
       " ('concordance', 0.013732809390635424),\n",
       " ('cohort_study', 0.013652932359525072),\n",
       " ('safety', 0.01363393977706283),\n",
       " ('gene_sets', 0.013631109822955404),\n",
       " ('cohorts', 0.013582145668614626),\n",
       " ('interest', 0.013573747963106095),\n",
       " ('ideas', 0.013552899587437234),\n",
       " ('localization', 0.013549760764771877),\n",
       " ('polymorphisms', 0.013549445668991786),\n",
       " ('efï¬\\x81cacy', 0.013537924152067355),\n",
       " ('dimension', 0.01352886279492302),\n",
       " ('to_be', 0.013527671481748748),\n",
       " ('average', 0.013496251696481212),\n",
       " ('day', 0.013467596116056055),\n",
       " ('literature', 0.013430567664797503),\n",
       " ('occurrence', 0.013427202497187663),\n",
       " ('enrichment_analysis', 0.013427083883872872),\n",
       " ('control_group', 0.013359604875801364),\n",
       " ('opportunity', 0.0132831370895234),\n",
       " ('expression_analysis', 0.013274806955596725),\n",
       " ('expression_patterns', 0.01327463688475689),\n",
       " ('release', 0.013270609523936614),\n",
       " ('strategy', 0.013265680169842045),\n",
       " ('comorbidities', 0.013232671270275612),\n",
       " ('angiogenesis', 0.013205253824097317),\n",
       " ('validity', 0.013195740648290937),\n",
       " ('signs', 0.01317524447327168),\n",
       " ('genotype', 0.013172478650396688),\n",
       " ('dataset', 0.013163959538409648),\n",
       " ('question', 0.013131719865216964),\n",
       " ('2', 0.013126376780259866),\n",
       " ('drug', 0.013103649098819238),\n",
       " ('B', 0.013101413639900403),\n",
       " ('years', 0.013063401068149991),\n",
       " ('less', 0.013000409863386374),\n",
       " ('women', 0.012973008931026566),\n",
       " ('committee', 0.01297099723300692),\n",
       " ('Figure', 0.012922776206453032),\n",
       " ('populations', 0.01285734613453459),\n",
       " ('dysfunction', 0.012808630979698662),\n",
       " ('enzymes', 0.012789386317634863),\n",
       " ('identification', 0.012743075606249642),\n",
       " ('efficiency', 0.012742984619942364),\n",
       " ('replication', 0.012729039353876221),\n",
       " ('transition', 0.012703304648973379),\n",
       " ('existence', 0.012682057875218922),\n",
       " ('the', 0.012677807922115968),\n",
       " ('fluorescence', 0.01264107209497887),\n",
       " ('genotype_data', 0.01263170505149585),\n",
       " ('chemotherapy', 0.012617890710813014),\n",
       " ('nature', 0.012606732026763694),\n",
       " ('DAPs', 0.01259814178232473),\n",
       " ('cutoff_value', 0.012580204873378173),\n",
       " ('target', 0.01255639361291167),\n",
       " ('treatment_strategy', 0.012539307492892459),\n",
       " ('expression_activity', 0.012526613715213429),\n",
       " ('protocol', 0.012507083712306827),\n",
       " ('techniques', 0.012496576668355453),\n",
       " ('weight', 0.012450011603692919),\n",
       " ('dispersion', 0.012449274281111993),\n",
       " ('placement', 0.012406623340943404),\n",
       " ('serum_levels', 0.012399343890406114),\n",
       " ('loci', 0.012389911907400858),\n",
       " ('collection', 0.01238687018384062),\n",
       " ('architecture', 0.012386055842790816),\n",
       " ('administration', 0.012381824619437485),\n",
       " ('scale', 0.012316765730709483),\n",
       " ('weights', 0.012315469739674977),\n",
       " ('ALK_expression', 0.012308542371375613),\n",
       " ('rna', 0.01229823131405121),\n",
       " ('adult_patients', 0.012272294997545952),\n",
       " ('regions', 0.01226863397021042),\n",
       " ('plot', 0.012267447650752043),\n",
       " ('discrimination_heterogeneity_studyindicated_role_enrichment_includinggo_kegg_analyses',\n",
       "  0.012227609663034095),\n",
       " ('burden', 0.01222615518113762),\n",
       " ('histology', 0.012224257870533373),\n",
       " ('repair', 0.012223690578772258),\n",
       " ('imaging_techniques', 0.012222568917564134),\n",
       " ('aspects', 0.012203485058525233),\n",
       " ('RNA', 0.012194612958949072),\n",
       " ('points', 0.012175966305642239),\n",
       " ('cell', 0.012151166325873252),\n",
       " ('participation', 0.012150135161997493),\n",
       " ('induction', 0.012139631440184519),\n",
       " ('excision', 0.012133612347255098),\n",
       " ('theory', 0.012125748884263595),\n",
       " ('fact', 0.012112631569424107),\n",
       " ('module', 0.012089527650427546),\n",
       " ('consumption', 0.012078420498066006),\n",
       " ('vessels', 0.012072628556149958),\n",
       " ('program', 0.012072163155112756),\n",
       " ('tools', 0.012070619551655266),\n",
       " ('malignancies', 0.01204472676427025),\n",
       " ('barriers', 0.012044722543517287),\n",
       " ('mir1179', 0.012035168491177233),\n",
       " ('os_pfs', 0.012035093228425199),\n",
       " ('applicability', 0.012031944392651197),\n",
       " ('pipeline', 0.012031886023130873),\n",
       " ('classifier', 0.012031886023130873),\n",
       " ('routes', 0.012031886023130873),\n",
       " ('communication', 0.012028681380063992),\n",
       " ('escape', 0.012028681380063992),\n",
       " ('epitope', 0.012028681380063992),\n",
       " ('ALK_rearrangements', 0.012028681380063992),\n",
       " ('fusion_protein', 0.012005662895533927),\n",
       " ('hub_genes', 0.011946114630353872),\n",
       " ('presentation', 0.011894877502725647),\n",
       " ('advances', 0.011873227299978457),\n",
       " ('plasmid', 0.011863471917861334),\n",
       " ('programme', 0.011854310495115636),\n",
       " ('cohort_studies', 0.011846613771801018),\n",
       " ('qRTPCR', 0.011835557851103693),\n",
       " ('overview', 0.011832154945101793),\n",
       " ('Hsp70', 0.011812406516465373),\n",
       " ('tumor_cells', 0.011780297316246482),\n",
       " ('usefulness', 0.01176996810485487),\n",
       " ('repositioning', 0.0117693468228586),\n",
       " ('overlap', 0.011754499311017394),\n",
       " ('sample_sizes', 0.011749284173294317),\n",
       " ('s', 0.011743393736579424),\n",
       " ('confirmation', 0.011740702534567828),\n",
       " ('NSCLC', 0.01172879518864922),\n",
       " ('blot', 0.011688195131153765),\n",
       " ('tumor_uptake', 0.011667844839312394),\n",
       " ('obstacle', 0.0116652836955979),\n",
       " ('laboratory', 0.011645596283940417),\n",
       " ('output', 0.01163639520109688),\n",
       " ('mirnas', 0.011634721162644723),\n",
       " ('region', 0.011625239692212016),\n",
       " ('novel', 0.011613080162808632),\n",
       " ('requirement', 0.011609379611986725),\n",
       " ('list', 0.01160544091903155),\n",
       " ('intensities', 0.011603184579627652),\n",
       " ('database', 0.011600525889737812),\n",
       " ('handout', 0.011593754802783313),\n",
       " ('clinicians', 0.011558736594338504),\n",
       " ('Patients', 0.011491761702619677),\n",
       " ('areas', 0.011488433123342056),\n",
       " ('thrombi', 0.011471088169080499),\n",
       " ('efforts', 0.0114676104143228),\n",
       " ('PCA', 0.011440996355380338),\n",
       " ('cytokines', 0.011424019350532682),\n",
       " ('data_sets', 0.011341029174020729),\n",
       " ('mRNA_expression', 0.011324911009353827),\n",
       " ('line', 0.011293603043365295),\n",
       " ('source', 0.011285065961560774),\n",
       " ('molecules', 0.011262019620527967),\n",
       " ('deaths', 0.011231828841704006),\n",
       " ('AA_genotype', 0.011228483034706365),\n",
       " ('means', 0.011216859425599074),\n",
       " ('12', 0.011208823104840688),\n",
       " ('0c', 0.011198631133307662),\n",
       " ('networks', 0.011198021834093408),\n",
       " ('domains', 0.011196939863908491),\n",
       " ('BMI', 0.011195033461465631),\n",
       " ('deregulation', 0.011170716401312713),\n",
       " ('thoracotomy', 0.011160134160394073),\n",
       " ('power', 0.011146954302337342),\n",
       " ('agents', 0.01112378384549857),\n",
       " ('ICC', 0.011112036844334618),\n",
       " ('hypermethylation', 0.011099892928149791),\n",
       " ('software', 0.011099031412481142),\n",
       " ('advice', 0.011087814474109404),\n",
       " ('content', 0.011084886521688566),\n",
       " ('index', 0.011066922558355109),\n",
       " ('degradation', 0.011059576860175358),\n",
       " ('tool', 0.011046166271298615),\n",
       " ('subtypes', 0.011030080942718535),\n",
       " ('±', 0.011016988604295548),\n",
       " ('details', 0.011005466138828105),\n",
       " ('synthesis', 0.011003554870134848),\n",
       " ('26', 0.010998521580642738),\n",
       " ('advantages', 0.010995035494883017),\n",
       " ('migration', 0.010988174125010906),\n",
       " ('recovery', 0.010981988684681693),\n",
       " ('image', 0.010942229556720591),\n",
       " ('pairs', 0.01093458091105588),\n",
       " ('procedures', 0.010890545639988869),\n",
       " ('inclusion_criteria', 0.010874449763788806),\n",
       " ('decline', 0.010872675714604825),\n",
       " ('pilot_study', 0.010869851606834482),\n",
       " ('PFS', 0.010850619439025119),\n",
       " ('\\x82uence', 0.010848995151821314),\n",
       " ('agreement', 0.01084678048751662),\n",
       " ('CNN', 0.010819368036729003),\n",
       " ('feelings', 0.010796400607661936),\n",
       " ('expression_changes', 0.010796163943913827),\n",
       " ('survival_analysis', 0.010790315314313223),\n",
       " ('flow_cytometry_analysis', 0.010767392602110001),\n",
       " ('links', 0.010761247432926167),\n",
       " ('CTL_clone', 0.010746014537593824),\n",
       " ('databases', 0.010732859400289523),\n",
       " ('cliques', 0.010732532826664073),\n",
       " ('assignment', 0.010717534877686551),\n",
       " ('generation', 0.010680088093768513),\n",
       " ('study_cohort', 0.010665303020547332),\n",
       " ('sequencing', 0.010654810325157455),\n",
       " ('ways', 0.010646511495154703),\n",
       " ('definitions', 0.010646194716788793),\n",
       " ('therapies', 0.01057097730262263),\n",
       " ('invasion', 0.010569214662016865),\n",
       " ('inhibitors', 0.010567625771024212),\n",
       " ('CRC_patients', 0.010542862026876654),\n",
       " ('expression_data', 0.010529402455372894),\n",
       " ('case_definitions', 0.01050872316468729),\n",
       " ('tumor_size', 0.010502861786465808),\n",
       " ('interpretation', 0.010498889859364976),\n",
       " ('nodes', 0.010484334908279535),\n",
       " ('rise', 0.010461587226475742),\n",
       " ('search', 0.010448430288050835),\n",
       " ('gene_pairs', 0.010440840728146043),\n",
       " ('countries', 0.010430587041527314),\n",
       " ('observations', 0.010412161540700423),\n",
       " ('to_increasein_prevalence_role_16s_hypothesis_prebiotics',\n",
       "  0.010378960443961947),\n",
       " ('target_genes', 0.010366686614459912),\n",
       " ('ESC_clones', 0.01036236748293325),\n",
       " ('you', 0.010356704132916011),\n",
       " ('connections', 0.010318099195448828),\n",
       " ('ALDOA', 0.01029587334339305),\n",
       " ('examinations', 0.010268801903275443),\n",
       " ('localization_ability', 0.010262038031746759),\n",
       " ('settings', 0.01025586700711074),\n",
       " ('throat_images', 0.010232726438332835),\n",
       " ('actions', 0.010224530118276514),\n",
       " ('halflife', 0.010224521933048262),\n",
       " ('materials', 0.010146655355880704),\n",
       " ('I', 0.01014406857752837),\n",
       " ('variance', 0.010142455547929452),\n",
       " ('variability', 0.010139912060708503),\n",
       " ('candidate_genes', 0.010136857667707198),\n",
       " ('problems', 0.01013207940344647),\n",
       " ('cluster', 0.010123865649001331),\n",
       " ('gene_set', 0.010110198265796778),\n",
       " ('regression_model', 0.010109247016337754),\n",
       " ('ROC', 0.010109247016337754),\n",
       " ('cell_repertoire', 0.010107739978370736),\n",
       " ('graphs', 0.010106553097620144),\n",
       " ('control_study', 0.010105918214388618),\n",
       " ('screen', 0.010103860614134662),\n",
       " ('expression_datasets', 0.010103860614134662),\n",
       " ('NMF_method', 0.010103860614134662),\n",
       " ('reporter_constructs', 0.010101169564734799),\n",
       " ('cardiomegaly', 0.010101169564734799),\n",
       " ('detection_product', 0.010101169564734799),\n",
       " ('to_guide_ _clinicians_ _and_ _researchers_ _to_ _better_ ',\n",
       "  0.010101169564734799),\n",
       " ('trait', 0.010101169564734799),\n",
       " ('LD_blocks', 0.010101169564734799),\n",
       " ('contact_points', 0.010101169564734799),\n",
       " ('surface_roughness', 0.010101169564734799),\n",
       " ('totalof_genes', 0.010101169564734799),\n",
       " ('decrease_reduction', 0.010101169564734799),\n",
       " ('values_sensitivities', 0.010101169564734799),\n",
       " ('similarities_differences_impact', 0.010101169564734799),\n",
       " ('subgroup_analyses', 0.010101169564734799),\n",
       " ('thisfunction', 0.010101169564734799),\n",
       " ('deconvolution', 0.010101169564734799),\n",
       " ('mL_syringe', 0.010101169564734799),\n",
       " ('MOI_MOI', 0.010101169564734799),\n",
       " ('ros', 0.010081434648666086),\n",
       " ('cancer_page', 0.010077080665118318),\n",
       " ('DDR_genes', 0.010061811217718724),\n",
       " ('higherlevels', 0.010060147095826309),\n",
       " ('CASC2', 0.010053297139036306),\n",
       " ('nrf2', 0.01005279776515385),\n",
       " ('vector', 0.010043224013589936),\n",
       " ('researchers', 0.010042720663859181),\n",
       " ('testing', 0.010026425561662182),\n",
       " ('taxa', 0.01002321947493134),\n",
       " ('few', 0.010011659129110907),\n",
       " ('mode', 0.010011063796469679),\n",
       " ('probe', 0.010010331347271391),\n",
       " ('property', 0.010007155654095509),\n",
       " ('sequencing_study', 0.010007017372743484),\n",
       " ('kinds', 0.010003204997184),\n",
       " ('spread', 0.010001115704540313),\n",
       " ('conflict', 0.00999893898395528),\n",
       " ('environment', 0.009995106949785336),\n",
       " ('miRNA', 0.009984825142223564),\n",
       " ('modeling', 0.009957075985385345),\n",
       " ('rationale', 0.00994586385294037),\n",
       " ('profiling', 0.00992461902771482),\n",
       " ('lung_injury', 0.0099145221765384),\n",
       " ('clusters', 0.009907561156424157),\n",
       " ('measure', 0.009891964116182187),\n",
       " ('coverage', 0.009871145844227401),\n",
       " ('guidelines', 0.009866364529303647),\n",
       " ('description', 0.00985614892457117),\n",
       " ('First_Affiliated_Hospital', 0.009853111221527572),\n",
       " ('action', 0.009850265529889308),\n",
       " ('ones', 0.009845600337111713),\n",
       " ('to_bereplenished_by_anaplerotic_reactions_such_as_glutaminolysis_  _previously',\n",
       "  0.009838411865292652),\n",
       " ('challenges', 0.009831154275184505),\n",
       " ('increases', 0.009820834809168497),\n",
       " ('os_ci_pfs_safety_signals', 0.009816615055978778),\n",
       " ('inhibitory_effect', 0.009815108996947665),\n",
       " ('dimensions', 0.009813886869778176),\n",
       " ('flora', 0.009785672024122003),\n",
       " ('FGD4', 0.009775285378492102),\n",
       " ('cancer_cases', 0.00977352345186592),\n",
       " ('vaccine', 0.009770453295985483),\n",
       " ('statistics', 0.00976240825312633),\n",
       " ('implication', 0.00973263465881316),\n",
       " ('following', 0.00973216994978617),\n",
       " ('function_mechanism', 0.009721894687907864),\n",
       " ('members', 0.009708032817886679),\n",
       " ('tumor_tissues', 0.009691771519790175),\n",
       " ('radiotherapy', 0.009685282696351494),\n",
       " ('ihc', 0.009680576535070016),\n",
       " ('RNA_seq', 0.009674357722928819),\n",
       " ('summary', 0.009673139321067108),\n",
       " ('advantages_limitations', 0.009645672085496843),\n",
       " ('hr', 0.009631049321694821),\n",
       " ('shifts', 0.009628051296463441),\n",
       " ('to_identify_significant_predictors_of_poor_sleep_which_in_turncould_offer_a_therapeutic_target_of_poor_sleep_in_dementia',\n",
       "  0.009625917649762094),\n",
       " ('development_validation', 0.009625917649762094),\n",
       " ('toevaluate', 0.009625917649762094),\n",
       " ('surgery_to_ensure_adequatestaging_and_oncologic_resection_for_colorectal_cancer_  _themore_lymph_nodes_harvested_the_better_the_prognosis_[_]_in_this_study_the_average_number_of_harvested_lymph_nodeswas_   _we_found_that_patients_with_ _15_harvested_lymphnodes_had_better_os_and_rfs_than_those_with_ _harvestedlymph_nodes_several_studies_have_shown_that_elevated_preoperative_cea_was_a_poor_prognostic_factor_in_colorectal_cancer[\\x93_]_manuscript_gxl_xhf_theprocedure_study_content',\n",
       "  0.009625917649762094),\n",
       " ('nacht_domain', 0.009625917649762094),\n",
       " ('clones', 0.009620719533252177),\n",
       " ('to_be_elucidated_he_staining_isthe_gold_standard_for_tumor_diagnosis_with_the_development_of_biomechanics_in_the_past_two_decades_  _to_be_investigated_based_on_biomedical_and_physical_parametersin_validate_our_findings_and_developtrop2_as_a_specific_and_efficient_prognostic_biomarker_forosccthese_findings_could_promote_new_methods_for_the_earlyoscc_diagnosis_depend_on_the_stage_of_cancer_and_developing_screening_methods_with_high_sensitivity_andspecificity_more_detailed_studies_ew',\n",
       "  0.009617879859496466),\n",
       " ('resource', 0.009614267068063537),\n",
       " ('foxa1', 0.009594357983736937),\n",
       " ('cell_death', 0.009583837766921345),\n",
       " ('physicians', 0.00958368763487529),\n",
       " ('followup', 0.009580569244879447),\n",
       " ('bronchopneumonia_cd8positive_tcell', 0.00956085131526928),\n",
       " ('using', 0.009558582466819097),\n",
       " ('death', 0.009537845540089358),\n",
       " ('notion', 0.009530460681216532),\n",
       " ('6_7', 0.00951380260020359),\n",
       " ('biogenesis', 0.009512184108905749),\n",
       " ('smokers', 0.009487320104865858),\n",
       " ('hct116_cells', 0.009483572841284708),\n",
       " ('example', 0.009479786360247489),\n",
       " ('sequences', 0.009448675832375637),\n",
       " ('andor', 0.009425511109101375),\n",
       " ('mdamb231_cells', 0.00942419067652102),\n",
       " ('predictors', 0.009414112063836945),\n",
       " ('ligands', 0.009408863446953073),\n",
       " ('using_ _rtqpcr_ _as_ _shown_ _in_ _fig_a0_1a_circ_0001776_expression_level',\n",
       "  0.009402273855496782),\n",
       " ('These', 0.009390181774550498),\n",
       " ('motif', 0.009389158249929138),\n",
       " ('biomarkers_indicators', 0.009377019240926395),\n",
       " ('little', 0.009367947706156177),\n",
       " ('conï¬\\x81rmed', 0.00936119697260216),\n",
       " ('otherstudies', 0.00936119697260216),\n",
       " ('\\x93', 0.00935193419820223),\n",
       " ('overrepresentation', 0.009348260276360359),\n",
       " ('guidance', 0.009335962285191925),\n",
       " ('sum', 0.009314538770160198),\n",
       " ('relations', 0.009310089551188668),\n",
       " ('promotion', 0.0092974253902078),\n",
       " ('h', 0.00929543517976271),\n",
       " ('works', 0.009263779657168306),\n",
       " ('coexpression', 0.009221755324518324),\n",
       " ('behaviour', 0.009219155823230282),\n",
       " ('normalization', 0.009218114930268058),\n",
       " ('chance', 0.009209033001572355),\n",
       " ('angiopoietin2_quantikine', 0.009207011347846057),\n",
       " ('superiority', 0.009201178451424933),\n",
       " ('association_gene_expression', 0.009188990888067902),\n",
       " ('theeffect', 0.009184760002252044),\n",
       " ('tumours', 0.009183889280972753),\n",
       " ('incorporation', 0.009179717701950214),\n",
       " ('gold_algorithm', 0.009179643237235907),\n",
       " ('BPNN', 0.009177197673452755),\n",
       " ('patient\\x99s', 0.009177197673452755),\n",
       " ('mrna_protein_expression_fig', 0.00917475341225259),\n",
       " ('measurements', 0.009163937026134081),\n",
       " ('prediction_model', 0.009161222042947347),\n",
       " ('cancer_progression', 0.009160662200633128),\n",
       " ('virus', 0.009139421294617945),\n",
       " ('thepatients', 0.009136444926594631),\n",
       " ('cleavage', 0.009120562984652492),\n",
       " ('enhancement', 0.0091140589242586),\n",
       " ('oxygen', 0.009109796634619612),\n",
       " ('deficits', 0.009082868579462843),\n",
       " ('analysis_results', 0.009074928878039805),\n",
       " ('ultrasound', 0.009052954755544008),\n",
       " ('capability', 0.00904257023194988),\n",
       " ('camera', 0.009024977894805218),\n",
       " ('subgroup_analysis', 0.009023308280505396),\n",
       " ('concept', 0.009015164315281394),\n",
       " ('regeneration', 0.009000592400181385),\n",
       " ('propolis', 0.00899137520212376),\n",
       " ('act', 0.00898466116451423),\n",
       " ('tendency', 0.008983744187947444),\n",
       " ('signals', 0.008971490494326485),\n",
       " ('funding', 0.008964719684192598),\n",
       " ('protein_level', 0.008962619265057457),\n",
       " ('her', 0.008961093188495407),\n",
       " ('mutation', 0.00896081131395079),\n",
       " ('methylation', 0.008957815422498024),\n",
       " ('CR', 0.008955520157538317),\n",
       " ('ors', 0.008955452438566772),\n",
       " ('row', 0.008946767333091705),\n",
       " ('mortality', 0.00893423195181211),\n",
       " ('management', 0.008925570699009686),\n",
       " ('feces', 0.008924137157652832),\n",
       " ('indication', 0.008906790220277657),\n",
       " ('hydrolysis', 0.008905624496697255),\n",
       " ('papers', 0.008897577550881356),\n",
       " ('edges', 0.008889778054174582),\n",
       " ('period', 0.00888346196588835),\n",
       " ('HBOT', 0.00887605804136215),\n",
       " ('lung_metastasis', 0.00886858229165827),\n",
       " ('siRNA', 0.008853782033120582),\n",
       " ('analysis_method', 0.008846945435462824),\n",
       " ('methylation_status', 0.008843005271481371),\n",
       " ('NSAID', 0.008841296486185325),\n",
       " ('examples', 0.008837518656657467),\n",
       " ('bcl2_protein', 0.008825713094140469),\n",
       " ('chemotherapy_immunotherapy', 0.00882539320237558),\n",
       " ('kinases', 0.00882193187916451),\n",
       " ('concepts', 0.00882067455819375),\n",
       " ('cathel_kerr_bsc_phd', 0.00882067455819375),\n",
       " ('gemcitabine_nab_paclitaxel', 0.00882067455819375),\n",
       " ('stability', 0.008811586412051564),\n",
       " ('much', 0.008809753283579408),\n",
       " ('coefficient', 0.00880599950678056),\n",
       " ('tumor_growth_metastasis', 0.00879352127651008),\n",
       " ('fibroblasts', 0.00879342456074119),\n",
       " ('benefits', 0.008789657989057271),\n",
       " ('expressionlevel', 0.008780988725059006),\n",
       " ('estimate', 0.008769287255167731),\n",
       " ('module_map', 0.008769018852838371),\n",
       " ('thepossibility', 0.008750317064173637),\n",
       " ('migration_invasion', 0.008737914345493064),\n",
       " ('univariate', 0.008727551352526425),\n",
       " ('translation', 0.00872602218172254),\n",
       " ('substrates', 0.008724968989130086),\n",
       " ('theseï¬\\x81ndings', 0.008720010909717722),\n",
       " ('cdkn2bas1', 0.008720010909717722),\n",
       " ('mark', 0.008720010909717722),\n",
       " ('phosphorylation_levels', 0.008707820378879313),\n",
       " ('measurement', 0.00870373166408192),\n",
       " ('strains', 0.00870040594774884),\n",
       " ('proportions', 0.008685101393674075),\n",
       " ('immunohistochemistry', 0.008680253255256735),\n",
       " ('activities', 0.008679726028477507),\n",
       " ('formula', 0.008678103208406522),\n",
       " ('top', 0.008664425213669601),\n",
       " ('classification_accuracy', 0.008658634921874441),\n",
       " ('complexity', 0.008657525039349735),\n",
       " ('frequencies', 0.0086539637162627),\n",
       " ('processes', 0.008649238190375743),\n",
       " ('thelevels', 0.008641715344283823),\n",
       " ('reviewers', 0.00863042861960599),\n",
       " ('diseases', 0.008628547392065615),\n",
       " ('era', 0.008624251799635175),\n",
       " ('membrane', 0.008620561716719542),\n",
       " ('spectrum', 0.008593904946624582),\n",
       " ('role_mechanism', 0.00859121354974701),\n",
       " ('term', 0.008585390975243651),\n",
       " ('woman', 0.00857643888151255),\n",
       " ('rebound_effect', 0.008571309280431393),\n",
       " ('cell_cycle', 0.008566279368998727),\n",
       " ('age_group', 0.00852837914907542),\n",
       " ('research_progress_hemsleyanum_root_tubers', 0.008521634825566903),\n",
       " ('pathway_analysis', 0.008521359322049667),\n",
       " ('t_cells', 0.008521138549246653),\n",
       " ('contrast_3d_tumour_platform', 0.008515175913617057),\n",
       " ('cancer_growth', 0.008504747025144428),\n",
       " ('maturation', 0.00849939211534094),\n",
       " ('CHEK2', 0.00849939129445212),\n",
       " ('associationbetween', 0.008476023803406818),\n",
       " ('gastric_cancer32_andintrahepatic_cholangiocarcinoma_studies_expression_gene',\n",
       "  0.008476023803406818),\n",
       " ('risk_score', 0.008464333654983886),\n",
       " ('estimates', 0.00846247726665206),\n",
       " ('nomograms', 0.00845723946684088),\n",
       " ('exon', 0.00845587840335114),\n",
       " ('PPI_treatment', 0.008439833469482344),\n",
       " ('ethics_committee', 0.00843695073498099),\n",
       " ('reasons', 0.008432422645547236),\n",
       " ('cell_line', 0.008426853622648016),\n",
       " ('feedback', 0.008425152223270132),\n",
       " ('laboratory_results', 0.008423380778526678),\n",
       " ('BMC_Cancer_Page', 0.00841567688399522),\n",
       " ('1e', 0.008400046986555094),\n",
       " ('drugs', 0.008383947151124933),\n",
       " ('characteristic', 0.008382412445033035),\n",
       " ('previous', 0.008381426081138607),\n",
       " ('diagnosis_treatment', 0.00837541138798254),\n",
       " ('center', 0.008358455299654352),\n",
       " ('D', 0.008344036307796026),\n",
       " ('lim_ledger', 0.008334501062014117),\n",
       " ('Fig', 0.00832322350053295),\n",
       " ('thepresence', 0.008322723629293304),\n",
       " ('isoforms_1A_3A', 0.008321763904719092),\n",
       " ('effect_ofscfas_patientswho_kc811_showa_denko_nonsurvivors',\n",
       "  0.008316158006441407),\n",
       " ('active', 0.008315738632372787),\n",
       " ('marker', 0.008312786757935519),\n",
       " ('safety_profile', 0.008306919377999586),\n",
       " ('t', 0.008301427629067654),\n",
       " ('microarrays', 0.008300122562247221),\n",
       " ('expression_signatures', 0.00829601396027308),\n",
       " ('RasG12V_expression', 0.00829601396027308),\n",
       " ('TC6_cells', 0.008293895100454574),\n",
       " ('dysbiosis', 0.008293410786873909),\n",
       " ('17', 0.008291650432896857),\n",
       " ('listing_table_genes_pathway', 0.00828996167413341),\n",
       " ('bft', 0.008281937337709403),\n",
       " ('performances', 0.008278220568251327),\n",
       " ('inthis_study', 0.00827651888438549),\n",
       " ('%_specificity', 0.00827442564394049),\n",
       " ('phosphorylation_level', 0.008273663047907382),\n",
       " ('family', 0.008267608324063484),\n",
       " ('labs', 0.00826667531873185),\n",
       " ('barrier', 0.008266153588852411),\n",
       " ('immunotherapy', 0.008265136512817085),\n",
       " ('delivery', 0.008264574610204606),\n",
       " ('channels_K_channels_transporters', 0.008260360095168527),\n",
       " ('attributes', 0.008259865935194703),\n",
       " ('idea', 0.008256617715041034),\n",
       " ('thedownstream_pathway', 0.008255465562950008),\n",
       " ('serum_concentrations', 0.00825430252809772),\n",
       " ('serum_samples', 0.00825096842068282),\n",
       " ('nats', 0.008240713152697587),\n",
       " ('positives', 0.008239339048935023),\n",
       " ('benefit', 0.008233635066198551),\n",
       " ('microRNAs', 0.008223587042629148),\n",
       " ('course', 0.008219728953639574),\n",
       " ('toxicities', 0.008215401627676113),\n",
       " ('germline_mutation', 0.00820994705671373),\n",
       " ('vectors', 0.00820461628644885),\n",
       " ('subunit', 0.008202723160598814),\n",
       " ('fitness', 0.008200536391594971),\n",
       " ('functioning', 0.008198351370194378),\n",
       " ('histone_methylation', 0.008198351370194378),\n",
       " ('wnt', 0.008198351370194378),\n",
       " ('assumptions', 0.008197240905911776),\n",
       " ('phosphatidylinositol', 0.008196167512828208),\n",
       " ('transmission_portion', 0.008196167512828208),\n",
       " ('expression_pattern', 0.008191927635380633),\n",
       " ('sensitivity_tocisplatin_bleomycin', 0.008183955112702026),\n",
       " ('carcinogenesis', 0.008182125878975577),\n",
       " ('to_be_atherapeutic_target_in_GC', 0.008181775462191775),\n",
       " ('invasion_migration', 0.008181775462191775),\n",
       " ('lim_ledger_hennessy_current_components_ï¬\\x81bronectin_laminin_kalluri_zeisberg_erdogan_webb_ï¬\\x81broblasts',\n",
       "  0.008180164474814969),\n",
       " ('increment', 0.00817996792620004),\n",
       " ('comments', 0.008178971667251492),\n",
       " ('effectiveness_analysis', 0.008176592891676224),\n",
       " ('way', 0.008172884131984658),\n",
       " ('incubation', 0.008170463679927553),\n",
       " ('iodine_intake', 0.008169481654665195),\n",
       " ('mrnas', 0.00815652077622397),\n",
       " ('pathways_b6_metabolism_pathway_abundances', 0.008147768157512702),\n",
       " ('ppi_network', 0.008120801201576792),\n",
       " ('ratios', 0.008108090177763325),\n",
       " ('variables_v2test', 0.008102680481436095),\n",
       " ('evolution', 0.008100943211762399),\n",
       " ('tumor_types', 0.008096511476133631),\n",
       " ('Results', 0.008093109855683471),\n",
       " ('cis_meQTLs', 0.008091628505263002),\n",
       " ('traits', 0.00808917233718746),\n",
       " ('mrna_protein_expression', 0.008077688832360186),\n",
       " ('lung_tissue', 0.008073040165727022),\n",
       " ('to_overcome_pre_existing_ad5_nabs_by_replacing_the_ad5_fiber_with_that_of_a_rare_adenovirus_serotype_ _ad35_ _international_ _seroprevalence_ _\\x93_ _to_improve_antitumor_immunity_in_mouse_models_expressing_the_gastrointestinal_gi_cancer_antigen',\n",
       "  0.008070115206513344),\n",
       " ('thedata', 0.008066893477119464),\n",
       " ('csgrp78', 0.008063528617409927),\n",
       " ('laboratory_findings', 0.008062769862311314),\n",
       " ('lengths', 0.008049118781575493),\n",
       " ('IHC', 0.008042582573488204),\n",
       " ('publication', 0.008040065747800453),\n",
       " ('confusion_matrix', 0.008038927305023013),\n",
       " ('effect_ofuse', 0.008020065009294948),\n",
       " ('energy', 0.008018008780812378),\n",
       " ('dendrogram', 0.008016101240303783),\n",
       " ('gefitinib', 0.008014920496733488),\n",
       " ('radio_opacity', 0.008009945811710136),\n",
       " ('factor_tbx3', 0.008002352267672447),\n",
       " ('srsf1', 0.008001217496245569),\n",
       " ...]"
      ]
     },
     "execution_count": 168,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sorted(dict(temp_inconsistent).items(), key=lambda x: x[1], reverse=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 184,
   "id": "77af7104",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.001184022710969853"
      ]
     },
     "execution_count": 184,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sum(dict(temp_inconsistent).values())/len(dict(temp_inconsistent).values())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "bf4e5010",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "id": "f9c5617a",
   "metadata": {},
   "outputs": [],
   "source": [
    "highest_degree_node = 'lung_cancer'\n",
    "second_highest_degree_node = 'role'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "8bf58f18",
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\pouri\\anaconda3\\envs\\myenv\\lib\\site-packages\\IPython\\core\\pylabtools.py:152: UserWarning: Glyph 129 (\\x81) missing from current font.\n",
      "  fig.canvas.print_figure(bytes_io, **kw)\n",
      "C:\\Users\\pouri\\anaconda3\\envs\\myenv\\lib\\site-packages\\IPython\\core\\pylabtools.py:152: UserWarning: Glyph 151 (\\x97) missing from current font.\n",
      "  fig.canvas.print_figure(bytes_io, **kw)\n",
      "C:\\Users\\pouri\\anaconda3\\envs\\myenv\\lib\\site-packages\\IPython\\core\\pylabtools.py:152: UserWarning: Glyph 147 (\\x93) missing from current font.\n",
      "  fig.canvas.print_figure(bytes_io, **kw)\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAzMAAAKACAYAAACogibZAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjcuMSwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/bCgiHAAAACXBIWXMAAA9hAAAPYQGoP6dpAAEAAElEQVR4nOzddVhU2RvA8e8MAwzdSCkgmFjY3d2da/eurrru2l1rr665q67d3d3dBbaCitiEID1zfn+wjI6ggoKxv/N5Hh/hxrnn3plh7nvPOe9RCCEEkiRJkiRJkiRJ3xnl166AJEmSJEmSJEnSp5DBjCRJkiRJkiRJ3yUZzEiSJEmSJEmS9F2SwYwkSZIkSZIkSd8lGcxIkiRJkiRJkvRdksGMJEmSJEmSJEnfJRnMSJIkSZIkSZL0XZLBjCRJkiRJkiRJ3yUZzEiSJEn/WXJe6NSR10mSpO+VDGYk6Rvm5+dH8+bNcXJywsjICGdnZ5o1a8bly5fTXNaIESNQKBQZUMv05+HhQbt27TKk7FevXlG3bl1MTU2xsbHh9u3bybZZtGgRCoWCXr16pVhGel7L8uXLU758+XQp61McOnQIhULBoUOHvlodUqNdu3Z4eHi8d31gYCAKhYJFixYBEBYWRps2bTh69Gi6HP/cuXO0bt2aLFmyYGJigpeXF126dCEgICBdyv+a/P39KVWqVLqUlZr3U7t27VAoFGzatCnF9en5mVAoFIwYMSJdypIk6dskgxlJ+kb5+/tTokQJXr58yYwZM9i7dy+TJ0/m/v37FC9enFOnTn3tKn6XlixZwtatW5k8eTKbNm3C09PzvdvOnDmTY8eOfcHaSZ/K2dmZkydPUqtWLQAuXbrE0qVL0Wq1n132rFmzKFGiBE+fPmX8+PHs3LmTAQMGcOjQIQoXLvxJDxe+JWvXruXkyZNf/LjdunUjJCTkix9XkqT/FtXXroAkSSmbOnUqdnZ27Ny5E5XqzUe1fv365MiRg9GjR7N9+/avWMPv08uXLwHo3r37R1tXLC0tad++PVeuXMHExORLVE/6RMbGxhQvXjzdyz1+/Di9evWiR48eTJs2Tbe8fPny1K9fH19fXzp06MD58+fT/dj/ZaampoSEhNCzZ0+WL1/+tasjSdJ3TLbMSNI36smTJwghkj1ZNjMzY9q0aTRt2lS3LKVuWUldpQIDA/WWb9q0iezZs6NWqylWrBj79+/XW3/jxg1q1qyJpaUlmTJlYvDgwXTo0EGv24dCoWDkyJEULlwYExMTRo0aBcCRI0eoVq0aNjY2GBkZ4enpyYgRI3TnkNQVaNWqVdSpUwdTU1OyZMnC6NGjk51nfHw8/fr1w8nJCTMzM6pWrcqdO3c+eM1iYmIYPXo0OXPmRK1Wky1bNiZMmKAru3z58rouJ0ql8qNd2aZMmcLdu3cZNGjQB7eDxG5I1atXx87ODktLS+rUqYO/v7/eNg8ePKBhw4ZYWVnh5OTE1KlTUyxr/vz5+Pj4YGxsTJYsWRgxYgQajeaDx3/fa3L79m0aN26su44VKlTg+PHjHyzLz8+P2rVrY2lpiaWlJQ0aNODevXsfvQbz58+ncOHCmJmZYWJiQoECBVi7dq1u/aJFi1CpVJw+fZoSJUqgVqtxd3dn8uTJeuWEhobSvn17bG1tsbGxoX///h9tYXm7m9mhQ4eoUKECABUqVNC9d+/evUvdunWxs7PD1NSUEiVKsGPHjg+WO2nSJKytrRk3blyydQ4ODkydOpX69evz+vVrADQaDbNnzyZv3ryYmJiQJUsWBgwYQExMjG6/du3aUblyZRYuXEj27NkxNjamQIEC7Nq1K83XKiYmhn79+pE5c2aMjY3Jly8fq1ev1ttGCMEff/xBrly5MDExwdvbm8mTJyOEYMSIEYwcORLQ75Kl1WoZP3483t7eGBsbkz17dmbMmJHsGvz1119kz54dExMTypUrx/379z94Pd++dgMHDmTFihVs2bLlo9uvXr2awoULY25ujpOTE926dSM0NFRvm8OHD1OiRAlMTU3JkSMH+/btS1ZOaq7X+fPnqVSpElZWVlhYWFC5cmXZEi5J3zIhSdI3afbs2QIQBQsWFDNnzhTXrl0TWq02xW3d3d1F27Zt9ZYtXLhQACIgIEAIIcTw4cMFIGxtbcXMmTPFtm3bRKVKlYShoaE4e/asEEKI58+fCwcHB+Hj4yPWrVsnVq1aJbJnzy6MjY1FuXLldGUDwsjISEyZMkVs27ZN+Pn5iUuXLgmVSiVatmwpdu/eLXbt2iVat24tALFy5UohhBABAQECENbW1qJVq1Zi586dYvDgwUKpVIp+/frpnY9SqRQ1atQQu3btEosWLRI2NjaiUKFC771eWq1WVK5cWZibm4tJkyaJPXv2iIEDBwoDAwPRuXNnIYQQ/v7+omPHjgIQJ0+eFHfu3EmxrLevXbdu3YRSqRTHjh3TrU+6lkkOHDggDA0NRdWqVcXmzZvF6tWrRf78+YWlpaW4fv26EEKIyMhI4e7uLry9vcXq1avF2rVrRa5cuYShoaHetR03bpxQKBTi559/Frt37xYTJkwQarVadOjQ4b3n/r7XxN/fX1hYWIhChQqJNWvWiE2bNokKFSoIQ0NDcejQISGEEAcPHhSAOHjwoBBCiJs3bwoLCwtRpEgRsWHDBrFmzRqRL18+4eTkJJ4+ffre48+cOVMolUoxevRocfDgQbF+/XpRtGhRoVKpxMOHD3XXVaFQiCxZsohp06aJ/fv3i5YtWwpA7Nq1SwghhEajEUWLFhWOjo7in3/+EZs3bxalSpUShoaGwt3d/b3HT3pvLVy4UISHh4tZs2YJQMyaNUv4+/sLjUYjcubMKSpWrCi2b98u9uzZI2rVqiUMDAzE7du3UyxTq9UKtVotmjZt+sFr/7aOHTsKQ0NDMXToULFnzx4xYcIEYWpqKqpWrar7/LZt21ZYWVmJXLlyiZUrV4odO3aIQoUKCRMTExESEpLqa6XVakX16tWFhYWFmDp1qti1a5fo2rWrAMTixYt1dfr111+FgYGB6Nevn9i7d68YN26cUCqVYty4ceLhw4d6n4mk16pLly7C0NBQDB8+XOzevVsMGjRIKJVKMWrUKF25M2bMEIDo3bu32L17t+jXr58wMjLSez+lpG3btsLd3V3ExcXp3lsvX77UrS9XrpzeZ2L06NFCoVCIn376SezatUvMnj1b2NnZiXz58omoqCghhBDnz58XRkZGonr16mL79u1i1qxZwt7eXgBi+PDhqb5e4eHhwt7eXjRt2lTs3btXbNu2TRQvXlxYWlqKsLCwVL8PJEn6cmQwI0nfsKFDhwq1Wi0AAQh7e3vRqlUrcebMGb3t0hLMrF27VrdNdHS0cHZ2Fo0aNdI73qNHj3TbBAYGCiMjo2TBTKVKlfSOt2TJElGjRg2h0Wh0yzQajbCyshJdu3YVQry54Xx33169egkjIyMRHh6uO5/MmTOLuLg43TZDhgwRgG6bd+3YsUMvcEoyevRoAQg/Pz+96/Ahb1+7iIgI4e7uLrJly6a7cXq3jKJFi4rcuXOLhIQE3bLQ0FBha2srmjRpIoRIvNlXKBTC399ft82DBw/0rm1YWJgwMTER3bp106vP/Pnz9c4hJSld16ZNmwp7e3vx6tUr3bL4+HiRI0cOUaRIESFE8mCmZcuWIlOmTHrX+eXLl8LKykr8+uuv7z3+L7/8Ivr376+37Pz583qvSdJ1nT9/vm6bmJgYoVarRY8ePYQQQmzbtk0AYufOnbptIiMjhb29faqDmZTO6/HjxwIQy5cv1+0TFhYm+vTp897r+uzZMwEkO6/38ff3F4D4/fff9ZYvXbpUAGL79u1CiMSbeUAvmD58+LAAxLp164QQqbtWe/bsEYBYtWqV3vF++OEH4ezsLOLj40VoaKhQqVSid+/eetv8/PPPonr16kKI5O/nmzdvCoVCIcaPH6+3z5AhQ4RarRYvXrwQWq1WODo6imbNmult061bt1QHM0IIceHCBaFSqUSrVq10698OZkJCQoSxsbHub0iSI0eO6IJVIYRo3LixcHNz0/ubsWrVKr1gJjXX6+TJkwIQx48f162/c+eO6Nevny7QkyTp2yK7mUnSN2zUqFEEBwezYsUKOnbsiKWlJcuXL6dYsWL8+eefaS7P0NCQhg0b6n5Xq9XUqFGDI0eOAHDgwAFKliyJi4uLbht3d3dKliyZrKwCBQro/d66dWt27NhBXFwcV65cYf369QwfPpyEhARiY2P1tm3Tpo3e740aNSIuLk5vEHKxYsUwNDTU/Z40UD8sLCzFczt06BAqlYomTZroLf/hhx+AxC4on8Lc3JwFCxZw+/ZtBg8enGz969evOXv2LE2bNsXAwEC33Nramjp16uiyOh09ehQvLy9y586t2yZz5sx64zxOnjxJdHQ0devWJSEhQfevTp06AOzdu/eDdX33NTl06BC1a9fGwsJCt0ylUtG8eXPOnTtHZGRksjL2799P+fLlMTU11R3f0tKSMmXKfPD4U6ZMYfz48YSFhXHq1CmWLVvGrFmzAJK9/iVKlND9bGxsjIODg66b1tGjRzEyMqJatWq6bczMzKhZs+YHz/1jMmXKRO7cuencuTNt27ZlxYoVaLVapk6dio+PT4r7JI1V+1gXvyRJ77EWLVroLW/evDkGBgZ6Gb4cHBzw8vLS/e7m5gaguw5JPnSt9u/fj0KhoFatWnrvl7p16/L48WP8/Pw4deoUCQkJep97gOnTp7Nz584Uz+PAgQMIIahTp06ycmNiYjh69Cg3b97k2bNnuvdmkre7v6aGr68vAwYMYPny5WzdujXZ+lOnThEbG5vsmpYpUwZ3d3e9z1f16tX1/mY0atRI7zOZmuuVJ08eHBwcqF27Nt26dWPjxo04OTkxYcIE3WskSdK3RQYzkvSNs7GxoUWLFsyfP5+7d+9y4cIFcuXKRb9+/XSD2VPLwcEBpVL/Y+/o6Kjre/78+XMcHR2T7ZcpU6Zky8zNzfV+j46OplOnTlhZWVGgQAH69etHYGAghoaGyeawcHV1TVYHQC+zkZmZmd42SfV+39iJkJAQ7O3t9W5eAJycnID3B0GpUalSJbp06cL06dM5ceKE3rqwsDCEELrjvHvspOMm1e9dzs7Oup+TXs+aNWtiaGio+5d0/YODgz9Yz3dfk5CQkPfWSwjBq1evkq17+fIlq1ev1ju+oaEh27Zt++Dx7969S+XKlbGxsaFcuXJMmjSJ+Ph4IPkcJqampnq/K5VK3esaEhKCra1tsuQMb1+nT6FQKNi7dy9t27Zl9+7dtGrVikyZMtGsWbNkYy+S2NjYYGFh8cFxIK9fv9btn/T+ffeaq1Qq7O3t9d6DKV0DSP7+/tC1evnyJUIILCws9F6rpIAiODhY955K6XP9Pkn7+Pj46JVbtGhRXblJ5/rue/pTXqehQ4eSN29eunbtmuy1eN81TVr2oc9X0nV/+7w+dr3Mzc05evQotWrVYvXq1TRs2BAHBwe6deuWLCiXJOnbILOZSdI36NGjRxQpUoTRo0fTsWNHvXW+vr6MHTuWBg0acPfuXezs7FAoFMmeHqf01D3pxvvtG8UnT57obnTc3Nx4+vRpsv2ePXv20Tr36tWLdevWsWbNGipXrqwLRlK6iXrx4oXe70nHTMsN17tsbW158eIFGo1GL6B5/PgxkPymK60mT57Mrl27aN++PfXr19ctt7a2RqFQ8OTJk2T7PH78WHdce3v7FBMYvB2QWltbA7B8+XKyZ8+ebNuUgsoPsbW1fW+9AOzs7JKts7a2pnLlyvTt2zfZurez6r1Nq9VSq1YtjIyMOHv2LAUKFEClUnHt2jWWLl2apjrb29un+DqmNXBPiYuLC7Nnz2bWrFlcvnyZdevWMX78eOzt7XWtSO+qVq0aBw8eJCYmBrVanWz9vHnz6Nu3L2fPnsXW1hZI/Ey5u7vrtomPj+fFixef/R58l7W1Nebm5hw8eDDF9d7e3rpkD8+fPydHjhy6dQ8ePODu3buULl06xXIhsYXm7Va9JFmyZNEFEe/+vfiU18nIyIiFCxdSvHjxZHM7vX1N364/JL6Ps2bNCiS+b96tixBCLzhKzfUCyJEjB0uXLkWj0XDmzBmWLl3KnDlz8PLy4rfffkvz+UmSlLFky4wkfYOcnJxQqVTMmjVLLwtSkps3b+qydUFiCuGgoCC9bVKaHyUqKkrvizwyMpLt27frMj+VK1eOkydP6t0AP378OFVzUBw7dowKFSpQr149XSBz/vx5nj9/nuxp87uT5a1btw5TU9PPSq1brlw5EhIS9LJnASxbtgwgxZu2tLCwsGD+/PncunWLv/76S7fczMyMwoULs2bNGr2AMjw8nG3btumOW6lSJQICAjh37pxumxcvXuhlSSpevDhGRkY8evSIwoUL6/6pVCoGDhyY5gkay5Urx7Zt24iIiNAt02g0rFq1iiJFimBsbJziPteuXaNAgQK64xcqVIipU6eycePGFI/z4sULbt68SceOHXX1BXTdmNIy10ulSpVISEjQe4/ExcWxZ8+eVJcBJGuhO3nyJJkyZeLs2bMoFAoKFCjAmDFjyJs37wdbXvr27cvLly8ZMmRIsnVPnjxh8uTJ5M6dm4IFC1KuXDkAVq5cqbfdqlWr0Gg0n/0efFe5cuWIjIxECKH3frl69SojR44kISFB113z3S5cU6ZM0XV/e/dalS1bFkh8Xd8u9/nz5wwdOpSXL1+SLVs2MmfOnOzzllJXsdQoVKgQ/fr1Y+nSpVy8eFG3vFixYhgbGye7pkePHuXBgwd6n68dO3YQFRWl22b37t3ExcWl6XqtW7cOBwcHnjx5goGBASVKlGD27NlYW1unOlObJElf2FcaqyNJ0kds27ZNqFQq4ePjI+bMmSMOHTokduzYIXr37i1UKpXe4NxBgwYJhUIhxo0bJw4cOCB69+4tHBwckiUAMDIyElmyZBHLly8XW7duFaVKlRLm5ubixo0bQojEQesODg4iX758Yt26dWLdunUif/78QqlUigoVKuiOx1uDapO0bdtWmJiY6Oo6ffp04eDgIBQKhWjYsKEQ4s0gbaVSKXr16iV2794tBg4cKJRKpd6g6dQkNHiXVqsVFSpUEObm5mLy5Mli7969YsiQIUKlUumVldYEAO/q1KmTLiFDkn379gkDAwNdNrO1a9eKggULCjMzM3H16lUhhBCxsbEib968ws3NTSxZskRs2rRJFC5cWJiYmOglVxgyZIgwNjYWQ4YMEfv27ROLFy8WWbJkEe7u7h/MppTSa+Ln5yfMzMxEoUKFxNq1a8XmzZtF5cqVhYGBgdi7d68QIvlA+cuXLwtTU1NRrVo1sWnTJrFr1y7RoEEDoVAoxPr16997fA8PD+Ht7S3WrVsn9u/fL3777TdhaGgoAPHnn39+8Lq++3pXq1ZNWFtbi9mzZ4vt27eLatWqCRMTkzQlALhy5YoAxK+//iouXbokoqOjhYeHh8iRI4dYuXKlOHjwoBg8eLDePu8zZswYAYiaNWuK1atXi/3794vp06cLNzc3YWtrK65du6bbtm3btrpsZnv37hWTJk0SZmZmokKFCrrkGG8PgH9f/VNzrTQajShbtqxwdnYWs2fPFgcPHhQTJkwQxsbGol69erp9fvvtN6FSqcTQoUPFvn37xNixY4VKpRLTpk0TQgjx559/CkCsWLFC3Lt3TwiROCjeyspKTJw4URw4cEDMmTNH2NjYiIIFC+oSXaxYsUIAolOnTmL37t1ixIgRwtLSMk0JAN4WGxsrfHx8BKD3mRg+fLhQKBSiR48eYvfu3WLu3LnCwcFB5M6dW0RGRgohhLh165YwNzcXpUuXFlu2bBELFiwQzs7Ouoxsqb1ewcHBwsbGRhQrVkxs3LhR7N+/X3Tp0kUoFApx4MCB956TJElfjwxmJOkbdv78edG8eXPh5uYmjI2NhaWlpShfvnyym8rIyEjRuXNnYWNjI8zNzUWzZs3Eli1bkgUzrq6uYsWKFcLDw0MYGxuLsmXLivPnz+uV5efnJypVqiRMTEyEo6OjGDlypChRooSoU6eObpuUbpxfvnwpWrZsKezs7IS5ubnImzevmD59uujSpYtwdnYWCQkJuhu2sWPHiipVqgi1Wi2yZ88u5syZo1fWpwQzQgjx+vVr0bdvX+Hq6iqMjIxEjhw5xKRJk/QyrH1uMBMeHi4yZ86crIyDBw+KMmXKCBMTE2FtbS3q1q2bLEvW8+fPRatWrYS1tbWwsbER/fv3F02bNtW7cRNCiFmzZoncuXMLIyMjkSlTJtGqVStx//79D9Y5pddECCEuXrwoatSoIczNzYWFhYWoVKmSOHr0qF693735PH/+vC6Frbm5uShevLjYvHnzB49/6dIlUa5cOWFubi7s7OxEmTJlxK5du0TOnDl1Gd1SG8y8fv1a9OjRQ9jb2wtzc3PRsWNH0atXrzQFMxqNRrRo0UKo1Wrh4+MjhEi84W3YsKFwdHQURkZGwsfHR/z1118fPK8kO3bsEDVr1hTOzs7C2NhYeHt7i27duokHDx7obZeQkCDGjBkjsmbNKgwNDYWHh4cYNGiQiI6O1m2TXsGMEImf/T59+gg3NzdhZGQkPD09xcCBA/WOp9VqxaRJk4SXl5cwNjYWOXPmFHPnztWtf/TokShSpIgwNDQU3bt3F0IkZr0bNWqU7jzc3NxE9+7d9VIoC5GYMczHx0cYGxuLwoULi5UrV35yMCOEEGfPnhUGBgbJPhNz5szRfSacnZ3Fjz/+qEtjneT8+fOifPnywsTERHh4eIjly5eLTJky6X0uUnO9zpw5I6pWrSpsbW2FWq0WhQsXFhs2bHjv+UiS9HUphHhnZKYkSf+3Tp8+TUhICDVq1NAtS0hIIEuWLDRv3vy9kzymVmBgIJ6enixcuPCjE1ZKkiRJkiR9jEwAIEmSzoMHD2jWrBnDhg2jfPnyvH79mr///puwsDA6d+78tasnSZIkSZKkRwYzkiTpNGnShJcvXzJ79mwmTZqEkZERxYsX58iRI+TKletrV0+SJEmSJEmP7GYmSZIkSZIkSdJ3SaZmliRJkiRJkiTpuySDGUmSJEmSJEmSvksymJEkSZIkSZIk6bskgxlJkiRJkiRJkr5LMpiRJEmSJEmSJOm7JIMZSZIkSZIkSZK+SzKYkSRJkiRJkiTpuySDGUmSJEmSJEmSvksymJEkSZIkSZIk6bskgxlJkiRJkiRJkr5LMpiRJEmSJEmSJOm7JIMZSZIkSZIkSZK+SzKYkSRJkiRJkiTpuySDGUmSJEmSJEmSvksymJEkSZIkSZIk6bskgxlJkiRJkiRJkr5LMpiRJEmSJEmSJOm7JIMZSZIkSZIkSZK+SzKYkSRJkiRJkiTpuySDGUmSJEmSJEmSvksymJEkSZIkSZIk6bskgxlJkiRJkiRJkr5LMpiRJEmSJEmSJOm7JIMZSZIkSZIkSZK+SzKYkSRJkiRJkiTpuySDGUmSJEmSJEmSvksymJEkSZIkSZIk6bskgxlJkiRJkiRJkr5LMpiRJEmSJEmSJOm7JIMZSZIkSZIkSZK+SzKYkSRJkiRJkiTpuySDGUmSJEmSJEmSvksymJEkSZIkSZIk6bskgxlJkiRJkiRJkr5LMpiRJEmSJEmSJOm7JIMZSZIkSZIkSZK+SzKYkSRJkiRJkiTpu6T62hWQJEmS9MUkaAiLiSc8NoF4rRatAKUCDJVKrIxVWKsNUasMvnY1JUmSJOmrk8GMJEnSNyA8Jp57YVEER8YQq9ECoEhhO/Hv/8YGSlzM1WS1NsVKbfjF6ilJkiRJ3xKFEEJ8fDNJkiQpvQkhCI6M5VZIJKEx8Sh4E6ykRtL2tmpDstma42JujEKRUggkSZIkSf9NMpiRJEn6CmISNFx8Es7j17GfXVZSUONsZoyvk5XsgiZJkiT935DBjCRJ0hcWFBHNhSfhaLQiTS0xH6MADJQKCjpZ4WZhko4lS1+bHEclSZKUMhnMSJIkfUG3QyK5+jwiw4+Tz8ESb1uzDD+OlHHkOCpJkqSPk8GMJEnSF/KlApkkMqD5/shxVJIkSWkjgxlJkqQvICgimjPBYV/8uEVdrGWXs++EHEclSZKUdjKYkSRJymAxCRr2BDwnQfvl/9yqlAqqejrIm9lvnBxHJUmS9GmUX7sCkiRJ/2VCCC7+e5P6NWi0gotPw5HPrb5dt0MiORMcRkI6BzKQ2DqToBWcCQ7jTsjrdC5dkiTp65OTZkqSJGWg4MjYdOk29KkE8DgyluDIWFwt1F+tHv9F6ZFh7EuOo7ry/BWAHEclSdJ/igxmJEmSMtDtkMivXQUU/9ZDBjOfLz0zjAVFRH/RhBCQGNCoDZWyy5kkSf8ZMpiRJEn6iE99Ah8eE09ITHy61ePErq34FCmBlZ19mvYTQEhMPOGx8VgZG+Lh4cGIESNo165dutXtv+xjGcY+1DUsVqMlMDyKgPAovQxjsRotF56EZ3DNU3bhSTj2JkZyHJUkSf8JMgGAJElf1bc6GWB6PIG/+CScwPCodBkH8exREN0rFWXOvtM4umVO8/4KwMPKFF8nK54/f465uTkmJvLp/MdkRIYxJ1MjtMDzqLh0HyOT2no4mRtT3MVGpm2WJOm7J1tmJEn64r7VyQDT+wl8cGRM+t2sfuZzJwEER8bgixUODg7pU6f/uLczjKWHpFKeRMWlS3mfUw85jkqSpP8Kmc1MkqQvQgjBo4gYDt5/wf77LwgMj9IFMpB4g/XuvyRJgcL++y84dP8FjyJi0j07V0yChlOPQjkdHErov13D3neEGxfOMLhlPVoUyEpLXy/GdPmB0GdP2b9hNYNb1uPPsSPwdrKnXdmC7Fu7XLefVqtl04LZdK9cnBb5szKsTWPu37yuW98opwv71q3gxyolaFUwG9N+/Yno14kZqLpXLqb7/8CG1QCcO7iXXxtWpUX+rPSqVY5Te3boygq84c+g5nVoUSArncsWZM2sqcRqtMQkaPDw8GDRokUAXL58mZIlS2JqaoqrqyujRo1Kr0v6XcvIDGPfgqRxVJIkSd87GcxIkpTh0hIovE/S9qEx8ZwODuXUo1BiEjTpUr+giGj2BDznSSq6Er2OeMXYrm3IX6oc07YdYtiClTy5H8iGv2cAcOfqJQKu+/P7qq007dGXeaMGcenYIQDWzprKln/m0mHQSCZt2I2DixtjOrciJipKV/7K6RPpOHg0Ixev4/7N6/w1vB8AE9bu0P1fqmZdrp46xqSfO1G+XhOmbNpLpcYtmfpLN+76XQHgz/698Mydh2nbDvHj2Clsmj+L84f3E/bOGJ42bdrg6+uLv78/CxYsYMKECezYsYP/Eg8PDxQKhe6foaEhOXPmZNq0aQAsWrQIDw8P3fanbgbQtmULWhfOQcfS+Vk6eQyahAQAngU9pFFOF54FPdQ7xr61y2mcy5UD61fpLT+wYbUuSH1Xt4pFdYHpu548vM+FIwc+46w/7O1xVPfu3WPnzp0ABAYGolAoCAwMzLBjS5IkpScZzEiSlKHSEiikhq6rzutY9gQ8Jygi+rPKS+sT+LiYGJp0702TH/uQyS0LOQsWpXjVmjy8cwsAhULJzxP+JEv2nFRq1ILSNeuzd81yhBDsWLaQ5j/3o0jFarh5ZaP76EkoDZQc2bJeV36Dzj0oVL4y3nnz02HwaI7v3MLriFdY2tgBYGljh7HahJ3LF1K8ai1qt+2Mi6cXddt3pXjVmmz+Zw4Azx89xNzaBgcXN3zLVGD4P6vxyp2X8NgEvfMJDAzEzs4Od3d3qlevzr59+yhYsOBnXdNv0bRp03j8+DGPHz/m3r17DBw4kF9//ZUlS5bobRcUEU3XDm2JinjFuFVb6Tvtb45t38Sm+bPfW/aZ/bv4a8QA2g0YQcVGzfXWHdu+CacsHhzetC5N9Z09uC+3L19I0z5ppQDuhUbRsWNHTp8+naHHkiRJyigymJEkKcN865MBfsocHzYOjpRv0ISti/7mz/4/069RdbYsnItWk9hK5OTuoZdtzCtPPoLu3Sb85Qsiw0PJnt9Xt05laIhXnvwE3butW5bTt4juZ+88+dFqNDwOvJesHkF3b5Mtv37QkaNAYR79W1bDrj1ZP2c6ncoUYNbgX4iPi8PGwZF4rVZvn0GDBjFmzBicnZ3p2LEjsbGxODk5pemafA+srKxwcnLCycmJzJkz07ZtWypXrsyGDRt028QkaDj94BnWdg50Hv47mb2zk7twMYpXrc31C2dSLPf6+dP88cuPNO7Wi9ptO+utC3/5gqunjtHkp1+4fv40T4MepL7CXyA3T9I4KpkHSJKk75kMZiRJyhBfejLAtAY0nzrHx8unj+lTtxJ+p46T1Scf7QaOpE77rrr1KpV+XhWtVotSocTQ2DjF8rQajS4QAlAZvtlfq01crlAk/1NtlEJ5Wq0W7b/jkBp07sGsvSep3+knnj58wIh2Tdi7djnvjmXv378/d+/epX///ty7d4+KFSsyf/78j1yF/waVSoWRkZHu94tPwlGqjOg1aSbO7p4APLh9k3MH95CnaIlk+z+4dYPfu7ejSrMfaNbz12TrT+zaipmFJWXrNMTG0YnDm9a+ty63Ll+gVUFv9q9fyYwBvfE/e5I1s6YyrHWjj57HgX/Hai2dMpZWBbPRtUJhvbFaUZERzBrUh/Yl89Isrzs9a5Th9L7EbmWTf/uZw4cPM3LkSMqXL6/bZ+PGjXh5eWFqakrdunUJDQ3l5cuXGBgY4OfnB0B8fDxmZmYMHz5ct1/Lli0ZMmQIAPPnzydnzpwYGRlhb2/PTz/9hEaj4eHDhyiVSi5ceNPy9OzZM1QqFXfu3Pno+UqSJL1NBjOSJKW7rzUZYGq7nMUkaD55jo/Te3dibmXNoL+WULtNJ3IXLsbThw90T7cf3w/UDdoHuOt3GfccuTCzsMTa3oFbl97cwCXEx3PX/younl66ZQHX/XU/3/G7jMrQKHH9Oyl0XTy9uHXpvN6ym5fO4+LpRVxsDAvGDkVlaEjd9l0ZtWQdVZr+wKk9O1C+VUxMTAy9evXCyMiIX375hYMHD9KlSxfWr1/Pf1l8fDwbNmxgz5491KtXDwCNEDx+HavXgjj0h4b0qVMBMwtLqrdsr1fG88ePGN25FRbWNrQfODLF4xzfsZlC5SqjVCopUrEqhzavS7EVJDjgLr93a0OzHr9SqVELOgweRY4Chajbviu/zUhdYHnn6iUC3zNW65+xQ3kUcJdhC1byx9aD5C5cjDlDfiU+Lo4Og0dRuGgx+vbtq9dKtXjxYlatWsXBgwc5f/48EyZMwM7OjkKFCnHoUGK5Z8+eJTo6muPHjwOJST72799P9erVOXz4MD///DPjxo3j1q1bzJ07lwULFrB582YyZ85M6dKlWbfuTde79evX4+vri7e3d6rOV5IkKYkMZiRJSlefEyh8rgtPwj+aFEAIwcXPSLdrYW3Di+BHXDl5lCcP77Nx3kxO79lOfHxiut2YqNf8PaI/Qfdus3fNck7s2kb1lm0BqNOuC6tmTOLsgT0E3b3NnKG/ER8bQ6ma9XTlr5oxCf8zJ7l1+QL/jB1K+fpNMDEzQ22aOCdM4E1/ol+/pnbbLpzas51tS+YTHHiPrYv+5vTeHVRv2RYjYzU3zp9hwZghPLp3hztXL3Pt3Ck8c+XBUPnmz76hoSEHDhygRYsWTJkyhW3btnHkyBF8fX35r+nWrRvm5uaYm5ujVqtp27Ytffr0oVWrVgDEa5K/HzoOSUzEEB8Xxx99u+utm9qnK5ncMvMs6AGHNycfD/Pi8SNuXDhL0crVAShWpQZPH97n+nn97mrhL58zunMrKjdpRd0O3QAws7BEZWiE2tQMC2ubVJ3f+8ZqAeQuUoJuIyfimSsPLh5Zqdu+GxFhoYS/fI65hSUKlSHm5ubY2trqyps4cSJFihShWLFiNG3alMuXLwNQtWpVXTBz5MgRatSowenTp9FoNFy5coXY2FiKFy+Oubk5CxYsoGHDhnh4eNC4cWNdogmAFi1asHbtm5aqNWvW0Ly5/ngjSZKk1JDzzEiSlG4+N1D4XBqt4OLT8A9OBhgcGftZEyCWrFGXa+dOM7lXFxQKBV558tO2/3BWz5hMQlwc9s4uWDs40r9xDawdMtFr0gxyFiwKQJ323YiKjGTusN+Iiowgh29hRi1Zj5Wtna788vWbMGNAL15HvKJ0rfp0GJT41N/Sxo6ydRsxpXc3Wv86mNptO/PzhD9ZPXMKSyeNwcXTi75//EXe4qUB+OWPucwbNYj+TWpioFJRsnodGv/Ym6iQ50RHR3Ps2DGCgoKoUKECO3bsYNCgQajValq0aMHQoUM/+fp8i5OgJiQkEBsby65du6hQoQJr1qyhYcOGvHz5krVr1xIVr0GbQouJR04fAH4a9wf9m9TQy2CWOVsOBv+1lMUTRrHw9+HkL1kWG8dMuvXHdmzG0MiYmOjETHV5ipbE3MqaQ5vWkLtwMd12q/6cjCYhHjtnl886x5TGau1evRRIfE+d2beLvWuW8ejeHe76XwXQdUlM6dPq5fWmtdDKyoqYmBgAqlWrxt9//40QgiNHjtChQwdOnz7NpUuXOHToEJUrV0alUlGoUCFMTEwYPnw4/v7+XL16ldu3b1OtWjUAmjRpws8//8ylS5dwdnbm2LFjLF269LOugSRJ/59kMCNJUrr53EDhc6VmMsDPnVvDwMCAriPG03XEeL3ltdt25sCG1SgUStr2G0bbfsNS3Ldl7/607N3/veXnLVaaFj/3S3Fdr4kz6DVxhu730rXqU7pW/RS3dXb3ZNiClcmW79mykh9//BEAjUaDnZ0drVu3BqBHjx7Y2dkl2+djvtVJUN/l4eHB48ePsbW1xcDAgP79+yOEwNO3qG6bqMgILh45QInqdVD+24qV2TsbAK9CQ7C0SWy96DpiAoZGxrTqM5CzB3Yzd3g/Bs5ZrCvn2PZNxMXG8Gf/n5k5sDeQOD7q5K5tdBwyBmN1YktbofKV8ClSgpXTJlCiWm29wDYt3jdWC2BG/5+5cfEc5eo2olqLttg4ODKweZ0PlmdgoB9wJnWPK1GiBDExMVy5coXjx48zYeYc8hcpxrrd+zl2YB+Va9Xh5stILhw9SIcWTWnTpg01atRg+PDhuvcdgL29PZUrV2b9+vW4uLhQvHhx3NzcPuncJUn6/ya7mUmSlG7ScxK+q6eOEXT39sc3BOLj4nRdaj40GWB4TDwh78yzkp72rV3Bq9CQ964Pf/mCE7u2ZtjxP8bYQEmrZk0xMzNLcf369evZuXMnfn5+hIWFfTDL1bc+Cer7ODk56Qb9Jx3z7bl3YqOjmfpLd720yHf9r6I0MMDFM6tumYFBYvBgYm5O52G/c+7gXg79290sOOAuAdf88M7rS+EKVZmycS9TNu7ll6lziIqM4MzenbpyCleoSvVW7bHN5MyyyWPeVPQ9LYvv876xWlGRERzdtpG+f8yl+c+/UaxKDSLCwxLP/99X5X2tmCl5nSAoVLIM/X+fjJmNPbfjjXDLW4j9+/dz9sQxXAqW5NqLCP6c8xflGzaj7m+jKFirMS6e3ty9e1fvdW7ZsiVbt25l+/btsouZJEmfTLbMSJKULj4lUOhWsShNe/SlYsNmydaNaNeUkYvX4eaVLcV9D2xYzZqZU5h74AzHtm9i5fQJ5CpUFDevbLrJAK2M9Z/63wuLQkHaJ+xML0snj0EIKFn9w0/FM4ICcDFX4+aUiZ9++ol169Zx796blM8ODg44ODhw+/ZtzpxJHNdhYWGBm5sbbm5uZM6cGWdnZ1QqFTEJGi4+CddrhfvcSVCdzYzxdbLK8C5oCoWCgwcPcujQIRYvTmxJsbDegtrUjNevwlkyaTRKAwOGtm5IsSo1qdykJfNHDaJoper8UreSrsvg7lWLaf5zP5ZNGceJnVtQKBTMHNCL0OfPiI+JxshYzZ2rFwG4f8OfuQfO0KduRRxc3Di4aS1l6jQkJuo1SyaOomLDZlRs2IxF40cQ+eoVfqeOYeOYicf3A9g8fw67Vi7iVehLvHzy03HIGNxz5Ep2XkljtRp178X1c2c4sWsbIxevwdDIGGMTU07u2Y6ljR2PAu4yf/RgAOLjEl8/U1NTbt++zbNnz1K8ZkIIYjVaDt5/QWhMPNmKlWbh7yMoW6cBALkKF2Pp5DG4eWfHzskFQeLYspsXz3Hrmj93lEo2/D2Dx48f8yLiNUIIFAoF9evXp2vXrty5c4d//vknXV9nSZL+f8hgRpKkdPEpgcKEdTtRm5p+0vFK1axLofKVgcSbrfCXLwh78Rw3r2y6yQB9naz09gmOjMnQQMbZ3VOX0jclH2t8WH8jOJ1r9Naxgaw2idfaxMSEVq1asW/fPk6ePAlAnjx5KFu2LACvX78mKCiIhw8fEhQUxMGDB0lISMDAwIAseXwxz5EfFMo0tx68r17wZhLUgk5WuFmYfHa5H/Prr79y/fp1YhI02OcqwNaFfzFrcF80CfGMXrqBDX/P5NSe7Zzdv4tqLdrhW7YCp/ZsxytPfgAKV6zKxr9ncOHwPn77cx4olQxr3ZDlU8bilMWD8g2aEhkeCkCnoeN0xy1SsRq7Vizk5dPHevXxzJUHgGtnTzJ+zXaunTvFovEjObFrK/1mLMDF04vDm9cxvG1jZu4+jrmVtd7+Hxqr1WvSDBZPGMWOpQtwdMtC4+69WDltIgHX/HDLmo227TvQ96duXL9+XS+jGSSOgQqKiCEiNoHQfx9WFChdnoT4OHIWSiw/a+68GKnV+JYur9uvWY++zBjYm4HNa2NqbknBchWp1qItx8+c49SjUHydrLCwsKBGjRq8evUKR0fHz3xFJUn6f6UQcrYsSZLSwfY7T/W6GaV6vyXz2bLoL8JfvCBLthy0HzSS6b/15HlwEABNf/qFZj1/Zd/a5Wz+Zy7Pgh5gYmZOqZp16TB4DNfPnWZ428a68ubsO42Dqxsb507nwJqlREVFUaZMGaZM/xO/+JTH0bxr+dTfObBxNVGvXpEtny+dho0jS7Yceq1BSYa1boRP0RI06/krMwb0Jvp1BFqtlktHD+Hs7kmHwaPJW7wUq2dMZs2sqQA4uLhRuWkrju/Ywh9b9uvK2vLPXM7s38WY5ZtolNOF7mMms+GvGYS/fEGRilXpOnIiJv92Ebt27jSLfh/Owzu3cMriQdMefSlRrRYAz4ODmDPkV25eOoeR2oRSNeryy4ixVPZ2TnauV65cYdeuXbRu3Rpn5+TrIXFszdOnT7n+LIxwExvdk/WMks/BEm/blLvCfYrAwEA8PT0JCAjA09OTgwcPUr58edq1a0d4bDxtRkzm8YNAelYvzaLT1zCzsATg/s3r/NqgCotOXyPgmh/D2zZm+o7DuGVNbC08vW8nlja25CqUOKA/Pi6W5vk8Gb1sI7kLF2PGgN4A9Bw/DYBGOV0YuXgdeYqVBPRbF/1On0hW/pBW9SlZvQ41W3fUnctvDatRoUFTvWUpvS/ToqaXY4otYkER0Vz4N6FHet4oKAADpYKCTlY0q16ZTp060b59+4/uJ0mSlBI5ZkaSpDQJDAxEoVCwfft2PDw8MDc356eeP3P7+jX6NapOS18vxnVtQ3RkJPFxcSz8fQSdyxakaZ4sdKtYlD2rl+nK6lTGl0UTRtJl2O9M23YII7WaYa0bEfbiOQDtBoygbofu+J85yZyhv+GePRfGJqY4umZm7+rldCpTgBy+hfWeUu/fsIoOJfOydekCFi1dyqlTp8iUKRN5c+Vkz+qPZ0s6vXcne9cs49dpf/HH1gNYOzgwa1CfVF+f03t34p49F5M37SF/qXJM7NmR1xGvqNuhOyVr1KFkjTpMWLeT0jXr8eDWdYID7ur2PbFrq16a5pXTJ9JxcGJ64Ps3r/PX8MTEAKHPn/F7tzaUb9CUqVv2U7/zT8wc2Jtr504DsGDMENRmZkzeuJf+M//h5J7tnNmyJsX65suXj379+r03kIHEweCv1ZaEmySmCc7IQAY+bRLUT5WUeC/o7m20Wi1dyhWkVUFvWhX0ZlCLOmi1Wp7cD9Rt7+iaWfdzsco1iIuJYdH4kYzt2ppulRKDmrcnQU2rt8sPunubpZPH6urTqqA3gTevERx47wMlpI2xgTLFQOZ2SCRngsNISOdABhJb4y6eOEa/oSPw879GkyZN0vkIkiT9P5HBjCRJn2T8+PFs2bKFefPmMXvmDCb07EirXwYybMFKbl46z751K/S64fy58yjl6zdhwZjBumBFo0lAgQIHFzcOb17Lo4C7NO3RlwlrdwCwfu6fKBQK1KaJT+mfPAjg91Vb6TnhT+xdXEmIj8fQyIimP/UF4Lc/51O/44/Ex8VhYWVDvmKlyJkzJ7179yYuLg4TM/OPntezRw9RGRph7+yKUxYPOg4ZS7sBwz+6XxKvPPlp0asfblmz0abfUCysbTi2fRMmZmYYGZtgZGyCla0dTlk8yJbPlxO7t/173CDuXbuqN56mQeceFCpfGe+8+ekweDTHd27hdcQrdq1YRN4SZaj5Qwec3T0pV7cRVZr+wLbF83RlmZpb4ODiRq6CRfhj6WpaNKib6nN417c+CWp60GgSMLWwZPLGvXr/Zu4+jpv3m3FbRsZvWvdWTJvA9H49MTBUUb5eY35ftS1Nx9RqEpIte7t8jUZDrTad0GqF7p/K0IgDG1bpgptetcun/WT/lTSO6l23QyIz/PU+vHktWxf9TeeRE3gSl7HBsSRJ/21yzIwkSZ9k6NCh5MuXj3z58tGzVy/K1KpH/lLlAMhXsjSP7t3Bt2wF8pYoTfYChQBo1O1n1s7+g+DAe1jbO2BkrMbYyZQ+dSuiNDCgYJmKVGrUAttMTgAolUqObFlP1eaJqYNtHDKxYtoEHty6ztOH9zH9tzuQiXlikJLUQhP9OpJHAXfwdLTFQKkkLi5xQsvQZ08/el6la9Vn5/KF/Fi5ONkLFKJopepUatwi1dclW74Cup+VSiUeOX3em5WtdK36HNy4msbdenFi1xZ8ipbQmyskp28R3c/eefKj1Wh4HHiPoLu3OX9oL60KvpktPSE+ARePxGxb9Tv9yKxBfTi9bxeFylakR/vWeHqWT/U5vO1rT4Jqb2KUYUkB3m5hcvX0JiriFQqFAqcsHkBiN7NVMybRY9wfKe6/Z9USuowYrwtAH965BbzJkqZQ6I+TUhkaEf36Taa9pw8ffLB+rp5eoICpm/fpli2dPIYCpcqRt0QZAAxUhji6uqWYRONj3h5HleRLBa49fp+m+/nK81eoDZVfZKyUJEn/PbJlRpKkT5I165s0tcZqE73uMUbGJsTHxX20G45CoaDJj334dfo8tBoNd/0v81ujarrB0S6eWQm6d5uLRw8BiTeGvmUr8Ov0ee8daJ/0tNvRLQutu/7IpUuXcHd3p++IMam64bNxcOTPHUcYMHsRWbLnYvM/cxjYrDax0VEpdq/SvPN0Xal8d34OLSrDlOdSKVWjLg9u3eDx/QBO7d6u18UMQGX45nmTVpt0zZRoNAmUrdNQrwVh2raDDJy7BICydRoy98BZfug7CKOEGFo2a8qQIUM+eu7v+lYmQc2ooZ1mZmY8fviAl08f4+aVDd8yFZj2Ww/uXL3EPf8rzBzYm5io15hZWqW4v4W1DecO7uXJw/tcP3+aP/v1BCAhPjF4NjYx5fmjh7r3s3fe/Oxc9g/Bgfc4e2A3Bzau/mD96rTrws5lC7l56TwKhYJ9a5dz6dgh8hQvrUs24ej6aXOzKABbtaFexr+vHbjGJHx69zxJkv5/yWBGkqRP8u4kfQpF8j8nH+uGEx8Xx/lD+8hXMvEp84DZC4mLjeXG+cSBzFqtFq1Gw761iXPI1O/0I5Ubt8TNKxvhIS/fOvabIMPM0gorO3uy5s7DuZMniI+P59GjR5w7cUxvfMr7nD+0j33rVlCofGW6jhjPlE37CA68x/1bN1AZGurN5SGE0JsVHuD+rRu6nzUJCdy7dhXXrN7/1lP/WDaOmfApWpID61cReOMaxavU1FsfcN1f9/Mdv8uoDI1w8fTC1dOLx/cDdDe0zu6enN2/m6NbEzNRLf9jPOEvn1O2WBEmjB3DyJEjWb9+/UfP/V1Jk6B+rSwxSZOgnr8dQHR0+nU502g0CCFo3bo19+/e4Zd6lRFC8PPEP3F0zZyYFrxDc1w8vfhlypz3lvPTuKkEXPenT+0KzBzYh5I16pAtny8B1/wAKFevMY8C79L33/I7DhlDRFgofepUZNP82TTv+dsH61mqZj1a9u7PqukT6VOnIldPHmPgnMW6FrjPIYBstm+6Xf7XA1dJkv67ZDczSZIyzMe74Sg4e2A3J3dtxdLGlp3LFxET9Rr3HLkxNjHh4Z1bFK1cnYT4xJSwTx/ex9LWjo1/zyAq4hUm5hYAqE0Su8q8fBKMJiGBOu26sOWfuUS+CmfatGk4ODjgd/E8HUd7v1vFZLRaLUsmjsLG3hHPXHk4tn0TxiYmuHhkxdzKmsjwUHYsXUDB8pXZuewfIv+dgDDJ9XOnWDd3OsWr1mTH0n9IiI+nTK36QOKT+oe3b/Ly6WPsMiUOuC9dqx4LxgwlX8kyydLtrpoxCUfXzBgaG/PP2KGUr98EEzMzqrVox46l/7Bi2gTK12/C3auXWP7HeH4al5gt7dG9OywbN4RiBX05oVSyfft2XF1duXLlCtmzZ0etTl1Wt/ScBPVTCa2W6y/D2b5yKfb29ro5b9zc3HBwcEhVMoIbN25w8eJF3Nzc9G6WixUrxv2gIHbcTZxfxdLGjl+mphy85ClWMlnq7JwFi+plo4PEcU5JsucvyIKjl3S/Z82dl0kbduttX6Vpq/eWD1CrTSdqten00XNMCwXgZG6Mi7mxbllS4Pq1JAWuwZGxuFqk7v0pSZIEMpiRpP9rMQkawmLiCY9NIF6rRStAqQBDpRIrYxXWasPPGq+Q1A0nq08+Qp894Z+xw4A33XBUhoZUbNSczQvmEPkqnCNbNlC7XWcAMmV258GtGzx5EEizHn3Zu2YZ80YNxNzKhoLlKpKnWCluXjoHQJ7ipVAolMwc9Au2mVyo26E7Ma9fs2nBbP7++29y5crFgpVrePVOsJCSIhWr0rznbyz8fThhL57jmtWL/rMWYm5ljbmVNW37DWPd3OmsnD6RCg2bUfzfdMhJytdvwvVzp1k76w/cs+dk8NwlGP8bbJWr15gJPTrQt15lFp70Q6FQULxqLf4eOZDS/wY875Y1Y0AvXke8onSt+nQYNBIAR1c3BsxZxLLJY9m8YA62mZxo238Y5eo0xECpYO7c2Yzp15clS5aQkJBAtmzZKF26NBs3bkSpVJIrVy4aNmyIUvn+xvlPmQQ1IyiUSswcnKjRoBHPH94nKCiIy5cvI4TA2NgYNzc3ChcuTI4cOd4b2AwaNAiVSkWBAgVYu3YtPXv2ZMiQISiVStQqFcYGyk9KK/69MlAq8M1kpXe9voXAVfFvPWQwI0lSWshgRpL+z4THxHMvLIrgyBjdDVxKt4BJz6+NDZS4mKvJam2KlTrlsR9KRcqTZf40bip/jRhIn9oVsM3kROUmLTFQqQi45odvmQoA5ChQmO6jJqHRaFg9YzL7161g14pF5PAtzB9bDpAle05deUPmrdCbo+Ppw/tAYtDUoPNPbFs8j3MHd5O3eEla9O5PAa8sTBg1ggsXLoDKUPcE/mPqduhG3Q7d0rwuaT6R93n3ST3Aq9AQVIaGFKlYLdn2eYuVpsXP/VIsK3/JsuTfkDjJZdJkpU7mxvhmskKtMmDdunWcOXOGnTt36u2n1Wp58eLFR1s0PmUS1IyiAAwdM1MrX+LEkrGxsQQHB+sm9YyLi0Or1WJgkDzwjoqK4sWLF2i1WgYPHkyVKlXo378/pUuXJiQkhF27dlG8YUscsvmg+EBwl94CrvsRGx1NzoJFkq17d36aD3l7nqOPeXw/gMm9OvM44C6//fYbo0ePBjIucH0W9JDulYsxZ99pHN0yf3R7AYTExBMeG683lgdgxIgRHDp0iEOHDqV7PSVJ+r7JYEaS/g8IIQiOjOVWSCShMfHJblI/dMMaq9ESGB5FQHgUtmpDstk5odVq9Z/q3r2nFyi8fRP2oW44Go0Gw38HxxsYGNCyd39a9u6fYj3e7YJTsWEzvQH9rX4ZSKtfBupt8+rlcxo0aKDrVvUtPYGPjozE78Rhjm9cSaW6DTExM0tz8JC0vY3akGy25riYG+u9Lrlz504WzNjZ2dGmTZuPBjPBkTHfRCADiecYHBmDL4kD8Y2NjfH09MTTMzEJxIcm8bx58ybBwcFcvHiRvHnzArB7926mTZtGhQoVWLFiBWZ2DlTKkfeLnEuSiT060uSnX1IMZjoMHpUhx9y5fCFqlQH+/v7Y2trqlmdU4Grn7ML8o5ewtLVL9T4K4F5oFL5OKSddkCRJepcMZiTpPy4mQcPFJ+F6/eHTetOStH1oTDyng0NxNjPG18lK1wVNrTJIU6AQHRlJwA1/wl8+x8bRKY21+bjAm9cIuuHPwrlz2bp1q265OiaCxsXyf3Df5RfupHt9UqIAZg7pS3Zvb9auXIHayjbFFrN3b9HT0mJmbm6Ou7s79+/fR6FQoFAoSEhIID7+w0/hbwcEMqJLF66cPIqVrT0VGzajUffeHN68jkMb15C7SHF2rViERqOhYsPmtBswXBdM7Fm1lI3zZvIq9CVePvnpOGQM7jlyAdCtYlFK1azLoc3rsLF3YNKGPdzzv8q80YO4f+Manrl8yFuyDNfPnmbwvGV0LJWfHr9Po3jVmsRqtEREx+Dh5sqaNWuoVKnSm2v5gcDsyJEjeHt7kzdvXl3QU65cOXr27Em+fPlwdXVlytjRnHoa+UW71X1ooLvZvynH05txfAxFC/ri5eWltzyjAlcDAwNsHBzTtM+7gaskSdLHyGxmkvQfFhQRzZ6A5zxJp4G9STc8T17Hsifgud6khi7m6hS7q6XE/+xJxnRuScFylVJ8Mv257vldZs6IgXTu3JnSpUvrlvt6uiWbFPHdf1+K2tycoGcvOH/+PJkyZcJKbYivkxW1vDNR08uRxxHRNK1VjWy2ZnjZmBH3+D7qV8/R3PPj2sYl5FRE4utk9d5AJklSa4StrS0dO3YEYPHixYSHp5yCVwhBk8aNsLKzZ/KGPfT4fRpHt21kw19/AnDz0jmCA+8ydsVmOg0dy46l87ly4ggAZw/sYfWsKXQcMoZJG/aQq3AxhrdtrJck4cjWjQybv5Iev08jKjKCMZ1b4uWTl8kb91C6dgM2/j0TSEz3XbRydU7ufpMBb8vO3RgaGlK+fPlUX+fDhw9TvHhx3bkB+Pv7o1arCQoKonbt2qjVar3MXhltWOtGPA8OYtagPnSrWJRuFYvy14gBtC6cg43zZjJjQG9dVzMhBOvn/kn3SsVoltedTmV8WTNzSqqPpQBUSgUrR/Vjw8plLFmyBIVCQWBgILGxsfzU82daFMlFu+I+TP+tBxFhoUBiF7FGOV1YO/sP2hTNxbxRg1g9YzLjf2rPkB8a0LZYbvzPnOTl08dM+rkzbYrmolleD35tWJUbF87olZGU8a9RThf8Tp/Q1e3AhtV0q1hU93vQ3duM7tSSJgW8cXF1ZdSoUWi1KT8gOXnyJKVLl8bMzAxPT0/mzp2b6mvi4eHBP//8Q5EiRTAxMaFq1arcv3+fRo0aYWpqSoECBfD39/94QZIkfRNkMCNJ/1G3QyI5ExxGglak+1NXASRoBWeCw7gTkpiqOKu1aaqPU7hCFVZcvMuAWQvfOwfL56jYqAVPQsOYOHGi3nJbMzU+ObLrpTR+99+XkNIcH29TqwxwMleTw86cPA6WZDbUcOPwbs7t2kz4o/toYmNYu3YtUVFRHz1W3rx5KVOmDO3atcPFxYV27dohhGDRokWEhYUl2/7AgQM8fPCA7qMm4ZrVmzzFStKm3zC2LZ4PJM4R1O3fdeXqNsI9Z27uXL0MwOYFs2nUpSeFK1TBxSMrLXr1w8HFjSNb3qSFLlu3Ie45cuGR04fjO7agNjWjw+AxuGb1puYPHShe9U1ChdK16nP+0D7iYmNQAOvXraVJkyYpjo1JiVar5fbt2zx//pyoqCiUSiXBwcEcPnyY3Llz8+rVK0qUKAGArUrwwP+Sbg6kjPTbjPnYOTnTftAoOgwexfPgIOJjY1iwYz8NmiR2nUx6MHBo01q2LZlH9zGTmbHzGE1+6sPqmVO453/lg8dI2t/J3Jiqng7Mnz2Tpk2b0rRpUx4/fkzmzJkZNGgQZ86cYfDfyxi5eB2vI14xpXdXvXJuXDjLxHU7dRnVzu7fTZnaDRixaA3e+Qow/beeaLUaxq3awuSNe7DL5MxfIwaSVq9CXzKkVX1sHTMxfs12xk2ZxowZM5g+fXqyba9fv07FihUpW7YsFy5cYMSIEfTt25eNGzem+nhDhgzh999/59ixY1y8eBFfX1+qVKnC2bNnMTU1ZdCgQWk+B0mSvg7ZzUz6z8roTF3fstshkV9kFm9InL0bwNvWDFu14VfPgKUgcQzJ+wKFbLbmnA4O/bKVese7c3x8zIULF4DEm/MnT54AiYPg161bxw8//PDBrGRGRkZUrFhR97u1tTXt2rVj8eLFLFq0iLZt22JjY6Nbf/36dcJCQvihcHbdMq1WS1xMDJFhoVjZOWD6b0psAFMzCzQJia950N3bLJ08luV//K5bHxcbS3DgPd3vb0+uev/mNTxz59ULTnIUKMTpvYnjfPKXLIuhkREXjx6kcLnK7NuxjZ3bt6fyqsHjx4+5efMmKpWK7du3U6BAAbp164ZKpaJMmTIcOXKEggULAmBiYsI/Y4YwbOlGIGP/LlhY26BUGmBqboGpeWKXssZdelC/REGMDZSsMjXiVWziNXVwdqXHuD/IVyJxLqZqzduwZtZUHty5RVaffMnKft84KrWVFSYmJgA4OTkRFRXFzJkzWbvvCBrHLAig18QZtCvuw/2b1zExS3x/1m7bGacsHrryre0dqNa8DZDYalS0cnVKVK2JnZMLANVbtmdc1x/SfE2Obt2IsYkJ3UZNQqVSkdu+IKNHj2bkyJH06dNHb9t58+bh6+vLuHHjAMiRIwfXr19n4sSJNGjQIFXHa9euHZUrVwagYsWKPH78mG7dEhN7tG7dmmnTpqX5HCRJ+jpkMCP9p2REpq7vTVBE9BcLZJJcef4KtaHyuwgUXMyNcTYz5slXmgwypTk+PkSj0XD+/Hm935MEBARw8OBBvfEjqWFlZZUsoEkaEJ6QkIBHtuz0/XNBsuvjf+ZEii1pSd23NBoN7QeOJG+J0nrr3w5+DI3enLeBSsW7I7je/s1ApaJ4tdqc2rMDIyNjzC0sKVmyZKrPM+kp+6hRo+jYsaMuiOnbty/r169HoVCQM+ebbHlPgh7Co7vgnvMDpWaMyr65dQ9XTFRKTFTGVHK3x9OqCgePnWDZlHEE3btNwHU/wp4/Q2g0yf62peXv2b1794iLi6N59Uq83Xar1WoJDryH17+BkoOrm95+Dm8FowqFgmrN23B8x2ZuXjzHo3t3uOt/5b1dwz4k6N4dsvrk+/c9AfFaLSVLluTJkyfJWhCvX79OsWLF9JaVLFkyTV3NsmZ9M/GoiYkJHh4eer/Hxn69OXckSUobGcxI3710zdSVQkao70lMgoYLT1IeC5HRLjwJp4qH/TcfKCgUCnydrNgT8JyErzDbeUpzfHzIjRs3iI6Ofu/6Y8eO4erqqndTnhqWlpa0bduWJUuW6AIaOzs7cuTIwZOgICxt7TD9dyD65eOHObhxDXmKl/pgma6eXrx8+livu97Mgb0pVqVGiqmnM3vn4OyBPWi1Wl3r0rvdp8rUbsCEnzpgYmpGtbr10/TZPHr0KIUKFaJOnTo8e/aMp0+fYmpqirm5OevXr9fdwAohSEhIoGHDhkwdMZh5G7ZxM/zL3sxmz2SnS1CQdI5WakPOb1vL8D59aNehAxWaNSV7gfG0rV8bexMV2mdBGCq0ZLY0oaaXY5pamhMSEgBYtHUXLxKUep9XazsH3dgZIyP9OV+M3gpGtVotozo053XEK0rVqEvhClVIiI9nYs+OqaqDVpPwplxj/c+sVrwJ3DXvdP1LadJXjUaTbLsPUan0b38+1LopSdK3TX56pe9aTIKGU49COR0cSui/3Zs+N1PXqUehxCRkfL/59CaE4OKTcDRf4QYdQKMVXHr2igKZLDFQfp1gMLWBglplQMGvlPq14FtZ4FLjzJkz7z2fpOWnTp36pLokBTTGxsYsXryYFy9eULVqVVwzZ2b6bz24f/M6186dZu6wfhibmKBUfrjeddp1YdvieRzavI4nDwJZOnkMJ3ZtxTVrthS3L12rPtGRESwaP4LggLvsXbOc4zs2w1vnm6tQUdSmJhzcuIbaDZuk6fzWrVuHj48PkPj5yJQpExYWFigUCiZMmMCCBQt06wwNDenTpw8JCQm0qVWFC9s3JK77hFaG1Eh67ULvXgcgPj6eP/74g0KFCrFr1y4CAgKIi4tj7ty5DBs2jBnTp9OzcweKZfMg5PkzCH/J+F9+JPTpE8yNVGnuMuvl5YWBgQGvQkN048VMzS0SJ4t9+TxVZQTducW1c6cYvnA1jbr9TKHylQl9/hRIOVubytCI6NdvJud8+vCB7mcXTy/u+V8h4d9Me0pF4iB/BwcHvTTSkNit7N33/MmTJ8mRI0fqTl6SpP8UGcxI360vmanrexAcGcvjr9QiAonX73FkLCExCd9FoOBmYUI+h4xJgfs++RwscbMwSfX20dHRPHjw4L1pfN3d3WnWrBnNmjVLcX1qWFhY0LZtW9RqNYsXLyY0NJSla9ajFYIBzWox6edOFCxXkQ6DR3+0rFI169Gyd39WTZ9InzoVuXryGAPnLMbFI2uK25uYmTFwzmKunT1Jn7qVOLRpDWVqN9DryqZQKChRrQ62Ts6UKpa2zHcLFizg559/1pXztrfnplEqlQghyJEjB5s3b6ZLly5EBd3F6GkAhiqDVGfpSy0FYKQ24fT2DZTwSRybVKtWLXbt2kXXrl1xdnbmypUrHD58GDs7O/bt28etW7dYv3499evXJz4+nufPn2NlZYWFhcWHD/YeFhYWdO7cmTH9fsHv9Ake3rnFn/1/5smDQBzdsqSqDDNLS5RKJce3b+LZoyBO7trG6hmTAYiPS/532TtvfnYu+4fgwHucPbCbAxtX69aVrd2Q+Lg4/hrej6C7tzmyawfDhw+ne/fuyV67H3/8kUuXLjFo0CBu3brF4sWLmTVrFj/99NMnXQtJkr5vspuZ9F3KyAHub2fqinHQ4m1rliHHSW+3QyI/vlEGU/xbj/Lu9sQ4aHXJAb6EtAYKgO61/RL1zOdoibdN2t5LarWaFi1aoNVqefbsGQcPHqRNmza4ubkxbtw4lEplmruXpcTc3Jy2bdvqxtC0aN2GwX8tTbbduxOVAoxaul7v91ptOukyX71r7oEzer8/DXqAVqvRS4k9b9RAbBwy6W0X9uIZZWrVxzqN49qSBnin5N0b5KTfnZ2d6dr1TUavt+dpElotis/ojqTValAqDchkaoSjrRWXz5yiWzc/APbt20dISAjW1tacOHECQ0NDxo8fz+TJk/nxxx/x8fFBoVCg0WhwdXXl6NGjZMmSRTeo/1NMmTKF6F59mPhzZzQJ8eQuXJzBfy9LdbY4OycXOg8fz9rZf7D8j99x8fCiw+DRzBjQi4Brfslex45DxjBnyK/0qVMR77z5ad7zN9bPTcxWZmJuzpB5y/ln3DD6NqiKg4M9vXv3ZuDA5JnRsmTJwrZt2/jtt9+YMmUKWbJkYerUqbRv3/6Tr4UkSd8vhfjQzF2S9A36kpm6IPEm+VsPaMJj4tl//8XXroZOJQ97rIwNuRPy+psNFN4WFBHNhX+76KXvH0SBSqmkoJNVmgOtdwUGBrJ48WJ69OiBnZ0dEyZMQKVS0bdv33SqK7x+/ZolS5bw+vVrctRtRXwGfzsEXPdjYLM69Jo4A6+8Bbjnf4WZA3vTZ8psCpWvzK1L57nrf4Wlk8cwe8dhOpRP/zmJUqLRaFAoFLpxFEnj8m6HJE6s+e64vI9J2v7hzWu4qZUU8HKnY8cONG/enG7dutGvXz8mT56MlZUV1tbWlClTBltbW+bMmUNsbCzz5s2jR48eLF++nBIlSjBx4kTWr19P2bJl+eeff1IcQ5JaMQkadtx99sn7Z5S0jgGSJOn/l+xmJn1Xvlamrm+9y9m9sKgPdoV5d/K6jKQA7oUmzn/ibWtGURdrVEpFhnTVUSkVFHWx/qxABhK7nFX1dMDJzFhX9udIGmfhbK6mqqfDZwcyAKampgC6uWVsbW15/fr1Z5f7NjMzM9q2bYu5uTkvAm6la9kp8cyVh05Dx7Dsj9/5uUYZlk0ZR7sBwylUPrFF5eLRgyybMo5WfQbimzP7R0pLPwYGBnoDwhUKBZlMVJR3t6eSuz0eVqYYG7y1HlAgEltu0H//xEW95sXtawxtWZe7+zbTqGoFzp07ixCC7NkTz+ns2bP07NmT4OBgxo4di6WlJSdPnqRVq1acP3+eLVu28OOPP9K4cWNcXV354YcfCA8PJ1u2bJ8VyEDi+LG3z+VbYGygTLdAJiZBw5PIGG6+jMTv+SuuPHuF3/NX3HwZyZPImO9yfKQkSfpkNzPpu/G1M3XZmxh9s08KgyNjPvik2M7ZhflHL2Fpa5fhdRH/1seXxHEzbhYm2JsY6brqpPWpdrLy/+3q42RujG+mtA2m/xC1yoDirjbp8gQ+ISKMkjk8cbM0SbfMeO8GM+7u7gQHB/P06VMyZcr0oV3TfJy2bduyfP0m8Mj4AKJyk1ZUbtIqxXXNev5Ks56/ApDVxjTD6/IhSdmvrNSG+DpZkU9jTrzgvXNZmSgFR/fsZNWypcTFxTFyYH+qVUvM6BYVFcWrV69wdHTU/W5iYoKJiQktW7akZcuW3Lx5Ey8vL7Zt20Z0dDRlypTR1SUhIYECBQropRdu0KABe/fu5X3++usvWrVK+Tq7mKsJDI/6auPt3qYgsT6fKuk6aAWk1M7adeREytVpCPy3U/RL0v8TGcxI34VvIVPXxafhFHex+ebSNsckaHRz6ryPgYEBNg6OqSrvwpED+J89meI6Bxc3qrdo+9EyYjVaYhI0ukAjPQOFqJfPCLnlR/HqldM9uFQoFLhaqHG1UH/SnEVP71zn+U0/OrRshoNV+t58J42NSApmcubMycmTJ7l27Vq6BjNJx2rVqD5brt5DZWH9WeNEPtfHJkH9WgwMDDAAnMwNcDJ/k73r7b8PrZo1pVWzpsn2LVOmDKNGjaJ69eoEBQXRoUMHpk6dSt26dSlRogSzZs1i3rx5LF++HGNjY4KDg3VZ2QDu37+PjY0NXl5eumWzZ8/m9evX3LhxAxMTE5ycnDB+K93xh94jWa1NCQiP+pzLkW4Enxa4JnUFbDVoNJW7//bevy/Wdg7Jlv/XUvRL0v8bGcxI34WkTF1fS1KmruDIWFwtPq9bR3oL+zcl9Yc8C3pI98rFmLPvNI5umT+4rYmZGa37Dk5x3fXzp9NULyfzN8HG5wYKSU9Op636G4B58/6matWqFC9ePENuOpKewPtiRUyC5r1P4K2MVVirDQkKDODc6cMAnD9/nmrVqqVrvQwMDFCr1bpgxs0tcTLDwMDAdDvG20xMTCjmnZkLz9O3K1tafWwS1G9FSq+1RqNBCJFsThNvb28CAgK4c+cOAG3btuX06dOJabFdXTEwMKB27drkyZMHe3t77ty5w5MnT3Sphw8dOoRSqdRLRezs7AzAzp07CQkJAcDBwQE3Nzfc3NywsrLC3Nw8xXpaqQ2xVRsSkoq/JRnpUwPXt5M0KC3tcLZMewv0uyn6nc2M8U1jGnVJkr4OGcxI34VvKVPXtxbMhMcmfHbXrfSmILFeTu+5B01roPD2DYVSqdTNML5nzx7u3LlDgwYNMDfPuBtetcpA9wQ+JdHR0WzevFn3++nTpxFCUL169XQNaExNTXXBjFKpxNTUlBcvMi7xg7uNBUGRcTyNikWh+PKtM6mZBPVb9r6sYElpob29vdFoNKjVav755x8mT57M+fPnsbW1pVChQgDY2NjQpUsXRo8eTVRUFGfPnmXhwoV069YNBweHZGX36NGDkJAQHj58SFBQEEFBQVy6dAkhBGq1WhfcZM6cGVdXV13rTTZbc04Hh2bcxUiFTwlc307ekV51gDcp+tMjeYckSRlLBjPSNy88Jv6rPzGExC+5kJh4wmPjv6kuL/EZNKnf50ptvT4WKLzLwMBAF8wABAQEMHv2bDp27IidXcaPCUrJzp07iY3Vbzk8c+YMQghq1KiRruNmkoIZAHt7ex48eIBWq82QGcwVCgWFXWzYc+858VrtF+92k9pJUDOaRqNBq9ViaGiIEAKtVpvq9MUpeft8DAwMdF3UbG1tqVKlCvAm4DE2NqZfv378+uuv9O7dm1y5cpE7d27s7e3fW7adnR12dnYUKFAAgNjYWB49eqQLcE6dOsWhQ4cAcHR0TAxs3Nyws3QiJD69M/qlzqcErjJFvyRJIIMZ6TuQlKnrW2h5SMrU5fuVJoVMyVcaRvRRGVWvd2/ak276NJqvk5XI39+fq1ev4uvry8WLF/XWnT17FpVKRdWqVdPlWO8GMx4eHjx48ICgoCCyZEndRIdppVYZUNDZijPBYRlS/oekZRLUjKRUKrl27RovXrwgLi4OJycnPDw8sLJKn78Dbwc3Se/nt5dlyZKFNWvWAIljpu7cuZOmAM/Y2JisWbPqEgYIIXjx4gVBQUE8fPiQBw8ecP78eVRqE7LXaoZSZfjNB65fMkV/Unp5GdBI0rdJBjPSN+9jmbq+pHczdX0LlN/oGNWMqte7Nzv58+enVq1aGBp++dayiIgItm3bRu7cuTE1NdXrAqdQKBBCEB6efhn43u1Wljt3bo4cOcKNGzcyLJiBxIx038MkqBlFoVCQN29eAObOnUtERAQGBgacP3+evHnzptjd63OO9S6tVotWq0WlUmFqakq+fPk++xgODg44ODjg6+sLQExMDEFBQdx9/pzXtq6fVf6nSEvg+rVS9KsNld/Me1KSpDdkMCN901KTqetLezdT19dm+BUzTX1IRtVLrVaj0WgoWrQoJ06c4N69e18lkBFCsHnzZlQqFbVq1WLHjh16gYyHhwd16tTBxsYm3Y5pYmKi1zKTKVMmFAoF9+/fT7djvE/SU+nvYRLUjBITE8PTp08pVqwYefLk+WLHVSqVei2SSa036UmtVuPt7Y23N19sstskaQlcZYp+SZLe9W3eBUkScPz4ccqWKUOLAllp6evFmC4/EPrsKZA4md6vDavSokBWfqlXmSsnj+r2O7xlPT1rJO43qHkd7l27qlu3Z9VSulcqRquC3gxr3Yj7N6/r1l09dYy+9SvTPJ8n3SsXZ8+qpW/qsmMzPauXpnk+T3rVKsfKteu/wBVIHStj1TfTcpVEkFivjNC2bVt69+5N5cqVyZ8/PxEREVy9evXjO6azc+fOcffuXerWrYupqSm+vr5UqlSJnj17ki9fPiIiIrC2tk7XY77bzQwSJ7pMyl6V0b6XSVAzysOHiZPOuru7f3ZZSa0tnyKju4B525qRz8EyQ4+RJJ+jZaq7b30rKfqTxjhJkvRtkC0z0jcpPDycWrVq0aZbDzqM+YOQZ0+YOfAXNvw9gyrNWvN797Y0/ekXStaoy6k925nwU3tm7j5B4I1rzB78Cx0GjyZfiTLsWLqA37u1Zfa+U1w6dojVs6bQfdQkXDy9OLx5HcPbNmbm7uOYmFswuVdX6rTvQtnaDblx8Swz+v9MrsLFsLSx5c/+P9N15ETyFCvFyV1b6d6hLfWqVcbW1vZrXyqs03mSt4iwUJZOGZviOhuHTOQqVCxV5aR3vXTlvhUg1KpViytXrrBr1y5dN6Av4eXLl+zdu5dChQqRLVs2ALy8vHTzfvj4+HD58mWePXuW7hNaxsTE6A34d3R05N69exmWBOBd6T0JatL+6T0Jaka4f/8+5ubm6dLaduvWLQBy5Mjx1RMcpMTb1gy1oVKXKSw9b98VJI6RSWumMJmiX5KklMhgRvomRUdHM3ToUKq27sSd0Cgc3bJQvGpN7ly9xP51K8npW4TG3XsD0LBLT2Kjo3kdEc7eNUspXasB1Zq3AaBNv2GoDA2JDA9j84LZNOrSk8IVErMFtejVjwuH93Nky3rK1GlIZHgo1nb2OLplxtEtMzYOmbBxcOTZo4ckxMdj5+SMo6sb9Tp0o1RhX9Tqb+PLTK0ywNhA+cHueBpNAgCqVHTHKlqpOkUrVf+sOhkbKL/ITalKpaJIkSKcPn2as2fPUqRIkQw/plarZePGjVhYWLx3YH/WrFlRq9X4+/unezADiZ8PM7PEp9menp7cu3ePu3fv6gKrjJbSJKiahAQMVKn/SkkKYmy+o0kKHzx4QJYsWdKlng4ODsycOZNatWpx4sQJqlatSs6cOdOhlunHzcIECyUcDwgmxtD0swNXodWiUCoxE3H42lvjkMbxJzJFvyRJKZHBjPRNcnJyom3btoyfPYtzFy4SdOcWgTevkdO3CMGBd8nqoz8AtkWvfgA8CrhLtWatdcsNjYxo2384AEF3b7N08liW//G7bn1cbCzBgfewsLahWou2zBn6G2vnTKNw+SpUatQccytrzCytKFSuMqM6NMfF04uilarRoWMn3Y3lt8DFXE1geFSKNxohT59w6dghVIZGWKTj+I33Ufxbny+latWqnD9/nv3791OoUKEMb504duwYwcHBdOjQASMjoxS3MTAwIGfOnPj7+1OhQoV0Tc0MiRmtkoIZHx8f9u/fz82bN79YMANvJkF9evsawwYMol77rnj7FkXz73w0QqtFASjeHuvx7/9vT4JqlUEteOktPj6eR48epVtmOjs7O7y8vDhx4gShoaE4OTmlS7npKTg4mGXLlhEdHU3zLj/yOE5BSEz8JwQ1AlBAdCQvbl7l6i1/TgKWlpZkzpxZN++Nk5PTe1NeyxT9kiS9jwxmpG/So0ePKFy4MNnz5se7SCkqN2nF+cP7uH3pwgef/r470/bbNBoN7QeOJG+J0nrLTc0tAOgy/Heqt2zHmf27OLNvF3vXLGPA7EUULFuRQX8t4faVi5w9sIfTe3ewZ+USjh87qpvH4WvLam1KQHhUiuu2L1vAnpVLaNTtZ9oV9/lgOcsv3Pnsugggq82XC/SUSiUlS5bkyJEjHD9+nDJlymTYsYKDgzl8+DClS5fGzc3tg9v6+Phw6dIlnj59mm43qm8HM0lsbGxQKpUEBQWlyzHS4vLly7Ro0YJixYpRr0hevL1d2bpzF0fOnMfJwwv/GzeoUrUaefP4vHcS1O/Fo0eP0Gq16TJeJkmRIkVYtWoVjo6O6T6+6nNotVqOHTvGoUOHdONDXMzV5LCwIDwmnnthUQRHxuhag1MK1VMOXJ2hYA4iIqrp0kIHBQWxb98+NBoNKpUKFxcXvYk9kybDzegU/d0qFqVpj75UbNjso9s+fXifpeeO06NVYwIDA/H09CQgIAAPD48Mqp0kSR8igxnpm7Rx40ZsbW35e+U6rr2IQAA7lv2DEAJnd08CrvvpbT+oeR1qtu6Is3tWAm9e0y3XaDT0qFqSXpNm4Orpxcunj3F299StnzmwN8Wq1MA7ry/r5vxBuwEjaNytF4279WJ0p5acPbAHR7fM7F+7grb9h5Mtny8te/WjX72K7N69+5sJZqzUhtiqDVN8ctm672Ba9x2MRqOhTO0GGVoPBYndhr70E8ty5cpx6tQpjh49SqlSpTKkdSY+Pp6NGzfi6OhIuXLlPrq9p6cnJiYm+Pn5ZWgwA2BhYUFo6Jedvf369etUqVKFBg0a0LhxY549e8aePXsoWbIkk4YPBmD16tV0b1SLXbt2UbRo0S9av/T24MEDjI2NcXR0TLcykwLir5GN731CQkLYsGEDjx490lue9KDISm2Ir5MVvlgRk6AhLCae8NgE4rVatCIxJfvHAlcLCwty5cpFrly5AEhISODJkye6AMfPz48TJ04AiWPkMmfOjEHuYgjFt5GzaNbgvuQrVoIerRqTOXNmHj9+nK7puSVJShsZzEjfJDs7Ox48eMCVk0d5rrbh5K6tnN6zHa+8BajWvA29apVny8K/KFKxKid3bePhnVvkLlwcG0cnRndsQa5CxchZsAg7li5AK7R45s5LnXZdmD3kV5w9spLTtzB71yzjxK6tNOz6M+ZW1pzauxMhoG77rrx8+oTAG/4Uq1ITMwsrdq9agpmlFWXqNOTh7Zs8evhANz/DtyKbrTmng99/Q2tgYKAXyGUE8W89vjSlUkn58uXZs2cPBw4coHLlyul+jP379xMaGkrXrl1TNft7Uleza9euUalSpXTpapY0TuvdYCZTpkzcunWLhISED7ZOpie1Wk2dOnXo1KkTR44cYeHChcTFxbFt2zayZ8/OkCFDKFSoEKampkRGfv2xDp8rabxMegbKN27cAODp06dERUV99a6rL1++5K+//iI+PvlDkZQCLrXKACdzA5w+8yOvUql0rTHFixcHEpPAJAU3j54+w+YbCWQAEAKNVuhS9H+LXQQl6f/JN/TXQZLeaNq0KT/88ANdWrekf+MaXD11nLb9h/Po7m3snJz57c95HNiwij51KnJy9zYGzFmMbSYnfIoUp/Pwcayd/Qe/1KtEwA1/Bs1ZgrHahFI169Gyd39WTZ9InzoVuXryGAPnLMbFIyuGRkYMnL2IwOt+/FKvElP7dKVioxZUbtISGwdHfvtzASd3b6N3rfLMGz2I0WPGplvf+ZgEDU8iY7j5MhK/56+48uwVfs9fcfNlJE8iY4hJSN3M9i7mxjibGad7ytzUUgDO5sa4mBt/leOXKFECtVrNqVOnSEhISNeyAwICOH36NJUqVUrTE9g8efIQGhrK48eP06UeSqUy2VwzgC6L2s2bN9PlOKnh6enJX3/9RZEiRdi+fTtly5bl1q1bdO/eHUNDQ8qXL8/kyZNxcXHRdRV62/eU3lar1fLw4cN0n5jUz88Pd3f3xJTDFy+ma9mfwtTUFBcXlxTXpSaAf1dgYCAKhYLAwEDdshEjRlC+fHkWLVpE6dKlGTBgABYWFmTJkoX58+frtqtXrx5z587lxx9/ZNiQwURHRvLi8SN+796WFgWy0q1iUdbMnIJG8+bv46Vjh+hTpyIt8mdlTOdWzB89mBkDegMwY0Bv3c9JGuV0we/0iWT1joqMYNagPrQvmZdmed3pWaMMp/ft1JXjf/Yka2ZNpWKFCsnOMTQ0lC5dupApUyasrKxo3bq1rtX00KFDeHh4MGfOHFxdXTEzM6N169bExibP0JZe3wuS9P9AtsxI3yQDAwPmzJnDnDlz2H7nqa5vdu22nQEoXKGKLivZuyo1akGlRi1SXFerTSdqtemU4jrvvAUYt2priut8y5THt0x5ILEPeC3vz8tQ9Xn9zlPukqJQKPB1smJPwHMSvsI8DAZKBb6ZrL5qRqoqVaqwdetWdu/eTa1atdKlzJiYGDZt2oSHh4fuqXFqeXh4YGpqir+//3tvEtMqpblmcufOzc6dO7l9+zY+Ph8eF5WeVCoV0dHRGBgY6J7m16lTh9y5c3Px4kW2bt3K2LFjKVq0KHFxcQQEBGBhYYGLiwsKhSJDJn/MCE+ePCEuLi5dg5mIiAgCAwOpU6cOVlZWnDt3jhIlSnyR9NrvY2JiQtu2bTl37hw7duzQLTcwMMiQ1+nMmTOYm5tz8uRJzpw5Q7du3ciSJYvuQdHChQvZs2cPj6M1KMzMGN6uCR45czN5wx5Cnz/jr+H9UCiVNPmxD08e3mf8j+1p3L0XJarV5si2DayfM51y9ZqkuV7/jB1KcOA9hi1YibGJKZsXzGbOkF8pWLYSHQaP4nHgXXL4FmbQoEGAfhbJBg0aEBUVxbZt2xBC8OOPP9KuXTs2b94MJI67W7duHbt27SI4OJgGDRpQtmxZOnfunCHfC+nlU7sUStKXIIMZ6Zv3oUxdX9rnZOoSQhAcGcutkEhCU8gI9KHzi9VoCQyPIiA8CtsPpLJVqwwo6GTFmeCwT6rj5yjo9PXnCClYsCAHDhzgwoULVKlS5b3ZxtJi586dxMbGUr9+/TTf0CmVSnLlysW1a9eoXLlyutwQmpqaEh0drbfM3NwcAwODZOMcvgQTExNmzZpF+fLl6dChAy4uLty4cYPw8HDGjx9Ps2bNGDlyJBs2bODx48c4OTnRrVs3fvzxx+8moLl//z4GBgbpFpAC+Pv7694fjo6OXLlyhTt37pA9e/Z0O8anUCgU3L59GxsbG0qXLs3BgwczLMBSKpUsWbIER0dH8uTJw+HDh/n77791wUzt2rUpWbIkfs9fsX77Lp4HBzF+zXaUSiWuWb1p028YMwf2ocmPfdi/dgXe+QroUva3+LkfV44f/cDR3y93kRLUbd+NLNkTU2XXbd+NfWtXEP7yOfbOrqgMjVCbmmFmZQ2v30xYe+XKFQ4fPszNmzd1r+OyZcvIlSuXrtU0Pj6eP//8Ex8fH/LmzUv16tU5dOIU3lUbZNj3wqf6loMrSXqbDGakb96HMnV9aZ+aqSsmQaObZPDtstJ6bIDQmHhOB4fibGaMbwoBhJuFCTEOWq48f5Xmen6qfA6WaZr8LiPVqFGDdevWsW3bNho2bPhZZV27do0rV65Qv359rKysPqkMHx8fzp8/T3BwMK6urp9VH0i5ZQbAysqKsLCwzy7/U2TPnp1Tp04xf/58Nm3axNOnTxk7diytWrWie/fu3Lhxg/r161OvXj1u375Nly5dcHNzo27duigUCkJCQjhw4ACNGzf+KvX/mAcPHuDm5pau45H8/f3Jli0bJiYmuLq64uzszLlz5756MBMQEMDt27dp3LgxPj4+5MuXj7i4uAw5lre3t15ChcKFCzN37lzd70nZwbQiMbV+ZFgorQu/uT5arZa4mBgiQkO4f/M63nkK6JWfvUAhIsPD0lyv8vWb6DJaPrp3h7v+VxOP985cXu82gF+/fh1ra2u91zBnzpzY2Njo1gG6FOoxCRpiDYwJC098wAUZ972Q6vK+wEM3SUpvMpiRvnkfytT1JX1qpq6giGjdLNrpIamUJ69j2RPwPMVZtL1tE+cg+RIBTT5HS7xtzDL8OKnl4+PD3r178fPzo2bNmp88uWlERATbtm0jV65c5MuX7+M7vIe7uztmZmb4+/unWzDz7NmzZMudnZ0JCQkhJibmq0zomiVLFgYPHsy+ffsoU6YMnTp14q+//uLGjRu0b9+edu3aAYmtZ1u3buXOnTdpwE1MTFi2bBkajYZmzT6eGvdLEkLw4MEDChUqlG5lhoaGEhQUpAu2FQoFRYoUYcuWLYSGhmLzBeaDSokQgn379uHq6kru3LmBxK6EnxrEpXQT+/Z4tneTCmg0Gr1WoKT3sVKRuM4lqzcDZi1MVqaphSVKlUEK47De/K5QwNurNR8YVzej/8/cuHiOcnUbUa1FW2wcHBnYvE6y7ZTvnN77PncajUZvbI+RkZHueyE6QZsuvQ5S873wMV/yoZskpSeZAED6LnyNDFnv+pRMXbdDIjkTHEaCVqR7NzkBJGgFZ4LDuBPyOtl6b1szirpYo1Iq0j0pgAJAk4C7MvabCmSS1K5dGyEEmzZt+qT9hRBs3boVpVJJ7dq1P+vJYlJXIn9//3QZ9P6+lhlvb28g8enw12JsbMzWrVuZNWsWAGvWrCFnzpy6QCbp/G/dugUkZqy6dOkSJiYmrFu3jmbNmukNFv8WvHz5kqioqHSdX8bf3x9DQ0Ny5MihW5YnTx7UajVnz55Nt+N8Sr2Cg4PTrUtkUjfPiIgI3bJ79+7pfr5z545eprtz586l+ODAUKnE1dOLF8GPsLS1w9ndE2d3T54FPWD1jMmgUJDZOwf3/K/o7Xf3rd9VhkZEv35zrKcP76dY56jICI5u20jfP+bS/OffKFalBhH/tu7o/or/e20M3+l+lyNHDsLCwvQScVy7do1Xr17pvdZf83vhfYIiotkT8Jwnr5MnI/jUesCb4CooIvqD20vS55DBjPRd+B4zdd0OieTq84iPb5gOrjx/leIXl5uFCVU9HXAyS6z3516/pP0zmRlzfctKtq1YzMqVK1NsKfiavL29sbW15ebNm5+UFvjChQvcvn2bunXrpku63Dx58vDq1at0mdjyfcFMzpyJ/fvfbvH4Guzs7AAICwsjMjIyWZrs+Ph4Jk+eTKNGjZg7dy7Nmzfn4sWLKJVKjh49Sq1atRg3btzXqHqK7t+/j0Kh+OgkqWnh5+dH9uzZ9cZ0GRoa4uvry6VLl1JMjZzRNBoNBw4cIHv27Ok2+WOmTJnInDkzkyZN4t69eyxatIjt27fr1kdGRtKtWzdu3LjBvHnzWLt2LT/++GOycqyMVeQrVQ4HVzem/9aD+zevc+3caeYO64exiQkGBgZUafoDty5fYOO8mQQH3GX93D+5fu50UtyBd978XDlxhCsnj/Lg1g3mjR6EyjD5mDpDI2OMTUw5uWc7z4IecvHoIeaPTpw3KT4u8UZfbWLK4/sBxL8K0ds3Z86c1KhRgzZt2nD27FnOnDlD27ZtKVu2LHny5NFt97W/F971LQZXkpQWMpiRvgtJmboM3m3X/0LSmqkrKCL6i31hJbny/FWKT7/UKgOKu9pQzMUGm38HZab1KiZtb6M2pJiLDSVcbTBWJf75uH37NnPmzGHdunW8fPnyM84gfdWrVw8LC4s0D4oXQnDu3DkKFiyYbuMXkmYy9/f3/+yyTE1NiY2N1eu2AoldXAwNDdMtDfTnMjMzw97ens2bNxMVFUVoaCjnzp3D0NCQPHnysHbtWrZs2UKTJk3w9fXlzJkzjBkzBltbW7p37/61q6/z4MEDnJycMDZOn5Tjz58/5+nTp3o3t0kKFy5MdHQ0fn5+KeyZsc6dO0dYWBiVKlVKtzKVSiULFizgzJkz5M6dm7Vr1zJ48GDd+syZM+Ps7EzhwoWZOHEiy5Yto1SpUsnKsVYbYmBgwIDZixBCMKBZLSb93ImC5SrSYfBoABxd3fh1+t/sX7eKPnUrcfPiOYpUqqYLWMrVa0zxqjWZ8FN7RnduRZlaDbBxSD4BqqGREb0mzeDU7u30ql2ORRNG0Lh7L2wcMhFwLfF1qdSkBRePHqR1w/rJ9l+yZAlZs2alUqVKVKtWDR8fH10L8fOo9Gn1SIv3fS8k+RYeuknS51KI7ynZv/R/431pIKPiNQRFxHzx+hR1sU51/+OYBM1XS4+sUiqo6unwwf7J6ZWhZtWqVXrdKZRKJUIIypcvT9myZdPjdD6bRqNBoVCkKRuTVqvl3r17ZMmSJV2yoSXZuXMn169fp0+fPp/VhefWrVusXLmSX375BQsLC711s2bNIjQ0lCFDhnxuddPF48ePKVWqFJkzZ+bkyZM0btyYIUOGsGvXLtasWUPVqlUZNWoUFy9epE+fPsTHx7Nt2zZsbGwYPXo0hw4dYv/+/V/1HKZNm0bOnDmpXr16upR38OBBTp8+za+//priWJTly5cTFRVF586d0+V4qREbG8uff/5J9uzZqVev3hc55qJFixgxYkSquxW+naI/JQ9u3SAhIZ6sufPqlo3t2hrvPPlp1vPXz61uMmlN0f8tfi8ERUR/lcyXafk+laTUkAkApG9Gam+yvzTLqBAW//kPOXLkIHfu3GTNmvW9Az2FEFxMx8H+aaXRCi4+Dae4i817b5it1Ib4Olnhi9VnzR3g6OjI7du30WoTX6uk/7+l5yOfMtGfUqnUjT9JTz4+Ppw5c+azJ19M6vYWFRWVLJhxc3PjxYsXREZGpjhR5Zfm7OzMhQsXuHjxIhqNhuzZs7NmzRo2bNhAlSpVGDVqFJcvX6Zv377ExcXpAhmAX375JV1bCT5FeHg44eHh6TZeRgiBn58fuXLleu+g+iJFirBy5UoePXqULgkjUuP48ePExcVRoUKFL3K8T/GxFP1PHgYya1Bffpk6G2cPL66cOMzVk8do9cvAdK9LWlP0f4vfCzEJGi48Cf8q9bnwJBx7EyOZFEBKNzKYkb6qz0kD+SXkc7Qk4Wk4xxMS8Pf313UTcnFxIVu2bOTJkwd7e3vd9sGRsXqZYL40ATyOjCU4MhZXi49/2apVBjiZG+D0Cfe9Dg4OugAGEoOAxo0bkytXrrQX9n8gc+bMWFhY4O/v/1nBjIlJ4hPNlMbNZMuWjUuXLuHv70+xYsU++RjpydramgoVKhAVFcX06dPZvn075cuXZ/To0Vy5coW+ffsSFRXF9u3bsbW1pVOnTuTIkYPffvuNkiVLEhISglqtTpexS2n14MEDgHSbLPPx48eEhIRQs2bN927j7e2NtbU1Z8+e/SLBTEREBKdOnaJYsWJYWlpm+PE+1cdS9BetVJ0H7W8ye0hfwl++xMXTi1/+mINHjtzpXpe0puj/1r4XvsXgSpI+hxwzI301MQkaTj0K5XRw6Cfn2M8IChKb5R1jw/C0VJMjRw7d/ABJgoODOXz4MBs2bNBbfjsk7YPN05viC9Xj7fkh7Ozs0Gq1vH4t+0O/j0KhIHfu3Fy7dk0vCEyrt1tm3pU0xufu3bufXH5GUalUXL16lQIFCjBu3Dj8/Pzo27cvERERbNmyBTs7O/r168c///xDsWLFCA8PJzY2looVKzJ//vx0SZ6QVvfv38fe3h4zs/TJ2Ofn54eZmRmenp7v3UapVFK4cGH8/PxSfI3T26FDh1CpVJQuXTrDj/W2du3apSlzXVKK/g9p3K0Xfx08x6orAUzdvI+ildKna+DbFIBtGlP0f2vfC0nB1df6vn07uJKk9CCDGemrSO80kOkh6fmQk7kxWWJfsn/jGqZMmcLly5cpUqRIsu0NDAz0+tGHx8R/9blwIPGLIiQmnvDYjK2Lvb09zs7OlC1blh9//JFChQqxe/fuby6z2buSBs6/PRHgl+oa5+PjQ2RkpO6J/6dQq9UoFAqio5MP6lWpVBgZGfH06dPPqWaGMDIyYuHChcycOZNLly7Rr18/wsPD2bJlC46OjvTv35/JkyezYcMGypYtS+XKlfH29sbd3Z2SJUvi4uLyxev84MGDdGuVEULg7+9P7ty5PzqGy9fXF0jMqpeRnj9/zsWLFylTpsxXmZsorb7HFP1J3wurZ0xmWOtGGVexj3j7e+Fzgiu/0ydolDN1n8UDG1bTrWLRFNd9qYdu0v8HGcxIX1xGpoH8FO9m6iruYoO3R2If+ejoaHr37k2bNm10zeH+/v5ERkaSP39+vRude2FRGTrGRwjBrhWLUrWtAjh0wY8CBQqgVqsZOnRoutfHwMCALl26UL58eebOnUu1atWwsbGhbt26tGnTJt2P97lev37NmjVraN++PZkzZ6ZZs2asWLHii9bBzc0NKyurz8pqplAo3pueGcDW1vaT0lF/CcbGxgghmDdvHv7+/mzevJlMmTIxcOBAJk2axNq1a6lfvz7h4eFER0fz6NEjrKysKFy4cJqSOKSHuLg4FApFugUzDx484NWrVylmMXuXqakpefLk4fz585/Vivcx+/fvx8rKKsWHNd8SIQSvXr3i1aNAMpkYflcp+pO+F+p26M5vM+ZnWN1SQwHceBGZ6oduMwb0ZsaA3hlSl7eDq0OHDn2R7mbt2rXTzXkl/bfIYEb6or5kGsgkihT+JTE2UOJhZUold3vKu9vjapH41Nvc3Fw3NqFkyZI0atQIIQRhYWGsXbsWJycnLly4wP79+3VP9YMjYzI0OLt29hTzRg1K1bYC+OevOUBi8PXLL79kWL2OHDnCTz/9hKGhIY0bN6ZKlSrUqlUrw473KaKioujbty8TJ04kLCyMYcOGkSVLFvr06cP+/ftRKBTJUh1nhKSuZtevX//srmbvC2YyZ86MVqslJCQkxfVfm0KhYMqUKZw7dw5nZ2eGDh3KxIkTWbVqFY0aNeLp06dUqVIFDw8Pli5dirGxMSEhIbrXJyNv7t9maGhI9+7dU5zE8VP4+flhaWlJ5syZU7V9kSJFCAsLy7B5gx48eMDNmzepWLHie5MRfG1arZbw8HDGjx/PH3/8wZrVqwm7fuG7SdEPb74XTMzMsLC2ybjKpYIAnryOSXUw2GHwKDoMHpVh9VEA90Izviul9N8ngxnpi/kac68AuFqoyWZrhpeNGdlszchtb0FJVxtqejlSyzsTvk5WeimHkzg7OwOJT5OTxikkBS6NGjWiSpUqHDt2jC1bthAVF//BtKHpIa1doSJehZMnbz68vLx0GaIywtv1cnR0pF69ety4cYNr165l2DHTIj4+njZt2rBnzx5GjRrFli1b6Ny5M9OnT6dLly78/vvvwKdlPvsUPj4+vH79mvv3U56BPDU+FMwkjZtJjzltMoparcbBwYG//vqLsWPHsmLFCpo2bcrz58+pV68eNjY2DBgwgFatWjFv3jxiY2N13ReVSuUXCzzf/j814uPjCQ4OTvZZ1Wq1XLt2DR8fn1SX5+rqiouLC2fPnk19pVNJCMHevXtxdnZOVUtRRvrQ3zWlUomFhYUuy5pKpaJCmdIUdLL65OPduHCGwS3r0aJAVlr6ejGmyw+EPnvKgQ2rGda6EevmTqdN0Vx0LJ2fQ5vXcXLXNrpWLELrIjnZNXuSLgOXh4cHixYt0pX7dutCYGAgCoWC4SNH0qxQDuaNGqTXzSzpWKv+nES74j60LpKThb+P0LsWe1YtpXulYrQq6M2w1o24f/N6qs7vWdBDGuV04fyhfXSrWJRWBb1ZMHYoD27doF+j6jQr4MXYrm2Ifqv19sCG1fxcsywt8melX6Pq+J89BYCZhSUKhYKpv3SnVcFs9KhWmjt+l/SO9+LxI37v3pYWBbLSrWJR1syckurPpyAx2JOkzyWDGemLSEsayMf3AxjdqSWtCnrTtUJhti9JbJoPunub0Z1a8kOh7HQuW5A1s6bqntKunjGZP/v/zPzRg2lV0JtuFYty6dghdiz7h6r5slMhtxeHVi0ij4MlOezMcbYwYevGDeTKlQtTU1NatGhBQEAAFStWxNTUlDJlyqBSqVAqlRw8eJCFCxeiVCqZPn06AJ6enty6dYsnT54wfPhwGjRqlOy4HUrlo32JPLr6A7x+Fc70fj35oVB2OpXxZf7owcTGJI598Dt9gm4Vi7Jr5WI6ly1IS18vpvfrSXxcLM+CHjK8bWMAGuV0we/0iQ9ewxkDenNw4xqWL1uKQqEgMDAwVV++GzZswMvLC7VaTe3atfWe7u/atYuCBQtiampK/vz52b9/P4GBgbobDYVCwaFDh5g5cyYHDx5k69athIWFsW3bNgoWLIiJiQm5c+fWS5pQvnx5xo4dS7Vq1TAxMSF79uzs3r07Ve+T1Hr58iUPHjxgzpw5uixSCQkJALx69QonJydiY7/c2C0XFxesra0/K9j4UDCTNWtWAAICAj65/C+lXbt27N69m2bNmhESEqKb6HTIkCGUKlWK2NhYZsyYgaenJw0bNqRv375AYuD5pVpo0uLq1avMmzePv//+m1u3buluTu/du0dUVBR58+b9SAn6ihQpwp07d9K9le3GjRsEBQVRuXLlr5ZNSqvVIoT46PGVSiXFixfH3d2dqlWrYmpqipuFCfkc0p557XXEK8Z2bUP+UuWYtu0Qwxas5Mn9QDb8PQOAm5fO8/ThfSas3UHpWvX5e0R/ti+dz8A5ixkydjxzpk3l4sWLqT7ekWPHGTh7EUF3b7Fu7nRuXT7PmplTEFot186dYuvieYxasp5OQ8eyfck8Wvl68+LxIxaMHcr8MUPI6pMPrVZw7/pVBrWoQ2R4GADDWjdi/ujBdK9cnK4VChMdGakLKn6uWQaAv0cOpN/Mf+g2ahI7li5gUMu6BAfeQ2i1XDp+mM0L5wKwa8Ui5gz9lefBQRioVMTFxjC2yw+8fPqYGQN607d+FYID7jB66XrK1m3IiqnjAehVqxwnd29nYs9OWNnZk8U7J3lLlGHT/Nm0yOdJj2qleXDrxkevUaxGS9w7wc/Dhw+pW7cupqameHh4MHLkSDQaDVqtFldXVxYuXKjbVgiBm5sby5YtA+Do0aMULlwYExMT8ubNy/r161M8blhYGI0aNcLa2hobGxt++OEHXr16lerXVvq2yGBGynBpSQMZFxvDqI4tUJua8fvq7XQaOo4V08ZzeMt6hrSqj61jJsav2U7n4ePYuewfvUDh+I4tmFlaMWXTPrLl92VKn25cOnaI0UvW06BdZ/r27cvz58912w8bNoxFixaxfft21q9fT8mSJenevTsnTpzg8ePHbNu2Da1Wqzfp4s6dOwE4c+YMzZo1I1OmTFy7dg0DYxMmb9yjd9xRS9ZTs3VHFk8cRXjISwBmDe5LVMQrxq7YTP9Z/3DH7zLzR7+ZETv0+VNO7d7OkHnL+e3PBZzas51Dm9Zh5+zCb38mnuv8o5fI4Vv4g9exw+BRlKxRhxr1GvL48eNUd20ZN24cK1eu5PDhw5w9e5YpU6YAiU/569SpQ8OGDbl8+TItWrSgXr16GBoa6r4sHj9+TMmSJYHErk7GxsaMHTuWhg0b0qZNGy5fvkynTp1o1qwZ58+f1x1z7NixtGjRAj+/xDE+nTt3Ttcb1dDQUO7fv6+7yYfEJ7zBwcE8evSI6tWrp9vs7qmRHl3NTExM3hvMKJVK1Gq13nv9a/rQk3djY2OqVKmCRqNh+vTpxMfHM3bsWMqUKYNCoUChUFCxYkVOnjzJxIkTWbFiBb169QL44mNoUiM+PnEswtOnT1m5cqUuqPHz88POzg4nJ6c0lefj44OJiUm6ts5otVr279+Pl5eX3mfiSxJCoFQqUSgUHDx4kGHDhrFq1ar3ZqzTarU0atSIQoUK6ZZ525qR18Eixe3fJy4mhibde9Pkxz5kcstCzoJFKV61Jg/v3Pq3Xlo6Dh6Ds7snVZr+QGx0NM16/krdMsUZ2LM7jo6O3Ljx8Rv0JC07dWPh+BFkyuxO1Watcc3qzdFtGzl3aB8oFKhUKi4dO0SBUuVQKJTkK1UOe2dXLh45gNBqiIl6zYQ122k/cCQxUVGsmDZBV/bBjavpNXEG/Wb8g9rMTBdUDPpr6b/XTMP5Q3spU7sBalMzDAxUjFqyjkkb92BmacnhzesAWD1zCtb2DkxYu5PRyzaAQoGpuQU7ly0kIT6OZ48e0mHwGF5HvGL93OkUqVQNgEqNWzK1T1eePAik26hJGJuYcGz7Rio1aYna1BSPXD4c3Lg6VdcpMu5NMCOEoGHDhjg6OnLx4kUWLVrEihUrGDduHEqlkiZNmug9EDt16hQvX76kXr16PHnyhNq1a9OuXTuuXr1K//79adeuHUePHk12zOHDh/PkyROOHz/OwYMHuXTpEmPGjEn1ayt9W77NjrLSf0pacuxfPn6YVyEv6THuD0zMzcmSLQcdB48hIiwUYxMTuo2ahIFKhZtXNkKfP2PNrKnUadcFAEsbW5r//BsKhYIKDZpxYudWOgwejVNmd+xd3Zg3+Xfu3LmDg4MDAH369NHNxeHr60uOHDlo0qQJkNiN7OzZs+TMmZNMmTKh0WhwcHDg9OnTQOIcK0ljahwcHBgycSqPY0Wy49bt0I1Vf07iyf0AoiMjOLt/F4tOX8PMIvGpYvdRk/i1QRXaDRgBQEJ8PB0GjyZLthy458iFb5kK3Ll6iSpNW2FuZQ2AjcOblMjvY2ZhibGxCYbGqjTdQI0cOZKiRROzz7Rq1Up3E7VgwQJKlSqlm1l+wIABvH79moiICGxtbQH0jmNgYECjRo2oVq0aZcqUoXfv3kDiRIhnzpxh8uTJrFy5EoBatWrpBmX+j72zDosqff/wPQPSDRYhLWJji91d2GJg97rq6q6uuu6u7rr2hrUqJiaC2C12ICoqFqCAlEFJx8z8/mDnLEgNqfv9cV/XXuswJ945c+a871OfZ9GiRTRo0ICoqKhSUa+SyWTY29tjbW3Nb7/9Rvfu3bG2tqZ27dqcOnWKunXr4ubmhpKSEu3atcPY2BiJRFLmKWd16tTh5s2bvH79Gmtr6yLvX1BkBrKksiMiIkoyxFKlMA+8kpISiYmJJCQk0KRJEzw9PTl27Bh+fn6MHTuWbt264eDgwK5duxg7diwuLi6C4hdkGRGVKikulZsduUFZWsaRSCQSDLioqCjhPq9duzbe3t7IZDKUlZVRVVWlWrVqVKtWLV9julKlSjg4OHD//n06duxY7M+Ynfv37xMdHc2gQYNKfKziIr8XZsyYwZ49e2jWrBnXr1/HzMwMU1PTXNuLxWK0tLSE/T58+MClS5d49uwZjTt0QVrdCokCgjL6lavQfsBgju/8m+Dn/oQFviT4xVNqOWQJIOgaVkbtn5RiVdUsdbfODnWw0c+S5lZXVy9SFDfqbRTvI8JYcegkhzesRVNbl2FfzWfd3GnoGVZm5NyFbF++mCd3bqKupYmVfR0AYt+/QyqV8sz3DguG9ZZfNB5e9xaO3bh9Z2o1yhr3o1vXhPN8iAgHYPDU2bitW8HgabMRiUSoqqtT2cQMbT19ajdpQUZ61udIiIvFvKY9VU3NUFXX4Jvf/8bz778IexWAJFMCMhmWterw54JZtOjaiz4uk7h97iR9x07m2nEPXj19zKgmNUlPTQWRiAuH3UhPTaWHswu3zhxH9Z95Mj9EQEI2Y+bSpUuEhIRw584dxGIxdnZ2rF69GhcXFxYvXsywYcNo3749CQkJaGtr4+7uTs+ePdHW1mblypV07tyZGTNmAFk9mx48eMD69etp06ZNjvMGBwejpaWFpaUlGhoauLu7f1ENnysoGhXGTAVlTlHkF8NfB2FsYYV6tu7lHQcOY8vS77CqUx+lbIWqdg5NiHv/jqSPWelrVUzNhMlO5Z+JqIpJVkRCTS3rgZp9IsrulVRXV8fCwiLHa6lUyrx581ixYgVRUVEMHjyY337L8oxlf+hZWlqipaWNOCMp13lV/zlvRno6YUEBSKVSJrVrlOMzS6VSokKChdfVzf/tQaGuqY0ks/zknm1tbYV/6+joCJ7mFy9e5PCKAvz8889A1oItL8zMzEhKSkJFRYXXr18LvTUcHR1xdXXN95zwr4e7pEilUpSUlNi1axcrVqzgm2++QSwWU6tWLTIzM0lNTUVHR4eNGzfy999/c/ny5XKpnalevTr6+vr4+/uXiTFTo0YNwsPDiYyMFGq/PhdXr16lbdu2hW63atUq4uLi8PX1ZcOGDejp6dG/f38ePnzIpUuXmD59OoGBgaiqqubocbRt2zZOnDjB77//jrm5eZHH96kRU1zj5vbt2/j4+OS7IFJWVubly5ekpKQI9568tsDIyAhjY2OMjY1z9bVq0qQJN2/e5MmTJzkMuOKQnp6Ot7c39evXL3KUqLS5desWly9f5ubNm9SpU4fw8HCqVq2KVCrN89rLn+0XL17k+vXrwt99L59nyIiRxGnqE5mUlqvxcnai30Yyf1APrGvXp36rtnQe7IzvlQsEPMySwFZSUhL2r6ypAoCJTt7NMT81zuWpq9mJCAsjMS6WUU1qkpGejlQqJeDxA9JTU9HS1aN9/8Fc8jjIg+uXsa5TX7h3pFIJ+lWq8vOefyMQV44e5vrpY8Lryib/RtvDggKE88jvX9dfFpORnk5CbAxqmpokJXxkQpuG1GnakuSkRKrXsACy5qjwV4GMdaxH/ZZtaNGtN+pa2iTExQrHlyEjLCiArsNGo5zNoK5sbMKbwJes9jzP+m+mY1W7Hn3HTclxDRSxDySyfyPUz549Izo6OkcDV6lUSkpKCtHR0bRo0YLq1atz8uRJhg0bhoeHBytXrhT2PX78OFrZ1g8ZGRlCHWF2Zs2aRb9+/ahcuTKdO3dm0KBBjBgxovDBVvBFUmHMVFCmFLX3irJy3p5HlTw8l1K5utE//1dSyn07yydF+fM0Mf3fCedTBZ+8JtDsvRcMDQ3p3Lkzq1at4vHjx8LiXFlZmU/FdfI6lkSSiYa2DivdT+d6z6BqNQL8snKxK6mo5HivtJxFiky+KrnOnXXy4nqEDQwMMDAwwNPTkylTpqChoYFEIslRIPrpObOft6TIDRNbW1s2btxIQkICrVq1IjIyktmzZzN06FBUVVUJDw+nbdu2uLq6Mm7cuHwXVKWFSCSiTp06+Pr60qtXryIbUBoaGmRkZOQbkbC3t+fWrVs8e/bssxszr169QkNDo1D5X7FYzPbt20lISCAkJISvv/6a3r17ExoaysWLF+nfvz+2trb06dMHHR0dfvvtN/bv38+jR4/47bffimXIjB07lnfv3tG7d29at25NvXr1im3cvHjxIsczRZ4mp6uri5KSEgMGDMh13Pfv3xMREUFkZCQRERH4+/tz9uxZ7O3tadGiBWZmZujr62Nra4uPjw8NGzYsUY3LrVu3SE1NFercyoP8rl9UVBQikYi3b9/y4cMHjh49yvPnz8nMzGT+/Pl06dIl1+9QKpXSrFkzfHx8cjimzE2qU0tdnYjENAJisqSH8zJq7pw/jZauHgu37Bb+dmqva1bk8J/X+mqVsDXQIl2l4MJ0FRUVEhL+FbR59epVrm1kEgkmVjZ8u2EHJ/dsJ+DRA75e9Re3z53k7P7dpCQl8fZNMJBVzyNHz6gK6SnJORxbD657k5HtM6uo/DsnSiUSjK1s+G7DDqKjIvlhzCAWbd2HYbXqaGjroKxciTHzl6Clq4fv5Qs8uXuLd2GhyGQyzGztsGvYGItadfC9cpEtS+ajqq5OhwFDiHn3DpFITODjh8Ic/OrpE+G82vqGZGZkoGNgiKqaOnpGlXkXFsplz0MMmzmvwOuXnewZ6JmZmdSqVQsvL69c2+nqZgk/DB06lCNHjmBra8v79+8F9czMzExGjhzJwoU5VT/zekZ27NiRN2/e4OXlxcmTJ5k0aRJnz54Vam8q+G/x5SUdV/A/RVF7r1Q3tyQqNJi0lH+9zrt++5HTbjt48eAemdk89i8f+qJjYIjWJ3KXB/9czY5fluR5/MgSKqfY2dkBcOXKFSIjI4W/V1Jg4WtiaUNywkdEIhHVzS2pbm5Jemoqu1f9TGa2Bo75UZxFTHYjS5HJNz9sbW3x8/PL8TdHR0cOHDhQ4Ljs7OxIS0sjMzMTLy8vZDIZt27dEq5jeaKqqsrr16/5+PEj+/fvZ/To0ULfExMTE9q2bcuTJ1kTdXnUY9SpU4eUlJRiFerL1fXyapwJWUpYQIkU00oLsVhcpCah2traWFlZsX79esLCwjAzM0NNTY2GDRvSuHFjZs+ejbZ2Vq3Eo0ePsLGxYd68rIVTUY3gBg0aoKenh6urK/369aN27dpCBPb27dvCYrqw+0EmkzF69GgaNWokfObGjRszdepUEhISaNCgQa59xGIxVatWxcHBgZ49ezJhwgTmz59Pjx49iIqKwtXVlW3btvH06VOaNGlCZGQk4eHhRfp82UlKSuLmzZs0a9YsR+SnLJHXxojFYu7fv8/u3bs5f/48SUlJ1K9fH319ffr160fnzp159uwZ2traVK1alTFjxpCenp7ruovFYjQ1NenatavwN3V1dTQ0NBCJRJhoq9He3IhO5kZY6GqgqvTv/iJAR0+fDxHhPL51jbdvQvDc+hd3zp1EkpGOkYYKaspKOST6C6Jp06Zs376dJ0+e4O3tLdQXZsfcwpL3EeHoGBiirauHqqoa78JCuXvhDAD7f/8NbT19xi9axtvQEFL/+T03bN2euOgPnD/kRlRoMHtWL+PV08dY2NXOcyzGltZ8+Oc88qyA6KgIDv65GkQiUpOTCX7mj2P3Psz87XcaOLYhPvoD8dEfMLaw4uyB3YjEYkbMmk99x7YkxMXSafAIlCtVomoNc7YvW4S2vgE+F89y6K9/P2fix3jUNDT4fd4MUpOTeB8RxuZ/jCFxERw02ecpOzs7QkNDqVy5MjY2NtjY2PD69Wt++OEH4TsZNmwY586dw93dXRAKkO8bEBAg7GdjY4OXlxdubm65zrlu3Tp8fX0ZM2YMhw4dYseOHfmKBVTw5VNhzFRQphS190rD1u3RM6rM5h++JexVAD6XznLu4B60dPRIT01lyw/zCQsK4O7FMxz8czXdho3ONen0HTeVoV/l7RX6kFK40VAQmppZudPJycm4ubkJ0Q1dVeVCP6eptS0ObTqwft4MAh8/5JX/I/5a8DWpyUlo6hQuNaqqnvXADnryiPS0wo0yGaCSbTGgyOSbH1OmTOHatWusXbuWwMBAfv31V/z9/Wnbtq1wTXx9fUlNzTmu2bNn4+XlRXx8PLdu3eLrr7/Gw8ODadOmKXzu0sTX1xdTU1MhpVAu8PDy5UvOnz8vpPGUh1JW1apVMTAwKJaqmXzyLkgEQENDgw8fPpRojKWBWCwuspFx9uxZVFVVGTNmDDVr1mT27NnY2tqycOFCLCwscHV15fvvv2f27NlYWlri7++PRCLJUa+iCNOmTWPTpk1s3bqVgQMHEhQUxMePHzl37hyjR4/GxsaGQYMG8e233xaY+iiPwtjZ2dG+fXu++uorevXqRWRkJJmZmQrLH6uoqNC0aVNmzJjB8OHDUVFR4fDhwzx8+BBdXd0SCQFcuXIFsVicq3agNJFIJDmEJ+TP5vnz59OuXTsOHTrEjBkzGDhwIBKJhPPnz+Ph4UFgYCC7du3i0KFDDBo0CHNzc2JjY/M8h1gsplGjRlStWhVA+H92dNUq4VBNl142VelpXQVHE31qG2kzxnk4fQYPZc3Xk1gwuCdvHt5lxcpVRL4OpJqaUq4Ie0EsW7YMPT09GjduzKxZs4S02+x0aNeWyiam/D5vBnHRH0hK+MjmJfNRVlEhMyOdM/t2MmHxL3QdOopKqqo8vH4ZANv6Wc+hHb/+wNe923Pj1DFAxIBJ0/McS4NW7YTzhL/K6kvktvZXVNXVUVJSQiaTcvWEJ49uXeNtWChvw0JRVVNHW98AHX1DNLS02bNqGbP7duL5/buY2dTE1MpWGIudQxNePLjHkzs3sPinruf4zr+5e+E0E3/4FZlMxqtnT7h55jiN2nVk3Pe5r0VBKIn+nae6du2Kubk5I0eO5PHjx1y7do1JkyahoaEhRLAbNmyIsbExf/31F0OHDhX2nTZtGvfu3WPRokUEBASwb98+Fi5cmGfUNiwsjBkzZnD79m0CAgJwd3cvcRpnBZ+PCmOmgjIjNVNS5N4rSsrKfLtxB7Hv3jJvQDdcly9h9PwlqKip0WfsZCJDg/lmQFe2/fw9vcZMZMiMubmOoa6piYZW3io3GRIZqZnF71FhZGTEyJEjcXV1xdvbmxcvXgCgl0efmrz4auUfVDExY6nLEH4cNwxjS2vmrNmk0L7mdrVo4NiWhcP7cv/KJYX2UcnmmVRk8s0Pa2trjhw5gqurK3Xr1sXd3Z3jx49jbGxMvXr16NKlC46Ojpw6dSrHfs2bN2fPnj0cOXKETZs2cfDgQbZs2ULHjh0VPndpIF/g9ujRg0ePHvHgwQMSEhKQSqU8ePCAadOmYWJiQu/eWcW25RGZkaeaPX/+vMh9UwozZiBLmCI5OfmzSxiLRKJijeHkyZPMmjULFRUVunbtytKlS7GysmL37t1MnjyZb7/9ljVr1nDy5Mkc/VuK0gBVRUUFHR0dAgICuH79OhcuXODAgQPs3buX/fv307FjRzw8PHj79i2VKlUq1FDS09OjXbt2QjrMkydPMDU1LXIkRCQSUbNmTUaPHs3gwYN59eoVaWlpPHnyhKSkpCIdC7LkyX19fWndurUgXFIWPH78mJMnT5KeLdL86NEjzp8/z/Hjxzlx4gSHDx/mypUrfPPNN6ipqdG0aVNCQkIIDAwkNTUVV1dXoaYsP6RSKbVq1UIkEuWon8oLNWUlqmmpYWeoRYNq+hzauZ2PcXHExcbgfeE88+bOIT4+nsmTJxMcHCzsZ2FhgUwmy1FLGRwcLIiVWFhY4O3tTVpaGn5+fgwZMkS4P+T7Nqxtx3cbdyKTyfA+eoiYd1E0ateRhZt2o2dUmTa9najVqClisZilOw8RFvhSKPI3qm5Mt+GjUVJWRqlSJWav2UCtRs3y/IxKSkrCeVZ+NR4dA0OaduoqGBU7bj2h27BR/DH/K2b1bIe2nj7L9h1FSUmJ4bPm0aRDF6RSCWIlMbb1HViweXe2Yyszbdka9j0IYvaajYS/CkS5kgqXPA4yd90W2vUdyPdb9lC7cXP6jZvKxCW/CrWiAMvdjhb4/cgALZV/ozhKSkocO3YMqVRK8+bNGThwID179uSPP/7Isd/QoUNRUlKie/fuwt/Mzc05fvw4p0+fpm7duixatIg1a9bg7Oyc67w///wzrVq1om/fvjRo0ICkpKQ8IzgV/DcQySrkGyooA4KDg7G0tOTrVX+xe9UyUlOSad9/MC7f/oD7pvW8fu5PYnwcbwJeMP/P7dg2cODgn6u5dsKTxPg46rVozcQlv2BU3YQlowbi73MLgPb9hzBzxXpCXz5n27JFBPjdx6i6Mb1GT6D7CBcgK83M/+4tftpzhEseB/H2PETtpi04s28nEomEkaPHsPnP30vcX+Hp06ccPnyYHj160KxZM04Gvi3zxplFQVVJTC+b3F7Lz0VmZibbt28nIyODSZMm5VkrU5bIVcrmzZvH+fPnEYvF6Ovr4+3tTa9evdi6dSvq6urs378fS0tLunbtWua1M2/fvmXz5s2MGDEihxBCYaSlpbFixQoGDhyYr9f/8uXLXL16lTFjxuRYkJU3+/btQywWM2zYsGLtP27cOMaMGUO7du1wc3Nj3LhxzJkzR2h2unLlSl69esXHjx+xtrYWjHRFvrvMzEyUlZUZO3YsMplM6MMkV1979+4dX331Fb1792bkyJEK9UWRk5KSwurVq+nataugmlhcYmNjOXz4MJGRkdja2ha5UPnw4cOCJ7o0FNHyY+3atWzcuJHdu3cTEhJC79692bNnD/v37+fatWucPHmSqVOnUr9+fVauXImKigqGhoZMmjSJe/fuIRaLqVatGkePHhVUJ/NCKpUSEBDAgQMH6N27dy5xki+J4swLlzwOcuivNWy+dLeMRvVl0dO6itCMtIIKikNFZKaCMuXQhrXMWbeJ+X9u5/a5Uxz4czUAPhfP0qb3AJbuPIRN/YZs+eE7bp8/zcwVf/DLgeNIMjNZMX1slqLYn9swrFadsQt/Ytz3P5GWmsKySc7YN27GGq8LjJ6/hMMb1+H9j27+p7x4eI+I4CCW7/Ni4uLlbNu0gQsXLpT4s9WuXZtmzZpx7tw5IiIiMNZSK1J9UFkiAoy11ArdrjxRVlZm0KBBfPz4UejXU57IF6HLly/nr7/+onfv3tSvX5/79++zb98+fH19mT17Nhs3bmTPnqxeDWUdoalSpQpGRkZFTjVTUVFBLBYXGJmpUycrHUQePfxciMXiEkWHXF1dadeuHf7+/kycOJHZs2cLhszw4cPZsGEDNjY2tGzZkkOHDgleWEW+O3nBfvPmzbl//z6BgVkpOvJ7pUqVKgQHBwvN9Iri+3v27BkymUz4HkqCvr4+48ePp3LlygQEBBQp3Sw8PJynT5/SoUOHMjNk5Ndlzpw56Ovr06FDB/766y80NDSws7MjMTGR4cOHM2rUKKZOncqxY8eIioriu+++Q11dnXXr1nHw4EH+/vtvbty4UaAhA1nfjzzFtzQk3MuS0p4XXFrUwbmRTb7/vY/Iu1cPADJZkVLpygNVJXGFIVNBialQM6ugTBk9bxH2jbO8ksO/mseeNcvpNmw0ekaV6TZsNACJ8XFcPebO93/vpV6LVgDMWvUXkzs0we/GVRzatEcsVkJDSxtNbR0uuO9D18CI4bPmA2BsYcX78Dec3LWV9v1y906QSiRM+WkVGlramFrZcG7PVnx8fOjSpUuJP1+XLl0ICwvD3d2dYS7jeB1f4kMqxG8zxvHo5tV835/840o6zpxUPoMpAoaGhvTs2RMvLy+srKyK3BG9JMgXtyoqKrRu3ZpWrVohEomElJcHDx5k9QxatEjoN1TWyFPNbt++LUQJFN2vMHnmKlWqIBKJilR8XxaIxeIip9Hlxb1794SmmgCDBg3i5s2bJCcno6yszMyZM+nYsSMjRozg2bNn2NvbK3zsMWPGsH//fpo2bcqAAQPo1q0bVlZW/P7777x7946ePXsCRRPhePLkCRYWFjlkYkuCkpIS/fr1Y9u2bZw+fRodHZ1ChTRkMhnnz5+nSpUq1K9fv1TG8enx5UX+GRkZvH37lpiYGFRVVXFyckJJSYkqVaqgra3NtWvXuHbtmmDc3bhxQ2gca2pqmmd/mfzOKf/dWFhYCDV7XypWehq8js//d1pUVhw+hawA54BBlQIkt0UiqmuqFbmWtSTER39gWpcW+Q8JEclJirdvqKCCvKgwZiooU+RNvQCs6zbgY0w0CXExOTTyI4JfIZVKsW3wb/8VbT19jC2tCX8VgEOb9jmOGR4UQPCLpzg3shH+JpVI81VP0TWsnKOGRlNbp9T6mMijDVu2bMH7zCmqNO9YJCnq4jJpya+kpuQ9QYoACxNjdFXLLp2kJDRo0IBXr15x4sQJTExMhKab5Y1IJMLT05NFixZhZmbGlClTGDNmTJ4e/aKkFxWV2rVrc+XKFYKCgoqk8laYMQOgpaVFTExMSYdYIopbM/MpY8aM4cSJE5w7dw5TU1NCQkLYvn07mZmZjB49GrFYzFdffcWHDx+KJHwglUpRV1fn8uXL7Ny5k5MnT7JgwQKioqJo3bo1+/fvF9L0FL0HEhMTCQ4OFmqwSgsTExOMjY2Jj4/H3d0dFxcXQbkuLwICAggJCWHEiBGlHmWUp22KRCKioqLIzMzE1NSUoKAgfv31V7Zv307Dhg3p1KkT/fr1w93dnatXr2JjYyPU/xS1hufT3+GXbshAlhiBgVqlIs0LHZ2G0tFpaJ7vVTMrugQ5ZM0L+mqVqGWoRXgJVT2LgpaePqs9z+f7vqNp/rVRFVSgKBXGTAVlilK2vjFSaZZ3ViQS59DIz6uHDGQZKNI8PLoSiUSoqVEE5TxSK0qzVEwuL3ro0CGq2NQCzYJTJErlnFUKroVpYPzlThAikYhevXoRFhbGkSNHGDduXJk0qiysZiI6OppVq1ZRq1YtDh48mCsqcuvWLYKCghg5ciQZGRllVuNTpUoVKleujL+/f5GNmfykmbMfOygoqMxrfwqipGlm2Tl8+DAA3t7eBAQEYG1tTc2aNXFzc2PEiBEcPHiQGjVqKFxDIY8qxMTEEB8fj7GxMfPnz6datWpUqVIFqVSKpqZmkY1Zf39/RCJRkaJDitKsWTOOHj1KtWrV2L9/P9OnT8/TIJBKpVy4cAELCwtsbGzyOFLRyN7TSCaTCb/ZH3/8kQ0bNlC9enXs7Ow4dOgQCxYs4OzZs/z555/UqVOHsWPHIpFImDt3Llu3buXDhw8YGBhw8uRJha+rXHnwv4itgRZ3IvJWZysvZP+MozjGVUlQUlLK0S9Hjty4cjA3KpdxVPC/TUXNTAVlSvCzf2sBgp74YVClGtqf9IWpamaBkrIyL//pwgyQEBtDZMgrjC2zuqNnn8SMLa2JDH5FFdMaQr+Wl373ObXXlcKQSqXEx8Xh4+PD/v37OXPmDHfv3iUgIIAPHz7k2UhSEezt7WnevDnXTnqhpyT7bLUzIqC6lirGWnkbiF8KqqqqDBo0iKioKC5evFjqxw8LCyt08a6np0dkZCRDhw7NYcj4+/vj7OxM//79OXLkCBKJRDBkgoKCSn2skFXf8uLFiyJFDBWJzMgbu5bVuBWhNI0ZOUpKSpiamgpNbeWpiykpKbRq1eofOdqCHRZyA+XGjRv07duXFi1aMGDAADIyMggJCSEoKAhNTc1iLaKfPHmCjY1NmSiH1alTB3V1dYyNjcnIyODKlSt5bufn58f79+/p3LlziYwAmUzGs2fPsLOz4/79rGe0SCQiJSWFkSNHsm/fPn7//Xfmzp3LxYsXWbFiBQDr16/nwYMH7N69G11dXebPn8+DBw/46aefWL16NQ8fPiwwqiRHfu9kZmb+Z40ZYy1VqmuqfjHzgq1B6aQ+lgS5cVVBBaVBhTFTQZmy/ZfFBD72w+/mVQ78sVpQHMuOuqYmnQc7s23Z9zy5c5PgF0/5ff5MjKoZ06BVWwBUNTQIfx1IQlws7foMJC01JavnzKsAfK9cxHX5YnQNC/fwiMRiNNRU0dPTQyqVEhgYyNmzZ9m3bx8bNmxg+fLlrF+/nl27dnHs2DGuXbuGv78/ERERuXqofEqXLl2oXr06/uePo/SZZi0lsQiHqrr/iUnf2NiYTp06cevWLaHwujRISkriwIEDREdH57uglafIjBgxgp07d3LgwAFevnyJi4sL3bt3Jzo6mvXr17Nz506UlJQ4ceIEvXr1Yvr0vPs8lJQ6deqQnp5eJKNDEWNGXp/w/PnzEo2vJBSnz0xhtGnTBktLS3r16sW6deuYNm0aCQkJHD16lHnz5qGqqlrob0AkEpGens748eNp164dr1+/JjMzExUVFa5evUrLli3x8fEpckQrLi6OsLAwhXvLFBVlZWUcHBx4+vQpjo6O+Pj45Eqry8jI4PLly9SpU0chg6Eg5BGmSpUq8dNPPxEfn1UYGBsby4sXL9i5cyfDhw8XenR8//33+Pv707BhQ6ZMmcKWLVv47rvvmDhxIgYGBvTu3ZshQ4YodG6ZTEZycjJv3rwpd/XD0iA9PZ3Xr19z/fp1gm9dJjMjvdR/C4qQfV7IyMgg5MkDEiPfwGcSs/2vON0q+O9QkWZWQZnSqkc/fpkyCplUStfhoxkwaQaHN6zNtd2Y+YvZtfJnVn01kcyMdOo7tuGHHQep9E86WvfhY9izehmRwa+Y/+d2Fv29F9dff+Cb/l3R1tOnu7MLTpNmKjQmHS1NbG1tBdUjqVTKx48fiY2NJSYmhtjYWGJjY4mKiuLp06ekpaUJ+6qrq6Ovry/8Z2BgIPxbR0dHqJ9JeeVPJcuSqxgVlUbVdP9TyjAtW7bk1atXHD16lClTppS4WFomk3HixAlkMpnQFTwv5AvU5cuXs2HDBqZNm8bHjx9p2rQpP/74I05OTujp6XH9+nU2bdpEYGCgoF6XkJAgdKAvLYyMjKhatSr+/v7UqlVLoX0UMWb09PQQi8Ul6hxfUkqrZuZTjh8/ztdff83Vq1eJjIykd+/eVK1aFdV80lazI0+78/b2JiUlheXLl/Ps2TN0dXWpW7cuzZo1w9fXl507d9K0adNCj5edJ0+eoKysXKSUwaLSpEkTbt68iYaGBjo6Opw9ezZHL407d+6QlJRUKv2c0tLSUFVV5fTp09SsWZM9e/YwY8YMHj9+jLKyMjY2Npw5c4b169czadIkgoKCGDp0KE+ePGHBggV8/PiR8+fP06dPn0JVyuTIv5/Hjx8TFRVF165dS/w5ikt6enouQ0ouaFFQeqxMJuPUqVP4+fmhrKyMmpoaGukSqjYpu6al+aEWHYbX/StERkYKxqiJuSXKxmZkfgZ75r/kdKvgv0GFMVNBmdKx7wCcJuc0MobO/CbXdqrqGkz64Vcm/fBrnsfpPsIlR1THqk59lu31zHPb7Mf/tJBSVUnM1U/SMsRiMXp6eujp6QlpOXJkMhkpKSmCgZPd2Hnz5o0g2QpZE5vcwHl+5wb2lVRRNi15rrqi6CTFoC/WKbfzlQYikYj+/fuzefNmPD09GTlyZIkmOD8/P54/f86QIUMKTPGRd4oXiURYWVnh4ODAkCFDGDx4MAYGBty7d4+NGzfi5+eHjY0NEyZMoHPnzrnuj9Kkdu3aXL9+PUdtQkHIjZnC6jm0tbXz7aZeHpRFmpmc9evXI5VKkUgkRZIdll+vmJgYqlWrhkwm48yZM9jb2wsNSR0dHTl+/DigWM8aOU+ePMHOzq5MIwn6+vrUrFmT+/fv06VLFw4fPkxwcDAWFhYkJydz/fp1mjRpUiriGnLj0MrKil9++YWFCxfStm1bunXrhrq6OsnJyezevZt27doxefJkLl++zODBg1m0aBHLli1j2bJlLFy4UGEHgFQqFQyB0NBQJkyYUOLPUFTi4uLQ1tZm4MCBNGrUiCVLlggRFZFIpFCNn0wmo1atWjx69IjMzEwSExNJCnqOpp4+WjZlE7XLi4j7N4kNfJrjN6isrEzjBvVIlyQRLi5/EYX/mtOtgi+fCmOmgjKlqqYq6VBuMpAFUZzeK3IJXA0NjTzTNTIzMwXjJruxo6amxrPrlzCs+Q7jRo5lqoYFYCxK4+xxd24cz+qCXKdOHWrVqlXqEYSyQEtLiwEDBrB3715u3rxJq1atinWcuLg4Tp8+TYMGDRQqvJZ/Hz169KBu3bqYmZnx+PFjvv/+e+7cuYOZmRnTpk2jc+fOmJv/qyBUVsX0derU4fLlywQEBFC7du1Ct9fQ0CAzM7NQcYJq1arx4sWLPD3M5UFZRWbkiMXifBXo5OfPa0wA3bt3Z9euXaxbt46TJ0/SuXNnIMsoPn36NG3aZHnRFf3O379/z9u3b2nfvn1xP47CNG3aFDc3N7S0tNDX18fPzw8LCwuuXbuGTCajbdu2pXKe5ORkxo8fz5o1a5g/fz4eHh7MmTMHDw8P2rZty+bNm3n27BkrV67EwMCAiIgIbGxs+OWXX+jbty/NmjVT6Dkkf0YmJCRw+/ZtHjx4wKRJkxSWKy8tmjRpQseOHVm5ciWLFy8WIqXyeyYtLY1Tp07h6uqKubk5Li4uNGnSJNczXiwWY25uniOtTCaTEex7C9PMTPRqNSzzz5L5JoCYAP9cqW1SqZRjx46hra1NX5fJPHr/MZ8jlD71K+tgql36tWQV/P+mwpipoEwx01Gn9KohSoYMsNLXKNVjKisrU7ly5VzpExKJhB07dvAxMgRTGhKOWlZ6cikaNCKywvWNqulirKnKZRUV0tPTCQkJISQkhFOnTmFiYkKTJk1o2LBhqZ23LLC2tqZVq1ZcunQJc3NzhXtOyJHJZMTFxTF9+vRiGXDypoRPnjzByMiIiRMnMnLkSDQ1NXnw4AEZGRlUqVIFHR2dMjNKDQ0NqVatGk+fPlXYmIGsxWZBRoq1tTUvXrzg5cuXZVbHURBlUTOjCPLoW0FkZmby3XffMW3aNJ49e0ZwcDCvX7/m8uXL1K9fX4gKKKq29+TJE1RVVUtFPawwrK2t0dfX5969e9SrV487d+7g6OjI3bt3adeuXbFliz813FRUVLh58yZTpkzh2LFjHD58GCsrK7Zu3crcuXOJjY0lISEBPT097t69y969e/ntt99o1aoVVapUUeicMpmM1NRUgoKCEIlE3L59u0hpaaVBamoqampqNG7cmMDAQMLCwgRVvOTkZOLi4vj9999JSUkhICAAU1NTfH19OXr0KIGBgYIYRXbU1dWpVq0aUVFRAPTt25cGDRogFosJS0jhflQ8EqmsVJ192ecFdaM6PL/pnWsbuXPB0dERpfh36CQl81Gz7CXy61fRwUb/y5fTruC/R4UAQAVlgoWFBTKZjPp2thioff5+JyLAQK1SufVeUVJSYvDgwWRmZhJ0/y7dratS/Z+oUImXwv8s0PQrQUdTfUy11RGLxTg4OORaaIeHh+Pt7f1ZFpNFpUOHDlSvXp0jR44UKrbwKTKZjBo1ahTb2NDS0kJZWZm+ffuyceNGpk6dytatW6lRowYTJkzA0dGRkSNH8uLFC0HJSX7e0qROnTq8fPmS9PT0QrfNbswUhDxK9fLly5IPsBiUZZpZYeR1L8i/s/v37zNlyhTatWuHv78/d+7cYcSIEWRkZPDTTz9x4MABIa1QkXtKJpPx5MkT7O3tyyWaIBKJaNKkCU+fPsXa2pq0tDROnDiBhoYGLVrk36SwMMRiMSkpKURERABZDptjx45x9uxZtm3bhpmZGatWrWLJkiX4+vri4uJCZmYmTZo0oX379oIqnKKGDGT1wzl37hwmJiYcP36cBg0aCIIC5YXcGOnXrx/Pnj3j3bt3vHv3jpYtW7Jz504MDQ159OgRW7duZcaMGWzdupUTJ04QExODh4dHnseUSqVYW1sjFoupVasWDg4OgqFoqq1OV8vKVNPMSuMr6bwg37+alipdLSuTFBHKpk2b8n1GiUQinj9/zu7du7l9ypNmxnooi0WlrrgmApTFIpoZ61UYMhWUGRWRmQrKnC9JY7880dXVpX///uzfv58HPndp2bIlEYlpBMQkEpOagYiipd/JZFJEIjHJ0e94/8yPx+HBXCFrIW5gYICKikquiUtdXb3EdSjlhZKSEgMHDmTLli2cPHkSJycnhcYtkUgQi8XF/oxyT/Svv/6Knp4eCQkJ9OzZk6dPnzJr1izatm1LfHw8u3fvxtnZmXv37qGurk56ejoZGRml2rivTp06XLx4kYCAAEGJLD8UNWa0tLRQUlISFqflTVmnmRUVeTrQ48ePiY+PF2qUmjZtWuRi/+xERUURExNDjx49SnG0BePg4MDly5cJCQnByMiI0NBQevfuXeR0QvlvQCqV8u7dO0aMGEHLli1ZtGgR6urqNGjQgCVLljB37ly6devG119/jbu7O9999x3Hjh3Dx8eHhw8fUrVqVerXr6/weWUyGWfPniU4OJixY8cSGRnJrFmzUFNTK5NnlkQiQSQS5UoZlEgkeHl5cfbsWRo0aEBycjJPnz6lUaNG6OjoEBQUhKqqKq1atSIgIIAGDRoAWdHUFi1acOHCBYYOHZorgicSibC1teXGjRs0a9Ys13jUlJVoYaJfonlBvr2+WiVsDbSoplGJEydO8PDhQ5SUlBgyZAj379/PpRgpk8kICQkBwNTUFFNtdYzUVXgQFU9kUlqRx5HfuKppqeJQtaJGpoKypcKY+Y+RmikhLjWD+LRMMqRSpDIQi6CSWIyuqjJ6apW+uIeGXGM/Kints9TOiMiq3fkcMpA1a9bE0dGRCxcuYGZmhpmZGSbaasSnZvAqLpmIxFTSJFJhnNnJfq0qicBUVwsrPQ10alYjsb51DjGC2NhYoqOjc50/NTUVd3f3HKpr8n/r6up+tkaK+aGvr0/v3r05cuSIUJhfEHKJ5ZIgvwbyYuldu3bx5s0b9u3bR5MmTYSFoaGhIdu3bycxMZG1a9eydOlSlixZwtKlS0t0/uzo6+tjbGyMv79/qRkzkGVYy1WMypvPlWZWGAEBAQQHB3PgwAFGjRqV6/2i1rk9fvwYDQ0NrKysSnOYBaKurk7dunW5d+8eYrGYSpUq0ahRI4X3l39GsVhMZmYmysrKVKtWjaZNm3Lr1i3Onj1L//79Afj22285duwYkyZN4vTp07i7u2NsbMzKlSv54Ycf6NKlS5HGLpPJCAgIoFmzZnTr1g2RSCTUppWV8yW/Z8WePXtYsWIFbdu25c6dO7x584Zbt24xcuRImjZtyoMHD3j37h0NGzakatWq+Pr6CqmwAwcOZPXq1cTFxWFoaJjjuCKRCDMzM6pUqYKFhUWe5xaJRJhoqyk8L8C/c4OqkhhjLTWs9DTQVavEx48f+euvLcTFxWFgYMDYsWPR0tIiMTExX/l7kUiEtXVWP7eyMK6MtQqXSa+ggpJSYcz8ByjpA+5zIxKJcKimy7nX78mUlv+iRoyMy3u34S3NpHr16lSpUgVDQ0OMjIyEOoiypGPHjrx58wZ3d3cmT56MhkbW9+JQTRcHdAs0UFVkmZw/5knMu7fUGzYMXTVdIEuhSltbO0dhOsCFCxe4ceMGKioq2Nvb8+jRI9LS0khNTeXp06fEx8cLC0uxWIyurm6eho6+vv5n6+tQt25dXr16xenTpzE1NS0wb16u4FRSg0aOXAmqR48eODo65njv2LFjeHp6snv3bqpUqcLvv//O4MGDS+W82alduzbe3t6CJG5+VKpUCWVlZYWMmerVqxMTEyPUBZQnnzPNLC/kxqtIJEJdXZ0xY8bw3Xff4eDgQNu2bWnfvj2NGzcu0j0lk8nw9/endu3a5e4gaNasmdCAMi+jrCDki0w3Nze2bt1K7dq1+fbbb/npp58YNGgQhw8fxtbWljp16qCsrMySJUvo06cPO3bsYOzYsbi5uZVI4a9mzZo5jMbiLHpDQkIYP34827Ztw8LCgszMzDxFIWJjY3Fzc+Py5cs0a9aMIUOGYGlpSUpKCmvWrKFv376sXLkSiUSCrq4u169fJy4ujnbt2nH27Fmhd46WlhaPHj2iX79+AAwYMIBZs2bx6tWrXMYMZN1vzs7OCn02ReeFvByXT548wdPTE6lUStOmTenZsycA169f5+LFizRt2pSgoCBiYmJynFMmk+UQtynMuJLlIYZRkrXHf9FBW8GXR4Ux84Uik8mISEzjZUwisXl4RwoyCdIkUoLjk3kdn4zBF+IdUVNWolE1Xe5GxJX7uRtW0eGpTEJ6RgahoaGEhYUhk8mESXTGjBmlImGaH0pKSgwaNIjNmzdz9OhRhg8fnuO7UFNWopqWEtXyyYIb4zyCQ4cOsXfvXpycnAosDndwcCA0NJQePXpQvXp17O3tOXz4MFWrVmX69OmIRCLi4+NzRXVCQ0Px8/PL0YFeU1Mzh3GT3djR1NQs0/upe/fuvHnzhiNHjjBhwoQ8axDevHlDQkJCqY5DQ0ODiIgIwVMpZ/PmzaxZswZbW1u+++47Bg0aVOJmhPlRp04dLly4wMuXL6lXr16h41XEmLG1tcXf319InSlPvjRjRs7UqVOZNm0aQUFBPHz4kMePH+Pp6cnGjRuRSCQEBQUpbNDLZdo/h8BCtWrV6NKlCy1btlQomvRpgf+VK1eYP38+Q4cO5cCBA3z48IH169ezePFipk+fjqenJ5aWlmhoaPDu3TuqVavG+PHj6devH8OHDy/WmEtqwGTH3NycS5cu8ejRIywsLHI9K+T33sKFC7l+/Tp9+vTh3LlznD59mmXLlmFmZoaWlpagoqikpMTYsWO5cuUKjx49omnTpigpKXH//n06dOiAiYkJL1++FJwNxsbGaGlpcfr06XzTFIvjMCtsXsj++Y4cOcLTp09RVlZmxIgRWFtbI5PJuHTpEtevXxeMdJlMhqura66+U8bGxnke+1Pj6vbDxzwPeUPrtu1KZHT81x20FXx5VBgzXyCpmRIhb1VOUeMZ8u1jUzO4ExFLdU1VHD6ztruptjqplaXlLgNprq9Jz549OXr0KPDv5CYSiTAxMUFPT6/Mx6Gjo8OAAQPYt29fkeWHVVVVGTFiBEePHuXw4cP07Nkz30nT0NCQcePGCa/t7OwYNmwYBw4c4NChQwwZMgQDA4M8jTeZTEZSUlKufjqxsbEEBQWRlJQkbFupUqVckRz5a11d3RJHSlRUVBg4cCDbtm3j3LlzgpdRTnp6Op6engwdOrRAT/inze0CAgKwtLTM0ziSp6wtWbKEP//8E2dnZ2rWrMn+/ftJTU3l22+/xdnZmRo1apRpgbeenh4mJiY8ffq01IwZe3t7QXWpvI2ZL61mRo6hoSG+vr5oamrSuXNnRowYIdTSvH//XqhBU2SxnZaWhoWFBTVq1CiHkec+d8uWLRGJRIWOVSaTCb+XixcvEhoair+/Pz/99BPjx49n8ODBzJ49m40bN7Js2TIGDx6Ml5cXiYmJODs7c/DgQQ4cOJDvM0RRFDVgZDIZ8fHxOZ7RUqkUqVSKkpKS8P9mzZpx4cIFHBwc2Lp1K3fu3MHJyYkhQ4agr6/PkSNHOHfuHH5+fmhpaZGWlsbUqVOZPXs2169f58OHDzmeb/JCfV9fX9q2bYulpSVPnz4lMzMTBwcHPDw88Pf3F35LkyZNwtDQsMwl+D8lNjYWV1dXEhMTqVq1Ki4uLqipqQl9eu7du0eXLl2EKLNEIhEaCmdmZpKeno6enp5C0Vo1ZSVkCbGkhAZSt3KfIo/1f81BW8GXRYUx84WRXa6xNJAfJSopjXOv39Oomu5n1Xi3Mcgqli4Pgya7DGS9evW4fv060dHROfpP9O7du9zSQmxtbWnVqhUXL17EzMysSAsfJSUlnJyc0NLS4tSpUyQkJNChQweFHuY2NjYMHz6cAwcOcODAAYYOHZpng0GRSISWlhZaWlqYmZnlej89PT3P5qHPnz8nPj4+h5H4afpadsNHkQ7tkOVx7tq1K6dPn8ba2jpHR/WzZ8+SmJhYqHTrp0bVqVOnmDJlSp7GiHzbrl27EhYWxoQJEzAzM2PEiBGMHTsWa2vrUktnKwy5EEBhqWYaGhqCslpBqKioUKlSJUEitjz5kmpm5FGJK1eusHr1ah48eEBERARqamrUrVuX+fPnM2jQoAJ71HyKTCbD2toaW1vbsh5+nudWUVHJd5w+Pj68e/eOXr16Af9+nsWLF7N8+XIcHBx48OABW7ZsAaBly5YMGDAAT09PmjRpwty5c4mLi8PDw4OtW7fSrl072rRpU26LSAsLC+bMmcOsWbOEv2VPIZM7IHr27Mnu3buRyWSEhoZibm7OL7/8gp+fHxs3buTt27fUqFEDf39/tmzZwpUrV4iJiaFdu3aoqqpSvXp1fHx8cHJyEhb2ysrK3Lp1i9mzZ9OyZUv27NkjFP+fPn06Rw3aypUry+V6ZOf+/fucOHECmUyGo6OjULMklUrx8vLi0aNH9O7dW5CXlhs4b9++Zdy4cairq+Pu7p4rVbkgUlJSCmxGnB//qw7aCr4cKoyZL4iAmEQev08ok2PLgEypjLsRcaRWlgpGxefAxkATtUriMtfYz260icViunTpwv79+//dViTi4MGDODk5FbmvSXH5tH6mKEpYIpGIbt26oa2tzfnz50lISKBPnz4KGWPW1taMGDGC/fv3s3//foYNG1bkmhgVFRWqVq1K1apVc70nlUqJj4/PZeiEh4fz+PHjHFLDGhoauaI68n9raWnlWCg1bdqUV69e4eXlxZQpU9DR0eHly5fcv3+/0M/++PFjTp06hb6+Pp07d6ZGjRr4+flx/PhxBg0alOc+8sVRs2bNmDNnDi4uLtSqVavcG/fVrl2bc+fO8eLFiwLVoTQ0NEhMTFTomHp6erny5cuDLynNTH6/fPXVV9StWxcvLy8aNmzI48eP2bZtGzNnzsTQ0JAOHToo7GVXJCJSVhR07qSkJNzc3KhRo4ZgzPj5+bFhwwa0tbV5+vQpRkZG9OzZE09PT5ycnDA0NGTevHncu3ePvXv3UqtWLX755RemT59ObGxsuaXRyY14Hx8fQeJZ/n08efKEP/74g2fPntGpUydmz57N2LFjWbp0Kbdv3+bKlStoaGiwbt06NmzYQEpKClKplHv37tG/f3+6devGzz//TPv27YmOjiY1NZWxY8eyadMm1q9fz3fffceFCxd48+YNiYmJvHjxgrZt2+Lj44NIJKJ169acOnWqXK5DXkilUvbv309gYCAqKipCtBiy+ia5u7sTEBDAwIEDc3xfvr6+PHjwgH79+glpZRMnTizSuYtTc/e/7qCt4MtAJPtSXGb/zylLQyYv6lfW+awGDeT01pSWDGT1AmQgZTIZ27dvJzw8nDp16tCxY0c8PDyIiIgQPI7lEaX5+PEjW7ZsoXr16goXhn7Ko0eP8PLywsbGhkGDBuUZacmLkJAQ3NzcMDY2ZsSIEeVS5C+TyUhOTs4zqhMTE5NjMa6srJzL0NHQ0ODs2bMYGBgwePBgNm/ejLGxca7ao+xs3bqVTZs2oaWlJUzAy5cvZ/Xq1ejr67N169ZCr1lhUZGyxtXVFXV19QLrEk6dOkVISAhTp04t9HheXl48fPiQ2bNnl7noRXZu3bqFt7c3CxYsKLdzFkRISAgNGzYkIiIih5c5LS2N0aNHIxaL2b17t8K/qS8NiURCZGQkpqamuRafFy9eZNCgQVSvXp179+6hoaHB69evsbW1Zd26dUyePBkVFRV8fX0ZM2YMnTt3ZtmyZWhplY+sfV4G5KtXrzAyMkJHR4fo6GicnJwwMjKia9eubNq0iYYNG7Jz506qV6/OpEmT+PHHHwG4e/cuI0eOZMuWLYhEIhYsWMD8+fMZMGAAkCUeMnPmTEaMGMHw4cNZuXIlW7ZsQVtbm/j4eMaNG4eqqiqjR4+mWrVq5fL5C+P9+/fs3LmT5ORkTExMGD16tPAMT09P58CBA7x584bBgwdTs2ZNYb83b96wc+dOGjdunCtltyi4ubmhrKzM0KFDFdq+vNY1X8J6poLPy5ely/r/lLCElHI1ZCArzSssofD0lLJELgPZ3Fgf/X+K+oq6rJdvr69WiebG+rQw1s837CwSiejVqxe1atWid+/egnRlmzZtuHLlCjt37iQ2tuz74ejo6ODk5ERQUBDXr18v1jHq16/P8OHDef36Nbt371aobgKyimVHjRpFZGQke/fuJS0trfCdSohIJEJTUxNTU1Pq1atHu3bt6N+/P2PHjmXu3LksXLiQqVOnMmzYMDp27IiFhQUSiYSAgADOnj3LkSNHSExMJDQ0lHXr1pGSkoKqqirPnj3L83wfPnzgl19+oUuXLpw5c4a7d++SmZnJjRs3SEtLw8vLi6tXr+YZLcjIyBBqq8o7GvMptWvXJigoqMAGoorWzADC4ubp06elMj5F+dJqZsLDwzE1NcXf31/4m0QiERauPj4+VKpU6YtJjSsqjx49YtmyZSQmJqKmpsb79+/p0KEDO3fupFOnTnzzzTe8fv1a+O1bWlry66+/smjRIvz9/ZHJZDRu3JgZM2YwePDgMjNkJBKJUNMmRyQSkZ6ezsmTJxk3bhyvXr3CxsZGiISsX7+e6Oho1qxZw+TJkzl06JCgKubo6Mjjx4+F34uJiQl2dnacOHGCVq1aYWpqypo1awgLCwOylB8fPHggRD7nz5+Pl5cXX3/9NWfPnmXx4sXMnz//izFkbt++zaZNm0hOTqZDhw5MmDBBMGRSUlLYs2cP4eHhQq2fnMTERA4fPoyJiQndunUr0RiKEpkpTwfto/cfCYxJKnzDCv5nqYjMfGZSMyWfTbJYWSyiq2XlLybn9HMqnISGhuLp6UlycjI9e/akfv36ZZ46IleaGTNmTJHylrMTERGBm5ub0BxTUTGDsLAw9u7di5GRESNHjix3uV5FkUqlfPz4kdjYWM6dO0dUVBRGRkZUqlQJa2trOnTokCuaduLECWbPns21a9eEhcjt27eRyWT07duXefPm8dVXXwmFstm/Zz8/PxwcHAgKCsLS0rJU+tgUl48fP7Ju3Tr69etHw4YN89zm7t27nD17lkWLFhV6v2ZmZrJ8+XJsbW0ZMWJEGYw4b+7evcu5c+dYtGhRuZ0zP+TTXf/+/UlISGDTpk3UrFkTkUgkNGyUSqW4u7sLfVfyQm6cfWl9mgCio6OpXLkyP/30E0pKSlhbWwvyvNeuXUNTU5NWrVphZGTEmTNnhP1at24NgKenZ6G1aMWlsNS9VatWcf/+fcLDwzExMWH//v20atWKhg0bsmHDBqHeb+/evbn23bNnD/PmzePBgwdUr16d1NRUVq1ahZeXF/fu3SM0NJTu3bujoaFBUlIS0dHRLFq0iK+++qpMPmtpkZmZyd69ewkJCUFNTY3Ro0dTvXp14f3ExET27t3Lx48fGTlyZA5lMolEwu7du4mJiWHy5MklNkz/+usvatasSdeuXQvcLiwh5bMolzYz1qtIOft/ypf3JP5/hEwm40Ep5pIWFYlUxoO38V+MB1IuA9nLpio9ravgaKJPbSNtbA00sdbXxNZAk9pG2jia6NPTugq9bKriUE23VKQaa9SoweTJk6lVqxZHjx7Fw8OjQI94adC+fXtq1KiBu7t7DiWdomBsbMz48eORSqW4urry9u1bhfYzNTVl9OjRREdHs2fPHoWKyD8HYrEYPT09DAwMiI2NRUNDg/T0dEaNGkWnTp3yXBgFBwdjZGSEvr4+kLXwbNGiBRoaGkRHRzNu3Lh8jbcGDRowbNgwvv32W6Dsmvcpgo6ODjVq1CgwkqKhoYFUKs1Rk5QfysrKqKqqKnyPlBZfUs2MvMbku+++Izk5mR49etCmTRs6dOhA27ZtiYmJYc6cOUD+hkp6enqOInSpVPpFPEPlkQ553cuSJUvYu3cvXbp0YcqUKVSuXJkZM2agqqrKH3/8weXLl3F1dRX237dvHy9fviQuLq5UxiOTycjMzMzx3ct/T0lJSezevZs2bdowbNgwbt26BWSJfnh5edGkSROhvrF3795cunSJlJQU7O3t8fPzA7IW+ZC1mD948CBDhgzh3bt3BAQEAKCmpkb9+vV5+fIlz549o0aNGty8eZM5c+bw/fff8+zZsy/ekImIiGD16tWEhIRgYWHB3LlzcxgycXFx7Nixg6SkJFxcXHJJLJ89e5awsDCGDBlSKhE2RQQAUjMl3I/6PA1670fFk5opKXzDCv7nqDBmPiMRiWlEJqWVagF8UZABkYlpRCSWfapRUcnS2FfDzlCLupV1qF9Fh7qVdbAz1KKallqZRJPU1NQYMGAAAwcOJCAggM2bNxMSElLq55EjFosZOHAgMpkMDw+PYi/4DAwMGDduHJqamuzYsYPg4GCF9jM2NmbMmDHExsYWKVWtvJHJZBw9elRIA0pPT+fYsWP5enmVlJSIjo4W6l3EYjExMTG8evUKZWVljIyMgKxFaEJCQq7r/v3333PmzBmePXuGWCzOlQqTF6GhocC/C6zSok6dOgQFBeVrbGpoaAAo/N3p6+srLBhQWohEIqGv05dCy5YtuX37NmvXrqVnz540aNCAkSNHsmvXLkHGNldjwH/GP3LkSOzt7XF1dSU+Ph6xWCzch5/DsJHJZIJEsZKSEikpKfj6+tKoUSNUVVVRUVGhVq1azJgxg5s3b+Lm5oajoyMLFixg9uzZREdHA1kOnfDwcIVV2eTnzQ+RSISysnKO39C7d++YPn06EyZM4OTJk7Rt25bw8HAmTZpEaGgobdq0oW7dujmiofLncUBAAB07dsTf358PHz4IUbNz584xb948lJWVqV27NqdPnxbOJ1dylPfP0tPTY8SIEYwcOTLPBpdfEleuXGHr1q2kp6fTrVs3xowZkyNS+OHDB3bs2IFUKmXcuHGCUIKchw8f4uPjQ48ePfJUpywqMpmsUGOmwkFbweeiwpj5jATElO+iIi9EX8g4viTq1q3L1KlT0dPTY+fOnVy8eFGhBW1x0NbWxsnJiVevXhW7fgZAS0sLFxcXTExM2Lt3r8J1EdWqVWPMmDF8/PiRXbt2FTtCVJbcuXOH4OBg+vXrR9WqVenXrx/Pnz/PNxpRp04doqKiBG/vkydPGDFiBDNnzszRrTwuLo59+/blMojq1KnDwIEDmTt3LlBwdObGjRt07dqVFi1aAKVfZ2Nvb49UKuX58+d5vl9UY6Zv377Mnj271ManCHKj4HMuMOTnTktL49y5c3z99dfs3LmT5s2bs3DhQtavX88PP/xQYCNU+X3QrVs3Xrx4wcyZM9HX16dp06Zs27aNjIyMHIZNeSESiRCLxdy4cYP69eszaNAgVFRUuHfvHoGBgSxbtgyxWEznzp0ZNmwYS5cu5e3btyxevJgqVaowevRo4ViKiB5IJBKkUikvXrwgLi4u3+81MTGRVatWUa9ePTp37symTZuIiopCJpPh7u6Os7Mzy5cvZ9u2bYjFYk6ePEmNGjWwtbXl7du3wjO3Zs2aaGtrc/PmTdq2bUutWrWYPXs2jx8/BmDv3r10794dJSUlWrVqxevXr4V969Spw5YtWwpUBPzSSE9PZ+vWrXh7e6OhocHUqVOF54ucqKgoduzYgaqqKmPHjhWi0HIiIiI4ceIEDRs2FKSZS2NcMpmsQGOmwkFbweeiwpj5TMSnZhCTmlH4hmWMDIhJzSA+7fOP5UtCV1eX0aNH07FjR27evMn27dv58OFDmZzLysqKtm3b4u3tzevXr4t9HHlzTXt7ew4fPoyPj49C+8mbrSUlJbFr165y99wXxPv377lw4QLNmzfHysoKgFq1atGkSZN8DYcmTZowefJkJk+ezFdffcU333wjLArkURnI8myePHmSxMTEXAuyRYsWcfPmTe7du4dYLM4Vcbl79y7du3enTZs2XLhwgaFDh/LkyROgdKMz2traWFhY5ChWz46GhgY2NjaCUVMY1apVKzdlKjnZ07E+F/LF7Zo1a5g4cSLe3t78+OOPQtPcLl26sHjxYiHClh+XL19m06ZNbN68mUePHuHr60ubNm2YPXs2Ghoa9OzZEy8vr/L4SDk4e/Ys/fr1o0ePHri4uNC5c2cANm/ezKpVq7h8+TJ6enqMHj0aS0tLJkyYgJKSEqdOnWLPnj0Kn0ceDRWLxdSqVQsDA4N8jbejR4/i5ubG1KlTGTNmDAcOHGDJkiU0a9YMsVhM3759gazGvpaWljx+/BiRSES9evV49+4dQUFBwrE6duzIuXPnANi0aROxsbEMGzaMypUrExoayoQJE4Csmo4DBw6Ui0pjWRAaGsqaNWuIiIjA1taWuXPn5qpfkiuT6erq4uLikkuZMCkpiUOHDlG1alV69epVasa1PDpcUH3ll+AYrXDQ/v+kwpgpJ5YuXUr79u2F16/ikous3FVWiIBXsSVLMbKwsGDnzp0AJCQksHv37jzfK4j27duzdOlS4F/v1OdELBbTpk0bxo8fT1paGn///Te+vr5l4mFu164dFhYWeHh4lMiYkDfXbNGiBadOneLSpUsKjbdy5cq4uLiQkpLCrl27SEgoX3W9vJBIJHh6eqKvr0+nTp1yvNe1a9d8C/M1NDSYP38+kyZN4sOHD7Rv355Vq1bh5+eXo59QSEgIkZGRPHz4MNeEb21tzZgxY5gxYwbwb8TFz8+PgQMH0rJlS5SVlblx4wZXr17F3t6eli1bkpaWhrKycp7XXCaT8eHDB8LCwkhKSlL4PqpduzavXr3KM/qira2Ns7OzwsIPn6MG6EuIzMjHsG3bNr766ivOnDmDr68v9+/f5/fff8fS0pKNGzdy9uxZIH/Da8uWLXTr1o1JkyZhbW2Ng4MDa9euZcWKFVSvXh0dHR0WLFjAH3/8AWTVD0QlpvIiOpEn7z/y6N1Hnrz/yIvoRKISU4uU319QWtfVq1fp2rUrv/32G4MHD6ZLly5CL6Z+/frx3Xff8f79e2xsbBg1ahShoaG8fPkSW1tbDAwMFB6D3JApDKlUys8//8yqVauYNm0aLi4uzJo1i2PHjhEaGkqNGjW4evWqsH3jxo0JDAwkLCyMZs2akZqaysOHD4X3BwwYwNGjRwUZ/QMHDrB8+XJOnjzJvXv3aNasGaBYZEkRPkda5Pnz59mxYweZmZn06dOHESNG5LrWQUFB7NmzR4iof+rEkEqlHDlyhIyMDIYMGVKqkWK5MTNq1Chhns5OaTtoH9++TlhQQJH3kztoRSIR3t7egOJrkAr+u1Q0zSwnvvnmmxzFhhGJqZ8tFPspMrLG44BusY/h4+MjeHzXrl3L5cuXhfSF7O8VhIeHh+BR279/P8uXLy9yU6+ywNjYmMmTJ3P27FlOnDhBQEAAffv2VdgbrghisRgnJyc2b96Mh4cHI0eOLLZSUnGbaxoZGeHi4sLu3bvZuXMnY8aMKdd+JJ9y5coV3r59y/jx43MtUgpbtMiLneXGCMChQ4dy1J5Uq1aNXr16CRP+pzU4s2fPplOnToSEhGBubs7hw4cZOnQoXbp04dq1a0JtBWQpQW3YsIG7d+/m2yFdJBJhaGjIH3/8QVxcHCoqKjn66WTvr6Orqyt8X/b29pw9ezbPegb5eT6nUEFhZK8n+VyIxWLS09OpXLkynTt3FlTuDAwMaNiwISNGjGDFihVoa2sL23+KTCbD0NBQSG+Cf5usTpo0CXd3dyZOnIh/UDDRUmWOvYgg8x+XVWmoMmZkZOQbcTA0NGT16tX8+uuveHl5kZSUxLNnz7CysuLnn39m0qRJDBo0CLFYzNdff82tW7dK9fn1KbGxsaSlpeHt7c3ff/+Nt7c3SkpKDBs2jCZNmnD16lXOnj1L27ZtAWjTpg0nT57kyZMnNGvWDFVVVW7evMmQIUOALGNm8uTJQlRAS0uL/v37l9n4JRIJMpmsXHoNpaamsmPHDt69e4e2tjbjxo3L0znx7Nkzjhw5gpWVFYMHD85zbBcuXCA4OJjRo0ejq1v8+Twv5M/O/OYRuYO2tNY1S12G8OMud0ytFavhys6nvzdF1yAV/HepMGbKiew/pNRMiSA9/KWQJpGSmikpdmF99lD4px4tRWU+s3sIv7QCPhUVFfr06YOtrS3Hjh1j06ZN9O/fH2tr61I7h5aWFgMHDmTPnj1cvXo1RySvODg6OqKlpYWXlxfJyckKNdc0NDTExcWFXbt2sXPnTkaPHq2w1780CQsL4/r167Rr1y6XQo8iyL3YMpkMJSUlYUGdPd+7Xr161KtXT3j9qUFgYWGBr6+v8Pn79u3LxYsX6dChQ47tkpOTuX//PufOnctVhJsXU6dOJTAwUGgcGhsby9OnT4mP/7dwVa7iZm9vT82aNZk3bx6qqqoKd6X/kqhZsyazZ8/+bKk/UqkUsVhMbGwszZo1Y/78+axZswYzMzNhwVepUqVCIxQikYgxY8bQu3dv5s2bx5w5cwRlqZu3bpGupo3Mog6mprWpnpkpGDJQ8AIvTSIlOD6Z1/HJGKhVwtZAC2Mt1Vzfc0Fe9uHDh/P06VO2bNlCp06daNq0KU5OTgwZMoQrV67g7e3N5s2bqVu3rtCXpTTJ6760tbVl8+bNTJ8+nUmTJtGsWTPS0tI4evQobdu2FaJgkJUamp6ezpUrV+jRowe1atWievXqgjy2pqYmmzZtKvVxZyc9PZ1Hjx7x5s0bunfvXqhqV2kQGBjIwYMHyczMpE6dOjg5OeVpLDx8+JBjx45Ru3ZtBgwYkGdU+smTJ9y6dYtu3bphYWFR6mOVq3vmZ8x8aQ7a7JSV1HgFXw7/M2lmf/zxB+bm5qipqdGkSROhmNrHx4fWrVujoaFBzZo1OXDgAAA7d+6kVatWDBgwAF1dXdzc3JDJZPz8888YGxujp6dHnz59cuRQx8XFMWrUKHR0dDA2NmbmzJmCt8Lb2xsLCws2bdqEiYkJmpqajBo1SmhMlj3NbMs2V5aMGsiBP1bh0qIOo5rWYsevS3Ms4I/v/JuJbRsxsnFNti9bxJLRg7jkcVCha3Fy9zYmd2zKsPqWzB/YnWe+d4T3Ql8+Z8noQQxvYMXM7q05s2+n8N6iJT/g7OzM1KlT0dHRoUqVKqxcuVJ438/PD0dHRzQ0NDAxMeGnn34S3pOHcXfu3MmPP/7IlStXhMlN/t6ZM2dyNfk7d+4cOjo6pKSkCGlm3t7ejB07lpCQEEQiETdu3EBZWZn3798L+/n6+qKhoVHu6VC1atVi6tSpVK1alb1793LmzJlSrZGwtLSkXbt2XLlyhVevXpX4eMVprqmvr4+LiwsymazcGolmJz09HU9PT4yNjWnTpk2xjiESiVBSUkJZWTnfxX9hakxADkNOVVU1hyGTmprKs2fPSE9Pp1WrVlSuXLlQQ0MkEqGiokLt2rVp1aoVvXv3ZtSoUcyaNYvvv/+emTNnMmHCBCZPnsyUKVPo3LkzJiYmgjJbaRsy5ZFOo6Kigo6OzmczwuSLryNHjrBp0ya8vb2ZPHkyP/zwAzt37uTatWsEBAQUKn4hk8lo1qwZGzdu5MyZMzRs2JD69evjNGQo14LfMnf9Fj5mZl1LpSKm98i/gdjUDO5ExHI7PDZXClpBkdXq1auzbds2goOD2bJlC1OmTKFKlSo4ODigrKyMg4MDGzduZObMmUUaV0G8f/+eU6dOcfz48Vzfra6uLvb29jRs2JCffvqJLl26oK2tzdq1a3F3d8fa2pqgoCChDlFLS4vevXvTuHFjZDIZv//+O99++225NK6VyWTcuHGDX3/9ldDQUPr06VMuhsyJEydwc3NDKpUyaNAgIXL2KXfv3sXLy4uGDRvi5OSUpyHz9u1bjh07Rr169WjevHmRxhEcHIxIJOLnn39GX1+fGTNmcOLECRo1aoS6ujq1a9fGw8ODlJSUPNMMt2zZgoWlJYMaWLFk1EBCXuTdzDgv8lurTOmYlTb4w5hBHPxzNZc8Dgp/k7Nk1EAO/rlaeH1ow1rGOtbDpUUdLrjvAyD9n1q57Glmha3zDh48iJ2dHWpqatSuXVtoolzBl83/hDHz4MED5s2bx8aNG3n+/Dlt2rRh8ODBvHv3ji5dutCwYUMePHjAwoULGTNmjKBTf/PmTerUqcPt27fp1q0bf/31F25ubuzbt4/bt29TtWpVunbtKsg6jh8/nvj4eG7cuMHRo0fx8fHJkcYSERGBu7s7Z86cwcPDgyNHjuSoHZGTnCnhxcN7RAQHsXyfFxMWL+fUnm08upmVQ3z1uAcH/1zN2IU/8suB47wLf8NTn1sKXYtXTx+ze9UyJi35lT9OXcW+SXNWfz0ZqVRKWmoKyyY5Y9+4GWu8LjB6/hIOb1yHt5c7IiA1U8rhw4dRU1Pj/v37zJs3j2+//ZaXL18CMHr0aBwcHPD392f79u389ttvQmdmOUOHDmXu3Lm0bNmSyMjIHO917twZTU1NTp8+LfztyJEj9O3bN8fk4ejoyPr16zE1NSUyMpIWLVpgYmKCp6ensM2hQ4fo1auXkBZSnsjrFLp168a9e/fYunUr7969K7Xjt2nTBisrKzw8PErFWLOxsWHMmDHExMTg6uqqUB8JPT09XFxcUFJSYufOncTExJR4HIpy/vx5Pn78yIABA8q0KaGi+f+fkpmZib+/P4mJidjb2wsL9ZKOVUlJCQMDA0xMTKhSpYoQRSuLpp2RkZHs2LGDBQsWMGPGDBYvXpzr9/q/xrRp04iPj8fb25suXbrw5MkTli5dyvjx4+nbty83b94scH+5I2DQoEFcvHiRLVu2MPbrbxi6aAW1m7UqlTHKjZqopDTOvX5PWILi/Z9kMhk3b96kT58+bNq0iUmTJrF9+3a6d+8OlPw+Sk9P5/bt22zfvp1ffvmFjRs34uPjw9OnT3M5BZSVlRkyZAi3b99m2bJlhIWF8fDhQ44cOSJ0qLe1tc0hePLTTz8xePDgcjV6pVIpp06d4sKFC7Rp04YBAwaUuQGVmJjIn3/+ia+vL/r6+syePZs6derk2k4mk3H16lVOnz5Ny5Yt800VTklJ4eDBgxgYGNCnT59iX78bN25w79496tWrh5OTE6NHj8bPz48JEyYwdOhQHj58mKv4//jx4yxdupSfV65hlcc57Js054cxg0iMjyv0fAWtVX5zz1ojzPtjG33HTS30WOcO7uXk7m1MX76WH3Yc5JJ7Vo+ixPTcNWkFrfPevXvHqFGjWLBgAS9evGDcuHEMHz68XOe/CorH/0SamdyzYG5ujoWFBcuWLaN3794cOHAAAwMD/vjjD8RiMXZ2dsTExAjRFJFIxPfffy8spFeuXMnGjRv/jaBs2UL16tU5c+aMYKHHxMQIqQlbt26lYcOGrF27FsjKaf7jjz+oU6cO9erVo3v37vj4+OSq+5DIZEglEqb8tAoNLW1MrGw4vnMLgY/9aNCqHWfcdtBrzAQcu/cBYOaK35nUXjF5xffhYYhEIiobm1LF1Izhs76lcfvOyKRSrp3wRNfAiOGz5gNgbGHF+/A3nNy1lQ79BiH9Jyd89erVKCkpMW/ePFasWMG9e/eoWbOmII9rbm6OpaUlFy5cyCF1C1lpPFpaWqioqAh56XKUlZUZOHAgR44cYeDAgUgkEo4ePcq2bdtybKeiooKuri5KSkrCMYYNG8bhw4eZNGkSAIcPH2bVqlUKXZOyQCQS0aJFCywtLTly5Ah///03Xbp0oVmzZiWejD+tnxk1alSJF8omJiaMGzeOvXv34urqirOzM1WrVi1wH11dXcaMGZOjhqasezMEBgZy7949evbs+cX2gUhLS6NOnTqCQtaX2AW+INzc3FiyZAnKysqYm5ujqqrKxYsXuXPnDqtWraJBgwZCes//EuvXr8fe3p769esLBcwZGRk8fPiQEydOCPVIeaVMpaenM378eE6fPk29evUYN24cDTv1QFpGfXVlQKZUxt2IOFIrS7Ex0Cx0H7kSmIWFBSdPniQ9PR0fHx/s7OyKNQapVMrr16+5f/8+ISEhOSJXurq6WFtb06RJEx48eEBYWBhmZmY5rlvr1q355ZdfcHd3FxTIRo8ezYABA9DR0eHatWvFGldpkZ6ejru7O4GBgfTp04dGjRqV+TmfPn2Kh4cHEokEBwcHQdHtU2QyGefPn+fWrVu0b9+etm3b5jmvSKVSIWoyatSoEtX4fP3111hbWzNv3jwGDRrE119/DcCcOXO4e/cue/fuxcnJKcc+K1euZOHChTTr2JWnHxIYPms+969c5OqxI/QcNb7A8xW0VtE1yHr2a+nqoa5Z+L1/4bAbvcdMpEmHLgBMXbaGr3u3z9OYKWidZ2pqSkZGBqamppibmzN37lzq169foIJbBV8G/xOzVbdu3YT8dwcHB/r168fEiRPx8PDAwcEhx2JD3t35+fPnVKlSRTBkEhMTCQsLY+jQoTm2T0lJ4eXLl4hEIqRSaa4+BFKplMDAQOF19gJdHR0dIaqTHZkMdA0ro6H1b1RBQ1MbSWbWtiEvnzFg0r/pAFq6ehhbKlab0bB1O2rUrMXsvh2xrF2XZh270XmwM0rKyoQHBRD84inOjWz+Hb9Eivgfj52MrDSn7B48bW1t4TMsXLiQBQsWsGXLFiE95lODpTCGDRtGv379SE9P5+bNm0JDsMIYPnw4a9euJTo6mlevXvHhwwd69epVpHOXBVWrVmXixIlcuHCBM2fOEBgYSL9+/UpcbKipqcnAgQPZvXs3V65cyVWnURwMDQ0ZP348bm5u7Nixg2HDhhWaW62jo5NDFGD06NFlln+cnJyMl5eXsEj6UtH8Z3Iti4hJcUlNTVVowg0NDeWPP/6gf//+LF26VIhsRkdHM3jwYHbt2sXatWvzNGT+i/U6coKDg9mwYQPh4eHY29vTunVrrK2tqV27NnZ2dvz444/Ctnl9xuvXr6OsrMxff/1FYGAgvsER6JWRIfMpj95/BFDIoNHW1mbTpk0kJycXq8A/Pj6eu3fv8vLlS2JiYoSIi5qaGtbW1jRo0IA6deoIc6Svry8+Pj7Ur18/z+s2a9YsBg8eTFhYGE2bNv1i7p+EhAT27dtHTEwMzs7OpVr7mBdSqZSjR4/y+PFjlJWVGTFiRL7NSaVSKSdPnuT+/ft07969wLQxb29vgoKCcHZ2ztVrpqjI54Jnz54xZcqUHO/JsyU+fcY8e/aM+fPn8+13C5D9E1dMT0sjIrjwFOmC1ipFJSzoJYOn/ds/y8ymJmoaGkhkOSOGha3zevfuTa9evejSpQt2dnb069ePCRMmlKlYRgWlw/+EMaOhocGdO3e4cuUKx48fZ8eOHWzatIk+ffoUuF/2H6a87uHw4cO5PFkGBgZcvXoVXV1d7t27l+s4JiYm3LmTlev5aZFrXvnoIhEo5+FBEYp/lZTJVcKmYF67qroGKw6dxP/uLe5dPs8lj4OcPbCblUfOIJFIqNeiNROX/JLnvqI8xp99XN9++y1DhgzB09OT48eP07FjR/7++29B418R2rZti5aWFufPn+fMmTMMGDBAocLghg0bYmNjw9GjR3n58iX9+vX7YrwllSpVokePHtja2nL06FE2bdpE3759i+0RlWNhYUH79u25fPkyNWrUKJUJV95c8+DBg4KnrXbt2oXu82mERpFC96Igk8k4deoUmZmZ9OvXr1iLHplMJizqv5RFU1mSlpbG9evXOXbsGPv27cPf37/Q7+X06dOkpKSwZMmSHCmahoaGtG3bVkg1CwsLIzExkVq1agnb3L59mwcPHmBgYED9+vWxt7cv0nWWP0fK87uRq409fvyYhQsX0qdPnxy9hhSlY8eOdOzYEYCwhBTuRsSV8kgL5tH7j6hVEmOqrVgth6KLL5lMRmZmJlevXuXu3btCI1qxWIyRkZHQ0ymvdN6QkBBOnTpFkyZNckief4qxsXGxRDzKinfv3gk1smPHji2yQ66oxMfH4+rqysePHzEyMmLs2LH5fj/ybAV/f3/69etHw4YN8z3u8+fPuXbtGp06dSqVuUE+n+Y1r0okEjIzM3PVEmVmZrJ+/XpMGjYjND5FWLVkd9TmR0FrFcOq1XNsm9czQyL5tFY15xpJSbkS0k+WTYWt80QiESdOnODu3bscO3YMDw8PNm7cyLVr1wr8Lir4/Py38iPy4datW/z666906NCBtWvX8uLFC1JTUzE1NeXRo0c5DIqhQ4fmmZ6kp6dHlSpViIqKwsbGBhsbG2rUqMH8+fN58eIFdnZ2xMfHIxKJhPdTUlKYN2+eUOSvKEqFTOZmNjUJevJIeJ2cmEBkSLBCx37x4B4ef/9JvRatGLtgKX+euUZ6WhrPfe9ibGlNZPArqpjWoLq5JdXNLXnpd59Te10BEBcwrtTUVGbNmoWKigpz5szh8uXLTJo0iSNHjuTatqDFilgsZvDgwZw8eRIvLy+GDRuW53Z5HWPEiBEcP36ckydP5rvf58TGxoapU6diamrKgQMHOHHiRL5d6hWlTZs2WFtbl1r9DGQVsjs7OxepuaampqYg1bxz506ioqJKZSxynjx5gr+/f4nqoEQiEZmZmaxbt47jx49/NkW89PR0vLy8GDlyJLdv3y71Y1+4cIExY8ZgYmJC9+7d+fPPP+nTp49C183Ozo6UlBTB4y6RSIiNjeXIkSMcPHgQPT09Fi5cyHfffceCBQuE/WQyGXXr1sXCwgKJRFJojVh4eLhwjyQmJnL48GF+/PFHvv/+e3bs2EFYWFgJrkLRyczMxMXFpViGTHZSMyXcj4ovpVEVjftR8UXqS1MQ8t/GkydPWLt2LdevX0dVVZV69erh4uLC4sWLmTp1Kh06dMjzvoqLi+PQoUPUqFFDqMn50hQo8+LVq1e4urqirq7OhAkTytyQ8fPz448//uDjx4+0aNGC6dOn52vIZGRkcPDgQZ4+fcrgwYMLXDx/+PABT09P7O3tadWqdOq15NjZ2eV6bt26dYuqVavmMmbs7OwICwvDwspaWFMc2fw7L/18Cz1PQWuVT1GuVImUbGmOMpmMd2FvhNc1bGsR+NhPeP0u7A1JH+MRf7KMKGyd9/z5c7755huaNWvGsmXL8Pf3x8zMLIfyXgVfJv8Txoy6ujo//vijoOZy4MABEhMT6dq1K9HR0cyfP5+AgAB27tyJl5cXXbp0yfM4c+bM4fvvv+f48eMEBAQwYcIEbty4Qa1atbC3t6d79+44Ozvj4+PD/fv3cXFxITExscjStRqFyB/3HDmOk3u2c/vcKcKCAtj4/VxSk5MU8miqqKlxeMNaLhx2413YG66f9CI1OQlzu9q06zOQtNQUtvwwn7BXAfheuYjr8sXoGhohA9SU878d1NTUuH79OjNnzuTFixfcu3ePq1ev4uDgkGtbTU1NIiIiCA4OzvNYw4YNY8+ePaSmpgrezryOERsbS0BAgOBNGT58OGfPniUyMpKuXbsWei0+B5qamgwbNoxevXrh5+fH33//TURERLGPJxKJBClOd3f3UuvVIW+u2bx5c4Wba2poaAhSzbt37y61gvGPHz9y6tQp6tatS926dUt0LG1tbfr06cP9+/dL3ZAoiPT0dPz8/Lhz5w7KysrExsaSnJzMpEmTcHXNchaUVPVu+vTpVK5cmb59+xIREcGaNWsICgpi+/btpKWlKfR5HR0dadKkCT169GDx4sX88ccf/Pjjj/z222+8f/+eW7ducffuXTQ0NDAzMxOU7EQiEdra2vTs2RNnZ+cCZcNPnDiBlZUVDx48wN/fn0aNGjFt2jQuX77MnTt3WLx4Mc2bNy+X70eeCjhgwIASR4RkMhkPouKRfOruLSckUhkP3saX2GiQ7+/h4YGvry+dOnXi+++/Z86cOTg5OWFubl7g/unp6ezfvx9VVVUGDx4sXOOoqKjP2kuoMB4+fIibmxumpqaMHTu2THtoSaVSDhw4wNGjR1FSUmLMmDEFplOnpaXh5ubG69evGTFiBPb29gVue/DgQXR1dYsdxS6I2bNn4+7uzu+//05AQADr1q3Dw8OD1q1b54razJkzh/Xr13PK/SBRocHsWb2Mm2eOY2JVeG+YgtYqAGoaGoQGPCcp4SPWdRuQGB/LqT3biXoTws4VS3OIDPQYOY6Tu7dx6+xJQl8+Z+OiuYjFYpREudc0Ba3z9PT02LRpE8uWLeP169ecPHmS4ODgPNc5FXxZ/E+kmTVs2BBXV1d+/vlnZsyYgbm5OXv37qVly5acPHmSr7/+mj/++AMrKyv27dtHw4YNc3QXlvPNN9+QkJDApEmT+PjxI02aNOHs2bNCLuqePXuYOXMmnTp1QllZWfCKFhWNSgUbM6179ScqNJgtS78lIy2NLkOcqWxsmmdq2qdY2tdl2vK1uG9cx7afF1HZ2IRZK/8UGk8t+nsvrr/+wDf9u6Ktp093Zxec/qnPKciYgSzJwunTp9O0aVNBrWbx4sW5thswYACbN2+mdu3aeRo0LVq0wMjIiO7du+dbZNyxY0dsbGyoV68e169fp0mTJtjY2FC7dm0aNWpULs3MiotIJKJJkyZYWFjg4eHB9u3b6dChA46OjsUqFpfXz+zatYvLly/TqVOnUhtnt27d0NHRUbi5prq6OqNHj2bv3r3s3r2bkSNH5qojKwoymQwvLy8qVapEz549i32c7Nja2tKiRQsuXLiAubl5uaS4rFixgv379xMcHMyECROYOXMmLi4u/P3333z77beMGzeu2AX18lQpCwsLfvnlF4YMGZKjbmns2LFoa2uzc+fOQmurVFRUsLS05Ny5c2RkZKCrq4uBgQFt27Zl3LhxiEQievXqhampKb/99hsXL15k0KBBeR4rv0XU4sWLWbduHT169KB169a0aNGCnTt35rivZs+ezeTJk/H19c3zukRGRqKsrIy+vn6JhQjk8tMlFWqISEwjMqloUfjSRAZEJqYRkZiGiXbxU2zl39unxdwKjUEmw9PTk7i4OMaPHy9EGQICAvD39y/TRpbFRSaTceXKFa5cuUKjRo3o2bNnmda7RUdHs2PHDpKSkqhevTouLi4FplInJyfj5uZGdHQ0o0aNokaNGvluK5PJOHr0KAkJCUycOFGQbC9Nmjdvzp49e1i6dCnz58/Hzs6OQ4cOERoamisyM3ToUN6+fcuqFct49/YdZjY1WbBpF8YWVoWep7C1Ss+R49mzahlv34QwdsGPjJm/BPfNv7P/95V0cBpKi27/1sy26zuQjzHRbF+2iLTUFJwmzSD4uT9aKrm/58LWeR4eHnz77bcsX76cKlWq8Ouvv36xztMK/kUk+y/Ehv8HORn4Nt/Gmf53b1HVrAZG1bMWiZLMTFxa1uXbv1yp29wxz31KiqqSmF42BatbfW6kUinm5ubs3r07Z7+PTAlxqRnEp2WSIZUilYFYBJXEYnRVldFTq1TsZqAlRSKRcPnyZW7cuIGFhQX9+/cvdmfm69evc/HiRZydnbGxsSl8hyLg5+fHsWPHsLGxUai5ZmpqKm5ubrx//x5nZ2fMzMyKdd47d+5w5swZRo4cWapFuBKJRIhYTJo0qUwmfTlPnz6lX79+TJ06lf79+7Ns2TLEYjGbN29GJBJhYmLCxo0bi7V4VISQkBAWLVpEWFgYly9fLnT77du38/btW8zMzJDJZERHRxMYGEhAQAA+Pj7Mnz+fBQsWsHfvXqpVq0bnzp2LNB4tLS18fHywt7dHU1OT27dv52hOCllefCsrK6Kjo/Ps6eHh4cHjx4+BLBEKfX194T8DAwPh3+rq6nkaVXI1NrloQWmIF3iHfCAmNbegS3kiAvTVKtHevGTpcsXl8uXLXL16lWHDhgk1BwkJCWzevBlLS0sGDhz4RdWrSSQSjh8/jp+fH506daJVq1ZlOr67d+9y5swZZDIZbdu2LdS5kJCQwJ49e0hKSmLkyJFCE9b8uHr1KpcvX85x/cuLX3/9lfbt29OyZctc76VmSjgVVHrtCUqLntZVPtvcX0H58j8RmfkvYqylRnB8cp4dc+9ePMOLB/eYtHQF6ppanNy9DQ0tLWo2LBvpSNE/4/mSOXnyJGfPnkVdXZ127doRn5rBq7hkIhJTBaMwrylKfn1VlcQYa6lhpaeBrlr5RXWUlJTo3LkzNjY2eHp6snnzZnr37p1nX4HCaNWqFaGhoXh4eDBlypRSTZNo0KABmpqaHDp0iN27dzN8+PACi4jV1NQYOXIk+/btY+/evYwYMaLQ9JRP+fDhAxcuXKBp06alriakpKTEoEGD2LJlC6dOnWLAgAGlevzsVK5cmejoaDp27IiVlRXffvstP/zwA3PmzKFWrVpoaWkVukgpKpGRkfj7+/Po0SOePHnCo0ePctS4FIS9vT1btmwhNTWVjx8/YmhoSL169XB2dmbFihU0aNAAqVTKyJEjizU2ExMTHj9+jL29PY0aNeL69evY2tqipqaGVColMzOTY8eO0bhx43wXlj169KBx48bExMQQGxtLbGws796948WLF4K0PmQ1hc3ru121ahX9+vWjdu3aJCUl5XkvBwcHY2lpyevXrwtV9YtPzfjshsyf330NwMwV64lPy0BXtfDnmFQqLTXpcH9/f65evUqnTp2EhbRUKsXT0xOxWEyPHj2+KEMmNTWVgwcP8ubNG5ycnHIZ1KVJZmYm+/bt4/Xr16iqqjJq1KhCI9axsbHs2bMHiUTC2LFjC63nCggI4PLly7Rt27bcDRmJREJ6enq+zUTVlJVQVRLn66D9HKgqiSsMmf9HVERmPhPxqRlcDPmQ53spiYls/Xkh969cJD0tFTuHJoxb+DNmNjVxaVGHjPT8Ux3Wn/CmsnH+yjL50cnCSKHJ8XPRoUMHXrx4wV87dqNfqyGxqRmIyKX5ViDy7Q3UKmFroIWxlmq5Tr4pKSmcOHGCp0+f0qBBA3r06FHkiEFycjJbtmwResCUdrpEeHg4+/btQ0NDA2dn50LrweT58+Hh4YwYMaLQRaEciUSCq6sraWlpTJ48uczSBh89eoSnpyf9+/enQYMGZXIOgHHjxvH+/XtWrVqFoaEhrq6uLFq0SBBwWLVqlXAtS7LAfPnyJYcPH+bt27eCRLmVlRWOjo50795doYhdcHAwu3btolevXtStW1fIg5cX7GcvipanuBWFzZs38/PPPzN+/HhSU1P5888/GT16NC1atEAkEuHr68vGjRuZPXs2K1asKHIaWWpqKrGxscTExKCvr0+1atVyXc/u3bvj6uqKsbEx3t7etGnTJtfnkEgkvH//nsqVKxf6GR9ExefrfCovkhKyJJq1tHWw0NXAoVrhEd6oqChiY2MLrMFQhMjISFxdXbG3t89Rf3Tt2jUuXbrE6NGjc/Uc+5zExcWxb98+EhISGDZsWJEdLUXh7du37Nq1i5SUFGrUqMGoUaMKvaffv3/Pnj17qFSpEqNGjSr0ORsTE8PWrVsxMzNj+PDh5W40JiUlsXr1aoYOHZpD4TA7n/5GymqtoggiUPg3kh9fcsZHBbmpMGY+I8VJW4h6E4KsgCLLKiZmRdJpFwHqSHhy/ACqqqooKSkhlUqRSCRIpVJUVFQKlJIsL1IzJTyIii+VnHW5UVNdUxWHarrl+kCSyWT4+flx+vRpNDQ0cHJyKnKKVmhoKDt37sTR0bHIKUCKEB0dzd69e5FIJAo118zIyODAgQOEhoYyfPhwrKwKz5f29vbm6tWrjB8/vkQ1N4pw9OhRnj59yuTJk8usEWd8fDzffPMNly5dQkNDAwMDA3R1dWnbti1BQUFkZGRgbGzMDz/8gJKSUrHTnh4/fsygQYOEZpezZs2ic+fO+Pj44OzszLp16+jZs6dCx37//j1PnjyhXbt2nD59miVLlhAVFcXQoUP54Ycfip0OCbB//37c3NwICwtDSUmJ1NRUJBIJIpGISpUqoa2tzdu3b3nw4EGx1esUITk5GT8/P6HOr7gUlBb8OVA0LVgsFnPp0qUCBRsKIzExka1btwqy7nLHw5s3b9ixYwetWrUqtTq+0iAiIoL9+/ejrKyMs7NziRXsCkKe+isSiYQ0NkXGt3fvXrS1tRk1alShPcnS09PZvn07mZmZTJw48bO0JPjw4QMbNmzAxcUlX8PwUwdtaa9VikpxHLT/lYyPCnJTYcx8RsITUrkTEfu5h4GNqgTPXdvzfE9VVZU5c+Yo1AumrAhLSOH+PypCpXmzigAlsYhG1XQV7t9QWsTExODp6Ul4eDht27albdu2RfLW37hxgwsXLjB8+HBq1qxZ6uNLTEzEzc2N2NhYhZprZmZmcvDgQYKDgxk6dGiBEYLw8HC2b99O27ZtS7TIUpS0tDT+/vtvVFVVS1SIXxj379+nVatWtG/fngYNGvDLL7+wZ88efvnlF1q1asWjR49o164da9asKVbEQ468AeSLFy94+fIlU6ZMoXfv3jx+/JibN2/mKT3/KW/evKFfv340btyYrVu30rJlS3R1dZk0aRI///wzc+fOZeTIkSUap5zAwEDu3LlDSkoKMplMcJakp6czderUUq9nKshQfPPmDdOnT+fChQsYGBgQHh5OYGAgNjY2VK9eHX19fQIDAzE3NycyMpKnT59y5tx51m7cTK3GzTjjthMtXV0GT5tN58HOACwZNZAaNWvhe+UiUkkm6497k5QQz9afFvLo1jV0DYzo6DSUgVO/RklJicyMDLb+tIA750+TkZ5G3eatmLR0BYZVq5P0MZ4N38/l8e3riEQiGrfrxMQffkVDSztHmhnAgv6dyUhLITIyEktLS5YtW8aTJ0/466+/iI2NpXfv3hw9ehQVFRXMzc35888/FWpQnJ3MzEx27dpFXFwcEydOFFJbU1NT2bx5M9ra2ri4uHwxDWRfvnyJu7s7VapUYfjw4UKD29JGfl3CwsJQV1dnzJgxhTp9IKu+bd++fVSuXBlnZ+d807bkyGQyPDw8ePHiBRMmTCj1/l6K8ubNG1xdXZk6daoQ0ZT3npFIJGRkZPD27Vs06zYnRfR5qxeKWlcmk8mISEzjZUzifzLjo4IsKmpmPiPGWqpU11QlKints6QviIBqWqrUM9ZH5OSEh4dHrm2aN2/+WQ2ZgJhEHr8vnf4qnyIDMqUy7kbEkVpZqlCH7dLCwMCAsWPHcvXqVa5evUpQUBBOTk4Kd3F2dHQkNDSUo0ePMnny5BJ50fOiqM01lZWVGTp0KIcPH+bAgQMMGTIkTyMrIyMDT09PqlevTps2bUp1zPmhqqrKwIED2b59OxcvXizygk5RatWqJdTJhISEIBaLuX79OhoaGri6unLnzh169erFzz//XKJIZ0BAAIcPH+aHH34gNTWVS5cuoaWlJTSvVSSN7fTp02hqarJgwQLi4+NJTU2lT58+ODk5cerUKS5cuFDsmpnsbNq0iVmzZqGnp4eRkRFisRixWEylSpVISEhgzJgxpW7MZF9IZFcyk8lkODk50aBBAx48eMCDBw8YPnw4GzZsALLShfr27cvGjRvp2LEjTZo0wczMjA8fEwh8/BA1DU1+PXCcgMcP+HvpdxhVN6Fh6/YAXPY8yOJt+6mkooqapiY/uAzGolZtVnucI/b9O7b8MB+RWMzgabM57bYD/7u3WbJ9Pyrq6vy9dAE7fl3KN+u3cODP1cR9eMfyfV5IMjP4ff5M3DetZ/S8nKqRj29fJyjwJUpiMTt27CAqKorBgwejqanJvn37WLp0KceOHQPA1dUVLy8vJk6cSHBwsHBvZGRkFJjeKZPJOHnyJJGRkTmkjGUyGSdOnCA1NfWLMmR8fHw4ffo0dnZ2ODk5lVnq6ps3b9i7dy/p6elYW1szYsQIhRxRAQEBHDp0CDMzM4YOHarQfX/79m2ePHnCoEGDPpshA1nGK2SpWbq6uhIXF5fndvZaeihbFr0etDSRAbYGBUe75OSV8VHUtZh8+9jUDO5ExH6WjI8K/kf6zPxXEYlEOFTTRenTzk7lhJJYhENVXUQiEfXq1aNZs2a5tnnw4AF3794lI6P8i1/L0pD5lEfvPxIYk1T4hqWIWCymffv2jB07lsTERDZv3szDhw8V6iMhEono378/KioquLu7I5GUTjO97BS1uaZcrtvW1paDBw/y/PnzXNucP3+e+Ph4oXdOeWFsbEznzp25ffs2AQEBZXIODQ0Nli9fzsWLF7l58yYJCQk0atSI5ORkwsPDef/+PVWqVCl23yH5faGmpkZycjJjx45lypQptG/fHk9PTwAsLS3z7e+UndTUVKRSKVZWVoSFhSESidDR0SE+Pp7g4GAMDAwAil3bI+83smbNGpYuXcq7d+94+vSpIFbg6+vLy5cvFTbei4tIJBI+w6VLlwgJCeHvv//Gzs6OFi1aALBjxw4AnJ2dOXDgAKtWrcLGxkbosRMY8gaRSMxXv/1BjZq16DRwOK179uf8ITfhPI3bd6ZWo6ZY163P49vXeR8RxpSfVmFiZUPd5o6Mnr+EE7u2AfAu/A0qampUNjHD1MqWGb+ux2nidADeh79BTUOTqqZmWNrX5Zvf/6ajU+4GwafddtC97wBmzJjBkSNHmDNnDrq6ulhYWNC7d2+0tLSEFFQTExMWLVrEmzdvcjS7ffPmTa7jZuf27ds8fPiQvn375kgFlfcP6tOnT5F7rJUFMpmMc+fOcerUKZo3b87gwYPLzJC5dOkSrq6uZGRk0KtXL0aOHKnQb8Tf358DBw4Ixo8ihszr1685f/48jo6OxRKMKU3kohtqamo0adIkz210dXXp37Et1TVV80zNKg9EQHUtVYy1Cr++YQkpnHv9nqhSkluXz9pRSWmce/2esISUArevoHSpMGY+M2rKSjQqQZFaSWj0ifega9eumJiYIBKJEIlE1K9fHwsLC86cOcPvv//O9evXBQ9NWROWkFJuhoycR+8/fpYHkJmZGVOmTMHe3h4vLy+OHDmSQ7EpP9TV1Rk0aBARERFcvHixTMZW1OaachWxWrVqcfjwYZ4+fSq8FxQUhI+PD507dy7TPPb8aNGiBba2tkKfhrJAJpPx7Nkzhg8fjra2Ntra2ohEIt6+fUtCQgJ2dnYK1RTlhTzi0KZNG7S0tNi2bRsikYjp06cTFhaGs7Mzzs7OBAQEFGoQt2/fnsDAQK5evUpaWhovXrygWbNm3Llzh/DwcL766qsc5ywuMpmM5s2bl+gYnyKVSomMjCQxMbFIDSSfPXtGdHQ0Ojo6aGlpCQtEuZd55MiRODg4cObMGSZMmCA4cJJSUqlWwxxdw3/vWeu69Ql79a9RXNnk37q3sKAAEuNiGdWkJs6NbHBuZMPaOVNIjI8lITaGLkNGEvv+LRPaNOSnccO4f/UiJv/01ug1egIvHtxjrGM9VkxzIfCxH9Xz6NnxJvAl7+M/8tdff/Hy5UsgKzU0MTFR2KZx48ZCmpU8qpLdKfXq1at8r19AQADnz5+nVatW1K9fX/j7+/fvOX36NI0aNfrsC2zI+jzu7u7cunWL7t27061bt1JTb8tOamoqW7Zs4dq1a2hpaTFjxox8F/Wfcv/+fY4cOUKdOnUYPHiwQmmu8fHxuLu7Y2lp+UXUI6WkpKCsrEylSpWwsrLK5YgSi8UMGzYMFRWVL8ZBWxAB0BuQPgABAABJREFUMYncjYgjs5RT1yFnxkd5O0j/P1ORZvYFYKqtTmplKY/efyy3c9avrJOrTkRJSYmhQ4eyefNmUlNT6dy5M9ra2rRv356bN2/i7e3N9evXadq0KS1atCizfOTUTAn3o+LL5NiFcT8qHiN1lXIPEauqqtK/f39sbGw4efIkmzdvZsCAAYXWqpiamtK5c2fOnTuHubl5mUh2yptramtrc+HCBRITE+ndu3e+iwYlJSUGDhyIp6cn7u7uODk5YWubtVibNm3aZzFkIOtz9OvXj82bN+Pp6cmoUaNKPbdZJBLRvXt3Vq5ciaOjIzVq1CAsLAxDQ0OGDRuGk5NTjutWVCEAeQ3LsmXL+PPPP3F1dUVXV5eMjAxevnxJ27ZtcXBwKPSY9evXZ+7cufTs2ZPk5GR69+4tRGYvXrxY4kaj8vNPmjSJbdu2YWVlRdWqVUlLS0Mmkwn59lWrVi108ZmcnMybN28ICwsjLCyM8PBwpFIpCxYsKNK1y8zMpFatWnh5eQEQFhZGhw4duHz5Mh06dEAikRAUFATAixcvhIW+kpISSso5Pf1SqRRxtu7iKir/eoKlEgnGVjZ8t2FHrjFoaOugrW/A5ot38L1yEd/LF3Bb+yvXT3jy815P6rVozd/e97h78Sy+Vy6yZcl8/K57M2vVXzmOo6qmRvPmLXDb/FeOKIQ0W8G1iopKrghFduMlISGBkJCQXM+YDx8+cOTIEWxtbenYsWOO63fkyBH09PTo3r17Hle4fElKSuLAgQOCaEV+Klsl5dWrV+zfv5/MzEzs7e0ZNGiQwgbTrVu3OHfuHI0bN6ZXr14K3a8ZGRkcPHiQSpUqMXDgwDIxzopKSkoKqqqqeHl54efnh5qaWg6HW6dOnQQVRLmD9m5EXLmP81MHbV6Ud8YHUK4p7P9fqTBmvhDkN3t5GDT1q+hgo5/3j0tbW5sxY8YQHx8vqAwZGBjQu3dv2rVrx61bt7hz5w63b9+mUaNGODo6lmq9hkwm48E/xf6fA4lUxoO38bQw1v8sRXx169bFzMwMT09Pdu3aRatWrejQoUOBKVktWrQgJCREqJ8pi9QPkUhEq1at0NLS4tixYyQlJRXYXFMsFjNgwADEYjFpaWmoqqpiaWn52SdmTU1NnJyc2L17N9evXy+Tup0ff/yRW7duMXDgQB49ekSvXr3Q19fn48eP/P7777x+/Zq6devi4uKCoaFhkaSa5dt16tQJV1dXwsLCsLGxoWfPnjRu3BgHBweFBQ7mzJlDjx49SE9Pp1q1aly+fJk3b97QsmVL4TvLD0WFAeLj4zl9+jSnT5/G0tISNTU1oYYlJiaGS5cu5TKcZDIZ4eHh+Pj4EBYWRkxMDJD13ZmZmdGuXTusra2LnKZoZ2dHaGgolStXRldXV7hO69evB7KaiRoaGrJgwQLmz58v/I401NWJCg0mJSkJ9X8cOEFP/DC3y1vu2NjSmg8R4egYGKKpnRUR8btxhcueh5j52x94Hz1MJRUVWvXsh2P3Prx86MuCYX2Ij/7AtROemNvZ02HAEDoMGML1k0fZsHAOs1blPkfgsyd4eXmRlpbGwoUL0dbWzlFQHhcXl29tA/zb3DS7MZOSksL+/fvR0dHJZXifO3eODx8+MHHixDJL41KU6Oho3NzcSE9Px8XFpcwUEU+fPs3du3eF51n2KFVByGQyQbFRrvamyHwik8k4deoU79+/Z9y4cZ9dRRSy7okXL16QlJTEy5cv6datGw4ODmzZsoWYmBjMzc1zNdL8Uhy0n/K5Mj7UKonLXWTo/xsVxswXhI2BJmqVxJ9duatKlSp5Fhtqa2vTtWtX2rRpw507d7h79y737t2jfv36tGrVqlQ87hGJaaUiv1xcZEBkYhoRiWmYaH+eRqK6urqMHj2amzdvcvnyZV69eoWTk1O+11cecdiyZQvu7u6MHTu2zOpRitJcUywW079//xyvvwQsLS1p3bo1ly9fxsLCosjS2Ipw5MgRHj58iLq6OnZ2dmhra+Pt7c3+/fuxt7fH3d0dHx8fDhw4UKTjyhdEVatWxdzcnLlz59K8eXOhxuXVq1csWrSI3bt3F2rUKCsrU69ePQ4fPsyiRYtITExEJBLxzTff0KhRI37//Xfs7OzyNLYUvb8sLS1ZtGgRmpqaSCQSZDIZSkpKqKiokJiYmKcsrVQqJTAwkA8fPmBjY4OpqSlmZmbo6haePlIQXbt2xdzcnJEjR/LLL7/w7NkzAEHq9ujRo1y9epUWLVqwcuVK3r9/D4CZqQmpyUn8vfRbBk6dxbN7d7l55gQ/7jqU53katGpHZRNTfp83A+fZC0hK+MjmJfOp75jV6yY54SNHtvyBtr4BVc3MuXrcA8Nq1dHWNyA6KpLzh/Yy45d1aOnpc+vsSSztc6dz9R4zkUUj+nPu2FF+++031q1bR1xcHCkpKRw5coSkpCS8vLwK/M1ZWVkJvVi0tbWRSqW4u7uTkpLChAkTchizz58/x8fHh549eyqk2lWWhIaGcuDAATQ1NRk/fnyZ1F0lJyfj6upKdHQ0urq6jBs3TuEmxTKZjLNnz3Lnzh06depE69atFT7vvXv3ePjwIf379y/1RrtFJSMjg9u3b3Pjxg0yMjLQ0dFh2rRpwn3Rs2dPzp07h5OTU56/yy/FQSvn/2PGx/8nKqSZv0CyK2wUVSbwU4SeKlqqOFQtXYWN9PR0fH19uXXrFgkJCdSuXZvWrVuX6CFcnN47pU1RpR3LkoiICDw8PIiPj6dbt24Fdk0PDw/H1dWVZs2alZliV/ZzFaW55peGRCJh586dJCQkMGXKlDLr3fD06VPWrl3Ljz/+yKlTp/j6669JSkri3bt32Nra4uvri42NTZHSzfLbdv/+/fz000/Y2Nhw8OBBhby6f/31F9988w3Tp0+ndevWmJmZ8fHjR1xdXYmIiODSpUt5GjPR0dEK9+zJzMwkNTUVdXV1wQgqKLIjl28uqUGe/TrJ//3q1StmzpzJ5cuX0dDQIDo6msePH1OvXj26devGmTNnAFiyZAk///wzZ8+e5dmrEJb9tBTHHn05d2A3epWr4jz7Oxy798nadtRA6jRrydCZ3wjnjnoTwvZli3hy5wZqGpo4du/N6PlLUFVTRyqV4rb2F654HSExPg7ruvUZv2gZVrXrkZaSzPbli/G5dI7U5CTqNG3JxB9+pappjVzSzD+NGUTk60Di4uKws7Nj6dKlhISEsGrVKt69e0f79u15+PAh7u7uWFhYYGlpyevXr4VITHp6OqtXr8bR0ZH27dtz5swZ7t69y6hRo3I0wPz48SObN2/G3NycIUOGfFbZWX9/fzw9PTE1NWXo0KGFShsXhxcvXnD48GEkEgkNGjSgb9++CjtipFIpx48f5+HDh/Ts2ZOmTZsqfN7Q0FB27dpFkyZN6NGjR3GHX2KkUikPHjzA29ub5ORkGjduzIcPH1BRUWHYsNxiFIXxJbRWkMlk3A6P/ezKsZ8r4+P/AxXGzBeKXPs8ICaRmC9c+zwzMxM/Pz9u3LhBbGws1tbWtGnThho1ahTpnJ823frcFKfpVlmQnp7OuXPn8PX1pWbNmvTt2zffeqXbt29z9uzZMs0hl1PU5ppF4bvvvuPly5d5yoWXFnFxcWzevBlra2sGDRpUJr+PX3/9FQ8PDzw9PfH392fMmDGcO3cOPT092rdvz19//UXPnj1LdA6pVMq6devw8PCgY8eOfPvtt4U24gOIjY2lX79+DB8+nKlTp+Z479mzZzRp0oSEhIQ8F3IfPnxQKBL77NkzJkyYgK+vL127dmX79u0EBgbi6urKtGnTcHBwUPyDFoOIiAiMjIxKJC+/dbsr3y/5gc2X7pbiyEpOT+sqJXZOnThxghcvXtC+fXtOnDhBjx49cqhaSqVSdu/eTWxsLFOmTCkT40ERZDIZN2/e5MKFC9SvX58+ffqUer+o7IZIdiETRcnMzMTDw4Pnz5/Tv39/hVPSIKt+6e+//8bQ0JBRo0Z9FrlruXjJpUuXiI6Opl69enTo0AF9fX22b9+OkZER/fr1K9axP7eD9kvp6dfcWP+zZXz8r/Nl5H1UkAuRSISJthrtzY3oZG6Eha4Gqkr/fl2iPP6To6okxkJXg07mRrQ3N8JEW61MvQHKyso0btyYGTNm0KJFC0aNGsW6devYsWMHL1++VFhx6FVccqlJOg6sZcyTOzcL3e5d2BsG1jLmXVhOmVIR8Co2uZRGUzJUVFTo3bs3w4YNIywsjE2bNhEYGJjnts2bN8fe3p6jR48K0rJlhaGhIePHj0dTU5MdO3YQEhKS4/3i+kl+++031q5dS+/evUtjmPmip6dHnz59ePr0Kffv3y+Tczx+/Jg2bdpgamqKjo4OBgYGvH79muDgYMzNzXF0dCzR8V+8eMHUqVM5fvw4ffv2ZfHixWhpaRH3f+yddVhV2ffGP5fuEhSxUFAUE8HE7sAWLFRssRVH7MDu1jEwMbC7CxMxUBQRC1RCURGQjnt+fzD3DEhdEJ2Z78/3eXgUzjn77L1PrbX2Wu8bFZXn/Ovr6+Pr6ytSFEO6QQbpbFYVKlQQaaSl3yl555XaI9vf1dUVHR0dLl68yLt373B3d6d48eJ8/vwZFxcXQkND8z3m3CAbc0REBHPnzsXZ2Zndu3f/EHW5sqIC/7ZgqqqiQqGssteqVYvY2FhOnz6NtbV1lpWEGzdu8O7dO7p27fqPOTJSqZTTp09z6dIlGjZsSOfOnQvdkYmJiWHNmjU8evSIIkWKiHpR8iI5OZn9+/fz4sULevTokS9HJi0tjQMHDiCRSOjevfs/4sgEBQWxdetWDh48iJ6eHkOHDs2ke5aYmPhDq9dqSorULaFPHRN99NXSA4T5faRk++urKVPHRJ+6JvpyPwMvI2Pz3uknQ/Iv6cf/Kn47M/8B6KopY2WsS3vzYrQzK0r9EvpYGmpT3kATM31NyhtoYmmoTf0S+rQzK0p782JYGeuiq/ZrVxUUFBRENq2OHTsC6akvmzZt4unTp1kMou8RFptYaEvAW288wsIqb+rMIsVN2HrjEUWKf1eE/Fd//k2wsLDA2dkZY2Nj9uzZw9mzZ0XjUwaJRELHjh1RV1f/afozGSET1zQxMWH37t0EBQUBebN0ydJ5vkdCQoJYjzNw4MAs4ytsVK5cmZo1a3Lu3DmxRqIwYWdnh6enJ69evcLAwID379+jqqpKw4YN2bp1a4HT82RG+7lz59iyZQs+Pj74+fnh4OCAsbEx48aNkyuAYW1tzcaNG3n27Bnx8fEoKSnh7e3NsGHD6NChAyVLlgSy1jvllXYj69+rV69wdHSkYcOGjBs3Dn9/f5SVlTl69Cjv37/n3bt3mfb/UcjamTx5MufPn8fR0VHuWofcoCiR/GPaGd9DAphoFU50V01NDQUFBVRUVGjbtm2me+bt27d4eXnRqFEjypQpUyjnyy9kToKvry8dO3akWbNmhR6Ye/LkCatXryY6OppatWoxatSofBXeJyYm4uHhwbt37+jdu3e+GSXPnj1LeHg4Dg4Ocq2oFibCw8Px8PBg165dAPTr1w9HR8csqeIJCQl5OrOPHj3i9u2cA4j/VIA2OjGFpqZGcgU3fwRXjngyvFlWrT4ZBCAyMYXopH82jf57REREcPDgwX+6Gz+M3wQA/zGoKSlirKWI8a995+Ub5cqVo2nTprx7944bN25w+PBhrly5gq2tLdWrV88SWUtMTSMpLXdnJz/QN5JPLVlRUTHHfZPSpCSmpv2riva0tLTo06cPPj4+XLx4keDgYLp27ZopxUtNTQ17e3u2bdvGhQsXfnr+taqqKr179+bKlSsUL148T0fm6NGjdOvWDU9PT+zt7TNtU1ZW5tatW2JxtpKSktzMWQVFmzZteP/+Pa9fv8bQ0LBQjaXevXuzZ88eevfuzadPnyhSpAh169ZFIpHw6tUrPn36hKGhIaVLl0ZFRUVuZjPZHDs4OKCtrY2FhQVBQUGEh4fTv39/JBKJXPO2du1aZsyYQfXq1dm+fTuOjo6YmZlx8uRJqlSpwsePHwkNDeXVq1eoqamJQQp558jc3FxcfalTpw779+8XNX6+fftGUlLhkn0oKCiQkpLC/v37efz4MeXLl2fjxo0/dE2dnJzo0rPPvyYFVgDK6f84y1VKSgr79u0TRVi/fPkiEr8kJCRw5MgRSpUqRaNGjX74XAXBt2/f2Lt3L5GRkfTu3RszM7NCbV9GeBAQEICSklKBzhEXF4eHhwdRUVH069dPdP7lha+vLw8ePMDOzi7fx/4IIiMjuXr1Kk+fPqVIkSLY29tTqVKlbJ8TQRDkcma6dOnCrFmz5FptlgVordAlMTWNqMQUopNSSZFKkQqgIAFlBQV0VZXQU1P+oW/wm6h/R4YF/J3xYfUPaQtmB1dXVwRByPIt/q/h98rMb/w0KCgoEBQUhKOjI0OGDCEwMJDmzZuzZs0a1q9fj6mpKRs3bqREiRIY6OqwetJoUpL/Nm6unzzCiJb16FWjHCtdRrBigjOea5fJde6MaWbDm9Xm3N4dTO5hR89qZXHp3ILXT/2ArGlm36enbdq6TSyYvXbtGqampjg7O6Orq8ucOXNQUFDIlKIUERGBkpJSjmlghQGJREKdOnUYOnQoAFu2bMHb2ztTdNvExIRWrVrh4+OTSbjyZ0FJSYmWLVuioqKSq+F448YNHB0dmTlzZrYvTyUlJVRUVKhatSru7u6A/MxZBYWysjKDBg2iTp06PyUdc/fu3axatYrx48cTGBjI7du3sbKyYvDgwbi5udGpUycmTkwvHs8vRXPx4sUZOHAgtra2ODo68scff9ClSxfs7OzyXAkFqFq1KocPH8bX1xdjY2OePXvGnTt38PHxYdasWYwfP57JkyezaNEiNm3aJB6X10qKrH+DBw9mx44dbNy4kWLFivHmzRv8/f3ZuHEjKioqP4U44unTpxgbG1O0aFHevHnD3bt3f5hJT1dNGYNfvNKdHSSk10H+aC2fIAicO3eOyMhI+vTpg6amJvfu3RO3nThxguTk5Cz0zL8KHz9+ZOvWrcTHxzNw4MBCd2S+fv3KypUrCQgIoFixYri4uOT7HDExMSKJiJOTU76dkdDQUE6fPk3NmjWxtrbO17EFRWxsLGfOnGH9+vUEBwdjZ2fHiBEjsLS0zPHdl5KSglQqzdOZKejqanqAVg2LIlpUMdKhWlEdqhjpYFFEC2MttR8OJv6bMiz+jRkf/ytl87+dmd/4JTAxMaFWrVro6OhgZmbGgwcPCAkJYcuWLRw7dow1O/bgfeE0144dAiDgwV3WT51A50EjWHrkPGoaGtw+e6LA5/dcu4wuQ0ay4vglNLR0cJ8/Pc9jJEB8auY0rbdv35KYmMiDBw8YMGAADRo04NChQ+L2w4cPY2Vlhbm5eYH7Ki+KFi3KkCFDsLGx4fz583h4eGRStq9VqxaWlpacOHFC1Or4mZBIJLkaPs+fP6dnz550796d2bNnA2SbRqagoICioiKDBg0iPDz8Z3U3E1RV5SPI2LBhA4cPH85X2wYGBtSvX58xY8awY8cOhg8fLurL7Ny5k/3797N3715Onz4NZK1PyQtSqRRBEBAEgSNHjtCpUydMTU05depUJsX37JCcnMymTZvw9PRk//79jBkzhrlz57Jjxw58fX3R0tKiffv2rFixgm3btuWrTwCXLl0iODiYsWPHYmhoyMePH3F0dGTMmDEMGTKEChUqAPKv9MgDCwsLatasyYIFC/D09MxSy1VQlDf455fDhULsR82aNbG3t8fExARra2v8/PxISkri/v37PH/+nE6dOhWqhpi8ePPmDdu3b0dDQ4NBgwYVOhX0gwcPWLt2LbGxsdja2haIzTAyMpJt27aRkpLCgAED8t3HuLg4Dhw4gLGx8S9hLktKSuLq1ausWbMGPz8/mjZtypgxY7C2ts7TWZWJY+Y2R02aNOHt27cMGDAAU1PTLM+zk5MTTk5OAMyePZt+/foxevRotLS0MDU15cKFC6xbt45ixYphZGTEmjVrxGO/fv3K0KFDKVasGLq6uvTt21esB/0+wLh48WIA3NzcKFq0KIaGhpz29MjUl5TkJNznz8CpbmWc6lZm9R+j+BaV3t6KCcNZ6zo20/4rXUawYboLAJ/DQ1no3J9eNcoxvFltDqxbnmMqd8jrl8wd3BtH6woMaVSTA+tXIJVKSUqTMn3mTHr27MmAAQPQ0NDAwsKCEyf+tm9MTU3Ztm0btWrVQl1dnVatWvH27Vu6deuGhoYGNWrUwN/fX9z/xo0b2NjYoK6uLgaoMs79hAkT6NGjBxoaGpQqVYrdu3eL12Lnzp3s3LkzT4Hufzt+OzO/8UuhoKBAp06d6Nq1K2lpaTRo0IBLly5RrEw5rBo25dWTRwCc27sT23YdadWzLyXLlWforEUUMS445XOTLg7UadEWk7JmdBw4jNdPH8t1XFo2UQtXV1fMzc0pXbo0vXr1ypRveuDAgQLRVxYUSkpKtGnTBkdHRyIiIti4cSPPnz8H0g3EDh06oKGhwaFDh356/UluCA0NpVu3boSHh6OpqcmAAQPE/mdnvMs+ht/nbufX0C8M+Pj4YGRkRI0aNVi/fj3Dhg3DwcEh3+2EhISwePFiRo0ahaenJ9ra2uzdu5eqVatib2+Pp6cnkH89HgUFBSQSCbt27WLWrFlIpVI+f/5M6dKl8xQ3VFFR4dChQ1y/fl1MW9u0aRMXLlzgwoULbN68mbFjx9KkSZNMBltezodsDI0aNeLgwYM8evSIZ8+eibU98fHxzJgx46eIAmpoaDBy5Eju3r3LypUriY6OZvny5URHp2tMyO6hnCKSski0bLuMKtpESxVjTdV/rHZGAhhrqlJcU+WHo6kSiYTixYtTvnx5IL12KiUlhZs3b3L+/HlsbGx+OhtidvD19WXPnj2UKlUKJyenQql3kkEqlbJnzx5OnTqFsrIyAwYMoEWLFvlu5+PHj2zfvh0lJSUGDBggN0V5xn7I6hkdHBwKncwgI1JTU7l79y5r1qzh1q1b2NjYMHbsWBo0aCC38KnMmcltZebIkSOULFmSVatWsXr16jzb9PT0RE9Pj8ePH1OnTh0cHBw4f/48165dY8yYMbi4uIg1jF26dOHRo0ecOnWKixcvEhAQIDpGkDnA2KtXLzZv3syqVavYtm0b+0+c5sqhfZnOvWfFIl4/ecS0zR7M2XmIuG8xLB83DADbdp24f+0iqX8FgVKSk3hw7RK27TohCAJLRg9Gt4ghy45cYNTCVdw4dZQjm9bwPWK+fmF6n84YFC3GogOnGTJrAWc9tnF611YAElOlHDlyBEEQePDgAQMHDqRbt26ZsiimT5/OwoULuXnzJr6+vlhZWdGyZUvu3buHhoYGU6dOBeDDhw/Y2dnh5OTEkydPcHV1xcnJiRs3bohtrVu3Dmtra54+fUq3bt0YNmwY0dHRTJw4EQcHBxwcHMSV2f8qfjsz/1IkpqbxITaRwC+xPP0Ug19EDE8/xRD4JZYPsYkkpv7cwu6fDVmh45w5c6hduzYRnz6hpqFJWmr6S+TtiwDMq1QX91dUUsIsw+/5RfEy5cT/q2tqiy+rvJCdzZAxgmFvb09wcDCPHj3i48eP3Lx5kx49ehS4nwWFmZkZzs7OlC5dGk9PT06ePElycrJYPxMREcGFCxd+eb8gXQXezs4OXV1dPD096devH69evaJ169akpqbKZbzLPqgKCgo/ndTge1y6dInY2FgSEhI4fvw4586dQ0lJiYiIiHy14+fnh66uLn369KFIkSJMmzaN5cuXA+mFuPnRpPgeL168YNq0aXTu3Fl0kGR1R3nBw8MDLy8vtmzZQpMmTXj8+DFr167l2LFjBAcHA4iCl/JC5ux07tyZJk2aULJkSYyNjTE0NERPT4/IyEiCgoLE61rYaNq0Kfv27WPKlCnUqFGD69ev4+zszJMnT8T7LTuHLC0tTdTYefz4MQ8ePBBXHCWSdE0LRYV/xp1RVJCg+DGYhw8f8vnzZ7mvR077ZXzudHR0qFChAnfu3MHAwIBWrVoVSp/lhSAIXL16lRMnTlCjRg169eqVSbTzRxEREcGyZct49eoVJUqUwMXFhdKlS+e7nZCQEHbs2IGWlhYDBgwo0MqVjNnP3t6+UJ21jBAEAT8/P9avX8/58+epUKECo0ePplWrVvlmpZPHmTEwMEBRURFdXV255sTQ0BA3NzfMzMxwcnIiOjqa1atXU6lSJSZOnEhqaiqvXr3Cz88PLy8vPDw8qFWrFrVr18bDw4MTJ04QGBgotpcxwLhlyxbGjx+PnZ0dpSwqM2LecnG/pIR4zu7ZzrA5SyhfzYoyFpUYu2Qt/j63eRsYQM1GzZBKpTy9ewuARze9UFFTo0odW5543+RTWAjD3ZZSopw5VerUp9+kmZzauTXL+G6cPIqqujrD3ZZS0qw8tZu3oefYSRxz34CEdGfGwMCATZs2UalSJVxdXalfv36m1W8nJydatGiBtbU1zZo1o0qVKgwfPpzKlSvTt29fMWi5fv16WrRowahRozA3N8fR0ZGhQ4eyatUqsa3q1aszadIkypUrh5ubGwkJCfj7+6OlpYW6ujrq6uoYGRnled3+zfhNAPAvQnRiCm+i4gmLTRSL4bP7bMo+TaqKCphoqVFOT+OXM5cVBNmtDOjr69O8eXMehUfiIZGIzoOiomKWj/CPRCOV5IxCfQ9pWtY+Z1xuNzQ0pEWLFhw+fBgTExPq1q37Sws5M0JDQ4MePXrw8OFDzp8/z9u3b+natSsmJia0bt2aM2fOUKZMGSpXzqoo/rOQkpJC165dSUlJ4fz582KB8YgRI5g6dSofP36kRIkSebajqqoqihvK7o2fLT4WFhbG0KFDefPmDRMnTmTFihU8ffqUzp07s2HDhnwbMiYmJrx580Z0xvr27cuKFSsoX748SkpKuLq65ruPsnnw8fGhdOnSTJ48GU1NTXr27MmaNWtwdHTM83gTk3Qmv2XLlnHkyBG0tbUBWL16NeXKlWPNmjXUrVsXqVQq95zLyAcGDx7M4cOHKVKkiOgQSaVSEhMTiYqK4urVqzRu3Fhu4gN5EBkZyaFDh1BVVaV69ep069ZNbsP169evuLm50bt3b65fv87o0aM5ceIEtra2QHp+f01jXXzCogqlr/lBTWNdvHwuo6+vj41NzkyN38+lvNesatWqBAYGUr9+fbmj9oWBtLQ0Tpw4gZ+fH82bN8fW1rZQn22ZPo0gCDRt2rTAhAZBQUHs27cPY2NjevfuXSCq4idPnuDt7U2bNm1+CkOcIAi8evWKy5cv8/HjRypWrEjv3r1/yFBNTEyv8ShMau6yZcuK11jWrixIKPs9KSmJd+/eoaenJ6ajAlSsWBF9fX0CAgLEmruMAcZnz54xc+ZMAFKkUkqZV0DtrxXgj+/fkZqSzNReHTL1RyqVEhb8hjIWlajdvA13L56lRoMmeF84Q73W7VFUVCTk9Utio77S16ZCpuOSExP59jVzGnfIm1eUq1wNxQyrbhZWNkR9iiAuJhqpIGBjY5PJYbexsckUgCpXLkMAVl090xjV1dVF8pSAgABOnjyZiQkvJSUl05zJVmAB0YHOKwX5v4bfzsw/DJk45ovIWL5mI46Zm/melCYlODqeoOj4XyKOmV+oqKhkquF48+ZNjvuqq6ggQSKOt5S5BW/8n4jb09LSCA7wx9TC8md1FwAlZRUS4v7mgg97l3e+fe/evVm+fDklS5b8pSlm2UEikWBtbY2pqSmHDx/G3d2dJk2aUL9+fd6+fcuJEycwNjbOd2pEQdGvXz9evnzJ9evXRUfm69ev3LlzhzJlyqCgoEBqaipSqVRk85JIJFnuYQUFBSwtLXn//j2lSpX66ff4kSNHmDJlCqampixevJgOHTqgq6tL8eLFSUpKQk9PL1/GPUCNGjWwtbWlf//+NG3alHr16rFu3TpGjx7NpEmTqFevXraq9fKgcuXKPHv2jLi4ODQ1NenSpQszZ84kPDwcY2PjHNuR/X3ZsmVMnTqVxYsX06BBA0xNTREEgaVLl+Ls7Iyvr2++xiojbRg6dCht2rQRKYClUinfvn3D09MTRUVF0ZH90euZmpqKkpISly5dYv78+YSHh5OcnEx4eDjKysr06dOHadOm5RloOHPmDC1atEBbW5uePXty4MABLl26JDozACW11Uk0kuL3KeaH+pwfVDPSoaS2eq6CuZB+z8gcmVOnTvHs2TPKlClD586d81zpsLS0pE+fPvj5+VGjRo3C7H6OkFGxv3//nm7dulGlSpVCazs1NZXdu3fz7t071NTU6NevX5a0VXkRGBjIwYMHMTU1xcHBoUAirB8+fODEiRNUq1YtkzBpYSEkJIRLly7x9u1bSpcuzcCBAylVqtQPtytbmZF3pSy7Z1n2fMqQXWpddsGMnBzGtLS0TCv03+8nC3xKZcFRJeW/jksPTs7bcww1jczPkV6RdIevQftOrJsyjoHT3Lh/9QKT1qWvlkjT0jApZ87k9duz9EdDO/MKm0o2cyX9q7/StDQEyBIwSEtLyzQH389RTsGe1NRUHB0dxbQzGTK2n939+r9S+C/D7zSzfxCJqWl4h37lbthXviame8n5vb1k+39NTOFu2Fe8Q79mm4Im+2jIo/dSWKhVqxZr167l5cuXnDhxgu3bs74EZNBVVco09rZ9BnDzzHEuHdpL6JtXbF8wk4jQ9z/diDWvWp2zHtsIC36Dz5XzHNu3J89jOnfuzIsXL7h27dq/ht5QJmhZv359rly5wu7du2nUqBFaWlq/rH5mw4YNeHp6cuLECTGqFBcXx65du/D19aVRo0bcuXOHhg0b0q9fPy5fviym82T3olVUVMTExOSn378jR47E1dWVTp06sW7dOtq3b8+tW7dYuXIlrq6udO7cGUA0zvMDd3d3Wrduzfbt2zl//jwWFhYcP36cjh07Mn78eNq1a8eOHTsA+Qx82T5WVlZYWFgwcOBA1q1bh6qqKnZ2dhw5ciTPPsbGxrJv3z42bNjA+PHjqVWrFkZGRhQtWpSxY8cSGBhITExMgZ69+vXr07NnTzp37kzHjh3p3Lkzffv25dSpU4SFheHt7Q38+IdV5jzNnTsXU1NTjhw5wps3b0hISGDv3r3cvn1bnNfczrVjxw5GjBgBpEcuAwMDxVWdjPNobqBJNaOfkyL0PaoV1cHcIN3w0tbWzvU6yMa2YcMGhg0bxr59+/jy5UsWQzS7OZBIJJiZmVGrVi1iYn6+oxYVFcW2bdv4+PEj/fr1K1RHJiwsjGXLlvHu3TtMTU1xcXEpsCPz5MkTPD09qVChAj179iyQI5OQkICnpyeGhobY2dkV6nfs8+fPeHp64u7uTkJCAr169cLJyalQHBlI77ssGJEbZGOSzY+8gczcYGFhQVRUVKaUsmfPnhETE5Ojnk+VKlXE+g8FSTpjaVxMer2ccSlTFBQV+Rb1leJlylK8TFk0tLTZvnAWUV/Sa3Sq1WuINC2Nk9s3o6KmjqVNHQBMyprxOSwUHYMi4rERIe/SGVa/u54mZc144++XKZ39xaMH6BgUQUtPHwnpaccZ3yn379/Pl9hqxjl6+fIl5ubm4s/x48fZsydv2wUKl3zln8RvZ+YfQsi3BC4EfeJDXOHoLMg+TR/ikrgQ9ImQb5lz0T99+kRAQACHDx9mw4YNv8SpWbt2LV++fKFKlSosWbIENze3HPfV+y5NzsLKhiEz53Nw/Qomdm1FQmwsFjWsUVLO/4ckPxg0fR7for4yvkMzjm3dwKy/WLdyg7a2Nm3btqVevXri6sO/AYqKijRv3pz+/fvz9etXtm3bhpWVFZ8+fcpRtLIwMWLECJ48eSJGeVNSUtizZw/Hjh2jXr16uLm5oaysTPPmzalSpQrt2rXDwyOdeSanF6yiouJPffmeOnWK48ePM2XKFJo0acLTp0/x8PCgTJkyvHz5ks2bN/Pu3TtGjx6daz9zQvHixZk8eTLPnz9n2bJlKCoqUqpUKdzc3Ni5cycWFhbMnz9fZPORx+mURSj37NlD8eLF2bFjB48ePcLV1ZWKFSvmSW2tpaVFUFBQplQEGXx8fLCwsMh3fVBGCIJAYmJipvdNQkICNjY2ooH5I9c0KipKnIOIiAj69++PpeXfK7h2dnZMnDiRXbt28fz58xzPFR8fj6+vL5cvX8bT05NBgwaRlJRE3759gayRUXMDTWqb6KGkUPiCmhJASUFCbRM9zPUzR5BzmysFBQVevHjBrFmz2Lp1K76+vrRv355Tp07h6urKn3/+mWsbEomEkiVL/tD1lgdhYWFs3bqVtLQ0Bg4cWKD6lZyQnJzM3r17SU5Opk2bNvTv37/ARfb379/nyJEjVKtWje7duxeoHUEQxBXlHj16FFoKX0xMDCdOnGDDhg2Eh4fTuXNnhg0bRoUKFQr1HSmPxgyApqYmz58/p0SJEqirqzN//nyCgoJYunQpvr6+BTp3xYoVadu2Lf369ePevXv4+PjQv39/GjVqlKPzO3r0aFavXs3hw4cJCnzO+uku4rOrrqVFC/s+bJ49had3b/P+1QvWuI7hw7tgipZMvwcVlZSo26o9hzetoX6bvx3P6raNMSpRktV/jOJtYADP7t/lz5mTUFVXz/KObWTXlZTkZDbNmkTI65f4XD6H59pltO7ZL70GTyLhzZs3TJo0icDAQObPn8+DBw8YNGhQvudoxIgR3L9/n+nTp/Py5Uv27t3L1KlT5U5j1NTUJDg4WNQD+6/id5rZP4CXkbE8+fQt7x0LAAFIlQr4hEWRaCQVI3oZERkZyeHDh7l27RpNmjTB0tKy0PLVZekpsv8/ePAg0/YhQ4YA6VSOGaODakqKTFy6RqwVeunnSyXrOmy6el/cZ6xdE/TkFMM8/DxM/P+fV3wybatSp764XbbsLKupKWdZlaVHzgPpNUntzYsxYviwbPucER8+fGDw4MFy9e1Xw9TUlOHDh3P69GkuX75MiRIlePDgAWXKlKFq1ao/5ZyytIKM9Tn79+/n6tWrqKioUK9ePfbs2YOZmRlz585FIpGgo6MjEkJkzPf9HjkVbheGHo2dnR1XrlxBR0eH0aNH8/TpU5KSkjh37hx9+vShffv2rFq1ij59+jB69Ohc+5kbVFVV2bt3L0eOHGHXrl28efOGOnXqsGrVKqysrJg2bRpjxozJ03gSBEEct7m5OZs2bSI1NZW4uDj09fXl7k/jxo3ZtGkTgiBgaWlJYmIiDx8+ZOLEiXTu3PmHaDv37dvHuXPnaNCgAX369CE2NhY/Pz8WLlwo5rwX1Pjy9vamXbt2dOnShXr16tGmTRtWr16NpaVlpsBC8+bNGTBgQK5pZt++faNTp06cP3+e169fU7t2bfbv3y8y7mX3jiyprY6hugq+H6IJj0vKkiacX8iON9ZSxaqYboE0NuLi4qhYsSIlS5YUabHv37+Pqakphw4dQklJKdd3lUQioWjRoj9NrDYwMJDDhw9TrFgxevbsmWvaXEGgpKSEvb09mpqaGBoaFridmzdvcvnyZWrXrk2bNm0KfI8KgoCZmVmB3xXfIyEhgZs3b+Lj44OysjKtWrXCxsbmp7GiyVZm8sKIESOYNGkSL168YMuWLUydOpU1a9bQtWtXRo0aJbKT5Re7du1i9OjRNG/eHEVFRTp16sTKlStz3N/R0ZFPnz4xevRo4uLj6Th4JMHP/6YxdnKdyc4lc1k6ZghpqSlY2tRl2maPTPe6bbtOXPDcjW27TuLfFBUVmbxhB+7zpjO5R3vUNDSp38aOfpNmZumDupYW07fsYduCmUzs0godAwPa9x9C16GjEQA1JQXq1KnDp0+fqFGjBhUqVODMmTOZ6mTkRZkyZTh58iSurq4sXbqUEiVKsHz5cvr06SPX8X379qVz585Ur16dT58+/WdXaiTC/1ri3L8cP9ORyQ7VjHQw09fg6dOnHDlyJNt9TExMiI6OJjExESUlJZSVlSlatCjFixfHxMQEExMTdHV1f/pN7vshmuDoeATg1K6tnPXYxuhFq9EvWoybp45xdMs61p67ib6cDk1eiPz4gbuXzrJj0Rw8HgSirPJ3KoYEMNXVyFOp9+rVq9y6dYvly5fz/v37TEV4/zbIGG7OnDkj6pIMGzasQB982fHyOsGvX79m4MCBKCkpoaqqirq6Ovfv36du3boYGhqyZMkSLly4wODBg/H19ZUrUiuL9Mv6UJjG1507d+jatStnzpzB1NSUDRs2cOPGDSZMmIC/vz9bt27l4sWLYvF8QdCpUydKlSrFunXrWLhwIR4eHvj7+3P9+nXGjRvHyZMn5SJHgKxF3xkhT+3Ns2fPmDx5Mr6+vpiamhISEsK3b9/o27cvixcvzndqjaw/GzduZOHChdjY2HDjxg1cXFzo3r07nTp1wszMjK1bt/7QauaXL19Yv349d+7c4c6dO2J6VLt27XBwcMDKyornz59z5swZALZv357tXMlqeXR1dYmJiUFHR4fk5GS5xy0IAqHfEnj1NZ7IxBSkaWko5ONelDkxBal9/P76BgYG0rFjRwwNDblz5w7NmjVj2LBhtGvXjt69e1O3bl2mTJmSa5uyFLvCTP2C9JW+c+fOUbFiRbp06SLXKkVKSkqu+2V3f/8IQYggCFy5coWbN2/SqFEjmjRp8q8w8FJSUrh79y63bt0iLS2NevXqUb9+/UJlfcsOBw8eJDExUVyh/C8hMTWNM69/7ipjQfBwz0ZuXr/OtWvX/umu/M/g98rML0TIt4Rf6sgA+H2K4fzpk3x+E5jt9iJFitC0aVPS0tKIjo4mNTWVpKQkPn78iJ+fH7dupVMUamhoYG5uTp06dX7IgMsN5fQ0CIqOB6BtbyciQt6xdMxg4r99w7RiZaZv8UDfqCh/dG1NWPDrHNuZtnmPmOeaG057uHNh3y7sR4zL5MhAumFRTj9vDYxdu3Zx/PhxNm/e/K92ZCA94lq9enVKly7N4cOHCQ0NZceOHYwaNSrfzDzh4eEUKVIEFRUVuT70ZmZmzJw5E2NjYyZPnkydOnU4ePAgZ8+e5datW1SoUAEjIyM6d+6cLfNOdoalrGZFZrgUZhRZR0eHxMREUlJS0NfXZ9q0acycOZOuXbtStWpVmjdvjoGBQYHbj4uL4+XLl/Tq1QtAnMsXL15w/vx5ihcvjrGxsVxttWrVirZt2zJ+/PgshbYg36qHpaUl+/btw8vLi6dPn1KqVCmaNWuGkZERoaGh+c6/lzkMXl5edOjQgfXr17N3716OHTuGg4MDt2/fpl27dpw7d45+/foVmM2sSJEiInMRpN+XV65c4fDhw0ycOJHPnz+L22SpldnNh4KCAk5OTsTExNC1a1c6dOiQr9QniURCSR0NhOgvTBzUh7nrtyBV0RNXmhGEv1IGhb9EYZUKhZUy47y9f/+eIkWKYGFhgbu7O+fOnaN3794MHjxYfE6joqJEvZ3cEBkZyf379wvNmREEgQsXLuDt7U3dunVp1apVnvdldHQ0I0eOREdHhw0bNuS4X3bt/Igjc+bMGe7fv0/Lli2pX79+gdopTEilUh49esS1a9eIi4ujZs2aNG7c+Jd9bxISEn6KHlRhQSqV8vDhQxQUFNDS0hJ/NDU1UVNSRFVR4e/n8F8AVUUFlAopE+Y3/sZvZ+YXITE1jYcf8v6IFDYEQcDEpgHVzE25cuG8WFxtampK06ZN8/xgx8bGEhYWRmhoKH5+fvj5+VG6dGnq1atHhQoVCi09DUBXTRkDNWUiE1NQVFJi4FQ3Bk7NWmczaZ17rjoxBsXkMwL7ukyjr8u0bLcpJMYR+Pg9SkpKYlG6RCJBRUWF8uXLi4ZzbqQG/1bo6+szcOBAzp07x71791i7di2DBg3Kl3FuYmLChw8f5DK4Zc5G8+bNiYmJISgoiKpVq6KgoED79u2pXr06J06coESJEri6upKcnMzJkycJCAhAS0sLFxcX0ZHZtGkT5ubmNG/eHMi/wKS8qFy5Ms7OzgwbNoyRI0cC6cZV6dKlad++PVOmTOHdu3ekpKSgqKiImZlZvgxyTU1NbG1t2blzJw4ODqSmphIQEICGhgZ//PGHmH4lQ26R5oYNG3L48GHGjx//Q/OhqamJlZUV5cuXp3z58ty9e5cWLVqgpKTE0KFDGThwYL4ZjbS0tMSoevXq1Tl58iQvXrygTZs2qKio8OHDB3F8BYGM6lkQBJSUlChevDh9+vQRUywiIyO5e/cu27dvz/UcgiAwYMAAzp8/z44dO3BxccHNzY1Jkyblqz/GxsZoKkp4fuUM48ePJzE1jajEFKKTUrl+6zYfIyKwrV8fE0N9dFQU0VdXKVAqmQyy67148WJ27dpFfHw8AwcOZODAgcybNw9IFyh8+vQpL1++5PXr13LpTaWkpPD27Vs+fvyYb3X77No6evQoz58/p23btnIzecnetefOncPT0zNH/a7CommXSqUcP34cPz8/7OzssLa2/uE2fwSCIPD8+XOuXLnC58+fqVKlCk2bNv2hIEpBkJiY+MvPmR8kJCRw+vTpbLcpKChQv7sjyQpqP5T+WViQACZa+af0/o288duZ+QUQBAHfD9GkSX/94ySRSECiSFqx9GKwMmXKyOXEyKClpUWFChWoUKECjRs35vnz53h7e+Pp6Ym+vj7t27fHzMys0Ppb3kCLu2Ffc93HyOTn67gE3bvF49DgTH/T0NBgwIABPyWP/FdDQUGBdu3aoaqqys2bN9mwYQPt27enRo0achsG8q4cZGxPR0eHjRs30qlTJz5+/IiamhoXL16kdOnSzJ07l6JFi4q50UpKSiQlJbFjxw6ePHnCiRMncHZ2ZtmyZTRr1izXfhZGytmCBQswMDBg7969XLt2jXr16jFz5kx69uzJvXv3GDVqFDExMaioqLBlyxZq166dr/MuW7aMtm3bYmZmhp6eHkOHDsXExAQFBQWRBc7Ozg57e3uUlJRyNNocHBxYsmQJUVFRWZyg/CAxMZEBAwZgZmbGmjVrcHV1xcTEhGbNmrF06VLKli1LmzZt5HLaZP1s2LAhHh4eXL16FVtbW2JjY3n9+jWfP3/m8+fPP1wvkd2KnEzPRlFREQMDA9q2bUvbtm3F7R8+fKBYsWLiGARBIDY2lo4dO9KxY0dCQ0O5ePEi9erVA3JP4csIqVSKsrIyDRs2ZObMmSQlJTF27FiMtdQx1oJjAb7c9vJi+uDctX/kQcY0z+vXrzNr1izWrFlDQEAAx48f5927d/Tr14+GDRvi7+/P3bt3KV68OF5eXnI5pMWLF6do0aIF0lLJCBmb3MePH+nbty9ly5aV67jU1FTU1dXFWov169dTrVo1KlWqlGXfwnBkUlNTOXToEC9fvix0iuiCIDg4mEuXLhEaGoqZmRldu3YtMBvbj0JeAoB/CpqampQqVYqQkJAsAQsFBQUqGOpwLzL5H+pdZsgyPmbLQSz0G/nD75qZX4DQb4l5Gui/AlaGGpQtkn/F4uwQGhrK5cuXCQoKokGDBjRt2rRQouSCIOAd+pUPcUn/SCRFQnrx7ZdHd3hw/2/yAQUFBYYOHYqRkdFPWw34JyAIAocPH+bZs2di8XfHjh1/Wh62zDAMDg5m+/bteHp6oqqqyqpVq2jcuDE1a9akSJEiLF++nGrVqpGcnIyzszP16tVjxIgRTJ8+HVdX1xw/rgXVackJqamp4urEvn37xBS4CRMmcP78eTw8PDh58iTu7u68fZu3JtH3ePv2Lc+fPycqKgozMzNsbGzYvXs3gwcPpkGDBiQkJFCnTh1WrlyZq6NkY2ODk5MTo0aNKrAjt3btWtzd3dm8eTMVK1akTp06DBgwgEmTJtG7d28MDQ1Zs2aNXO3L5v7GjRsMGDCADx8+0KpVK3x9fdHR0UEQBFRVVdm0aRM1a9b8qSKoaWlpoqMRGRlJx44dOXXqlOj4paamsmvXLvbv30+TJk1o167dD+usLFu2jBMnTpCQkECTJk34/PkzJ06cYNu2bXTq1KnA1+j7NMIPHz6wZcsW0tLSRAPp9OnTLFmyhCJFijBy5EhxFTO/qXxJSUkoKSnl2E9/f3+KFCmSY1BDEASSkpLYvXs3Dg4O+RaZBXj16hXbt2/nxIkTWFtb4+7unm1/fuT+SU5OZv/+/bx//x57e/tCK9QvCD58+MDly5d59eoVJiYmNG/evEBF4YWJRYsW0ahRo39Fyl12iIiI4MKFC7x+nTn1XFVVlcGDB2NoaMi1t5+JTPxnRSIlgL6aMk3KFJyU4jdyxv+OVfYvxsvI2Lx3+smQAG9jC+9hLlGiBH379qV58+bcunWLHTt2yJWLnRckEglWxrooKvwzBZeKChKsiunStk0bTExMxA+ktbU1RYsW/Z9yZCB9vjt27EiRIkVEUUgVFZWfJqglq3MxNTVl6tSptGnThkaNGtG0aVMWLFiAoqIiq1atonr16n/VFijy6NEjhg8fjrOzMy4uLrlGCSUSiUgMIJFIflhPR0lJiaVLl3Lq1ClSUlKYOXMm3759w8TEhM+fP2NlZcXYsWNRVlbm4sWL+W6/TJkytG7dmjp16nD48GE+fPjAu3fvMDc35/LlyyxcuJAtW7YQHR2dq/Hbo0cPdu3aBRQ8Uv3t2zdKlChB7dq1CQ8PR0tLC21tbZKTk/n69auYLibvKgXArVu3MDY2ZuTIkZQpUwZ7e3vatm1L3759OXz48E93ZCCdhUg2dxcvXiQkJCSTYa2kpIS5uTlVqlTh+vXrdOrUKdcajYyQUUK/ffuWo0eP4uTkxJYtW7C2thZ1g27duoVEImHLli106tRJ7FNB0Lt3b27fvg2kG/CrV69m8eLF+Pv/zdbUvn171q1bh1QqZd68eaxZs4bExMR8z7GKikqOjsPz589p0KABu3btIioqKtvjZWm5gwcPLpAjs27dOqytrfn48SMpKSlcvXqVuXPn5niugiAhIYHdu3cTGhpKnz59CtWRuXv3LgcOHCAxMTHPfb9+/cqRI0fYtGkTkZGRdO/encGDB//jjoxUKiUpKemnrcwkpqbxITaRwC+xPP0Ug19EDE8/xRD4JZYPsYnZauZBuqP94MEDtm7dysaNGwkLC8siONm3b1+R3Ka8wT9fzyr8S/rxv4r/6TSzgwcP0rhxY4oWLYogCGzcuFEURPtRPHr0iPj4eOrXr8+1a9do2rRptgZgdGLKPx4RgPQHKTIxheikFHRV889z/+3bN44ePUq/fv2AdLrf2bNn4+TkRJkyZTh8+DCbNm2if//+mXKsk5KSsLa2Zt26dTRp0iRLu9HR0VhaWjJ//nycnJyAdJrmmsa6+IRFFWCkPwZT5VRUFdNrZOzt7dm4cSOpqak0bNjwl/flV0FFRYUePXoQGxtLmTJlfjpzj4KCghiZX7FiBXFxcUD6M1WzZs1MdNExMTG8efOGoUOHMn36dLS1teVqX6amnButrgx5GdM2NjZIJBLOnj3L7t276du3L7a2tmzfvh0PDw+qV6+OmpraDxFjrFu3TnReLCws+PLlC+Hh4VhaWmJmZsbLly+xsbHJ8fihQ4cyf/58IiMjMTAwKBDDk62tLRs2bODOnTt8+PCBZ8+eUb16dS5fvkxwcDCLFy8G5DMcZUbw5MmTmTx5crb7xMXFkZiY+MOpTPJAdg+cP3+eFi1aZBlD9erVsba2FrU7ZGlpebHEycbZq1cvBEGgTp06DBs2jPnz5zNmzBjat2/PnDlzMrVTUOft5cuXWFtbixFyiURC3759iYiIYPv27WzdulWkXK5atSrbt29n6NChclPrfo/ctGgqVqzIxIkTcXd3x9jYmO7du2dbJF7Q4E9KSgrHjh1j9uzZjB8/nq9fv7JhwwZOnz5N1apV6datW7bH5WduY2Nj8fDwICYmhv79+xc6sc2uXbu4evUqFhYWVK9ePdt9pFIpFy5c4N69e2hoaNC+fXusrKz+NanMMkesMJ/R6MQU3kTFExabKBbmZ3fFvifIKKunTkzEB3x9ffH39yc1NRUzMzPs7e2xsLDg7NmzPHjwAIlEQo8ePTIxQZpoqVJcU/Ufz/gw0fq5zHP/n/E/68y8ffsWBwcHgoKCALh+/TojR44sNGemS5cuzJo1i/r161O/fn3Cw8Oz3e9NVPwPaw8UFiTAm6/xedINZ4cVK1Zw9epV0ZnJiFKlSjFs2DB27tzJ3r17GTRokMgG1bt370xRw+/h6upKWFhYlr+X1FYn0UiK36efr0QtQ7jvHZ4EPuGsmhrm5uaUK1eOFi1aEBoaKpcR/V+GoaEhRYoU+WUUpLIVFAUFBbS1tUlLS0NZWTnTB0gQBNq0aUPdunWZMWNGvgqRFRUVSU1NRVFRMVeDKj/1H58/f8bS0pLy5ctjYGCAkpISL168oEuXLixatChL7Vh+DKsXL17QtWtXID0HXEdHh1evXolF2HnVuOnq6mJhYcGff/7J1KlTxfMmJyfj5eVFVFQUXbp0yVWLon79+tjZ2YnsV02aNMHGxoakpCT27duXL3Vq2dgvXLjA4cOH0dXVJSUlBalUSnJyMoIgEB8fj5OTE82aNfvpqzOya3zz5k1mzZqVadunT58wMzNDU1OTjRs3MmzYsCzHZQdZn+fOnUtSUhJ3795FSUmJ7du3U7duXVatWkVQUBAbN27M1E5Bx1m+fHn++OMPAFauXMnjx4/ZuHEja9asoVixYsyZM4dXr16xaNEiIJ3o4+DBgwU6V26QPTPTpk3jw4cPLFmyBD09Pdq1a1cgrZPvU+6kUimhoaE8fPiQGTNmAOlj6devHzExMaxduxZra+tstY/knduoqCh2795NcnIyTk5OhSp2LBvPwoULqV27NqdPn8bMzCxb9jFZYKdJkybUqVMn3xToPxsJCeni2z+6MiMIAmGxSbyIjOVrYkoWmyg3+ygpTUpQVBxB0fHEff5CQnwKtg0aYFWjBjo6OuJ+NjY2PHnyhPbt22Nubp6pDVnGx4WgT6T+A7XLsoyPfwPF9/8q/rdyZjLg+1WSwk6bydieiopKjnnDYbGJ/wpHBtJfGGGxeS95Z3tsHvOnrq4uMgjt2bMHX19f6tatmyWPNSNkomQ5zZ25gSbVjHSy3VZYkI3LKC2OYkrpUaLExET8/f05ceIEZ8+epXHjxrmOX/bC/6/jV79oMxp4ioqKWFtbs3LlSg4fPsyOHTuoV68eKioqrF+/Xm69lYyQx7CSGRPyvB+6d+/OlStXRGYsPT09Xr9+jaamJo0aNeLt27dcunRJvOczprzlBVtbWzw9PQEoV64cr169QlNTk44dO+Lv7y+XsbVnzx6x1ikpKYnevXtTunRpOnTogK+vb57zoayszJ9//smcOXOYPHkye/fuRUlJidjYWIoUKSLXOGSQzWdERASPHz8mMDCQ169fExwczPPnzzl48CA3b94U07QK8n4WRLrjvKGgoEBCQgLh4eFiYT+kG54nT57Ezc2NHj16sHnzZrnTZWUpky9fvhTrqnr16kXDhg1p2rQpDRo04NSpU4SEhPxwpD3j/CQmJiKVSnn9+jX9+/cnIiKCBQsWMGPGDI4ePUrPnj3lficJgkBERITc8y9zZGTXbe3atVSoUIGFCxdy8+bNfI8royMTGBhIbGwsCgoKmJqaUqlSJTw8PMR9S5UqRZMmTQgICGD+/Pn5PpcMnz9/FvWGBg4cWKiODPy9Kqmjo0O3bt04ffo0fn5+2e4rC9g0bNjwX+fIQOE4M4mpaXiHfuVu2Fe+/pWlku+n/a9vk6ZhMQxr2qJSrgoqGpnJQ4yNjXF1dc0x6CLL+PgnUNO4YAK4vyE//vPOzK1bt2jQoAEaGhpoamrSrl07wsPDRdaUsmXLsmPHDpo2bQqkGxgyoaJNmzZRtmxZtLS0aNKkCU+ePBHblQnl1a1bFzU1NWrUqCGq2Tdp0oS3b98yYMAAnJycuHbtWiZDMCQkBAcHBwwMDOhVqxLu86aTkpwEwJUjnszs2439a5biVLcyfWtVZPvC2XJ/TJISE9gw3YW+NhYMaVSTS4f2Yl+5FBEh74kIeU+3iiYc3LCSfrUrscVtKgD3r15kYtdW9KpejuFtGrL/4CEgPbqXMXVlz549SCQScTUrNjYWFRUVtm7dypw5c/Dy8so0Tn9/f+rXr4+amhpWVla8fv2aPn36EB0dLRZ037lzJ/txJCUxZMgQ1q9fn2uxubmBJrVN9FBSkGS7FP0jkABKEkh69YQrB/fw/v17cZvselSsWBF9ff0cDf3Xr1+jp6fHs2fPCrl3/17Ia6DnFxMnTmTq1Kn4+PgwcOBAUlJS2LhxY5YoW24ICQnJtNInj4Mmo93OC2ZmZqxdu5aVK1dSo0YNnj59ysyZM7l79y5du3bFxcWFvn374ujoyPjx4+U+P6SvUOro6GBlZUWLFi1o27YtpUqVIj4+npiYGK5fv87Xr1/F+zK7a2Bubo6Li4uYwqeurs7MmTMJDQ1lwYIFcvUD0p02fX19OnXqhKGhoVgfN3PmTEJCQoC8nQ+Zo+ro6Ii3tzfHjx/nxIkTHD9+nKtXr+Ll5UXdunVFkcv8QrYqoqSkhJeXl/jsyor9v98XwMvLi6JFi1KmTBlxm6KiIurq6owePZoxY8bw6NGjfCmVKygo0LBhQ4KDg3n16hVnz54VC/ErV65MkSJFePz4cYHGmBEZ68DU1NQYP348rq6uxMXFMXDgQG7cuMHQoUNZuXIlAQEBNG3alOTk3BmcBEEgOjqa2Fj5ajplqZuQ7qTKCC8OHDiApqYmCxcuFL+R8kJRUZHIyEhatGhB9+7dadCgAd26dSM8PJz+/fvj6+srOvmQ7tBoaGjg7e3NqVOn8nUuSC+w3759O6qqqgwYMAB9ff18tyEP9u3bR7169QgPD8fHx4dTp05le6/L++75p/CjzkzItwQuBH3iQ1xSIfUofa4+xCVxIegTId8yO+15rbKX1Fb/6QHS71HNSIeS2v9eNrj/Ffyn08yio6Np3749EyZMYPfu3YSFhTFgwAAWLlyIj48PtWvXxsfHB0tLSzFKEh4ejoGBASdPnmT27Nls2bIFCwsLdu3aRdOmTXn58qX4gps1axZbtmzB0tKSIUOGMGbMGG7dusWRI0eoXr06EydOxMnJCV9fX7FPycnJNGvWjPLly3P47AWuPw9i44w/QCJh0LT04sXAR/fRMzJi/t7jvHr6mHWTx1KzUVOq2zbOc8zb5s8g0Pc+M7buJS0tlQ3TXJCmZS6Se/7wHksOnUUqlfLE+yZLxwym78Tp1GzUjPvXLtG3dy/KlytL69at+eOPP4iOjkZXV1d0Vm7dukXZsmXx8vKidOnS9OnTh+fPn3P79m2OHDkinmfr1q3s2LGDSpUq4ezszPDhw/H29qZnz57s3LmTNm3a5Ci2tWDBAqysrGjVqlWeYy6prY6hugq+H6IJj0v64bQ92fHGWqpYFdNFzcKEMKsq3Lp1K4tT0qhRo1xTYFatWkX58uWzpQz9X0BERAS3b9/m8ePH2NjY0L59+59CgiCL0Lq6uuLl5cXRo0dZsWJFpvqZvPD582esra1p0KABhw8fLvQ+AgwePJjWrVsTGBhIvXr1uHTpEpMnTyYqKoqaNWsSHh7O3bt3adWqFS1btqRdu3Zyt+3p6cnNmzfF2qWrV69y5swZLl68iJqaGmXKlKFRo0Zy03q6u7sDEB8fj6urK+PGjZOL3vXYsWNMmjQJOzs7TE1NefnyJUuWLGHSpEkEBQWxe/dupFLpD602VKlSBUVFRS5evEi3bt3yzbR19OhRtm7dSr169cT3+MCBA7P0SRaQUVFR4ezZs9jY2GTZp127digqKvLw4UOkUmm+nGdIT8+bO3cuFSpUoEuXLtjY2PDt2zcePnzIu3fvRDaxgkLGYPbhwwcWLlyIoqIitra2dOvWDWNjY1avXo2LiwtjxozB0dERIyMjkpKS8oz0SyQS9PT00NXNO/0lY33QgAEDePz4McHBwbRp04bBgwdz9OhRGjduzLJly5g1axYVK1bMtS2Z3llkZCRdu3YVx6Gvr0+5cuVQV1dn5MiRNGjQgHHjxpGYmCiu1FStWpWlS5diYWGRr3l8//49e/bsoUiRIvTp06dQhCCz+zbcu3ePuXPnMmjQIMqWLUt0dDQ7duygVatW2daN/pshq5kpiDPzMjL2p4mEC0CqVMAnLIpEIynmBvJTvMv2/RUp7NWK6mCu/2P0878hH/7TzkxCQgIzZsxgwoQJSCQSypYtS7du3fDx8REpVI2MjNDU1BRFn2QpTUuWLGHq1KnY2dkBMHfuXM6cOYOHhwejR48GwMnJic6dOwPg4uJC9+7dATAwMEBRURFdXd0sLC3nzp0jNDSUu3fvEiFVpppeCYbMXMBC5/70HpdeCCtNS2O421I0tLQpUc6ckzs28erJ4zydmYS4OK4dO8T0LR5UqJEu6DVw2jzmDemdaT+7/kMwLm0KgMfy+dRt1R67/kMA6FTWjE+BT1m2bBn79u2jePHi3LhxAzs7O65fv07btm25desWjo6OXLp0iTZt2qCuro6WllaWdDpnZ2eRnWfMmDH07NkTSF/VqlmzJteuXcvWGH327Bl//vlnjkvv2UFNSZG6JfQJi03iZWQskdnk3eYF2f76asqUN9DCREtV/BCZmJhgb2/P7du3RVaqcuXK5aql8vHjR9zd3dm9e7f4cU5LSytQ3vi/DYIgkJCQwJIlS3B3d8fCwoI9e/awdetWjh49CsDx48fR09OjceO8nfC8kNHAbNy4Mbdv30ZPT0/uqGV8fDydO3embNmybNmy5Yf7kxtKlSpFqVKlgHSHoW3btjRv3lxk6OrWrRs9e/bkyZMntGvXTm4a3lKlStGrVy8gvXh43rx5IonB69evOXjwIE5OTnTp0oXq1avn6ABknLOUlBTs7e3x9/enX79+GBkZ5Xp/fvnyhdWrV9OkSROWLVuGl5cXvXr1onbt2qxbtw5bW1tAfjautLQ04uPjxWcjJSUFVVVVfHx8ePjwoTje/EanW7RowfXr17l27RqCIDBjxgy2bNmCjY0NTZs2xdbWlmLFitGzZ0/+/PNPSpYsyevXr8X3ecb+ffz4kZ49e/Lu3TsmTpwI5F7vJNsWHR2NmpoalStXxsfHh5kzZ7J161ZatGhBfHw8nz9/ZsqUKWJNWEGcP6lUKl6vhg0bYmBggEQiwcfHh+fPnzNu3DgWLFjA6tWrWbVqFU+ePBGJGuSFvKuXAEOGDOHBgwesWLGCb9++sW/fPmbOnMmMGTM4cuQIzZs3Z/PmzYwdOzbTClh2baWkpJCQkMDXr1/Zu3cvJUqUYPny5QDY2dlRtWpVSpcujaamJrNmzUJTUxOJRMLx48fzrW32+vVrPD09MTExoVevXj9MPS8Ta83uml65coXU1FRcXFwA6Nq1K40bN+bEiRNYWloWelrbz0RCQoKo+ZUf/ExH5nvInJL8OjRqygo8/Ev/rzBLASSk18jUNNb9vSLzC/GftrqMjY3p378/K1eu5NGjRzx79ozHjx+LH9zcEBAQwKRJk5gyZYr4t8TERF68eCH+Xr58efH/Ojo6pOSiOp+x3QoVKqCvr0/oXw+ZhZUNaampfHiXnr6lW8QIDa2/C8o1NLVJS8277dA3r0hNSca8Sg3xbxZWWVWKjUr8LSoZ8volrXpmLtqvVqs2Zw/sBaBVq1Zcu3aNWrVq8eHDBxYtWiQWXV66dImFCxfm2J+MHxRdXd1MFJTNmjXD39+fq1evZjpGEASGDBmCm5tbvpWlJRIJJbTVKKGtVmBGlHJ6Guiq5czmVrt2bW7cuEFiYiItWrTINWK8detW1NXVUVdX5+rVqzRt2vR/wpGB9LlWVVVlyZIlzJo1C21tbV6/fk2XLl04duwYX79+ZdeuXSgoKHDixIkfFj+EzAakoaGhmJefF1JSUhg6dChv377l9u3bGBgYkJKSIlIJ/yw8efKEa9euMX78eJo2bcrChQsZMWIE1tbW3L17VyzaV1RUJCkpSW4D6sWLF4wdO5Y5c+YwZMgQypcvz6FDh7C3t+fkyZPs27dPpK7OC9euXePFixccOHCAypUr5zmnenp6+Pr64u7ujoKCAhUrViQ+Pp7ExESSkpIwMjIiPDw8zxUemfG+Y8cOnJ2dKVmyJCkpKUgkEtGBaN26tejM5He1T0dHh6VLl3LlyhXi4+OZMGEC9+7dw8/Pj4sXL/Lt2zdSU1OJj4+nZMn09+Hhw4ezpMcpKioSGBhIlSpVGD16tJiOnNe4AgICGDt2LE+ePMHOzo7evXszY8YMBg4cyP79+zE0NMTW1lZsr6CrmbLj+vbti4mJCV5eXsTFxYnBhXfv3jFjxgxmzZqFhobGD1ORf4+M77+EhAQCAgJYsmQJLVq0AKBatWqsWbOGhQsXcvjwYTZu3Ei3bt3Q19fH1dU1x9WhtLQ0Dh48SKlSpVBXVyctLY0mTZoQFhbGuXPnqFSpEr1792bnzp3Mnz8fFxcXoqKiCkRVHBAQwOHDhylXrhz29vYFei/Ex8dnWsmRibW+ffuWEydOYGpqSr169TA0NERBQYFKlSplErF1cXFh0qRJtGzZMpOA678dMsHM/AQbQr4l/DJHRga/TzGoKSvky3n46Rkfv2tkfin+05ZXaGgoNjY2WFtb07JlS4YMGcLp06fx9vbO89jU1FRWrVqVJQUgIztGQQryMlIYykgzZGlg0r+MbqVsXqby1Mwo/vVwZIwjZHecisrffVDJxoBKTU0TjZpWrVqxdOlS6tatS7169WjUqBEBAQE8f/6cly9f5vpxzy3SqKmpSePGjbNob7x7905MW5JFruLj4xk+fDienp6cPXs2xzYzQldNGStjXazQJTE1jajEFKKTUkmRSpEKoCABZQUFdFWV0FNTlvvFoqSkRKtWrUhLS8vVYJNRhSYmJnL69Gn27duHtbU1O3fuzETxWRhK9P8UZP2WMbmVKlUKY2NjLl68iJ+fH5aWlsyYMaNQHBn4O2K7atUq2rRpQ8WKFeVKPxo/fjx79+6lbdu2LF68mEmTJlG6dOl8py7lF0lJSRQvXlw0sIYNG8atW7eoWrUq9evXF1mx7t27x6JFi5g7dy4VK1bMs09+fn6ULVuW3r17o66ujrOzMzNnzqR79+68evWKunXr5tk32dhfv36Nvr4+tWvXBvJeUVFUVKR48eLs27ePadOmUbx4cYyMjNi5cyfnz5+nc+fOcgUhZOdp0qQJ27dvR0dHRzQAJRIJpUuXplKlSuI1L0jdgLKysqjRo6enh729PQBBQUE8fvyY6OhocWU4LS0tR2eyQ4cOtG7dOtP7Pqf+yMbl5OSEsbExY8aM4eTJkwwfPpyOHTvSt29fVq1aleW4H6mLSExMJDo6Wlw12rx5M5UrV6Zjx46sW7eOsWPH0q9fP9zc3Ap8ju8hCywoKCjg5+eHv78/9erVIywsjM+fP4v7mZmZ0bdvX06dOsXt27fp0KEDa9asoUaNGrl+P2WF70WKFOHDhw+Ympri5OSEp6cnxYoVIzg4mJs3b3L79m3at2+PgYGBmF2RHzx69EhcEenSpUuB3sXR0dFcu3YNW1tbDA0NSU1NRUFBATc3NxYvXkzLli3x8/OjRo0aTJo0iapVq7Jr1y58fX3F72fHjh0ZM2YMBw4coFq1agUiNPknkF9a78TUNB5++HG9uYLg4YdoDNVV8uVE/OyMj9/4dfhPEwAcPXoUAwMDTp06xdixY2nYsCFv3rzJNkXg+98tLCwICQnB3Nxc/Jk/f75cjlB27WVs98WLF0RGRiLTfQx89ABFJSWMS2e/7C4vjEuXRUlZhddP/07PeuOfe6qWSVkzXjzKXJTp98BHzDdu0aIFfn5+nDlzRkxjqFixInPmzKFBgwaioVqQh7N27dpZ0vBKlCjBy5cvefTokfhjYmKCm5sbW7duzfc5IP2FZKylhkURLaoY6VCtqA5VjHSwKKKFsZZaviMkVlZWuWp6AGzYsAFBEPDy8mL9+vXcu3ePJ0+e8OjRI+BvMT3Zx1PeVYZfgZMnT/Lu3bt8H6ekpIS1tTXXr1+nY8eObNq0iZIlSxZ6NFimOn/79u082camTZuGu7s7y5cvZ8iQIUilUurVq8fbt2/ldmQKSmhgY2NDsWLFGDVqlJjyNG/ePDp27EiHDh0wNDRk7969jB07FlVVVaKiouTqk7a2NqGhoWJgZfTo0aSkpNCxY0ekUimNGjXKsw3Z8yqr7/H29iYlJUWuoImrqyv79++ncePG3Lt3j+7du+Ps7ExSUhKDBw/Ol4NoZmZGnz59sLOzo127drRq1YrmzZtTqVIlzp49y759+0Sa5oIgLi6OCxcu0K9fP1q0aMG0adP4/PkznTp1on///tSsWRPI24lTUVERC+bzuh++fftGxYoVWbJkCVOmTOH27dv88ccfnDt3jr59+zJ16tRCJQRRVFTk48ePeHt78/LlS7y9vRkyZAgjR46katWqeHl5MWfOnAKTKWQH2f0TGBhIt27dxHvX2NiYe/fuZRLKtLGxQUlJSaTgHzBgAFZWVjnOY0pKCh8/fhQZ8tauXYuSkhL29vaio+zn50fJkiWxts6aeSAvfHx8OH78OFZWVnTt2rXAQaUbN27wxx9/EBERAaRfj69fv3L16lX27dvHiRMnxDnp1asXbdq0QU1NjQMHDoiEGe/evRPrtu7evVvgMf1qJCYmyl0vIwgCvn+lbf0TSJMK+H6Mzjczoizjo0kZQ5qXMcRUVwNVxQxU6tn8yKCqqICprgbNyxjSpIwhJbTVfjsy/xD+0yszRYoU4d27d1y+fJmyZcty8OBBDh8+TK1atUQj/PHjxxgaGoq/P3jwgMqVKzNhwgQGDx5MhQoVqF+/Pps3b+bAgQNMnTpVrnNramry/PlzIiMjM/29ZcuWlCtXjr59+zJs8kyevHmP+7zpNGzfBU2dH6MFVNfUpFnXHmxbMBPnuUtBEHCfn54ShkQC2TzEdv2HMr1PZ07t2krNRs14eO0Sl0+f5MKFC0D6HNaoUYM9e/aIqygNGzZk06ZNLFmyJNN4w8LCCA4OzpbfPzsoKiqKNIkyY16mtp0RSkpKFC1a9D8TrYqPj2fNmjW4urqKTk9MTAwlSpQgICAAPT09du3axevXr2nTpg0uLi7/mtWZlJQU5s+fj5+fH1u3bqV37955H/QXFBQUWLBgAX/88UemqKuSklKuNQaydB9tbW25XvS6urocP36clStXEhERIdY5fL/SIlM/P3TokLiPra0tx48fx9fXN8ec/YwQBEGk2C3IKs7Jkyfp27cvvXv3xsjIiPnz57Nnzx7i4+OZPHmymK5Vt25dUewwL02V1q1bU6JECfr06UP9+vXp0KEDU6dOxdnZme3bt1OlSpU8+yWr4SpbtiwODg706dOHunXr4u7unmek1cnJiRIlSnDp0iUSEhLo378/VlZWdOzYMd9F0wkJCZw7d06k7U1NTSUtLQ0VFRUuXrxIVFQUN27coGLFiowcOTLfz8mYMWM4duwY9vb2omG/b98+Bg8eLPe7XAZZimhe90FQUBDv37/n+PHjTJo0CUgnhhg8eDBLlixh4cKFdOjQIV/nzghZwX9qairJycloaGhw5MgRvnz5wqdPn/j48SO1atUC0lOhjY2NmT59eqasgsLAtWvXGDx4MNbW1gwcOBBVVVUmTZpEz549KVu2LI6OjhgaGvL69WtUVVVFx1GG7OZR9ry5urqKtMuyd6SDgwO2traYmpqKQYDcahZzgiAI3Lhxg6tXr9K5c2eqVav2QwamnZ0ds2fPZsCAAaSlpbFr1y7evHlDeHg4nTt35sqVK0yePJnPnz+L99zcuXNZsGABbdq0YeLEiZw8eZLmzZtTp04dsU73vwBZmpk8CItNIrzQWMvyDwEIj00iLDaJEtoFE/n8WRkfv/Hz8Z9emXFwcMDR0ZHu3btjY2PDlStXWL58OQEBAWhra+Po6IiDgwNbt26latWqtGzZkvr163PmzBl69OjB/PnzmTFjBlWqVOHy5cucPHkyU51MbhgxYgTr1q0TFZdlUFRU5MSJEwD0aN2UFS7O1GrWmmFu+SvKzAn9Js3E1KIScwY4sHTMEBq27wKQYx5wheo1GbN4Def37WR8h2ZcPuLJpp0eNGvWTNyndevWAGIqSsOGDcU0ABm6dOmCVCrF0tJSjFDJA5nhJYtQ/S/A3d0dqVSa6do/fPgQdXV1MQ3r7du3dO7cmU2bNlG5cuUslKWyAtJfDWVlZW7cuMHUqVPp378/Tk5OfPnyRe7jJRIJurq6pKamMnbsWHbu3AnkniapoKAgphnl5zzjx4/HzMyM/fv3i+3InOK9e/cyadIkNm7cmKmo++zZs6ipqWVrdGc33zKjX+bQ5Be6urp4enpy5coVzp07R7t27bh58yZdunTh4cOH9O7dmxEjRvD8+XORLEOeedi1axcGBga4u7szd+5cBgwYwIcPH7C0tOTUqVPs27cvWyrx7LB27VqWLVuGpqamWIyfF1q2bMnixYuxtbXF0tKSnj17oqGhIfccyfY7efIkPXr04MGDB6LOTGhoKGFhYSQnJ5OSkkJiYiLBwcF8/PgxX23funWLM2fOcP36df78808WLVrEkSNHGDt2LIsWLeLy5ctytQd/G9k5zY3svtu1axcODg48efKEBQsWsHbt2kwUyJMmTSIkJCSTlk1+ICMQ+fr1KwMGDKBXr17Mnz+fEiVKUK1aNZ49e8abN2/EOdu9eze2traFUlSecfVYEAS0tLTQ1NTk3r174j3buXNnli5dytq1a+nQoQNOTk60aNECMzOzPJkppVIpEomEBw8eEBAQIIqXqqiosHDhQjZt2kTNmjVJSkpi7969zJ07N99jEARBfP+6uLhQvXp1uZ63pKQkUZIg4zykpKQQERHBly9fuHfvHnZ2dlhaWlKkSBGUlZWxsbHBwcGBJk2a4OPjg62tLa6urrRp04YdO3ZQv359Dhw4QEpKCm5ubjg5Of0r9WRygrzOzKdPn7j3JgThH/imZYSEdPKBwkBhZ3z8xs+FRChsNcnfEJGYmsaZ1/Ib/vLg7qWzVKvXCPW/VppePXnEtN6d2PPwVba1ONmhnVlR1JQURZ2BL1++EBkZSbly5fItjicPNm3ahIGBgZjT/l9GSkoKFSpUYNCgQUyfPh2AN2/eMHv2bJKTk9m/fz+fPn0SdY8gPfVwwIABTJ48OUt7Mu2GX7U0nbGGZ/fu3fTv3x9LS0uWLl2ar8JUqVRKTEwMFhYWnD59GhsbmxxXHGSvmJzGePnyZYKCgnBwcMgSXZZKpaSkpHDx4kUxovnixQsqVqyIm5ubeA0gnUlw06ZNqKio4O7ujqampphuJivGz6mGqbAU6Ldv387q1aupVasWffv2FVPCAgICaNSoEWfOnBGj6vIgKCiIMmXK8ODBA5YuXcr79+9JSUnh1atXlC9fnjlz5uSL/vnz588UKVJErrH+yJzIVrq2bNnC0aNHOXPmTJZ9/vzzT+7duydSSOe37SVLlnD+/PlsnRZnZ2cEQeDPP/+Uaxzy1rZVrlyZHj160KVLF86fP8+8efMoWrQo8+fPL9T3m62tLampqVSqVEl8vs6ePcu3b99EdjpBEGjdunW+5y8jPn/+jKGhYaY5CgkJQU9PDy0tLW7cuEGHDh3o168fa9asEY+7fPky9+7d48OHD5QtW5axY8cCOc9jWloaiYmJ3L59m5YtW7JgwQKOHj3KtGnTsjDMFXSVVCqVcvPmTUqVKiXqzMmLBg0aYGZmxrJly0Qm1OfPn2Nqaoqamhp37txh0qRJVKxYkaVLl/Lp0yecnZ35/Pkz58+fF9Pjpk+fzpUrVzh+/LjYTkaHIK93YW549OgR8fHx4grvr8CGDRsoV65cpsCmDElJSfj7++Pr68vnb/GUb9v9l/UrLzQ3NURX9ecSwHz+/Jlu3bpx9+5devTowbp16zh69Cj9+vXL++DfKHT8p9PM/u1QU1JEVVFBZNsqDBxcv4IH1y7RZcgoEuJi2bVkLrWatZbbkSE1hd3bt4lFpRmjUI0bN/4pPPhVqlTh6tWrYvrEfxmXLl3i7du3YnE3wPXr1/nw4QONGzfGzc2N4OBg9PT0qFChgpg/Lfs4P3z4kAsXLhAZGcm4ceMykQX8Csg+ooMHDyYiIoJ27dqhrKyMnZ0dw4cPZ+nSpXKlEikoKKCnp8fs2bNxd3fHxsYmxw90Tn9PSUlh//79zJgxg7S0NMaNG8f9+/czaVQoKCigoqKCnZ0dQUFBlC1blgoVKnDp0qVMq4s3b95k27ZtxMXFsXTpUrS0tFi+fLmo/9G4cWOWLl2KoqJitsZSxj4W1Ih3c3Nj5cqVqKioMGLECKysrMRtiYmJ6OjoYGhomK82y5Yty7dv35gzZw6qqqoMHTqUFi1aYGBgwMKFC5kxYwbt2rVDEAS2bdtGs2bNcjTkAgMDRaptefAjzp1sfgcMGEDfvn2JjY0lMDCQ8PBw9PX1MTExYfjw4QwfPpyUlBSUlJQynS+3d4Ws7erVq3Pw4EHu3buXxUH89OmTmKKUE4Vuxuucm/Esu198fHxo0KABnTt3pmrVqlStWpV+/fqxYMECBg4cyNSpUzl27BiVK1fOx0xl7UtkZCTFihVj06ZNaGlp4e/vT//+/bGwsODmzZts2bKFe/fukZaWVmAHShAErl27RqdOnbhw4QJ169YlKSmJVq1aERYWRvHixRk7dizdunVjy5Yt9OrVi/Lly4uyBc2bN89CnpOXQ7ho0SLu37+PoaEhQ4cOJSgoiHXr1lGlShXMzc3FeS6II5OWlkZ4eLioC5af4xQVFRk2bBgLFizgyZMnFC1alIEDB/Ly5UuqVq3KwIEDcXJywtXVlREjRmBnZ0enTp1o1aoVBw4c4NatW2LmQmBgIDY2NqIjA+kaLbK6vx8hJOnSpQuzZs36pc7M9yszgiAQEhLCw4cP8ff3JyUlBXNzc2rVb040P8YGVliQAG++xmNl/GNp/XnBw8NDrP8tUqQIK1as4OrVq7+dmX8I/23L8j8AEy01gqPj5XrIF48aiN/t6zluHzZnCWOXrsd93nQmdmmFkrIKtZu3wmnKHLn6IgFiQoMzKaRnRH65++VFqVKlSEtL48uXL/mmY/63oW3btgQHB4sfq+DgYLy9vREEQfy3atWqqKmpcffuXcaOHUuFChWoV68er169wsHBgSpVqpCQkEDlypVZunRpllTFnwkFBQWePHnCsWPH8PLyolKlSigoKODt7U3v3r25ceMG27Zty5MAQQYVFZUCfaBjYmJEDahp06YxcuRIvL29s01pkBl5GWu1Mjoy9+/fZ/v27YSHh7NhwwbMzc1JTU2lWbNm2NjYoKysTLdu3fj69Stbt27Ntb8yo7Ig0eGxY8eSmppKUFBQJkcmIiICFxcXihYtKq4Q5QczZ87k8ePHXLp0KZNQYMuWLXn16hWbNm3i7NmzPH/+nMTEREaOHJltOzJtp1/JsKekpMTdu3cZOXIkfn5+KCoqkpaWhqmpKePHj8fZ2TnbFFl56pgaN26MlpYW/fv3x9HRkSpVqlC0aFEuXLjAo0ePREKRvJzsvJxXWV9WrlzJ0aNHRUcZoGjRoqxatYrRo0czefLkHxZiPHToEMHBwTx79oyoqCiMjIywsrLi+PHjjBkzhooVK7J//366du36Q+eRSCQ0bdqU6tWrM3z4cPbs2cO0adMwMjJiwIABeHl5MXHiRJElLiQkhLFjx1K2bFns7OxEZzOjAGZuDqOioiIdOnTg3r17rFy5kg0bNjB06FBGjhzJ6tWrWbt2bYEN/bS0NCQSicg+WRAnvG/fvmzZsgUPDw9SUlJo3bo1ixcvxt3dnfHjx9O7d2/s7OzYsGEDO3fupGHDhgwYMIBv377Ro0cPGjduzIsXL9DW1mbmzJlZ2pdIJD+88vurk2hkWmPq6urExcXx+PHj9FWYz5/R09PD1taWGjVqoKury+lXHxEKMWj7IxCAsNhErPi5zkx0dDTly5cXg2+/k5z+YQi/8VMRlZAsHH4eJtfP1uu+wrrzt3L88bj/Qu62cvr5GB0rbNiwQZg9e3amn7lz5wr37t0TYmNjC30O4uPjhdmzZwtPnjwp9LZ/NaRSaabfb9++LVhZWQnTpk0T7OzshKVLlwqCIAhpaWlCWlqa0KhRI2HkyJFCTEyMcOzYMcHc3Fzw9vYWBEEQ3NzchFq1aglpaWn5OuePwtfXVzA1NRVu3bol9lUQBCE0NFTQ1tYWJBKJsHXrVrnamjRpknDs2LEC9aNy5cqChoaGUKlSJSEhIaFAbcTGxgqjRo0SKlasKDx69Eh48eKFMH36dKFjx47Czp07hZcvXwqCIAhXr14VSpcuLdy/f1/utgsy72fPnhVMTEyEW7duCXFxccKpU6eEJk2aCC1bthQePnyY73YTEhKEzp07C2vXrs2ybfjw4YKurq7QokULYeDAgcK+ffuEkJCQbNuJiYkRzM3N5bpWycnJYh+lUqmQlJQkJCcny91n2XGCIAj+/v6CjY2N0KtXLyEhIUFYunSp0LZtW8HPz0+oWrWqOK7vnwF55yghIUGYMGGCULduXcHW1laoXLmyYGRkJBw4cCDHNqRSqfDp0ychMjJS7nPJruWoUaMELS0toXHjxsLVq1ez3Tev5zm7/giCIBw7dkxQUlISqlatKmhrawutW7cWAgMDxf0+fvwoDB06VFBVVRUiIyN/6L2QkpIi/r9ixYpCnTp1BDs7O+HNmzeCIAhCcHCwMGLECMHMzEzw9/cXBCH9WZdIJMLTp0/lHpfsHSPD8uXLBX19fWHu3LmCIAiCl5eXEB8fX+BxSKXSAs13xvFHRUUJqampgpeXl6CtrS2ULFlSePfunSAIghAeHi5UqlRJcHZ2FgRBEG7duiWULl1a2L17t3i8j4+PsG7dOsHDw6PA48gLjRs3Fki304UyZcoI35tu/fv3F/r37y8IgiDMmjVL6Nu3rzBq1ChBU1NTKFOmjHD+/Hlh7dq1QtGiRQVDQ0Nh9erV4rGRkZHCkCFDhKJFiwo6OjqCo6OjEBkZKSQmJgr9+/cXAMHNzU2YO3eucOjQIaFr166ZzmXXsaNQyaaOoKWrJ7jtOpyr/eE8b5mgpKwirDt/Szj8PExYfcZLUFZRFVzXbxMOPw8TNl29J9g0bSmoqKkJRiYlhR6jXIQD/u+Fw8/DhJELVgqVa9UT7EeMF7T19AUNbR3Brv9Q4VBAqNj+yAUrhRLlzAUVVTWhZk1rwcvLSxxnfHy8MGjQIEFHR0cwMTERtm7dKigqKgpBQUFCUFCQOE49PT1h5MiRglQqFebPny+YmpoKysrKQvHixYXZs2eL45ZdD0DYvn17pt8FQRAuX74sVK9eXVBVVRXKli0r/Pnnnz/t/vgNQfhPEwD8F6CrpoxBLiKNGaFftBjFy5TN8UddS6vA/ZAABmrKFNXRZMCAAZiYmGTSeNDQ0ODMmTMsX76cnTt3cu/ePb59KxzhK3V1dbS0tPJFHPBvxffRtXr16nHu3Dnc3NzQ19fnwIEDPHr0iAcPHjBq1Cjev39PixYt0NbWpk6dOkRFReHq6srbt29p2bIlDRo04O3bt7meU5YKuHr16kKhfJXpxcjU02URUSMjI7p27cqUKVOypJB8D+EvOl0/Pz8aNGiQ7z5MmDABFRUVzpw5Q9OmTfH19eX169fidnnpnjU1NXF2dmb+/PlUr16dCRMm8OzZM7S0tLh27Rp//PEHZ8+e5cWLFyQmJmYplBZyiaYVJJLapk0bWrduzcCBA6lQoQJ9+vShatWqTJkyhRo1auS7XTU1NeLj4/Hx8SEuLg5IT2scMGAAx48fp2XLljg6OjJr1ix69uyZIyOgtrY2ampqmeb4+7GnpaXx9u1bHj9+THBwsNhXJSUl/Pxyp4D/HrK2nz9/TkJCAlu2bEFNTU0s+K9atSo9evTg6NGjQFZyBnnmKDY2lq9fv7J8+XLOnTvHmjVr2Lt3LxEREXTv3j3HNqRSKdu2bRMFgeU5l4aGBu3bt2fOnDl4enpSsmRJ+vXrh4ODQ5a5yc8Kg6woPi4ujkOHDrF582bu37/P1q1bUVZWxtnZmStXrgDpq0BLly4lMDAQfX39H6pnUlJSEkWgb926RXh4OKdPn+br168AlClThhEjRmBjY0O/fv348uULixcvxtXVVW6ygQ8fPojaTzKYmppStGhR7t+/L9aRycuW9T2EDFo4uSE8PFx8h8qOUVJSIjk5mcuXL9OtWzfWr19Po0aN6NixIwYGBiQlpbNyFS1alMmTJ7N582YiIiKoX78+9evXZ8WKFVSrVo1Vq1ZRq1YtRo4cSZ8+fQD53135wZEjRyhZsiSrVq1i9erVee7v6emJnp4ejx8/pk6dOjg4OHD+/HmuXbvGmDFjcHFx4dOnT0B6+tqjR484deoUFy9e5OnTp9jZ2bFu3TqxvVatWuHi4kK3bt1E3TEZTp04QUO7LszecQDzajVy7Vfzbr2wqGHN9oWz0mvaZk6iTsu21G7eBkEQWDJ6MLpFDFl25AKjFq7ixqmjHNn0d61W4KP7hAW/Zv7e4wyeMZ8zu7eK2SxXjnjiPm8aXYeOZtnRC9Rv3IR27doRGhoKpDMf3r59m/Pnz+Pp6cmSJUuySCbcunWL+/fvM3bsWHbt2sWqVavYunUrL168YObMmcyePZuHDx8yceJEXFxcqFevHuHh4XTp0iXT77IUUHt7e54/f87cuXMZMWJEoVK2/0Zm/HZmfgHKGxTcCSksCBn6oaamRr9+/cR6DUEQ6Nq1Ky4uLrRv3x5FRUXOnTvHihUr2L59O97e3kRH/5gQVtGiRcWX5/8SBEGgaNGiKCgosGLFCiwtLenWrRuTJ09m+/bt2Nra0rFjR86dO4eSkhLnz58nOTmZP/74AxMTE5YsWZJrsaogCCgpKRETE8P48eMLpFHwvdFapEgRxo0bx8yZMxk6dCghISF8+vSJyMhIrly5QuPGjTE1Nc2VuUoikXDkyBHOnj1LkSJF8rXEfvr0aQ4dOsTw4cOxtrYmNTWVwYMH07x5c9EgUFJSEs8vIwHIaWyWlpZ07dqVxMREPn/+TKNGjdizZw8TJ06kX79+9OzZU6xryFijlJycjEQiEQ2XwsK2bds4deoUGzZs4MmTJ8ybN4+mTZsW2PjcsGEDUVFRtGrVijp16jB16lQEQWDevHmsWLGC/v37i+lr2V0H2d/mzp3LsWPHqFevHr169cLZ2RkXFxeWL1/O3r17uXHjBoaGhtjY2GS6JxUUFETnJr9QVFTMlMaVkckpNjZWTMuSd25k98SZM2dwcnKiS5cutGjRglmzZvHixQskEgmJiYli6lNOfapRowYPHz6U+76V7WdgYEC7du1YvHgxy5YtIzU1FWtra06fPi1XO99DQUGB1NRUZsyYQUBAAFKpFBUVFRwcHBg9ejQlS5Zk+vTpbNu2DUgXdZaHcjwnyAhHIP3+j4qKwsDAgIsXL6KqqoqHhwexselsUJUrV8bFxQV9fX2aN2+OIAgsXLgQIyOjHHWzhAyaUMWLF2fx4sVMmzaNrVu38vjxYzw9PenRowebN2+mUqVKBR5HxnsqN7i7uzNgwIBMzjmkC/Pq6+uzatUqrl27xv79+/n8+TN//PEHX758wdvbWxTHbN++PTY2NowbNw6A5cuX4+joSMeOHTOldMrG/TPqQg0MDFBUVERXVzeLdlt2MDQ0xM3NDTMzM5ycnIiOjmb16tVUqlSJiRMnkpqayqtXr/Dz88PLy4vt27ejqqpKQEAAtra23L59O9M46tSpk6PTaVi0KG169qNspSqoquXumEokEoa7LeHJnZus/mMUYUGvGTQ9nbXuifdNPoWFMNxtKSXKmVOlTn36TZrJqZ1/689J09LE7Y07dqNMRUtePXkMwBkPd9o5DqJJZ3tKljNn1LTZVK1alXXr1hEbG8uuXbtYt24ddevWpUGDBpkILWQYN24cZmZmlC9fntKlS7N9+3aaN2+Oqakpw4cPx9jYGH9/f7S0tNDS0kJFRQVjY2N0dXUz/R4dHS3WvpmamtKnTx8uXbqUqxD3b/wYftfM/AKYaKlSXFOVD3FJ/0iBnAQw1lLFROtvBWxVVVX69u2Lh4cHUVFRlC5dGgUFBaytrbG2tiYhIYHAwEACAgK4dOkS58+fp0SJElSqVIlKlSrlW41ZR0fnf9KZyZh3b2hoyI4dO0hISMDX15cNGzZgaGiIVCpl8eLF2NvbM2zYMObMmUOPHj1Ys2YNy5Yty/XDLKNqnTlzJtWrV6dTp075YsSR1UckJiZy//59Lly4QI0aNbC2tubOnTv07NmT8+fPo6enhyAIVKxYUaRYzSniKZVKiY6OxtHRMdM55MHXr1/5448/6NChA127dkVLS4vWrVvzxx9/EBcXh7OzM3Xr1uX48eNifdXdu3eZM2cOCxYsyKJlkXEOZKQEp0+fZtCgQVhaWvLt2zcqVKhAjRo1mDp1Kv7+/nh4ePDw4UO0tbWZNm2aWB/Up08fKlWqlIkhTV6j6XvIhHgLA2ZmZnTu3JlZs2ZRtWpVOnbsSJMmTTIRJcj6mV1fZX9r27Ytu3bt4vHjx5QqVYoSJUpQv3596tSpg1Yuq75JSUk51tnlBNk5y5cvj4aGBuPHj2fjxo2iY+7l5cW5c+dwcXEB5F/NkO03cuRIypcvj52dHUlJSbx69YqNGzeSnJxMTEwMe/fupXr16tm2IQgCrVq1EkVE5bm+39fXlChRAnt7e2rWrEnXrl1p3749kDtxQU5QVFQkNTWV0NBQTp48ibW1NTVq1KBVq1ai8OrcuXMpUqSISO9dEGQkQhgxYgQBAQGEhoYydOhQhg8fzsWLF2nUqBGlS5dmxIgRqKioYGNjw4QJE3j8+HGmecrpeU9LS8Pd3Z0dO3YwZMgQOnXqRFhYGJMmTUJFRYWqVasyY8aMHzb4c7pmgiCQnJzMunXr6NKlC927d8fOzi5TrebTp0/ZtWuXSJ187949Bg8ezK5du5gwYQItWrTAw8OD2rVrU6FCBQwMDJgyZQpdunRh5syZVKxYkfHjx2e5J/5NYolly5YV+yNzQmQ1h7Lfk5KSePz4MZqampw6dYrExETKlCnD0KFD2bt3r9wrZial8lcHaFLWjC5DRuK5bjmjF69BRz+dQTXk9Utio77S16aCuK9UKiU5MZFvX9P1/HSLGKGh9ffKkIamNmmp6YGu0NevcBg5QdyW8peAckBAAM+fPyc5OTkTUUh29OkZ6zKbNm3K3bt3mTJlCgEBATz09eXDhw+ERMfx9FMMH+OSiEtJI/BLLLqqSqRmCP4ZGBjg7OzMkCFDmDt3Lh06dGDgwIHo6+vna65+Q378dmZ+ASQSCVbGulwI+kTqP6COq6ggwaqYbpaXraqqKgMGDCApKSmLMaGurk6NGjWoUaMGSUlJvHjxgoCAAK5du8alS5cwNjamUqVKWFpaysXQ9G960f8MyIrGBUFAXV1dNBLDwsJQUlKiRo0anD17lhEjRtCyZUuGDBmCj48PSUlJqKqqZtumbFUmNTWVP//8kxUrVmRyIuUxxGRGh4ODA1FRUUilUi5fvszXr1+5desWr1+/xtPTk9jYWMqUKSO+4HNzUBQUFMSXck5MUTlhxIgRlCtXjh49ehAcHMz27dspV64cUqmU6tWrs27dOjp06EBISAjFihUjLCyMffv28fz5c8zMzHI0FgVBQEVFhZMnT9KsWTO6dOnCt2/f8PPzo3379sydO5fAwEDatWtHkyZNqFatGqmpqbRt25ZPnz4xd+5cDh06xN69ezO1K1u5yekaFQQFcZBkBAbt27eX24n5/pyqqqq0a9eOUaNGUbt27VwdmIx48uRJJsV3eSDrj6WlJXPnzsXZ2ZklS5ZgY2PDw4cP6dGjBy4uLjg6OuZ7PoKDg4mIiODVq1ciocCHDx949+4db968ITAwMEe9MNm5rl+/LjogBRmX7P/m5uaZVkrkMdK/H69EImHNmjU0bNiQRYsWsXr1avr160fTpk2pWbMmOjo6YiCjoMiYTjpnzhyuXbsmGmnbtm3D19eXdevWsXPnTlE0tUuXLigpKdG6dWuRtj2na5WSksK3b98YNmwYX79+xdzcnLFjx2JpaYmbmxsODg4kJSVhbW1d4DHIA9nK3OzZs4mPj2fcuHEUK1ZMFG1t0KABT58+FdknZWLNz54948yZM3Tq1IlZs2bRqFEjvLy8MDU1RUVFhSZNmjBv3jz09fVFYor8BJUKe4zf4/v3Ynb3oez6JyQkAHDixAnCw8ORSqXY2NhgZWUlfl9kVNrynEtFNf8ClcGBz1BQVOSp902adEqndJampWFSzpzJ67dn2V9DO52yPzvWVtl1UP7uHS0V0schCwhm3Pf7/8uQUVB469atjB8/no69+mLWoAUtR0xiVv/uhH1L5GVkHJEJySSkpPHs8zcE4GVkHF8SkvH9EE05PQ02bNjAyJEjOXbsGMeOHWPTpk2cOHEiXxIIvyE/fjszvwhqSorUNNbFJyzql5+7prFujgJPCgoKeUZgVFVVRSrS5ORkXr16xbNnz7h16xZXr17FyMhIdGyKFi36P++45ISMDqHMyC9VqhQAPXr0YNCgQZibm1OhQgWCg4Oxt7dHVVU1R9Ym2Ut43bp1JCcnc/fuXVavXs2SJUvo1KmT3PO8Y8cO7t27x7179yhZsiTVqlWjXbt2hIWFcfHiRXr06JFpfyEHZqKMY5P1Nz/1AYcOHeLEiRNs376dV69esXbtWiA9GiaRSLCwsKBcuXIYGRmRmJhIUlISp06d4ujRo2zbtg1dXV0GDhzI48ePuX//fhaDUFYLcP36dQ4dOsT69eupV68e8+bNQxAE2rVrR9euXZk5c6aYbpaQkMDgwYPZsWMHO3bsoEuXLpn6nJqamqMgbUEglUpJSkrKd52Arq6uuIoBWZ2YvJi/MlJy5xcfP34UV+PkSXH5Hm3atCEoKIiIiAiSkpK4ePEiDRs2REVFJV+scbIxa2trM2rUKLy8vGjWrBmKioqUKFGCEiVKyCVWuXnzZmrUqFEorG5SqVS8P4YMGcKCBQsy0fLmNo5Lly7x6NEj/P39admyJW3btqVkyZJMmTKF1atX8+XLFzp27Fgoq3wyI3/jxo1cvHgRV1dX+vbtC6RHqNesWcO8efNYvnw5/v7+9OjRQ6Q/z3h9ctKRio2N5dKlS6Lujr6+PhYWFvj5+VG3bl1RPPlnIzU1FV1dXaZNm8bBgwdp06YNlSpVwtnZmQYNGmBtbU1cXByVKlXKVNsyZswYdu7cyc6dO3Fzc6N79+6sX7+eWrVqiYxdU6dOzXSuf8qJkaVqfvv2TaxfefPmDRUqVMjxWEjXrPL19RXrNrS0tOjXrx/79++nZMmSoiPz7NkzYmJiKF68uFgPlt9z5Qafy+d4dPMaU//cxaIRTjTu1J2qdRtgUtaMz2Gh6BgUQfMv5+XxLS+uHj3A6MVZU8K+h0lZM148ekjt5umaOAoS8Pb2pmHDhpibm6OiosKDBw9o2rQpQBYhaxkEQSAsNomla9bRxXkcXQaNQADiYqKJ/vI5PZUy4/5//Zue2grB0fE8fBXMyc2rWbFiJVOnTmXatGm0adPmtzPzE/G7ZuYXoqS2OtWMdPLesRBRzUiHktoFK7DMDioqKlhaWtK9e3cmTpxIjx49KF68OHfv3uXPP/9k3bp1XL58mbCwsP/XVIXfG2h169bF39+fGTNmULt2bXbv3s2UKVNybUMWTZozZw41a9akRYsWzJ07l8qVK+dLrf7Tp0907dqVkiVLsnDhQmJiYpg8eTL+/v6MHz+egICATPvnlsKR2/a80L17d44ePUqHDh3w8/NDXV0dX19fFi5cyNixY7l+/Trjxo2jWrVq2Nracv/+fdauXUufPn1o2bIlJ06cwMPDg8mTJ2dbE6GgoCDm8nfv3h0HBwcaNGiAhYUFf/75J9bW1kyZMiVT3rKfnx8eHh6sWrUKBweHLNdNSUnph7Qhvsfbt29ZvXp1gckwvr8GsvtAEAQGDhyIj48PQI41DQWBzJD29/cvcBvBwcEcOnSILVu2cP/+fc6fP090dHS+i+UBZs2axdKlS5k4cSJXr14lJiZG7jYkEgl16tShdu3ahUJPLevTihUrePDgQZ6iw7IVkkuXLmFvb8+rV6+QSqVMnz6dkSNHUq9ePdzd3VFRUWHFihW4u7sX2rV8//49V65cwdvbm8jISPHvHTp0oHPnzhw7doyvX7+yaNEi+vTpIxfNtIzAQF9fn8aNGxMVFYW+vj4HDx4kLS2NatWqFUrfc0J8fDyQvjIkC2YATJw4kcTERA4ePIiWlhajRo3iyZMneHt706JFC7y9vbl//754/bS0tKhUqRL79u3D39+fKVOmUKpUqSzX85/8pmlqavL8+XNKlCiBuro68+fPJygoiKVLl+Lr65vtMTExMTx+nF5TsmvXLsLCwkRjvlmzZrRt25a2bdvSr18/7t27h4+PD/3796dRo0aUKFGCkiVL5nmu/HwNEmJj2Tp3Gt2Hj8OqYVPa9hnIn7NcSU5KpLptY4xKlGT1H6N4GxjAs/t3+XPmJFTV1eV6Vjs4DeXsnm1cO36IsKDXrJk3m8ePHzN48GC0tLQYMGAAY8eO5e7du3h7ezNmzJj0/mf4niWlpuEd+pW7YV9R19HD7/YNQoNe8/qpH8vHDyc1JYWUlORsz6+qrkFkxEc+hrxHS1cPr3OnGTFmLIduPeTS1as8evQoE2X/bxQufq/M/GKYG6Srwvt9kv8DXFBUK6qDub7mT2tfWVmZihUrUrFiRdLS0njz5g0BAQE8ePCAmzdvoqenJ9bY5Mf4/l+ELArcv3//TH+D7Fc3ZEv5S5cuRVtbmyNHjhRIowRAX18fDw8Pzp49y8KFCzl48CCGhoY0adIEfX19Pn/+LFc7GdnvClpLIqvHUVdXJyUlhejoaCpWrIiWlhZ169ZFEATmz5/Ply9fWLZsGfr6+ixatIjQ0FBGjRpF//79sbe3z/H8GQvOnZ2dxb8/efIEPT29TClB3t7ePHz4kNmzZ9O/f/9MxemQeRUlJSWFbdu2Ua1aNbmi/zmhZMmS6OrqcujQIYYMGZLvVZ/vxT0jIyMJDAwkODiYU6dOiXVMso9/QdXUM0KmP/XmzZsCCfYdPXqU/v37Y2hoiIaGBs+ePaNcuXJYWFiwY8eOPFcyZJCNqV27dqiqqnL9+nVat24t1mK0aNGCevXq0bJlyxznNTU1FW1tbbnnJbf7XJYGKpVKWbRoEd7e3nJpGCUmJuLq6srEiROZNm0agYGBogCnTPtp69atjBw5EnNz8wI5XRnHl5KSgoKCAuXLl2fZsmWkpaVx6dIlWrZsKa6YDBo0SFSv79atG7t3785z/AD79+8nPDwcFxcXLl68yJAhQ6hTpw73799n0aJF1K1bN999lwefP39m2rRpGBsbM2fOHPF6y1KjVFVVcXZ2Zs2aNXTr1g0nJycOHz7M/v372bRpEz169GD58uUUL16cWrVqERUVRVxcHLGxsRw4cIA5c+Zw8uTJLOf9J7MORowYwaRJk3jx4gVbtmxh6tSprFmzhq5duzJq1CixJlUqlRIfH8/evXt59eoV7969A9IFbEuVKpVlDLt27WL06NE0b94cRUVFOnXqxMqVK3n48CH6+vq5ngtASUEidy3wnpULUVFVp8OAdNHpHqNcuHn6GAfXr6TPhClM3rAD93nTmdyjPWoamtRvY0e/SVl1e7KDbduORH2KYP/qJUR9/kTVatW4cOGCmJa7bNkyhg8fTvPmzdHV1WXkyJFMmzYNFRUVkQTm+vtIDE3SnfiB09xYP2UCLp1bolOkCLZtO6KmoUHQs6fZnr9Oy7Zc8NzNWLvG/HnZhykbdrBt/gz6tmqIuqYWjk5Ov1RT7v8bJML/5/D5P4iQbwk8/BBNmlQoVFIACek1MjWNdQt1RSY/kEqlovDb8+fPiYuLQ1FRER0dHTp16kSpUqUKNdr9X8L3RpRM8C2n+TAyMmLatGmMGzdObkHH7w2Q5ORkevfujZeXFy1atGDfvn1AeqS9UaNGnDt3LouCujwoqEMD6eldnTp1Ijg4mMaNG3Pu3DnU1NSYO3cuPXv2xM3NDXd3d86cOUPlypWxt7fn4cOHIrVwXufOOFeCIDB27FiUlJRYtWoVkJ5y0bBhQzp37syCBQvQ0cm8YpqamkpMTAyamprcvn2b0aNHo6KiQpUqVXB3d0dBQaHAkf2IiAi2bNlC9erVsbOzy9exste1LMI/depUVq5cSa1atahatSrr168H0lXkL1y4QExMDEOHDi1QPzNi0aJFqKioMGHChLx3zoDXr1/TpUsXunbtyuzZszlw4ADLli3Dx8eHLl26oKury44dOwrsdH3+/Jn79+9z+fJlvLy8uH//PqGhoRQvXjzbeyQ5OTmL05odIiMj+fLlS5bam4xtygIUkyZNws/Pj7Nnz+ZKBy0b3927d5kwYQJr166lcuXKmJmZ4ejoKN77FSpUEGmjC4KMfdy5cyfXrl3j7du39OzZEzs7OyIiIpg5cybm5ub88ccfFC9enMDAQBwcHNi7dy+VK1eWq/0bN27w8uVLBg8ejL+/P5UqVeLSpUt8+/aN6tWrU65cuQKPIS9IpVIGDx7Mly9fWLNmDWXKlKF///5ERUXRsmVLRo0aBUCtWrWwsbFh48aN7Nu3j+XLl+Pm5kb9+vXp27cvjx8/pmPHjty6dYuaNWtSvnx53N3d8ff3R0VF5ZcKzP4oPn36hK+vL48fPyY+Pp4SJUpgZWVFlSpVClTzd+rUKUJDQxk2bBixsbG8f/8efX199PX1M7WXmJrGmdf/PtmFdmZFM6XXHzt2jBYtWoi1gvfu3cPW1pa4uDiCvyXx5FPhSFHkhmpGOmJA+zcKF7+dmX8Qialp+H6IJjwuCQn8kFMjO764lipWxXKukfnVkEqlvH//nj179iCRSEhOTkZTU5OKFStiaWmJqanp/zvH5s6dO5w/fx5XV1exdiKjUyNblTlw4AC9evXiyZMnWFpaytW27Ng3b95w7NgxTp48ybx58/j06ZNotFepUoXU1FRu3bpF5cqV8fDw+KHxZEx9yq+Dc+TIEUJDQ5k4cSKurq64ublx8uRJxowZw8SJExk5ciQbNmxg1KhR+Pr6Ur169QIZvhcuXKBNmzZMmjSJsLAwTp06RZs2bVi1alUW3Yy0tDQiIiJ4+vQpq1ev5uPHj9SoUYMlS5aIxAcZSQEK4tQ9ePCAU6dOYW9vL/e1lfVt+/bt7Ny5U4xASyQSOnbsSO/evVFTU+PChQtcu3aN+/fvIwgCJ0+ezMI+mHEO5en/5s2b+fDhQ7bq5tlB1ua9e/fo0KED7969Q0VFhb179+Lm5sbz5885cOAAU6dO5dWrV4VmNGbM7c8vZM/Onj172Lx5M8+ePcPLy0u8PhkLn2XzFxkZSdmyZfHy8hJ1hL5Hxrnu2LEjdevWJTAwEHNzc06cOIGZmRl79+5FQUGBsWPH8vbtWw4fPvzD87Fw4UIWLlyIm5sb0dHR3Llzh5CQEB4/fsyBAwfYuHEjnz9/pmXLlnh7e6Onp8f58+dzbVNGvXzkyBEaNGjAx48fsbKywtjYmGPHjlG7dm25+1fQYIjMIb169SoLFy6kRo0avH//Hmtra0aNGpWpiPvFixd06NCBDRs20Lx5czp16oSuri6rVq1CTU0NT09Pbt68iZGREYsWLeLly5fUqlWLBw8eiCuS/2YkJyfz9OlTfH19CQkJQV1dnerVq2NlZSW3HlBOOHToEPHx8fTr14+rV69y/fp1cZuamhoGBgYoKytTvHhxUs1qkJT278m+UFVUoL15sUx/s7KywtramsmTJ/Pt2zfGjx+PkZERCzZt/yWOjAy/HZqfg99pZv8g1JQUqVtCn7DYJF5GxhKZmJJvp0a2v76aMuUNtDDRUv1XFeArKChQtGhRUlJS6Nq1K/r6+jx79kxMR1NXV8fCwgJLS0vKlSv3n4mC5Ya8PtKqqqpcvHiRVatW4ejoyOzZs0VGOJlTAzB06FAEQeDp06eiQSVP2gtA+/btqVSpEubm5rx9+5bevXvTsGFDpkyZQkxMDG/evMHR0VEsKs/NQchrPBkpSvNq63t07dqVb9++ceLECQYPHszr169ZtWoVNjY2jBw5kkePHjF58mTmzZtH9erVC2z0tmrVigcPHnD79m2WLFmCvb09S5YsyVZEU1Zj9PjxY1FAtH79+nz9+pUhQ4YQERGBgoIC3bp1w9HRsUDPW82aNXnz5g0nT57ExMQEPT29PI+RETOYmpry6tUrzMzMaNWqFb169aJEiRLcv3+fffv28fjxYxQUFBg4cCD29vbZGvf57XOpUqUIDw/n06dPcqeFQbrRo6qqysuXL6lcuTLKysriuf39/cWVj8J6Z8nqPO7fv8/Lly/p1auXXMfJnp20tDRGjRrFtGnT2LNnD8rKyixfvpy7d+9Su3ZtnJ2d0dTUFO91FxcXGjZsmKMjA3+nkd68eRNVVVWGDh3KxYsXmTJlCgoKCuzcuVPcJzIyEk1NzR9+DyYlJXHz5k3c3d2xt7fnxYsXrFq1ikGDBhEVFUWvXr1IS0tj+vTpPHnyhIEDBzJsWHrqT07PryAISKVS+vbty/Tp0zE2Nub169d06tSp0ASWc4Ps2ZetrDVt2pQLFy5w5swZhg0bxogRI7IcU6FCBU6fPs3atWtp3Lgxw4cPZ/r06ezdu5dRo0bRq1cvmjdvLqbwLlq0iC5duvyrHRlBEAgJCcHX1xd/f3+Sk5MxMzOje/fuWFhYFJrOTUJCghhsK1euXCZnJjExUaRr//TpEy2q1yU4Op7+dSuTkpyzbteqU9cwMilZKP3LCRLARCsrw9qePXsYPXo0VlZWqKio0KlTJya6LfiljgyklxioKSv8Y5kz/6v47cz8w5BIJJTQVqOEthrRiSm8iYonLDZRjHLIPvHpL3IF4O/8VFVFBUy01Cinp4GuWv4ZlxJT04hKTCE6KZUUqRSpkM4AoqyggK6qEnpqyoWywiMrdi5WrBhFixalZMmStGzZkvDwcAICAnj27BmPHj1CVVUVCwsLKlWqhJmZWaGySP1MpKamEh4ezvv370WK4woVKuRIW1yzZk1u3brFlStXWLJkCeXKlaNz587MmzdP/KgmJCQwZMgQSpYsydatWzE0NKRZs2ZyORUbN25EWVkZDw+PTEW89+/fp379+jg5OWUyWORhwsorHS7j+SF/UVdtbW0uXrwIpDtwz5494+nTp6SmpjJixAhRIwZy1rfIC1KpFCsrK4oVK8bdu3dxdXWlZMmsH1VBEOjXrx8NGzZk48aNopF669Ytpk2bxrt379iyZQt37tzB2dkZQRBEVqj8QCKR0KFDB/7880+OHDmCk5OT3A5g2bJlqVy5Mlu2bKFs2bI8ePCADRs2cOnSJR4/foyBgQFDhw5l4MCBQN7aJ/Jcp0qVKuHj44O/vz9NmjSRa3yQ7gTVq1cPBwcHdu/ejaamJmFhYaxZs4b9+/ezcuVKIH+seLlB5mSsWbMmC/uUPP3dtm0b5cuXZ+LEiURHR+Ps7MylS5ewtbVlzpw5lCxZkp49e6KoqEhgYCA7d+7k3r17ebYvS+nU09MjODiYXr16ERISgru7O0uWLEFRURElJSWOHz/Oo0eP8j3u7538uLg4vL29cXNzw8vLi06dOjF06FCmT5/OkiVLsLW1xdHRkTdv3uDt7Z1JODYnOl4FBQWCgoI4ePAg3bp1IyoqismTJzNu3Di6du2ab4c0t/1l76SM45L9GxgYyIYNG2jXrh3Dhw8nKiqK4cOH59hWuXLlcHNzw8fHh7Zt27J161axLX9/f2bPnk1oaChRUVGoqqqyfXtWauB/A+Li4nj8+DG+vr58/vwZXV1d6tevL7KtFTYSEhLQ09MjLS2NpKQkkQY9I/T09Bg8eDCpiioERcez6OAZhFzqYw2KGhd6P7+HAJTTz0peYWlpyeXLl8XfE1PTuBD0z2jfPfwQjaG6yr8mg+Z/Ab/TzP6lyOhoJKelcdfnHibFjTEzNf0hRyM3hykjCsthgnRD8Nq1a0yePDlbY1QQBCIiIkTH5tOnTygrK1OhQgUqVapE+fLl5cpz/1WIjo4mJCSE9+/fExISwocPH0QaZRMTE0qWLEm5cuUoXbq0XA7Z3bt3Wbp0KefOnaNp06bs2bNHrOGIj49n7NixqKioiPUQeUEmWnfjxg3g77SMFStWMG3aNPz8/HLU4cgIQRB49uwZRYoUwdg4/x+hgrCf3bt3T8x7nzJlChs2bCAoKAgDA4MfqtGBvw2k3CLPEomEhISETBHgr1+/0qpVK8LCwkhJSeHu3buULVuWlStXcuXK/7F31mFZbF0b/z10CAgKKBICgoCIoiKieAzsVmwRE7vz2N167G7FbuzCRMUARAVFQpFS6e7n+4PvmReUVDzxvue+rnMdeWZmz56ZPXvW2mut+3bnxIkTKCoq/lDfPn36xP79+7G3t6dly5Yl7p//Hvj6+nLhwgUuXbqElpYWzZs3p1+/fjx79owFCxbg5OTEtGnTCo1mfXsvS7q3ubm5LFmyBAMDAwYPHlyma/z69SszZsxAT0+Prl27YmtrS7169ViwYAEdO3b86ef6bT+lpKSYMmUKf/zxR6n2z87OFp71zZs3GTNmDOvXr2fr1q1ERUUxY8YM+vXrx4QJE5CSkuKPP/5ASkqKhw8f8uDBgwKshMVdy5EjR5gwYQLNmjXj+PHjyMnJcerUKZ4/f46Hhwc2Njb06tWrzCQLkmv+8uULW7duxcjIiEaNGnHw4EEePnzIs2fP2LhxIyNGjCA9PZ26devi6OjIsmXLSEpKYvHixfj4+NClSxfGjx//Xfs5OTlkZmby/v17qlWrxooVK/D09MTZ2RlnZ+dy1WACOHPmDIcPH+bcuXMF7uWVK1dYvnw5ioqKPHv2jP79+7Nt2zYyMjKQkZEpdqFDshiTm5tLVlZWAWp0f39/Hj58iIaGBo6OjuV6LT+L3NxcgoKC8Pb25t27d4hEIszMzKhXr14BYcxfcd7169ejrKxMYmIiaWlpKCgokJGRIYxxDQ0NhgwZgrJyXsrU3Y/RxKZn/ZL+lBYi8rJUmhsUr30nFot5Eh73lwuZN9JR/1tl0vyT8a8z8w/B+fPn+fTpE+PGjSvz4JfwpgfEJhP3E6lsGj+YyrZjxw4qV65Mz549S7V/dHS0kIoWFRWFjIwMNWrUwMLCAlNT03L/eBYHSdQlLCxMcGAkKRUVK1ZEV1cXXV1d9PT00NbW/qn0kJcvX3L16lWcnZ0F+mDJfS5udf1b4/zmzZv06tWLTZs2MWDAAKFPiYmJdOzYkQ0bNpQoXpednc379+8ZPXo0T58+Zdy4cSxbtgwZGZnvlK9Lwo8Yq69evaJOnTocOnQIJyen7wzy8jSAS8LixYvZs2cPoaGhLFmyRHBiYmJiWLZsGTdv3vyp537//n3u3LmDs7MzhoaGpTomMTGRwYMHc/nyZbp27cr27dsL0MguWrQIDw8Pbty4ARQvggqlSw1cvXo1UlJSTJs2DaBURuSPnOdnIRm7ZmZmZRojOTk5xMfHs2jRIvbs2UPVqlU5evQotra2ADRt2pQmTZqwcuVKYfx9Ow5Lur4nT57Qq1cvqlWrxvnz5wssEpT13uRfLPDz86Nhw4YYGRkRHR2NpaUlWlpaBAUFYWZmJkQbcnJyaN26NQMHDmTIkCEAhIeHM2nSJBo0aMDMmTMLnCM3N5ecnBzi4uLo0KEDp0+fFlTSf9U7ePXqVSpWrIidnZ1wT3x9fenRowcDBgygXr167Nixg+joaNzd3alQocIPfRMlbf8djcm4uDi8vb3x8fEhKSkJbW1trK2tqV27dqkos38Eubm5fPz4kTdv3uDv709qaiqKiorUr1+fWrVqkZGRwYEDBwAERya/8G54UjqeEXG/pG9lga2OOtVUihfy/Cf19V+UDv86M/8QBAcHc/jwYYYNG1ZoekxRyE8y8LMQSAaU5bEuRogzP758+cL27dvp06dPAeXy0iIuLk5wbMLDw5GWlsbY2Bhzc3Nq1qxZZvHBkpCYmChEXMLCwoiMjPwu6iL570cLjcsCCRtXfsrhonDq1CmaN2+OpqYm48eP5/Xr13Tt2lUwnq5cuULfvn3x9fUVDJKikJWVha+vL7Vr1+bBgweMHz+ew4cPF+oE/Sqn5vHjx4XSIEuoR5OTk38oYlRWTJ48mYiICE6cOIFYLGbBggXs2LGDKlWqoK+vz8WLF7+7rrIYprm5uRw+fJjo6GhGjRolrHQWBcl9PHz4MNu2bWPz5s00aNBA2J6ZmUnDhg1p0aIFa9asQVpaulwMtn379hEWFsbcuXPx8PBASkqKRo0aldmRkxSR/4hTU9x9lWx79eoVtWvXLnPbkOcIiUQikpKSkJOTIyYmRrjuS5cu8fHjxyLFPnNzc4mNjRXq34pCREQEPXv2JDQ0lDNnzgjO0o/i9evXvHv3jhcvXrB8+XJu3rzJ6dOnCQwMRElJCRkZGTIzM+nYsSNubm4EBATw+PFjtLW1hbH05cuXYgvGIyIiBHHPn0Fxc8C39zQyMhJ1dXUUFBT4/fffcXd3F3SUkpKS8Pf3p0GDBv81BDLZ2dn4+/vj7e1NSEgI8vLyWFpaUq9ePapWrfpLnC4JQc/r16/x9/cnJSVFkFR4/PgxnTp1EuZ8sVjMhg0bkJGR+c6RkWz/p0Q7/klRpH9ROvxbM/MPQfXq1VFRUcHX17fUzkx++ufygKSVqJQMboR8LRX98+vXr1FQUPhhBWt1dXWaNGlCkyZNSEhIwN/fH39/fy5cuICUlBSGhoaYm5tjZmZWohH4LbKzs4mKiirgvEgE+NTU1NDT08PS0hJdXV2qVKnyl5ATlKS+LUFwcDBr1qxh9+7dLFy4kDVr1rBo0SLOnDmDq6srGRkZZGVl8fvvv1O9evUSje2wsDDq169Pbm4uDg4OaGho4OrqSv369QkMDOTw4cMsXLhQUKEvTWF+WdnOitJzEYlEuLu78/LlSxwcHLCzs/slH3pJXxUVFYmJiRHOvXjxYjQ0NNiwYQMbN25EJBKxevVqRCIRxsbG9OjRo9h0tm8hJSVFjx492LFjBxcuXKBfv36lup7OnTuzaNEi0tLShN/u3bvH8ePHkZaWZtSoUUI0z8vLizVr1jBy5Mgia16ysrKKTYs0MDDg06dPbN68mfj4eOrUqfND74RkzJQV+cdYYeNIsi5XqVKlHyaKkNwvyWq/mpoagYGBqKiocOLECeTk5AqNkorFYjIzCxfT+xY6OjrcvXuXUaNGYWdnx82bN3FwcChzXyGPMKBBgwaIxWLWrFkDQOvWrcnOzubYsWOEh4fTp08f7ty5g5ubGxUrVuT169coKSkVGJ/5HRnJ7+7u7sLKfGZmZqnSIAvr3969e8nOzmbWrFlFPrdv6wtfvnzJyJEj6dixI/PmzUNFRaXA4pGKikqRzGnp6ekFGM3+DEiK8SU6T2VBZGQk3t7evHr1ivT0dAwMDOjWrRsWFha/pG5ULBbz6dMn3rx5g5+fH8nJyaiqqlK7dm0sLS3R0dEhPT2dx48fF1gsFIlEDB8+HDk5uUKzI0QiEdZV1LgR8pXscrI5ygJpKRHW2moFxpdIJKJfv34cPXpU+C0hPYvTR105uWUdO9zznOPsrCzO7NjI3Qunif0cRcXKlWnUphN9x09DMZ/TlpubyxXXfbifOU7kx2BUNSrRsGVbeo+bikrFPKbLzb9PAmD8yg1F9jU5IZ7T2zfiefMKSbHRGBgYMHLkSCGV9V+UHf86M/8QSElJYWlpiY+PDw4ODiWmWr2PTf5lLB1iIDtXzNOIeNI1c4ukGczOzsbX1xdzc/NyYVhRU1OjUaNGNGrUiKSkJN6+fYu/vz+XL1/m8uXLGBgYCCKdhUVNEhMTC9S6SKIu0tLS6OjoUKtWLfT09P60qEt5Qk9Pj1mzZgm0xv3792f58uX4+PgQHBzMu3fvaN68uZCPX5QxmZOTw8uXL6lXr14B4zYuLk5gsVq9ejV79uzByspKEJ0s7Ue3PJwOkUhEhw4dUFRU5ObNmwQGBtKtW7fvtGLK4zwAEyZMwNramn79+gn6Jc7OzvTu3RsdHR3evHnDzZs3qVatGuvWrePFixcsW7asTA6NiooKXbt25dixY3h6ehYrNijJ/a9YsSLNmzdn3LhxVKlSBVVVVZKTk8nIyGD+/PnUrFmT169fs2vXLl68eIG8vDzh4eFFthsaGlosi5Ok+Dc+Ph5LS0u6dOlS4nWVF3JzczE2Nmbq1KmMHj262PlER0fnu98+fPiAnJxcodsKg6R9JSWlAmxj+bd9iwcPHpTa4JeTk2Pfvn3Y2NiUKMIqFovx9vamXr16323T0NDg4sWL9OrVS2CXAmjfvj1JSUkcOXIET09PXF1dCzgLRaWt5ubmkpuby+rVq/H09MTd3Z2OHTsWMAZLAx8fHzZv3syFCxeIjY1l4cKFQOFEDyKRCGlpabKzswkPD8fAwAADAwMaN27MnTt3mDBhghDtevDgAU2bNi3yvK9fv2bdunVMnDixWIa58kRGRgb79u3j/v37dO/evVSLaunp6bx69Qpvb28iIyOpUKEC9evXx9raukC6aHlBLBYTHh4uODCJiYmoqKhQq1YtatWqha6uboG5WbJA8m3mQ0nfRQUZaepVUeNpRHy5X0NJqFdEtsixY8cYPny48G4Gx6d+Vyd8eO0yfB/dZ/SSNVTRq07Upw/sWz6fyI/BzN5xSNhv7cQRBL/xZeC0ORjXrkt0RDiHVi9mqcsAlrieRU6+ZCc6KS6W3/t2RkNTm7HL1lHP3JSUkLeMHz+eoKAgNm/e/FP34X8V/zoz/yDY2try7NkzHjx4QKtWrYrc71c6Mt/C92teJKMwh8bT05PExMRfogKtoqKCjY0NNjY2pKSk8O7dO/z8/Lh+/TpXr15FV1eXatWqIS8vT0xMDJ8+fSoQddHV1RWcl78q6lIYfjQPXVZWlu7du2Nubs6ZM2c4ffo0jx49YvHixd8VtRZ3jqysLA4ePEi9evWEfdzc3JCTk6N+/fq8e/cOV1dXLC0tiYiI4NatW5w+fRo3Nzdq1qxZ9gv+QcjIyNC6dWuMjY05f/4827dvp3PnzmXSbCkNcnJyqFKlCt7e3oL6toqKCrq6uiQnJ3P16lUsLCw4cuQIWlpaPHnyhA4dOmBiYlKAoSwoKKhEuldTU1NsbW25desWBgYGQt1Ucdi6dSs3b97E1dUVfX19DA0N6dOnD7m5ucydO5ebN2+irq5Ot27daNWqFdbW1nz+/Bltbe3v2vr06VOhfUxNTeXw4cNERUUBULly5SILpfOLesJ/ojCSdMkfrVHIzs5m+vTpHD9+nIcPHzJt2jTq169fgPFK8g4XZqj36tWL0NBQFi5cSNeuXalSpUqpnExJOyW9lxkZGYSEhJR5Hhk9enSx28ViMRkZGSgoKJCSklKoody6dWv++OMPXFxcqFevHr179wagZ8+eJCQksGnTJm7evEm7du2APIelOGdw3bp1vH79Gicnp+8if8UhPT2d8+fPs2HDBp49e0ajRo1YvHgxr1+/Jj4+nqNHj9K/f/9Cn09aWhpmZmYoKSkxaNAgJkyYQK9evXj69Cn79+9nwIABHD16FHd392KdGR8fHwIDA1mxYgVOTk507ty5VH3/UYjFYuTl5WnVqhU+Pj5cuXKFXr16Fbnvhw8f8Pb2xt/fn5ycHExNTWnWrBkmJiblviIvFouJjIzkzZs3vHnzhoSEBJSVlbGwsKBWrVro6+sXOaaLcmZKA10VRdI1cwXb4M+AlaZqkVki1atXZ+zYsbx8+RI5OTkiktO/S4O7e/4kY5atw8oub2xp6eoxcuFK5g7oTtyXz6hraXP/4lle3L3Fxst3qaJfHYAqegbM3nmYMa0bce/CGVr3HlBiX13/WI6snBzz9h5FTl4BkbQUfRrWQUlJia5duzJ+/HhMTU1/5nb8T+Lfmpl/GD5//szXr18xMTEpNDoTlpT2l6yKNNSpWGAyycrKIiAgAHV19VKvhv4MJFGXDx8+EBQURGxsrLBNTk6OKlWqUKtWrSKjNn83lLSiLzEIzp8/L6zQS5CUlMTFixdZvnw5YrGYnj17smjRolI5Sh4eHowaNYr79++jrq6OWCymYcOG1KpVi5UrVzJr1iz8/f25cuUKGhoahIWFUbduXfbv31+o4VASLXB5IC0tjYsXL+Lv70/dunVp165duZJESIzl/M9E4ig+e/aM2rVrU7t2bVxcXLCysqJRo0Y0btxYYNPy9vZm+fLl6OnplciwlZ2dzd69e8nMzGTkyJFlZvGLi4tjz549nD59GmVlZVq1akWvXr0E9roXL16waNEi3Nzcvjv28uXLtG7dusA5vby8uHz5Mrm5uZiamhIWFoZYLGbGjBmF3qeoqCgSEhLQ0NBAW1tbGG+xsbEEBwdjbW39U/TaT548Yd26dURGRjJ8+HCBfrokZGZmsmjRItavX4++vj5TpkyhQ4cOVKtWrVyihffv3+fLly+lJjkpDbKzs8nMzCx1wfeCBQtYs2YNt27dEiKwKSkphISEYGlpWeyxuf9PpyslJcXjx4+ZM2cOVatW5dChQ6V+XhKxyZEjRzJ69GisrKyEbZJobkBAQJHHe3t7c/jwYW7fvo2Liwvjxo1j3rx5gpbMjRs3sLa2pkaNGsXOKXfv3mXHjh2kpaXRuXNnhg4dWq6OglgsFuooJQgNDRWowAsTIRaLxbx48YLLly9TqVIlrK2tqVOnznd1J+XRt8+fP/P69Wv8/PyIi4tDSUkJc3NzatWqhYGBQanuRWBgIEeOHGHSpEk/TPscGJvypzg0Vlqq1FAvPBomEolwdXVl9OjRzJw5k6kzf+dK0Bfcz54okGY2uFEtmnbqzpDZi4X7k5OTQ0RIEFUNDJGRlWXR0D6oVFRnyh87vjtPwEsvqhoYolJRvdg0s6zMDAY3ssR5xjza9nUWfu9grIW8tBR3796lcePGfyrJ0X8L/o3M/MOgpaVVpGhdenYOXlEJf3KP8vAtb7q0tDTm5ua/pJYhJyfnO4YxSdRFVVUVPT09bGxs0NLSIikpiXfv3vH+/XtCQ0Px8vLCwsICc3PzMon//V0wfPhwhgwZQpMmTYA8leajR48yf/585syZg6ysLCoqKvTv3x8PDw9ev34tpC2U5lno6OigqqpKw4YNsbe358GDB4hEIiZPnkxMTAyHDx/mxo0bgqL8hw8fMDAw4OvXPL7+sLAwgYGnX79+v9yRgbzVw169euHj48PVq1f5+PEjPXr0KBNRRnGQGHP5jYCHDx/y6dMngTL13r17DBs2jN9++42srCzBePT29mbXrl1ERkaWSsBRRkaGnj17snPnTq5cuUK3bt1K1cfo6Gg2b96Mu7s7IpGIdu3a0bNnT2rXro2fnx8LFiwQohmtWrUiOjq6QKG6WCymVq1aBAQEYGlpSXp6OkeOHCEsLAxZWVl69+5NzZo1OXToECEhId852zExMZw4cYL4+Hgh8pEfERERXL58mdq1a/8QYYBE46hx48Y0btxY0Gc5duwYkydPpnXr1kWmOubk5CAnJ8eyZcsYPnw4Xbt2ZdSoURgaGjJ+/Hh69OiBnp7eD89VYrFYENUsT2RlZbFy5UoWL15cqv0XLVrEp0+f6NOnD+7u7piYmKCsrCyMxaIWSHJzc3n79i0xMTE0bdoUOzs7xowZg7m5eamelWTBYvfu3ejq6hZKgPDhwweqVKlCQkJCocaxRAfK2tqaSZMmcfXqVTp27EifPn3w8PBg/fr1LF26tMSosqysLM2bN8fDw4MjR44wf/58QkNDGT16dKkinaWBSCQS5jWJiKy+vj42NjYcPXqUt2/ffkd2IxKJqF27trBveX4XJdIGkghMbGwsioqKmJub06lTJ6pXr15mZy49PR34sciMBDU0lFGQlRLqdstz1VxEXo1Maep2q1WrxqJFi5gzZw6tuzqC7Pfjr6PzcI5vWsPT29eo16wVVnZNqWvfHL0a/4mQfHjrR/fhYws9h2md71NAC0NU6EfSU1OoYVm3wO/x6VlUqaBAixYtStXOv/ge/zoz/zAUVTwrFovxLsdi/7IiJ1eM9+cEgUmkvFfC3r59K9S6RERECKvlVatWxcLCQqh1Kaxuok6dOmRmZhIYGIi/vz8eHh7cuXMHTU1NzM3NsbCwQEtL629F0SklJfXdhzspKYmvX7/y22+/MXPmTJYvX46rqyvt27dn3LhxXL16lb179wrGS82aNZGVlWXcuHFA6Ri2DA0N8fDwEOosZs2aRYsWLTAyMqJnz5789ttvQu5xRkYGd+/eRU5OjmbNmhEXF8ewYcMIDw9HSkqK8ePHs2bNGoECFkqmCP5RiEQirK2tMTAw4OzZs+zbt49mzZrRtGnTX1JQGR8fj7KyMvr6+ujr6wsisHv27KFXr15069aN9+/fs2vXLnx8fJg9e3apU14qVapEhw4duHDhAkZGRgVWuIvCjRs3OHnyJI6OjnTv3p369esTHBzM0qVL8fDw4PPnz9ja2tKhQwcmTJjw3fEikQgDAwOuXLkC5FHB5+TkYGRkVMAprV69OiEhIYSEhAgpae/evePcuXNUqFABFxeXQhcJ8gu0lhUikYjIyEiio6Px9vYmKysLNTU1evXqxbJly3j79i1//PFHkek9kvGWlZVF9+7dad26NdOnT+fjx4/88ccfbN26lTFjxtClSxcMDAzK7ICnp6eTmppaLBuYBGVJIz1w4ABfvnwp0zG7d+/G1tYWFxcX3N3dC4z9ot4DKSkppk+fjkgkQlVVlTp16pQpwiS5X9/WqHz8+JEdO3Zw7tw5AgICcHR0FJ7Ft3NR/n9369aNZcuW4erqyrx582jfvr1Qr1XcfZA4s0OHDiUkJIROnToRHBzMgwcPCA8PZ/To0QVY/0qDwsgJvn79yvLlyzl9+jTGxsZ07NiRkSNH0qpVK86dO8e5c+cKaA9JIC8vj4GBQZnOXxy+fv0qODDR0dEoKChgZmZG+/btMTQ0/Kl5Ni0tDSkpqZ8mINBVUaSyopzAqFpWWYhvITm+SgV5rLVLx6gKeXWPBw4cYObUyUzYtO+77b3GTEZbz4BrRw9w66QrN44fQlG5AkNnL6alY18AUpMSUfrJrI6UxLzF5vztiICEjGyqlG+Q7n8O/zoz/yWISM4oF/rlH4UYiEzOICI5o9x500UiEW/evOHTp0/o6uri4OAg1LqU1vCQk5PDwsICCwsLsrOzCQoKwt/fH09PT+7fv4+Ghobg2PwqGsyy4ts+qKio4OrqipubG9OnT+fGjRucOXOGAQMG0KJFC4YMGYKNjQ3jxo1DRUWFlStXcvz4ccExKotRP2LEiAJ/e3h4cPbsWTw8PITfnj17xv3792nWrBnGxsYkJCQwffp0GjRoQMWKFVm/fj0LFy7EwsJCoJ/91bVJEv2D+/fvc+/ePYKCgujevTvq6urlep65c+dy5swZHB0d6dKlC+/evSMkJARHR0dWrFhBWloaf/zxB15eXsyYMUNwZEorJFqnTh2Cg4O5fPkyhoaGJaZG9u/fHxMTE2xsbAgLC2PNmjW4u7uTkZFBkyZN6NOnT4FUo6Ic22rVqnHmzBlkZGRwdHT8Lj3JwsKCO3fu8O7dOwwNDbl79y4PHjzAzMyMbt26FZke8TPOzLt37zA3N0dDQwMrKyvi4uJISUmhWbNmLF++nISEBAwNDYtMaZQ4A/v37ycrK4t169YJ2+bOncv8+fOZOnUqGzZs4PTp09jY2JSpf5GRkQBCHVJxzofkd0mEoqh9AwICmDFjBq6urmViAZSWlubu3btkZmaW6X1fs2YNbdu2JTU1tdTHfAtJHy9evMjhw4d58uQJ1atXx8nJiUqVKhEdHU3z5s2FOq6irql58+ZcvXoVDw8P3rx5Q9++fQXijZLuwbt377h58yYnT54UiBUkNYRbtmxh69atZWK9lJATiMViYmJiqFy5MitXruTFixfs2rWL58+f4+rqioeHB+fPn8fKyoo7d+4wc+bMX7KIEhMTI6SQffnyBXl5eczMzIT6wfKaX9PS0n5YCPhbKMhI06iaOhHJGbyPTSb2J7Tu1H9Q605aWprt27djb2+P7a2rhe7zW+ce/Na5B0lxsfg8vMsV1/1smzsVg5oWGFtaUaGiOsmJP5f5ImE8S/mmnawfmBf/RUH868z8l+B9bPJf3QVE/9+P8nZmxGIxnTt3Lrc8UhkZGWrWrEnNmjXJyckhJCQEPz8/vLy88PDwQE1NTXBsvmV5+SuRk5ODiooK9vb2TJ06lenTp1OjRg2WL1/O9OnTuX79Otu3b2flypWYmJgwffp0gXHqZ68hPj6e3r17CwZCRkYG7u7uJCYmMn78eDIyMrh06RJKSko8fPiQtm3bMmrUKObPny+koDk4OLBhw4YiNUBiYmLKhclHWlqaFi1aYGxszLlz59ixYwcdOnTAysqqXJ5lTk4OSkpKvHz5khkzZnDgwAHu3bvHoEGDWLJkCdnZ2Sxfvpxnz56xcOFCOnXqBBQ0ckuKUIlEIjp27EhYWBjHjx9n+PDhJfbd0tKS5cuX8+TJE5KSkoQVdnt7e+7cucO9e/cEkoCizlmnTh1ev35N7969C63XqVy5MlJSUnz8+JGjR48SHBxMy5Ytsbe3L7Z/+YVWy4qKFSvy5MkTdHR0SE5OFmom0tPTkZcv2aiRbK9QoQI5OTm8e/eOmjVrCs7P5MmTefjwISYmJlhbW5e5f1++fEFaWrpYAx3+40Du37+fefPm0a9fP5YtWyasfktU6pctW8aFCxcYO3YsXbt2LTMpiKQOo7gxJhaLmTNnDi4uLhgaGmJhYYGvr+9POf0ikYiAgAAGDRpE27ZtWbZsGfXq1cPAwEDok5ubG7t27WLmzJnFXlefPn3w9PTk0KFDrFq1qtT3QEFB4bvsBUdHRypXroyamlqZvyGhoaFcv36dCRMmsGTJErp168a2bdu4dOkSDg4OtG/fnvbt29OoUSOeP3+Og4MDT5484caNGwLhws8iNjZWYCGLiopCTk6OmjVr0rJlS4yNjX9JKm9aWlq50luLRCKqqShQTUWBhPQsguNTiUhOJyMnz4gv7MlKZgp5aSl0KihgVFEJNYUfjxQ1btyYbv2c2Lt8Pt2GjRF+//DOj7vnTjH49wUAqKhr0LRzDxq17cS4to155fkQY0srjC2sCH7jW2jbR/5YgVplTTo5Dy+2D1X0q6OkokrQG19q1K4r/C5JqJEQABRH8PQvCse/zsx/ARLSs/5yASjIm3xi07NIyMhCTb78+PFFItEvK4iTlpamRo0a1KhRg06dOvHhwwf8/f159eoVT548QUVFBTMzMywsLNDX1/9LOeAlhkmbNm1o1qwZCxYsEIyf8+fPc/78eUaPHs2IESOEImwoH9X1jh070rFjR+Hve/fucePGDXr27ImioiL9+vXj8ePH2NvbIy0tzYoVK5CSkqJ27dro6ekREhKCp6dnkcZVcHAwY8eOpU+fPgwePPin+iqBvr4+I0eO5OrVq5w/f57AwEA6duz40x9paWlpcnJyUFBQYOPGjWzcuJHQ0FBWrFgBwLJly3jy5AnLly+nadOmHD16lF27dmFoaIiOjg7Lli37jlCgMMjLy9OzZ0/27t3Ls2fPSqzJUFRUxMfHB21tbebNmydEGI4dO8b8+fNRVVUlOzubCxcuFKk1JBaLadasWbHEA4qKinz58oWkpCQGDBhQIksb/FxkRltbG3l5eeTl5YUUNrFYXOA5lsbYbdWqFZs2beLgwYOMHDmSatWqAQhOSPv27X/IMJSkfpZ0fikpKb5+/cr06dNZunQpqampjB49mvr16wupQZ8+faJz587069dPIG34UYbDklbpJdozvr6+SElJlUv00tTUlCtXrlC1alX09PSE556RkcHJkycJCQkRfitu7NerV48uXboIc0FpRXkNDAwwNjZmyZIl7Nq1S3jGzZo1K/U8KBaLuX//PqamptSsWRMbGxuuXLlC3bp1efPmDWpqagJrolgspkGDBrRq1Ypt27axYcMG9u/fz4ULF37KmYmPjxdSyCIjI5GVlcXU1JTffvuNGjVq/BL9mfxIT08vd0FqCdQUZLGuooY1aqRn5xCfnkVCRjZZubnkikFKBLJSUqjJy1BRQbbUqWSlwZT5i7l15RJu+/5TxJ+bnc3FAzv5rUsPjCz+s9AmKyeHnIIiqup5C2y/denBllmTifr0kSp6/0kXjPkcybWjBxgw5fvUwm8hLSODfYeuXD2yn5Y9+iL7//OslAguXryIm5ub8B35F2XDv87MfwEkvOnlUS3jaKbDooOnsbRtXOK+If6vyUhLw6yeDa89H7FgUE/Ovo0gOC4V6yo/xoDyV0JKSgojIyOMjIxo3749nz59ws/Pj7dv3/Ls2TOUlZUxMzPD3Nyc6tWr/3RIv3v37vz2229Mnjy51MccP36c3Nxctm7dKnzQBg4ciIuLCyYmJuzYsYO+ffsKjozkusobioqKyMvLC/Sp/v7+nDx5knr16hETE8PTp08ZO3Yszs7O1KhRg+fPn9OgQQOBqAHy0tSio6Np3749RkZG7N27l+TkvAjjjxpw30JBQYHu3btjYmLCpUuX2LFjB927d//p3HVJ6olIJGLixIm0bNkSOTk5lixZwpMnT1i6dCm2traMGDGC169f07VrV4yMjFiwYAHh4eEcOHCgVM9FR0cHBwcHrl69Sq1atYpMkZGswq9du5Zq1aoRHBzMoUOHcHJyYu/evZiYmLBz505mz57NuHHjuHTpUqHtSElJoaenR2ZmZqEOzcuXL4VUpGHDhpU6kvYzzsyKFStYvXo16enptGrVCgsLCxo1aoSZmRkZGRnUrVu3VGNFS0uLmTNnMnbsWNzc3Bg8eDBZWVkEBwfj4+ND27Zty9w3yKvFadKkSZFjNr8RraCgQP/+/Rk6dChycnL4+vqya9cujh07RsOGDRk2bFiB6FBZ00NLC5FIxKlTp7h37165t5+fij84OJhbt27x6NEjoqKicHR0ZNSoUUUem/8eTpkypdjzFEZCUblyZRYtWsTSpUuZNWsWo0ePxs7OrtT3UXL+z58/06xZM+zs7AgICKB69eqoq6uTkpKCiYkJ169fZ/DgwcL+7dq1Y+fOnaiqqtK4cWNOnDhBaGgo+vr6JZ5TgoSEBPz8/Hjz5g3h4eHIyMhgYmJCkyZNMDExKTOz4c9Akmb2q6EgI02VCtLlVi8SFxfH1atX0dLSKnSO16xcmYHT5rBt7jQ0dfIIYoxqWVG/WStWjR2C05TZ1LS2IT76C3fOnyIrIwO7NnmLeE06dOXOuZMsGtybgdPnYmxZh/DgQA6tWUI1YxOhtgYg9ksk3g/uFDi3tp4BOtWN6D1uKr/37sCS4f3pM24qlatUxe+aF+sWzWPixInlLi/wv4J/nZky4M9eRSgtCuNN/1HseeBDBbWKpdp39bhh9Bo7BbN6NtS0bsCeBz6I/78/1vzznJn8kJKSEsTb2rVrR3h4OH5+fvj7+/PixQsUFRWpWbMmFhYWGBoalnlFNzExkStXrjBgQMm89PlhYGCAWCwmMDAQc3NzsrOzMTQ0ZM2aNTRo0EDQcSiNEvXPOAxNmzblxo0bSEtLk5qaSmZmJl+/fkVZWRllZWV2796NmZkZLVu2RFlZmZSUFAICAqhTpw6QFy1YsGABLVu2pEaNGiQnJxcw4r4tuv1ZWFpaoqenx7lz5zhw4AD29vY0b978p84hEokEJ8LKyort27dz9uxZli5dSvv27Rk+fLhAOjFt2jScnJywsbFh6NChpdKdkcDOzo6QkBDOnDmDs7NzoftIrkNiPC1duhQZGRmcnZ3R09Pjw4cP6OnpMWTIEEaPHi2wMBWGnJwc0tPTCxhPOTk5XLt2jefPn1OtWjXCw8P58uVLmZ2Z0qaZScbm+/fvWbFiBStXrkRPT4+uXbsKhfuVKlXCzc2tyHEseTYSynaAdu3aERQUxPLlyzl8+DCqqqoYGRlx5syZHzLexGIxXbt2LVY/R/L79u3buXLlCpcvX8bBwYEuXbpgZWXFqlWr2L17N1evXmXixIns3btXeI7lleJa2D3S1dUt8/xTWjx9+pTz58/z8eNHMjIykJOTo3Xr1ojFYk6dOoWDg4Mwl32r2F5aSMbU1q1buX37tjAely5dyoABA7h48SIuLi7cvXsXdXX1Ur3rkvNLyCQGDx7MqlWr+Pz5M4aGhlhZWWFoaMilS5cK6Ejdu3dP0AapXbs2d+/e5ePHjyU6M0lJSUIK2adPn5CWlsbExIQePXpQs2bNP9WByY+0tDQqVqz4l5z7Z5CcnMz79+95//69UN95/vx54uLiqFatGvoWVrR07MftM8eJ/RwlHDd1ww5O79jEiS1/EB0ZjryiEnXtm7HE9SyK/58iKRKJmLl1H+d2beHo+lXEREWgVqkytq3b02vM5AKCmb6PHuD76EGBvjmOmkj/STNR19Ri2dELnNiyjg3Tx5EcH4ehkRGLFy8uUXfqXxSNf52ZEvBX5XeWFunZOUK/ygPqmiUz8kiQ3zCRlZMTjs3IySU9O+cvcex+BUQiEbq6uujq6tK6dWuioqIEx8bHxwd5eXlq1qyJubk5xsbGpUoBuHHjBoqKinTv3r1MfalUqRK5ubns2LGDjRs3Ck6UtbU1/fv3p2fPnnTt2rXU1+Xv70+FChXQ09MrUz/gP9EJU1NTnJyccHJywsHBgfj4eDw8PJg5cyb29vZAXgjd3t4eRUVFzp8/z/LlywU2qqlTp/LgwQNOnz5N5cqVUVJSEtouT6dGTU0NZ2dnPDw8uHv3LkFBQfTo0aNQKtmy3AMJRo8ejZGREW3btiUqKorHjx8ze/ZslJWVGTx4MCkpKfTq1Qt/f/8CEaqSIBKJ6NatGzt27BDoZ4vDp0+fePXqlbCybWpqSmBgIMHBwdy4cYPq1asXuObAwEB0dXWFtC1paekCrICJiYmcOnWKiIgIOnbsiImJCRs2bCAgIABzc/NSXwOUPjIjee6XLl3CwsKCMWPG8OLFC9q0acO1a9e4ePEiO3bsKDb1TvJsnJ2defHiBdra2lhaWtKrVy/mzJnDokWLyMnJ+amUHUmBeEn7XL58mbFjxzJo0CAqV67Mxo0bkZKSomnTplSsWJFJkyZRvXp1oqKiyrSa/y2KcuwK00b5lXj16hUeHh5Ur16dz58/M3ToUPr378/FixeZOXMm+/fv58iRI+jr6/9QGqzkOg8ePMjChQuZNm0aLVq0oFGjRmhoaLB//35atmyJkpIS6urqxbZfWK2e5B4OHDiQoKAg3rx5g42NDVWrVqVLly5Mnz6dUaNGMXLkSD58+MDHjx+ZO3cuAC1btqR9+/bF9j0yMpLr168TGhqKlJQUNWrUoHv37tSsWfNvoTGSnp5erjUzfxaqVq2KlJSUMM8sXLgQAF9fX3x9fZlqlRfFXX6soM6WvKISAyb/zoDJvxfbvpy8An3GT6PP+GlF7jN+5YZCNWbyo3LVaoxd9h/NsQ7GWv819tJfhb+uAOBvDLFYTHhSOnc+RnP7YzQfElILOAziQv6TICMnlw8Jqdz+GM3dj9GEJ6UXuRpZp04dtmzZgoeHh1BrIC0tTYcOHYiMjGT79u1UqVKFihUrCtsUFRXp0KEDb9++xdHREe1KlXBuaM7G6eNITU4S2nY/e4IJHX6jXx0jZji2482zJ8K29NRUdsyfwSDbWgyyrcX2edPJzMjjlXc00+G15yMgLxd0zQQXnBua06d2dab1aMNbrzyRqfkDHfkaEcbW2ZPZ/PskXns+wtHsP+KYN+89FOiOpaWlad68ORkZeWxr3bp1Q1tbmwYNGiAlJSV81P8J+q0ikYiqVavi4ODA2LFjGT16NI0aNSIqKooTJ06wZs0aTp8+zZs3bwQ60cJw5swZGjRowJMnTwRO/+Ig2cfU1JSDBw/i6uqKvb09vr6++Pj4cPr0aU6ePFlAU6I0MDIy4sKFCyxcuJDIyMgyPwPJ8120aBFhYWH06NEDOzs7TExM+O2331BRUSE5ORkFBQUsLCy4cOECU6ZMoUePHixbtgxvb298fX3p1KkT+vr6QkpRQEBAAUPxR9KTCoNkrA0bNoyMjAyBgvpnx57kWUtSle7cuUNUVBTdu3enW7du7N+/n5kzZ+Lk5ESzZs2oUaNGoW0UNWaUlZXp3r07MTExJfZFT0+P7OxswWFSU1MjNDQUBQUFOnTowPjx4xGJRHz48IFNmzYxdOhQ9u7d+11fcnNz+fjxI7t27SIhIYEhQ4bQoEED1NTUkJaWJjw8vNT3p6xpZhJjMiIiQljxDgoKQltbm/fv39O5c2dWrFhRZHuS+/jHH38IquuLFi3i/PnzrF27lp49e3L06FEePMhbPf2Vc49YLKZt27a4u7uzf/9+/P39UVZWZvr06ezbt4+QkBAgb16UpGCVdbzn5uZy4sSJIp+JhNGwuDmptNdSmu19+vRh/PjxPHv2jPT0dBYuXMiCBQuwtLTEy8uLqlWrMm/ePKHvZe2DSCQiKSmJ3bt3M2/ePGbOnElUVBTq6uqMGDGCDRs2EB8fT6VKlUp0lHr37s3MmTML3SYSiVi0aBH169fny5cvAPTs2ZN169bh7+9Pjx49cHFxoVevXnTo0AFAcEaKute5ublERkYiJydH165dmT59Ov369cPKyupv4cjAn5dmVh5IS0sjICCA27dv4+rqWuh4kpeXZ+DAgVRQkENe+u9l9spLS/3ryJQD/o3MfIP07ByBE12Csn7mJPvHpWfhGRFHVWV5rKt8z4netm1bbt68ydy5c5k4cSLe3t5kZ2cLqRX37t0jKyuLnJwcxowZw/Pnz1FUVCQwMJC+ffuirKzM1GWrUKxqwOZZkzi9fQPO0+fhfvYEe5fOwWX+CkysrHE/d4LlI53YdPUBlbSrsm3uVD4G+DNr+37k5BXYOGM8xzasYtDMBQX6t3H6eJRVVVl+3A1xrhjXdcvYuXAW691uM33zHqZ2a0WXoaNp0b03IX6vheOyMzMZ0qsHWpU02LdvHz4+PixcuJAuXbpw/fp1II8BqGLFily7do39+/dz/PhxDhw4UECT5O8OkUiElpYWWlpaNG/enOjoaPz9/fHz8+P06dOMHz8edXX171ZKk5KSePjwIVlZWSQkJBS5MixhW7pz545gBI0ZM4b+/ftz69Yt5s+fj62tLdra2qioqLBixQqMjY3LtNIpLy/PuHHjyMzM5OzZs3z48IGhQ4cKKUhlSfuQ0CKnpaWho6MjFKBLWKROnDjB27dv6dKlC4sWLQLy1LKlpaXp168fQUFBuLm5ER8fz8GDBzE1NeXQoUOoqKiUe16/jo4OI0eO5Pr161y6dIn379/TpUuXUqutf4tvV+erVatG1apVhfSU7t27U7FiRQYMGMDQoUNRUVHB3d2dT58+oaCgQJ8+fYQ2MjMzSUhI+C4NzMjIqETdEUlq1Zw5c5g8eTKBgYGEh4ejpqZG1apV0dHRISUlhYMHD3L58mViYmKoWbPmdwxnkr48ePAATU1NHB0dC6iVq6qqEh8fX+r7U1ZnRrJ/mzZtGD16NBcuXKBSpUoEBgaSmZkJUKz+jqT/EuYwIyMjrl+/Ts+ePRk5ciQjR45kwoQJ1KlTBzs7u19quElEFps1a0ZOTg6VKlXi4sWLLFu2jM2bN+Pj48OoUaNo3Pg/dYplGe/R0dHs37+f1NRUEhMTGTZsWKHHl0fRuEgkIjAwsFBnXLId8t55KSkp5OXl2b17N35+fly8eJHjx48za9Ys+vXrx/DhecxPpY0WSVIzJVTVKioqVKpUCXNzcyIiInB2dmb16tXY2dnh4eGBmZlZqVJpz58/T1ZW8QQ6lpaWBcZujx496NixI0FBQUXWOBQVsZOSksLKyor69euXcMV/Hf6uzoxYLCY+Pp7Q0FA+ffpEaGiowJYpyTAwNDTkw4cPwrPX0tKiX79+JCcn4+bmRoycKmqGphSeY/PnQgToVPjnRcD+jvjXmcmHsKQ0Qa22PCBpJSolgxshX79Tq23Tpg379u1j7ty5NGnShAsXLvD161caN27MmzdvCAgIoFq1agwaNIi5c+cSGhpKTEwMp06dYs+ePdSrVw+FCmoY1LRg2sZdwgmvuO6lg9MwmnfLy/sdOHUOfk+fcNV1P92Gj+Hx9Uss2HcCs3p5KRojF63mg//r/F1HLBbTsFU77Np0oFKVvIhLu/5DWD4yrxZDpaI6UlLSKFVQQVmloFCl1313UpOTeRoUiLq6Op06dSI8PJwdO3YIBd4AT548QV1dnTZt2nDq1CmuXbv2j3JmvkXlypVp2rQpTZs2LVLpGuDu3bt8+fIFNze3IouOxWIxMjIyJCcn07lzZ1q3bo2hoSEjRozg0qVLLFu2jIsXL/LmzRtSUlLQ0dERFO9/JM9eTk6Ovn37kpuby9WrVwkODqZ///5oaGiUuT1FRUUmTZok/J2cnMyRI0eIi4tj4cKFgsrx7du3efnyJS1btsTExITFixfz4cMHduzYgZGREenp6axbt46EhASWL19e4ONaHgxtcnJydO7cGRMTE9zc3Ni+fTvdunUrdS1Lcfjtt9+oVq0ajo6OODk5ERQUROfOnXn//j1KSkp07dqVT58+ER8fj5KSEhs2bODx48eIxWKqVatGkyZNOHPmzHcGUeXKlYs10CT79+nTh+TkZG7dukVERASHDx8mJSWF48ePc/XqVW7evEnjxo1xdnZm0KBBhbaVm5tLly5dBMM0P6pUqYK/v3+p01HKWjMjQevWrXFxcUFZWZmWLVsyf/58Ll++TG5uLmZmZsUa6ElJSejp6ZGQkKfp4OXlRePGjXFwcGDWrFns27ePhQsX/mlGW25uLomJiQJr2Jw5c2jatCn9+/cvwBRYFnh6enL9+nXEYjHNmzenWbNm5dnl7/Dy5Uv69OnD06dPUVFRKTKlTSQSoaSkRFhYGObm5kI64rp165g4cSIhISEYGBjw6dOnUqe4urm5kZWVxYwZMzh//jzdu3dHVVWVpUuX8vXrV0aMGCHoYw0ZMqRIgWkJLl++TEhIiCAqXByVtYyMzHeOuLy8vODIZGdnIy0tXaq5UiQS/XI2sp9BVlYW2dnZf4s0s5ycHD5//lzAeZHYEJqamujp6dGkSRP09PSEhcOAgAAh2mlqakr16tU5duwYnz9/Rk1Njdo2tiT8DRwZyDPZjNR/bAHtXxTEv87M/+N9bDKvviaVvOMPQAxk54p5GhFPumYuNTTyGImaNm1KWloatra2LFu2TFCSdnV1pW7duigqKpKYmMiSJUtwdXWlYsWKZGVl8erVKywsLHj06BH3HzzA0tYeu/adadopr/4iPCiQ3mMLMsGY1q1PWPB7okI/kJuTg3Gt/6xqWjSwxaKBbYH9RSIRbfs643HlAu+8nxMeHEjQG99SrayGBb1HVUOjwEcqOzsbyMvPh7xVwvxUoDIyMsKK638DinJkIC8a0bVr1yIdmfyG+uHDh+natStHjhwB4P3793Tr1o1mzZqxdu1anJycCnxAf5YFTEpKSjCsfHx8qFSpUqmFHguDhEVo9OjRyMjI0KdPH2HbpUuXkJOTo3///rx8+ZK7d+8ybNgw+vXrJ+wzbtw4mjdv/t1KYXlGaszMzKhWrRoXLlzA1dUVW1tbWrVq9cP1BRKj6Pr160yePJlbt24hLS1NVlYWSkpK2NnZkZGRIWjuSEtLM2jQIDw9PXFxcaFGjRqsWLGiUMOqLIxMw4YNY9iwYQDcvHmTVatWERUVhbKyMh07dkQsFvP48WMGDRpETk7Od0XsUlJSBWpn8qNGjRr4+/vz7t07gdShOJSlZkYy/iMjI7l58yZfvnzh2rVrhIeHY2Vlxblz55gxY0aJ7aioqNC2bVt8fX358OEDycnJQm2EgYEBsrKyJdJdlyekpaX58uULR48eZezYsUCe0xscHFzmQu/s7GyOHDnChw8fkJeXx9nZGR0dnZIPLAWKq685ceIENWrUKHJcwH+edbt27VBXV2f58uX06dMHR0dHVq9eTdWqVUlKSmLRokWldmRycnKIiYnhyZMnHDt2jOjoaLp3787GjRvp3LkzISEhAjlGVlZWiXUy0dHR9OvXjylTpgiOvYQpsKiFkuLa+7Nqkf4MSFKa/4rITHp6OmFhYYLjEh4eTlZWFtLS0lSrVo06deqgr6+Pnp5ekf3T09NDWVkZFRUVgoKCCAgIoGbNmjg4OGBsbIyUlBR3P0b/5XIWIvJEQMtTxuJ/Gf89b+BP4Fc6Mt/C92teHnsNDWXk5eVp2LAhnTp1QkFBgXbt2qGqqsr169eJj4+nQ4cOLFy4EBsbG1JSUggNDcXU1JQpU6bg6enJp0+f2Hr4OFeuXGHn/Bm8fHiXiWu2IFtI3m1ubg65OTlIl3LSzc3NZfHQvqQkJdKkfRcatGhNdlYWq8cPK/FYWXl5ZGVl8fTxEX5LSEigQYMGQh5xYR+Gf0LNzM8iPT2dGzdu4OXl9d22zMxMUlNTBRaZp0+f4u7uLjiCACYmJrx584aZM2cyaNAgzp07x6FDh4QUoPIU+Kxbt+53bZbVWZKs0C5durSAIXvlyhV8fX3p0KED1atXZ8GCBaSnpwurpAAbNmxAJBIJESLIW13ftm0bmzdvRl5eXqgF+FkKWxUVFQYMGICnpye3bt0iJCSEHj16CKruZYG0tLSQIrh+/XqysrKQkpJCWlqalStXkpWVxd69e6lbty5SUlJkZmYSHx+Pg4MDFhYWHDhwgJo1a5Z4nqKeRf7f3N3d2bx5M/Hx8VStWpUhQ4bQo0cPlJWV+fr1K4aGhnTu3Flwbkp7DnNzcy5evMj79+9L5cyUJc1MYkyuWrWKI0eOULNmTbS1tXn58iWVK1dm69atJYqOSq5l7NixfP36lapVqxIUFMTz58+pW7cu69atw9DQsFQGm2R1uDycBW1tbaZNm8bDhw/ZsmULlSpVKrMjExkZyaFDh0hPT8fAwAAnJ6dyNaYlaXHZ2dk8fPiQ6tWrCxpbcnJyWFlZcfHixWJ1eSTP58iRIyxZsoRVq1YJ+7q4uNCjRw8aN26Mr68v2traaGtrlxhxXLp0KaNHj8bd3Z22bdvy6NEjGjduzPbt21m4cCF169Zl8uTJrFmzpsRrHDx4MHZ2dvTv3x8zMzO2bduGg4MDJiYmQgH5X6kp9lciLS0N+HOcmYSEBEJDQ4XIy+fPnwFQUlJCT0+P5s2bo6enR9WqVUsc42lpafj6+uLl5UVKSgqysrL89ttv1K1bFxUVlQL7mmhUwDMi7pddV2kg/v9+/Ivywf+8MxOWlPanOTIS+H5NREFWCl0VRTQ0NBCLxWRnZ7NixQoiIiLYvXs3ioqKVKhQgWXLlqGjo8ObN2948uQJdnZ2Qnj+xYsXGJlbMKV1FzyuXGDr7ClMXAM6hsYE+HjR0OE/ol3vX3phXr8h2noGSElL8+HdG8zr50Vjnt6+xsmtf7D27I3/3JfAAPyeP2Hfo1eoaeStZl47egD4j4FT1IenmqExMZ+jUFNTE/L+p02bhpSUVLmk8PyTce/ePUEg71uMHz+eZs2a0b9/fwC8vb0JCQnh/fv3bNmyhREjRgiGz6pVq+jYsSPHjx8vUMvwq/GzUR8JIiIiyM3NpWfPnrx48YJHjx7RunVrjIyMgLzV1V27duHo6CikcqSnp7NlyxYuXrzInj17hP1kZWUFmuTiKHJLc22NGjXC0NCQs2fPsnv3blq1aoWtrW2Z25SRkRHek/wpJY8fP8bGxoZ69eoJBresrCwBAQE0adKEP/74o1SODOQJEcrLyxfbt6pVq5KZmcmAAQPo3r17AdYmRUVFTExMBNrikhyj/FBUVERGRobIyMhS9bUszozESTl37hzbt2+nZ8+eREZG8ubNGyIiIqhXr16JbUj6LSMjg5aWFjk5Oezbt48NGzbg5OREVlYWhw8fLlXf/fz86N69O8bGxlSqVAljY2Osra3R1dXFwMCg1A5vbm4uCgoKeHh40KdPH0xNTQkKCioTBe79+/e5c+cOIpGINm3aYGdnV+pjy4JNmzYxf/58zM3NCQsLw8nJiTlz5ggO+r59+7h//z4mJiaFjhHJM6xbty7R0dHUrl0bR0dHOnbsiIGBAfLy8ty7d49BgwYJCztFjbX8rIbm5ubMnTuXt2/fsmTJEgYMGICTkxNnz57lypUrNG/evERHZMOGDTx48ABvb2+Bwv7BgwcsW7aMjh07smPHjv9ZRwZ+nTOTm5vL58+fhajLp0+fBJKSSpUqoaenh62tLfr6+qVObxaLxYIt5OfnJ6SftmnTBiMjoyLb0KkgT1VleaJSMspN1qKsUJGTRgr+q5hf/0r8Tzsz6dk5eEUl/CXn9opKoLKiHI0aNeLs2bNUqVKF9PR0bt68SUZGBhkZGRgYGLBq1SoyMjJwdXXlxo0bqKmpcenSJbS1tRk3bhxd+zmhayvN4+uXMTSvBUDnwSPYNmcKujVMMbWy5vbZ43x468e4lRtQqqBC82692LtsHiMXrkIkkuLI+pXU+61lgf4pq6oiJSWFx+XzNGjZlqBXPpzYvBaArMwM5OQVkFdSIjwkkKT4giscdeybI6+gSL169di6dStv3rxh/fr1WFlZ/SO568sTEjX4/JAYvbVr16ZHjx5AXlRm5MiRNGvWjDVr1nD8+HFCQkJwcXHBzMwMyEtR+e2334Di871/JX40rW348OF069ZNoKkNDw/HxcVF2L5hwwbk5eXp2LGjkLL3+vVrjhw5wuXLlwHYvHkzT58+FSIeVapUEY7/+vUrHTp0YMOGDTRp0qRMfdPW1sbFxYVbt25x/fp1AgMD6dq163ereyXh2/uSlZWFSCQSnBXJ9tatW6OlpcW6deuoVatWqduXkpIiOzu72Px7c3NzXF1dv1N3j46OZtSoUfj6+tKgQYNiz1PUM1ZTUys1CYDk+NJEXyUF3qNGjSIlJQXIc8qqVq1aqnN9C8l7YW5uzq5du/j06RMaGhqlfp4VKlTAxcWF1NRUYmJiuHz5MmvXrsXMzAwlJSWUlJQwMjJCR0cHW1vbIpXfc3JyePDgAa1bt+bly5dcv3691PNhZmYmhw4dIjw8HCUlJQYNGoSWVulp9PMj//MsbN4ICQnB1dWVTZs24ezszP379xkzZgxfv35l+fLl7N+/n5EjRwosc0VBQns9efJkqlatip2dnXCuK1eusGLFCi5duvTd2Py2DQmTZ1JSEhMmTADyIrRbtmxhz549fPr0iUmTJglsYsXB19eX6dOnc+bMGXbt2kVwcDCXL1/G1tZWqFeV1JL9r6K8nJnMzEzCwsIExyUsLIzMzEykpKTQ0dERtL8kaWFlQWpqKi9fvsTLy4vo6GjU1dVp1qwZdevWLdXinkgkwrqKGjdCvpJdTjXSZUVyZg6P/z869GdLevw34n/WmRGLxXiXY7F/WZGTK8b7cwKTJ09m0aJFxMbG0qBBA2xsbARdiClTphAbG8u2bdsYOHAg0tLS2NjY0KdPH+bPn0+7du3Yu2UjiSuWUsvGjolrtwLQpH0X4r9+4fjG1cRHf6W6eS3m7T2GrpEJAENnLWbvsrksHtoXGVlZGrfvQv9JBakpK1XRwWXBSk5tW8+R9SvQqW7M0DlL2Pz7REL8XlPTugHt+g3i8NqlRH4IpoPTf9LPpKWlcT1ylKGDBgqCcjY2Nri7u/95N/hvCLFYzMyZM79jzJIYFpIUKzc3N2bMmMHgwYMZMmQImzdvZufOnVy+fJm5c+fSu3dvevfuXaCN0jgyPxu5KAw/05ZE62TEiBHUr19fIDDIzs7Gzc2NVq1aCcZ9amoqmzZtwsLCglatWrF//34mTpzIihUrePToEXXr1uXMmTOC46KpqcmoUaN+uCZCRkaGdu3aUaNGDc6fP8+OHTvo0qVLqaMmhUFWVhYLCwvWrl2LhYUFWVlZrFmzhtTUVA4dOiTQapcWcnJyxMXFoaamVuxKcn5jMTk5mWnTprF7924aNGjA/fv3sbW1LfJYKPoZ6+joEBMTQ3JycokGRGkjMxJDOzk5GbFYzOjRo0lJSaFu3bpUqVKF6tWr//CqueQdqVatWpnSsgwNDQXq3u3bt/Pu3TtGjRqFnZ0dOTk5+Pv7s3v3brKysqhevTpQuJMgKyvLgQMHUFRUxN7eXtCYKimSEBoaypEjR8jMzKRGjRr069fvh+/BoUOHuHr1Krt27UJFRaXQeeP48eMoKyvj7OxMcHAwGzZsIDw8HGNjY7S0tOjduzfnzp0jICCgQLpnfojFYqHtnj17FhhD27dvZ8GCBezbt49atWoVG5GRtDFp0iQ8PDzIyspi3bp1ODg4sGLFCjZv3sz169eRk5Nj6tSpxV57RkYGAwYMYMyYMcjLy7N69WpOnjxJ69atkZGRISkpCU1NTWJjY7879q9aLPorIKmZKSsBQGJiYoGoS1RUFGKxGEVFRfT09GjatCl6enro6Oj8EAGCWCzm48ePeHl54efnh1gsxtzcXEhVLuu3SEFGmnpV1HgaEV/mvpQHCpP0CElIRUNBFhONCuhUKD7q/i8KQiT+XyhUKAThSel/ec4kgK2OOtVUfo415HLg53IVzvxZyEtL0bFG2WsN/kUe0tLSWLx4MXfu3MHU1JRhw4bRrFkzHjx4wO7du/Hx8WHp0qV06dKlxLYkxmFmZuZfpiZdFuTm5pKenk6/fv3Q1tZm165d5Obmcv/+fVq1asX169dxcHBg4sSJ3L17l5cvXwJ5it0VK1Zk9+7dJCUlIS0tLTiNP+vEpaSk4ObmRkBAAPXr16dNmzZlvpf5V8Pnzp1LdHQ0u3btom7duuzbt0+oTyoLnjx5wv3795k4cWKx+hSSmqLRo0fj6uqKoaEhs2fPplOnTqiqqhIYGIiOjo5wv0pbL/D69WvOnDlDhw4dBBruohAfH8/GjRtxcnIqNtVUUmu0ePFiDh8+THZ2Njk5OUJK3KVLl4o9z6+odZCkAcvKytKkSRP69u3L+PHjC+xz/Phx9uzZw+rVq4UUwsLGW8+ePRk7dqzA6FcSbt26hYeHByKRiE6dOpUqxa44eHp6Ymdnh7u7O82bN+fevXvs3r0ba2trGjdujJ2dHUeOHGHDhg1YW1tz/Phx2rVrx5IlS0hLS+Pt27f07duXU6dOsWTJEnr27Mm8efOKfLdCQ0PR0dER2MC2bNmCm5sbs2fPpmXLloUe8y1mzZrFnj17mDdvHo8fP+bWrVssXbqUkSNHCumD9vb21KxZs9hnv3z5ctatW8fz589p3Lgxffv2ZdmyZSgpKZGdnc3ly5eZMmUKq1evxtHRkfT0dIHVS5I2CuVbl/h3xOPHj7l79y6zZs0qcp/c3Fy+fv1agGVMwhqorq4uFOnr6+tTuXLln7pnKSkpQhQmJiYGDQ0N6tevT506dcoc0SkMgbEpQi3z3wEi8hydoiQ9/kXh+J+NzLyPTS55p18M0f/342edGZ0KCnxISP3Lcj/z41/e9KJRmo9hbm4uioqKrFixgmvXrrF+/XoWLlxI9+7dGTx4MOvXr+fYsWOlcmTyn0tVVZUDBw4UoNvNf878q6B/JaSkpFBSUqJBgwasXbsWExMTEhIS2LFjB3Z2djg4OJCTk0OvXr3YtWsXffv2ZfPmzfTs2RN/f38gTyhx06ZNgsCk5Lp+1BhRVlamb9++vHjxguvXr/Phwwd69OhRpoJwSU2PpJB527ZtmJmZsXv37jI7MqmpqRw+fJioqCjk5eVJSUlBTk6uyOsSiUQEBwdz9epV/vjjD4YMGYJYLObkyZNs3LiR+Ph4jIyMaNy4MQsXLiy1M5BfzLIkZ6a01MyS/Xbt2sXMmTMZP348qamp3L9/n/v37xdKBf3gwQMCAgIK6KuUp1OTv+4pLS2t0NS6Xr168fvvxauHi8Vinj17VqpzZmVlsWfPHr58+UKFChUYOnRoselYpUFubi62trZ06tSJJUuWEBYWxuTJk4Xauz/++IMzZ84IWkQPHjzA09NToFWeOHEiUVFRdO7cmV69etG+fXvi4uKKHHfTpk3j0qVL7N+/n3r16rFq1SqOHTtGz549BZHkb4/99rdXr15x9OhRrl27Rv369dHU1OTcuXOMHj2a58+fs2bNmgLpqcVh9uzZDBo0iMGDB1OxYkWmT58uOPA+Pj6sXbuWZs2a4ejoyP3795k0aRIVKlQgPj6eNWvWFMk++d+GtLS0796xrKwswsPDBefl06dPZGRkICUlRdWqVTE3Nxecl/Ko4RSLxXz48IEXL17g7++PSCTCwsKCTp06YWBgUK4OpYRd9u/i0JQk6fEvCsff2pn58OEDhoaGhISECOH78kBCelaZafkeXbtILRs71CpVLnHftORkPG9dFXReRrVsSO9xU2nZo0+B/cRAbHoWCRlZP0XPZ1RRiZCE1B8+vjzxL2960SjNBJyfSaddu3bY2NiwdOlSjhw5gq+vLy4uLkI6WkkGm8R4dnd3JzMzk2PHjhEWFsbNmzfZv38/mZmZpKenF0uz+ldh3rx5mJubc/78eWrVqkVsbCybN28mOzubnTt3MmTIEI4dO8aiRYtYvXo1q1atQiwW8/nzZ/bv3y8oqa9duxZFRUXGjh1bbJ1ASRCJRDRo0IDq1atz9uxZ9u7dS4sWLWjcuHGpjWZpaWnBWBszZgxdunQpM0OWl5eXoLNiampK7969hXaLigbk5uZibGyMr68vFStW5NOnT/To0QNfX1+ysrLw9fXFx8eHJUuWoKKiwtSpU0t1j+Tk5JCTkyMqKqrEfpeWmllyL2fNmkXlypXJyclBSUmJdu3aFVmL8ujRI/744w927NjBkCFDGD169C9xaiDPIB43bhzKysq0atUKY2NjlJWVhciFpJ6tsOcQHh5O/fr1S4zKpKWlCSx4FhYWODo6lss1SBzJjRs3YmxszOfPn1m5ciXDhg0jISGB2bNnM3ToUE6fPo29vT3BwcFC6ifkORb29vbCaniFChUEw7WwsTd48GA8PT0ZO3YsAQEBQo3P8OHDi4yU7t69m5YtWwqinImJicjLy6OtrU1AQACHDh3i/v37ZGdnY29vT2hoKF27dmX06NGlml+rVavG9OnT0dDQEGqwwsLC2LNnDwkJCWzdupWjR4+ybt069PT0GDp0KH5+fgwcOJCTJ0/SvHnzMt71fx7S0tKQk5PDz89PcFwiIyPJzc1FXl4ePT09GjdujL6+PtWqVStXzZzk5GR8fHzw9vYmNjaWypUr06pVK+rUqfPDgsalQQ0NZRRkpQSdwb/DwnBRkh7/onD8rZ2ZX4Xg+FQhlFcafAkPY92kkWy/5Vmq/S8e2Mlrz0eCM7Pq9FUUingRRUBwXCrWVYrWJSkJagqyaCjI/tfypufm5uLt7c3Xr1+xtLQs8IH9b0R+Q6xSpUqsX7+e06dPs3DhQpo0aSLUOJRk4EiMl61bt2JlZcWsWbNo1KgRsbGx3L9/n61bt+Lh4UHlypWZN28ejo6O37XxK+psSouePXvSs2dP/Pz8eP36NXXr1uXZs2dMnTqVVq1a0a1bN5KTk3F2dsbBwYF27dpx8OBBYmNjWbZsGampqfzxxx+YmJjw+fNnsrOzWb58+U9FoCpXrsywYcO4c+cOt2/fJjAwkO7duxerK5QfIpFIMLCLGsdeXl5YWFgUWB1NT0/nyJEjhIWFISsrS+/evQvU70iK5guDZJxIis1XrlyJgoICkZGRDBo0iF27drFp0ybEYjHr1q1j6tSppb5H6urqggJ3cShNzYzkvjx79oy1a9eSnJxMxYoVady4cbHF+kOGDKFRo0ZcvnyZXbt2sWvXLoYOHcrw4cMLpM6VJKJYGnTs2BF/f38OHTrEkSNHSE1NJSIigqpVq7J3794iDa6cnBwSExM5e/as8Hdh9zgrK4tt27aRk5ODo6NjmeuoioO0tDQ5OTkYGhoyefJk1q9fLywSqqmpsXnzZipXroy3tzfjx49n4sSJmJmZ4ejoyNOnT4mNjRXqfL5FYffV0tKSO3fu4OPjg46ODllZWVSuXLnI1KBz586xYsUK3rx5Q//+/bG1tUVbWxtLS0tiYmJ4/vw5+vr6VKxYkcqVK2NqasrXr1/LXC/Rpk0b4d/JycmcP3+eGzducODAAb58+cKRI0do2LAh27dvB6Br1648fPgQDw8PmjdvLrAIwq9Ja/yzIRaLiY6OFqIu/v7+ZGZmcurUKSpWrIienp6g76KlpVXu3wKxWExwcDBeXl68ffsWkUhErVq16Nq1K3p6en/at0dXRZHKinJ4RyUQmZJRJhvxVyO/pMe/KBz/k85MRHJ62QZpGcuKvjUqJNTGhe77//2x5sedGfjv5k2XkpLCy8uLiIgIPD09EYlEVKhQgapVq2JiYoKlpeXfQq24vJE/StOzZ0+aNGlSJkYnSZHz1atX2bhxo8BaJdEesbe3Z/bs2Vy8eJFNmzZhZmb2HZvW3yH1zMLCQhAN1dPTw97enjNnzjB79myaN2+Oqqoq2dnZREREsH79eiHXe+3atcTExODg4EDNmjVZvnw5Xl5enDp1qoBxXNb0M2lpaVq1akWNGjU4d+4cO3bsoGPHjqU2PIszfpKSkrh58yYvXrzAyckJRUVFXr9+zfnz58nJycHIyIh+/foVWsAucWiKu46IiAiePHnCoEGD0NDQYOrUqXTu3JlVq1YhJSVFtWrVSElJQUlJqdQr3Z8/fyY+Pr5YZq7SODOSfRQUFLC3tycoKIhOnTqhqKiInZ0dbm5uhdYGaWlpoaWlRVxcHB8+fODMmTNs3ryZTZs20atXL6ZOnSqQTfwMJMXM8+bNo1u3bnh5eZGbm0vVqlUxNjbGxMSkyPsvLS0tUIwXF/U6efIksrKyTJs27ZfofEj6Nn/+fDZt2iRQa0tqlVxcXNi6dSuPHj3i0qVLbN68mbdv39KyZUsWL15cZj0bGRmZEtnyJOjevTuZmZls2bKFqKgonJyc6Ny5MytXrsTAwIBNmzaRnZ2NqakpmZmZGBoasmDBAho1alS2m5APcXFxbNu2jfbt2/Pbb7+xc+dOIiIiWLFiBfCfiFPFihWpUqUKAQEBAhlI8+bN/5GaNNnZ2YSHhwtRl9DQUNLT0xGJRFSpUgVFRUU0NTXp3bv3L43aJyUl4ePjg5eXF/Hx8WhqatKmTRusrKz+EsFOyCMFaFRNnYjkDN7HJhObnvW3cWryS3r8i+/xtyYAkKSZrV69mo0bN5KYmEi/fv3YtGkTx44dY/fu3WhpaeHu7s62bdvo378/S5cuZfv27aSmptK0aVO2bt2Kvr4+kKcXMHHSJB56PCInO5sateswavEadI3zWL6O/LEC93MnSE1MxMTKmuHzl6NvUhNHs/+kgoxdvv67dLH8cD97gq2zJwt/n3kbUSDN7MPbN+xa+Dshb99QQbUirfs40XvsFDoYa/Ho/j2mTJnC27dv0dHRYebMmYwcORLI+wjduXNHCHMfOHCAhQsXChoRr169YvDIMbz2ek7lqjp0dB5Ou/6Dy/FpFA8RUKWCPI101H/ZSsrnz5959eoVISEhxMTEkJGRIWyTlZWlUqVKGBgY/FdGb/J/MCMjI0t0avKr0Pfs2RNvb29q1KhBWloaTk5OvHr1ij179gjUzs2bN6ddu3b8/vvvZGVlcffuXS5fvoyKigrDhg37Ls1TYpT+FR/xCxcuMGbMGEHrxMDAgJ07d3LixAlWrlxJXFwcSUlJ6OvrM3fuXCZOnIiMjAyHDh1izpw5PHjwoMi01cuXL+Pu7s6cOXMEoc7ikJGRwcWLF3nz5g116tShffv2xRbjF4eEhATU1NSIiori0KFDqKiooKCgQGhoKDIyMnTr1q1M1M2FITExEQsLC06dOiVolHTo0EFgRqtXrx7r168vdXvv3r3j+PHjtGrVqlgK7IyMDFauXEnPnj3LdA1fvnzB09OT3NxcOnfuXOx4MzAwYNKkSdjb2yMtLY23tzcHDx4kLCxMKLw3MDAo9bkLw82bNzl16hTZ2dmMGTMGQ0NDKlasKEQ9ShLyLGpuzM3N5enTpwLz44/MoaU1qiX9nDx5Mrdv3+bhw4eC0Tp16lSCg4M5fPiwkEKWv91fxeqV/xzPnz9nwYIFpKWl0b9/fxwdHVFXVxfosZ2cnNizZw/BwcF4e3sDP04RDxAcHCzoW3Xv3p3s7GwuXrwI/Od6g4ODSU1Nxc3NTYiQ16hRg507d/7tHZmUlJQCLGMSjS85OTl0dXWFWhddXV3k5OTYvXs32trapa7LLAtyc3MJCgrCy8uLd+/eIS0tjaWlJfXq1UNXV/dvR66QkJ5FcHwqEcnpfwuSJRkpEW0MNf8lBSgE/4jIzK5duzhx4gTZ2dkMHDiQFStWUL16dR49esScOXNYvnw5mpqabNmyhSNHjnD06FGqVKnC2rVradOmDa9evUJaWprOnTvTpHlL1p1fRGpSIrsXz+Hw2qXM2n4Qz5tXuXnSlZlb96Guqc3RDSvZOnsyq05dYdWpK8zs1YFVp66gZ1I8NWuTDl349P4t77yfM33z3u+2b5o5EfP6Nkxcu5WIkCDWTBiOsWUdbKt0p1evXkyZMoUBAwbg4eGBs7MzTZs2FVb0ikJaWhodOnTAydkZl0Wr+Bj4nh3zp6OgXIHmXXv+1L0vLaSlRFhrq/3SyUiiFC1BZmYm/v7+vHv3joiICL58+UJUVNQ/MnpTkiEiWXPw9/dn0aJFbNiwoYCuSlH779+/n+bNmwu1GZ6enkRERKCtrU3fvn3Jzs6mVatWqKqqCgX0CxcuZNu2bXTv3h1/f39OnDjBmTNnqF27ttB+/r7mj2zExsYKVMG/aix07dqVrl27cu7cOSpXroy1tTUxMTGC0B/kMRepqqoyevRoYTU5KSkJLS0tkpLyRHJ9fHzw9fUlJyeHIUOGAHD48GGSkpL4+vVrqZwZeXl5HB0dsba25uTJk3z8+JEePXqgp6dXpmvy8/Pj7NmzODo6Ym5uzm+//cb169eBvOiHs7NzqRnUijLscnJyUFVVpX379syYMYOpU6fSokULlixZQvPmzWnRogVLly4tto1vYWKStxAUEhJSrDNT2pqZb6GlpUXnzp1L3O/27dtkZ2fj7OwsCIPWrl2b2rVr0717d3bt2oWBgQFjx44t0/klfZaSkmLPnj1s374da2trDhw4QLNmzXj06BFbt25l//79NG7cuNh2irqfOTk5JCQkULdu3R+aoyQGd2mNasl+69atQ0VFhfnz59OvXz9q1KiBp6cnnTp1KlDELYk+iESiH3Jk3r59i5GRUbHjN39UsUGDBhw6dIgFCxawc+dOwsLCGDlyJDNmzKB169b4+vqioKDAzZs3C1z/j0LiyADY29vz5MkT4e/Q0FAMDQ0xMjLi7NmzrFq1ir59+9KpUyeOHz/OmTNn6NWrl7D/X03hLBaLiYmJKeC8SIhQVFVV0dfXp3bt2ujp6aGtrV3omElPTy/3yEhiYiLe3t54e3uTkJCAtrY27dq1w8rK6m/9XVZTkMW6ihrWqJGenUNcWiavviaRnJXzl/RHIunxKxeN/6n4Rzgz+YXvlixZwsyZM1m5ciUikYg5c+YIL97q1avZtm2bEL3YuXMnVatW5dq1a7Rs2ZJRo0bRqo8zH9JyEQMtuvfm/N5tAHwJ/4SMrByVq1ZDU0eXYXOXERESCICqeiXh//IKxb/k8gqKKCgpIyMrh7rm96JmX8M/YePQBk0dXbR19Vmw7wTauvqEfY0hNjYWbW1tqlevTvXq1dHR0SlVWtHRo0fR0tJixbJlhCWl8VTfkK/hn7h8cPef5szUy0chGBcXx9mzZwvN4Zd8dLOysqhWrRq1atX64bxYOTk56tSpQ506dYTfvo3eBAQEEBAQwOXLl/820ZvCHJeSHBnJB7JHjx60aNGiUEdGLBYLH1OJAX/y5En27Nkj5PLHxsYiEonYuXMnFhYWXL16FTc3N7y8vHB2dsbb25tDhw6xfv16Bg8eTG5uLn369GHJkiWcPHkSsVjMpUuX8PPzo23bttStW7fAs/P09MTNzY2NGzf+ciro/Pn7W7ZsITIyksmTJxMbG8v27dtZs2aNcN1v377l/v37WFpaUrt2bQ4ePMiYMWNo2LAh796949atWzg4OBASEsLIkSOpWbNmqQ16kUiEsbEx06ZN48aNG+zfv18QNC0LM5iZmRknT55ES0uLL1++ICUlhYyMDJmZmWWi1i6O1Qzy5tMxY8Ywbtw4VFVVOX/+PA8ePBCMam9vb6ysrITV+uIcbSkpKRQUFPjy5UuxfSqtzsyPwtzcnEqVKvHw4UO6du0K5EVrGzZsyOjRo0lNTWX06NE/1Lak7ytXrmTy5MmMHTuWe/fuoa2tzaBBg7h69So7duygbt26ZS5Sloyx0jjORUEyN7i7u+Pp6Unjxo2pU6dOkWl/IpFISCtbtWoVEyZMwNfXl/fv32NoaMiAAQO+O+Znog8lrbhL+pKWlkZYWBgfP36kbt26bNmyhe3bt7Nv3z7Cw8OZM2cOgYGBREdHIy8vj7q6epHOg1gsJj4+vkQNpm9hb2/P8uXL6d+/P7q6upw5c4bff/8dKysrNmzYQMuWLTl06BAAvXv3JiQkhMDAQMLDw2nWrFmpInTliezsbCIjIwuwjKWm5pEBaWtrY2hoSLNmzdDX1y91XV9aWlq5ODO5ubkEBgbi5eVFQEAAMjIyWFpaUr9+fXR0dP5xxriCjDS5iP4yRwby0t0ikzOISM74aRbc/zb8I5yZ/MJ39erV4/Pnz8TFxaGlpSW8dMnJyYSFhdGnT58Ck1daWhoBAQF07tyZ0aNHs2rbLh4/fUZYcCAhfq8FdjL7jt24emQ/Y1o1wrRufRo6tMOhZ79yv5YeI8dz5I8V3DzhSv3mrWjWpSfqmlooqykzevRoXFxcWLJkCZ07dy41Hae/vz8vX778D7MMkJ2dg9SfNKFaaaoWyONUV1enbt26giaEra0tDRo04MaNG7x//x7Iy6VOTEzk6dOnVK5cGVtbW+rUqfPTzCj/hOiNZHzu2bOH58+fU7VqVWbNmiUYq98ajxKDZ9q0acjLy7NmzZoC7UmYrCTGrwSRkZG0bt0ae3t74beGDRvy7NkzQRiuffv22NjYkJCQgLGxMU5OTtSrV09wFKSkpBg0aBDe3t7Ex8czdepUPDw8MDQ0ZN26dTg6OgqFspL22rdvL1xHeRRdlwa///67oAA+ffp0KlSowODBg4Xtd+/eJTAwkH379nH58mV27tzJ5MmTWbx4MYmJibi4uLBlyxbq1KlDq1atgLJTOMvKytKxY0caN27MuXPnCAoKolevXqXKO5eRkcHa2hp/f3+BjnfUqFGkpaVx6NAhDhw4wKBBg4othBeLxdy9exdLS0sqVapUqMOcm5uLsrIyBw8exMfHBzU1NdTU1Lh27Rq3b9/mxo0bfP36lYYNG9K9e3cmT55cxNn+Aw0NDaH2oij8iDNT2lomsViMpqYmdevWpX///ixatIipU6cKkUIPDw9MTU1/yiBPSEjg69evDBo0iNTUVKKiogQChoULF9K1a9di60mKcozL4/348uULQ4YM4cmTJ9SpU4eDBw+ya9cuIYW0MEj6Om7cOCZPnoyjoyMODg4CG1t5QllZudj0OklfunTpQmpqKkFBQZiYmFCvXj02btyIrq4ua9asYcKECTg5OdGrVy+hvcKcBsn8eeLECbS1tenevXupHQxbW1tevXrFzJkzSUhIYMaMGVhaWnL69GliYmK4cOGCsO+5c+fYtWsX79+/R05OjgoVKnDx4sUC35/yRlpaWoGoS3h4ODk5OcjKylKtWjUaNGiAnp4eurq6P/QtE4vFPx2ZkSyIeHt7k5iYSJUqVejQoQO1a9f+4RTcvwv+myQ9/tvwj3Bm8k9Cko+hnJxcgZc1OzsbgFOnTn2n0q2hoUFycjI2NjYoqqlT+zcHmnTsRnhwIG77dgCgrqnFpiv3eelxj+d3b3Fh33ZunTrC2nM3yvVauruMo3H7LnjevMrzOzdZOLgXoxavxnjECLZt28bYsWM5f/48586dY+fOnUyfPp1u3bp9147keiX/dnBwYOvWrcJvH+NTefsnvHhWWqrUUP+eYaN+/fqEhYXx9etX2rZti0gkon///nz9+pWbN2/y/v17QdwQ4MqVK7i7u1O/fn1sbGzKrfDw7xa9kXxUt2/fzsKFC2nVqhWOjo7Iycnx6dMn9PT0ChSVSlYtHzx4wK5du7h69ep3bEAikYiJEydy48YNevfuzYABA6hZsyZVq1YVUpUk0NDQYMCAAWzYsIGKFSvy4cMHli5dSseOHZk3bx6enp5MnTpVMJqzs7Np27YtnTp1YuTIkXz9+lVYlfby8mLYsGGcPXuWHj164O/vz549e1iyZAlKSkp/ei65lZUVkJde5ODgIDjG/v7+3LlzRxgH8+fPx8rKinHjxiElJSWwI928eZOZM2eio6PDokWL6NSpE/Xr1xfaL22kRl1dnaFDhwrF6La2tpibmxdr0J05cwY/Pz+kpKQwNTUlICAAd3d3OnbsyODBgzl48CAHDhzA2dm50BXWtLQ0zp49S2BgIJqammhqahZ6rvzPRKJvs337dtavX4+lpSXbtm3DxsaGM2fOMHPmTEaPHo2CggKvXr1CJBIVSnKgp6dHREQEnz9/LtKQk1x7WUs0SxsZk5WV5dChQzRo0IBdu3axcuVKGjZsSGRkJOnp6Rw+fLjYNsRiMbm5uUUavCkpKUJEr02bNqipqQl1V1+/fhVqEIpzWgo7Z1kcmaL6+PTpU+Lj4/H390dLSws/Pz9BG6a480jmlvfv3xeoISvvyEJx1ygZjy4uLsTGxnL16lXk5eUxMjKiadOmhIWF0a5dO4yNjRkxYgRhYWHFtpeTk0NOTg5ycnKMGjWKxMREwsLCyjSP6+joCOMlOzubLVu2cPbsWbZs2SIsLgYEBDB48GB69OjBkSNHqFChAv3792fcuHEcP368XO6fWCwmLi6uQNRFwhxYoUIF9PX1adWqFfr6+mhra5fLOTMyMhCLxWV2hHJzcwkICMDLy4vAwEBkZWULRGH+G/Ajkh6/AuUl6fHfhn+EM/Pq1SuaNWsG5E3curq63xl0FStWREtLi6ioKDp27Ajkrcr37duX6dOnExMTQ0REBPfcPQhJzEAMvPS4h4RR/MXdW3yNDKddv0HUb96K3mOnMLxpXT4GvKVi5e/TxYpDUZNtZkY6h9cuo9vwMXQZMpIuQ0ayc8FMnty4Qu9uXRk1fwbDhw/H2NiYbt26ER8fz82bN6lfvz5ycnJCrj/kFS1KULNmTS5cuIChoaEwoT1xdcXL4zFdp8wrd950EXk1MiWJOUnSPfJDU1OT/v378+XLF27dusX79++Jjo5GWloadXV1nj59yqNHj6hVqxaNGjX6JRPhXxm9kZaWJj4+nlWrVrFnzx46d+6Mr68vv//+O3v37kVTU5NTp05Rq1atAquWQ4YMYfLkyUXWJcycOZPatWtz8uRJNmzYwIULF2jatOl3q8VKSkpMmzaNKVOmCEa2qakpTk5OJCcnY2BgQGpqqmBk5D/+9OnTxMfHM3DgQHr37s3w4cPR09PDy8uLHj16sGHDBm7fvs2YMWNYtWoVTZo0YdCgQT98r34UkyZNKvC3m5sb7969Y+vWrYSFhfHlyxe6du1aIFUvODiY1q1b06lTJ27cuMGFCxdQVlYu4MyUdQXdwMCAIUOG8PbtW27evEmzZs2+W5n89OkTR48eJT09HU1NTZydnalQoQI+Pj64ubmRkpKCo6NjAYdm0KBBBVKIoqKiOHHiBBkZGQwYMEDQ6CgNvLy8mD59OitWrCigaj927FiuXr3KgQMHUFBQ4MKFC6SkpHDjxveLO2ZmZnh6euLn51esMyOhpS4NcnLyUjmKMtAkzn5aWhqvX7/m3Llz1KxZE0NDQ/bs2cO7d+948OABjo6OtGzZskQ2s5SUlCIpg3NyctDR0WHatGmsXLmSAwcOICUlhY+PD+7u7uzcuVOIAhbnEOVHWR0ZyfVKS0uTmJjI69evsbOzQyQSce/ePTIzM/n48SPPnz/nzZs3nDx5ElNTU/r27YuUlFSx55M4MpJ9/syaD7FYTEZGBpGRkSxduhQtLS3GjRuHjo4OkyZNYsuWLVSsWJEpU6Zw7dq1YnVtIG+c5U/HVFVV/amFsbS0NG7cuEHbtm2FiDNAnz590NTUxM3NDU1NTVavXs2iRYtwcnIiNja2QGS0LBHGqKgoPnz4IERfUlJSgLzvpr6+Pk2aNBHoqX9FxDstLQ2g1JGZ+Ph4vLy88PHxISkpCR0dHYHZ8Z8ehfkWJUl6PHO/zq5Fs0lOiGPG5n1YN21e5nOIxWKuHztYInlTeUh6/LfhH+HMjBs3jj179pCYmMj8+fOZPn16oftNmTKFOXPmoKWlhZmZGUuWLMHDw4O9e/fy9u1bkpOTuXftCgr6prx8fJ+rR/ajVCFvBTo3N5dDqxejXlkLQ3NLHl4+j7yiIjrVjcjNzfuwfnj3BhV1DRSL+OhJIK+oROyXz3wJ+4SW7n8KgeXkFXj74il7oyIYMHkWaSkp+D1/QkOHdsTHx3PkyBFevHhB48aNSUxMJCoqilq1aqGhoYGNjQ2bN2/GzMwMf39/9u/fL0wWTk5OLFy4kJEjRzJt2jSCg4OZMGECU6dOpY2hZrnxpkuOr1JBHmtttZ9i1NDS0qJ///58/vyZ27dv8/79eyIiIpCSkkJPT4/Q0FBevXqFvr4+jRo1ombNmr9spf/Pjt7ExMRQqVIlMjIy+PjxIy4uLmRkZLBo0SIuXrzI77//zoULF4TrHThwIFpaWsydO7fINqtVq4aLiwsuLi7ExMSgoKBQZNqLpaUlN27cIDMzk9DQ0ALGr6SOZsqUKaSkpLBixQqCgoIYNGgQWVlZ3Lp1ixs3brB+/XomT55MSkqKQL16/fp1XFxcMDY25smTJ1SrVk1oNykpiU+fPmFhYfHdyu/PMBGVBgYGBtSvX58mTZoQGRmJj49PgZVrCXNRr169kJOT49SpU5iamtK/f39hnz179tC0adPvor7FQXJNNWvWxMzMjICAAJSUlNDV1SU3N5eLFy/i4+ODSCSiZcuWNG3aVDi2bt26KCsrc+rUKQ4fPky/fv0YPHhwgZQzdXV1fH19uXjxIpUrV8bZ2bnMKvE+Pj5YW1sLrIkS3LlzB29vb9TU1AgKCqJGjRoMHz680DYkbJEfP34s8X6U1pkpiUBCsm3s2LG8fv0aTU1NoaZlzpw5mJqaltqRzsnJKXYMSsZqt27dSElJ4dy5c6SkpFC/fhnk9ZkAAQAASURBVH1q1KjBxIkTGThwoNDv0qCs410SrZ06dSr79+9HWVkZOzs7tm/fTp8+fXB3d8fW1hZ1dXUsLCwIDw9HXl6esLAwZsyY8d315q+ri4uLQ1395wqK86e6lgaSPiQlJaGqqkpqaio+Pj5ERERw8uRJbt26hZaWFsnJyZw5c4aRI0eW6MhI7lN5QkVFhcuXLxc4382bN4mJieHevXtERUXh4uLCixcv6Nu3L9HR0VSoUEHoR/76k5IiXrm5uYKobWpqKtbW1gLL2J9FVVwaZyYnJ6dAFEZOTg4rKyvq1atXJumAfxpKkvQ4vmkNde2b0WvMFNQqFS3HURz8nj1h9+LZJToz5SXp8d+Ef4QzI1HLzszMZMSIEUyaNEkowsuPadOmkZSUxIgRI0hMTKRBgwZcv34ddXV17OzsmD9/PktmTCE1LQ2Dmua4zFvOtrlTifkciU3LNvQdP539KxYQH/2VakbGzNy6nwpqFQH4rYsj6yaNYuC0OXQa5FJsf21bt+fGicNM7NSMHbefFtg2Zf0Odi+ezcxeHZCWkaFxu870HDMJfcU8o/XixYts374dOTk56tWrR926dXn06BEtWrTg6NGj1KpVC0tLS6ZMmcKWLVuAvAn36tWrTJo0ibp161KpUiXGjRvHrFmzkJKS+mnedMn+6gqymGhUQKeCfLkZn9ra2vTv35+oqCjc3d15//49oaGhABgbG5Oens7JkyepWLEiDRs2pF69en/Kis+PRG/69OlTqsJGY2NjrKysmDlzJiEhIbRu3Zp58+Zhb2+PkpISx44dIzU1lQoVKuDv709AQAB79+4tdT1RpRImUsmqt5yc3Her+EOGDGHo0KEYGhqiq6tLXFwcy5YtIzk5WYhMtWjRghUrVvD69Wv8/f0xNTXl48ePhIaGCnUrKioqVK1aVVhR3rdvH6tWrWL//v20bduWpKQkIZXtV9fU9O3bl969ewN5dS2NGzfG29sbOzs7vnz5wrp16zAyMqJdu3Zcu3aN4OBg+vfvL0QFc3NzkZWVLRMpQH5I9q9RowYikYjQ0FCuX79OREQEGhoaDBw4sNBibRMTEwYNGsTRo0fZt28fTk5OQoRm//79GBoa4uvrS506dejYsWOh46Oo/kp+z8zM5PPnz4LxFR0dzZMnT9i1axcZGRlkZ2cze/bsYmlapaSkUFJSKlE8UxIhKA1KojGWkpLC09OT8+fPc/v2baytrdHV1aVBgwacO3cOV1dXDh06VCpWOT8/vwJMfRIEBQWRlJRE3bp1sbKyYvv27QwYMIABAwaQnZ2NtLQ0mZmZwnz0s055YmKiEEWQpIBJkJaWxrhx4/D39+fUqVPIyMgwceJENmzYwOLFi7l27RpBQUFUqVIFaWlpNDU1GTRoEAEBAcL9khjT+Q3qnJycUheGF4b8dXGlvXYJoUlMTAx9+vRh9erVuLi4sHPnTjw9Pdm1a5eQMmppaYmvr2+BcfNnF47nT5EUiUTIy8uTk5NDWloadnZ2PHr0iIkTJzJy5EicnZ1RVFQUiFcAWrZsye+//460tHSxZBrS0tIoKCgIc9VfgeKcmbi4OLy8vPD29iYlJQVdXV26dOlCrVq1fjnZy1+N9OycEqmZU5OSMK/XEK1qP56aXpY03IycXNKzc/6laf5//K11Zn4F0rNzuBJUPPPOX4EOxlqQncXVq1fx9fUtsM3GxoasrCxiY2OJiYkRQs+QV1xZqVIlNDQ0qFSpkvBvDQ2NQo2bwnjTC/s0SAaFvLQUOhUUMKqohJrCr8/PjIyMxN3dncDAQOEjYmJigkgk4v3790KhtGQV8q9E/uhNtWrVBEP+W0iMiOzsbGEFU5Jml5uby5AhQ4iJiaFy5cq0atUKHR0dwVnPzMwkJCSkTBGB8sDFixf58OEDvXv3Rltbm6CgIJo3b86KFStwcnICYNu2bejp6dG5c2dmz57N5cuX8fDwAGD06NHo6uqyYsUK3r9/T8uWLZk7dy4jR47kwYMH7Nixg8ePH2NhYcGcOXMEzZM/Azt27GDs2LF0796dV69eER8fz549e2jTpg0uLi5kZmayceNGwZlNTExEWVm53NJvcnJyEIlEhIWFCVGN4hATE4Orqys5OTk4OTmRk5PDvn37yM7OplmzZjRr1uynDDw7OzuMjIxQUlJCVlaWt2/fUqFCBVxcXArQIhdnrO/bt49Pnz4xb968Io21FStW0Lx583J71kuWLMHHx4czZ86we/duVq5cybt370hISMDa2prNmzcXmuqaH2KxmJs3bxZQhZfgzp07zJkzB5FIxOPHj+nSpQu2trbUrFmTmjVroqenh6qqKq1bt2bPnj0/pWEjKXp//Pgxtra2wu8RERHo6Ojw9u1b7OzsePDgAZaWlkRHR2NjY4OGhgYrVqygTZs2PHjwgAoVKlC3bl3i4uJo06YNU6ZMoX///gWMaEm9ZVkFMItDXFwcx48fp3Xr1hgbGxc5TvKPoZ07d/Lw4UMOHz5MdHQ006dP5969e0yYMAFzc3NkZGQYOHAgY8eOZc6cOeXW15/Fmzdv6Nu3Lxs3bqRly5ZAXppqTEwM2dnZ2NnZCbp4GhoarFu3DkNDQy5cuFCA8vrviDdv3nD69GlmzpyJgoICOTk5vH37Fi8vL4KDg5GXl8fKyor69ev/UqKDvxuiktN5FF60KPmolg35GhEGgKaOLpPWbuHw2mUE++XVGlrY2DF26TrUtfLumfeDOxxZv4Lw4ECqGhgx+PcFVNGrzuhW/3n3Fx08jaVt8XTvjaupU6XCv0QA8D/ozABcDvz8txBAkkBeWoqONf4zMfj5+eHm5iaIQkomFgkyMjKIiYkR/pM4Od8KSaqqqhZwcCT/loi8pWfnEJ+eRUJGNlm5ueSKQUoEslJSqMnLUFFB9i/z+iMiIrhz547g1IjFYszMzFBSUsLf35/09HTMzMxo1KjRD1M7lzcKM/by/zZ69GiCgoIE/RMHBwcgz2hatmwZ0dHR5OTk4OPjIzg/5WlwlAbFrRzOnTuXgwcP0qJFC2JiYnB3d+fSpUs4ODhgZGSEs7Mzc+bMQVZWlmbNmtGpUyfGjh2Ls7MzKSkpXL16lcuXLzNz5kw6depE+/btcXV1JSgoiAsXLhTL1FXeiIyM5Pr165w8eRI1NTW2bdtGQEAAkyZNwsXFhaFDhwr7/iqq1ZycHOFelzR+k5KSOHLkCHFxccLquoyMjKCtUlTBPxT9TCXX9erVKyZOnMjz58+xt7enT58+ODs7F9CG+fb4b8e6u7s7Dx48YOjQoUVGQ1atWoW9vX2xejSFtV0Urly5wpQpU3j48CFNmzZl5MiRQr1U586dMTMz+47579vzREVFoaGhUWi0Nycnh+PHjxMcHMyCBQvo27cvcXFxJCYmClTZycnJvHr1iszMzJ9+V1u1aoWysjIXLlzAzc2N2bNnA3npjy1atMDd3Z2+ffsKYqC6uroEBARQr149/vjjD9asWcO+ffvQ1tbG19eXZs2asXfvXqFe6PHjx2hra2NgYFDm8SxxwPOPg+zsbJ4/f86rV6/YsWMHHTt2ZPHixaVqb+bMmezevZs+ffoUoHGfOXMmz58/x9PTk1q1amFtbc2OHXkkPb8iHfVH21ywYAHr1q2jXbt2vH37Fn19fXbt2oWuri6+vr7Iycmhr6+PkpIS4eHh2NrasnbtWvr27fvT5/6VeP78OVeuXGHMmDF4e3vj4+NDamoqenp61K9fHwsLi59mHP0n4l1MMn7RSUVmtCTExjC9Rxu6DB1NQ4d2TO3Wis6DR9Csa0/ivkSxZdYUrJs2Z9jcpYS+f8e07q3pPXYKjdt34cmNy5zZsZFNVx/w/qU3ayYMZ88DHyqoVUS2OG0mwKKyCjUr/b0d5D8L/5POjHdUAh8SUn+ofmTf8vncPn20yO09RkzAcdSEUrcnAqqrKX1XyJWUlMT58+dJSEhg3LhxpWpLLBaTmppaqJMTGxsrrMhJGJy+dXIqVaqEqqrq32qCDQ8P586dOwQFBQl54zVr1kRLSwt/f3+io6PR0dHB1taWWrVq/aWCZYVBYghOnDgRNzc3unbtSnx8PPfu3aNv377Mnj2b5ORkzp49i6qqKk2bNqV69ep/iSNTWL+/hbu7O8eOHRPEDBs1akRgYCDm5uY8evQIGxsbABo1asSsWbO4ceMGYWFhLF26lNq1a9O+fXs+ffrErVu3hAJ8BwcHWrRowdy5c0lLS8PLy4tbt27Rt29fTE1Ny5SLX1bEx8fj5+dH48aNefz4MW3btsXLy6tMRfSFQVIbUpp+l4bCWiwW4+Hhwe3bt4E8GltTU1MOHTpEcnIyzs7OP7VSOmTIEOzt7XF2dhaMlaLGQFZWFl5eXgUiCJGRkezatQs7O7tCoxyQpwNmZ2dXoDaorPi2T926dePDhw9ERkbi7++PoqIiERER2NjYcPbsWUFzrDBIBAZLIgf49OkTx44do1evXgItc1RUFBEREWRlZdG0adOfuiYJvL29BTa2U6dO0bp1a2JiYrhx4wY2NjZs27aNV69esXjxYpo0acLkyZNZuHAhu3fv5siRI/z22294enry8OFD7O3tC0TAfHx8GD9+PA8ePPipPmZlZQlaYU+fPmXevHn4+/uzdevWUombSvD48WNGjx5NVFQU165dE5j1IG8sZWZmIisrK6R6lueCQnk5Effu3ePq1asoKirSu3dvFBUVmTx5spD2aGxsjIODA02aNMHR0REnJ6fvqM4lCxp/h29udnY258+fx9/fn9zcXBQUFKhTpw716tVDS6tsJEj/bXj9NZH3sSnF2oyjWjak97ipWDdtwYOLZ+k8ZKTwXF3XLSfwlQ8LD5xk/4qFhPi9YvHhM8Kxxzaupmnn7sR//cqCQT058zaixD6JABMNZSw1y4f59Z+O/0lnJiE9i9sfo3/s2NgYUpMSi9xeQa0iKhXLlv7kUL1ykRR75TXxisViEhMTC3Vy4uLiBONLRkZGcHC+dXSUlJT+skk3LCyMO3fuEBwcLDg1NWrUwNjYmMDAQIKCglBRUcHGxob69euXWbzuV+LVq1fY29tz584d6tWrx4QJE7h48SI1atRATk6OFStWCDnif1cUNw7Xrl3Lhg0b8PX1RUNDg8TERBYsWEBISAgPHz7k6tWr2NjY8O7dO6ytrbGysuLdu3dUqlSJ8ePHs3XrVkGYc9SoUVy5ckWg9razs6Nz5840a9bsl+dlh4SEkJycjKWlZYnjPCgoCGNj4xKjFmV5f4vaNysri4sXL/Lq1SsaNmxIcnIy/v7+dOjQAQsLCw4fPkxCQgLOzs6FiqmGhoaiq6tbbHQmv7FYUp/9/Pw4deoUEyZMKJDquXjxYnR0dIokCli7di0NGzYsVv+kNPjy5QvNmzfn2LFj6OjoMHXqVFxdXWnRogVycnIEBQVRp04dTp06VWQbEhat4pgJJQsKa9as4f79+wJRRH6Ud9RuyJAhHDx4kEGDBrF//37EYjGbNm3i6NGjrF+/nkOHDvH+/Xtu3ryJlJQUEyZM4NChQxgZGeHq6oqFhUWBa8zPrhYdHV2i41YYi5xYLObEiRNs2rQJBQUFGjVqxIQJE6hcuTK///47bm5uvH37tswLDl+/fsXZ2ZnHjx/j6upKp06dCt2vPCMY+dt69OgR0dHRtGjRolyiwnv37mXkyJGEhYXx5s0bgoKC2L9/P+Hh4YhEIm7evIm+vj6XL1/m7du3dOvWjVq1an3Xrz8b0dHRAiNZWloaMjIydO7cGQsLi790Qe3PRHBwMHfu3KFmzZpYWlp+V8Po+yWRoLjSOTMte/QhMS6Gu+dP8+HtG8ICA/jwzg8zaxsWHz7DspEDqWZYg8G/L/iujdeej8rkzBirK2Ol9a8zA/8QAoDyhpqCLBoKsj/EGa6mUQk1jR9jqvgWIvKK6ovjCi+vCU4kEgkCeUZGRgW25eTkEB8f/52T8/r1axISEoT95OXlC01b09DQ+OVik7q6ugwcOJBPnz5x584dQkJCBPVlIyMjunbtSmhoKPfu3eP+/fvUqVOHRo0alfjx/lX49uNka2tL3bp1efv2LQEBAWzevJnk5GQGDhzItWvXGDNmDJs3by5Tm2WBpGD5R4/Pn3IkKeCV9GnatGk4OTmhoaGBWCxGVVWVDx8+4ObmxvLly4VozZs3b1BQUODJkydERERw7do1Tpw4IZALnDlzhrNnz3Lw4EHat29PVFQUbdq04fTp02zZsoUePXr8UN9LC0NDw1Ld4wMHDjB58mTevn2Ltrb2d8eIRKICehelhYTtK3+UJjY2lpMnTxIbG4ujoyOWlpaIxWKuXbvG5cuXSUpKYuDAgbi6unLw4EEGDhz4HZ35+/fvi0z9kjzH/MXJ+a+lsPtRo0YNZGRkePPmTQFBVmVlZWJiYoq8PskixM8gNzcXTU1NGjZsyKhRo1iwYAGHDh1i8uTJ7N69G3V1dcaPH19AaLkolDRnSYxzJSUllJSUChToS1BSUXdZMX/+fM6cOSNEBiVMd48ePWLt2rVoaGhgamrKly9f8Pb2xs/Pj/nz59OoUaMCjkx+KmcJSjMXSvbPf02PHj1i5cqVdOzYERsbG9avX4+/vz87d+7EwcFBqKErKzQ1Nbly5QozZsyga9euLF26lFmzZn23X1nnLEnf819DUlISycnJVK1albNnzzJhwgRyc3NRVVWlevXqrF+/HnNz8592KqysrNDU1MTBwYGWLVuioaHBiBEjWLlyJaampowbNw5XV1datWrFkiVLWL16NRMmTPjTHZns7Gz8/Pzw8vLi48ePKCoqUqdOHeLj40lKSvrbL66VN2JjYwkLCyMsLIzbt29TrVo1rKyssLCwyGOnK8PjifkcyYye7TG2sMKqyW+06jWAF/du8d7HCwDpcnQQy9Kv/3b8TzozACYaFfCMKLqg68+A+P/78VdDWlpacExMTEwKbMvKyiIuLu67Gp3g4OASiQgqVaqEurp6uebY6unp4ezsTGhoKHfv3iUkJITQ0FCCg4PR19ene/fuREdH8+zZM168eEGNGjVo1KgRRkZGf+oHQ3Ku1atX4+XlxfPnz/Hy8sLX1xctLS2sra3R0tJi9+7dtGvXjp49e5bYplgsZvfu3cJHuXbt2oWKGH6Lu3fvcujQIe7cuUPbtm2ZNGnSDyt9f2u0Sa5TEhGQ/N2iRQvMzc0LrNLn5ORQqVIlvL29sba2ZujQofTs2ZO0tDRSUlJYv3499evXF/QcqlSpgpmZGe/fv//p1fzSojRjpFatWjRo0IDJkydz9OjRQo/5ljVKgtzcXEGxOz4+/rsVQMn9jY2NJTo6mnPnzqGkpMTw4cOFVA+RSES7du1QUVHh9u3bJCcn4+TkxNGjRzl06BADBw4sQIudm5uLv79/AWO3MOR/thKiCj8/v+/GmJycHKampvj5+RVwZjQ1NQkJCSnSuC8PZ0bS7o4dO1i/fj2rVq0iPT2dbt26sW3btlI5FmVNRvDz8+Ps2bP4+fnRuXNn6tevT+3atalRowZSUlLlmgJpaGjI4MGDcXV1ZcaMGcjKylK7dm2aN2/OpUuX+Pz5M5BH3Z2WlsayZcsKTUP+0T6dOXOGzZs3k5SURNu2bVm4cCHLli2ja9euLFq0CMgzhHv37k2jRo0YP348CgoKP3w+kUjEmjVrsLa2ZsSIEdy5c0egv/9RxMfHs23bNrS0tBgxYoSQ0rt27Vo6dOiAq6sr/fv3Z/Xq1bx7945z584JNVPF1TyWhM6dO7N582ZsbW0ZP348jx494smTJzRv3pwRI0YAcPv2bSZMmMDixYtxdXVl+fLlODo6FnhffyW+fv3Kixcv8PX1JS0tjerVq+Po6IiZmRkyMjKcOHHiT6OB/jvh23k4PDyc8PBwrl69ipGREQ07dC91W543r1JBrSKzd/6HcfeK6z5h3qlqYEiI/+sCx8zu25kOA4ehrlm2VGHZP1mY+u+M/1lnRqeCPFWV5YlKyShXQcnSQkSeXotOhb+3sJSsrCxaWlqF5symp6d/F8358uUL/v7+BYgI1NTUCo3mSIgIfgT6+vo4Ozvz8eNH7ty5w8ePH4mMjOT06dPo6OjQoUMHMjMz8fT0xNXVFU1NTRo1akTt2rX/tAJGiZpylSpVOHz4MNbW1pw9exYpKSmqVatGYmIiiYmJWFhYlBgVEIvFhIaGCnS6AQEBKCoqUqtWrWI/tl++fGH48OH07duXS5cu8fbtW3r06MGOHTvIyMggKSmJbt26lSisV1ZMmPB93VinTp3YsWMHe/fuZenSpdy7d49Vq1bh7OxMhw4d8PX1pW3btsL+nz9/RkVFhdq1axe6qpy/v7+qSD8/JIayjY0NY8aM4ffff2ffvn0MHTq0UCP62yiLZB/JfkuWLCE2NpY1a9Z8d32PHj3ixYsXmJqa0r179++iCCKRCHt7eypUqCCIa/bt25eTJ09y+PBhBgwYIERjlJSUuHfvXonOzLftX7lyhefPnyMvL//dIketWrU4deoUsbGxaGhoAHmGeEhICMHBwYXWHJVFZ+ZbSFK+AgICUFVVRUZGhlmzZqGvr8+QIUN48OABv//+e7FECPn7URpInpO9vT2ampq8fv2aBw8e4ObmRmJiInJyckhJSXH//v1C0/t+FHPmzGH//v0cPHhQWAxwcHDg2bNnBAQEcPbsWTw9PWnXrp0wl5X07kq2F1ef5ebmxrJly+jYsSM6Ojrs378fCwsL1NTUiI+PZ86cORw4cICcnByGDh3KgAEDyi2dt3///tSoUYOjR4/+0PyclpZGTEwMurq6pKam8vr1a4Gifs2aNTRv3pwBAwbw5csXnj17hpGRER8+fCApKYn+/fsXyipY1vlQS0sLH5//Y++sw6q83z/+OnQ3CAiKAiKiIFiIhTk7p86YOt1m52znZnfMmDprtjOwA3UGBoKiGISigtJdEoc45/z+4Hee0YLi5vb1fV1cwHme83k+T9/vO973I+bNm8eTJ0/Yu3cvdevWZc+ePYIUvYODAwcOHGDYsGG0bt2axYsX8/DhwxJkpiqfZ3l5eUKfPT09PRwdHWnSpAlaWlolhC+MjY3/k6llMpmM7OxsUlNTSUlJKfV3aRCJRJibm6OrqlRhO1FbT5/E6Cie3L2FiUUN7nqexffyeawbNATgi6+GMbmbO2d+/40m7Tpx1/McES9DqNfYleT4AmfFq4AnWNrWQUW17OixDNBV/e+dq/fF/+yREIlEOJvqcjksgXzp309nFBVEOFfT/SQK/94XampqmJubl0hrKS5EICc64eHhPHr0qFQhguJkp6JCBDVr1mTEiBG8fv2a69evEx4eTkJCAseOHcPExITWrVujoaGBr68vZ8+e5erVqzRu3Fh4mFc1Chu1qqqqDBgwgLFjx+Ln50e7du0wNDTk5MmT7N+/n8uXLyOVSunWrRtQvpElEomwsrLiu+8KehxJJBKBLJVHgPbv309cXBzDhg3D1tYWBwcH3rx5w/r16zlx4gRmZma8ffuW4cOHExgYSI0aNdDR0flgYlPay1hdXZ2ZM2cyffp0atWqhbm5Oba2tvTv3x9DQ0OCg4OLNMQNDQ0lKiqqzL4LIpFIMHLltQFVmfJTHPJxIyIiePz4MdbW1ixfvpyuXbtiampaYtuF/169ejUBAQGoqqqyfft2QkJCeP78OVZWVqUStcTEgpq+vLw88vLyykyJKtxc8+jRo/Tt21foszJ48GBq1qyJuro68fHx5R6b0s53+/btefDgAefOnStRuGxra4uysjKBgYFC8Xu9evW4du0az58/L5XMVKbPTHHIz3HTpk1RU1OjQ4cOSCQSOnXqxObNm9myZQvbtm1j7ty55RqB73NdDxo0SPg7IiJCMIBCQ0N5/fr1exMZeSqikpJSkfNSrVo1pk2bxqJFixg8eDAaGhrUqVOH1q1bU7duXQwNDYVie/n1/y4iI5VKefz4MV5eXoLiW3GcOXMGXV1dFi9eDBQ0Y87NzeXy5cuCWtnGjRvp0KEDioqKqKurV6kDpGnTpkJ6YGUEUCQSCWFhYQwaNIghQ4Ywc+ZMatWqxaNHj/jzzz8JCwsThDNMTEyYMmUKS5YsYePGjdStW5e8vDy++OILZs2aVaTp4/vu19KlS0lPT+fEiRN8//336OjoMG/ePHr06MHq1asZOXIkixcvFmoNO3bsCBTU4aWnp+Ps7Fyiju19IJPJuHr1Ks+ePaN///5ChLW8/ZJLTf8bkZeXJ9ybcoJSmKwUdrCqqqqir6+Pnp4ederUQUdHh8uXLxcZz8LCgj59+mBgYIA4X1Lhebh16UmQny9rJn+PSCTCur4Tw2f9zJFNa8jLzcG0hhUzNu7gwLplHFq/AkubOszeuheDaqZo6+vj5NaauYN6MnXtFlw7ld7uQQ69v6Fdxr8F/5MCAIUR+Tabe9Gpf/t2m5rrYaH9vxfOLSxEUFx1LSUlRTB23keIQCaTERYWxo0bN4iIiEBVVZWcnBwMDQ1p3bo15ubm3L9/H39/f6RSKfXr18fV1bVKvapyHDlyBDc3N8E7/tVXXyGRSBgzZgyHDh3i6tWr1KhRg3379mFlZfVRIgu5ubksWrSIQ4cOkZubS3p6OlZWVohEIl6/fk1aWhrz58/nzJkzTJkyhfHjx/P777/z5ZdfEhISgqmpKfr6+uTl5VV5NCsqKoqkpCQhNzsnJ4eBAweip6fH77//TmpqKrNmzeLx48d4eHhgYfH+jcgqg3cZZ2FhYTg6OtK/f39iYmK4d+8ebdq04cSJE+WOO3PmTBQVFbl//z4GBgbUrFmTp0+fsmDBAlxdXYtsNycnh8jIgp4Fp06dQiKR0KNHD+zt7cscPzIykkOHDqGpqcnAgQM5f/48UVFRDBo0iJycHI4cOcIPP/xQgsDLtxsfH19q9PXkyZM8efKEvn37lmgsefz4cRITExkzZozw2eLFizExMWH06NElxvr111+xsbEpEn2rDLKysti9ezfr16/HwcGBfv36sXv3bt68eYNEIiEqKopz586V2e/pfREREcHq1at58OABlpaWuLi40K9fP6Gpb2XrBWUyGQEBAVy/fp2aNWuW2gvn7du32NraMnr0aCG9q7JEXV7fdu/ePW7cuIGhoSHOzs64uLiU+qxZvXo1ixcvpnfv3qSkpGBkZIS1tTWRkZG8evWK3bt3C8+zrKwsVFRUqtSLL38Gvn79GisrqxLLC0eXSjsOR44c4fXr14Ls8+7du3nx4gXq6up4enoKxfZQ4CyIjIwkJCSEJ0+ecP78eYYMGcL06dOrzCEivzaSk5OpX78+y5cvZ/jw4ezbt4+JEydy4sQJ2rdvj5eXF8ePH+fgwYPUrl0bsViMh4fHB/cWk/dQql+/PmZmZv9qxykUXM/p6emlkpWUlJQiae+Kioro6emhp6cnkJbCv9XU1EocjzVr1pCZmYmioiLt27enWbNmRa6DT72lx/86/ufJDMDL5EyeJJStUFbVcDTWwcZA82/b3r8FciGC0qSl09P/Oj/vEiKQyWSEhoZy48YNIiMjUVNTQywWo6enR6tWrbCzs+Px48fcu3ePtLQ0rKyscHV1pU6dOlXywH/w4IEQ+Zk2bRpubm5kZ2dz584dnJyc6NOnD7m5ueTn52NkZPS3pEgBZGZmEhUVRVBQEHl5efTv35+bN2/SuXNnXFxcGDx4MOPGjSM7O5vFixezdu1afvnlF/r164eqqiq6urpVErEpS4r07t279OvXj5o1a2JmZsapU6eEzuAVxYfOz9vbGzc3t3LPycaNG5k0aRK5ubmcP3+euXPnMm7cOCZOnFimuplcXjo1NZXu3buTmZlJp06dWLlyZZF1pVIpOTk5Qt56VlYWZ8+e5dmzZzg7O9O5c+cyRQUKN9ccOHAg165dIzw8nPbt23Pp0iXGjRtXahrWy5cvOXjwIL1798bJyanIstzcXFauXImamlqRqBlAcHAwR48eZfz48UJ0af369YjF4lILubds2UKtWrWEmqj3QX5+PseOHWPGjBm0adOGrVu3kpuby8OHD0lNTa2y7uny8+jl5cWsWbNQUlKiTZs2REZGCipY69evZ8SIERU2fmUyGa9eveLq1avExsZiZ2dHu3btypS9XblyJffu3ePYsWMl6pnKu8blPWHk/Vqsra1xcXF5p9NGIpEwZ84cAgMDqVatGnFxcQQHB1O9enWMjY1JS0tj1apVODg4oKysXOb9Ud7xKGuZPBJz9+5d2rdvz8OHD4vU9UkkEnx8fLC3txeERooLVWRkZKCiooKqqirXr19n7NixaGpqYmxsTEZGBhs2bKBRo0Y8e/YMPz8/2rdvj5mZGYmJiXTp0oU+ffoIvX2qEpmZmYwYMQITExM2b96MSCTCxMSE5cuX07p1a8aOHUtubi67du3C1NSU6dOn8+rVKzw8PNDV1X33BspAZeThPwXIMzoKk5XCv9PT04ukqero6AgEpThZ0dbWrvR7wMPDg9TUVHr16lVqtPxDWnpUNcpq6fG/jM9k5v/xdxEaRxMdbPQ/E5nKIi8vj+Tk5BI1OklJSWUKERgYGJCfn8+zZ8+Ij49HXV2d7OxstLW1admyJQ0bNuTFixf4+PgQGRmJgYGBoDr2ITLAubm5TJo0ie3bt2NjY0PLli1JSUnBz8+P/Px8VqxYwfDhw/8ROU757V5YOjgyMpKMjAzB85+UlMTs2bORyWTs3LkTgPPnz7Nz50527tyJrq6ukPZT1S/KpKQkTpw4gUQi4cSJE/To0YOJEyd+8LgVOdZ//PEHgwcP5tWrV2XWMMnT++S1ApmZmezZs4c1a9Zw9epVateu/c7j4ubmRk5ODrt27aJhw4bvlHKWyWT4+/vj6emJtrY2ffv2LbNgWN5cMy0tjf79+3P37l3CwsKQSCSMGDGizC71p06dIigoiNGjRwu1BnJcuHCB+/fv0717dxo1aiR8npeXx5o1a2jRooUg0HDo0CFevHjBvHnzSnjtt23bRo0aNSoVOZEfy3v37pGZmUnbtm2BgnqqrVu3kpmZyfjx47GysqrS+0luXA8cOBA1NTWWLVtW5JhPmzaNW7dusX///gqJaURFRXH16lXCwsKwtLSkQ4cOpdZpfAjkx+rp06e8ePECW1tb7O3tS42elHesCkdir169yoABA7h8+TJTp05l5MiRDBs2rEJk5cqVK/j5+WFpaUnt2rVxcyu9m7nccZCRkUGDBg346quvWL58eYl1evTogYODA6tXry7V2ZCfn8/XX3/NkCFDaNOmDT169MDJyYmff/6Zr7/+mtevX+Pj4yOklRkaGtKnTx/OnTtHdnY2R44cKXHtVxWCg4Pp3r076urqKCgokJCQwOXLl9m0aROPHz/m6dOnjBkzhnXr1pGZmUmdOnW4ePFiCVWxwo6RfyNycnLKrVvJy/tLYVZdXb0EWZH/L38HVSVkMhlv3rwRGuAqKysLv5WVlUFV471benwMlNfS438Rn8lMIUS+zeZhbBoSqaxK2beIghoZF1Pd/8nUso+N0oQI5H8XzpOV5yHLO6erqanRuHFjWrRoQWJiIj4+PgQFBaGiooKLiwvNmjWrtGcsLS1N+M7q1auJiIjAyckJXV1dDh06xKlTp2jQoAH37t0rtev4P4XiJAeKGibx8fHs3r2bNm3akJ2dzf79+1m2bJlQMFoVzd+KG1jZ2dlIJJL3qm2Se/AK9xJ519ySkpL45ptviI2N5d69e2WuV9yQCgwMpHv37ri5uXHw4MFyt/Hy5UvGjBlDixYthPQhOd5ljMuJXmxsLO7u7rRo0aJUo0YsFnPkyBEiIiLo06cP/v7+vHr1ipYtW9K+fftSx87NzeW3335DRUWFUaNGFTEUpFIpy5YtQ1lZmRkzZhTZ5okTJ4iLi2Ps2LEA+Pj4cOnSJfr3719CcGD79u2Ym5uX2U+kPIwePZq9e/diaGiIu7s7mpqavH37luTkZLKzs9m8eXOVysnKr/3GjRszceJEhg8fTl5eHhKJBDU1NTIzM3F1dWXVqlV06dKlzHOXkpLCn3/+SVBQkCDZW9kI8Lsit/K5vnr1SlCYK9z/R478/HxevnxJYGAgzs7OWFlZlYj4eHp6smHDBtatW4eOjg7Lli0jOTmZffv2lajtKQ8zZszgzJkz2NnZERsbS3JyMr/++iudOnUq8xnTunVrjIyMOH78eKnbWbt2LXfu3CkzpVMqlXLo0CHmzJlDcHAw8+bNIzo6mmPHjpGUlESnTp3IyMjgzJkzyGQy1q1bR0BAAM7Oznz33XdFGnd+LOzatQs9PT0aN25MtWrV6NSpE1999RVt27Zl+PDhiMVipk+fzt69e9m+fTvW1tZAwf0pd7DJrzUvLy/atGnz0edcGUgkEtLS0sokK1lZWcK6SkpKZZIVfX39v/39mJWVxerVq8tc3qFDB/Is7N6rpUdVQt7Sw73mP9N24lPFZzJTDOJ8Cf6xacRk5iCCDyI18u+baaniXE0XNaVPqzv9fx3FhQgSExMJDw8nNjZWECGQQ0NDAzMzM3R0dEhLSyMyMpK8vDzs7e1p3rx5hWo2Dh8+zLVr16hfvz4TJ04kLCyMNWvW4ODgIMinXrx4EWNjYxo3bvxRi9WrGsVVkHJycoS/ExMTi/Qa+lBiU57iUkUgk8nIz89HJBJVyHtX+Dw8ffqU9u3bM3XqVObMmVOhcxQREUHbtm158+YNu3btYtiwYWWu+/jxY37++Wfmz59Po0aNKh1NkEgk3Lhxg9u3bwtS5MVlReGvbt5BQUF88cUXeHp6IhKJGDBgQJmRhJiYGHbu3EmTJk3o3LlzkWVXr17l9u3bdOjQgRYtWgifP3v2jCNHjggpbOnp6axfvx4nJyd69+5dZIydO3diYmJCz549K7y/ckRGRqKtrc3Tp0/x9fUlPT2du3fvEhgYSExMDD/99BMLFiyo1JgVOfYTJkwgPDycM2fOFPk8PDwcR0dHfH19y6xtkEgkLF26FG1tbdq2bYujo2OV3u/yazMuLg5PT0/s7e1L9NfJz8/n1atXBAYG8vz5c3Jzc6lWrRpt27YtlVQlJibSt29fMjMzefbsGQ4ODvz6669Cr6iK4NatW/Tu3ZsLFy7QrFkzZs2axYULF7hw4QKhoaG0bNmyBDmbMGEC169f59atW4I6XmG8fPmSli1bMnv27DIFDKDguaSlpUVqaio7duzg119/5dq1a1haWhIWFsasWbOYNm0arq6uFd6fj4Xg4GDq16/PnTt3cHV1JTMzk59//pmNGzdibm5OQEAAgYGBnD9/nrCwMKysrARxhp9//pnFixcTFhZWZrT1Y0Mmk/Hy5UuCgoIEspKenl7EMaarq1smWdHU1Pzk6nj27NlDeHh4CaESDQ0Nxo8fT4pE4R9v6QHQzFyf6toft7ffvw3/s2pmZUFNSRHX6vpEZ+TwIjmDZHFepUmNfH19NWVsDbQw11L95G7a/wWIRCI0NTXR1NQsktIhk8l4/vw5165dIyEhAVVVVbKysggLC0NVVRWxWCw8zIKCgggKCkJdXZ0aNWpQp04dzMzMSvRVAXBycuLPP//Ew8OD5cuX8+OPP2JiYsK8efOIiYlh6dKlReoFKppnX1jat7i8b1ZWFn5+flSvXl3w4n0MFJ+r3Gsml55WUFAgJyeH0NBQLl26xMCBAzEzM3uvvO0PNfhEIlGlBAvk27t58yYnTpygQYMGzJs3j/79+2NjY1Om7HJubi6PHj3i4sWL1K1bl0OHDr2zWaOioiINGzYU0rUq+1yQF6fa2Nhw8uRJQWWqeHG+kpIS/fr1Q1NTE09PT8ELeuzYMfr161eqTLOZmRkdO3bk0qVL1K5dmzp16gjL2rZti6+vL15eXjRv3lw4HjY2NqiqqhIYGIi7uzs6OjooKioSFRVVYnyRSPReambh4eFcunSJ1NRUTExMGDVqlEDgkpOTef78OY0bN67UmIV775R3DqZOnUrTpk1p1KgR3bt3x87ODg0NDdavX0/jxo3LLdJOSEigY8eONGnSpEpTYuTHMCcnBz8/P65fv07v3r2FyJREIiE0NJTAwECePXtGTk4OxsbGuLm54eDgUG7zTCMjIzw9PQkKCsLS0pJq1SpeYCx/ViUmJuLg4ECzZs04ceIE27Zt4/Tp00IE78iRIzRo0ECIOO3du5fDhw9z9erVIkRG7ozS1NQkJyeH+fPnM2DAABITE8vcB1VVVXbv3o2mpiaOjo4MHz5cOPa1atXi6NGjFd6fjw1zc3PatGnD48ePcXV1RVVVlZkzZ9KjRw/09PQICAhgxIgR6Onp0a5dOw4dOoSKigpffPEFy5cvZ9u2bSWa4f6dqcsikYiQkBASEhLQ19fH0tKyCFmRPwv+LZBKpVhYWPDmzZsin8uj1RoaGqjLZJ9benyi+ByZeQfSxHmEpmYRnSEWlCxKe1TID6KqogLmWmrU1tNA97Ns3icNmUzGs2fP8PLyIi4uDl1dXTIyMhCJRDRo0AArKysyMjIEiWCxWCx819DQkP79+2NiYlIibeLt27ecOXOGgwcPYm9vz8WLFwkJCWHdunXlehWhwBBJSUnh2LFjjBw5ElVV1VLVxOSGwPr167l8+TIrVqwoUrxd2ktt//79NGjQ4KOnU4wYMYJevXrRp08fNm7cyJdffom5ubmgrvQpvuAOHjwoFPGnpKRw7tw5dHV1efLkSZnfkclkeHt7M2rUKPbu3UuzZs2A8oucz58/j52dHXXr1hXOkUwmE1KYKtOwTiwWc/78eQICAnB0dKRLly4llLVkMhl37tzh6tWrGBsbU61aNQIDA+nbt2+pDVdlMhmHDx8mKiqKMWPGoK2tLSy7c+cOf/75J61atSoi4Xry5Emio6MZN24cIpGIjRs3kpGRUaKY+vfff0dPT48+fd7dgE5+ff/555/MnTuX8PBwmjRpQnJyMikpKQwbNoyJEyeiqVn5+sPc3Fw8PDywtbXFxcXlnXLVz54947fffiM8PJy4uDghurBp06YyjX254+Fj5PXLxz569ChhYWEC6X79+jUBAQE8e/YMsViMoaEhDg4OODg4lCkyUBUofr37+fkxefJk5s6dy9dff82yZcsYM2YMYrEYR0dHVq5cKVwD8mtXLiUuhzwCef/+fWbPnk16ejohISFCr5+lS5diampa4jknkUjKlTL/1LB582amT5/O8OHD8ff3x9LSkiVLlmBiYoKNjQ2jRo3ihx9+wMzMjKdPn/Lzzz9z+/ZtOnfuzJYtW0qk4L5PtP/27ds4ODigr69PVFQUsbGx2NraoqOjU5W7+skiNzcXf39/fHx8SE1NRVlZuUjtzpAhQ4pIzYvzJf9YSw8lBRGdahl/zvIpBZ/JTCUgzpeQKs4jLSefPKkUqQwURAVdWHVVldBTUxYussqs+xn/LGQyGcHBwXh5eREfH4+enh4ZGRkAuLi40KJFC3R0dIiNjeXu3bsEBAQgEomoXr06zZo1w97evtSiTLFYTEBAANHR0SxdupT169eXWQRbGHv37mXatGmcO3eOmjVrsmLFCi5cuEBWVhZubm7MmzcPZ2dnUlNTWbBgAeHh4UIeeXn9GTQ1NVm4cCHTp0//wCNWNmQyGTExMWRmZmJiYkL9+vVZv349/fr1Y8uWLXTv3l1Ii/gnBBDK2u7EiRNJTU1l//79QEH6VIcOHZg3bx5jx46t0Fzf1cclPz+fjRs38sMPP5RYduXKFR4+fIirqyuurq4VNsZkMhlPnz7l/PnzqKur07dv31ILyzdt2kRycjJ16tRBVVWVgICAIt78wsjMzGTbtm0YGRnx9ddfC/sklUpZvXo1eXl5zJ07V/g8JCSEw4cPM3bsWExMTDh27BhBQUHMmjWryH7s3bsXLS0t+vXrV6F9g4L7r0OHDixcuFAobj979ixnz55l0aJFla6/ycjI4NChQyQlJTFlypQKkcfMzEzu3LlDVFQUFhYWtGzZ8m/vkl44dUcsFnPo0CFiYmJwd3cnOTmZ4OBgsrOz0dfXx8HBgfr165dwtHxsDBw4kM6dO/PNN9/QsWNHvLy8+PLLLzl06BBQUPPVrFkzVq1aRd++fYECYYSTJ08KabhySKVSQkJCCAwMxNDQEC8vLzw8PAgICEBfX1/o1/J3KUFWFpV5tt2/f599+/YhEon44osv6NatG2PHjiUoKIiDBw8KKc6pqalUr14dFxcXfv/99yIGduF+W6VFkct6Lu3atYvNmzezd+9edHV1cXd3JyoqCmNjYzw9PUtEfP9LyMzMxNfXFz8/P8RiMQ4ODri5uREfH8+pU6cASqTVyvG5pcenh89kpgrxOYrz74ZMJiMoKAgvLy8SEhIwMDAgIyOD/Px8GjZsKBTWZmRkcP/+ffz8/MjKyqJ58+a0bdv2nc3r5Nsoax35Syc1NRV3d3d69epFdnY2169fZ8OGDURHR7Np0ybU1dU5f/4869evZ/bs2QBC/r6ysjJPnz5FKpViY2MjeK4zMjKoXr0658+fp2XLlu+cS0WO1bsa9V27do3vv/+eM2fOoK6uzsCBAxk7diwjR44ECsQSCktofmzDS+7VLm78ZGVl0bNnT5o2bcqyZcuEz58+fYq9vT2KiorvnFtFjSp5ikzhnhnZ2dkEBweTlJSEn58fSkpKuLm50axZswqr6qWkpHDy5EkiIyNp2bIlbdq0KTKfI0eOkJaWRmJiItWqVRPSWHr27Imzs3OJ8cLCwti3bx9t27YVlMqgwOt+/vx5mjRpIqiSSSQSVq9eTbNmzWjbti0PHz7k7NmzJcbev38/2traJWppykJERASdO3fmjz/+KGJU5efn07t3byQSCWfPnq1w9CM+Pp5Dhw4hlUoZPHhwmVLF8nMTFxfHnDlzOHbsGDVr1sTS0hJjY2O++uorunbtWqVkPCcnh4CAAB4+fIitrS2tW7cu1QB9+/Yte/bsIS0tDWVlZUFyXh6BMTU1/cdSmufNm8eNGzc4ceIEubm5fPnll4jFYgYNGkR+fj63b98mLS2Nu3fvAuXfMykpKXh6enL37l2uXbuGVCqlV69e9OjRg1u3brFt2zZCQkKqvP/VpwD5sXNxcWHBggXCdXb06FGGDRvG6dOnSwgpyMlMaZLVZamfJScn4+joyLRp0xg+fDgLFy7E09OT69evs3TpUsLCwrh48eLfss9/J5KSkvD29ubx48coKCjg7OxM8+bNhdRViUTC5s2bsbCwoG/fvmXeT59benxa+Fwz84GQyWREZ+QQkpxBSin1NeUxxRyJlNdpWYSlZWHwub7mH4dIJMLBwQF7e3uB1OTm5mJoaEhQUBD+/v44OjrSsmVL2rZtS6tWrXjy5Ing3enVqxcODg4lPGGF/y/r3Obn55OXl4e6ujppaWnUrFkTmUzGqFGjGDlypFC0bWVlRdOmTcnPz2f06NHcunULXV1dJkyYgLKyMmvWrGH//v3ExcWhqKjIzJkzmTx5MrGxsWRkZKCrq8urV6+oUaNGuYZARUjXggUL+PLLL0tNVxKJRHh7e1OzZk2srKy4dOkSKioq1KpVS1hn27ZtnD17ltu3bwsF+woKCqUSjqqASCRCUVGRgIAA9u/fj7m5OW5ubjRp0gR3d3e2b99ehMxUxitZ0fnKc/0LE7inT59y6dIl9PX1cXd3JzU1FS8vL3x8fGjRogVNmjR5p9Gmr6/PiBEjuHXrFl5eXoSGhtK3b1+hBkFdXZ309HSGDRvGoUOHEIvFNGjQgDNnziCVSotILkNBfUHLli25ceMGtWrVEnLzGzduzPXr13nw4AEdO3YU+o3Y29sLdTP16tXj7NmzvHr1qgiZEYlE1K5du2IHlIJUTk1NTfbs2cPatWuFz5WUlJg8eTKzZ8/m7du3pSp3FUdYWBhHjhxBT0+PwYMHl5tCI7/2R44cSUZGBkeOHEFLS4vg4GCuXr3Kl19+yYEDB4TowvtCJpMRHh6Ov78/QUFB5OfnY2NjQ7Vq1YrUFslkMiIiIvD39+fJkydIpVK0tLRo0KABDg4OmJubfxLvjEGDBuHj48Pu3buZM2cOvr6+jBs3Dh8fH6KiomjatCmrVq0C3k3+IyMjGTVqFC1btmTevHkMGjRIWObm5ib0yyreF+lTQV5eHmKxuEiaZkWhoqJCbm6ukOokr0OaMmUK8+bNo127diXO99y5c1m5cmWp10FZUZnY2FjEYjHTpk0jMTGRS5cu8d1331G9enX69evHkCFDKj33TxkRERF4e3vz7NkzNDU1ad26NU2aNCkRZVVUVGT8+PHvdGLJicXfQWgM1JQx1nj/dhH/C/hMZj4AhZXP5KhsmEu+foo4D9/oFMw0VXE2/ax89k9CQUGB+vXrU69ePQIDA/Hy8kIsFmNsbMyLFy94/PgxDg4OtGrVChcXF5ydnQkLC+PGjRv4+/vTp08fNDQ0hAdhRXKYRSIRsbGx1KpVi4iICLKzs7G0tERbW5ujR4+yefNmkpOTCQoKwsbGhpycHOLj48nOzqZly5Y0bdqUY8eOsWDBAlasWMG4ceM4fPgws2bNonnz5oKowdatWzl//jzJycmMHTtWMC6g4AWckJDwTuNIbmgtWrRISGkpDDnZuXDhAlZWVmhqauLn54epqWmRFKjr168LhehZWVkoKSlx48YNtLW1ad68eZXXG0BBF/oZM2bQrVs3nj59yo4dOxg0aBADBgxg165dLF26lHnz5lX5dsuCSCTC1dWVmjVrcvv2bf78809h/zMyMrh69Sp3796lZcuWNGrUqNxjoqCgQJs2bbC2thYKr7t06ULDhg3R0NAgKysLCwsLRo0axYEDB3j9+jX169fn3LlzSKXSEopV7u7uvH79Gg8PD8aMGSOkjHXp0gUPDw/Onz8vRFnq1avHo0ePiIuLw9TUFCUlJWJiYsjNzSU2NhYjIyNUVFQq1JNFDg0NDYYMGcK+ffvYtm0bbdu2xc7ODolEwvHjx4Wmee/C48ePOXPmDFZWVgwYMABVVVWCgoJKFUGQH0dAqDWSE73WrVszevRoli5dyurVq2nXrl2pSnLvQkZGBo8ePeLRo0ckJSWhr68v9L2Skyx5/6eAgACCgoJ4+/atIGwh77fyTxIYORkpnNZav359Ro4cyTfffEPNmjUZPHgwW7ZsISsrS4gwymXc30X+GzRogL+/f6kCC5mZmUyePLlKBE9Kk6SvCigpKbFkyRJGjx5dod5ThecjEolwd3dn69attGjRgoiICLZs2YKTkxOjR48u4djIycnhl19+Yfz48SWUzUrbr8JRYT09Pfbs2UNERAQxMTH079+fjIwMfHx8ijie/q2Qi/14e3sTERGBoaEh3bt3x8nJqdxnaUXfPTYGmqgpK3yUlh6FkSLO4+qbxM9O73Lwmcy8Jwr3pKkKyEeJzczhcljC5540nwAUFBQE7+fTp0+5efMmWVlZVKtWjfDwcLZt24adnR2tW7emRo0aiMVisrOzuXXrFu7u7pWqezhy5IiQzhMREYG+vj43b95k165dqKmp0aVLFzp27MiqVaswNjZGR0eHx48fk5ubK3jNPTw8aN++vZB/3qlTJ2JiYsjKyiIiIgKAatWqERYWxq5du1i4cCGdO3emXbt2REZGsnbtWk6cOEFiYiLdunVjw4YNmJmZCfPMzs5GXV0dRUVF0tPTUVJSwtbWttTjBrBw4ULB6xUUFIS+vr5QMJ2fn8/jx4/5+uuvAfjuu++YMWMGXbt25dGjRzg5OTFhwgShf0llUZrYQGJiIqdOnWL37t189dVXQIEa17lz5xg4cCB//PEH9vb2/0gevpmZGf379ycxMZE7d+7g7e2NqqoqjRs3JjMzk0uXLuHt7U2rVq1wdnYud34WFhaMHj0aT09Pzpw5w4sXLzAxMRF6PBgaGjJy5EgOHjzIy5cvsbe358KFC0gkkiKStYqKivTr10+IoH355ZeIRCLq16/PlStXePLkCZ07d0ZNTY3atWujpqbGvXv3MDU1RVFRkeTkZKH5oZubG7a2tpVOCxo9ejRhYWGsWrWKM2fOCPLMioqK7Nq1q9zvymQy7t27h6enJ87OznTr1g2ZTMaePXswNTWlbt26ZRqYaWlpNG7cmMDAwBJRq759+7JixQr09PQqbAxLpVJevHiBv78/ISEhQjSrW7duWFlZCUIQUVFRBAYGEhQURFpaGlpaWlhZWfHq1SvU1dUZNmzYB3WFryrIr7/mzZvTsmVLnJ2dGTBgAEOGDCEyMpJLly7RokULatasiaqqKoqKisKxqsi9JZPJsLOzKxIhvnjxInv27OHOnTu4uLjQsmVLBg8ejIWFxXvL3FfWIJRIJEIE+V3jfvfddyxevJjff/9daMT4LiNZPp/Zs2eTnJyMp6cnO3fuxMrKiuXLl5cq5BAQEIBUKuXNmzdCRL+8/ZIvq1u3LjNnzmT58uXIZDKmTJmClZUV48aN4/z586xYseJdh+OThfz9cvfuXZKSkrC0tGTgwIHY2dlVOQmw0FbHSF2lylp6lIbPTu934zOZeQ+8SM7gacLbjzK2DMiXyrgXnYrYWPo5R/ITgIKCAk5OTjRo0IAnT55w8+ZN3r59i5mZGTExMezYsQM9PT3evn3L999/j4mJSaUkaF+8eMHt27eFGoTY2Fh0dXU5e/Ys/fr1Y9WqVULH+T179ghezujoaKDAeM3MzOTNmzf06tULKIiyGBsbM378eNTU1Bg3bhwdOnTg559/BgoKq2vWrEloaCjt2rVj9erVPHjwgOvXr5Ofn8/MmTOZNGkSx44dAwqKVJcsWcKlS5fo3bs33bp1Q0NDo0TH7MIv0k6dOgmfnzx5koSEBEF9Jyoqiri4OFxcXJBKpTx79oz9+/fTsGFDGjZsiLa2No8ePSI9Pb3Cqjq5ubns2LGD8ePHFzE2rl69Svv27cnNzSU8PBxXV1fu3bvH8OHD0dXVZceOHWhoaGBjY1MldUQfMoaRkRG9evXC3d0db29vHj58iEgkwsnJiezsbM6fP8+dO3do06ZNuX1LVFVV6dWrF7a2tpw9e5awsDByc3MFT7q2tjYjRozgyJEjhISEYGdnx6VLl5BKpUVEKvT09OjZsyfHjh3j4cOHgmHfvXt3Dh06xOnTp+nduzd+fn4YGxvj7+9f6nzMzMyKSD2XBrlBmpmZyc2bN3nz5g3W1tasX7+eiRMnsm/fPnJzc6lbty4DBw4sM7ICBeciLS0NT09PISU0NjaWffv2IRaLyxTikJ+75ORkVFRUmDRpEtHR0bRs2RIjIyOSk5M5evQoHTt2BCrWiNXf35/Hjx+TkZGBqakpXbp0oX79+qirqyOTyYiNjSUwMJDAwEBSU1PR0NCgXr16ODg4oKCgwOHDh9HT02Po0KHvpd5WHgob5+9z3X799ddcuXIFPz8/Zs2axU8//SQU73t5eTFs2DCBvFRm7MJpmLGxsYwaNYpr166Rm5vLd999R8eOHdm2bRt3797l5MmTFXreVjYKEx8fj0wmK6JYJ9+X8PBwsrOzsba2LpOg2NjYoKKiIty3NWrUeKd0e2GsWrWK+Ph4fHx8GD16dKnpvDk5OWzatEmQGi9c3/YuxMXFYWVlxbJlyzAwMKBt27bExMTQsGFDBgwYgLu7e4XH+lSQnZ3N/fv3uXfvHpmZmdStW5devXqVkLCualRFS4+K4LPTu2x8JjOVxMckMsUhz8X8TGg+DSgoKNCwYcMipCY9PR0jIyMSExOBAu+hu7t7pRqZbdy4kdq1awtRjJCQEMLDw+nYsSOPHj3Cz8+P+vXrs3z5ck6fPi14zCIjI1FRUcHY2Bg1NTUiIyOF1Av5C1Y+5uPHj4uosmRmZiISibCwsODOnTvcvHmTQYMGYW5ujpqaGtOnT2fJkiVCo70JEyZgamrKgwcPOHnyJD/88AP16tUrYVyV1d1bJBIV8SrWrFmTmJgYwVDYvn07w4YN4+jRo1hbW5Odnc2oUaMqJQ966tQpNmzYQF5eniCBvXDhQs6fP8+9e/dISUnB2NiYH374gStXrjBlyhR++ukn8vPzhb45H+K1kxOZwpGd9x1PV1eXLl260Lp1a3x9fbl37x75+fnY29uTm5vL6dOnuX37Nm3atBGM3tJQr149LCwshDoZT09POnfujJKSEmpqagwZMkRormljY8OVK1eQSCS0atWqyBguLi54enpiaWmJiYkJtra26Ovr8+zZM9avXy/0MikOZWVl7O3tK5QWlZOTg7q6OrNnzxbU+WxsbNi1axd9+/Zl5syZlTLmT5w4QZ8+fXB0dOTmzZtcv35dUIyqVatWqcdMPscXL14gFotp2LAhf/zxB56enqipqfH48WOhlu3gwYNoa2tTv379IrVAMpmM6Ohorly5wps3b1BTU6NBgwY4OztjZmaGTCYjPj4eb29vgoKCSE5ORl1dXThOVlZWKCgoEBYWxoEDBzA1NWXw4MFVIjecnp5OREQE4eHhGBkZ0bhx40oJcMgJT1hYGEpKSkyaNInx48eTkJDA/v37OXnyJGZmZvj6+uLr60vt2rUFwZHKQr6ts2fP8ubNG/z8/Lh79y6rV69m27ZtNGrUCGdn53L7zhRGZe7F3NxcpkyZwtChQwUnE8CjR48YN26ckKZobGzMmjVrsLW1LUEG8/Pz6dy5M4mJiejp6TFu3DhOnjyJhYUFEomkQqlMJiYm+Pr6IhaLi6wvlUo5ePAgo0ePZtSoUfTv35/09IrVbsifT7t37yYgIIAjR44Iy8zMzPj+++8rNM6nhNTUVO7evYu/vz9SqZSGDRvSvHnzEs62jwmRSER1bTWqa6uRJs7DPy6NZHHeu7/4Hvjs9C6Jz2SmEoh8m/23ERk5niSko6as8Jl9f0JQVFTE2dkZR0dH/Pz8uHTpEgCWlpZkZGRw/fp1RowYUeHxNm/eXOT/ESNG8Pr1a9zd3Rk/fjxdu3bF0NCQjh07oqWlRW5uLlDw8ExNTUVNTQ1FRUX09PR49OgR/fv3RyQScerUKY4fP87y5cuJi4sr4slOSEhALBZjbW3NlStXSE5OZt26dSxbtgwFBQWUlZVJSEggJSWFixcvYmhoyPr166lduzbVqlXj0KFD1KhRo1yJ2nelYhT2eDZr1oygoCDu3r1LWFgYbm5ulc6Jb9++PU+ePOHo0aM0a9aM5s2b8+rVK6FI2MHBARsbG/bv38/x48eFXhcVUSuDv8hZeR5skUiEkpISoaGhmJqaCsfnfUmNpqYm7dq1w83NDT8/P3x8fMjKysLa2pr8/HxOnDghpDXa29uXuh0dHR26devG7t278ff3JzIykn79+mFsbFykuea9e/eoWbOmoB7Vpk0bYYzOnTsTERHB8ePHGTlyJAEBAWRnZwMFJAQKiIuamhrGxsZYWFhga2tLjRo13plW9Pz5c+zs7FBXVxdkoW/evEmNGjW4ceMGly9f5tdff+XYsWO4uLgwdOjQcj2tMpmMlJQU2rVrh7m5OTt27CA6OhoNDQ2hCWF5kMlkdOrUiU6dOiGVSklNTeXRo0eEhITQpEkTgoODuXXrFtevXycxMZG5c+cWITMikYirV6+ioKBA3759qVu3LsrKysTHx3P9+nWCgoJITExETU2NunXr0rVrV6ysrIocp+fPn3Ps2DGhzqeiqnbF9yM+Pl4gLxEREaSmpgJgYGBQQhHrXZAbwZcvX2bq1KnExMTQtWtXhg8fTseOHZkxYwZff/01qampODo6cuPGjQ/qaSUSicjMzOTMmTN06dJFEDuYN28e3t7eAvELDQ2tEJmpKKRSKSoqKoSHh3Po0CFsbGxQUFDAxsaG3377DXt7e44cOYJEImHJkiV89913HD9+vMQclJSU+OKLLwgJCcHExARVVVX8/PwwMDAgNTUVMzOzCtdTlvacdXJyIigoCCsrqyJzf9eY8uV2dnZCDaidnR2qqv++OoyYmBi8vb0JDAxETU2N5s2b07Rp0yqPYFYW8Vk5H43IFMdnp3cBPpOZCkKcL+FhbNo/su2HsWkYqat8zo/8xKCoqEhMTAzKysq0bNmSBw8ekJaWVmo6QGXQrFkzoQHj8ePHgQLyITeO5B66zp07s27dOpo3b050dDQLFixgwYIFGBgYUKtWLaZNm0bfvn1RUVEhKSkJe3t7YRvx8fGIRCKqVatGXFwczs7O7Nq1CxUVFUJDQ4mOjiYhIQFXV1emTp1K69atBQPSyMgIIyMjzM3NhYjGh0Je39KyZctKe3KlUikikQhDQ0P69OnD8+fPWbt2LcePHyczM7NIStHatWu5fPkyb9++RSKRoKCgUKEXeOFC54qk49SqVYvU1FSio6MxNzcX0gRlMhnp6eloaGhUqn5ETU2Nli1b0qxZM/z9/fH29iYtLQ1LS0skEgnHjh2jWrVqtG3bljp16pSYn/zl3rVrV3x8fNi+fTudOnUSPPOdO3dGW1ubq1evYm5uzo0bN5BKpbi7uwuF519++SU7duzg4MGDREZGCmOrqKhQu3ZtHB0dqVWrFmpqakilBdL0FTHWRo4cyd27d1m2bBndunVj1KhR2NjYYGxszJAhQ+jVqxeXLl3iypUrHD16lPbt278zbURBQQEFBQXWrl1Lbm4utra2fPXVVygoKAhph2VBXhwdEhLCjRs3CAsLY/78+bRo0UK43sViMZGRkTx58qTUXj09e/ZET0+PxMREwdhKSEhAVVWVunXr0qlTJ2rXrl0q0Xv69CknT56kbt26Re73dyEvL4+oqCiBuERERJCTk4OCggKmpqbY2dlRo0YNQVikMpDfn1FRUfTr14+pU6fSuHFjFi1axKJFiwgPD+fLL7/E1NRUqEeSp7iWV4NW3r0kk8nQ1NQkISFBSJ/S19enV69eLFmyBBcXF4yNjSuVulUW8vPzBadGXl6eUK+2adMmzp49y/79+zEzM+P48eM8ePAAS0tLrly5go+PDxERETx79qzU55aGhgZKSkoYGBigpKTE8+fP6dOnjxBpLO86LA8KCgolrruK1vrJ1SJfv37NgQMHuHHjBl26dMHc3BxjY2MMDQ1RVVXF1dW1TPnyfxIymYxXr17h7e1NWFgYenp6dO7cmYYNG74X6a9qfHZ6/zP4TGYqAJlMhn8VFvtXFhKpDP+4NFzN9f91npP/MoKDg3n8+DG9evUSwtqPHj3izZs3Vb4teQpP4ZSHevXqERkZSXh4OAB9+vQhMjKS33//HalUypgxY5g+fTqBgYGkp6cXMQATEhLQ0dFBW1sbV1dXtm3bRlZWFoaGhjg5OZGQkCAY4PHx8VhaWhbpYxAfH4+dnd17Fd2WBvl1Xdm89uIv8EaNGvHVV1+xevVq5s2bR2JiIqdPn6Z9+/aYmZlhaGjInTt3qFWrlkCC3gWZTIaSkhJpaWnMnDmT9PR0atasSZcuXWjTpk2p3lCRSIS+vr6gtpWcnExUVBT+/v6EhYWhrKyMra0t9vb22NraVpgUKisr07RpUxo1akRAQAC3b98mMTERU1NTpFIpf/zxB9WrV8fd3R1ra2th/+TnUk1Nje+//57Lly9z4cIFXrx4Qc+ePdHS0qJly5ZoaWlx5swZjI2NuXnzJhKJhPbt2wtpgl988QXnz5/HxsYGExMT6tSpg6WlJQoKCkXORWWui/3793Pq1Ck2bdrE/PnzkUgktG3bloEDBwIIjTZ79OjB3bt3yzVe5X017t+/j7e3NwoKCvTo0QMXFxeg4J6NiYl555wOHTrE6NGjadu2LZcuXWLo0KGcOHECqVTKrFmzhBqrwo0L5ZBKpTx9+pTAwEDi4uJQUVHBzs6O9u3bl1tjAX/18WnYsCE9evQo9zhmZGQUibrExMQglUpRVVXF0tISNzc3LC0tqV69+gcbefLraNWqVfTp04dFixYBMGPGDBQUFNi6dSuJiYkMHDhQiBTI0+LeV0xDbnSPHz+eH3/8ES0tLbp3786UKVOYMmUKrq6uwjw+tOeP/JzExcUJqUmhoaGoqakxZcoUevbsiZ+fHw0aNGDKlCncu3cPBQUFhg4dyjfffFPmuBKJBDU1NYFMymsGp0+fLtyT74vi+1zR4yxfr3r16gwbNoy8vDxCQkK4ffs2KSkp5OTkkJKSwuHDh4V78FOARCIhICAAb29v4uPjMTc358svv8Te3r7K3kMfis9O738On5tmVgBRb8X4Rqf809Ogmbk+1bU/PG/6Mz4cmZmZHDp0iGrVqtGjR48SudIVTV36OxAXF8fRo0cZN24cioqKZGZmMm3aNF6+fMnVq1dJSkqiU6dOODs7M378eIKDgxk7diyLFi1i8uTJ9O/fHz09PXbs2AEU5JPr6elx6tSpIkX+/xTS0tIYM2YMIpEIIyMj5s6dy9atWzlz5gyPHz/G1dWV0NBQvvjiC7Zu3fpeRsSzZ89o3749bm5uODk5kZqayrp16/D29i6iAFYRJCUlERwcTHBwMNHR0SgqKmJjY4O9vT12dnaVqo2QyWQ8e/aM27dvEx0djYGBASKRSFDwadeuHVZWVshkMhYvXkyXLl0ECeaQkBBOnz6NSCQSxAKgoF7k2LFjaGpqkpqaiqurq5CSJJc6lUvmltWQ730QFxfH9evXOXr0KGfOnGHo0KEsW7YMc3PzSo1z9epVbt++jba2NiNHjhTSytLS0ti2bRudOnWiYcOGZd6fb968oXXr1uzYsYN69ephb2/Py5cvuXTpEuPHj2fnzp0MHDiwzIaE4eHhHDhwADs7O+rVq4eNjU2FonC3b9/m6tWrNG3alM6dO5dofpiYmFgk6pKcnAwU1FfJIy41atTA2Ni4yo07ueH8zTffkJuby8GDB1m8eDFRUVH8+uuvQjPH+vXrs3r16iI1V+Whoipkq1at4sCBA4wYMYIJEyagoqLy3gpmpWHPnj2sWbOGlJQUOnfuzPjx43FxcWH+/PlCNCYpKYmBAweSkpLCkiVL6Nq1K+rq6pw6dYozZ86wfPnyIqmzlUVVNmH9lLb1ocjJyeHBgwf4+Pjw9u1bbG1tcXNzo2bNmp/UPshkMnyiUojNzPloEs3lQQSYaqn+zzq9P5OZCuDGm8S/Lf+xLIgAfTVl3GtWXW7wZ3xcfKweBlWB3NxckpKSBOllf39/Jk2aJHQgHzhwIJMnT0ZDQwMPDw/Gjx/PgQMHsLCwYMqUKfj4+HD79u0PTqn7ULx8+ZLOnTtTr149OnTowIkTJ1iyZAnq6uosXboUHx8fAgMDCQ4Oxt7eHm1t7ffqX7Nr1y6OHTuGp6cnUOCRXr9+PTdu3KBFixbvrWKWmppKcHAwQUFBREZGoqCgQO3atbG3t6du3boVJl4ymYywsDBu3brF69ev0dHRQSQSkZaWRq1atWjbti1HjhyhSZMmRWphMjIyBPnmJk2aCI0wIyMjOXToEIqKimRkZBQxsCuzn+J8CaniPNJy8smTSpHKQEEEygoK6KoqoaOiiIZKgaF/8+ZNNm7cyLhx44iLi2Pjxo34+vrSp08fFi9eXK56mfwYiMViVq1ahYODA3379hWMXalUyt69e0lKSqJv377UrFmzhCdbbhx7eHgwZ84cQkJCuHLlCt9//z2hoaGIRCIWLVqEl5cXV69eLfU4yGtstLW1K5xGKJPJuHr1Knfu3KF169a4u7sjkUiIjo4uQl6ys7OF1NDC5KUyIhmVhfyYyH+fOXOGwMBA+vfvz6JFi2jdujXffvstBw8eZNWqVYwaNYpJkyZVePzC6ZulofAxLmyqVPY+k8lkZTbjXbt2Ldu3b2f8+PFoaWlx4MABVFVVuXjxIjExMVSvXp3z58/TpUsXJk6cSGhoKJs2bRLqpIYMGUJ0dLTQGLg8FCZgVUnG3hcnTpzgypUrvH79mlWrVhEdHY2RkRHOzs7/+NzS09Px9fXlwYMH5OXl0aBBA9zc3EqVp/4U8Nnp/c/ic5pZMbi7u+Pu7s6CBQsASBPnfVQiEx8ZwdgOzdj6py8mFuUUtQLJ4jzScvLQVa1cr4Z3QV6svmfPniod938d5TUs+6ehoqJSpIeMs7Mzt27dAgrqAVRUVISXWa9evYiIiGDo0KHY2dmhoaGBiorK315kWZr08d27d6levTpHjx5FTU2NMWPGCAaF3Mjw8/MTpHQrgtJyz319fWnQoAFQ8IyIjo7Gx8eHzMxMlixZwvz589/rvOrp6dG8eXOaN29Oenq6ELE5e/Ys586dw8rKCnt7e+zt7YUUldIgEomoXbs2tWvXJjIyktu3b/P8+XM0NDRITExk9+7dQhF6YWhpaTFo0CDu37/PlStXCAsLo1+/flhYWAi9aOT9Y9TV1WnTps079zNNnEdoahbRGWJyJAW1M6V9Q26aqioqkBT2gh2rlmJhZICFhYWgUjVp0iQOHjxI/fr18fDwEEQbyjoGt2/fpl+/fiVI9p9//kl4eDgikQhNTc1SjVr5fikrK2NiYsLbt28JDAwsUoOUkZEhXF+lKVIpKChgYGBQ7vEpcgxkMi5cuICfnx9OTk7k5+fz+++/Ex0djUQiQUVFBQsLC5o2bUqNGjWoXr16ldWplQW5kZ2Xl4eysjI+Pj6sW7cOZWVl7OzsGDlyJOrq6hw7dkzoaRUREUGDBg347rvviozxLsiPa1nrF77WKnp/7dmzh+TkZCZPnlxEVVDe6+bly5fY2NggEol49eoVmzZtYsWKFULvqeDgYHbt2kVISAh16tShRYsW7Nmzhy5dujB8+HCWLFlCmzZtmD9/PiEhIfj5+bFy5coKpfIV3sd/miycOHGCuXPn4uLiwqVLl/jpp5/w8fFh2bJlHDt2jJ49e/4j85Ir/T19+hRlZWUaNWpEs2bNPipprwq8SM74p6eA6P/n8b9IZj5HZopB3l9Abjj4x6bxOi3ro4UNK0pmoOBCtdLVwNm0apumfSYzn1EZyL2cFS2erwqU5cH96aefOHLkCM+fPwcKIk4qKir4+PiQnJxMjRo1Khw9KhxJS0xM5NWrVygrK+Pi4sKBAweYMmUKysrKNG/enM2bN2Nubs7q1as5efIk586dQ1+/6sL7GRkZPHv2jODgYMLCwpDJZNSoUUNIe6rIiz0+Pp7bt2/z9OlTVFVVycvLQyqVYmdnh7u7e4ni3oSEBDw8PEhISKB9+/Y0b96cjIwMDh48SHJyMlZWVgwePLjUbclkMqIzcghJziDlPXosSPLzUVRSwkBNGUl8BCvmzuTGjRtoa2vz3Xff0aNHj3KFIWQyGfn5+eTk5BQhfWKxmIsXL/LkyROUlJRo27YtzZs3L/c8yWQy+vbti0wmIzIykjp16jB79mxOnTrF6dOnGT16NN9///17N1eVyWQkJyfz+vVr7ty5Q0rKX95cbW3tIlGXatWq/e1Gb6dOnRg7dix9+vQhKSmJ2rVr06FDB7KyssjNzcXU1JQJEyawadMmjIyM0NHRYd26dZw+fZqOHTtWKuJQlc4d+VgrV67E2dm5SApsUlISW7duZdmyZdjY2GBpacnvv/+OiYkJkydPZvbs2Tx9+pSdO3cSHBxMdna20Dj49OnTDBo0iEePHlGnTh1SU1NZtmwZvr6+KCoqMn369CK1jJ8Syju+9vb2jBkzhsmTJ2Nubs6pU6do2rQp8+fP58KFC9y8efNvc1jJZDJev36Nt7c3L1++FGo5GzVq9FHJ+6NHj8jKyiqz71Th+W3dupVx48YBJW2mNHEeV98kVtm8jmxaw7m9O0Ak4rfr99HQqpxgR3sro1Kd3q9fv6ZWrVqEhYUJzXqvX7/+r+wpVByfycw7cP5lnOBd/BioDJmBAi9mN5v3z8stDZ/JzGf8GyCVSlm5ciVKSkrUq1ePrl27cuzYMTZu3MiCBQvo0KGDsG7fvn3ZunUrJiYmlTaWTp8+zahRo7CwsCA6OpoHDx6Qk5PDDz/8wPPnz3n27Jmw7pw5c3j27BknT54sd8y3b98SEhKCg4NDpfuFZGVl8fz5c4KDg3n16hVSqRQLCwshYiMXGSgLKSkp3LlzhwcPHiASiVBVVUUsFlOvXj3c3d2L9IfJz8/n2rVr3L17l1q1atG7d29UVFQ4cuQIampqpRYEi/MlQvfrqkLoIz8Gt3Xl1PFjnD17loMHD1Yq4pGfn8/9+/e5desW2dnZ6OjoMHr06Aql7YWHh6Ojo8Py5cs5deoUEokEMzMzEhIS+P777xk7dmy5kuTFIZFIiImJEVLGwsPDycrKEpbXrl2bhg0bYmlpia6u7j8auS3cQ2fx4sXY2tpy+vRp9uzZw9u3bzl9+jRHjhwhMzNTUOlKTEykd+/eTJgw4b3JSWWUBcsbo7TUwYULF/Ly5UtiYmKYPXs2KioqjB8/njp16rBkyRIcHBy4desWK1eupGXLlvTr1w8PDw/27Nkj3OvW1tZoaWlRo0YNNm7cSK1atRCLxVXS++efgpaWFq9evaJatWro6Ojw4MEDbG1tiYqKws7OjvT09I9OpKVSKUFBQXh7exMTE4OJiQlubm7Ur1//vYUjKoNatWrx888/v7OVgpeXF+7u7oLDq7jNVJVO74y0VIY3q8eYRatxatEGk+oWlfp+eU5viURCQkICxsbGQl3vf4XMfBoSEB+I169fIxKJWLx4Mfr6+kyYMIGTJ09Sr149NDQ0aNq0KV5eXgB4enqioaFR5GVy+fJldHR0yM7OLpJiJs6XcPbgXsa2b8YQFxt++rofb54HA7Br6XxWT/pOGOP4tg0MbGBFbo4YgOiwV3zlWAtxoe2UB+9LZ/muTSOGNqrDtp9mkpf7l2Hw3N+PeYN7MdjZmpHuTdj06xZhWW5uLtOmTaN69eooKytjZWXF9u3bheVWVlbMmjULMzMznJ2dkclk3Lp1C2dnZ9TV1RkwYECRY/EZn/Ep4sGDB9SqVYtz585x4sQJxo8fz9ChQ2nYsCHq6uqcPn26iErVwYMHMTIyqrRx9PjxYyZNmsSCBQu4e/cu169fx8LCgtq1aws9Sjp16sTevXtZv349W7dufadXViaTkZCQwLlz51i5ciXLli3jt99+w9PTs4jEcVnQ0NDA2dmZwYMHM2PGDPr06YOWlhbXr19n48aNbN++nVu3bpGUlFTq9/X19enevTuOjo5oaGgIhuPLly/ZsmULJ06cEL6rpKREp06d+Prrr0lMTGTr1q2EhoYyZMiQUuV8I99mczksgdgqJDIAtZ0a4ZcmoXbDJjx+/LhcD7E8UggFxtGjR4/YvHkzV65cQVVVFTU1NUaNGlXh+qMvv/yS+Ph4Vq5cyc2bN9m+fTuTJk3i5s2bTJs27Z1EJjs7m5CQEP78809+//13VqxYwa5du7h+/brQiLNatWooKioyePBgvv76axo0aICent4/noIqEonYvXs327dvZ8GCBUyZMoXk5GTEYjHa2toMHTqUiRMnCgIQtWrV4sqVK0K6WWmQn5vyUBnDNSOjIJ1HLsAgkUhKjPHrr78ybtw48vPzMTMz4+zZs1hYWNCpUyfc3d05cOAAycnJnD59GplMxvDhw3FxceHbb7/F1tYWf39/QkJC2L17NwCHDx+me/fuTJo0iVq1aiGTyQQJcvn2/w2Qn4ucnBxcXFzYsmULycnJKCgooKenh1gs5sKFCxgZGX1UIpObm4uvry+bNm3Cw8NDaOA7ZswYnJyc/hYiA0XrsD5kvegMcZVl72T9//Xt6Naq0kQGCiLi0RniUpcpKipiamr6tx3fvxP/qZqZO3fu4OfnR0ZGBq1atWLbtm00bdqUCxcu0KVLF548eUKHDh3Q1NTk4sWL9OvXDwAPDw969uxZ4iV19MQpjvy6lrGLVmNeyxqv08f5efiXbL50h4Yt3dk8Z4rgiQq6dxdJfh6vAh5j36gZj71vUrdRE9Qq+AK9cvQgP6zfiiRfwsZZEznxmwkDJ04n8tULFowYQPfh3zFuyVpCHj9k1swZWJib0adPH5YvX8758+f55ZdfiIyM5Pnz50yYMIFevXoJyioHDx7k8uXLSKVSEhMT6d69O6NHj+aPP/7g8OHDLFy4kOHDh1ftyfiP4VOpdflfxd69e3F3d2fv3r1kZmYSHh5O48aNady4MSNHjmT79u18++23/PLLL9jY2KCiolLhnguFX9ovXrxAT0+PCRMmkJKSgre3N1u3buXt27f079+fTZs2MW/ePHbs2EFmZiZbt25l0KBB5W5DJBJRo0YNevfuzfPnz4mOjiY+Pp7Y2Fh8fX0RiURoaWlhZmZGnTp1yo3eqKmp4ejoiKOjI7m5ubx48YKgoCBu3brFtWvXMDExwd7eXuhOXvia1dXVRUlJifHjx3Pv3j18fHwQiUQ8e/aMgIAAnJycaNOmDXp6etSuXZsxY8Zw7tw5jh07RsOGDencuTNZWVkCKXiRnPHx+imIRORLpOQbWjB+/pJyU01EIhG3bt3CyMgILy8v4uPjsbe3x8nJiZs3bzJw4EB0dHSQSqUkJSVhaGhYpqEWFxeHoqKicPyrVatWYYUqmUxGTEyMoPqnpaWFpaWl0BfH1NSU3NxcDh06REpKCkOHDi3S8PBjIj8/n9TUVFJTU0lJSSElJQUDAwMaN25c6vrDhw+nQYMGjB07ljt37vDq1SscHByAgjQ0ExMTdu7cSVRU1DvrWioqGvGu5ZGRkYwcOZKvvvqKkSNHCusrKiqSl5fHqVOnsLGxwdnZGUVFRXx9fXn48CG9e/fmwIEDRciss7MzderUISAggJCQENTV1alevTpGRkb4+PiQl5dHx44d2bVrFyNHjqRp06ZFJMHl2/6n614qC/l8VVVVWbBgAT/99BNhYWGkp6dz4MABXr9+zdGjR5k3b95H2X5mZia+vr74+fkhFotxcHBgwIABReo3/y64u7vz5s0bvvnmG27cuMGsWbOYOnUq3t7eaGtrM3r0aH788UfCw8Np27YtgBDJgAKBgq+++oozZ86gqafP0GlzadWjLwB5uTnsW72EW2dPAODcqi0j5y1GW6/8KLo8UwdgXAdX3HsPYOKKX/jz2EFO795GfGQ46ppatOjak5HzlqCoqMim2VPQMzIiPioCv+tXMKluyeTVm7m1+wbbtmxBS0uL9evX079//xJpZnIcPHiQSZMmERcXJ6Rze3h4MHXqVN68efOvsH3+E2lm8hN08eJFOnfuzNdff42JiQlr164V1unXrx9WVlasXbuWMWPGkJ6ezqFDh5BIJJibm7Nz50569OhRRACgcXM3GrbvStevRwnjzOj7BW37DKD9l4MY1rQeqz08qV7bhuHN6lHXpQkOTZvT57sJrJwwkrrOTeg1amy5c5dfvHO37aORe0GazPWTRzmwdim7bj/m9+ULePH4Acv+OAsUhBAvblnN03t3uX37Nhs3biQ8PFyQH3V2dqZXr17cvHmTVq1aYWVlxVdffcWKFSuAAo/V+vXrefHihXCBNm3alHr16n1OMysDEokEkUj0zhdXccO4cB8TqVQqvNBLS4WAggflv+Gh8TFRWm1MYmIijRs3Zv78+YwaNUpIJzl06BCjRo0iNDSU+Ph4xGIxTZs2rfQxfP36NevXr2fDhg2EhoZiY2NDu3bt8Pf3p3r16hgYGJCdnY2qqiqenp6oqqoilUoFb3VZEr3vQlxcHE+fPiUsLIykpCRycv6KbigrK2NoaEjNmjWpX78+Fhble+jy8vJ4+fIlwcHBPH/+nNzcXAwNDQViY2pqiq+vL9euXWPu3LlAgXf0wYMHeHt7k5GRgaKiIlKpFBcXF1q3bo2Ojg4ymYxHjx5x8eJFtLW1GTFiBJqamrxKzaoUkcnOyyQ2I4w8aS7KCiqYatVCXbni+fiOxjqldriWyWRkZ2ezdetWMjIysLKyokOHDigpKbFjxw5cXFxwdXXF39+fR48e0b59exwdHUucK/m96+fnx5gxYzA0NGT16tXY2NhUOKIjkUgIDw8nPT2dGjVqlIi0ZGRksH//ft6+fcvQoUMrLTldHqRSKW/fviUlJUUgLIXJy9u3f50rBQUFdHV1qV27Nt27dy933KSkJIYNG8adO3fYs2cPvXv3FpbFxsaira2NpqZmuXUyp06domvXrkUK5CvjHPLz8xNI17Vr12jXrp0whkwmY8eOHcycORNzc3MUFBRo0qQJv/76K506daJLly78+OOPzJgxg4SEBBYsWCAYcRs2bMDDw4OTJ0+yatUq9uzZg6mpKeHh4YIhW1x041NQIHtfxMbGcvr0ab799lug4Hq9fv0627dvJyEhgdevX2NlZcWMGTPo0aNHlW47KSkJb29vHj9+jIKCAs7OzjRv3lywW/4JJCcn4+TkxPTp0+nduzeNGjWiZ8+ezJgxg5CQEL799lvmzp3LpEmTmD59Or/88gtXrlyhRYsWjB07lr1797Jq1Spad+7Osl82cvHA7+y68xhNbR32rFhIyCM/vpm7CBVVNQ6uX06uWMyCPUfLnZNEIiEs6Cmz+ndl5bELmFnV5nVwIEu+H8LkVZupXa8BrwIes2HmRKas+RXXTl3ZNHsKt8+f4pu5C3Fya82vc6cS/uI5vfr0Zf7smWzcuJE//vhDkHYvrWamcePGmJiYFGm3MHDgQGrUqMHq1av/jtPxwfhPRWbkD6ng4GCOHj3Kb7/9JizLzc3liy++AOCrr76iV69e5Obm4u3tXWRZYbwKec5Tf38Orl/+1zg5OUS/DkVVXQP7Rk0JuOdNjjgbY3MLXFq349EdL3qOlBB47y6DJs2s8NxtHJ2Fv2vXa0BqYgIZaalEhb7A1smlyLr1XRpzaNd21qxZg1gsJikpCV9fXxITE9mwYQNQYBQWPy4AQUFBODk5FXmRNGnShMzMzArP9X8NoaGhggxneZC/5OQv6sIvvfKiBB/ycpSTJPk47yNZCp+GfLS8OSXAmTNnBCUvIyMjDAwMePLkSZF1Bw8ezJIlSzh//jzffvtthQ2k4uulpaWxadMmTE1NmTNnjtDxe968eXTo0AFHR0fCwsJo2rQpb968wd7eHkVFRZSVlcsUQqjIXIp7/XNzcwUyUtnojbKyslBDk5+fT2hoKMHBwfj5+XH79m309PQwNjYmLy9PEElQUVGhefPmNGnShCdPnnDr1i1SU1Px9/fH39+fxo0b06pVK5ydnalZsyYnTpzg7NmztO7Rp0JEJiIthMsv9/Eg5ipxGeEUlQQQUU2rBo3M2tPJZhiWunXKHau8DtdeXl5oamrSq1cvrK2tyc/P57fffkNDQ4O4uDg2bdqEiooK1atXFxp8Fof8MzkxjoyMxNnZGT09PaytrWnYsCF16tShZ8+e1KlT+lwVFRWpVatWqctSU1PZv38/ubm5jBgxotLysnLSVpysFCYthdO5tLS00NfXR09Pj5o1awoNXPX09NDR0anwM8fQ0JDz588ze/Zs+vXrx4IFC5g/fz5AEQGJssZLSUmhS5cuqKioFLknKvq8ycvLY9WqVQwYMIAvv/ySdu3akZeXR0xMDDVq1CA8PJwtW7awYcMGhg0bxu3btzl//jzKyso0btwYX19fYmJi6Ny5MytWrODq1auMGlXgnExMTCQxMRFDQ0NWrFhB8+bNiYmJYeDAgUXqswoTmH9C2KCq8PjxY3799VdGjx5NSEgImzdvZuPGjaXaPlWFiIgIvL29efbsGZqamrRu3ZomTZpUqubsY8HAwABFRUV0dXU5ffo0GhoabN++HSUlJezt7YmJiWHhwoVMnTpV+M6dO3d49OgR8fHxuLq6MmPGDJ4nZdB/7BTO7N5GVOhLatapy8WDv7Pq+EVq2tkDMHnVJka4OvDmebDwWWlQVFRER7+gaauOviGa2jqoaWgybslaXDsVpDObWFhy5vffiHj5XPjM2qEBnQcVZNe07N6H35f9zMwlK6lrYczEiRPZunUrcXFxZW5XS0uLHj16cOzYMTp16kRWVhbnz58XyjP+DfhPkRn5yz0/P59Zs2YxbNiwIsvlN1Dr1q3R0tLiypUreHp60qdPn1JlFSX5Er6Zs5AGzYuq6MiVJZxatCbw3l3ycnKo26gpdRs15cjmdbx6+gg1DQ1q1Klb4bkXfkjKZAUvJSVlFZRLSa+IS0ggLy8PsVjM1atXefjwIQ0bNsTJyQkLCwt++eUX9u7dy927d0lPT8fLy0uQ2QwKCiI9PZ2DBw+ipKSEsrIyERERZGVlceXKFZSUlITPy/td2mf/xTzMN2/eEBMTg7W1dZHPPTw8OHbsGGvWrMHCwoI9e/Zw6NAhFi1ahKurK2FhYWzfvp3evXvz9u1bDh8+jEwmo379+gwaNEgIqycmJvLw4UOys7OpXr06DRo0qJR6S2kv18q8SCv7wi0cYSrcL6H4XCpDkuTjiUQiAgIC6NWrFykpKWhra9OhQwd27drFkCFD2Lt3L7dv36Zly5ZCHUrnzp2FYszKEhl5hMfJyYl9+/YxfPhwHB0d6datG926dROaUAIcP34ca2trdHWLFlWWdvwlEgkymYyLFy8KHcUNDAwwNDQU/i7tHKuoqODk5ISTk5PwWfHoTUhICCEhIZw7d67M6I2SkhJ16tShTp06dO/endevXxMUFERgYCAAmzdvpl69etSrVw9LS0uUlJRwcXGhYcOGBAUFcfPmTRISErh//z4PHjygadOmtGjRgm+++QavO97v7HAdlxHOb/dn8jjuJgoiRaSy0moKZMRlvMHz5V4uvNiNU7XWjG6yimpaNcoct7QO1zk5OVhaWtK5c2cAYmJiOHnypFADpKqqipmZGfHx8YSFhb3TEzxgwAAGDBjA27dviYyMJCgoCH9/fwICAjh06BDq6urUqVPnnf1RCiMxMZH9+/ejoKDAyJEjyxRsyMvLK0JSikdXcnNzhXVVVVUFcmJnZ4eenp7wv56eXoV73FQUK1aswNnZmW+//ZZr165VqKeKTCYrsq/vY9ynp6ejqanJ/v37cXZ2RltbmwEDBuDs7Mzq1at58OABWVlZNGvWDAUFBVq3bo2rqysqKir06dOHGTNmcOPGDfr168f27duZNWsWb9++RVdXl2PHjrFo0SJhboWjToUFCd7H2fSpERk5QkNDmTlzJm/evMHT05NOnTqhqKiIgYEBurq66OjooK2tXWp9XEUhb6zr7e1NREQEhoaGdO/eHScnp/fq8fV3ICgoCGdnZ3Jzc8nKyiI/Px87OztiY2N5+vRpEUdBZmYm0dHRQEEtlUO7rmhqF6hL5uXkEBcRTn5eLnMHFY1uSaVSol+HlktmSoN1fUdU1NT4Y+NqIl6GEB4STMybMBq2/KtfWDXLmsLfKqpq6BkZofj/7xi53Vs48l8aBg0axHfffcfWrVs5f/485ubmNGrUqFJz/SfxaV5ZHwg7OzvCwsKwsbERPps5cyZ16tTh22+/RUFBgf79+3P+/HnOnTvHzp07Sx3HysaGpLgYzGr+5W3bPGcKzTp2oUm7L2jY0p0zv/+GRJJPi849sKrrgFSSz7l9O2nY0r1Scw4PeYZD0+YAvHjyCENTM9Q0NDCvZU3QPZ8i60a/LogUaGlp4efnR/fu3XFwcEAkEgmSra6urjRs2JBNmzZRo0YN7OzshBv0xIkTKCgokJ+fT3Z2Ns+fP8fAwIBnz56Rl5dHfn4++fn55OVVrr+OSCQql+yURogqS5iK//6YIf+cnBxOnTpFu3btSrycLC0tSUxM5M2bN1hYWHDz5k3+/PNPxo4tSCu8dOkSr1+/Zv78+eTn52NpaYmioiLr168nKiqKRYsWoaSkxLJly7h06RIymYyMjAwmT57MhAkTyiU0coP83LlzrF+/ntevX2NqasrkyZMF9amyUJE0ifIazBX/bmkKQpWNkMjXvXPnDmfOnGHQoEGMGTMGT09Pxo8fT+fOnfnuu+94+PAhY8eOxcPDAwMDA1JSUli3bl2Fizih4BrNzc1l/vz52NvbC0Ro6NChPHz4kGHDhuHn50e1atVYuXIlR44cwc7OjoCAAI4ePfrO1CD5XN68eYOenp5Qp/Hy5csiQhtaWlqlkhwDA4MiL/yqiN5YW1tjbW2Ns7Mzu3btokaNGgQGBuLr64uWlhZ169alXr16AilycHDgxYsX3Lx5k6ioKHx8fLh//z7NXF1Rs3VCkl32c+HPVwfZ9XA++dKCdUonMn9Bvvxp/B2mXHRnlMtiOlgPKXVdiVSGf1ya0OFaJpOhoqKCtbU19+7dw9/fX/A+ampqkpOTQ2JiItWrV6ddu3Y0aNCgwg4XbW1tIdIlr60EhGLvihqrsbGx7N+/H01NTQYPHiw0Ny2NrBSOjisqKgrExNLSkgYNGghkRV9f/6N7tku7hwcOHIitrS2HDh2qUE+V9zHoi5NEPT09cnJyuHDhAmfPniUmJgZnZ2devXpFbGwsOTk5qKmpCcdD3psnICCAevXqYW5ujpeXF/369aNr167cu3cPT09PcnNz+frrr4sQGPl+Q+UECeRIS0vj3r17vHnzBldX13+8oXBxtGzZkqVLl3L16lWeP3+OVCpl9erViMViwVhXVlYmNTWVYcOGMXv27EqNn5+fz+PHj7l79y5JSUlYWloycOBA7Ozs3nktSKVSwe6oih+JRFKh9dLS0jhz5gwxMTGkpqYWSamSC8ocOHCAtLTSHTghISHUdmsn/F8gSFGQFbPk4CnUNIqmxuoZGlNZ+N+6waoJI2nT60ucW7dlwPhp7Fg0p8g6CopFTXmRSAFpJQtIunTpQn5+Pl5eXhw/frxU5cpPGf9JMjN16lRatWpFkyZN6NatG2fPnmXdunVcu3ZNWOerr76iY8eOqKurCzm4xfHN2InMnTweM6va1HVuzJWjB/D2PEvf0QUdjq3qOqCgoID/zeuMmrcYBQUF7Jwb433xDD+s/63UMcvCzsXzGLtkDdkZb/lj02p6jSwwijsPGs6Ffbs4uG45bfsMIOTRA478vpNfN2/m66+/ZuPGjbx8+RJzc3PS09Px9vYumJuVFa6urqiqqmJvby/kQTZv3pwTJ05w584dJk6cyJkzZ3j16hXNmzdn4sSJReYkV4qRE5vCv0v7rLx15H/n5uaSmZlZ5hiF0+MqAgUFhY9GnO7cuUNmZmapRbq2trbExsaSmpoKIHhN5R6b69ev4+joyJs3b2jTpg1DhhQYaNu3b2fr1q2MGTOGFy9e4OHhwY4dO+jUqRO7d+/m0KFDtG/fnoYNG5bZYVxBQYGDBw+yYsUKevTowZQpUzh+/DgzZ86kc+fO5RoaPXr0YMiQIWX2Cyl8XJOTk1mwYAFt27alT58+7Nq1i23btpGYmEiXLl2YP38+ZmZmLF++XJC+VVJSKvfFFRUVRfXq1YG/jB15IXvr1q0xMDDg2LFjWFhYMHz4cKKiovjmm2+IiYlh1apVjBgxgr59+7J//34hglGRF2VhEpafn4+vry8vX77E2tqaVq1aAbBy5UoePnzI0KFDuXbtGkuXLqVBgwaC19bQ0PCdRE1eEyUnEIWRnZ1NcnIySUlJJCUlkZycTGxsLIGBgUW87np6eiVIjqGhIXp6eh8UvalRoyDq4ezsTL9+/YTIgzwdTVlZGUVFRTp27IiTkxO2traEh4dz48YNXr9+zdOwSGpa1Ctz348HbuDw05XlnouyIJVJyJVI2Hp/BqniRL50mFxiHRkQk5FDdEYO1bXVkMlknDt3jsePHyOTyYoonuno6ODg4EC9evWE6EBlnTOlQX4dffHFF6xbtw5HR8e/5ieTkZmZKZCU169f8+jRI5SUlMjNzWXjxo1FiLeOjg76+voYGhpibW1dhKxoa2v/o979srbt4uKCi0tB2vP79tkpDfJ7VE5kwsPDMTMzIysrS2gc2rdvX6pVq0bfvn2ZOnUqXl5e9OjRg5EjR/L48WOsrKyE+fTt25fZs2czZMgQlixZgo+PD61btxbIuryGtKL7XRzyfU9NTUVPT48rV64wZ84cVFVVycjIYM+ePcyZM4du3bp9MilnmpqajBkzhhEjRrBu3ToiIiIYP348ycnJZGVlkZGRQXZ2NrGxsWUKQ8iRlZVFYGCg4BCNiIggKiqKvLw8dHV1sba2RlVVFX9/f+7fv/9OUlERxbviUFRULPJuL+tHXV293GUNGjTA3t6e3bt307dvX2H9gwcPYmhoyPTp01m3bp2wXbkDztDQkB9++IHX2VIQ/+WIMLW0QkFRkbepKdSyLyC0aUmJ/DpvGt/MWYh6Oc2PS8Ofxw7Srt9AvvupoNxBkp9PbPgb6jdrUe73FCp5yamqqtK3b19OnjzJ5cuX+emnnyo3wD+M/ySZcXV1Zf/+/SxYsIAZM2ZgbW3N4cOHad26dZF1jIyM6Ny5c5mhz0FfDSQgLJw/NqwiLSkRS5s6zNm6F3OrgvoJkUiEo1trgu7fxdi8IMVDrmTm6NaqUnP+YvBwVowbQX5eHh0HDKH78ALZZ2NzC+Zs28u+1Ys58/tvGJlXZ8HylXzzzTcAHDp0iNGjR7N161a0tLQYMWIEurq6+Pv7C6kXhaGvr4+npydjx47FycmJ1q1bM2zYsFIfJiKRSLjp/y49fXnzu/chTKUty8/PRywWl/vdd0lrvnz5EkdHxyIvbn19fVRVVYmJieHy5csYGhrSsWNHoqKiBIOyT58+zJs3j2fPnuHh4UFMTAxeXl5CGFuu9X7x4kUMDQ3p3LkzPXr0EFKZylIGgoIHz+zZsxk4cCBKSkr06NGDb775ptxmit7e3ly8eJEff/yx3P2Vb0NfX58NGzYgEok4efIkq1evZsyYMdSqVYvFixczZ84c9uzZg6amJgMGDHhnCsGSJUt48OABS5cupV69AqN4/fr1hIaGsmnTJhYtWsSaNWtITk4GCryE48aN4/Lly/Tr14/Lly9z5coV8vLyUFRUrFBUrrCnNyAgAHV1daytrfntt9/4/vvv2b9/PyYmJtjZ2aGsrMzSpUtp1aoVP/zwA5s3bxaKZeHDjTe5YpKczMkhN4LlJEdOdF6/fs3Dhw+F61NBQUEwfotHddq3b1+EHJYVvYGClLkaNWpQp04d2rRpQ6dOnYiOjubAgQOIxWLOnj3LpUuXhMjEkCFDSEhI4G7sWwooRcnr8s9XB9+byBTH4acr0VMzpoN1ScIt73BtpqnC7du3CQwMRCQSIZVKycnJQVVVleHDh2NmZkZ6ejrh4eH4+PgQERGBtbU1bdu2/aBorjyyd+3atSLF4TKZjDdv3rB3794i66uoqFC7dm0MDAyK1K3IleU+dZRniFdlWrE8U+DUqVNCZLpdu3asWbOGPXv2sGLFCvbt28fatWtp1aoVFhYW/PnnnwwZMoRevXqxZ88eateuTYMGDQgNDUVNTQ1zc3OcnJxwcHBAS0uLWrVqUadOHZ4/fy7UQVYmXRD+EnWJjo5mypQpaGlpsXfvXjZt2kS1atU4f/482dnZzJ8/n5CQELp161ahcYu/9973R1lZGTMzM3R0dEpVCFNVVUVVVZUpU6YU1Gfo6JCbm4uysnKFCZdMJiMqKgpPT09EIpHwfFJVVcXQ0BA1NTXBKVmYTFSUfJT3UzilvSoIooGBATk5OYwdO5adO3eyfv16ZsyYQWBgIL/88gvjx4/H2NhYeK9GR0fTunVr6tati6qqKlpaWijnZBQZU11Liw79h7B9wRzGLFqFrqERe1YsICE6EhOLstNoy4K2nj7P/f148zwYkYICJ7dvIiUhjry83HK/p/wez7lBgwbRo0cPbGxsBPXCfwv+E2pmHwvifAkXXsX/09MogZrZ8WS9TSchIYHY2FiSkpIEMjJ+/HiMjIz+4Rn+uyB/kchJTlpaGocOHcLExAR3d3eMjIzQ0tIq8fAcM2YMNWrUIDQ0FHt7e9TU1Lh//z5ubm6cOnVKUD/x8PCgWrVqGBgYEBwcTExMDMePH8fBwYE1a9awefNmlJWVqV+/PhMnTiwzUlgcISEhXL16leDgYF68eMHSpUtp2LBhmcZahw4d0NPT4/jx46X2Zijv+ECBN07u/fby8mLgwIH4+voKHv93vVzOnDnD0qVL6du3LxMmTEBTU5O2bdvSsWNHQWHLzc0NKysrlixZIogu+Pr60qFDBzw8PIp09a7IvOVzGjJkCN7e3qSnp7Nw4UImTJiAp6cn8+fPp1u3bkyePBl9fX0uX77M0qVLuXPnDgEBAdStW37d28f2ukqlUtLT04uQHPnfqampwrlRVlYWyE1hkmNoaIi6ujrx8fE8ffqUO3fuoKSkVCQCqqKigp6eHvHxRZ91mpqaZGZmoqKiQp0GDRHZNix1jnEZ4Uy56E6upPTeBqXid8AKaFv6YhVFNX7pcqPMGpr66hKOH9iHnp4eDg4OpKen8/DhQ5o3b05GRgbh4eFCaoiBgQGWlpa0bt0afX399z5f8nPt7+9P9+7dCQ0NFdJBpVIpcXFxpKWlkZKSwp9//om1tTX9+/ev8vqVfzNKe+7k5uZy/Phxjh07hra2Nm3btkVdXZ2xY8cyadIkfvzxR+7du8fw4cNZvnw5/fv3Z9u2bezdu5cNGzagr6/PlClTCAoKYsSIEZw7dw5DQ0M8PDxK9Cc6ceIECxYsYNKkSUUcFRWBXNYbCqJ8Y8eO5cWLF3h5efHtt9/i5eXFggULqFmzJvb29sK6xfc/ODiYP//8s0RaVGUhj2QpKSlRvXp1mjRpgo2NTYn03cKQL0tLS2P37t14eXmhrq4u1MvIa8r69++Pra1tqduVyWSEh4ezd+9e1NTUaNKkCU2bNi23F9Snii1btjBz5kw6derE/PnzmTx5Mvfu3cPY2JgxY8YwZ84cFBQUuH37NmPHjiUkJITDhw9z5swZoKBpZmyGGO+oFPrVNWfh3uPUb+ZGTnYWe1ct5s6FM0jy86jX2JVR85dQrQJkpngj9ZT4ODbNmcKzh/fQ0NLBpU07lJRViA1/zU+7DrNp9hQAJq74BYBrJ45wdPNanjx/gamWWhE5ZqBUNTN500x5g+DJkyd/NHnuj4XPZOYdOP8yjhxJ5UOgHwtKyPD/Y0epy1RVVZk5c+a/VjryU4BMJuPIkSNEREQwduzYEtKchfHHH3/g5eXFkSNHOHjwIPXq1WPQoEGoqanRvn17XFxcmDZtGhMmTKBt27bUq1ePgwcP8ssvv/DHH39gaGiIpqYm6enpeHp6sn//fu7cucOdO3eKpK8Un59IJGL79u2sX78eJycn6tevT4sWLQQt/NJw9+5dWrRogYeHB02aNHmn1G9525b/Dg8PF4hMRfHTTz9x8+ZNJk2aRN++fbGxseHXX38VFHV8fX3p378/06dPZ+TIkWhpaZGXl0dgYGCZqXflISMjg+7du5OZmcnq1avx8fFh8+bNLF++nK+//poNGzbwxx9/0Lx5c4YPH87PP/9M9+7d6d+/f4li/+KQy+Hq6Oj8I2kkEomElJSUEiQnOTmZ9PR0YT01NTWB2Dx79gxra2tcXV2Jj48nNDSU6Oho0tPTS609MjY2pk6dOsQraaFmWgNK2c9F17/iafydd9bHFME7yIyCSJEGJi34qe0fpS5XzUzFXCTm7du3QgQKCgw8MzMzLC0tqVGjBpaWluXew5WBPDK3a9cufvvtN+7du1dinUePHnHmzBnq1atHnz59/pOiKFWB9PR0AgICcHNzQyaTsXPnTqZNm0b//v2FRpWLFi3i9u3brFmzBhsbG7777jvS0tI4d+4ccXFx9O/fn44dOzJv3jxSUlLYvXs3d+/epUmTJkydOhU1NTXheSEXwJEL4rRv3/6dktuFsxV27tzJ8ePHuXz5shDNWbduHbt37yYgIIBnz54xbdo0AgMDhTSrSZMm0bZt2yLPLKlUSmxsLM+fP/+gCEVFI9PFIb+G582bx549e2jUqBGGhoYkJSWRlpZGTk4OISEhHD16lA4dOpQ5xtOnT8nNzaVhw4YVqp/6L+NTdXp3tTYpIpZSEaSnp2NqakpAQECFFFw/JXz6ce5/GOZaarxOy3rv7q4jXB3Iyy1bReKXczeEFLV3QQRY6mqi6uqKj49PieV6enokJCRgYmLySeTo/hvx6NEjnj9/zsCBA99pBHXs2JElS5aQnp6Ora0tNWvWRCwW4+Pjw4IFC8jIyCA+Pp42bdpQr149YmNj2bhxI+np6RgaGnLlyhVOnjzJmjVrGDJkCN26dcPMzKxcCUU5li9fzvjx4xk+fDh6enpCmkZZKRPywsZTp04xcuRI3N3d2b59O8bGfxUkVqQepDAsLS3fOU855Dnxs2fP5uHDhxw9ehQtLS309PRISUkR1mvWrBnDhg1j165d1K9fn3bt2qGsrFzh+pji++Dn50d6ejq3b99GQ0MDsVhMdHQ0v/zyC9bW1kyePJn09HSOHz/OoUOHsLW1ZejQoUUMobKQnp4uELF35Zh/DCgqKmJkZFRqJDY3N1cgOoXJTl5eHsHBwQQHBwN/CRFoaGgIBa+FkZCQQGJiIg59h5dKZCLSQngcd7PK900qk/A47iaRaS+w0C3pIc5QUOHM6aOoqqqSn5+Pvr4+PXr0wMLCgvz8fKFu5fHjx6SmppKWlsbAgQM/iFzIyd79+/eFNMnCCAwM5PTp0zg7O9O9e/d/lVPp76rr8Pf3Z968edy4cQNdXV26du3KTz/9RM+ePVm7dm0RtbnevXtz7tw5bt26haOjI927d2f69OmCE6VevXp4enrSs2dPoV9I4X0oXCsnj47p6OiU20Ol8HeePHnCuHHjuHnzJq9fvxYcBPLlIpFIiHAaGxtz4cIFQkNDuXHjBn/88Qdjx44lICCgyDNZQUEBc3PzKu0x9D44evQoP/zwA9OmTav0dxUUFEq0d/hfhpqSIqqKCp+U01tVUaFSREYmk+Hh4YGHhwdubm7/OiIDn8nMO1FbT4OwtKx3r1gGVhy7gKyc4jYDE9MylxWHDKitr4HzF19gZGTEuXPniixPTExk27Zt6OrqYmtrS506dahVq9a/Ijf7U0Bqaiqenp40bNjwnelFUqlUSCNwdnYWiozlylNWVlZYWFjg5ubGwIEDqVmzJjKZDA0NDe7fv09aWhpOTk4sXLiQ+fPn07RpU7y8vLC3ty9XBUdudOTm5grNUnNycsolXl5eXpw+fZodO3bwxRdfsGTJElq1asWJEycYPXq0sJ689gDK76dQ2V4R8vGkUikaGhpMnz6dH3/8kcOHD/Pw4UM2bdrE5cuXGT16NM2aNWPJkiXcuHGDK1eu4O7uXuH+OaWRudTUVBQUFEhNTRWUC48dO8amTZuYNWsWBw8eZP78+UycOJGQkBChy3dZ9TFyg/bly5fEx8djZmbGhQsXyMrKwsjIqELCEn+HkauiolJq9/p9+/ahqqpKy5YtixCdkJCQEmMoKyujpqaGrqERIuXSva+XX+4rkF9OlsAGCiItd4EGgA1wHUgE9IB2QFn6AX7AbSATMAe6goKpIpde7mVUoyUl56auQaeu3Xh4z5fU1FQMDQ25fPkyKSkpRSRIVVRU0NfXF9QE34XyjHr5548fPy5V6efs2bM0b96cjh07vle/p/IUnYrXAVaVmlN+fj4uLi507NixUvN9H7x9+5aFCxdibGzMo0eP8Pf3Z8uWLezYsYMlS5bQr18/Tp48KRRbOzo6Ym1tzd27dxkwYACtW7cW6mIGDx7MkCFDSE5OpkGDBsBf50cuq1yZnjDy31FRUYKT5vnz57x69QolJSUaNGjAjh07hIL/lJQUbt68KTxvtm/fTnR0NJs2bRKURr/55hvy8vI+qfev/Jg0adKk3PrK8iCTyRCLxRVuJvu/gIo6vV8+fcTPw78sc7mRuQUbzt34oLmI/n8+lfqOSMTMmTNRVFTk7NmzH7T9fwqfzl32iUJXTRkDNWWSxe+nhGNaSP/7QyAC9NWU0VUt8DA1atQIVVVVTpw4IbyAp06dSlxcHM+fPyckJERQKKpduzZ16tTB1tb2g/Tj/8uQSqWcOnUKdXX1UoUTikP+Urh37x4SiUQ4rjt37iQlJYXq1aujoKDAL7/8IvTtqFatGm5ubuzbtw8NDQ1q1qzJli1b2Lp1K9u3b6dOnTocPXq01MLN4tvdsmULs2bNwszMjDt37mBjY1Omsfbzzz/Tt29foVlcSkoKJiYmvHz5UujM/PLlS7p161ZmQ8CqgHzu7u7udOvWjfXr1+Pg4MBPP/3EnDlz6NmzJ+3atWPYsGGcOnUKQ0PDChuFUqkUJSUlpFIp8+fPRyQSUb9+fdzc3Pjll1+QyWRcuHCBTp060a9fP5SUlOjTpw8TJkxg4sSJdOzY8Z1ERl5kfu7cOSIiIgQDUyaTcf369Uodh8rIkFeFhLn8OGpoaJCVlVVCiOD27dvExsZibm6OtrY2eXl5AtF5W85r4kHM1aLpZeHA90AocAToCNgCIcBx4FsKyEphPAduAD0AI+AxsAekkyQ8jLnGqDK27e3/hIzERLS0tJBKpZibm+Pg4FBCwrgyxEIkEiEWi0sVPJFfvxERESXSQDMyMqhWrRpSqZQLFy68V/H2+6D4NVJW0XRZik7KysqIxWKSk5OLNIr8GPD09MTHx4dXr16hqalJRkYGiYmJXL16lTlz5tC9e3cOHz7MuXPn6N69OwB9+vQRnqH9+vVj586d7N+/n549ewr3a3FUNvomkUjIyspiyJAh9OvXT5Br19DQEFQG27Zti729PYMHD2bGjBl4e3vj6ekpNEmtUaMGv/76q/AM8vPzY+zYsairq38yambwF+GrVasWq1evJisrC0dHR0GUQltbG01NzXKlvxUUFLh69SpWVlYCkfxfR0Wd3jXt7Flz8kqZyxWVPry+Tu70rixCQ0M/eNv/JD6TmQrA1kAL3+iUd6/4ESH7/3kURv369VFRUeHo0aNYWlqiqalJ7dq1qV27Np07dyYxMbGITKtMJsPc3FxoqGdqavrJPGT/afj4+PDmzRuGDx9eqaaVxb1TxY3E0iR6Fy9eDBR4uFq3bl1EZa+i6NmzJ02aNCEvL4+aNcsmzNevX+fWrVs8fvxY+OzBgwdCJ/AjR44wb9482rZty5w5c+jduze//vqrEHWqTPPLikCexjF9+nT8/f2JjIykXr16+Pn5cfXqVTZs2IC2tnalRSwUFBSIjIykXbt2mJiYYGVlJdQetWzZkiNHjnDx4kUWLFgAwKtXr3B1dcXOzo6GDRsWGassY0hBQQF1dXX69+9f5POkpCS2b99OrVq16Nq1a7my4+Wp80kkEuF/sVhMRkbGeyvwFYdcSUgqlSKVStmyZUuphCg+Pp7k5GThczMzM/S1DMkoZczsvAziMsKLfugKGACXKYjCNP//z42AKMAbKO6YvAO0Auz+//92wAvgCcQ2e0N2XibqysWKi2Uy1PUNMVAWCU0s8/PzyczMJC0trUR0wt7eHicnp3K99bGxsZw5c4YnT56gr6/PjBkziImJwc6uYGIikYjs7Gyio6OL9DCTyWTEx8fz9u1bsrOzyyQTVaHmVPinohHL8iCPZlZF6ey7jPZWrVqxcOFC0tPTWbt2LdevX8fKyoqkpCROnTrFV199RePGjdm7d69AZrp27crKlSuJjo5GIpFgZ2fHkiV/Reo+lCjInSDp6em8ePGCt2/fCstUVFTIy8sjJycHU1NTfv/9d6ZOncrAgQNxc3Nj3rx5/PZbQQuGIUOGoKWlxaFDh8jPz2fAgAFC1PtTfMcmJiaipKTEqlWrhIgyIIiD3L59u9z3oKGhISdOnODly5d07dq1Uu/M/yIq6vRWVlEt0rewqlHc6f2/hM8CABWATCbDJyqF2Myc966d+RCIAFMtVaFZXHEkJiairKxcbsFyVlYWL1++JCQkhJcvX5KTk4O2tja2trbY2dlRq1at/1nVnbi4OHbs2EHTpk0rpZZVFgq/YGUymfAjV5gp3JBSnl4iX66oqEhcXBxZWVmoqqqirq6Ompoaqqqq75We5O7uTvXq1Tl48CBQUOexdOlS7t69yx9//EFeXh4ZGRk4ODgQEBBA//79GTp0KPPmzauUFHFFmnHKIR/X19eXqVOn0rlzZ8aOHYuxsfEHyR//9ttvnD59mpMnT6KqqkpiYqJAirZu3cqFCxeYOHEiampqfP/998yZM4fhw4cDH24UBQUFcezYMbp06VKmx7gqUVyBr6KE6cWLF0LjwYqSLj07Rwxs65eomQlLCWD6pf+/X1IoSDMbDxgDm4HGFJAbOXwAf2AsRQUAVgJ5FFV8zgeaAF1hzReXqaVfNPVSKpGQ+PwpSUEPK2T4u7m5CdHSIuP8/3X77NkzFi5cyNOnT4GCdNEtW7YwceJEOnXqxPTp04XvvH79mpo1axa5xz9Fg/VdqMp5P3z4EBcXl3LHlKd//fzzzwQFBTF69GgcHR0ZOXIk+vr6HDhwgP379zN+/HgCAgIEcZH4+HhMTEyKjFWZ501FIE+dkpPP4khNTeXGjRtFmmz+/PPPXL9+nZs3b1b5fD42fH190dbWRlFRkYSEBNLS0sjKyiIpKYmMjIwi13tZePLkCefPn0dTU5O+ffu+l6jMfwlRb8X/uNMboJm5PtW1/55WGp8SPkdmKgCRSISzqS6XwxLIr2xb1SqAooII52q6Zb4kKuLF1tDQwNHREUdHRyQSCeHh4ULU5uHDAoOgdu3aQq3N++bT/tuQn5/PyZMnMTQ0rLAk8rtQ+DyVJpFZ2FiXE5jC2LRpE7/99pvQTKx4HcusWbOYM2fOOw0RPz8/bt68WSQqc/v2bYKCgnBzc+PNmzc8f/4cmUxGbm4uzs7OGBgYCAIEioqKFTJ4CteqZGVlCdGqsr4r399mzZrRs2dPdu/eTffu3YW+O++LW7dukZGRIXgJ5cXEnp6eaGlpkZCQwNSpU4mMjGTKlCkCkakKQ6RevXo0bdqUy5cvY2Fh8dELfEUiEcrKypV2QCgpKREZGckXX3xRakPW7OzsIj9ZWVnEidTIEolKOHLypKX0OVAq9rswZP//UxxSoDNQ3GGpWs52ALPq5jibG6Curi78yLvBq6mpVehakp/7HTt2kJKSQkBAAGvWrOHmzZvY2dnRvHlz9u3bR6dOnYTUsuJNdP+NRAY+bN6F720vLy/69u3LkydPSvRQKgxFRUXu3bvH6tWruXPnDi4uLiQlJfHgwQOysrLw8vKiXbt29OnTh9TUVIHMyIlM4W1W5H6VPzfLkikuDJFIVG5qlZ6enkBkZDIZOTk5fPvtt0yaNEmYT3HH1d9JbuREsaLntFmzZoSGhuLj4yP0PGvWrFml1CkdHR2xsLDgxIkT7N69m7Zt29KiRYt/FamrSphrqWKmqfqPO73Ntf43o2SfyUwFoaakiIupLveiU//2bbuY6lZaYq80iPMlpIrzSMvJJ0/LEDPn5lR3aU6eWExqbBQRL55x4cIFzp8/j6mpqZCOZm5u/q99Yb8LN27cICEhge++++6TKdRcuHAhc+fOFTzjubm55OTkkJubi1gsxsjIqELno3Hjxjx58kQQFEhNTeX27dvk5OTw4sULfvjhBxQUFKhTpw4HDx4kKSmJ9u3bs3LlX80PK7IdJSUlxGIx33//PTExMVhYWPDzzz+XMPoKQ/7CnzlzJr17936n4EJF0KpVKw4ePEhAQAD169cXjNm5c+fSq1cvrly5QkREBICgRlWVHtWOHTsSGRnJsWPHGD169N/WaLY4pFIpYrG4CCGR//3mzRskEgnHjh0jNze3yPLChfOFYdawGYZ1GiAqdpyUFcqRZDUEIot9FvH/nxeHEZBebNkpoG7BT2nbEYkgMT6ep498y0y5U1FRQV1dHQ0NDb799ttSz7P8+r5//76gcnX58mVcXQtCSj/++CPnzp3j3r17ODo6/us88B8KiURSwjD38vLCzs4OU9MC8Zq4uDhatGhRoVS1lJQUzM3NiYmJISMjg7Vr19KuXTsUFBR4/Pgxbdq0KdF4VI6KvoPk0V15CllVQyQSoaamVkLNsSKkqSrw4sULatasiYqKinA9yp91cXFxJUQ/ikMmk3H69GkWLFhATk6OIPGuoKDA6NGjWbRoUYXnYmBgwDfffIOXlxfXrl3j1atX9OnT552y9v9FfOpO7/86Pg3r7V8CC211xMZSniSkv3vlKoKjsQ4W2mV7jN6FNHEeoalZRGeIBenA0i51mY4pWo1McWnSFvW8bNLCnnPv3j1u3ryJlpaWELGpXbv2f0ZXPjw8HG9vb9q2bSu8mD8FKCoqVplSTGFltODgYC5evIiTkxNJSUl06dKF+fPnExoaiqamJuHh4e8lMRwcHEzv3r2xtbWlXbt2SKXSIhGD0iI0cllTJSWlKiEy8BdBOXz4MNOmTRPqfpo1a4ZYLEZbW1tYR254VaVhqqSkxJdffimkuw0YMOCDvd9yUlKYkBQmKaUtF4tLb14pT7mCgk7W8shbWWRAWVkZHR0ddLQ0S90PU61aFDxNSnlxNwd2U5BaJhcACAa+LmVDzYEzFJAZS+ABEEhBHQ2i/99OcYjIycpCIpEITf+0tbWFqIyKioqgoFeegpzcCGzRogW3bt1i4sSJhIaGMmbMGKBA4jouLk6okSnrfBY25P8LxkRxIzk7Oxt1dXUiIyOZMGEChoaGHDt2DGNjY6E+rXgqWGHInwEODg60b9+e8ePHk5SURIMGDVixYkWJusH3TTct/KwpXAv0XzgnUBC137dvH2vWrKFNmzbCfnl6evLTTz8hFouxsrJi/PjxQu+u0p6/L168oGXLlsyfPx8TExPS09M5cOAAK1aswMbGhmHDhlV4ToqKirRr147atWtz8uRJtm3bRs+ePbG3t6+6Hf+X4L/g9P634nPNzHvgZXLm30JoHE10sNGvfFddmUxGdEYOIckZpIjzyjI3yoR8fX01JfQl2cS/es6LkBASExNRVFSkVq1aQtTm3+qBycnJ4bfffkNLS4sRI0b8z3hbfX19qVu3LuPHjyc3N5ejR4+Sl5cnSJm+66Vfmmf6yJEj/PLLL9y9exeAsLAwFBUVycrKKpOoVNRYSUtLQ1tbWzBM33WeNm3ahIeHBzVr1mTkyJHExcUxYcIENmzYwKBBg965vapAcHAwR48epXPnzjRr1kxISymLkMgJSGnLS4OSkpKQVqWhoYGamhrKyspCqotUKhUievJtvH37tojBraioiK6urtD5W/4j/19XV5fc3FwiIyMJS0wlp1rpRavjzjUnLuPNXzUzkwH9/1/4lAKVslQKiIo7f0kzF2+a6UOBpHMmBTU3HYHaYKplxa/dvUvdtjQsEA1pLkpKSmRlZZGSkkJycjIZGX/JFSgpKdG4cWPBsCsLoaGhfPPNN4IE744dO1BXV2fdunWoqalx9uzZd/adkkqlREdH4+HhUeQcFU9/+5C0uI+J0u4vDw8PNm7ciEwmo0uXLsyZM4fQ0FB69OhBx44dWbVqFcnJybRu3RoPDw8aNGhQodTUK1euUKNGDUFcAd6fwJSGf2sdU1mQ709wcDCjRo2id+/eTJ8+HQUFBZ48ecLIkSPp0qUL3bp149y5c1y+fJkxY8YwcuTIUseS96ODosd98eLF3Lp1i8uXL7/XPLOzszl79izBwcG4uLjwxRdf/Gecn5XB32UjyuForIONQeVtxf8SPkdm3gM2BpqoKSvwMDYNiVRWpfmRIgrChS6muu8VkRHnS/CPTSMm86+UkcrOT75+qjifFJQxs2/EqLbtyEpPE+psPD09uXDhAtWqVRNEBMzNzf81pODy5ctkZGQwdOjQf82cqwLNmjUD4LvvvmPcuHHcuHGDNm3aAO/2XhaujUlKShIiH2KxmKioKNatW8fTp08JDQ0lMDCQ3Nxctm7dypAhQ4q8MAsLILwLN2/eRCaT0bNnT+E8lWZ0yT+bOHEixsbG7N69mzFjxpCTk8P8+fPfSWQqYvzISUlZhKTwj5aWFp6enty4cYOcnJxSU3AUFRUFQiI3bk1MTIoYu3IVLIlEIqQbZmRkkJ6eTnp6OmlpaURERBSJrigoKAiExNjYuAhJUVBQ4NChQwwcOBBb27+aUUqlUuLi4oiIiODp06dERESQmpoKgIFJNaqXQWYambXH8+VepPoSWFBsYYP//ykN3xT735WiYgGAgkgRF7Oy69hiwl6SHF9Q36WtrY2FhQV2dnaYmZmhqqpKeno6KSkpQo+n8s5v7dq1+eOPP/jhhx8wMzNj0qRJWFtb4+joyIwZM95JZKDguFevXp2hQ4dy//59IWqWnJxcJO3vXWlxhQlPRf5WVVWtkvqXwveUVCpl6tSpXLhwge7du6Otrc28efOoUaMGQ4YMYenSpcybN48NGzbQsWNH6tatS1ZWgTRtedGrvLw8VFRUhL42cvKtqKhYpWTuv0Rk4K9zZG9vT5MmTbh37x4PHjygSZMm/Pnnn6irqwsqmeHh4Sxbtgx/f38yMjJKXLsikQgTExNBjrvwcc/IyPigYydXe/T398fT05M3b97Qr1+/ctsN/BchJxafstP7v4bPkZkPQGHiUNnoR3HIv2+mpYpztfcLF0a+zf7bCJZYLObVq1e8ePGCkJAQsrOz0dDQEPrZWFtbf7JyjSEhIRw+fJju3bvTqFGjf3o6/zqMGTMGb29vmjVrxrfffouVlRULFixg//79ODk58cUXX+Dk5ISvry979uwhOjoaKOoBrAh5yMnJYfjw4SgqKjJ48GCCg4PLVdkpTnJiY2NRUFAQPJBlRXZkMhmJiYncuXMHfX39IoZncbJS2uNSLtlcmJSoqanx6tUr8vLyaNOmDbq6uiVIirKyMrm5uaSlpRUhJ8X/zsv7S+5TJBIViaQUj6bo6OigqVl6WhhAXl4ey5Yto1u3bujq6hIREUFERAT/x95Zh1WVdm38d+jubgERRUXAQkWxu3scu2PUsR0Vexx1rLFjHMVO7O7CBgVUQkAUFJDuOuf7g+/slyNtTL3vfV1cwDl7P7uevfe6V9wrOjqavLw85OXlMTU1xcLCAktLSywtLdHU1ORs2AdyCoof+9uUECaf9yz1mnwp1rW/iYV21WKfiwrycNdTQl1dnejoaN69e8e7d++Ijo4mPz8fOTk5TE1NqV+/frGmilJI56OPjw/btm1j5cqVQlpmfHw8CQkJ2NnZfVWVR6kKXdGUwKJzTfp/0c+LflbS/JPWcEjnnYeHBw4ODmU6aUqqhfHx8eH169cMHTqUd+/e0bt3bzZv3kzLli0BaNOmDcrKyuzfvx9NTU0OHz7MTz/9xJQpU1iyZAn3798vsYC8pG1JC+X/SkdSURXJT1UmS3tW5OTk4OXlxYcPH0qt7flWiIqK4siRI7x584YbN24wevRoxo8fz+TJk4XeMJs2bUJVVZVp06bRqVMnQV79U4jFYt68eUN4eDg6OjoYGhpy5coVfvvtN4YPH84PP/zwxfv78eNHjh07RlxcHK1ataJhw4b/OpJZHr6VTQag8AVO738j/kdmvhDSlK7QxHQSvyClS09Fkap6GphpfJ6XLTQxnYD4tPIX/EKUFM4Ui8VER0cTHBxMaGgocXFxyMnJYWNjI6Sj6erqljLin4uMjAw2b96MmZkZ/fv3/697uEpR0TSMoi/1169f0759e/T19enYsSP37t0jKyuLgwcPYmxsTFJSksx1/u2337h16xYHDhyQyb+vDEJCQujevTsvX75kxIgRbNu2rdx0s0+PTSwWl1mcGxAQwOnTpwVjXkdHR4aYFE3pKukzRUXFEseOj49nx44dGBkZ4erqKpCUokTl06J7TU3NMomKhoZGpQ1AKVl79+4db9++xc/PT/hOXV1dIC2WlpaYmprKFE3HxcXh5+dHDCpoWdkXEwEAWHS9HwFxd2WbZ34h5ETy1DJqjFfzgyUdECmRoUQ9uIGBgQE1a9akZs2a6OvrU1BQQGxsLO/evUNZWRlnZ+dy5/rDhw+ZN28eEomEjh07MnToUEHN8VMlwYrgW6U4fRoZLInwZGVlUaVKFZycnErc509TudLS0tDU1GTIkCFcvXoVsVhMgwYNaNKkCfLy8nTr1o2XL1+yY8cO7t69S0pKCteuXRMEEry8vHj27BmnT5/m+vXrNGvWTCAqnxbgx8TEsHbtWrZv386FCxeEKHFFjrsy51O6vFgs5u3bt6Snp2NpaVkhhc7ytiWRSIiIiCApKQk3NzcZQiSRSL56qqB07ICAADp16kT16tWxs7Nj165dNGrUiBMnTrBz504mTZqEq6srU6dOpXv37qioqDBkyBBatWrF999/X+r4EyZM4PXr1wQFBfHhwwfmzp3L3LlzvxrJzM/P59q1a/j6+mJnZ0e3bt0qFOX8NyE7v4DH75OJyyxZlfFzYaSmRF1Tnf/qOpmi+B+Z+YqocLH9//9WlpfDTEMFWx01tFU+3/v3ZxEZKcrLz0xKShIiNpGRkRQUFGBoaCgQGwsLi7/EIyeRSDhy5AiRkZGMGzfuv+6h+iW4ffs2MTExHD58mGPHjgHw888/s3TpUoYMGcLGjRt58eIFhw4dQktLC0NDQ3788UemTJnCnDlzgIqnckk9thKJhMDAQHr27El2djaTJ09m9OjRqKurl9vPojyjQvrYS01NRSKRoKqqSlhYGD4+PlhYWNC3b98ypVrz8/OLEZOiUZXU1NRiNS/q6uoyxORTwiLt+/ClyM3NJTo6mrdv3woEJjs7Wya9xNbWlrZt26Kjo1PsPObk5BAUFCQ0NVVTU8Oxjht5ViUX9MamRzH5vCe5BSULD3wOlORVWNv+BsYaJUvFOmuAODOdwMBAXr16RW5uLqamptSsWRMnJ6dK1/K9f/+e3bt3s2nTJpSUlBg1ahRjx45FU1Pzs4/B29sbXV1d9PT0ZH7/HSLWvr6+jBkzBkVFRapXr466ujobNmzg7t27LFmyhDp16rBy5UrOnTvH3r17cXBwYMGCBTg7O9O8eXNWrFiBkpISqampbNiwgaVLl3Ls2DHatWtXbFsnTpxg7dq1PHnyhMaNG/Pdd9/Rv3//MiNeRR0WFSUz0vs+NzeXkJAQxo8fL/TsatOmDStXrhScLc+ePWPmzJnExMQwYMAAnJ2defv2LSNHjuTJkyekpqbSvHlzYV/y8vK+2XUrzTkTEBBA1apVUVFRYdKkSbx48YLLlwu7x589e5bZs2cze/ZsOnfujLm5OatXr2b48OFAYa1hrVq1mDRpElOnTi1xuwUFBcTHx+Pr68umTZvQ1NRk8+bN5aqhfQ5ev36Nj48PEomErl274uDg8NW38XfFu7QsnrxPpoTA9hfhS0sS/m34H5n5RpCRQRaLEUtATgSKcnJoKyugo6L4VRj1u7Ssv0Q5o76ZToVuoJycHMLDwwkJCSE0NJSMjAxUVVUFdTQ7O7s/TcL22bNnnDhxgt69ewuqVv9DcUiNAumj4ciRI6xZs4a0tDTatm3LqlWr2LBhA7t27aJ27dq8fPmSH3/8kY4dOzJv3jxu3LiBWCxm0qRJDB1aWBxRnkHy6tUrHB0dZZaT7kdGRgarVq3i4sWLjBw5kiFDhpQ6ZtG6npkzZ9KuXTvBKKkIoqKiOHDgAKqqqrRs2RKxWFxi+pe0PkAKVVXVUonK8+fP8ff3Z9iwYV+9sZxEIhHqZqTk5cOHD0gkEpSVlbG0tBRSxszNzVFWVmbr1q2Ym5sLXdal40ijNkFBQeTl5WFvb0+NGjVISEjg0aNHVGvXE9RKNu6vvN7H5kfTv9pxja33K63svivpiMlO+kjoRR+qV6+Oh4cHBgYGhIaGEhgYSEhICC1atKBRo0YV3tan82j37t2cOHGCvLw8OnXqxODBg8sktiUhPz+f48ePk5iYSFJSErm5//HKqqmpCcTmU7JTVorg18CBAwc4efIkderUEXoyzZ8/n/Hjx7N+/XoApk+fzsuXL5k4cSJz586ladOmzJw5E0NDQ5o2bUpSUhK7d+/G1dVVGFdfX59Tp07RuHFjCgoKSElJYe7cuZw+fRo5OTn69evH8OHDyzRipRFUqbS4oqJiucXj0ggQIKSy3bx5k8WLF9O7d29Gjx5NXFwc3333Hebm5uzevVtI0apXrx6tWrXiwoULnD9/nnbt2nHo0CH69+/Ps2fPePHiBVD43pgwYQKDBw+mX79+TJo0idq1azNp0iT27NmDWCymTp06ODk5IS8vX6Hrd/HiRTZt2sTJkydLdL7cuHGD8ePHM3bsWCZMmMCoUaNITk7m8OHDwjKjR48mNzeXnTt3Mm/ePC5evIirqysjR45k+/bt+Pv74+PjU6GeVwEBAQwYMABLS0t27NjxTWpcMjIyOHnyJKGhodSvX5/WrVv/bdohfCv8lRkz/234d8+kvxAqCvKYaMhj8g2d/9n5BTz9kPLtNlAGnn5IwUBVqVxCpqysTPXq1alevToSiYTo6GhBROD58+fIyclhZWUlRG2kReVfGykpKZw/f57atWv/j8iUg6JyrGpqaqirq2NlZcXAgQPR19fnzJkzXL9+nfnz59OgQQN69OjBunXrcHNzY/Xq1SQkJKCuri5DUst6wc+aNYtnz56xZMkS3NzcCAoKYsyYMaipqeHs7MyKFSuYM2cOISEhHD58GDMzM9q0aSOMKTWCJBIJCgoKpKen06lTJ96/f19MYlQqRRwbG0tycjKpqalC+lhycjKRkZFkZ2eTnZ3N0aNHgcI5LCUmpqamVKtWrRhpKcvosrS0JD4+nqNHjzJ69OhKG8ZFkZ+fz4cPHwTyIk2jgUKD0tLSEjc3NywtLTE0NCzxvKupqQlRo/T0dJ49e4a/vz8fP35ER0eHxo0bU61aNYKCgrhw4QISiYR69erhaGvBo1KeN63sBpCc/ZEDActL/L4y+K7WrFKIDIAIj+r2OCp15u7du2zbtg17e3s8PDzo06fPZyliiUQinj17Rnx8PHJycmRmZpKZmcnly5d5+PCh0Fy1MlBQUKBPnz5A4ZwrqraWlJQk/B0RESGjvqaoqCgQGx0dHRmio62tXaljK4nsm5qacvjwYRITEzl79iyKiopcv36d7Oxs4uLiMDIyokmTJoSEhPD777+Tl5fH4MGDMTQ05Nq1a+Tm5vLx40d8fArJpKqqKhKJhKpVqxIaGkrjxo2Rl5fnxYsXBAQEsG7dOtq3b19ulFNBQYGMjAwOHjzI77//LpCs8hoZ5+XlsX//ft68ecP8+fOBwrTBFy9eoKKiwvnz56lVqxYeHh6cPXtWqOMwNDQUtqOnp8fFixcFKWGRSCQjaZ+dnY2SkhJaWlpkZWURGRkp9NCys7OjYcOGlU4xk5eX5/Tp00JPrLy8PO7cuSM4XqpVq4aHhwdXrlxhwoQJqKurk5yczNu3b4X+Nh06dGDatGlcuXKFBQsW4ODgwNatW+nXrx/m5uZs2LChXCIjreGqVasWvr6+NGjQgICAgG9CZtTV1enfvz+PHj3i0qVLREZG0rNnzzIlvf/J+DMzZqRCA//NhOZ/ZOYfColEgt//F5b9FSgQS/CLTaGhmW6FPYkikQgLCwssLCxo0aIFKSkpQsTm6tWrXLp0CX19fYHYWFlZfZV0NIlEwokTJ1BWVqZ9+/ZfPN6/HcnJyUIT0QMHDtCxY0fmz5/P06dP8fLyolmzZjRu3BhPT080NDTIy8sjNDSU3r178/TpU/T09ARyUZG50a5dO27fvs2BAwdISEhg8uTJ1K1bF11dXdatW4eioiJLly7l559/Zvjw4ezfvx8LCwuMjY3R19cX5ohIJMLX15fevXtTv359jh8/jp6eHvAfw+7Ro0dcvHgRsViMuro6I0aMQEdHRyhSrl+/Pjk5OSQkJHDmzBni4+Pp2bOnjPJXZSEvLy/0nzlx4gT9+vWr8D2Tnp4uE3WJiYmhoKAABQUFzM3NqVOnjhB9qWhvIlVVVeLj4zl06BAhISGCSlL79u0xMjLi/v377Ny5E4D69evj7u5OZmYmBlqqvEvLLrXDdS+nSeioGPD703nki/MqVUMjJ5JHQU6R4a5LSiUyIkC1IBszDSMsXV2pU6cOQUFB3Llzh927d/P999+X2Ki1pHko/SwoKIh27dphZ2dHUlISUVFR1KtXj9atWzNkyBAUFRW/iHxC4bxUV1dHXV29xMhcbm6uDMGR/h0SEkJycrJM5EFbW7vUqE5RQp2VlYWCgkKxVK5mzZrh6uqKvb298N3333/P6tWref36NUZGRnh6enLs2DGUlZX58OED48ePRywW8+LFC1auXEmjRo0Ewz89PZ2FCxeSmppKkyZNhO00adKE27dvl3tucnNz8fPzQ11dXZDJd3Z25scff2TdunW4uLiUWW/5/v17du7cKRNljIqKIjExka1bt/Lx40fS09NJS0ujefPmPH/+nPDwcBo3biykjTVo0AA3NzeBjMTHx2NnZyeMl5qaSkFBgUBm6tevz4gRI4DC+6My7yhpSpm7uztt27Zl7ty5nDhxglOnTtG7d2/evXuHmZkZpqameHh4sGbNGu7cuUP79u2ZP38+165dE8h1lSpVePPmDYcOHaJ27doMGjSIzp07k5+fj6GhYYX2RyQSCfMgOzubpKSkb5p+LX3GWltbc+zYMbZv306bNm2oW7fuv6p+9V1a1p+a+g+FhEZFUe6/NuXsf2TmH4qY9BwZ+eU/GxLgfXoOMek5mGt+XpqYtrY29erVo169euTm5hIREUFwcDABAQH4+vqioqKCvb09Dg4O2Nvbf7ZRcf/+fSIjIxk0aNBf1pX974xPc7ZVVFR4/vw5oaGh2NnZMXv2bLy8vJg/fz4jRowgOzsbMzMzNDU1OXToEMrKypw5c0aIeElfShXNc/f09GTEiBFs376d9+/f06JFCzZs2ABAixYt6NGjB87OzvTp04fZs2cza9YsBgwYwOvXr7ly5Qr169cHCnvM/PTTT0ydOhUvLy8ZKWeAFy9eICcnR9++fQXZYuk+FvWqKisrY2ZmxsiRI3n16hVnz57Fw8Pji5TvtLW16datGwcOHMDX17fENCixWExcXJxMrUtSUpKwvoWFBU5OTlhaWmJsbFzpCERiYiJ+fn6EhISQl5eHSCSiTZs2Qmf7e/fucfDgQUQiEQ0aNMDd3R1FRUWuXbuGi4sLQLkdrlvZDaCWsQdbH83gWewt5ETyZZIa6fe1jBozut6KUmtkoDA/PPjKeR4ciUdPTw9TU1MMDAxo1qwZZmZmaGuX3P26rM9UVFQYNmwYLi4u1KpVSzBipU0ioXJiGVL5bC0trQobZ0pKShgbG5dYqyAWi0lJSSlGdN69e0dAQIBM+pq6urpAcqKjo2ncuDEuLi4y+yESiRgwYAC//vqr0ENn4MCB/Pzzz/j6+uLi4oK2tja1a9fm4sWLTJ8+HR0dHYKDg9mzZw9VqshKdGtoaHDnzh06dOhQopJZeWjXrh3t2rXjwYMHglJa/fr1cXBwICYmhoyMjBLJjPSaSAURDAwMhO/ev39Pv3792LVrl8xnCgoK5OXlkZycLJxraTRXKvwBhc6comQgPT0dRUVF7OzsMDY2ZtmyZcIzpaJpUtKIofSZpK6uzpgxY+jevTsfPnygZ8+e2Nvbs2XLFhYtWgRAo0aNOHfuHNu2bcPb25v9+/ezYcMG9PT08PT0xMfHhxo1apCfn09CQgLGxsbCuZIKE1SkdjAsLIyUlBRWrlwpKJF+axgbGzNy5EguX77MuXPneP36NV26dPlqzaL/SvwTMmb+jfhfzcw/FDfefCQxO6/8Bb8hRICuiiKe1gblLlsZSCQS3r9/L6SjvX//HpFIVCwdrSLGQlxcHNu2baNu3bolFqf+k1H0hZ6fn4+6+ueHmKOjo7l8+TJNmzYVem5Mnz4dc3Nzmjdvjr29PQEBAbi7u+Pv78+GDRuoU6cOT58+FeQ8P3f/pb+XLVvGggULaNOmDadPnxaWmzdvHmvXruXBgwfUqFGDW7ducf/+ferVqyekZfTo0YMHDx6wceNGunXr9tnnoaR9BAgKCiIrK+uLPYiXL1/G19eXoUOHYmhoKJAWqbRwbm6uICtcVB65IkpMJSEvL4+XL1/i5+dHZGQkysrK6Ovrk5SUxPTp08nIyODevXs8fvxYIDENGzZETU2NyMhITp06hZycHOPHjxeOu6J1em9TQrgU5s3T99f4kP4GWZ1HESYa1riatqCt/eAS5Zc/RX0zHaIC/IQiaCgkI/379y9VVCQnJ6dChdvJycnk5uaioaHxWQaVlIju2rWLnJwcNDQ0hDolqUrc15R4hv+kr0lJjvR3ZGQkqampmJiYMHr06GLrxcfHY2VlxZEjR4SIxsSJEwkLC2Pt2rU4ODjw7Nkzjhw5wqBBg2TqXIoqA1akiW15sLCwYOrUqbi5uTFr1iwyMzPR09MjOTmZmTNn0rdv31KPXaryNXDgQBYvXkznzp0BWLZsGceOHWPTpk2Co2PMmDFYW1sza9YsGjZsSOfOnZk7dy4AwcHB9OvXj5kzZ9KvXz8cHByYPHky48aNA+Dx48fY2dmhq6v7xUp19+/fJy4ujoYNG6KkpESbNm1wdnZm+/btrFu3jsWLFxMRESEIT2zYsIFt27axb98+bGxsGD9+PA8ePCAtLQ0tLS02b95cqZrAosjPzyc7O5tOnToRHByMtbU1f/zxhxB1+7MQHBzMyZMnkZeXp3v37tja2v6p2/+akEgk3I9OKjV6/a0hAkw0lCuVMfNvwf/IzD8QKdl5XH3z8a/eDQEtbQzQVv66L+qiSE1NFdTRwsPDyc/PR09PTxARsLa2LtEDVVBQwI4dO8jPz2fUqFFf1ZgQi8XldnWX/tjY2NC4ceOv9nD5+PEjMTEx1K5dm9u3b7NgwQKGDRvGgAEDBOO7vG19aogEBATw/fffU7NmTf744w+io6NZv3496urq5Ofnc/HiReTl5ZkzZw4dO3bEx8eH4OBgBg8eLHhkP0fuOSYmhpUrV1K/fn2hSDg0NBQvLy+hsR5A165dCQsL4+HDhzKkTSwW8+TJE7y8vFi9evU3exFL9zkxMbHStQtQeG4SExN58+YN165dIysrS/DuqqmpyRTqm5mZfdFclToD/Pz8CAgIICcnBxsbG1xcXKhevTr+/v6cP3+eBg0a8PjxY+Tl5YV0MlVVVXJycrhy5QqPHz/G2tqa/v37FyMEIQlpBH5ML2UPiiMrL4MP6RHkiXNRlFPCRKMKqooVJ9+1DbWw01UjISGBjRs3AoXpcgMHDsTY2LhEozo/P7/Ugmzp9bxw4QJr1qwhOzsbAwMDrKysMDY2xtbWlrdv39KjR49i0YiykJGRIUNQY2JiyMvLQ05ODhMTE+EaW1hYlBpJ+hK8evWKQ4cO0bx5cwwNDTE2NkZHR6fY+enTpw8ZGRmcPXsWKDTYPTw88PHxKdHpU568+eciNTVVSOULDAzk0aNHJCYmUr9+fTw8PIDC57icnFyJ27537x4dOnTg2LFjQj+cuLg4Bg0ahJycHH369OHu3bucPHlSSEebP38+Pj4+bN++HTc3N0aMGMGePXu4evUqnp6eVKlShUmTJjF58uTPPvaiQiQA4eHhDBs2jICAAOzt7cnIyGDHjh2EhYUxfPhwoVmliYkJ8+fPF/q8nDlzhv79+zNixAjWrFlDXl4eb9++JTIyUqae6HOIpUQiISoqipSUFHR0dD4rsva1kJaWxokTJwgPD6dRo0a0aNHiq8tc/xmITsvmQUzSX70bNDDT/eyMmX8q/kdm/oHw+5BCZEpmqcw/LzeXGyeO0LrPAAC8BvbEqb47fX8oveHg50IE2Gir4WJSOSnUz0VeXh4RERFCrU1qairKysrY2dkJDTulntVr165x9+5dRowYUWpBo0QiKda4rrSu7kW/y84uWYZWXl5eph+Jmpoajo6O1KpV66sZAhs3buTSpUucPHmSzMxMRCJRpVPwSmpa9/TpU6ZMmYKamhpr165l5cqVtGrViiZNmvDLL7+wceNGHBwcePXqVbGxKnJsny63c+dOrl27xtmzZ6lVqxZbt25FT0+P/v37Y21tzdSpU4VC3I8fP1K1alXWrFkjqJlJUdGUiq8BqdFQ3jHn5eUVk0eWFt0bGBiQlJSEgYEBvXv3FmqMvhRZWVk8f/4cPz8/YmNj0dTUxNnZGRcXF6F2KC0tjVOnThEWFoaysrIQiZHOn7CwMM6cOUNmZiatWrWiXr16xfbN19eXDRs20HXoGBQs7b94v8tD0Q7XEomEJUuWoKamxuDBg9HT0/us6ID0+tWpUwczMzNatGjB3LlzqV+/Pm/fvuXDhw/UqlWLgwcPYmtr+9keebFYLPS9+TR1UENDQ6gh/BrRm48fP7Jt2za0tbXJy8sjJSUFT09PmjZtWmzfb926haenJ2FhYYIn/OHDh0Iko+j+/5WNLcuC9NkdEhKCvb29jGR7UFAQ69at4+HDh5iZmeHl5SX0xsnLy2PSpEkcOXIEY2Njqlatyq1bt7h06RJubm48ePBAiMB+6bGnp6ejoaHB6tWrOXnyJIcPH0ZeXp6DBw9Sr149zM3N8fDwYPDgwSxYsIA5c+Zw4MABrl69SpUqVdiyZQv79u0jIyODI0eOFEsB+xzBi78rJBIJvr6+XL16FWNjY3r27PnNBIG+Ff7NGTN/d/yPzPwDcTYsVuhjUxKu+xzm0Ppf2XLtIfBtyQwU9svpaC+b752YmMjVq1exsbGhXr1632S7EomE2NhYgoODCQkJISYmRuiloaWlRWhoKPb29lhYWJRJSkq6BeTl5Ys1S1RRUSm3meLnGCNSYgEVa873+++/4+XlRXR0NFD4QsvLy6tQPVB5Xsa0tDSaNGlCx44def78Ofn5+Vy4cAGA7t27Iy8vz86dO4XmjRUx8vbu3UujRo1k0gcWLlzIqlWrWLRoER8+fODgwYO0aNGC5cuXExISwuTJk2nTpg2TJk0S1G4SEhIq9HL7klSQpKQk8vLyylXY+TQClpaWxps3b2TkkcViMUpKSjLpYubm5qioqBAaGsr+/ftp2bKlTOF0ZSFt4ufn58fLly+RSCQ4ODjg4uKCvb29MJ/S0tK4c+cOT58+RSQSkZeXx6hRowSSn5WVxaVLl/D398fW1pbOnTsLNQSf4sSJE6xcuRKRSETDNh1p2HMAcgoKlNxV6/NQVg+F6OhoNDQ00NDQ+CJDLi0tDX19fd6+fYuxsTH169fH29sbU1NTOnbsKKjzfW1jURq9kf5ER0cXi95I50xFojdisZiXL19y6tQpcnNzUVRUpGbNmri5uWFmZlbq+h4eHixdupSmTZt+cfqUlPSkp6eTmZmJgoJCiRGhsiB9DkodE0lJSZw/f17oW6Wvr18hVbeKHEtGRgZhYWFkZmby4cMHjh07xrZt21BTU/usc/GpkyMqKoqGDRvi4+NDgwYNcHBw4LvvvmPBggWALAlZuXIlS5cuJTk5mZycHGxtbTE2NkZZWZnk5GRWrVpF/fr1ZeqCPgfSc/u5ETaJREJMTAwJCQnC+05FRUX4/bXuk5iYGI4dO0ZaWhrt27enTp06/4iUqf+2jJm/G/4nAPAPQ3Z+QZlEBijROP+WyCkQk51fgIpCYcOyO3fucPfuXaEgtjJkRiKRkJubW6koifRv6fqxsbHExsYChZ7myMhIoWGhmpoaBgYG5XZ3L62r+7fApy+Xot7QgoICYmJigEKJ3+joaDZu3EhcXBz29vZ4e3uzbt06xo0bR7NmzUrdhrQfg/SFIxaLefToEW5ubjLpEJqamhw8eJDdu3eTl5fH5cuX8fHxoXv37uzevbtY7UZ55+jGjRucOXNGZt/S09Px9fVl7dq1DBs2DIDWrVuzbt061q9fz6JFixg7dixbt25FU1OTqVOnoqioKBCZ8ryRRSWbK0q4pJgxYwa3bt0iODi4zOU+vV4aGhooKiqSmZmJoaEhLi4ugjxySQZd1apVadKkCdeuXcPKyqrSKR4pKSn4+/vj7+9PcnIy+vr6NG/eHGdnZxk1otTUVIHEKCoq0qRJE6pUqcIff/xBQUFhYX5wcDBnzpwhLy+Pzp07yxSNl5Ti061bN7p168bZs2c5dOgQGyYNp/PoSVSp7UZhXcwXGMUFBcjJy2OioYyLsXaxQlaJRIKJiUmZXnOpMl1p30vnQ2hoKObm5hgZGREfH4+lpSUvX77E0dGR0aNHs2/fvjLn2edGLdTV1alWrRrVqlUTxikavQkNDeXhw0JHVFnRm5SUFPz8/PDz8yM1NRWRSESzZs1wd3evUJ1QUbWxzzVuRSIR+fn5hIWF8eTJE16/fi1D9B0cHOjXr1+Fxvv0OZicnMymTZuIj48XnvN5eXmIxWJBze/Ro0fFotLSOrxP+88Uhbq6Os7OzkAhqe3evXuFU3RLgpycHNHR0RgYGKCsrMzbt29RVVUVpJEdHBxknE/S/lknT56kWbNmbNiwgU2bNjFu3DhOnTrFzZs3iYmJYcqUKcIYX0o4i55fKbHJzc1FQUGhVCGDotv08/Pj/Pnz5Ofnl7iskpKSDMGp6N/Kysoyx2VmZsbo0aO5cOECp06d4vXr13Ts2PGLVQW/JhYsWMCNGze4ceOG8Fl4ciYiZCsDP82S+RJEvAwkJysLR9d6BD64x/zBvTj2KqbEZUVAeFLmn5Yx83fA/8jMn4TKNtGMjIykSpUqHDt2jOnTpxMdHU2rVq1YuWkbICLY7zHeKxcT8TIQbT0Duo0cT9t+gwh8cI+NP/0IQE9HMzZfeQBAQux75n3fg9DnfthUd2LMohXYVCtUn8pITWHHkrk8unoRFTV1GrbpwMDpc1FWKXx4RIW8YseSuYQ+e4qBqRkdB42g3XdDADi0/lfev4ngpLEBxw7uBwpVWBo3bgwUGlMfPnyoMCEpWktQFNJUqqKkQ09PD3Nz82KE5PHjx4SEhNCmTRs+fvxISEgIKSkpZGVlYWdnJwgJfEnB/NeG1OuVn5+PtbU1AFOmTMHb25v8/HxBVczT0xNHR0f8/f1ZtWoVdevWRUdHh9evX5eYTiKFSCRCXl6e58+fs2XLFrS1tXF2dqZ+/frFjLLq1aszZcoUDh06xOXLl3n58iVdu3YVilIr81L19PSkSZMmKCgoEBUVhZWVFerq6rx584a4uDhhuZYtWxIcHMzq1auxs7Nj2LBh+Pr6kpKSUsygrKgH8NMO4uUZn9IUrCVLllTqOKVjOjg4CAZqRdC8eXPevn0r9J8pbz4WFBQQHByMn58fYWFhKCoq4uTkJBCnovuakpLCnTt38PPzQ1FRkaZNm1K/fn1UVFRISyuUDE1KSuLBgwcEBgZStWpVOnXqJENWi/a0+HQ/5OXl6dixoxDBO3HiBCdvXaVBx+6YVKla7KVeHqQkJj4qgmZOValeRgFrafUTd+/eFfqcAGRmZqKqqlpsWen/hoaGmJubM27cOKZPn46WlhZv3rwBCgl3fHy8zPHK7K9YzJ07d3jz5g1OTk5Cz5XPgVTwwdTUVHD8fBq9uXnzpqBAp6uri1gsJjk5GUVFRQwNDUlNTaVPnz44OjpWatuf1nZUBtLzqKCggKOjI46OjoL6mlSMIDk5+bNToapUqcKdO3eE/czNzSU7O5vU1FTS0tLIyckp9ZxLn3dlQXp/S++7ij7TSjpn/v7+tG7dmurVq/Prr78SGhqKiooKlpaWZGdn06RJE06cOEF0dDTm5uYAnDt3jtWrV7N//366du3K1KlTGTduHG5ubjLKid+iXkk63uXLl3n//j2jRo0qdTkpXF1dcXFxIT8/X3hXf5qiLf1f+jslJUXms5IcrSKRSCbCU5TwODo6EhwcTHh4OO7u7lhZWckso6Cg8Kc4Hd+/f8/Jkydp1KgRtWrVKnGZmPTsYs+8O2dPcGzLuq9CZlZMGE7v8VNwdK1HNZe67LjtX+qykv/fHxf+R2b+h6+AlOw8wpMziUnPFqIpJd120htAWV4OMw0VbHX+o6bz888/c+DAASQSCV26dGHd2jU4terMgiF96DR4JOOWrCLk2VO2L5qNjr4hrs1aMvSnRZzauZnlR86jpVfozb7uc5ihsxcyetFyjm5ay4oJw1l/4Q7y8vJsnDOVgvw8lu4/SW5ONr8vnceOxXMYv3Q1OdlZLBk1gObd+zJm0Qqiw8PY4jUdFXUNPLv2AsD34hlU2nVi2LBhvHr1isuXL1OtWjUMDAyIi4tj69atwvFISUnRH11dXczMzEqMkEg/U1JSqtBDKzQ0lJcvX9KhQwfBMGjfvj1xcXGCOtqpU6cAMDc3F9TRjI2N/9JQtkgkwtTUVHjYZ2ZmUqdOHYYMGYKTkxOzZs3i1KlTdOrUiV9//ZXDhw9Tr149oZnbrVu3GDp0aJnb+OOPPxg/fjyDBg3i3bt3+Pr68vbtW6ZPL9653cjIiB9++AFHR0eZQnzpvlYEeXl5KCoqoqCgwK1bt/jpp58YPXo0AwcOpF69ekRERPDu3Tuh98a4ceNYtGgRGzduxMbGhm3btpW7rYoQjop6z729vZFIJEJNjkgkqpQhVtn5IycnR8+ePdmyZQs+Pj4MGDCgxDHi4uLw8/Pj+fPnZGZmYmFhQefOnXFycirmgS9KYpSUlGjWrBn169eXWU6ajnjmzBlBQejTmq5Hjx5hY2NT4vmVno+MjAyysrLQ19fnxx9/RFFRkSNHjmBva06+pj7vM3JKfe5JikRw0pISSIoKx9FIh7HtmgKlR99KO8f379+nTZs2eHl5MXPmTG7duoWtrW2JfV2ksLS0ZMaMGQQGBmJjY0PVqlXZsWMHUVFR+Pj4CBGFkgwwOTk5LCwsiIiI4PTp05w7dw57e3tq1qyJg4NDuZ3ry8On0ZvExETu3r1LUFAQiYmJwrnJy8sjJiYGfX19EhISePPmTaUEJL52B3Y5OTlBHvprQho9UFNTE+q/vhTSuVTZ6Jr0nN27dw81NTXq1KlDnTp1uHr1Kr/99htNmjTB3d2dJk2akJOTg4qKCk2aNBHIy6pVq4BCZ4JUpXPSpEm4u7sDsiqPn9Y1fm1kZ2dXioSLRIV9aRQVFSutsCiRSAQp7U+J0Kd/S50J2dnZiEQisrKyuHbtWrExpengRQnOp+lvpX1eGYIdHR1NbGwsPj4+PHr0SKbRLZSeMfM1s2SKjqWopISuYdmp0EUzZv4b8D8y85UhkUiISc8hJDGdpOy8Yh7KsqZ2ToGYyJRMIlIyyY1PBArDmdKizAEDBnD/6RNiElOpUt2JAVNmA2Bua8+78FBO7NhEg9btUdPQRE5OXmayN2jVng7fF6b0jF6wnBFNXXh+7xam1lV4dPUCux68QF2z8OE0dtFKpnVvzZBZC/C9eAZtPQP6T5oBgJmNLfHRbzm7e7tAZjR0dOk3ahxvnxR6Ru/cuUNMTAwGBgYoKioyePBggZR8GlL+msjMzOTUqVPY29tTt25d4XORSCT0cfDw8CAjI4PQ0FBCQ0O5e/cu169fR0tLSyA2VapU+eov+Yqg6EtLTU2N7777DgUFBSQSCYsXL0YkEqGsrExBQQEaGhq8ePECMzMz9PT0ePbsGWlpaWhqapZ6fi9dusTcuXP56aefAOjZsyczZ85k/PjxKCsryzzcpS9UKZGprHe1oKBAMKhCQkLQ1dXF0tKS06dP06BBAwYPHszo0aOpUaMGw4cPR0NDg6ioKKpXr45YLGbPnj3UqFEDQ0PDMiMqlZlLZRkF+fn57Nq1i1q1avHrr7+iqanJhAkTvnlxraamJj169GDv3r3cuXNHUHDKyckhKCiIp0+fEh0djZqaGrVr18bFxaXEep7k5GSBxCgrK+Pp6Um9evWKkZ309HRBwUpHR4eBAwfKpKVJJBKuX79OYGBgiTLUUqnjiIgIli5dyu7du3FxcUFdXR0PDw/Gjh2LiYkJEokEVzm5EiPSIkBJXg4tJXm0lRRQtjfidvZHIiPD2bkzDGNjY1q2bFnhcx8aGkqDBg1YsGABmzZtQkFBgZiYGMFoLAuGhoZoaGhw+fJlOnbsKDg9Fi9eLMgWl7Yftra22NrakpaWRlBQEIGBgRw7dgxFRUWqVatGzZo1sbe3/+w5VFBQQEhICE+fPiUsLAwlJSVq166Nq6srpqamREdH4+3tLTSclEZvPrf25n8oG9Jn4pUrVxgzZgz5+fno6uqira2Nt7c3tWvXZseOHTRu3Jh58+bx4cMHoRlm/fr1mTRpEgMHDiQsLAxNTU0uXrzI4sWLUVFRwc7OTijul16nb6Ee9ymysrL+tN4u0giMiopKpcluXl4eN2/e5N69exgaGtKwYUPk5eVLjAYlJibKkCNpOu2nqExa3KNHj9i5cycxMTFYWlpiYGAgZJU8efKECZMm8+rFC0ysbOgzYSrubTuWmCVjaG7B0c1ruXjAm5zsLKq71Wek188YmhU6XVISPrJjyRz8bl1HWVWVFj368d2Ps5g/qBfxMe/Y+NOPBD30pXn3PjJpZgkfYvjjl4UE+N5GJBLh0ak7g2bMIzk7jwtH97Br1y6aNWvGxo0byc/PZ9iwYaxatepf9Uz4H5n5isjOL8DvQ4pMM8vK8nLp8ik5hXmpGVpGArvW0tIiLy+fd+GhVHV2lVnP0aUulw7uKXVc+9p1hL9VNTQws7Hl3etQCvLzEYvFjGomO55YLObDm0iiX4cSGfyCAa7/US0SF4iRK/KCNja3pG79+nRv7Mbjx49RVlYWUsXy8/PLLEL9WpBIJJw9e5aCggK6dOlS5vbU1dUFb1pBQQFv3rwRRAQeP36MoqIitra2gjqaNL3qz4aUUEm9YfLy8kgkEszMzPjpp59ITCwkvPr6+oJkp42NDcrKysXIWHx8PA8fPmT16tU8f/6cHj16YGhoyJMnT3j48CEeHh4yhKU0b3x5kL7w5eXlCQkJoUuXLsTHx9OhQwcsLS2Jiopi2bJlbN26lQkTJrB//35Onz5Nz5492bNnD7a2towcOZLOnTszadKkUmtOxGIxr169wsDAQMa4/9w6hrt37/LkyRPc3d2Rl5dn7dq1gvpQ0Rfvp7VHXwN2dnZ4eHhw7do1lJWVef/+PUFBQeTl5WFvb0/v3r2pVq1aidtMTk7m9u3b+Pv7o6KiQosWLYSIXVFIJBKeP3/OhQsXBMW9qlWryhAZsVjM6dOn8ff3F6RhP4WUHI0bNw6xWMzJkyeFsW/fvs2kSZPYv3+/MP9UFOQx0ZDHpIym4lOnThUEDExNTUlMTKRly5bMnDkTBweHMq/pr7/+yoMHDzhy5AgDBgwgNzeXTZs2UbVq+X1rZs6cyeHDh7GyshJqMdTU1IRIYpcuXYDyCbOmpiYNGzakYcOGJCUlERgYSGBgIAcPHkRFRYXq1atTs2ZNbGxsKjQ3k5KSePr0Kf7+/qSnp2Nubk6XLl1wcnISrmtubi6nT59GXV2dkSNHoqqqWqzpqlTKHEBPT4+xY8f+JU6ashAbG4uurm6pkSzp/SadA6WlGP4ZkEZL1q1bR48ePVixYgXp6en07duXAQMGsHfvXqytrenVqxfbt2/HyMiIwYMH4+/vz6RJk+jZsyempqZcv36d0NBQTp06JURj/ipkZ2d/tUjXt4SioiKtWrWiWrVqHD9+nIsXL9KxY0caNGhQ5noSieSL0+Ly8/PZsGEDVlZWdO7cmYiICC5cuIClpSXz589ny5YtTJ67gNEu7gQ/e8qG2ZPR1jegmkvdYlky5/fu5Nbp40z+dSM6hoac2rmFRcP7s+bUNRQUFVk+fihyCgos2nOMrIwMVk8Zg66RMdPX72Bqt1Z0GTaW5t37EPEiUDjGvNxc5g/ug6lNFRZ5HyM1KYHN86YXqjWuWQsURhFNTEy4e/cujx49YvDgwbRv375Y1sU/GX+vJ9s/GO/Ssnj6IYWCUjpjVxbSUZLz4FJEPK5CIZcExRKKO8UFYsSleCAA5OQ+LaQVo6CoSEFBPmqaWqw4er7YOnrGJhQUFFCrYRNGev1c6tgKikrIiUBXV5fWrVujra2Nq6srJiYmJCUlfXXjryQEBATw4sULevXqVSnyIS8vL3hY27VrJ9TYhISEcObMGYE8VK1alWrVqgnFx58iNzeXlJQUUlNThd/Ozs7o6OgUW/5zCjmLkgx5eXmmTp0qfNayZUtCQ0P5+PEjmpqaJcpQGxoaUqVKFTw9PYmNjWXChAnMnTsXiURC586dmT17ttCn4XPxaS759u3badeuHa1atWLz5s2IRCJ0dHSIjY1l6dKlLFy4EDc3N7Zu3crZs2exs7PD29sbKPR6Z2Zmlrqt7Oxsevfuzfz58+nTpw+JiYkyMr2VrQVo2rQpt27donbt2mhpaeHs7MyQIUOIiopCV1eX8PBwRCIRVapU+epzOT09HSUlJRQVFQX1psaNG1OnTh20tUvOeU5KSuL27ds8e/asTBIDhXVrZ86cITQ0lFq1atGuXTv27dsnc37z8vI4evQoYWFhdO/evZiBc+fOHdauXcu4ceNo0qQJYrGYn376SRB2aN++PW3atKFHjx6MHz+eLVu2VGiO9+zZk/v37zN//nzWr1/PsGHDmDBhAm3btmX16tVs2bKlTDLTvHlzxowZAxQ+f6ZNm0ZWVpZQbF0apMXly5Yto3bt2qSkpBATE0NsbCwfP34kKirqs2pgdHV18fDwwMPDg7i4OAICAggKCsLPzw8NDQ1q1KhBrVq1MDc3lzk/0nqoJ0+eEB4ejrKyMrVr18bNzU3oVi+FRCLh9OnTJCYmMmLECGE/pREZExOTEmtvXr58iZOTU7nCCH8WxGIxpqam7N69m4EDBwKF/W/c3NyYMGEC6urqXL16lY8fP2JiYkJWVhbu7u6Cyl5OTg4KCgpfrGwmfVZUZNkHDx6QmJjI/PnzycnJ4ffff+fu3bs0atRIIDsqKiq8ffsWLy8vBg8ezPLly9myZQubN2+mT58+NGrUSGb/4PNEB74GsrKy/laF9eXB0tKS0aNHc/bsWY4fP87r169p3759qYIXXyMt7uTJk2RnZ9O5c2ehRu3Nmzekp6fj7+9P06ZN6TtsJKGJGZhYVyHiRSBndm9nxvodxbJkTvy+iZFey6jZoHAOjF64ghEedfC7fR1DcwuC/Z+w6cp9jC0KBWFGL/iF7MxMNHV0kZOTR01DU8igkcL/znUS497zy+EzaGjrADDS62eWjR2M18JFQOHzZdu2bWhpaVGtWjVWr17No0eP/kdm/gdZhCamExCf9k3GlgD5YgkPY5JJzMpFBJhXsSPo4X2Z5YL9H2NeRTZMXRRRIS+FvzNSU4iJDMfc1h49IxMy0wqVcEysbAB4E/ySg+tXMuHnNZhVsePR1YsYWVgJL42bp44RFuDP8DmLhTEVP3lBWlpaMmTIkD/lBZmSksK5c+eoVasWTk5Onz2OSCTC0NAQQ0NDGjduTGZmJmFhYbx69QpfX19u3ryJiooKenp6qKioIBKJSEtLIzU1tVjfGUNDQ5o1a1bisX+N81H0BV6lShVWrlxJfn4+BQUF3Lhxg1atWhXbzsCBA5k3bx7z5s1j6tSpQGGRd0hIiIwa3Ofun5Q8bNiwgcTERJ4/f86yZctwdXVFW1ubdevWIS8vj6GhIX5+fmzbto1Ro0bh4eHBx48fhW1PnjyZ/Pz8YsXnRfdNXl4eY2Nj3r59CxR66LOzswVvU2U90CKRSKaxqUQiwdramhcvXrB//37Onj1LYmIiJiYm/PLLL7Rp00ZY93MKnKVGTF5eHn5+fjx58gRbW1vevHmDvr4+Hh4eJRqdSUlJ3Lp1i2fPnqGmpkbLli2pW7duiSRGIpHw9OlTLl++jJKSEv369RNqMNTU1IRrnpmZyYEDB4iNjaV///7Y2xfvHRMdHU1GRgZz5szBwMCA2NhYrl+/LpAZOTk53NzcWLFiBb/99ht5eXnl1o08evSI169fs2fPHlq0aEFqair79+9nwoQJDBs2TBBiKOvcSgulz507x7Jly9i7dy9z5szh7t27Qs1WSQgJCcHExIQJEyYU+07qjCht3YoaoEZGRrRs2ZIWLVoQExMjEJuHDx+io6NDzZo1sbS05M2bNzx79oyMjAwsLS3p2rUrTk5OpW7//v37BAYG0qtXr3IlxD+tvSkqA19UFCMrK4uAgADi4+PR0dHBwsLii5u3lgc5OTkhGieFiooKmpqawnaPHj1KUFAQ27dvZ/jw4Tg6OjJjxgz8/PwYPnw4K1asYMiQIdSvX5/jx4/LHGdF0rRSUlL4448/mDx5cpnLSsdTUlLi8ePHTJs2jUOHDmFnZ8f69evx9PQkNDQUKysrQkNDUVBQwNramurVq9OmTRv27NkjRPqk433repiK4J9GZqBwjvTo0QN7e3vOnTtHVFQUPXv2FIQVvhZyCsQk58OTl6EYm1tiVb8pEnEB4rw8XBtGE/oiEG1tbU6dOsV1G7P/rwOE/Lx8zGxsi42XlZFBwof3rJ4yRua652Zn8z4ynLzcHDS0dQUiA1C/ZfEGtp/i3etQzGxsBSIDUM2lLgX5+URGhANgbGwsQ+YKs3z+2n44Xxv/IzNfiG9JZD5FbEYOYomEtv0Hc9b7d/atXkbz7n0I9n/Chf27GDF3KQAqqmoCYZHeGLfPnKCaSz0cXetxYN1yTK2rUKthE0QiES4ezVk7fQIj5i5BTk6OzfOmo6Gjg7qWNs069+TwhlVsnT+DLsPGEPs2ip1L59F56GiZfdNWLnkq/RnpZSdPnkRJSYn27dtXev2CggJSU1NlIirS39Kfoh7s7Oxs3r9/L7zctLS0sLa2pkqVKpiYmKClpYWWllapBlhoaCiqqqpYWFjIGOdfQiKkD0apl7JVq1YlLtetWzfu3bvHxo0bqVGjBubm5hw4cABNTU0hLUfqXazMvhSVQO7QoQNPnz7F1NSU58+fM3r0aFxdXfHw8CAiIgIfHx+hM/n+/fuxsLCgbdu2XLp0iUWLFqGqqkpCQgJnz54VJEmhOGFISEggOzubgoICoTj6+fPnPHjwgKFDh3Lt2jUcHByE5SsSqSl6Ldq0aUNBQQE2Nja8f/+e5cuX4+bmxvLlyxk5ciTe3t6CIf85kRrptpSUlGjSpAlNmhTei+/eveP333/n9u3bMnLWiYmJQiRGXV2d1q1bU7du3VKNzaSkJE6fPk1ERAQuLi60adNGpg+RmpoaycnJJCcns3fvXrKyshg8eHCpBkHfvn1xcXHB19eXhw8fEhYWxq+//opIJKJ///7CuY6KiiImJqZMIlPUMIyKihJqAps3b87ixYvJyMjg+vXruLu7l0pIihZJi0SFfXNUVVX58ccf2bJlC02bNi12vS9evMjjx4/x9PRETU0NDw8PtmzZIkR2pNDW1i41IgaF893f3x8NDQ0cHBzKvVdEIhHm5uaYm5vTpk0bwsPDuXv3Lvfu3ROUqszNzenatWu56XERERFcvnyZRo0afZbj5tN9lZOTIycnh7dv35KWlsbHjx959uyZUHtjbGws1N1YWFiUGGn+Enyq/ieNzErx448/EhMTg6OjI6tWrWL69Om4ublhbm6Ol5cX33//Perq6ty/fx8NDY1K91FJS0tj1qxZ1KtXj8aNG5c636TjOTs7U7t2bS5cuMDFixdxcXFBQUEBHx8f5syZw4sXL4iPj+fdu3eC8aiurl5sjv0Z9TDlQSwWCwIF/zSIRCKcnZ2xtLTk+PHj7Ny5E09PTxo3bvxFBLEk0abYzBzklJTRs68hbFvB/xlpzwN5m5RGux69GTZxqoyambxC8TkkLigsHZi2dhtmVWSbn2po6/Di8f1i61QEisrFr580S0ciLvxdmrPr34T/kZkvwLu0rD+NyEiRnS/G0MyC2Vt2471yMaf+2IqBmTlDZi6gRc9C9Z2aDRtjYmXDlC4tWbLvBAAdvh/K1WMH+H3JXKq51GX6+t+Fh+nEFb+xY/FcFgzpg7yCAnWaeDJibqFXVFVDg7nb9rJz2XymdWuDpo4u7QYMocco2Zx6HZW/pjnTw4cPiYiIYODAgcU8TGKxWIiclERUUlJSyMjIkFlHRUUFLS0ttLW1MTc3p3r16sL/UqKiqKhIQkKCkI4WEhJCcHAwJiYmgohAaXVCP//8M0pKSkKR+Zs3b7C2tpYxzL4k9aCsdbS1tVm8eDF5eXmMGzdOCL/v379fxqj4HFUuf39/Hjx4QJ06ddi/fz/y8vK0b9+evXv34uDgQM2aNQUVNWldUqtWrWjSpAny8vI0btyYzZs3ExcXR69evYqJETx58kSmO/m1a9d49uwZZ86c4eDBg3z48EEwbp48eYKlpSXp6ekEBgbSsGHDSkVqpIZG+/btkZOTE6RbTUxMWLNmDXv37uXVq1c0a9YMDw8Ppk2bRteuXWXG+FwVNAsLCyZPnsyFCxeIiIhAS0uL27dv8/z5c9TV1WnTpg1ubm5lRg0ePnzI1atXUVNT4/vvvy/WNRxAVVWVqKgofv/9dxQUFBg2bFi5DUmlc7tdu3b069ePM2fO8ODBA+7cuYOWlhaZmZmIxWI2bNhQoeN1dnZGSUkJb29v2rdvj5OTE2ZmZowZM4bXr1+zdOnSUo9TOkZMTIxABNTU1FixYgUTJkzgwIEDxeZxUFAQq1evZvny5WRkZCCRSDhw4AAPHz6kbt261K5dm6pVq2JgYFDmtZOXlyclJYUzZ85gZGSEh4cHNWrUKNeISkhI4MmTJzx79ozMzEyhiWpaWhohISHs378fMzMzatasSc2aNYuly6akpHD06FFsbGy+OCW0KJSVlYVrCwi1N9L0tNevX/Po0SOg0DCX7relpeU3j95Io0oSiYSGDRsKvXHS0tLQ0NAQrvHn1jVaWFgwaNAgvvvuOywtLdmyZQs1a9YsdXl5eXl69+7NihUrcHBwEJ4rJ06cEIhofn4+586dw9zcXCZF8s9O4ysP0myCf1pkpij09PQYOnQoN27c4Nq1a4SHh9O9e/dKpZSVJ9pkWdWR92/CycrMEFK8pDUrZrb2BPs9Rqxvisn/Pz5P7dxCXm4uPcdMlLne6lraaOsbkPQxDjfPQodjXm4ua6aOpeuwsZha25KeksTH99EYmBY6lc567yDgwV1mbfyj1LljXsWOmMhw0pKT0NQprO8M9n+CvIICtrZ2BL2LqPC5+CdDJPm30bM/Cdn5BVyKiCf/K9XI/JOhLC9HR3vj8hf8ipBIJLx584a9e/dSpUoV7OzsihGV9PR0Ge+DVMa4KDH59O/PkVTNzs4mLCyMkJAQQkNDycvLY+bMmcVe8lJVspcvX3LgwAEAatasiY6ODhcvXkRdXb1EIzg/Px95efmv+iKMi4sjJiaGOnXqAJ9fOC/Fzp07GTFiBM7Ozly7dg1dXV1evXpFx44d6d69O5MnT8bCwoLk5GQmTZqEp6enICVd3ks+IiKCHj16sGTJEho3bsyuXbvw9vamZcuWzJ8/n169emFlZcW2bduEdWbOnMn9+/eJjo4mMzOTNWvW0Ldv30obFPn5+fj6+rJ+/XrEYjGGhob4+vqycOFCOnTogK2tLZs2baJz585fzViRjpOSkoKvry+hoaHUr18fV1fXMg3HhIQETp06RVRUFPXq1aNly5al5pKfPHkSf39/TExMGDBgQDFFs9LqvAoKCvjw4YPQ5ykgIIArV65w7tw5/Pz86NKlCzt37iz3GKXzfOfOnSxbtgxjY2N++eUXTp48ye+//866devo379/mSRUIpHQpEkTlJWVGTlyJP379+fMmTOsWrWKX3/9FVdX1xKvR0ZGBlFRUbx+/ZqnT5/y8OFDXr58SXR0NCKRiJycHK5cuUKLFi3KPIY3b95w+/ZtXr9+jZ6eHk2aNKF27doy929+fj4vX77kyZMnvHnzBlVVVZydnXF1dcXQ0FBYLi8vj5CQEAIDAwkNDRWigk5OTtSoUQMlJSX++OMPMjIyGDVq1J+mQCVFZmYm7969E8QFoqOj/7TozdeCWCxGIpHIXJ+PHz9SrVo1kpKSmDBhAr/99luFnoVubm7k5ubSqlUrEhISuHLlClu2bJFJJfu7IyEhgQ0bNjB48GBsbGz+6t35YkRGRnL8+HHy8vLo0qUL1atXL7ZMfn6+4OBMTU0lMTWdJBUdxBo6SCRiRKLi1z0/L4+p3VphYedA/0kzClthLJxN1douTPhlHZM6NKXz0NF4duvN6wB/Nvw0hfE/r6Zp5x74XjjDprlTWX70PMYWVpz6Ywtndm9nzKKVmNvac3TzWvzv3OC3c7fQ0NZhwZA+yMnJMXjmfNKSk1g7bTw9x0yk/YChTO7cHDfPVnQbPo43wS8FNbOCggKmdWuNgZk530/5idSkRDbPm0Z11/oc2OvNhaMHWbBgAZGRkcIxeXp64unpyYIFC77hFflz8b/IzGdAIpHg9xWL/f/JEAFmGl83TC2RSMjMzCw17Uv6v5SohIWFERkZKRASfX19qlSpIhAV6e9vJQutoqIieFPFYjHx8fGlpiq8f/9eeFEePXqUFy9e0LBhQ9TV1UlLS2PDhg28evWK3bt3Cz1YvoUCkZGRkZBv/7lN7Ypi2LBhRERE8Ntvv5GUlISuri6Ojo4sX76cqVOnYmdnR//+/dHR0eG3334T0ngqYjhYWVnRvn17+vTpg5OTExEREQwZMoSlS5eyefNmcnJy6N27N1BYTL97927Wr1+Pv78/RkZGHD58mOXLl+Pi4iKTeiY9dqlCUnx8vIyBCYWpe40bNxbm3sSJE2nYsCFOTk7Ex8dTrVo1kpOThWO5ffs2P/30E+fOnRMKlaXbEYlK70pfFNI5qqWlRdu2bWnbtm2Z81YsFuPr68uNGzfQ0tJiyJAhQuPVkhAUFMTz588BGDx4sEyaSUlERjo/QkJCmDRpEpGRkTg4OODh4UGHDh348ccfGTRoECdPnsTExETYp7KOVTrfhg0bhoeHB1euXMHY2JiVK1eycuVK4uPjK5QWuGHDBubOncv27dtJT09n5MiRZGdn8+jRI1xcXEo8b+rq6lSvXp3q1asL8stQKJQQFRXF48ePhcZ4ZRFUa2trrK2tiYmJ4fbt25w6dYobN27QqFEjLC0tef78Oc+fPycrKwsbGxt69OhB9erVSzwuaQNUJycnsrOzefnyJYGBgZw7d45z586hqalJeno6gwYN+tOJDBSmJVYmelNUFtrCwuKbC8BUBNL5mJiYiL+/P7Vr18bAwIBz586xaNEiwsML6wvK8u9K74Vjx45x+fJlLly4gJqaGjdu3Cj2bKkoitYtRUdHk52djY6ODrq6uqipqX0zYiitmfsnR2aKwtzcnL59+3Lp0iUOHz6MmZkZxsbGZGRklJgyrmVZBYv6zZCTV0AEJRIZAAVFRX7auofNc6cxvUdbrKtVp913g3kd+Bwjcwtmbd7F3l+XcvL3zegZmzB4phdNO/cAimfJdBk2lqyMDLbMn0FWehp2Ts7M27FfqHeZtGI92xbNZna/TqhpaNG6zwChQXm7/oPZ8+sS3keG0+H74cL+ycvLM2vzLnYsnsOsvh1RVdfAo1MPBkyZ9ZdlzPwV+F9k5jMQnZbNg5ikv3o3/jZoaWOAtnLFbhqJREJ2dna5RKWoNry8vLwQPZH+xMbG8vr1a7p164a9vX2Jnb7/jmjVqhUdOnSgRYsW/PHHH+zfv59+/fqxfv16Dh06xKlTp9DT08PY2Jhdu3aRmJjIsGHDmDVrFgYGBjJjSSQSCgoKvrncakUjDgUFBTRv3pz8/HyuX78uRAXmz5/Phg0bOHjwIK1bty5W71BRpKenc//+fWxsbLC3tyckJIRp06Zha2vL2rVrAXj69CnDhw/n2bNnzJ8/nx9++AE9PT3atGlDt27dGDduXIljv3jxgkmTJtGrVy9Gjx5d4jIRERH07t2b/v37M3XqVKGB5alTp2jSpAl79uxh9+7dGBsbs2/fPnJzc3n9+jV2dnZf3ESxNMTFxXHy5Enev39Pw4YNad68eZnRmwcPHnDhwgWsrKyIiopixowZMsZMWWSmS5cuZGZm0qdPHw4fPkxQUBA1a9akdu3aQpPayioGFYW0nisoKAhNTU1UVFTo27cv/fv3R11dvdi+Sf9PTk5m/vz5BAQEMHToUAYOHMiBAweoU6cO1apV+9OKrGNiYrhw4YIgSqGoqIirqyv16tUrN4WvNKSnp3P+/HlevHgBFJJradpm1apV/1ZSy9LojfQnOjqa3NxcjIyMGDly5FePLlcWqampzJw5E29vbyH1ctSoUUyYMIFz587RqVMnIiIisLa2rnCkumgtnrT+qaLHKJ2/6enpvHjxgsDAQBISEmQMbiUlJfT09IRGpNK/9fT00NLS+qK5HRYWxr59+/jxxx+/6L79M5CTkyNjJ0h/ikZZpOSsKOTl5TE3N8fQ0FDGfkhVVCc8s3iTy38T/oqMmb8Sf58n4T8IoYnp5S/0XwARoKuiKENkcnJySq1Pkf5dVEVDWkQvjaCYmZkVSwFTV1eXeUFER0dz7949mjZtSu3atf/MQ/4iFBQUYG5ujrKystDlvn379ujr65OTk8PGjRupVq0ajx49wtnZmX379pGVlcWcOXPYu3cvkydPJikpicjISKpUqYKOjo6MMfO1FHI+JRslvZxLkkWVl5fn4MGDuLm5MXnyZDZv3gzAwoULUVZWpmnTwu7uRZvCVXR/xGIxGhoaMuIGhw8f5u3bt0yaNEn4zNfXl9jYWG7cuMGiRYtYvXo1EydO5OPHj8TFxQGFBv25c+d48OABvXv3Zvjw4Vy6dAmJRCJEFooiKyuLFStWsHPnTgwNDWnSpIkwjp6eHnXq1CEyMpKZM2cyYsQIvLy8CAwMZNasWcTFxREcHMz333/Pzz//XGZheWUgkUh4+fIlPj4+6OjoMGzYsDK73UskEq5evcrdu3dxd3enatWqeHt7k5mZKZCZ0silvLw8iYmJXLt2jUePHlG9enVOnz5Nv3790NDQ4JdffuGPP/5gwIABrF+//rOO5+bNm8yePRs7OzsyMzNxdXXFzc2NPXv28PbtWxYuXFiMuEv3VUdHh5kzZ7J48WJ2796Nmpoa/fv35/Tp09+USEoRFxfHkydPeP78OdnZ2VhaWqKgoCColCkrK9OgQYPPiqgkJiby6tUr6tWrR6NGjYTmnIcPH0ZZWRlHR0dq1qyJra3tX66MVVb05uHDh9SsWRMtLS3BUfWtojWliX2cP38ePz8/bty4gaGhId7e3sydOxdra2s6d+5M/fr1mTdvHt7e3mWSmaLjKygoCD3VKnv+pfNXQ0OD+vXrCzWBOTk5JCUlkZiYKPxOTk7mxYsXpKSkCJEjOTk5dHR0ZMhOUcJTXi2T1Pj/KwUApPLHJRGVoj85OTky66mrqwt2gpWVVTFnp6amJikpKRw7dozo6GgcHR1p2LAhIpGI0MR0wv/kWuc/G98iY+bvjr9FZEZqnEVERPypuZsikYjr16/j6elZ4XVSsvO4+uZjpbaTl5vLjRNHaN1nQCX3UBZx794ytlUDNl95gJGFZfkrfIL1syYD8MMva79oP4pCLjqU9JgogbDk5ubKfK+pqVlmnYqGhkalXgJ5eXls3boVZWVlhg0b9rdIX6goMjIy+O233zh//jz5+fls3LiRq1ev8vLlS9q1a8fs2bOZOHEi8+bN45dffmHo0KGoqKhw8OBBtm3bxpEjR/jw4QOjRo1CUVERBQUFOnTowMSJE4u9vL9m/QZQjEz+/PPP/PbbbyU2sbt+/TodO3Zk5cqVjB8/Xua7L63NKYrMzEyuXr1K586dhc++++47obBbKlP9yy+/cPXqVZ4+fcq7d+8YM2YM9vb2NGjQgMuXLwsKU0ZGRsIxFd3fa9eusX//fu7evUvr1q1ZvXo1SkpKHD58mPPnz+Ph4cHFixdJTU3l/PnzhISE0KdPH7p168bw4cOJiIhg1qxZjBo1iiFDhnyVY5eex4r02igoKOD06dM8e/aMNm3a4O7uTlxcHJs3b2bYsGFYWlqSmZlZprF969YtZs2aJfT9mDhxInPnzsXNzY0+ffpgZGTEwoUL0dfXr/Q1Tk5Opnv37mhoaLB3715Wr17N3bt3uXLlCt7e3ixcuJDXr1+XO6cjIyNZunQpjx8/ZuPGjTL9PMpDZUU38vLyCAoK4smTJ7x7905oxOvq6ir06ElNTeXevXs8efIEkUhE3bp1cXd3r3CxelpaGtu2bUNPT49BgwYVq/UICAggMDCQxMRE1NTUhB42lpaWf9sodXZ2Nunp6eTl5aGgoIC6urrMvCtqjlTmGEpy5Lx48UKmSL9mzZq0atVKiOIC/PDDD9y4cYOAgAD27t3LsGHDSE5OLnYvlBQFj46O/upywOWhoKCAlJQUGaKTlJQk/BR1FGpoaJQa1ZF2tb906RJz5sz5JvNFIpGQlZVVajRF6uD8VCJYajNISUlJRKWiEcn8/HyuXr3K/fv3sbOzw71tJ54lFo/g/BtRmYyZfwP+FpEZS0tL3r9/Xyxf/Vvj/fv3le5+G56cWUztojzcOXuCY1vWfTGZ+VIMm7Poq40lEYvJjI0mK+wV2traVKlSRYaoaGtro6Gh8dXJxuXLl0lJSWH06NH/KCIjFotRV1cnMDCQO3fusHjxYlxcXDh58iTXrl1DX1+fvn37Ehsbi4GBAVu3bmXGjBnY2dlRu3Ztbty4gaamJo8fP+b+/fsMGTIEZ2dn1NTUyMvL4+nTp5w9e5aaNWvSvXv3CjeBKw8lpfWYm5uzdOnSUmttmjdvzk8//cTs2bMZMGCATO3I1yIyEokENTU1gchIDeimTZuybds2oYlmy5YtsbKywsDAgOfPn7N9+3aaNWvGvn37AGjYsCGTJk2iWrVqDBkypNj+ycnJ0apVKxo0aMDBgwdJSEgQPP1WVlbcu3ePkJAQXFxcWLq0UBp9+fLlPH/+XIgyNG3alPHjx+Pl5VVhMhMSEoKGhoaMPPWn+wWUWuAvRW5uLkeOHCE8PJwePXoItSBSYy0zM5PMzMxy50uDBg0IDw9n3bp1QnQsP79QatTR0ZHo6Gghlaqy1zg2Npbw8HCuXbuGtrY2Xbt2Zd26dUDhOdbW1iY9PV1GpECKovtsY2PDpEmTuHDhQoWIjEQiEWpkGjRogLm5eTFS8+k5SU5O5t69ezx//pycnBzs7Ozo3bs31apVK3YvaGlp0a5dOzw8PLh//z6PHj3i4cOHuLi40LhxY5n74lMUFBRw5MgRRCIRvXv3Lja2gYEBzZs3x9PTk/fv3xMYGEhQUBCPHz9GS0sLJycnatWqVWqT378KKioqMpEAsVhMQkIC8vLyQtTyc1Ucpevt37+fadOmkZubS+vWrZkwYQKNGzfG2NhYOI/S58WYMWPYsmULz549o2/fvixcuJDvvvuOpk2b0rVrV+zs7IRIjNSA3rp1K15eXvTv35/Fixd/tpLa50BeXh49Pb0S7RaJREJ6enoxkpOQkEBoaKhM+pqysrIQubl69aoM4alI+pq0rrW8iIr0GQGF16goOTEyMipGVL62zaCgoEDbtm2xs7Pj9PkLPP+YDnL/HLvhc1BSxsx/A/4WZEZeXr7E9I5vjc/ZZlEt8YribxD8AijWOfZLoKggT+8mbqh41i9/4a8EaZFp+/bti9WP/N0hfTlkZGTg5OREv36FMtpBQUFCo8RevXoxduxYhg8fzk8//URISAhXrlzh/PnzdO/eHSUlJa5du4aZmRm///47UPhS/vnnn9m9ezfOzs4cOHCANWvWcPz48a9+TxU1MnR0dIQXVUlG8Ny5cxk1alSZBtvX2hf4z/lt1qwZ69atY9iwYbRr144zZ86QmprK6dOnefz4MRkZGUyfPl1Yz9ramqSkJJycnErsUyTNg9fU1GTkyJEy3929e5fQ0FBcXFyYN28exsbGJCYmcvr0aRYuXMiLFy9o0KABDRs2FAQRpGld5Rls/fr1w8rKihMnTnzmGSqca/v37+fjx48MGDAAW9v/NHKTppalp6fz6NEjmZ42UNgvJjs7GwcHB16+fImamhoXLlwgOTkZS0tLrly5wtChQ0lLS+PQoUPMnDkT+DwxCamaVGRkJHZ2djg7O6OhocG6devYt28frVq1KpHISJGWliYYlFIhjopAJBLx8OFD3r17R2BgIK6urnTo0AF5eXmCg4N58eIFurq6mJubo6SkhK+vL8HBwUJakIuLC7q6uuVuR11dnZYtW9K4cWMePnzI/fv3efr0KbVr16Zx48YlPssuXLhAdHQ0Q4cOLfPYRSIRZmZmmJmZ0bp1a6KioggMDOTZs2f4+vqir68vnJO/4zNTTk7us+uJPsWWLVt4+/Yt8fHxrFixAlVVVdasWcOiRYu4ePEijo6OhIeH8/79e6FRp6amJvb29jx//hxnZ2d27NjBpEmTEIlEDBo0CCg0iLOysvjll1/YsmULhoaGzJkzh2HDhpV5bf5sSJ9TmpqaWFlZFfv+0/Q1KSEPCgoqlr4mJRYqKioCicvPzxcia2lpaTJ1rdJ1pD+mpqYlpov/VamQdnZ2NOjen9iM3PIX/odDAlTV+/vMyz8Lf22S7f8jMjISkUgk/D5y5AjVq1cXcp8jIiJo0aKF0OgsOjoaKDSifv75Z6pUqYKSkhJmZmYsXLhQGFcsFguF0/r6+ixZsgR7e3tu3LgBFN780r9tbGzYtGkTDRs2REVFhTp16vDkyRNhrPDwcFq0bEmPWjb82LkFJ3/fzJgW5RvygQ/usfGnH4mPeUdPRzPi3r1FIpFwZNMaRni4MLCeIz+PGUR8zDthnZSEj6z6cTTfuzkwvIkz+1YvkyFED66cZ1xrd/rXsWXZ2MGkpyQDcO34IbwG9uTgbysZ0tCJgfUc+WPZAmHd9bMmC6lmAJcO7mF087oMrFuNfauX4TWwJ9eOHwLAa2BPDq3/VVg27t1bYf8B7FQkjBw6BC0tLczMzPjhhx9kCvB++uknTE1NUVVVxdPTk6CgoHLPVVnIysri5MmT2NraUq9evS8a66/EiRMnuHnzJnZ2dkgkElJSUpCTk2PAgAGCvLR0fjs4ODBu3DiWLFnC3r17iYqK4unTp/To0UMY79y5c+zYsYMjR45w9OhRgoODMTY2lrkPvhWkL7mivXGKwsjISMgn/7NQvXp1bt68iY6ODt7e3pibmzNp0iS0tbWJiIhARUVFqHmBwvQpV1dXunbtWiLBkKbRFe2cLkXTpk0ZPXo0CxcuxNi4sNAyLCwMa2trWrVqxYEDB/D398fZ2ZmAgADU1dXJy8srl8gEBQXx4sULgSB8rjNEWr8xZMgQGSIDhQ4kZWVl/Pz8qFmzZrFtxMbGMmPGDPbs2UPv3r25efMmderUwdPTE2NjY4YNG8aiRYuoWbMmqqqqDBs2TBi3MpAaRAMHDuSnn35i3LhxREZG0r9/f+bPn0+tWrWYOnVqqedBJBKhoaHBiBEjKrVd6VhxcXFUq1aNLl264O/vz549e8jMzKRatWrUqlWL+/fvs3//fnbt2kVOTg59+/Zl8uTJtGjRokJEpihUVFRo2rQpkydPplWrVrx+/ZqNGzcK6aNS+Pn58fjxYzp06FBmHdSnEIlEWFtb07FjR6ZMmcKAAQOwsLDA19eXjRs3snXrVu7evUtKSkql9vvvDum11NTUZNmyZURGRjJgwAB69uzJvHnzePXqFY8ePaJPnz58/PhRiMpCYSpaWloadevWBQqdIffv38fHxwcDAwMhrdfMzIxLly6xfv16/Pz8mDhx4t+KyFQEysrKGBkZYWFhgbW1Naqqqqirq+Po6IijoyMmJiaoqakhkUhITk7m3bt3hIWF8erVK169ekVYWBjv3r0jMzMTLS0tbGxscHNzo0OHDgwZMoSRI0cyZMgQevbsSZs2bWjYsKHQnFlTU/MvremKSc/hQ0ZupR3R/zSIAFMNZcw0yo7Y/xvxt4jMfAovLy927dpFZmYmbdu25caNG/z222+sXr2aXr16sWLFCtatW4e3tzdr167lwIED2NnZceHCBcaOHUvnzp1xdXVl2bJleHt7s3//fgwNDRk7dqwgv1gS5s+fz/bt26lRowYjR45k4sSJ3L17l/z8fDp16oStQzVWHL1A5MtAtsyfKTQoKgvVXOoy9KdFnNq5meVHzqOlp8/5vTu5dfo4k3/diI6hIad2bmHR8P6sOXUNBUVFlo8fipyCAov2HCMrI4PVU8aga2RMXc/WANw4cZgpqzcjFotZ+cMIDqxcxMglqwEI9n+MjqEhS/efJCzwGRtmTcK1aXOcG8t6Xp/cvMrOn70Ys2gFtjVq4f3rEoL9n+DZvU+5x1TbUIuZIweRl5fH3bt3ycrKYuLEiUyYMIHff/8dHx8ftm3bxokTJzA1NWXOnDkMHTqUhw8fljt2aTh37hx5eXmlGp3/BEgjGHp6esLfJ06c4OXLl1hYWCCRSJg9ezZz5sxh3759uLi4sHDhQqKiojh9+jRv377l9evXzJs3TxjzwIEDREVFMWTIENq2bcuUKVPo2rUrW7duBSpXoyLNC/8c1aHSlv+zX2BisRgjIyN27dpFVlaWjFJXRESE0AATCp0o/v7+1KpVi+bNm5c5bknHV69evWLEumrVqsTHx+Pn54e7uzs2NjZMmzaNCRMmAIWNS8tL//vtt9+oU6cO7u7uwrY/p9ZIV1eXdu3alfq9vLw8OTk56OnpFdsfc3NzdHR0mD17NjExMQQGBnLr1i0cHR0xMjJi+vTpODk5YW1tLURCyorKlHbM0mP6+eef2bp1K5cuXcLX15ehQ4diY2PDd999h66urow3/VOIRCJ69uxZoXMChTVdYrGYpk2bkpiYSIMGDXBxcUFfX5+DBw+yYcMGNDQ0iI+PR1NTE319fWJiYnjz5g1OTk5fnAajpKSEu7s79erVw9/fn7t377J161aqVq1K9erVOXv2LC4uLri5uX32NuTl5bG3t8fe3p6OHTsSFhZGYGAgN27c4MqVK1hZWQlS0EXviX8ipPNqwIABLFiwACsrK/Lz8wW5a3d3d5YvX87Ro0fp1KkTc+bMITg4GBsbG7y9venevTv29vbCeCoqKkIa1dixYykoKOD48ePlPiP+ahQUFMioe5X082nvNZFIRGhoKFpaWhgbG1O1atViqV8qKipkZGQUS19LTEwUeihJoaysLFOfU/TvL1Vf+xL8t4g2ycuJcDHW/sfaSF+CvyWZ+fHHH2nQoAEALi4uVKtWTegj0bNnT/z9/YHCfOo//vhD6IY8ZswYFi5cSFBQEK6urmzatIklS5bQpk0bAHbv3o2jo2Op2x0yZAjdunUDYOrUqfTq1Qso7Db+9u1b9py7QlSOCEt7B96EvOLO2RPlHouikhJqGprIycmja1jY1+PE75sY6bWMmg0K87pHL1zBCI86+N2+jqG5BcH+T9h05T7GFoWh4tELfiG7SL7rwGlzsa9VB4BG7TvzMTwEcUwhSRMXFDBm0UrUNDQxt7Xn9K6thAU8K0Zmrh7dj0fn7nh2KzyvE5evY7Rn+REPRwMNREkfOHHiBImJiUKe8/bt26lTpw6rV68mMjISJSUlrKyssLKyYv369QQHB5c7dmkIDAwkMDCQHj16/O0lJMtC0QeM9G81NTXc3NwEY69t27Y8f/6cKVOmoKqqSrVq1Zg2bRoGBgbs379fRhUM4PTp02zYsAFFRUV8fHyoUaMGSUlJNGvWjNjYWCFiUBY+fPggKK19KyGBPwtycnJCNEhVVVVm/0ePHo2XlxePHj1CQ0ODxYsXEx0dzdy5cz9rWyUZ77q6ugwePJhNmzahpKRETk75NxFkAAEAAElEQVQOq1atYtq0aUL0oqzzGRsbi4+PD82bN2fEiBHUqFGDKVOmfJYRUNY6r1+/JjMzUybKVxRmZmbs2rWL4cOHExoayqVLl/Dx8cHDw4POnTvj6elJ27ZtOXTokPB8LcvIL+2YpZ9ra2szY8YMZsyYARSSUgUFBY4fP87du3e5f/8+586dK1UgpqQUwaIoOg9UVFS4dOkSmZmZiMViDAwMiI6O5tmzZ+Tn55OXl0d2djYeHh54enoiJydHVFQU+/bt4+zZswQFBTFgwIAvlkVWUFCgbt26uLq6EhAQwK1btzh16hRKSkpUr179q917ioqKQl+dnJwcXr16RWBgIBcuXODChQvY2tpSs2ZNHB0d/1Jlq09RGXVGaV3LhAkTWLZsGXPnzsXGxgYLCwt69OjBtGnTCAgIYObMmejq6go1hpMmTSpRrl0ikaCurs7OnTsrHYH7FsjPzy9Xmjg9XdZgL9ok2tDQEDs7OxmScvr0afT19enevXu52y8vfa0kQYLo6GiZfnDy8vJC/5xPCU9F1NdKQ0BAAMnJyTRq1KjEZ1BKdh6J2XklrPnvg6uJNioK/+6aoNLwtyQzn+Z2F32BqaqqCjJ9zZs358GDB8yePZuXL1/i5+cnGGYfP34kJiZGxnNarVq1Mh9MVatWFf7W0tISVDaeP3+Og4MDyuoakJNROJaLW4XIzKfIysgg4cN7Vk8ZI/OQzs3O5n1kOHm5OWho6wpEBqB+y0LvqjTFy8TqP+dDTUOTArGYXs0b8+ZlINr6hqgW8bSpqWtSkF/8Ro4OD6Ntv0H/OV5dfUysq5S4zyIKGT+AjbYagYGBiMXiYkouYrGYsLAw+vfvz4YNG6hSpQru7u6CqtPnIDU1lbNnzwoFrf9WSI0WVVVVvLy88PLy4v3796iqqqKjo8OHDx84e/aszL0RExODoaEhVapUoX379owcOZLU1FSCgoIEj3t5WLx4saCoJi8vz4gRI5g0aZKQx160EPpzozZ/NoreV0X3tUWLFhw9epSePXtibW3N/fv3+fHHH2ndunWxMSpiSJZmvC9YsAB1dXVWrFghXJtPm1OWhl27dvHx40cyMzNp2LAhmzZtIiIiokTJ4y9pdqqgoED16tWpUqVKiccpHXv58uVCrcWRI0fYunUrkyZNwtbWlvj4eKpWrVqhnkEVOZ+xsbGC6tzTp09JTU1FJBIRHByMs7MzcXFx2NjYVDpKJTWmbt26RaNGjXB3d0csFnPlyhWgULI3Li4OLS0tGjdujJOTE1evXuX27dsoKyvTqFEjrKysmD59Onv27CEyMpJff/2VAQMGYGlZeVXJTyEnJ0etWrXw8/MjIyMDLS0t9u/fj7m5OR4eHjg4OHy1e05ZWRlnZ2ecnZ3JzMwU+pucPHmSM2fOULVqVWrWrImDg8NnG5dfA9JrXNHjlhLLSZMmMXfuXE6fPs348eORk5OjXr161KpVizlz5nDq1ClGjRpV7N75dE5J//4ziExeXl65hfRFi/ehkJBLSYmJiQkODg7FIioVEQf5Gg0zlZWVMTU1LTFyWlBQQHJycjGiExkZiZ+fn4xAgKamZqlRnaJ1hhKJhBUrVrBlyxYSEhIwMzOjZcuWBAYG0rNnT6EZtBSfI9r0d4bXwJ441Xen7w/TZD6vbaiFhea/owHq5+BvSWY+9XiV9uLasWMHP/74IyNGjKBnz578+uuvQihYOsanedZl5Z+X1o9AqvQjLrLq5+axiwsKb95pa7dhVsVO5jsNbR1ePL5f7hhyn6hxSPdFX00ZTTUVzDRUeZ+Rg/T2LWlflVVUi32uWPT4i7xETDSUcTD9T0QkPz8fbW1tHj9+XGxcc3NzVFVVefXqFZcuXeLMmTOsXLmS7du34+fnV6leCxKJhFOnTqGoqEjHjh0rvN4/GUVJQ9GXg7GxMdOmTRNSQvLz89HT06NevXps3bpV8Ew/ffqUGzdu8MMPP5RrjHz48IEXL14wYMAAunTpwsWLF5k9ezZWVlaMGDGCV69ekZ2dTc2aNWXUfP6p0NDQwNvbm9jYWG7fvo2Ojo4Q1S0KiUQieHor27dHarRLowwpKSkV7i2Tk5PDunXrWLZsGZMmTRKUnzZt2kRcXJzwkpZuQ2qMfY4H39LSEmtr6xK/k84/aTTC1NSUIUOG0Lt3b3r37s3Lly/ZunUr2traQrRJLBaXSawyMjKK9YuSQrr/Pj4+rFmzRkixq1atGg4ODsjLy3P27Fm8vLy4cOFCpY4TCgltQkICt2/fJjY2loYNG/Lx40eBhInFYr777jvs7OyEa92nTx+uX7/OlStXiIuLo3PnzigoKDB06FAePHjAxYsX2blzJ+7u7kJk6ktw+fJl3r59y6BBg7CysiIsLIzbt29z8OBBjI2NadKkCTVq1PiqaTpqamrUrVuXunXrCk6QwMBAjh49ipKSEtWqVaNmzZrY2dn9acqR0rkgJydHbm4uS5cu5f3797Rt27bcVELpPTtu3Di2bt1Kv379MDQ0xNLSki5duvD8+XNhGenxSOf6t0p/KqvZo1SaODs7W2YdNTU1gZCYm5tTvXr1YkTla/RO+jQN91tAXl4efX39EkUepOprn0Z14uPjCQ4OlqnBVVZWFojNnTt38Pb2ZuXKlbi4uDBmzBj27dvHhAkT2Lp1Ky1atMDd3V24pp8j2vR3xvT1O1BQlL3+tY20sNf9Z6eLfin+0dbJli1b8PLyEtSJkpOTiY2NRSKRoKOjg5mZGU+ePBEaK4aHh5OcnFzp7Tg5OREaGkpWRhpSzYTXQc8rvH7RF7i6ljba+gYkfYzDzbNQ4jQvN5c1U8fSddhYTK1tSU9J4uP7aAxMCyMfZ713EPDgLsNmly+tLAIamusSk55TZp6ohb0DYYHPhP+zMzN5HxkujKGgqIgkJ4sGZrqYaShz+fJ/iEu1atVISUlBJBIJnZQDAgLw8vLijz/+4Nq1a0RFRTF27Fg6duzI/PnzMTU1JSAgQEgfrAgePXrE69evGTBgwDd/6P5dIBKJSiQNIpFIJoIgJRejRo1i3LhxNG/eHDMzMy5evMjAgQMrpBBkYmLChg0bkEgk6OvrM2jQIPbv38/jx48ZMWIEd+7cYdu2bdSpU4cPHz7QoEEDJk6ciKampownU2oQ/hkGT0FBgWDsVBbS9DNjY2N69epFq1atSlRbE4lEKCoqEhISQkpKCs7OzgIxLI80SL+XGk1SIlORRoGHDx8mMzOT6dOnC8dXv359VqxYwYcPHzAyMuL48eM8ePCAp0+fMnr0aHr16vVZXvui1+7T9aX72L17d+Tl5fnuu+/Iy8vj5MmTxMfH4+Hhwdq1a2W82+Vd+zdv3lCjRo0yl+nevTtmZmbUqlULCwsLGTJubGzMkiVLSEhI+Cz1K3V1dSH68eLFC7S1tdHX1ycvL4+PHz/y4cMHmci8SCSiRYsWGBoacurUKRISEoQmoQ0aNMDBwYE//vgDX19fQkJCGDJkyGcXhAcEBHD//n3atWsnEMyqVatStWpV3rx5w+3btzl27Bg3btygcePG1K5d+6vfa1paWri7u+Pu7k5CQoKQ2hsQEICqqirVq1enVq1aWFlZfXXDv+izRCQSkZ6ezp07d9i5cyehoaFYWFjQu3dvfHx86Ny5c6nbl56TefPmsXLlSk6dOsWwYcNQUFBg+PDhJT5XK3IeS7pHpA6PpKQkGZKSkpIik/pVVrNHa2vrEnuo/BkRMWkPmL/yvVpUfa0kx0p2drZMfY7075MnT1K3bl2io6OJjo6mffv2PHv2jKioKOzs7Lhy5YoglKNvbEJOwZ8rQvOtIa3VlmbMuJpo/1dHZKT4R5MZfX19rly5QteuXUlLS+Onn34iLy9PeID88MMPeHl5CX0mJk6cCFRex75ly5ZYWlqyaMok2o2cSFRoMOe8f0dDW6dC66uoqpGRmkJMZDjGFlZ0HjKKA2uXo61ngLmtPUc3r+XV00eMW7IKDW0dajVswqY5Uxk8cz5pyUn4bN9IzzETSx3/06MRiUSYa6pgrqmCjooiOiqKKMvLySzfZcgoZvbpRA23BtSo14Cjm9eRmZ6GopwIG201Wjdx5+C+vcSMGkoMhaIMUlSvXp127doJHb/l5eUZOXIkenp66OjoIBaLmTZtGiYmJri4uHDgwAGhO3RF8fHjRy5fvkzdunVlijP/m1FSek2LFi24dOkSe/bsISIigsOHDwudpEuC9MUsbT565coV1NTUyMnJITs7mw8fPgiFx2FhYTx9+hQHBweaNGnCnj17UFRUZOrUqcjLy/PixQtq1KghEyX41pBuJzc3V/BOSs9LeelHRQ14oFzZaAcHB3Jzc3n69CkZGRnUrVsXbW3tCqU5KSgoCISmaEPKsojfhg0b+P7775GTkxOIgjT1qHbt2vz222+sX7+eHj164OrqyrRp04iIiJCRmpaioqlYJRlpUmGKlJQUXr58iYKCglCHULVqVdatW8fp06dljP/y8PDhQ5ycnMrcB2NjY7p06VLiMvv27cPW1pa4uLgKkxmJREJcXBy+vr4EBQUJ4hBxcXE0bdqUu3fv4ujoiKqqKteuXUNOTo7GjRvLjFGrVi309PQ4ePAg27dvp1+/fpiamqKrq8vkyZM5efIkz58/Z+3atXTr1q3CstBSfPjwgVOnTlG7du0S71tra2usra2Jjo7mzp07nDp1ips3b9KoUSNcXFy+ieGrr69Ps2bNaNq0KbGxsQKxefr0KZqamjg5OVGzZk3MzMy+KP2tpKhIeno6Cxcu5MSJE9StW5cHDx6gpKTEgAED2Lx5M7Vr16ZKlVLSoUUi8vPz0dDQYOzYsSgoKAj7JyUylUlRlC77abNMKJxbDx484OrVq8JnRXuofNp3TUpU/i690fLz8ykoKPjmNVJ3795l5syZPH36FJFIRLNmzfj9998xNTXlwoUL/PTTT7x69YqqVauyevVqIVLu4+PDnDlziIyMpGbNmqxcuVLoKWZra4ulpSUaGhqEhYVx9uxZAJkIV2JiIocOHeK7UcXroaJCXrFjyVxCnz3FwNSMjoNG0O67IUgkErwG9kROXp6Fu48AcPC3lVz3OcTa0zc49ccWoiPCUFJW4e75UxiYmDFoxjzqtWgLwJgW9WncoQs3Th5F18CQlccv8TY0uMRtAWSkprBxzlQC7t9BJBLh1qwlI+cvQ01Dk/iYd2yeO41g/8coqajSuH0XhsxagIKiopBmNnn2HFyMtTm4dw/Lly8nMjISJycnVq9eLdTV2tjYMGPGDLy9vfH398fR0ZHff//9i8RF/q74R5OZdevWMXToUJydnTEyMqJv376oq6vj5+cHwLRp03j//j09e/ZEXl6e2bNnc/v27UqHaOXk5Dh+/DiDhw1nSrfWmNva07xHX/xuXavQ+jUbNsbEyoYpXVqyZN8JugwbS1ZGBlvmzyArPQ07J2fm7dgvkKNJK9azbdFsZvfrhJqGFq37DKDdd0OIj35X4vgKcqW/UBTkRJhqqNDR3piDmirkFoipYaBJ1cYNKNi4lXVLFuC9YiHDRo0hwsoKZ2NtXEy0sZ4xnZCXL2jatCnm5uasW7eOTp06CePu2bOHH374gZYtW6KgoEC7du2EvP7OnTuzaNEifvzxRz58+ICjoyMnT56scP6xWCzmxIkTaGlplVjP8N+K0l7CVlZWzJkzR+az8uopdu/ezd69e/Hw8KB27dqYmJiwZ88eQkNDadq0KXFxcfj7+/Pdd9/h7e0NFBr/U6dOZeLEieTm5tKgQQNWrVrFq1evqFWrFv369Svm6ZNGQ76WNzc/P59bt25x7949srOzWbx4MQUFBUycOJG1a9dWiNRUxgBTUlKiYcOGhIWF4e3tjaGhIe7u7lhbW5eb3iU1gFxcXLCzs2Px4sW4ubkJ1yU/P1+oQbp58yaPHj3CxsZGuHYpKSmsXr2aH374gSdPnrB582bq1q3L8uXLAWjbti1Dhgzh+++/L5avLj3+ytaXSI+nW7dugrG8ePFi9u/fz6+//sqPP/6Ip6cnly5dqjCZkTanrMy+5OTk4Ofnx6lTpzh//jzPnj1j5syZFdqmNFXz+PHjvHz5El1dXZo1a0adOnVQV1fnzJkznDlzBgBDQ0Pc3NyEGhqRSFSs4aa5uTkjR47k0KFD7Ny5k27duuHk5IScnBzdu3fHycmJI0eOcOzYMQIDA+nTp0+FjjMrK4tDhw5hYGBAp06dypxL5ubm9O3bl7i4OO7cucOFCxe4desW7u7u1K1bt9z6iM+BSCTCxMQEExMTWrZsKfTjkUaSdHV1hR42n9YpVATS++DatWs8ffqUrl27UrVqVVq3bs2BAwcwMjIS3tXTp0+na9euPHz4sFQyI91ngI0bN5b4fWXuhcePH3P16lWmTZtW4vdaWlro6+tjbm6OjY0N1tbW6Orq/u1rCgEhhetbRmZSUlIEmfA9e/YQExPD0KFDWbZsGaNHj6Zz587Mnz+fvn37cuzYMbp27UpYWBixsbEMHjyYLVu2UL9+fc6dO0f79u15/vw59vb2MtL6sbGxPH36FLFYLER3zMzMcHBwwNnZmdicfJl6mZzsLJaMGkDz7n0Zs2gF0eFhbPGajoq6Bp5dezF60XKmdWuD78WzWNhVxWf7RmZt2oXq/0ddH1w+T5OO3Vl57CKPrl1k5cSRrDpxBUv7QkftrdM+eO04gEQiJjcnu8xtHVr/K8kf41i6/yQF+Xmsm/EDRzevZdD0efy+ZC4q6ur86nOZlISPrJw0Egu7qrT7bggKciLMNVVpaKbL7t27mTBhAps2baJBgwb88ccfdOjQgeDgYKGmuTSV3n8bRJK/S0fHb4ALFy7g5uaGoaEhAPHx8RgZGREREVGqKk5JiIuLw8/Pj2YtW3HudRxQqEj29MZVFu059i12vVLoYGf0VRQsbGxsWLBgQYW7lH8r3Lx5k5s3bzJs2LBK9Vn4J+FLirc/hdTbX1LBbGnpTStXruT333/n1atXwmczZ87E39+fXbt2ERAQwJo1a5g8eTJt2xZ6nq5evcr06dM5cOAAHz9+FIiQu7s7V69epV69ekIPh+zs7G/m9ZOeO7FYTEZGBiKRiKFDh3Lt2jX69OnDggULMDY2/ipqUAkJCZw9e5aIiAiMjY1xd3cnNTWV8PBwXFxcqFmzpkz38ZLw5MkTtm7dytGjR6lSpQqzZs0S1BmlWLhwIYcPH6Zu3bqMHz+enJwcduzYwZUrVwgLC2P69Ok8evSImJgYJBIJY8eOxdPTk4ULF7J69Wpq1qzJ69evOX36NEFBQQwePFjmpf85kEaW3r17R0hICA0aNEBdXZ1mzZrRpk0b5syZUyGCkpeXx88//8z06dPLrZkLDw9nyJAhhISEkJCQQK1atejYsSN9+/atUNSjoKCArKwsvL29MTIywtXVtZjIQUFBAbt27eLdu3f06NGDWrVqIZFIuH79Ordv36ZNmzaCLPanx3Hq1CkCAwNp1qwZzZo1E8bNzs5m9+7dfPjwATU1NQYNGlSmkqBYLGb//v3ExMR8VnPZxMRE7ty5w7Nnz1BSUqJBgwY0aNDgT0kbEovFREZGEhAQIMjKf//992WuUzQiKb0vb926xdixY3n//j0GBgYoKyuzbNky2rZty8iRIwkPD+fmzZvCOe7SpQvq6uqsWrUKMzMzmftbSmCLRlDy8vIqFbmSPiuzs7PZunUrM2bMYMuWLaX2MEpLSxOUThMSEoDCehcLCwssLCywtLTEzMzsq9S3fG3ExsayZcsWhg8f/s3esR8+fGDfvn1MmTJFuE6zZ8/m4cOHODs7C/WdUsybN48BAwawdOlSjIyMWLVqlfBdz549sbGxkfkMYO/evQwbNoxWrVoxd+5cnJycZGoUA+NTCU3MEMjMlaP7ubh/NyuPXxSWObfnd677HBY+O7xxNdd9DqOjb4iFfVXGLy1se3Fo/a9cOrSHLdceoqhU6DyY930P7Gs5M3jm/MLITMeuDJw6p9xtHb5yi6lDvyM1I4vp63egrKpGdHgoSMDCrio/dm2FbY2ajFm0EgVFRd69CsLOzIgmtarTtV1rPD09WbBgAa6urrRr146ff/5Z2Ia7uzuenp4sW7YMGxsbevfuzcqVKwE4deoUvXr1Ijf339c89B8dmSkPW7duJT8/n+XLlyMSifDy8qJevXqVIjJSdOnShbVr16JSox6R4a85u3sHPUb/8PV3upJQlpf7V0nxxcTEcPPmTTw8PP61RCYgIIDLly8zZcqUEr+vrBEuTfOS+iWWL1+Oo6MjXbt2LabYk5+fj5KSEq1bt2bTpk1MmDCBNm3acPPmTX777TdGjx6Nqakp3t7epKamynipo6KiUFRUREtLi+3bt1O3bl2WLVtGy5YtuXv3Lv379+fEiRN069aNlStXcufOHQYOHIiJiQmtWrWSOS6xWIxEIvksQiddR05ODk1NzcImtEeOEBMTg76+vuClzsrKEprAfQ6pkRptmZmZ9OnTB0dHR2Gc+vXr8+DBAzZt2oSzszMNGzaUSWspCjc3N7Zt28bChQvZvn0706dPZ/r06YwYMYJZs2ahoKDA/PnzmTZtGqtWrcLd3R0HBwdq1KiBt7c3qqqqREVF0aZNGxYvXszhw4dZs2YNS5YsIT8/HzU1Nfbu3cuePXvIzc3Fzs6O7t27M3r0aJYsWSKzL9I5UpHzITUMzc3NMTc3RyKREBgYSHJyMmPGjKnwOFJVyLS0tFLJjJQUaWtro6enx9q1a/H09MTExKTC+y6V8t2xYwcuLi40a9asxOXk5eWpU6cO79694+rVq9ja2qKurk7z5s0Ri8VcunQJOTm5YvV9ioqK9OjRA0NDQ65fv058fDzdunVDUVERFRUVRo8ezc2bN7lx4wZbt27F09NTRka9KK5fv054eDgDBgyoNJEB0NPTo0uXLjRr1ox79+5x9+5dfH19qVu3Lu7u7t+0oaOcnBy2trbY2trSsWNHMjIyyrzHpNdWet9KhRek0f7FixcjkUgYNGgQe/fupXXr1nTu3Jnly5dz4sQJQTp48uTJjB49midPnggpbkWfI9L5unz5cm7dusWWLVsqpTYXERFB//79iY2NpVmzZojF4jJbOWhqatK1a1eg8Fnz7t074efOnTvk5uYiEokwNjaWITh/h+jNnxGZMTExYfDgwaxZswZ/f39evHjBs2fPaNy4McHBwcVSnRYvXgzAy5cvOXz4sNArDQrTiqVONSl8fX2ZMGECHTt25NixYyU6VcSfuOqjX4cSGfyCAa7/SV0XF4iRK/Ie6j5yArdPHycm8jVzd+yTWd/OyVkgMgB2NZ15Fx4m/G9k/p/5Vta2FOXl8Joxja5duzKicW08PFvQolMX2nbvhUhOnjGTfsRr0jieXLtI23bt+K5fPzrWa1Xs+F6+fMn8+fNlPnN3d+fly5fC/6Wp9P7b8K8mMxs2bGD8+PE0atQIiURCy5Yt8fHxqfQ4RkZGHD58mHnz5hEc8iNa+ga0HzCUdt8N4dQfWzm0fmWp6zbt3JPRC5d/yWGUChFgpvH36QvwpcjLy8PHxwcTE5NSjYB/KgoKCnj37h0nT54kKSkJgKSkpBJT73JyclBUVKy0oS+thYmIiGDjxo0MHjwYFxcXevfuTa9evWTSNurUqcOWLVvYuHEjv/zyC/b29hgbG2NtbU1OTg6+vr7ExcWhqakpjH/v3j2MjIwwNTXl4sWLgvAAQOPGjVFUVCQmJgYojOIEBARgaGjI27dvMTAwoE6dOgQHB2NsbFzMgKtMT4mSjhsK0wukaW1Q2N07KSmJVq2KvwQqCnt7e1xdXYsZH9J+P1JS89tvv+Ho6Iinp2epTQhNTU3x8vJi2rRpHD16lAULFpCVlcXSpUsRi8Woq6vj5eXFlClTCAkJwdXVVVj3w4cPArnv06cPffr04cmTJ4SGhmJtbY2npycdO3Zk8+bNQGEDwSlTptC/f3+cnJyIjIzE1NRUIHqZuXkkZ+eRlicmTyxGLAE5ESjKyaGtrICOiqLgJJEeu0gkwtHREX9/f0QiUYWji9KXZ3p6eqnRCul119fX58SJEyUuUxHxBXl5eRwcHLh37x4uLi6l9qVKSkpCQ0OD/Px8Dh48yKBBg1BUVKRly5aIxWIuXLiASCQqVsciEolo2rQphoaG+Pj4sHPnTvr16yd4g5s1a4ajoyO7d+/m+vXrvHr1ikGDBslEKV++fMmdO3do2bKlIKDyudDW1qZ9+/Y0bdoUX19fHj16xMOHD3FxcaFx48YVVtL7XBQVuSgNcnJyJCcnM3fuXJ49e0bt2rVp1qwZFy9eZNWqVSgpKXHq1CmuX7+OtrY2V65coVWrVhw7doyDBw8KZKZFixYoKChw9uxZPD090dDQEOZNamoqS5cuZefOnZiZmTF27FjMzMwqdSz29vY8evSItLQ0Pn78SL169SqcSqmqqiqINkAhgYuPjxfITWRkpKD+WTR6Y2Fhgbm5+Z8evZHWl3zLmpno6Gjq1q2Lm5sbrVu3ZuTIkZw9e5b79++XGTHLz89n5syZDBo0SObzosTrxo0bdOrUiTZt2nDo0KFS3xufZuAXFBRQq2ETRnr9XOLyAKmJH0mKjyM3J5vIl0E41f9PlFZeUdZkFosLZJ5LRYlOadsS/f9+tWjRgrdv33Ly5EnOnj3L/CkTeX73Jnv37qX22BEM6d6JEydOcObMGXr16sWsWbOKOadKun4FBQVClBFKV+n9t+FfTWbMzc1LfTFWFl27dqVr166kZOdx9c1H4fOWPftRr0Xp0pxqGpqlfvelkAC2uhWXOi4PkZGRX22sz8GVK1dITk5m1KhRf5tCyc9FRkYGb9++5d27d8JvqaGtpKREnTp1kJOTK9GjqaysjJOTE5s2bcLT01PwbErTfsqCoqIiW7ZsIS8vj2fPnnH69Gl27tzJrFmzsLCwoH379qxcuRI5OTnatm0reLuSk5MLH6K1axMaGkpcXBwSiYSjR4/Srl07VqxYwe3bt/nll194/fo1KSkpuLq6Ci+RgoICUlJSMDEx4fnz5/j6+rJu3TqGDRuGkpISjx8/ZujQobx8+ZKgoCCqV6/Oxo0bhT5Q5aVqVRRFX2p16tQpsS9ORSM1IpGoXENNRUWFZs2a0aBBA+7fv8/69euxsrKiTZs2GBgYlLgtaRrSwIEDBQ+pdC6IxWI0NDRkiAzA4MGDOXToEC9evMDS0pKNGzeioKDAtGnTWLZsGYmJiZw8eZLr168zZcoUhgwZQmpqKhkZGcL6DZo1p3Gnnoi09cj/f1XGks6C1JmpLC+HmYYKtjpqaKsUGh9F519F71FpSkNZBszcuXOxs7Nj6NChFZrnpUGqQvbixQsuXbokND7+FPHx8RgbG9O8eXN27drFyZMn6dmzp6AaKJFIOH/+PHJyctStW7fY+tWrV0dXV1dGGEBKNqUy6ocPHyY4OJhVq1bRp08fqlatSnx8PCdOnKBGjRrFxAa+BOrq6rRq1YrGjRvz8OFDHjx4ICh5NmnS5LMU4L4WsrOz6du3Lzk5OYwfP55169ahoqLC2rVrUVBQYM6cObx69YoZM2bw6NEjjh8/TocOHWjTpg1btmzh6tWrQmH44cOHsbGxEZws4eHhLFy4EB8fH1xdXdmxYwedOnX6oveHVGFLKhj0OZCTk8PY2BhjY2MhAvF3it78GZEZHx8f9PT0hPo0gPXr1yORSKhatapQ2yxFo0aNmDhxItWqVSMiIkJG+GfGjBk4ODgwYsQIAgMD6dKlC+3bt+fAgQNlPisUPyE5ZlXseHT1IkYWVsIcuXnqGGEB/gyfUxgZ2rFkLjXqNcS6Wg22eE1n9amrAkl5E/xSJrX2deAzatQrnpJa1rZeB/jT0m0ta9asoXbt2gwePJjBgwdz8OBBhg4dyt69e5kzZw59+vRhzJgxjBkzhl9++YXdu3cXIzPVqlXj/v37QoQQ4P79+3h4eJR6Tv6t+FeTmW8BbRVF9FQUhY6y6lraqGt9W+9XSRABuiqKaCv/dY3NvibCw8N5+PAhbdu2FWqc/imQeuGKkpfExEQAwUsvfQB27NixmKH6KUQiEZaWlqxbtw7P/+9AnpycTFRUFGZmZqUayUWhqKgo9JBYuHAhUVFRnDlzhtDQUEGhRwppZ+YJEyYAsGnTJuTk5Bg6dCjTp09n8uTJgrezW7durF27lqysLJkoyJkzZwSP4/3791FXVxdSkSQSCdOnTycrK4tFixZRtWpVFixYwLJlyzh06BB+fn5cuHCB8ePHFzO6vqTupbSXXEXHq8x2VVRU8PT0FEjN9u3b0dbWpnnz5jLpaZ+OXzTtqixVuN69e3P16lXc3NxwdnYmNDSUpUuXAoVRsKlTpzJu3DiOHTvG6tWrGT9+PJqamuTk5uIfHkXnibOxrelMXkEBcvznBV9WwWROgZjIlEwiUjLRU1Gkqp4GZhrKlb4e0shMWWQmKyuLnTt3MnTo0C824lRUVGjdujUnTpzA1dVVptGsFPHx8Tg6OmJubk6PHj04fPgwurq6tGzZEpFIRJs2bZBIJJw9e7ZQaagE9R8TExNBGGDXrl107twZZ2dnoNCY7devHwEBAZw4cYL9+/dTs2ZNYmJi0NbWpmvXrt/EWFVVVaVZs2a4u7vz+PFjfH19efbsGTVq1MDDw6PMOp5vhfPnzxMaGsrp06dxcnKiffv2JCYmUqVKFX755ReeP3/O8OHD6datG6NHj+bq1as8fPiQdu3asXPnTi5fviyQmaKNk9evX8+sWbNo3749Fy9eLLHO6e+EkqI3Hz9+FN4bf2b0JisrC2Vl5W/WXwcKo6xRUVFcvXqVKlWqCCIZ9erVY8yYMdSoUYPVq1fTpUsXjhw5QlBQEE2bNsXGxgYPDw/q1atHx44dOX36NKtXr+batULBpdGjR2Npacnq1av5+PE/jmVtbe1i5ExbWUHmGdesc08Ob1jF1vkz6DJsDLFvo9i5dB6dh44G4P6lc/jfvsGaM9fR0Tfk1qmjHNm0lu8mzwQg9u0b9qxcTKveA/C9dJbwoAB+WP5bicdf1ra0lQtrEbdt28Yff/yBvr4+R48excXFBYBXr14xYcIENm7ciLy8POfOnfs/9s46rIr0b+Ofc2gBCQFJBURRwcAA7FZQUWzA7l5dY621c9dYXdfuRLCwu1ExEAMULFAEBJRuOOe8f/CeWVBAUIzd397XtdcKzDzzzMwzM9+8b+FveTFhwgQGDRpE9erVcXBwYOvWrTx48IAdO3Z87m37x+I/Z+YzUFlXg1uR8d91DrL/n8e/ARkZGRw5cgQLC4sS6dB8L2RkZBARESF8hN68eUNmZqbA/mNlZYWZmRkymYzjx4+TlZWFkZERffv2LXYkrHv37vma87W1tfOVZpXUEKpQoQKjRv1NU/mh0Sx3thITEwkODqZ8+fLMmDGDX375RaCwlRtCR44cISUlhRs3btCgQQMCAwOZP38+bdq0oVq1asybN08Q8YTcpsOgoCCOHz8ulO389NNPNG7cmMjISAwMDJgzZw4DBw4UnJn4+HhEIhHa2tr5yplycnIQi8Vf9SP8JVBVVUVDQwOZTIaBgQGVK1cuFSICucZMWFgYDx8+pGbNmpibmyOTyTAxMeHp06eUL1+eUaNGMWrUKK5cucK9h48QV6jKy/RszKvlNs+LSxixlhsC8RnZ3IqMx0hdBTtDrRL16cmdmaKMsR49erB9+3ag+BmfolCzZk0CAgI4efIkI0aMyOfYZmVlER8fLwRNqlWrRps2bTh37hy6urrY2dkhEolo164dUqmU48ePIxKJCgxCqKur069fP06cOIGPjw+xsbG0bNlSWJ81atTAwsKCbdu2ERgYCEC/fv2+eumHsrIyDRs2xN7enoCAAK5fv8769eupUqXKN+9HTE5OJi0tTaDm1tLSQktLC4lEwv79+3F3d8fV1ZXs7GwiIyNJS0tj8ODBBAYGsm3bto9K8eTvgy5duuDs7PyPpe4Xi8UYGBhgYGBQaPbm+vXrwrclb/bG1NQUXV3dz36vpKenf3Va5p49e3L16lVBC6t+/fosX76c2bNnY2pqysGDB5k6dSrTp0/HxsaGY8eOYWxsjLGxMbt27WLOnDlMnjyZSpUq4enpSdOmTXn79i03btwAcr9pebFt27aPyIu0VfMHUNQ0NPh14262Lp7NJNe2aGrr4NR7AF2HjSUtJZktC37FdcgoDM1ymdEGTJnDysmjadw+N/NRuVYdkuLimNSlLUbmlkzfsEvY9kMUdSxt1VyWyMTERDp16kRKSgrNmjUTCHTWrVvHqFGjaNasGTk5OXTo0IE///zYaerZsydv375l5syZvH37ltq1a3P27Nkie73+rfhXs5l9LchkMvwi4nmbmvldlGVFgKGGCo7G37+RsDRw6NAhnj59ysiRI796jXdJIZPJiI+PJzw8XPgvJiaX0U5NTU0oC8jLXCOVSjl48CCPHz9GLBbj5OQklFP96Hj48CHDhg2jWbNmAgVwXkRGRtKgQQNGjRrF9u3bKVOmDFlZWejr67Nr1y4UFBSoWrUq+/btw8nJCYABAwaQkJDAzp07hR6GR48eMXToUKZNm0bVqlVxcnLi9OnTWFtbk5GRwYwZM/Dx8SEkJARFRUUSExO/2tooDWcDchmmjh49yqtXr+jatavAvlUaYxclFrpmzRp27twp9JudPn2a8KQ0jOo0QiIrOvtSUnyOUNuzZ8/Yu3cvP//8M+rq6gWeR3p6OlZWVoLRUlJK6YIQExMjNOLnLbuIjIxk06ZNDBkyRKAvlWdhAgIC6N27t5DNkclknDx5krt379K5c2dq165d4LFkMhl+fn6cO3eOypUr07Vr13x0yXJiAMhdD87Ozt/0nSCRSHj06BG+vr68f/8eExMTqlatiqqqquBstG3btsDs2Zfei6tXrzJkyBA2bdokGGdZWVn88ccfBAQEEB8fz5w5c9i+fTthYWFMmjQpn4EPJXtGS+t5/hHwYfbmzZs3QjbiS7I3x48fJyIiguHDh3/N6f8QOPE8ulSEM71WLyPo9s0vZrBVURDTwerbZ0j/7fgvM/MZEIlE2BlqcTY0lpwP6TK+ARTEIuzKa/0rXthBQUE8evSILl26/BCOjDw6mLdkLC0tDcjVpDA1NcXR0REzMzPKlSv30T14/fo1np6eZGRkYGBgQN++fb8qs1Bpo2bNmmzZskWYs0QiySccd/r0afT19QW2LC8vL3R1dQWq4T179pCUlCQ4MpBb0mNjY5OvGfvJkyeoqKigq6uLWCzGzMyMFy9eYG1tzZ49e7h8+TKrVq1CUVGRvXv3sm3bNp48eYKTk1OBeiMymYzs7GyUlZU5cOAAFy5cYMaMGUVGoOVGz5c+R1KplFu3bnHx4kWh1r44mkolMbrk2YqC9unSpQvHjx+nWrVq2NnZUa6KLb0nziDnK7yaZECOVMbtyAQy9KVY6RZMdpAXFSpUELIaXl5etGjRAkNDw3znoaamRqNGjfD29i6WM1Oca2dgYICjoyNXr16lRo0aQmZTHozIW84qEolo3749CQkJeHt7M3jwYPT19YXfS6VSjhw5gkgkEkrJ8kIkEtGgQQP09PQ4ePCgQAygo6PDs2fPuHz5Ms2aNcPS0pI9e/Zw8uRJgoKC6NOnz2f3BxV0TdLT0/Mp0n/4X2JiIoCgng65117eXF8QvtSprFGjBnZ2dmzYsIFmzZqhqKiIVCpl3bp1goZSz549qV+/PuvWrStQXLmk7I7/FhSWvclbGZA3e2NgYCAE2IrK3mRkZHwTGu8fAcYaqoQlpn2XwPOH+LeRNv1I+M+Z+UyoKipQx1CL25EJ3/zYdUpY5vGjIjk5mRMnTlC9evV8tdDfEklJSULG5c2bN0RFRSGVSlFSUsLU1JR69eoJka+iXv5SqZSjR4/y4MEDRCKR0Iz7IyCvOGNxkFepXW5Ey/+/fft2KlSogI6ODtra2vkie1KpFIlEgqurq3BcRUVFmjZtytatW5kzZ47QI3L8+HHU1dWxsbFBW1tbEPmKiooSGqY7duzIlClTuHXrFp07d2b69On8/vvvLF++nPXr1+crPxOJREJUMigoiJs3bxZKeVtaTgzkOmpHjhwhIiICR0dHWrduXewyKTlFrfzfeedW1D4fwtjYmFOnTnH79m0Co+LQrvqxsf018DA2CeCTDo2ysjIdO3YkKyuLChUqoKJScN+NnKYXCi81y8rKIjk5udgN7c2aNSMwMJDTp0/j5uYG5N4zbW3tj6LYYrGYHj16sHXrVvbu3cvgwYPR0NBAJBLRsWNHZDIZPj4+iEQiatasWeDxKleuzODBg/H09GTTpk04OTlx8uRJqlSpIujSTJ48md27d/Pq1SuWLl1K7969PyqZ+RCfoqWWSqUkJyezf/9+wUkRiUSC+nzZsmUpX758PjX6uLg4/P39iY6OpkaNGgWOPWvWLEaNGpWPIrukGlk6Ojp4eHgwcOBAli5diqurK/fv38fU1JQuXbowZswYsrOzhee1JPTh8nMXi8U8e/aMS5cu0aZNm4+ENaVSaak9898bampqWFlZCeV1H2ZvXr16hb+/P1B49iY9Pf1f58zExMQU2B8HIPn/NbXn3vMC//6tUNqkTf/hb/xXZvaFeB6XKnzUvwVq6pctVjT0R4dMJmPv3r28ffuWkSNHflJMrzQgkUiIjo7OVzKWlJR777S1tYVyMTMzMwwMDIodkYyKimL37t2kpaWhq6tLv379vmuWSSaTERkZyY0bNxCLxTg7O5fa9T137hwKCgq0aNHik/S8ciMjMDCQQYMG0bRpU9q0acOuXbs4e/Ysq1evplevXkRHR1OvXj1OnjzJihUriI+PZ+/evWRmZmJtbU2vXr1YunQpqqqqJCQk4ODgwJ9//km7du0ICQnBx8eHgwcP4uzsjIuLC8uWLUNHR4d169Z9tZITiUTCjRs3uHLlCtra2ri6un52H4Jc/ycnJ0dgMyvpXMRiMREpGd8luBL/8BadmjcqFnGHnIK7IMPyzZs32NraCvTd8rWVlJSEgoIC6urqbNiwQWAD69+/PzVr1vxkFufx48fs378fNzc3IfMnEonw8PAocPvExEQ2b96MlpYW/fv3F0qvZDKZELDo0qVLkQGYtLQ0vL29efXqFerq6owZM+ajHoU7d+5w6tQpZDIZderUoU6dOgVmU2rWrImdnd0n30fyT3lSUhJisRh1dfVi7SOniP/wfkRHR9O2bVvmzJkj0CN/CdauXcuOHTt49+4dCQkJzJs3j9GjRwt/L6qUsrC5i0Qi/P39SU9PRyKR8Oeff6Kjo8PmzZsL3Ucu3vlvxofZm4iIiHzZm+TkZPT19XFxcfmi3psfCRKJhNDQ0AL/disijoTMHIwqWhT4928BOWlT84p6320O/2b858yUAr6VQ1PToCxWOv98Rwbg7t27nDhxAg8Pj2Jz+ZcUaWlpQqlYeHg4ERERQpbC2Ng4Xzo+r55KcSHXo7hz5w4ikYgmTZoIuivfC5mZmRw5coQnT57QsmVLGjVq9E2b5Qui1ZXJZJw+fZpFixbx6tUrWrZsSadOnejatSuQa2wuW7aMpKQknj59ys6dO6ldu7bQHFyjRg2eP39OpUqV6NevH5MmTeL8+fPY29tTp04d9PX16dChA3fv3kVNTY3Y2Fj69OlDv379vooz8/btW44cOUJ0dDQNGzakefPmnywVSk5OLnKNSSQSEhISOH/+PD179izxnDNyJN+l7FUmk5GZloZaRDBdXDqWaL+CzrFKlSrMmTNHcDTCwsLYsmULffr0ITExkcaNG9OpUyekUilJSUmcP3++WCVpe/bs4f3794waNYo1a9ZgY2NDmzZtCt0nMjKSbdu2UaVKFaGBGf7OwD58+JBu3brly2J+eMwDBw4QHByMVCqlevXqVK1alZSUFJKSkkhOTiYxMZGEhARSUlLy7auoqChkUKysrL5bhvf+/fsMHjyY9evXU79+fbZt28alS5eYO3fuR5mP4iI1NZXAwMAvInqRr52YmBjGjh1Leno6hw8fRkFBgeDgYNzc3NiwYQMODg5ER0dz8eJFnj9/TteuXQu9X/92yGQyQfcmPDychw8fCmyU8uyNiYkJZmZm30X35msjIjnju5M2ATgY62Ci+V+Z2dfAf2VmpQArXXVUlcTce5uIRCr77g23Pzrev3/P2bNnqVu3bqk5MvKXdd5el/fv3wOgoaGBmZkZLVq0wMzMDCMjoy+uU4+NjWXXrl0kJyejpaVF3759v6uWA8C7d+/Yv38/BgYGTJw48bv06hR0XeUNz3KGs4yMDCFKLTf07t27R2BgIBs3bhSarP38/GjYsCFXr14lJCSE06dPc+zYMerXr49EIuGvv/4iKyuLixcvoqKiQkhICA4ODpiYmAhUrqXpyOTk5HDt2jV8fX3R09NjyJAhxRLmW7hwIS9fvuSPP/4oVMRRQUEBHR0dunfvXmIHTCaTEfD/755vDZFIhLKaKvo1HUpUHlTYNrdv30ZbWxuZTEZOTg7Lly/n9OnTDBgwgKioKKEnKikpCQMDA1JSUj65zuV9L2vXruXSpUskJiZiYGBQ5D7GxsZ069YNLy8vLly4IAivisViOnXqhEwm4+DBg6SlpVG+fPmPsikRERFC1hdyHfbHjx8LIpNly5alXLlyWFhYoKGhQXBwMKGhoYjFYlxcXAotY/sQS5cuZfz48UXSXn8uAgICSE5Opn79+kRERDB79mzevHnDuHHjsLCwIDMzMx/JQXGgrq4uODIl1ROS08krKCggkUjYu3cv9+7dQ09PD11dXSwsLOjVqxexsbG8e/eO7OxsBgwYwNu3bzE2Nmbx4sU0atSINWvWfNSXI5VKkclk/9qMjTwjY2BgQJ06dQgODsbBwQFTU1Phm3njxo0S9978U2CsoYKRusp3J20y1ijZ8/Ifio//nJlSgqmmGnpqygS8TSQqNRMRX8YiJN/fUEMFu/L/jh4ZyP1o+Pj4oKGhQdu2hYuNfgqZmZn50ujh4eH5KCwtLS1p1qwZpqamaGtrl+qL+Pz581y/fh0AR0dHQXjye+L58+e8e/eOgQMHfjHlpjxilzfa/aUZjryGSN75yY9hYGDA6NGjhb4GyHVCs7OziY6OxtraGmtra4Eo4uXLl9y6dYtu3boJBpWxsTH29vaUK1dOYKkqLURERHDkyBHev39PkyZNaNKkSbENn5ycHMLCwlixYgUzZswo1PAsTERVjsL+FpmSSVRqZvFPppQhFisQk5FDRHI6pmXLlLhcKC/kjoxIJEJJSYnLly/z559/UqlSJS5evIiFhQWvXr3i3bt3GBkZ8fjxY4Huuyjo6urSqFEjrl27BvBJZyYnJwcDAwPq1avH9evXef/+PZqamvka6eVMZ3KoqKhQtmxZFBUVSUpKwszMjNq1a1O2bFmSkpI4d+4c6urquLu7fxT4sLe359mzZ3h7e3P48GGCgoJwc3Mr8pnLysri9OnTNG3a9KtQ2p88eZK+ffvy6NEjvLy8iI+Pp1GjRtStW5fMzEzWrFkDwM8///xZ74biODLytZCWlsbu3buxt7cXxHCfPXtGtWrVOHr0KKGhofj4+ODj40NCQgL16tUjJSWFoUOH4ujoiLGxMeHh4TRq1IgzZ84IzkxUVBSqqqrFIuz4t0AqlZKRkYGmpma+3psPszd5e2/kzJ1yB+eflr35j7Tp34//nJlShKqiAo4mOkSmZPIsLoW4jOwSOzXy7XW+QKTuR4avry8REREMHDiw2C9DmUxGQkLCR/TIMpkMVVVVTE1Nadiw4Vd/ycbHx7Nz504SEhLQ0NCgT58+30WELi/k5TZWVlZYWlqWSklZ3jHkke+8DeqfU3P+qe3Pnj37Uf9N//79OXjwIHv27GHgwIEcPnyY33//nZUrV2JiYkJQUBDDhg0Ttg8LC0NZWVlQbC8Net/s7GwuX77MzZs3MTQ0ZNiwYcW+53JDbPbs2SxYsICbN2/yxx9/8MsvvxS6T3Ga/2NiYjAwMBCu17O4lEL3+VYQAc/iUjFSVymSea1YY+XpxVJXV+fWrVs4OzuTkJCAiooKioqK7N+/H2tr6wLFLAtD48aNuXv3rsBOGBoaSmJiouCgJCcnC/+WbyNHcHAw2tra6OnpYWRkhLW1NRoaGjx69Ijw8HC6dOmCra0tCQkJbNy4kUqVKuHh4ZFv/Zmbm+Pp6cnmzZvp3r37R/oplStXZuLEiezcufOTCvDyssULFy4U+/xLgpiYGIyMjFBWVmb58uVUrFiRJk2aCE7T2rVr8ff3R1tbm7NnzxIXF0e7du3Q1dUt1XnIr4GcsSuvpkxWVhaJiYlIJBIsLCz4+eef6d69O8rKypQvX56IiAhMTEzw9fUVWCgNDAxISEgAYNOmTRw9epQbN25gbm7OokWLPgpM/RszNpmZuYGPDwkAPszewN+9N3Ja6IKyN3IH50fP3vwIpE0ZORISMrJJzMwhWypFKgOxCJTEYrRUFNFWVfrXBK6/Nf5zZkoZIpEIDSUFtFSUSM7KIbsEUQBlsQgTTTUstcugpVr6ZQPfG1FRUVy5coVGjRphZmZW6HY5OTlERkbm63dJTU0FQE9PD1NTU+zt7TEzM0NPT++bvECvXr3K5cuXhWbdDh06fHfhRrmxKC9d+pz5FOScvH79munTp3P58mXq1q1L9erVWbx4MZB7D1+8eIG9vT0qKiql0pMizwR9aDDIDZTZs2ezePFiTExMaNKkCU5OTrx7947Xr1/nK/N68uQJ8fHxNG/eHPjyzNLr1685cuQIiYmJtGzZkoYNG5boGuc9prm5OdevX2fr1q2UL1+e/v37l2guchw5coQRI0Zw//59ypcvT2JGNnEZ2Z81VmlCBsRn5uDSvReGOmWZN29eqQgzDh06lDVr1vDmzRsuX75M9erVMTExoVevXgwePPiTRubTp08JCQkRnJSMjAwANm7cKGxTpkwZoUfF1NQ0HwNY2bJlUVdX5+DBg4SHh9OmTZt8WR07OzsOHjzI4cOHEYvFXLt2DRUVFbp27frRWtHV1WXw4MGCg96uXTvs7e3zrUtVVVWGDRsmPBMFQSKRUK9ePQYMGMC0adOAv4kVSuOdJJPJKFOmDElJSezbtw8XFxfatGlDeno6SkpKPHz4kPnz5zNmzBgOHDhAZGQkJiYmzJ8/n6ZNm7J06dLP6kEsCm3atPmox2nMmDH07duXv/76ix49erBy5Upu3LjB9u3befDgAb/++ivx8fE0bNiQ9+/f4+fnh7q6OtWqVeP9+/fMnj2bnj178scff7B9+3Z++eUX6tati57e3w3apZmd/lGQnp4OfOzMFIQPmdNKkr0xNjYucRni14apphoZ+tJvStpUWUed2NQsHkQnCXo3Ba0iuaWooiDGWEP1X2sHfi38RwBQSpDJZESmZPI0LoX4z8jIyKH7L83I5OTksHHjRhQUFBgyZEg+IyQ5OTkfPXJkZKRAj2xiYpKvdvdbsJ7lRVJSEjt37uT9+/eoqanRu3fvUi9h+hyU9oc1LS2N+Ph4TExMGDZsGDExMYwcOZL09HSmTJmCh4cHo0aNQl9fn/fv39OjRw/U1NSYO3cuderUEUqkSsug+hAvX74kOzsba2trIHfN9O3bF11dXdavX4+/vz+TJk1CQ0ODM2fOFDjGoUOHMDIyokqVKkX2N2VlZXHhwgVu376NqakpnTp1KhZTV2FwcXEhJiaGypUrc/XqVSpWrMjIkSMLZdMqCPJMxfr16zlw4ADnz59n/fr1vBWXoVazNoW+a0KfBJKZnk5Odjaz+3fnYHDkZ51DekoKt86forlrj0K3kUokiJPesXnedHJycti/f/9HrH4lpcjNzs7m9OnT/Pbbb9SuXZsZM2agr69PcnIycXFxXL9+HWdnZ/T19T96JmQyGREREZw6dUqgI37x4gWpqamIxWL69euHnp5escqdMjMz2bp1K5mZmQwZMiRfn45EIuHAgQOEhIQgFosZMmRIPirjj66TVMq5c+fw8/OjTp06tG/fvkSR/xkzZrB9+3bOnj0r7CdX/C4pbXJhePXqFRYWFpQvXx5fX1/BgdTS0sLQ0JBHjx7RsGFDfv/9dxITExGLxWRlZVG3bl3mzZtHly5dSEpKQlNT86t9xyQSCZs3b2bBggUAGBoa0rNnTyZPnkzPnj1RUVFh4cKFZGRkCJTZ0dHRAtth27ZtadmyJStXriQqKoqePXsydepUOnToQEREBLt37+bRo0d069atUDY3+ZrLyspCUVHxuwe4ioOIiAg2b97M8OHDi1ynxUVGRoaQuZH/96Nnb74VaZOaopj0HOlnV+j8W+3Br4H/MjOlgIwcidArI8fneojxGdnciozHSF0Fu3+JngzAhQsXiIuLY8iQIcTExOTrdZGn/bW0tDAzM6NGjRqYmZlRvnz57/pxkCt6S6VSbG1t6dKlyw/zsfqcF1tBZVcBAQHcu3ePSZMmsWDBAtq1a8eFCxc4c+YMVlZWQpnZtm3baNWqFfr6+gLtq6mpKW5ublhYWODp6Ymenh5Pnz4V6tFLw7GRG2cf6gdoamoyYcIEPDw8qFatGubm5ty6dYt58+YVeK6ZmZlkZGRw8eJFzp49i66uLlWqVKFKlSpUqFBBMABDQ0M5evQoKSkpQuT8S87h1q1bPHv2DB8fH6pWrUp4eDhLlizB29sbPT29T/aNyc9DHnOSlxLevXuXqVOnstn3fpHvmt/HDKbH6AkYmBSeCS0Ojm3fQOCtG0U6M2IFBVT0jDh58iSVK1fG09OTESNGcO/ePVJSUmjatKlwLYtrdCspKeHi4oKLiwuxsbEEBQXh6enJrVu3ePLkCcHBwezYsQN3d/cCnwlTU1OGDh0q/LxixQpq1qzJ/fv3efDgQbH73VRUVPDw8GDz5s3s27cvH2WzgoICFStWFJjLPmQn++g6icW0a9cOAwMDjh8/zvv37+nZs2exAjXnzp1j8eLFnDhxgkmTJhEZGcnbt29xc3Nj1apVpeLIyJ9bDw8PGjduTKVKlQgJCeHYsWPY29tja2tLt27d2LFjB3p6eujr69O1a1cWLFhAhw4duHHjhiDkGhgYyKJFi754TgVBQUGB4cOHM3z4cKHE1NjYGJlMRpUqVbh06ZKg3xMaGoqvry+urq5YWlqioqLCsGHDmDx5Mq9evWLWrFns378fQ0NDTp06xR9//EFWVhY1a9Zk4sSJgohvYbh9+7bAlNekSZOvcr6lBXl2srR0ZlRVVQvN3rx584bXr18XmL2RM6h9j+zN1yZtglwbMD1HKvy7JJBv/2+1B78G/nNmvhBvktOFB6I0IB/lbWomZ0Nj//EsZunp6fj7++Pn54eOjg5bt24lOzsbsViMkZERVatWFbIuhTE9fWukpaWxc+dOoqOjUVFRwc3NDXNz8+89rc+G3HD80Ch/8uQJHTp0QF9fn507d+Li4oKXlxeVK1fm8OHDeHt78/TpU5o0acJff/0lZEXKlCnDpUuX8PX1Zfr06fTo0YPq1auzf/9+nj9/zpgxY9ixY0exmL4+haKMs6ZNm/LmzRtu3rxJcnIypqam2NraAh87e3JjNCsri9DQUJ4+fUpgYCB+fn6oqKhgYWFBRkYGYWFhmJubC1mfz0HeDMHr1695//690B9hZmbGmDFjWLhwISYmJp/MsMnvmYeHB05OTvTo0YPQ0FDs7e2ZNnM2YqWiDYHSSrwXd5xMiZSTZ85Rq9bfwp0bN27k4cOHtG/fHkVFRUaNGpXvWS9OlvHmzZtMmTKFly9foqmpSd26dZk+fbrgYBc0xoc/Z2RkkJycjJmZGWXLluXixYvUrl272D1QWlpauLu7s337dg4fPkyPHj0QiUS8evWKc+fOYW9vT0JCAvv27cPd3f2jnpgPYWdnR7ly5fDy8mLTpk0MGDCgSH2quLg4Bg0axKRJkwC4dOkSd+7cITMzEzc3NypUqMDEiROLdS5FQSQSYWZmxu7duwXijkOHDgFQvXp1Jk2axMaNG4mOjiY0NJRr166xcOFCqlatSmJiohBQOHbsGD4+Ppibmwulc1+rbCvv+1kkEuHi4sL+/fsxNTWlWbNm3L59m5iYGNq2bUtqairbt29nzJgxmJmZsXTpUiZMmMC+ffsAmDZtGo6Ojqxfvx7ILXXs2bMn586dE0rd4uPjiYqKonr16kDuuzQhIUHoNfmRIS8z+1KimMJQUO/Nh9mbH6H35muRNpWmY/Rvswe/Jv5zZr4Az+JSeBSb/FXGlgE5Uhm3IxPI0Jf+I4QyZTKZoEQsz7y8e/cOyDXKDAwMqFu3rlBP+6X0yF8D/v7+nDx5EqlUirW1NT179vxhsjElQV7DQe4QeHt7ExwcTNu2bbGzs8Pa2pqWLVvi6+tLs2bNAHBwcKB///48f/6cgQMH0q9fP8zMzPD29ubixYvMmDGDy5cvY2xsLGTSDh8+TGBgIM2aNaNGjRosXryY48eP079//68adZOfY4MGDQBo27btJ+mBlZWVBWY0mUxGVFQUfn5+BAUFCX0KUqmUJ0+eUKVKlRL1ZMnnk3f7pk2boqGhwZYtWxgxYgQA1apVY/r06VStWrVYY6ekpKCnp8eVK1cYNGgQly9fpl+/fvjdf0TdIirVZvXtRmzkG9ZM/xl949z+lTP7dnJg7UrSUpJo0K4jw+f+hpJybu/ToQ2rOb9/D3Exb9HU1qVtrz70HDORi4e88F6zAoBuVY0/Waq2csMmLh07QuPGjYmNjeXWrVu8evWK1q1bc/HiRVasWMGxY8eKzcAVHx/PvHnzyMzM5MSJE/kcJTmKcx1jYmIA0NfXp3r16jx48IATJ04wcODAYt9jY2NjunbtipeXF+fPn8fBwYH9+/djZmYmrD9vb2/BoSlMkVyOChUqMHToUI4dO4aqqmqRBv7QoUPR19dn3rx5XL16FYlEwsuXL+ncuTO9evXiyJEjjBs3rlTeq/IAiPzd0a9fPzIyMhg5ciRisZjQ0FChL6ZJkyaC3taxY8cYNmwYFy9e5NChQyxevJhOnToRERGBtrY2KioqxMbGoqKiUupkAXnh4OBASEgI58+fF7LF+/fvR1dXl7t377J69Wpq165N586dKVeuHAMGDODIkSM0bNiQhw8f8vr1ay5cuECPHj2YMWMGioqKwrds1apVgtaQpqYm8+fPF3pB1dXVS4V45GsiPT0dsVj8TdnICsreyG2F75m9KU3SJjVFMWk5hfe6fQn+ifbgt8aPZ03+Q/A1HZkPIa/t/NEWcFZW1kf0yPIUdvny5alYsSJqampER0czYsSIH5r+MiMjg927dxMREYGSkhJubm5fTczzWyDvxzQkJIQ+ffoQFxdHzZo18fLyws7Ojt27d9OlSxf27dsnRGDNzc2xs7OjVq1aTJ48Wfjg7d27l9TUVGbMmIG/vz9KSkqCcJ6RkRFGRkZAbpOzlZWVIP74NZ0Z+Tnm7dUpSUQvIyOD27dv8+jRIypVqkSLFi14+/Ytz5494/Lly1y/fp3+/ftjYGDwyXHlx3/w4IFgmJqbm9O9e3e6dOmCj48PhoaGuLq6AggR3aIgN4o0NDQYMGAAHTp0YM6cOcyZMwcfHx82HzmV26dSSPZq8urNTHRtTadBIzEwMeW30YO4eeY4MzfvJT42mt/HDqZyrTq0c+vHZZ/9HN+5iZ+Xr8XQzJwA30tsnDOVei3a0Kh9J8KfBRMScJfJq7cUOWcRsGjFKhJGDaNRo0Zs2rQJZWVltmzZQpcuXYiPj6dly5aCM7Np06Z8ZWAFQVtbm+vXr3P8+PECHZmUlBSysrLQ1dUt0pCMjY1FJBKhp6eHgoICHTp0YMeOHTx48EDQNioOqlatSrt27Thz5gyPHz9GQUGBHj16CIZ/z5498fLywtPTEw8Pj08KTGpra9O7d2+gcKfs999/5+TJk1y+fFnICg0aNIhp06ZhampK48aNMTExKbUA0YcZURMTE+bOnSv83Lt3b44fP86xY8dwcXHh/Pnz3L9/nxEjRiAWi9m3bx+1atViwoQJwj5z587l6NGjiMViHj9+jLu7OytWrPiqfTWtW7cWNIKcnJyoXr06KioqmJqasn79ekxMTHjy5ImQIbhw4QJ169bl2LFjnDp1il27dqGnp0dmZiY5OTncuXOHiRMnMn36dDZt2sS5c+fYtWsXT58+Zfny5UDpalt9DaSnp6Oqqvpd5ykSidDX10dfX7/E2RtTU1PKlStXavMXiUSYaKpioqlKYkY2LxPSiEzJKFGzvoIYnsenFbBl6eNHtQe/N/5zZj4Db5LTv5kjI8fD2CRUlcTfLcUok8lITEzMR48cHR2NTCYTPg6Ojo4CPbKKigpPnjzB39+fzp07/9COzKNHjzhy5AgSiQRLS0vc3d1/yKxRYSio/+DixYs8evSIcePGceLECXR0dLhz5w6QW/pkbm5Ohw4dBCHRbdu2CYbHhAkT+O2333B3d2f27NncunWLFy9esGzZMgCGDx/O9OnTP5qHXARvy5Yt6OnpFenIyGQysrKygFySBQ0NDdTU1D4rqlmShnI5njx5wokTJ5BIJHTu3JlatWrlftRMTKhbty7Z2dnIZDIUFRWLLQLp4+NDv379aN26NVpaWvz6668EBgbSpUsX3r9/z4wZM3j16hVjxowpUIclb3+MSCQiPT0ddfXcD5a9vT2bN29m5syZODo64uTkRJt2TjyLSy00iqiprYNYrEAZDU3KaOSWdQ2btRhji0pUqFKVmg2bEhb8GAA9IxPGLPqDmg1y6/3bufXDe80KXj9/iqVNTVTLqKOopIyOftH6LFKphEtXr+Ncx4acnBwOHTpE8+bNhfIcHR0dJBKJ0FcSEhJCeHh4oeyG8rXdoEEDrly5Qv369VFTUyMkJITr16/j5+fHjRs3cHd3Z8aMGUXOLSYmBl1dXeHZNjc3p0aNGpw7dw5ra+sS9RA4ODjg7+/Pu3fvcHJyEu4T5Oqn9OrVC09PT8Gh+VSZ6qfWfGRkJIsWLeLmzZv8+eefuLu7M3LkSAICAti+fTurV68uding55AEfPhcVqtWjS5dutCjRw9q1arF69evsbe3Z/To0dy+fZuLFy8KDIiQmxWWZzQaN27Mw4cPGTJkCL6+vrRv375Ec/lcODg4CM/WzJkzmTlzJjY2NlhbW9O3b1+cnJxYuXIlZcuWRVVVlYEDBzJw4EBCQ0OJjY0lJyeHTZs20aRJE6GUzsXFhQULFlCmTBk6d+4M/DOcmdLqlylN/AjZGy1VJewMtbBDq9g0ym+S07853fP3tgd/RPxzLLYfBBk5Eu69Tfwux773NhE9NeVv0gSWk5PD27dv8zkvcgOkXLlymJmZUa9ePczMzNDX1//oBZ6SksKxY8eoWrVqgdHUHwFZWVl4enoSFhaGoqKi0PvxT8OHhklmZiZ//fWXkC3x9vZm+vTpJCcnM2fOHI4ePYqBgQG6urro6urSs2dP1q1bJzgzPXr0QEdHh0WLFtGjRw/S0tKYNGkSrVq1AhCYwD40iuRGYmFsb3JnJzU1lfj4eAYPHsy9e/dQU1Pjp59+YuTIkYKDo6OjUyJF+eIiNTWVU6dOERQUhLW1NR06dCiQRrYoRfX09HTmzJnDb7/9BuR+dOPj41m6dCmzZ89m4sSJAgtXaGgoTZo0wczMjAsXLtCxY0egYOO1c+fOLFu2DGtra7KysmjTpg2VKlVi2LBhWFhY0LlzZ44cOcKJEydwcnLic9r0ylcwF/5dRqMs2Zm5mdQajo14+uAeu5cv4s3LZ4Q+CSQhNgbp/2fsiguJREoZdQ1sbW3Zs2cP2dnZNGnSRGD/unfvHkFBQezYsQPIjcYGBgZibGxcoIEtv/fz58/n119/xdPTkzJlygiimhUrVqRr167UrFkTKNopiI2N/Ugss23btvz111/57k1xEBAQwLt37zAwMODSpUtYWFjkG1tRURE3Nzc8PT3Zu3cvvXv3pmLFisUe/0OsXLkSyNVjMjAwIDIyktq1a9O7d28WLFjArFmzis24d+3aNRwcHEpk0H54XZWUlFiwYAETJ07k6NGjVKlShdq1ayMWizlw4AD6+vr06PE3WcSsWbNISEhg2rRpTJ8+HWdnZzp27MiqVau+mTMDf6+nRo0acfHiRVJTU4mKihIM6FatWrFmzRr8/f1p1aoVYWFhzJs3j2HDhqGvry8QMMihqKiIjY0NFSpUQCwW//AlZpD7zP2IzsyHKCx7k7ca5MPsjYmJidCD+6XZG1VFBQw1FDDUKHyb/xV78J+A/5yZEkAmkxFQis3+JYVEKiMgOhFH46IF1T4HKSkpH9EjSyQSFBUVMTExoVatWsJLIm8UsiDIZDKhnKBjx44/ZKQqODiYQ4cOkZ2dTYUKFejdu/cPr2gsk8mEe5IXFy5cYOfOnSxfvlzIiGRkZAjsSEZGRnTv3h0NDQ3q1KnDggULaNu2LdeuXSMzM5NevXqxatUqHj58SM2aNcnJyaF169Y4ODjw/v37QqPKxYnufsjG9eTJEypXrky5cuXQ1NSkWrVqbNu2TWiW3rRpE6tWreLOnTuC3kNpNArLZDKCgoI4deoUMpmMbt26YWNj81njPnnyhKdPnwo/i0QiFBQUkMlkeHh4EBYWRqtWrWjUqBFLly5l0qRJeHh4MHjw4ALPRf47U1NTgWQhPDycwYMHs3XrVqZNm0ZmZib9+vWjY8eOeHh4UL16dZp0713iuX94z+TB/PP797Bt8Rxa9/DAsW0H+v8yi9n9u5d4fCUlRZo1zc3u7Nmzh9q1a2Nvby/8/Y8//qBBgwbY2dkRHBzMnTt3aNmyZaFrSW4YVq5cGRUVFfT09LCxscHR0ZEGDRpgaWlZ7Cxqp06diI6Ozvc7DQ0NWrRowenTp7GzsysW7fqbN284efIkdevWpU2bNmzbto29e/d+RNmspKSEu7s7e/fuFRwaObtWSZDXQG7QoAGqqqo0b96coUOHsnr1atq1a1eiTHKDBg2+OPMs16fS0dHJp5nk6+vLrl27WLFihfC706dPExUVxZ07d9i/fz8DBgygcuXKxMTE0KJFi4/OsSBkZGQwdOhQBgwYIARVSgPq6ur5hDhr1KhBr169cHV1xdbWlqSkJEQiEatWrSIqKopXr17lc3qjo6MJCwsTAkE/4rfuQ/yomZniQFVVlUqVKgnfiw+zN+Hh4dy7dw/48uyNRCIpsnT532wP/hPxnzNTAkSmZOajX/7WkAFRKZlEpmRiopmfiUQmk3Hv3j309fU/+cGUSqUf0SPHx8cDULZsWczMzKhevTpmZmYYGhqWuCTh3r17PHv2DHd39086Pt8aOTk5eHl58fz5cxQUFOjcuXOJ6uW/J0QikWCE3LhxAxMTEypWrIi6ujp+fn5MnTqVv/76C1VVVWrWrMmjR4+A3FrxS5cu4efnJ9Amv379msmTJ7Nu3TpatmyJpaUl8+bN48CBA8L91tTUFLIWOTk5KCgoFPulKTfQX7x4wfr161myZAlXr14lMjKSoKAgGjRoQJ8+fVixYgVr165lxowZiEQi7t27x08//ZRPuO5LX9TJycmcOHGCkJAQbGxscHZ2/qx1GRQURGhoKB07duTw4cNAbjlfy5YtAXj79i2rVq1i7969ODk5sWbNGpSUlPDz86NTp06fPJd169YBMGXKFDIzM1m+fDmDBw/G19eXkJAQFi1aRLNmzdDX12fRokXsa+UMFP1xLu61O7tvFz1G/4zr4FEApCYlkvj+neDtFP8eiFASi4XMhaurq5CxiIyMZP/+/Xh6egK5fVhly5YVMoiFQW40Dx48mKpVqwqsWSdOnGD58uWYm5vTrFkz6tWrh7KycqHOr5aWVoFsYfXr1+f+/fucOHGCIUOGFGlUp6Sk4O3tjZGREU5OTigqKuLh4cGmTZvw9PRkwIAB+bJ6eR2aPXv20Ldv3xKLiebtDdPU1OTy5cvMnz+foKAgPDw86NevX7HKeGNjYwG+SDNJjrwOfN5r3bhxY9auXZtPQykiIgJra2sqVKjAkiVLmDRpEhs2bOD06dNCJvxT2QxVVVVWr14t/Py1MiCqqqosW7aM0aNH4+Pjg5WVFY6OjpQtW5Znz55hbGzMhQsX6Ny5MxkZGZw+fRpAoFj/UOfoRzQyMzIyimTN+yehJNkbQOi9KU72Rt4n6u7uXuD1+pHtwf9F/OfMlADP4orWD/gWEP3/PPIu3qysLHx8fHjy5AmWlpb07ds33z7yxjp55iUiIoKsrCzEYjGGhoZUqVJFeLi/9CUXFxfHmTNnsLOzEwznHwUvXrzA29ubrKwsjIyM6Nev31ejpyxtyCOh27ZtY9q0aSgpKWFgYCBQiO7atYs+ffqwcuVKpk6dipKSEqampmRnZ9O6dWs0NDTw8vJizJgx6OjosH//ftTU1ARWrx07dgjsQgW93IsTyZWXkUVHR3P58mW6dOnCkydPOHz4MCtXrkRfX59y5coRHh6Orq4ux44dY9y4cYLBHhMTw7Jly+jWrVupXbPHjx9z/PhxFBQU6NmzJ9WqVfvssQ4dOsTs2bPx9fWlYcOGXLp0idatW7NhwwaGDh3K1KlTGT16NN27dxcU5qVSKS1atKBp06aFjv3h9a5bty69e/fm6dOnrFu3jsaNG9O4cWP69+/P2bNnsbW1xcfHBwuj8kR/olZbpUwZIkKfU0ajaEV2DW0dHt64hn3LdqSnprLnj8XkZGeTnZ1b9qeiVoa4mGhi3oRjYFq4Zo0M0FJRxNrOjkuXLgllg5CblTEzM6NLly7ExcVx5coVGjduLJShFtTLkVerSE6esHLlSpYtW4aysjL29vacO3eOdevWMWzYMH799ddCjcjCjBaxWEyHDh3YsmUL/v7+1K9fv8DtJBIJ+/fvRyqV0rNnT+GZKFu2LB4eHmzbti0fZbMcysrKeHh4sGfPHnbv3k3fvn0/S3hXJBIJ12jmzJlkZmbmizQXlfXLzMzk1q1bpV7SVdA1lTsycofD3t6eOXPm8OzZM/T19dHT06N169YMGjRIeP8WZfinpaVx+/ZtmjdvTk5OTr6xvxYsLCz4+eefhZ+lUil169ala9eu/P777ygqKnL69Gm2bdsmsBR+OCeRSERQUBD6+voflTd+T6SnpxebjvyfiMKyN3ltoA+zN/LyNHn2Jicnh7CwMKRSKevXr8fNze2jMtEf1R78X8V/zkwxkZiRTVxG9veeBjIgLiObxMxstFSUSEhIwNPTU4i6hYeHExsbK0Qm5D9Drj6ImZmZUMNvbGxcZG9ASSGVSvHx8UFdXb3YYnTfAlKplIMHD/L48WPEYjHt27cv1GD5USESiXj27BkbN25kxYoVQpnY2LFj0dfXZ/78+cyYMYMlS5Zgb2+PkpISSUlJKCkpUalSJZYuXcq0adM4duwY6urqPHr0iBkzZghG1ZdcD3n526NHj7CwsMDPz48lS5YQGRnJzz//jKWlJZGRkejo6KCgoECdOnXQ0tLi2rVrjBo1itq1axMfH0+NGjVKjf0sJyeHc+fOcfv2bWrVqkW7du2+qLRCJBIxduxYoqOjadu2LQEBAbRo0YKFCxcyduxYTExMcHd35/Hjx2zduhVPT0+0tLQICwsr0sCG/EaQTCajZ8+eODg44OzsTKtWrdi2bRsODg4oKyvTvn172rdvz/jx48kqRnmDk3t/di1bwHmlPUVuN2jGPNZMm8BE1zaULVeORs6dUC1ThtDHgQA4tHHmrNcuxnVsxvoLt9Eqp1foWNqqSkilUtTV1YUMmEQiwc/Pj0GDBgG5GiRpaWk0adKEMmXKEBQUJKjYf3jdw8PD2bRpE0OGDOH27dssXbqUWbNm4eTkhJ6eHhKJhBs3buDi4sLkyZM/aw2ZmppSp04dLly4QLVq1fKVi8lx9uxZ3rx5Q//+/T/qszIyMqJbt27s27eP8+fPC4QHcuR1aHbt2kW/fv0+S4cpr7MnP8/s7GyUlJSKdODu3bsnUJh/K8jXtLm5Oa1atcLd3Z1evXoRFBTEgwcPOHjwoEDPXVQG4+rVq7Rv356nT58KJWFyR7KkGeMvPZfJkyczf/58pk2bhoODA2lpabi5uRV4DlKplLNnz5KUlISBgQG2trbY2tp+dzKcf3KZ2ecgb/bGzs4O+Dh74+fnx+XLl4Hc7I2Ojo5A1Z+ZmcmOHTto37499erVA769PTiipT09x0ykZddezOrbDRv7BvQaO+kje1B+vpcuXaJ58+aYm5szZ84cBgwYQPPmzWnevDlz5swhKyuLHTt2fJJJ8p+E/5yZYuJlQtoXiyoVF4nv3xF05yYNnVyAXG2HuTsOYOvQEMj1xl/Gp6GbmSvQlpmZKfQkZGdns3btWiD3oTQzM6Nhw4bfRIzqxo0bhIeHM3DgwO+i6lsQXr9+jaenJxkZGRgYGNC3b98CDZV/AuRZJWdnZ/T09OjevTsvX77k3LlzXLlyhf79+/Pq1StmzpyJvb09z549E/Z1d3fHwcGBQ4cOkZmZye7duz+KDn9uWcS1a9eYOXMmJ0+eRF1dnfT0dF68eMHGjRsZPnw4tra2ghFWrVo1Xrx4QbVq1QTD5FPigiWBTCbjwYMHnDp1ClVVVTw8PL6YYltO/aytrc2MGTOIioqiTZs2PHjwgGnTphEdHU2vXr24dOkSv/32GxoaGsyYMQMjIyMOHDiAsrJyoddVHmnPysri9OnT3Lp1i+rVq+Ps7Mzjx4/p1q0bzs7OrF69ml69egl9UCKRCFVFMSoKYoFCtCA4eQzAyWNAgX8bu2Sl8G9Ty8os9jpW6DiGFcxZc/bGJ6+VioK4wIZUBQUFrl27JhgIOjo6REdHC0bismXL2LZt20f7yWQy9uzZw/nz5xk3bhzbtm3D3d2d4cOH59vO0dERe3t7Hj9+jJ2d3Wet5VatWvHkyRPOnz8vZIHkePjwIbdv38bZ2bnQMl5ra2uBsllXV5e6devm+7uKigq9e/dm9+7dgkPzqRK7wpCcnExQUBCOjo4oKSkJWdGC8OLFC5SUlNDW1v4uzemampps376dXbt24enpSe3atRk2bFixdIbS0tJYv349bdq0wcrKiqNHjzJ27Fj8/f3R09MTzll+v+Pj4wkICBBKP0sbZmZmQtY1OjoaExMTwcD9cL2JxWJ++uknnj9/TmBgINeuXePixYuYmJhga2uLjY1NgeQjXxv/a85MQfhU9iZvT6Tctjpx4gRPnz6lZ8+e39QeBPjtwClU///d/yHk9qCdYW5VTVRUVIEaTocOHRL6gj09PVm4cOG/ypn5sWk3fiBEpmR8s4W7a9kC/C9fEH7efO0+1nb1hJ9lwKv4JLZv305GRsZHlJwODg5MmTKFkSNH4uLiQu3atUuVl70gvH37lkuXLtGoUaPPanItbcizRNu2bSMzM5PWrVszcuTIH8aRkWczigO5ARgaGoqZmRl6enrCPe/QoQPp6elC2nzWrFnUqFGDAwcOoKurS1JSkjCGpaUlkyZNEjIyUqk039opzvqQyWRkZmZy//59rl27BuQaK61atSIjI4OZM2eyfft2xo8fj6amplDnvmnTJlq0aMGwYcOoX78+hoaGNGrUqJhXi2Jdq7i4OHbu3MmRI0ewtbVl5MiRpaIVJKdRfvLkCd26dSMnJ4fXr18LpWMrV66kQ4cOuLi48Pr1axYsWICvry+XLl3C0NCwyAZSuZPn4uLC3Llzef78OZMnT6Zdu3ZERERw8OBBpk+fzpAhQxg/fryg3i0f01hDtUAdhO8BEbnzKQjy+yc3pps2bUqTJk3YunUrDx48YMeOHWRnfxzpFIlEnDp1ih49elCuXDlCQ0MLdAD27t1LTEwMgYG5maSCaIrlz1FhKFOmDK1bt+bBgweEhYUJv4+KiuLYsWPUqlXrkxlMBwcH6tevz4kTJ3jx4sVHf5c7NOXKlWPnzp28ffu2yPGKmuuZM2fo1asXkJup+PB5BkhMTOTp06fUq1evxL2PpQX5de/bty8nT55k0aJFAo3xp3Dv3j2OHj3KokWLANixYwfh4eEsW7YMHR0dFi5cmM9xzczMZMGCBXh5eX2dk8mD8uXLM2fOnCK3UVBQwNramm7dujFp0iS6deuGhoYG586dY8WKFezYsQN/f3/huf7ayMnJIScn5x9TXv2tIM/e2NnZ0alTJypUqFDge/vZs2dcu3btm9qDAFq65VBRLdgBlZFrn8phaGhYIJmRrq6uYP8Ul8b9n4T/nJliICNHUmT0s7Tx4TrT0TdA6YPFKRUrUkbz7/6WvBG3jIyMb/qyysnJ4fDhw+jr69O8efNvdtzCEBUVxfLly3nw4AG6urqMGzeuRIbz14b841tS46J9+/Zcu3ZNEP8DsLGxISEhQaglB1iyZAm1atVCV1dXyJDlXR9yo6ekIpOvX7/mp59+YvLkyfz555907dqVHTt2ULlyZWbNmsXOnTsJCAhg0qRJTJkyhYoVK7J7926ys7OZMWMGs2bNokyZMhw8eFAoRywM79+/59mzZ0JWRH6tQkJCCtxeJpMRFhZGQkICffv2xcXFpVSfgcjISDp37kzjxo2ZO3cuXl5eiEQiHB0dAdi3bx81a9akffv2REVFYWxsXGRGBv52SFatWsWrV6+4cOECXl5eVK1alSpVqpCWlsb9+/eZPn06Xl5eJCYmfhRRtdQu800/qkVBBljqFBw9/HCta2trs2fPHvbs2UN8fDzt2rVDSUmpwI9shQoVuH//PpArHunr68uGDRuE7F/Xrl0ZP348OTk5wvooKANRnKyEnZ0dpqamnDx5EolEQlpaGt7e3ujr69OhQ4dPPi8ikQgnJyesrKzw9vYmJibmo21UVVXp06cPurq67Ny58yOGteJAQUGBWbNmMX36dGxsbLh586bwPMvfBRKJRKAYLsp4iYiI4NGjR/n6m0oT8usud2jlc8nJySlyXhkZGaxevRpHR0fq1q3L1atXOXz4MBMnTqR3797s3LmTP/74gyNHjgj7GBoacvHiRcHJ+5GgrKyMra0tbm5uTJo0CRcXF0QiESdOnGDZsmV4enp+1fsACE7T/1JmJiwsDJFIxPz589HR0WHMmDEcPnyY6tWrU6ZMGezt7bly5Yqw/YMHD/jll1+YP38+y5cv58qVKxgbG9OoUSM2bNjAHf97jOrQAg+7Siwc3pf42L+f8TcvnjF/iAd96lZhaNM6eK9ZITjzXquXsXLSaDbMmUqfulUY2LAGPpvX/D3P4CCmu7ngXttS2FeOES3tuXjobwf9fXQUM/t0xa2mBVN7dSTkcSAZObnPl0gkEkrm8kJeYnb58mUGDhzIq1evEIlEXL9+HUVFRaEdAcDf358yZcqQnPxt9RS/BP+zzox8ge/duxcTExO0tbUZN24cOTk5zJkzB1dXV5o2bYquri4nz18kKzODXcsWMKx5XTzsKrF4ZH/eRUUAEPMmnG5VjfG/fJ4RLe3pXceKLQtn8vppML90c8LDrhKLhvcjPeXvhrGLh7z4qX1T3GtZ8ks3J4Lu+AG5C/6yjzeXfbwZ0TKX0rRbVWMCb+WWeOSdx+yZM7h9+zZNmzalfv36KCgoMGfOHM6fP0+lSpVQVVWlY8eOxMXFfdVrefHiRd6/f0+XLl2+q9ikVCrl5MmTbNy4kfT0dJo2bcrYsWO/O3PLhx9skUhEdHQ0kyZNokWLFixevFjIrBQUPZYbA927d0dJSYmtW7cKH6WXL18SHx+f7xy1tbU5cOAA+/btK7DcryROTHZ2Nm/fviUlJYXOnTvTvn17/vzzT7Zu3UrVqlVZsGABz58/JzIyktmzZzNu3Dhat26NSCTi+fPnBAUF0b9/f8qVK8eoUaNYuXKlQMdaGLy8vNDX1+fWrVuC45eamkrr1q2ZOXNmgQaiSCSiTp06jBo1CktLy2KdW1H48D6kp6cjk8lwd3endu3a9OjRg6NHjxIXFyeUJB09epSMjAwuXbpUrGPI10VsbCyOjo5oa2szefJkwsLCWLZsGdevX8fDw4OYmBi6d+8uRJvzZqm0VJXQVS29vrfPhQjQVVUS6rY/BalUilQqRUFBgebNm3Pq1KnccQpYl4MHD+bWrVssWrSI1NRUXr9+zciRI7Gzs8Pb2xszMzPWrl3L4cOHGTBgQKEGcnGikSKRiA4dOvDu3Tv8/Pw4ePAgWVlZ9OzZs9j9hWKxmG7duqGjo8PevXsFfa68kDs02tra7Ny586M1LZPJCAkJ4fXr14XOXSQSUbNmTU6ePImrqytz584F/s7SPHnyhIoVKxbaU5KYmMi0adOoW7cubm5uWFpacvHixWKd4+dA7tBmZWWRlpYmCNJKJJIC33sPHz7k4MGDLFmyBMjVGnJ2dmbp0qXUqFGDBg0aoKOjIziw169fZ+nSpWRmZuYb71MZue8BNTU16tSpQ79+/ZgwYQJt27YlLS2NQ4cOsXTpUg4cOEBwcHC+IFVp4H/RmZHj+vXr3L17l6FDh9K/f39+/fVXHj58SJ8+fXB2dub58+cA9OvXj9q1a7Nt2zZWrlzJrVu3MDExoXXr1igrK7Ng/jxch4xi8b7jZKans/SnIQAkxb/n196u6BqUZ4n3CYbOXsSp3Vs5sXOzMIebZ46jrKLC0kNn6Dx4JLuWLSQyNDeD++eUcVhUt2Xl8cuMWrgcn81r8L9y4eMTAS4d9qaBU0eW+ZzF0Kwiv48ZzPvUjAK3/RANGzZk5cqVmJqaEhUVhaOjIyYmJgJDJ+SWtBemwfaj4n/WmZFDHmU9fPgwBw8eZPbs2QAcOXIEDw8PLl68SCXb2mycPRW/c6cYu+RPFu07hiQnhyWjB+Z7UR7e9BdT121nxLylnNy1hd/GDqb3hGnM2uJJyH1/zh/YC+Q6MlsWzKDrsLEsO3yWGg2bsGh4H95HR9Fp0EgaOrvQ0NmF3w6c+mi+G/5/Hj8t+ZN9py4glUqZOHEibdu2pU+fPgDcvHkTT09Prly5wp07d1i+fPlXu35hYWHcvHmTFi1afFeGlNjYWFauXMmdO3fQ0tJi9OjRnzSavzYkEkmBtfvPnj2jffv2BAYG0rx5c86ePSsYEYVFjyUSCSKRiFmzZrF9+3Z69uyJp6cnQ4YMwc7Ojn79+uXbXp6V+NwPeVJSErt378bc3Bx/f39u3bqFoaEhdevW5a+//sLCwoKoqChWrVqFmZkZMpkMfX19bt68ydu3b/n111+pUqUKZ8+eZfTo0cU+blpaGj4+Pri5udGnTx/EYjHe3t507doVCwsLtm/fno+2+UOUFqGF/D7Io1VJSUmkpqYK91KuT7Ru3TqOHj3KL7/8goqKCiEhIfloaYuCfCwrKyukUil79uxh48aN7Nq1CyMjI+rUqUNaWtpHxvCHWY7Kut+/dFKWZx7FcRrEYvFHEfvC0Lx5c1avXs2ePXuETMSCBQs4dOgQGzdu5Oeff6ZHjx7o6upibm5eqKNeXAfe0NCQ+vXrc/HiRUJDQ+nevTva2trF2lcOFRUVPDw8kEqleHp6FlhCp6amRt++fSlbtiw7duwgJiaGnJwc/P39WbNmDdevXxeeraLOqWLFigQHB3PgwAGaN2/Ou3fvEIvFVKtWDQsLiwIzwOnp6cybN4/du3ezdu1aDhw4wE8//cSiRYt4/Phxic61pDh9+jQaGhqMGTOGd+/eoaCggFgsRiKRCGshMzOT1atXY2dnR9OmTblz5w4XLlxg1qxZwjhysVV5Q72Pjw9Lly5FRUUl33tULmb5Izo1kKt15ODgwODBgxk3bhzNmjXj3bt3eHl5sWzZMo4cOcKLFy9KZf4ZGbkG7/+iMzN+/HgqVarEsmXLGDp0KB4eHlhZWfHTTz/h7OwsUOOHhYVRs2ZNPDw8GDRoEOfPnxdonwG6uveleaduVLSuxuhFKwgJuMvrp8FcO3YYFTU1Rsxbimmlyti3csJt3C/4bFkr7KuhrUO/X2ZhVNEC18Gj0NDS4UXgAwBiI8LR0NZB39gUuyYtmL3VC8vqNQo8F4fWzrTvMwhTy8oMn/Mbie/fcerM2WJdB2VlZbS0tFBQUBCkN9zc3Ni/f7+wzf79+wVii38K/uedmd9//53GjRvTokUL5s+fz6ZNm5DJZJQvX54RI0ZQu3ZtUtLTuHL0AENnLqSGYyPMraszbulfRIa+4MH1q8JY3UeOx9y6Ok06dkGrnB6NO3SmVqNmVK1jT82GjYl4mev5n9y9hfZ9BtPctQcmllb0nTiDCpWrcWr3NtTU1VFWUUNZRQ0t3XL55pqSmMDVPPOwrFadPXv2EBISwrlz54Tt5s2bh729PQ4ODvTu3Zs7d+58lWuXmZmJj48PFSpU+OZMOXlx7tw51q5dS3JyMo6OjowfP15Qqf/WyPvBkUdE5XW2ciPP399f0CiYPXs23t7ejB8/vshx5R/nkSNHsmbNGsqWLcvixYuxsbFh48aNhZZUfU7D79OnT+natSvTpk1jy5YtdOjQAXNzc86fP4+NjQ1r1qzh119/5enTpxgaGjJ79my0tLQYM2YM27dvx9bWFj8/PyZNmkTr1q1LVOKnoqLC+/fvUVFR4cKFC/z+++8YGhpy7tw53r59i5KS0jdrYvby8qJatWoEBQVhZ2dHjRo1GDZsGPC306SlpYWhoSHLli3D19f3k0ZC3lKbrKwswsPDcXJy4uzZs/Tt25dFixYJ1ys1NRWJRCIYIIXBSF0ZI3WV79Y7IwKMNFQwUs8thY2KihKywcVxbOTGdlHbtmnThqCgIF68eMGKFSuYMmUKjo6OHDp0iC5dulCuXDnq1q1Ljx49hHfhlxh/RkZGSKVS9PX1sbCw+KwxypYti7u7O7GxsRw6dKjA85M7NOrq6mzevJkVK1Zw/PhxrKysGDhwICKRqFhOmI6ODv7+/piYmDBx4kQAwUkoCKdPn+bSpUssWbKErl27Uq1aNTw8PHj9+jUODg6sWrXqs865OOjcuTNnzpwhNDQUS0tL+vfvT3h4OAoKCigoKAg6aHv37mXatGkALF68WBDyhVxn7MKFC0gkErp27UpgYCCnTp3i119/BXLLUQ8fPszUqVN58uRJPuf5R4a2tjaNGzdmxIgRjBo1Cnt7e169esXu3btZsWIFJ0+eJDw8/LN7HuSZmf/Fnhm5+POTJ0/466+/0NDQEP47duyY0PQ/ffp0FixYgJGREYMHDyYzMxNDQ0NhnJp5RIDLm1ZAQ0uHNy+f8eblcyxtaqKQpzrF2q4eCbExpCYl5m5vYpYvuKCmri5k37oOH8vBdasY0qQ2a2ZMIDsrCx39gim9rWrW/nsMDQ2MzS15GhL82dfG3d2dy5cv8/79e+7cucO7d+/o0KHDZ4/3PfDjP91fGXkNrXr16hEbG8u7d+/yqZ6HPs+NilSu9bd3rqmtg7FFJSJe/s0YVd7sbx5yZRVVDEzM8vysRvb/18JGvHhO5Vp2+eZRpXZd3uQZqyBEhr3MNw+pLLepy9ramidPngjb5W16Llu2bIFRwdLA6dOnSU9Px9XV9bt8KOLj41m1ahU3btxAQ0ODESNGfHdK6LzXwdvbm2rVqmFnZ4ebmxvjxo0jLS2N1NRU0tPTGTduHKNHj2bu3LnMnDmTgwcPAoWXlECugdKyZUs2b97Mw4cPWb169WdRvH6ImzdvsnjxYs6fP4+BgQEtW7YkIiJCiEhVqlSJjh07YmxszL179xg8eDBisZi7d+/i7e2NRCLh559/5tixY1y5coUbN26UiO5ZJpORnZ2NgoICCxcuxMfHhzZt2hAWFkbTpk0ZOXIkDx8+/Ko1vB8av7169cLMzIwBAwYQGRnJmjVreP/+Pc7OzoSHh5OQkMCTJ09o0qQJjx8/pnHjxkUannl7f4YNG0br1q1p2bIlUVFRXLhwAXNzc3bt2sWqVauYP38+AwcOpHPnzoKwYGFjikQi7Ay1UBB/H3dGQSzCrvzfZY6XL1/GyckJgISEhGKP86lrBxAcHIyKigqZmZm4uLiwZs0aunbtyr179zh+/DgaGhoMHz5cUO/+HMTExHDy5ElMTU2JiYkRyk8+B0ZGRnTv3v2jgJMcCQkJXLlyhYSEBLKzs8nOzmbgwIE4OTmVmLBFWVmZPXv2CBHmogzerVu3UrlyZXr37p1vLgAtWrRgyJAh+QgVShtt2rThxIkTnD17luTkZKpXry5Qm4vFYszMzIiOjhYcFR8fH8GxAbhz5w43btwQmB29vLyQSqWMGTMGPz8/unbtypo1a3j48CEODg4sXry41Eu2CkJpNlbr6+vTsmVLxo4dy9ChQ6lRowbBwcFs3bqVVatWCQGekhzzf7nMTO7A5eTkMGXKFO7fvy/89/jxY9avXw/kiha/ePGCKVOm8PLlS+F7K4eCQv7sv1QqQSQSo1xASbf0/4NX8v8rKn3cmC+/f12GjmHNuZu4DhlNdPhr5gzowfn9BVPqi8Uf6nFJCxy7uKhduzZWVlb4+Phw4MABOnfu/I9zeP/nnZm8ZSl5GXfy3kg11YJphqUSqbBIARQU8veLiEQFX16lgha9VJJvrILw4cMit13ypueBj5gsvgZzRXBwMPfv38fJyem78OZfvXqV1atXk5CQQJ06dfj555+/S5nbhwZwfHw8s2fP5vr162zatAl3d3fevHnD3LlzuX37NocOHaJ///4MHDiQY8eO8fjxY8LCwjh//jy9e/fm2bNnhRoxeT/G8o9RTk7OF0WgExMTcXV1pXPnzgQFBdGxY0dOnjxJ8+bNsbKyYs2avxsUp06dSnBwMGvXriUkJIR3797h7e3N0KFDhZ4dGxsbbGxsSjSHnJwcRCIRSkpKREVFsXr1asRiMZUrVxYoeBcuXEhOTg4LFiz47HP91Bzkxm9eA/z27dvExcUxaNAg1NXVOX78OK9evaJp06Y0btyYsWPH0rFjxwI1Uj6E/L5OmTJF0AjaunUrqqqq2NjYCLTMhw8f5vLly3Tr1o2//voLKDjLIHdkcmmaFahj+H16w+oYauWjY1ZQUCA1NZWcnBzOnj3LmDFjhPkWl8HvQ4hEIvz9/XFxcSE4OJhVq1bx7t07Ll68yMyZM6lZsyYODg7s2rWLrKwszp49KxyzJMjIyMDLywsdHR369OmDubk5p06d+iJDuEqVKrRr146bN29y9+5dIDd7dfDgQf78808ePXpEgwYNGDlyJFZWVhgYGHxy3teuXctn3OdFXvruDyGTyUhJSSE4OJiOHTsKv09OTubWrVtIJBIsLS1xdXWlbt26uLq60qtXr6/GfiTPrvn6+gK5eleJiYnIZDL09PQEFsa1a9cKZcNZWVlcu3aNjIwMBg4cyNOnTzl8+DCjRo0iISGBOXPmoKenx/nz5zl58iSHDx/Gy8uLyMjIAufwuWvyQ0ilUt69e1fqTpNIJMLY2Jh27drx888/079/f6ysrAgICGDDhg2sXbuWK1eu8P79+0+OlZ6ejrKy8ndjtvsRYG1tTWhoKFZWVsJ/Gzdu5NSpU2RkZDBu3DiUlZWZMGECly5dYtiwYUKgEeBp0CPh31GvQklLTqKidTWMLSrxMughOXmCx0/v+1NWtxwa2kXbSFmZGWxZOBNFJSU6DRzOvJ0HaNOzD35nTxa4/eunfwevU5MSiQx7iWUJmDsLE7s9duwYJ06c+MeVmMF/zozAkgNw9+5djI2NPypRsrCshIKiIk/v3xN+lxwfR9SrlxhblFwjw9iiUr6xAJ49uIfJ/49VWECuvJl5vnkoicUC65O1tXWJ5/G5SE1N5dixY1hbW1O7du1vdlzI7V3466+/uHTpEqqqqgwZMgQXF5dvlhn68KMuFotJSUkRKJDv3r1LQEAAc+bMITs7m1mzZqGtrY26ujphYWH4+PigqKjIzJkzefnyJcePH+fQoUP4+fmhq6v7kRGW11GVN8xGRUUJH0xFRcUvOne5NtDly5fZvXs358+fp1q1atjY2NCnTx9BowdyaWeXLFnC3r176dq1q5ABHDx48GcdW17HLieNmD59Ok5OTgwcOJCoqCg0NTX566+/ePPmDdra2vz5559CJq40EB8fz9GjR4Hc65idnc2UKVOYNGmSkAFSUlLi5s2b3Llzh4kTJ2Jtbc3du3fZsmULixcv5tq1a/Tt27dEx7x79y5z586lR48eNGnShGrVqpGVlcWIESOYNWsWly9f5sKFCyxcuBCgwCxDQX0Upppq1NQv+yWXpMSoqV8WU81cx1o+x4YNG1KzZk3Gjh3L+fPn8fX1JTg4mGXLlrFnzx5h7ZbUQN62bRv16tWjfv36XL58mS5dumBhYYFUKiUrK4uMHAk3Hj1h+K/zUDOvysOYJAJjkwh5n8LblAyB7acwyGQyDh8+TFpaGr169UJFRYX27duTkJDA9evXP+Pq/I28lM0bNmxg48aNRERE4OTkxPjx42nRogUGBgb07Nnzkyx4kNtn8anyw4Lw9u1bxGIxderU4ebNmwCkpKRw7tw5tmzZgrKyMuHh4Ziamgrvpjdv3jBq1KivluEHqFWrFp6enrx48QItLS3BeReLxZQpU4YRI0YI2z548IDDhw/TqFEjjI2NOXDgAJmZmQwbNozdu3cTERHB3bt3cXR05MiRI9StWxddXV2Cg3PLcGQyGS9evODBg9xehQ8Ne4lEIrzPS4KcnBz27NnzVXuORCIR5ubmdOzYkYkTJ+Lh4YGxsTE3btzgr7/+YuPGjdy4cYPExMQC909PT//HRdxLGz///DP79u3jzz//5MWLF6xcuZIVK1ZQpUoVVFVV8fX1ZezYsYSEhHD37l2uXr0qiG0C7Nm0ntsXzxAW8pg1MyZQq2FTjM0tadqxK9lZWWyY/QtvXjzj9oXTeK1eRju3fp98npVVVAn2v82WBb8S8fI5zx894PFdPyyq2Ra4/bXjPpzz3kP486esmTEBo4oWNG5W/B5hdXV14uPjefbsmfA+dnd358yZM0RFRdG2bdtij/Wj4H/emRk3bhx3797l/PnzzJo1q8BmZeNy2rTu0ZvNC2YQeOsGYSGPWfXLWPQMjanVqGmJj+kyYBin9mzl8pEDRIa+YNfyhYQFP6ZVj9zGYRW1MsRGhPM+Oirffmrq6sI8Ht26QcSzJ/Tp0wczM7OPFKe/FmQyGceO5YrryaklvxX8/PxYtWoV79+/x9bWlkmTJn0k/Pi18eH5Xrx4kcqVK7N48WIgt3Y9Pj6eKVOmMHnyZIKCghg1ahSbN2+madOmhIeHc+vWLaKioliwYAHe3t4oKyuzc+dOLCwsaNGiRb4ItryOPD09nZUrV2JhYcGIESMKjTJ+CtevXyc4OJjMzEwgtyQoPT1dKGVq3LgxdnZ2aGlp0bp1a8qVK5ePQGL8+PGcP3+e3377jUuXLnH+/PnPZg+T17H7+flRsWJFduzYwaNHuVEvZWVlFi5cyJkzZzh79iyZmZl069YNd3d3Ro0aJcz/S6ChocEvv/zCzz//DOSWrigpKREWFsaKFSuEl7yBgQGXLl3iwIEDzJo1i5ycHFq2bImLiws1atQokVGupaVFampqPodMJpOhrKxMbGwsv/3220f7FBRFFYlEvH79+qNjW2rndWi+LmlzTYOyWOnmp9eWSqWYmZnx22+/ERUVxenTp0lOTsbe3p4NGzagpqYmOK8lfXekpaUJWYe6dety48YNAp+/5EFMMudex3PyRQxvlbWp2qQNMRIFXsSn8jw+jcfvkrkRkfv3E8+jCXibSHRiykfX7sqVK0K/mFx0Tl9fnwYNGnDt2rXPZoWUSCQ8ePCAV69eAblii23atGHMmDHY29vny6TLNY0Kw5kzZzh37hx2dnb88ccfJZ5L//79uXz5MsOGDWPXrl24ubnh7OzMTz/9RHp6ulBusnDhQmrVqkXNmjUZOHAg165dK5Vn7lOQ9ybkXfMf3qf69eszYcIExowZQ1hYGIcOHcLNzQ1lZWXu3r1LrVq1ePv2Lc7OzowYMYI6derg6+uLkpKSIOrs7OxMx44dqVmzZr5nMSAggMGDB39WwERZWZlhw4YVyF73NaCgoEDlypXp0qULkyZNokePHmhra3Px4kVWrlzJtm3buHPnDqmpqcI+GRkZ/5MlZnnh6OjIrl27WLt2LdWrV2fjxo14enoKumFeXl6kpqZSv3592rZtS9OmTZk5c6awf6/efdi9YjEz3Duho2/AhD9yy9PUNDT4ddMeol6HMalLWzbPn0GH/kPpOWZiseY14Y/1ZKSlMaVHe+YPcad6PUe6jxpf4Lbt+wzkwkFPJndtR2pSEpNXb0G7BKyWLVu2xMrKiho1aggBfSsrK6pXr07Xrl1LjUjnW+L78ej+IOjVqxcdOnRAKpUycuRIpk6dyrx58/Jto62qRP9fZrLj9/ks/WkoOdlZ1GzYhNnbvFBSLrnSfSPnTiTExrBv1e8kvIvFvJoNM7d4YmqZG+lu1rk7v40ZxMTOrdl2M3/Nct55LJVk07p1a86fP18gBe/XwP379wkJCaFXr15F6oSUJtLS0gQ9BhUVFdzc3PL1NH1LZGVlsWXLFiFCXLFiRaKjo9m8eTODBw+mXr16PH/+HFVVVVq1akWvXr3Q1tZm9erVyGQy+vbty8WLF5k6dSpxcXFs3ryZxYsXExMTw4wZM6hatSoikUgw+C5dusSqVau4ePEi1tbWjBs3jt69e6Ovr1/kPBMSEihbtqxgGAUFBdG1a1ciIyMxNDTE1dWVpUuXUqFCBdTU1Hjz5g2mpqZkZ2eTlZXF5s2bKVeuHF26dGHLli1MmjQJFRUVpFIpOjo6+UpUSoIPMwpjxoxh7dq1zJ49G3d3d1xdXYWMT7t27XBxcWHDhg3Y2Njg4ODAH3/8Qfny5Vm/fj3jxo37rDnIoaSkxIYNG2jXrh2rVq1i3bp1zJkzh3nz5nHlyhXU1dWZNGkSkNs8amFhwaJFi6hatarAHAglM8plMhmtWrXi+vXr3L9/H1tbW+FeN2nSpFiaIzKZjMDAQHbv3i3Q1uadi5WuOl57dlGpSVsUlZURl2JJiYjcHpk6hlpCRiYvxGIxoaGhaGlp4ePjw/v37wkNDaVcuXJYWFggkUjIysoqUNTtU3B1deXnn3/m1u3bDBw3EeuQMJ5K1JDGJec7R3kDbkGuXKZESlhiGqGJkB3yClNVMfbVrHj58iVXrlyhRYsWHwmtNm3alMDAQE6fPo27u3ux77dMJiMpKYmtW7eSlJRE5cqVad26NRcuXODWrVvUqFGjRNSnZ8+eFaiJ5dmGkiA7OxtFRUVevXrFyJEjefPmDevWrePly5dUqFCB6dOn8/vvvzN8+PB8fXgKCgqULVs2XzlWUQxrpY28x5FKpYjFYjw8PMjIyGDDhg3ExcUJBCrPnj3Dzs4OTU1NgSre09OTS5cu0aJFCzp06EB2djazZ8+mXbt2TJ8+nbVr11KvXj2ePHnClStXuHjxotB3VFKoqanRoEEDYZ7fCkpKSlSvXp3q1auTkZFBcHAwQUFBnDp1ilOnTlGpUiVsbW1JSUn5n3NmzM3NP3KI3dzcCi2lsrKy4syZM4WOV8+uNu3GFlziaVm9Bgt2Hy7wb73GTvrod+sv3hb+bVTRgllbPAvcN+9283YdLHAbuTOT91zziv/m1Z7R1dXF398/3/5y4o3isnH+aBDJ/o1SoMVAWFgYFhYWhIaGFsswPvE8+psKZ34KKgpiOlh92x6RhIQE1q1bR/Xq1Yut4Pyl8Pf35+TJk0ilUqytrenZs+d3ZaWRyWTY29tTpUoV1q5di5aWFp06dcLf3x93d3f69+/PypUrqVWrFgYGBkyYMIFnz56hrq7O9evXadKkCaampvj5+WFsbIyfnx+pqam0atVKOEZOTg5btmxh9uzZKCgo0KlTJ8FRKilev37N8OHDadKkCVlZWYwZM4aVK1eyd+9eNm/ejJaWFpMmTaJTp05ChkLO3rJt2zZMTU1xc3Pj999/p2vXrl907XJycvLpEMXFxbF69Wo6dOhAvXr1iIyMpFGjRpw9exYrKytEIhGZmZk4OjrSuHFjpkyZgqmpKQ8fPqRmzZpfNBc5nj59KvS7bN26lQEDBpCQkMD8+fN58OABvXr1YujQocTGxjJ37lycnZ1xdnYu1hrMa9AkJSWRnJyMrq4uUqkUJycn4uLiWLRoEZUrV0ZLSwsnJye6dOnyUTAlL3JycgRHVVlZWTBQPzQs79y5w+17AahVskHbzBKpRPJFTo2IXOfASEMFu/L5e2TkkEgkKCgosGTJEo4ePcrSpUs/YrJzd3enevXqzJw5U9i+sHE+hFQqZcIvUzCo7UjV+g0L3a64kMmkiERiUqLCibhzjQrGhnh4eBRopAcHB+Pl5UXPnj2pVq1aiY4TEBCAiYkJBga5zERJSUls3rwZTU1NBgwYUKwoqFxL5vfff6dGjRq0bduW169fY2JiUiLHYvXq1cycOZNly5ZhbW3NyZMnOXbsGBs2bCA6OppBgwbl6xmLi4tj7NixxMXFcerUKW7fvs3Ro0dJTk6mefPmdOnSpUTXorRw5swZ3rx5w8aNG2nRogVLlixBKpWyevVqDh06hLe3N+XLl+fy5cskJCTg6urK3r17WbRoEUuXLsXZ2RmAe/fu0bx5c65fv86vv/7KsWPHaNq0KZcvXxbeV3ITqaRBi29ZtVAYUlNTefz4MYGBgbx+/RqRSISGhgZOTk5Urlz5HxmB/54wNzdnzpw56Dd2/lfZgydOnODMmTOcPn2a4ODgfwTz34f4n8/MFBfGGqqEJab9EGrbInLn8y0hlUrx8fGhTJkyAlPR10RGRoZQ/6ykpISbm9tHEdPvAZFIxK5duxg0aBBr1qxh/Pjx2NraUqlSJTIyMli5ciXly5dHKpUSFxeHkpISL1++REFBgbVr1zJu3DhevHjB48ePMTY2FhTk4W9jX27Er1ixAhcXl88Srnr37h1OTk54enpy9+5dzpw5w9WrV9HT02Ps2LFERUXx22+/cebMGerXr8+OHTto3Lgx9evX5+nTp1SuXBlLS0tsbGy4ceOGYIh9CeSOzKxZs0hJSaFGjRr89NNPAoHEy5cvSU1NpUKFCoKYnoqKCgsWLKBz5844OTlhamr6RY7MhxHTKlWqcPv2bXx9fRk0aBC6urqCY7do0SJWrlyJt7c3L168wMPDo0R0lXJjRl6Sd/fuXRo0aED9+vW5du0aAwYMYNq0aSQnJ6Ojo4OJiYngyBRkDMlkMhITE0lISGDPnj00a9ZM6Fn7cPv69etTv359ZDIZkSmZPI6JJzkHcl2S4htZcidGR1WJyroaGGuoFGqk5WUc8/PzY+rUqfz000/06NFD2CY2NvaTDsj+/fsFBfe8x4pMzaTl8Ink/L8R8aVNzHKCFnVDE6ycuhF515djx47h6Oj40Xq3tramcuXK3L59G2tr62J/7GUyWb56e8hlmPTw8ODEiRPCNkUZvsePH6dLly4sX74ca2trOnbsiIqKCgcPHqRmzZo0b9682JmAsWPHoq+vz7x581BVVaVixYpMnz6dRo0acevWLSpWrMiDBw+oVasW7969Y/v27Rw6dIjHjx+zatUqfHx80NHRoUqVKgwcOBA/P78CSyO/JpKTk1m6dCkPHjzA1dVVyJ4CdOrUiX379lGrVi3s7e25fv26kPGV6/DkDQqZmpoya9YsatSoQbNmzbhx4wZPnjzh7NmzQt+A/N6UxHn+ERwZyO2NkL8LEhMT2bp1K9nZ2ezfvx9lZWWqVq2Kra0tlpaW/9OkACXFv80eXLZsGSEhIXh5ef0jHRn4z5kpNiy1yxCamPa9pwHkGheWOmW+6TH9/Px49eoVAwYM+OolbY8ePeLIkSNIJBIqVaqEm5tbvoj+90bVqlWZNGkSY8aMoVGjRoSHh9OtWzfU1NSYMmUKb9++ZdWqVTg4OHDq1ClcXFyIiYmhW7dujBs37qNMoNyYkZ+jgoICP/300xfNUU9Pj7S0NDZs2MDq1asZMGAAZcvm9lKUL1+erl27MmrUKC5dusTMmTOJiIjA2dmZWrVqcfPmTfr374+1tTUKCgpf5MjkNbJevnxJ586d0dLSokKFCjx79gxNTU26d+8O5Dpg5cuXzxcJXb16NcOGDeP06dO0bt36i65J3rns3LmT+/fvo6CgwPTp06lRowZRUVF069aN69evY29vz4wZM2jYsCG+vr64urqWSPxTPv9Dhw4xf/58du/ejZWVFWPGjOHgwYNMmDCB7du38/jxY96/f4+SkhJ169YFis5M7Nmzh59++okrV66wb98+rly5UmTDuEgkwkRTFRNNIxIzsnmZkEZkSoYQVSxoL/kHWkEmIet9NPpiCU3s6xZb8+TNmzfMmTMHDQ0NJkyYQHR0NMOHD0dJSYnU1FRhHRYEiURCVFQUoaGh+fRdnsWl8Cg2WX5Sn5xDSSASiVFQVsGsYStigu6xbt06LC0tcXR0FDKEIpGIrl27lrg8rrDrZWhoSL9+/QQtqsJw9OhRunXrxqpVq6hQoQLOzs706dOHmjVrkp6eTrt27bh48WKJtJzc3NxwcXEhISGB8uXLC++dunXrYmNjQ+vWrXFzc+PcuXPIZDK2bNlCbGwsP//8M5UrV2bLli1YWlrSsmVLFixYQEJCQolFRb8EmpqanD9/nhcvXmBkZESZMmWQyWSIxWIsLCy4efMmR48eJTAwkHHjxlGrVi0gtwSybNmyQomuRCLBwMCASZMmCfTP/fv3Z9myZaSlpQlOjUQi4aeffvqhvkGfAy0tLRQVFbG1taVOnTo8evSIwMBAHj58iJqaGtWrV6dGjRpCMOk/fAx52VZiRva/yh68dOlS6UzmO+Kf/XR+AQqqoywKWqpK6KoqEZfx9RhdigMRuVFSLZVvlx6Ojo7m4sWLNGjQgIoVK356h89EVlYWe/fu5dWrVygqKtKjR48iNTa+BWQymfChzIuuXbty+PBhzp07x82bN3F0dGT06NHcu3ePGTNmcODAAXr16sXevXsJCAigbt26+XqM8pZcfa0Px+rVq3F2diYkJIRy5cpx8OBBqlWrJhjOrVq1YtGiRZw7d449e/Zw/fp17ty5w4oVKwQD4HOQ1xnJe918fX0pU6YMly9fRlFRkdjYWKGhG3JLWjIzM1FVVeXGjRuCsde1a9cvdmTgb7atyZMns3XrVlq1akXFihXJzs5GRUWFuXPnEhUVRZs2bQgICEBZWZnmzZvn648pLuTX4MSJE/z888+4urpy8eJF7t27x6lTpzh37hxPnjxhypQpHzU7FxYhnTdvHhMmTACgX79+LF++nOTk5GILxGqpKmFnqIUdWmTkSEjIyCYxM4dsqRSpLJfqXUksRlNJjJpIio6mBpDbR/Xq1Ss0NDQE2uCi1mx6errgyJQrV46pU6cSGhrK8uXLycjIQENDAyh83cvLHeXI58h8Zeja1KGKdRWCr19i79696Onp0a5dOypVqlTqLFCfKvE5duwYrq6ubNiwgfLly9OpUyemTp3K5MmThWzm6dOn2blzJw0bNizRe0RdXT3f+0gikaCoqMjevXvZtWsXjx49omfPnrRr1w5HR0dq167N6NGjiYuLo379+qxfv54ePXrg5ubG/fv3ad68+Wddgy9BpUp/M4l+mD3p1KkTnTp1yre9kpKSQMIA8PDhQ5SUlLC1tcXX15dXr16xc+dOAGbOnMmdO3dQVVUlISGBlStXsmnTpu+uY/alSE9PR01NjXLlytG8eXOaNWtGdHQ0jx49IigoCH9/fzQ1NbGxsaFGjRoYGRn959gUgP9le/BHxf+sM/M5qKyrwa3I+O86B9n/z+NbIScnh8OHD1OuXDlatmz51Y4THBzMwYMHycnJoUKFCvTu3fuzmoRLCykpKTx48ICAgADq1auHvb39Rw7NhAkTOHz4MC9fvuTq1auMHj2aESNGcP36dRo2bIhMJkNTU1NgSZFIJIKB/y2ifK1atcLOzk5obJ8+fTr9+/fH0tISQ0NDunXrRq9evThy5AidO3emUaNGJYrwfohTp04JtejyD+CZM2f4448/WLNmDdeuXcPY2Fg4d3mE9NGjR5iZmZGVlYWVlRVTp05l6dKlTJw4kd9///0Lr0J++Pn5CcKetra2vH37lri4OPz8/GjdujXr168nLi4OGxsbsrKyOH/+PKampsUeX25Myc8/MzOThIQEEhMT6dmzJ3PnzqVRo0YsX76cNWvWMHz48HzOSEGGg0QiwdPTExMTE0HPJzAwkMTExGI7Mh9CVVEBQw0FDAt5leTVtVFSUhIY64oTAAoPDxfusXy9ubu7k5GRwevXr4ucc15HTiqVEpma+c0cGTneKWrQ3q0vouQ4xGIxRkZGSKXSb94zYWlpybZt21BTU6NHjx78+uuvTJ48WSg7ffLkCYmJiZQvX/6Lj6WgoCCs3b59++bLYoaGhiISiXB1daVVq1Zs3ryZ4cOHM2vWLCpXroz9/yuiHz16VGggzhuk+JaQr5+Cyu4GDRrEwIEDGTp0KOXLl2fJkiXMmTMHgEOHDtG2bVvMzc25ffs2f/zxB56enkK545gxYzh06BDt2rX7qPdPft2uXLnCo0ePGDlyJGKx+IdzAmQyGRkZGfmccpFIhKGhIYaGhrRu3Zrw8HACAwN59OiRIBdga2uLra3tJ0ln/tfwv2gP/sj4z5kpAYw1VDBSV+FtauZ3qZUUAYYaKhhrfBvmMshlwIiNjWXo0KFfxQDPycnBy8uL58+fo6CgQOfOnb+5do0cUqmU58+fc+/ePZ4+fYpYLKZ69eqYmpoWWEdqZ2eHtrY2CxYsICYmhsTERHR0dDh+/HiB43/tmuSCDKj58+fj4uJCSEgIs2fPxtPTkylTpqCoqIidnR3Lly+nTp06X3zcX375hezsbFq0aIGqqipSqZQdO3awZcsWmjVrRqVKlbC0tPyIJUauxVO1alXKly/P6dOnCQ8P58GDB9jaFsyx/yXQ1NREKpXy8uVL3r59y59//klAQADx8fFYWFhw//59jh07xu7duzE0NBSE+ooL+T0eP348bm5uDB06lIULF1KtWjVcXFyErEOLFi3w9PQsVmYlJiaGcePG0bhxY54/f05oaCi+vr5s3boVKFkt/6cglUpJTk4WnKYPUZSBJp9Dly5dhF6wzMxMmjRpws2bN+nTpw/x8fGCuG1RY/n6+mJcwZzAzO/ziboXnUhbC0OB6KC4deQXLlygVatWpWLI2tjYYGZmhqmpKePGjeOXX34RslrPnz9n48aNJCQkFJgtyBs4KS7yrqG8+ykoKBAf/7fRNmTIEBo2bMjixYtRUFBALBbj7OxMYGAgFhYWTJs2DS8vr68a/PoUCjrvNm3acOzYMRYsWIBEIhGCCdu3bycoKIjVq1cDueLAGhoajBw5koMHD7Jq1SrGjx9P48aNWblyJWpqamRnZ3Pnzh0qVKiAqakpmZmZHDx4kMOHDwsisT8aMjMzkclkhbKZiUQiKlSoQIUKFXByciI0NJTAwEBu3brF1atXKV++vODYfMuywh8V/4v24I+M/1k2s89FRo6Es6Gx5Ei//WVTFItoa6FfIJPQ18Dr16/Zvn07LVu2pHHjxqU+/osXL/D29iYrKwsjIyP69ev3XQS94uLiCAgI4P79+6SkpGBoaIidnR01atQQXvzyyGxBNKHnzp2jRo0aGBoaCg6FXOjwW0TnUlNTuXfvHo0aNSrwI+7g4ECbNm0wNTVl1KhRPHv2LF+JxpdAfr7R0dGCkSqTyThz5gxTpkwhOzsbf39/1NTUiI6Opnbt2gwdOlRodJc7QIMGDaJ8+fLExMQwcODAUplbQXjx4gUTJkzAz8+P2NhY3NzcaN68Oe3ataNevXosW7aM/v37f9bY8mtx9OhRJk6cyIULFxCJRMydO5dLly4xZMgQhgwZQmZmJuPHjyc2NpYrV64UOl7e6PKjR49YsGABioqKqKmp0aFDB7p06VKqrEnyT8GLFy+wsrL6rP1FIhFbtmyhcuXKNG7cON96TE9PZ+vWrXTv3l1YK4WhX79+dBk3DTS0v6uh4GisU6zrK78/+/fv5/nz51haWpYaPW90dDQaGhpCWdjz58/5888/OXLkCLt376ZJkyZcvnyZvXv3YmFhQbt27YQARXBwMPHx8TRo0OCzj5+cnEzv3r2RyWQsW7aMd+/eERAQQLdu3VBWViYzMxMbGxvWr19Pr169mD9/PpcuXeLgwYNCOdz3xoeMZHmzK+PGjePmzZvcvn2byMhIqlSpwtmzZylTpgxLlizh1KlTQC5ZiJ+fH5cvX2batGkkJCQQGRnJ4MGD6dy5M2PHjmXSpEkMHDiwVAMMpYX4+Hj+/PNP+vbtWyJtsJycHJ4/f05gYCAhISHk5ORgamqKra0tNjY2goP9v4j/JXvwR8d/mZkSQlVRgTqGWtyOTPjmx65jWDAl6tdAZmYmPj4+mJqa0rBhw1IdWyqVcvDgQR4/foxYLKZ9+/bUr1+/VI/xKWRnZ/P48WMCAgJ49eoVKioq1KhRgzp16mBkZJRv23fv3hEYGEizZs3y/V5uqOQVLJV/LL/FhywlJYUbN25w9+5dRCIRlpaWGBsbf2R8zZkzhw4dOvDixQtGjRpVYn2KoiA3YA0MDMjJyeG3335DW1ub0aNHc/fuXRYtWsSdO3do2rQpenp6rFixgt69e2NkZIS9vT1xcXHExMR8M+HXSpUqsWLFCsLDwzEyMhJ0dlJSUqhUqVKJSso+hEgk4syZM6xZs4ZmzZpRoUIFABYuXMiiRYs4deoUCxYsoHLlykgkEq5duwYUnlmRyWQMHz6cUaNGUatWLby8vIiPj/+qBuKJEyc+WuefM0ZSUhKOjo60atWKatWqUb58edTU1D5JovDu3Tvc3NzQNbdCpqH9RfP4EsiAqJRMIlMyMdEsPMCSmprKnDlzWLVqFZqamjRp0oRTp04xevRoxGJxqTg0eR2/4OBg1q9fz5EjR9i7dy9WVlYMHTqUCxcuYGhoSGxsLPPnzyc4OBgFBQXmz59PeHg4O3bsyEeoUBJoamqyZ88eunTpQocOHUhMTKRp06a0bdsWIyMjdHR0sLCwYM2aNfTq1QtnZ2fmzp1LXFzcD+PM5O2p+bDMt0aNGqxevZoTJ04ImYnY2Fg6d+7Mvn37CAoKwsfHB0VFRe7evcvQoUNp2bIlo0ePRklJiRkzZrB3717EYrEQiPmwXPJHYIhKT08HKLHOjKKiIlWrVqVq1apkZmYSEhJCYGAgZ8+e5cyZM1hYWGBra0u1atW+SzDye+J/xR78J+C/zMxn4nlcKg9jk77Z8Wrqf6y2/TVx7NgxHj16xIgRI0rV+H39+jWenp5kZGRgYGBA3759v1lkRyaTERUVxb179wgMDCQzMxNzc3Ps7OyExvgPERwczOHDh9HV1WXYsGFF0tJ+qxrplJQUrl+/zt27d1FQUMDe3p4GDRoU+ZGaPXs248ePL1Xj4sPa8fT0dAYPHsz79+9ZsWIFurq6jBw5kpycHA4dOiT0QC1fvhxvb2+SkpKIjY1l+vTpQmP718SH9+jx48ccOXKEypUrs2PHDkJDQ7l+/XqhJVbFwfnz53FyckJVVZUzZ87g4OAgaFU8efKEiIgINDQ0qFSpkuAAFla+GR4ezpgxYzh27BiDBw9m3rx5LFy4kDFjxgjaOKWJU6dOCbpEX4KoqCiOHj3Kvn37iIyMpF69enTq1IlmzZqho6NTJBuiv78/8+fPZ/iS1aSLvm+sTd5c27yiXoF/P3DggLBulyxZQsuWLYmJiWH48OHUqlWL9evXl6ohm5mZydSpU9m2bRv79++nTZs2DB48mIiICAYMGCCIAE6aNInU1FSysrKIioqiV69en51thPzO9oMHDyhTpgyVKlVCLBYzYMAA5s+fT2RkJIMGDaJr166MHj2aW7duFalFdvHiRaysrDAzM/shekvi4uIA0NHRwdnZmdq1a7NkyRKys7M5cuQIZmZmWFpaClTtz549E/bt1q0bhw8fZuPGjQwZMqTAe/4jZGpevnzJrl27GDduXKmUiaWnpwsaNmFhYSgoKGBlZYWtrS1VqlT5rj2v3xr/dnvwn4D/nJkvwLdawDUNymKl8+0W7tOnT/H09KRjx44CXeyXQiqVcvToUR48eIBIJKJVq1Zf1GxeEqSnp/Pw4UMCAgKIjo5GU1OT2rVrU7t27UIdNalUyqVLl/D19aVq1aq4urp+dUrqTyE5OZnr16/j7++PgoICDg4OODo6fldF57i4OObPn4+enh6Ojo5UqFCB8ePHY25uzqpVqzh58iRLliyhc+fOTJkyRdgvKSmJZ8+eUbFiRfT0CjYWvzbOnj3L6tWriYqKomLFiuzbtw8lJaXPdkzl+8XExNC6dWuSk5PZsmULjRs3LtGHPe/xk5OTOXXqFL/++ithYWGYmpry8uXLEs+tOMdctmwZdnZ2pcIcJ8fbt29Zt24dGzZsICsrCzc3NwYNGkSdOnUKNPKzs7NJypJw5U1uj8YjP1909MtjWunzNKa6VTVm7o4D2Do0ZERLe3qOmUjLrr1KNEYrc718bEEZGRm0bduWGzduMHHiRH799dd8WlB//fUXq1ev5tatW6XeW3D//n3evXtH69atuXDhAoMGDeL3338XGtUh15nZu3cvdevWxcPDA3d3d+DLMgQFGeO3b9/GycmJq1evUqVKFZYsWcL69eu5cuVKoZpgMpkMb29vfvnlF/766y/at2//XY18mUyGVCrNN4dDhw4xbNgwKlasiLq6Onfu3MHLy4umTZtSt25dxo4dy/jx45HJZGRlZTFt2jTOnj3Lw4cPP7q+MpmM9+/fExER8UUMkaWBoKAgDhw4wJQpU0o9g5KcnExQUBCBgYGCNpy1tTW2trZYWVl9d0fuW+Dfag/+U/BfmdkXwEpXHVUlMffeJiKRykq1tlsEKIhF1DHUwlTz2xmrqampHD16lCpVqnxxY7gcUVFR7N69m7S0NHR1denXr98XRb+LA5lMRmhoKAEBATx58gSZTIa1tTWtWrUSooqFIS0tjUOHDvHy5UvB6fqe0cOkpCTBiVFUVKRRo0Y4ODh8VycG4Nq1a7i6ulK/fn00NDQ4dOgQR44cwcnJiQMHDrB371769u3LnTt3OHLkCC1btqR+/frk5ORQtmzZEjnKn3IwPscBadu2Lc2aNSM1NVVwar/E4BOJROTk5GBgYMDDhw/p2bMnLi4urFy5kt69exeL4SknJ4f09HTBONbU1KRnz560bt2aZ8+eCSWQRWV0PgdRUVGkpaWVmjBtZmYmL1++JCEhAXNzc/r06cP+/fs5e/Ysu3fvpnbt2mzYsIFq1arl209JSYnX79MEsc45A3oyd8eBz3Zm8uK3A6dQLSHLlgh4GZ+GneHf7ytVVVXhvn74jrx27Rrbt2/H0dHxqzRJy8lRpFIpXl5eVKxYMZ8jk5CQQO3atZFKpbRt2xYnJydSU1NRV1f/ondYQcaotbU1VatW5dixY0ybNg1XV1c2btzI8+fPC11HI0eOxNvbm+nTp9OxY8fvnpURiUQfnVvXrl3p1KkTa9asQVVVlcWLF9OoUSNCQkKIjIwUdLFEIhFv3rzBz8+PPn36FFhWKBKJCA4OJjg4+Ls7M+np6YhEoq8SlNPU1MTR0RFHR0fi4uIIDAwU/lNVVaVatWrUqFGDihUr/hAldyVBUTT2WiqKaKsqoaqo8K+0B/9J+M+Z+UKYaqqhp6ZMwNtEolIzhY/w50K+v6GGCnblv21NpEwm48SJE0ilUlxcXL74QyOVSjl9+jR37txBJBLRtGnTErNDlRSJiYncv3+f+/fvk5CQgJ6eHi1btqRmzZrFKmeLiorCy8uLrKws+vTpU6JGydJGUlISvr6+3Lt3DyUlJZo0aYKDg8M3q0vO6yAUZOQfPHiQHj16sH79eiC3jMHU1JRhw4bx8OFDvL29cXR0ZPDgwdy9e5cZM2Zw9uzZEhvhn3JU8kaN8xIvFFXaIR9TWVlZ+LiXRkmQoqKi4Gh4e3vz22+/MXr0aG7cuMHKlSuLdOKlUilpaWm4uLgwdepUgeYaQFdXFwcHh3zHKU08f/4cFRWVL+oZkmPTpk3cu3ePly9f8vjxY7S0tHBxceHo0aPUqlULqVRK//796dKlC8HBwR/tH5mS8VWa/rV0S05jLSN3Pnbk3jf5Gpk8eXK+7V68eMGJEye4desWOjo6DBs2LP84pVyGKhaLqVixolAeJYempiZubm6CNtLmzZs5ePAg27dv/yTpQkmhpaXF5MmT6d+/P9euXSM4OJjq1asXyc538+ZNkpOTOXbsGD/99JOQsfyWZbqfglxzZ9y4ccLvZDIZWlpa2NjYcOrUKYYOHUpCQgIHDx4kNjZWEDnO+/6Qn5Oenh4RERFERkZibGz8zc9HjvT0dFRVVb/6ddbV1aVp06Y0bdqUmJgYQZwzICAADQ0NQZzTxMTkh7nnH6KkAsMqCmKMNVSx1C5DWwv9f4U9+E/Df85MKUBVUQFHEx0iUzJ5FpdCXEZ2iRexfHsdVSUq62pgrKHyzR/0hw8f8uTJE3r27PnFfSyxsbHs2rVLoHnt27fvZ2tifAo5OTmEhIQQEBDAixcvUFJSwsbGhjp16mBqalrs63j//n1OnDiBvr4+AwYM+G70k4mJifj6+hIQEICSkhJNmzbF3t7+mzZXxsXFIRKJ0NHR+UibAHKNulu3buXLrsgFVSMjI3F1dWXdunWsXbuWFStWMHLkyBJrT3zIQFTYNnKHZcGCBTx//hw9PT0WLlyIiopKoRmMD52dzMzMUotYKioqCmNPmTKFmjVrMnbs2E86IGKxmJycHGxsbOjYsSM9e/Zk2bJlmJiYlMq8ioK9vT1mZmZfXA4ikUhYsWKFwKq1du3aj5jzxGIxHTt25Pr168Lv/vzzT5YvX050dDSmVtYMnD6XVZPHAjC7f3d6jp6AvokZ3n8tZ/3F28J+s/p2w8a+Ab3GTgLAe80KTu3Zhkwqpc+kGfmOm7fMTCaTcWDdSs547iQzI51qde0ZOmsR+sa5ztz1k0fY9+dSYiMjKG9WgeW/LaFnt64fObtJSUlcunSJ06dPExoaikQiwcTEhOvXr/Pbb7/h4eFBjx49UFBQKPVG8GbNmnHw4EGSkpJQV1dHQUHho8bzZs2acfPmza9WytmlSxcaNmzI1q1b6dGjB/Xq1aNGjRr5tpEb9ePHj0dRUZETJ04QHh5Oamqq4MzIs5rfQn/rU1BQUPjo3SPXY2nRogXz5s0jNjaW69evc/XqVX755RfKlClT4P0NDg7G1NQULS0t7ty5U2Qf0ddGRkbGN8/mGxgY0KpVK1q2bElERASBgYEEBQVx+/ZttLW1Barn0na0PwcymYzIlEyexqUQX4ANV5Q9lymREpaYRmhiGrqqSlTWUcesrBrP41P/sfbgPw3/9cx8BXyJV6+l+n2UXBMTE1m3bp3QH/IlOHfuHDdu3ADA0dHxq6kmx8TEcO/ePR4+fEh6ejqmpqbY2dlhY2NTIsM0JyeH06dP4+/vj52dHe3bt/8uH9XExESuXbvG/fv3UVZWpkGDBtjb23/zXp3s7GxcXV0JDQ3l8ePHQK5wntwwbdu2LZaWlnh4eKCjo8O8efMERzUhIQETExPu3r3L+fPn2bx5M+vXr/8iatjCkNcZGTFiBMePH8fR0ZGAgAC0tLS4d+/eR9vJkddwmj59OvPnzy/1um6ZTIZMJkMsFpOdnY2SklKRBu2pU6cQi8XUrl2bsLAwxowZw4sXLxg3bhyzZs366h+zLzG2MzIyBIP99evX+cqMCqMplx8vICAAR0dHDh06hIG5FfOWLsf35BGWHz7H4Ma1mPznZmo1asbNM8eLdGbOeu1mz4pFjF2yinKGRmyaO42Q+/4F9syc3LWFU3u3M3zOb2jr63N063qe+N/mj6MXSU1KZFjzugyf+zu2Do24efoY3quXEhER8VGP3aZNm1i1ahUVKlRAU1OTzMxMHj9+TIMGDTA2NubixYvY2tqyZcuWr8JqJZFIgMLZEwuilM977QtDcQIJ8uMX9dzIHZnTp08zdOhQZs+ezZAhQ4DcnrVXr16RmJjIpEmT8m3/I2P79u1cvnyZtLQ0zp8/z6tXr/L1TAFCP83KlSuRSCQYGhoSGRnJhAkTvpugqFzUVH79vxekUimvXr3i0aNHPHnyhIyMDPT19QXHpjQJh4qLjByJkE35UsgdESN1FewMtcjMkf7j7MF/Ir5/GORfCC1VJewMtbBDq9j1lt8aOTk5AALTko+PD6qqqjg5OX32mPHx8ezcuZOEhAQ0NDTo06dPqUdcMjMzhZR1REQEZcqUoXbt2tjZ2X2WQnFSUhLe3t68ffu2VAkPSoKEhATBiVFRUaF58+bUr1//uxEOKCkpMWvWLJycnNiwYQMtW7bExsaGxo0bs3nzZs6dO8eqVavo0qULs2fP5vLly3Tr1k3Y19jYmJiYGPr27Uvjxo2xs7P7KvOUG1FXr14lMTGRK1euUKlSJUJCQnB1daVNmzacO3cun7o5/O3ISKVS3N3d2bRp02cZmZ8yvORGZFZWFsrKymRkZAB8lOWSSCT4+voya9Ys0tPTcXBwYPz48dy5c4fFixdz7NgxZs+eXeL5lRSfa2i/f/+etm3bYmhoSJkyZQTGPA0NDcqWLYuGhgYaGhqoqqpSrlw5XFxc8h0vLCwMkUhExYoVUTI0wWPcFOo2b42m9v+Po6WNmvqnG17P799Dx/5Dqdcil+J75ILljO/YvMBtfbasZeisxdg65NLOD5/7O0Oa1Cbg2iXKGRqRk51NOUMjDExM6TxoBE3t6+a7b/J737RpU96+fcuQIUOYNGkSmpqa6Ovrk5yczOLFi/H396d169ZMnjz5qzDQfcoBz3tPExISGDhwIOvWrcPQ0LDI/UQikeAIfer4RT0HIpGIhIQExo0bR9euXXF3dyc8PJxVq1Zx8OBBGjRowOPHj1m/fj1nz579rmW9n4LcARwwYAADBgwQtL3kQrwf9sqoqKgwZswYbt26xa1bt5BIJOzdu5fu3bt/l6x/enr6d++zhNw1aWFhgYWFhSAZEBgYiK+vL5cuXcLExAQbGxtsbW0/chK/Bt4kpwt9LqUB+ShvUzM5GxpLHUOtH94e/DfgP2fmK0NVUQFDDQUMfzBdqaNH/4+9s46qYov3+OfQLSAIigGCoIIBKogJtqLY2IHdXVcxr3XtxO7u7gBERUEFW1JUGgGRrnPeH7wzVxSVMu57ftdyLTlnZs+ePfvs2b/6fs8SHBxM586diY2NJTQ0tFiilR4eHnh4eCCRSLCyssLBwaHEvJASiYR3797h6+vL8+fPyc7OxsTEBCcnJ0xNTYvsUQ8NDeX48ePIysri7Oz8U9J5PsWnRoySkhL29vZYW1v/UkpL6Ua/bt26zJgxg7FjxzJs2DA2btzI0KFDuXTpEuvWrWPVqlWsWrWK8+fPs2XLFiIiIujduzd79uxBSUmJypUro6mp+cMMGSn27dvHgAED0NLSYsaMGUCuuN3evXvp2LEjffr04cCBA4JBA7kGfHx8PG3btuXYsWOoq6sXyBtcFK9xTk6O8DxbtWrFokWLaNy4sfB9VlYWmZmZNG3aFB8fH86ePcu8efMYNGgQ165d46+//hK81r9LGs7nkNKDSzeuYWFhpKSkkJqaSmpqKmlpaaSnp/PhwwcqV65Mhw4d8mz+WrduTY0aNahRowbVatSkZtOWtOjeB9lC3mtYcADdR00U/q5gYppvwX9aSgpxUZGsmjQizxqVmZ5OZGgIde1bUqdpCxYM6kk5I2Osm7dmyJAheTzqIpFIIBWZPXs2mzZt4uLFiwJlb7Vq1bh06RJt27alWrVqfPz482hbvwYp/XhISEgegd+vQUZGRnACfM9gyQ/ScwYPHkz58uUF7Z1169axa9cu+vfvz+rVqwEYMGAAu3fvFsR0f0dI54p0TKysrAQCiK+961RVVWnWrBkNGjRg9+7dREREsHbtWmrVqkWjRo1+KpNjenr6TzEOCgNZWVlMTU0xNTUlMzOTgIAAnj17xo0bN7h69SqGhoaChs2PiGgFxifzNDapxNuFXKMmWyzBO+ID6briXIKA33Q/+H8Bv9+b8Q9+CsLCwkhNTeXAgQMA1KtXr0iiah8/fmTv3r3ExcWhrKxMnz59SswoSE5O5vHjx/j6+hIXF4empiaNGjWidu3aaGhoFLldiUTCvXv3uHbtGpUqVaJbt26CuvbPQEJCAp6enjx+/BglJSWB5etX8/JLC18hl9Wud+/evHz5EldXV9zc3ABo27Yt/v7+nDx5kpMnT7Ju3TrWrFnD3Llz2b17N2FhYWzbto0KFSr8kD5+7gHt168f4eHhLFu2DG9vb0xMTFBVVaVOnTrs37+fbt26MXToULZt24ZIJEJGRoagoCBatmzJiRMniqRzce7cOdzc3NDV1WXYsGFCit3nffu0nqdbt26kpqbmEYeVpqJkZGSgoqKCSCTC0dGRli1bYmxszMGDBxk1apSgf/Q7GjIAmpqabNq0qVDnfDpOKioq3L9/Hw8PD3YeOcGVk0e4cngvy05cznNOfs8pJyf7s0/yeldl5b5M0xD/7zlT1mylnFHeeh61UpqIRCJmbtlL4BNffG5e5f61i1w9tJc7tz0FNrHP+xMQEEC3bt2EzemkSZMYOXIkLi4uREdHF6rw+1PDoST1ScaOHUubNm0wMzPL0/9vXUNWVpbAwEBMTEwKbcyLRCISEhKIj4+nfv36mJqa4u7uzp07d2jdujUHDhwgOjqagwcPUqtWLa5cuZJvO9IUzd8F0rEqTNqgkpISDg4O7Ny5EysrKwIDA3n8+DHVq1enUaNGXwg1/wikpaUVKXvhZ0FBQUFINUtPT+fly5c8e/aMCxcucPHiRYyNjbGwsMDMzKxEshZ+pCHzOaSUzX+0YX4cfs+34x/8UIjFYhITE/N8FhgYSFhYWKHYjLy8vLh+/TpisZgaNWrQqVOnYkdjxGIxgYGB+Pr6EhAQgIyMDNWrV8fBwQFDQ8Ni51NnZmZy9uxZnj9/ToMGDWjevPlPo4qMj48XjBgVFRWaN29O3bp1f5oRExgY+E3qXVlZWZ48ecKwYcOQk5MjKyuLJUuWcPr0aQIDAwVl+AEDBvD06VP27NlD9erVmTt3Lv369SM2Npa6dev+ME0Baf1JQEAAQUFBREZG0r9/f2bMmEFkZCRr166lbNmytG7dGnl5eZo2bcq6devYuHGjUODv6elJu3btOH36NJaWlgWeT9KNy4ULFxgwYAC2trbo6urmESH9muL7ggUL8PHxwdPT84vI54gRIxgyZAhNmzYlKysLkUiEsrIyTZs25c2bN8UftJ+E7OxsIVoRHByMh4cHGRkZaGtrC0QSKSkpZGVlCbonUnh5eXHz5k1mzZqFrkUdOoyegnPDWrx66J3nODl5edJSUoS/JRIJMWHvhL8rVqlK0NPH1GuWW6MXE/aOlI951zkAVY1SlCqtQ8L7GOrY5WrqZGVmsnrySDoOGolqqVLcOHaQAdPnUqWmJb3HT2Nqx2ZcuXIljzEj7YNIJKJGjRq4uLgQGxuLtrY2Y8eO5fr164wbN44lS5YUal2Vzsk3b96wYMECFi5cWCKbXZFIhJmZGWfOnOHp06eoqqrSs2dPypYt+02DpkqVKuzcuZN+/foV2qjQ0tLC3t6e/fv3M3fuXJ4+fUpsbCx3797l7du39O7dGxMTExo0aICOjo4QfYyNjSUzMxMDAwPhmqtWrcLU1JT27dsXeyxKAoV9b5QvXx59fX2SkpIYN24cjx8/5s6dO2zdupUqVarQuHHjH+YEgt8nzawgUFJSwtLSEktLS5KTkwVxzlOnTiEnJ4epqSkWFhZUqVLlCydPREQE7u7udOjQ4auRqLCktJ9myEjxJPYjSvIyf6iVfxD+GDP/D/Hx40fEYnGezz58+MDOnTsZN27cd/N5U1NT2bt3L9HR0SgqKtKzZ08MDQ2L1ae4uDh8fX15/PgxycnJ6Ovr06ZNG2rUqFFiC3BcXBxHjhzhw4cPdOvWDXNz8xJp93uIj4/n1q1bPHnyBBUVFVq2bEndunV/qrfxypUrjB07locPH6KmppbvJt7Ly4uuXbvSrVs37OzsePfuHVWrVmXy5MmMHz8eJycnNDQ00NLSon///ixatIh//vmHbdu2Ubly5R+e7y4SiTh37hzOzs7UrVuXgIAA9u3bR69evVi7di1dunRh0aJFqKmp0bRpU2RlZfPQ1GZmZnLt2jV2795N8+bNC3VtGRkZPn78yOTJk5kzZw4TJkzg3bt3HD16lJMnT6KsrMyiRYuETat0c3jhwgVWrFjB6dOnqVixYp42MzIySEhIoGfPnhw6dAg7Ozuhn0+ePKF+/frAjymKjo6OJicnp8SoYqUbinfv3jF16lRu376NgoICMTEx6OnpER0dDUDfvn3p1atXns2zsrIy8+fPR09Pj/I163L7pgfpqSlUMquOkooKbwNfYVTdAmOLWiQnJnBx3w6s7Fpwaf9OkhM/CH1o23cQ2+b/hWFVcwyMjNm5eM5XN5wdBg7j0Jp/KKWtg0FlE45vWsOrRz6MWriSrMxMrhzei6pGKRp36EJYoD8R797mmzIpfS6DBg3i4MGDtG/fnpycHCZMmMCqVat4+fIlPXv25PHjx6ipqaGnp4eamtpXn+ndu3cpW7YsRkZGBAYG4u/vj4+PD46OjgWeB4mJiZQqVSrfOo6cnBwaNGjA1q1byczMZNmyZfj4+HzX2Bo0aFCevwszJ+fMmUPv3r1RUlIiNTVVqKOsWLEibm5urFy5kpkzZ3L06FHCwsJYv349J0+eRElJCWtra/bs2YOfnx+LFi1i3LhxtGjR4qcyO5YURCIR9erV49y5cyQlJVGnTh0sLS2FepGdO3diaGhI48aNMTIyKvHf/H/JmPkUampqWFtbY21tzYcPHwT9mqNHj6KoqEi1atWwsLDAyMgIGRkZvLy8CAwMZPfu3Tg7O3/BzJqencOjqC+dHD8Dj6IS0VFW+FMX8wPwx5j5D6OoxWSfaxNI02/q16//XTHLhw8fcvHiRcRiMWZmZjg5ORU5spGVlcWLFy/w9fXlzZs3KCkpUaNGDSwtLUs87O7v78+pU6dQU1Nj6NChPyXcHhcXh6enJ0+ePEFVVZVWrVpRp06dn2rESDc0Dx48ICsr65s50/fu3cPCwoJ169YB8PLlSxITE7G2tqZevXr07NmTixcvArm0sLdv30ZLS+unpT+FhYXh4uLCvHnzGDNmDB8/fkRTU1PIWz927Bht27YVmMkaN24s9E0ikaCgoICLi0uRI2ESiQRDQ0M0NTUJCwtjxIgRhISEYGBgQHZ2NvPnz2fLli3k5OTkij++fcuAAQNYuHAhzZo1y9NOVlYWSkpKHDlyhHnz5tG6dWtsbW0xMjLC398feXn5PDoXJQHpXNi5cydz5sxh8uTJTJw4EW9vb27cuIGJiQkdO3Ys0vhI2/b29sbb2xsfHx+CgoL4559/uHHjBjt27GDfvn356nHUrl2bnTt38vfff/P69Wt0DSowftl6yhtXoV3fwexbvpDod29w/ms+A6bN4fjmtRxauwz7Lj2o39pBaKepY1c+xsexY6ELGelpdBk2htBXz/Ptr+OgkaSlpLB57jTSkpMwNq/F7O0HUSulCcDUdTvYv3IhJzavQ6N0aWbOW0CrVq3ybUtqmB05coQbN27g6+uLoqIitWrVIj4+njp16pCZmUlkZCQNGzZkzpw51KlT54saqJycHKpUqULt2rXp06cPqqqq1KtXTyBMKMjmds2aNfzzzz+EhISgrKz8RcRFVlYWHR0dzp49i6ysLH369GHWrFns2rWrQOv4rVu3uH79OvPnz//usfDvvDAxMQGgbt26bNiwgTNnzmBvb8+jR49o3rw5Hz58ICcnhzZt2lCuXDkmTpxI3bp1mTlzJocOHWLVqlV06NChWHWdvwNq1KjBtWvXePDgAS1btkRGRoaaNWtSo0YNXr16haenJ/v27cPAwIDGjRtjampaIkZNTk6OsOb8lyFNNW/UqBGxsbGCYePn54eqqipmZma8fPkSyE3n3rNnD87OzkK9jUQiwbcEi/0LixyxBN/oROqX0/rtWfv+a/hDzfwfQ0nQPt+7dy9PfnLNmjVp1qyZYMhIJBJSUlLyeDTS09PZv38/4eHhyMvL07179yKphUskEiIjI3n06BHPnj0jIyMDIyMjLC0tqVq1aolv9MViMe7u7nh6egq00z+aJez9+/d4enoKqRyNGjXCysrqpxkxYrEYsVicZ6P0/Plz6tSpw4IFC2jfvj1VqlT5oj+HDh2iT58+zJkzh2vXrpGUlMTr169RVVVl/fr1DB06FFdXV3r37g38/IL0Fy9e0LZtW169esXHjx9p1aoV5cuXZ8uWLZw7d44hQ4bw4cMHrK2t+fvvv4WITEkhOTmZXr168erVK968eUOdOnWYPHky3bp1Y/HixTx8+JBjx44Jm0Jzc3MaNGjAtm3bhDYkEgkxMTHY2NhgYGAgMPrUqFGDdevWkZqairW1NQ4ODhgbG5f4GKenp1OxYkVmz56No6Mjr169wsnJCSsrK+Lj43F1daVhw4aFble6ad28eTP79+/n9u3b3Lx5E1dXVxYsWED16tWZOnUqsbGx7N69+6tpTbfv3SdGq2I+V/i1aGdcplDeVIlEwsyZM9myZQs9evSge/fupKSkcPPmTS5cuEBAQMBXz4uJiaFHjx60bt2a6dOnF8jIkEgkTJ48mTVr1lCzZk3mz5+Po6PjN8VjJRIJU6ZMITw8nMOHDwuffW+TNW/ePAYOHFjkaPzq1auZO3cuxsbGxMTE0KtXL1asWEH37t1JTk5m/vz5WFtbAzB//nw2bNiAhYUFf//9N40aNSrSNX8nXLlyhcePHzNx4sQv1mBpmqanpydv376lTJkyNG7cmOrVqxcrHTo5OZmVK1fSs2dPoWbq/wqkewopy6mUNRIQREudnZ1RVlYmPCmd+xEJv7C3ubApp4WB+n/bsPzd8Ccy8x9AiYo5aasRFBQEQIUKFWjXrt0XNJ2enp54eHgwePBgypUrx9OnTzlz5gw5OTkYGxvTs2fPQm+w0tLSePLkCb6+vkRHR6Ouro61tTWWlpZ56g5KEqmpqZw8eZKQkBCaN29Ow4YNf6g35P3799y6dYtnz56hpqZGmzZtsLKy+umF2zIyMsKLLz4+Hg0NDQYNGkRmZibr16+nUqVK+b7Q2rRpw5QpU9i3bx8NGzbExsYGBwcHJkyYgKurK/369aN///706NEDWVnZH3pf+W3ANDQ0MDc35+jRo8ycOZPWrVuzdetWUlJSmD17Ntra2vTo0YNHjx6VyJySbtBDQ0ORlZXFwMCAAwcOcODAAVRUVPLUfgQGBpKZmSmM+7Nnz6hTpw5r167N02Z6ejqzZs1i/vz5xMbG8vTpU1xdXenTpw9bt279QryzpMZYei+XLl1CXV2dsWPHEhsby/z582nRogXr1q1j1qxZrFu3rkjGjBRSrZXg4GDKlCmDjIwMT548oXr16qSnp5Oamgr8q2PyORraWHP6ZRgS2d/n1ZSTkcbrwADMzMwKvKH08fHhypUruLq64uDgIEREbW1tOXv2LG5ubtjb239xnkgkQk9Pj8GDB9OvX7+vjtOnSElJoU+fPri7u7N8+XKUlZXZvHkzy5Yt486dO1+thRGJRPTs2ZPLly/n+Qy+TQowb9483r17x/3797l48SJz584t0LhI5+DEiRPp1KkTT548oXz58lSuXJnXr1/z9u1bxowZk4ceX0lJifT0dAYNGpSHPOO/jLp163Lv3j2eP3/+RQ2WSCTCxMQEExMT3rx5g6enJydOnMDNzY1GjRpRs2bNItUkpqWlAfwn08y+B5FIRLly5ShXrhxxcXEEBgYKvxuJREJsbCyurq6MGjWKwPiU77T24yEil3zgjzFTsvh93hh/kC/yE3MqbChNenxCehb3IxIo36A55rVqY1nD4otjk5KSuHXrFmKxmBMnTqCmpsbbt2+Rk5Oje/fuVK9eveDXlUgICQnB19eXV69eCVSmzZs3x9jY+IcW3kdGRnL06FEyMjLo06fPFyrkJYnY2FjBiNHQ0KBt27ZYWlr+MvapyMhIli9fzuHDhylXrhx9+vRhypQpHD9+nKysLHr06EFqairKysp5jDstLS2WLVvGsmXL8jAIWVlZERoaiouLC6NHj/5hBf5SfBqNePr0KZmZmVStWpVy5cohIyODs7Mzo0ePZv369UDuPKtYsaJgwEhrvoojUijdzLm5uTFu3DjCw8Np3bo1I0eOZOTIkUBuJMvNzY2oqCju3buXR6TTwsKCXbt2fTFWixcvZvz48YJKemBgIDt27GDNmjU0bNjwC/X0koJ0HNLT06lQoQLu7u5s27aNDx8+sHr1agwMDLCyshI89IUdO+mxdnZ2nD59mvnz57N48WL09PTYt28fiYmJ3Lp1SzAAv+ZUCAkJQfzhIzKl9Qu9zv0QSCTIpSZRqqJuocbjwoULKCkp0b59+zwR7oCAAOTk5L4Z1ZZIJEJU8XvOl/DwcBwdHUlKSsLT01OYPx07dqRmzZpcvnz5m9ph9erVw9LSkjVr1hAXF4esrCzjxo1DW1v7mwZNhQoVePr0KYcPH2b+/PlCDea3xkhGRkYQkpXqjEgRGBjIixcvsLKyEq4ZGhrKzp07GTFiBO3atftlulsljdKlS2NsbIyPj88XxsynqFSpEpUqVSIiIgJPT0/Onj2Lu7s7DRo0KHSkXxqt+L9ozEiRkZFBUFCQQBTzaV1wcnIyL4JDiZfX/OK8rMwMpnZtwxCXRYLu1I+EBIhPzyIxI4tSit9/hgMHDgRyxVolEgmbNm1i1KhRP7aT/0H8MWZ+Y/woMaeELPiopINuUtoXzBo3btwQFoH4+Hji4+OpWLEiffr0KXAufWJiIn5+fvj6+pKYmIiOjg7NmjWjVq1aP4UC2c/PjwsXLqCrq8uAAQN+mEBZTEwMt27d4vnz52hoaODg4EDt2rV/mREjTRFxdXXlwYMH7Ny5k1evXrFjxw7Mzc1xdnbGycmJ9PR0FBQUBOalT/srkUjw8fFh3rx5tGvXjuDgYLZt28bOnTvR09MrcRHU/CDtT/PmzUlOTubVq1e0aNGC5s2bc+jQIczNzUlKSuLy5ctYWFiwe/duoqOjhc2RdANYVENGSqkcExNDp06dGD16NLa2tixcuJAZM2YwePBgQRA2NTUVCwsL5s6dS/ny5fNsAD/fCF69epXt27cLmiqQyxS1dOlSrl+/zrlz536YMSNFx44d2bt3Ly1btkRXV5cNGzZgY2ODu7s7e/bsoV+/fkDB6jPyg4GBAbNnz8bLywsNDQ0mTpzI8OHDmTRpEkOHDmXEiBHA18Uez5w5g3bZ8miU/rao40+DSIR97WpoKBTuNx0XF4exsbFgyEiNQz8/P1q3bi3QeeeX1lXQsX/w4AHNmjXD2tqay5cv56kDPH78OAoKCl+QTuQHGRkZwsLCyM7O5tWrV+zevRtfX9/vRjfbtWvHo0ePuH79OrGxsaiqquLo6PjNc6RCsp+jVKlSVKlSJc9vdsqUKVhaWjJgwABhvP6voF69ehw+fJjw8PDvShmUK1eOHj16EBMTw+3bt7ly5Qqenp7Ur1+/wOLK/5cjM5/CyMgIBQUFtLS00NLSQlNTEy0tLUqVKsXT9ymIElPzOEkyM9JZM2U07wL9f2o/RUBIQiqW+t+uUf4ct27dYvTo0X+MmXzwp2bmN8XP4kCvqashcJ9HRUWxZcuWL44ZNGjQdykjs7Oz8ff3x9fXl+DgYOTl5bGwsMDS0pLy5cv/lGK3nJwcLl++zIMHD6hduzYODg4/xLCIjo7m1q1bvHjxglKlSgnaN7+DDsiLFy+oU6cOx44dEyhMnz9/To0aNXj48CGNGjXi3LlzNGvWjIcPH1KzZs0vPHypqanMnDmTwMBAUlNTWbZs2U9N8RCLxfTu3Zvw8HBOnjyJRCKhZ8+evHr1irCwMJ4/f87EiRPx9/dHQ0ODpKQkDh8+TIMGJetVmzx5MhERERw6dAiA6tWro6qqikQioXv37owcOTKP3tG36g1SUlKYNWsW586dE4QD27ZtK3w/bNgwxGIx27dvL9F7yA9ZWVk8ePAAbW1tzMzMmDVrFl5eXri4uGBvby9QLBf3N5uSkoKiomKhfheRkZGULVuWm69j+JCZU6zrFxciQEtJHrtKBRc2lBotr169wtramokTJ1K/fn3k5eVp0SKXBjoqKoqoqCi0tbUpXbo0qqqqX0RBCjL+N27cYOvWrezdu1fY0KalpXHkyBEuX76MjIwMu3btIjU1FTU1NeTl5fONuOXk5JCdnS204eDgQLVq1VixYkWB+uHn58eYMWMwMjJi9+7dRYrcZmVl4eTkxKNHj3BycuLmzZvExsaydevWb0aW/qsQi8WsW7cOQ0NDOnXqVKhz4+PjuXPnDn5+figoKGBtbY2Njc03RSUfP37M6dOnmTVr1m/xnvoVuBAULdQZA7wLCmDNlFFIJPDG/wXz9xz/KZEZKRRlZXAw+b5z8NPIjLu7O/b29gVKP/3/hv+fs/o3x68QczLWUuHUqVP5HnPkyBEmTJiQ7yIYExPDo0ePePLkCWlpaZQvX54OHTpgbm7+U9MCPn78yLFjx4iIiMDBwYE6der8EDpbDw8PXr58iaamJu3bt6d27do/PO2qMEhOTkZeXl7Y2GdnZ2Nubo6FhQVeXl7Y29tz9OhRmjVrRpkyZTh8+DB9+/bNM1YqKiqsWbOG1NTUH6K6/D1kZmYSExPDsmXL0NXVZc6cOTx9+pTjx4/j4eGBsbEx586d4927d8THx2NiYoKOjk6x0so+hXQDl5SURHZ2rsDi4sWLadCgAZs3b2bw4MHMmzePkydPsmTJEoGp7FvzTVVVlWXLltG9e3c2b97MunXruHTpEp06deL169dcvnwZV1dXoHjpcd9DeHg4ERERBAUFUb9+fcRiMXPmzEFRUTHPxrWov5309HROnjyJu7s7kOsJVlBQQFVVlaysLHr27PnN6JOmpiYXLlwgWUYB+cpfpsH+TEiAKtqFk+qWkZEhJyeHqlWrsm7dOq5fv86GDRsYPnw4NjY2LFiwgA0bNtCkSRPevs2lez548CCysrKFHv/mzZvnoRiPi4vjwIEDuLu7k5SUhImJCZMmTeLSpUvUrl2bGTNmYG1tnS/DmUQiISEhAS0tLaytrXn//n2B+1G7dm1cXFyoXr260G5CQgKampoFnkfy8vKcOnWKQ4cOcfnyZfz9/fnnn39o0qRJgc7/r0FGRoa6devi7u5Oq1atCrXOamtr06FDB5o2bcrdu3e5e/cuXl5e1K1blwYNGnxBRQy5Rq68vPx/wpAJDQ3FyMiI8+fPM3r0aN6/f8/gwYMZOnQoAwcO5OXLl9jb23Po0CHGjh2LhoYGr1+/5vr161StWpWNGzcK77+YmBjGjh3LpUuXkFVUolmXnvSeOAORSMRzHy8sbBrSe8J0eluaFKqP62dMAOD1y2ckxEaz6OAZSmmXZvtCF3xuXEFJRZX6rdrRb6oLikq50bADq5Zw89QRUj9+pEpNS4bMWUy6oQ6H9+9j3rx5hIaGCu3b2dlhZ2fHvHnz8oyLtM5OJBLh5uZG5cqVGTJkCHfv3kVFRYUePXqwatWq30pk9mfh95/Z/8/wq8ScHj/0ISYm5ovv5OTkSElJwc/Pj7p16wK5ualS5pDw8HBUVFSoXbs2lpaWv0RhODQ0lOPHjwv1FIURqCsIoqKi8PDw4NWrV2hqatKhQwdq1ar1WxkxUqipqWFqasr169dxcnISUgbt7e05c+YMvXr1EmhVdXV1CQoK4sWLF/lq7vwMQyY/z6+SkhIfP37k+fPn7N27l4sXL3L27Fmsra3p0aMH9erVY/r06ZiamgrnlIQBIG1DLBYjKytLx44d8fPzIzg4mICAAGxtbZGTk8PBwYFHjx7Ro0ePPJTLX8PTp0/x8/MjNjaWrl27snr1ak6cOMHBgwfZuHEjJiYmzJo1S4iklbTXTXpfZ86cYcaMGVSoUAFbW1u6dOmCjIyMkD5aEsZ/YmIikyZNokKFClSsWJGUlBTS0tLIycnh9evX2NraUqNGjXyfl0QiYePGjWRlZdGyVSuyVBWJSsn4JbUzIkBfTZFyaoV3yEjva+DAgQwcOJCkpCQiIiIwMzMjMzMTWVlZtm/fTmpqKt27d2fu3LnMnz+/WNGwkJAQDh06JBiRKioqeHh40LRpU44dO8aBAwdo164dz58/zzdVVE5ODnV1dd6+fcvt27eFmp5P+yQWi7+aJvZp9OT9+/dUqlSJo0eP0rZtWyFt81uQGli9evXC2toac3NzWrdu/cUaJBaLyczM/M9TDANYWlri7u6Or69vkUg3NDQ0aNOmDY0bN+bevXv4+Pjg7e2NpaUlDRs2zJNenZaW9p8bs6VLlwoC17179+bixYu4urqioqKCo6OjEMXevHkzkyZNYvny5WzevJl27doRFBSEjo4OnTp1Qk5OjhOXrnLvdSSrJo1Aq4we7foOok2vAcXq362zx5m2YSdaumUoZ1iZZWOHkJOdxaKDZ8jMSGfHotls/3sWoxet4v61S1w7up/pG3eipavHwTVL2ThzIj3tvAp8vQoVKnDixAm6du1KZGQk2tradO/eHTU1Nfz8/IiJiaFr165Uq1bt/2Ua2h9j5jfCLxNzkkgQ6xtSqvQL6tSqgb6+PlpaWjx9+pRbt24B4Ovri66uLr6+vrx48YLs7GxMTExwcnLC1NT0l2zsJRIJ9+7d49q1a1SqVIlu3bqVaE1OZGQkHh4e+Pv7o6WlhaOjY5HZZH4E8oucSJnKjh8/jpOTEwoKCqSlpfHmzRtUVVVp0qQJb9684fHjx9SqVYs2bdrw8uVLqlev/lN575OTk/OId4aGhqKgoICcnBxlypShTZs2zJs3Dzk5Oby8vARxx6SkJGJjY79or6iGjHRTLSU88Pb2ZtmyZSgoKGBqaoqzszOampocOXKEYcOGAbl6NxYWFgwfPjxPG/nh3r179O3bF4lEQpkyZZg6dSrDhw9n9erVtG3bls2bN/Po0SPOnDlDpUqVaNOmTYnPL+n9bd68mTNnzlClSpU8fS7J566np8ekSZOYNm3ad/v0ObKysjA0NKRVq1ZoaGiQnp3D1dexZP8CTQhZGRGWeqWKNDafn6Ours6KFSto2LAhmzdvxsnJiQULFrBt2zbGjRvHrl27mDFjRrHqGby8vNiyZQtjxowhJSWFly9fYmBgwPXr19m0aRN16tQhODiYs2fPMnTo0HzbkJOTw8DAgL/++ktgO5QyA1aoUCGPtzcpKemrmlUhISGULVsWS0tLZGRkyM7O/q6zQTrnJRIJxsbGX50/IpEIPz8//P396dOnz38i0vA1qKqqYm5uzoMHD7C1tS3yGqaqqiqwdXp7ewtkJDVr1qRhw4bo6OiQnp7+n6uXmT17NjVr1qRmzZpMmDCBXr160bJlSwBatGjBq1evgFwK/KVLlwKwatUqzp49y+HDh2nSpAleXl6EhISQqaFLsk4lhs9bSvr/MioWF8Y1alOvWa72VNTbUHxuXGb3/ReoquemHo9csJwpnVsycMY8YsLfISevgE5ZA3TLlWewyyIiXweRmJFd4OvJysqira0NIDDQhoaGYmVlRaVKlTAxMeHixYs/jB32d8d/dyX4P4ZfKuYkEiGroIBN556CmNPDhw8FQwYgIiKC3bt3o6WlJdSIfFov8LORmZnJuXPnePbsGba2trRo0aLEUnMiIiK4deuWYMR07NiRGjVq/HIjRiKREBUVhb+/P/7+/rx//57p06fneaGrqqoKuhZLliyhV69e+Pj44O/vz6ZNm6hcuTJDhw4V7sXW1van38ewYcPw9PTE19cXJSUl1q9fz8qVKxGJRFSoUIFx48YxcuRIvLy8BIFKPT09nj59SnBwcInqx7Rq1YrBgwfTq1cv4uPjadWqFS1atCAhIYHbt2/j7+/P2LFj6dKli5ACs3LlSo4fPy7Uz3xr3g0YMIBRo0YxcOBAFBQU8PLyYuzYsdja2nLp0iVmzJjB1atXuXLlCpMnT+batWusXLmyxO5PuolMSUnh0qVLwueFncsSiUSIWH0LOTk5tGvXrkh9lZWVpVu3bsLfSnKyWOmXwjviQ5HaKw6s9Et9VVfm9evXREZGFrhGKyoqCm9vb4YMGULp0qVZtmwZ9vb2LFq0iMzMTAwNDYu90ezTpw+ampq0aNGCKlWqMGnSJCZMmEDnzp1p3Lgxnp6eRERE8PHjx2+2Iysri729PaGhoXTo0IHr169TpUoVZGVlefjwITIyMhw6dIjTp0+zYsWKfGsppUXYEydOxNXVlfj4eOTl5TE0NPxu9Ol7xqNIJKJ+/fooKyuzevVqevbs+d16zt8Z9erV48mTJwQFBeWJNBcEb9++5cCBA1hZWdGwYUPU1NRo0qQJ9evX5+HDh9y9exc/Pz/Mzc3JyMj4zxkzlStXFv6vrKycR9dIWVmZjIxchtdPo1oyMjJYWlry8uVL9PT00NbWxsjIiGf/m05v3bzk6q/KGPybARIWHIhYLGZYU6s8x4jFYqLehNLIoROXDuxiVIv6mNaug3XzNrTo1ousTxjXioJp06bh7OzMqVOnaNu2LT169MDS0rJYbf5X8ceY+U0QkZyRh37550NEZHIGEckZfHgbzPnz5784onr16nTr1u2XK9fGxcVx9OhREhIS6NatW74pUkVBREQEHh4eBAQEoK2tTadOnahRo8YPpZD+HrKzs3n9+jX+/v4EBASQlJSEoqIiVapUoUGDBvk+C0dHRxYtWsT58+dZvXo1YrGYGTNmCIZLfiQPPxOzZs3C3t6efv36MWfOHFavXs2KFSuQlZXl5cuX9OjRg2PHjrF69WrmzJlDq1atqFKlCm/fvqVz584C41ZJwNTUlAEDBhAcHEyNGjXo2LEje/bsISUlhbNnz3Lo0CFcXFyQk5MjJyeHly9fsnDhQiF9Jr/xl37+8OFD2rdvj4WFheBRa9myJZcuXaJLly6cOnWKESNG0K1bN+rUqcPx48dL3LiUzl2pIG5RIL0fqSHzLS+7rKwsZmZm7NixAysrKxQUFFBWVkZZWRl5eXlKly791fUjP0OpvLoy6bpiobbvZ6CmrsYXLI8fPnzAy8tLEG1dtGgRt2/fLlB7SkpKJCcnU7VqVQDq1KnDwIEDqVy5Murq6t+NYhU0/czBwUEQuW3dujUAO3bsoHXr1lhZWVGmTJk8NTZfg0gkwsjIiFatWrFkyRJEIhFz585lxIgRtGrVioMHD5KcnPzVOaCrq8utW7dwcHBg8ODB3L17l/fv33P69GkcHR2/SflcUNSsWRMdHR0OHTpEzZo1adWqVbHa+1UwMDCgbNmy+Pj4FNqYSUxMJDMzk/v37+Pj40O9evUEo8bW1pZ69erh5+fHnTt3+PDhA6qqqoSFhZV4GvaPwudRt6/Nt8/rQ3JycpCRkcnz+Y/wEcsr/Ju2l5OTjYq6BsuOX/riOG09fRSVlFl38RaP73jwwP06Z3Zu4vqxA5x0u5Pvb1taq/k99OnTh+bNm3P69GnOnz9Pt27dmDFjBgsXLiz6jf1H8ceY+U0QGJ/8q7uACHgeFY/X8eP5fh8SElIg7+yPhL+/P6dOnUJNTY0hQ4ZQpkyZYrcZHh6Oh4cHgYGBlC5dms6dO2NhYfHLjJiUlBQCAgIICAggODiYrKwsNDU1qV69OmZmZlSsWPG7z2DKlCn07duXjx8/Fvol+aNRqVIlzp49S9OmTQkODqZmzZp07doVkUhE586dhejS06dPOX36NO7u7sTExFCqVClhk1YSGyIAV1dXmjRpwtChQ9HU1MTCwoK0tDRUVVXp1asXOjo6nDp1iuDgYCpVqsShQ4cK5D1OSkrCzs5OqBn5dLNlZGSEra0tPj4+ODs7o6CggJGREVOnTi32/XyrT8U5Ny4ujgULFnDjxg1sbGywt7f/aoRMVlaWsLAwVq1aJaRBysvL8/79ey5fvpzH41oQSNkWf6RBIzXQapbRwETr31TVe/fusWHDBk6cOIGWlhbBwcG0bds2DxPd99rV1NTEycmJcePGMWPGDMzNzZkyZQqRkZEYGxszceJE4N/US6DIZAwqKiqkpKRw/fp1qlWrhoaGBkePHqVLly5oa2tTu3ZtEhISUFZWRlFR8ZttjxkzRvi+V69erF27lg8fPiArK8v+/fu/SimcnZ2Njo4O9+/fJzg4mNq1a9OjRw8cHR25desWurq6VK1atdhzsly5cowYMYIDBw6wYcMGBg4cmG/x++8MkUhEvXr1OHv2LPHx8YLTozCQSCTk5ORw//59vL29qVq1Kq1btyY5OZkyZcrQpUsXjh8/Tnp6Ojt27MDIyIjGjRtjaGj4yx2TJQE/Pz/h/zk5Ofj5+eHg4ECVKlWIj4/n3bt3yCjlOnMu7N3O0/t3mLFxV4n2wcDIhNSkj4hEIvQrGgLwxv8lh9cvZ8zi1Ty7d4fYyHDa9BpAHbsWOI2exJDGtQl+9QIFBQWSkv6tk5ZIJLx+/Trf63z+vGbNmoWTkxMjRoxgxIgRLF26lD179vwxZv6g8PDz8yM1NbVYtLCJ6VnEp2cV6pyrR/ZzaM1SMjPSWXr0IhVMirZhzcrMxP30MVo69UECTOrTDZOKBnRq70BmZibJycmkpKQgFotJT08nISEBHZ2CU5WWFMRiMe7u7nh6emJmZkanTp2KXdAYFhaGh4eHUCzYpUsXzM3Nf7oRI5FIeP/+vRB9effuHQDly5enSZMmmJqaoqurW+gXj76+vpBb+7vBwsKCM2fO0LlzZ7Kzs4XNm1gsZvTo0cImcvXq1djZ2eU5tygG9beiCT179hRqYLy8vAgICKBWrVpAbiSlTJkybN++nbCwsDzP4FvPQ11dnRcvXrB06VI2bdqERCJh7dq1KCgokJ2dTUREBFpaWgLjX0lQIRcXX0sly8jIYMqUKbx+/ZpZs2bx6tUr1qxZQ1hYGDNmzPiiHZFIJDBnpaenk56eTmZmJh8+fCjy2mGirYqSvIygu1WSjlaJWIycjIi65TTzRGSmTJnC2rVr6dq1K7dv38bQ0FDw9hb0eUmPWbJkCSkpKSxbtozk5GR27drFhg0b0NbWZu/evUyZMoWGDRvStm1bgaa7KMa6np4ea9euZfDgwZw/f5709HSGDx/O/fv3UVBQwMXFBQ0Nje9Ggz7tO+Q6IKTpnhs3bvymNoo0iikrK4uxsTH//PMPjRo1AmDlypW5BdknTgDFm/cikQhVVVWGDBnCiRMnWLNmDZ06dcLC4tey4BUWFhYWXL16lQcPHhQowpSdnU1kZCSBgYF5PpcKkr548YLk5GTevXuXh0xERkaG0qVLEx0dzd69e9HT08Pe3h5TU9NfvvYUB+7u7qxcuZL27duzfv16gVhDU1OTZs2aMXjwYMbM/ptnr8M4tW0jXUeMK/E+lDeugmVje9ZMHcMQl4XIyMiwafZU1DQ1UdUohVgsZu+yBWjplMGomgW3L5xGUVkZkypV0BJXID4+nvXr1+Pg4MD69euJj4/P9zrSmuCHDx9ibm7Oq1evGDNmDBs3bkRWVpaLFy/+v00z+6MzU0wYGRkxd+5cgQu8KPCNSiT0MzGn76Ffvao49BtMs669KK1ftsheardTRzmyfgWbb3oDkPwhAWOdUjQ0/vdlJZFIyMjIIDs7+5d4vtLS0jh58iRBQUE0a9aMRo0aFWvxfffuHR4eHgQHB6Ojo0PTpk2pXr36TzVicnJyePv2rWDAJCQkIC8vj7GxMaamppiamv4UgdFfjTNnztClSxe2b9+Os7Oz8PmgQYNITU0VFOmLioyMDOTk5AT62W9tEj98+MDAgQO5ceMGu3fvpmvXrsJ3UVFRqKmpoaam9t1i5qtXr+Lr68v06dOFv8eNG0dMTAwNGzZEIpGQnp7OgQMH0NPTK7EoU1Hx+f2IxWJev36NsbExkFsE3rx5c969e4eamhofP36kYcOGpKWlcfHixa9G/j58+CDolygoKJCRkVHsOrv07Bx8oxKJTMlABMUyaqTnl1VTxFLvyxqZa9euYWVlhYyMDFpaWgJJRGHx6fONjIxERUVFSNtLTEykRo0adOvWDWtra8aOHYuvry9mZmbFYuhzd3fn/v37ZGRk4ODggKmpKQ4ODty+fZuQkBAqVapU4DX00y1CYYysz5nQZGRkcHR0xNraGhcXl8Lf1Hfg4eGBu7s7ZmZmODk5/dL04MLi6tWr+Pn5MXHixK/OsdTUVLy9vfH29iYtLe0LlXvIjczVr18fW1tbMjIySEtLIzs7m927d1OhQgWUlZWJiIggLi5OOEddXZ3mzZv/8pRqKaTUzK9fvxbqZAwNDZk3b56wz/p0v5WQkEB2djY3b97EysoKV1dXwRkVGRnJqFGjuHL1Kkqq6rR06oPTmMlfzP2uVcsVSmdGSs08duka4bOPCXFs/9uFRx43kJWTo3YjO4a4LERdKzfadnbnZi7u38mH97EYVDam/7Q5jOzeEX01JVauXMmyZctIT0/H2dlZEN399J53795NRkYGHTp0wMPDg0OHDtGoUSNGjRrFjRs3yM7OxsHBgQ0bNvwSh/Ovxh9jppj4/EdWFHwu5lQQdK1ajnm7j1GjfuEpHT/FzZNHOLphpWDMQMHFnH4GIiMjOXr0KBkZGXTt2lXYYBUFb9++xcPDg5CQEHR1dWnSpMlPNWLS09MJCgrC39+foKAg0tPTUVdXx9TUFDMzM4yMjIrEziP9Cf9XvWubNm1i7NixnDp1ikaNGqGlpUX37t3R0dFhw4YNyMjIFOneHB0dsbOzY9KkSQDUqlWLVatWfbduYPbs2SxevJjZs2fn4fkvKDZv3syoUaOoWbMmW7ZswcbGBoBly5axZs0akpKS2Lt3L507dy502yWJzzfLEomEmTNn4urqSunSpRk1ahRjx47Fzc2NHTt20K1bN3bt2sXdu3dp2rQps2bNokqVKvmqs+fk5PDw4UPmzJlDZmYmYrGYgIAAXr16la9BI5FIyM7OLpCxIJFIiEjOIDA+mfj0rEIbNdLjtZXkMdFSoZyaUr400dnZ2cjJyf2Q1NqFCxeir69Px44dqVChAqdPn6ZNmzZ0794ddXV1du7cWWLXkkgkDBs2jJCQEJo2bYqLi8sv27ROmDABPz8/rl69SmRkJCEhIYJ2xudRms//LojRHxwczOHDh1FQUGDAgAElkob8MyD1zDs6On7hWf/w4QN3797F19cXkUiEpaUltWrVIjY2ltOnTwO5BknTpk3z1T2TSCT8/ffftG3bVhA/Tk9PJywsjNu3b/PmzRsgt7arcePG2NjY/HKym4Li043+t5CencPF4C+lJ3412hmX+SrRyB8UDr/eDP8Pw87Ojjdv3uDs7IyhoSGGhoaMHDmSUqVK8c8//5CZmcmkSZMwMDAQ2Fy2bt0qnG9oaMja9RuY2K0dPWsaMblTC4KfPRG+v7B3O8Ob1aNnTSOmdW3Dy4f3gVxDBmDewO7M6ZfrPX4b8Io5/bvRq1ZlxrZpxOWDu/P01ePsCca2bUyv2pWZ2bMDIS+e8uz+XTbOnEhsRBhdq5YjJuwdc/p1Ze+aZaRn56pv7969m2rVqqGsrEzdunXzMJwZGhri6upK/fr1UVJSonbt2jx8+LDExvfx48fs3LkTZWVlhg0bVmRD5s2bN+zdu5ddu3aRnJxMt27dGDly5E+pi0lISODevXvs3buX5cuXc+LECd6/f4+1tTVDhw5l4sSJtG/fnipVqhTJkImLi+P06dP/WUMGYOTIkbi4uNC5c2esrKzo168fHh4ezJw5E1lZ2SLdW3x8PPPnzxfqOkJDQ9HW1qZ+/frCMV/z4/z9998cPnyYVatWYWdnJ7DmFBSDBw/m6dOnVK9eHVtbW/r06UNaWhrTpk3jwYMHODo60q1bNwYNGkR4eHih7624kN63dO5LiSKePHlCdHQ0Z8+epWPHjuzfv58bN26gqanJjRs3GDVqFFWrVuXevXuCaOmOHTvyHR9ZWVmsra2xt7enfPny3L9/nyFDhnw1siuRSAgLCyuQxo5IJMJAXQm7Sjo0r6SDYSkVFGX//R2L8vknhaKsDJU0lGlWqTR2lXQor6GS7xogFouRl5fPQ3xQUggJCWHt2rXo6+tTunRpmjZtKggWZ2RklLhXVcrM16NHD+bMmfND1oqC+kQXLlxIUlISDRo0wMbGhhkzZuDl5cWHDx9ITMwrS5Cdnc3ly5c5efIkkDuncnJyvtm+sbEx48ePR1ZWls2bN+d5X/3O0NbWxsTEBB8fH2EsJRIJXl5erF+/nmfPntGwYUMmTJhA27ZtKVeuHHp6epQtWxYHBwfGjx9PnTp18p2rmZmZSCSSPGxmSkpKmJiYMHDgQMaPH4+FhQWZmZlcu3aNFStWcP/+fbKyCpf6/jtDSU42zxrxO0BRVuaPIVOC+FMzUwycPHmSWrVqMWXKFAwNDenUqRPp6ek8fPgQBQUFlixZwoULFzhx4gRlypRhz549jBkzho4dOwrCZQvmz2fI/H+oYGzKptlT2bHIhcWHzhLy4il7ly9k2vrtVDAx48K+7ayYMJxtHo/Y7unHkMa1mbpuO+bWtmSkp7FwWB/sO/dgxIJlhIcEsXnOVJRU1bDr2A1fT3dcZ01i0Ky/qWnbmIv7drBkxABcr9/DeeYCzu7cxD/HLqGh/a+H9UN6FpeP72PMmDG4urpiY2PDrl27aNeuHf7+/kLO9Ny5c9m2bRvVq1dn6NChjBs3jjt37hRrXHNycrh8+TIPHjygdu3atGvXrkjpHaGhoXh4eBAaGoqenh7du3enWrVqP3TjL5FICA8PF+iTY2NjkZWVxcjIiDZt2mBqalosZikpxGIx9+7dw83NDXV19SKnwPwumDdvHmKxmIULF7Jlyxa2bduGkpJSkVKwvLy8mDBhAleuXEFTU5Po6GgMDQ25ceMGMjIygsf3W/Oge/fumJqasm/fPqGu5Wv4tN5HyqJjbm7Otm3b6NWrFzNnzqRs2bKsXbuWAQMGcODAAYYOHUqfPn2Ij48XvKs/Ep/ryqSlpREdHc2SJUs4efIkOjo6TJ48mdGjR9O0aVNMTExITU1l165dHDt2DGNjY5o2bcqKFSuENrds2YK2tvZXxyc7OxtnZ2fKlClDzZo1cXd3/6rzQCQSkZCQwIcPHwqV811KSR5L/VJYUor07Bw+pGeRmJFNlliMWAIyIpATiSilJI+WknyBNw8/0jMdHR2NtrY2derUQUZGhnLlyvH+/Xvi4uKoVKmSoKVRUnj//j2ysrLUqVOnRNv9FAVZU3NyclBTU+Phw4dcuHABsVgsRGJr1KghiALKy8uzY8cOjh8/zps3b9DW1uavv/7ixo0bBWLiUlNTY8KECRw4cAA3NzdevXpF//79f3vRyHr16nHo0CHCw8PR1dXl7NmzvHjxAltbW+zs7ARxWyn09fUF7atvIS0tDeCr1Myampp07dqV9u3bc/HiRZ48ecLly5e5desWDRo0oG7dut9dA/8LKKemVKB0/rO7tnBk/fKvft+kQ1eGz/+nWH0R/W9//qDk8MeYKQa0tbWRlZWlVKlSwgZ1+vTpmJiYALlpLc2bNxe8wTNnzmTBggUEBAQIxkynnr2p36ItEsBx0HBWjM9dnGLDc4uNdcuVp0z5CvQaP506di2QiMVo6eaGztVKaaKuqcX14wcppa1Dr/G5RZ3lDCsTG/6OC3u2YdexG9eO7qORQ2da9+wPQP9pc5CTlyc58QMqaurIyMgKbUqRmJHNunXrGDduHP375563dOlSPDw82LBhA0uWLAFyw7ydOnUCYPLkyXl0IoqCjx8/cuzYMSIiInBwcKBOnTqFNj5CQ0Nxd3fnzZs36Onp4eTkVGz2nG8hMzOTkJAQ/P39CQwMJCUlBWVlZUxNTbG3t6dy5col+jKIjY3lzJkzhIeHY2NjQ7Nmzf7ThowUc+fORV1dXSiCLWotiYqKChs3bkRTU5OAgACqVq3K9u3bGTRoEFDwvP9atWoJudff6ot0Xq1ZswZjY2OaNGmClpYWqqqqODg4YGJigp2dHc7Ozjx79ozly5djZ2fH27dvv6v7UVxI+/25ETFp0iR27txJv379iIiI4OXLl3Tv3l1IATMwMKBevXq4urri7+/PqFGj2Lx5M8OGDWPmzJncv3+f+Ph4IYUvP8jJyQkq5F26dBGE7fKDSCSiVKlSHD9+HBMTk68KMn4LSnKy6KvJov+bE1pJ6bc3bdrEggULyMnJITAwEDU1NVatWoW8vDwREREoKyujpaVVrNoZgIoVKyKRSLhy5cp311NpDcaPiFhLIyuysrI4ODgIn48bN46kpCQ2bdqEsrIyCxYsYPv27ZiZmREQEABAv379cHFxYdu2bQVa62RkZOjbty937tzhxo0brFy5EicnJ6pUqVLi91VSMDExQVNTk9u3bxMXF8fHjx/p3r071atXL1a76enpwNeNGSkUFRXp3Lkz5ubmnDp1iqysLG7cuMHt27exsbHBxsbmt9Oq+V562aeorKnC68TvC2Y279pTEMPMDypqhV+bPocEqKyl8t3j/qDg+GPMlDA+FXbq1KkT165dY/Lkybx69YpHjx4B5AmVlzf6RBhKVZ3s/w3t1m7UlIqmVZno2Ayj6hZYN2tNi+59kM0nFSk8OJBQ/xf0sTIRPhPniJH5381X+OtgWvf4V5tDXkGBAdPnfvM+ssRiXr58ydy5eY+ztbXl5cuXwt+fvhw0NDSKFZp+8+YNx44dQ0ZGBmdn50Lx4UskEiES8+bNG/T19enRowdmZmY/xIhJSkoSivdDQkLIyclBR0eHWrVqYWZmRvny5Ut8Q5CTk8Pdu3fx8PBAU1OTQYMG/XaCccUpZpeRkRHoiaX1CkWB1ACBXO/lrFmzGDVqFAEBASxduhRZWdlCt/+te5JIJCQmJrJ//36Sk5NxcnISmPEUFRWpVq0aQ4cOpX79+kK9jtSg+tFqzdJ+Hz9+nJSUFBo0aECVKlWYNWsWW7ZsQUFBIZeSuGZNmjdvzsuXL3n69Ck1atTAxsaGc+fOsW3bNlasWIGGhgYuLi60adOG2NhYJk2a9N0ogoKCAnFxcdy6deu7m1Ap5fiFCxfo0aNHif9ufwfGOOm82759OxMnTmTjxo3o6+szZcoUFBUViYiIYNCgQXh7e9O4cWOWLl1KtWrVivW7UlJS4uDBg5w8efKrhtHHjx/R0ND44rviGlKf4/N7SEtLIzY2FjMzMypVqoS3tzc3btygdevWnD9/nn79+rFv3z769+/PuHHjSEtLK7DjRiQS0ahRI8qWLcvBgwc5ePAgtWrVwtHR8bcodP8cMjIymJubc+fOHUqXLs3QoUNLJOXwe5GZz2FqasrIkSM5efIk7969w9DQkDt37uDl5UXdunWxtbX9z1FgQ24UV1tJ/rvMsaoapVDVKH72xNcgArSU5Cml+N93QP5O+GPMlDA+DWVLPUnOzs70798fV1fXPMYOgJy8AvlBUVmFpUcv8Nzbiwdu17h58ghXDu9l2YnLlNYrm+fYnJwcatRvxNA5i/NtqyibQrGEfMPyOTk5eYyxz0PfRYFEIuH+/ftcvXqVihUr0q1btwIvllJOdg8PD96+fUvZsmXp2bNnidNNSiQSoqOjBQMmIiICkUhExYoVad68OaampvkWQpcUoqKiOHPmDNHR0TRo0AA7O7sib/Z/FD6NeGzYsIGwsDBCQ0OZOHEiJiYm3xyfT42L6OhoIXJZWHxupGhoaDB37lyqVavGyJEjefHiBWfPnkVOTq5YBtOnEIlEaGpq8ujRI3bt2sWSJUtwc3Nj8ODBNGjQAD09Pc6cOUPlypWFDcWP2Ezlt+G9c+cOzs7OZGZmYmBgwPjx49m0aRO9evWiVatWREVFkZqairq6Ot27d2f69Ol4e3tTo0YNLCwsaNiwIUePHiUwMJCuXbvStGlTwsPD8xiM38PixYs5evQogwcP/uZx8vLyODg4cPToUZ4/f15sil3p883IyCAzM7NI0Z6vwdfXl3fv3uHo6FioeSQnJ4dEIqFx48YcPnyY4OBgVFVVBT2eDRs28PTpU44cOcLZs2fp1asXfn5+xU57q1Wr1jfXxFmzZnHjxg1mzpyJiooKXbp0Af6dpz+KcU8aiZFSf79584Z3795x7tw5Fi5cSPv27bGxsaFjx45YWFjkSx6RmZn5zfeQVMtn9+7dPH78mNevX+Ps7CxEDX8XZGRk8OrVKwDMzc1LrHZKaswUJs1OQ0ODfv36cfDgQV6/fk3v3r0JDg7Gx8cHb29vLC0tadiwYYmkTP9MVNFW435Ewi/tg+R/+/EHJYvfzz3xH8O3NsybN29mw4YNLF26lB49epCSkgLkLZb82un+vg84uXU9Neo3xPmveay/7ElmRgavHnp/cWw5I2MiQ0MoU74iZSsZUbaSEQGPH3Fxfy4jTtlKlQn1fyEcn5OTw8jmNrx65P3V/suIwMzMjHv37uX5/N69e5iZmX31nguLzMxMTp48yZUrV7CxsaF///4FMmQkEgnBwcHs2rWLffv2kZ2dTa9evRg6dGiJRWOys7MJCgriwoULrFmzhi1btuDl5YWWlhadO3dm6tSpDBw4EFtb2x9myGRnZ+Pm5sa2bdsQi8UMGTKEFi1a/HaGDPy78Rk+fDiLFy9GXl4eOTk5+vXrx9KlS79aSP/pZrBTp044OzsXKcInFouFdo4dO8a6desIDg4mJyeH3r17c/HiRV68eIGFhQXv378XNpZFhdSof/78Oa6urty+fRtnZ2e8vb2pW7cu8+bNo1evXtStWxdASHMraUhTg/LbbG7cuJEWLVoQGhoqUEQvXboUT09P5s2bx4ULFwQ2I3t7ewwMDPD29haM9Vq1aqGtrU1wcDCAEH0EBH2gb0EikVC1alU2bNhQICG3atWqUb16dS5duiSsl0XB+/fvefv2LYGBgQwePJjmzZuTmvr9FJNv4ePHj2zfvp1mzZpRp04d1q9fDxTeWSRdm0xMTGjdujXq6uq4uroSGRlJ6dKlkZGRoWXLlri4uBAbG1vsGkQplJWV810XxWIxd+/eJSYmhrt377Jv3z5OnjzJhQsXOHv2LPDjaogkEglVqlTh1KlTGBkZERcXR+nSpdHQ0EBPT4+bN29iYWGBi4uLUKfp6emJq6sr69atIysrSzBkli5dyrJly/K9jpqaGmPGjKF+/fp8/PiRdevW4ePj80PuqSgQi8UcP36c5ORkqlatyuPHj7+gXS4qimLMQO4zd3JyQlNTk9OnT2Ntbc2ECRNo1KgRz549Y926dZw5cyYPzfPvjnJqipRVVeRXxWdF5FLBl1P779cg/W74/XZE/zGoqqp+lW60dOnSnDt3jjp16hAREcH48eMB8mzqZL+y6VZQUuLYxlVoltahpm0Tnvt4kZ6aQiWzL/Nnm3boytENK9kydxqOg0YQ/e4tOxfNpoPzcADa9h3E34N7Ua2ODVWt6nFx3w7EEjFG1WuQEBNDysdEIkJD0CtfUWhTXkaGSZMmMWjQIKpXr46NjQ07d+7k8ePH7Nmzp1hjJkV8fDxHjhwhISGBrl27FsgTKzViPDw8CAsLw8DAgN69e2NiYlIiBkxqaiqBgYH4+/sTHBxMZmYmmpqaVK1aVUiF+Fm0leHh4cLLonHjxjRu3Pi3pMz8NH3n+fPn+Pj4cP36dapXr46XlxcHDx6kbt26JCUlIS8vnycq8akh065dOyIiIjh8+HCRaoCk7Y4YMYJTp06RmZnJP//8w8yZM+nZsycNGzbk0qVLjB49mjJlyuDr61uoCMOnkHqqQ0JC6Nq1K6mpqUycOJGGDRuioaHB2rVrmThxIkePHqV8+fJCnURJRYM+hfS+N2zYwPXr12ndujV2dnZoaGjg5eUl1Kqoqqoybdo0Xr16xb59+9i6dSvlypXjyJEjmJmZIS8vT4cOHVi1ahV37tyhe/fu2Nvb07x583z7XJD7EIlEDB06FPg3ZcnPz4927doRGhqar0e9bdu2uLq6cvny5TxaP9/D0qVLefDgAfv27UNHR0fwbG/bto0aNWrg4eFB27ZtC5069fDhQzZu3MjRo0dRVVXFzs6OKlWqYG1tzaNHj7CysipW5OLEiRM8evQIXV1datWqhbKyMm5ubujo6CASiYocpSwoHjx4gK+vL4cPH8bJyYng4GBatmyJqakpT58+ZdKkSezfv1+o/fz09y4lHjl+/Djbt2/n/PnzhZrfIpEIiUQiPI++ffsSHh7O2bNnadOmDcHBwbi4uNCzZ09atmzJuHHj8PT0JCUlBV1dXRYtWkR0dDRubm7MnDmTf/7555vPt3Xr1lSrVo0DBw5w8eJFnj9/Tt++fX+5c+jmzZsEBwfTp08flJSU2L59O4GBgSXiOExLS/uqIfs9KCoq0qdPH7Zv387BgwcZMmQITZs2xdbWlgcPHuDl5cXjx48xNzenUaNGP3yuFhcikQhL/VJcfR1Ltvjnq5LIyoiw1Cv1y9Nd/y/ijzFTTIwaNYpp06bl+1LeuXMnI0eOxNzcHAMDA4YOHYqcnBy+vr60adMGABU52XzZNYyqWTBq0SqOu65m+98u6JYzYPyy9ZQ3/rKAUVlNDZet+9m5ZC5TOrVCXVOLNn0G0mXYWADM69Vn6NzFHHNdTUJsNMYWtZi5aS+KSspY1G+IfkVDJjk2Z+GB00KbYomEWs3bMXbmHGbMcuF9TDTVLGpw6PR5DE0KX0R58+ZNdHR0qFmzJgABAQGcPHlSUHD+nh6ARCIhKCgIDw8PwsPDMTAwoE+fPhgbGxd7YXj//r2QPiZVTTYwMKBhw4aYmZlRpkyZn7r4ZGVl4e7ujpeXl8BY87u+JD6vQ0hKSiI2NhZjY2N27drF+PHjWb16NfXr12fevHnMnj1buJecnBzk5ORITU2ladOmKCsrc/Xq1SJpQ0j78eDBAx4+fMjFixepXbs2ixYtYtmyZURGRjJkyBCqVKnCwYMHWbBgQbGiadKN6/Dhw7G1tWXXrl1ERUWxf/9+VqxYgY6ODhMmTPhCab04m6aviX5+/PiR4cOH8/TpU9q1a8eePXvw9PRkw4YNRERECB5tKZtUzZo1uXjxImlpaUyYMIG1a9cyYsQIDAwM6NKlC69evcLKygr4N420OLUTn7PHpaSkCFG7/KCmpkabNm04deoUFhYWBd7Q3bx5E1tbW5SVlcnOziY7OxslJSUyMzMpU6YMoaGhBe7z+/fvOXDgALt27eLJkycYGBhw+PBh2rdvL3y/dOlShg0bxoMHDwT19aKsE7GxsdSuXRs5OTlMTEzIyMggISEBXV1devfuTcWKFb/fSDGwf/9+ateujZOTE8+ePWP06NE4Ozsze/ZsIDddeu7cuZw9exZFRUVEIhEfPnxAU1NTcDrs378fKNr8/nTM1NTU+PvvvxGLxQQFBXHo0CFUVVWZM2cOU6dO5fDhw2zfvp2GDRtSunRpRo4cybZt25gwYQITJ05kzJgx352nFStWZOrUqezfv583b96wYsWKnzLOX0N8fDxeXl7Y2dkJ8gPlypXjwYMHJWLMpKenF4vJTV1dnd69e7N161bu3btHo0aNUFBQoEGDBlhbW+Pr68udO3fYvHkzZmZmNG7cWFhzfkcoyclipV8K74gPP/3aVvpfivP+Qcngj2jmL8bvKuYE5BuKlU4WRVkZyqkpUVlThVJK3/aiR0dHs3nzZkQiEf369SM0NJRbt25hZmZGp06dvrnQSiQSAgMD8fDwICIigvLly9O0adNiGTFisZi3b98SEBCAv78/8fHxyMnJYWxsjKmpKaampr+swPHt27ecOXOGxMRE7OzsaNCgwW9ZrPop0tLSaNy4MVu3bqVixYr07t2b8uXLc/LkSbZt20b37t2Ji4ujfPnyHDhwgC5dugie7PDwcOzs7LCwsGDfvn3FGvfQ0FDmzJkjaO9IN1r79u3DxcWFli1bMnr06EJR/34LUVFRdOzYERcXFzp06MCwYcO4e/cu1atXR0lJibS0NI4dO1Yi1/qWMXHjxg169+6Nm5sb1atXJyUlBXd3d4EN0MbGBldXV+H48+fP07t3b+Li4pBIJCgpKXHo0CGcnJx+OG25SCTi8uXLjB8/Hn9//28ee+jQISIjIxk9enSBNmN//fUXfn5+bNmyJc/GVKobdPjwYWrUqPHddubPn8/8+fOpUKECnTp1Ijg4mHbt2jFq1Kg8BsvevXtZuXIld+7cKdK8lT5Tb29v7OzsOHv2LBUqVMDCwoItW7bkSUuMjY1FV1c3z3klAbFYTMWKFZk8eTITJ07k77//ZvHixejr6zN06FCGDRvGu3fvcHZ2xtPTE1lZWS5dusSWLVt49uwZ7du3Z86cOVSrVo2DBw/SoUOHEuujdKwlEgmpqanMmjULa2trunXrJhjZAwcOZO/evXTr1g1XV9dC15n4+Phw6dIlJBIJ9evXp3Xr1sXqc1Fw/Phx3r59y9ixY4U1y8/PjzNnzjB27Fi0tbWL1f65c+eIiooSIqRFxeXLl/H19WXMmDFf1J/l5OTw9OlTgYmtcuXKNG7cmEqVKv22UYig+BSexP5YNslPUVNXAxNt1Z92vf9v+GPM/Aa4EBRNRk7J5Mf+THyqpF1FW41yaor5LlwnTpzg+fPnuef8rx6Hvb09jRs3/upCJ5FICAgI4NatW0RERFChQgWaNm1K5cqVi7Q4ZmRkEBQUREBAAAEBAaSnp6OmpoapqSlmZmYYGRn9UnrjzMxMbty4gbe3N+XLl6djx44lLp73IyFN31izZg0DBgxg3759bNmyRXiBStOxdu7cKRgTjx49olWrVnTt2pUNGzYUefylm549e/awefNmnjx5wq1bt/Loanh5eTFo0CC0tLQ4ceIEZcuW/UaL/9a1fWuuSSQSevTowZs3b9DU1OTevXssW7aM4cOHExsbi4aGBgoKCiX2Ms/IyGDVqlU8ePCABg0a4OTkRIUKFVi9ejVnz57l2LFjX8yZkydP0r9/f06dOkWzZs2QlZVl7NixvH79mv3796OpqcmtW7do0qRJnvNKmsXq0zaPHTvG33//zZMnT755/MePH3F1daV69eo4Ojp+t31/f3/GjBlDZGQkjo6OvHnzBk9PT+Li4ti2bRu9e/cuUD+9vLwIDw+nW7dupKenY25ujru7ex7mwNDQULp3706HDh2YM2cOHz58wM/Pjw8fPghU9QWBdExmzZqFm5sb9+7do2fPnri6uqKpqUl4eDijR48mICCAbt26sWDBggK3XdB7tbe3Jzg4GAMDA5o1a4aFhQVVqlThzJkz+Pj4ICMjg5qaGjdv3uTmzZusXLmSZs2a0b17d/bu3YtEIuHs2bNERUUJ7Hhfu8+i4lPD5tPfk62tLQoKCmzfvr3ItMsJCQns3r2bjx8/oq2tjbOz809zZoWHh7N9+3YcPIq2pQABAABJREFUHR3zOFmysrJYvXo1tWrVKraBdezYMTIyMgQB4aIiLS2N9evXY2ZmRseOHfM9Rvy/LKienp5ER0dToUIFGjduXGJp4EXF1zSoPmZkE5VSOFHkoqBmGQ1MtP4YMj8Sf4yZ3wC+UYkFEnP6XSE1asqqKmL5WRg1ISGBdevW5Tlemh6QX4651Ijx8PAgMjKSihUr0rRpU4yMjAq9GH748EFIHwsNDUUsFqOnpycYMOXKlfstvEYhISGcO3eO5ORkmjdvjrW19W8djfl0QyH9/5o1azh//jxXr15FJBJhY2ODmpoatra2WFpasmbNGmRkZLhx44ZgtGzdupWAgIA8QoyFwecbJIlEwt27d5k3bx7x8fG4uLjQuXNn4fuwsDDOnz/PiBEjCnWP34Kfnx8TJ06kTJkyzJs3j2rVqgGFY39KSUnh4cOHNGnShJycHCQSiUBOIO1DUlISnTt3JjY2lt69e3Ps2DHKly/P9OnTiYmJYcKECdy4cYPKlSsL5w0bNoyJEyeyZs0aLly4QKNGjYiPj+fp06fs3LmTtm3bFqh/JQXp89q5c6eQsvI9PHz4kPPnzzNw4EAqVar03ePfv3/PggULuHv3Lvr6+jRv3py+ffuirKzMunXrGDRoEPr6+gV6vtJnaGtrS6VKlWjdujWWlpbcuXOHXbt2kZmZyZw5cxCJRNy+fZsnT56QkJCAh4dHgZnTPp3Dr1+/JjMzk6CgIBISEsjMzKRbt248ffqUhIQEJk6cyLBhw5g6dWqJsYv16tWLly9f4ufnR1JSEoMHD8bY2FjQEQsPD+fOnTsEBAQwZswYatasybhx4xg7diyKiors37+f/v37M3ToULZs2cKyZcs4evQo7u7uP9wgyMnJwdfXl1KlShVbP0YsFnPu3Dn8/PyQkZGhU6dOBYriFRd79+4lOTmZESNGfLHmX7t2jUePHjFp0qRiOdr27t2LqqpqoerPvoYHDx5w4cIFhg0b9k2HkDSjwtPTk7CwMPT19WnUqBHVqlX7ae+2xPQsQj6kEpGcLjiLv5VtUtIQkVsjY6VfivLqv5c+z/9F/DFmfgMkpmdx4837X92NYiO/H+/58+d59OjRF6xHFStWxNnZWfhbIpHg7++Ph4cHUVFRVKpUiaZNm2JoaFhgg0MikRARESEYMNHR0cjIyGBkZCSkj/1OdJzp6enCC8vQ0JAOHToUO6XgZ+H8+fNoa2sLdKmxsbFUr16dadOmMXXqVD58+MDChQu5c+cOcnJyVKhQgYMHDwIlQ/P66Sbw+vXrhIWFoaysTPv27YmKiuKff/7B19eX/v37M3bs2GLfb37Iz6grigd6w4YNgnCgqmr+3rudO3eyceNGHj58CEBQUBCOjo7o6Ojg5uZG6dKlWblyZR764/LlyzN//nwGDx7M5cuXuXjxIkpKSkyePPmX1GBJn/vatWs5ffo0bm5u3z1HIpGwb98+4uPjGT9+fKGdDzk5ORw4cID9+/fz5MkTzp07R7169QrV36dPn+Lq6sqDBw8IDw8nPj4eKysrWrRoQXh4OM+ePUNTU5OWLVvi4OBAtWrVilw/k5OTQ48ePXj//j1PnjyhU6dODBo0iEaNGnHy5EmGDh3KmzdvSsxQ2LZtG1paWoLY8ejRo/Hx8eHu3bvIycnx4sULnjx5Qtu2bXny5AktW7YkJCSEcuXKARATE0OFChU4ceIE7du3p169etSuXRtXV1fk5eUJDw/n6tWrtG7dWjhHiuzsbGRlZYvlUCpp7aCgoCCOHDlCdnY2pqam9OjR44dtvhMTE1mzZg2dO3cWakk/hdQR2KFDB6GGrSjYsmUL5cuXzyNUWlSIxWLWrVuHiYmJUD/2LUj13zw9PXn9+jU6Ojo0bNiQGjVq/BAyG4lEQkRyBgHxySSkZwmO1p8Jwbmrpoil3p8amZ+FPwQAvwEKKub0u0MCZOeI8Y74QKpONnpy4jyGjIyMjEA3+fbtW2JiYtDV1eXVq1d4eHgQHR2NoaEhAwYM+EKP52vIysoiJCQEf39/AgMDSU5ORllZmSpVqgjhbUXF348GMTAwkPPnz5Oeni7UNvwOUaKv4fNN+r59+7hx4wadO3emX79+NGnShCVLlnDs2DE6d+6MiYkJy5YtQywWk5iYKBTblxSbl7QvkydP5sKFC2RmZqKhocGoUaM4evQoixYtYvXq1Rw8eJAXL16wYcOGEn95fpr2In12Rdn49OnTh7lz53LhwgW6du3K9OnT8fPzE1LwjI2NSUlJoWrVqgQFBTF79mwuXrxI3bp1mTx5MrKysgwZMoRdu3YBMHjwYE6fPo2BgQF2dnYAtGnTRiAdgR+TRgYFS8/7+PHjV422zyESiejQoQObNm0iNja2wOQQoaGhnDx5kh07diASiejZsydbt24t8LoC/5I81KhRg02bNnH06FGePHlCamoqwcHBuLu7U7VqVebNm0ebNm3y3HNRf8uenp54e3uzZ88eIW1z1apV1KxZEz09PeTl5Xn48CFNmzYtUvuf4/M6itGjR9OvXz9atWpFkyZN2Lp1Kw0bNqRTp07cuXMHS0vLPM/Ax8cHRUVFHBwcSEhI4OHDhyxdulSIJDx//pwxY8Zw5swZwZiRkgeUlMZTScLExITJkyezd+9eIWo8YMCAH2L8v3z5EllZ2a8W+WtpaVGlShV8fHywtLQs8r1K2cxKAjIyMlhYWPDo0SPatm373TVVJBJhZGSEkZERYWFheHp6cubMGTw8PGjQoAGWlpYlxiSXnp2Db1QikZ+kjf1MQ0ZqxGh9J+3+D34M/hgzvwl+BzGnEsH//nifvU/G86WvsNkrW7YsBgYG+Pv78/FjbtHduXPnyMzMJCYmBiMjowKnkiQnJwvF+yEhIWRnZ1O6dGlq1KiBmZkZFSpU+G3TtNLS0rhy5QqPHz/G2NiYDh06/PbCY59GUkJCQqhUqRJHjhzh/PnznD59mlatWrFy5Uoht/7Dhw/Av7ovUkPmUx2YksCVK1fYt28fly9fxsjIiOzsbFauXEmrVq04fPgwf//9N8uXL8fNzY2EhIQfUoNUEi8rLS0tnJycWLJkCf7+/ty/f5+WLVuyc+dOTp8+zdWrV8nMzOT69eucPn2arl27cuHCBerXr8/Zs2c5deoU8+fPZ8mSJcyZMwdXV1devXrF1KlTv9i8i8ViRCLRD/t9fGs8pNdMSUkRRCILAi0tLZo1a8azZ8+wt7f/7ph7enqyc+dOUlNTmTdvHg4ODnmuVxRv/vXr19mwYQNycnKoqKjQokULunTpkodoQDq2xZkTFStWJDExkTJlyqCvr8+CBQsYM2YMjRs3pmLFioJY4Y9C9erVOXnypBCJ+uuvvwSSFk1NTZKTkwkLCxPm1bZt22jdujUikYjdu3dTsWJFIT0rPT2dR48eYWJiQosWLcjMzGTu3LncuXOHd+/e0atXL/766698i8llZGR+2UZQSUmJYcOG4enpiZubG5s3b8bOzq7EDEgpXrx4gbGx8TedbfXq1ePgwYOEh4dTvnz5Il2nJI0ZyDXu79y5Q3BwMKampgU+r3z58vTq1Yvo6Gg8PT25ePEit27dwtbWlrp1637BCJuQkICcnFyBUjbDktJ4FJVIzg+kWy4pQqQ/+DH4k2b2m0AikXAvPIGolIz/bO1Mfnh75zqJ70LQ0NBAXl7+C4Gt8uXL07Jly2/SYkokEmJiYoT0sfDwcEQiERUqVMDMzAxTU9P/RLH8y5cvuXDhAjk5ObRu3ZpatWr99p6bTz34I0aMwM3NDXV1daZPn07nzp2Rk5Nj+/btHD9+nFKlSnHs2DF69erFgQMHflifpJvRXbt2cfz4cc6fP59nHBcuXMj+/fvx8PBAVVWV5ORk9PX1C9X2z8bLly+pWbMm2trauLu7U61aNYKCgujRowfNmzenT58+DBgwgF69ejF9+nQgVxOpTp06DBo0iKlTpwK5yvRBQUG0bt06X+2rHwmJRMLDhw/x9vYmMzMTNTU1VFVVUVdXR1ZWltq1a1O2bFlSU1PJzs4uVP/EYjFXrlz5bp3Pu3fvqFSpEurq6lhbW6OiooKOjg5GRkYoKysTFxfH33//XeAonXQ+hIeHs2DBAkaMGJGnUPvly5fMmzcPLS0txo8fT7Vq1YqcRin9rY0ZM4YXL14watQotLW1OXbsGOfOnaNJkyaMHTtW0PiQirH+LERGRtKuXTsGDBiAo6MjK1euZPPmzZw7d4527dpRs2ZN7O3tWbFiBfLy8oSGhjJs2DCsrKwEGutjx46xfPly1NXVWb9+Pb1792bUqFEl1keJRMLHjx9LzEEUExPDnj17SE1NRV9fnwEDBhSL5liKpKQkVq1aRceOHaldu/ZXj5NIJKxfv54KFSrkqf8rKHJycli4cOEXBAPFgUQiYdOmTejr69OlS5citxMXFyfUmikqKmJjY4ONjQ1KSkrk5OSwZs0aRCIRI0aM+KbzIzA+maexSUXuR0Ghr6qIhqKcQB4gLyNDKUU5NJXk/6SS/Qb4Y8z8RkjPzvllYk4/CnIiESYk88j7nqAi/ilUVVWZMGHCFx77nJwcQkNDhQhMYmIiCgoKmJiYYGpqSpUqVQrl3f2VSElJ4dKlSzx//hwzMzMcHBwKXCD8u6BDhw68fPmSJUuWcPr0aYKDgxk9ejS9e/dGVlaWZ8+eERISwrBhw1BXV8fNza3InsSv4fNN4ooVK1i8eLHAoiTdDN6+fZtOnTpx9erVAuWa5+TkkJ6eXuDUp8KioCldXbp04e3bt/j4+AgG1eHDhxk+fDjv379n1KhRPH78mHnz5tG0aVPc3d2ZMWMG27ZtEwQNP8XP8nBL7+/atWtMnjyZ2NhYSpcuTUpKCunp6YjFYmJjYwV2u6Ju9uPi4tDW1v7u/ezZs4eYmBjS09MpV64cOjo6HDlyhMOHDyMSiXj58mWhPMqfIiQkhClTpiCRSKhXrx7Dhg3j+PHjeHp6EhQUxP3794vULuSdJy4uLuzfv5+YmBgaNmxI586dGTBgACKRiOPHj3Po0CGmTJlC8+bNf1jK4OeQSCQcOHCAiRMnYmlpSWRkJLGxsYSFhZGcnIyBgQHHjx8XDM7Lly8zbNgwLl68SHBwMH///Tdz5swRmOlcXFy4cuUKPj4+vHnzhvPnz3PixAlsbGwYM2bMF1olBYl8SQ1qsVhMvXr1SmTui8Vijh07xqtXr5CTk6Nbt27F1n958uQJp06dYurUqd99j929e5ebN28yceLEQq9RKSkprFixgh49elC1atXidDkP3N3duX//PtOmTSv2GCcmJnLnzh18fX2RkZGhXr16qKmpceXKFSFNrU+fPvnO8Z9lyEjxh17598WfNLPfCL9SzOlHIUciIUZeNV9DBnIX26VLl2JoaEjFihURiURERUURHBxMRkYGpUqVEtjHKlWq9MuVmgsDiUTC8+fPBR2Drl27Ym5u/ttHY6SQeqXd3d2JjY3Fy8sLXV1dMjIy6N+/P+rq6igqKuLk5ISFhQUWFhaCZ/pHGjKLFy/G19eXpk2bYmVlxbBhw5g9e7YgOFe5cmUMDAzIyPg+5aZEIiExMfGHEkMUdKM5cOBAevbsSXp6upAWYm9vj7KyMnfu3BHELUePHo2CggJhYWHMnDkzDwX1p/gRBbb5QbqZ3rx5M2XLluXChQsCjbFEIiEnJ4fMzEwhjaSo/SpdujSpqanf3fz1798fkUhETk4O58+fZ/ny5Tx69IiePXvSq1evIgn6SSQSIY0xMjKSFi1acOzYMUQiEX/99Rf9+/enbNmy3L59m0aNGhXJwJDWFMrIyDBkyBD27dvH8OHDGT16NCYmJri5ubFnzx6OHz+OgoICq1evpnbt2pQuXfqnGDQikYi+ffvSt29f4uPjOXXqFP7+/sjJyRETE4OJiQlPnz6lbdu2vHnzhlOnTgkkITt27KBy5cp5KMC7detGkyZN8PT0ZNmyZXz8+BEHBwcuXbrE06dP2bFjR55aFen9Sesuv3a/pUqV4uDBg0RHR9OuXbti/w5kZGTo0aMHz58/59SpU4JeUadOnYo85nFxcaipqRXIIVe7dm3c3Nx49OgRjRs3LtR10tLSAEo0zQxAX1+f9PR0kpKSih0BLlWqFO3ataNJkyZ4eXnh7e1NVlZu/bBEIiEkJAQPDw/s7e3znBeWlPZTDRmAJ7EfUZKX+cNO9hviv7Mz/H+C8urKpOuKf6qY04+EBIjPAoNqNZFLTURJSYnw8HCSk5OFY7S0tAgPDxcMHhkZGXR1dalevTqWlpb/uSgG5KYRXLhwAX9/f8zNzWnbtu0P8/yXJD5VmZcaXREREbx+/RoNDQ0uX77M7t272bZtG6dPn2bt2rWULl2a5s2bAwgUqSWdriXdkHTs2JHY2FjMzc3Jzs6ma9euXL16lbFjxzJ69GjEYjEbN24UaKG/B5FIhIqKyhdse0VFflGHU6dOER0dzYgRI74ZlXBwcKB06dJs27aNcePGAbljr6mpSVZWFioqKmzfvp3AwED8/f1xdHQssnFfks9H2o5YLKZNmzZ59FhEIhFycnIl5oSQpqB8bQyl93Xv3j3OnDlDSkoKvXr14vDhw8UysEUiEfLy8ly5coWZM2cyaNAgatWqxcGDB7l+/TotWrSgXr16nD9/nkaNGhV5bKWbY0NDQxYtWkTv3r0JDQ3l77//5tq1awCsXbuWevXqMX36dMaMGcOhQ4d+eo2gtrZ2HuY8U1NTHBwcmDdvHq9evSItLY0jR44wb948IDf9T09PD01NTSHCIk2vGjJkCPHx8Zw8eRI9PT2mTZtG1apVOXToEBMmTCAjI4Nbt24REBCAo6Njnvn1OUQiEU+fPsXS0hJfX1/i4uJwcnIqkSi+ubk5hoaG7N69m6dPnxIaGsrAgQOLxEAZHx8v1BJ+DyoqKlhYWPDw4UMaNmxYqGednp4OlLwxIyWBkOpplQTU1NRo2bIl2tranD9/Ps93t27donz58sL7JT07h0dRiSVy3cLiUVQiOsoKf1LLfjP8MWZ+Q0jDmP9XDBoRYGLTmIblSnHkyJE8hgzkakOYmppibGyMiooKkZGRhISE4ObmhpubG2XKlKFy5coYGxtTqVKlXypu+T1IJBIeP37MlStXkJWVxcnJSdAe+Z1x8uRJunTpgkQiQVZWloCAAM6dO4epqSkVKlRg06ZNREVFcfbsWRo1asTgwYMxMDCgXbt2TJw4kalTp9KvXz+hvR8Rfbp16xaPHz/mxo0bQhQGcj17ffv2xc3NjapVq1K2bFmuX79e4HZLIgdeis832RkZGVy9epXU1FRGjBjxTS+xrKwso0aNYuHChairq9O9e3fu3LmDqqoq1tbWACgoKGBubo65uTlQuFSyrKws4bdTksaMdHPVoUMHzpw5Q+XKlalTpw6ysrIoKCggJyeHrKwsqqqqxb6mjIzMNw1PkUjE3bt3adSoEQBGRkaIxWJUVFRQU1MjISEBBQUFBg4cWKjrSg0oS0tL7t69y6BBg+jWrRuRkZG4uLjg5+eHl5cXffr0EfpRVEijLH379uXQoUPs37+f+Ph4Wrduzfjx49HS0gJyCVRWrFgh1M/8qnovKRYvXkyHDh24evUqtWvX5uLFizRr1gzI3bxLDQoZGRlCQ0NRUVEhKiqKx48f8/btW6pVq0b9+vUZPnw47du3582bNwCCaGhaWhp//fUXAwYMYPny5fn+brOzs0lLSyMoKAhlZWUiIiLYsmULffr0KTAT3regqqrK6NGjuXr1Kl5eXmzYsIHWrVtjY2NTqHbi4uIKXMcHuUQAfn5+BAYGFirF7UdFZqRsdDExMXnW4uJCIpF8VX/q8OHDDBs2jDJlyuD7g4v9v4UcsQTf6ETql9P6z2RZ/H/AH2PmN4WJtipK8jICQ8evqqIZ0cwapzGTadalB2nJydy/fgm7Tt2/+O5bmN2vK+bWtjyrbU70m9c8fvw4T2qMnJwc3bt3F7y3FhYWQG4KWkhICCEhITx//px79+4hKytLxYoVBeNGX1//t1lQEhMTOXfuHMHBwYJyc0m/RH4EgoOD6datG1OmTGHZsmW4ubnRvn17KlasSEZGBrVr12bp0qWIxWKhsB5yX8h2dnb07t2bXr16/fB+qqio5GG3SU9PR0lJCV1dXSwsLDh27Bhly5ZFQUGhQAZKQVKWvgWxWCwYf1K8ePGCFStWsHPnTgAUFRWJj4+nevXqBWpz8ODBrF27FhcXF44cOYK7uzuurq5oaGjku1ktSApNdnY2MjIyhISECBuhkvTkS/v1/v17QTepZs2alCpVCnl5eZSVlUlJSWHhwoUFYiv8Hr73e69Tpw5z584lPj4eeXl5FBQUuHDhAi9evEBTUxNNTU06d+5cqCJx6TXnz5/PhAkTGDRoEE2bNsXHx4fnz58jJyfH1KlTv9DOKsra9OmzSU1NRSKRsGHDBmHNlBo7Dx8+ZO7cuURERFC3bt3fYh20tbUVIqJ37twR1vIRI0awYsUKzp07R9WqVenWrRs2NjZUrlwZTU1NVqxYgba2Nlu3bmXKlCkEBwfTp08fUlJSuHbtGkOHDsXFxYUHDx7Qpk0bnJycvki5kkgkZGVl0adPH2JjY7l//z6PHz/m48ePbNmyhTZt2hRYY+h7aNWqFdWrV2f//v1cvnyZFy9e0K9fvwJHIOPi4gSHREFQrlw5DAwM8PHxKZIxU5IOG8idozo6OsTGxpZou5mZmQLb6afXgn9TzrJVSuWhX/7ZkACRyRlEJGdgoF6y4/oHRccfAoDfHJ9yp/8KAajE+DiUVFRQVFLm6IaVPLt/lwX7Tnzx3beQ9CEBeXkFsuOiOLN5NTdu3GDixIl5BAd79+79TRVniUTC+/fvCQ4OJiQkhNDQUCH1pnLlysK/X0FzLC06vXbtGkpKSrRv377YitQ/G2fPnsXJyYkFCxaQkJCAnp4eEyZM4NChQxw6dAgVFRUGDhzIhg0b6NevH1ZWVnTv3p3u3bsza9YsoGTEML+F0NBQatWqxYwZM/jrr7+Ez+Pi4qhTpw7btm2jZcuW391ESlPpSoqiOCUlhdjYWAwNDfH19aVJkyYMHDiQKVOmUKlSJaZPn46vry9Xr14tUG1Dz549UVVVZcaMGUWeR5+OQUZGBpGRkYXSWCkKduzYwfv375GXlycpKYm4uDgyMjLIyMggPDyc7du3l4gxUxR8Oh5v3rxBX1+/yPpTW7duZcaMGYhEIuzs7Khfvz7169encePG+Pv7s3XrVlauXFmsSMnXzpXWHgUEBDBp0iQMDAzYsmVLka7xMyC9j5SUFObMmcP27dsxMjKiUqVKrFmzhoyMDGxtbfHy8hIK1D9+/EhoaCiqqqoYGxvTokUL3rx5w7FjxzA0NGTbtm1YWVkJqa2fYsuWLSgqKmJlZUW1atXIysrC29ubO3fukJ2djba2Nq1bt6ZKlSolYvxlZ2dz8OBBXr9+jYKCAn369PkmM6cUCxYsoF27doVipHv8+DGnT59mzJgx30xRk0gkvHv3DpFIREBAAF5eXvz1118lvjbv378fRUVFunfvXqLt5uTkAHw14uz+5v0v1+QTkasnY1fp92dR/f+CP8bMfwBSVdvA+GTif5GqLcCR9St47u0lGDOFhaKsDLG3LzF37lzc3d2JiYkhJiaG+Ph4WrZs+YVC9LeQk5PDu3fvBOMmIiICAB0dHSFqY2ho+AV3fUkjPj6ec+fOERoaipWVFS1btixxL9jPwvbt2xk2bBg6Ojrs2bNHYCU6dOgQe/bsQSKRICMjw/v37wkKCqJDhw7s3bsX+HmUxps2bcLV1ZX27duzZMkSAMLCwmjatCk7duwQRCK/hqysLHJyclBULJygmUQiEe5fimfPnjFz5kw8PDwwMjLCycmJmTNncvXqVRYuXIiZmRnbtm0T6ouOHz9eoEjd57oQhVFKl6aS+fv74+HhgZKSEg0aNKB8+fLCvPzRzyo5OZnExMQiFdqXNMLCwjhy5AjPnj0jPj4eExMTbGxscHJyKnRb0nG7ePEiCxcuZNq0adSoUUNIs/Hy8mLatGlkZGTg5uZWIjVy0mt+7ihwcnLi9evXbNy4UUhB/Pyc3xXBwcFUqFABBQUFoqKi6NixI23btmX27Nm8fv2a9evXY2pqyujRo0lJSSEmJoYRI0YQERHB5MmTGThwYL73KJFIePbsGY8ePSI0NBQlJSVq1qyJlZUVpUuX5tixYwQEBAC5ZBL169enVq1aJZK2/PDhQy5evIhYLMba2vq7FOILFy6kVatWXzy7byE7O5vVq1dTo0YN2rRpQ1paGpmZmV848GJiYpgzZw5ZWVl5DCs5OTlatmxZqGt+Cz/KmPkWEtOzuPHm/U+73vfQ3FCHUopfzh+RSISbm9t330c/G+7u7tjb25dYjejvhD9pZv8BiEQiDNSVMFBX4p+Vq1mzehVxsbFUrGKG88z5VK9jw5uAV+xY6ELA40folC2HQ/8htOk9EMg1QiLfvEZZTR3PcyeRV1Sk46ARdBoyGoDQV8/ZOm8Gr189R01Dk5Y9+uI0ehLwbyoZwNGNqwDoWrUcJ15FCN9p6ZZh2djB7PZ6hqJybtqO3213Vowfxo47j1k0tC/m1raYWzdg7v+mYVSuXJnbt2/TuXNnIiMj0dXVBXJfCo0bNyY6Ovqbhf+ysrIYGhpiaGhI8+bNSU1N5fXr14SEhODv74+3tzcyMjJUqFBBMG7Kli1bYuk1YrEYb29vbty4gZqaGv369aNy5col0vavwpAhQ8jIyGDs2LGC8CVA9+7dSUpK4tq1a2RlZbF//35iY2OFuoQfHZH5FNKi4+3bt3PmzBksLS158OAB9erVK9CLIzU1FQUFhUJt9qTRlE/PefXqFc7OzlhaWnL8+HGePn3KlClTaN26Na1atSInJ4c+ffpgb29PTEzMd9MhP619kRoy0nEtSOqK9OX0+PFjdHV1hdqis2fPoq6ujrm5OV26dGHkyJE/jBEwPT2ddevWcf/+fby8vLh06RIeHh5kZ2czePDgnx41DQsLY9KkSURFRQEQFBSEiYkJixcv5tGjR0LqZEHXBCkxRuvWrbGysspT83D69GlmzJhBrVq1WLp0aYkYMp/+rmRlZZFIJCQkJDBt2jTevn3LiRMnhM3q8+fPAX4KW2JxjaVPayz09fX566+/GDFiBDt37kRPT4/k5GT69etHZGQks2fPZtWqVWzatInly5czevRo9PX1adOmTb59qlGjBjVq1CAuLo5Hjx7x+PFjvL29KV++PFZWVpiZmXHhwgVSUlK4cOECN2/epE6dOtSrV69Yhex16tTBxMSEXbt24e3tTVBQEAMHDvzqO0zKXFcYyMnJYWlpibe3N6mpqULa5JgxY/Icp6ury7FjxwShVSmys7P/E2nP30LIh9Rf5sz9HCIgJCEVS/0v17XIyMgiEUP8QdHxe8qk/0G+8PX1Zc7MGWzfspkA/1e0bW7HukkjMVSWYemIftg2bMhJj7u4LFzCyU1rcD9zXDjX68p5FBQVWX7yCh0Hj2TfikVEvM5lD1s3fTxG1S1Yc96dUYtWcnr7Rh563Mhz7YbtHHF0Ho5Z7Tps9/TL811N28YoKavw6Jab8Nm9qxep16xVnhQ0M8u6LPhnOeXLlycyMpL69etjYGDAqVOnhGOOHj1aJB0WFRUVzM3N6dChA+PHj2fMmDG0adMGJSUl7t69y/bt21m+fDlHjx7l4cOHJCQkFKr9T/H+/Xt27drFlStXsLKyYuTIkf95Q0aK0aNHM378eIYPH86jR4+A3Jdonz59sLa25s2bN2RnZ/8SQwZyC+CHDx/O/v376d69OwYGBkycOJHDhw8X6Pw7d+6QmZn53eOys7OF/8vIyBAZGcn8+fNZtWoVHz9+5MqVK2RlZbF161ZatmyJk5MT8vLynDp1iszMTNq2bcu8efM4ePAgT58+xcfH54uInZTuFxAiL3fv3mX27NnCxrmgkOpv1K1bl0qVKuHk5MSRI0c4d+4c6urq6OnpsXTpUrp161bgNguLbdu24erqiq2tLbGxsYjFYkqVKoWLiwubNm0q9OatOBCLxezYsYMHDx6watUqXFxcyMrKYuXKlWzcuJGNGzd+EWn7HqTPIzs7WzBksrOzWbNmDbNmzcLBwYEDBw5gZGRUIp5PWVlZUlNThboEKU16eno6ffv2xcvLi+XLl1O7dm3Gjx9P+/btcXd3B3JZ8ApCTV4UiEQi4f5K4j47depEVFQUmzdvZubMmXh6elK3bl0iIiLw8vLixIkTVK5cmSVLlmBvb8+FCxfy7dOuXbs4c+YMCQkJlC5dmpYtWzJx4kS6d++OoqIiZ8+e5cqVK5iamiIjI4OamhrGxsZ4e3uzdu1aTp48KUT4i4JSpUoxbtw4LC0tiY+PZ82aNTx+/DjfYwtrzGRnZ/P48WMCAgLIysri2bNnQjrW5xCJRF84bEQiEeXLlxdqmP6riEhO/y0MGcg1qCKS0/P9Tl9f/4dnhfxBXvwxZv5DCA0NRSQSUalSJQwNDVm6eDEHD+zH+9JpDPT12LpqGQ42lozs48SISVO5sGebcK6aphb9p82hbCUjOg0ehVopLYKf5S60seHvUNPUQrdceSwb2zN35xEqV6+R59qKSsooqagiJ6+Alm5eVhhZOTnqt3Lg3tXcl0xOTg7eNy7ToK1jnuMUFBSQU1FDVlYWfX19ZGVl6dmzJ8eOHROOOXbsGD179izWOIlEIkqXLk29evXo2bMn06ZNY9CgQdjY2JCcnMyFCxdYt24d69ev58KFC7x8+VKgsPwWxGIxt2/fZvPmzaSlpeHs7Ezbtm3/zy1aq1evxsHBgQ4dOvD69Wsgl8Vn8ODBHDt2LE/h6s80ZKSQkZGhWrVqzJ8/n2XLljFixIhCnfs1KmZpLQ0gRC8SExNJSEigVatWXL16lUWLFvHXX3+RnZ3N8uXLCQwMZPbs2fTo0QMbGxu2bt3Ku3fvABgzZgwODg7cv3+fxMREwsLCgNx5lJOTI9AWA+zcuZNatWrRoUMHQkNDCzQfP4dYLBb6L9VpaNGiBXXr1mXkyJG4u7sTFhZWKKa3wmDJkiVs2bKFKVOmoKGhgaysLAMGDOD48eNs3LhR6NPPgIyMDAcPHmTx4sXUrVsXW1tbsrOzefPmDQ0bNkRTU5OnT58Wqs3nz58zbdo0oqOjgdxaJFdXV86ePcvAgQNZuXIlcnJyREdH59lIfm3T+T1IJBKaN2/OoEGD8PT0ZN68eTg7O3Pw4EH+/vtvTp8+zdWrV+nSpQuLFi1i8eLF7N27l/Xr1zNixAhatGjB1q1bi3Tt70EkEpGYmEhKSkqJpay0a9eOzp07o6OTW4dQp04dHBwcWLRoES4uLkyaNInAwEChzkQ61yUSCcnJyURHR+Pn58e6detYvnw5586dIzk5merVq9O3b1/Gjx9P/fr1CQ8PJzU1lfT0dF6+fEnLli1p0aIF7969Y9u2bezatYuXL18WyfiWkZHB0dGRvn37Iisry+nTpzlw4MAXbcnKyhbq93D37l1Onz4tGLbSMc+PwMTOzo6oqChOnz7N6tWrmTdvHhKJBAcHB0QiEQMHDhTY/ObNm0f//v0ZO3YsampqGBoacvXqVTZs2ICenh66urqsW7dOaDshIYFhw4ahp6fHsGHD2LBhg+AYdHd3x9DQkJEjR1KqVCn++eef796XoaEha9asoWbNmqiqquLg4CBEUj9vb+GSJWTkiLl58gjj2jWhV63KTOvahuc+/7KfZaSn4eoymX51zRjaxIrrxw/S3bwCMWHviAl7R9eq5Tjmupr+1tXYtmAmAPevXWK8Q1N61a7M9O7teO7tJbQX+uo5M3t2oFftygxtYiVkpwA8vXebMR2aoaSkROXKlfPUrkkdD5AbsZ4+fToVKlRAVVUVR0dH4R0h3dOdPHkSY2NjoeY2Pj7+u2MHCM+yVq1alClThsDAwDzPqFSpUvTr1++rztt3797h6OiIiooKhoaGzJ8/v8jr1a/GnzSz/xBat24thNEtLS3p2LEjQ4cO5dKlSzx+/Bg1NTXh2OycHEQy/2409Qwq5Nl4KquqCl7hLsPHcmDVEq4d2U8duxY0dez2hcHyPTRs15F/RjuTlZmJv+8DsrOyqN3I7ovjcj578fXq1YtVq1YRFxdHSEgI79+/x8HBoVDX/h6k6WYVKlTAzs6O9PR0QkNDhXqbBw8e5KbyGRgIKWkGBgZ5xis6OpozZ84QFRWFra0tdnZ2vzVFdHGxb98+2rVrR8eOHbl+/TplypRBW1tbCJ3/7nn5n+PSpUs8ePCA0qVL06pVq3z7/qm6+I4dO1i6dCkGBgZoa2vTv39/pk6dyvbt2zlx4gTVqlWjZcuWTJ48mcTERGbPnk2bNm1QV1fn2rVrGBoaIisry8iRI4mOjubw4cPCfJFGAyIiIli2bBkHDhygdOnSDB48mAEDBuRLISut2ZGy/eR3jNTbm5GRgaKiIllZWbx+/ZorV64wdOhQqlSpQlpaWp4UwpJEUlISJiYmQK4xJU0rq1atGrGxsUUuuC8qZGVlhXtVV1fH0NCQCxcukJ6ejomJibBpLij09fXZtGkToaGhlCtXjtjYWA4dOoSenh42NjYMHTqU+/fvY2ZmRlRUFEpKSly7dq3IBr9IJGLs2LFs376dsWPHoqSkxKRJkyhbtixt27ZFTk4OXV1dwSBOT0/n7NmzXL16VdBjmTFjBj169PghKX6lSpXC19cXd3d3evXqVSiq4YJi2bJl1K1bl927d6OlpcWWLVto0KAB8O/vSCQSoaamxowZM4iMjMTT05Pg4GAePXrEo0ePUFNTo1q1ajRq1Ah7e3uaNm1KUFAQDx48IDAwkAsXLqCnp4ejoyNpaWncv3+fo0ePoqmpiY2NDZaWloWeu8bGxkyZMoU9e/YQFBTEihUr6NevH2XLlgVya3bevy947YelpSXPnz8nNjY2j/GYnzFz8uRJatWqRatWrUhNTeXw4cPUrVv3q8/nyJEjTJs2jcePHzNz5kyBKc7d3Z3jx48zefJkevXqha6uLp07dyY1NZXz588LTG4DBw7kzJkzQC65Rnp6Og8fPiywk2/u3Lls3LiRWrVqMW7cOLp27cqdO3e+aO9DlpjdJ4+wY+Eshs5ZQpWaltw8dYTFw/uy7pInpfXKsnPRbPx9HzB7+0FycrJxnTUZ8Web81ePfFh2/BJisZjQV89ZP2M8w+ctxaSmJY88brBwWB9WnblB2UpGrJs+nmp16jF+xUYiXgezfNwQjC1qUbuRHSvGD6eD8zAmDnEmwO8B/fv3p3Hjxl8wV44YMYI7d+6wd+9eSpcuzfTp0+nYsSMPHjwQjlm8eDGHDh1CIpHg6OjIypUrWbRoUYHGb9++fZw+fRp9fX2qVKmCnZ2d8IwkEgmjRo3K84ykkEgkdOnShVq1auHr60tkZCTDhw9HRkaG2bNnF+javxP+GDP/IaioqHD//n08PDw4d+4cu3btYtOmTXTo0IHmzZuzceNG4dhXcUm8TUwT/paT/3JhkS6KnYeOoUFbR+5fu8QDt2vMG9idEQuW0aJ7nwL3rXq9+iipqPLk7i18Pd2wadEG+XwWs8+deLVr18bExITTp08TEBBAx44df3gBvZKSElWrVhXYcz58+CAYNt7e3ty6dQsFBQWMjIwwMjIiLi6OBw8eoKOjI+ir/F/Cp+rsUsjJyXH8+HHMzc0ZNWoUx48fz/N9UQ2Z9OwcPqRnkZiRTZZYjFgCMiKQl5GhlKIcmkryJSpGJpFIePLkiVDPMmvWrG+mFs2fPx8VFRXevn3LiBEjePHiBbt27aJjx45ALtOYu7s73t7e7Nq1S4jytWrVisePH5OZmcnBgwcxNzcXqGMnTpzIypUr82xqXVxcWLx4MW3btmXnzp20adMmX+M4OzsbOTk5wdAaM2YMT5484f79+/k+AxkZGeTl5Zk6dSrx8fFcvXqV5s2b06JFC7y9vXn37l2+LFDFhVgsxtHRkfnz5zNt2jRycnJISkrizZs3rFixIg8V+8/CwIED2b59O/7+/kydOpX27dszd+5cateujbOzc6EIRyB3A3r+/Hn27t1LRkYGmpqa9O3bF1tbW6Kjo1FUVGTChAlkZWWRmppaKArdr0FKex4VFSVshD+Hn58fBw8exM/Pj1q1auHm5oazszP16tWjbt26REVF/bB6JWlK1ZYtW36YppaTk1OBCRvKli0rHBseHo6npychISH4+Pjg4+ODuro61atXp1GjRvTu3ZuPHz9y+vRpXr9+zd69e9HR0cHKyoqmTZvi5+fHtWvXcHNzw8rKChsbGzQ1NQvcbwUFBYYOHcqdO3e4ceMGW7dupUmTJtjb26Onpyfo6BQE6urqQmQ8KChI+Dy/GhhtbW1kZWWxsLAQ0tzs7e2/2raOjg4LFiwQojZHjx5l7dq1VK5cmSlTpjBnzhyCgoKIjIzEw8MDf39/KlSogLa2NsuXL6djx474+/sL7U2fPl1wahQEgwYNom/fvkBuhLpy5co8e/bsi/b845K5uH8H7foOFuQh+k2exQvve1zav4uuI8bjfvo4Ltv2Y1o7d70ZNGshC4f2znO99gOGol/REIC108bSonsfGnfoAoBD/yE89/kf9s47LIqri8Pv7tKroEgREbBhb9grFozYYhcs2HvsRo2JLYnGaGLsGnvvvYO9gooFFRXpAiJK72V3vz/ITkSKINV8+z4Pj+7uzJ07M7tz77nnnN9x4+L+XQybs4D3IW9o3MEeIzNzjM0tWLDtIOXNLUiMiyU+JooyZcuhZ1KBQYOqY2ZmluU3GhUVxe7duzl//rxwD/bu3UvFihVxdXUVnhGLFi0ShBkGDRrE/fv383z9GjduTPfu3QHw9PQU7lG1atWADKGGGjVqZLpHAFeuXCEwMBB3d3fEYjHVq1dnxYoVDBs2TGnMKCla7t69y5UrV5g3bx52dnYsXboUY2NjzM3NuXTpElZWVsKE6bDLZm67uTNi3s+5tpmakszuFb/y7agJ9Bg+lh7Dx7JpwWzcXM5lMWZym8CKxWKaf9MNj+uX8bjmyvifV2S/XTZtODk5cfr0aXx8fPLkmi5sypQpQ6NGjWjUqBEymYy3b9/i6+vLy5cvuXDhApBRL6RChQpER0djaGj41SdSKoiMjGTPnj20a9eOOnXqZLrHenp6PHr0qMAeqJjkNPyiEwmNTyZFmhFukd03SWHnqkvEmOloYF1GC32NLz92WloaKSkp1KtXj/v376OpqflZI0wqlTJ79mymTZvGjBkzSE1N5fr164SHh5OYmIiOjg7NmjXj+vXr7NixAxMTE8zNzZFKpRw4cICePXsSFRUlFIZNTU0VZGffvXsneAOGDBmCo6NjjrUmFJ6vq1evIpFIhOKDCxYsoFatWqxdu5bvvvsux/OYMmUKCxYsYMOGDTRu3Jg9e/awYsUK+vXrJxRdLEzEYjHz5s1j/PjxzJkzh9TUVH777TdBcfDQoUOFfszPMX78eCQSCceOHePUqVM4ODjw9OlTxo0blyWBPK+0bduWtm3bAggeMCBfQgL5RSQSZWvIxMbGsnfvXi5cuEBSUhLNmzdnwoQJ7Nu3j4SEBGQyGc7OzkXWLwXt27cnKiqKY8eOMWzYsFKz2FOhQgUhZDkoKIibN28Kkzd3d3f09PSoXbs2ffv2JSAggGPHjhEfH4+rq6sQytq7d2/evn3Lw4cPcXd3x8bGhmbNmlGxYsU8L+i0bNmSatWqsXPnTm7cuMGrV6+oV68eHh4ewmJFXlBTU8PR0ZELFy4Ik93cvH4GBgaCJz23elpWVlbCuSjGNYWMu+J1SkoKQUFBlClThmrVqhEUFARA06ZNMTAw4MWLF4Khl18J+JYtW2bqi6GhIS9evBBEgRTtpclkhPj6COJECqrVb0Sw32tC/HxIT0ulSu36wmfVG2RdRDGqYC78P8T3NXfOn8b10G7hvfS0NOq1zPiN5xa10tnRmQ0/zeLEptX07tmDESNGZHm2ent7I5PJMhVVNTQ0pHr16rx48UIwZj6W4NfT08tXCOLH11txHxSGDICNjU2We6TYNiIiIpPwhUwmIykpiYiIiFzlv0sjSmPmK0JTU5NFixZhbGxMx44duX79OvHx8fTu3Zv169czduxYZs6ciZ+fH8vmzabrsDGfbVNNXYOXHvfYGhbKoGlzSUpIwOuBG006ZB3s1TW1iAx/R3jwG8qbV8zyeSuHniwaMRA1DQ3qNGuV7fEUVbhfv36NlZUVKioqODo6smTJErS0tLC3t8//hSlExGIxxsbGvHjxgrCwMMqXL0/Dhg2JjIzEz8+Px48fAxlFzBQhaRUrViyR3JGCEhoayr59+1BXV89xcFZMvvOb6K+QE/eOjCcqGznx3KLsU6QyAmIS8Y9JxFBDlaqGOpjpqAuJx3mdRMTExLB06VL++OMPNDQ08rTfhAkThBhuyJhAdO3alQsXLtC9e3dsbGywt7fn7t27WFhY8OTJEwYMGEBQUBCVK1dm9+7dmQyUwMBAhg8fTt26dTO9n9uqfVJSEk+ePKF27dosXLiQBg0aUKtWLYyNjalYsSILFy5k8eLF9OnTJ1vvglgsxtzcnK1btwrtRUVFMWXKlCItblqzZk1cXV3Zs2cPjRo1IiAggJ49ezJixIh8rWgXFrq6uoKUb5kyZZBIJPz999/4+Pjg6ekp3OMvQSHv/bFk96f/L8owzEuXLrFjxw7evXuHpaUlTk5OwsrvyJEjM01QilqkQyQS0bNnT3bt2sX+/fsZNWpUidzv3LCwsGDQoIzFOX9/f27dukVQUBB37tzhzp07lClThrp16/L69WskEgm1atXC19eXZ8+eYWBgQNOmTVFRUeHRo0ds374dMzMzmjVrRs2aNfN0bY2MjJg+fTpHjx7Fy8uLS5cuIZfLef/+fY4et+wQi8V06dIFXV1drly5kknkIbPXW86b2CTqtO0IK1cSFp8seL0/NaCyM6ayM4A/jpgIDw8XclOlUmmmPIv8RlZ8ulimUHb8tD2ZHFSzCfeTyaTIpFIk/3j0Py4xnl0+l5rav/2TStP5dvQE2vXMLC+t9s8xc4taGbNgKV2chuFz+zJuly6wadMmTp06lUmWO6dr8ek1+zQyIj95aB8fI6/Hgwyvv42NTZbwM6BE6vUVFKUAwFdE/fr12bZtG8uXL8fGxoYlS5awZ88e6tSpw/nz5/H29qZ+/fqMHj2aEWPH0WtMziu3HzN95UaSExOZ3c+Bn0c5UtO2GX0nTM2yXdNOXZDLZUzp1paYiKzxvtXqN0LPwJBm9l2RZPOAlAP2HdpTpUoV6tSpIxgGVapUoWbNmvTu3bvE81DevHnDxo0bcXNzw87OjjFjxtC0aVO6dOnCxIkTmTZtGj169MDQ0JCHDx+yc+dOli1bxr59+3Bzc8sS01xa8fX1ZefOnZQpUybbFaVPyc9kKDldiltIFO6hUUT9U9wsv1dEsX1UchruoVG4hUQRn5wqTBDzokj2119/ZclT+RwmJiZ07dpVqJ8DGQpv3t7ePHr0CLlcTrVq1ahQoQJBQUFC4vX58+d5+PChYLAo8tGqVq3Kd999x44dO3I8pmKQUazGbdmyhc2bN6Ojo8PQoUN5+PBhpqT9yZMno6ury8SJE3NsUy6XCxMdTU1NvvvuO4YPH17kIZwRERHUqFGDIUOGsHPnTkaOHFnidZfU1NSERSALCwtGjRpFv379mDZtmqBeld/frOL38HHh1U//r/gOFMXzICkpiTdv3tCvXz/++OMP7OzsePHiBSNGjBDyJZYvXy6o4hW1kpyqqioDBw5EVVWV/fv3f5GARXFhZWXFkCFDmDdvHk5OTlhaWhIXF8ejR4+Ij48nOTmZ+/fv07x5c4YNG0bFihW5desWV65coVy5crRr1w4NDQ2OHTvGqlWruHXrFklJSZ89rlgsFgoNKzh58qRwbxSLS4mJibm2IxKJaN26NYMGDaJVB3sehcVw1ucd53zDuRMShdeHONJlcsITUniXlPFsufzqDed8wznr846nr16TKs3/96F69epER0fz6tUr/P39MTExwdvbm9jY2AKFVCrmAZAhnx4TE5PtQoNYBGZWlfF+/DDT+6+fPKSCVWVMLKxQUVXD95mn8Jnfc89Pm8mEmVVlwoPfYFrJSvhzPbSHRzeukJqSzNZff0JFVZUew8eyeNcROvUfjJvLOaLeh7N58VxMK1kydvos7t+/T4cOHTh16lSm9itXroyKigpubv+KFERERPD69etCCUP9lI/vkQIvL69s71H16tUJCgrCyMiIKlWqUKVKFfz9/VmwYMFXlQ+rQFk08z9KcrqUc77hJd2NLDhULp8lJ0Imk1GpUiV27dqVa2xvUZKamsqVK1dwd3enQoUK9OzZU3Bz54RcLicsLAw/Pz98fX0JCgpCKpWiq6sreG2sra0LpeZEYeLp6cnJkyepXLkyffv2LVQ1tuC4JB6GxSCVyQtVQlMESMQiGpros2T2DN68eYOenh7r169HT09PWBFXKHr5+vrSsWNHZs2axeTJk/N1rLt379KqVSu8vLyEAeDbb79FV1eXJUuWULFiRdzc3PD19aVv376ZkoO/xIPl5eXFhAkTqFatGjNmzODDhw9899133Lt3D1VVVXr37o2GhgY//vijkFx6//594uLihPCznAgJCaFChQpFGgal4Pbt2yxbtowHDx4glUq5efMmc+bMoVatWvz8c+7hrkXJ999/j4uLC2PHjqVp06ZoaWlx8+ZNdu3aRbNmzVi+fDlJSUmoq6sX+BopPDJxcXG8evWK+fPn4+DgwKRJk/IVUpQXAgMDqVSpEpARhz9p0iQqVqzI1KlTef78Oe7u7tSoUYPNmzcXy/0HeP/+Pdu2bcPMzAwnJ6evymP98uVL7t69S3BwsGBgKIrO1qtXj5cvX/Lw4UPevXuHvr6+IKjx8uVLRCIR9erVo1mzZnkSlkhMTGT16tWkpKSgra2Nk5MThw4dIiYmhhYtWtCpU6cc9/2c1xtganc7GrXryDeOzkx2aIPDkJHYDxjC3YtnOLh6BS269GDBX+s4tfEvHt69JShvZVdU8eMCkA4ODrx//55GjRpha2vLpk2b0NLS4vr1619UkNHS0pLY2Fh27NiBpaUlkyZNQkNDAxcXlyztvYqIZ/PuvaybN53RC36jWt0GXD52gLM7t7DihAvm1lXZtGA2Lx89YPzPy0EuZ/1PM3nz+hUbLt8DuZzxHZuy4ZK7EFni/diDHwf3wvn7+TRq15EHV13Z+ftiFu44TK3GzZjVuzNGFcyFqJU1cybTpMM39J80g3EdmtC0YxdmTJ+OemI0/fv3Z/HixYwZMybTNZswYQKurq5s3rwZQ0NDZs+ejZ+fH56enrx9+xYrKyv8/f2FcLGFCxdy7do14Z7khkKV7uPFMgcHByIiIli7di1yuZyJEydme4+kUin16tXDysqKJUuWEB0dzdChQ+nYsSObN2/O/oClGKVn5j+KhooEdUnpur3qEnEWQ+bs2bNMnToVTU1NIRa9uPH392fjxo14eHhgb2/PiBEjPmvIwL+x7C1btmTo0KHMnj2bQYMGUbt2bcLCwjh27BgrVqxg06ZNuLq64uvrW6zytNlx584djh8/Tt26dRkwYEChGjKvI+O5FxpNeiEbMpAxWKfL5NwLjSZZ24AuXbogk8no06cPW7ZsQS6XEx4ezq5du7C2tmbatGkMHDgwV0NG4RH5dPBt3rw59erVY8OGDcJ7gwcP5uLFi4Isb7NmzRg0aJBgyCjayOvkLT4+nvfv3yMSifDx8cHf3x91dXXGjx+Pra0tycnJ7NmzB8jwxPj6+nLgwAHBI9W4cePPGjKQMUGDLxdsyCuBgYEsWLCAChUq8Ntvv1GmTBkqVqxIx44d2bZtG+vXrweKxkuRGx4eHri4uDBt2jTGjx9Pw4YNsbGxYfTo0QwZMoQrV64AGd6rgkz2Fd8lkUjEL7/8wrhx47C1teXbb79l27ZtQOHLmCsMmTNnzjB+/HhmzZqFp6cnI0aM4I8//mDTpk0cOXIEHx+fYjFkICOcqn///gQEBHDu3LkC3W9F2F5xYWNjw/Dhw5k3bx59+/ZFX1+f5ORkrly5wsqVK7l//z516tRh2LBhWFtb8+TJE7y8vLCwsMDGxoaXL1+ybt069u3bh5+fX65919LSok+fPgAkJCSwefNmYmJiAHB3dycuLi7b/fLq9f7G0ZkLe7ezfekCxv+8gltnTzC1WzsCX3rxzaBhQIbXOyQuidiUdJLT8ybHq1Dk2r59OzNnzqRWrVqcOHEiT/vmxLBhw5g7dy4tWrTA1NSUgwcPZrudvroKLbr0wGnqHA6s+p3pPTvy/N5dftq6H3PrjJyTod/Px7J6DRYN78/yyaNp3bUXkDWUTUG1+o2YvGw1F/bvZErXdrge2sO0P9ZTq3EzIOeoFVU1Neau30HAi2f0bNuc/v37M3LkSEaNGpXlGCtWrKBTp0706dOHli1boqGhwaVLl4pM3VExBnbo0IHOnTvneI8kEgmnTp0Scnr69OmDg4NDJinurwmlZ+Y/zKOwGAJiEktFkSkRYKmvlaVarp2dHa9eveLgwYOC+lNxkZKSgqurKx4eHlSqVInu3bsXatJbfHw8fn5+gucmPj4eFRUVLCwsBK+NsbFxsbh05XI5Li4uuLm50bp1a+zs7Ar1uK8j43n6PvsBuCioa6RHFUNtDh8+zJYtW6hevTqrV69m69atzJs3j0mTJjF16lR0dHQ+m7+Q3ec7d+5k1KhRvH//Xoj/9/Pzy1Ic9UtyI4KCghg/fjw+Pj7cunULIyMjqlatyowZM7h79y7h4eFUq1aNlJQUNmzYgEgkYvz48ZQvX5558+blywC9e/cuzZs3L7KVecX5nz9/nqlTp/Lq1SsuX77MuHHjeP36NQDLly/nzJkzXL9+vdiLrN67d4+OHTsSGxub6f20tDQmTJhAu3btaNGiBVeuXOHixYvs3r0735OM1NRUtmzZQosWLahevTqTJk0iMjKSI0eOMGvWLJ4+fcqJEyeKzEP7008/cfPmTa5evYpIJBKECZ4+fYqjoyN79+6lXr16RXLsnHj06BGnTp2iU6dOgpTyl6D4fimmKcUd/vLy5UuOHDmCSCRCKpUK/TAyMqJevXqoqanx+PFjQkND0dbWxszMjKioKD58+ED58uVp2rQpdevWzdYjJ5PJ+PPPPzEwMBBqUCmwtbXNUqKgOLze5rqfF7bZvXu3IC5RUCwtLVm4cKHgYciNvESbuF86T93mbdD857fm8/Qx85x6svehDypFFMKeXbSJkuJHKQDwH8a6jBb+MbnH3xYXcsDaIKuiytWrV4u/M2TE5p4+fZqkpCS6dOlC48aNC32g1NHRoW7dutStW1dI9lRIQF+9ehVXV1e0tbWxtrYWwtJ0dXULtQ+Qkb9x8uRJnj17RpcuXQQJyMIiOC6pWA0ZAM/3sWioZsSgf/jwgVWrVvH+/XtGjhxJfHw8f/75pyBRnNskPiEhAbFYnEWdrm/fvqxZs4Y3b95QpkwZ5HI51tbWWYyXvH5n/Pz8OHDgAOnp6QwdOpRTp07xzTffMH78eL7//ntmz56Nu7s7mzdvxsHBgWPHjlGzZk1iY2PR19dn1apV+TJiZDIZLi4ugmpXUa3MK67HxzkSaWlpmWpexcbGCscv7rWzJk2a0L59exYsWMD06dNRU1PDzc2N/fv3s3XrVrZv3w5keDkqVqzIhw8f8q3GlZaWxuzZs3n69CmampqEh4ejr69PZGQkUVFRDBgwAG1t7SIRBZDJZLx48YKmTZsiEomQyWSCMXbkyBHi4uLylWBeWCgkm11dXSlTpkyW2ht5RZF79PbtW/T09NDR0SlWY9jGxoaxY8eyf/9+kpKSaNSoEX5+foSFhXHp0iVEIhHly5endevWJCYm8uzZM1JSUjAxMUEkEnH69GkuX76Mra0tjRs3zvS7EIvFVK1aNVPOiIIHDx7QokULIZexKBeLMnm9jWRUMczZ6A4PD8ff359u3boVSV9yQxFtkpJLvs/hdX/ice0SvUZPIikhnl2//0zj9p2LzJDJLtpEScmg9Mz8x7kW+IHI5JINbRIBBhqqtKuUvyJ1RUFSUhIuLi48fvwYa2trunfvXiLKO+np6YJsrZ+fH2/fvgUyVvwUhk2lSpUKHAaWkpLCwYMHCQoKonfv3l88qciJ5HQpLv7vSZcV/2NERSzC3sqI1MQEqlSpwo4dO3BwcABg48aN/Prrr0Kl5c9RVJ6LtLQ0pkyZwtGjR3F0dOT06dOULVuW8ePH07dvX+bNm8fjx4/p1KkT0dHRzJs3j/fv3zN79mxOnTrF27dvMTY2znM/FY/zp0+fIpVKadCgQbHkS/j7+zNt2jShivXRo0dxcXHh0qVLeHt7M2rUKKpUqVIixVaTkpKEpGrF8RX1eFRUVJBIJIjFYsRi8Rf3LTQ0lPT0dLS1tYmLi0NTUxNjY2NSU1ORSCRFMgFXnMuDBw+4desWAwcOxMTEhPDwcG7evIm/vz/29vbUrVuX9PR0RCKRIAZQHGFncrmco0eP8urVqwJLNqelpbF//36Cg4MZPHgwFhYWhdjTz5OYmMjhw4cJCgqia9eu1K9fn4cPH/LgwQPCw8OFe2FsbIyJiQkfPnwgODgYDQ0N9PX1iYiIQC6XU7t2bZo1ayYUsDx8+DBeXl4AmTxQkFHXaNKkSSXm9f4UuVzOnj17iI6OZsKECZ/9Tvfq1QtXV9ccP9+0aRPz5s3Ls2cGPh9t8sbHm62//Mhrz0eoqKrRpIM9w+YuQltXL4c9vpycok0Kiz///JP58+fn+PngwYPZuHFjkRz7a0RpzPzHCYlLxj00qqS7QVMzAyrolqyq0cuXLzl79ixpaWnY29vToEGDUqPakZiYKISj+fn5ERsbi0QioWLFioJxY2pqmq/+xsfHs3fvXqKiohg4cGC+9f8/h1wuxy0kirCElBIJZRQBJjrqlE2IoHv3buzevRtbW1thonbq1Cm6d++e5ZopJnOKVdTcCjrmJ2k7u4n648ePGTduHJs3b6ZOnTrEx8fz119/sWfPHg4ePEjNmjX54Ycf+OOPP6hTpw67d++mbt26BAUFIRKJqFgxqwR6bseXyWRERUXlu7p9YXDjxg1++eUXIYFaT0+P7777jiFDhpSIEVOcZDeMFuf5pqenZ0naVhhnimRfhdFWnKSnp7Nr1y4iIyMLLNmclpbGvn37CA0NZfDgwfn6bRQGUqmU8+fP4+HhQdOmTbG3txdER+7fv8/Dhw8JD88IgxKLxdSqVYtatWphYGCAqqpqJvluFRUVVFVVM6mgKaS+P5bRjUwX8STy80pphU0TszJZQs5SU1NJSEhAW1s7T4tsb9++JSEhIcfPjY2N8x2JEJOcxuXArEqqJUUHy3LoqxeN1yc6OpoPH3I+Vz09PcqXL18kx/4aURoz/3FKy4SzmZlBiU1mEhMTOX/+PM+ePaNatWp07do1Ux2G0oZcLiciIkIwbAICAkhNTUVTUzNTSFpuWvARERHs2bMHqVTKoEGDMq3uFxalxVA+s+EPIvxfC3r5eVl5jouLo0mTJpibZxRQ2717N+XLl8/3ZO/jmH7F9/tjA2j79u2Ceo0ixOT169fMnTsXFRUVDhw4AMCkSZNYv3498+bNy6T8lZccE8U2qamphSrokB8+7qei6nqVKlUyFcRTUnooTuMyISGBrVu3oqKiwogRIwok1Z2amsq+fft4+/YtQ4YMEX6/xcn9+/c5f/481tbW9O3bN9P5pKenc+/ePVJSUrCzsytQjlhp8HqXxhAqZbSJkuxQGjP/B/y/PhQVsrcKVZ1vvvkmS5X7rwGpVEpwcLDguQkNDUUul1O2bFnBsLG0tBRi5UNCQti3bx9aWloMHjy4yApglYZBRSaVkhYXhWPTOkD+pJEjIyO5f/8+ly9fJjg4mH379uX7+K9fvyY9PZ0aNWoQEBAgaPQ7OjrSoUMHDh06xJo1a1izZg22trbCfosXL+bOnTvs3buXsmXLEhERwe3bt3FwcMiXfK9cLuft27eMGzeOCxcu0KBBA+zt7XFycqJGjRr5Pp8vQTExDg8P59atW0JoX+/evTE3N//qfm9KCp8PHz6wdevWQpFsTk1NZe/evbx7944hQ4YUKHztS/Hz8+Pw4cNoa2vj6OiYrXBMQQxG5SJkzpSWRbTSEG2i5F+Uxsz/CcFxSdwLjS7242bnri4O4uPjOXv2LC9fvqRmzZp06dIlU/Ll10xSUhL+/v6CcRMdHS1UfdfX18fLywsTExOcnJzQ0soqulAYlDZ3f21NKdUszAs8gYC8hwelpqYyffp0zpw5w82bN+ncuTPVqlUjIiKCqKgo5s+fT4cOHWjevDnDhw9n4sSJgkfwhx9+4NSpU3h4eGRRz/qS1dzk5GTu3bvH2bNn2bZtG8OHD+f3338vtvyI4OBgFi9ezMWLF9HT00MsFnPw4EFsbGyK/NhKvg4CAgLYvXs39erVyzb8Mz+kpKSwd+9ewsPDGTp0KGZmZoXY07wRERHB/v37SUhIoG/fvlSuXLnQ2lZO2HNGaegpyQ6lMfN/hE9kAp7vYz+/YSGRUyJhUSKXy/H09OTChQtIJBIcHBwKPem9tBEZGYmfnx8PHz4UhATU1dWxsrISJKANDQ0L7XiHDx/GsEYDYlW1kcnlXNy/k2+chhVK2/4vnpGSlIRNw8Y8c7/DAue+HH0Zmus+MqkUz+uXGN2tQ7HE0X9sbPj4+NChQwcMDQ2xt7dn2bJlxMbGMmvWLEJCQti+fTsnT55k/fr1dO/endGjRxMbG8u4cePo3r07s2bNKpI+KkLOijqcKC0tDVVVVebMmcPFixdZsWIFHTp0KLLjKfm6efz4MSdPnqRjx44FDkFMSUlhz549fPjwgaFDh5aIaltycjJHjhzBz8+Pb775ptBUMUuD17s0h1L9v0abKMmZ0lVVUUmRUsVQm7pGxZMrUrd88RsyMTEx7Nu3jxMnTlCtWjUmTJjwnzdkAAwMDEhOTubt27c0aNCA4cOH07x5cyFXaM2aNaxatYozZ87g5eWVKek0vwQGBtK/f38CP0QhB7zuu7F58Q+Fdi6/TxpJaIAfANUb2LLl5uPP7iOWSKjZrGWeCp0WBEVSrkQiIT09HYAqVaqwcOFCnjx5IigU6enp4ejoSEpKCqtWrWLUqFGMHj2a7du34+DgQIsWLTAxMWHSpElF1ldF7kxRrxwqQuKePXtGt27dBEMmt+KwERERqKqq8vz58yLp0++//067du1KvEBtcaGQ+s6O+Ph4xowZQ2ho7gsCxUX9+vVp3bo1ly5dElS8vhR1dXUGDRpE2bJl2bVrF2FhYYXUy7yjoaGBk5MTTZs25fz585w9exaZLGfp4LwQk5yWb0Pm4JoVzB/Sp9C2gwzJ5sjkNGJSPt+Xdu3asXDhwjy1WxhoqEhoWEQqYp+joYm+0pAphSjrzPyfUcVQGw1VcZEW37Iuo4VUJufZ+1hkchCLQFUsRl9dhTIaqoX+IJDL5Tx8+BAXFxfU1dVxdHSkWrVqhXqM0opMJuPixYvcu3ePtm3b0rZtW0QiERYWFrRt25aUlBQCAgIEMQEPDw9EIhFmZmZCvo25uXmew5oUjtxUqTzT68Li4/ZU1dQwMMqbWoualg6oFI2qjALFNfrzzz+5ePEi5cqV46effmLQoEHs37+fM2fOMG3aNCBjcL9165ZQjHH8+PF0796dwMBAdHR0hCKGBQ0DK64wsuxISUkRasp06dKF27dvc//+fRo3bpxjxW34t7J7URlaCjWowmj/U4UwBYrrLpPJBAGIT+/Dp/dGJpNlkob+dFvFsXKSiFZcN8WxFNs0atRIMKQVbSkm1HFxcWzZsoVJkyaVSChWdtjZ2REVFcXx48fR09MrUBK/hoYGgwcPZvfu3ezatQtnZ+ciETvJDbFYTOfOnSlfvjxnzpyhVq1aWFpafvH3zy86ERHka2zuMWI8DkNGftHxckME+EUlFpn8cEEw19Uk2UhW7NEmJRE2r+TzKI2Z/0PMdTUpp6nGo7AY3iak5PvBmRvpMjnekQlk9xhXHENdIsZMRwPrMlroaxRsAhoVFcXp06fx9/cXkp8LopbzNZGens7x48d58eIFXbt2zZRgrkBdXZ3q1atTvXp1IEPu0c/PDz8/Px48eMDNmzdRU1PD0tJSMG7Kli3LnTt3mD17Ng8fPkQkEtG2bVu2bt2KlZUVAOM7NmXikpWs+yFj8t7HxoxFO49Qu2kLXA7s5vjmtcRGRVC5Vj1G/vgLlapnJKOPa9+Eb0dN4NrJIwS8eE4F68pM+OVPKteuy/whfXgfGsy6H6bx/N5d7Hr1zxRmFhEWyvbfFvH07k1EIhGtu/Vi6Pc/oaqmzpVjB1lx7hid2tuxbt060tPTGT58OPb29gB06dKlwNc7Li6OoUOH4unpibOzMy9fvsTLywsbGxsWLFiAnZ0dR48epU+fjJXPIUOG4OnpyZo1a6hfvz7m5ubCxO3jSemXIpfLefr0KTY2NvmuWl8YfPfdd9y+fRtTU1NUVFRwcXHh7t27fPvttxgbGzNu3LhspXiLo5p7YbWdUzuK+6b4N7vtPr23ud3rvHwPRCJRtseZMmWK8H/Fd0rRnpaWFmpqaiWmcpcdIpGInj17EhMTw4EDBwos2ZydQVMSkrUNGjSgbNmyJCYmFshYD41Pzvd4nFHxvvAjIeT/9KcBpc+YAYToj+IwaOqW16OKQfFGmyjJO8ows/9TNFQkNKtgQFMzAwz+MSgKOvzLP/n/p38KUqQyAmISuRz4gWuBHwiJS/7sCv/bt29Zu3atkBMil8txd3dnw4YNREZGMnjwYHr06PF/Y8gkJyezd+9evL296d+/f7aGTHaUKVOGhg0b0rdvX2bOnMno0aNp1aoVqampuLi4sG7dOpYuXYq9vT316tXjwYMHuLi44OPjw9KlS7l37x4Ayw6fo8U33Zm1egsAW24+pnoDW+5fceHguj8Y+eMvLD/mQg3bpixw7kt8TLTQh4NrVtBr9ET+PHkJLR09tv76IwCz1myhrIkpw39YzIh5izP1Oy01lQXO/UlJSmTxrqPM+GsTHtcvs2v5L0DGd/eBuxuvXr3i1q1brFq1ilWrVgmVuwuD169f4+fnh5ubG/Pnz2fLli106NCB+Ph4WrZsyeTJkxk/frywfaVKlfjmm29o3rx5FkW57Fbn80tYWBgnTpwosRCitm3b0rVrV+rWrUuFChUYM2YMjRo14sGDBxw8eFAoVPkpione+fPnqVWrFtra2nTr1o2IiAgADh48SIMGDdDS0sLY2JjJkyfnGrqjyFvS1tamffv2vHv3Tpj4P3r0iNatW6Orq0u9evUyhWNFRETQr18/ypYti7m5OXPmzMnU7saNG7GxscHU1BQnJyciIyOFzywsLFi1ahVVq1bFycmJhg0bcuTIkUz729nZsX//fiAjPLNPnz5YWlrSsWNH7t69K2yXnJzM5MmTqVmzJo0aNWL16tXZnmd6ejrnz59n2LBhuLm5Ce9PnTqVy5cvAxnfq7NnzzJ48GCGDh3Ks2fPhJDI0oSKigoDBgxATU2Nffv2kZycXKD2NDU1GTJkCHp6euzcuVOo91LcWFhYYG1tnePnt2/fplWrVmhpaaGtrY2DgwNv374lLS2N0aNHY1W1eq4V7hWEB7+hj40Zh9evZGiTGmxe/IMQPpaelsaGn2YyrFktBjWswtLxzkS8e5uljdSUZOY59WTxiIGkpabmeKwUqYxfflsmhNkCHD9+nGrVqqGtrc2kSZMyfVbcVDHUpolZGVTEogLPYT5FREaOTBOzMkpDppSjNGb+jxGJRFTQ1aBdpXJ0qFQOS30t1CX/fiVE2fwpEBfwqaEwXaKS03APjcItJIrk9OwfiHK5nLNnzxIREcHx48cJDw9n+/btXLhwgfr16zN+/PhCVZIp7cTFxbFjxw7CwsIYMmTIFytGicVizMzMaN26Nc7OzsyePRsnJycsLS3p3LkzRkZGHD58mOfPnwuTVAMDAwD0DcqioaWFjn4ZAAyMyqOqpsbJrevpM+Y7bO06YWZpjeOU7zEyM+fGqaPCcdv16k/Tjl0ws6pMjxFj8X32BADdMgaIxRK0dHSzVGx+fOsqkeFvmfL7GipVr0GdZq0YPX8JF/fvJOmfwmxSqZRNmzZRtWpVtLS0MDExQSqV8u233xZKOJyOjg7Pnj1j+/btLFiwgH79+tG2bVtq1arFyZMnGTt2LIaGhplyYUaMGMG8efOKxMj28fFBTU2t2KuhQ8ZvctCgQfz+++/8+eefbN26lY0bN3LkyBFu3rzJo0ePcgxrksvlSCQStmzZwubNm7lx4waenp789ttvuLm5MWrUKKZMmcLDhw9ZvXo1W7ZsyTG/QiaT4eDggLGxMffv32fAgAFs2rQJqVRKdHQ0nTt3plu3bty5c4dp06YxZMgQbt++DWR4NJKSkjh//jzbtm1j27ZtrFu3DoB9+/axYsUK5s+fz4EDB5BKpXTp0kUwDIKDg9m8eTNr165l3Lhx1K5dm8OHDwtGl7e3N9evX6dZs2akpqbSsWNHzM3NWbFiBa1bt6ZPnz48ffoUyFC28/LyYs6cOYwcOZJFixaxY8eOLOeqqDAfFBTEqFGjiIrKULvas2cPz549A8DV1ZXp06ejoaFB2bJl+emnn0o0FDE3tLW1cXJyIi4ujkOHDhV4QqwwaHR1ddm1axfv378vpJ7mDzU1tWy9MjExMXTt2hV7e3ueP3+eaZFo7dq1XL9+nd1HjuXrWC8f3uf3I+dJiI0R3ju/dzvP77kxf+t+lh05T1JCAtuXLsy0n0wmY+WMCcikMr5fuw3Vz3ju3J88Y8mSJQB4eXnRv39/xo8fj4eHB2lpady6dStf/S5szHU1sbcywkQ7w0NdUKNGsb+Jjjr2VkbK0LKvAGWYmRIA9DVUaWCiTwP0SU6XEp2cRkxKOmkyWaa8lzSZDN+oBApLRETRTFhCCi7+72loop/lwfHs2TNCQkIAeP/+PZs2baJMmTIMGzaMSpUqFU5HvhI+fPjAnj17kMvlDB8+vFDDKdTU1KhatSpVq1bF3t6ev//+mzt37vDy5Uv8/f2pWLEiGzduBCCnbKtg39fsXvEre1cuFd5LTUkRkvoBTCv9u3Kpqa1Leh4StYN9X2NmaS0YT5AhECBNTycsyB+Askbl0dPTQy6X069fP9atW0e1atUKbSJnbGzMwoULWbJkCeXKlcPe3h47OzuePn3KvHnzuH//PjNmzGDs2LH8/PPPguEHn89tUXgrQkJCOHPmDO/evcv0eXaTI8XEeenSpVk+y277T9/L62tdXV0mTJiQ5bOP8zyyMxYlEkmOoTbp6eksW7aMFi1aADBw4EA8PT3p378/69atY+jQoQDY2Niwbt26HFfar169SlhYGBs2bEBfX5+aNWty7do1wZPbqlUrZs+eDUCdOnV48eIFq1evpmXLljx79gxbW1uaNGkCwIkTJ4R7tnjxYpYvX06vXr2ADC+UmZkZly9fpnPnzqioqDBo0CA6d+4sXI+uXbuSnJyMlpYWR48exc7ODisrK9auXUvVqlVZtWoVAH379iUiIoJ169axceNGLl68SNu2bYVzNjIyyjaPRCKR0LBhQ65cuYJYLObFixe0aNGCcuXKCRLs8+fPp02bNqxduxZ1dXXmzZvHtWvXsr12crmcx48fC16sj0PmPg5p+zg/59NtPn6d3f65tS0SiZBIJHTt2pWjR49y/PhxOnXqJOSmKY778f45/atAS0uLIUOGsGvXLiHkrFy54lfjyu57n5SUxE8//cT06dMRiURYWVnRp08f7t27h0gkQlNTE+2yRogSpHkOM+vmPBoTC0tMK1kR+S5DACE85A1qGhoYVaiIbhkDJi39i/joyEz7bf1lHm8D/fl59zE0PiPfLwJGTpzMyJ7f8NNPP7F9+3batGkj5AeuXbuWM2fO5LHHRYci2iQ0PoXXkfFEJqflO4Resb2BhipVDXUw01FXyi9/JSiNGSVZ0FCRYKIjweSTsiyvI+PxjkwokmPKyci3uRcaTbKRTIiFTU1N5eLFi5m2lclk9O7du0SKpZUkb968Yf/+/ejo6DB48GChZklhExISgq2tLY0aNaJTp07Mnj1bqKXSvHnzf7bKfoiQSqUMn7uIOs1bZXpfS0dX+L9KLsnhOaGqntWzIftnJVf2T1iG6j8roh8PPoUpUKCvr89PP/3E5MmT0dLSEpLcb926xc2bN0lISGDYsGH06tUrkyEDuedEyGQy0tPTuX//Pq9fv0ZdXV2QmP7UWFDk2shkMsLCwtDT00NbWzvb7XL7Nz+faWpmvypZ0HyfKlWqCK8NDAxISkqiYcOGGBkZ8dtvv+Hp6cmzZ894/vx5jvfx+fPnVK1aNdNvoXHjxpw5c4bnz59z/vx5IR9DJBKRmJgoLIBMmzaNUaNGcebMGbp3787AgQNp0aIFqamp+Pn5MWLECMaNG4dcLkdFRYWwsDA8PDzo3LkzMpmMunXrCsds3bo1Ojo6XL58me7du3PgwAEmTpwIgJubG7dv36Zq1arIZDJUVFQIDQ0VQg+HDRvGDz/8wN27d+nevTt9+/bN1LYCmUzGw4cP+eOPPxCJRMTFxQEZvzm5XE5KSorwuSKHaurUqfz222/ZXjuZTJajClpJ8Pz580JXuFN42vLD5yavuX0uEono1asXNWrUyPL7MDExwdnZmZUrV/L48WO8vLx48uQJLVu2ZMyYMezfv59Va9bSdehoJHksnGtUIavR26n/YG6dPcGo1vWp1bg5TTp1wa5Xf+HzV4898HrgRtW6DTMtDuVEWloq58+cITIykoiICLy8vKhfv77wuaqqaqbXJYki2qSCrgYxyWn4RScSGp8shO4VVy6vkuJHacwoyROvI+N5+j6uWI6lSOarYqjNjRs3SEjIbECJRCLOnDnD6NGjS2X4RFHg7e3N4cOHMTMzY+DAgTlOMAuD48ePY2homGm1bc2aNaiqqgq5OSKyT3yuYFWZiHdvMa1kJby3du5UmnbqQuP2nT977JwmChWsKhMa4EdcdBS6ZTIMhVePPZCoqGBiUYkg7xf5O0nyn4iu8J5ERkaydOlSYVV86tSpdOrUCX19fVRVVSlXrly+Cl+KxWLU1NRo2bJlnmtveHl5cfjwYYYPH16g5OmSQOFR+ljxTKEKdv36dXr37k2vXr1o3bo1M2bMYPr06YjF4myTqj/2DilQTOTT0tIYMGAAM2fOFDxJEolECPlzdnamdevWHDt2jIsXL9K1a1cWLFjApEmTkMlkrFmzRhC8kEql6OvrC0pZ2Rl5ffr04fjx49jY2PD69Wt69+4NQGJiIh07dmTQoEGIxWKkUik6OjpC7adZs2bRoEEDTpw4wcWLF9m4cSPLli1j+PDhWc41LS2NJk2acPDgQeH7pUj6j4+PJz09HV1dXeF9hZGX3XNSLBbTt2/fTAayYj/F36evC/LZ59p+8+YNoaGhVK5cGUNDwxz3z62dj7dJS0sjMDAQqVSKhYUFqqqqObbz6Xv52ebTRYCcQko/XSQaPXo0Z8+exc3NjVq1ahEQEMC5h16QD0+AmlrWY1lUrc7Gy+54XL+Mx9VL7P1zKbfOHOfnPceBDLGAWWu2snTcUC4f2UfHfoNyPYaqqirDR4xk3qghggH+6W+uNAlMKMhrtElRqawqKV6UxoySzxIcl1RshowCz/expCbGC/HtCvlTyHiQvn//nvj4+CLzTpQmHj58yJkzZ6hevTq9e/fOVfa2MChbtixBQUFcvnwZKysrDh8+zNGjR2ncuDHa2hkeM/9Xz9ExMERdMyNEwfeZJxWrVqP7sDGs/3EmppbW2DSwxfXQHu5cOE3vsZPzdGx1LS1C/H2Ii85c/bpuizYYm1di9ezJDJ7+A7FRkWz95Udad+2Ftp4+cvKfx5Xf8AHF9np6ekRERDBnzhxiYmL49ttvs6wA59WQ+VJ8fHwoV67cV2fIfMynHjSxWMymTZsYOHAga9asQUVFBZFIRFBQUJbtFdSuXZvXr18TGxsrTLQeP36MXC6natWq3L9/n9q1awvbb9q0SShqumTJEvr378+MGTP47rvvWL58OXv27GHu3LmUKVMGVVXVTMblxIkTGTZsmCCD/Gl/Bg0aRM+ePalRowZ2dnZCeFOFChUIDAwUjBuAM2fO4OnpSePGjdm2bRu9evWiZcuWhIeHs3LlSlavXp3FmBGLxTRs2JDmzZvz/fffZ5GNLlOmDOrq6rx79446deogEomIjo7O8dqJRCJq1aqVyx0qXuRyuaDO2K5duwJJNiuIj49nx44dRERE4OzsXKjFg/NLTotEcrmcXbt2oa6uTq32XXgdmVAgddFrJw6jqqZGS4eetPimO96PPZg7sDsxER8AsKhqQ63Gzeg7fgp7/1xK004OwgJR9oiIjY5m06pl7Nq1i9q1a3Pnzh3hU5lMxpMnTwS5+dJITtEmSv47/H8sayv5YpLTpTwMi/n8hkXA6wQpegZlqVy5Ms2bN6dLly4MHDiQcePGMXPmzP+8ISOXy7lx4wanT5+mUaNG9OvXr8gNGYD+/fszePBg+vbti62tLVeuXOGPP/7gxYsX6Orq4ug0iD+mjuPykX1Uqm5DvRZt+MGxBw+vX6GlQ0+cps7mwKrfmda9PU/v3mLuhp2YWeas8PMx3zg6c2Hvdjb8NDPT+xKJhDkbdgAwZ0BXVs4YT+P2nRm7eJmwjbiAsc3ZrfJnR9myZdm0aROurq48ePBAMGSKS9FHLpfj4+OTKUzra0LhAchugq2vr8+DBw/w9/cnMDCQMWPGEBgYmON9ad++PZUqVWLUqFF4e3uzd+9e9u3bB2QYH25ubixevJjg4GBOnDjB1KlTheKq9+/fZ9y4cQQGBhIZGcmtW7eoWrWqsO+sWbO4desWkZGRTJ8+nT179ghiCxKJJIu3o2nTpmhra7Nq1SocHR2F98eMGcPZs2fZtGkTycnJ3Llzh8GDBwtqb4cPH2bcuHHIZDIsLCwICwvL1khVSC6PHDkSqVQqPAtUVFSQSCRIJBK6devG4sWLef/+PWlpacyePTvbvkLh14gqKCKRiB49emBqasr+/fsFgYOCoKOjg7OzMyoqKuzcubNQ2vxSPl4k8vPzY9myZRw9epSUlBRiYmKYP38+skIo9JoYF8u2JfPxvHuTd8FB3Dh9jLImpugaZDbkug4djbZeGfatzD4MUYFcLuf4sSNoaWkhkUgYPXo0Dx484Ndff+XVq1fMnDmTwMDAAvdbiZKCIJKXtieaklKDXC7HLSSKsISUQi2umVdEZKiJNDMz+L9LwpPJZJw7dw4PDw/s7Oxo3bp1qboGZ33e5UlCtLhQl4jpWqV4iuV9Gu6kmJwXV8jju3fv2LhxI4MHDy7VKn451doIDg7GwsICHx8fQcZ28eLFuLq6cvDgQYYNG8adO3fQ09OjU6dOqKqq0q5dOwYNGpRtewEBAYwaNYo7d+5Qp04dWrZsyYMHD7hx4wYXLlxg7ty5vHjxAlNTUyZOnCiErQUHBzNu3Dju3LlDeno6dnYZNYrMzc1JSUlh1qxZHDp0iKSkJKpWrcqyZcvo0KEDkHGvXV1dhdcKpkyZwpo1a4iOjs602LJlyxb+/PNP3r17h76+Pj169OCXX35BR0eHhw8fMnnyZIKCgpBKpYJYwKcr3WlpaZw5c4b9+/fj6urKnDlzmD17Ntra2ixbtoxJkybh6+vL6NGjiY2NRVtbm4oVK7Jv3z5evXolGGoKSqvKWWJiIlu2bEEikTBy5MhCUQKMjY1l586dSKVShg0bViIeTalUyqRJkzhw4AAikYjGjRvTpUsXFixYQHh4OBEREci19XEP+3zNlPDgN4zv2JQNl9wpb16Rg2tW8PzeXRbvPopMJmPvn0u4fvIo8THRVK5dl5E//oJ1zTqZtgPwuHaJ3yYMY+nBs1Spk7Nn5fHJ/cz9brwQWunq6sq0adPw9fXl22+/JT4+nkaNGrFw4cJCuVZKlOQXpTGjJEdC4pJxD/38StatsyfYtmQ+aSkpiCUq1G/Vlml/rC+0fjQ1M6CC7v9H/RjImLQcO3aMV69e0a1bNxo2bFjSXcrCo7AYAmISS8TI/RQRYKmvJVSpVnhYijrUq6S4ffs2169f5/vvv0clj4nCXwMK40cqlQpJ7R+f3+fu58c5UB8bUunp6YLX7FPZ3NTUVJKTM+pcqaurZ5o4p6amEhcXR3p6OhoaGplqBYWFhVG2bNksntL4+Hiio6OzhEjJZDKCgoKIjY1FXV0dCwuLTDk3wcHBhIWFIZPJMDU1FQQgPkYqlRIYGIiqqioBAQEYGhpSq1Ytzp49S82aNYX8Hm9vb27evIlMJqNLly64urrSr18/dHQyx9ikpaUhlUpLZW2uiIgItmzZgqmpKYMGDSqU33JsbCw7duxALpczbNiwLLWfSgPJ6VLO+ZZMjZzccKhcXplToqRUozRmlOTItcAPRCZ/3u0dHxNNSlJGyIRYokKZckaFV4GbDJnEdpWKX16zJEhKSuLAgQOEhobSr18/qlWrVtJdypaY5DQuB34o6W4IdLAsh7561hC8glTizg1FwnRJGEw7d+5EVVUVJyenYj92bgQHB2NiYoKKigpv3rzB1NT0P2Vs/ddIS0vD1dUVBweHku5KtgQGBrJr1y7q1q1Ljx49CuV3HBMTw44dOxCJRDg7O5dKg+b/2eutRMmXUvp8zEpKBTHJaXkyZAB09Mvw6OZVxrSzxeP6pUKdPMqByOQ0YlIKHktc2omJiWH79u28f/8eZ2fnUmvIQIZSjGEpkK+USaVEhQShLs9YeXdxceH7779n586dxMXFFVlonqJGRnGTkpJCUFBQqcqXkclkHDlyhClTpvDhwwdev36Nk5MTkZGRn99ZSZ75WDlLEdr46f8V28lkMuH9nHK5xGIxDx484O3brNXhSwOVKlWiR48ePH78WBCCKSj6+vo4Ozsjk8nYuXMnsbGfD+kqbsx0NAq9kv2XIiKjP0qUlHaUxoySbPGLTszXA/XW2ZOYWFhy/cSRQu+LCPCLSiz0dksT4eHhbNu2jdTUVEaMGFEoSj5FTVXDkpeGEUskuJ89jpqaGlu3bmXatGkEBgby+++/07JlS16/fl3SXSxU/P39kclkpcqYCQwM5KeffsLc3BypVMrq1asJCgoSZIiVFA6fFrJU8Gnei6LIpOL9nIxusViMkZERZ8+eLXViAArq1atH27ZtuXz5cqHVoClTpkwmg0ZRr6e0YF1Gq1SE70LGYqK1Qe5FNZUoKQ0ojRkl2RIan5znB2pU+Due37tDv4nTeeHhzrvgoEyfr/thGrv/+DXL3/ofZ+Spffk//fmvEhQUxPbt29HU1GTkyJElUrH6SzDTUcdEW63EVhGl0nQeXHVBkhiDWCzm8uXLmJiYcPDgQZ4/f46RkRHLly/PsnKdGx/X2yiN+Pj4YGhoWKISswoUE+CgoCCSkpJYtWoVMpmMq1evMnXqVMqVK1cqE8yVZCASiejatSshISE8fPiwpLuTI23btqVOnTocP36cN2/eFEqbBgYGDB06lPT0dHbu3El8fHyhtFsYlBavtwgw1FDNNnxXiZLShnKkUZKF5HRpvmJ2b184ja6BIW2698bAyJjrJzN7Z9r3GciQGfOy/H1clfhzpEhlJKf/91Z5X758ye7duzExMWHYsGFCwbvSjlQqRSQS0dCkDBKxqERWdiWA+/H9NGrUCMhYxb169SpLly4lMDCQ1atX0717d6HgYm4oJjOKVe2PKS2r1qVVkllR8PLp06ccPnyY0NBQevbsSUpKCr6+vqXaOPx/x8LCgvr163Pp0qUsxYlLCwrJ5goVKnDgwIFCk1c2NDTE2dmZ1NTULAZNXFxciXoVqxpol9ixFcgpHd53JUrygtKYUZKF6Dzmyii4ffYkjdp1RCwWY9vePosxU1L9Ku08ePCAQ4cOUa1aNQYNGlQqVYVyQhG6MnvGdCpr5L8AZWHw8so5PoS9pVWrVgDMnDmT3377jX379jF16lRUVVXp3r07kH3/FEZKYGAgHTp04NixY/zxxx9cvHgx03alRRI7IiKCmJiYUmPMKK5LjRo16Ny5M46Ojqxbtw4nJyesra359ddf6devHx4eHkDpMQqVZKZjx44AXLp0qYR7kjMqKioMGDAADQ0N9u3bR1JSUqG0qzBokpOT2bVrFwkJCfj4+LBq1SquXbtWKMf4Esx0NdBKT0ZeQgsBIsBURx0zHfUSOb4SJflFacwoyUJMSnqeQ4feBQfh/cSDxu3tAWja8RvCggJ4+fBeofZJ9E+/vlZu3bolJLHK5XKuXr3K2bNnady4MX379v0qVZ/8/f25c+cOdy+eoa5R8RYwfXLxJD9OHo+5uTk2NjZs3LiRkydPMm3aNJYuXYq/vz8DBw7MdRVXMbn28vLCy8uL1atX4+3tTb9+/fjuu+9ITEzk0KFDPH78ONv9P06yLg5ev36NRCLB0tKy2I6ZF0xMTJg7dy6Ojo7Mnj2bVatWER4eTmpqKrNnz6Zx48ZFpipX2Ny9e5d+/fplES+4ffs2I0aM4MWLFwBERkbi6urKvHnzOHDgQL6OkZiYyNmzZ7l3L+/PSD8/Pw4dOsSjR48K3SjU1tamQ4cOPH78uNDCuIoCLS0tnJycSEhI4NChQ4XmOSlbtizOzs4kJiayefNm9u/fj1QqxdPTs8QMcJFIxHtPd5ITE0vEsykRi2hgrP9V/GaVKAH4+mZQSoqctHw8PG+fPYmahgb1WrQBoHbTlmjp6nH1+GFsGjYpsX4VlOR0KdHJacSkpJMmkyGTg1gEqmIx+uoqlNFQzbPufmJiIlevXhWK1L1//55Hjx7RoUMHWrZs+dUMGJ8W2bOysqJdu3asWbMGZ2dn5Ojy9H1ckRfjC/G4TXmJlIEDBwqVp/39/dmwYQO9e/emW7duaGho0LVr1yx1QLLj0qVL2NjY8P333+Pg4ECtWrWYOXMm7969IykpiQsXLjBhwgRWrFiRqb3izgepV68eRkZGeTqn4qZSpUrMnTuX2NhYwsLC0NDQ4LfffiMmJobo6OgSKVL4JTRv3pwnT56wcOFCunfvjpGREdu3b2fNmjXMnTuXGjVqcPPmTY4ePYq7uzvVq1fH0dExX8fQ0tLCx8eHhw8fYmtrm6fvkbW1NZGRkZw6dYoPHz7QsWPHQn1uNGzYkEePHnH27FnGjBlTanOdypYty4ABA9i9ezdnzpwpNMnmcuXK0bZtW86dOye8p/gum5qa5qmNgo4ZCoM/Pj4eHR0dhjgO5MyNu6TqWBb09PJNQxN9ZV0ZJV8VSmNGSRZk+ViMunn2BKnJyQy2rf7v/lIpdy+eYeSPP6OmXnihU/np15cQk5yGX3QiofHJQs5QdsOkohvqEjFmOhpYl9FCP5eETU9PT2F1zcXFBYCePXtSv379Qux90aGYjGY3wVm+fDmXL19m6tSprFu3Dk1VCffeRCCXyRAV4oRIRMZqYUMTfcyr9wVg5MiRBAQEADBkyBCuXbtGq1atqFOnDg8ePKBt27bo6Ojk6BVQnI+npydt2rTB3j7Du6ilpYW2tja9evXC0dGRTZs2sWzZMoYMGYKtrS2RkZFcuHABd3d3OnbsiIODQxbFKEXhTrFYXGiTTi0tLaytrQulrcIkKiqKLVu24OLiglgsRltbG4lEglwuJyQkhIEDBzJlypRSW3H+U44cOcLcuXMZPHgwampqaGhocPHiRdq0acPWrVs5fPgwCQkJjB49mhEjRgD5r2fUrFkzLly4wL1792jWrFme9rG1tUUqlXLhwgUkEgnt27f/ovPLDrFYTNeuXdm8eXO++lQSKCSbjx8/jqGhIa1bty5wm69eveLChQuZ3hOJRHh5eeVqzBTWmKH4/ly4cIFNmzaRkpLCnDlz6NamDceu3QFTq4KeYp6pa6SHua7m5zdUoqQUUfpHFiXFjjiPY/IbH2+CvF8wev4S/jjuKvxNWb6WhNgY7l+++PlGiqBf+UEulxMSl8zVwA9cDvxAQExiJvEDeTZ/ClKkMgJiErkc+IFrgR8IiUvOEpYgl8t58OBBpvdEIlGpLNaWHT///DNDhgwhPT0jxO/EiRNUr16dCxcu4OvrC8C8efMICAjA29sbc11NHKqZYvbPYFjQW6bY30RHHXsrI8y01YXwEg0NDWxsbJDJZNSuXZvjx4/Ts2dPPnz4wOTJk9m3bx+Qfa6G4r1nz54RExNDzZo1UVFRISEhgZcvX9KoUSNhxb1OnToEBwdjYWGBTCbD3t6ebdu28ebNG6ZPn860adNITs6sticWi5FIJIXudStNxoDiPhw7doxVq1ZRvXp14uPj8fLyonz58ty6dYuoqChBoOFr8UDWrVuXvXv3cuPGDY4fP87r168pW7YsU6dOZcOGDVhYWLBz584vNmQAGjdujFgsxt3dPV/7NW3alE6dOnHz5k2uX7+er30/h5mZGba2tly9erXUyRV/St26dWnbti1Xrlzh2bNnBW7Pw8NDELJQIJfLefr0abbP9MIeM0QiEceOHaNnz56UL1+exMRERo4cyaFDh+jdrgXyt/4ZbRdxdELd8npUMSx58QElSvKL0jOjJAuqeZww3Tp7Aj0DQzr0dUJVTU1436KaDYfXr+TaySO0dOhZ7P3KK8npUh6FxfA2IUV4L7/OH8X2UclpuIdGYaqtToOPXPTBwcFERERk3kcuZ//+/UyYMKHUh99MnDiR7t27o6KiQnR0NDo6OrRq1YqJEydSo0YN2rZty+DBg/nll1/YsGEDK1euRENFQhNTfcIS03gdGU9kchoi8ndtFdsbaKhS1VAHMx31HCeMigm+mZkZs2bNyvRZenp6tnU2ZDIZEomEO3fuoKOjIxQoffPmDb6+voLXLD09HTc3N4yNjSlfvjxz585FQ0NDSJYODQ3F1taWb775BgcHB6RSKWfOnOHy5ctUqVKF3r17Z1szSKEGV5qMk/yimOS5ubnRqlUr1q5dy9q1a/H19WXlypWMHDmSH374QShM+LXkzUBGLZIyZcoQFBTExo0bOXz4MFKplGnTpjFo0CDg37DLLzknsViMtbU1Pj4+REZG5ktqu0WLFkilUq5cuYJEIhEEMAqD9u3b4+XlhYuLC3369Cm0douCtm3bEhUVxYkTJ9DX16dixYpf3Fb//v15/fo1z54949WrV4KhHhMTQ0hIiPAbLqoxw1iWyKJFi9iwYQMjRowgISEBPT09Fi1ahEgkol+/fhy7dI1kwwpoaGoVqtcbMhYKjbXVSUyT8ux97BeFUytRUpIojRklWdBXV8nTA/rWuZO07t47kyGjoPPAoez8fTFR78NxObCbB9eyKuVEhb+jRqOmeeqT/J9+FRbBcUk8DItBWkixa4pWwhJScPF/nxEOpauZqXK1SPSvhPHXUEsmPT1dqGly//59hgwZwo4dO9i6dSvu7u7cu3ePFStW4O7uToMGDdi2bRsODg506tQJiURCBV0JFXQ1iix8L8v+cjlSqTSTR+RjYYX09HREIhESiUQwIlxcXDAxMRHCt/z8/AgPD2fIkCEApKSkcPHiRbp160ZUVBTXr1/Hzc2N9u3b07ZtW7p3746joyMuLi44ODiwcuVKli9fTv/+/dmxYweLFy/mp59+YsqUKZn6mlMhw6+R5ORk4fusp6dHVFQUr1+/pmHDhqiqquLl5YWDg8NXp2YWExPD/Pnz8fT0pGXLlsyePVuY1CpCCAtCx44d8fHx4dKlS/Tvn3eZeoDWrVuTnp7O5cuXkUgkNG/evEB9UaCpqYm9vT0nTpygQYMGpTKsUYFIJKJ79+7ExMRw4MABRo4c+cX1l1RUVKhRowY1atQgNTWV169f8+DBAwICAggKCsLc3LxIx4xwxJjXqkeLFi2IjY1l3LhxTJkyhdjYWCZOnIiKigq9e/XivOslVCyqE4c43wtEuSGTQ1h8CpDVSPvS57ESJcWJ0phRkoUyeXxgrbt4O8fPujmPppvzaACmLF9brP36HK8j43n6vmjCKORAukzOvdBokoykeHt7Axn5DtWrV6dy5cpYWVmhpVX6qyp/bAg0btwYfX19+vTpw65du+jQoQNNmzZl0qRJ/P777wQFBREXF8ezZ8/o1KlTpnb0NVRpYKJPA/QLVVjhU0QikdDnp0+fsmrVKiwtLenbty82NjZZFOPS0tKwsbFBX1+fChUqAPDkyRPS09OFyWFkZCTu7u7MmjWL58+fI5VK2bBhA6mpqRw/fpyNGzfy7t07hg8fDmQk6e/Zs0e4BvPmzWP16tVMmjQJuVzO/fv3WbduHcbGxjg6OmJra/tF51oaUEzm27Rpw+bNmzl9+jQ1atRg586duLm5oa2tjb+/f67y2KUZfX19mjdvTseOHRk8eDBQMG/MpxgbG6Orq4u3t/cX5RO1a9cOqVSKi4sLEomEJk0KR3Clbt26PHz4kHPnzjF+/PhSbXirqKjQv39/tm7dyr59+xg5ciSamgXL91BTU6NWrVrUqlVLuC9FPWZI5TBywTLepsRw+/BhVFVV+e6777CyskJPT4+ZM2fi5ubGb7/9BkBIXBI+UYlf5PXOrR/ZoQiN849JxDAPnnIlSkoCkfxrWy5TUiyc9XmXr8KZRY26REzXKsYFbqcoB6XsKJsWR1VDHUxNTb+qh7/Cw/Epw4YN48iRI+zatYuuXbuirv5vHQIPDw8hP6KkiYqKYu/evRw4cICXL1+ioqJC8+bN6dWrFw4ODtl6xpKTk1mzZg1ubm4cPXoUgAsXLtCtWzcSExN5+fIlHTp04NWrV8IKcGRkJC9evMDKygozMzNevXqFt7c3sbGxNG7cmKNHj3LgwAGePHkiJJbb2dkRHh7O8+fP+eWXXxgwYABJSUlERUVhZmaWqU9fQ9J8fHw8s2fPpnz58ixYsIC5c+fy4MED0tLSUFNT488//6R27dpfVZhZdhRF/69fv861a9e+WBBELpfj4uKCm5sb3bp1K7TfX3h4OBs3bsTOzq5QEuyLmoiICLZu3YqxsTGDBw8uVAOsuMcMtxMHUIuL4JdffiE4OFgQHvnuu++wsLDItG1+vd4FRWE4fRpOrURJSVO6R0klJYaZjkaBk7cLCxEZ/SkowXFJxTooAUSo6iLTNfiqJnEKQyYmJoYffviBoUOHMm7cODw9PdmxYwfjxo3D0dGRffv2ZUp8V0ykirpytmL9JbfjGBgYMGnSJG7duoWPjw+7du3C0tKSlStXYmxszMiRI3n37l2mfTQ0NJg1axZHjmQUfZXJZDx//hxzc3PU1NQoV64c6urqbNu2DcioEr5//36uX7+OmZkZS5YsoUWLFmzfvh0XFxdGjBjBvHnzaNo0I5Ty5s2b6Onp8ddff3HixAnat2/P+vXrAdi7dy8tWrTIlMycnp6OWCzOFJ6lCKUrLchkMnR0dJg5cyaVK1fG1dUVe3t7rKysMDAwYMaMGdSqVQv4+jwzn/Jx/xVqdQVFIc3+cThqfvtkb29P48aNOXPmTI41kfJL+fLladasGTdu3CA6OrpQ2ixKFJLNb9684cyZM4UW0lgSY0azbwdSuWETEhMT2bFjB1KplNmzZwsCJB+j8Hp3rWKMg7UR1iqp1CynS1VDbSobaGOio05h/uw+DacOjiuc4qVKlBQUZZiZkmyxLqOFf0xiSXcDyHiAWhsULCwrOV3Kw7CYwulQPnkYFkM5TbWvZhVLIpEglUpp1qwZ5ubmdO7cmVOnTmFvb8/JkydZsWIF5cqVY/z48YSEhDBz5kw0NDQy7V8YSKVSQRb64zZFIhG3bt3i6dOnjBgxIpN3KDvKlCmDvb29IL0cFBTE+/fvs42v/9gTIhaLmTFjBuPHjwcyBAZ+//13ZsyYwcWLF9HS0sLd3Z0//viDsLAw/v77b1auXIm9vT1SqRQjIyOqVKlC48aNAejWrRubN2+mT58+LF68mNmzZwsG1b1792jSpAlly5YFMmoT9ezZkyZNmvDrr78SEhJChQoVhJwfBXK5vFDyN74ExXHv3r3Lr7/+SkREBGKxGKlUiq6uLqqqqkyaNIljx45Rp06dr94z8zGhoaEEBgbSsmXLArWjoqKChYUFgYGBQn2R/CISiejSpQtSqZSTJ08ikUioU6dOgfoFGQn2z54948KFCwwcOLDA7RU1lSpVomfPnhw7dgwDAwPatGlToPZKasyQy2SoVapBu46d8Hn5gkuXLlGuXLlcf+dyuRy/196cPnqU4cOHY25uzuvIeHyiUrLdvsB95N9w6mQjmVIBTUmJozRmlGSLvoYqhhqqRCanlWg/RGQoWumrf3m+jFwu51EhJm7mF6lMzqN3MTQz+3o8NKtXr8bY2BhXV1cgowJ6o0aNKF++PI8fP2bOnDloaGiwaNEiJk6cmMmYKQz8/f05d+4c6enpTJo0KcvnrVq1Yu7cucTHx2dSMMvLhNnCwiJLuIaCTycLcrk8U36Tk5MT9erV4/Dhw6Snp7No0SLq16/P69evMTIyIjQ0FBMTE2JjY1m/fj3R0dHUrl2b9PR02rZty5kzZ/j555+ZMmUKc+bMoUePHkDG9XV2dhaMmcjISDw8PBgzZgwA9vb21KxZE2traywsLBg5ciQaGhqIRCLhfIvbWFAowv3444+kp6czbtw4ypcvT3JyMklJSaSnpxMTEyOEzpXm735+r11AQABXrlwRwgsLQvv27dm+fTuXL1+mZ88vU38UiUR069YNmUzG8ePHEYvFgkfsS1FXV6dz584cOXIEb29vQfGvNFOnTh0iIyO5evUqBgYGX2zUleSYIRKL0dDWYs7qzdQto06VKpVzDPtVkJ6eTnp6OlWrVsXAwKBYQ+M832eoFSoNGiUlidKYUZIjVQ11cA+NKtE+yP/pR0EIjU/JJKVZ3MiBt/EphManUEG3cCf9RUVycjIGBgZAhmypj48PV65c4cqVKyxZsoTbt28zdepUhg8fjr6+fqFNpOPi4nB1deXp06dUrFiRrl275jiIu7q6ZjGiCnvCnF17iuTgj6latSp9+vThl19+4dChQ1SpUoXTp0/TpEkTGjZsyIEDB3jx4gW//vorZmZmzJs3jzFjxlC/fn0SExOJj4+nTp06qP2jDPjixQtiYmLo2bMnMTExvHv3DhUVFerVq4eXlxeJiYlER0dz4MABDA0N6dGjR7Yy3x9LQB87dozw8HDGjRtXKNdGEcrz/PlzDhw4QLt27Qql3ZIgv9+bFi1a4OXlxcmTJxkzZkyBvJEWFhZoamri5eX1xcYM/KvuJZVKOXbsGBKJBBsbmy9uD6BmzZpUrlyZ8+fPY2Vlhapq6VezatOmDZGRkZw8eRJ9ff0cFy5yo6THDJFIDLoGaBobCIsGuaGqqkrdunWpW7fuP6Fx0cXT0X/wfB+LhqpYWWxTSYmhzJlRkiNmOuqYaquXWO6MCDDVUcdMJ/cwos/xOjK+cDpUAESlpB/Z8WkcNoCNjQ3p6emMGTMGDw8PTp06hZGREdbW1kRFRREeHg6Arq4uUHAjQiaT4e7uzrp16/D19aVnz54MHz4cY+OcRR8Uhkx2/f+YwtY4UeStfNrunDlzCAgIYMaMGfTt25dx48aho6NDQkICCQkJHDt2jEePHmFjY8OIESOoUKECISEh3LlzBxMTEywtLYGMVdYrV65QvXp11NTUuHr1KgkJCaxZs4Yff/yR33//nZcvX9KwYUOuXbvG0qVLadasWZbirEAmGeo///yTixcLr5CtQh1u9OjRXL9+naiokl34KE7EYjE9evTgw4cP3Lx5s8Dt1a9fn9TUVF6+fFngfn377bfY2Nhw+PBhXr9+XaD2FCFscXFxhXKexYHCqDM3N+fAgQNERkbmu43S8KxWjBn5CSEt6XDq5PTSk8+n5P8LpTGjJEdEIhENTPSRiHOeqM4f0oeDa1YUyfElYhENjPURiUQ8fvyYO3fu5LuNmOS0YguVu3LsIOPaZ8ijPnO/Qx+bf8NP5EBkchoxKZ/vy7Bhwxg2bFjGfnK5kCSeF8LDwzl8+LDwWiQSce3atRy3/zgO++jRo6xdu5a//vqLzp07ExoaypYtW9i0aRNWVlYAhISEoK6uLqwUFkauRnBwMJs3b+bChQvUrl2bSZMmUb9+/TwbSLn14XOGzpegyFv5tH9yuZxy5coxaNAg+vfvz8qVK9m+fTuGhoaMHDmS2rVr06NHD/r06cPcuXOpWrUq9erV4/HjxxgbGwshZvHx8Vy8eFGQND516hRNmzYVcgBevnzJokWLmDFjBidOnODFixf069dPCElTnPfu3btZvnw5z58/JzU1lRcvXuDs7Fwo18DBwQF7e3v69evHgwcPWLRoEaNHj+bnn39m9erVbN26lUOHDnHq1KlSJViQG6Ghofn6vpiYmNCqVStu3ryZRUwivyi8WtevXy9QO5Dxe+jduzdVq1bl4MGD+Pr6Fqi9smXL0rJlS+7cuZOlAHBpRUVFhQEDBqClpcW+fftISspIVD98+LCwEJMTeRkzxrVvwpVjBwutv9mR25ixcOFC4TuzY8cOLC0tkcvlbD1+lp7VTAEID35DHxszwoPfFGk/FSjCqZUCuUpKAmWYmZJc0VCR0NBEn3uh0cV+7IYfST/26tWLBQsW0KJFi3y14RedWKjFxfJK9Qa2bLn5ONN7IsAvKpEGJvq57rtq1Srh/zdu3GDixIlMmDAhT8edPXs2crmcfv36AfD27dtcC8kpJuRLlixh9erVNGrUCLFYTIcOHbhy5Qp2dnZMnTqVDh06oKamxo4dO5g5cyaVKlXKU39yIzExkcuXL/Pw4UNMTU0ZNWqUUO+loCgG1Li4OPT1c7/ehYXiWspkMiGXpXz58sjlclRUVDh8+DBXr17FxcUFe3t7hg8fLtS0OHv2LDExMejr67Ny5UoeP37M33//DcCVK1eYPHmycJxLly5x48YN/Pz8eP/+PY6OjrRv354bN24QHh5OfHw8P/zwAw8fPsTY2JgDBw4wevRo4uLi8v37yYmGDRsSERFBYmIiEokEJycnQkNDOXHiBAkJCSQnJ5OSkkJMTAyRkZGlulaJAi0tLVatWsWAAQPynAfTunVrXrx4walTpxg5cuQXG/dqamqYmpry9u1bkpOTC5yDJpFI6Nu3L4cOHeLAgQM4OTkJCxJfQqtWrfD09OTcuXMMHjy4VOc/KdDU1MTJyYktW7Zw8OBB2rRpQ//+/fH39891v7yMGcuOnEejGGqF5XXMgIzQuIikfw2fsqZmbLn5GD3DskXYw3/5GsOplfx3UBozSj6Lua4myUYyIdGvOKhrpJcp/vZLV3tC45OL3ZABUFVTw8CofKb35P/0pwG5D0wfT77ze96fbm9iYvLZfby8vISV9BYtWmQqLnn27Fn+/vtvnj59iqqqKosXLxbUvb40T0Yul/P48WMuXbqEVCqlS5cu2Nra5mki+LGhkBvh4eF4eHjg4OCQ7/4VlE/PQyQSCdfKzs4OOzu7TJ93796dvXv3Ur9+fRwcHPDx8UFLSwtbW1sCAgIIDQ2lc+fOwvY3btzA0dGRevXqcePGDTp37kxERAR6enpCvY03b96wYcMGOnTowKZNmxg/fjx2dnaUL5/5O/ml/PLLL3na7nOJy6UJfX19ZDIZL168yLMxo6KiQo8ePdi2bRt3794tkLqZnZ0d+/bt4+rVq3Tp0uWL2/m4b/379+fAgQPs37+fQYMGffEihKqqKl26dGH//v14eXkVWFyguDA0NGTgwIHs2rWLS5cu5WmfvIwZ+sVoIORlzICsoXESiSTLGFTUKELjlMaMkuJGGWamJAu3b9+mVatWaGlpoa2tjYODA9opsdQ10sPd9TyTOrfCqUFlNi/+AZksI4Qk2O81fWzMeBccJLQTGuBH3xoV+PA2hLTUVLYvXcjoNg3pX9uCce2b4HJwj7DtuPZNuLBvB3MGdMOxnhV927fEw8MDyAjBCAwMZPjw4UL41alTp2jQoAEaGhqUKVMGR0dH4uP/fZjv3bsX68qV6V3HkpUzJvDn9PFCOJxcLufw+pWMat2AIY1tWDJuKO9Dg/89/3Mn+e6bVgysa8WUrm1xv3Q+39fw4zAzhbvf49olhre1RUdHhylTpvDs2TNsbW3R1tamW7duxMVlqM8owswCAgKEia8iXCw1NZXp06dToUIFVFVVsbS0FFbwFy5cyM6dO9m5c6eQf/FxmFlycjKzZ8+mYsWKaGtr06NHD968eSMkoLdt25ZTp05RuXJlNDQ0aNKkCc2aNWPmzJns378fHR0dfvrpJ3R0dOjevTuhoaH5vi7v3r1j+/btnDp1iipVqjBp0iSaNGmSJ0NGKpVy/fr1zxoyfn5+bNq0CVtb23z3r6j42GvzadiVmZkZN27c4PHjx8yaNYupU6fSrFkzAI4dO4aampqQyJ2SkkL58uXR0tJiypQpHD16lKCgIB48eMCuXbswNzdn7969jBgxgg4dOgDQp08fjIyMaN++fTGecQZfiyEDGffI3Nyc4ODgz2/8Eebm5jRr1oxr164VKAyratWqqKur8/Tp0y9u41MU4VYVKlRg3759+T63j6lWrRo2NjZcvHiRlJSCJcdnN8a8ffuWHTt20KpVK+bMmYOuri4WFhZs2bJF2E8mk7F8+XKsra3R1NTEzs4u0/USiURs3bqVypUro6ury6BBgzA0NKRnz56MHTsWACsrK3bs2AHAmTNnaNiwIZqamtSsWZMDh48IxScDXj7nh4Hdcaxvzeg2DTm07k/hOB+HmeW23ed4G+jPz6OcGNSwCmPtbDm7699zDfJ+yfyhfeld25Jq1avnGm4sk4OdpRH+L/6tU/VpmFkfGzOunzrK1O52DKhjyY+DvhXGa7lczr6/fmP+0L441rNmUudWrJw5UWgrITaG378bxZDGNgxtUoNVsyaRGJ9VLS2n0LgrV67w4sUL4N+wOCVKChOlMaMkEzExMXTt2hV7e3ueP3+Oi4sLPj4+LF26lNSwQP6cNpYuTkNZfvQC0vR0XnjcA8DcuiqWNjVxdzkntOV28SzVG9hSzrQCx/9ew8Prl5i1ejOrz9+k3bf92PrLPKI/vBe2P7hmBd/P/p6nnp7o6+sLoTXHjh3D3Nycv/76i1WrVuHr60vfvn2ZMGECL1++5NChQ1y6dEmY1N+6dYsRI0Ywbso0lh+7iIaWFnfOnxKOc37PNm6cPsbUFetYevA0ZcoZsXikI+lpacREfGD17Mn0GvMdq8/fpH3vgfw1YyJx0QVPbj6+eS1zNuxg+Zp1rF69ml69erF06VJcXFy4e/dupkEboGLFikIl+rdv39KiRQuWLl3K2bNnOXr0KK9evcLZ2ZlJkybx7t07Zs6cSf/+/enfvz/379/Pcvxx48Zx7Ngxdu3axd27d0lLS6Nnz57o6uoKymVLliwRCkEGBgYSExPDvXv3WLt2LdevX8fFxYUHDx4QHx/PtGnT8nzuKSkpXLx4kU2bNpGUlISzszO9evXKV10NNzc3bt68mclo/ZTk5GSOHDlC/fr1C80LUZiIxeIsE3xFnkbVqlVp0qQJzs7OwiqysbExU6ZMQSKRIJPJUFdXp06dOhw7dowPHz4AGTLWp06dwsLCgrCwMN6/f0/79u2FGjTa2tpER0fTtm3b4j3ZrxBzc3NCQkLynWtlZ2eHnp4ep06dKlDOQM2aNUlKSiIgIOCL2/gUVVVVHB0dMTExYc+ePV+0CKGgc+fOJCUl5ZqH9zlyG2Mgo+bS48ePuXv3LgsXLmTChAm4uLgAsHjxYlasWMFff/3Fw4cPqVSpEt988w0JCQlC+z/++COrV6/m6tWreHp6MnbsWOrUqcPGjRsB2LdvHwMGDODKlSv07t2boUOH8uTJE0aNGsUQJ0d8n3kCsHr2FKxq1uavM9eY8OsfnNiyDo/rl7OcT163+5TUlGQWj3REQ0ubpQfPMuqnJez76zceXHUlJTmJX8YMokajJvxx8hI//ryExYsXs3v37mzbSs/j9/XgmhWMnPczy49eIDYqkv1/LQPgye3rHN24Wjhew7btuX3uJNdOZhQQPrBmBdEfwvl130kW7TyM/8vnHNnwV7bHUITGfUyHDh2EvLIBAwZkOz4pUVIQlMaMkkwkJSXx008/8dNPP2FlZUXLli3p06cPz58/Z/v27bRp04Z1i3/Etk5tRv30K4bl/w1jaunQEzeXs8LruxfP0LJLRh2NSjY1mfDrH1Sr3wiTipXoM24y6WlpvA3wAzKS/UcMH8YoxwFUq1aNGTNmCA88Q0NDJBIJ+vr6QijImjVrGD16NJaWltjb29OxY0eeP38OwPr16xkwYAA9Bw2jonVVxiz4jbImpkK/Tmxdz9BZP1G7aQvMrasydtHvxMdE8+jmVSLevSU9LY2yJqaUr2BOjxHjmL1uG2qfKcyYF/qOn4pV9Zq079GH8uXL4+joSKdOnWjZsiUdO3bMomQkkUiEfBcTExPU1NSoV68eW7dupVmzZlhbW/PDDz+QlpaGt7c3Ojo6aGpqoqmpiZGRUaa2oqKi2L17N6tXr8bOzo5atWqxZcsWXr16RUBAAI0aNQKgX79+NGzYkKZNm9K3b1+kUilpaWkEBASgqamJpaUlNjY27Nixgzlz5nz2nOVyOc+fP2fdunV4eHjQoUMHxo0bl++VudjYWK5fv06TJk1yNYBu3bpFWlraVyUTrPBKKSbBH3tuBg0axK+//pppO0dHRxo0aIC9vT3Tpk2jX79+nDt3DlNTU0JCQgQpWkU43r1791BTU6Nhw4bZHj8wMJC0tIKLZKSnpxMdHf3VJPxnh7m5OWlpabx///7zG3+Eqqoq3bt3JygoqEATNYX37MqVK1/cRnaoqanh5OSEkZERu3fvJiws7IvaKVOmDG3btsXd3f2LRQ9yG2Mg43u+a9cuateuzYgRI3B0dOTvv/9GLpezZs0afv75Z3r06EGNGjXYvHkzEomEPXv+9fLPmTOHrl27Ymtry+rVqzl48CAxMTFC0dwHDx7w/v171q5dS9++fZk6dSrVqlVj+vTp2HfryaltGwB4H/IGnTIGGJmZ06C1HQu2HcS6Zta6NXnd7lOe3L5ObGQEk5asxKJqdRq3t2fkvF8QSyTcPHMcfcNyOE75ngqW1jTt0Jl58+bx119/ZduWNI8GdPdhY6jTrBUW1WzoPHAoPk+fZPTlToZSneOU7zGztMbSphbaOnqc3blZOEcNLW2MzStiVaM2M1f9Tfve2RdSVYTG5UR245MSJQVFmTOjJBMmJiY4OzsLScheXl48efKEli1b4uXlRf369dFQkdCsggEW+lpUrVUbyFiNaeXwLfv/WkbkuzDS09IIeOVF828yFJmaduzCk9vX2fHbIkL8ffDzyggN0JaIaGpmgLpETI3q1YV+6Onp5TjBUoRj/Prrrzx79oznz5/z/PlzhgwZAiCsxqX9s1olUVGhcu16ACQlJBAR9pY/p4/LFNqUmpzM2wA/bO060ahtRxaPGIiZVWWadOhMh75OqGsWPNnTuGJGvHqaTCYYBgo0NTXzFLrx7bff4urqyowZM3j58iUPHz4E+OwE0tvbG5lMRosWLQgPD+f777/n+fPnqKurs2bNGtauXcu+fftYu3YtSUlJ6Ovrc+3aNeRyOZ06daJChQrs378fExMT2rVrR69evYSQv5yIiIjg3Llz+Pn5YWNjwzfffPPFyfguLi6oqanlaqTExMTg7u5O8+bN0dPT+6LjlCSKULSPPTfp6emZcpgATE1N2bFjB3v37uXWrVuMGzeOrl27Uq5cOczNzdHQ0ODYsWPMmDGDgIAAVq1aRbNmzTIV/1QQExPDjh07kEgkWFhYULlyZaytrTExMcl3PtT79+/5+++/GT16dIELSZYUpqamiEQigoODc5UFzw5LS0tsbW25dOkS1apVy7buz+fQ0dHByMiI4ODgbO99QVBXV2fQoEHs3r2b3bt34+zs/EXey+bNm/PkyRPOnTvHsGHD8v09yW2MAahSpUqmftna2rJx40bCw8OJjIykadOmwmeqqqrY2toKIUxAprwlW1tbpFIp3t7ewgTa1NSUAwcO8OzZMyZO/DeUCqBu4yYc2L0TgN5jv2Pvn0txPbiHRu060rZH32xzUD63XXjwG8Z3bMoPG3exefEPxEVH0r6Po+BtHdm6HrWbtGTaH+t5ft8NAD0DAwJeeTGoYRWSExNR19BAREbY4NixY9m1a5cgnV+/YSMUtkygd8Z1GFjXikrVa2Tp6+kdf7Nz2WJU1dUxs6pMeloq4cFvBAOuj40ZauoapKZkGCPxXtGEB7/BYchIfh0zGKcGVZCoqFCxSnW+X/NvJEEfGzMm/76G45vX8jbAn6p161N5/15sqlYRxjk7OzsWLFiApaUlCxcuFLyPL168YNq0ady5cwddXV3Gjh3Ljz/+iFgsZuHChbx+/Ro9PT327t2LhoYGM2fO5Pvvv89ybkr+v1F6ZpRkIiQkhDp16nDlyhUaNWrEypUrmTFjhvC5YvVYJBJRQVcDU30drMpoYamvRcVKlahcpz7ul87j5nKWmrbNMDQqjwjY/9cyVn3/HRJVFTr26seesxlhNPVN9IVkQUXBwM/x5MkTatWqhZeXF23atGHr1q0MHPjvKpGKigpyuZyPizcr+i2TpgMw86+/WXHcVfhbff4mdr0HIBKJ+GHTLn47dJbmnbvx4Kors3p3zhSL/KVIJBkTE0W/vkT56Mcff2Tw4MGoqqoydOhQ3Nzc8rSfQh0pNTWVli1bkpyczLx581BXV+fs2bO4uroCMHToUKEIolgsFiSSbWxsCAgIYO/evZiamjJ37lzs7e2zDalJS0vjypUrbNiwgcjISBwdHRkwYMAXGzJ+fn48f/4ce3v7XFWerl69ipqaWoGSsEsbOU1mjYyMmDp1KkeOHGHChAlCYneVKlUYNWoU69evx9nZmZkzZ3LixAkcHR2zbUdPT4/x48fTsWNHVFRUuH79On///TcrVqzg6NGjPHr0iNjYvAl/KBYfvobCijmhpqaGsbHxF+eWdOzYES0tLU6fPv3F4WatW7dGLpcXSV0XDQ0NBg8ejJ6eHrt27RJCFfODRCLBwcGBoKAgnjx5ku/9PzfGfPr9kUqliMXiHH/7Uqk002LOx/sr3v/4WdutWze0tLRITEwkNTU1U1vp6VJk/+TM9Bo9iXWud/l21ETevQli4bB+XDq8N8vx87qdIsx43OLlnNu9lWsnj1DW2IT5W/fz6rEHl47sy9TvOs1aseJ4xnN5/h+refr0KW3btuXWrVuCAMitW7c4/E8oMoDHtYxxddnhc5lyWsKCAgBo0rELq8/dYMbKjQT7eJMYH0dZUzMate0IwK/7T/H70Qv0GTeFMuWM+HX/KcqamhHs40050wr0Gj2JOs1aEeT9khnfdiL9owXHT0PYfvjxRwDBU3n06FFmzpyZ6Zp8+PCB1q1bY2Zmhru7O+vXr2fNmjWZFD0PHz6MhoYGDx8+ZNasWcyePRtvb+8s11fJ/zdKY0ZJJo4fP46hoSFnzpxhypQptG7dGj8/P+RyObVr184UQiGTyXjy5AkaKhIamOjTtYoxo4cMws/9Bs9uuNK7Xz8qG2hT1VCbS4d2s3zlX+xfv4plU8ZipZ2x+pzXAf/j1b/du3fTpk0b9u7dy/jx42ncuDGvX78W2qpVqxYeHh4oyuNIpVICXmSEMGjr6aNfthxRH8IxrWSFaSUryplWYPeKXwj19yXY7zU7ly2iat0GOE2dzV9nrlHO1IzHt64VwtXNIJeyPVn4dNVz48aNrF27lt9++40BAwYIseIfG5nZUblyZVRUVFi1apWwMtm6dWvCw8Np2rSpkGA+atQo9u/fz40bN/j2229RUVFBKpWyd+9eTp8+Tb9+/di5cycXLlzg1q1bWWo2eHt7s379eu7cuUPLli2ZMGEC1apVy/sJf4JUKuXcuXNYWFhQp07OoRthYWE8efKEdu3aoV4IIYGlHUXhzuxyO6ZOncpff/1FmTJlGDRoEACNGzfOth2FfHSzZs1wcnLi+++/x9nZmYYNGxIZGcmpU6dYuXIl69at4/z583h7e2eZACpQvJ/XRYnSypeIAChQV1enW7du+Pn58fjx4y9qo06dOqioqAhe18JGU1OTIUOGoK2tzc6dO79ItMDKyoo6derg6uoq1HDJK7mNMQA+Pj6Z8uIePHhA3bp10dfXx9jYONMCTlpaGh4eHlT/yKv/8XV/8OABampqVK9eXXg2amho4OTkRLly5Th69Cjp6enC9p4e9zCzqkxqSjJbf/0JFVVVegwfy+JdR+jUfzBuH+WEAnneDjLCjC2r16R1t17oly1H3eatiYn4gFWN2tRt0YoQPx98nj3mtedDzKwq8zbAj/LmGSGjpmZmXL58mXPnzrFu3TosLCzQ0dFh06ZN6JQxEI7RtkdfACpVr0GLf0K84d+8PNt2HSlvXpH6rdphXqUa0vQ0JBIJJpUyZLur1m1AxSrVMLGwRJqezu1zJ5FIJOxf/Tvtvu3P4Bk/8NOWfXy3bBVJCfE8unlVOMbHIWzfDBzKw3+K+Co8YoaGhllChPft24eWlhZ///03NWrUoGfPnvz888/8/vvvwjZly5ZlxYoVVKlShVmzZmFoaJhtgWAl/98ojRklmShbtixBQUFcvnwZPz8/li1bxtGjR0lJSWH06NE8ePCAX3/9lVevXjFz5kwCAwMz7T/IcSDut2/x/PEjJg8bTN3yetQ20qN8uXLcdL1IaFAgt27dEkLC8qqKo62tzcuXL4mMjKRs2bJ4enpy7949vL29hfwaRVuTJk3iwIEDnNy3mxA/H7YvmU94yBthMOs+bAz7/1rG/SsuhAb4seGnmbx8eJ8K1lXQ1tXn4oFdHNnwF++Cg/C4donwkDdY1ahdaNdYNR8eGW1tbQA8PDxITk6mbNmynD59Gj8/v2yvo7a2NgEBAYSEhGRqR0dHh9GjRwuyvZ6entSuXRtVVVWOHTsm5Ai8fPkSFRWVTIUxJRIJMTExTJkyhcuXL+Pv78/evXsxNzenXLlyQEa40sGDB9m/fz+GhoaCFHBBV+nd3NyIjIzEwcEh13AWV1dXypYtm2NeyH8NReHO7Lx7YrGY7t27s2rVKnr16kV4eHiuhuDHqKioYGlpSYcOHRg9ejSzZs2ib9++VKxYkVevXrF//36WLVvGjh07uHHjRqZk+f+CZwYyjJkPHz6QnJxz3H9uVKlShXr16nHx4kVBoTC/VK9enfj4eN6+fftF+38OLS0thgwZgoaGBrt27SIqKv8CJ506dUIqleY7vye3MQYyisaOGzeOly9fsnnzZg4fPizU2Zo+fTrz58/n9OnTvHjxgtGjR5OcnMyAAQOE9ufPn8/169dxd3dn8uTJODs7o6OjIzxLnzx5gpqaGosWLeL+/fuMHTsWb29vVq5cyeWzp+ni5IyaugYvPe6x9ZcfM4yMp0/weuCWZRzI63bwb5ixYr86zVpSppwRGxfMJi01jbeB/oT6+2FY3oS23fuQkpzEpgUZ4VTPPDz4/vvvkcvlQn4jZHjxmrZpJ7w2/Cg0UlP7X8PBzNIagOunjvLn9PFM69EB36ePhfC0ei0yCvJuWvA9wX6vCXjlRXxMNPply5GUkEBiXBwH1izHsZ4VjvWtWTNnCoCQ8wpgWunfOkaaOrqkp38+D+/Fixc0atQokwe6RYsWhIWFER0dDWQYzh+H3urq6hZKjp+S/xZKY0ZJJvr378/gwYPp27cvtra2XLlyhT/++IMXL15QsWJFTp06xf79+6lfvz5v377NUsfDzMwMW1tb2rVrJ1Q0B9i2bRuPHz+mVq1aDBs2jP79+9OkSRMePXqUp35NmDCBtWvXMmrUKCZPnkzz5s3p2LEjrVq1IjAwkPnz5wttNW/enHXr1rF+xW/M6G1PUnw81es3QkU1Y8W4x4jxdOjrxMYF3zOzVyfehwTz05Z96OiXwcCoPLNWb+XuxTNM7dqOzT//wKDpP1C/VbtCub5yQF8973HwderUoVOnTrRo0YJz58599joOGTKEV69eUa9evUyr9qNGjcLGxobOnTsTEhJCgwYNiI2Nxc3NDTMzMyHHISYmJtt+TJw4EWdnZ4YMGUKNGjV49OgRp05lKMTdunWLdevWERISQt++fRk8eHCme/+lxMTECEn/ueUv+Pj44OfnR8eOHb8qKeDsUKxOF7SKtlQqFdTMFAbnl6ClpUWtWrXo0aMHU6ZMYdKkSXTu3BkNDQ1u377Nli1bWL58OYcPHxZCP/4LxgxQIBnjzp07o6qqytmzZ7/oXnbsmBH2c/ny51WxvhQdHR2GDh2KiooKO3fuzPG3nxO6urrY2dnx4MGDLIsnuZHbGJOSkkLFihUxNTXF1taW33//nT179gihozNmzGD06NGMHj2aRo0aERwczLVr1zIllDs7O+Ps7Eznzp1p27Yta9asAaBcuXIMHjyY/v37s2XLFnr27Mlvv/3GyZMnqV27Ntu3b2fTzj3UbtYKgOkrN5KcmMjsfg78PMqRmrbN6Dthapbzyet2ijBj4bWKKrPXbycq/B0eV13xefqYKnXqUtbEDE0dHX78ew+h/r4A7NiwOpPB9jEff71EouyndAEvMyIT3oe8oWbjZkz89Q+q1m0gfK6umVHTLTTAj5nf2nPt+CE0tXXoPeY7ITS7Xos2qGloIpfLsWnQmIU7D2PX+98+KcbX7PqVE9mFDipCAxX/ZufpLejzUcl/D5Fc+a1Q8h/j3r176OvrU6lyFc75ZoRBTenWjp4jxtO+d/YDQnHiULk8GirFN+m+fv06U6dO5cSJE+jr67No0SIOHz7MiBEjWLx4MQAXLlxg1KhRXLx4Mc8F8QICAjh79iwRERE0bdq0UEK89uzZg66uLh07duTcuXMEBgYyadKkHOPlZTIZf//9N2pqagwfPvyrqEyeG4GBgbi6utK/f/9SL2IglUoJCQnB19cXPz8/YfJvaGiItbU1lStXxtLSssDV7IsbuVzO8uXLadKkSYFU8V68eMGhQ4fo06cPtWvn37O7evVqYmJimDdv3hfl1+UVhQiESCRi2LBh+freyWQyNm/ejEgkYtSoUQXu544dOzIlh+cXkUjE1atX83Xfbty4wcOHD5k4cSJSkVgYMwoLhQDAhkvulDevCGTUqek/aYYwHq2ZMxXIKLYcGxUpJNeH+vvyXZfWXLx0iWaNG2NoaMi1a9do1SrD4Dp58iRzf5rPr4cv0NvGjEU7j1C7aQsArhw7yKG1f7Dxyj12LltEsJ8P8zb9K+08u58D5tZV+W7ZKp7fu8v8oX04+jJDtvvq8UMcXLOCjVcySi+MaFkXp2lz6NjXCYC01FRWzhhPzxHjqd7Alj6fHPvqsYMc27CSkKCMyI2P78vH93jjxo0sWbIEX19fYRFk/fr1LFy4kHfv3rFo0SKuXbuWSQpcISDwOQEaJf9fKD0zSv5z3L17l65du/LwnjtRoW84unE1EW9DadDa7vM7FzHqEnGxGjJbt26lR48emJiYUK5cOcqUKcO8efPo1q0bV69epVatWvTr1w8nJyemTp2aJ0MmMTGRY8eOsXPnTjQ1NRk7diydO3cusCEjl8uFXIO//voLLy8vOnXqlOtk2NPTk3fv3mFvb//VGzIAr1+/JioqCl1d3ZLuymdRKKDZ2dkxcuRI7OzskEgkWFtb4+vry8GDB/n999/Ztm0b165dIygoKN/1W0oCRfHM/HgbsqNGjRrUrFmT8+fPZ6qDkleaNWuGTCbD3d29QP34HPr6+jg7OyOTydi1a1eudZw+RSwWCwUvFUWOvzZat27N2LFjM0QGVCSoS0puWlSlTj0879zA8+5NgrxfsvnnH1BRVUNNIkFPTw9nZ2cmT57MvXv3ePDgAT/88APNPwozywndMoYEvvLitecjQv192fHbInyePiYtLSO0T6HW6fvMk9SUZDQ0tUiIjSE0wA9penquodl5QVtbm2fPnmXx/g0aNIiUlBTGjh3LixcvOHnyJAsWLGD8+PH/iee5kuJDKc2s5D/HxIkT8ff3p3fv3kTHxFCpei1+3LwnW1nNvOLz9DELnPvm+Hk5M3NWnbmWaxsiwEyneFepnZyc2LJlC5cvX8bNzY02bdpQrlw5/vzzT27fvs3NmzfR0NDA0dGR3r17AxlGRXYDiVwu59WrV5w4cQKJRELPnj2pV69eoQ06ycnJQviAIin3zp07GBoaUrFixSzbK1TTatasKYQGfe34+vpSpUqVr3Yg19DQoGvXrkBGbSM/Pz98fX1xd3fn+vXrqKurY2lpKUhAGxoalspzrVChAm5ubjn+FvJKly5dWL9+PRcuXKBPnz752tfW1paLFy8KcuNFSZkyZRg6dCg7duxg165dODs7Czkmn6NixYo0aNBA+C3mdb/SgkgkQkNDQ7jPZjoaBMQkUtCQlWHNapGWmoL8H/nKqd3aIfpH/SU5KSnbQsxte/bl5cP7LJs4HC1dfRwnz+L9P0pkAH/99ReTJ0+mU6dOqKmpMWDAAGYtWozHh8QsbX2Mw5CR+L14xqLhA1BVV6embTP6TZjG7XMnAahU3YZ6Ldrwg2MPpv2xntrNWmJiYcn0Hh34Ze8JeowYT1JCAhsXfE9SfByVa9UTQrOzQ05moZvJkycza9YsfH19qVevnvC+rq4uFy5cYMqUKTRo0EBQaZw7d24errASJf+iDDNT8p8mJjmNy4H5lx/9lLTUFD68zblytkRFlfIVPj+h7mBZDn314skp+LhOhZ2dHd7e3uzfv58WLVrkKPkrk8lyDBW5fPkyt27dolGjRnTo0AHNf+KsC4uIiAjWrl2b5X2RSMSMGTOyTJJu3rzJtWvXmDhxolBc9GsmLi6OP//8k969e+c5Yb80cenSJZ4/f86UKVOyfCaTyQgNDcXPzw8/Pz/evHmDTCZDX19fMGysra0L/Tv1pfj6+rJnzx4mTpxYoJwjyPAeHj9+nIEDB2ZS3coLe/fuxcfHh++++65YvuMfPnxgx44dQj5NdrWJsiMxMZG1a9dSrVo1vv3226LtZBFTWGNG2JtA5Ll4IstXqIgkD3WEPjdmJKdLCz00rjAo7nBqJf/fKD0zSv7T6GuoYqihSmRywdRPVNXUM6m15BcRYKChWmyGDGQoUykMmqtXr9KnTx969erFrl27+Oabb7JNls/JkDl//jxBQUGMHDmyyLwgiYmZVxdFIhFisZgOHTpkMWQSEhK4desWtra2/wlDBjIm0JAho/01kpaWlmPyv1gsxtzcHHNzc9q0aUNKSgqBgYFCvo1ChtjMzEzIt6lYsWKJCTpUqFAByBABKKgxU6dOHZ4/f86ZM2eoVKlSvnKIOnbsiI+PD5cuXaJ///4F6kdeKFeuHM7OzuzYsYM9e/YwdOjQPPVXS0uLjh07cvr0aRo0aCDUPfoaKawxw6Riwa5BXscMRWhcirT0hHAWdzi1EiXKnBkl/3mqGup8fqMiRl5C/VAYNJBRtKxfv344Ojqybdu2TIXmcuPOnTuULVuW0aNH59mQSU6XEhafzKuIeJ69j8UzPJZn72N5FRFPWHwyyelZj/2pMWNlZcXEiROzDbG5fv06IpGItm3b5qk/XwM+Pj5UqFAhz6vhpY20tLQ815hRV1enWrVqdOnShYkTJzJ16lR69OiBoaEhHh4e7Ny5k2XLlrFv3z7c3Nx4//59sSoYaWhoYGRkVCBFMwUikYiuXbuSlpaGi4tLvvY1NjZGV1cXb2/vYss3MjIyYujQoURHR7Nnz548y+c3aNAAc3Nzzp07l+dnS2nlaxszzHQ0KC3BmiURTq1EidIzo+Q/j5mOOqba6oQlpBQ4DvpLEAEmOuqY6ZRMMUdF4UuJRMLGjRtRU1Nj9+7djB49Otf95HI5AQEB1K1bN0uxs+yISU7DLzqR0PhkYZUwuwFWcQ/UJWLMdDSwLqOFvoaqkHCtqqpKt27dqFOnTrb5ChEREXh4eGBnZ/fVTvw/RSaT4evrS5MmTUq6K19Mbp6Zz6Gvr0+DBg1o0KABcrmcsLAwwWtz6dIlLl68iK6ubqaQtKLOzahQoUKBRQAU6Onp0alTJ86cOUOtWrXy5X2ztbXl6tWreHp6Ur9+/ULpz+cwNjZmyJAh7Nq1i7179zJ48ODPGqoikQgHBwc2b96Mu7s7LVq0KJa+FjZyuVwYM0LjkhAVoZJcTuR3zLAuo4V/TO55M8WFHLA2+G88l5V8PSiNGSX/eUQiEQ1M9HHxf0+6rPjNGYlYRANj/RJNdJZIJEI+zOrVqwVvTU4JzjKZjKSkJKyscg+tk8vlhMan4B0ZT1RyGiLIZDDmdrVTpDICYhLxj0nEUEOVslZVsQ4JoXfv3rlOVC9fvoyOjg5NmzbNtW9fEyEhISQnJ1O1atWS7soXk5qaWig1ZkQiEaamppiamtKqVSvS0tIyhaQpKrybmJgIIWkWFhY55oF9Kebm5jx58oTU1NQ8e5xyo2HDhjx//pzTp08zYcKEPLfZokULrl27xq1bt4rNmAEwNTVl8ODB7Nq1i3379jFo0KDP3l9TU1MaN27M9evXqV27dqmXF88OxfPQlGSCUlNQUdco9md3fseMwgqNKyglEU6tRAkow8yU/J+goSKhoYl+iRy7oYn+Z+OHvyQsK79hJ2KxGKlUikwmQ0VFhaSkpBxVy0Qi0WdXvpPTpbiFROEeGkXUP4Nofk1FxfZRyWn4pqpQxa4rEvWcQxTevHnDixcvaN++/VdfnPFjfHx80NTUFIqXfo3kJ8wsP6iqqlKlShU6d+7M+PHjmT59Ot9++y3ly5fH09OT3bt3s2zZMvbs2cOdO3cICwsrlJA0c3PzDGM9NGfhj/wgEono3r07iYmJXLp0Kc/7qaioYGFhQURERL5kkwuDChUqMHjwYEJDQzlw4ICwCJIbdnZ2qKqqcvHixWLoYeEjl8u5d+8e1hbmbPv1xxJZhMrLmPEpX1tonBIlhYnSM6Pk/wZzXU2SjWR4vo8ttmPWNdLDXDd7haaChGXpqIqF5GhXV1dSUlKwsbGhSpXP6/6LxWLOnz/PtWvXWLBgQaZQrbxK0QbHJfEwLAZpIXm6FK2EJaTg4v+ehib6Wa6bXC7H1dUVY2Pjr1LtKzd8fHyoXLlykRZHLGoKEmaWH3R1dalXrx716tVDLpcTHh4ueG2uXr2Kq6sr2traQjha5cqVv6huj5GREWpqagQHB2NpaVkofTcwMKBDhw5cuHCB2rVrY2Fhkaf92rdvz/bt27l8+TI9e/YslL7klYoVK+Lk5MTevXs5ePAgAwYMyNULpqGhgb29PcePH8fX1/erELT4+LknEolo0qQJc+bM4bfffsNxiDN61eoWW19yGzNy4/89nFrJ/zdKY0bJ/xVVDDO8DcVh0NQtr0cVg8zejcIMy6pqqMOU4YPx9PQkLS2NHTt2ZDJmFHkyn7728PCgT58+LFy4MEvOSV4MmdeR8Tx9H/fZ7b4EOZAuk3MvNJpkI5lwvwBevnzJmzdvGDx48Fc96f+UhIQEQkNDady4cUl3pUAUVphZfhCJRBgbG2NsbEyLFi1IT08nKChIkIB++vQpkGGYKPJtKlWqlCcPklgspkKFCoUiAvAxTZo04fnz55w6dYqxY8fm6ZpZWFigqamJl5dXsRszkFF13dHRkf3793P48GH69++fq9JcnTp1ePToEefOnWP8+PGFHgJYmHxsyHz48IGkpCQqVqzIkiVLUFFRYcKAXhy/4UaCrlGR9yW7MSOvKMOplfw/U3qfMEqUFBFVDLXRUBULnoXCfOyLyHioZ+dZSE6X8igshrcJ/6oDFSQsyz00inrd+7Nu02ZkqclIJBKePn1KeHg4HTp0QCKRCAO1QqLZ398fBwcHZs2axffff5/v8ytKQ+ZTFAZnFUNtpFIply5donLlyl/FSm9+UEgy58WrVpopLs9MbqioqAgeGcgwFP39/fH19cXLyws3NzckEgkVK1YUvDampqY5TsDMzc15+PBhgYtnfoxIJKJHjx5s3LiRa9eu0alTpzztV79+fe7evcvLly+xsbEplL7kB2trawYMGMCBAwc4evQoffv2zXFRQSEGsHHjRm7fvl2qVQcV93XdunVs27aNiIgIypYty4QJE1i8eDEymYzebZvz+8atmDRqiVwkQiwuPNnh3MaM/KIIp74XGl0ofcsPXxIap0RJYaE0ZpT8X2Kuq0k5TTXBuPjUQ5JfFPub6KjTwDjrQ72owrJqNmmJe2QKhPixb+Majh8/jqWlJS1btmTbtm2ZDJno6Gjat29Pnz59WLRoUb6PGRyXVGyGjALP97FoqIoJffGUyMjIYqm1Udz4+PhgamqaJ8W40kxR5cwUBG1tbWrXrk3t2rWRy+VEREQIIWk3b97kypUraGpqZgpJ09f/N7fO3NycmzdvEhMTQ5kyZQqtX+XKlaNdu3ZcuXKFmjVrCnVtcqNdu3bcvXuX69evl4gxAxkGd79+/Th06BDHjx+nV69eORo0RkZGNG/enFu3blG3bl0MDAyKubefR2GkHjhwgB9++IE//viDKlWqcOjQIbZt24a/vz+//PILIpGI75ydaNGmHYNn/UT5KjYFHjMUiABTHXV0VQtnOlbawqmVKCkOlMaMkv9bNFQkNKtgQGh8Cq8j44nMJuzrcyi2N/gn7MtMRz3LCm5RejNEYjGp6VLEptZUbdaGbd27Exsby/bt24mIiMDQ0BAVFRVkMhmtW7emWbNmrF27Nt/HSU6X8jAspgjO4PM8fBuDj5s79evXx9jYuET6UFTIZDJ8fHxo1KhRSXelwJREmFl+EIlElCtXjnLlytG06f/au8+oqK4uAMPvzFCG3hURpdnFgjF2DdhLosYSe9dYYiyJXWMvscbeu/EzJrbYuxh77L0hghSxIgoKwsx8PyaMIFhQFND9rJUVmLnlzD0Cd99zzt6l0Wg0hIaGGoKbzZs3o9PpcHBwMAQ2Tk76qUWhoaHpGsyAPkvZpUuX2LhxI99///0bC4SamJiQI0cObt++TWxsbJqKb6an/Pnz06hRI/766y9UKhX16tV75ahVpUqVOH/+PNu2baNZs2aZYgrSnDlzKF68OGXLlkWhUKDRaNi/fz8//PADHTt2BPSB46RJk/j999/x8fFh1KhRJCQkMG3aNH6Ki6S0i907/814mRYIfRxLyONYw/Th1P6OpEVGT6cW4mP7dCaeC/EOFAoFOa3U+Lo5UsXNEXcbc0xVL34sFKn8l8hUpcTdxpwqbo74ujmS0yplCs+PMS0r8cmoT61vKV2rPoULF+b58+dER0cb2lOpUiVy5szJ4sWL07zeRKfTcTodR5XSKkGrxd77S3x9fTPk/B/S7du3efbsWZZOyQz6fyOZYZpZWqhUKtzc3KhcuTIdO3akb9++NG7cGDc3N65fv84ff/zBrFmzMDIy4ujRo4SGhqZr4UqlUkndunW5f/8+Bw4ceKt9/Pz8ANi3b1+6teNdFCxYkAYNGnDu3Dk2bdr0yuxxJiYm1KxZk+vXr3P16tWP3MqU7t+/z6hRo5g4cSKnTp0C9P8OIiIiuHPnDoDhs/Tp0wd3d3emT58OwLhx4+jYsSMdOnTg8PZNVMplTxU3R1ytzN67YOXL04ePhkWmmsEyLfLYW1DKxRYjpSLdC2oqACOlglIuthLIiExBRmaE+I+N2hgfZxt8sCE2QcOj2Hii4hKI12rR6kCpAGOlEhtTI2zVxm+cH5xR07LWrlpD0aJFcXNzA/TrBipWrEj//v0xM0v7VIDw6Lhk63w+OoUC65xuRCtNyZjk2h9OQEAApqamuLq6ZnRT3otGo0Gn02W6aWZpYWZmRqFChShUqBA6nY7IyEhu3LjBwYMHCQ8PZ9GiRZiamuLh4WFIJmBvb/9e53R2dqZChQocOHCAggULvnHkMW/evJiamnL+/Hlq1ar1Xud+X97e3mg0GjZs2IBKpaJ27dqpjiYUKFCAvHnzsn37djw9PTPs34hOp8PR0ZGDBw/SsGFDRo8ezaBBgyhZsiSenp7s3LmT27dvkyNHDsM+5cuXZ8+ePYbkKdOnTycmJob27dtTuXJlnpmYczsmNv3a+N//X5fVMS0+9nRqITKKQpceCfmFEMnEJmgyJKuMVqsl4Xkc9Qu7oTZSpcvTcv/g+xlejA3AXm2Mr5tjRjcjXS1atAhra2saN26c0U15L8+ePWPChAk0btyYQoUKZXRz0tW///7Ljh07aNWqFUFBQQQGBhIaGopOp8POzs6w3sbDw+OdHhYkJCQwf/58jI2N6dChwxtHTjdt2sSpU6do06ZNuqWMfh+nT59m48aNlC5dmho1aqQa0Dx8+JDZs2dTpkwZqlatmgGt1EsMSgIDA6lfvz6enp5MnDgRNzc3SpQogb29PStWrCBbtmyYmZnRoEEDLC0tWbp0qaE+F8D169fBIcdHeVhV1Mk6WVbHd5GYRfN9p1On1zQ4IdKbjMwIkc4yclqWUqnEVG3G6r0H8VAr0Gq1+Pn5vXMRwQqVviJn0ZI0+bFPmve9cOwww9o0Yu2V9ys6qNPp2LFqGTWbtyUqLp6enTsBsHTp0vc6bkZ7+vQpYWFh+Pj4ZHRT3lt8vD7YzUrTzN6Wq6ur4UbW19cXX19fYmNjDYHNjRs3OHnyJAqFAhcXF8Oojaur6xvXwYA+A1vdunVZvHgxR44coXz58q/dvkqVKpw6dYq9e/fSvn379PqY78zHxweNRsOWLVtQqVRUrVo1xY2uvb09FStW5J9//qFYsWI4ODhw9uxZnJycPsqoZOJC/8T+8PT0ZM2aNTRq1IjevXszefJk9u7dS40aNahduzaWlpZYWlpy9epVTp06hVKpNBQdVqlUHy2QgeRZHd9V4nTqnFbq96pvZqP+9H6+xadBghkh0llGT8vSAf3at2LAkF/wKfB+azFGz1tG+LM3V/3+kC4dP8qCkYOo1bwtgZFPmTZtWoa2J70EBgai0+myfEpm0C/+B7L0NLNXyZ49O0ZGRoSEhBhuvNVqNQUKFDBkFXv06JEhsDl+/Dj//PMPJiYmuLu7G5IJODg4vDYFdJkyZfD396dAgQI4ODi8sj3m5uY4OTkRGhpqyFSY0UqWLIlGo2H79u2oVCoqV66cYpvy5ctz9uxZ1q1bh0aj4d69exQsWPCDZyjUarWG0a6TJ0/y7NkzjIyMKFOmDNu2baNOnTr079+fKVOmcPr0aZYsWUJISAhqtZq//voLe3t7QxCjUqkyNKtjemQMS+/p1EJkBhn/W1CIT8z1h9EZ3QR0Oh13ot9/LneMsRlqZfoten4XiaNKOiA8OhYf508jo1lAQADZsmXD2to6o5vy3j7lkRmVSoWLiwthYWGv3MbW1pYSJUpQokQJtFotERERhixpO3fuRKvVYm1tbQhsPD09UxSs9fPz4+rVq2zcuJG2bdu+dhpPxYoVWbduHQcOHDAkBchoiRnidu3ahUqlSlFb5vnz59jZ2REYGGj4bNHRH/53ZWIgM378eGbNmoWLi4uhSO3IkSNZv3499erVo1evXkycOJF27dol2z9p8eEMzeoYEYWjmUm6BhdqIxXOliqcs3ZWeCEkm5kQ78rX15fhw4cney0qNj7V9SVRD+5zePsmw/cNC7hw4djhD9Kuoa0aci88lPF9e1CzZk0A5s6dS86cObG0tKRdu3bExcUZ2r9+/XoKFSqEubk5pUqVYv/+/YD+D3f/5t+yesYkAGYM6MWSccOZ3LszzYp78r3vF/j/vcZw3qfRT5jyU1dalMhL9xoVCLhwxvDe3dAQGhZw4W5oiOG11TMmMbRVQ8P3pw/so0+D6jQr7slP9apy7sgB7oaGMKxNI8M1O3n4IK1at6Ft27aG/TZv3kyJEiUMC7jXrVtneM/X15cxY8ZQo0YNzMzMyJcvHzt27Ei/i/2OdDodAQEBn8SoDHzawQxAzpw5CQ0NfattlUolLi4uVKxYkTZt2tC/f3+aN29OwYIFCQsLY+3atUycOJH58+eze/dubt68SUJCAsbGxtStW5dbt25x/Pjx156jSJEiGBkZGTJyZRblypXDz88Pf39/Dh06ZHj933//ZerUqdy8eRN48YDiYwQzADt37mTy5MnMnz+fo0eP0qdPH/7++2/Cw8Px8PBg48aNhISE0K1bNy5evJisjYmBTEZnddRodZy+E/XOU4aF+JRJMCNEOgp89DTV+ccrJo3mpP8ew/cLD5whv0/JD9KGvjMW4uCcg+IVfHF19wBgzZo17Nixg/Xr1/PXX3+xZMkS1q1bR40aNWjTpg1Dhgzh3LlztGzZklq1ahEQEMCjVIKy7f9bglfhovy2aR9lqtdh3rB+xDzRz+meN6w/4TcDGLViLR2GjGbTknlv3eZb168yrmsbylSrzeQNu6lQpx7jf2iHytiIvtMXAi+u2XPNi5GivXv30qBBA1q3bs3Zs2fp2LEjTZo04eTJk4ZtxowZQ7Nmzbhw4QLFixenU6dO6Zpi911EREQQExPzyQQzidPMPtVgxtXVlaioKJ48Sfv0IhMTE/LmzUvNmjXp1q0bvXv3pl69ejg6OnLmzBmWL1/O+PHjWblyJeHh4RQuXJhdu3bx6NGj1x43f/78REdHc/v27Xf8VB9GpUqVqFSpErt37+bo0aOcPXuWbdu2GQLepJ4+ffpB2vDyz3dwcDA+Pj7UrFmTffv2MWLECH799VeyZcvG5MmTcXd35/fff8fS0tKQVOHlkbHE6cMZFUrogNvRcYRHZ2BmSSEyKZlmJkQ6Co+OTfWP3csP0+ycsn2wNljZ2qFUqjA2MUWj0D+vmD17Nvny5cPb25tq1apx9uxZunTpwuzZs+nUqRPNmzcHoEePHuzfv585c+bw/aARKY7tlr8Q9Tv+AEDTHn3ZsnwhIdevkitvfg5v38SIZWvwLFwUgMbderNg5KC3avOeNaso4PMljbr2AqDB9z8S9+wZz2KisbSxBfTXTAE812oxQ/+0dObMmTRq1IhevfT7/fTTT/z7779MmjSJVatWAVCnTh3DSM6QIUMoVqwYERERuLi4pOm6pqeAgABMTEzInTt3hrXhfel0OrZs2UJcXBwxMTEAHD16FHNzc9zd3bP0Z3tZ4lqZ0NBQChYs+F7Hsra2pnjx4hQvXlw/HfTOHcOUtMQ0wAqFgkWLFlG1alW8vLywtEw5D6hq1apcvHiR3bt306pVq/dqU3rz9fVFo9GkGAXNkyePPhPYf+Li4pKtaUnqfdZzJB7v1KlTlChRAicnJ6ysrFi3bh3t27dn4MCB9OnTh127djFkyBCqV69OkSJF2LBhAwqFItU2ZYbpw4r/2pHTKmMKpgqRWUkwI8R/goKC8PDwYOTIkUyZMoUWLVpQpUoVBg8eTFBQEN7e3kycODHFXHDQP5nu068fK1etJurhfeyzOdOgcw+qN2nJ6hmT8N/wJwAX/z3M3L3/0rCACyOWrcG7dDmex8WyesYkDmxeT3TUI4qUqUCnoWNxzJGTu6EhdK1amr7TF7J84ige3omgaNmK/Dh+Gla2diTEx7Ng5ECO7dpG/PM4vEuX5/vhvxrapUnQL97/4osvMDc3p3///tjY2BAbG4uvry/Xrl3jwYMHTJ8+3fBHXKPRYG1tjU/lmik+Zw43D8PX5pZWhnPcDgpEq9HgUaCw4f08RYq/9bUPD7phCIISNevZD4BH9+4lez3pLI/Lly/TpUuXZO+XK1eOxYsXG75PWpAycX1Kak+JP6aAgAA8PT3fKttVZqXVarlw4QJxcXGGp9jHjx9Hq9WSL1++TyqYsba2xtra2hDMJGbHel8KhQJnZ2ecnZ0pX7488fHx3Lp1i5MnT3L58mU2bNgA6JMQJKaAdnNzw9jYGFtbW+zs7AgKCnplQJBRFAoFNjY2KV5zdXWldOnSbNq0iago/dqTp0+fGoK19My0deXKFUqWLMmePXsoUqQIZ86cYcOGDQwfPpz+/fsD4ODgQIECBVK09eVrGRUbz37/fdg5ZcfV692SqiT9nf+u7oSG0KBqac5euUbR/HlRKBTs27fvkywoLERaZJ7ffkJkEocOHeLEiRN06tTplVOwXjZu3Di2btlK3+kLmL7tAL71G7No9GAe3b9H3fZdKVfrG8rV+obxa7al2HfesAEc3bWNH3+dztg/NqFJSODXH9olmyqxbt50ek+ezcgVawm4cIaN/03h2rZyCRf/PcrQRasYv2Ybz2JiWDJuuGG/kIBrAJw5c4YBAwbw888/ExX1Yt61Vqulf//+fPPNN+h0Ojp06MD27dtp3Lgx3Zo3JiEh+U2/kXHKbFVJ53DrkoxLGSWdcpTKjZ9G86LCteodMzKp1SmfUGo0mmTHTi3DVkbMO1+6dCmLFi1i79693Lp1C09Pz4/ehvSkUqkoVaoUCoUi2b8n4I3phbOa6OhobGxsuHDhAkuXLmXcuHHJ1oSkF2NjY7y8vPjuu+8oXrw4JiYm1KpVC2dnZ86fP8/KlSsZP348y5cv59ChQxQsWBCtVsuxY8fSvS3v4/z582zdujXZazqdjkuXLuHl5cUPP/xAkSJFUCqVaLVawp7Esi/4PnuC7xMU9dQQyIA+cHn5v0RxGi1BUU/ZE3wf/+D7hD2JNfxbLFCgAO3bt2fDhg14eXkxYsQIjIyMMDY25tChQ4SFhTFx4kRMTEwMxUpfFaAGPnrK8Lbf8ej+vVTf/9hCHj/L6CYIkalIMCPES3r16oWXlxeTJk0yTMHKkycPPXr0oFatWsyZMyfFPsWKFWPk1JnkL/4FzrncaNilBwnx8YQHBWJmYYGJqRkmpmbY2CdPuRod9Yh/Nq6h0y9jKFKmPO75C9Fz4kzCb97g7KF/DNs1+bEPeYv6kK9YCSp+3YAb588AcDcsBBO1GqecuXD1zEv3cVNp0OkHwx9lKzt9hXIvLy969+6Nra0tDx8+NBzX0dGRmzdvYm1tjbe3N/PmzWPPnj2UKlUKa1tboh7cf6tr5uLhhZGxMQH/tQsg8NIFw9eJaymexbyYqnEnJNjwdQ43D4KuXkx2zEFNv+Hglg2vfQKeP39+jh49muy1I0eOkD9//rdq98f0+PFjQkNDOXjwIKBf77N+/XrCw9+vDk9GSgxmEikUCgoUKPDJjMrExsYyc+ZMJk+eTEhICI8fPyY4OJj4+PgPnhK5evXqmJiYEBgYSL169fjpp5/o2rUrVatWRaVSsX//fg4f1icR2bdvH6dPn+bx48cftE1vS6lUGh40JB3luHPnDo8ePcLY2JgGDRrQd+AgLj5O4Fh4JJH/rdFL62OGxO0jY+M5Fh7J0bBIYhP0DzMS0y+Hh4fTokULfvvtN9atW8e3335LrVq1uHjxItu3b8fU1PS16+jC0yEzZHq6k4Gp/4XIjCSYEeIliQtAL1++zMyZMw0F1CwtLdm0aRPXrl1LsU/9+vWJfvqUJb+OYEznVnSpUhoAbZIRgtSEBwWi1WrJW6yE4TUrWztcPLwIC3wxtzz59C5LEv6bPlbtu5ZE3rtDx4rFGdm+Kaf+2UNOr7yYmpvz5NFDrP8LZhLZ2NgkG7UoU6YMf/zxB5cvX8bb25upU6cyZcoUChQoQKGixYiLfbsngOaWVnxVrxGLRg/h2tlTXDh2mD9nTn5xXkcnHHO48PfiOUSEBLN33WpO7X+REKFG09ZcPvEvG5fM43bwTdbNm0FIwDUKlSyDqZk+he2NC+d4HheLMkls07t3b9asWcO0adO4fv264WalW7dub9Xuj8nFxSXZKEZsbCznzp3jxIkTGdyyd2dpaUnRosmnB2Zkhff0Zmxs/MpgOvH3xIdiZmZG7dq1uXr1KhcvXkShUJAtWzbKlClDixYt6NevH61bt8bOzo74+Hg2btzIb7/9xqxZs9i2bRvXrl0zJGb42AoXLkzfvn1p2bIlRYoUSZYYInFEK/TJM3bevEdEOt2YJwY14U+esT3gDqFPntGxY0dy585N165dAejatStr1qxh586dLFiwgGPHjmFnZ0dCQoIh6Jo+fTpubm6o1Wr9NDX//bT7Sp+sZVibRqyeMYm961bTpXKpZOcf2qqhIfMjwJ+zptCuXBHalinM7jX/M7z+z6Z1tCld2DAFGODIji109iuJTqfjwZ3bTOzRidalCtKkiDt9GlTnyql/k53ruUZnCNiEEBLMCJFC4hPFhIQE+vfvz5kzZwz/Xbp0iblz56bYZ8iQIQzs9j1Gxkb41mvEuD82v9W5TExNU31dq9EmC4RSTO/674Y4d978zN1zjJ4TZ2LnlJ2VU8YxqkMzajRtTcC5M0QE33zt+V1dXVmxYgVXrlxh1apVzJ8/n1WrVlGpUiWUOi2KVGesp67DkNHk9ynJyPZNmTGwJ7VbvqhOrlQq6TZ6MtfPnaZXHV+O7NhMwy49DO8753an7/QF7F33B72/qcyRHZsZMGcZ9tmdcctfgGLlKjGoWV1O7t+LSZInvaVLl2bFihXMmTMHb29vlixZwp9//plq0b6MliNHjmTfKxQKnJycqF69ega1KH2ULVvW8PWXX3752oKPWY1KpaJZs2aYvvRzqlaryZbtwyXxSFSwYEEKFy7Mtm3bDEkWEhkZGeHh4UHTpk0B/dqwRo0akStXLq5evcqqVasYP348S5cu5Z9//iEsLOyjZvFTKpV4eXlRv359+vXrR+PGjQ0L8a8/jObf8EckaHXpnh1MoVSSoNPxb/gjAh7GMGDAANRqtWEUy9XVleLFi1O6dGnMzMzQarWGUbbTp0/Tt29fZs+ezZUrV6hYsSLNmzbl1z+3ANB3+kLqtu/6xjbsXP07W5Yv5IcxUxi2ZDV716wyvPdl5Ro8j3vG+aMHDa8d3r6RcrXqolAomNb3R7RaDWP/2Mik9TtxyJ6DecMHpjhHatkmhfhcSQIAIV4hf/783Lx5M1n63H79+pEvXz46duyYbNu5c+cyaPxkPCtUR8eLtSqJT+EVipQZzQCy53JHZWTEtTOn8KnoC8CTyIfcDg7ExcPrjW303/AXxiYmlK9dj3I1v+HamZMMbPoNfaYt4PHDB1z89wh/bNmebJ+OHTvStm1bw6LRpk2bsn37doKDg9m3bx+gX3dy+cJ5vuv+M9W+awHAj79OTXH+tVdeTJEyVZvRbfRkuo1+MSJTt/2LxfnFyn/FjG0Hku2fmBkNoKRfNUr6VUtxDmMTU4Yu/sPw/ciubZNlMWratKnhhi7F9fH3T/a9u7t7htVpcHZ2TvLvQYGVlRWtWrVKdd1PVpItWzZsbGx4/Phxqskxsjp7e3saN27M77//bnjNw8MjXRIAvI1atWoxa9Ystm/fTsOGDVO8ny1bNqysrAgMDKRp06YULlwYnU7Hw4cPDVnSDh06xL59+1Cr1YZEAp6entjZ2X2Uz2BkZEShQoUoVKgQ1x9Gc/5e2lNcp0XiKMu5e48JvRPJtWvXOHLkCOXKlUvRb0mnwQUFBaFQKHBzc8Pd3Z3Ro0dTrFIVLG3118nSxhYzC4s3nn/3Xyv5uk0nw++zrqMn0+trXwDMLCwo6VeNIzs2U7yCL3HPnnJq/x5GLl+HTqejVNWalK1eGwdnfbbFms3bMbZzy2THVwBRcQkIIfQkmBHiFXr37k3FihX58ssvqVOnDps2bWLKlCns3bs3xbYODg4c2LkDc7f8PLwbweIxQwFIiNdP8zA1Myfk+lUe3LmNQ/YXT+jNLCyo2rgFC0cPpuvIiVja2vL7pDE4OrtQrHwlIu/efW0bnz55zNp507Gysyd7Ljf+2bQOB+cchrUyoE9l+jb8/f2ZPHkyX3/9NTNmzODZ06f41qn7Vvt+LKYqZbpWwP6YnJ2dDV+r1WratGmDlZVVBrYo/bRs2ZLIyMgUVe0/FV5eXlSrVo1du3YB+mDmY7GwsKBmzZqsX78eb2/vVNeDlSxZkn379nH27Fl8fHxQKBQ4ODjg4OBAqVKl0Gg0hIWFGYKbLVu2oNPpsLe3x9PTEy8vL9zd3T94YB365NkHD2Re5lqyAubOuejbty9fffUVJUu+ur5XjRo1KFKkCEWKFMHHx4d69epRsUFTotK4Pir0xjUad+tt+D5Xnnyok/xsVKhTn7m/9OX7Yb9ycv8e7Jyc8fLWT9es0bQ1h7b+zdXTJwgLDODGxXOpjqjFZ3CtLCEyEwlmhHiFMmXKsGLFCoYPH07fvn3x8vIyTMF62eLFi+nUuQvbvvbDPrszVRs3R2VkxM1LF/Cp6MdX9Roxvnt7fq5XlSVHLiTbt02/X1g2YRQTe3QiIf45RctVZNiS1RibpD4FLamaLdrx4M5tpvfrQXTUI7y8izJg9tJkKX9tTN/ux7xu3brs3buXIUOGUKJECXbt2oU2e3aCop5mWKG4pBSAi2XWHcWwsLBApVKh1Wpp1aoV9vb2b94pk0pZA8QEpW12rj6IfmMNkKyqbNmyXLlyhZCQkI+e4KBIkSJcvHiRzZs3G9ZzJFWuXDn8/f05dOgQPj4+KfZXqVTkzp2b3Llz4+fnR2xsLDdv3uTGjRvcuHGDEydOGFInJ47a5MyZM11Th8cmaDgVEZVux0uL3hNnUCC3C0WKFHntdubm5hw7doz9+/ezadMmlixZwoxZs/n1pSyUqY3KaTQvj5Qk/62pMnqxbqhEpcpoNBouHj/CkR2bKV9b/9BIq9Uysn1TYp48pnytupT0q0ZCfDwTfuyQ4nzazPBLWYhMQoIZIf6T2hSkt53CVL58eU6dOcPWGy9GUr7t1N3wdb5iJVh04Izh+2TTs8zM+X7YOL4fNi7FObK55kq2LegzmyVSKpW06jOEVn2GpNg3cTvbJPUXgoKCUm0/gJ2dHUuXLk32WlRsPDejPkyV7rTSAZ52mffJ/9sU+fP19cXe3j7F+pmsID1rgGRFCoWCVq1ace7cOWwcHImIjn2ngo7veu46deowe/ZsduzYQb169ZK9b2RkRO7cuQkODiY6OjrVIptJqdVqChYsaCgAGhkZaRi1SbyZNzU1xd3d3TByY29v/8qpdadOnQKgRIkSqb6v0+k4HRGFJoPuwFXGJnT4ZSwmJiZoNJpXBmlHjhxh7969DB48GD8/P8aNG4dTtuxcPpl8Ab6RsTHPkqxh0ul03A0NMXyfO28BAs6f5cvKNQC4GxpCzOMXgZyxiSmlq9Xi2K5tnD30D427/QRAaMA1Lp04yuLD5w2ZL7f/b6nhHEkpP84sRyGyBAlmhEgnaiMVpiplshoJGe19p2XZqI2xVxvzMIMXmyoAO7UxNqaZ66Y4zTf4znmxsFQTFRufJW7wdTod4dFxXHsYTWRsPAqSP29+3a1pYg2Qm1FPsVcbk9feEhdL04+21iS9JfZ1hI0rwf89tPiYwZy1tTXVq1dn06ZNeHt74+WVfE1dlSpVWLx4MXv27EkR7LyJnZ0dJUuWpGTJkmi1WsLDwwkMDOTGjRvs2LEDrVaLjY0NXl5ehpEbMzMz/efV6di1axexsbHcu3eP6tWrp+jj8Og4bmdgOmEdEBETR3h0HDmtXj26a2ZmxogRI8iePTtVq1Zl//79PI2Jxj1/IdTm5ty6fgWPQt54eRcjOiqSrSsWUcK3Ktt+X0x01CPDcWq1bM+CEQNxL1CYnB5eLB47NEUhzgp16vNr17Y453Ynd1791EELa2uUSiWHtmygZOUa3Dh/xpAhLf558uv3ttOHhfgcSDAjRDpysVR/ctOy8tpbciw88v0b9B50/7UjM/hcbvBjEzScjohKdhP6vjVAcliY4uNsk2WmoGW2vvbx8eHChQts2rSJbt26JSsImytXLszNzbl06VKag5mklEolrq6uuLq6UqlSJeLi4ggODjaM3CSOwri4uODp6YmtrS2xsfo6LEePHuXx48d8++23yerwXH8Yneq5PibFf+14XTBTvHhxFi9ezKhRo+jevTtubm7MXLiYbF55qd2yAysmjuZOSDDtBo6gTb+hrJk7jVXTJuDXoAllatQxHOerug15/PABi0YPIS72GQ2+707QleR1tLxLl0dtYUH5Oi/6ysHZhU7DfuWv2b+x8rdxuLh70X7wKGYM6MnNSxewc9IX99Tx9tOHhfgcKHQZldpHiE9QVGw8e4LfrtDkx1DF3fG9RzN0Oh1HwyIz7MmqAnC2NKWMi12G3/SndoP/rhJvjDPjDX7ok2ec+m9aUHr+gVAAKqWCEs42uFqZpeOR019m7evIyEjmzJlD8eLFqV27drL3du7cyZEjR2jSpAkuLi5cv36dQoUKGUZR0kNUVBSBgYGGkZtnz1LWosqdOzfNmjVDrVZn+d+JsQmaZNOH08vT6Cd0qFCM3zbtwzmXW5r3r+2VLVP9zhAiI0kwI0Q68w++n2mmZfm6OabL8S7df8yVBzFv3vADMFIqqO7hlOF/uD+XG/yPkToXoKiTNXns35zmNiNk9r4+duwY27dvp23btri5vbgRfvbsGRMmTMDExMRQMLNRo0YULlz4fZueKp1Ox4IFC7h9+3aK99RqNd27d+fak4RMM1p98dhhhrZplOb07FsC7qTb9GGdTsfRHVs4snMLjyMfMHzJn2k+hqlKSZ082dOlPUJ8CmTSpRDpLDNMh0rPaVnXH0ZnWCADUCITjFp8yCJ/OiBB+6LIX0b6WIEM6GuAZPTnTU1W6OtSpUqRK1cuNm7cSHx8PLGxsSxfvpzp06cDGAIZ4IOmy05ISODOnTuAPklB0pFTjUZDdHQ04dGxmSKQAcjnU5IVh8+leT8XS3Uayge/nkKhYPmk0dy4eI6Ov4xJ+/5k7ayOQnwIMulSiHTmYmlKDgtTImLiMuSPeOK0LBfLN6d2fpOMqAuRVFEn6wwfrfjYN/hAhoxYZERfn7v3GLWxMsP7OFFW6WuFQkHdunWZO3cu69evJyQkhOjo1NelWLxFkcd3FRsbi0qlwtraGldXV1xcXMiRIwc5cuTA1NSU2AQNcY/Sf4rWuzI2McHY3pHYBE2aHpB42pqna1bHObuPvvO+mT2roxAZQUZmhEhnCoUCH2cbVBmUO1OlVOCT3ea915dkZF0IgIIOlhk+DSmjbvBDn6Rch/AhZWRfn4qIIjZBkyHnTiqr9bWFhQVOTk5cvnzZEMioVKoUP/dvStP8KkFBQSgUCv73v/+RM2dObG1t6dmzJwkJCQwfPpz69etTp04dJk2aRPHixalTpw4bNmygYsWK2NvbU7duXS4GBBqOFxESzPB239GsuCe9v6nM34vm0KVyKQD2rlvNoGZ1Gd+9Pa1K5uefTevQ6XT8Nfs3Olb0odWXBRjbpTX3wkMNxzu09W9+rFmBpkU96FnnK47tflELZsvyhXSu/CVNi3rQr2FNLp88BsCFY4dpWMCFR/9NAw4NDeW7777D3t4eR0dHevToQVycfo3U0qVL8fX1ZdiwYXi55qD1lwVYMm54mqeopScFYJ8JszoKkdEkmBHiA1AbqSjhbJMh506PaVkZXRcC4FFcfIbeOHwuN/gZ3dcarY7Td6Kkr9MgLCyMmTNnGqZ4JXJ2dsba2jrZa++7+H/EiBGsXr2a9evXs3btWoYNGwbA33//TfPmzdm7dy+lSpWiS5curFu3juXLl3PkyBHi4+Np/V1jdFotmoQExnVpjYWVDRPWbKfB9935c9aUZOe5evoEufLkZ9zqzRSv8BXbfl/MP5vW0WvSLMat3oStoxMjOzQjIT6eqAf3md6/B99+/yPTtx2gcoOmTP35B548iiTw0nmWTxzN90PHMX3rPxQsWZpJvTqj1b5Y8xIVl8Dz58+pXLkyMTEx7N+/nz///JMtW7bQr18/w3aHDx/m6tWrHDp0iLGTp7J1xULOHf7nva7n+8hMWR2FyExkmpkQH4irlRmxTlrDdJKPIb2mZWV0XQiA29FvrgvxoWSWG/yPkcEto/tah/R1Wvs6MjIy1SxiMTExdOzYkWXLlnH//n2USuV7//uZMGECFSpUAGDUqFH079+frl27kj17drp06WJoz4oVK9i2bRt+fn4ArFy5EtdcuTh76B9QwP3b4YxbvRlzSyty5clH8LUrHNyywXAehUJBwy49MFXrf39tWDSbTkPH4V26HACdR0ygY8XinD6wDwfnHCTEx+PgnINsOV2p274LbvkLYmJqyr2wUBQKBU4urmRzzUWznv35wrcquiTBTLxWy/bt2wkLC+PYsWPY2dkBMGvWLL755hvGjNGvZdFoNMyfPx9ra2vy5cvHrOlTCTh/lmLlv3qva/ou0nP6sBCfGglmhPiAEqdJfYyApmg2a/LYpc+0rKxSF+JD+Zxu8KWvs15fe3t74+TkxLZt2wgODja8/vjxYywsLOjYsSNTpkwhPj4erVaLUqkkNkHDo9h4ouISiNdq0er0VeSNlUpsTI2wVRunOqJbvnx5w9clS5bk3r173L9/H3d3d8Pr165dQ6vVUrp0acNr9vb2uHnlITTwOpqEBFzcPTG3tDK8n9/ni2TBjI2DoyGQeRYTw4OI20z5qUuyYpPPY2O5HRRISb9qfPFVVUa2b4qLhxelqtSgSqPmmJqZU7zCV+TOV4DedSvjUcibUpVrULVxC1RJ6t5odXD58mXy5ctnCGQAypUrR0JCAgEBAQBkz57dMNKlUCjIbm+LTpPwVn2U3tJr+rAQnyIJZoT4wPLYW6A2VmbqVK9JRcXGG1JLP4uO5tjubfjWb6x/78F9Lh4/Qrma36TLuV7WpXIpvuv+M5UbNEEHPIyNJyou/qPPEf+UbvCbNWvGwYMHuXr1aorMVn5VqnI7Moox//s7Q2+SXtXXZ86c4enTp5QrV+6DnTur9nX27Nlp06YNly9fZvv27Tx58gStVkt0dDRWVla0adOGFX+u5eCNcJ4ojA2phVPr5cTfSaYqJS6WajxtX/w7MTZ+0R8ajX46nFKpRK1+0dakXyel1WjRajSojIx4+Tffy9MKjU1Mk+ynDxj6TJ2Pi4dXsu0sbWxRKBQMmrec6+dOc3zvTo7t2sr2/y1j9Mr1eBT05tc/t3Dx3yOc2LeLvetWs+OP5UxYu91wDKUi9TYnfr7E/yctSqrfT4GzhUmK/T6GzJDVUYjMStbMCPERuFqZUd3DCWcL/R/s971tTNzf2dKU6h5O6ZoNKvDRU8PxNy2dx961fxjeWzFpNCf99wBwNzSEhgVcuBsakuIYe9etNizuTYvxa7ZRvnZdw/cKIDAy/bIIvY2kwVxGSnqD/z4mT55MVFQUY8eOTfb6unXrOHjgH7qMmPBOgcy79vGrpNbX3377LdeuXUu3c7wsq/e1QqGgUKFC/Pjjj5QoUQKVSoVOpyPsSSxX403IW6sRD7SqZDVSdKn8lyhOoyUo6il7gu9zNPQhAKdPnza8f+LECVxcXHBwcEjWDi8vL4yMjDh69EWWrgcPHnDr5g1yeniRK08+bgfd5FmSjGs3Lr46RbKFtQ02Do5E3r9LDjcPcrh54JgjJysmjSb85g1CA6+zbPwI8hb1oXmv/kzd7I9jDhfOHPTn6ukTrJs/gyJlytNu4HBmbD/A87g4rpz813B8Y6WS/Pnzc+3aNR4+fGh4/ciRIxgZGeHl5ZVaswCwNjWmqJP1K9//EDJDVkchMjMJZoT4SNRGKsrktKO0ix12av3TzrTeQiZub6c2prSLHWVc7NL9aV3SuhAvPz390Gu0bewdDFNNQH+jFR4d+2FP+pKkwVxGS49gzsXFheHDhzN58mRu3rwJ6Isr/vTTT9Rv34Xc+Qq803HL167L+DXb3rxhKhKzSiWVWl+/KSlA27Ztadu27Vud88mTJyxfvtzwvbu7O1PnLUiXvj5/9CChN66/1zFe19d79+7l8uXLr9zX2NiYb775hj4DBnLxcQLHwiOJ/C9IS+uPbOL2UXH60ZFmrVqzedt2du/ezdChQ/nhhx9S7GNpaUmnTp3o3r07/v7+nDt3jpYtW5IzpytFy1eiSNmKOOZwYc7QPoTeuM6R7ZvZunzRa4Pob9p+z6qp4zm+dyfhQYHM+aUPV04dJ6dnHiysbNjxx3LWzJnKndBbnPTfzd2wEDwKemOiVvPXrCns/msld0NDOLjlb2KfxuCWv5Dh2DamRlSrVg1PT09atWrF+fPn2bdvHz/++CPNmzfH1tb2tdcoj73FRwtoimbLvMVlhcgsJJgR4iNSKBTktFLj6+ZIFTdH3G3MMVW9+DFUpPJfIlOVEncbc6q4OeLr5khOK/VbPVF/XYpVnU7H2LFj8fDwwMTEhBwuLqyYNhHQP3n/c9YULh4/QsMCLqyeMQn/DX/iv+HPZE/kl/w6jJZf5KNjRR8WjhpMXKx+YXL88zi6VC7FvOEDaFUyP+sXzGTGgF4sGTecyb0706y4J9/7foH/32sMx+pSuRR7160GYGirhqyZO43BbZtgZmZGvnz52LFjh2HbBw8e0KBBAywtLfH09GTu3LnpMlUqMxX5S69grkePHuTJk4e+ffsCMHHiRJQqFQ269uLBndtM7NGJ1qUK0qSIO30aVOfKKf1T7MTRt6M7t9KtWlmaFvVgbOfWPHkUianaDBt7B84c9Kf3N5VpVsyT0Z1asHDUYGYM6PXa9uT3KcnCA2eIfx7HojG/0LZMYdqWKcyEn7oRfvceAL6+vgQHB9OuXbu3DlheZ8qUKSxevNjw/fHjxylSpXa69PXwtt/x6P699zrG6/q6SpUqKTKXvSz0yTN23rxHRDqt/0m8LhGhITRv0YImTZvRsWNHBgwYkOr2kyZNolq1ajRs2JDy5cujVqvZtnMnxiamKJVK+s5YyMM7Efxcvxp/zZmKX4MmGBm/evpo3fZdqdKoOXOH9aPPt9W4FxbKLwv/h6WNLXZO2eg7fRFHdmymVx1fFowaRIufBlG8gi8eBb3pNmYKfy+aQ4/alVg3bzo9J8zA1Suv4di2amNUKhUbN24EoHTp0jRt2pR69eoxb968t7o+eewtKOVii5FSke4PPxSAkVJBKRfbdFsHKcSnTKHLyHyYQgiAd16c+zaCgoLw8PAgX758LFq0iPj4eFq1akWbNm3Ily8fffv2ZdWqVXh5ebH6700M6NWDiWu3k9MrL39Mm8DV0yfoO2MRanMLZg/5CYCOv4wl7ulTulYtjatXXp48iiT2aQymZhaUqORH4VLlWDllLI/u38Pv2+8o6VeddfNncPPyBbQaDRW+rk+znv3ZumIR2/+3lGw5c3EvPBSNRkPhL8sydPEfjGj7HZdPHqNw6fJYGys5cvAAKpWKvXv3UqFCBapVq0ZsbCwzZ84kLCyMDh06EBERYXia7+/vT9u2bRk6dCiDBg0iLi6OgQMHUqZMGb7//nvCwsL49ttvWbp0KUqlEl9fXwoW9mbdxk1oNQkMmruCn+pVoe/0hSyfOIqHdyIoWrYiP46fhpWtftHw7r9W8vfiudwNvYWZhSXla9el/eDRqFRv7qv453EsnziaA5vWAeBT0Y/2g0dhZWvH7jX/Y8GIQUzdvI8cbh54xT+kdMkvWL16NcWKFcPDw4OVK1fSt29fYmJiaNOmDZMnT8bIyIjhw4dz5swZHj58yIULF1i/fj1lypShRYsWrF27FisrK549e8bsxctwKOXH0NaNePLoIU8iI3ny6CEmajWWtvbM2XWEu6EhdK1aGpWREQqFklx583EvLJTqTVuTw82DVdPG8yQykkZde+JR0JtFY37hTkgwJmozvu30A4269kKpVLJ6xiRuB9/EzNKKA5vWYWxqSr32XXh0/z7Xzpyg3aCRmJiqWfnbOMx0CRzw38fDhw8pVqwYffr0oW3bttjYpEx1nhjkLF269I3Xe/jw4fj7++Pv7w/of+a23kifgo4NC7gwYtkaQ+at91HbK1uKn3WFQsG+ffvw9fVNdZ8PUewzse8B5uw+RjbXXBR1SvsowZaAO9y9e5fASxfwqehreH3Dotmc8t/DyBVr07PZb2SqUlInT/Z0O15sgobTEVHcjolDQdpHwpJK3D+HpSk+2WWNjBBvS0ZmhMgE1EYqnC3V5HewxNvJmqLZrPF2sia/gyXOlup0+aOWmGLVz8+PUaNGsWDBAnLnzs2SJUuoUqUK7u7u1G/ZDlunbNwKuIap2gy1uQVGxibYOWXDzMICE1MzTEz1T+QTC9jFP39OvxkLGTzvd5RKJf4b/uJ57Iu0sVUaN2fW4J/IW9SHkr7VcMqZi6M7thIbE02x8l+hSUjA79smzNh2ECsbWy6fPMbxPfoRGAdnFy6fOEqh4iVYt24d8fHx1KlTh6NHj7J7926WLVtGsWLFqF27NsOHD0/xmcPDw1m/fj379+9n8ODBDBw4kF69erF06VJWrVrF6tWr+fvvvw3bL1+2lJ4TZtBvxmLMLPT1HNbNm07vybMZuWItARfOsHGJ/sntxX+PsGjML7ToPZAZ2w7Sefh49qz5w9D2N1k55VdunD/D4Pm/M2LZGmKePGZyr876a9awGfmLf8GSccPQ6XR07tyZBg0aUK9ePcP+r6r/ASlrgAwaNIjw8HBq1qzJ06dPyZYtG4sXzAedDi/vYoTfvEHXUROZse0g3qUrcDckGK1Wy5mD/gA079WfaVv8cXH3RGVkzI3zZwCIjYkhT9HiVG/aihkDelL4yzK45S9EvmIl2Pb7YrYsX8jt4Jvs37iWA5vX88+mtdRp1YHS1WqzYtIYtv6+mM4jJnDtzEnGdm3N2UP/cHC/P8uWLcPe3p74+HiGDx/OsmXLcHBwIHv27Ia0uS97eZTRxcWFESNGAPpgZ8SIEezfv98wepfXyzPFKODIDs1oVsyT7jUqcPqA/1v1Y+Io5bA2jVg9Y9I7FYAMCbjGyA7NaFEiL7aWFlSsWNEwrSwxa5ifnx/Dhw83FHMcM2YMdnZ2OGXPzoyFSziyfTOdK39Jqy8LsGLSaMOxXx79mta3O08eRQKvH3lLqmvV0uxdt5pz9x4T8DDmra5LIhdL/UL7X7u1ZfuqZdwNC+Xs4X/YsmwhZWt+naZjvS9Fkvakl6wyfViIT5kEM0J8JlJLsert7Y2joyMDBw6kfv36+BUvxKN7d9Fq3lzE7/Yt/fqLh3cjGNWxOWO7tCLm8SNAn/Us0fUzp7C0saXDkNGYW1mTv/gXtPhpIM9jY7F1cAKgQIkvyeaaC1Mzcxxz5CQk4CoAZpaW5MqTjx5DhlOsWDEAbGxsWLBgAfb29nh6ehrOU7Zs2RRtjI+PZ/LkyeTPn58ffvgBrVZL9+7dKVOmDF9//TXFixfnypUrhu19q9WkYIkv8fIuanityY99yFvUh3zFSlDx6waGG3m1uQXdRk+mTPXaZHPNRdmaX+NR0NvQ9teJe/aUbSuX0HnEBPIW9cEtf0F6TpjBxX8PE3z1MgqFgi4jJ3D+yEGm9e1OwPVrTJ8+PdkxUgtOE0elEmuAFC9eHJ1Ox8yZM5k3bx5TpkxBo9Gwbt06/j10gFvXrpCnSDF0Oh371v/JzIG9OHtoPwA6rZYHEbcByFPEB+fc7nQYMoYSlSqTkKBfT5EQH08e7+Ic2LQeUzMzuoycSJEyFXDMkZOmPfuxYeEsRnZohpGxCVZ29vQYP4PNyxdQ0rcqAJqEeAY0qcPisUOJenDfMKLVq1cvQ5HDx48fs3z5cnbt2sW8efOYMGECCxYsSHFNly9fztSpU1m4cCHXrl1j6NChDB8+nFOnTtGkSRN+/vlnypYty+3b+s+k1SW/6Vw7dxoV6tTnt017cS9YmLlD+yQrtPgqieuG+k5fSN32XYG0FYDUarWM69qG7K65mbJhF//bupuEhAT69+8P6KfDAaxdu5Y+ffoA+oXqgYGBbNx3gDK16jF/eH+2rFjIwDnLaDtgGBsWzibw0nng9UFzolcF7IbP+NdWQ2KOc/ceE/okZY2bV/G0NcfGwZGfp85lx6rl9KhVkdlDfqZWi3bUbN72rY+THnSAp535G7dLq4yYPiyEeEFSMwvxmUgtxerixYsZPXo0HTt2pGHDhnQcOIy29eu81fESA56Ry9capl2F3bzBuC6tMUmyiP9OaDAeBb0N9SKMjE2o2y75zdSetX+w9ffFPLwTgUarMRxbqVRSwOdLktYzLFy4MOHh4akkJ0h9gkdiwJNYCT1pfQwzMzPi4l6sMXDOlSvF/jncPAxfm1taGm7kvbyLYqJW88f0iYQEXOPWtcvcDr5J8QpvLqh3J+QWCfHPGdQseYprrVZLeFAgbvkL4uLhxbedfmD1zMmMnTkPR0fHZNu+qv7Hy58xMDCQ58+fU7ZsWcM1qly5MlqtlrCbAWxdvgiVkRFHdmwmey43SvpW5dC2jaiMjChZuTpr5k5leLvvyF/8C0pVqYmNvQN3Q2/pD67QX/fQwAA8Cxf9r5aH/hz5fUry6P49TM3Mqd2yPZeOH6F01Zp0GDwaZZJpeM169mfllHH0nbaQnB6eOBmDOvqBIZDQarUsWrSIYsWKUaJECXr16sW8efPo1KlTsuuRdJQRoEuXLowYMYKLFy9SokQJLC0tMTExwdnZOdU++eKrqlRu0ASARl178nO9qjy6dxf77Klvn8jGXp/Zy9LGFjML/RSstBSALFKmAtWbtqJms7aYmZuT196Ctm3bMmHCBACcnPQBv729PZaWloZrMmHKbxy6+5Rq37Vk87IFNPmxD+75C+GevxArp4wjLDCAnB5ebFu5hAlrtuGWvyAAPSfMoG2ZwgRfvWwYfUwM2AFDwN6i9wDm7D5G16qlsbZLnpjjVEQUjmYmbzV6YKM2xl5tTKkqNSlVpeYbt/9QFOhHPj50mncbtTE+zjb4YPNBpw8LIV6QYEaIz8SZM2f46iv9jXZiitW//vqLoUOHGhaGHw64pR9V+e+m9+UnhArFi4xm2XO5AaBSGRlu+G9evgiAUvliP5XRq28eEqfyREc9olTVGlw9fQL1S7VQVMbGJDkcGo2G7NmzExkZyc2bN/Hw0J/75MmTqZ7DyCj5r7mkRfheZmKacgqKkfFLdSX+uwCnD/gzoXt7vqrXCJ9Kfnz3w08sGDnwlcdOSvNfHY3RKzegNk++BiFxtAog6OollCoVRw/+Az98n2y7V9X/gOQ1NBKDr4MHD/Lo0SP8/PzYsmULT81sOBcUzpXTx1l48CyhAdc4sW8X/hv+BOB+RLjhRr3ryIkEXDjL34vnoNVocPXUL6Y2MjIm8OI5PAsXMZzvxsVzZHd1MwSkzrncMDYxMVzHyg2bcuHYYeC/J9oeXrjlL8jYLq3Ina8ACk0CK5ctxcjICIVCgampqWFUDvSB26RJk1JcUz8/P44dO8bAgQO5fPkyp0+fJiIiwnBt3iRZ0GphlezapVVaCkB+Wbk6NZq2wf/vvwi8cJYHt25y5fxZsmd/9bqO7Nmzc+1JAhqtzvBv1inni0DcxFRN/PPnbwyavQoXTfnZkwTsr6LR6jh9J4oyLnZvNYqQ196SY+GRb9zuQ9L9146PST99WIXzxz2tEJ8dmWYmxGeiZ8+enDhxIlmKVQcHB3bv3s21a9c4efIk/b5vT0J8PPHxzwEwNTPn4d07hloypmbm3AsL4cGd2+TIrb8Bmtb/RwLOnyHw4jmWjR+BsYkJVnYv6lDkcPMg+NrlZCMnk3t3ZsOi2ez+ayUAddt1pmqj5qiMjIh6+CDZtkGXL2Kc5Cbw0qVLVKpUiRo1atC+fXvOnTvHrl27GDp06Htfo7RM7tj910oqN2xCl5ETqNqoOa5eeYm4FfzGdMIAzrncUapUPHkUaaijYW5pxZJxw3j0QJ8V69892zlz0J9Bc5ezde2f7N27N9kxzpw5Y/j6VfU/QF8DRKVS8eDBA8OIjaWlJROHDkKTEI9CoWDO4J/InsuNAj4lDTenF48d5vzRgwAUKVOBzsN/ZfKG3fpkD8/0KYTVFpZcO3uKu2EhXD97ir9m/cblE8dQKODamZOozS2SjcK8rNCXZVkybjit+gym25gpPIuOJiw4iAYNGhAWFmYIypLWAtFoNKkGpAsXLqRq1arExsbSsGFD9uzZg6ur65u6wiDVzFrvmB/nVQUgJ63fZfhv+rYD+DVowrOYGPo3rsXBzevJ6ZmHbv0GMnHixNceX6FScTsmLtlic6Ui5TVJGjQnPffMHYcoXv7FCOKrAvZX0QG3o+MIj367zGkulqbksDDNsJTnCvSL6l0sTd+4rRAi65FgRojPRJMmTahTpw7Nmr1IsTpt2jQeP35MsWLFaNCgAcWKFqV0tVrcvHQBgNLVaqHTaen59VdEPbjPV/UaERZ0g5/rVTVU9I68E8HQVg35pVVDoh7ep2GXnsnOW+mbBkQ/imT5xFE8jX7C7eCbHN+zk2LlKhmmp90JCebW9as8eRTJ0yePDcEUwIV/D7Nq3kxu3LgBQGxsLI0bN2bJkiVYWFhQunRpunbtSrt27VJU7E4rZRrmqlvZ2nH19AmCr17m1vWrzBzYi8h7d5K1/VXMLC2p2rgF84cP5MKxw4QEXGN6/x5E3Aoim2tunkVHs3DUYBp16UWJin607NiZzp07Exv7InVvasFpqu20sqJTp0507drVUNTw559/JjToJvl8StKgc09O7t/Dj7UqsHrmZMrW0C/KVv5XgBHgzEF/7oaGsG/dalRGRoZRB5VKRZ9p8wm+eoXIe3fZ9dfveJcpz8O7d1g9YxIl/apxJySYhIQXxSCXjR/BojG/AFChTj1y583P2C6tWTJ2KLnzFmDfsRPExcVx8OBB6tWrR1xcHM2bNzfsf+LECYoWfbGmKdHcuXMZOnQov/32G61atcLR0ZE7d+4YPkNGrUN4UwHIi/8eJvLuHUYsW0P9Dt2o5FeFW7duvTYojte8XZD1NkHza73mminQZ1F7GwqFAh9nG1TKjOkDlVKBT3YbWYsixCdKghkhPhPNmjXjzp073Lt3j5EjR+rXoxQowJEjR3j27BnBwcFMnjSRfjMW0WWkfr6+c253Zu08zKozgdg4OJKvWAkWHTjD0qMXSayu0OLnQagtLFAZGVGnVQdDMGNsYsraK+FYWNswaO5yLp84xqn9e4iOiqTXpFl4FPSmSfefKVb+KxaNGcLI9k2pUKceNZq14ealC4xcsRb3At58Wbk6xw7+w9dff025cuXYs2cPJiYmHD9+nPXr1/Ps2TMCAgIoWrQoOXLkeK9rpDZSvnVq1Sbdf8ba3pGBTb9mZPumGJuaGtr+Ntr2H0rRchWZ2KMTA5t8jUplxOD5v6NSqVj52zhMTM34pl1ndMDgX4YSExPDyJEjX5w/leD0VSZPnkzVqlX54YcfsLKywsrKik2bN6NSqWjeqx89Jswgm4srEbeCuHDsEL0nz6bi199StXFz2vQbyrr5M+hRuxKHtv3N4Pm/M2aVPgNcQkI8Ds45mL3rMBPX7SCba24uHjvCtbMnqdOmE93HTcXW0YkT+3YTF/uM43t3sHP1Clr+pJ+OZ2RsQuMfeqPVaGg7YBgdfxnDlTOniI6OpmjRotSvXx/Qj8ZcuHCBtWvXMn369FQDt5dHGZs0aUJ8fLxhTZSFhQXh4eEEBQUB+rUL6VWXQG1uzq3rV4h58jjV919XANLK1o7YpzH8u3s7d0JD2LxqBTNnzky2lsvCwoILFy4QFRXF03gN2rccMXpT0Pzmz6UPWoOuXuRZTPIsZjrgYWw8UXHxqeyZyrGMVJRwTple+2Mo4SxpjoX4lMmaGSGEgdpIhalKSZzmzVmcsrnmYu2VcABqNmuT7L3KDZoYFlODfjH4r39uSXEMu2zZGbpo1WvPY21jy7b/Uugm0mq1tG/fnq5du9K+fXsiIiIYMWIEjRs3Nmzj6+v7xiQBiTVHEr9OWnsk6edL1OTHPmlq++uYmpnz/bBxfD9sXIr3Ov6SPP2wq5M94eH6tiTejDdr1oyBA1Ou0UktRbW5uTmzZ89m9uzZyV6/EXCHOI2Wr+o25Ku6DVNtZ932XajbvkuK1ys3aIKljQ0j2jXlpymzyeHuhW+9RgScO8PolRtw/6/iev/ZS1g4cjBXT59g8ZihtO43FFMzc8MxALqNmcKa2b+xcNQQPNzd+P333ylYsKChUGStWrWoUKEClpaWjB07NtlITaJp06bRrl07ihUrRrZs2WjSpAkWFhacPn0agG+//Za5c+dSqFAhgoKC0jQK9ya1W3ZgxcTR3AkJTlZpPlHd9l15FhPD3GH9eBb9BK/CxQwFIPP7lKRxt97MHzmQ+Lg4ihcryqxZs+jQoQNhYWHkzJmTHj160LdvX27cuIGte95UWvBqbfsPZdmEUUzs0QlNQjyFSpYxBM1vYm3nQKW6DZncqwut+gzm6zbJky4ogMDIp/i8ZZDiamVGrJOWc/dSD/o+hKJO1rhamb15QyFEliVFM4X4xCUWzbx582ayLFevcjoiiqCop+n21Pp9zBzQC0sTFRtX/y/FewcPHqRPnz6cO3cOa2trWrZsyZgxYzA1fb958Vv+u8HPLF4u8pfW/nyd9OjrNXOnsWv1CqIePMDFw4umPfpQqkpNxndvz7nD/7xyv84jJlDpmwaG7xWAu415shtjf39//Pz83mod0rvI7H2dmqzY5pcFPIz5KAFN0WzW5LFLW5FPIUTWIyMzQnzi3N3d03Qz6Glrzs2opx+wRW9PB1iapPw1dffuXWrW1Kd5VSqVREdHM3fuXObOnWvYJjr67ebzv8zFUv3eN/hpvZF/lQ9R5C+p9OjrRl160uildVIA3w8dZ0gUkJqkWdvgw9UAeZ306Ov0klpfJwauK1eupG/fvsTExFC+biPa9h/GmjlTuXnlItFRjwi5fpV+MxaRt5gPq2dM4sDm9URHPaJImQp0GjoWxxw5AbgdfJOFowZz5dS/WNrYUrddF+q07gjArWtXWDh6CNfPnsIxhwt1Wnc01IGJeRzFrME/c/7oQRQKBV98VYVOw8ZhbmlFaMgtqnZtydEjRzA3N6dJkyZMmTIlWba9l+Wxt0BtrORURBQarS5dr78C/RqZEs42MiIjxGdCghkhRDKJdSEexr7dXPgPRQEMmzoLXzfHFO85ODgky+aVntLjBj+tN/KvktoNflqD09f5kH1tl+3tn9Z/rBogL3tTX0c9uE+3amVee4yVpwLSpS2vC+ZGjBjB6tWrufM4hu/bt0NtboGRkRHH9+zg++G/kq9YCVw8vJg3bABXTh/nx1+nY2Vnx++TxvDrD+2YsGY7CfHPGdmhGZ6FijBu9RbuhAQztU83sudyo0jZCoz+vgV+3+qz84UFBjB3aF/UFpb41mvEHzMm8ej+Xcb87280CfFM6/cja+ZMpXXfX1g0egiOFuacOXOGu3fv0rBhQwoWLEi3bt1e+3ldrcxwNDPhdEQUt2PiUPB+a5gS93e2NMUnu6yREeJzIsGMECKFzF4XQqVSkSdPng9y3vS4wU/LjfyrfKwb/Mzc16mte0pPb+prS1s7Jq3f9cHOn+hNfT1hwgQqVKjA1QfRNOvRlxWTx1CjaWtsHZ2o0bQ1oK/V9M/GNQye/ztFyj7j4I0AAAg8SURBVOgLqvacOJPOfiU5e+gfEuLjePzwAd3H/oaZpSW58+Y3FDA9sHk9NvaONOvZDwAXd0/uhYWwZdkCfOs14l5YCGpzC7K75sLUzJw+0+YbIo+7YaG4lvDBzc2NPHnysHXrVuzs7N7qc6uNVJTJaUd4dBzXH0bzMDY+zUFN4vZ2amPy2lviYmkqWcuE+MxIMCOESCGxLkTES7UsPhYF+iesGVUXIjPf4Kc36etX97VKpUpWUPJDeVNfly+vD07itVryeBfj8cMHPHn0MFmhzPCgQLRaLXmLlTC8ZmVrh4uHF2GB10lIiMfF3RMzyxfnqdywKaBPlx109RItSrx4QKDVaA01guq07siv3drRrlwRipatSJkaX1Px628BqN+xG7MG9cZp62Zq1apFkyZN8PHxeevPrlAoyGmlJqeVmqjYeAIfPSU8OtawLii1sCTx36mpSomLpRpPW3Ns1B93VE8IkXlIMCOESCGxLsTOm/dI0H78W9yMrgvxOd3gS19n/r5OXH+i1YFWq9Hvp1BikqQ4p8krEl9oNVq0Gg1GRq++2ddoNIb1NakpUqYC8/1P8O+eHZzcv4d5Q/tx9qA/PSfO5KtvGlC3ZnWuHdzD5s2badSoEQMGDGD06NFv+ugp2KiN8XG2wQcbYhM0PIqNJyougXitFq1On07bWKnExtQIW7WxTCUTQgBSZ0YI8Qqfc12Iz63In/R15u7rxPVhSgUEXDiLfTZnQ8HZRNlzuaMyMuLamVOG155EPuR2cCAuHl7kcPMg4lYQcUnWci0bP4JFo4fg4uHF7aBAsrnmNhTXvHb2FFt/XwzApqXzuXHxHH7ffkefqfP4YewUju7cCsDK334l8t5dunTpwubNmxk9ejRr16597+uiNlLhbKkmv4Ml3k7WFM1mjbeTNfkdLHG2VEsgI4QwkGBGCPFKrlZmFHWy/qjnzCx1IT63G3zp68zb1z179uTEiRMcP7CfP6ZPMmQZS8rMwoKqjVuwcPRgLhw7TNDVS0zr9yOOzi4UK1+J4hV8sXV0Yu6w/oQGXjcUMC1ewZevvmlIXOwz5g3rR2jgdU7u38PiMb9g46BPvvEg4jYLRw3m2pmThAcFcmTHFjwKFgYgLDCAcYP6cu7cOS5evMjWrVvTNM1MCCHel9SZEUK80edcF+JjffZERZ2syWOfcddA+jrz9HViauaxY8cydepUEjRaKjdpSZPuffhr1hQu/nuEkStejILEPXvKsgmjOLR1IwnxzylariIdBo8ypGYODbxuKGBq6+hE/U4/GBIIBF48x+Jxwwg4dwYrWzsqN2pKk+59UCqVxD17yqIxv3B8705in8ZQ+MuydBo2juyuuYl6cJ+1E4ZyaL8/CQkJ1KlTh5kzZ+LomDILoRBCfAgSzAgh3krok2efbV2Iz+0GX/o6c/T1ywVSYxM0bL1x94O3La1qe2WTaV9CiAwjCQCEEG/lc64L8bkV+ZO+zpx9rTZSYapSGjJ9ZQamKmWm7k8hxKdPghkhxFv7nOtCfG43+NLXmbOvXSzVBEU9zZDMay9ToG+PEEJkJJlmJoR4Z59jXQidTpcuN/j2WewGX/o6c/R1VGw8e4Lvv9cx0lMVd8cPXthVCCFeR4IZIUS6+BzrQnyON/ggfZ3Rfe0ffJ+HsfHpesy0UqAfcfN1k4X+QoiMJcGMEEKkg8/xBv9zldF9HfYklmPhkR/s+G+rtIsdOa1kmpkQImNJMCOEEEJkITqdjqNhkUTExGXI2hkF+vU/ZVzsssQUSSHEp02KZgohhBBZiEKhwMfZBpUyYwIJlVKBT3YbCWSEEJmCBDNCCCFEFqM2UlHC2SZDzl3COfNl3xNCfL4kmBFCCCGyIFcrM4o6WX/UcxZ1ss409ZCEEAKkzowQQgiRZeWxtwDg3L3HH/xcRbNZk8fO4oOfRwgh0kISAAghhBBZXOiTZ5yKiEKj1aVrUgAF+jUyJZxtZERGCJEpSTAjhBBCfAJiEzScjojidkxcmgt8vixx/xyWpvhklzUyQojMS4IZIYQQ4hOh0+kIj47j+sNoHsbGpzmoSdzeXm1MXntLXCxNJWuZECJTk2BGCCGE+ARFxcYT+Ogp4dGxxGm0gD5YeVniTYCpSomLpRpPW3Ns1MYfrZ1CCPE+JJgRQgghPnGxCRoexcYTFZdAvFaLVgdKBRgrldiYGmGrNpapZEKILEmCGSGEEEIIIUSWJHVmhBBCCCGEEFmSBDNCCCGEEEKILEmCGSGEEEIIIUSWJMGMEEIIIYQQIkuSYEYIIYQQQgiRJUkwI4QQQgghhMiSJJgRQgghhBBCZEkSzAghhBBCCCGyJAlmhBBCCCGEEFmSBDNCCCGEEEKILEmCGSGEEEIIIUSWJMGMEEIIIYQQIkuSYEYIIYQQQgiRJUkwI4QQQgghhMiSJJgRQgghhBBCZEkSzAghhBBCCCGyJAlmhBBCCCGEEFmSBDNCCCGEEEKILEmCGSGEEEIIIUSWJMGMEEIIIYQQIkuSYEYIIYQQQgiRJUkwI4QQQgghhMiSJJgRQgghhBBCZEkSzAghhBBCCCGyJAlmhBBCCCGEEFmSBDNCCCGEEEKILEmCGSGEEEIIIUSWJMGMEEIIIYQQIkuSYEYIIYQQQgiRJUkwI4QQQgghhMiSJJgRQgghhBBCZEkSzAghhBBCCCGyJAlmhBBCCCGEEFmSBDNCCCGEEEKILEmCGSGEEEIIIUSWJMGMEEIIIYQQIkuSYEYIIYQQQgiRJUkwI4QQQgghhMiSJJgRQgghhBBCZEkSzAghhBBCCCGyJAlmhBBCCCGEEFnS/wFKh6LjMkEnQwAAAABJRU5ErkJggg==",
      "text/plain": [
       "<Figure size 800x600 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "neighbors = list(G_combined.neighbors(second_highest_degree_node))\n",
    "\n",
    "# Create the subgraph consisting of the second highest degree node and its neighbors\n",
    "subgraph_nodes = [second_highest_degree_node]\n",
    "for n in neighbors:\n",
    "    if len(n) < 25:\n",
    "        subgraph_nodes += [n]\n",
    "# subgraph_nodes = [second_highest_degree_node] + neighbors\n",
    "subgraph = G_combined.subgraph(subgraph_nodes)\n",
    "\n",
    "# Draw the subgraph\n",
    "pos = nx.spring_layout(subgraph, k=1.5, iterations=50)  # positions for all nodes\n",
    "\n",
    "plt.figure(figsize=(8, 6))\n",
    "nx.draw(subgraph, pos, with_labels=True, node_size=700, node_color='lightblue', font_size=10, font_color='black', edge_color='gray')\n",
    "\n",
    "# Highlight the second highest degree node\n",
    "nx.draw_networkx_nodes(subgraph, pos, nodelist=[second_highest_degree_node], node_color='green')\n",
    "\n",
    "edge_labels = nx.get_edge_attributes(subgraph, 'relation')\n",
    "nx.draw_networkx_edge_labels(subgraph, pos, edge_labels=edge_labels)\n",
    "\n",
    "plt.title(f\"Subgraph of Node {second_highest_degree_node} and its Connected Nodes\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "id": "72dd5654",
   "metadata": {},
   "outputs": [],
   "source": [
    "G_combined = G_combined.to_undirected()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "id": "7618f525",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Find the node with the highest degree\n",
    "highest_degree_node = 'role'\n",
    "\n",
    "# Get the neighbors of the highest degree node\n",
    "neighbors = list(G_combined.neighbors(highest_degree_node))\n",
    "\n",
    "# Nodes to include in the subgraph\n",
    "subgraph_nodes = {highest_degree_node}\n",
    "\n",
    "test = []\n",
    "\n",
    "# Include neighbors that have other connections and those connected nodes\n",
    "for neighbor in neighbors:\n",
    "    if len(neighbor)<25:\n",
    "        other_connections = list(set(G_combined.neighbors(neighbor)) - {highest_degree_node})\n",
    "        if other_connections:\n",
    "            for con in other_connections:\n",
    "                if len(con)<25 and (con=='colon_cancer' or con=='lung_cancer'):\n",
    "                    subgraph_nodes.add(neighbor)\n",
    "                    subgraph_nodes.update([con])\n",
    "\n",
    "# Create the subgraph\n",
    "subgraph = G_combined.subgraph(subgraph_nodes)\n",
    "\n",
    "# Draw the subgraph\n",
    "pos = nx.spring_layout(subgraph)  # positions for all nodes\n",
    "\n",
    "plt.figure(figsize=(10, 8))\n",
    "nx.draw(subgraph, pos, with_labels=True, node_size=700, node_color='lightblue', font_size=10, font_color='black', edge_color='gray')\n",
    "\n",
    "# Highlight the highest degree node\n",
    "nx.draw_networkx_nodes(subgraph, pos, nodelist=[highest_degree_node], node_color='red')\n",
    "\n",
    "edge_labels = nx.get_edge_attributes(subgraph, 'relation')\n",
    "nx.draw_networkx_edge_labels(subgraph, pos, edge_labels=edge_labels)\n",
    "\n",
    "plt.title(f\"Subgraph of Node {highest_degree_node} and Relevant Connected Nodes\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 88,
   "id": "c85fd166",
   "metadata": {},
   "outputs": [],
   "source": [
    "from pyvis.network import Network\n",
    "\n",
    "net = Network(notebook = True, cdn_resources = \"remote\",\n",
    "                bgcolor = \"#eeeeee\",\n",
    "                #font_color = \"#00FF00\",\n",
    "                height = \"1400px\",\n",
    "                directed=True,\n",
    "                width = \"100%\",\n",
    "                select_menu = True,\n",
    "                filter_menu = True,\n",
    ")\n",
    "\n",
    "# net.from_nx(subgraph)\n",
    "\n",
    "for node, data in subgraph.nodes(data=True):\n",
    "    net.add_node(node, label=str(node), **data)\n",
    "\n",
    "for u, v, data in subgraph.edges(data=True):\n",
    "    edge_label = f\"r: {data['relation']}\"\n",
    "    net.add_edge(u, v, title=edge_label, **data)\n",
    "    \n",
    "for node in net.nodes:\n",
    "    node['shape'] = \"circle\"\n",
    "    node['color'] = \"#00FF00\"\n",
    "    if node['label'] == highest_degree_node:\n",
    "        node['color'] = \"#FFFFFF\"\n",
    "    \n",
    "net.set_options(\"\"\"\n",
    "var options = {\n",
    "  \"physics\": {\n",
    "    \"forceAtlas2Based\": {\n",
    "      \"gravitationalConstant\": -50,\n",
    "      \"centralGravity\": 0.005,\n",
    "      \"springLength\": 200,\n",
    "      \"springConstant\": 0.08\n",
    "    },\n",
    "    \"maxVelocity\": 146,\n",
    "    \"solver\": \"forceAtlas2Based\",\n",
    "    \"timestep\": 0.35,\n",
    "    \"stabilization\": {\n",
    "      \"enabled\": true,\n",
    "      \"iterations\": 150\n",
    "    }\n",
    "  }\n",
    "}\n",
    "\"\"\")\n",
    "\n",
    "\n",
    "html_content = net.generate_html()\n",
    "\n",
    "with open(\"KG_subgraph_with_menu.html\", \"w\", encoding=\"utf-8\") as file:\n",
    "    file.write(html_content)\n",
    "\n",
    "# net.show_buttons()\n",
    "# net.show(\"KG_with_menu.html\");"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d41e3512",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "8ff1f306",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "9ec8bfb5",
   "metadata": {},
   "outputs": [],
   "source": [
    "word_dict = {}\n",
    "i = 0\n",
    "for G in Gs:\n",
    "    for node in list(G.nodes):\n",
    "        word_dict[i] = node\n",
    "        i += 1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "b43fcbda",
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(\"Data/combined_graphed.pkl\", \"rb\") as f:\n",
    "    node_vectors_list_cmb = pkl.load(f)\n",
    "word_vec_dict = {}\n",
    "for i, node in enumerate(list(GG.nodes)):\n",
    "    word_vec_dict[node] = node_vectors_list_cmb[0][i]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "261c300c",
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(\"Data/individual_graphed.pkl\", \"rb\") as f:\n",
    "    node_vectors_list_ind = pkl.load(f)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "282a1c05",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[88, 76, 91, 90, 117, 125, 94, 106, 188, 203, 182, 170, 167, 183, 203, 45, 144, 185, 182, 161]\n"
     ]
    }
   ],
   "source": [
    "len_each_graph = [len(i) for i in node_vectors_list_ind]\n",
    "print(len_each_graph[:20])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "0559fbb7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1009270"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vec_list = np.array(node_vectors_list_cmb[0])\n",
    "len(vec_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "89bbf2b7",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Classification"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "ca39fe0a",
   "metadata": {},
   "outputs": [],
   "source": [
    "labels_extended = []\n",
    "for i, l in enumerate(len_each_graph):\n",
    "    labels_extended.extend([labels[i]]*l)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "9322ce5f",
   "metadata": {},
   "outputs": [],
   "source": [
    "X_train, X_test, y_train, y_test = train_test_split(\n",
    "    vec_list, labels_extended, test_size=0.1\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "d1372abe",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<style>#sk-container-id-1 {color: black;background-color: white;}#sk-container-id-1 pre{padding: 0;}#sk-container-id-1 div.sk-toggleable {background-color: white;}#sk-container-id-1 label.sk-toggleable__label {cursor: pointer;display: block;width: 100%;margin-bottom: 0;padding: 0.3em;box-sizing: border-box;text-align: center;}#sk-container-id-1 label.sk-toggleable__label-arrow:before {content: \"▸\";float: left;margin-right: 0.25em;color: #696969;}#sk-container-id-1 label.sk-toggleable__label-arrow:hover:before {color: black;}#sk-container-id-1 div.sk-estimator:hover label.sk-toggleable__label-arrow:before {color: black;}#sk-container-id-1 div.sk-toggleable__content {max-height: 0;max-width: 0;overflow: hidden;text-align: left;background-color: #f0f8ff;}#sk-container-id-1 div.sk-toggleable__content pre {margin: 0.2em;color: black;border-radius: 0.25em;background-color: #f0f8ff;}#sk-container-id-1 input.sk-toggleable__control:checked~div.sk-toggleable__content {max-height: 200px;max-width: 100%;overflow: auto;}#sk-container-id-1 input.sk-toggleable__control:checked~label.sk-toggleable__label-arrow:before {content: \"▾\";}#sk-container-id-1 div.sk-estimator input.sk-toggleable__control:checked~label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-1 div.sk-label input.sk-toggleable__control:checked~label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-1 input.sk-hidden--visually {border: 0;clip: rect(1px 1px 1px 1px);clip: rect(1px, 1px, 1px, 1px);height: 1px;margin: -1px;overflow: hidden;padding: 0;position: absolute;width: 1px;}#sk-container-id-1 div.sk-estimator {font-family: monospace;background-color: #f0f8ff;border: 1px dotted black;border-radius: 0.25em;box-sizing: border-box;margin-bottom: 0.5em;}#sk-container-id-1 div.sk-estimator:hover {background-color: #d4ebff;}#sk-container-id-1 div.sk-parallel-item::after {content: \"\";width: 100%;border-bottom: 1px solid gray;flex-grow: 1;}#sk-container-id-1 div.sk-label:hover label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-1 div.sk-serial::before {content: \"\";position: absolute;border-left: 1px solid gray;box-sizing: border-box;top: 0;bottom: 0;left: 50%;z-index: 0;}#sk-container-id-1 div.sk-serial {display: flex;flex-direction: column;align-items: center;background-color: white;padding-right: 0.2em;padding-left: 0.2em;position: relative;}#sk-container-id-1 div.sk-item {position: relative;z-index: 1;}#sk-container-id-1 div.sk-parallel {display: flex;align-items: stretch;justify-content: center;background-color: white;position: relative;}#sk-container-id-1 div.sk-item::before, #sk-container-id-1 div.sk-parallel-item::before {content: \"\";position: absolute;border-left: 1px solid gray;box-sizing: border-box;top: 0;bottom: 0;left: 50%;z-index: -1;}#sk-container-id-1 div.sk-parallel-item {display: flex;flex-direction: column;z-index: 1;position: relative;background-color: white;}#sk-container-id-1 div.sk-parallel-item:first-child::after {align-self: flex-end;width: 50%;}#sk-container-id-1 div.sk-parallel-item:last-child::after {align-self: flex-start;width: 50%;}#sk-container-id-1 div.sk-parallel-item:only-child::after {width: 0;}#sk-container-id-1 div.sk-dashed-wrapped {border: 1px dashed gray;margin: 0 0.4em 0.5em 0.4em;box-sizing: border-box;padding-bottom: 0.4em;background-color: white;}#sk-container-id-1 div.sk-label label {font-family: monospace;font-weight: bold;display: inline-block;line-height: 1.2em;}#sk-container-id-1 div.sk-label-container {text-align: center;}#sk-container-id-1 div.sk-container {/* jupyter's `normalize.less` sets `[hidden] { display: none; }` but bootstrap.min.css set `[hidden] { display: none !important; }` so we also need the `!important` here to be able to override the default hidden behavior on the sphinx rendered scikit-learn.org. See: https://github.com/scikit-learn/scikit-learn/issues/21755 */display: inline-block !important;position: relative;}#sk-container-id-1 div.sk-text-repr-fallback {display: none;}</style><div id=\"sk-container-id-1\" class=\"sk-top-container\"><div class=\"sk-text-repr-fallback\"><pre>GaussianNB()</pre><b>In a Jupyter environment, please rerun this cell to show the HTML representation or trust the notebook. <br />On GitHub, the HTML representation is unable to render, please try loading this page with nbviewer.org.</b></div><div class=\"sk-container\" hidden><div class=\"sk-item\"><div class=\"sk-estimator sk-toggleable\"><input class=\"sk-toggleable__control sk-hidden--visually\" id=\"sk-estimator-id-1\" type=\"checkbox\" checked><label for=\"sk-estimator-id-1\" class=\"sk-toggleable__label sk-toggleable__label-arrow\">GaussianNB</label><div class=\"sk-toggleable__content\"><pre>GaussianNB()</pre></div></div></div></div></div>"
      ],
      "text/plain": [
       "GaussianNB()"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#model = LinearSVC()\n",
    "model = GaussianNB()\n",
    "model.fit(X_train, y_train)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "379e475f",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Accuracy: 0.4820216592190395\n",
      "F1 Score: 0.5294615838586663\n"
     ]
    }
   ],
   "source": [
    "y_pred = model.predict(X_test)\n",
    "accuray = accuracy_score(y_pred, y_test)\n",
    "f1 = f1_score(y_pred, y_test, average=\"weighted\")\n",
    "\n",
    "print(\"Accuracy:\", accuray)\n",
    "print(\"F1 Score:\", f1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "8ce55ab2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "conf_matrix = confusion_matrix(y_test, y_pred)\n",
    "disp = ConfusionMatrixDisplay(confusion_matrix=conf_matrix)\n",
    "disp.plot()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "7e1aede4",
   "metadata": {},
   "outputs": [],
   "source": [
    "#y_probs = model.predict_proba(X_test)\n",
    "#fpr, tpr, thresholds = roc_curve(y_test, y_probs)\n",
    "#roc_auc = auc(fpr, tpr)\n",
    "#plt.figure()\n",
    "#plt.plot(fpr, tpr, color='darkorange', lw=2, label='ROC curve (area = %0.2f)' % roc_auc)\n",
    "#plt.plot([0, 1], [0, 1], color='navy', lw=2, linestyle='--')\n",
    "#plt.xlim([0.0, 1.0])\n",
    "#plt.ylim([0.0, 1.05])\n",
    "#plt.xlabel('False Positive Rate')\n",
    "#plt.ylabel('True Positive Rate')\n",
    "#plt.title('Receiver Operating Characteristic Example')\n",
    "#plt.legend(loc=\"lower right\")\n",
    "#plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "1b92afb6",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "66cb61e4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Accuracy: 0.4095112285336856\n",
      "F1 Score: 0.48479871972121086\n"
     ]
    }
   ],
   "source": [
    "# Classification on whole data\n",
    "model = GaussianNB()\n",
    "model.fit(vec_list, labels_extended)\n",
    "\n",
    "y_pred = model.predict(vec_list)\n",
    "\n",
    "y_pred_reduced = []\n",
    "cumsum_len_each_graph = np.cumsum(len_each_graph)\n",
    "for i in range(len(cumsum_len_each_graph)):\n",
    "    if i==0:\n",
    "        y_pred_reduced.append(np.argmax(np.bincount(y_pred[:cumsum_len_each_graph[i]])))\n",
    "    else:\n",
    "        y_pred_reduced.append(np.argmax(np.bincount(y_pred[cumsum_len_each_graph[i-1]:cumsum_len_each_graph[i]])))\n",
    "\n",
    "accuray = accuracy_score(y_pred_reduced, labels)\n",
    "f1 = f1_score(y_pred_reduced, labels, average=\"weighted\")\n",
    "\n",
    "print(\"Accuracy:\", accuray)\n",
    "print(\"F1 Score:\", f1)        "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "b8a5fe51",
   "metadata": {},
   "outputs": [],
   "source": [
    "#"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "eb210be5",
   "metadata": {},
   "outputs": [],
   "source": [
    "def linear_assignment(cost_matrix):\n",
    "    try:\n",
    "        import lap\n",
    "        _, x, y = lap.lapjv(cost_matrix, extend_cost=True)\n",
    "        return np.array([[y[i], i] for i in x if i >= 0])\n",
    "    except ImportError:\n",
    "        from scipy.optimize import linear_sum_assignment\n",
    "        x, y = linear_sum_assignment(cost_matrix)\n",
    "        return np.array(list(zip(x, y)))\n",
    "\n",
    "def map_labels(true_labels, pred_labels, cluster_no):\n",
    "    true_labels = np.array(true_labels)\n",
    "    pred_labels = np.array(pred_labels)\n",
    "    cost_matrix = np.zeros((cluster_no, cluster_no))\n",
    "    for i in range(cluster_no):\n",
    "        for j in range(cluster_no):\n",
    "            cost_matrix[i][j] = np.sum((true_labels == i) & (pred_labels == j))\n",
    "    \n",
    "    mapping = linear_assignment(-cost_matrix)[:, 1]\n",
    "    d = {}\n",
    "    for i, j in enumerate(mapping):\n",
    "        d[i] = j\n",
    "    return d"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "32bb499c",
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(\"Data/topics_clf_test.pickle\", \"rb\") as f:\n",
    "    topics = pkl.load(f)\n",
    "topics = np.array(topics)\n",
    "topics = topics + 1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "eb9ecfb1",
   "metadata": {},
   "outputs": [],
   "source": [
    "topics_extended = []\n",
    "for i, l in enumerate(len_each_graph):\n",
    "    topics_extended.extend([topics[i]]*l)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "f769662b",
   "metadata": {},
   "outputs": [],
   "source": [
    "mappings = map_labels(labels_extended, topics_extended, 3)\n",
    "y = [mappings[val] for val in topics_extended]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "ecf66d36",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "657644"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "differences_index = []\n",
    "for i, l in enumerate(labels_extended):\n",
    "    if l != y[i]:\n",
    "        differences_index.append(i)\n",
    "len(differences_index)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "34c78a2f",
   "metadata": {},
   "outputs": [],
   "source": [
    "vec_list_reduced = np.delete(vec_list, differences_index, axis=0)\n",
    "bert_reduced = np.delete(y, differences_index)\n",
    "labels_extended_reduced = np.delete(labels_extended, differences_index)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "906422c7",
   "metadata": {},
   "outputs": [],
   "source": [
    "X_train_r, X_test_r, y_train_r, y_test_r = train_test_split(\n",
    "    vec_list_reduced, labels_extended_reduced, test_size=0.3\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "285032a1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<style>#sk-container-id-2 {color: black;background-color: white;}#sk-container-id-2 pre{padding: 0;}#sk-container-id-2 div.sk-toggleable {background-color: white;}#sk-container-id-2 label.sk-toggleable__label {cursor: pointer;display: block;width: 100%;margin-bottom: 0;padding: 0.3em;box-sizing: border-box;text-align: center;}#sk-container-id-2 label.sk-toggleable__label-arrow:before {content: \"▸\";float: left;margin-right: 0.25em;color: #696969;}#sk-container-id-2 label.sk-toggleable__label-arrow:hover:before {color: black;}#sk-container-id-2 div.sk-estimator:hover label.sk-toggleable__label-arrow:before {color: black;}#sk-container-id-2 div.sk-toggleable__content {max-height: 0;max-width: 0;overflow: hidden;text-align: left;background-color: #f0f8ff;}#sk-container-id-2 div.sk-toggleable__content pre {margin: 0.2em;color: black;border-radius: 0.25em;background-color: #f0f8ff;}#sk-container-id-2 input.sk-toggleable__control:checked~div.sk-toggleable__content {max-height: 200px;max-width: 100%;overflow: auto;}#sk-container-id-2 input.sk-toggleable__control:checked~label.sk-toggleable__label-arrow:before {content: \"▾\";}#sk-container-id-2 div.sk-estimator input.sk-toggleable__control:checked~label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-2 div.sk-label input.sk-toggleable__control:checked~label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-2 input.sk-hidden--visually {border: 0;clip: rect(1px 1px 1px 1px);clip: rect(1px, 1px, 1px, 1px);height: 1px;margin: -1px;overflow: hidden;padding: 0;position: absolute;width: 1px;}#sk-container-id-2 div.sk-estimator {font-family: monospace;background-color: #f0f8ff;border: 1px dotted black;border-radius: 0.25em;box-sizing: border-box;margin-bottom: 0.5em;}#sk-container-id-2 div.sk-estimator:hover {background-color: #d4ebff;}#sk-container-id-2 div.sk-parallel-item::after {content: \"\";width: 100%;border-bottom: 1px solid gray;flex-grow: 1;}#sk-container-id-2 div.sk-label:hover label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-2 div.sk-serial::before {content: \"\";position: absolute;border-left: 1px solid gray;box-sizing: border-box;top: 0;bottom: 0;left: 50%;z-index: 0;}#sk-container-id-2 div.sk-serial {display: flex;flex-direction: column;align-items: center;background-color: white;padding-right: 0.2em;padding-left: 0.2em;position: relative;}#sk-container-id-2 div.sk-item {position: relative;z-index: 1;}#sk-container-id-2 div.sk-parallel {display: flex;align-items: stretch;justify-content: center;background-color: white;position: relative;}#sk-container-id-2 div.sk-item::before, #sk-container-id-2 div.sk-parallel-item::before {content: \"\";position: absolute;border-left: 1px solid gray;box-sizing: border-box;top: 0;bottom: 0;left: 50%;z-index: -1;}#sk-container-id-2 div.sk-parallel-item {display: flex;flex-direction: column;z-index: 1;position: relative;background-color: white;}#sk-container-id-2 div.sk-parallel-item:first-child::after {align-self: flex-end;width: 50%;}#sk-container-id-2 div.sk-parallel-item:last-child::after {align-self: flex-start;width: 50%;}#sk-container-id-2 div.sk-parallel-item:only-child::after {width: 0;}#sk-container-id-2 div.sk-dashed-wrapped {border: 1px dashed gray;margin: 0 0.4em 0.5em 0.4em;box-sizing: border-box;padding-bottom: 0.4em;background-color: white;}#sk-container-id-2 div.sk-label label {font-family: monospace;font-weight: bold;display: inline-block;line-height: 1.2em;}#sk-container-id-2 div.sk-label-container {text-align: center;}#sk-container-id-2 div.sk-container {/* jupyter's `normalize.less` sets `[hidden] { display: none; }` but bootstrap.min.css set `[hidden] { display: none !important; }` so we also need the `!important` here to be able to override the default hidden behavior on the sphinx rendered scikit-learn.org. See: https://github.com/scikit-learn/scikit-learn/issues/21755 */display: inline-block !important;position: relative;}#sk-container-id-2 div.sk-text-repr-fallback {display: none;}</style><div id=\"sk-container-id-2\" class=\"sk-top-container\"><div class=\"sk-text-repr-fallback\"><pre>GaussianNB()</pre><b>In a Jupyter environment, please rerun this cell to show the HTML representation or trust the notebook. <br />On GitHub, the HTML representation is unable to render, please try loading this page with nbviewer.org.</b></div><div class=\"sk-container\" hidden><div class=\"sk-item\"><div class=\"sk-estimator sk-toggleable\"><input class=\"sk-toggleable__control sk-hidden--visually\" id=\"sk-estimator-id-2\" type=\"checkbox\" checked><label for=\"sk-estimator-id-2\" class=\"sk-toggleable__label sk-toggleable__label-arrow\">GaussianNB</label><div class=\"sk-toggleable__content\"><pre>GaussianNB()</pre></div></div></div></div></div>"
      ],
      "text/plain": [
       "GaussianNB()"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# model_r = LinearSVC()\n",
    "model_r = GaussianNB()\n",
    "model_r.fit(X_train_r, y_train_r)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "8aa2cd04",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Accuracy: 0.5760465645381465\n",
      "F1 Score: 0.5921113324562108\n"
     ]
    }
   ],
   "source": [
    "y_pred_r = model_r.predict(X_test_r)\n",
    "accuray = accuracy_score(y_pred_r, y_test_r)\n",
    "f1 = f1_score(y_pred_r, y_test_r, average=\"weighted\")\n",
    "\n",
    "print(\"Accuracy:\", accuray)\n",
    "print(\"F1 Score:\", f1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "7b39080a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAgwAAAGwCAYAAADFZj2cAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjcuMSwgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/bCgiHAAAACXBIWXMAAA9hAAAPYQGoP6dpAABZY0lEQVR4nO3de1wU9f4/8Nfuwi7XXUEFJEAx8kJeUFSki2mRq5Fl2inNU2RqPw0sobyVoekp+uoxL2laWVLnyPFSaQmlESZqYiqKdylvocIiirByZ3fn9wcxumHCOiCXeT0fj3mcduYzM+85qPvm/bmMQhAEAURERES3oGzsAIiIiKjpY8JAREREtWLCQERERLViwkBERES1YsJAREREtWLCQERERLViwkBERES1smvsAKSwWCzIzs6Gq6srFApFY4dDREQ2EgQB165dg7e3N5TKhvsdtqysDBUVFZKvo1ar4eDgUA8RNT/NOmHIzs6Gr69vY4dBREQSnT9/Hj4+Pg1y7bKyMvi3d4Hhklnytby8vHD27FlZJg3NOmFwdXUFAPxxoAO0Luxdaeme6tS9sUOgOyj/xX6NHQLdAeaKMhxLmCf+e94QKioqYLhkxh/pHaB1vf3vCuM1C9oHn0NFRQUThuamuhtC66KU9IeAmgc7hX1jh0B3kEotv3+Q5exOdCu7uCrg4nr797FA3l3fzTphICIiqiuzYIFZwtuTzIKl/oJphpgwEBGRLFggwILbzxiknNsSsI5PREREtWKFgYiIZMECC6R0Kkg7u/ljwkBERLJgFgSYhdvvVpBybkvALgkiIiKqFSsMREQkCxz0KA0TBiIikgULBJiZMNw2dkkQERE1sPfffx8KhQJTpkwR95WVlSEyMhKtW7eGi4sLRo4cidzcXKvzsrKyEB4eDicnJ3h4eGDq1KkwmUxWbbZv347evXtDo9EgICAA8fHxNe6/fPlydOjQAQ4ODggJCcHevXttfgYmDEREJAvVXRJSttuxb98+fPzxx+jRo4fV/ujoaGzevBkbNmxAamoqsrOzMWLECPG42WxGeHg4KioqsHv3bnzxxReIj49HbGys2Obs2bMIDw/HoEGDkJGRgSlTpmD8+PHYunWr2GbdunWIiYnB7NmzceDAAfTs2RN6vR6XLl2y6TmYMBARkSxUz5KQsgGA0Wi02srLy//2nkVFRRgzZgw+/fRTuLm5ifsLCwvx2Wef4YMPPsDDDz+M4OBgrF69Grt378aePXsAAD/++COOHz+O//73vwgKCsLQoUMxb948LF++XHzz5sqVK+Hv74+FCxeia9euiIqKwtNPP41FixaJ9/rggw8wYcIEjB07FoGBgVi5ciWcnJzw+eef2/T/HxMGIiIiG/j6+kKn04lbXFzc37aNjIxEeHg4wsLCrPanp6ejsrLSan+XLl3g5+eHtLQ0AEBaWhq6d+8OT09PsY1er4fRaMSxY8fENn+9tl6vF69RUVGB9PR0qzZKpRJhYWFim7rioEciIpIFy5+blPOBqldxa7Vacb9Go7lp+7Vr1+LAgQPYt29fjWMGgwFqtRqtWrWy2u/p6QmDwSC2uTFZqD5efexWbYxGI0pLS3H16lWYzeabtjl58uStH/gvmDAQEZEsmCXOkqg+V6vVWiUMN3P+/Hm89tprSE5ObjGvwmaXBBERyYJZkL7VVXp6Oi5duoTevXvDzs4OdnZ2SE1NxdKlS2FnZwdPT09UVFSgoKDA6rzc3Fx4eXkBALy8vGrMmqj+XFsbrVYLR0dHtGnTBiqV6qZtqq9RV0wYiIiI6tkjjzyCI0eOICMjQ9z69OmDMWPGiP9tb2+PlJQU8ZzMzExkZWUhNDQUABAaGoojR45YzWZITk6GVqtFYGCg2ObGa1S3qb6GWq1GcHCwVRuLxYKUlBSxTV2xS4KIiGShvsYw1IWrqyu6detmtc/Z2RmtW7cW948bNw4xMTFwd3eHVqvF5MmTERoaiv79+wMABg8ejMDAQDz//POYP38+DAYDZs2ahcjISHHcxMSJE7Fs2TJMmzYNL730ErZt24b169cjKSlJvG9MTAwiIiLQp08f9OvXD4sXL0ZxcTHGjh1r0/MzYSAiIlmwQAEzFJLOr0+LFi2CUqnEyJEjUV5eDr1ej48++kg8rlKpkJiYiEmTJiE0NBTOzs6IiIjA3LlzxTb+/v5ISkpCdHQ0lixZAh8fH6xatQp6vV5s8+yzzyIvLw+xsbEwGAwICgrCli1bagyErI1CEJrv67eMRiN0Oh2u/tYRWlf2rrR0eu+gxg6B7qArE2wrl1LzZK4ow+H4t1BYWFjrQMLbVf1dceC4J1wkfFcUXbOgd2Bug8balLHCQEREsmARqjYp58sZEwYiIpIFs8QuCSnntgSs4xMREVGtWGEgIiJZYIVBGiYMREQkCxZBAYsgYZaEhHNbAnZJEBERUa1YYSAiIllgl4Q0TBiIiEgWzFDCLKGwbq7HWJojJgxERCQLgsQxDALHMBARERHdGisMREQkCxzDIA0TBiIikgWzoIRZkDCGQeZLQ7NLgoiIiGrFCgMREcmCBQpYJPyebIG8SwxMGIiISBY4hkEadkkQERFRrVhhICIiWZA+6JFdEkRERC1e1RgGCS+fYpcEERER0a2xwkBERLJgkfguCc6SICIikgGOYZCGCQMREcmCBUquwyABxzAQERFRrVhhICIiWTALCpglvKJayrktARMGIiKSBbPEQY9mdkkQERER3RorDEREJAsWQQmLhFkSFs6SICIiavnYJSENuySIiIioVqwwEBGRLFggbaaDpf5CaZaYMBARkSxIX7hJ3kV5eT89ERER1QkrDEREJAvS3yUh79+x5f30REQkGxYoJG+2WLFiBXr06AGtVgutVovQ0FD88MMP4vGBAwdCoVBYbRMnTrS6RlZWFsLDw+Hk5AQPDw9MnToVJpPJqs327dvRu3dvaDQaBAQEID4+vkYsy5cvR4cOHeDg4ICQkBDs3bvXpmcBmDAQEZFMVFcYpGy28PHxwfvvv4/09HTs378fDz/8MJ588kkcO3ZMbDNhwgTk5OSI2/z586/HazYjPDwcFRUV2L17N7744gvEx8cjNjZWbHP27FmEh4dj0KBByMjIwJQpUzB+/Hhs3bpVbLNu3TrExMRg9uzZOHDgAHr27Am9Xo9Lly7Z9DzskrjD1n3ogc/jvDF8fB4mzb0IAPj+v63x80Y3nDriiJIiFb4+cQQuOnONc3/9SYs1izxx9oQj1BoLuvcvxpzVZ8Xjly7Y48OZPjj0iyscnM149B9X8dKb2VDd8FOuKFdgzSJPbPvaHVfz7ODuYcKYaAP0o/Mb/NnJNsNevIynJ12Ce1sTzhx3xEez7kJmhlNjh0U36NU+G8/ffwhd2+WhrbYEr/9Pj9ST/uLxlwfuw+Bup+GpK0KlWYkT2W3xUUo/HLvoCQAI7nARH4/dfNNrv/DxCBzP9oDazoSZj+9AV+/L6NDmKnb91h5vrB1i1banXw5efXQP2rcpgIO9CYYCV3yT3hUJaT0b7uGpVsOGDbP6/O6772LFihXYs2cP7r33XgCAk5MTvLy8bnr+jz/+iOPHj+Onn36Cp6cngoKCMG/ePEyfPh1z5syBWq3GypUr4e/vj4ULFwIAunbtil27dmHRokXQ6/UAgA8++AATJkzA2LFjAQArV65EUlISPv/8c8yYMaPOz9MkEobly5djwYIFMBgM6NmzJz788EP069evscOqd5kZjkj6b2v4B5Za7S8rVaLPQCP6DDTi8zjvm567M0mHxVN9MXZGDoLuL4LZDJw76SgeN5uBt1/oCLe2Jiz67nfkX7LDglfbQ2Uv4KWZOWK7d/9fBxRctkP0wix4+1cgP9cOgkXeL1Rpih564ipenp2ND2f44OQBJzw1IQ/vJpzBuAc7o/CKfWOHR39ytDfhd0NrfHegC/49emuN439caYX53z+Ai1e10NiZ8FzoYSx/IQnDl4xGQYkjDp33gn7BC1bnTHx4L/r6X8Tx7LYAAKVCQLnJDmt/7YaHu56tcQ8AKKuwx/pfu+H33NYorbRDkJ8Bbw7bgdIKe2xMD6z/B2+mpC/cVHWu0Wi02q/RaKDRaG59rtmMDRs2oLi4GKGhoeL+NWvW4L///S+8vLwwbNgwvP3223ByqvrFIC0tDd27d4enp6fYXq/XY9KkSTh27Bh69eqFtLQ0hIWFWd1Lr9djypQpAICKigqkp6dj5syZ4nGlUomwsDCkpaXZ9PyNnjBUl0pWrlyJkJAQLF68GHq9HpmZmfDw8Gjs8OpNabES/xfVHlMWnMf/llhnkyMm5AEADu12uem5ZhOwMvYuTJiVjSHPXa8EtO9ULv73gVRXZP3mgPfXHYNbWxPuBvDCtBx89q43nn/dAHu1gH0/u+LIHhfEpx2H1q2qguHlW1HPT0r1YcTLl7ElwR0/rnMHACyd7oN+jxihH52P9cs8azmb7pTdp/yw+5Tf3x7feuQeq8+Ltt6H4cEncY/nFew76wOTWYUrRderRiqlGQ91Pod1e7sDf/aXl1Xa4/3EAQCAnr4GuDrU/DubaWiDTEMb8XNOgRaDup5Fr/Y5TBhuYBEUsEhZh+HPc319fa32z549G3PmzLnpOUeOHEFoaCjKysrg4uKCjRs3IjCw6mfy3HPPoX379vD29sbhw4cxffp0ZGZm4ptvvgEAGAwGq2QBgPjZYDDcso3RaERpaSmuXr0Ks9l80zYnT5606fkbPWGor1JJU7fszap/8HsPKML/lth27u9HnHA5Rw2FEnjl0U64mmePjveWYsLb2ejQpQwAcHy/Mzp0KYNb2+uDYfoMvIYPZ6jwR6YDArqXYs+POtzTowQbPvJAytducHCyoP+jRkRMy4HGUd5LnjYldvYW3NOjBGuXXU+YBUGBgztdERhc0oiRkRR2KjOeCj6Oa6Vq/Jbb+qZtHur8B3RO5dh8sLOke3X2uowevgas2NbyKrVNwfnz56HVasXPt6oudO7cGRkZGSgsLMRXX32FiIgIpKamIjAwEC+//LLYrnv37mjXrh0eeeQRnD59GnfffXeDPsPtaNSEwdZSSXl5OcrLr/9W/deyUFO1fVMrnDriiA+//+22zjf8oQYA/HehF16ecxFevhX4aqUHpo4MwGe7TkDrZsbVPDu4ta20Oq9Vm6rPV/Oqfsw5f6hxbJ8z1A4WxH52DsZ8FZbN9IXxqgpvLD4v4QmpPmndzVDZAQV51n89r162g29A+d+cRU3VA53+wHtPJ8PB3oTLRU6I/PJxFJY43rTtk71PYM8pH1wy3rzaWJukmP/AzbkUKqWAT7b3wbcHukoJvcWxSOySqF64qXrWQ12o1WoEBAQAAIKDg7Fv3z4sWbIEH3/8cY22ISEhAIBTp07h7rvvhpeXV43ZDLm5uQAgjnvw8vIS993YRqvVwtHRESqVCiqV6qZt/m7sxN9p1FkSly9f/ttSSXW55UZxcXHQ6XTi9teyUFN06aI9VsTehenL/oDa4fZ+i7f8uR7p6Ndy8WB4Ie7pUYrXF2VBoQB2Jraq83UEC6BQADOW/YEuvUrQ75FreHnORfy0wR3lpRzHQNQQ9p/1xnMr/4GXPnsKaaf8EPdMMtycS2u089AWoX/ABUlf8hM+fxLPfzwScYkPYnT/w9B3+11K6C1O9dsqpWySY7BYrH7xvVFGRgYAoF27dgCA0NBQHDlyxGo2Q3JyMrRarditERoaipSUFKvrJCcni+Mk1Go1goODrdpYLBakpKRYjaWoi0bvkrDFzJkzERMTI342Go1NPmk4ddgJBZftEam/XmK0mBU4sscZ361ug8Rzh6BS3foa7p5V3Qx+95SJ+9QaAV7ty3HpYtUAOLe2JmQedLY6r+Dy9WPV12ntVQln7fUV0f3uKYMgKHA5xx53deR4hqbAmK+C2QS0ams919qtjUmsFlHzUVZpjwv5OlzI1+HoBU9882oCnux9AvE7e1u1G9YrE4UlGqRmtr/te2UXVP3We/pSa7R2LsXLg/Zj69F7ajmLGsrMmTMxdOhQ+Pn54dq1a0hISMD27duxdetWnD59GgkJCXjsscfQunVrHD58GNHR0RgwYAB69OgBABg8eDACAwPx/PPPY/78+TAYDJg1axYiIyPFbpCJEydi2bJlmDZtGl566SVs27YN69evR1JSkhhHTEwMIiIi0KdPH/Tr1w+LFy9GcXGxOBSgrhr1X582bdrYVCqpy0jUpibowWv4eJv1wJKF0X7wDSjDM5GXak0WAOCeHiWw11hw4bQG3UKKAQCmSiD3vBqePlXdDoF9irF2qScKLtuhVZuqL5oDO1zh5GqGX6eqROPevsXYubkVSouVcHSuShounNZAqRTQpl3lTe5MjcFUqcTvh53Q64FrSNuiAwAoFAKCHijCd/E37/um5kOpANSqv06bFjAs6CSSDnWG2VKHfxTqQKEQYF/jPvJmhgJmGxdf+uv5trh06RJeeOEF5OTkQKfToUePHti6dSseffRRnD9/Hj/99JP45e3r64uRI0di1qxZ4vkqlQqJiYmYNGkSQkND4ezsjIiICMydO1ds4+/vj6SkJERHR2PJkiXw8fHBqlWrxCmVAPDss88iLy8PsbGxMBgMCAoKwpYtW2pU92vTqAnDjaWS4cOHA7heKomKimrM0OqNk4tFHJhYzcHJAlc3s7g//5Idrl6yR/bZqrEKZ086wMnZgrZ3VUDrZoazqwXhz1/BfxZ6oa13JTx8KvDViqoBcQ8+XgAA6P3QNfh1KsP8yX4YNysbV/PsEf9/Xhj24mWoNVVdIYOeuoo1izyxMNoPz7+RA2O+HVb9yxuDR+Vz0GMT880nbfDG4vP47ZATMg9WTat0cLLgx7XujR0a3cBRXQlf90Lx811uRnTyuozCUg0KSxzw0oAD2JHZAZevOaGVUxme6XcUbV2L8dMx6wFtff0vwsf9GjYd6HLT+/i3zYe9ygKdYzmcNJXo5HUZAPDbnzMj/tHvKAwFLjh3uRUAoHeHHPzzvkNY92v3Bnjq5ktqt4Kt53722Wd/e8zX1xepqam1XqN9+/b4/vvvb9lm4MCBOHjw4C3bREVFSf5ebfT6Zn2VSpqzpC/b4L8fXK+ovPFUVQnx9UVZGPxs1TTKCW9fhEolYP6rfqgoU6JzrxL834bTcG1V9RuESgXM/fIMPpzhi+hhneDgZEHYP/IRMfX6GgyOzhbErT2Nj2b5YPKQznB1M2HAEwV4cVoOqGlJ/c4NutZmvDDVALe2Jpw55oi3xviL3UzUNAR6X7JaeClmSNVg7c0HOyEucQA6tCnA40Fb0cqpDIUlDjie7YEJnz+JM3nWid+TvU/iUJYn/rjsdtP7LBnzPbzdisTPCZO+AgD0mV21jLBSISAq7Fd4u12D2aLEhXwtPvypP77ZzymVVH8UgiA0+q+Wy5YtExduCgoKwtKlS8XRordiNBqh0+lw9beO0LpyleuWTu8d1Ngh0B10ZYJtA7KoeTJXlOFw/FsoLCys88wDW1V/V8T+GgYHl9tPusuKKjE35KcGjbUpa/QKA1A/pRIiIqJbudNdEi1Nk0gYiIiIGhpfby2NvJ+eiIiI6oQVBiIikgUBClgkTKsUJJzbEjBhICIiWWCXhDTyfnoiIiKqE1YYiIhIFurr9dZyxYSBiIhkwSzxbZVSzm0J5P30REREVCesMBARkSywS0IaJgxERCQLFihhkVBYl3JuSyDvpyciIqI6YYWBiIhkwSwoYJbQrSDl3JaACQMREckCxzBIw4SBiIhkQZD4tkqBKz0SERER3RorDEREJAtmKGCW8AIpKee2BEwYiIhIFiyCtHEIFqEeg2mG2CVBREREtWKFgYiIZMEicdCjlHNbAiYMREQkCxYoYJEwDkHKuS2BvNMlIiIiqhNWGIiISBa40qM0TBiIiEgWOIZBGnk/PREREdUJKwxERCQLFkh8l4TMBz0yYSAiIlkQJM6SEJgwEBERtXx8W6U0HMNAREREtWKFgYiIZIGzJKRhwkBERLLALglp5J0uERERUZ0wYSAiIlmofpeElM0WK1asQI8ePaDVaqHVahEaGooffvhBPF5WVobIyEi0bt0aLi4uGDlyJHJzc62ukZWVhfDwcDg5OcHDwwNTp06FyWSyarN9+3b07t0bGo0GAQEBiI+PrxHL8uXL0aFDBzg4OCAkJAR79+616VkAJgxERCQT1V0SUjZb+Pj44P3330d6ejr279+Phx9+GE8++SSOHTsGAIiOjsbmzZuxYcMGpKamIjs7GyNGjBDPN5vNCA8PR0VFBXbv3o0vvvgC8fHxiI2NFducPXsW4eHhGDRoEDIyMjBlyhSMHz8eW7duFdusW7cOMTExmD17Ng4cOICePXtCr9fj0qVLNj2PQhAEwaYzmhCj0QidToerv3WE1pW5T0un9w5q7BDoDroyIbSxQ6A7wFxRhsPxb6GwsBBarbZB7lH9XRG+dTzsndW3fZ3K4gok6Vfh/PnzVrFqNBpoNJo6XcPd3R0LFizA008/jbZt2yIhIQFPP/00AODkyZPo2rUr0tLS0L9/f/zwww94/PHHkZ2dDU9PTwDAypUrMX36dOTl5UGtVmP69OlISkrC0aNHxXuMGjUKBQUF2LJlCwAgJCQEffv2xbJlywAAFosFvr6+mDx5MmbMmFHn5+e3LBERyUJ9VRh8fX2h0+nELS4urtZ7m81mrF27FsXFxQgNDUV6ejoqKysRFhYmtunSpQv8/PyQlpYGAEhLS0P37t3FZAEA9Ho9jEajWKVIS0uzukZ1m+prVFRUID093aqNUqlEWFiY2KauOEuCiIhkob5mSdyswvB3jhw5gtDQUJSVlcHFxQUbN25EYGAgMjIyoFar0apVK6v2np6eMBgMAACDwWCVLFQfrz52qzZGoxGlpaW4evUqzGbzTducPHnShqdnwkBERGST6kGMddG5c2dkZGSgsLAQX331FSIiIpCamtrAETYMJgxERCQLjbEOg1qtRkBAAAAgODgY+/btw5IlS/Dss8+ioqICBQUFVlWG3NxceHl5AQC8vLxqzGaonkVxY5u/zqzIzc2FVquFo6MjVCoVVCrVTdtUX6OuOIaBiIhkQYC0qZX1MUPAYrGgvLwcwcHBsLe3R0pKingsMzMTWVlZCA2tGvAbGhqKI0eOWM1mSE5OhlarRWBgoNjmxmtUt6m+hlqtRnBwsFUbi8WClJQUsU1dscJARESycKcrDDNnzsTQoUPh5+eHa9euISEhAdu3b8fWrVuh0+kwbtw4xMTEwN3dHVqtFpMnT0ZoaCj69+8PABg8eDACAwPx/PPPY/78+TAYDJg1axYiIyPFcRMTJ07EsmXLMG3aNLz00kvYtm0b1q9fj6SkJDGOmJgYREREoE+fPujXrx8WL16M4uJijB071qbnYcJARETUAC5duoQXXngBOTk50Ol06NGjB7Zu3YpHH30UALBo0SIolUqMHDkS5eXl0Ov1+Oijj8TzVSoVEhMTMWnSJISGhsLZ2RkRERGYO3eu2Mbf3x9JSUmIjo7GkiVL4OPjg1WrVkGv14ttnn32WeTl5SE2NhYGgwFBQUHYsmVLjYGQteE6DNRscB0GeeE6DPJwJ9dhGJg4CXbOdVsv4WZMxeXY/viKBo21KWOFgYiIZIEvn5KGv5YTERFRrVhhICIiWWCFQRomDEREJAuCoIAg4UtfyrktAbskiIiIqFasMBARkSxUL8Ak5Xw5Y8JARESywDEM0rBLgoiIiGrFCgMREckCBz1Kw4SBiIhkgV0S0jBhICIiWWCFQRqOYSAiIqJatYgKw1Ode8BOYd/YYVCDa7bvSaPb0PrTtMYOge4Ak1B5x+4lSOySkHuFoUUkDERERLURAEh5P7Pcf2VhlwQRERHVihUGIiKSBQsUUHClx9vGhIGIiGSBsySkYZcEERER1YoVBiIikgWLoICCCzfdNiYMREQkC4IgcZaEzKdJsEuCiIiIasUKAxERyQIHPUrDhIGIiGSBCYM0TBiIiEgWOOhRGo5hICIiolqxwkBERLLAWRLSMGEgIiJZqEoYpIxhqMdgmiF2SRAREVGtWGEgIiJZ4CwJaZgwEBGRLAh/blLOlzN2SRAREVGtWGEgIiJZYJeENEwYiIhIHtgnIQm7JIiISB7+rDDc7gYbKwxxcXHo27cvXF1d4eHhgeHDhyMzM9OqzcCBA6FQKKy2iRMnWrXJyspCeHg4nJyc4OHhgalTp8JkMlm12b59O3r37g2NRoOAgADEx8fXiGf58uXo0KEDHBwcEBISgr1799r0PEwYiIiIGkBqaioiIyOxZ88eJCcno7KyEoMHD0ZxcbFVuwkTJiAnJ0fc5s+fLx4zm80IDw9HRUUFdu/ejS+++ALx8fGIjY0V25w9exbh4eEYNGgQMjIyMGXKFIwfPx5bt24V26xbtw4xMTGYPXs2Dhw4gJ49e0Kv1+PSpUt1fh6FIDTfpSiMRiN0Oh0GKobDTmHf2OFQQ2u+f1SJ6G+YhEpsx7coLCyEVqttkHtUf1f4r34LSieH276OpaQMZ8e+e9ux5uXlwcPDA6mpqRgwYACAqgpDUFAQFi9efNNzfvjhBzz++OPIzs6Gp6cnAGDlypWYPn068vLyoFarMX36dCQlJeHo0aPieaNGjUJBQQG2bNkCAAgJCUHfvn2xbNmyqmexWODr64vJkydjxowZdYqfFQYiIpIFKd0RNw6YNBqNVlt5eXmd7l9YWAgAcHd3t9q/Zs0atGnTBt26dcPMmTNRUlIiHktLS0P37t3FZAEA9Ho9jEYjjh07JrYJCwuzuqZer0daWhoAoKKiAunp6VZtlEolwsLCxDZ1wUGPRERENvD19bX6PHv2bMyZM+eW51gsFkyZMgX3338/unXrJu5/7rnn0L59e3h7e+Pw4cOYPn06MjMz8c033wAADAaDVbIAQPxsMBhu2cZoNKK0tBRXr16F2Wy+aZuTJ0/W+bmZMBARkTzcxsDFGucDOH/+vFWXhEajqfXUyMhIHD16FLt27bLa//LLL4v/3b17d7Rr1w6PPPIITp8+jbvvvvv2Y20A7JIgIiJZqH5bpZQNALRardVWW8IQFRWFxMRE/Pzzz/Dx8bll25CQEADAqVOnAABeXl7Izc21alP92cvL65ZttFotHB0d0aZNG6hUqpu2qb5GXTBhICIiagCCICAqKgobN27Etm3b4O/vX+s5GRkZAIB27doBAEJDQ3HkyBGr2QzJycnQarUIDAwU26SkpFhdJzk5GaGhoQAAtVqN4OBgqzYWiwUpKSlim7pglwQREcnDHV64KTIyEgkJCfj222/h6uoqjjnQ6XRwdHTE6dOnkZCQgMceewytW7fG4cOHER0djQEDBqBHjx4AgMGDByMwMBDPP/885s+fD4PBgFmzZiEyMlKsbEycOBHLli3DtGnT8NJLL2Hbtm1Yv349kpKSxFhiYmIQERGBPn36oF+/fli8eDGKi4sxduzYOj8PEwYiIpKFO7009IoVKwBUTZ280erVq/Hiiy9CrVbjp59+Er+8fX19MXLkSMyaNUtsq1KpkJiYiEmTJiE0NBTOzs6IiIjA3LlzxTb+/v5ISkpCdHQ0lixZAh8fH6xatQp6vV5s8+yzzyIvLw+xsbEwGAwICgrCli1bagyEvJU6rcPw3Xff1fmCTzzxRJ3bSsV1GGSG6zAQtTh3ch0Gv09iJa/DkPXy3AaNtSmrU4Vh+PDhdbqYQqGA2WyWEg8REVHD4e8dt61OCYPFYmnoOIiIiBoU31YpjaRZEmVlZfUVBxERUcMS6mGTMZsTBrPZjHnz5uGuu+6Ci4sLzpw5AwB4++238dlnn9V7gERERNT4bE4Y3n33XcTHx2P+/PlQq9Xi/m7dumHVqlX1GhwREVH9UdTDJl82JwxffvklPvnkE4wZMwYqlUrc37NnT5vWpCYiIrqj2CUhic0Jw8WLFxEQEFBjv8ViQWVlZb0ERURERE2LzQlDYGAgdu7cWWP/V199hV69etVLUERERPWOFQZJbF7pMTY2FhEREbh48SIsFgu++eYbZGZm4ssvv0RiYmJDxEhERCRdPb2tUq5srjA8+eST2Lx5M3766Sc4OzsjNjYWJ06cwObNm/Hoo482RIxERETUyG7rXRIPPvggkpOT6zsWIiKiBnPjK6pv93w5u+2XT+3fvx8nTpwAUDWuITg4uN6CIiIiqnd3+G2VLY3NCcOFCxcwevRo/PLLL2jVqhUAoKCgAPfddx/Wrl0LHx+f+o6RiIiIGpnNYxjGjx+PyspKnDhxAvn5+cjPz8eJEydgsVgwfvz4hoiRiIhIuupBj1I2GbO5wpCamordu3ejc+fO4r7OnTvjww8/xIMPPlivwREREdUXhVC1STlfzmxOGHx9fW+6QJPZbIa3t3e9BEVERFTvOIZBEpu7JBYsWIDJkydj//794r79+/fjtddew7///e96DY6IiIiahjpVGNzc3KBQXO+7KS4uRkhICOzsqk43mUyws7PDSy+9hOHDhzdIoERERJJw4SZJ6pQwLF68uIHDICIiamDskpCkTglDREREQ8dBRERETdhtL9wEAGVlZaioqLDap9VqJQVERETUIFhhkMTmQY/FxcWIioqCh4cHnJ2d4ebmZrURERE1SXxbpSQ2JwzTpk3Dtm3bsGLFCmg0GqxatQrvvPMOvL298eWXXzZEjERERNTIbO6S2Lx5M7788ksMHDgQY8eOxYMPPoiAgAC0b98ea9aswZgxYxoiTiIiImk4S0ISmysM+fn56NixI4Cq8Qr5+fkAgAceeAA7duyo3+iIiIjqSfVKj1I2ObO5wtCxY0ecPXsWfn5+6NKlC9avX49+/fph8+bN4suoyHbPRuXi/qEF8A0oR0WZEsf3O+Gz97xx4bQDAMDTpxxf/nripuf+6/91wM7EVgCAtt4VmPz+BfS87xrKilVI3uCGz+O8YTHLOzNujoa9eBlPT7oE97YmnDnuiI9m3YXMDKfGDoskau1ViXFvZaPvoGvQOFqQfU6DhdG++P1w9c9WwAtTczHkuStw0ZpxfL8zls7wQfZZTaPGTWRzhWHs2LE4dOgQAGDGjBlYvnw5HBwcEB0djalTp9p0rR07dmDYsGHw9vaGQqHApk2bbA2nxejRvwibv2iDKcPuwczRd0NlD7yXcBoaRzMAIC9bjVFB91ptXy7wQkmREvu2uQIAlEoB8748A3t7C6KfvAcLpvjh0WfyETE1pzEfjW7DQ09cxcuzs7HmAy9E6jvhzHEHvJtwBrrWNZdlp+bDRWfCB9/+DrNJgVn/7IgJAzvjk7neKCpUiW2eiczDky/l4cMZPnjt8XtQVqLEewlnYK+xNGLkLQQHPUpic4UhOjpa/O+wsDCcPHkS6enpCAgIQI8ePWy6VnFxMXr27ImXXnoJI0aMsDWUFuWtf95t9XnhFD+sP3IU9/QoxdFfXWCxKHA1z96qzX1DC7FjcyuUlVT9Y9P7oWvw61SGGaPuRcFle5w5Bny5oB3GvZmN/yz0gqnS5vyQGsmIly9jS4I7flznDgBYOt0H/R4xQj86H+uXeTZydHS7nom8hMvZaiyM9hP35Z6/sXIgYPj4PPxviSfStuoAAPNf9cO6Q8dw35BCpH7LmWjUeCStwwAA7du3R/v27W/r3KFDh2Lo0KFSQ2iRnLVVlYVrBaqbHg/oXoKAbqVY/paPuC8wuBjnTjqg4PL1xGL/dle8+r4F7TuV4fQxlrObAzt7C+7pUYK1yzzEfYKgwMGdrggMLmnEyEiq/oONSN/uirc+PoceocW4bLBDYnwb/JDQGgDg5VeB1p4mHNjpKp5Tck2Fkwed0DW4hAmDRApIfFtlvUXSPNUpYVi6dGmdL/jqq6/edjC1KS8vR3l5ufjZaDQ22L0ak0IhYOI7F3F0rzP+yHS8aZsho6/gj980OL7fWdzn1tZUowpR8OdnNw8TcKzhYqb6o3U3Q2UHFORZ//W8etkOvgHlf3MWNQft/Crw+AtX8M0nbbH2Qw906lmKSfMuorJSgZ82uMPdwwSg5s++IM8O7h7sjqLGVaeEYdGiRXW6mEKhaNCEIS4uDu+8806DXb+piHrvAtp3LsXrT91z0+NqBwsGDb+KhCVedzgyIpJCoQR+P+yI1e+3AwCcPuqEDl3KEP78Ffy0wb2Ro5MBTquUpE4Jw9mzZxs6jjqZOXMmYmJixM9GoxG+vr6NGFH9i/zXBYSEGfH6iABczlHftM2D4QXQOAo1/oG5mmeHzr2Krfa1alv1W8nVS5J7n+gOMearYDYBrdqarPa7tTHhah5/js1Z/iU7/PGbg9W+879r8MBjBeJxoOpnn3/perWwVVsTTh+7ebWRbMCloSVpVqPgNBoNtFqt1dZyCIj81wXcN6QQ054J+MtAKGv6UVewJ1mLwnzrL4/j6c7o0KXMaiR97wHXUGxUIut3h79ehpooU6USvx92Qq8Hron7FAoBQQ8U4Xg6x6E0Z8f3OcP3butupbs6luPSxapfDgxZalzJtbP62Tu5mNGlVwlO8GdPjaxZJQwtWdR7F/DwiHy8H9UepUVKuLWthFvbSqgdrKdSeXcoR/f+xdjy5yCpGx1IdUXWbw6YtjQLHQNLEfyQES9OM2DzF21QWcEfdXPyzSdtMPS5fIT9Ix++AWWY/P4FODhZ8ONalq2bs28+aYsuvYsxanIuvDuUY9BTV/HYP/Px3eo2f7ZQYNOqthj92iX0H1yIDl1KMXVpFq7k2mP3Fl2jxt4i3OFplXFxcejbty9cXV3h4eGB4cOHIzMz06pNWVkZIiMj0bp1a7i4uGDkyJHIzc21apOVlYXw8HA4OTnBw8MDU6dOhclkXYHcvn07evfuDY1Gg4CAAMTHx9eIZ/ny5ejQoQMcHBwQEhKCvXv32vQ8jVrfLCoqwqlTp8TPZ8+eRUZGBtzd3eHn53eLM1ueYRFXAAD//vqU1f5/R/sief315EA/6gou59gjPdUVf2WxKBAb0RGT485j0Xe/oaxEiZ82uOOLBe0aNniqd6nfuUHX2owXphrg1taEM8cc8dYYf6sZMNT8/HbICXPH+WPszByMic6F4bwaK2O98fPG67Mf1i9vCwcnC16bfwEuWjOO7XPGW2M6orKcSb9UUldrtPXc1NRUREZGom/fvjCZTHjzzTcxePBgHD9+HM7OVQPWo6OjkZSUhA0bNkCn0yEqKgojRozAL7/8AgAwm80IDw+Hl5cXdu/ejZycHLzwwguwt7fHe++9B6DquzM8PBwTJ07EmjVrkJKSgvHjx6Ndu3bQ6/UAgHXr1iEmJgYrV65ESEgIFi9eDL1ej8zMTHh4eNz8AWo8vyA0Wq/M9u3bMWjQoBr7IyIibpod/ZXRaIROp8NAxXDYKfgPaYvXeH9UiaiBmIRKbMe3KCwsbLBu5urvig7vvgulw+13z1rKynDurbduO9a8vDx4eHggNTUVAwYMQGFhIdq2bYuEhAQ8/fTTAICTJ0+ia9euSEtLQ//+/fHDDz/g8ccfR3Z2Njw9q9ZgWblyJaZPn468vDyo1WpMnz4dSUlJOHr0qHivUaNGoaCgAFu2bAEAhISEoG/fvli2bFnVs1gs8PX1xeTJkzFjxow6xd+oKevAgQMhCEKNrS7JAhERkU3qqUvCaDRabTdO97+VwsJCAIC7e1XXYnp6OiorKxEWFia26dKlC/z8/JCWlgYASEtLQ/fu3cVkAQD0ej2MRiOOHTsmtrnxGtVtqq9RUVGB9PR0qzZKpRJhYWFim7q4rYRh586d+Oc//4nQ0FBcvHgRAPCf//wHu3btup3LERERNbx6Shh8fX2h0+nELS4urtZbWywWTJkyBffffz+6desGADAYDFCr1TXew+Tp6QmDwSC2uTFZqD5efexWbYxGI0pLS3H58mWYzeabtqm+Rl3YnDB8/fXX0Ov1cHR0xMGDB8XMqrCwUOxPISIiaqnOnz+PwsJCcZs5c2at50RGRuLo0aNYu3btHYiwYdicMPzrX//CypUr8emnn8Le/vq4gfvvvx8HDhyo1+CIiIjqS3293vqv0/s1mlu/STQqKgqJiYn4+eef4eNzfTl/Ly8vVFRUoKCgwKp9bm4uvLy8xDZ/nTVR/bm2NlqtFo6OjmjTpg1UKtVN21Rfoy5sThgyMzMxYMCAGvt1Ol2NhyYiImoyqld6lLLZcjtBQFRUFDZu3Iht27bB39/f6nhwcDDs7e2RkpIi7svMzERWVhZCQ0MBAKGhoThy5AguXboktklOToZWq0VgYKDY5sZrVLepvoZarUZwcLBVG4vFgpSUFLFNXdg8rdLLywunTp1Chw4drPbv2rULHTt2tPVyREREd8YdXukxMjISCQkJ+Pbbb+Hq6iqOF9DpdHB0dIROp8O4ceMQExMDd3d3aLVaTJ48GaGhoejfvz8AYPDgwQgMDMTzzz+P+fPnw2AwYNasWYiMjBQrGxMnTsSyZcswbdo0vPTSS9i2bRvWr1+PpKQkMZaYmBhERESgT58+6NevHxYvXozi4mKMHTu2zs9jc8IwYcIEvPbaa/j888+hUCiQnZ2NtLQ0vPHGG3j77bdtvRwREVGLtGLFCgBVMwJvtHr1arz44osAqt7VpFQqMXLkSJSXl0Ov1+Ojjz4S26pUKiQmJmLSpEkIDQ2Fs7MzIiIiMHfuXLGNv78/kpKSEB0djSVLlsDHxwerVq0S12AAgGeffRZ5eXmIjY2FwWBAUFAQtmzZUmMg5K3YvA6DIAh47733EBcXh5KSqlftajQavPHGG5g3b54tl5KM6zDIDNdhIGpx7uQ6DB1nvyd5HYYz77zZoLE2ZTZXGBQKBd566y1MnToVp06dQlFREQIDA+Hi4tIQ8REREdUPvnxKktteGlqtVosDLoiIiKhlszlhGDRoEBSKvx8pum3bNkkBERERNQiJ75JghcFGQUFBVp8rKyuRkZGBo0ePIiIior7iIiIiql/skpDE5oRh0aJFN90/Z84cFBUVSQ6IiIiImp56e/nUP//5T3z++ef1dTkiIqL6VU/vkpCr2x70+FdpaWlwkDBdhYiIqCEpJI5hkDT+oQWwOWEYMWKE1WdBEJCTk4P9+/dz4SYiIqIWyuaEQafTWX1WKpXo3Lkz5s6di8GDB9dbYERERNR02JQwmM1mjB07Ft27d4ebm1tDxURERFT/OEtCEpsGPapUKgwePJhvpSQiomanvl5vLVc2z5Lo1q0bzpw50xCxEBERURNlc8Lwr3/9C2+88QYSExORk5MDo9FotRERETVZnFJ52+o8hmHu3Ll4/fXX8dhjjwEAnnjiCaslogVBgEKhgNlsrv8oiYiIpOIYBknqnDC88847mDhxIn7++eeGjIeIiIiaoDonDIJQlVo99NBDDRYMERFRQ+HCTdLYNK3yVm+pJCIiatLYJSGJTQlDp06dak0a8vPzJQVERERETY9NCcM777xTY6VHIiKi5oBdEtLYlDCMGjUKHh4eDRULERFRw2GXhCR1XoeB4xeIiIjky+ZZEkRERM0SKwyS1DlhsFgsDRkHERFRg+IYBmlsfr01ERFRs8QKgyQ2v0uCiIiI5IcVBiIikgdWGCRhwkBERLLAMQzSsEuCiIiIasUKAxERyQO7JCRhwkBERLLALglp2CVBREREtWKFgYiI5IFdEpIwYSAiInlgwiAJuySIiIioVkwYiIhIFhT1sNlix44dGDZsGLy9vaFQKLBp0yar4y+++CIUCoXVNmTIEKs2+fn5GDNmDLRaLVq1aoVx48ahqKjIqs3hw4fx4IMPwsHBAb6+vpg/f36NWDZs2IAuXbrAwcEB3bt3x/fff2/j0zBhICIiuRDqYbNBcXExevbsieXLl/9tmyFDhiAnJ0fc/ve//1kdHzNmDI4dO4bk5GQkJiZix44dePnll8XjRqMRgwcPRvv27ZGeno4FCxZgzpw5+OSTT8Q2u3fvxujRozFu3DgcPHgQw4cPx/Dhw3H06FGbnodjGIiISBbqa1ql0Wi02q/RaKDRaGq0Hzp0KIYOHXrLa2o0Gnh5ed302IkTJ7Blyxbs27cPffr0AQB8+OGHeOyxx/Dvf/8b3t7eWLNmDSoqKvD5559DrVbj3nvvRUZGBj744AMxsViyZAmGDBmCqVOnAgDmzZuH5ORkLFu2DCtXrqzz87PCQEREZANfX1/odDpxi4uLu+1rbd++HR4eHujcuTMmTZqEK1euiMfS0tLQqlUrMVkAgLCwMCiVSvz6669imwEDBkCtVott9Ho9MjMzcfXqVbFNWFiY1X31ej3S0tJsipUVBiIikod6miVx/vx5aLVacffNqgt1MWTIEIwYMQL+/v44ffo03nzzTQwdOhRpaWlQqVQwGAzw8PCwOsfOzg7u7u4wGAwAAIPBAH9/f6s2np6e4jE3NzcYDAZx341tqq9RV0wYiIhIPuphaqRWq7VKGG7XqFGjxP/u3r07evTogbvvvhvbt2/HI488Ivn69Y1dEkRERE1Ax44d0aZNG5w6dQoA4OXlhUuXLlm1MZlMyM/PF8c9eHl5ITc316pN9efa2vzd2Im/w4SBiIhkoXrQo5StIV24cAFXrlxBu3btAAChoaEoKChAenq62Gbbtm2wWCwICQkR2+zYsQOVlZVim+TkZHTu3Blubm5im5SUFKt7JScnIzQ01Kb4mDAQEZE83OFplUVFRcjIyEBGRgYA4OzZs8jIyEBWVhaKioowdepU7NmzB+fOnUNKSgqefPJJBAQEQK/XAwC6du2KIUOGYMKECdi7dy9++eUXREVFYdSoUfD29gYAPPfcc1Cr1Rg3bhyOHTuGdevWYcmSJYiJiRHjeO2117BlyxYsXLgQJ0+exJw5c7B//35ERUXZ9DxMGIiIiBrA/v370atXL/Tq1QsAEBMTg169eiE2NhYqlQqHDx/GE088gU6dOmHcuHEIDg7Gzp07rQZRrlmzBl26dMEjjzyCxx57DA888IDVGgs6nQ4//vgjzp49i+DgYLz++uuIjY21WqvhvvvuQ0JCAj755BP07NkTX331FTZt2oRu3brZ9DwKQRCa7erYRqMROp0OAxXDYaewb+xwqKE13z+qRPQ3TEIltuNbFBYW1stAwpup/q7oPv49qNQOt30dc0UZjqx6s0Fjbco4S4KIiOSBL5+ShF0SREREVKsWUWFo9WMr2Dura29IzdrV+/MbOwS6g869a9sIbmqeLGVlwNxv78i96mtpaLlqEQkDERFRrdglIQkTBiIikgcmDJJwDAMRERHVihUGIiKSBY5hkIYJAxERyQO7JCRhlwQRERHVihUGIiKSBYUgQCFhxVgp57YETBiIiEge2CUhCbskiIiIqFasMBARkSxwloQ0TBiIiEge2CUhCbskiIiIqFasMBARkSywS0IaJgxERCQP7JKQhAkDERHJAisM0nAMAxEREdWKFQYiIpIHdklIwoSBiIhkQ+7dClKwS4KIiIhqxQoDERHJgyBUbVLOlzEmDEREJAucJSENuySIiIioVqwwEBGRPHCWhCRMGIiISBYUlqpNyvlyxi4JIiIiqhUrDEREJA/skpCECQMREckCZ0lIw4SBiIjkgeswSMIxDERERFQrVhiIiEgW2CUhDSsMREQkD0I9bDbYsWMHhg0bBm9vbygUCmzatMk6HEFAbGws2rVrB0dHR4SFheH333+3apOfn48xY8ZAq9WiVatWGDduHIqKiqzaHD58GA8++CAcHBzg6+uL+fPn14hlw4YN6NKlCxwcHNC9e3d8//33tj0MmDAQERE1iOLiYvTs2RPLly+/6fH58+dj6dKlWLlyJX799Vc4OztDr9ejrKxMbDNmzBgcO3YMycnJSExMxI4dO/Dyyy+Lx41GIwYPHoz27dsjPT0dCxYswJw5c/DJJ5+IbXbv3o3Ro0dj3LhxOHjwIIYPH47hw4fj6NGjNj2PQhCa7ygOo9EInU6H4ckvwt5Z3djhUAO7en9+Y4dAd9C5d0MbOwS6AyxlZTgz9y0UFhZCq9U2yD2qvyv6h8+Dnb3DbV/HVFmGPUlv31asCoUCGzduxPDhwwFUVRe8vb3x+uuv44033gAAFBYWwtPTE/Hx8Rg1ahROnDiBwMBA7Nu3D3369AEAbNmyBY899hguXLgAb29vrFixAm+99RYMBgPU6qrvwRkzZmDTpk04efIkAODZZ59FcXExEhMTxXj69++PoKAgrFy5ss7PwAoDERHJQ/UsCSkbqhKQG7fy8nKbQzl79iwMBgPCwsLEfTqdDiEhIUhLSwMApKWloVWrVmKyAABhYWFQKpX49ddfxTYDBgwQkwUA0Ov1yMzMxNWrV8U2N96nuk31feqKCQMREZENfH19odPpxC0uLs7maxgMBgCAp6en1X5PT0/xmMFggIeHh9VxOzs7uLu7W7W52TVuvMfftak+XlecJUFERLJQX7Mkzp8/b9UlodFoJEbWPLDCQERE8lBPsyS0Wq3VdjsJg5eXFwAgNzfXan9ubq54zMvLC5cuXbI6bjKZkJ+fb9XmZte48R5/16b6eF0xYSAiIrrD/P394eXlhZSUFHGf0WjEr7/+itDQqgG/oaGhKCgoQHp6uthm27ZtsFgsCAkJEdvs2LEDlZWVYpvk5GR07twZbm5uYpsb71Pdpvo+dcWEgYiIZKG6S0LKZouioiJkZGQgIyMDQNVAx4yMDGRlZUGhUGDKlCn417/+he+++w5HjhzBCy+8AG9vb3EmRdeuXTFkyBBMmDABe/fuxS+//IKoqCiMGjUK3t7eAIDnnnsOarUa48aNw7Fjx7Bu3TosWbIEMTExYhyvvfYatmzZgoULF+LkyZOYM2cO9u/fj6ioKJueh2MYiIhIHixC1SblfBvs378fgwYNEj9Xf4lHREQgPj4e06ZNQ3FxMV5++WUUFBTggQcewJYtW+DgcH3q55o1axAVFYVHHnkESqUSI0eOxNKlS8XjOp0OP/74IyIjIxEcHIw2bdogNjbWaq2G++67DwkJCZg1axbefPNN3HPPPdi0aRO6detm0/NwHQZqNrgOg7xwHQZ5uJPrMNwX9o7kdRh2/zS7QWNtytglQURERLVilwQREcmCAhKnVdZbJM0TEwYiIpKHG1ZrvO3zZYxdEkRERFQrVhiIiEgW6mulR7liwkBERPJww2qNt32+jLFLgoiIiGrFCgMREcmCQhCgkDBwUcq5LQETBiIikgfLn5uU82WMXRJERERUK1YYiIhIFtglIQ0TBiIikgfOkpCECQMREckDV3qUhGMYiIiIqFasMBARkSxwpUdpmDDcAeUby1C+sRzmHDMAQOWvguNYR9iHqgEAQrmA0mUlqPipAkKlAPt+9nB6wxlKd+sCUHlSOcrXlcF83gyFkwLqh9Vwet0ZAFD6WQnKPi+reXMHwC3Fveo+JgFlX5ah4odyWC5boPJTwXGSI+z7qxvw6el2DXvxMp6edAnubU04c9wRH826C5kZTo0dFt2gj2c2xnU7hG5t8uDhVIJXUvRIyfIXj7d2KMEbffbggbsuwFVdgf2Gdpj36/34w9hKbPNMp+N4vOPvuLf1ZbioK9FnzVhcq9DUuNdDPn8gMigdnd2uoNyswj6DNyK3DRGPt3O+hjmhOxHSLhsllXbYdKozFqaHwCywkCxil4QkTBjuAEVbJRwnOkLpqwIEoOKHchTNKIJ2tRaqjnYoWVqCyrRKOP/LBQpnBUo+KEbRm0XQrtSK1yhbW4qy/5XBKdIJqkA7CGUCLDnXJwU7jHaEZriD1X2vvXoNdl1V4ufST0pRsbUcztOdoWyvgmlvJYpmFsH1Yy3sOvGPQlPy0BNX8fLsbHw4wwcnDzjhqQl5eDfhDMY92BmFV+wbOzz6k5OdCZlXW+Pr37tg+SNb/3JUwPJHtsJkUeKVlCEoqlDjxW6HsFqfiPCNz6LUVPVzdLQzYedFP+y86Ic3+vx60/sMbn8G8+5PxaL0ftiTcxdUCgs6ueWLx5UKCz5+9AdcLnHEqKTh8HAswf8N2IZKixKLDoQ01OOTzDRq6hkXF4e+ffvC1dUVHh4eGD58ODIzMxszpAahfkAN+/vUUPmqqn6r/39OUDgqYDpmhlBkQUViOZwmO8E+2B52Xezg/JYLzEdMMB01AQAsRgtKPymF89suUA/WQOWjgl2AHdQPXq8MKJwUULZWipsl3wLLOTPUj1//TaViSzkcXnCsiuUuFTRPOcA+1B7l/7tJZYIa1YiXL2NLgjt+XOeOrN8dsHS6D8pLFdCPzq/9ZLpjdlz0w+ID/fDTDVWFah20hejlkYs5aQ/iyGUPnDW2wpzdA+CgMiHc/5TY7ovjPfDpkV44lOdx03uoFBa8FfILFuzrj7WZ9+KcsRVOF7rjh3MBYpsHvC8gQHcVU3c8gpP5bbDjoh+WHOiLMV2PwV5prv8Hb6YUFumbnDVqwpCamorIyEjs2bMHycnJqKysxODBg1FcXNyYYTUowSyg4qdyCGUC7LrZwZRpBkyAXZ/rv+Gr2qug9FSKCYNpXyUgAJY8CwqfK0DB8KsoersIlty//4egYnM5lL5K2Afd8NtoJaBQK6zaKTQKmA6b6vchSRI7ewvu6VGCAztdxX2CoMDBna4IDC5pxMjIFmpV1d/PcvP1Kp8ABSosKgR75tT5OoGt8+DlXAyLoMDGJzZg57Nf4tNHk3BPq+vJY5BHLn676o4rZde7rHZd9IWrugIBra7Ww9O0ENVdElI2GWvUOvSWLVusPsfHx8PDwwPp6ekYMGBAjfbl5eUoLy8XPxuNxgaPsb6YT5tg/H9GoAJQOCrg8p4LVP4qmH83AfaA0tU6d1O4K2DJr0pnLdkWwAKUfVkKpylOUDgrUfppCa5NuQbtlzoo7K2TAKFcQMWPFXB43rqLwi7EHmVry2AXZAflXUqY9ptQkVoh++VOmxqtuxkqO6Agz/qv59XLdvANKP+bs6ipOVPQCheLXPB68K+I3f0QSk12ePHew2jnXIy2TnVP/HxdrwEAonrtx/t778PFIleMvfcQ/jP0O+i/HoXCCge0cSzB5TJHq/Mul1Z9butYghP191gkY01qNExhYSEAwN3d/abH4+LioNPpxM3X1/dOhieJ0k8FbbwOrp9ooRmuQfG7xTCfrVupULAAMAFOU5xhH6KGXTc7OM9xgeWCBaYDlTXaV+6ogFAiQD3UeuCU02tOUPkqYXyuEAUDr6Lkg2JowjWAosYliEgik6DC5G16dNAWYt+Y1ch4fhVCvLKResEXglD3v3TKP4fmrzzUGz/+0RHHrrTFzF2DIAAY4n+mgaJvoYR62GSsyYx0s1gsmDJlCu6//35069btpm1mzpyJmJgY8bPRaGw2SYPCXgGVT1Vp0q6LHUwnTSjbUAb1I2qgErBcs1hVGYR8QZwloWxT9b8q/+ulTaWbEgqdApbcmuWB8s3lsL/fvsYsC6WbEi7vu0IoFyAYBSjaKFC6ohRKb1WNa1DjMearYDYBrdpadxW5tTHhal6T+StLdXDsSlsM/+4fcLEvh73Sgqvljlj/+Dc4erltna+RV1LVzXC6wE3cV2lR4fw1Ldo5V1UfLpc6oUebS1bntXEsrTq/lDNrqnFpaGmaTIUhMjISR48exdq1a/+2jUajgVartdqaLQuACgF2nVWAHWDaf/3LwfyHGZZcC+y6VX052HWv+l9z1vWKhMVogVAoQOlp/WVvzjbDdMBkNdjxrxQaBZRtlYAZqNxeAfWDHHXflJgqlfj9sBN6PXBN3KdQCAh6oAjH0/mPf3NUVKnB1XJHtNcWoFvrPKRkdajzuUevtEW5SQV/XYG4z05hxl0u15BdVDXOJeOSJzq55cPdoVRsc5/3BVyrUOPUDYkGkRRN4teVqKgoJCYmYseOHfDx8WnscOpd6YoS2IXaQ+mpBEqqxheYDprg8oErFC5KqB/XoPTDEii0iqpplYtKoOpmJyYMKj8V7B+0R8niEjhPd4LCWYHSlaVQ+qlgF2z9I6xILIeitQL2/WsmAaZjJljyLFDdo4Ilz4Kyz0sBAdCMcajRlhrXN5+0wRuLz+O3Q07IPFg1rdLByYIf1968u44ah5NdJfy0heJnHxcjurhfRmG5BjnFrhjS4TTyyxyQXeSKzu5X8Ga/X/BTVgf8kn29MtrGsQRtHEvg51o1JquTWz6KK+2RU+SCwgoHFFeqsTYzEJN77UdOsQuyi1wxrnsGAGDLubsBALuyfXCq0A3zB6Rgwb7+aOtYiim992LNiXtRaWEFUcR1GCRp1IRBEARMnjwZGzduxPbt2+HvX3NqUktgKbCgZF4xLFcsUDgroApQweUDV9j3q/pSd3rVCaXKEhS/VWS1cNONnN92QcnSYhRNLQIUgF2QHVw/cIHC7npfqGARUP5DBTSPaaBQ1ewjFSoElH5aAku2BQpHBexD7eH8tkuNAZfU+FK/c4OutRkvTDXAra0JZ4454q0x/ii4zGpQU9KtzSX8Z+hm8fObIWkAgG9+74SZux5GW8cSzOi3G60dSpFX6oRvT3XCR4eCra4xqvMxTO6VLn5OeOxbAMCMnQOx8VQXAMD8ff1hEpSYP2AbHFQmHMrzQMSWYTD+ucCTRVBiYvJQzLlvB9Y9vgmlJjtsPNUZSw/2bdDnb3YESBvkLe98AQpBaLyU6ZVXXkFCQgK+/fZbdO7cWdyv0+ng6Oh4izOrGI1G6HQ6DE9+EfbOXK2wpbt6P9cgkJNz74Y2dgh0B1jKynBm7lsoLCxssG7m6u+Kh3vNgJ3q9iuqJnMZth18v0Fjbcoa9VfLFStWoLCwEAMHDkS7du3Ebd26dY0ZFhEREf1Fo3dJEBER3RECJI5hqLdImqUmMeiRiIiowXHQoyQc7UZERES1YoWBiIjkwQJpK9vKfBl9JgxERCQLXOlRGnZJEBERUa1YYSAiInngoEdJWGEgIiJ5qE4YpGw2mDNnDhQKhdXWpUsX8XhZWRkiIyPRunVruLi4YOTIkcjNzbW6RlZWFsLDw+Hk5AQPDw9MnToVJpP1i+m2b9+O3r17Q6PRICAgAPHx8bf9f9GtMGEgIiJqIPfeey9ycnLEbdeuXeKx6OhobN68GRs2bEBqaiqys7MxYsQI8bjZbEZ4eDgqKiqwe/dufPHFF4iPj0dsbKzY5uzZswgPD8egQYOQkZGBKVOmYPz48di6dWu9Pwu7JIiISB7qqUvCaDRa7dZoNNBobv6GYDs7O3h5edXYX1hYiM8++wwJCQl4+OGHAQCrV69G165dsWfPHvTv3x8//vgjjh8/jp9++gmenp4ICgrCvHnzMH36dMyZMwdqtRorV66Ev78/Fi5cCADo2rUrdu3ahUWLFkGv19/+s94EKwxERCQPlnrYAPj6+kKn04lbXFzc397y999/h7e3Nzp27IgxY8YgKysLAJCeno7KykqEhYWJbbt06QI/Pz+kpVW9xCwtLQ3du3eHp6en2Eav18NoNOLYsWNimxuvUd2m+hr1iRUGIiKShfqaVnn+/Hmrl0/9XXUhJCQE8fHx6Ny5M3JycvDOO+/gwQcfxNGjR2EwGKBWq9GqVSurczw9PWEwGAAABoPBKlmoPl597FZtjEYjSktL6/Qix7piwkBERGQDrVZbp7dVDh06VPzvHj16ICQkBO3bt8f69evr9Yv8TmGXBBERycMdniXxV61atUKnTp1w6tQpeHl5oaKiAgUFBVZtcnNzxTEPXl5eNWZNVH+urY1Wq633pIQJAxERyYNFkL5JUFRUhNOnT6Ndu3YIDg6Gvb09UlJSxOOZmZnIyspCaGgoACA0NBRHjhzBpUuXxDbJycnQarUIDAwU29x4jeo21deoT0wYiIiIGsAbb7yB1NRUnDt3Drt378ZTTz0FlUqF0aNHQ6fTYdy4cYiJicHPP/+M9PR0jB07FqGhoejfvz8AYPDgwQgMDMTzzz+PQ4cOYevWrZg1axYiIyPFcRMTJ07EmTNnMG3aNJw8eRIfffQR1q9fj+jo6Hp/Ho5hICIiebjDKz1euHABo0ePxpUrV9C2bVs88MAD2LNnD9q2bQsAWLRoEZRKJUaOHIny8nLo9Xp89NFH4vkqlQqJiYmYNGkSQkND4ezsjIiICMydO1ds4+/vj6SkJERHR2PJkiXw8fHBqlWr6n1KJcCEgYiIZEPqOATbzl27du0tjzs4OGD58uVYvnz537Zp3749vv/++1teZ+DAgTh48KBNsd0OdkkQERFRrVhhICIieeDLpyRhwkBERPJgEWBrt0LN8+WLXRJERERUK1YYiIhIHgRL1SblfBljwkBERPLAMQySMGEgIiJ54BgGSTiGgYiIiGrFCgMREckDuyQkYcJARETyIEBiwlBvkTRL7JIgIiKiWrHCQERE8sAuCUmYMBARkTxYLAAkrKVgkfc6DOySICIiolqxwkBERPLALglJmDAQEZE8MGGQhF0SREREVCtWGIiISB64NLQkTBiIiEgWBMECQcIbJ6Wc2xIwYSAiInkQBGlVAo5hICIiIro1VhiIiEgeBIljGGReYWDCQERE8mCxAAoJ4xBkPoaBXRJERERUK1YYiIhIHtglIQkTBiIikgXBYoEgoUtC7tMq2SVBREREtWKFgYiI5IFdEpIwYSAiInmwCICCCcPtYpcEERER1YoVBiIikgdBACBlHQZ5VxiYMBARkSwIFgGChC4JgQkDERGRDAgWSKswcFolERERNZDly5ejQ4cOcHBwQEhICPbu3dvYId0WJgxERCQLgkWQvNlq3bp1iImJwezZs3HgwAH07NkTer0ely5daoAnbFhMGIiISB4Ei/TNRh988AEmTJiAsWPHIjAwECtXroSTkxM+//zzBnjAhtWsxzBUD0CpLK5o5EjoTjAJlY0dAt1BlrKyxg6B7gBLedXP+U4MKDShUtK6TSZU/RtkNBqt9ms0Gmg0mhrtKyoqkJ6ejpkzZ4r7lEolwsLCkJaWdvuBNJJmnTBcu3YNAJA0PKGRIyGiejf328aOgO6ga9euQafTNci11Wo1vLy8sMvwveRrubi4wNfX12rf7NmzMWfOnBptL1++DLPZDE9PT6v9np6eOHnypORY7rRmnTB4e3vj/PnzcHV1hUKhaOxw7hij0QhfX1+cP38eWq22scOhBsSftXzI9WctCAKuXbsGb2/vBruHg4MDzp49i4oK6dVoQRBqfN/crLrQEjXrhEGpVMLHx6exw2g0Wq1WVv+wyBl/1vIhx591Q1UWbuTg4AAHB4cGv8+N2rRpA5VKhdzcXKv9ubm58PLyuqOx1AcOeiQiImoAarUawcHBSElJEfdZLBakpKQgNDS0ESO7Pc26wkBERNSUxcTEICIiAn369EG/fv2wePFiFBcXY+zYsY0dms2YMDRDGo0Gs2fPlk2/mZzxZy0f/Fm3TM8++yzy8vIQGxsLg8GAoKAgbNmypcZAyOZAIch9cWwiIiKqFccwEBERUa2YMBAREVGtmDAQERFRrZgwEBERUa2YMDQzLeU1qXRrO3bswLBhw+Dt7Q2FQoFNmzY1dkjUQOLi4tC3b1+4urrCw8MDw4cPR2ZmZmOHRVQDE4ZmpCW9JpVurbi4GD179sTy5csbOxRqYKmpqYiMjMSePXuQnJyMyspKDB48GMXFxY0dGpEVTqtsRkJCQtC3b18sW7YMQNWKYb6+vpg8eTJmzJjRyNFRQ1EoFNi4cSOGDx/e2KHQHZCXlwcPDw+kpqZiwIABjR0OkYgVhmai+jWpYWFh4r7m/JpUIrq5wsJCAIC7u3sjR0JkjQlDM3Gr16QaDIZGioqI6pPFYsGUKVNw//33o1u3bo0dDpEVLg1NRNREREZG4ujRo9i1a1djh0JUAxOGZqKlvSaViKxFRUUhMTERO3bsgI+PT2OHQ1QDuySaiZb2mlQiqiIIAqKiorBx40Zs27YN/v7+jR0S0U2xwtCMtKTXpNKtFRUV4dSpU+Lns2fPIiMjA+7u7vDz82vEyKi+RUZGIiEhAd9++y1cXV3FMUk6nQ6Ojo6NHB3RdZxW2cwsW7YMCxYsEF+TunTpUoSEhDR2WFTPtm/fjkGDBtXYHxERgfj4+DsfEDUYhUJx0/2rV6/Giy++eGeDIboFJgxERERUK45hICIioloxYSAiIqJaMWEgIiKiWjFhICIioloxYSAiIqJaMWEgIiKiWjFhICIioloxYSAiIqJaMWEgkujFF1/E8OHDxc8DBw7ElClT7ngc27dvh0KhQEFBwd+2USgU2LRpU52vOWfOHAQFBUmK69y5c1AoFMjIyJB0HSJqXEwYqEV68cUXoVAooFAooFarERAQgLlz58JkMjX4vb/55hvMmzevTm3r8iVPRNQU8OVT1GINGTIEq1evRnl5Ob7//ntERkbC3t4eM2fOrNG2oqICarW6Xu7r7u5eL9chImpKWGGgFkuj0cDLywvt27fHpEmTEBYWhu+++w7A9W6Ed999F97e3ujcuTMA4Pz583jmmWfQqlUruLu748knn8S5c+fEa5rNZsTExKBVq1Zo3bo1pk2bhr++juWvXRLl5eWYPn06fH19odFoEBAQgM8++wznzp0TXzDl5uYGhUIhvmzIYrEgLi4O/v7+cHR0RM+ePfHVV19Z3ef7779Hp06d4OjoiEGDBlnFWVfTp09Hp06d4OTkhI4dO+Ltt99GZWVljXYff/wxfH194eTkhGeeeQaFhYVWx1etWoWuXbvCwcEBXbp0wUcffWRzLETUtDFhINlwdHRERUWF+DklJQWZmZlITk5GYmIiKisrodfr4erqip07d+KXX36Bi4sLhgwZIp63cOFCxMfH4/PPP8euXbuQn5+PjRs33vK+L7zwAv73v/9h6dKlOHHiBD7++GO4uLjA19cXX3/9NQAgMzMTOTk5WLJkCQAgLi4OX375JVauXIljx44hOjoa//znP5GamgqgKrEZMWIEhg0bhoyMDIwfPx4zZsyw+f8TV1dXxMfH4/jx41iyZAk+/fRTLFq0yKrNqVOnsH79emzevBlbtmzBwYMH8corr4jH16xZg9jYWLz77rs4ceIE3nvvPbz99tv44osvbI6HiJowgagFioiIEJ588klBEATBYrEIycnJgkajEd544w3xuKenp1BeXi6e85///Efo3LmzYLFYxH3l5eWCo6OjsHXrVkEQBKFdu3bC/PnzxeOVlZWCj4+PeC9BEISHHnpIeO211wRBEITMzEwBgJCcnHzTOH/++WcBgHD16lVxX1lZmeDk5CTs3r3bqu24ceOE0aNHC4IgCDNnzhQCAwOtjk+fPr3Gtf4KgLBx48a/Pb5gwQIhODhY/Dx79mxBpVIJFy5cEPf98MMPglKpFHJycgRBEIS7775bSEhIsLrOvHnzhNDQUEEQBOHs2bMCAOHgwYN/e18iavo4hoFarMTERLi4uKCyshIWiwXPPfcc5syZIx7v3r271biFQ4cO4dSpU3B1dbW6TllZGU6fPo3CwkLk5OQgJCREPGZnZ4c+ffrU6JaolpGRAZVKhYceeqjOcZ86dQolJSV49NFHrfZXVFSgV69eAIATJ05YxQEAoaGhdb5HtXXr1mHp0qU4ffo0ioqKYDKZoNVqrdr4+fnhrrvusrqPxWJBZmYmXF1dcfr0aYwbNw4TJkwQ25hMJuh0OpvjIaKmiwkDtViDBg3CihUroFar4e3tDTs76z/uzs7OVp+LiooQHByMNWvW1LhW27ZtbysGR0dHm88pKioCACQlJVl9UQNV4zLqS1paGsaMGYN33nkHer0eOp0Oa9euxcKFC22O9dNPP62RwKhUqnqLlYgaHxMGarGcnZ0REBBQ5/a9e/fGunXr4OHhUeO37Grt2rXDr7/+igEDBgCo+k06PT0dvXv3vmn77t27w2KxIDU1FWFhYTWOV1c4zGazuC8wMBAajQZZWVl/W5no2rWrOICz2p49e2p/yBvs3r0b7du3x1tvvSXu++OPP2q0y8rKQnZ2Nry9vcX7KJVKdO7cGZ6envD29saZM2cwZswYm+5PRM0LBz0S/WnMmDFo06YNnnzySezcuRNnz57F9u3b8eqrr+LChQsAgNdeew3vv/8+Nm3ahJMnT+KVV1655RoKHTp0QEREBF566SVs2rRJvOb69esBAO3bt4dCoUBiYiLy8vJQVFQEV1dXvPHGG4iOjsYXX3yB06dP48CBA/jwww/FgYQTJ07E77//jqlTpyIzMxMJCQmIj4+36XnvueceZGVlYe3atTh9+jSWLl160wGcDg4OiIiIwKFDh7Bz5068+uqreOaZZ+Dl5QUAeOeddxAXF4elS5fit99+w5EjR7B69Wp88MEHNsVDRE0bEwaiPzk5OWHHjh3w8/PDiBEj0LVrV4wbNw5lZWVixeH111/H888/j4iICISGhsLV1RVPPfXULa+7YsUKPP3003jllVfQpUsXTJgwAcXFxQCAu+66C++88w5mzJgBT09PREVFAQDmzZuHt99+G3FxcejatSuGDBmCpKQk+Pv7A6gaV/D1119j06ZN6NmzJ1auXIn33nvPpud94oknEB0djaioKAQFBWH37t14++23a7QLCAjAiBEj8Nhjj2Hw4MHo0aOH1bTJ8ePHY9WqVVi9ejW6d++Ohx56CPHx8WKsRNQyKIS/G61FRERE9CdWGIiIiKhWTBiIiIioVkwYiIiIqFZMGIiIiKhWTBiIiIioVkwYiIiIqFZMGIiIiKhWTBiIiIioVkwYiIiIqFZMGIiIiKhWTBiIiIioVv8f/MVCaaYgE30AAAAASUVORK5CYII=",
      "text/plain": [
       "<Figure size 640x480 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "conf_matrix = confusion_matrix(y_test_r, y_pred_r)\n",
    "disp = ConfusionMatrixDisplay(confusion_matrix=conf_matrix)\n",
    "disp.plot()\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0b8707e0",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "ac806ee0",
   "metadata": {},
   "outputs": [],
   "source": [
    "inconsistent_words = []\n",
    "for i in differences_index:\n",
    "    inconsistent_words.append(word_dict[i])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "18d3fd8c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "'role' in inconsistent_words"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "id": "6fc3b727",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['query',\n",
       " 'keywords_query_QPub_indexed',\n",
       " 'that',\n",
       " 'citation_subsets',\n",
       " 'research_areas_Zoology_etc_research_areas_papers_domainIMIA_Yearbook',\n",
       " 'research_areas_Zoology_etc_research_areas',\n",
       " 'papers',\n",
       " 'section_editors',\n",
       " 'to_be_caught_by_the_two_PubMed_queriesA_ _first_ _review_ _of_ _the_ _four_ _subsets_ _of_retrieved_ _citations_ ',\n",
       " 'Yearbook_editorial_committee',\n",
       " 'papers_domainIMIA_Yearbook',\n",
       " 'screening',\n",
       " 'editors_to_achieve_a_final_selection_of_ _candidate_best_ _papers',\n",
       " 'review',\n",
       " 'three',\n",
       " 'which',\n",
       " 'to_represent_complex_guidelines_They_promote_the_formalism_of_clinical_decision',\n",
       " 'They',\n",
       " 'formalism',\n",
       " 'disambiguation',\n",
       " 'specification',\n",
       " 'authors',\n",
       " 'ambiguity',\n",
       " 'it',\n",
       " 'modeling_guidelines',\n",
       " 'dimensions',\n",
       " 'levels_dosage_adaptation_intolerance_management',\n",
       " 'they',\n",
       " 'modeling',\n",
       " 'knowledge',\n",
       " 'Khalifa',\n",
       " 'CDSS',\n",
       " 'It',\n",
       " 'assessment',\n",
       " 'implementation',\n",
       " 'effectiveness_safety',\n",
       " 'qualitative',\n",
       " 'direction',\n",
       " 'methodology',\n",
       " 'works',\n",
       " 'to_be_cited_Some_of_them_deal_with_the_personalization_of_decisions',\n",
       " 'Jafarpour',\n",
       " 'use',\n",
       " 'creation_sharing',\n",
       " 'Huibers',\n",
       " 'STOPPSTART_criteria',\n",
       " 'design',\n",
       " 'purpose_Design_alerts',\n",
       " 'Kim',\n",
       " 'Watson',\n",
       " 'concordance_rate',\n",
       " 'year\\x99s_selection',\n",
       " 'transparency_sharing',\n",
       " 'users',\n",
       " 'tools_Vassilis_Koutkias_Multilevel_knowledge_formalization',\n",
       " 'to_thank_all_the_present_and_past_editorial_boards_of_the_IMIA_Yearbook_especially_Martina_Hutter_and_Adrien_Ugon_for_their_support_as_well_as_the_reviewers_for_ _their_ _participation_ _to_ _the_ _selection_ _of_the_ _best_ _papers_ _for_ _the_ _Decision_ _Support_section_We_can_not_end_this_synopsis_without_a_meaningful_thought_for_our_colleague_and_friend',\n",
       " 'We',\n",
       " 'synopsis',\n",
       " 'Forsythe_KJ_Myers_S_McGurrin_M',\n",
       " 'Learning_System',\n",
       " 'L_et_al_Use_ing_Study_JMIR_Med',\n",
       " 'JM_Kim_EH_Kim_K_Pak_K_Concordance',\n",
       " 'decision',\n",
       " 'CDTs',\n",
       " 'patient_tumor',\n",
       " 'criteria',\n",
       " 'Complex_guidelines',\n",
       " 'knowledge_formalization',\n",
       " 'D_Kert_S_Welzer_T_Nemec_Zlatolas',\n",
       " 'intolerances',\n",
       " 'to_build_eTTDs_from_clinical_practice_guidelines',\n",
       " 'Oct_Deciding_to_choose_a_clinical_predictive_tool_in_clinical_practice',\n",
       " 'effectiveness',\n",
       " 'framework_grades_grade',\n",
       " 'grade',\n",
       " 'evidence',\n",
       " 'We',\n",
       " 'case',\n",
       " 'we',\n",
       " 'lysis_time_increasedthrombin_generation',\n",
       " 'Scanning',\n",
       " 'layer',\n",
       " 'patient',\n",
       " 'to_be_heterozygous_for_ï¬\\x81brinogen_HaeIII_455_G_ _A_and_FXIIIVal34Leu_100_G_ _TConclusion_ï¬\\x81brinogen_HaeIII_and_FXIII_Val34Leu',\n",
       " 'factor_XIII_polymorphismsand',\n",
       " 'polymorphisms',\n",
       " 'scenarios_vein_SV',\n",
       " 'durability',\n",
       " 'SV_graft_occlusion',\n",
       " 'many',\n",
       " 'veins_Thepatient',\n",
       " 'surgery_resident',\n",
       " 'gdLWhite_blood',\n",
       " '103µLPlatelet',\n",
       " 'GPL',\n",
       " 'thromboplastin_time',\n",
       " 'IgG_phospholipid_unit',\n",
       " 'unit_time_SGU_standard_IgM_glycoprotein_unitTH',\n",
       " 'SV',\n",
       " 'downusing_the_same_protocol_staff_cardiacsurgeon',\n",
       " 'therapy_withaspirin_clopidogrel',\n",
       " 'completethrombophilia_screening',\n",
       " 'ApproachBecause_thrombophilia',\n",
       " 'screening_wasinitiated_showing_no_abnormalities_\\x96ºTable_Cancer_was_excluded_as_a_cause_of_thrombosis_Positiveantibodies_against_neutrophil_cytoplasm_antigens',\n",
       " 'wasinitiated',\n",
       " 'abnormalities',\n",
       " 'pANCAand_cANCA',\n",
       " 'to_analyze_ï¬\\x81brin_phenotype_using_the_previouslydescribed_methodology34_Brieï¬\\x82y_plasma_ï¬\\x81brin_clot_permeability',\n",
       " 'Ks_values',\n",
       " 'permeability',\n",
       " 'Fibrinogen',\n",
       " 'Clauss_method',\n",
       " 'Compared_withhealthy',\n",
       " 'n',\n",
       " 'clot_lysistime',\n",
       " 'plasma_sample',\n",
       " 'concentration',\n",
       " 'tissuefactor_TF',\n",
       " 'Abcam_Images',\n",
       " 'cells_nuclei',\n",
       " 'usingDAPI',\n",
       " 'vessels_clot_phenotype',\n",
       " 'us',\n",
       " 'thrombi',\n",
       " 'Specimens',\n",
       " 'analysis',\n",
       " 'contractileforces',\n",
       " 'XIII_polymorphisms',\n",
       " 'SV_thrombosis',\n",
       " 'to_change_in_revascularizationstrategy',\n",
       " 'cause',\n",
       " 'TF',\n",
       " 'blue',\n",
       " 'magniï¬\\x81cation_artery_bypass',\n",
       " 'media',\n",
       " 'stainedfragments',\n",
       " 'text_CABG',\n",
       " 'response_SV_dissection',\n",
       " 'ï¬\\x82ow_disruption',\n",
       " 'damage_hypoxia_vessel_wall',\n",
       " 'failure_disproportion',\n",
       " 'ï¬\\x82ow_disruption_damage_hypoxia_vessel_wall',\n",
       " 'background',\n",
       " 'intraoperativethrombosis',\n",
       " 'that',\n",
       " 'thrombin_generation',\n",
       " 'properties',\n",
       " 'tothe_discovery',\n",
       " 'FXIIIVal34Leu_polymorphism',\n",
       " 'to_be_associated_withrisk_myocardial_infarction21',\n",
       " 'extent_study',\n",
       " 'Jung_et_al',\n",
       " 'metaanalysis',\n",
       " 'association',\n",
       " 'stroke',\n",
       " 'polymorphism',\n",
       " 'risk',\n",
       " 'Leu34_alleleis',\n",
       " 'present_thefuture_J_Am_Coll_Cardiol_\\x93',\n",
       " 'contributory_role_study',\n",
       " 'grant',\n",
       " 'E_Undas_posttreatmentmodiï¬\\x81cations',\n",
       " 'clotstructurefunction_Undas_AFibrin_presence_al_clot_permeability_susceptibility_Hooper_GD',\n",
       " 'Alexander_graft_failure_Thromb_Haemost',\n",
       " 'clotstructurefunction',\n",
       " 'BlombÃ¤ck_M_Herzfeld',\n",
       " 'reaction_pattern_\\x93_Gu_L_Liu_W_Yan_Y_et_al_Inï¬\\x82uence',\n",
       " 'that',\n",
       " 'proliferation',\n",
       " 'case_report',\n",
       " 'male',\n",
       " 'diagnosis',\n",
       " 'examinations_craniotomy_skull_reconstruction_flapLTMF_transplantation',\n",
       " 'neoplasm',\n",
       " 'areas',\n",
       " 'which',\n",
       " 'scalp_defect',\n",
       " 'Followup',\n",
       " 'mass_lesion',\n",
       " 'patient',\n",
       " 'cycles',\n",
       " 'lesion',\n",
       " 'Wang_ZhengWen_He_Department',\n",
       " 'Hunan_Cancer_Hospital_University_Tongzipo_Road',\n",
       " 'use_reproduction_distribution',\n",
       " 'work',\n",
       " 'arare_case',\n",
       " 'resection_reconstruction_ofJournal',\n",
       " 'Afï¬\\x81liated_Hospital_ofXiangya_School',\n",
       " 'Computed_tomographyCT',\n",
       " 'mass',\n",
       " 'osteolyticlesion',\n",
       " 'all',\n",
       " 'hypervascularity_bleeding_volume',\n",
       " 'thesurgery_time_feeding_blood_vessel',\n",
       " 'ehomogeneouslyThe_patient',\n",
       " 'craniotomy_skull_reconstruction_LTMF_transplantation',\n",
       " 'tumour',\n",
       " 'likeappearance',\n",
       " 'blood_supply',\n",
       " 'Thetumour_mass',\n",
       " 'resectionincluding',\n",
       " 'involvedscalp',\n",
       " 'cm_bone',\n",
       " 'skulldefect',\n",
       " 'using_titaniummesh',\n",
       " 'muscle_pedicle',\n",
       " 'procedures_imaging',\n",
       " 'island_flap_muscle_pedicle',\n",
       " 'd',\n",
       " 'medialsuperior',\n",
       " 'scapula',\n",
       " 'LTMF',\n",
       " 'operation',\n",
       " 'healing',\n",
       " 'staining',\n",
       " 'presence',\n",
       " 'reasons',\n",
       " '4b_PADregimen_bortezomib',\n",
       " 'liposomaldoxorubicindexamethasone_wasadministered_photomicrographs',\n",
       " 'reviewafter_months',\n",
       " 'tumour_recurrence',\n",
       " 'Review_Board_detailsof',\n",
       " 'SPB',\n",
       " 'dose',\n",
       " 'anda_margin',\n",
       " 'size',\n",
       " 'chemotherapy',\n",
       " 'impact',\n",
       " 'they',\n",
       " 'information_relationship_tothe',\n",
       " 'MRI_examination',\n",
       " 'structures',\n",
       " 'embolizationDuringthetumourrecurrencecurrent_operationthetumour',\n",
       " 'to_involve_the_scalpand_subcutaneous_tissue_To_reduce_theprobability_oftheinvolved_scalp',\n",
       " 'information_relationship_tothe_muscle_compartments_tissue_ease_provision',\n",
       " 'muscle_compartments',\n",
       " 'tissue_ease_provision',\n",
       " 'supply',\n",
       " 'artery_dorsalscapular',\n",
       " 'method',\n",
       " 'problem_bloodsupply',\n",
       " 'byexcision',\n",
       " 'case',\n",
       " 'reportand',\n",
       " 'paper_HC',\n",
       " 'NR',\n",
       " 'paperAll_authorsread_ï¬\\x81nalmanuscriptDeclaration',\n",
       " 'paperAll_authorsread',\n",
       " 'ï¬\\x81nalmanuscriptDeclaration',\n",
       " 'project',\n",
       " 'grants',\n",
       " 'C_alWHO_classiï¬\\x81cation',\n",
       " '15a',\n",
       " 'response_assessment',\n",
       " 'recommendations',\n",
       " 'outcome',\n",
       " 'study',\n",
       " 'factors',\n",
       " 'Fortyone_patients',\n",
       " 'radiofrequency',\n",
       " 'controls',\n",
       " 'Serum_MMP2_MMP9_levels',\n",
       " 'immunosorbent_assay',\n",
       " 'levels',\n",
       " 'values',\n",
       " 'use_reproduction_distribution',\n",
       " 'work',\n",
       " 'malignancy_accountingfor',\n",
       " 'highincidence_low',\n",
       " 'technologies_theapplication',\n",
       " 'incidence_microtumors',\n",
       " 'reduction',\n",
       " 'quality',\n",
       " 'RFA89_RFA',\n",
       " 'manifestations_examinations',\n",
       " 'clinicalmanifestations',\n",
       " 'analysis',\n",
       " 'MMP9',\n",
       " 'IV_collagen',\n",
       " 'MMP2_MMP9_expression_levels',\n",
       " 'to_be_upregulatedin_thyroid_cancer',\n",
       " 'thesestudies',\n",
       " 'surgery',\n",
       " 'we',\n",
       " 'serum_levels',\n",
       " 'RFAWe',\n",
       " 'effectsof',\n",
       " 'who',\n",
       " 'ultrasoundguidedRFA',\n",
       " 'consent',\n",
       " 'ethics_review',\n",
       " 'the',\n",
       " 'nerve',\n",
       " 'mixture_basedon',\n",
       " 'washarvested_serum_levels_andMMP9',\n",
       " 'using_enzymelinked',\n",
       " 'Bioengineering_WuhanHubei_ablation_range',\n",
       " 'CEUS',\n",
       " 'ablation',\n",
       " 'Ultrasound_detectionwas',\n",
       " '0cwas',\n",
       " 'efï¬\\x81cacy_wasdetermined_effect_volume_reducedby',\n",
       " 'efï¬\\x81cacy_wasdetermined',\n",
       " 'RFAfor',\n",
       " 'disappearance_ofnodules',\n",
       " 'effect_volume_reducedby',\n",
       " 'CorpArmonk_Comparisons_betweengroups',\n",
       " 'regression_effects',\n",
       " 'subjects',\n",
       " 'weremeasured',\n",
       " 'declinedat',\n",
       " 'serum_levels_MMP9',\n",
       " 'monthsall_P_Table_results_results',\n",
       " 'ROCcurves',\n",
       " 'AUC_values',\n",
       " 'age',\n",
       " 'control_group',\n",
       " 'patients',\n",
       " 'andEvaluation',\n",
       " 'efï¬\\x81cacy',\n",
       " 'RFA',\n",
       " 'lesions',\n",
       " 'hypoenhancement_hyperenhancement_0cPan_et',\n",
       " 'nodules_examination_afterablation',\n",
       " 'contrastagent_perfusionin',\n",
       " 'RFAtreatmentthetumor_volume',\n",
       " '0cJournal',\n",
       " 'disease_prognosis',\n",
       " 'anddiameter',\n",
       " 'degree_ofcalciï¬\\x81cation_shape',\n",
       " 'matrix_metalloproteinaseFigure_Efficacy_evaluation',\n",
       " 'andMMP9',\n",
       " 'bloodflow_signals',\n",
       " 'enhancement_imaging_localization',\n",
       " 'tumor',\n",
       " 'markers',\n",
       " 'type_worldwide1516_Mostthyroidtumor_cases',\n",
       " 'nodules',\n",
       " 'that',\n",
       " 'highfrequencyelectromagneticwaves',\n",
       " 'isthen',\n",
       " 'thyroid_nodules',\n",
       " 'perfusion',\n",
       " 'greaterWe',\n",
       " 'levelstheAUC_values_andMMP9',\n",
       " 'diagnostic_prognostic',\n",
       " 'parenchyma',\n",
       " 'tumorstroma',\n",
       " 'results',\n",
       " 'thatfailure',\n",
       " 'blood',\n",
       " 'lesions_disappearedafter_PTC_ablation',\n",
       " 'secretion_microcalciï¬\\x81cation_shape_lesion_diameter_numbercells',\n",
       " 'The_lesions_disappearedafter_PTC_ablation_thus_reducing_the_secretion_of_MMP2_and_MMP9_and_therebyreducing_the_degradation_and_destructionof_type_IV_collagen_protecting_the_basement_membrane_of_normaltissues_andinhibiting_the_growth_and_metastasis_oftumorresults_alsoshowed_that_age_microcalciï¬\\x81cation_irregular_shape_and_lesion_diameter_and_numbercells_risk_factors',\n",
       " 'risk_factor',\n",
       " 'deposition',\n",
       " 'secretion',\n",
       " 'morphology_nodules_diameter',\n",
       " 'methodforserumlevels_MMP9',\n",
       " 'research',\n",
       " 'speciï¬\\x81c_grant_compartment_reoperation',\n",
       " 'alThe_accuracy',\n",
       " '\\x93_DOI_risk_stratiï¬\\x81cation',\n",
       " '\\x93_DOI_Current_guidelines',\n",
       " 'Chung_alResveratrol_supplementation',\n",
       " 'aorticatherosclerosis_calciï¬\\x81cation',\n",
       " 'loss',\n",
       " 'guidelines_managementof_thyroid',\n",
       " 'summary_ofrecommendations',\n",
       " '\\x93_kjr2011125525_Dinh_Radiofrequency_ablation',\n",
       " '1yearfollowup_\\x93_Lang_BHH_Woo_YC_Chiu_analysis',\n",
       " 'factors_inhigh_intensity',\n",
       " 'ultrasound_HIFUablation',\n",
       " 'understanding_skills',\n",
       " 'to_properly_managethese_complicationsKeywordsRadiofrequency_ablation_benign_thyroid_nodules_haemorrhage_management',\n",
       " 'use_reproduction_distribution',\n",
       " 'work',\n",
       " 'effects',\n",
       " 'symptoms_cosmetic_concerns',\n",
       " 'gold_standardtreatment_complications',\n",
       " 'scars_haemorrhage_lesions',\n",
       " 'UShave',\n",
       " 'to_be_effective_in_BTNsAmong',\n",
       " 'complications',\n",
       " 'Howeverseveralcases',\n",
       " 'study',\n",
       " 'EthicsCommitteethe_Third_Afï¬\\x81liatedHospital_consent',\n",
       " 'EthicsCommitteethe_Third_Afï¬\\x81liatedHospital',\n",
       " 'andwritten',\n",
       " 'consent',\n",
       " 'diameter_completeblood_counts_coagulation_test',\n",
       " 'complaints',\n",
       " 'exclusion_criteria',\n",
       " 'nodules_patients',\n",
       " 'inclusioncriteriaPretreatment',\n",
       " 'results',\n",
       " 'radiologists_TW_JR_years_US',\n",
       " 'USUSguided_FNA_CEUS',\n",
       " 'ofan_ML615centrelinearLaboratory_tests',\n",
       " 'levels',\n",
       " 'nodulevolume',\n",
       " 'using_the_followingvolume¼_length_02_width',\n",
       " 'cord_function',\n",
       " 'laryngologist',\n",
       " 'procedure_Atenrolment_allpatients',\n",
       " 'to_rate_their_pressuresymptoms_on_a_10_cm_visual_analoguescale_grade_\\x93_cm',\n",
       " 'score',\n",
       " 'physicianas',\n",
       " 'RFA_procedures',\n",
       " 'oneradiologist_JR',\n",
       " 'STARmed_Korea_andan',\n",
       " 'Localanaesthesia',\n",
       " 'hydrodissectiontechnique',\n",
       " 'attention',\n",
       " 'which',\n",
       " 'distance',\n",
       " 'andappliedtechnique2122_Ablationthe_movingshotwas',\n",
       " 'hyperechoic_zones',\n",
       " 'technique',\n",
       " 'byCEUS',\n",
       " 'RFA_untilthedisappearedTechnicalthechange',\n",
       " 'nodule',\n",
       " 'examination_CEUS_examinationhormonemeasurements',\n",
       " 'pressuresymptoms_grading',\n",
       " 'TE_wascalculated',\n",
       " 'analyses',\n",
       " 'Armonk_NY_USA_Continuousvariables',\n",
       " 'data',\n",
       " 'using_a_pairedttest_A_P_value_of_14',\n",
       " 'patients',\n",
       " 'RFA',\n",
       " 'Table_Figure',\n",
       " 'shrinkage',\n",
       " 'gradualenlargement',\n",
       " '\\x93_Figure',\n",
       " 'cysticsolid_nodule',\n",
       " 'ablation_ultrasound',\n",
       " 'who',\n",
       " 'RFA_effectsFeverPainDizzinessSensation',\n",
       " 'Most_disappeared_None_effects',\n",
       " 'fevern¼_pain_n¼_dizziness',\n",
       " 'andsome_reports',\n",
       " 'types',\n",
       " 'tip3031_Thyroid',\n",
       " 'totreat',\n",
       " 'vessels',\n",
       " 'movement',\n",
       " 'we',\n",
       " 'steps',\n",
       " 'shouldbe',\n",
       " 'patient_presentstudy_metconditions',\n",
       " 'he',\n",
       " 'coagulation_disorder',\n",
       " 'complex',\n",
       " 'to_improve_coagulation_function_before_the_procedure_preoperativelyDuring_the_RFA_procedure_an_effectiveclinical_strategy_and_adequate_technical_0cJournal_of_International_Medical_ResearchFigure_ _Ultrasound_examination_and_contrastenhanced_ultrasound_examination_of_patients_with_intranodular_haemorrhage_or_perithyroidal_haemorrhage',\n",
       " 'to_improve_coagulation_function_before_the_procedure',\n",
       " 'Reptilase_haemocoagulaseatrox_forinjection_Pentapharm_BaselSwitzerland',\n",
       " 'preoperativelyDuring_the_RFA_procedure_an_effectiveclinical_strategy_and_adequate_technical_0cJournal_of_International_Medical_ResearchFigure_ _Ultrasound_examination_and_contrastenhanced_ultrasound_examination_of_patients_with_intranodular_haemorrhage_or_perithyroidal_haemorrhage',\n",
       " 'hyperechoicmass_lesion',\n",
       " 'ablation_needle',\n",
       " 'contrastenhancedultrasound',\n",
       " 'mass_lesion_microbubble_extravasation_procedure',\n",
       " 'mass_lesion',\n",
       " 'microbubble_extravasation',\n",
       " 'procedure',\n",
       " 'anaesthesia',\n",
       " 'smallbore_electrodesshould',\n",
       " 'to_decrease_the_risk_ofbleeding35',\n",
       " 'et_alpowder',\n",
       " 'injection_methodsthus',\n",
       " 'injection',\n",
       " 'methodsthus',\n",
       " 'surgicalintervention',\n",
       " 'bleeding',\n",
       " 'CEUS',\n",
       " 'it',\n",
       " 'selection_ofpatients_sufï¬\\x81cient_preparation',\n",
       " 'Thephysician',\n",
       " 'realtime_US_RF_electrode_tip_drug_injectioninto_Jie_RenIIIstudy_materials_patientsProvision_ofKunpeng_Hu_Yufan',\n",
       " 'Mild_bleeding',\n",
       " 'morbidity',\n",
       " 'compression_bleeding',\n",
       " 'to_be_rarehowever',\n",
       " 'modalities',\n",
       " 'realtime_US_Mild_bleeding_morbidity_compression_bleeding_to_be_rarehowever_RF_electrode_tip_drug_injectioninto_Jie_RenIIIstudy_materials_patientsProvision_ofKunpeng_Hu_Yufan',\n",
       " 'Collectionand_assembly',\n",
       " 'authors',\n",
       " 'NaturalThis_work',\n",
       " 'NationalNatural_Science_Foundation_CNNoScienceFoundation',\n",
       " 'therapy_thyroid',\n",
       " 'SivroPrndeljF',\n",
       " 'distribution',\n",
       " 'factors',\n",
       " 'thyroid_nodules',\n",
       " 'EJalRadiofrequency_ablation',\n",
       " 'followup_results',\n",
       " 'consensusstatement_recommendationsKorean_Radiol_\\x93_imaging',\n",
       " 'DL_alSociety',\n",
       " 'case',\n",
       " 'literature_providesimplications',\n",
       " 'use_reproduction_distribution',\n",
       " 'work',\n",
       " 'genetic_features2\\x93_Recently_PMBCLwas_listed_as_a_separate_entity_in_the_latestWorld_Health_anization_ _classiï¬\\x81cation_of_hematopoieticand_lymphoidtumors5_PMBCL',\n",
       " 'presentation',\n",
       " 'features',\n",
       " 'situation',\n",
       " 'bypeople',\n",
       " 'antibody',\n",
       " 'bypeople_andDrug_Administration_FDA_agenttargetsthe_PD1_receptor',\n",
       " 'andDrug_Administration_FDA_agenttargetsthe_PD1_receptor',\n",
       " 'efï¬\\x81cacy',\n",
       " 'thatlarge_lymphocyteswere',\n",
       " 'patient',\n",
       " 'treatment',\n",
       " 'mass',\n",
       " 'woman_tomography_PET_scan',\n",
       " 'mediastinum',\n",
       " 'CD20_CD79a',\n",
       " 'CD30and_multiplemyeloma1_negative',\n",
       " 'She',\n",
       " 'tumor_resection',\n",
       " 'cycles_etoposidecyclophosphaprednisolonemiderituximabDAEPOCHR',\n",
       " 'she',\n",
       " 'twodoxorubicinvincristinecycles_ofgemcitabine_dexamethasonecisplatinumetoposide_and',\n",
       " 'site_bThe_patient',\n",
       " 'symptomsand',\n",
       " 'tissue_biopsy',\n",
       " 'Summary_monitoring',\n",
       " 'Upperpanel',\n",
       " 'chemotherapyRCHOP',\n",
       " 'cyclophosphamide_doxorubicin_vincristine_prednisolone_DAEPOCHR',\n",
       " 'chemotherapyRCHOP_rituximab_cyclophosphamide_doxorubicin_vincristine_and_prednisolone_DAEPOCHR',\n",
       " 'prednisolone_cyclophosphamide_doxorubicin',\n",
       " 'dexamethasone_cisplatinum',\n",
       " 'gland_lesion',\n",
       " 'prednisolone_cyclophosphamide_doxorubicin_dexamethasone_cisplatinum_myelosuppression_to_receiveblood_transfusion_treatment_risk',\n",
       " 'ofchemotherapy_patient',\n",
       " 'myelosuppression',\n",
       " 'to_receiveblood_transfusion_treatment',\n",
       " 'These',\n",
       " 'risk',\n",
       " 'disease',\n",
       " 'withsevere_myelosuppression',\n",
       " 'withsevere_myelosuppression_cell_transplantation_dexamethasone_mg',\n",
       " 'cell_transplantation_dexamethasone_mg',\n",
       " 'thatshe',\n",
       " 'CRb',\n",
       " 'nivolumab_treatment_mg',\n",
       " 'doses',\n",
       " 'fatigue_pyrexia_Blood_tests',\n",
       " 'normalfunction_thyroidFigure',\n",
       " 'bloodlevels',\n",
       " 'plateletcounts',\n",
       " 'bloodlevels_brainand_skin',\n",
       " 'signs_symptoms',\n",
       " 'brainand_skin',\n",
       " 'years_strategies',\n",
       " 'Therapeuticantibodies_BcellBased',\n",
       " 'ï¬\\x81ve_reportshave',\n",
       " 'using_nivolumab_for_treatment_of_PMBCLrrPMBCL_Table_ _asfollows',\n",
       " 'responses',\n",
       " 'efï¬\\x81ciency',\n",
       " 'ipilimumaband',\n",
       " 'combinedtherapy',\n",
       " 'who',\n",
       " 'failure',\n",
       " 'administration',\n",
       " 'Zinzaniand_colleagues',\n",
       " 'treatment_brentuximab_vedotin',\n",
       " 'safety_proï¬\\x81le',\n",
       " 'II_study_patients',\n",
       " 'withnivolumab_mgkg_vedotin_mgkg',\n",
       " 'Bcell_lymphomaNumberof_cases',\n",
       " 'events_mgkg\\x93_mgkgIpilimumab\\x93\\x93ResponseyesnoNoNo',\n",
       " 'iaand_peripheralneuropathy_indicated_achieved',\n",
       " 'events_wereneutr',\n",
       " 'pyrexiaYeschemotherapyNote_\\x93',\n",
       " 'remission',\n",
       " 'recovered',\n",
       " 'approaches',\n",
       " 'we',\n",
       " 'offlabel_nivolumab_GDP_chemotherapy',\n",
       " 'approaches_thyroiditisFigure',\n",
       " 'datawere',\n",
       " 'thyroxine',\n",
       " 'thyroiditisFigure',\n",
       " 'data',\n",
       " 'tonormal_levels',\n",
       " 'they',\n",
       " 'symptomsor_signs',\n",
       " 'that',\n",
       " 'CR',\n",
       " 'We',\n",
       " 'followup_observation',\n",
       " 'implications',\n",
       " 'investigation',\n",
       " 'to_beperformed_for_potential_application_of_singleor_combined_use_of_nivolumab_for_patientswith_rrPMBCL_who_experience_failure_withconventional_therapeutic_approachesDeclaration_of_conflicting',\n",
       " 'failure_withconventional_approachesDeclaration',\n",
       " 'research',\n",
       " 'speciï¬\\x81c_grant',\n",
       " 'al_management',\n",
       " 'BrJ_Haematol_\\x93_JD_Cancer_immunotherapy',\n",
       " 'Zinzani_et_alNivolumab',\n",
       " 'events_Zinzani_PL_Ribrag_Moskowitz_et_alSafety_tolerability',\n",
       " 'survival_statistics',\n",
       " 'increasedoverall_andhigher1',\n",
       " 'trial_polymerase_inhibitor',\n",
       " 'efficacy',\n",
       " 'subset',\n",
       " 'success',\n",
       " 'subtype',\n",
       " 'outcomesdue',\n",
       " 'increase',\n",
       " 'type_GC_increases',\n",
       " 'we',\n",
       " 'to_analyze_the_molecular_signatures_as_well_asdifferences_between_Lauren_classified_GCs',\n",
       " 'We',\n",
       " 'type_GC_increases_to_analyze_the_molecular_signatures_as_well_asdifferences_between_Lauren_classified_GCs',\n",
       " 'to_look_solely_at_Lauren_classifiedcancers_within_this_ _due_to_its_established_use_within_themedical_community_as_well_as_its_availability_and_relevancewithin_publicly_available_data',\n",
       " 'Database_SearchOncomine_Compendia_Bioscience',\n",
       " 'data_sets',\n",
       " 'to_explore_theup_and_downregulation_of_Lauren_subtypes_of_GC_Chen_Gastric_Mol_Biol_Cell_ _mRNA_DErrico_Gastric_EuropeanJournal_Dataset2_ _mRNA_and_Cho_Gastric_ClinicalCancer_Research_ _mRNA',\n",
       " 'genes',\n",
       " 'subtype_GC',\n",
       " 'fold_changes',\n",
       " 'andhave',\n",
       " 'P_values',\n",
       " 'Database_Database_University',\n",
       " 'foranalysis',\n",
       " 'AnalysisDGIdb_database',\n",
       " 'to_identify_druggable_targets',\n",
       " 'Protein_Atlas',\n",
       " 'to_identify_survival_curves_in_stomach_cancerwith_the_following_proteins_CWD43_Stage',\n",
       " 'v19proteinatlasProtein\\x93Protein_Interaction_NetworksSTRING_Database',\n",
       " 'to_identify_protein\\x93proteininteractions_for_the_following_genes_CWH43_METLL7ASLC2A12_MAL',\n",
       " 'Many',\n",
       " 'attempts',\n",
       " 'examples',\n",
       " 'which_targetshave',\n",
       " 'utility',\n",
       " 'promisinghave',\n",
       " 'to_be',\n",
       " 'investigations',\n",
       " 'to_be_distinctfrom_the_commonly_studied_and_clinically_intractable_targetsAlthough',\n",
       " 'significantupregulation',\n",
       " 'SPON2_CDH11_Table',\n",
       " 'status',\n",
       " 'CLDN1_hasbeen',\n",
       " 'to_be_highly_expressed_in_GC',\n",
       " 'SULF1',\n",
       " 'to_be_significantlyhypomethylated_causing',\n",
       " 'underrepresentation',\n",
       " 'publications',\n",
       " 'Lauren',\n",
       " 'landscape',\n",
       " 'GC_subtypesTable',\n",
       " 'to_explore_whether_a_potentialgenetic_link_exists',\n",
       " 'Literature_search',\n",
       " 'study',\n",
       " 'GC',\n",
       " 'molecularsimilarities',\n",
       " 'similarityCLDN1_expression',\n",
       " 'part_family',\n",
       " 'to_be_differentially_expressed_in_GC',\n",
       " 'to_be_upregulatedin_a_small_patient_population_being_linked_to_poor_survival_outcomes_indicative_of_an_oncogenic_function32',\n",
       " 'groupshave',\n",
       " 'claudin1',\n",
       " 'transition',\n",
       " 'to_be_downregulated_in_intestinal_type_GC_in_aof_ _patients',\n",
       " 'work',\n",
       " 'to_be_donein_order_to_elucidate_the_role_CLDN1_plays_within_intestinaltype_gastric_tumors_as_it_has_differing_functions_based_on_the_0cTechnology_in_Cancer_Research_ _TreatmentTable_ ',\n",
       " 'it',\n",
       " 'functions',\n",
       " 'biosynthesis_pathways',\n",
       " 'Cell_adhesion',\n",
       " 'trafficking260E6380E6833E6Cell_adhesion_molecules',\n",
       " 'to_analyze_gene_functionliterature_Many_of_the_processes_underlying_intestinal_GCinvolve_alterations_in_metabolism_and_cellular',\n",
       " 'pathway_analysis',\n",
       " 'similarity',\n",
       " 'cancer',\n",
       " 'investigation',\n",
       " 'similarities_to_induce_aggressive_cancers_by_protectingtumors_from_5flurouracil_5FUinduced_death_a_chemotherapy_commonly_used_to_treat_GC3738_component_notion_pertaining_to_highly_significant_downregulated_genes_in_GC_Using_the_Oncomine_database',\n",
       " 'gene',\n",
       " 'importance',\n",
       " 'similarities',\n",
       " 'Marfan_syndrome',\n",
       " 'hypermethioninemiaAHCY_Research',\n",
       " 'which',\n",
       " 'foryears',\n",
       " 'to_induce_aggressive_cancers_by_protectingtumors_from_5flurouracil_5FUinduced_death_a_chemotherapy_commonly_used_to_treat_GC3738',\n",
       " 'component',\n",
       " 'when_analyzed_as_a_whole_whichfurther',\n",
       " 'notion',\n",
       " 'studies',\n",
       " 'DNA_methylation3940_thanthis',\n",
       " 'influenced',\n",
       " 'pertaining_to_highly_significant_downregulated_genes_in_GC_Using_the_Oncomine_database',\n",
       " '0cSexton',\n",
       " 'KEGG_Kyoto_Encyclopedia',\n",
       " 'to_analyze_gene_functionfound',\n",
       " 'survival_outcomes',\n",
       " 'METTL7A_MALSLC2A12_Figure_1A',\n",
       " 'survival',\n",
       " 'METLL7AWe',\n",
       " 'Although_many_of_the_interacting_proteins_are_not_aswell_studied_as_AKT1_various_genes_such_as_MTUS1_PGAP3ALDOA_and_PMP22',\n",
       " 'influence_GC_cancer',\n",
       " 'to_look_intowhether',\n",
       " 'variety',\n",
       " 'to_conferresistance_to_pembrolizumab_in_other_malignancies48_but_little_isknown_in_GC_Downregulation_of_these_genes',\n",
       " 'expression_mutations',\n",
       " 'MAL',\n",
       " 'membrane',\n",
       " 'aplyronine_CWH43_isinvolved_involved_include',\n",
       " 'to_investigate_the_interaction_networks_betweenthese_uncharacterized_genes_of_interest_bold_and_miRNAsUsing_the_miRWalk_database_we_found_miRNA_to_interactwith_our_genes_of_interest_Figure',\n",
       " 'totherapies',\n",
       " 'to_understand_the_possible_underlying_resistance_mechanisms_within_subsets_of_GC_that_would_bring_forward_the_idealpopulations_that_benefit_from_conventional_and_commonly_usedtherapiesIncreasing_interest_has_been_placed_around_small_RNAsincluding_miRNAs_involvement_within_GC_development5152We',\n",
       " 'that',\n",
       " 'idealpopulations',\n",
       " 'miRNA',\n",
       " 'miRNA612miR612',\n",
       " 'PAX8_atumorsuppressor',\n",
       " 'FOXM1',\n",
       " 'studying_the_role_of_nuclear_export_and_miRNA_expression_and_uncovering_ways_in_which_tumor_suppressive_miRNAs_canbe_upregulated_within_the_nucleus_by_manipulating_nuclearexport_Nuclear_export_via_XPO1',\n",
       " 'role',\n",
       " 'majority',\n",
       " 'overexpression',\n",
       " 'to_be_atherapeutic_target_in_GC',\n",
       " 'blocking_the_protein_with_the_small_FDA_approved_molecule_selinexor_XPOVIO',\n",
       " 'expression',\n",
       " '¼_392E23',\n",
       " 'generation',\n",
       " 'change_ _P_¼_546E',\n",
       " 'trafficking156E9_Metabolism318E10_Membrane',\n",
       " 'adhesion_molecules',\n",
       " 'Values',\n",
       " 'to_analyze_gene_functionsignaling_pathwaynot',\n",
       " 'Analysis',\n",
       " 'data_sets_antioxidant_andthis_observation',\n",
       " 'GCs',\n",
       " 'to_have_moreprominent_downregulation_of_metabolism_related_genes_suchas_GSTA2_and_DBT_GSTA2',\n",
       " 'pathway',\n",
       " 'to_contribute_phenotypically_to_high_rates_of_invasion_and',\n",
       " 'downregulation',\n",
       " 'Zhang_et_al',\n",
       " 'ADRB2signaling',\n",
       " 'treating_with_antagonists_of_ARDB2',\n",
       " 'survival_benefit',\n",
       " 'differenceWe',\n",
       " 'tissue_sarcoma_rheumatoid',\n",
       " 'involvement',\n",
       " 'representationwithin',\n",
       " 'patients',\n",
       " 'gastric_Females',\n",
       " 'incidence',\n",
       " 'factors',\n",
       " 'moleculardifferences',\n",
       " 'anabundance',\n",
       " 'higherabundance',\n",
       " 'agreater_abundance',\n",
       " 'trend',\n",
       " 'to_use_ourcohorts_to_identify_whether_there_are_differences_in_actionabletargets_between_gendersFemale_Patients_With_GC',\n",
       " 'UnderrepresentedWithin_Clinical_StudiesWe',\n",
       " 'targets',\n",
       " 'us',\n",
       " 'scopeof',\n",
       " 'one',\n",
       " 'overrepresentation',\n",
       " 'cohortto',\n",
       " 'abundance',\n",
       " 'issue',\n",
       " 'May_Benefit',\n",
       " 'cohort',\n",
       " 'profile',\n",
       " 'thescope',\n",
       " 'thatmale_patients',\n",
       " 'targetssuch',\n",
       " 'transamination',\n",
       " 'pyruvatea_Glucagon_tacrolimus',\n",
       " 'glucose_metabolism',\n",
       " 'stimulation',\n",
       " 'alFigure_patients',\n",
       " 'signatures',\n",
       " 'Density_plots',\n",
       " 'Database_interaction_networks',\n",
       " 'TOMIL1Tacrolimus',\n",
       " 'development',\n",
       " 'targetingSSTR1',\n",
       " 'benefit',\n",
       " 'Hypermethylation',\n",
       " 'to_contribute_to_the_pathogenesis_of_GC_by_actingin_a_tumor_suppressive_manner',\n",
       " 'Paclitaxel_Docetaxel_Cabzitaxel_Erbulin',\n",
       " 'Panitumumab_Rociletinib',\n",
       " 'stress_treatment_modalities',\n",
       " 'to_be_beneficial',\n",
       " 'This',\n",
       " 'challenge',\n",
       " 'approach',\n",
       " 'to_ _offer_the_best_results_with_higher_patient_satisfaction_compared_to_monotherapy',\n",
       " 'we',\n",
       " 'literature',\n",
       " 'concepts',\n",
       " 'therapy_imiquimod_5fluorouracil_interferons_bleomycin_enzyme_inhibitors',\n",
       " 'knowledge_understanding',\n",
       " 'treatments',\n",
       " 'rise',\n",
       " 'typesKeywordsKeloids',\n",
       " 'healing_treatment',\n",
       " 'advances',\n",
       " 'to_shed_light_on_the_underlying_mechanisms_implicated_in_keloid_scar_formation_which_will_hopefully_lead_to_the_development_of_treatment_options_for_all_keloid_types_This_review_summarises_current_and_emerging_therapiesIntroductionWound_healing',\n",
       " 'review',\n",
       " 'therapiesIntroductionWound_healing',\n",
       " 'series',\n",
       " 'that',\n",
       " 'to_ _recur_ _after_ _excision_ _Keloid_ _scars_ _Faculty_of_Medical_Sciences',\n",
       " 'polymorphisms_involvement',\n",
       " 'which',\n",
       " 'use_reproduction_distribution',\n",
       " 'identified610_Genomewide_association_studies_mapping_studies',\n",
       " 'polymorphisms',\n",
       " 'ubiquitin_ligase_enzyme_myosin_genes',\n",
       " 'MYO7A10\\x93_Studies',\n",
       " 'involvement',\n",
       " 'lines',\n",
       " 'growth',\n",
       " 'factors',\n",
       " 'role',\n",
       " 'IL6_metalloproteinases_MMPs31418',\n",
       " 'pathways',\n",
       " 'IL6_ _and_ _matrix_ _metalloproteinases_MMPs31418_ _Furthermore_ _signalling_ _pathways_such_as_Tolllike_receptor_signalling_SMAD_signalling_and_fibronectin',\n",
       " 'to_be_associated_with_keloid',\n",
       " 'development1819Histopathology',\n",
       " 'abundance',\n",
       " 'Collagen',\n",
       " 'crosslinks',\n",
       " 'issues',\n",
       " 'quality',\n",
       " 'regions',\n",
       " 'chest_shoulders_regions',\n",
       " 'Figure_location',\n",
       " 'to_alter_its_morphological_characteristics_Some_keloids_can_develop',\n",
       " 'most',\n",
       " 'years',\n",
       " 'acne_insect',\n",
       " 'vaccinations_force45Epidemiology_incidence',\n",
       " 'to_ _be_ _in_ _the_range_ _of_ _\\x93_ ',\n",
       " 'Males_females',\n",
       " 'risk',\n",
       " 'are',\n",
       " 'to_reduce_scar_volume_and_height',\n",
       " 'studies',\n",
       " 'notion',\n",
       " 'pliability',\n",
       " 'pain_itching8',\n",
       " 'recurrence3',\n",
       " 'Corticosteroids',\n",
       " 'antiinflammatory_properties1',\n",
       " 'mechanisms',\n",
       " 'to_reduce_scar_volume_and_height_pliability_pain_itching8_recurrence3_antiinflammatory_properties1_to_be_highly_expressed_in_ _keloid_ _fibroblasts_ _compared_ _to_ _controls_ _but_expression',\n",
       " 'which_corticosteroids',\n",
       " 'scar',\n",
       " 'VEGF',\n",
       " 'to_be_highly_expressed_in_ _keloid_ _fibroblasts_ _compared_ _to_ _controls_ _but',\n",
       " 'angiogenesis',\n",
       " 'addition',\n",
       " 'expression',\n",
       " 'study',\n",
       " 'reduction',\n",
       " 'I_it',\n",
       " 'collagen_types',\n",
       " 'research',\n",
       " 'findings_dermis_band',\n",
       " 'treatment',\n",
       " 'to_be_ _the_ _most_ _effective_ ',\n",
       " 'to_be_ _the_ _most_ _effective_ _current_treatment_modalities_Figure_Some_trials',\n",
       " 'current_treatment_modalities_Figure_Some',\n",
       " 'trials',\n",
       " 'i',\n",
       " 'llof',\n",
       " 'I',\n",
       " 'lacipotnoitcenji_UFidoeKllygooisyhpohtaPdna_gnirracSdoeKli',\n",
       " 'fargilpAsresalidoeKl_dna_OC_tnemtaerTn_ii_sresaL',\n",
       " 'foydutS_toli',\n",
       " 'lecFVS_suogootua',\n",
       " 'inkSCSDAxirtacic_idoekl',\n",
       " 'foyparehT_sll',\n",
       " 'lamorts',\n",
       " 'ilteovartlu_VU_FVS_sll_ecnoitcarf_raucsavl',\n",
       " 'lynatit_ecmets_l_amyhcnesemdeviredesopdai_hserF',\n",
       " 'HealingA_variety',\n",
       " 'closure_flap_coverage_excision',\n",
       " 'These',\n",
       " 'To_ _reduce_ _risk_ _of_ _keloid_ _recurrence_ _the_ _surgeon_ _performing_ _the_ _excision',\n",
       " 'wound_closure',\n",
       " 'surgeon',\n",
       " 'excision',\n",
       " 'outcome',\n",
       " 'products',\n",
       " 'mechanism',\n",
       " 'effectiveness_improvements',\n",
       " 'it',\n",
       " 'they',\n",
       " 'hydration',\n",
       " 'environment53',\n",
       " 'regulation',\n",
       " 'collagen_synthesis56',\n",
       " 'Silicone_gel_sheeting',\n",
       " 'to_ _have_ _minimal_ _side_effects_ _including_ _local_ _irritation_ _which_ _can_ _be_resolved_ _quickly24_ _Studies_ _have_ _shown_ _that_ _the_beneficial_ _effects_ _of_ _silicone_ _gel_ _sheets_ _include_pain_reduction_tenderness_and_pruritus_and_flattening_the_keloid57_The_silicone_gel_sheeting_is_recommended_to_be_worn_from_two_weeks_after_primary_ _wound_ _treatment_ _for_ _\\x93_ _h_ _for_ _\\x93_months58Studies_have_demonstrated_an_improvement_of_up_to_ _in_keloid_scars_after_using_silicone_gel_ _sheeting35_ _and_ _a_ _decrease_ _in_ _the_ _incidence_rates_ _of_ _keloids_ _and_ _hypertrophic_ _scars_ _after_ _surgery59_ ',\n",
       " 'effects',\n",
       " 'reduction_tenderness_pruritus',\n",
       " 'keloid57',\n",
       " 'silicone_gel_sheeting',\n",
       " 'to_be_worn_from_two_weeks',\n",
       " 'wound_treatment',\n",
       " 'improvement',\n",
       " 'effectiveness',\n",
       " 'data',\n",
       " 'evidence',\n",
       " 'improvements',\n",
       " 'steroid_injections',\n",
       " 'side_effects',\n",
       " 'to_diminish_when_intralesional_TAC_is_used_in_combination_with_5FU45Surgical_excisionSurgical_excision',\n",
       " 'wound',\n",
       " 'series_study_patients',\n",
       " 'treatment_protocol',\n",
       " 'to_resolve_the_recurrence_of_keloids51_0cOjeh_ _the_ _lack_ _of_ _substantial_ _evidence_ ',\n",
       " 'trials_studies',\n",
       " 'to_gain_a_better_understanding_of_the_effectiveness_of_siliconebased_products_in_preventing_and_treating_keloidsPressure_therapyPressure_therapy_has_been_used_to_treat_and_manage_keloids_and_hypertrophic_scars_for_decades3563_It_has_been_routinely_employed_as_firstline_treatment_ _in_ _the_ _treatment_ _of_ _hypertrophic_ _scarring_resulting_ _from_ _burns64_ _The_ _underlying_ _mechanisms_of_action_of_compression_techniques',\n",
       " 'therapyPressure_therapy',\n",
       " 'to_treat_and_manage_keloids_and_hypertrophic_scars_for_decades3563_It_has_been_routinely_employed_as_firstline_treatment_ _in_ _the_ _treatment_ _of_ _hypertrophic_ _scarring_resulting_ _from_ _burns64_ _The_ _underlying_ _mechanisms_of_action_of_compression_techniques',\n",
       " 'hypotheses',\n",
       " 'perfusion_oxygen',\n",
       " 'some',\n",
       " 'pressure',\n",
       " 'perfusion',\n",
       " 'oxygen',\n",
       " 'apoptosis',\n",
       " 'application',\n",
       " 'using_a_variety_of_materials_such_as_adhesive_plaster_moulds_pressure_earrings_and_ ',\n",
       " 'cosmesis_rates',\n",
       " 'form',\n",
       " 'to_ _prevent_ _the_ _recurrence_ _of_keloids6667',\n",
       " '\\x93_h',\n",
       " 'a0_al',\n",
       " 'literature_review',\n",
       " 'radiation',\n",
       " 'as_ _monotherapy_yielded_higher_rates_of_recurrence_ _compared_ _to_ _combinational_ _therapy_ _with_ _postsurgery_excision_ ',\n",
       " 'Acute_reactions',\n",
       " 'desquamation_erythema_changes',\n",
       " 'changes',\n",
       " 'radiotherapy_Emollient_steroid_ointment',\n",
       " 'alleviate_the_side_effects19_A_recommended_radiation_dose_  ',\n",
       " 'effects1980_Radiotherapy',\n",
       " 'Protecting_fragile_ans_and_selecting_ _the_ _most_ _appropriate_ _sitedependent_dose_protocol',\n",
       " 'minimise_further_complications_of_radiotherapy87_0c_Scars_Burns_ _HealingCryotherapyCryotherapy',\n",
       " 'It',\n",
       " 'to_treat_keloids_as_a_monotherapy_or_in_combination_with_other_treatment_ _methods_ _such_ _as_ _intralesional_ _steroid_ _injections89_ _Various_ _delivery_ _methods_ _used_ _for_cryotherapy',\n",
       " 'intralesionalneedle_cryoprobe',\n",
       " 'to_ _be_ _the_most_effective_method_in_treating_keloid_scars90_Positive_outcomes_were_observed_in_a_number_of_studies_ _that_ _used_ _liquid_ _nitrogen_ _and_ _cryotherapy_to_treat_keloids_with_success_rates_in_the_range_of_\\x93\\x93External_ _cryotherapy_ ',\n",
       " 'nitrogen_cryotherapy',\n",
       " 'healing',\n",
       " 'keloids',\n",
       " 'to_need',\n",
       " 'cryotherapy',\n",
       " 'to_overcome_the_hypopigmentation_seen_mostly_in_darkskinned_individuals_with_external_cryotherapy',\n",
       " 'volume_decrease',\n",
       " 'inclusion_criteria',\n",
       " 'scars4898_lasers',\n",
       " 'skin_chromophores',\n",
       " 'lasers',\n",
       " 'erbiumdoped_leading',\n",
       " 'laser_beam',\n",
       " 'water',\n",
       " 'Common_examples',\n",
       " 'nm_nm_PDLs_NdVan_laser_laser',\n",
       " 'injury',\n",
       " 'nm_laser_Laser_therapy',\n",
       " 'Kumar_coworkers',\n",
       " 'cohort_study',\n",
       " 'scar_resolution',\n",
       " 'monotherapy120',\n",
       " 'CO2_laser_IFNÎ±2b_cyanoacrylate_glue98',\n",
       " 'months111113\\x93_However_optimal_results_ _can_ _be_ _achieved_ _with_ _combination_ _treatment_ _especially_ _with_ _intralesional_ _TAC_ _injections116\\x93_ _Kumar_ _and_ _coworkers_ _conducted_ _a_cohort_ _study_ _on_   _patients_ _with_ _keloids_ _previously_treated_with_an_NdYAG_laser_and_reported_complete_scar_resolution_and_flattening_in_seven_patients_ _only_ _when_ _intralesional_ _TAC_ _was_ _used_after_ _laser_ _therapy41_ _Moreover_ _combined_ _therapy_ _with_ _PDL_ _and_ _TAC119_ _and_ _PDL_ _TAC_ _and_5FU36_ _were_ _shown_ _to_ _produce_ _better_ _clinical_results_In_a_recent_study_that_evaluated_and_compared_ _the_ _efficacy_ _of_ _combination_ _therapy_ _of_0cOjeh_ _scars_statistically_fractional_CO2_laser_and_intralesional_TAC_injection_or_TAC_injection_alone_in_keloid_and_hypertrophic_significant_improvements_were_reported_in_overall_scar_quality_ _with_ _the_ _combined_ _treatment_ _options_ _comto_ _TAC_ _monotherapy120_ _Moreover_pared_combined_ _CO2_ _laser_ _and_ _IFNÎ±2b_ _injections_given_to_patients_with_auricular_keloids_resulted_in_no_recurrence_in_ _of_patients_three_years_after_treatment121_Laser_therapy_can_also_be_combined_ _with_ _other_ _laser_ _treatment_ _topical_ _corticosteroids_ _and_ _cyanoacrylate_ _glue98_ _and_ _have_shown_ _promising_ _results_ _however_ _larger_ _controlled_clinical_studies_are_needed_to_further_evaluate_their_efficacy_and_safetyRecently_ _lasers_ _are_ _also_ _being_ _explored_ _as_tools_for_assisted_drug_delivery_Kraeva_et_a0al',\n",
       " 'technique',\n",
       " 'CO2_laser_IFNÎ±2b_cyanoacrylate_glue98_results_Kraeva_et',\n",
       " 'results_Kraeva_et',\n",
       " 'to_further_evaluate_their_efficacy',\n",
       " 'to_be_effective_when_used_ _on_ _a_ _keloid_ _on_ _the_ _posterior_ _scalp_ _of_ _a_patient_after_each_CO2_laser',\n",
       " 'intraepidermal_delivery_options',\n",
       " 'Singhal',\n",
       " 'using_a_cryomilling_technique_for_freezing_fracture_After_ablation_with_a_fractional_ErYAG_laser',\n",
       " 'microps',\n",
       " 'highdose_intraepidermal_reservoir_systems',\n",
       " 'production',\n",
       " 'Studies',\n",
       " 'findings',\n",
       " 'coronavirus_SARSCoV2',\n",
       " 'to_cause_a_highly_contagious_disease_characterized_by_pneumonia',\n",
       " 'disease_COVID19',\n",
       " 'role_to_characterize_the_immune_microenvironment_in_COVID19_We_also_outline_the_emerging_imaging_techniques_such_as_the_RNAscope_which_might_also_aid_in_our_understanding_of_the_significance_of_COVID19specific_biomarkers_such_as_the_angiotensinconverting_enzyme_ _ACE2_cellular_receptorOverall_ _great_ _progress_ _has_ _been_ _made_ _in_ _COVID19_ _research_ _in_ _a_ _short_ _period_ _Extensive_ _global_ _collation_ _of_ _our_current_knowledge_of_SARSCoV2_insights_development_physicians',\n",
       " ...]"
      ]
     },
     "execution_count": 89,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "inconsistent_words"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "3cc430ec",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import wordcloud\n",
    "wc = wordcloud.WordCloud(background_color='black', max_words=50, max_font_size=45)\n",
    "wc = wc.generate('_'.join(inconsistent_words).replace('_', ' '))\n",
    "fig = plt.figure(num=1)\n",
    "plt.axis('off')\n",
    "plt.imshow(wc, cmap=None)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7fde61c9",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "0e63e899",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 700x700 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "transform = TSNE  # PCA\n",
    "\n",
    "trans = PCA(n_components=2)\n",
    "node_embeddings_2d = trans.fit_transform(vec_list)\n",
    "alpha = 0.7\n",
    "\n",
    "plt.figure(figsize=(7, 7))\n",
    "plt.axes().set(aspect=\"equal\")\n",
    "plt.scatter(\n",
    "    node_embeddings_2d[:, 0],\n",
    "    node_embeddings_2d[:, 1],\n",
    "    c=labels_extended,\n",
    "    alpha=alpha,\n",
    ")\n",
    "plt.title(\"{} visualization of node embeddings\".format(transform.__name__))\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "id": "b0a404b6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 700x700 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "colors = np.zeros(len(vec_list))\n",
    "colors[differences_index] = 1\n",
    "\n",
    "transform = TSNE  # PCA\n",
    "\n",
    "trans = PCA(n_components=2)\n",
    "node_embeddings_2d = trans.fit_transform(vec_list)\n",
    "alpha = 0.7\n",
    "\n",
    "plt.figure(figsize=(7, 7))\n",
    "plt.axes().set(aspect=\"equal\")\n",
    "plt.scatter(\n",
    "    node_embeddings_2d[:, 0],\n",
    "    node_embeddings_2d[:, 1],\n",
    "    c=colors,\n",
    "    alpha=alpha,\n",
    ")\n",
    "plt.title(\"{} visualization of node embeddings\".format(transform.__name__))\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "fd0173d2",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5c75a232",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "fd64dbc8",
   "metadata": {},
   "outputs": [],
   "source": [
    "# t-test"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "id": "2efb36fc",
   "metadata": {},
   "outputs": [],
   "source": [
    "res_accuracy = []\n",
    "res_f1 = []\n",
    "for i in range(30):\n",
    "    deleted_indices = np.random.randint(len(vec_list), size=len(differences_index))\n",
    "    #vec_list_reduced = np.array([l for i, l in enumerate(vec_list) if i not in deleted_indices])\n",
    "    vec_list_reduced = np.delete(vec_list, deleted_indices, axis=0)\n",
    "    labels_extended_reduced = np.delete(labels_extended, deleted_indices)\n",
    "    \n",
    "    X_train_r, X_test_r, y_train_r, y_test_r = train_test_split(\n",
    "        vec_list_reduced, labels_extended_reduced, test_size=0.3\n",
    "    )\n",
    "    \n",
    "    model_r = GaussianNB()\n",
    "    model_r.fit(X_train_r, y_train_r)\n",
    "    \n",
    "    y_pred_r = model_r.predict(X_test_r)\n",
    "    accuray = accuracy_score(y_pred_r, y_test_r)\n",
    "    f1 = f1_score(y_pred_r, y_test_r, average=\"weighted\")\n",
    "    \n",
    "    res_accuracy.append(accuray)\n",
    "    res_f1.append(f1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 94,
   "id": "f6ff6fcd",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "T statistic for accuracy: -521.2281049023396\n",
      "P-value for accuracy: 3.778430622877943e-59\n",
      "T statistic for f1: -297.60719495848565\n",
      "P-value for f1: 4.306400765362055e-52\n",
      "Reject the null hypothesis; there is a significant difference between the sample mean and the hypothesized population mean.\n"
     ]
    }
   ],
   "source": [
    "t_stat_accuracy, p_value_accuracy = stats.ttest_1samp(res_accuracy, 0.57)\n",
    "t_stat_f1, p_value_f1 = stats.ttest_1samp(res_f1, 0.58)\n",
    "print(\"T statistic for accuracy:\", t_stat_accuracy)\n",
    "print(\"P-value for accuracy:\", p_value_accuracy)\n",
    "print(\"T statistic for f1:\", t_stat_f1)\n",
    "print(\"P-value for f1:\", p_value_f1)\n",
    "\n",
    "# Setting significance level\n",
    "alpha = 0.05\n",
    "\n",
    "if p_value_accuracy < alpha and p_value_f1 < alpha:\n",
    "    print(\"Reject the null hypothesis; there is a significant difference between the sample mean and the hypothesized population mean.\")\n",
    "else:\n",
    "    print(\"Fail to reject the null hypothesis; there is no significant difference between the sample mean and the hypothesized population mean.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3759f5bd",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
